PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Schisterman, EF; Silver, RM; Lesher, LL; Faraggi, D; Wactawski-Wende, J; Townsend, JM; Lynch, AM; Perkins, NJ; Mumford, SL; Galai, N				Schisterman, Enrique F.; Silver, Robert M.; Lesher, Laurie L.; Faraggi, David; Wactawski-Wende, Jean; Townsend, Janet M.; Lynch, Anne M.; Perkins, Neil J.; Mumford, Sunni L.; Galai, Noya			Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial	LANCET			English	Article							IN-VITRO FERTILIZATION; MOLECULAR-WEIGHT HEPARIN; ANTIPHOSPHOLIPID ANTIBODY; RECURRENT MISCARRIAGE; WOMEN; METAANALYSIS; IMPLANTATION; PREVENTION; DRUGS; RISK	Background Preconception-initiated low-dose aspirin might positively affect pregnancy outcomes, but this possibility has not been adequately assessed. Our aim was to investigate whether low-dose aspirin improved livebirth rates in women with one to two previous pregnancy losses. Methods In this multicentre, block-randomised, double-blind, placebo-controlled trial, women aged 18-40 years who were attempting to become pregnant were recruited from four medical centres in the USA. Participants were stratified by eligibility criteria-the original stratum was restricted to women with one loss at less than 20 weeks' gestation during the previous year, whereas the expanded stratum included women with one to two previous losses, with no restrictions on gestational age or time of loss. Women were block-randomised by centre and eligibility stratum in a 1: 1 ratio. Preconception-initiated daily low-dose aspirin (81 mg per day) plus folic acid was compared with placebo plus folic acid for up to six menstrual cycles; for women who conceived, study treatment continued until 36 weeks' gestation. Participants, trial staff, and investigators were masked to the assigned treatment. The primary outcome was livebirth rate, which was analysed by intention to treat. The trial is registered with ClinicalTrials.gov, number NCT00467363. Findings Overall, 1228 women were recruited and randomly assigned between June 15, 2007, and July 15, 2011, 1078 of whom completed the trial and were included in the analysis (535 in the low-dose aspirin group and 543 in the placebo group). 309 (58%) women in the low-dose aspirin group had livebirths, compared with 286 (53%) in the placebo group (p=0.0984; absolute difference in livebirth rate 5.09% [95% CI - 0.84 to 11.02]). Pregnancy loss occurred in 68 (13%) women in the low-dose aspirin group, compared with 65 (12%) women in the placebo group (p=0.7812). In the original stratum, 151 (62%) of 242 women in the low-dose aspirin group had livebirths, compared with 133 (53%) of 250 in the placebo group (p=0.0446; absolute difference in livebirth rate 9.20% [0.51 to 17 89]). In the expanded stratum, 158 (54%) of 293 women in the low-dose aspirin group and 153 (52%) of 293 in the placebo group had livebirths (p=0.7406; absolute difference in livebirth rate 1.71% [-6.37 to 9.79]). Major adverse events were similar between treatment groups. Low-dose aspirin was associated with increased vaginal bleeding, but this adverse event was not associated with pregnancy loss. Interpretation Preconception-initiated low-dose aspirin was not significantly associated with livebirth or pregnancy loss in women with one to two previous losses. However, higher livebirth rates were seen in women with a single documented loss at less than 20 weeks' gestation during the previous year. Low-dose aspirin is not recommended for the prevention of pregnancy loss. Funding Eunice Kennedy Shriver National Institute of Child Health and Human Development (US National Institutes of Health).	[Schisterman, Enrique F.; Perkins, Neil J.; Mumford, Sunni L.] Eunice Kennedy Shriver NICHD, Epidemiol Branch, Div Intramural Populat Hlth Res, Bethesda, MD 20892 USA; [Silver, Robert M.; Lesher, Laurie L.] Univ Utah, Hlth Sci Ctr, Sch Med, Dept Obstet & Gynecol, Salt Lake City, UT USA; [Faraggi, David; Galai, Noya] Univ Haifa, Dept Stat, IL-31999 Haifa, Israel; [Wactawski-Wende, Jean] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA; [Townsend, Janet M.] Commonwealth Med Coll, Dept Family Community & Rural Hlth, Scranton, PA USA; [Lynch, Anne M.] Univ Colorado, Dept Obstet & Gynecol, Denver, CO 80202 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Utah System of Higher Education; University of Utah; University of Haifa; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Geisinger Commonwealth School of Medicine; University of Colorado System; University of Colorado Denver	Schisterman, EF (corresponding author), Eunice Kennedy Shriver NICHD, Epidemiol Branch, Div Intramural Populat Hlth Res, NIH, Bldg 10, Bethesda, MD 20892 USA.	schistee@mail.nih.gov	Galai, Noya/HII-8086-2022; Wactawski-Wende, Jean/AGH-5457-2022	Wactawski-Wende, Jean/0000-0003-3096-9595; Mumford, Sunni/0000-0003-0133-3176; Schisterman, Enrique/0000-0003-3757-641X; Perkins, Neil/0000-0002-6802-4733	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (National Institutes of Health, Bethesda, MD, USA) [HHSN267200603423, HHSN267200603424, HHSN267200603426]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008795] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (National Institutes of Health, Bethesda, MD, USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (National Institutes of Health, Bethesda, MD, USA; contract numbers HHSN267200603423, HHSN267200603424, and HHSN267200603426). We thank the EAGeR participants for their extraordinary commitment to the study, all of the EAGeR investigators and staff who devoted their time and energy to the success of this trial, and the members of the data safety monitoring board for continuous oversight, constant support, and advice throughout the trial	BEROYZ G, 1994, LANCET, V343, P619; Dentali F, 2012, J THROMB HAEMOST, V10, P2075, DOI 10.1111/j.1538-7836.2012.04886.x; Di Nisio M, 2005, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD004734.PUB2; Duley L, 2001, BMJ-BRIT MED J, V322, P329, DOI 10.1136/bmj.322.7282.329; Empson M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002859.pub2; Empson M, 2002, OBSTET GYNECOL, V99, P135, DOI 10.1016/S0029-7844(01)01646-5; Farquharson RG, 2002, OBSTET GYNECOL, V100, P408, DOI 10.1016/S0029-7844(02)02165-8; Gris JC, 2004, BLOOD, V103, P3695, DOI 10.1182/blood-2003-12-4250; Groeneveld E, 2011, HUM REPROD UPDATE, V17, P501, DOI 10.1093/humupd/dmr007; Kaandorp S, 2009, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858; Kaandorp SP, 2010, NEW ENGL J MED, V362, P1586, DOI 10.1056/NEJMoa1000641; KNIGHT M, 2000, COCHRANE DB SYST REV, V2; Laskin CA, 2009, J RHEUMATOL, V36, P279, DOI [10.3899/jrheum.080763), 10.3899/jrheum.080763]; Li DK, 2003, BRIT MED J, V327, P368, DOI 10.1136/bmj.327.7411.368; Lim W, 2006, JAMA-J AM MED ASSOC, V295, P1050, DOI 10.1001/jama.295.9.1050; Mak A, 2010, RHEUMATOLOGY, V49, P281, DOI 10.1093/rheumatology/kep373; Rai R, 2000, HUM REPROD, V15, P2220, DOI 10.1093/humrep/15.10.2220; RISCH HA, 1988, AM J EPIDEMIOL, V128, P420, DOI 10.1093/oxfordjournals.aje.a114982; Rubinstein M, 1999, FERTIL STERIL, V71, P825, DOI 10.1016/S0015-0282(99)00088-6; Schisterman EF, 2013, PAEDIATR PERINAT EP, V27, P598, DOI 10.1111/ppe.12088; Silver RM, 1999, MED FETUS MOTHER, P195; Siristatidis CS, 2011, COCHRANE DB SYST REV, V8; Tulppala M, 1997, HUM REPROD, V12, P1567, DOI 10.1093/humrep/12.7.1567; Tuthill JI, 2009, J AUTOIMMUN, V33, P92, DOI 10.1016/j.jaut.2009.05.002; Vane JR, 2003, THROMB RES, V110, P255, DOI 10.1016/S0049-3848(03)00379-7; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304	26	135	138	0	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2014	384	9937					29	36		10.1016/S0140-6736(14)60157-4	http://dx.doi.org/10.1016/S0140-6736(14)60157-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL1XL	24702835	Green Accepted			2022-12-28	WOS:000338919600023
J	Volkow, ND; Frieden, TR; Hyde, PS; Cha, SS				Volkow, Nora D.; Frieden, Thomas R.; Hyde, Pamela S.; Cha, Stephen S.			Medication-Assisted Therapies - Tackling the Opioid-Overdose Epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DEATHS		[Volkow, Nora D.] NIDA, NIH, Bethesda, MD 20892 USA; [Hyde, Pamela S.] Subst Abuse & Mental Hlth Serv Adm, Rockville, MD USA; [Cha, Stephen S.] Ctr Medicare Serv, Ctr Medicaid & CHIP Serv, Baltimore, MD USA; [Cha, Stephen S.] Ctr Medicaid Serv, Ctr Medicaid & CHIP Serv, Baltimore, MD USA; [Frieden, Thomas R.] Ctr Dis Control & Prevent, Atlanta, GA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services; Centers for Disease Control & Prevention - USA	Volkow, ND (corresponding author), NIDA, NIH, Bethesda, MD 20892 USA.			Frieden, Thomas/0000-0002-4759-2256	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Centers for Disease Control and Prevention (CDC), 2013, ADDR PRESCR DRUG AB; Clark RE, 2013, JAMA INTERN MED, V173, P1571, DOI 10.1001/jamainternmed.2013.9059; Jones CM, 2013, JAMA-J AM MED ASSOC, V309, P657, DOI 10.1001/jama.2013.272; Knudsen HK, 2011, J ADDICT MED, V5, P21, DOI 10.1097/ADM.0b013e3181d41ddb; Schwartz RP, 2013, AM J PUBLIC HEALTH, V103, P917, DOI 10.2105/AJPH.2012.301049	5	670	671	0	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 29	2014	370	22					2063	2066		10.1056/NEJMp1402780	http://dx.doi.org/10.1056/NEJMp1402780			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH9BM	24758595				2022-12-28	WOS:000336434000003
J	Mendenhall, CD; Karp, DS; Meyer, CFJ; Hadly, EA; Daily, GC				Mendenhall, Chase D.; Karp, Daniel S.; Meyer, Christoph F. J.; Hadly, Elizabeth A.; Daily, Gretchen C.			Predicting biodiversity change and averting collapse in agricultural landscapes	NATURE			English	Article							COUNTRYSIDE BIOGEOGRAPHY; FOREST FRAGMENTATION; EXTINCTION; DIVERSITY; ABUNDANCE; DYNAMICS; ISLANDS; HISTORY; MODEL	The equilibrium theory of island biogeography(1) is the basis for estimating extinction rates(2) and a pillar of conservation science(3,4). The default strategy for conserving biodiversity is the designation of nature reserves, treated as islands in an inhospitable sea of human activity(5). Despite the profound influence of islands on conservation theory and practice(3,4), their mainland analogues, forest fragments in human-dominated landscapes, consistently defy expected biodiversity patterns based on island biogeography theory(6-13). Countryside biogeography is an alternative framework, which recognizes that the fate of the world's wildlife will be decided largely by the hospitality of agricultural or countryside ecosystems(12,14-17). Here we directly test these biogeographic theories by comparing a Neotropical countryside ecosystem with a nearby island ecosystem, and show that each supports similar bat biodiversity in fundamentally different ways. The island ecosystem conforms to island biogeographic predictions of bat species loss, in which the water matrix is not habitat. In contrast, the countryside ecosystem has high species richness and evenness across forest reserves and smaller forest fragments. Relative to forest reserves and fragments, deforested countryside habitat supports a less species-rich, yet equally even, bat assemblage. Moreover, the bat assemblage associated with deforested habitat is compositionally novel because of predictable changes in abundances by many species using human-made habitat. Finally, we perform a global meta-analysis of bat biogeographic studies, spanning more than 700 species. It generalizes our findings, showing that separate biogeographic theories for countryside and island ecosystems are necessary. A theory of countryside biogeography is essential to conservation strategy in the agricultural ecosystems that comprise roughly half of the global land surface and are likely to increase even further(14).	[Mendenhall, Chase D.; Karp, Daniel S.; Daily, Gretchen C.] Stanford Univ, Ctr Conservat Biol, Stanford, CA 94305 USA; [Mendenhall, Chase D.; Karp, Daniel S.; Hadly, Elizabeth A.; Daily, Gretchen C.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Karp, Daniel S.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Karp, Daniel S.] Nature Conservancy, Berkeley, CA 94705 USA; [Meyer, Christoph F. J.] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Meyer, Christoph F. J.] Univ Lisbon, Ctr Environm Biol, P-1749016 Lisbon, Portugal; [Daily, Gretchen C.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Daily, Gretchen C.] Royal Swedish Acad Sci, SE-10405 Stockholm, Sweden; [Daily, Gretchen C.] Univ Stockholm, Stockholm Resilience Ctr, SE-10691 Stockholm, Sweden	Stanford University; Stanford University; University of California System; University of California Berkeley; Ulm University; Universidade de Lisboa; Stanford University; Royal Swedish Academy of Sciences; Stockholm University	Mendenhall, CD (corresponding author), Stanford Univ, Ctr Conservat Biol, Stanford, CA 94305 USA.	cdm@stanford.edu	Meyer, Christoph/A-4363-2012	Meyer, Christoph/0000-0001-9958-8913	Winslow Foundation; Moore Family Foundation; German Academic Exchange Service; German Science Foundation; Restoration Workshop Research Grant through the Las Cruces Biological Station; National Science Foundation	Winslow Foundation; Moore Family Foundation; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); German Science Foundation(German Research Foundation (DFG)); Restoration Workshop Research Grant through the Las Cruces Biological Station; National Science Foundation(National Science Foundation (NSF))	We thank P. Ehrlich, E. Kalko, F. Oviedo Brenes, R. Zahawi, L. Frishkoff, K. Holl, H. Kim Frank, M. Knope, J. L. Reid, A. Wrona, H. York and dozens of field assistants and Costa Rican landowners, and the communities and staffs of the Organization for Tropical Studies, Las Cruces Biological Station, the Smithsonian Tropical Research Institute and the Center for Conservation Biology at Stanford University. Research was funded by the Winslow Foundation, the Moore Family Foundation, the German Academic Exchange Service, the German Science Foundation, Peter and Helen Bing, Ralph and Louise Haberfeld, and a Restoration Workshop Research Grant through the Las Cruces Biological Station. C. D. M. and D. S. K. were supported by National Science Foundation Graduate Research Fellowships.	BONACCORSO FJ, 1976, J MAMMAL, V57, P181, DOI 10.2307/1379526; Brosi BJ, 2008, J APPL ECOL, V45, P773, DOI 10.1111/j.1365-2664.2007.01412.x; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Clement RM, 2001, HOLOCENE, V11, P419, DOI 10.1191/095968301678302850; Daily GC, 2003, CONSERV BIOL, V17, P1814, DOI 10.1111/j.1523-1739.2003.00298.x; Daily GC, 2001, NATURE, V411, P245, DOI 10.1038/35077178; Daily GC, 2001, ECOL APPL, V11, P1, DOI 10.1890/1051-0761(2001)011[0001:CBUOHD]2.0.CO;2; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; Fahrig L, 2013, J BIOGEOGR, V40, P1649, DOI 10.1111/jbi.12130; Gibson L, 2013, SCIENCE, V341, P1508, DOI 10.1126/science.1240495; Guilherme JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073619; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Heise U., 2008, SENSE PLACE SENSE PL, P250; Holdridge L. R., 1979, LIFE ZONE ECOLOGY, P146; Horner-Devine MC, 2003, CONSERV BIOL, V17, P168, DOI 10.1046/j.1523-1739.2003.01310.x; Kareiva P, 2012, BIOSCIENCE, V62, P962, DOI 10.1525/bio.2012.62.11.5; Karp DS, 2013, ECOL LETT, V16, P1339, DOI 10.1111/ele.12173; Karp DS, 2012, ECOL LETT, V15, P963, DOI 10.1111/j.1461-0248.2012.01815.x; Kueffer C, 2014, FRONT ECOL ENVIRON, V12, P131, DOI 10.1890/120201; Kunz T., 2011, ECOLOGICAL BEHAV MET, P920; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2008, BIOL CONSERV, V141, P1731, DOI 10.1016/j.biocon.2008.05.011; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; LEIGH EG, 1993, EVOL ECOL, V7, P76, DOI 10.1007/BF01237735; Leigh Jr E., 1982, ECOLOGY TROPICAL FOR, P480; Lomolino MV, 2000, GLOBAL ECOL BIOGEOGR, V9, P1, DOI 10.1046/j.1365-2699.2000.00185.x; MA Board of Review Editors, 2005, BEING SYNTHESIS; MAC ARTHUR ROBERT H., 1967; MACARTHUR RH, 1972, ECOLOGY, V53, P330, DOI 10.2307/1934090; Mann C., 2005, 1491 NEW REVELATIONS, P541; Mayfield MM, 2005, ECOL APPL, V15, P423, DOI 10.1890/03-5369; Mendenhall CD., 2013, ENCY BIODIVERSITY, P347, DOI [10.1016/B978-0-12-384719-5.00329-4, DOI 10.1016/B978-0-12-384719-5.00329-4]; Mendenhall CD, 2012, BIOL CONSERV, V151, P32, DOI 10.1016/j.biocon.2012.01.069; Mendenhall CD, 2011, P NATL ACAD SCI USA, V108, P16313, DOI 10.1073/pnas.1111687108; Meyer CFJ, 2008, J BIOGEOGR, V35, P1711, DOI 10.1111/j.1365-2699.2008.01916.x; Panama Canal Authority Remote Sensing Unit, 2003, BCI LANDC MAP 2003; Pereira HM, 2006, ECOLOGY, V87, P1877, DOI 10.1890/0012-9658(2006)87[1877:MBDICL]2.0.CO;2; Perfecto I., 2009, NATURES MATRIX LINKI; Reid JL, 2013, BIOL CONSERV, V167, P9, DOI 10.1016/j.biocon.2013.06.026; Ricketts TH, 2001, CONSERV BIOL, V15, P378, DOI 10.1046/j.1523-1739.2001.015002378.x; Rosenzweig M.L., 2003, WIN WIN ECOLOGY EART, P211; Rybicki J, 2013, ECOL LETT, V16, P27, DOI 10.1111/ele.12065; Sansonetti V., 1995, QUEME MIS NAVES ESTA, P99; SIMBERLOFF DS, 1976, SCIENCE, V191, P285, DOI 10.1126/science.191.4224.285; Stiles F., 1989, GUIDE BIRDS COSTA RI, P632; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; Wilson D., 1991, DEMOGRAPHY NATURAL H, P173; Wilson E.O., 1975, P522; Zuur Alain F., 2009, P1	52	217	219	9	473	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					213	+		10.1038/nature13139	http://dx.doi.org/10.1038/nature13139			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24739971				2022-12-28	WOS:000335454300036
J	Wiersema, K; Covino, S; Toma, K; van der Horst, AJ; Varela, K; Min, M; Greiner, J; Starling, RLC; Tanvir, NR; Wijers, RAMJ; Campana, S; Curran, PA; Fan, Y; Fynbo, JPU; Gorosabel, J; Gomboc, A; Gotz, D; Hjorth, J; Jin, ZP; Kobayashi, S; Kouveliotou, C; Mundell, C; O'Brien, PT; Pian, E; Rowlinson, A; Russell, DM; Salvaterra, R; Alighieri, SD; Tagliaferri, G; Vergani, SD; Elliott, J; Farina, C; Hartoog, OE; Karjalainen, R; Klose, S; Knust, F; Levan, AJ; Schady, P; Sudilovsky, V; Willingale, R				Wiersema, K.; Covino, S.; Toma, K.; van der Horst, A. J.; Varela, K.; Min, M.; Greiner, J.; Starling, R. L. C.; Tanvir, N. R.; Wijers, R. A. M. J.; Campana, S.; Curran, P. A.; Fan, Y.; Fynbo, J. P. U.; Gorosabel, J.; Gomboc, A.; Goetz, D.; Hjorth, J.; Jin, Z. P.; Kobayashi, S.; Kouveliotou, C.; Mundell, C.; O'Brien, P. T.; Pian, E.; Rowlinson, A.; Russell, D. M.; Salvaterra, R.; Alighieri, S. di Serego; Tagliaferri, G.; Vergani, S. D.; Elliott, J.; Farina, C.; Hartoog, O. E.; Karjalainen, R.; Klose, S.; Knust, F.; Levan, A. J.; Schady, P.; Sudilovsky, V.; Willingale, R.			Circular polarization in the optical afterglow of GRB 121024A	NATURE			English	Article							GAMMA-RAY BURSTS; RELATIVISTIC COLLISIONLESS SHOCKS; MAGNETIC-FIELD STRUCTURE; LINEAR-POLARIZATION; LIGHT CURVES; EMISSION; POLARIMETRY; DUST; JETS; EXTINCTION	Gamma-ray bursts (GRBs) are most probably powered by collimated relativistic outflows (jets) from accreting black holes at cosmological distances. Bright afterglows are produced when the outflow collides with the ambient medium. Afterglow polarization directly probes the magnetic properties of the jet when measured minutes after the burst, and it probes the geometric properties of the jet and the ambient medium when measured hours to days after the burst(1-5). High values of optical polarization detected minutes after the burst of GRB 120308A indicate the presence of large-scale ordered magnetic fields originating from the central engine(5) (the power source of the GRB). Theoretical models predict low degrees of linear polarization and no circular polarization at late times(6-8), when the energy in the original ejecta is quickly transferred to the ambient medium and propagates farther into the medium as a blast wave. Here we report the detection of circularly polarized light in the afterglow of GRB 121024A, measured 0.15 days after the burst. We show that the circular polarization is intrinsic to the afterglow and unlikely to be produced by dust scattering or plasma propagation effects. A possible explanation is to invoke anisotropic (rather than the commonly assumed isotropic) electron pitch-angle distributions, and we suggest that new models are required to produce the complex microphysics of realistic shocks in relativistic jets(9-11).	[Wiersema, K.; Starling, R. L. C.; Tanvir, N. R.; O'Brien, P. T.; Willingale, R.] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Covino, S.; Campana, S.; Tagliaferri, G.; Vergani, S. D.] INAF Brera Astron Observ, I-23807 Merate, LC, Italy; [Toma, K.] Osaka Univ, Dept Earth & Space Sci, Toyonaka, Osaka 5600043, Japan; [Toma, K.] Tohoku Univ, Astron Inst, Sendai, Miyagi 9808578, Japan; [Toma, K.] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 9808578, Japan; [van der Horst, A. J.; Min, M.; Wijers, R. A. M. J.; Rowlinson, A.; Hartoog, O. E.] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1090 SJ Amsterdam, Netherlands; [Varela, K.; Greiner, J.; Elliott, J.; Knust, F.; Schady, P.; Sudilovsky, V.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Curran, P. A.] Curtin Univ, Int Ctr Radio Astron Res, Perth, WA 6845, Australia; [Fan, Y.; Jin, Z. P.] Chinese Acad Sci, Purple Mt Observ, Key Lab Dark Matter & Space Astron, Nanjing 210008, Peoples R China; [Fynbo, J. P. U.; Hjorth, J.] Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, DK-2100 Copenhagen, Denmark; [Gorosabel, J.] CSIC, Inst Astrofis Andalucia, E-18008 Granada, Spain; [Gorosabel, J.] Univ Pais Vasco UPV EHU, ETS Ingn, Dept Fis Aplicada, Unidad Asociada Grp Ciencia Planetarias UPV EHU I, E-48013 Bilbao, Spain; [Gorosabel, J.] Basque Fdn Sci, Ikerbasque, E-48008 Bilbao, Spain; [Gomboc, A.] Univ Ljubljana, Fac Math & Phys, Ljubljana 1000, Slovenia; [Goetz, D.] Univ Paris Diderot, CNRS, DSM, AIM UMR CEA 7158,Irfu Serv Astrophys, F-91191 Gif Sur Yvette, France; [Kobayashi, S.; Mundell, C.] Liverpool John Moores Univ, Astrophys Res Inst, Liverpool L3 5RF, Merseyside, England; [Kouveliotou, C.] NASA, George C Marshall Space Flight Ctr, Space Sci Off, ZP12, Huntsville, AL 35812 USA; [Pian, E.] Scuola Normale Super Pisa, I-56126 Pisa, Italy; [Pian, E.] INAF IASF Bologna, I-40129 Bologna, Italy; [Russell, D. M.] Inst Astrofis Canarias, E-38200 San Cristobal la Laguna, Tenerife, Spain; [Russell, D. M.] Univ La Laguna, Dept Astrofis, E-38206 Tenerife, Spain; [Russell, D. M.] New York Univ Abu Dhabi, Abu Dhabi, U Arab Emirates; [Salvaterra, R.] INAF IASF Milano, I-20133 Milan, Italy; [Alighieri, S. di Serego] INAF Osservatorio Astrofis Arcetri, I-50125 Florence, Italy; [Farina, C.; Karjalainen, R.] Isaac Newton Grp Telescopes, E-38700 Santa Cruz De La Palma, Canary Islands, Spain; [Klose, S.] Thuringer Landessternwarte Tautenburg, D-07778 Tautenburg, Germany; [Levan, A. J.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England	University of Leicester; Istituto Nazionale Astrofisica (INAF); Osaka University; Tohoku University; Tohoku University; University of Amsterdam; Max Planck Society; Curtin University; Chinese Academy of Sciences; Nanjing Institute of Astronomical Optics & Technology, NAOC, CAS; Purple Mountain Observatory, CAS; University of Copenhagen; Niels Bohr Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); University of Basque Country; Basque Foundation for Science; University of Ljubljana; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Liverpool John Moores University; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; Scuola Normale Superiore di Pisa; Istituto Nazionale Astrofisica (INAF); Instituto de Astrofisica de Canarias; Universidad de la Laguna; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); Isaac Newton Group of Telescopes; University of Warwick	Wiersema, K (corresponding author), Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England.	kw113@le.ac.uk	Campana, Sergio/AAL-6012-2020; Covino, Stefano/AAQ-5188-2021; Hjorth, Jens/M-5787-2014; Karjalainen, Raine/AAA-4931-2019; Rowlinson, Antonia/M-7054-2018; Tagliaferri, Gianpiero/ABD-7556-2021; Curran, Peter A/B-5293-2013; Fynbo, Johan/L-8496-2014	Campana, Sergio/0000-0001-6278-1576; Covino, Stefano/0000-0001-9078-5507; Hjorth, Jens/0000-0002-4571-2306; Karjalainen, Raine/0000-0002-2656-909X; Rowlinson, Antonia/0000-0002-1195-7022; Tagliaferri, Gianpiero/0000-0003-0121-0723; Curran, Peter A/0000-0003-3003-4626; di Serego Alighieri, Sperello/0000-0001-8769-2692; Jin, Zhiping/0000-0003-4977-9724; Wijers, Ralph/0000-0002-3101-1808; van der Horst, Alexander/0000-0001-9149-6707; Wiersema, Klaas/0000-0002-9133-7957; Fynbo, Johan/0000-0002-8149-8298; Russell, David/0000-0002-3500-631X; O'Brien, Paul/0000-0002-5128-1899; Salvaterra, Ruben/0000-0002-9393-8078; Farina, Cecilia/0000-0003-4940-3751; Knust, Fabian/0000-0002-4523-3030; Min, Michiel/0000-0001-5778-0376; Pian, Elena/0000-0001-8646-4858	STFC; JSPS [231446]; European Research Council [247295]; Royal Society Fellowship; 973 Programme of China [2013CB837000]; Marie Curie Intra European Fellowship within the 7th European Community [IEF 274805]; Australian Research Council [DP120102393]; UK Space Agency; STFC [ST/K001000/1, ST/J001465/1, ST/L000733/1, ST/L001306/1, ST/H001972/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/L000733/1, ST/K001000/1, ST/H001972/1, ST/J001465/1, ST/L001306/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); European Research Council(European Research Council (ERC)European Commission); Royal Society Fellowship(Royal Society of London); 973 Programme of China(National Basic Research Program of China); Marie Curie Intra European Fellowship within the 7th European Community; Australian Research Council(Australian Research Council); UK Space Agency; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work is based on observations made with ESO telescopes at the Paranal Observatory under programme 090.D-0789. We thank all ING staff for their support of ACAM ToO observations. K. W. thanks J. Hinton for discussions. K. W. was supported by STFC. K. T. was supported by a JSPS Research Fellowship for Young Scientists no. 231446. A.J.v.d.H., R.A.M.J.W. and A. R. were supported by the European Research Council via Advanced Investigator grant no. 247295. R. L. C. S. was supported by a Royal Society Fellowship. Y.F. was supported by the 973 Programme of China, under grant 2013CB837000. D. M. R. was supported by a Marie Curie Intra European Fellowship within the 7th European Community Framework Programme under contract no. IEF 274805. This work was supported by the Australian Research Council (grant DP120102393). The William Herschel telescope and its override programme are operated on the island of La Palma by the Isaac Newton Group in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias. This work made use of data supplied by the UK Swift Science Data Centre at the University of Leicester, funded by the UK Space Agency.	[Anonymous], 2012, DOC NO VLT MAN ESO 1; Bagnulo S, 2002, ASTRON ASTROPHYS, V389, P191, DOI 10.1051/0004-6361:20020606; Barthelmy S. D., 2012, GCN CIRC 13889; Beloborodov AM, 2011, MON NOT R ASTRON SOC, V410, P2422, DOI 10.1111/j.1365-2966.2010.17616.x; Evans PA, 2009, MON NOT R ASTRON SOC, V397, P1177, DOI 10.1111/j.1365-2966.2009.14913.x; Fukue T, 2009, ASTROPHYS J LETT, V692, pL88, DOI 10.1088/0004-637X/692/2/L88; Ghisellini G, 1999, MON NOT R ASTRON SOC, V309, pL7, DOI 10.1046/j.1365-8711.1999.03025.x; Ghisellini G, 2009, MON NOT R ASTRON SOC, V393, pL16, DOI 10.1111/j.1745-3933.2008.00589.x; Gotz D, 2009, ASTROPHYS J LETT, V695, pL208, DOI 10.1088/0004-637X/695/2/L208; Granot J, 2005, ASTROPHYS J, V625, P263, DOI 10.1086/429536; Granot J, 2003, ASTROPHYS J, V594, pL83, DOI 10.1086/378733; Greiner J, 2008, PUBL ASTRON SOC PAC, V120, P405, DOI 10.1086/587032; Greiner J, 2003, NATURE, V426, P157, DOI 10.1038/nature02077; Hededal CB, 2005, ASTROPHYS J, V623, pL89, DOI 10.1086/430253; Hjorth J, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/187; Hutsemekers D, 2010, ASTRON ASTROPHYS, V520, DOI 10.1051/0004-6361/201015359; Klose S, 2004, ASTRON ASTROPHYS, V420, P899, DOI 10.1051/0004-6361:20041024; Lazzati D, 2003, ASTRON ASTROPHYS, V410, P823, DOI 10.1051/0004-6361:20031321; Lloyd-Ronning NM, 2002, ASTROPHYS J, V565, P182, DOI 10.1086/324484; Lyutikov M, 2009, MON NOT R ASTRON SOC, V396, P1545, DOI 10.1111/j.1365-2966.2009.14811.x; MARTIN PG, 1972, MON NOT R ASTRON SOC, V159, P179, DOI 10.1093/mnras/159.2.179; Matsumiya M, 2003, ASTROPHYS J, V595, pL25, DOI 10.1086/378879; Melrose D. B., 1980, NON THERMAL PROCESSE, V1; Mundell CG, 2013, NATURE, V504, P119, DOI 10.1038/nature12814; Pagani C., 2012, GCN CIRC 13886; Patat F, 2006, PUBL ASTRON SOC PAC, V118, P146, DOI 10.1086/497581; PEI YCC, 1992, ASTROPHYS J, V395, P130, DOI 10.1086/171637; Piran T, 2005, AIP CONF PROC, V784, P164, DOI 10.1063/1.2077181; Rossi EM, 2004, MON NOT R ASTRON SOC, V354, P86, DOI 10.1111/j.1365-2966.2004.08165.x; Sagiv A, 2004, ASTROPHYS J, V615, P366, DOI 10.1086/423977; Sari R, 1999, ASTROPHYS J, V524, pL43, DOI 10.1086/312294; Sari R, 1998, ASTROPHYS J, V497, pL17, DOI 10.1086/311269; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; SERKOWSKI K, 1975, ASTROPHYS J, V196, P261, DOI 10.1086/153410; SIMMONS JFL, 1985, ASTRON ASTROPHYS, V142, P100; Spitkovsky A, 2008, ASTROPHYS J LETT, V682, pL5, DOI 10.1086/590248; Spitkovsky A, 2008, ASTROPHYS J LETT, V673, pL39, DOI 10.1086/527374; Tanvir N. R., 2012, GCN CIRC 13890; Toma K, 2008, ASTROPHYS J LETT, V673, pL123, DOI 10.1086/528740; WARDLE JFC, 1974, ASTROPHYS J, V194, P249, DOI 10.1086/153240; Whitney BA, 2002, ASTROPHYS J, V574, P205, DOI 10.1086/340901; Wiersema K, 2012, MON NOT R ASTRON SOC, V426, P2, DOI 10.1111/j.1365-2966.2012.20943.x; Yonetoku D, 2012, ASTROPHYS J LETT, V758, DOI 10.1088/2041-8205/758/1/L1	45	69	70	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					201	+		10.1038/nature13237	http://dx.doi.org/10.1038/nature13237			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24776800	Green Submitted, Green Accepted			2022-12-28	WOS:000335454300033
J	Gigerenzer, G				Gigerenzer, Gerd			THE ART OF RISK COMMUNICATION Breast cancer screening pamphlets mislead women	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BENEFITS		[Gigerenzer, Gerd] Max Planck Inst Human Dev, Harding Ctr Risk Literacy, Berlin, Germany; [Gigerenzer, Gerd] Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany	Max Planck Society; Max Planck Society	Gigerenzer, G (corresponding author), Max Planck Inst Human Dev, Harding Ctr Risk Literacy, Berlin, Germany.	gigerenzer@mpib-berlin.mpg.de	Gigerenzer, Gerd/M-5595-2013; Gigerenzer, Gerd/A-6250-2012	Gigerenzer, Gerd/0000-0002-6163-5419				Gigerenzer G, 2009, JNCI-J NATL CANCER I, V101, P1216, DOI 10.1093/jnci/djp237; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Miller AB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g366; Schwartz LM, 2009, ANN INTERN MED, V150, P516, DOI 10.7326/0003-4819-150-8-200904210-00106; Welch HG, 2000, JAMA-J AM MED ASSOC, V283, P2975, DOI 10.1001/jama.283.22.2975	5	39	39	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2014	348								g2636	10.1136/bmj.g2636	http://dx.doi.org/10.1136/bmj.g2636			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG1DN	24770369	Green Submitted			2022-12-28	WOS:000335155400001
J	Hayashi, S				Hayashi, Shigehiko			Silencing Neurons with Light	SCIENCE			English	Editorial Material							CHANNELRHODOPSIN; CHANNEL; CONVERSION		Kyoto Univ, Dept Chem, Grad Sch Sci, Kyoto 6068501, Japan	Kyoto University	Hayashi, S (corresponding author), Kyoto Univ, Dept Chem, Grad Sch Sci, Kyoto 6068501, Japan.	hayashig@kuchem.kyoto-u.ac.jp						Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Deisseroth K, 2010, SCI AM, V303, P48, DOI 10.1038/scientificamerican1110-48; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; Grosse W, 2011, CHEMBIOCHEM, V12, P830, DOI 10.1002/cbic.201000793; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; SASAKI J, 1995, SCIENCE, V269, P73, DOI 10.1126/science.7604281; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Zaccai NR, 2011, NAT CHEM BIOL, V7, P935, DOI [10.1038/nchembio.692, 10.1038/NCHEMBIO.692]; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	13	4	4	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					369	370		10.1126/science.1253616	http://dx.doi.org/10.1126/science.1253616			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763579				2022-12-28	WOS:000334867800027
J	Schwartz, JH; Tattersall, I; Chi, Z				Schwartz, Jeffrey H.; Tattersall, Ian; Chi, Zhang			Comment on "A Complete Skull from Dmanisi, Georgia, and the Evolutionary Biology of Early Homo"	SCIENCE			English	Editorial Material							MANDIBLES		[Schwartz, Jeffrey H.; Chi, Zhang] Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA 15260 USA; [Schwartz, Jeffrey H.; Tattersall, Ian] Amer Museum Nat Hist, Div Anthropol, New York, NY 10024 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; American Museum of Natural History (AMNH)	Schwartz, JH (corresponding author), Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA 15260 USA.	jhs@pitt.edu	Zhang, Chi/AAK-9652-2021	Zhang, Chi/0000-0002-0418-6354				Bookstein FL, 1991, MORPHOMETRIC TOOLS L; Eldredge N., 1975, MODELS PALEOBIOLOGY, P218; Gabounia L, 2002, CR PALEVOL, V1, P243, DOI 10.1016/S1631-0683(02)00032-5; Goldschmidt R., 1940, MAT BASIS EVOLUTION; Lordkipanidze D, 2007, NATURE, V449, P305, DOI 10.1038/nature06134; Lordkipanidze D, 2013, SCIENCE, V342, P326, DOI 10.1126/science.1238484; Margvelashvili A, 2013, P NATL ACAD SCI USA, V110, P17278, DOI 10.1073/pnas.1316052110; Rightmire GP, 2008, J HUM EVOL, V54, P904, DOI 10.1016/j.jhevol.2008.02.003; Rightmire GP, 2006, J HUM EVOL, V50, P115, DOI 10.1016/j.jhevol.2005.07.009; Schwartz J.H., 2007, SKELETON KEYS INTRO; Schwartz J. H., 2002, HUMAN FOSSIL RECORD, V1; Schwartz J. H., 2003, HUMAN FOSSIL RECORD, V2; Schwartz JH, 2000, J HUM EVOL, V38, P367, DOI 10.1006/jhev.1999.0339; Spoor F, 2013, NATURE, V502, P452, DOI 10.1038/502452a; Vekua A, 2002, SCIENCE, V297, P85, DOI 10.1126/science.1072953	15	22	24	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182								10.1126/science.1250056	http://dx.doi.org/10.1126/science.1250056			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763572				2022-12-28	WOS:000334867800019
J	Barends, R; Kelly, J; Megrant, A; Veitia, A; Sank, D; Jeffrey, E; White, TC; Mutus, J; Fowler, AG; Campbell, B; Chen, Y; Chen, Z; Chiaro, B; Dunsworth, A; Neill, C; O'Malley, P; Roushan, P; Vainsencher, A; Wenner, J; Korotkov, AN; Cleland, AN; Martinis, JM				Barends, R.; Kelly, J.; Megrant, A.; Veitia, A.; Sank, D.; Jeffrey, E.; White, T. C.; Mutus, J.; Fowler, A. G.; Campbell, B.; Chen, Y.; Chen, Z.; Chiaro, B.; Dunsworth, A.; Neill, C.; O'Malley, P.; Roushan, P.; Vainsencher, A.; Wenner, J.; Korotkov, A. N.; Cleland, A. N.; Martinis, John M.			Superconducting quantum circuits at the surface code threshold for fault tolerance	NATURE			English	Article								A quantum computer can solve hard problems, such as prime factoring(1,2), database searching(3,4) and quantum simulation(5), at the cost of needing to protect fragile quantum states from error. Quantum error correction(6) provides this protection by distributing a logical state among many physical quantum bits (qubits) by means of quantum entanglement. Superconductivity is a useful phenomenon in this regard, because it allows the construction of large quantum circuits and is compatible with microfabrication. For superconducting qubits, the surface code approach to quantum computing(7) is a natural choice for error correction, because it uses only nearest-neighbour coupling and rapidly cycled entangling gates. The gate fidelity requirements are modest: the per-step fidelity threshold is only about 99 per cent. Here we demonstrate a universal set of logic gates in a superconducting multi-qubit processor, achieving an average single-qubit gate fidelity of 99.92 per cent and a two-qubit gate fidelity of up to 99.4 per cent. This places Josephson quantum computing at the fault-tolerance threshold for surface code error correction. Our quantum processor is a first step towards the surface code, using five qubits arranged in a linear array with nearest-neighbour coupling. As a further demonstration, we construct a five-qubit Greenberger-Horne-Zeilinger state(8,9) using the complete circuit and full set of gates. The results demonstrate that Josephson quantum computing is a high-fidelity technology, with a clear path to scaling up to large-scale, fault-tolerant quantum circuits.	[Barends, R.; Kelly, J.; Megrant, A.; Sank, D.; Jeffrey, E.; White, T. C.; Mutus, J.; Fowler, A. G.; Campbell, B.; Chen, Y.; Chen, Z.; Chiaro, B.; Dunsworth, A.; Neill, C.; O'Malley, P.; Roushan, P.; Vainsencher, A.; Wenner, J.; Cleland, A. N.; Martinis, John M.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Veitia, A.; Korotkov, A. N.] Univ Calif Riverside, Dept Elect Engn, Riverside, CA 92521 USA; [Fowler, A. G.] Univ Melbourne, Ctr Quantum Computat & Commun Technol, Sch Phys, Melbourne, Vic 3010, Australia	University of California System; University of California Santa Barbara; University of California System; University of California Riverside; University of Melbourne	Barends, R (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	rbarends@physics.ucsb.edu; martinis@physics.ucsb.edu	Wenner, James/G-3777-2014; Cleland, Andrew/AAG-7581-2019	Wenner, James/0000-0001-7107-4734; 	Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through the Army Research Office [W911NF-09-1-0375, W911NF-10-1-0334]; US NSF	Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through the Army Research Office; US NSF(National Science Foundation (NSF))	We thank F. Wilhelm, D. Egger, and J. Baselmans for discussions. We are indebted to E. Lucero for photography of the device. This work was supported by the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through the Army Research Office grants W911NF-09-1-0375 and W911NF-10-1-0334. All statements of fact, opinion or conclusions contained herein are those of the authors and should not be construed as representing the official views or policies of IARPA, the ODNI or the US Government. Devices were made at the UC Santa Barbara Nanofabrication Facility, a part of the US NSF-funded National Nanotechnology Infrastructure Network, and at the NanoStructures Cleanroom Facility.	Barends R, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.080502; Benhelm J, 2008, NAT PHYS, V4, P463, DOI 10.1038/nphys961; Brown KR, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.030303; Choi T., 2014, OPTIMAL QUANTUM CONT; Chow J. M., 2013, IMPLEMENTING STRAND; Chuang IL, 1998, PHYS REV LETT, V80, P3408, DOI 10.1103/PhysRevLett.80.3408; DiCarlo L, 2010, NATURE, V467, P574, DOI 10.1038/nature09416; DiCarlo L, 2009, NATURE, V460, P240, DOI 10.1038/nature08121; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Fowler AG, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032324; Guhne O, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/053002; Jeffrey E., 2014, FAST SCALABLE STATE; Jones JA, 1998, NATURE, V393, P344, DOI 10.1038/30687; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; Lucero E, 2012, NAT PHYS, V8, P719, DOI [10.1038/nphys2385, 10.1038/NPHYS2385]; Lucero E, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.042339; Magesan E, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.180504; Mariantoni M, 2011, SCIENCE, V334, P61, DOI 10.1126/science.1208517; Martinis J., FAST ADIABATIC CONTR; Megrant A, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3693409; Monz T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.130506; Neeley M, 2010, NATURE, V467, P570, DOI 10.1038/nature09418; Nielsen M. A., 2010, QUANTUM COMPUTATION; Ryan CA, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/1/013034; Sendelbach S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.117001; Strauch FW, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.167005; Vandersypen LMK, 2001, NATURE, V414, P883, DOI 10.1038/414883a; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851	30	1051	1073	16	308	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					500	503		10.1038/nature13171	http://dx.doi.org/10.1038/nature13171			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24759412	Green Submitted			2022-12-28	WOS:000334741600031
J	Record, KL				Record, Katherine L.			Treating Our "Situations" with Science, Not Shame	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Law, Ctr Hlth Law & Policy Innovat, Cambridge, MA 02138 USA	Harvard University	Record, KL (corresponding author), Harvard Univ, Sch Law, Ctr Hlth Law & Policy Innovat, Cambridge, MA 02138 USA.							[Anonymous], 2013, NIH RES PORTF ONL RE; Elbogen EB, 2009, ARCH GEN PSYCHIAT, V66, P152, DOI 10.1001/archgenpsychiatry.2008.537; Miranda J, 2008, AM J PSYCHIAT, V165, P1102, DOI 10.1176/appi.ajp.2008.08030333; National Institute of Mental Health, AN MENT ILLN AMI AD; Weintraub K, 2012, BOSTON GLOBE	5	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 24	2014	370	17					1579	1581		10.1056/NEJMp1401127	http://dx.doi.org/10.1056/NEJMp1401127			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH4TG	24758617				2022-12-28	WOS:000336120500004
J	Palmore, TN; Henderson, DK				Palmore, Tara N.; Henderson, David K.			Carbapenem-Resistant Enterobacteriaceae: A Call for Cultural Change	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Palmore, Tara N.; Henderson, David K.] NIH, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Henderson, DK (corresponding author), NIH, Ctr Clin, Bldg 10,Room 6-1480,10 Ctr Dr, Bethesda, MD 20892 USA.	dkh@nih.gov			CLINICAL CENTER [ZIACL004042, ZIACL004041] Funding Source: NIH RePORTER	CLINICAL CENTER		Balint Peter, 2009, Orv Hetil, V150, P1430, DOI 10.1556/OH.2009.HO2256; Boucher HW, 2013, CLIN INFECT DIS, V56, P1685, DOI 10.1093/cid/cit152; Centers for Disease Control and Prevention, 2013, GUID CONTR CARB RES; Diekema DJ, 2013, CLIN INFECT DIS, V56, P1614, DOI 10.1093/cid/cit038; Holmes O W, 1974, Am J Obstet Gynecol, V119, P852; Holmes OW., 1843, NEW ENGL Q J MED, V1, P503; Huang AM, 2013, CLIN INFECT DIS, V57, P1237, DOI 10.1093/cid/cit498; Palmore TN, 2011, INFECT CONT HOSP EP, V32, P1166, DOI 10.1086/662710; Semmelweis IF., 1861, AETIOLOGIE BEGRIFF P; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Tamma PD, 2013, INFECT CONT HOSP EP, V34, P990, DOI 10.1086/671731	11	7	7	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 15	2014	160	8					567	+		10.7326/M13-1910	http://dx.doi.org/10.7326/M13-1910			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG0ZE	24733200				2022-12-28	WOS:000335143700008
J	Bayer, M				Bayer, Martin			Patterning Cues from the Altruistic Sibling	SCIENCE			English	Editorial Material							PLANT; SUSPENSOR; EMBRYO		Max Planck Inst Dev Biol, Dept Cell Biol, D-72076 Tubingen, Germany	Max Planck Society	Bayer, M (corresponding author), Max Planck Inst Dev Biol, Dept Cell Biol, D-72076 Tubingen, Germany.	martin.bayer@tuebingen.mpg.de	Bayer, Martin/AAP-3372-2020	Bayer, Martin/0000-0001-5806-2253				Babu Y, 2013, PLANT PHYSIOL, V162, P1448, DOI 10.1104/pp.113.217166; Costa LM, 2014, SCIENCE, V344, P168, DOI 10.1126/science.1243005; De Smet I, 2009, NAT CELL BIOL, V11, P1166, DOI 10.1038/ncb1009-1166; Javelle M, 2011, NEW PHYTOL, V189, P17, DOI 10.1111/j.1469-8137.2010.03514.x; Kawashima T, 2010, TRENDS PLANT SCI, V15, P23, DOI 10.1016/j.tplants.2009.11.002; Lau S, 2012, ANNU REV PLANT BIOL, V63, P483, DOI 10.1146/annurev-arplant-042811-105507; Li J, 2012, NEW PHYTOL, V195, P290, DOI 10.1111/j.1469-8137.2012.04182.x; Maheshwari P., 1950, AN INTRODUCTION TO T; Marshall E, 2011, J EXP BOT, V62, P1677, DOI 10.1093/jxb/err002; Supena EDJ, 2008, J EXP BOT, V59, P803, DOI 10.1093/jxb/erm358	10	0	0	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					158	159		10.1126/science.1252985	http://dx.doi.org/10.1126/science.1252985			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24723601				2022-12-28	WOS:000334096300023
J	Watson, H				Watson, Helena			Medicine still needs feminism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Hosp Lewisham, London SE13 6LH, England	University of London; King's College London	Watson, H (corresponding author), Univ Hosp Lewisham, London SE13 6LH, England.	helenawatson85@gmail.com						Burns H, 2011, BJOG-INT J OBSTET GY, V118, P5, DOI 10.1111/j.1471-0528.2010.02847.x; Jayaprakasan K, 2014, BJOG-INT J OBSTET GY, V121, P300, DOI 10.1111/1471-0528.12504; McDonnell L, 2010, NEW DIGEST       OCT, P52; Moran C, 2012, BE WOMAN; National Institute for Health and Clinical Excellence, 2013, FERT ASS TREATM PEOP; Sandberg S., 2013, LEAN WOMEN WORK WILL	6	0	0	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2014	348								g2623	10.1136/bmj.g2623	http://dx.doi.org/10.1136/bmj.g2623			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SB	24709547				2022-12-28	WOS:000334348300011
J	Grotwinkel, JT; Wild, K; Segnitz, B; Sinning, I				Grotwinkel, Jan Timo; Wild, Klemens; Segnitz, Bernd; Sinning, Irmgard			SRP RNA Remodeling by SRP68 Explains Its Role in Protein Translocation	SCIENCE			English	Article							SIGNAL-RECOGNITION PARTICLE; ENDOPLASMIC-RETICULUM; GTPASE ACTIVATION; RIBOSOME; RECEPTOR; COMPLEX; IDENTIFICATION; MUTAGENESIS; NUCLEOLUS; DOMAIN	The signal recognition particle (SRP) is central to membrane protein targeting; SRP RNA is essential for SRP assembly, elongation arrest, and activation of SRP guanosine triphosphatases. In eukaryotes, SRP function relies on the SRP68-SRP72 heterodimer. We present the crystal structures of the RNA-binding domain of SRP68 (SRP68-RBD) alone and in complex with SRP RNA and SRP19. SRP68-RBD is a tetratricopeptide-like module that binds to a RNA three-way junction, bends the RNA, and inserts an alpha-helical arginine-rich motif (ARM) into the major groove. The ARM opens the conserved 5f RNA loop, which in ribosome-bound SRP establishes a contact to ribosomal RNA. Our data provide the structural basis for eukaryote-specific, SRP68-driven RNA remodeling required for protein translocation.	[Grotwinkel, Jan Timo; Wild, Klemens; Segnitz, Bernd; Sinning, Irmgard] Heidelberg Univ, Biochem Ctr BZH, INF 328, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Sinning, I (corresponding author), Heidelberg Univ, Biochem Ctr BZH, INF 328, D-69120 Heidelberg, Germany.	irmi.sinning@bzh.uni-heidelberg.de			Deutsche Forschungsgemeinschaft [SFB638, GRK1188]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by Deutsche Forschungsgemeinschaft grants SFB638 and GRK1188. We thank J. Kopp and C. Siegmann from the BZH/Cluster of Excellence: CellNetworks crystallization platform for support in protein crystallization; E. Hurt and S. Amlacher for C. thermophilum cDNA; and M. Becker, G. Bange, and R. Beckmann for stimulating discussions. Data collection was performed at ESRF (European Synchrotron Radiation Facilty, Grenoble). I. S. is an investigator of the Cluster of Excellence: CellNetworks. Coordinates and structure factors are deposited in the RCSB Protein Data Bank with the accession numbers 4P3E, 4P3F, and 4P3G for hSRP RNA-SRP19-SRP68-RBD, hSRP68-RBD, and ctSRP68-RBD, respectively.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Ataide SF, 2011, SCIENCE, V331, P881, DOI 10.1126/science.1196473; Bange G, 2013, NAT STRUCT MOL BIOL, V20, P776, DOI 10.1038/nsmb.2605; Battiste JL, 1996, SCIENCE, V273, P1547, DOI 10.1126/science.273.5281.1547; Bradshaw N, 2009, SCIENCE, V323, P127, DOI 10.1126/science.1165971; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Grosshans H, 2001, J CELL BIOL, V153, P745, DOI 10.1083/jcb.153.4.745; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Iakhiaeva E, 2006, PROTEIN SCI, V15, P1290, DOI 10.1110/ps.051861406; Iakhiaeva E, 2009, PROTEIN SCI, V18, P2183, DOI 10.1002/pro.232; Krasilnikov AS, 2003, RNA, V9, P640, DOI 10.1261/rna.2202703; Kuglstatter A, 2002, NAT STRUCT BIOL, V9, P740, DOI 10.1038/nsb843; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Menichelli E, 2007, J MOL BIOL, V367, P187, DOI 10.1016/j.jmb.2006.12.056; Nyathi Y, 2013, BBA-MOL CELL RES, V1833, P2392, DOI 10.1016/j.bbamcr.2013.02.021; Politz JC, 2000, P NATL ACAD SCI USA, V97, P55, DOI 10.1073/pnas.97.1.55; Rosenblad MA, 2009, RNA BIOL, V6, P508, DOI 10.4161/rna.6.5.9753; SCOULICA E, 1987, EUR J BIOCHEM, V163, P519, DOI 10.1111/j.1432-1033.1987.tb10899.x; Shen K, 2013, J BIOL CHEM, V288, P36385, DOI 10.1074/jbc.M113.513614; Shen K, 2011, RNA, V17, P892, DOI 10.1261/rna.2610411; SIEGEL V, 1988, CELL, V52, P39, DOI 10.1016/0092-8674(88)90529-6; SIEGEL V, 1985, J CELL BIOL, V100, P1913, DOI 10.1083/jcb.100.6.1913; Voigts-Hoffmann F, 2013, MOL CELL, V52, P643, DOI 10.1016/j.molcel.2013.10.005; WALTER P, 1984, CELL, V38, P5, DOI 10.1016/0092-8674(84)90520-8; WEEKS KM, 1993, SCIENCE, V261, P1574, DOI 10.1126/science.7690496; Wild K, 2010, ACTA CRYSTALLOGR D, V66, P295, DOI 10.1107/S0907444910000879; Yin J, 2007, RNA BIOL, V4, P154, DOI 10.4161/rna.4.3.5428	33	31	31	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					101	104		10.1126/science.1249094	http://dx.doi.org/10.1126/science.1249094			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700861				2022-12-28	WOS:000333746100062
J	Patel, DV; McGhee, CNJ				Patel, Dipika V.; McGhee, Charles N. J.			Hanging by threads: ectopia lentis	LANCET			English	Editorial Material									[Patel, Dipika V.; McGhee, Charles N. J.] Univ Auckland, Fac Med & Hlth Sci, Dept Ophthalmol, New Zealand Natl Eye Ctr, Auckland 1, New Zealand	University of Auckland	Patel, DV (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Ophthalmol, New Zealand Natl Eye Ctr, Private Bag 92019, Auckland 1, New Zealand.	dipika.patel@auckland.ac.nz		Patel, Dipika/0000-0001-9994-4631; McGhee, Charles NJ/0000-0001-7048-0706					0	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2014	384	9946					893	893		10.1016/S0140-6736(13)61838-3	http://dx.doi.org/10.1016/S0140-6736(13)61838-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5DK	24726475	Bronze			2022-12-28	WOS:000341362200031
J	Longo, N; Harding, CO; Burton, BK; Grange, DK; Vockley, J; Wasserstein, M; Rice, GM; Dorenbaum, A; Neuenburg, JK; Musson, DG; Gu, ZH; Sile, S				Longo, Nicola; Harding, Cary O.; Burton, Barbara K.; Grange, Dorothy K.; Vockley, Jerry; Wasserstein, Melissa; Rice, Gregory M.; Dorenbaum, Alejandro; Neuenburg, Jutta K.; Musson, Donald G.; Gu, Zhonghua; Sile, Saba			Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trial	LANCET			English	Article							TREATED PHENYLKETONURIA; PREFRONTAL DYSFUNCTION; CHILDREN; DEFICITS	Background Phenylketonuria is an inherited disease caused by impaired activity of phenylalanine hydroxylase, the enzyme that converts phenylalanine to tyrosine, leading to accumulation of phenylalanine and subsequent neurocognitive dysfunction. Phenylalanine ammonia lyase is a prokaryotic enzyme that converts phenylalanine to ammonia and trans-cinnamic acid. We aimed to assess the safety, tolerability, pharmacokinetic characteristics, and efficacy of recombinant Anabaena variabilis phenylalanine ammonia lyase (produced in Escherichia coli) conjugated with polyethylene glycol (rAvPAL-PEG) in reducing phenylalanine concentrations in adult patients with phenylketonuria. Methods In this open-label, phase 1, multicentre trial, single subcutaneous injections of rAvPAL-PEG were given in escalating doses (0.001, 0.003, 0.010, 0.030, and 0.100 mg/kg) to adults with phenylketonuria. Participants aged 18 years or older with blood phenylalanine concentrations of 600 mu mol/L or higher were recruited from among patients attending metabolic disease clinics in the USA. The primary endpoints were safety and tolerability of rAvPAL-PEG. Secondary endpoints were the pharmacokinetic characteristics of the drug and its effect on concentrations of phenylalanine. Participants and investigators were not masked to assigned dose group. This study is registered with ClinicalTrials.gov, number NCT00925054. Findings 25 participants were recruited from seven centres between May 6, 2008, and April 15, 2009, with five participants assigned to each escalating dose group. All participants were included in the safety population. The most frequently reported adverse events were injection-site reactions and dizziness, which were self-limited and without sequelae. Two participants had serious adverse reactions to intramuscular medroxyprogesterone acetate, a drug that contains polyethylene glycol as an excipient. Three of five participants given the highest dose of rAvPAL-PEG (0.100 mg/kg) developed a generalised skin rash. By the end of the study, all participants had developed antibodies against polyethylene glycol, and some against phenylalanine ammonia lyase as well. Drug concentrations peaked about 89-106 h after administration of the highest dose. Treatment seemed to be effective at reducing blood phenylalanine in all five participants who received the highest dose (mean reduction of 54.2% from baseline), with a nadir about 6 days after injection and an inverse correlation between drug and phenylalanine concentrations in plasma. Phenylalanine returned to near-baseline concentrations about 21 days after the injection. Interpretation Subcutaneous administration of rAvPAL-PEG in a single dose of up to 0.100 mg/kg was fairly safe and well tolerated in adult patients with phenylketonuria. At the highest dose tested, rAvPAL-PEG reduced blood phenylalanine concentrations. In view of the development of antibodies against polyethylene glycol (and in some cases against phenylalanine ammonia lyase), future studies are needed to assess the effect of repeat dosing. Funding BioMarin Pharmaceutical.	[Longo, Nicola] Univ Utah, Salt Lake City, UT 84132 USA; [Harding, Cary O.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Burton, Barbara K.] Ann & Robert H Lurie Childrens Hosp, Chicago, IL USA; [Burton, Barbara K.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Grange, Dorothy K.] Washington Univ, Sch Med, St Louis, MO USA; [Vockley, Jerry] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Wasserstein, Melissa] Mt Sinai Sch Med, New York, NY USA; [Rice, Gregory M.] Univ Wisconsin, Madison, WI USA; [Dorenbaum, Alejandro; Neuenburg, Jutta K.; Musson, Donald G.; Gu, Zhonghua; Sile, Saba] BioMarin Pharmaceut, Novato, CA USA	Utah System of Higher Education; University of Utah; Oregon Health & Science University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Icahn School of Medicine at Mount Sinai; University of Wisconsin System; University of Wisconsin Madison; BioMarin Pharmaceutical Inc.	Longo, N (corresponding author), Univ Utah, Salt Lake City, UT 84132 USA.	nicola.longo@hsc.utah.edu	Vockley, Jerry/AAF-8523-2020; Vockley, Jerry/B-5210-2016	Vockley, Jerry/0000-0002-8180-6457; Vockley, Jerry/0000-0002-8180-6457	US National Center for Research Resources and the National Center for Advancing Translational Sciences (National Institutes of Health [NIH]) [UL1RR025764]; BioMarin Pharmaceutical; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001067, UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025764] Funding Source: NIH RePORTER	US National Center for Research Resources and the National Center for Advancing Translational Sciences (National Institutes of Health [NIH]); BioMarin Pharmaceutical(Johnson & Johnson); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by BioMarin Pharmaceutical. One medical writer (Judy Wiles) created an initial outline of the report, and another (Nicolette Blase) helped to prepare the report for submission. Both medical writers are from Facet Communications, and received funding from BioMarin Pharmaceutical. The project was partly supported by the US National Center for Research Resources and the National Center for Advancing Translational Sciences ( National Institutes of Health [NIH]), through grant UL1RR025764. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Aoki Kikumaro, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P19; Azen C, 1996, EUR J PEDIATR, V155, pS29, DOI 10.1007/BF03036507; Bowersox J, 2001, PEDIATRICS, V108, P972; DILELLA AG, 1986, BIOCHEMISTRY-US, V25, P743, DOI 10.1021/bi00352a001; Feldmann R, 2005, J INHERIT METAB DIS, V28, P445, DOI 10.1007/s10545-005-0445-7; Fisch RO, 2000, EUR J PEDIATR, V159, pS142, DOI 10.1007/PL00014378; Gassio R, 2005, PEDIATR NEUROL, V33, P267, DOI 10.1016/j.pediatrneurol.2005.05.003; Gregory CO, 2007, GENET MED, V9, P761, DOI 10.1097/GIM.0b013e318159a355; Leuzzi V, 2004, J INHERIT METAB DIS, V27, P115, DOI 10.1023/B:BOLI.0000028781.94251.1f; Mitchell JJ, 2011, GENET MED, V13, P697, DOI 10.1097/GIM.0b013e3182141b48; National PKU Alliance, PKU FACTS; OZALP I, 1990, J INHERIT METAB DIS, V13, P732, DOI 10.1007/BF01799576; Sarkissian CN, 2008, P NATL ACAD SCI USA, V105, P20894, DOI 10.1073/pnas.0808421105; SCRIVER CR, 2001, METABOLIC MOL BASES, P1667; Walter JH, 2002, LANCET, V360, P55, DOI 10.1016/S0140-6736(02)09334-0; White DA, 2002, J INT NEUROPSYCH SOC, V8, P1, DOI 10.1017/S135561770102001X; White DA, 2001, NEUROPSYCHOLOGY, V15, P221, DOI 10.1037/0894-4105.15.2.221	17	103	112	0	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2014	384	9937					37	44		10.1016/S0140-6736(13)61841-3	http://dx.doi.org/10.1016/S0140-6736(13)61841-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL1XL	24743000	Green Accepted			2022-12-28	WOS:000338919600024
J	Du, DJ; Wang, Z; James, NR; Voss, JE; Klimont, E; Ohene-Agyei, T; Venter, H; Chiu, W; Luisi, BF				Du, Dijun; Wang, Zhao; James, Nathan R.; Voss, Jarrod E.; Klimont, Ewa; Ohene-Agyei, Thelma; Venter, Henrietta; Chiu, Wah; Luisi, Ben F.			Structure of the AcrAB-TolC multidrug efflux pump	NATURE			English	Article							CRYO-EM STRUCTURE; CRYSTAL-STRUCTURE; MEMBRANE PROTEIN; SYSTEM; CHANNEL; CRYSTALLOGRAPHY; REFINEMENT; COMPONENT; SOFTWARE; COMPLEX	The capacity of numerous bacterial species to tolerate antibiotics and other toxic compounds arises in part from the activity of energy-dependent transporters. In Gram-negative bacteria, many of these transporters form multicomponent 'pumps' that span both inner and outer membranes and are driven energetically by a primary or secondary transporter component(1-7). A model system for such a pump is the acridine resistance complex of Escherichia Coli(1). This pump assembly comprises the outer-membrane channel TolC, the secondary transporter AcrB located in the inner membrane, and the periplasmic AcrA, which bridges these two integral membrane proteins. The AcrAB-TolC efflux pump is able to transport vectorially a diverse array of compounds with little chemical similarity, thus conferring resistance to a broad spectrum of antibiotics. Homologous complexes are found in many Gram-negative species, including in animal and plant pathogens. Crystal structures are available for the individual components of the pump(2-7) and have provided insights into substrate recognition, energy coupling and the transduction of conformational changes associated with the transport process. However, how the subunits are organized in the pump, their stoichiometry and the details of their interactions are not known. Here we present the pseudo-atomic structure of a complete multidrug efflux pump in complex with a modulatory protein partner(8) from E. Coli. The model defines the quaternary organization of the pump, identifies key domain interactions, and suggests a cooperative process for channel assembly and opening. These findings illuminate the basis for drug resistance in numerous pathogenic bacterial species.	[Du, Dijun; James, Nathan R.; Voss, Jarrod E.; Klimont, Ewa; Luisi, Ben F.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Wang, Zhao; Chiu, Wah] Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Natl Ctr Macromol Imaging, Houston, TX 77030 USA; [Ohene-Agyei, Thelma] Dept Pharmacol, Cambridge CB2 1PD, England; [Venter, Henrietta] Univ S Australia, Sch Pharm & Med Sci, Sansom Inst Hlth Res, Adelaide, SA 5000, Australia	University of Cambridge; Baylor College of Medicine; University of South Australia	Luisi, BF (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1GA, England.	dd339@cam.ac.uk; bfl20@cam.ac.uk	wang, zhao/E-1996-2016; wang, zhao/E-7013-2015; Venter, Rietie/E-4795-2013	Venter, Rietie/0000-0001-5569-7755; James, Nathan/0000-0003-1147-6285; Wang, Zhao/0000-0003-4897-9986	Wellcome Trust; Human Frontier Science Program; National Institutes of Health [P41GM103832]; Herschel Smith scholarship; Cambridge Trust scholarship; Adam Glinsman award; Faculty for the Future Fellowship from the Schlumberger Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103832] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Human Frontier Science Program(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Herschel Smith scholarship; Cambridge Trust scholarship; Adam Glinsman award; Faculty for the Future Fellowship from the Schlumberger Foundation(Schlumberger); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Wellcome Trust and Human Frontier Science Program (B. L.) and partly by a National Institutes of Health grant (P41GM103832 to W. C.). J.E.V. is supported by a Herschel Smith scholarship. T.O.-A. is the recipient of a Cambridge Trust scholarship, an Adam Glinsman award and a Faculty for the Future Fellowship from the Schlumberger Foundation. We thank M. Pos for kindly providing pBAD-AcrAB-TolC. We thank L. Packman for mass-spectrometric analyses and S. J. Ludtke, M. F. Schmid, M. Pos and R. van Veen for helpful advice and discussions. We are grateful to the staff at the Diamond Light Source for access to facilities and invaluable help.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bavro VN, 2008, MOL CELL, V30, P114, DOI 10.1016/j.molcel.2008.02.015; Berthaud A, 2012, J AM CHEM SOC, V134, P10080, DOI 10.1021/ja301667n; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Du D., 2013, MICROBIAL EFFLUX PUM; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Eicher T, 2012, P NATL ACAD SCI USA, V109, P5687, DOI 10.1073/pnas.1114944109; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ge Q, 2009, J BACTERIOL, V191, P4365, DOI 10.1128/JB.00204-09; Henderson R, 2011, J MOL BIOL, V413, P1028, DOI 10.1016/j.jmb.2011.09.008; Hobbs EC, 2012, P NATL ACAD SCI USA, V109, P16696, DOI 10.1073/pnas.1210093109; Hsieh YH, 2013, BIOCHEM BIOPH RES CO, V431, P388, DOI 10.1016/j.bbrc.2013.01.042; Janganan TK, 2013, MOL MICROBIOL, V88, P590, DOI 10.1111/mmi.12211; Janganan TK, 2011, J BIOL CHEM, V286, P26900, DOI 10.1074/jbc.M111.246595; Jiang W, 2001, J MOL BIOL, V308, P1033, DOI 10.1006/jmbi.2001.4633; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lobedanz S, 2007, P NATL ACAD SCI USA, V104, P4612, DOI 10.1073/pnas.0610160104; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Mima T, 2007, J BACTERIOL, V189, P7600, DOI 10.1128/JB.00850-07; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Murray SC, 2013, STRUCTURE, V21, P900, DOI 10.1016/j.str.2013.04.016; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Narita S, 2003, BIOCHEM BIOPH RES CO, V308, P922, DOI 10.1016/S0006-291X(03)01512-2; Pei XY, 2011, P NATL ACAD SCI USA, V108, P2112, DOI 10.1073/pnas.1012588108; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Stark H, 2010, METHOD ENZYMOL, V481, P109, DOI 10.1016/S0076-6879(10)81005-5; Stegmeier JF, 2006, BIOCHEMISTRY-US, V45, P10303, DOI 10.1021/bi060320g; Su CC, 2011, NATURE, V470, P558, DOI 10.1038/nature09743; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tikhonova EB, 2004, J BIOL CHEM, V279, P32116, DOI 10.1074/jbc.M402230200; Tikhonova EB, 2011, CHEM BIOL, V18, P454, DOI 10.1016/j.chembiol.2011.02.011; Touze T, 2004, MOL MICROBIOL, V53, P697, DOI 10.1111/j.1365-2958.2004.04158.x; Trepout S, 2010, BBA-BIOMEMBRANES, V1798, P1953, DOI 10.1016/j.bbamem.2010.06.019; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Welch A, 2010, BIOCHEM J, V430, P355, DOI 10.1042/BJ20091860; Xu YB, 2012, J BIOL CHEM, V287, P11740, DOI 10.1074/jbc.M111.329375; Yum SW, 2009, J MOL BIOL, V387, P1286, DOI 10.1016/j.jmb.2009.02.048	52	372	379	6	217	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					512	+		10.1038/nature13205	http://dx.doi.org/10.1038/nature13205			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24747401	Green Accepted			2022-12-28	WOS:000336126000043
J	Hodgkinson, A; Idaghdour, Y; Gbeha, E; Grenier, JC; Hip-Ki, E; Bruat, V; Goulet, JP; de Malliard, T; Awadalla, P				Hodgkinson, Alan; Idaghdour, Youssef; Gbeha, Elias; Grenier, Jean-Christophe; Hip-Ki, Elodie; Bruat, Vanessa; Goulet, Jean-Philippe; de Malliard, Thibault; Awadalla, Philip			High-Resolution Genomic Analysis of Human Mitochondrial RNA Sequence Variation	SCIENCE			English	Article							DNA MUTATIONS; TRANSCRIPTOME; HETEROPLASMY; IDENTIFICATION	Mutations in the mitochondrial genome are associated with multiple diseases and biological processes; however, little is known about the extent of sequence variation in the mitochondrial transcriptome. By ultra-deeply sequencing mitochondrial RNA (>6000x) from the whole blood of similar to 1000 individuals from the CARTaGENE project, we identified remarkable levels of sequence variation within and across individuals, as well as sites that show consistent patterns of posttranscriptional modification. Using a genome-wide association study, we find that posttranscriptional modification of functionally important sites in mitochondrial transfer RNAs (tRNAs) is under strong genetic control, largely driven by a missense mutation in MRPP3 that explains similar to 22% of the variance. These results reveal a major nuclear genetic determinant of posttranscriptional modification in mitochondria and suggest that tRNA posttranscriptional modification may affect cellular energy production.	[Hodgkinson, Alan; Idaghdour, Youssef; Gbeha, Elias; Grenier, Jean-Christophe; Hip-Ki, Elodie; Bruat, Vanessa; de Malliard, Thibault; Awadalla, Philip] Univ Montreal, CHU St Justine Res Ctr, Dept Pediat, Fac Med, Montreal, PQ H3T 1C5, Canada; [Idaghdour, Youssef; Goulet, Jean-Philippe; de Malliard, Thibault; Awadalla, Philip] CARTaGENE, Montreal, PQ H3V 1A2, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal	Awadalla, P (corresponding author), Univ Montreal, CHU St Justine Res Ctr, Dept Pediat, Fac Med, 3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	philip.awadalla@umontreal.ca	Awadalla, Philip/AAC-4896-2021	Grenier, Jean-Christophe/0000-0001-7937-5160; Hodgkinson, Alan/0000-0003-1636-491X	Fonds de la recherche en sante du Quebec (FRSQ); Genome Quebec; Reseau de medecine genetique appliquee (RMGA); Fonds quebecois de la recherche sur la nature et les technologies (FQRNT); Canadian Foundation of Innovation; Canadian Partnership Against Cancer	Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Genome Quebec; Reseau de medecine genetique appliquee (RMGA); Fonds quebecois de la recherche sur la nature et les technologies (FQRNT)(FQRNT); Canadian Foundation of Innovation(Canada Foundation for Innovation); Canadian Partnership Against Cancer	A. H., Y.I., and P. A. designed the study. P. A. provided samples; E. G. and E.H.-K. processed samples for sequencing and genotyping; J.-C.G. and V. B. aligned sequencing data. Y.I., A. H., T.d.M., and J.-C.G. performed quality control on sequencing data, and Y.I. and J.-P.G. performed quality control on genotyping data. J.-P.G. compiled phenotype data from the CARTaGENE project. A. H. and Y.I. performed the analysis. A. H., Y.I., and P. A. wrote the manuscript. We thank E. Shoubridge, I. Thiffault, G. Gibson, J. Novembre, and E. Stone for comments on the study; C. Prive for help with study design on the Ion Torrent platform; and the CARTaGENE team for assistance with data collection. We acknowledge financial support from Fonds de la recherche en sante du Quebec (FRSQ), Genome Quebec, Reseau de medecine genetique appliquee (RMGA), Fonds quebecois de la recherche sur la nature et les technologies (FQRNT), Canadian Foundation of Innovation, and the Canadian Partnership Against Cancer. A. H. is an FRSQ Research Fellow and Y.I. is a Banting Postdoctoral Fellow. Requests for data published here should be submitted to the CARTaGENE program at access@cartagene.qc.ca, or the corresponding author, citing this study. The authors declare no conflict of interests.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Awadalla P, 2013, INT J EPIDEMIOL, V42, P1285, DOI 10.1093/ije/dys160; Bar-Yaacov D, 2013, GENOME RES, V23, P1789, DOI 10.1101/gr.161265.113; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Findeiss S, 2011, BIOL CHEM, V392, P305, DOI 10.1515/BC.2011.043; Goto H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r59; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Helm M, 1999, BIOCHEMISTRY-US, V38, P13338, DOI 10.1021/bi991061g; Helm M, 1998, NUCLEIC ACIDS RES, V26, P1636, DOI 10.1093/nar/26.7.1636; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Rackham O, 2012, WIRES RNA, V3, P675, DOI 10.1002/wrna.1128; Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Samuels DC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003929; Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Vilardo E, 2012, NUCLEIC ACIDS RES, V40, P11583, DOI 10.1093/nar/gks910; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482	24	67	67	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					413	415		10.1126/science.1251110	http://dx.doi.org/10.1126/science.1251110			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763589				2022-12-28	WOS:000334867800041
J	Cortez, D; Marin, R; Toledo-Flores, D; Froidevaux, L; Liechti, A; Waters, PD; Grutzner, F; Kaessmann, H				Cortez, Diego; Marin, Ray; Toledo-Flores, Deborah; Froidevaux, Laure; Liechti, Angelica; Waters, Paul D.; Gruetzner, Frank; Kaessmann, Henrik			Origins and functional evolution of Y chromosomes across mammals	NATURE			English	Article							SEX-DETERMINING REGION; DETERMINING GENE; W-CHROMOSOME; DNA-SEQUENCE; LONG ARM; MOUSE; IDENTIFICATION; PLATYPUS; EXPRESSION; ALIGNMENT	Y chromosomes underlie sex determination in mammals, but their repeat-rich nature has hampered sequencing and associated evolutionary studies. Here we trace Y evolution across 15 representative mammals on the basis of high-throughput genome and transcriptome sequencing. We uncover three independent sex chromosome originations in mammals and birds (the outgroup). The original placental and marsupial (therian) Y, containing the sex-determining gene SRY, emerged in the therian ancestor approximately 180 million years ago, in parallel with the first of five monotreme Y chromosomes, carrying the probable sex-determining gene AMH. The avian W chromosome arose approximately 140 million years ago in the bird ancestor. The small Y/W gene repertoires, enriched in regulatory functions, were rapidly defined following stratification (recombination arrest) and erosion events and have remained considerably stable. Despite expression decreases in therians, Y/W genes show notable conservation of proto-sex chromosome expression patterns, although various Y genes evolved testis-specificities through differential regulatory decay. Thus, although some genes evolved novel functions through spatial/temporal expression shifts, most Y genes probably endured, at least initially, because of dosage constraints.	[Cortez, Diego; Marin, Ray; Froidevaux, Laure; Liechti, Angelica; Kaessmann, Henrik] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Cortez, Diego; Marin, Ray; Kaessmann, Henrik] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Toledo-Flores, Deborah; Gruetzner, Frank] Univ Adelaide, Robinson Res Inst, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Waters, Paul D.] UNSW Australia, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	University of Lausanne; Swiss Institute of Bioinformatics; Robinson Research Institute; University of Adelaide; University of New South Wales Sydney	Cortez, D (corresponding author), Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.	diegoclaudio.cortezquezada@unil.ch; henrik.kaessmann@unil.ch	Grutzner, Frank/ABB-2820-2021; Kaessmann, Henrik/B-4989-2013; Grutzner, Frank/AAD-5834-2020; Waters, Paul D/B-7871-2015	Grutzner, Frank/0000-0002-3088-7314; Kaessmann, Henrik/0000-0001-7563-839X; Waters, Paul D/0000-0002-4689-8747	Mexican National Council for Science and Technology (CONACyT); ARC; European Research Council [242597]; Swiss National Science Foundation [130287]	Mexican National Council for Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ARC(Australian Research Council); European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank K. Harshman and the Lausanne Genomics Technology Facility for high-throughput sequencing support; I. Xenarios and the Vital-IT computational facility for computational support; S. Paabo for great ape DNA samples; C. Roos for marmoset DNA samples; P. Jensen for chicken samples; E. Tsend-Ayush for help in determining the complete sequence of the AMHY gene in platypus; P. Gonzalez-Rubio for help with figure designs; M. Cardoso-Moreira, F. Carelli, A. Necsulea and M. Warnefors for comments on the manuscript; the Kaessmann group in general for discussions; and the Marmoset Genome Sequencing Consortium for making the marmoset genome assembly and annotation data available and for granting permission to use them for the analyses described in this study before publication. D. T. F. was supported by the Mexican National Council for Science and Technology (CONACyT). P. D. W. was supported by an ARC fellowship. F. G. was supported by an ARC fellowship. This research was supported by grants from the European Research Council (Starting Independent Grant: 242597, SexGenTransEvolution) and the Swiss National Science Foundation (Grant: 130287) to H.K.	Adolfsson S, 2013, MOL BIOL EVOL, V30, P806, DOI 10.1093/molbev/mst009; AGULNIK AI, 1994, HUM MOL GENET, V3, P873, DOI 10.1093/hmg/3.6.873; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayers KL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r26; Bachtrog D, 2013, NAT REV GENET, V14, P113, DOI 10.1038/nrg3366; Berlin S, 2006, J MOL EVOL, V62, P66, DOI 10.1007/s00239-005-0067-6; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Carvalho AB, 2001, P NATL ACAD SCI USA, V98, P13225, DOI 10.1073/pnas.231484998; Carvalho AB, 2013, GENOME RES, V23, P1894, DOI 10.1101/gr.156034.113; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Chang TC, 2013, P NATL ACAD SCI USA, V110, P12373, DOI 10.1073/pnas.1221104110; CHARLESWORTH B, 1978, P NATL ACAD SCI USA, V75, P5618, DOI 10.1073/pnas.75.11.5618; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Chen N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-183; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Cocquet J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000244; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Cutting A, 2013, DEV DYNAM, V242, P380, DOI 10.1002/dvdy.23944; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehrmann IE, 1998, HUM MOL GENET, V7, P1725, DOI 10.1093/hmg/7.11.1725; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goto H, 2009, J MOL EVOL, V68, P134, DOI 10.1007/s00239-008-9189-y; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grutzner F, 2004, NATURE, V432, P913, DOI 10.1038/nature03021; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall NM, 2003, MAMM GENOME, V14, P437, DOI 10.1007/s00335-002-3068-4; Hattori RS, 2012, P NATL ACAD SCI USA, V109, P2955, DOI 10.1073/pnas.1018392109; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hughes JF, 2012, BIOESSAYS, V34, P1035, DOI 10.1002/bies.201200066; Hughes JF, 2012, NATURE, V483, P82, DOI 10.1038/nature10843; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Julien P, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001328; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; Katsura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045488; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim HS, 2000, MOL CELLS, V10, P512; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Kondrashov FA, 2004, TRENDS GENET, V20, P287, DOI 10.1016/j.tig.2004.05.001; Kortschak RD, 2009, REPROD FERT DEVELOP, V21, P964, DOI 10.1071/RD09084; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li G, 2013, GENOME RES, V23, P1486, DOI 10.1101/gr.154286.112; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; MA K, 1993, CELL, V75, P1287, DOI 10.1016/0092-8674(93)90616-X; Marais GAB, 2010, GENOME BIOL EVOL, V2, P347, DOI 10.1093/gbe/evq026; MARDON G, 1989, CELL, V56, P765, DOI 10.1016/0092-8674(89)90680-6; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; Mazeyrat S, 1998, HUM MOL GENET, V7, P1713, DOI 10.1093/hmg/7.11.1713; MITCHELL MJ, 1991, NATURE, V354, P483, DOI 10.1038/354483a0; Moghadam HK, 2012, P NATL ACAD SCI USA, V109, P8207, DOI 10.1073/pnas.1202721109; Moreira MAM, 2002, J MOL EVOL, V55, P92, DOI 10.1007/s00239-001-2308-7; Murphy WJ, 2004, TRENDS GENET, V20, P631, DOI 10.1016/j.tig.2004.09.005; Murtagh VJ, 2012, GENOME RES, V22, P498, DOI 10.1101/gr.120790.111; Nam K, 2008, GENETICS, V180, P1131, DOI 10.1534/genetics.108.090324; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; Park C, 2010, MOL BIOL EVOL, V27, P2446, DOI 10.1093/molbev/msq143; Potrzebowski L, 2008, PLOS BIOL, V6, P709, DOI 10.1371/journal.pbio.0060080; Rens W, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r243; Delgado CLR, 2009, CHROMOSOME RES, V17, P917, DOI 10.1007/s10577-009-9079-1; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Sayres MAW, 2011, BIOESSAYS, V33, P938, DOI 10.1002/bies.201100091; Schriml LM, 1999, BIOTECHNIQUES, V27, P608, DOI 10.2144/99273pf01; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Soumillon M, 2013, CELL REP, V3, P2179, DOI 10.1016/j.celrep.2013.05.031; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Sutton E, 2011, J CLIN INVEST, V121, P328, DOI 10.1172/JCI42580; Toure A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r102; Toure A, 2004, GENOMICS, V83, P140, DOI 10.1016/S0888-7543(03)00216-7; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsend-Ayush E, 2012, CHROMOSOME RES, V20, P127, DOI 10.1007/s10577-011-9270-z; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Veyrunes F, 2008, GENOME RES, V18, P965, DOI 10.1101/gr.7101908; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; WELLER PA, 1995, HUM MOL GENET, V4, P859, DOI 10.1093/hmg/4.5.859; Western PS, 1999, DEV DYNAM, V216, P411; WHITFIELD LS, 1993, NATURE, V364, P713, DOI 10.1038/364713a0; Wilkerson AJP, 2008, GENOMICS, V92, P329, DOI 10.1016/j.ygeno.2008.06.012; Wilson MA, 2009, ANNU REV GENOM HUM G, V10, P333, DOI 10.1146/annurev-genom-082908-150105; Wilson MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000568; Wu ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043997; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Zhou Q, 2012, SCIENCE, V337, P341, DOI 10.1126/science.1225385	92	310	320	8	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					488	+		10.1038/nature13151	http://dx.doi.org/10.1038/nature13151			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24759410				2022-12-28	WOS:000334741600029
J	Kaur, AW; Ackels, T; Kuo, TH; Cichy, A; Dey, S; Hays, C; Kateri, M; Logan, DW; Marton, TF; Spehr, M; Stowers, L				Kaur, Angeldeep W.; Ackels, Tobias; Kuo, Tsung-Han; Cichy, Annika; Dey, Sandeepa; Hays, Cristen; Kateri, Maria; Logan, Darren W.; Marton, Tobias F.; Spehr, Marc; Stowers, Lisa			Murine Pheromone Proteins Constitute a Context-Dependent Combinatorial Code Governing Multiple Social Behaviors	CELL			English	Article							MAJOR URINARY PROTEINS; IN-HOUSE MICE; AGGRESSIVE-BEHAVIOR; VOMERONASAL NEURONS; BINDING-PROTEINS; SCENT MARKS; GENE FAMILY; MOUSE; ODORS; SIGNATURE	During social interactions, an individual's behavior is largely governed by the subset of signals emitted by others. Discrimination of "self'' from "other'' regulates the territorial urine countermarking behavior of mice. To identify the cues for this social discrimination and understand how they are interpreted, we designed an olfactory-dependent countermarking assay. We find major urinary proteins (MUPs) sufficient to elicit countermarking, and unlike other vomeronasal ligands that are detected by specifically tuned sensory neurons, MUPs are detected by a combinatorial strategy. A chemosensory signature of "self'' that modulates behavior is developed via experience through exposure to a repertoire of MUPs. In contrast, aggression can be elicited by MUPs in an experience-independent but contextdependent manner. These findings reveal that individually emitted chemical cues can be interpreted based on their combinatorial permutation and relative ratios, and they can transmit both fixed and learned information to promote multiple behaviors.	[Kaur, Angeldeep W.; Kuo, Tsung-Han; Dey, Sandeepa; Hays, Cristen; Logan, Darren W.; Marton, Tobias F.; Stowers, Lisa] Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA; [Ackels, Tobias; Cichy, Annika; Spehr, Marc] Rhein Westfal TH Aachen, Dept Chemosensat, Inst Biol 2, D-52074 Aachen, Germany; [Kateri, Maria] Rhein Westfal TH Aachen, Inst Stat, D-52056 Aachen, Germany; [Logan, Darren W.] Welcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Marton, Tobias F.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	Scripps Research Institute; RWTH Aachen University; RWTH Aachen University; Wellcome Trust Sanger Institute; University of California System; University of California San Francisco	Stowers, L (corresponding author), Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA.	stowers@scripps.edu	Spehr, Marc/B-3140-2011; Spehr, Marc/AAK-3162-2021; Stowers, Lisa/K-6137-2015	Spehr, Marc/0000-0001-6616-4196; Spehr, Marc/0000-0001-6616-4196; Kateri, Maria/0000-0002-6746-7858; Ackels, Tobias/0000-0002-4964-1162; Logan, Darren/0000-0003-1545-5510; Stowers, Lisa/0000-0002-4403-1269; Cichy, Annika/0000-0002-4620-7854	Skaggs Foundation; Ellison Medical Foundation; NIH-NIDCD [R01 DC006885, R01 DC009413]; Deutsche Forschungsgemeinschaft [SP724/7-1]; Volkswagen Foundation [83533]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009413, R01DC006885] Funding Source: NIH RePORTER	Skaggs Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank K. Spencer, C.H. Engelhardt, and S. Lipartowski for excellent technical assistance. C. Dulac, L.B. Vosshall, and C.I. Bargmann provided critical advice on the manuscript. This work was supported by the Skaggs Foundation (to T.-H.K. and L.S.), the Ellison Medical Foundation (to L.S.), the NIH-NIDCD (R01 DC006885 and R01 DC009413 to L.S.), the Deutsche Forschungsgemeinschaft (SP724/7-1 to M.S.), and the Volkswagen Foundation (83533 to M.S.). M.S. is a Lichtenberg Professor of the Volkswagen Foundation.	Adams DB, 2006, NEUROSCI BIOBEHAV R, V30, P304, DOI 10.1016/j.neubiorev.2005.09.004; Armstrong SD, 2005, BIOCHEM J, V391, P343, DOI 10.1042/BJ20050404; BACCHINI A, 1992, EXPERIENTIA, V48, P419, DOI 10.1007/BF01923448; Beynon RJ, 2004, PEPTIDES, V25, P1553, DOI 10.1016/j.peptides.2003.12.025; Beynon RJ, 2003, BIOCHEM SOC T, V31, P142, DOI 10.1042/bst0310142; Blanchard RJ, 2003, HORM BEHAV, V44, P161, DOI 10.1016/S0018-506X(03)00127-2; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Chamero P, 2011, P NATL ACAD SCI USA, V108, P12898, DOI 10.1073/pnas.1107770108; Cheetham SA, 2009, PHYSIOL BEHAV, V96, P253, DOI 10.1016/j.physbeh.2008.10.005; Choi GB, 2011, CELL, V146, P1003, DOI 10.1016/j.cell.2011.07.041; DESJARDINS C, 1973, SCIENCE, V182, P939, DOI 10.1126/science.182.4115.939; Dewan A, 2013, NATURE, V497, P486, DOI 10.1038/nature12114; FINLAYSON JS, 1965, SCIENCE, V149, P981, DOI 10.1126/science.149.3687.981; Flower DR, 1996, BIOCHEM J, V318, P1; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; Hagendorf S, 2009, J NEUROSCI, V29, P206, DOI 10.1523/JNEUROSCI.3656-08.2009; HASTIE ND, 1979, CELL, V17, P449, DOI 10.1016/0092-8674(79)90171-5; Humphries RE, 1999, ANIM BEHAV, V58, P1177, DOI 10.1006/anbe.1999.1252; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; Hurst JL, 1998, ANIM BEHAV, V55, P1289, DOI 10.1006/anbe.1997.0650; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; Janotova K, 2011, J CHEM ECOL, V37, P647, DOI 10.1007/s10886-011-9966-8; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Kaur A, 2013, METHODS MOL BIOL, V1068, P189, DOI 10.1007/978-1-62703-619-1_13; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; KIMURA T, 1985, HORM BEHAV, V19, P64, DOI 10.1016/0018-506X(85)90006-6; KNOPF JL, 1983, MOL CELL BIOL, V3, P2232, DOI 10.1128/MCB.3.12.2232; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Logan DW, 2012, CURR BIOL, V22, P1998, DOI 10.1016/j.cub.2012.08.041; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MEREDITH M, 1979, J PHYSIOL-LONDON, V286, P301, DOI 10.1113/jphysiol.1979.sp012620; Mudge JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r91; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Nevison CM, 2003, P ROY SOC B-BIOL SCI, V270, P1957, DOI 10.1098/rspb.2003.2452; Nevison CM, 2000, P ROY SOC B-BIOL SCI, V267, P687, DOI 10.1098/rspb.2000.1057; Nodari F, 2008, J NEUROSCI, V28, P6407, DOI 10.1523/JNEUROSCI.1425-08.2008; Novotny MV, 1999, P ROY SOC B-BIOL SCI, V266, P2017, DOI 10.1098/rspb.1999.0880; Novotny MV, 2003, BIOCHEM SOC T, V31, P117, DOI 10.1042/BST0310117; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; Rich TJ, 1999, ANIM BEHAV, V58, P1027, DOI 10.1006/anbe.1999.1217; Roberts SA, 2012, SCIENCE, V338, P1462, DOI 10.1126/science.1225638; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; Robertson DHL, 1997, RAPID COMMUN MASS SP, V11, P786, DOI 10.1002/(SICI)1097-0231(19970422)11:7<786::AID-RCM876>3.0.CO;2-8; Stowers L, 2013, CURR OPIN NEUROBIOL, V23, P339, DOI 10.1016/j.conb.2013.01.007; SZOKA PR, 1978, GENETICS, V90, P597; Wagner S, 2006, NEURON, V50, P697, DOI 10.1016/j.neuron.2006.04.033; Wyatt TD, 2010, J COMP PHYSIOL A, V196, P685, DOI 10.1007/s00359-010-0564-y; Xia J, 2006, EUR J NEUROSCI, V24, P3333, DOI 10.1111/j.1460-9568.2006.05244.x	51	122	123	2	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					676	688		10.1016/j.cell.2014.02.025	http://dx.doi.org/10.1016/j.cell.2014.02.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766811	Green Accepted, Bronze			2022-12-28	WOS:000335392100016
J	Hicks, CW; Brodsky, DO; Yelland, EA; Gibbs, AS; Bruin, JAN; Barber, ME; Edkins, SD; Nishimura, K; Yonezawa, S; Maeno, Y; Mackenzie, AP				Hicks, Clifford W.; Brodsky, Daniel O.; Yelland, Edward A.; Gibbs, Alexandra S.; Bruin, Jan A. N.; Barber, Mark E.; Edkins, Stephen D.; Nishimura, Keigo; Yonezawa, Shingo; Maeno, Yoshiteru; Mackenzie, Andrew P.			Strong Increase of T-c of Sr2RuO4 Under Both Tensile and Compressive Strain	SCIENCE			English	Article							UPPER CRITICAL-FIELD; GAP STRUCTURE; SUPERCONDUCTIVITY; SYMMETRY; SCATTERING; ANISOTROPY; MODEL	A sensitive probe of unconventional order is its response to a symmetry-breaking field. To probe the proposed p(x) +/- ip(y) topological superconducting state of Sr2RuO4, we have constructed an apparatus capable of applying both compressive and tensile strains of up to 0.23%. Strains applied along < 100 > crystallographic directions yield a strong, strain-symmetric increase in the superconducting transition temperature T-c. < 110 > strains give a much weaker, mostly antisymmetric response. As well as advancing the understanding of the superconductivity of Sr2RuO4, our technique has potential applicability to a wide range of problems in solid-state physics.	[Hicks, Clifford W.; Brodsky, Daniel O.; Barber, Mark E.; Mackenzie, Andrew P.] Max Planck Inst Chem Phys Solids, D-01187 Dresden, Germany; [Hicks, Clifford W.; Brodsky, Daniel O.; Yelland, Edward A.; Gibbs, Alexandra S.; Bruin, Jan A. N.; Barber, Mark E.; Edkins, Stephen D.; Mackenzie, Andrew P.] Univ St Andrews, Sch Phys & Astron, SUPA, St Andrews KY16 9SS, Fife, Scotland; [Yelland, Edward A.] Univ Edinburgh, SUPA, Sch Phys & Astron, Edinburgh EH9 3JZ, Midlothian, Scotland; [Yelland, Edward A.] Univ Edinburgh, Ctr Sci Extreme Condit, Edinburgh EH9 3JZ, Midlothian, Scotland; [Gibbs, Alexandra S.] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Bruin, Jan A. N.] Radboud Univ Nijmegen, High Field Magnet Lab, NL-6525 ED Nijmegen, Netherlands; [Edkins, Stephen D.] Cornell Univ, Dept Phys, Solid State Phys Lab, Ithaca, NY 14853 USA; [Nishimura, Keigo; Yonezawa, Shingo; Maeno, Yoshiteru] Kyoto Univ, Grad Sch Sci, Dept Phys, Kyoto 6068502, Japan	Max Planck Society; University of St Andrews; University of Edinburgh; University of Edinburgh; University of Tokyo; Radboud University Nijmegen; Cornell University; Kyoto University	Hicks, CW (corresponding author), Max Planck Inst Chem Phys Solids, Nothnitzer Str 40, D-01187 Dresden, Germany.	hicks@cpfs.mpg.de; mackenzie@cpfs.mpg.de	Gibbs, Alexandra/AFQ-0263-2022; Mackenzie, Andrew P/K-6742-2015; Yonezawa, Shingo/J-2317-2016; Hicks, Clifford W/N-9719-2015; Gibbs, Alexandra S/M-6027-2013	Mackenzie, Andrew P/0000-0001-8000-4949; Yonezawa, Shingo/0000-0002-7476-3604; Gibbs, Alexandra S/0000-0002-7012-1831; Bruin, Jan/0000-0002-9476-118X; Hicks, Clifford/0000-0002-1736-1406	UK Engineering and Physical Sciences Research Council; Max Planck Society; Royal Society; Ministry of Education, Culture, Sports, Science and Technology [22103002]; Grants-in-Aid for Scientific Research [22103002, 23540407] Funding Source: KAKEN; Engineering and Physical Sciences Research Council [EP/I031014/1, 1265368, 1265332] Funding Source: researchfish; EPSRC [EP/I031014/1] Funding Source: UKRI	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Royal Society(Royal Society of London); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge useful discussions with E. Berg, C. Hooley, A. Huxley, S. Kivelson, J. Sauls, and S. Simon. We thank the UK Engineering and Physical Sciences Research Council, the Max Planck Society, and the Royal Society for financial support. Work at Kyoto University was supported by a KAKENHI grant (no. 22103002) from the Ministry of Education, Culture, Sports, Science and Technology.	Agterberg DF, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.052502; Blaha P., 2001, WIEN2K; Deguchi K, 2004, J PHYS SOC JPN, V73, P1313, DOI 10.1143/JPSJ.73.1313; Deguchi K, 2002, J PHYS SOC JPN, V71, P2839, DOI 10.1143/JPSJ.71.2839; Duffy JA, 2000, PHYS REV LETT, V85, P5412, DOI 10.1103/PhysRevLett.85.5412; Hicks CW, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.214501; Ivanov DA, 2001, PHYS REV LETT, V86, P268, DOI 10.1103/PhysRevLett.86.268; Jang J, 2011, SCIENCE, V331, P186, DOI 10.1126/science.1193839; Jin R, 1999, PHYS REV B, V59, P4433, DOI 10.1103/PhysRevB.59.4433; Kallin C, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/4/042501; Kidwingira F, 2006, SCIENCE, V314, P1267, DOI 10.1126/science.1133239; Kirtley JR, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.014526; Kittaka S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.180510; Kittaka S, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.103705; Kuroki K, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.060506; Kuwabara T, 2000, PHYS REV LETT, V85, P4586, DOI 10.1103/PhysRevLett.85.4586; Luke GM, 1998, NATURE, V394, P558, DOI 10.1038/29038; Lupien C, 2001, PHYS REV LETT, V86, P5986, DOI 10.1103/PhysRevLett.86.5986; Mackenzie AP, 2003, REV MOD PHYS, V75, P657, DOI 10.1103/RevModPhys.75.657; Maeno Y, 1998, PHYS REV LETT, V81, P3765, DOI 10.1103/PhysRevLett.81.3765; MAENO Y, 1994, NATURE, V372, P532, DOI 10.1038/372532a0; Maeno Y, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.011009; Mao ZQ, 2000, PHYS REV LETT, V84, P991, DOI 10.1103/PhysRevLett.84.991; Miyake K, 1999, PHYS REV LETT, V83, P1423, DOI 10.1103/PhysRevLett.83.1423; Murakawa H, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.024716; Nomura T, 2002, J PHYS SOC JPN, V71, P404, DOI 10.1143/JPSJ.71.404; Paglione J, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.220506; Raghu S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136401; SIGRIST M, 1991, REV MOD PHYS, V63, P239, DOI 10.1103/RevModPhys.63.239; Walker MB, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.214508; Wang QH, 2013, EPL-EUROPHYS LETT, V104, DOI 10.1209/0295-5075/104/17013; Xia J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.167002; Yi M, 2011, P NATL ACAD SCI USA, V108, P6878, DOI 10.1073/pnas.1015572108; Zutic I, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.217004	36	219	221	5	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					283	285		10.1126/science.1248292	http://dx.doi.org/10.1126/science.1248292			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744371				2022-12-28	WOS:000334474500031
J	DuPont, HL				DuPont, Herbert L.			Acute Infectious Diarrhea in Immunocompetent Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACUTE GASTROINTESTINAL ILLNESS; CLOSTRIDIUM-DIFFICILE; UNITED-STATES; ESCHERICHIA-COLI; TOXIN PRODUCTION; GASTROENTERITIS; NOROVIRUS; HOSPITALIZATIONS; MANAGEMENT; PATHOGENS		[DuPont, Herbert L.] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [DuPont, Herbert L.] Baylor Coll Med, Sch Med, Baylor St Lukes Med Ctr, Houston, TX 77030 USA; [DuPont, Herbert L.] Kelsey Res Fdn, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine	DuPont, HL (corresponding author), POB 20186, Houston, TX 77025 USA.	herbert.l.dupont@uth.tmc.edu	DuPont, Herbert/AAH-6776-2021					Anderson EJ, 2013, CLIN INFECT DIS, V56, P755, DOI 10.1093/cid/cis1010; [Anonymous], 2013, FDA INV MULT OUTBR C; [Anonymous], 2013, FOOD HANDL NOR WORK; [Anonymous], 2012, TRENDS FOODB ILLN US; Bresee JS, 2012, J INFECT DIS, V205, P1374, DOI 10.1093/infdis/jis206; Carter JD, 2009, RHEUM DIS CLIN N AM, V35, P21, DOI 10.1016/j.rdc.2009.03.010; CDC, 2013, NAT ENT DIS SURV SHI; Darkoh C, 2011, J CLIN MICROBIOL, V49, P2933, DOI 10.1128/JCM.00037-11; Deshpande A, 2012, CURR MED RES OPIN, V28, P1553, DOI 10.1185/03007995.2012.717529; Deshpande A, 2011, CLIN INFECT DIS, V53, pE81, DOI 10.1093/cid/cir505; DiCesare D, 2002, AM J GASTROENTEROL, V97, P2585, DOI 10.1111/j.1572-0241.2002.06027.x; DONOWITZ M, 1995, NEW ENGL J MED, V332, P725, DOI 10.1056/NEJM199503163321107; Dunlop SP, 2003, AM J GASTROENTEROL, V98, P1578, DOI 10.1016/S0002-9270(03)000375-7; Dupont HL, 2013, CLIN GASTROENTEROL H, V11, P1216, DOI 10.1016/j.cgh.2013.03.016; DuPont HL, 2010, AM J TROP MED HYG, V82, P301, DOI 10.4269/ajtmh.2010.09-0538; DuPont HL, 2009, NEW ENGL J MED, V361, P1560, DOI 10.1056/NEJMcp0904162; Ethelberg S, 2007, CLIN MICROBIOL INFEC, V13, P1095, DOI 10.1111/j.1469-0691.2007.01816.x; Flores J, 2009, CURR OPIN INFECT DIS, V22, P471, DOI 10.1097/QCO.0b013e3283304eb6; Forgetta V, 2011, J CLIN MICROBIOL, V49, P2230, DOI 10.1128/JCM.00391-11; Gastanaduy PA, 2013, J INFECT DIS, V207, P1058, DOI 10.1093/infdis/jis942; Godschalk PCR, 2004, J CLIN INVEST, V114, P1659, DOI 10.1172/JCI200415707; Hall AJ, 2012, CLIN INFECT DIS, V55, P216, DOI 10.1093/cid/cis386; Horton KM, 2000, RADIOGRAPHICS, V20, P399, DOI 10.1148/radiographics.20.2.g00mc15399; LaSala PR, 2013, J CLIN MICROBIOL, V51, P311, DOI 10.1128/JCM.02735-12; Liu J, 2012, J CLIN MICROBIOL, V50, P98, DOI 10.1128/JCM.05416-11; MacArthur RD, 2012, CLIN INFECT DIS, V55, P860, DOI 10.1093/cid/cis544; Marcon MJ, 2011, J CLIN MICROBIOL, V49, P2390, DOI 10.1128/JCM.00817-11; Marshall JK, 2010, GUT, V59, P605, DOI 10.1136/gut.2009.202234; Matsuda K, 2012, APPL ENVIRON MICROB, V78, P5111, DOI 10.1128/AEM.07990-11; Montoro MA, 2011, SCAND J GASTROENTERO, V46, P236, DOI 10.3109/00365521.2010.525794; Naravaneni R, 2005, J MED MICROBIOL, V54, P51, DOI 10.1099/jmm.0.45687-0; NEILL MA, 1991, ANN INTERN MED, V114, P195, DOI 10.7326/0003-4819-114-3-195; Newton AE, 2011, EMERG INFECT DIS, V17, P2166, DOI 10.3201/eid1711.110808; Ochoa TJ, 2007, ANTIMICROB AGENTS CH, V51, P2837, DOI 10.1128/AAC.01397-06; Ohara T, 2002, ANTIMICROB AGENTS CH, V46, P3478, DOI 10.1128/AAC.46.11.3478-3483.2002; Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866; Roy Sharon L., 2006, Journal of Water and Health, V4, P31, DOI 10.2166/wh.2006.017; Rump LV, 2012, APPL ENVIRON MICROB, V78, P1615, DOI 10.1128/AEM.07533-11; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Shen B, 2010, GASTROINTEST ENDOSC, V71, P887, DOI 10.1016/j.gie.2009.11.025; Tam CC, 2006, J INFECT DIS, V194, P95, DOI 10.1086/504294; Thabane M, 2009, AM J GASTROENTEROL, V104, P2267, DOI 10.1038/ajg.2009.302; Thornley JP, 2001, J INFECT DIS, V184, P606, DOI 10.1086/322845; Trivedi TK, 2012, JAMA-J AM MED ASSOC, V308, P1668, DOI 10.1001/jama.2012.14023; Villani AC, 2010, GASTROENTEROLOGY, V138, P1502, DOI 10.1053/j.gastro.2009.12.049; Wikswo Mary E., 2012, Morbidity and Mortality Weekly Report, V61, P1; Wilking H, 2013, EPIDEMIOL INFECT, V141, P2365, DOI 10.1017/S0950268813000046	47	80	88	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 17	2014	370	16					1532	1540		10.1056/NEJMra1301069	http://dx.doi.org/10.1056/NEJMra1301069			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF3HE	24738670				2022-12-28	WOS:000334601600010
J	Mei, TS; Patel, HH; Sigman, MS				Mei, Tian-Sheng; Patel, Harshkumar H.; Sigman, Matthew S.			Enantioselective construction of remote quaternary stereocentres	NATURE			English	Article							OXIDATIVE PALLADIUM(II) CATALYSIS; CARBON STEREOGENIC CENTERS; HECK-TYPE REACTION; ALKENYL ALCOHOLS; ASYMMETRIC 1,4-ADDITION; TRISUBSTITUTED ENONES; CONJUGATE ADDITIONS; ALLYLIC ALCOHOLS; ACYCLIC ALKENES; ARYL HALIDES	Small molecules that contain all-carbon quaternary stereocentres-carbon atoms bonded to four distinct carbonsubstituentsare found in many secondary metabolites and some pharmaceutical agents. The construction of such compounds in an enantioselective fashion remains a long-standing challenge to synthetic organic chemists. In particular, methods for synthesizing quaternary stereocentres that are remote from other functional groups are underdeveloped. Here we report a catalytic and enantioselective intermolecular Heck-type reaction of trisubstituted-alkenyl alcohols with aryl boronic acids. This method provides direct access to quaternary all-carbon-substituted beta-, gamma-, delta-, epsilon-or zeta-aryl carbonyl compounds, because the unsaturation of the alkene is relayed to the alcohol, resulting in the formation of a carbonyl group. The scope of the process also includes incorporation of pre-existing stereocentres along the alkyl chain, which links the alkene and the alcohol, in which the stereocentre is preserved. The method described allows access to diverse molecular building blocks containing an enantiomerically enriched quaternary centre.	[Mei, Tian-Sheng; Patel, Harshkumar H.; Sigman, Matthew S.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Sigman, MS (corresponding author), Univ Utah, Dept Chem, 315 South,1400 East, Salt Lake City, UT 84112 USA.	sigman@chem.utah.edu	Mei, Tian-Sheng/Y-3266-2019	Mei, Tian-Sheng/0000-0002-4985-1071	US National Institutes of Health [NIGMS GM063540]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063540, R56GM063540] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the US National Institutes of Health (NIGMS GM063540) for financial support.	Beletskaya IP, 2000, CHEM REV, V100, P3009, DOI 10.1021/cr9903048; Bouquillon S, 2001, J ORGANOMET CHEM, V634, P153, DOI 10.1016/S0022-328X(01)01149-4; Calo V, 2007, J ORG CHEM, V72, P2596, DOI 10.1021/jo070005f; Christoffers J, 2001, ANGEW CHEM INT EDIT, V40, P4591, DOI 10.1002/1521-3773(20011217)40:24<4591::AID-ANIE4591>3.0.CO;2-V; Dabrowski JA, 2013, ANGEW CHEM INT EDIT, V52, P8156, DOI 10.1002/anie.201304035; Dang YF, 2014, J AM CHEM SOC, V136, P986, DOI 10.1021/ja410118m; Das JP, 2011, CHEM COMMUN, V47, P4593, DOI 10.1039/c0cc05222a; Denmark SE, 2001, J AM CHEM SOC, V123, P9488, DOI 10.1021/ja016552e; Douglas CJ, 2004, P NATL ACAD SCI USA, V101, P5363, DOI 10.1073/pnas.0307113101; Dounay AB, 2003, CHEM REV, V103, P2945, DOI 10.1021/cr020039h; Du XL, 2001, ORG LETT, V3, P3313, DOI 10.1021/ol016529y; Gligorich KM, 2009, CHEM COMMUN, P3854, DOI 10.1039/b902868d; Hawner C, 2010, ANGEW CHEM INT EDIT, V49, P7769, DOI 10.1002/anie.201003300; JOHNSON LK, 1995, J AM CHEM SOC, V117, P6414, DOI 10.1021/ja00128a054; Jung B, 2012, J AM CHEM SOC, V134, P1490, DOI 10.1021/ja211269w; Kikushima K, 2011, J AM CHEM SOC, V133, P6902, DOI 10.1021/ja200664x; Kochi T, 2012, J AM CHEM SOC, V134, P16544, DOI 10.1021/ja308377u; Krautwald S, 2013, SCIENCE, V340, P1065, DOI 10.1126/science.1237068; LAROCK RC, 1989, TETRAHEDRON LETT, V30, P6629, DOI 10.1016/S0040-4039(00)70636-8; Lee Y, 2006, J AM CHEM SOC, V128, P15604, DOI 10.1021/ja067456m; Liu WB, 2013, J AM CHEM SOC, V135, P17298, DOI 10.1021/ja4097829; Luchaco-Cullis CA, 2001, ANGEW CHEM INT EDIT, V40, P1456, DOI 10.1002/1521-3773(20010417)40:8<1456::AID-ANIE1456>3.0.CO;2-T; Marek I, 2014, J AM CHEM SOC, V136, P2682, DOI 10.1021/ja410424g; Masarwa A, 2014, NATURE, V505, P199, DOI 10.1038/nature12761; Mauleon P, 2005, CHEM COMMUN, P4961, DOI 10.1039/b508142d; Mc Cartney D, 2011, CHEM SOC REV, V40, P5122, DOI 10.1039/c1cs15101k; Mei TS, 2013, J AM CHEM SOC, V135, P6830, DOI 10.1021/ja402916z; MELPOLDER JB, 1976, J ORG CHEM, V41, P265, DOI 10.1021/jo00864a017; Mermerian AH, 2003, J AM CHEM SOC, V125, P4050, DOI 10.1021/ja028554k; Oliveira CC, 2013, J ORG CHEM, V78, P4373, DOI 10.1021/jo400378g; SAWAMURA M, 1992, J AM CHEM SOC, V114, P8295, DOI 10.1021/ja00047a053; Shi WJ, 2006, J AM CHEM SOC, V128, P2780, DOI 10.1021/ja057654y; Shibasaki M, 2004, ADV SYNTH CATAL, V346, P1533, DOI 10.1002/adsc.200404203; Shintani R, 2010, ANGEW CHEM INT EDIT, V49, P3969, DOI 10.1002/anie.201000467; Sigman MS, 2012, ACCOUNTS CHEM RES, V45, P874, DOI 10.1021/ar200236v; Steinhoff BA, 2006, J ORG CHEM, V71, P1861, DOI 10.1021/jo052192s; Taylor MS, 2003, J AM CHEM SOC, V125, P11204, DOI 10.1021/ja037177o; Trost BM, 2006, SYNTHESIS-STUTTGART, P369, DOI 10.1055/s-2006-926302; Werner EW, 2012, SCIENCE, V338, P1455, DOI 10.1126/science.1229208; Werner EW, 2010, J AM CHEM SOC, V132, P13981, DOI 10.1021/ja1060998; Wu J, 2005, J AM CHEM SOC, V127, P4584, DOI 10.1021/ja050800f; Xu LP, 2014, J AM CHEM SOC, V136, P1960, DOI 10.1021/ja4109616; Yonehara K, 2000, J ORGANOMET CHEM, V603, P40, DOI 10.1016/S0022-328X(00)00069-3; Yoo KS, 2007, ORG LETT, V9, P3933, DOI 10.1021/ol701584f; Yoo KS, 2006, J AM CHEM SOC, V128, P16384, DOI 10.1021/ja063710z; Yoo KS, 2010, J ORG CHEM, V75, P95, DOI 10.1021/jo901977n; Zhang AB, 2006, J AM CHEM SOC, V128, P5620, DOI 10.1021/ja060999b; Zhang P, 2011, J AM CHEM SOC, V133, P9716, DOI 10.1021/ja2039248	48	318	320	10	252	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					340	344		10.1038/nature13231	http://dx.doi.org/10.1038/nature13231			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24717439	Green Accepted			2022-12-28	WOS:000334403000041
J	Harskamp, RE; Newby, LK				Harskamp, Ralf E.; Newby, L. Kristin			Review: CABG reduces long-term mortality and morbidity more than PCI in multivessel coronary disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Harskamp, Ralf E.; Newby, L. Kristin] Duke Clin Res Inst, Durham, NC 27705 USA	Duke University	Harskamp, RE (corresponding author), Duke Clin Res Inst, Durham, NC 27705 USA.							Takagi H, 2012, INT J CARDIOL, V159, P230, DOI 10.1016/j.ijcard.2012.05.046	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2014	160	8							JC9	10.7326/0003-4819-160-8-201404150-02009	http://dx.doi.org/10.7326/0003-4819-160-8-201404150-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW3QU	24733226				2022-12-28	WOS:000364907600008
J	Wichmann, D; Heinemann, A; Weinberg, C; Vogel, H; Hoepker, WW; Grabherr, S; Pueschel, K; Kluge, S				Wichmann, Dominic; Heinemann, Axel; Weinberg, Clemens; Vogel, Hermann; Hoepker, Wilhelm Wolfgang; Grabherr, Silke; Pueschel, Klaus; Kluge, Stefan			Virtual Autopsy With Multiphase Postmortem Computed Tomographic Angiography Versus Traditional Medical Autopsy to Investigate Unexpected Deaths of Hospitalized Patients	ANNALS OF INTERNAL MEDICINE			English	Article							INTENSIVE-CARE-UNIT; MINIMALLY INVASIVE AUTOPSY; CORONARY-ARTERY-DISEASE; CT-ANGIOGRAPHY; CONVENTIONAL AUTOPSY; DIAGNOSTIC ERRORS; DECLINE; RATES	Background: "Virtual" autopsy by postmortem computed tomography (PMCT) can replace medical autopsy to a certain extent but has limitations for cardiovascular diseases. These limitations might be overcome by adding multiphase PMCT angiography. Objective: To compare virtual autopsy by multiphase PMCT angiography with medical autopsy. Design: Prospective cohort study. (ClinicalTrials. gov: NCT01541995) Setting: Single-center study at the University Medical Center Hamburg-Eppendorf, Hamburg, Germany, between 1 April 2012 and 31 March 2013. Patients: Hospitalized patients who died unexpectedly or within 48 hours of an event necessitating cardiopulmonary resuscitation. Measurements: Diagnoses from clinical records were compared with findings from both types of autopsy. New diagnoses identified by autopsy were classified as major or minor, depending on whether they would have altered clinical management. Results: Of 143 eligible patients, 50 (35%) had virtual and medical autopsy. Virtual autopsy confirmed 93% of all 336 diagnoses identified from antemortem medical records, and medical autopsy con-firmed 80%. In addition, virtual and medical autopsy identified 16 new major and 238 new minor diagnoses. Seventy-three of the virtual autopsy diagnoses, including 32 cases of coronary artery stenosis, were identified solely by multiphase PMCT angiography. Of the 114 clinical diagnoses classified as cardiovascular, 110 were confirmed by virtual autopsy and 107 by medical autopsy. In 11 cases, multiphase PMCT angiography showed "unspecific filling defects," which were not reported by medical autopsy. Limitation: These results come from a single center with concerted interest and expertise in postmortem imaging; further studies are thus needed for generalization. Conclusion: In cases of unexpected death, the addition of multiphase PMCT angiography increases the value of virtual autopsy, making it a feasible alternative for quality control and identification of diagnoses traditionally made by medical autopsy.	Univ Med Ctr Hamburg Eppendorf, D-20246 Hamburg, Germany; CHU Vaudois, Ctr Univ Romand Med Legale, CH-1011 Lausanne, Switzerland	University of Hamburg; University Medical Center Hamburg-Eppendorf	Wichmann, D (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Intens Care Med, Martinistr 52, D-20246 Hamburg, Germany.	d.wichmann@uke.de		Weinberg, Clarice/0000-0002-7713-8556	Fondation Leenaards; University Medical Center Hamburg-Eppendorf; PMCT angiography	Fondation Leenaards; University Medical Center Hamburg-Eppendorf; PMCT angiography	By the University Medical Center Hamburg-Eppendorf. Dr. Grabherr had personal academic funding from the Fondation Leenaards. Fumedica provided consumables for multiphase PMCT angiography.	Aghayev Emin, 2008, J Forensic Leg Med, V15, P382, DOI 10.1016/j.jflm.2008.02.007; Bombi JA, 2003, PATHOL RES PRACT, V199, P9, DOI 10.1078/0344-0338-00346; Bruguier C, 2013, INT J LEGAL MED, V127, P639, DOI 10.1007/s00414-013-0840-9; Cabot RC, 1912, J AMER MED ASSOC, V59, P2295; Christine C, 2013, INT J LEGAL MED, V127, P981, DOI 10.1007/s00414-012-0814-3; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; Combes A, 2004, ARCH INTERN MED, V164, P389, DOI 10.1001/archinte.164.4.389; Dimopoulos G, 2004, INTENS CARE MED, V30, P2080, DOI 10.1007/s00134-004-2448-5; Esteban A, 1999, INTENS CARE MED, V25, P343, DOI 10.1007/s001340050853; eulerAPE, 2013, DRAWING AREA PROPORT; GOLDMAN L, 1983, NEW ENGL J MED, V308, P1000, DOI 10.1056/NEJM198304283081704; Grabherr S, 2011, INT J LEGAL MED, V125, P791, DOI 10.1007/s00414-010-0526-5; Jackowski C, 2004, J FORENSIC SCI, V49, P1339; Michaud K, 2012, INT J CARDIOVAS IMAG, V28, P1807, DOI 10.1007/s10554-012-0012-x; Minino Arialdi M, 2012, NCHS Data Brief, P1; O'Grady G, 2003, BRIT MED J, V327, P802, DOI 10.1136/bmj.327.7418.802; Palmiere C, 2012, FORENSIC SCI INT, V222, P33, DOI 10.1016/j.forsciint.2012.04.031; Roberts ISD, 2011, CLIN RADIOL, V66, P645, DOI 10.1016/j.crad.2011.01.007; Roberts ISD, 2014, HISTOPATHOLOGY, V64, P211, DOI 10.1111/his.12271; Roberts ISD, 2012, LANCET, V379, P136, DOI 10.1016/S0140-6736(11)61483-9; ROBERTS WC, 1978, NEW ENGL J MED, V299, P332, DOI 10.1056/NEJM197808172990704; Ross SG, 2012, RADIOLOGY, V264, P250, DOI 10.1148/radiol.12092415; Saunders SL, 2011, INT J LEGAL MED, V125, P609, DOI 10.1007/s00414-011-0559-4; Saunders SL, 2011, FORENSIC SCI MED PAT, V7, P271, DOI 10.1007/s12024-010-9208-3; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849; START RD, 1993, J PATHOL, V171, P63, DOI 10.1002/path.1711710113; Tejerina E, 2012, CRIT CARE MED, V40, P842, DOI 10.1097/CCM.0b013e318236f64f; Veress B, 1993, Qual Assur Health Care, V5, P281; Weustink AC, 2009, RADIOLOGY, V250, P897, DOI 10.1148/radiol.2503080421; Wichmann D, 2012, ANN INTERN MED, V156, P123, DOI 10.7326/0003-4819-156-2-201201170-00008; Winters B, 2012, BMJ QUAL SAF, V21, P894, DOI 10.1136/bmjqs-2012-000803; Zerlauth JB, 2013, FORENSIC SCI INT, V225, P32, DOI 10.1016/j.forsciint.2012.05.013	32	39	40	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 15	2014	160	8					534	+		10.7326/M13-2211	http://dx.doi.org/10.7326/M13-2211			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG0ZE	24733194				2022-12-28	WOS:000335143700003
J	Casale, TB; Burks, AW				Casale, Thomas B.; Burks, A. Wesley			Hymenoptera-Sting Hypersensitivity	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							DISCONTINUING VENOM IMMUNOTHERAPY; LARGE LOCAL REACTIONS; SYSTEMIC REACTION; INSECT STINGS; DOUBLE-BLIND; ALLERGY; CHALLENGE; ANAPHYLAXIS; SEVERITY; SYMPTOMS	Anaphylactic reactions after a hymenoptera sting should be treated promptly with intramuscular epinephrine. Patients who have had such a reaction should carry injectable epinephrine and be referred to an allergist for insect-specific testing and subcutaneous immunotherapy if indicated. ForewordThis Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the authors' clinical recommendations.StageA 24-year-old woman reported that a bee stung her upper lip while she was drinking from a can of soda at a picnic. Within 5 minutes, her lips swelled, and she became hoarse and light-headed and had difficulty swallowing. Diffuse flushing and urticaria also developed. She was taken to a local emergency department and received intramuscular epinephrine and intravenous fluids along with H-1-antihistamines. Her symptoms resolved, and after 3 hours of observation she was discharged with an epinephrine auto-injector. How should her case be managed from this point forward? The Clinical Problem Although anaphylaxis due to an ... Hypersensitivity to Hymenoptera Stings Stings from insects of the order Hymenoptera are important causes of systemic allergic reactions. In sensitized persons, venom that is injected by a sting binds to venom-specific IgE on mast cells, with the subsequent release of mast-cell mediators that cause allergic reactions ranging from local reactions or urticaria to anaphylaxis and even death. Acute systemic allergic reactions typically occur very rapidly after a hymenoptera sting but may be delayed for several hours or be biphasic. The treatment of a hymenoptera-induced anaphylactic reaction (as for anaphylaxis caused by any other trigger) is the prompt administration of intramuscular epinephrine. Patients who have had a systemic reaction to an insect sting should be referred to an allergist-immunologist for testing for venom-specific IgE. Subcutaneous immunotherapy should be considered routinely in patients who have had a systemic allergic reaction to an insect sting and who have a positive test result for venom-specific IgE.	[Casale, Thomas B.] Univ S Florida, Morsani Coll Med, Tampa, FL 33612 USA; [Burks, A. Wesley] Univ N Carolina, Sch Med, Chapel Hill, NC USA	State University System of Florida; University of South Florida; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Casale, TB (corresponding author), Univ S Florida, Div Allergy & Immunol, Morsani Coll Med, 2901 Bruce B Downs Blvd,MDC 19, Tampa, FL 33612 USA.	tbcasale@health.usf.edu	Casale, Thomas B/K-4334-2013	Casale, Thomas B/0000-0002-3149-7377	Stallergenes; Genentech; Novartis; ALK-Albello; Merck; Abbott Laboratories; McNeil Nutritionals; Gerson Lehrman Group Research	Stallergenes; Genentech(Roche HoldingGenentech); Novartis(Novartis); ALK-Albello; Merck(Merck & Company); Abbott Laboratories(Abbott Laboratories); McNeil Nutritionals; Gerson Lehrman Group Research	Dr. Casale reports receiving consulting fees from Stallergenes and consulting fees to his institution from Genentech and Novartis; grant support from Novartis, Genentech, ALK-Albello, Merck, and Stallergenes; and lecture fees from ALK-Albello. Dr. Burks reports receiving consulting fees from Abbott Laboratories, McNeil Nutritionals, and Gerson Lehrman Group Research; serving as an unpaid consultant for Dow AgroSciences, Merck, Novartis, Schering-Plough, Unilever, ExploraMed Development, Nordic Biotech Advisors, Nutricia North America, Perrigo, Portola Pharmaceuticals, Regeneron Pharmaceuticals, and Perosphere; owning stock in Allertein Therapeutics and Mast Cell Pharmaceuticals; and giving an unpaid lecture for Mylan Specialty. No other potential conflict of interest relevant to this article was reported.	Bilo BM, 2008, CURR OPIN ALLERGY CL, V8, P330, DOI 10.1097/ACI.0b013e32830638c5; Bilo MB, 2009, CLIN EXP ALLERGY, V39, P1467, DOI 10.1111/j.1365-2222.2009.03324.x; Bonifazi F, 2005, ALLERGY, V60, P1459, DOI 10.1111/j.1398-9995.2005.00960.x; Brown SGA, 2003, LANCET, V361, P1001, DOI 10.1016/S0140-6736(03)12827-9; Ellis AK, 2007, ANN ALLERG ASTHMA IM, V98, P64, DOI 10.1016/S1081-1206(10)60861-7; Forester JP, 2007, ALLERGY ASTHMA PROC, V28, P485, DOI 10.2500/aap.2007.28.3021; FRANKEN HH, 1994, J ALLERGY CLIN IMMUN, V93, P431, DOI 10.1016/0091-6749(94)90351-4; Freeman TM, 2004, NEW ENGL J MED, V351, P1978, DOI 10.1056/NEJMcp042013; Goldberg A, 1997, J ALLERGY CLIN IMMUN, V100, P182, DOI 10.1016/S0091-6749(97)70222-7; Golden DBK, 2009, J ALLERGY CLIN IMMUN, V123, P1371, DOI 10.1016/j.jaci.2009.03.017; Golden DB, 2011, J ALLERGY CLIN IMMUN, V127; Golden DBK, 2006, J ALLERGY CLIN IMMUN, V117, P670, DOI 10.1016/j.jaci.2005.12.1313; Golden DBK, 2004, NEW ENGL J MED, V351, P668, DOI 10.1056/NEJMoa022952; Golden DBK, 2003, J ALLERGY CLIN IMMUN, V112, P495, DOI [10.1067/mai.2003.1606, 10.1016/S0091-6749(03)01537-9]; Golden DBK, 1996, J ALLERGY CLIN IMMUN, V97, P579, DOI 10.1016/S0091-6749(96)70302-0; Golden DBK, 2000, J ALLERGY CLIN IMMUN, V105, P385, DOI 10.1016/S0091-6749(00)90092-7; Golden DBK, 1998, J ALLERGY CLIN IMMUN, V101, P298, DOI 10.1016/S0091-6749(98)70239-8; GOLDEN DBK, 1989, JAMA-J AM MED ASSOC, V262, P240, DOI 10.1001/jama.262.2.240; Golden DBK, 2001, J ALLERGY CLIN IMMUN, V107, P897, DOI 10.1067/mai.2001.114706; Golden DBK, 2009, MIDDLETONS ALLERGY P, V7th, P1005; Graft DF, 1998, J ALLERGY CLIN IMMUN, V101, P573, DOI 10.1016/S0091-6749(98)70161-7; Hafner T, 2008, ANN ALLERG ASTHMA IM, V100, P162, DOI 10.1016/S1081-1206(10)60425-5; HAUGAARD L, 1991, J ALLERGY CLIN IMMUN, V87, P699, DOI 10.1016/0091-6749(91)90391-Z; Hoffman D., 2003, MONOGRAPH INSECT ALL, P37; HOFFMAN DR, 1984, ANN ALLERGY, V52, P276; HOFFMAN DR, 1988, J ALLERGY CLIN IMMUN, V82, P818, DOI 10.1016/0091-6749(88)90084-X; KEATING MU, 1991, J ALLERGY CLIN IMMUN, V88, P339, DOI 10.1016/0091-6749(91)90095-6; King TP, 2000, INT ARCH ALLERGY IMM, V123, P99, DOI 10.1159/000024440; Korenblat P, 1999, ALLERGY ASTHMA PROC, V20, P383, DOI 10.2500/108854199778251834; Lerch E, 1998, J ALLERGY CLIN IMMUN, V101, P606, DOI 10.1016/S0091-6749(98)70167-8; Lieberman P, 2005, ANN ALLERG ASTHMA IM, V95, P217, DOI 10.1016/S1081-1206(10)61217-3; LIGHT WC, 1977, J ALLERGY CLIN IMMUN, V59, P391, DOI 10.1016/0091-6749(77)90024-0; Moffitt JE, 1997, ANN ALLERG ASTHMA IM, V79, P125, DOI 10.1016/S1081-1206(10)63098-0; MULLER U, 1991, J ALLERGY CLIN IMMUN, V87, P702, DOI 10.1016/0091-6749(91)90392-2; REISMAN RE, 1992, J ALLERGY CLIN IMMUN, V90, P335, DOI 10.1016/S0091-6749(05)80012-0; REISMAN RE, 1993, J ALLERGY CLIN IMMUN, V92, P831, DOI 10.1016/0091-6749(93)90060-S; Reisman RE, 2001, J ALLERGY CLIN IMMUN, V107, P781, DOI 10.1067/mai.2001.115042; Rueff F, 1996, ALLERGY, V51, P216, DOI 10.1111/j.1398-9995.1996.tb04596.x; Rueff F, 2001, J ALLERGY CLIN IMMUN, V108, P1027, DOI 10.1067/mai.2001.119154; SCHUMACHER MJ, 1994, J ALLERGY CLIN IMMUN, V93, P831, DOI 10.1016/0091-6749(94)90373-5; SETTIPANE GA, 1970, ACTA ALLERGOL, V25, P286, DOI 10.1111/j.1398-9995.1970.tb01264.x; SETTIPANE GA, 1972, J ALLERGY CLIN IMMUN, V50, P146, DOI 10.1016/0091-6749(72)90045-0; Severino MG, 2008, J ALLERGY CLIN IMMUN, V122, P44, DOI 10.1016/j.jaci.2008.03.031; Simons FER, 2011, WORLD ALLERGY ORGAN, V4, P13, DOI 10.1097/WOX.0b013e318211496c; VALENTINE MD, 1990, NEW ENGL J MED, V323, P1601, DOI 10.1056/NEJM199012063232305; VANDERLINDEN PWG, 1994, J ALLERGY CLIN IMMUN, V94, P151, DOI 10.1053/ai.1994.v94.a54889	46	29	30	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 10	2014	370	15					1432	1439		10.1056/NEJMcp1302681	http://dx.doi.org/10.1056/NEJMcp1302681			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6IW	24716682				2022-12-28	WOS:000334095200011
J	Hurley, JH; Schulman, BA				Hurley, James H.; Schulman, Brenda A.			Atomistic Autophagy: The Structures of Cellular Self-Digestion	CELL			English	Review							VACUOLE TARGETING PATHWAY; SELECTIVE AUTOPHAGY; CRYSTAL-STRUCTURE; ATG12-ATG5 CONJUGATE; SACCHAROMYCES-CEREVISIAE; MEMBRANE-BINDING; ANTIBACTERIAL AUTOPHAGY; RECEPTOR GALECTIN-8; PROTEIN LIPIDATION; SPINDLE CHECKPOINT	Autophagy is directed by numerous distinct autophagy-related (Atg) proteins. These transmit starvation-induced signals to lipids and regulatory proteins and assemble a double-membrane autophagosome sequestering bulk cytoplasm and/or selected cargos destined for degradation upon autophagosome fusion with a vacuole or lysosome. This Review discusses the structural mechanisms by which Atg proteins sense membrane curvature, mediate a PI(3) P-signaling cascade, and utilize autophagy-specific ubiquitin-like protein cascades to tether proteins to autophagosomal membranes. Recent elucidation of molecular interactions enabling vesicle nucleation, elongation, and cargo recruitment provides insights into how dynamic protein-protein and protein-membrane interactions may dictate size, shape, and contents of autophagosomes.	[Hurley, James H.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Schulman, Brenda A.] St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA	University of California System; University of California Berkeley; St Jude Children's Research Hospital; Howard Hughes Medical Institute; St Jude Children's Research Hospital	Hurley, JH (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	jimhurley@berkeley.edu; brenda.schulman@stjude.org		Schulman, Brenda/0000-0002-3083-1126	Howard Hughes Medical Institute; NIH [R01GM077053, P30CA021765]; ALSAC; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077053] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S. Baskaran and M. Ragusa are thanked for generating figures. B.A.S. acknowledges the Howard Hughes Medical Institute and NIH R01GM077053, P30CA021765, and ALSAC for support.	Baskaran S, 2012, MOL CELL, V47, P339, DOI 10.1016/j.molcel.2012.05.027; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bestebroer J, 2013, TRAFFIC, V14, P1029, DOI 10.1111/tra.12091; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Bruns C, 2011, J CELL BIOL, V195, P979, DOI 10.1083/jcb.201106098; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Cheong H, 2008, MOL BIOL CELL, V19, P668, DOI 10.1091/mbc.E07-08-0826; Chew LH, 2013, AUTOPHAGY, V9, P1467, DOI 10.4161/auto.25687; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Fan W, 2011, P NATL ACAD SCI USA, V108, P7769, DOI 10.1073/pnas.1016472108; Fogel AI, 2013, MOL CELL BIOL, V33, P3675, DOI 10.1128/MCB.00079-13; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Fujioka Y, 2010, J BIOL CHEM, V285, P1508, DOI 10.1074/jbc.M109.053520; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Graef M, 2013, MOL BIOL CELL, V24, P2918, DOI 10.1091/mbc.E13-07-0381; Hain AUP, 2012, J STRUCT BIOL, V180, P551, DOI 10.1016/j.jsb.2012.09.001; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Heenan EJ, 2009, BIOCHEMISTRY-US, V48, P6390, DOI 10.1021/bi900621w; Hong SB, 2012, ACTA CRYSTALLOGR D, V68, P1409, DOI 10.1107/S0907444912034166; Hong SB, 2011, NAT STRUCT MOL BIOL, V18, P1323, DOI 10.1038/nsmb.2165; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Huang WJ, 2012, CELL RES, V22, P473, DOI 10.1038/cr.2012.24; Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Jao CC, 2013, P NATL ACAD SCI USA, V110, P5486, DOI 10.1073/pnas.1220306110; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kaiser SE, 2013, AUTOPHAGY, V9, P778, DOI 10.4161/auto.23644; Karanasios E, 2013, J CELL SCI, V126, P5224, DOI 10.1242/jcs.132415; Kaufmann A, 2014, CELL, V156, P469, DOI 10.1016/j.cell.2013.12.022; Kim BW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2606; Kim JY, 2013, CELL, V154, P365, DOI 10.1016/j.cell.2013.06.012; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kondo-Okamoto N, 2012, J BIOL CHEM, V287, P10631, DOI 10.1074/jbc.M111.299917; Krick R, 2012, P NATL ACAD SCI USA, V109, pE2042, DOI 10.1073/pnas.1205128109; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Kumanomidou T, 2006, J MOL BIOL, V355, P612, DOI 10.1016/j.jmb.2005.11.018; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; Li S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003730; Li XH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1648; Mao K, 2013, P NATL ACAD SCI USA, V110, pE2875, DOI 10.1073/pnas.1300064110; Mapelli M, 2007, CURR OPIN STRUC BIOL, V17, P716, DOI 10.1016/j.sbi.2007.08.011; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; Metlagel Z, 2013, P NATL ACAD SCI USA, V110, P18844, DOI 10.1073/pnas.1314755110; Miller S, 2010, SCIENCE, V327, P1638, DOI 10.1126/science.1184429; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Moreau K, 2013, TRENDS BIOCHEM SCI, V38, P57, DOI 10.1016/j.tibs.2012.11.004; Noda NN, 2013, EMBO REP, V14, P206, DOI 10.1038/embor.2012.208; Noda NN, 2012, J BIOL CHEM, V287, P16256, DOI 10.1074/jbc.M112.348250; Noda NN, 2011, MOL CELL, V44, P462, DOI 10.1016/j.molcel.2011.08.035; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Otomo C, 2013, NAT STRUCT MOL BIOL, V20, P59, DOI 10.1038/nsmb.2431; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Qiu Y, 2013, PROTEIN SCI, V22, P1691, DOI 10.1002/pro.2381; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; Ragusa MJ, 2012, CELL, V151, P1501, DOI 10.1016/j.cell.2012.11.028; Reggiori F, 2013, GENETICS, V194, P341, DOI 10.1534/genetics.112.149013; Reggiori F, 2010, CELL HOST MICROBE, V7, P500, DOI 10.1016/j.chom.2010.05.013; Rieter E, 2013, J CELL SCI, V126, P593, DOI 10.1242/jcs.115725; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Rogov VV, 2013, BIOCHEM J, V454, P459, DOI 10.1042/BJ20121907; Romanov J, 2012, EMBO J, V31, P4304, DOI 10.1038/emboj.2012.278; Rozenknop A, 2011, J MOL BIOL, V410, P477, DOI 10.1016/j.jmb.2011.05.003; Rubinsztein DC, 2012, CURR BIOL, V22, pR29, DOI 10.1016/j.cub.2011.11.034; Sakoh-Nakatogawa M, 2013, NAT STRUCT MOL BIOL, V20, P433, DOI 10.1038/nsmb.2527; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Schreiber A, 2014, BBA-MOL CELL RES, V1843, P163, DOI 10.1016/j.bbamcr.2013.03.019; Scott SV, 2000, J BIOL CHEM, V275, P25840, DOI 10.1074/jbc.M002813200; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Shintani T, 1999, EMBO J, V18, P5234, DOI 10.1093/emboj/18.19.5234; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Sugawara K, 2005, J BIOL CHEM, V280, P40058, DOI 10.1074/jbc.M509158200; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Suzuki H, 2014, STRUCTURE, V22, P47, DOI 10.1016/j.str.2013.09.023; Suzuki K, 2013, J CELL SCI, V126, P2534, DOI 10.1242/jcs.122960; Suzuki NN, 2005, AUTOPHAGY, V1, P119, DOI 10.4161/auto.1.2.1859; Taherbhoy AM, 2011, MOL CELL, V44, P451, DOI 10.1016/j.molcel.2011.08.034; Tamura N, 2013, J CELL BIOL, V202, P685, DOI 10.1083/jcb.201302067; Thielmann Y, 2009, FEBS J, V276, P1140, DOI 10.1111/j.1742-4658.2008.06857.x; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; von Muhlinen N, 2012, MOL CELL, V48, P329, DOI 10.1016/j.molcel.2012.08.024; Watanabe Y, 2012, J BIOL CHEM, V287, P31681, DOI 10.1074/jbc.M112.397570; Wei YJ, 2013, CELL, V154, P1269, DOI 10.1016/j.cell.2013.08.015; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Weiergraber OH, 2008, J MOL BIOL, V381, P1320, DOI 10.1016/j.jmb.2008.06.086; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yamaguchi M, 2012, STRUCTURE, V20, P1244, DOI 10.1016/j.str.2012.04.018; Yamaguchi M, 2010, J BIOL CHEM, V285, P29599, DOI 10.1074/jbc.M110.113670; Yamamoto H, 2012, J CELL BIOL, V198, P219, DOI 10.1083/jcb.201202061; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yeh YY, 2011, J BIOL CHEM, V286, P28931, DOI 10.1074/jbc.M111.250324	100	137	155	1	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					300	311		10.1016/j.cell.2014.01.070	http://dx.doi.org/10.1016/j.cell.2014.01.070			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725401	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000334304500006
J	Martin, I; Kim, JW; Lee, BD; Kang, HC; Xu, JC; Jia, H; Stankowski, J; Kim, MS; Zhong, J; Kumar, M; Andrabi, SA; Xiong, YL; Dickson, DW; Wszolek, ZK; Pandey, A; Dawson, TM; Dawson, VL				Martin, Ian; Kim, Jungwoo Wren; Lee, Byoung Dae; Kang, Ho Chul; Xu, Jin-Chong; Jia, Hao; Stankowski, Jeannette; Kim, Min-Sik; Zhong, Jun; Kumar, Manoj; Andrabi, Shaida A.; Xiong, Yulan; Dickson, Dennis W.; Wszolek, Zbigniew K.; Pandey, Akhilesh; Dawson, Ted M.; Dawson, Valina L.			Ribosomal Protein s15 Phosphorylation Mediates LRRK2 Neurodegeneration in Parkinson's Disease	CELL			English	Article							REPEAT KINASE 2; TRANSLATIONAL REPRESSION; NEURONAL TOXICITY; GTP-BINDING; MUTATIONS; TDP-43; 4E-BP; AUTOPHOSPHORYLATION; DROSOPHILA; MODEL	Mutations in leucine-rich repeat kinase 2 (LRRK2) are a common cause of familial and sporadic Parkinson's disease (PD). Elevated LRRK2 kinase activity and neurodegeneration are linked, but the phosphosubstrate that connects LRRK2 kinase activity to neurodegeneration is not known. Here, we show that ribosomal protein s15 is a key pathogenic LRRK2 substrate in Drosophila and human neuron PD models. Phosphodeficient s15 carrying a threonine 136 to alanine substitution rescues dopamine neuron degeneration and age-related locomotor deficits in G2019S LRRK2 transgenic Drosophila and substantially reduces G2019S LRRK2-mediated neurite loss and cell death in human dopamine and cortical neurons. Remarkably, pathogenic LRRK2 stimulates both cap-dependent and cap-independent mRNA translation and induces a bulk increase in protein synthesis in Drosophila, which can be prevented by phosphodeficient T136A s15. These results reveal a novel mechanism of PD pathogenesis linked to elevated LRRK2 kinase activity and aberrant protein synthesis in vivo.	[Martin, Ian; Kim, Jungwoo Wren; Lee, Byoung Dae; Kang, Ho Chul; Xu, Jin-Chong; Jia, Hao; Stankowski, Jeannette; Kumar, Manoj; Andrabi, Shaida A.; Xiong, Yulan; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat & Stem Cell Programs, Baltimore, MD 21205 USA; [Martin, Ian; Lee, Byoung Dae; Kang, Ho Chul; Xu, Jin-Chong; Stankowski, Jeannette; Kumar, Manoj; Andrabi, Shaida A.; Xiong, Yulan; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Kim, Jungwoo Wren; Jia, Hao; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Kim, Min-Sik; Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Kim, Min-Sik; Zhong, Jun; Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Lee, Byoung Dae] Kyung Hee Univ, Dept Neurosci, Age Related & Brain Dis Res Ctr, Seoul 130701, South Korea; [Kang, Ho Chul] Ajou Univ, Sch Med, Dept Physiol, Suwon 443749, South Korea; [Martin, Ian; Kim, Jungwoo Wren; Jia, Hao; Stankowski, Jeannette; Andrabi, Shaida A.; Pandey, Akhilesh; Dawson, Ted M.; Dawson, Valina L.] Adrienne Helis Malvin Med Res Fdn, New Orleans, LA 70130 USA; [Pandey, Akhilesh] Diana Helis Henry Med Res Fdn, New Orleans, LA 70130 USA; [Dickson, Dennis W.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Wszolek, Zbigniew K.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Kyung Hee University; Ajou University; Mayo Clinic; Mayo Clinic	Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat & Stem Cell Programs, Baltimore, MD 21205 USA.	tdawson@jhmi.edu; vdawson@jhmi.edu	Kim, Min-Sik/M-3488-2016; Kim, Min-Sik/N-5010-2018; Wszolek, Zbigniew K./AAB-1431-2019; Zhong, Jun/D-1662-2010; Dawson, Valina/Y-9757-2019	Kim, Min-Sik/0000-0001-7317-5360; Kim, Min-Sik/0000-0001-7317-5360; Zhong, Jun/0000-0003-3148-4143; Dawson, Valina/0000-0002-2915-3970; Dickson, Dennis W/0000-0001-7189-7917; Kim, J. Wren/0000-0002-0957-7821	Merck KGAA; National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) [P50NS038377]; JPB Foundation; MDSCRF [2007-MSCRFI-0420-00, 2009-MSCRFII-0125-00, 2013-MSCRFII-0105-00]; NIH/NINDS [P50 NS072187]; New York Stem Cell Foundation-Druckenmiller Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS072187, P50NS038377] Funding Source: NIH RePORTER	Merck KGAA(Merck & Company); National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); JPB Foundation; MDSCRF; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); New York Stem Cell Foundation-Druckenmiller Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge the Adrienne Helis Malvin Medical Research Foundation and the Diana Helis Henry Medical Research Foundation and their direct engagement in the continuous active conduct of medical research in conjunction with The Johns Hopkins Hospital and The Johns Hopkins University School of Medicine and the Foundations' Parkinson's Disease Programs. The authors acknowledge the Johns Hopkins Stem Cell Core Facility for providing a subset of the human neurons used in this study. Funding for a portion of the research described in this article was provided by Merck KGAA. Under a licensing agreement between Merck KGAA and The Johns Hopkins University, Dr. Dawson and the University shared fees received by the University on licensing of some of the reagents described in this article. Dr. Dawson also was a paid consultant to Merck KGAA. The terms of this arrangement are being managed by The Johns Hopkins University in accordance with its conflict of interest policies. Mayo Clinic and Dr. Wszolek have a financial interest in a technology (LRRK2 gene) referenced in this manuscript. This technology has been licensed to a commercial entity and Mayo Clinic and Dr. Wszolek receive royalties from that license. Dr. Wszolek's annual royalties are less than $200 per year. This work was also supported by National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) P50NS038377, the JPB Foundation, and the MDSCRF 2007-MSCRFI-0420-00, 2009-MSCRFII-0125-00, MDSCRF 2013-MSCRFII-0105-00 to T.M.D. and V.L.D., NIH/NINDS P50 NS072187 to D.D. and Z.K.W., and a New York Stem Cell Foundation-Druckenmiller Fellowship to I.M. T.M.D. is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases.	Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; [Anonymous], 2011, REPROD HEALTH MATTER, V19, P4, DOI DOI 10.3389/C0NF.FNINF.V0L.58; Belin S., 2010, CURR PROTOC CELL BIO; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Covy JP, 2009, BIOCHEM BIOPH RES CO, V378, P473, DOI 10.1016/j.bbrc.2008.11.048; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Khairulina J, 2010, BIOCHIMIE, V92, P820, DOI 10.1016/j.biochi.2010.02.031; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008730; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; Li XJ, 2010, J BIOL CHEM, V285, P29569, DOI 10.1074/jbc.M110.127639; Liu Z, 2008, P NATL ACAD SCI USA, V105, P2693, DOI 10.1073/pnas.0708452105; Luzon-Toro B, 2007, HUM MOL GENET, V16, P2031, DOI 10.1093/hmg/ddm151; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Nuytemans K, 2013, NEUROLOGY, V80, P982, DOI 10.1212/WNL.0b013e31828727d4; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Ramsden N, 2011, ACS CHEM BIOL, V6, P1021, DOI 10.1021/cb2002413; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Trancikova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047784; Tsika E, 2012, CURR NEUROL NEUROSCI, V12, P251, DOI 10.1007/s11910-012-0265-8; Webber PJ, 2011, J MOL BIOL, V412, P94, DOI 10.1016/j.jmb.2011.07.033; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Xiong YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000902; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	38	169	170	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					472	485		10.1016/j.cell.2014.01.064	http://dx.doi.org/10.1016/j.cell.2014.01.064			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725412	Green Accepted, Bronze			2022-12-28	WOS:000334304500019
J	Leclerc-Madlala, S				Leclerc-Madlala, Suzanne Madlala			Silver bullets, glass beads, and strengthening Africa's HIV response	LANCET			English	Editorial Material									Global Hlth Bur, Off HIV AIDS, USAID, Washington, DC 20036 USA	United States Agency for International Development (USAID)	Leclerc-Madlala, S (corresponding author), Global Hlth Bur, Off HIV AIDS, USAID, Washington, DC 20036 USA.	Sleclerc-madlala@usaid.gov						Airhihenbuwa C, 1999, J HLTH ED, V1, P267; Ezo MO, 2008, S AFRICAN J PHILOS, V27, P386; Green E, 2011, AIDS BEHAV CULTURE; Kippax S, 2012, AM J PUBLIC HEALTH, V102, P789, DOI 10.2105/AJPH.2011.300594; Ware NC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001369	5	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 5	2014	383	9924					1203	1204		10.1016/S0140-6736(14)60593-6	http://dx.doi.org/10.1016/S0140-6736(14)60593-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE6LO	24712031				2022-12-28	WOS:000334104600013
J	Curry, SJ; Grossman, DC; Whitlock, EP; Cantu, A				Curry, Susan J.; Grossman, David C.; Whitlock, Evelyn P.; Cantu, Adelita			Behavioral Counseling Research and Evidence-Based Practice Recommendations: US Preventive Services Task Force Perspectives	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH; TRANSLATION; INTERVENTIONS; ISSUES; PRECIS	The U.S. Preventive Services Task Force (USPSTF) makes recommendations on which preventive services to routinely incorporate into primary care for specific populations. Behavioral counseling interventions are preventive services designed to help persons engage in healthy behaviors and limit unhealthy ones. The USPSTF's evaluation of behavioral counseling interventions asks 2 primary questions: Do interventions in the clinical setting influence persons to change their behavior, and does changing health behavior improve health outcomes with minimal harms? This article discusses challenges encountered by the USPSTF in aggregating the behavioral counseling intervention literature to develop guidelines. The challenges relate broadly to study populations, intervention protocols, assessment of outcomes, and linking behavior changes to health outcomes. Recommendations to address these challenges include use of the PRECIS (Pragmatic-Explanatory Continuum Indicator Summary) tool as a guide for the development of feasible, replicable, and generalizable behavioral counseling interventions; improved reporting of study methods and results; consensus measures for key behavioral outcomes; and use of existing data sets to link behavior change and clinical outcomes.	Univ Iowa, Iowa City, IA 52242 USA; Grp Hlth Res Inst, Seattle, WA 98101 USA; Kaiser Permanente Res Affiliates Evidence Based P, Portland, OR 97227 USA; Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78228 USA	University of Iowa; Kaiser Permanente; University of Texas System; University of Texas Health San Antonio	Curry, SJ (corresponding author), Univ Iowa, Coll Publ Hlth, 105 River St,S153A CPHB, Iowa City, IA 52242 USA.	Sue-curry@uiowa.edu						Barton M, 2010, PEDIATRICS, V125, P361, DOI 10.1542/peds.2009-2037; Bouchard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037887; Chaudoir SR, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-22; Community Preventive Services Task Force, 2012, 2012 ANN REP C AG RE; *CONSORT GROUP, CONSORT STAT; Curry SJ, 2003, FULFILLING POTENTIAL; Davidson KW, 2003, ANN BEHAV MED, V26, P161, DOI 10.1207/S15324796ABM2603_01; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Elder JP, 1999, AM J PREV MED, V17, P275, DOI 10.1016/S0749-3797(99)00094-X; Fisher EB, 2011, AM J PREV MED, V40, pE15, DOI 10.1016/j.amepre.2010.12.031; Glasgow RE, 2003, AM J PUBLIC HEALTH, V93, P1261, DOI 10.2105/AJPH.93.8.1261; Glasgow RE, 2004, ANN BEHAV MED, V27, P3, DOI 10.1207/s15324796abm2701_2; Glasgow RE, 2013, HEALTH EDUC BEHAV, V40, P257, DOI 10.1177/1090198113486805; Glasgow RE, 2012, HEALTH SERV RES, V47, P1051, DOI 10.1111/j.1475-6773.2011.01347.x; Green LW, 2009, AM J PREV MED, V37, pS187, DOI 10.1016/j.amepre.2009.08.017; Green LW, 2006, EVAL HEALTH PROF, V29, P126, DOI 10.1177/0163278705284445; Haskell WL, 2000, AM J CLIN NUTR, V72, p541S, DOI 10.1093/ajcn/72.2.541S; Hughes JR, 2007, PSYCHOL ADDICT BEHAV, V21, P127, DOI 10.1037/0893-164X.21.2.127; Jonas DE, 2012, AHRQ PUBLICATION; Kennedy D, 2004, SCIENCE, V305, P451, DOI 10.1126/science.305.5683.451; Kobinsky Kathleen H, 2010, WMJ, V109, P79; Lin JS, 2010, AHRQ PUBLICATION; McTigue KM, 2009, TELEMED J E-HEALTH, V15, P851, DOI 10.1089/tmj.2009.0036; Moyer VA, 2012, ANN INTERN MED, V157, P59, DOI 10.7326/0003-4819-157-1-201207030-00442; National Cancer Institute, 2012, BEH RES PROGR RES TO; Sawaya GF, 2007, ANN INTERN MED, V147, P871, DOI 10.7326/0003-4819-147-12-200712180-00007; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Selby P, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-101; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P502, DOI 10.3945/ajcn.2008.26285; Thompson FE, 2008, NUTR PREVENTION TREA; Thompson M., 2012, FRAMEWORK FACILITATE; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI [10.1503/cmaj.090523, 10.1016/j.jclinepi.2008.12.011]; U.S. Preventive Services Task Force, 1996, GUID CLIN PREV SERV; Whitlock EP, 2002, AM J PREV MED, V22, P267, DOI 10.1016/S0749-3797(02)00415-4; Wright JD, 1994, CONS WORKSH DIET ASS	36	24	25	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2014	160	6					407	+		10.7326/M13-2128	http://dx.doi.org/10.7326/M13-2128			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD8MW	24723080				2022-12-28	WOS:000333521300017
J	Jolly, S; Griffith, KA; DeCastro, R; Stewart, A; Ubel, P; Jagsi, R				Jolly, Shruti; Griffith, Kent A.; DeCastro, Rochelle; Stewart, Abigail; Ubel, Peter; Jagsi, Reshma			Gender Differences in Time Spent on Parenting and Domestic Responsibilities by High-Achieving Young Physician-Researchers	ANNALS OF INTERNAL MEDICINE			English	Article							SEX-DIFFERENCES; CAREER-DEVELOPMENT; ACADEMIC MEDICINE; FAMILY; DIVISION; PRODUCTIVITY; SATISFACTION; GENERATION; SUCCESS; LABOR	Background: Female physician-researchers do not achieve career success at the same rate as men. Differences in nonprofessional responsibilities may partially explain this gap. Objective: To investigate the division of domestic labor by gender in a motivated group of early-career physician-researchers. Design: Nationwide postal survey between 2010 and 2011. Setting: United States. Participants: Physician recipients of National Institutes of Health K08 or K23 awards between 2006 and 2009 with active academic affiliation at the time of the survey. Measurements: Time spent on parenting and domestic tasks was determined through self-report. Among married or partnered respondents with children, a linear regression model of time spent on domestic activities was constructed considering age, gender, race, specialty, MD or MD/PhD status, age of youngest child, number of children, work hours, K award type, and spousal employment. Results: A 74% response rate was achieved, and 1049 respondents were academic physicians. Women were more likely than men to have spouses or domestic partners who were employed full-time (85.6% [95% CI, 82.7% to 89.2%] vs. 44.9% [CI, 40.8% to 49.8%]). Among married or partnered respondents with children, after adjustment for work hours, spousal employment, and other factors, women spent 8.5 more hours per week on domestic activities. In the subgroup with spouses or domestic partners who were employed full-time, women were more likely to take time off during disruptions of usual child care arrangements than men (42.6% [CI, 36.6% to 49.0%] vs. 12.4% [CI, 5.4% to 19.5%]). Limitations: Analyses relied on self-reported data. The study design did not enable investigation of the relationship between domestic activities and professional success. Conclusion: In this sample of career-oriented professionals, gender differences in domestic activities existed among those with children. Most men's spouses or domestic partners were not employed full-time, which contrasted sharply with the experiences of women.	Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Canc Biostat, Ann Arbor, MI 48109 USA; Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA; Duke Univ, Sanford Sch Publ Policy, Durham, NC USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Duke University; Duke University	Jagsi, R (corresponding author), Univ Michigan, Dept Radiat Oncol, UHB2C490,SPC 5010,1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA.	rjagsi@med.umich.edu		Jagsi, Reshma/0000-0001-6562-1228; Jones, Rochelle/0000-0001-7757-5396	National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Primary Funding Source: National Institutes of Health.	Bianchi SM, 2000, SOC FORCES, V79, P191, DOI 10.2307/2675569; Bickel J, 2005, ACAD MED, V80, P205, DOI 10.1097/00001888-200503000-00003; Blau Francine D., 2007, EC VOICE, V4, P1, DOI [DOI 10.2202/1553-3832.1190, 10.2202/1553-3832.1190]; Bolzendahl CI, 2004, SOC FORCES, V83, P759, DOI 10.1353/sof.2005.0005; Breen R, 2005, EUR SOCIOL REV, V21, P43, DOI 10.1093/esr/jci003; Carr PL, 1998, ANN INTERN MED, V129, P532, DOI 10.7326/0003-4819-129-7-199810010-00004; Coltrane S, 2000, J MARRIAGE FAM, V62, P1208, DOI 10.1111/j.1741-3737.2000.01208.x; Dillman D.A., 2014, INTERNET PHONE MAIL, V4th ed.; Dyrbye LN, 2011, ARCH SURG-CHICAGO, V146, P211, DOI 10.1001/archsurg.2010.310; Fox MF, 2005, SOC STUD SCI, V35, P131, DOI 10.1177/0306312705046630; Greenstein TN, 2000, J MARRIAGE FAM, V62, P322, DOI 10.1111/j.1741-3737.2000.00322.x; Howell LP, 2005, ACAD MED, V80, P527, DOI 10.1097/00001888-200506000-00003; Howell LP, 2009, ACAD MED, V84, P985, DOI 10.1097/ACM.0b013e3181acf408; Jagsi R, 2006, NEW ENGL J MED, V355, P281, DOI 10.1056/NEJMsa053910; Jagsi R, 2013, ACAD MED, V88, P1689, DOI 10.1097/ACM.0b013e3182a71519; Jagsi R, 2012, JAMA-J AM MED ASSOC, V307, P2410, DOI 10.1001/jama.2012.6183; Jagsi R, 2011, ACAD MED, V86, P1415, DOI 10.1097/ACM.0b013e3182305aa6; Jagsi R, 2009, ANN INTERN MED, V151, P804, DOI 10.7326/0003-4819-151-11-200912010-00009; Jovic E, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-55; Kaplan SH, 1996, NEW ENGL J MED, V335, P1282, DOI 10.1056/NEJM199610243351706; Lachance-Grzela M, 2010, SEX ROLES, V63, P767, DOI 10.1007/s11199-010-9797-z; Pohlhaus JR, 2011, ACAD MED, V86, P759, DOI 10.1097/ACM.0b013e31821836ff; Schiebinger L.L., 2008, DUAL CAREER ACAD COU; Shelton C, 2005, NEXT REVOLUTION WHAT; SISON CP, 1995, J AM STAT ASSOC, V90, P366, DOI 10.2307/2291162; Sobecks NW, 1999, ANN INTERN MED, V130, P312, DOI 10.7326/0003-4819-130-4-199902160-00017; Taylor P., 2007, GENERATION GAP VALUE; Tilly C., 1999, DURABLE INEQUALITY; U.S. Bureau of Labor Statistics U.S. Department of Labor, 2011, AM TIM US SURV 2010; UHLENBERG P, 1990, SOC SCI MED, V30, P373, DOI 10.1016/0277-9536(90)90192-U; University of Michigan, 2013, SURV AC CLIM ACT; Waite LJ, 2001, WORKING FAMILIES TRA, P23; Warde C, 1996, J GEN INTERN MED, V11, P729, DOI 10.1007/BF02598986; Warde CM, 1999, J GEN INTERN MED, V14, P157, DOI 10.1046/j.1525-1497.1999.00307.x; Willis G.B, 2004, COGNITIVE INTERVIEWI	35	407	410	2	53	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2014	160	5					344	+		10.7326/M13-0974	http://dx.doi.org/10.7326/M13-0974			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC8OT	24737273	Green Accepted			2022-12-28	WOS:000332793900007
J	Cornell, JE; Mulrow, CD; Localio, R; Stack, CB; Meibohm, AR; Guallar, E; Goodman, SN				Cornell, John E.; Mulrow, Cynthia D.; Localio, Russell; Stack, Catharine B.; Meibohm, Anne R.; Guallar, Eliseo; Goodman, Steven N.			Random-Effects Meta-analysis of Inconsistent Effects: A Time for Change	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOM-EFFECTS MODEL; LIKELIHOOD INFERENCE; CLINICAL-TRIALS; META-REGRESSION; PRE-ECLAMPSIA; PREGNANCY; TOXEMIA; CHLOROTHIAZIDE; PROPHYLAXIS; HETEROGENEITY	A primary goal of meta-analysis is to improve the estimation of treatment effects by pooling results of similar studies. This article explains how the most widely used method for pooling heterogeneous studies-the DerSimonian-Laird (DL) estimator-can produce biased estimates with falsely high precision. A classic example is presented to show that use of the DL estimator can lead to erroneous conclusions. Particular problems with the DL estimator are discussed, and several alternative methods for summarizing heterogeneous evidence are presented. The authors support replacing universal use of the DL estimator with analyses based on a critical synthesis that recognizes the uncertainty in the evidence, focuses on describing and explaining the probable sources of variation in the evidence, and uses random-effects estimates that provide more accurate confidence limits than the DL estimator.	Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; Univ Penn, Philadelphia, PA 19104 USA; Amer Coll Physicians, Philadelphia, PA USA; Johns Hopkins Sch Publ Hlth, Baltimore, MD USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA	University of Texas System; University of Texas Health San Antonio; University of Pennsylvania; American College of Physicians; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Stanford University	Cornell, JE (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, 7703 Merton Minter Blvd, San Antonio, TX 78229 USA.	cornell@uthscsa.edu	Guallar, Eliseo/D-3807-2014	Guallar, Eliseo/0000-0002-4471-9565; Goodman, Steven/0000-0002-3872-5723				[Anonymous], 2012, REV MAN REVMAN COMP; Biggerstaff BJ, 1997, STAT MED, V16, P753, DOI 10.1002/(SICI)1097-0258(19970415)16:7<753::AID-SIM494>3.0.CO;2-G; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; CAMPBELL DM, 1975, BRIT J OBSTET GYNAEC, V82, P572, DOI 10.1111/j.1471-0528.1975.tb00689.x; COLLINS R, 1985, BMJ-BRIT MED J, V290, P17, DOI 10.1136/bmj.290.6461.17; CUADROS A, 1964, AM J OBSTET GYNECOL, V89, P891, DOI 10.1016/0002-9378(64)90058-4; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; FALLIS NE, 1964, AM J OBSTET GYNECOL, V88, P502; FLOWERS CE, 1962, AM J OBSTET GYNECOL, V84, P919, DOI 10.1016/0002-9378(62)90069-8; Guolo A, 2012, J STAT SOFTW, V50, P1; Guolo A, 2012, STAT MED, V31, P313, DOI 10.1002/sim.4451; Hardy RJ, 1996, STAT MED, V15, P619, DOI 10.1002/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A; Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Kontopantelis E, 2010, STATA J, V10, P395, DOI 10.1177/1536867X1001000307; KRAUS GW, 1966, J AMER MED ASSOC, V198, P1150, DOI 10.1001/jama.198.11.1150; Lambert PC, 2005, STAT MED, V24, P2401, DOI 10.1002/sim.2112; Landesman R, 1965, BRIT J OBSTET GYNAEC, V72, P1004; MENZIES DN, 1964, BMJ-BRIT MED J, V1, P739, DOI 10.1136/bmj.1.5385.739; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Sterne J. A. C., 2009, METAANALYSIS STATA U; TERVILA L, 1971, ACTA OBSTET GYN SCAN, V50, P351, DOI 10.3109/00016347109157337; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; WESELEY AC, 1962, OBSTET GYNECOL, V19, P355; Whitehead A., 2002, METAANALYSIS CONTROL	29	284	284	0	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2014	160	4					267	270		10.7326/M13-2886	http://dx.doi.org/10.7326/M13-2886			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB3BO	24727843				2022-12-28	WOS:000331666500006
J	Chescheir, NC; Goodnight, W				Chescheir, Nancy C.; Goodnight, William			Improving livebirth rates: a role for preconception aspirin?	LANCET			English	Editorial Material							LOW-DOSE ASPIRIN; PREVENTION; PREECLAMPSIA; METAANALYSIS; TRIAL		[Chescheir, Nancy C.; Goodnight, William] Univ N Carolina, Sch Med, Chapel Hill, NC 27517 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Chescheir, NC (corresponding author), Univ N Carolina, Sch Med, Chapel Hill, NC 27517 USA.	cheschei@med.unc.edu		Chescheir, Nancy/0000-0002-0205-5051				Bujold E, 2010, OBSTET GYNECOL, V116, P402, DOI 10.1097/AOG.0b013e3181e9322a; James AH, 2008, OBSTET GYNECOL SURV, V63, P49, DOI 10.1097/OGX.0b013e31815e8731; Roberge S, 2013, ULTRASOUND OBST GYN, V41, P491, DOI 10.1002/uog.12421; Roberge S, 2012, FETAL DIAGN THER, V31, P141, DOI 10.1159/000336662; Schisterman EF, 2014, LANCET; Schisterman EF, 2013, PAEDIATR PERINAT EP, V27, P598, DOI 10.1111/ppe.12088; Thornton J., 2013, BJOG, V120, P73; Villa PM, 2013, BJOG-INT J OBSTET GY, V120, P64, DOI 10.1111/j.1471-0528.2012.03493.x	8	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2014	384	9937					5	6		10.1016/S0140-6736(14)60112-4	http://dx.doi.org/10.1016/S0140-6736(14)60112-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1XL	24702834				2022-12-28	WOS:000338919600005
J	Rogers, T; Milkman, KL; Volpp, KG				Rogers, Todd; Milkman, Katherine L.; Volpp, Kevin G.			Commitment Devices Using Initiatives to Change Behavior	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SMOKING-CESSATION		[Rogers, Todd] Harvard Univ, Kennedy Sch, Boston, MA 02115 USA; [Milkman, Katherine L.; Volpp, Kevin G.] Univ Penn, Wharton Sch, Ctr Hlth Incent & Behav Econ, Philadelphia, PA 19104 USA; [Volpp, Kevin G.] Univ Penn, Philadelphia VA Med Ctr, Perelman Sch Med, Ctr Hlth Incent & Behav Econ, Philadelphia, PA 19104 USA	Harvard University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Volpp, KG (corresponding author), Univ Penn, Philadelphia VA Med Ctr, Perelman Sch Med, Ctr Hlth Incent & Behav Econ, 423 Guardian Dr,1120 Blockley Hall, Philadelphia, PA 19104 USA.	volpp70@exchange.upenn.edu		Volpp, Kevin/0000-0003-1423-4599				Bryan G, 2010, ANNU REV ECON, V2, P671, DOI 10.1146/annurev.economics.102308.124324; Gine X, 2010, AM ECON J-APPL ECON, V2, P213, DOI 10.1257/app.2.4.213; Milkman KL, 2014, MANAGE SCI, V60, P283, DOI 10.1287/mnsc.2013.1784; Milkman KL, 2008, PERSPECT PSYCHOL SCI, V3, P324, DOI 10.1111/j.1745-6924.2008.00083.x; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; TowersWatson/NBGH Employer Survey on Purchasing Value in Health Care Reshaping Health Care, 2013, TOW WATS NBGH EMPL S; Volpp KG, 2009, NEW ENGL J MED, V360, P699, DOI 10.1056/NEJMsa0806819	7	89	89	2	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 28	2014	311	20					2065	2066		10.1001/jama.2014.3485	http://dx.doi.org/10.1001/jama.2014.3485			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8MQ	24777472				2022-12-28	WOS:000336392400018
J	Treutlein, B; Brownfield, DG; Wu, AR; Neff, NF; Mantalas, GL; Espinoza, FH; Desai, TJ; Krasnow, MA; Quake, SR				Treutlein, Barbara; Brownfield, Doug G.; Wu, Angela R.; Neff, Norma F.; Mantalas, Gary L.; Espinoza, F. Hernan; Desai, Tushar J.; Krasnow, Mark A.; Quake, Stephen R.			Reconstructing lineage hierarchies of the distal lung epithelium using single-cell RNA-seq	NATURE			English	Article							STEM-CELLS; EXPRESSION; REVEALS; LANDSCAPE; ALIGNMENT	The mammalian lung is a highly branched network in which the distal regions of the bronchial tree transform during development into a densely packed honeycomb of alveolar air sacs that mediate gas exchange. Although this transformation has been studied by marker expression analysis and fate-mapping, the mechanisms that control the progression of lung progenitors along distinct lineages into mature alveolar cell types are still incompletely known, in part because of the limited number of lineage markers(1-3) and the effects of ensemble averaging in conventional transcriptome analysis experiments on cell populations(1-5). Here we show that single-cell transcriptome analysis circumvents these problems and enables direct measurement of the various cell types and hierarchies in the developing lung. We used microfluidic single-cell RNA sequencing (RNA-seq) on 198 individual cells at four different stages encompassing alveolar differentiation to measure the transcriptional states which define the developmental and cellular hierarchy of the distal mouse lung epithelium. We empirically classified cells into distinct groups by using an unbiased genome-wide approach that did not require a priori knowledge of the underlying cell types or the previous purification of cell populations. The results confirmed the basic outlines of the classical model of epithelial cell-type diversity in the distal lung and led to the discovery of many previously unknown cell-type markers, including transcriptional regulators that discriminate between the different populations. We reconstructed the molecular steps during maturation of bipotential progenitors along both alveolar lineages and elucidated the full life cycle of the alveolar type 2 cell lineage. This single-cell genomics approach is applicable to any developing or mature tissue to robustly delineate molecularly distinct cell types, define progenitors and lineage hierarchies, and identify lineage-specific regulatory factors.	[Treutlein, Barbara; Wu, Angela R.; Neff, Norma F.; Mantalas, Gary L.; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Sch Med, Stanford, CA 94305 USA; [Treutlein, Barbara; Wu, Angela R.; Neff, Norma F.; Mantalas, Gary L.; Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Sch Med, Stanford, CA 94305 USA; [Treutlein, Barbara; Brownfield, Doug G.; Wu, Angela R.; Neff, Norma F.; Mantalas, Gary L.; Espinoza, F. Hernan; Krasnow, Mark A.; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Brownfield, Doug G.; Espinoza, F. Hernan; Krasnow, Mark A.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Desai, Tushar J.] Stanford Univ, Div Pulm & Crit Care Med, Dept Internal Med, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Quake, SR (corresponding author), Stanford Univ, Dept Bioengn, Sch Med, Stanford, CA 94305 USA.	tdesai@stanford.edu; krasnow@stanford.edu; quake@stanford.edu	Wu, Angela/ABF-9819-2020	Wu, Angela/0000-0002-3531-4830; Snyder, Michael/0000-0003-0784-7987; Treutlein, Barbara/0000-0002-3299-5597; Espinoza, Francisco/0000-0002-1855-1914; Brownfield, Doug/0000-0003-4769-1518	National Heart, Lung, and Blood Institute (NHLBI) Progenitor Cell Biology Consortium Grant [U01HL099995]; National Institutes of Health (NIH) [T32HD007249]; Parker B. Francis Foundation Fellowship; NIH [5KO8HL084095, U01HL099999]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007249] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099995, K08HL084095, U01HL099999] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI) Progenitor Cell Biology Consortium Grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Foundation Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank W. Koh and B. Passarelli for help and discussions regarding bioinformatic pipelines and statistical analysis, S. I. Gonzalez for help with immunofluorescence, and J. G. Camp and members of the Krasnow laboratory for critical discussion and reading of the manuscript. This work was supported by National Heart, Lung, and Blood Institute (NHLBI) U01HL099995 Progenitor Cell Biology Consortium Grant (B. T., M. A. K., S. R. Q.), by National Institutes of Health (NIH) T32HD007249 (D. G. B.), by a Parker B. Francis Foundation Fellowship and NIH 5KO8HL084095 Award (T. J. D.), and by NIH grant U01HL099999 (A. R. W., N.F.N.). M. A. K. and S. R. Q. are investigators of the Howard Hughes Medical Institute.	Babraham institute, FASTQC; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Gonzalez R, 2005, AM J PHYSIOL-LUNG C, V288, pL179, DOI 10.1152/ajplung.00272.2004; Greif DM, 2012, DEV CELL, V23, P482, DOI 10.1016/j.devcel.2012.07.009; Guha A, 2012, P NATL ACAD SCI USA, V109, P12592, DOI 10.1073/pnas.1204710109; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; R Core Team, R LANG ENV STAT COMP; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Sasagawa Y, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r31; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schreiber S. L., 2008, CSH PROTOCOLS; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tariq MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr547; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Walker MG, 1999, GENOME RES, V9, P1198, DOI 10.1101/gr.9.12.1198; Wang X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014085; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Xu Y, 2012, J ENG FIBER FABR, V7, P7; Yin Z, 2006, AM J PHYSIOL-LUNG C, V291, pL191, DOI 10.1152/ajplung.00385.2005; Zemke AC, 2009, AM J RESP CELL MOL, V40, P340, DOI 10.1165/rcmb.2007-0380OC; Zhang HM, 2012, NUCLEIC ACIDS RES, V40, pD144, DOI 10.1093/nar/gkr965	41	849	896	8	304	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					371	+		10.1038/nature13173	http://dx.doi.org/10.1038/nature13173			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24739965	Green Accepted			2022-12-28	WOS:000336121200041
J	Kontoyiannis, DP; Mathur, M; Chen, YB; Shellito, PC; Tse, JY				Kontoyiannis, Dimitrios P.; Mathur, Mahan; Chen, Yi-Bin; Shellito, Paul C.; Tse, Julie Y.			Case 13-2014: A 41-Year-Old Man with Fever and Abdominal Pain after Stem-Cell Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INVASIVE FUNGAL-INFECTIONS; NEUTROPENIC ENTEROCOLITIS; HEMATOLOGICAL MALIGNANCIES; SYSTEMATIC ANALYSIS; ACUTE APPENDICITIS; ONCOLOGY PATIENTS; ADULT PATIENTS; LEUKEMIA; ASPERGILLOSIS; GALACTOMANNAN		[Kontoyiannis, Dimitrios P.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Infect Dis, Houston, TX 77030 USA; [Mathur, Mahan] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Chen, Yi-Bin] Massachusetts Gen Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02114 USA; [Shellito, Paul C.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Tse, Julie Y.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Mathur, Mahan] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Chen, Yi-Bin] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Shellito, Paul C.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Tse, Julie Y.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kontoyiannis, DP (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Infect Dis, 1515 Holcombe Blvd, Houston, TX 77030 USA.				NCI NIH HHS [P30 CA016672] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANGEL CA, 1992, J PEDIATR SURG, V27, P476, DOI 10.1016/0022-3468(92)90342-5; Ayuk F, 2008, BIOL BLOOD MARROW TR, V14, P913, DOI 10.1016/j.bbmt.2008.05.023; Coates EW, 2005, PEDIATRICS, V116, pE241, DOI 10.1542/peds.2004-2537; Davila Marta L, 2007, Curr Infect Dis Rep, V9, P116, DOI 10.1007/s11908-007-0006-3; Ebert EC, 2012, J GASTROEN HEPATOL, V27, P458, DOI 10.1111/j.1440-1746.2011.06908.x; Forghieri F, 2008, BONE MARROW TRANSPL, V42, P701, DOI 10.1038/bmt.2008.235; GERSON SL, 1984, ANN INTERN MED, V100, P345, DOI 10.7326/0003-4819-100-3-345; Gorschluter M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-35; Gorschluter M, 2005, EUR J HAEMATOL, V75, P1, DOI 10.1111/j.1600-0609.2005.00442.x; Issa NC, 2009, CLIN INFECT DIS, V48, P772, DOI 10.1086/597089; Kazan E, 2011, CLIN MICROBIOL INFEC, V17, P588, DOI 10.1111/j.1469-0691.2010.03310.x; Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263; Lamoth F, 2012, CLIN INFECT DIS, V54, P633, DOI 10.1093/cid/cir897; Leeflang MM, 2008, COCHRANE DB SYST REV, V4; Lewis RE, 2013, MYCOSES, V56, P638, DOI 10.1111/myc.12081; Marr KA, 2004, J INFECT DIS, V190, P641, DOI 10.1086/422009; McCarville MB, 2004, PEDIATR RADIOL, V34, P245, DOI 10.1007/s00247-003-1122-3; Nesher L, 2013, CLIN INFECT DIS, V56, P711, DOI 10.1093/cid/cis998; Pazos C, 2005, J CLIN MICROBIOL, V43, P299, DOI 10.1128/JCM.43.1.299-305.2005; Person AK, 2011, HEMATOL ONCOL CLIN N, V25, P193, DOI 10.1016/j.hoc.2010.11.013; Rammaert B, 2012, CLIN INFECT DIS, V54, pS44, DOI 10.1093/cid/cir867; ROGERS S, 1990, CLIN LAB HAEMATOL, V12, P471, DOI 10.1111/j.1365-2257.1990.tb00359.x; Tortorano AM, 2012, J CLIN MICROBIOL, V50, P1051, DOI 10.1128/JCM.05946-11; van Burik JAH, 1998, MEDICINE, V77, P246, DOI 10.1097/00005792-199807000-00003; Vehreschild MJGT, 2011, HAEMATOL-HEMATOL J, V96, P1855, DOI 10.3324/haematol.2011.049627; Yi HS, 2010, LEUKEMIA RES, V34, pE173, DOI 10.1016/j.leukres.2009.12.022	26	8	8	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 24	2014	370	17					1637	1646		10.1056/NEJMcpc1305994	http://dx.doi.org/10.1056/NEJMcpc1305994			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4TG	24758620				2022-12-28	WOS:000336120500011
J	Connolly, BS; Lang, AE				Connolly, Barbara S.; Lang, Anthony E.			Pharmacological Treatment of Parkinson Disease A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							IMPULSE-CONTROL DISORDERS; PLACEBO-CONTROLLED TRIAL; NEUROGENIC ORTHOSTATIC HYPOTENSION; QUALITY STANDARDS SUBCOMMITTEE; DEEP-BRAIN-STIMULATION; BOTULINUM-TOXIN-A; DOUBLE-BLIND; MOTOR FLUCTUATIONS; RANDOMIZED-TRIAL; FOLLOW-UP	IMPORTANCE Parkinson disease is the second most common neurodegenerative disease worldwide. Although no available therapies alter the underlying neurodegenerative process, symptomatic therapies can improve patient quality of life. OBJECTIVE To provide an evidence-based review of the initial pharmacological management of the classic motor symptoms of Parkinson disease; describe management of medication-related motor complications (such as motor fluctuations and dyskinesia), and other medication adverse effects (nausea, psychosis, and impulse control disorders and related behaviors); and discuss the management of selected nonmotor symptoms of Parkinson disease, including rapid eye movement sleep behavior disorder, cognitive impairment, depression, orthostatic hypotension, and sialorrhea. EVIDENCE REVIEW References were identified using searches of PubMed between January 1985 and February 2014 for English-language human studies and the full database of the Cochrane Library. The classification of studies by quality (classes I-IV) was assessed using the levels of evidence guidelines from the American Academy of Neurology and the highest-quality data for each topic. RESULTS Although levodopa is the most effective medication available for treating the motor symptoms of Parkinson disease, in certain instances (eg, mild symptoms, tremor as the only or most prominent symptom, aged < 60 years) other medications (eg, monoamine oxidase type B inhibitors [MAOBIs], amantadine, anticholinergics, beta-blockers, or dopamine agonists) may be initiated first to avoid levodopa-related motor complications. Motor fluctuations may be managed by modifying the levodopa dosing regimen or by adding several other medications, such as MAOBIs, catechol-O-methyltransferase inhibitors, or dopamine agonists. Impulse control disorders are typically managed by reducing or withdrawing dopaminergic medication, particularly dopamine agonists. Evidence-based management of some nonmotor symptoms is limited by a paucity of high-quality positive studies. CONCLUSIONS AND RELEVANCE Strong evidence supports using levodopa and dopamine agonists for motor symptoms at all stages of Parkinson disease. Dopamine agonists and drugs that block dopamine metabolism are effective for motor fluctuations and clozapine is effective for hallucinations. Cholinesterase inhibitors may improve symptoms of dementia and antidepressants and pramipexole may improve depression. Evidence supporting other therapies for motor and nonmotor features is less well established.	[Connolly, Barbara S.] McMaster Univ, Hamilton Hlth Sci, Hamilton, ON, Canada; [Lang, Anthony E.] Toronto Western Hosp, Morton & Gloria Shulman Movement Disorders Ctr, Toronto, ON M5T 2S8, Canada; [Lang, Anthony E.] Toronto Western Hosp, Edmond J Safra Program Parkinsons Dis, Toronto, ON M5T 2S8, Canada; [Lang, Anthony E.] Univ Toronto, Div Neurol, Dept Med, Toronto, ON M5S 1A1, Canada	McMaster University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Lang, AE (corresponding author), Toronto Western Hosp, Morton & Gloria Movement Disorders Ctr, 399 Bathurst St,McL7-403, Toronto, ON M5T 2S8, Canada.	lang@uhnresearch.ca	Lang, Anthony/ABF-8114-2021	Lang, Anthony/0000-0003-1229-3667	Abbott; Abbvie; Allon Therapeutics; Avanir Pharmaceuticals; Biogen-Idec; Boehringer-Ingelheim; Ceregene; Medtronic; Merck; NeuroPhage Pharmaceuticals; Novartis; Teva; Brain Canada; Canadian Institutes of Health Research; Edmond J. Safra Philanthropic Foundation; Michael J. Fox Foundation; National Parkinson Foundation; Parkinson Society Canada; Tourette Syndrome Association; W. Garfield Weston Foundation	Abbott(Abbott Laboratories); Abbvie(AbbVie); Allon Therapeutics; Avanir Pharmaceuticals; Biogen-Idec(Biogen); Boehringer-Ingelheim(Boehringer Ingelheim); Ceregene; Medtronic(Medtronic); Merck(Merck & Company); NeuroPhage Pharmaceuticals; Novartis(Novartis); Teva(Teva Pharmaceutical Industries); Brain Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Edmond J. Safra Philanthropic Foundation; Michael J. Fox Foundation; National Parkinson Foundation; Parkinson Society Canada; Tourette Syndrome Association; W. Garfield Weston Foundation	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Lang reports receiving financial compensation for consultancy work with Abbott, Abbvie, Allon Therapeutics, Avanir Pharmaceuticals, Biogen-Idec, Boehringer-Ingelheim, Ceregene, Medtronic, Merck, NeuroPhage Pharmaceuticals, Novartis, and Teva; receiving grant funding from Brain Canada, the Canadian Institutes of Health Research, the Edmond J. Safra Philanthropic Foundation, the Michael J. Fox Foundation, the National Parkinson Foundation, Parkinson Society Canada, the Tourette Syndrome Association, and the W. Garfield Weston Foundation; and receiving royalties from Cambridge University Press, Johns Hopkins Press, Saunders, and Wiley-Blackwell. No other disclosures were reported.	ABATE G, 1979, BMJ-BRIT MED J, V2, P1466, DOI 10.1136/bmj.2.6203.1466; Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; AlDakheel A, 2014, NEUROTHERAPEUTICS, V11, P6, DOI 10.1007/s13311-013-0218-1; [Anonymous], 2002, Mov Disord, V17 Suppl 4, pS1; Arbouw MEL, 2010, NEUROLOGY, V74, P1203, DOI 10.1212/WNL.0b013e3181d8c1b7; Aurora RN, 2010, J CLIN SLEEP MED, V6, P85; Avila A, 2011, J NEUROL SCI, V310, P197, DOI 10.1016/j.jns.2011.05.044; Barone P, 2006, J NEUROL, V253, P601, DOI 10.1007/s00415-006-0067-5; Barone P, 2010, LANCET NEUROL, V9, P573, DOI 10.1016/S1474-4422(10)70106-X; Barone P, 2009, MOVEMENT DISORD, V24, P1641, DOI 10.1002/mds.22643; Biglan KM, 2009, ARCH NEUROL-CHICAGO, V66, P563, DOI 10.1001/archneur.66.1.nct90001; Boyd JT, 2013, MOVEMENT DISORD, V28, pS143; Braun M, 2009, BRIT J CLIN PHARMACO, V67, P209, DOI 10.1111/j.1365-2125.2008.03334.x; Broeders M, 2013, NEUROLOGY, V81, P346, DOI 10.1212/WNL.0b013e31829c5c86; Burn D, 2006, MOVEMENT DISORD, V21, P1899, DOI 10.1002/mds.21077; Chinnapongse R, 2012, MOVEMENT DISORD, V27, P219, DOI 10.1002/mds.23929; Contin M, 2010, J NEUROL, V257, pS253, DOI 10.1007/s00415-010-5728-8; Crosby N., 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858, 10.1002/14651858.CD003468]; Crosby NJ, 2003, COCHRANE DB SYST REV; Cummings J, 2014, LANCET, V383, P533, DOI 10.1016/S0140-6736(13)62106-6; de Lau LML, 2004, NEUROLOGY, V63, P1240, DOI 10.1212/01.WNL.0000140706.52798.BE; de Rijk MC, 2000, NEUROLOGY, V54, pS21; Destee A, 2009, EUR NEUROL, V61, P69, DOI 10.1159/000177938; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Devos D, 2008, MOVEMENT DISORD, V23, P850, DOI 10.1002/mds.21966; Di Giacopo R, 2012, MOVEMENT DISORD, V27, P559, DOI 10.1002/mds.24909; Diederich NJ, 2009, NAT REV NEUROL, V5, P331, DOI 10.1038/nrneurol.2009.62; Dubois B, 2012, MOVEMENT DISORD, V27, P1230, DOI 10.1002/mds.25098; Bermejo PE, 2008, PARKINSONISM RELAT D, V14, P448, DOI 10.1016/j.parkreldis.2007.11.008; Bermejo PE, 2010, J NEUROL, V257, P1682, DOI 10.1007/s00415-010-5603-7; Eng ML, 2010, AM J GERIATR PHARMAC, V8, P316, DOI 10.1016/j.amjopharm.2010.08.004; Evans AH, 2004, MOVEMENT DISORD, V19, P397, DOI 10.1002/mds.20045; Evans AH, 2009, MOVEMENT DISORD, V24, P1561, DOI 10.1002/mds.22505; Fabbrini G, 2002, NEUROL SCI, V23, P41, DOI 10.1007/s100720200022; Factor SA, 2001, CLIN NEUROPHARMACOL, V24, P295, DOI 10.1097/00002826-200109000-00007; Fasano A, 2011, J NEUROL, V258, P656, DOI 10.1007/s00415-010-5817-8; Fernandez HH, 2011, CURR MED RES OPIN, V27, P907, DOI 10.1185/03007995.2011.560146; Ferreira JJ, 2013, EUR J NEUROL, V20, P5, DOI 10.1111/j.1468-1331.2012.03866.x; FOSTER NL, 1984, ANN NEUROL, V16, P505, DOI 10.1002/ana.410160412; Fox SH, UPDATE TREATMENTS MO; Fox SH, 2011, MOVEMENT DISORD, V26, pS2, DOI 10.1002/mds.23829; French J, 2008, NEUROLOGY, V71, P1634, DOI 10.1212/01.wnl.0000336533.19610.1b; Friedman JH, 1997, NEUROLOGY, V48, P1077, DOI 10.1212/WNL.48.4.1077; Ruiz PJG, 2008, MOVEMENT DISORD, V23, P1130, DOI 10.1002/mds.22063; Goetz CG, 2000, NEUROLOGY, V55, P789, DOI 10.1212/WNL.55.6.789; Goldman JG, 2011, EXPERT OPIN PHARMACO, V12, P2009, DOI 10.1517/14656566.2011.587122; Gomez-Esteban JC, 2005, CLIN NEUROPHARMACOL, V28, P111; Gronseth G, 2008, NEUROLOGY, V71, P1639, DOI 10.1212/01.wnl.0000336535.27773.c0; Gross RA, 2009, NEUROLOGY, V72, P8, DOI 10.1212/01.wnl.0000342200.58823.6a; Guidubaldi A, 2011, MOVEMENT DISORD, V26, P313, DOI 10.1002/mds.23473; Gunzler SA, 2009, EXPERT OPIN PHARMACO, V10, P1027, DOI [10.1517/14656560902828344 , 10.1517/14656560902828344]; Haehner A, 2009, PARKINSONISM RELAT D, V15, P490, DOI 10.1016/j.parkreldis.2008.12.005; Hanagasi HA, 2011, MOVEMENT DISORD, V26, P1851, DOI 10.1002/mds.23738; Hauser RA, 2007, MOVEMENT DISORD, V22, P2409, DOI 10.1002/mds.21743; Hauser RA, 2013, LANCET NEUROL, V12, P346, DOI 10.1016/S1474-4422(13)70025-5; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; HERRING AB, 1964, LANCET, V2, P892; Hicks CW, 2011, PARKINSONISM RELAT D, V17, P379, DOI 10.1016/j.parkreldis.2011.03.003; Holloway RG, 2004, ARCH NEUROL-CHICAGO, V61, P1044; Hristova AH, 2000, DRUG AGING, V17, P165, DOI 10.2165/00002512-200017030-00002; HUGHES AJ, 1993, ADV NEUROL, V60, P595; Hyson HC, 2002, MOVEMENT DISORD, V17, P1318, DOI 10.1002/mds.10276; Ishihara LS, 2007, J NEUROL NEUROSUR PS, V78, P1304, DOI 10.1136/jnnp.2006.100107; Ives NJ, 2004, BMJ-BRIT MED J, V329, P593, DOI 10.1136/bmj.38184.606169.AE; JANKOVIC J, 1993, AM J MED, V95, P38, DOI 10.1016/0002-9343(93)90230-M; Katzenschlager R, 2008, NEUROLOGY, V71, P474, DOI 10.1212/01.wnl.0000310812.43352.66; Katzenschlager R, 2003, Cochrane Database Syst Rev, pCD003735; Khan Tarannum S, 2012, Cleve Clin J Med, V79 Suppl 2, pS8, DOI 10.3949/ccjm.79.s2a.02; Kinnunen E, 2007, MOVEMENT DISORD, V22, P14, DOI 10.1002/mds.21131; KOLLER WC, 1987, ARCH NEUROL-CHICAGO, V44, P921, DOI 10.1001/archneur.1987.00520210023013; KOLLER WC, 1990, NEUROLOGY, V40, P40; Kunz D, 2010, J SLEEP RES, V19, P591, DOI 10.1111/j.1365-2869.2010.00848.x; Lagalla G, 2006, MOVEMENT DISORD, V21, P704, DOI 10.1002/mds.20793; Lagalla G, 2009, J NEUROL, V256, P563, DOI 10.1007/s00415-009-0085-1; Lew MF, 2007, CLIN NEUROPHARMACOL, V30, P281, DOI 10.1097/WNF.0B013E318149F290; Lipp A, 2003, NEUROLOGY, V61, P1279, DOI 10.1212/WNL.61.9.1279; Liu JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076651; Low PA, 1997, JAMA-J AM MED ASSOC, V277, P1046, DOI 10.1001/jama.277.13.1046; Mamikonyan E, 2008, MOVEMENT DISORD, V23, P75, DOI 10.1002/mds.21770; Mancini F, 2003, MOVEMENT DISORD, V18, P685, DOI 10.1002/mds.10420; Marsh L, 2009, MOVEMENT DISORD, V24, P277, DOI 10.1002/mds.22307; Mathias CJ, 2007, CLIN AUTON RES, V17, P272; Menza M, 2009, NEUROLOGY, V72, P886, DOI 10.1212/01.wnl.0000336340.89821.b3; Mestre TA, 2013, THER ADV NEUROL DISO, V6, P175, DOI 10.1177/1756285613476127; Miyasaki JM, 2006, NEUROLOGY, V66, P996, DOI 10.1212/01.wnl.0000215428.46057.3d; Mizuno Y, 2007, MOVEMENT DISORD, V22, P75, DOI 10.1002/mds.21218; Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; O'Sullivan SS, 2009, CNS DRUGS, V23, P157, DOI 10.2165/00023210-200923020-00005; Olanow CW, 2009, NEW ENGL J MED, V361, P1268, DOI 10.1056/NEJMoa0809335; Ondo WG, 2004, NEUROLOGY, V62, P37, DOI 10.1212/01.WNL.0000101713.81253.4C; Ondo WG, 2007, CLIN NEUROPHARMACOL, V30, P295, DOI 10.1097/WNF.0B013E3180616570; Onofrj M, 2001, EUR NEUROL, V46, P11, DOI 10.1159/000050749; Ory-Magne F, 2014, NEUROLOGY, V82, P300, DOI 10.1212/WNL.0000000000000050; OWEN DAL, 1965, LANCET, V2, P1259; Pahwa R, 2006, NEUROLOGY, V66, P983, DOI 10.1212/01.wnl.0000215250.82576.87; PARKES JD, 1986, CLIN NEUROPHARMACOL, V9, P517, DOI 10.1097/00002826-198612000-00003; Lloret SP, 2011, J NEUROL SCI, V310, P248, DOI 10.1016/j.jns.2011.05.021; PERRY EK, 1991, ANN NY ACAD SCI, V640, P197; Pintor L, 2012, CLIN NEUROPHARMACOL, V35, P61, DOI 10.1097/WNF.0b013e31824d5115; Poewe WH, 2007, LANCET NEUROL, V6, P513, DOI 10.1016/S1474-4422(07)70108-4; Pondal M, 2013, J NEUROL NEUROSUR PS, V84, P130, DOI 10.1136/jnnp-2012-302684; Rajput AH, 2009, NEUROLOGY, V73, P206, DOI 10.1212/WNL.0b013e3181ae7af1; Rascol O, 2005, LANCET, V365, P947, DOI 10.1016/S0140-6736(05)71083-7; Rascol O, 2000, NEW ENGL J MED, V342, P1484, DOI 10.1056/NEJM200005183422004; Reichmann H, 2005, ACTA NEUROL SCAND, V111, P21, DOI 10.1111/j.1600-0404.2004.00363.x; Rektorova I, 2003, EUR J NEUROL, V10, P399, DOI 10.1046/j.1468-1331.2003.00612.x; Rocha FL, 2013, J PSYCHOPHARMACOL, V27, P417, DOI 10.1177/0269881113478282; Rolinski M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006504.pub2; Sawada H, 2010, PLOS ONE, V31, P5; SCHENCK CH, 1986, SLEEP, V9, P293, DOI 10.1093/sleep/9.2.293; Schoffer KL, 2007, MOVEMENT DISORD, V22, P1543, DOI 10.1002/mds.21428; Schuepbach WMM, 2013, NEW ENGL J MED, V368, P610, DOI 10.1056/NEJMoa1205158; Schwid SR, 2005, ARCH NEUROL-CHICAGO, V62, P241; SENARD JM, 1993, FUNDAM CLIN PHARM, V7, P465; Seppi K, 2011, MOVEMENT DISORD, V26, pS42, DOI 10.1002/mds.23884; Shibao C, 2010, HYPERTENSION, V56, P847, DOI 10.1161/HYPERTENSIONAHA.110.154898; Shotbolt Paul, 2010, Ther Adv Neurol Disord, V3, P339, DOI 10.1177/1756285610389656; Singer W, 2003, J NEUROL NEUROSUR PS, V74, P1294, DOI 10.1136/jnnp.74.9.1294; Spatola Marianna, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS35, DOI 10.1016/S1353-8020(13)70011-7; Sriram A, 2013, J NEUROL, V260, P521, DOI 10.1007/s00415-012-6669-1; Stocchi F, 2011, EUR J NEUROL, V18, P1373, DOI 10.1111/j.1468-1331.2011.03512.x; Stocchi F, 2011, MOVEMENT DISORD, V26, P1259, DOI 10.1002/mds.23498; Tarsy D, 2012, JAMA-J AM MED ASSOC, V307, P2305, DOI 10.1001/jama.2012.4829; Thomas A, 2010, ANN NEUROL, V68, P400, DOI 10.1002/ana.22029; Thomsen TR, 2008, J NEUROL NEUROSUR PS, V79, P1413, DOI 10.1136/jnnp.2008.153163; Thomsen TR, 2007, MOVEMENT DISORD, V22, P2268, DOI 10.1002/mds.21730; Troeung L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079510; Van Gerpen JA, 2006, ARCH NEUROL-CHICAGO, V63, P205, DOI 10.1001/archneur.63.2.205; Waters CH, 2004, MOVEMENT DISORD, V19, P426, DOI 10.1002/mds.20036; Weaver FM, 2012, NEUROLOGY, V79, P55, DOI 10.1212/WNL.0b013e31825dcdc1; Weintraub D, 2010, NEUROLOGY, V75, P448, DOI 10.1212/WNL.0b013e3181ebdd79; Weintraub D, 2006, ARCH NEUROL-CHICAGO, V63, P969, DOI 10.1001/archneur.63.7.969; Weintraub D, 2010, ARCH NEUROL-CHICAGO, V67, P589, DOI 10.1001/archneurol.2010.65; Weiss Howard D, 2012, Neurol Clin Pract, V2, P267; Wickremaratchi MM, 2009, EUR J NEUROL, V16, P450, DOI 10.1111/j.1468-1331.2008.02514.x; Wolf E, 2010, MOVEMENT DISORD, V25, P1357, DOI 10.1002/mds.23034; Wright RA, 1998, NEUROLOGY, V51, P120, DOI 10.1212/WNL.51.1.120	138	817	842	11	239	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2014	311	16					1670	1683		10.1001/jama.2014.3654	http://dx.doi.org/10.1001/jama.2014.3654			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF4OU	24756517				2022-12-28	WOS:000334693900027
J	Fonarow, GC; Zhao, X; Smith, EE; Saver, JL; Reeves, MJ; Bhatt, DL; Xian, Y; Hernandez, AF; Peterson, ED; Schwamm, LH				Fonarow, Gregg C.; Zhao, Xin; Smith, Eric E.; Saver, Jeffrey L.; Reeves, Mathew J.; Bhatt, Deepak L.; Xian, Ying; Hernandez, Adrian F.; Peterson, Eric D.; Schwamm, Lee H.			Door-to-Needle Times for Tissue Plasminogen Activator Administration and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement Initiative	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMERICAN-HEART-ASSOCIATION; GUIDELINES-STROKE; THROMBOLYSIS; ALTEPLASE; BALLOON; DELAYS; CARE; SCIENCE; NINDS	IMPORTANCE The benefits of intravenous tissue plasminogen activator (tPA) in patients with acute ischemic stroke (AIS) are time dependent and guidelines recommend a door-to-needle (DTN) time of 60 minutes or less. However, studies have found that less than 30% of US patients are treated within this time window. Target: Stroke was designed as a national quality improvement initiative to improve DTN times for tPA administration in patients with AIS. OBJECTIVES To evaluate DTN times for tPA administration and the proportion of patients with times of 60 minutes or less before and after initiation of a quality improvement initiative and to determine whether potential improvements in DTN times were associated with improvements in clinical outcomes. DESIGN, SETTING, AND PATIENTS The Target: Stroke initiative disseminated 10 care strategies to achieve faster DTN times for tPA administration, provided clinical decision support tools, facilitated hospital participation, and encouraged sharing of best practices. This study included 71 169 patients with AIS treated with tPA(27 319 during the preintervention period from April 2003-December 2009 and 43 850 during the postintervention period from January 2010-September 2013) from 1030 Get With The Guidelines-Stroke participating hospitals (52.8% of total). MAIN OUTCOMES AND MEASURES The DTN times for tPA administration of 60 minutes or less and in-hospital risk-adjusted mortality, symptomatic intracranial hemorrhage, ambulatory status at discharge, and discharge destination. RESULTS Measures of DTN time for tPA administration improved significantly during the postintervention period compared with the preintervention period as did clinical outcomes. [GRAPHICS] CONCLUSIONS AND RELEVANCE Implementation of a national quality improvement initiative was associated with improved timeliness of tPA administration following AIS on a national scale, and this improvement was associated with lower in-hospital mortality and intracranial hemorrhage, along with an increase in the percentage of patients discharged home.	[Fonarow, Gregg C.] Univ Calif Los Angeles, Div Cardiol, Los Angeles, CA USA; [Zhao, Xin; Xian, Ying; Hernandez, Adrian F.; Peterson, Eric D.] Duke Clin Res Ctr, Durham, NC USA; [Smith, Eric E.] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB, Canada; [Saver, Jeffrey L.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Reeves, Mathew J.] Michigan State Univ, Dept Epidemiol, E Lansing, MI 48824 USA; [Bhatt, Deepak L.] Brigham & Womens Hosp, Heart & Vasc Ctr, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Univ, Sch Med, Boston, MA USA; [Schwamm, Lee H.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA	University of California System; University of California Los Angeles; Duke University; University of Calgary; University of California System; University of California Los Angeles; Michigan State University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Fonarow, GC (corresponding author), Ronald Reagan UCLA Med Ctr, Ahmanson UCLA Cardiomyopathy Ctr, 10833 LeConte Ave,Room 47-123 CHS, Los Angeles, CA 90095 USA.	gfonarow@mednet.ucla.edu	Peterson, Eric David/ABF-5033-2021; Smith, Eric E/C-5443-2012; Xian, Ying/O-1956-2019; Hernandez, Adrian F/A-7818-2016; Fonarow, Gregg C/D-5988-2014	Smith, Eric E/0000-0003-3956-1668; Hernandez, Adrian F/0000-0003-3387-9616; Fonarow, Gregg C/0000-0002-3192-8093; Saver, Jeffrey/0000-0001-9141-2251; Schwamm, Lee/0000-0003-0592-9145; Xian, Ying/0000-0002-1237-1162	Boeringher-Ingelheim; Merck; Bristol-Myers Squib/sanofi pharmaceutical; AHApharmaceutical roundtable; Alberta Innovates [201300690] Funding Source: researchfish	Boeringher-Ingelheim; Merck(Merck & Company); Bristol-Myers Squib/sanofi pharmaceutical; AHApharmaceutical roundtable(American Heart Association); Alberta Innovates	Target: Stroke is an initiative provided by the American Heart Association/American Stroke Association (AHA/ASA). The GWTG-Stroke program also is provided by the AHA/ASA. The GWTG-Stroke program is currently supported in part by a charitable contribution from Janssen Pharmaceutical Companies of Johnson & Johnson. The GWTG-Stroke program has been funded in the past through support from Boeringher-Ingelheim, Merck, Bristol-Myers Squib/sanofi pharmaceutical partnership and the AHApharmaceutical roundtable.	Albers GW, 2000, JAMA-J AM MED ASSOC, V283, P1145, DOI 10.1001/jama.283.9.1145; Alberts MJ, 2000, JAMA-J AM MED ASSOC, V283, P3102, DOI 10.1001/jama.283.23.3102; Austin PC, 2006, STAT MED, V25, P2084, DOI 10.1002/sim.2328; Berwick DM, 2008, JAMA-J AM MED ASSOC, V299, P1182, DOI 10.1001/jama.299.10.1182; Bradley EH, 2006, CIRCULATION, V113, P1079, DOI 10.1161/CIRCULATIONAHA.105.590133; Fonarow GC, 2011, STROKE, V42, P2983, DOI 10.1161/STROKEAHA.111.621342; Fonarow GC, 2011, CIRCULATION, V123, P750, DOI 10.1161/CIRCULATIONAHA.110.974675; GOMEZ CR, 1994, STROKE, V25, P1920, DOI 10.1161/01.STR.25.10.1920; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Krumholz HM, 2008, JACC-CARDIOVASC INTE, V1, P97, DOI 10.1016/j.jcin.2007.10.006; Lansberg MG, 2009, STROKE, V40, P2079, DOI 10.1161/STROKEAHA.108.540708; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Lindsberg PJ, 2006, NEUROLOGY, V67, P334, DOI 10.1212/01.wnl.0000224759.44743.7d; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Marler JR, 2000, NEUROLOGY, V55, P1649, DOI 10.1212/WNL.55.11.1649; Marler JR, 1997, THE NATIONAL INSTITU; Mehdiratta M, 2006, CAN J NEUROL SCI, V33, P214, DOI 10.1017/S031716710000500X; Menees DS, 2013, NEW ENGL J MED, V369, P901, DOI 10.1056/NEJMoa1208200; Meretoja A, 2012, NEUROLOGY, V79, P306, DOI 10.1212/WNL.0b013e31825d6011; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Schwamm LH, 2009, CIRCULATION, V119, P107, DOI 10.1161/CIRCULATIONAHA.108.783688; Shojania KG, 2005, HEALTH AFFAIR, V24, P138, DOI 10.1377/hlthaff.24.1.138; SITS International, REDUCTION OF IN HOSP; Summers, 2010, STROKE, V41, pE563, DOI 10.1161/STR.0b013e3181efa9de; Summers D, 2009, STROKE, V40, P2911, DOI 10.1161/STROKEAHA.109.192362; Tveiten A, 2009, EMERG MED J, V26, P324, DOI 10.1136/emj.2008.063610; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; Xian Y, 2012, AM HEART J, V163, P392, DOI 10.1016/j.ahj.2011.12.012	30	372	401	0	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2014	311	16					1632	1640		10.1001/jama.2014.3203	http://dx.doi.org/10.1001/jama.2014.3203			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF4OU	24756513	Bronze			2022-12-28	WOS:000334693900023
J	Salman, RAS; White, PM; Counsell, CE; du Plessis, J; van Beijnum, J; Josephson, CB; Wilkinson, T; Wedderburn, CJ; Chandy, Z; St George, EJ; Sellar, RJ; Warlow, CP				Salman, Rustam Al-Shahi; White, Philip M.; Counsell, Carl E.; du Plessis, Johann; van Beijnum, Janneke; Josephson, Colin B.; Wilkinson, Tim; Wedderburn, Catherine J.; Chandy, Zoe; St George, E. Jerome; Sellar, Robin J.; Warlow, Charles P.		Scottish Audit Intracranial Vasc	Outcome After Conservative Management or Intervention for Unruptured Brain Arteriovenous Malformations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTRACRANIAL VASCULAR MALFORMATION; POPULATION-BASED COHORT; CONTROLLED-TRIALS; RANDOMIZED-TRIAL; CLINICAL-TRIALS; HEMORRHAGE; THERAPY; ARUBA; SIVMS; RISK	IMPORTANCE Whether conservative management is superior to interventional treatment for unruptured brain arteriovenous malformations (bAVMs) is uncertain because of the shortage of long-term comparative data. OBJECTIVE To compare the long-term outcomes of conservative management vs intervention for unruptured bAVM. DESIGN, SETTING, AND POPULATION Population-based inception cohort study of 204 residents of Scotland aged 16 years or older who were first diagnosed as having an unruptured bAVM during 1999-2003 or 2006-2010 and followed up prospectively for 12 years. EXPOSURES Conservative management (no intervention) vs intervention (any endovascular embolization, neurosurgical excision, or stereotactic radiosurgery alone or in combination). MAIN OUTCOMES AND MEASURES Cox regression analyses, with multivariable adjustment for prognostic factors and baseline imbalances if hazards were proportional, to compare rates of the primary outcome (death or sustained morbidity of any cause by Oxford Handicap Scale [OHS] score >= 2 for >= 2 successive years [0 = no symptoms and 6 = death]) and the secondary outcome (nonfatal symptomatic stroke or death due to bAVM, associated arterial aneurysm, or intervention). RESULTS Of 204 patients, 103 underwent intervention. Those who underwent intervention were younger, more likely to have presented with seizure, and less likely to have large bAVMs than patients managed conservatively. During a median follow-up of 6.9 years (94% completeness), the rate of progression to the primary outcome was lower with conservative management during the first 4 years of follow-up (36 vs 39 events; 9.5 vs 9.8 per 100 person-years; adjusted hazard ratio, 0.59; 95% CI, 0.35-0.99), but rates were similar thereafter. The rate of the secondary outcome was lower with conservative management during 12 years of follow-up (14 vs 38 events; 1.6 vs 3.3 per 100 person-years; adjusted hazard ratio, 0.37; 95% CI, 0.19-0.72). CONCLUSIONS AND RELEVANCE Among patients aged 16 years or older diagnosed as having unruptured bAVM, use of conservative management compared with intervention was associated with better clinical outcomes for up to 12 years. Longer follow-up is required to understand whether this association persists.	[Salman, Rustam Al-Shahi; Wilkinson, Tim; Chandy, Zoe; Sellar, Robin J.; Warlow, Charles P.] Univ Edinburgh, Ctr Clin Brain Sci, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; [White, Philip M.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Counsell, Carl E.] Univ Aberdeen, Div Appl Hlth Sci, Aberdeen, Scotland; [du Plessis, Johann; St George, E. Jerome] So Gen Hosp, Inst Neurol Sci, Glasgow G51 4TF, Lanark, Scotland; [van Beijnum, Janneke] Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands; [Josephson, Colin B.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Wedderburn, Catherine J.] UCL, Inst Global Hlth, London, England	University of Edinburgh; Newcastle University - UK; University of Aberdeen; University of Glasgow; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Calgary; University of London; University College London	Salman, RAS (corresponding author), Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Bramwell Dott Bldg, Edinburgh EH4 2XU, Midlothian, Scotland.	Rustam.Al-Shahi@ed.ac.uk	Macleod, Malcolm Robert/B-2052-2010; Wilkinson, Tim/L-5184-2019; Wardlaw, Joanna M/Y-3456-2019; McGonigal, Aileen/V-3292-2018; Wedderburn, Catherine/GZA-8421-2022; Leach, John Paul/AGU-8942-2022; Lueck, Christian Joseph/O-4031-2016; van+Beijnum, Janneke/ACA-2245-2022	Macleod, Malcolm Robert/0000-0001-9187-9839; Wilkinson, Tim/0000-0001-8952-0982; Wardlaw, Joanna M/0000-0002-9812-6642; McGonigal, Aileen/0000-0001-6775-5318; Leach, John Paul/0000-0003-2086-9937; Lueck, Christian Joseph/0000-0003-1537-7612; Razvi, Saif/0000-0003-2307-550X; Kwan, Joseph/0000-0003-4635-3322; Wedderburn, Catherine/0000-0002-4887-1644; White, Philip/0000-0001-6007-6013; Whiteley, William/0000-0002-4816-8991; Al-Shahi Salman, Rustam/0000-0002-2108-9222; Williams, Anna/0000-0002-6329-382X; Sudlow, Cathie/0000-0002-7725-7520; Ironside, James/0000-0001-5869-2108; Connick, Peter/0000-0002-3892-8037	Medical Research Council [G84/5176, G108/613, G1002605]; Chief Scientist Office of the Scottish Government [K/MRS/50/C2704, CZB/4/35]; Stroke Association [TSA04/01]; Netherlands Organisation for Scientific Research; Netherlands Heart Foundation [2002B138]; MRC [G108/613, G1002605, G0902303] Funding Source: UKRI; Medical Research Council [G0902303] Funding Source: researchfish; National Institute for Health Research [ACF-2012-18-019] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office of the Scottish Government; Stroke Association; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Heart Foundation(Netherlands Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the Medical Research Council (grants G84/5176, G108/613, and G1002605); the Chief Scientist Office of the Scottish Government (grants K/MRS/50/C2704 and CZB/4/35); the Stroke Association (grant TSA04/01); the Netherlands Organisation for Scientific Research; and the Netherlands Heart Foundation (grant 2002B138).	Al-Shahi R, 2003, STROKE, V34, P1163, DOI 10.1161/01.STR.0000069018.90456.C9; Al-Shahi R, 2003, STROKE, V34, P1156, DOI 10.1161/01.STR.0000069012.23858.69; Al-Shahi R, 2005, PRACT NEUROL, V5, P194; Atkinson RP, 2001, STROKE, V32, P1430; BAMFORD JM, 1989, STROKE, V20, P828, DOI 10.1161/01.STR.20.6.828; Barr JC, 2012, NEUROSURG CLIN N AM, V23, P63, DOI 10.1016/j.nec.2011.09.010; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Bradburn MJ, 2003, BRIT J CANCER, V89, P605, DOI 10.1038/sj.bjc.6601120; Clark TG, 2002, LANCET, V359, P1309, DOI 10.1016/S0140-6736(02)08272-7; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Davies JM, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.5.FOCUS12107; Halim AX, 2004, STROKE, V35, P1697, DOI 10.1161/01.STR.0000130988.44824.29; Jayaraman MV, 2012, J NEUROINTERV SURG, V4, DOI 10.1136/neurintsurg-2011-010173; Josephson CB, 2012, NEUROLOGY, V79, P500, DOI 10.1212/WNL.0b013e3182635696; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; Mohr JP, 2014, LANCET, V383, P614, DOI 10.1016/S0140-6736(13)62302-8; Mohr JP, 2012, STROKE, V43, P1744, DOI 10.1161/STROKEAHA.112.653584; Ogilvy CS, 2001, STROKE, V32, P1458, DOI 10.1161/01.STR.32.6.1458; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Ross J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003436.pub3; SPETZLER RF, 1986, J NEUROSURG, V65, P476, DOI 10.3171/jns.1986.65.4.0476; Stapf C, 2006, NEUROLOGY, V66, P1350, DOI 10.1212/01.wnl.0000210524.68507.87; Stapf C, 2006, CURR OPIN NEUROL, V19, P63, DOI 10.1097/01.wco.0000200546.14668.78; Starke RM, 2009, BRIT J NEUROSURG, V23, P376, DOI 10.1080/02688690902977662; van Beijnum J, 2011, JAMA-J AM MED ASSOC, V306, P2011, DOI 10.1001/jama.2011.1632; Beijnum J, 2009, BRAIN, V132, P537, DOI 10.1093/brain/awn318; Wedderburn CJ, 2008, LANCET NEUROL, V7, P223, DOI 10.1016/S1474-4422(08)70026-7	28	139	139	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2014	311	16					1661	1669		10.1001/jama.2014.3200	http://dx.doi.org/10.1001/jama.2014.3200			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF4OU	24756516	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000334693900026
J	Ip, N; Hoddes, J				Ip, Natasha; Hoddes, Jane			Henna tattoo: infection or allergy?	LANCET			English	Editorial Material							P-PHENYLENEDIAMINE		[Ip, Natasha; Hoddes, Jane] Lister Hosp, Dept Paediat, Stevenage SG1 4AQ, Herts, England	Lister Hospital	Ip, N (corresponding author), Lister Hosp, Dept Paediat, L65, Stevenage SG1 4AQ, Herts, England.	natasha.ip@nhs.net						Almeida PJ, 2012, CONTACT DERMATITIS, V66, P33, DOI 10.1111/j.1600-0536.2011.01992.x; Jacob SE, 2008, ARCH PEDIAT ADOL MED, V162, P790, DOI 10.1001/archpedi.162.8.790; Kind F, 2013, PEDIATRICS, V131, pE1974, DOI 10.1542/peds.2012-2938; RuizMaldonado R, 1997, SEMIN CUTAN MED SURG, V16, P36, DOI 10.1016/S1085-5629(97)80034-X; Worsnop FS, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7474	5	5	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2014	383	9926					1436	1436		10.1016/S0140-6736(14)60483-9	http://dx.doi.org/10.1016/S0140-6736(14)60483-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG3LI	24759251				2022-12-28	WOS:000335318400030
J	Rossi, F; Diaz, L; Wollam, A; Panesso, D; Zhou, YJ; Rincon, S; Narechania, A; Xing, GL; Di Gioia, TSR; Doi, A; Tran, TT; Reyes, J; Munita, JM; Carvajal, LP; Hernandez-Roldan, A; Brandao, D; van der Heijden, IM; Murray, BE; Planet, PJ; Weinstock, GM; Arias, CA				Rossi, Flavia; Diaz, Lorena; Wollam, Aye; Panesso, Diana; Zhou, Yanjiao; Rincon, Sandra; Narechania, Apurva; Xing, Galen; Di Gioia, Thais S. R.; Doi, Andre; Tran, Truc T.; Reyes, Jinnethe; Munita, Jose M.; Carvajal, Lina P.; Hernandez-Roldan, Alejandra; Brandao, Denise; van der Heijden, Inneke Marie; Murray, Barbara E.; Planet, Paul J.; Weinstock, George M.; Arias, Cesar A.			Transferable Vancomycin Resistance in a Community-Associated MRSA Lineage	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STAPHYLOCOCCUS-AUREUS ISOLATE; GLYCOPEPTIDE RESISTANCE; ENTEROCOCCUS-FAECIUM; PLASMID; IDENTIFICATION; CONNECTION; USA300; LEVEL; CLONE; GENE	We report the case of a patient from Brazil with a bloodstream infection caused by a strain of methicillin-resistant Staphylococcus aureus (MRSA) that was susceptible to vancomycin (designated BR-VSSA) but that acquired the vanA gene cluster during antibiotic therapy and became resistant to vancomycin (designated BR-VRSA). Both strains belong to the sequence type (ST) 8 community-associated genetic lineage that carries the staphylococcal chromosomal cassette mec (SCCmec) type IVa and the S. aureus protein A gene (spa) type t292 and are phylogenetically related to MRSA lineage USA300. A conjugative plasmid of 55,706 bp (pBRZ01) carrying the vanA cluster was identified and readily transferred to other staphylococci. The pBRZ01 plasmid harbors DNA sequences that are typical of the plasmid-associated replication genes rep24 or rep21 described in community-associated MRSA strains from Australia (pWBG745). The presence and dissemination of community-associated MRSA containing vanA could become a serious public health concern.	[Rossi, Flavia; Di Gioia, Thais S. R.; Doi, Andre; Brandao, Denise; van der Heijden, Inneke Marie] Univ Sao Paulo, Dept Pathol, Cent Lab LIM 03, Div Microbiol,Hosp Clin,Fac Med, Sao Paulo, Brazil; [Rossi, Flavia; Di Gioia, Thais S. R.; Doi, Andre; Brandao, Denise; van der Heijden, Inneke Marie] Univ Sao Paulo, Dept Infect Dis LIM 54, Hosp Clin, Fac Med, Sao Paulo, Brazil; [Diaz, Lorena; Panesso, Diana; Rincon, Sandra; Reyes, Jinnethe; Carvajal, Lina P.; Arias, Cesar A.] Univ Bosque, Mol Genet & Antimicrobial Resistance Unit, Bogota, Colombia; [Hernandez-Roldan, Alejandra] CIDEIM, Cali, Colombia; [Munita, Jose M.] Univ Desarrollo, Clin Alemana Santiago, Santiago, Chile; [Diaz, Lorena; Panesso, Diana; Tran, Truc T.; Reyes, Jinnethe; Munita, Jose M.; Hernandez-Roldan, Alejandra; Murray, Barbara E.; Arias, Cesar A.] Univ Texas Houston, Sch Med, Dept Internal Med, Div Infect Dis, Houston, TX USA; [Murray, Barbara E.; Arias, Cesar A.] Univ Texas Houston, Sch Med, Dept Microbiol & Mol Genet, Houston, TX USA; [Tran, Truc T.] Univ Houston, Coll Pharm, Houston, TX 77030 USA; [Wollam, Aye; Zhou, Yanjiao; Weinstock, George M.] Washington Univ, Genome Inst, St Louis, MO 63130 USA; [Narechania, Apurva; Planet, Paul J.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Xing, Galen; Planet, Paul J.] Columbia Univ, Div Pediat Infect Dis, New York, NY USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidad El Bosque; Clinica Alemana; Universidad del Desarrollo; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston; Washington University (WUSTL); American Museum of Natural History (AMNH); Columbia University	Arias, CA (corresponding author), Univ Texas Houston, Sch Med, 6431 Fannin St,Rm 2,112 MSB, Houston, TX 77030 USA.	cesar.arias@uth.tmc.edu	Weinstock, George M/C-6314-2013; Munita, Jose/G-3601-2016; van der Heijden, Inneke Marie/O-2021-2019; Rossi, Flavia/D-5344-2012	Weinstock, George M/0000-0002-2997-4592; Munita, Jose/0000-0002-7870-1056; van der Heijden, Inneke Marie/0000-0002-1392-6000; Rincon, Sandra/0000-0002-8482-4554	National Institute of Allergy and Infectious Diseases [R01 AI093749]; National Institutes of Health [1U54 HG004968]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, U54HG004968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI101005, R01AI093749] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the National Institute of Allergy and Infectious Diseases (R01 AI093749, to Dr. Arias) and the National Institutes of Health (1U54 HG004968, to Dr. Weinstock).	[Anonymous], 2012, M100S21 CLSI; Arias CA, 2008, NEW ENGL J MED, V359, P2177, DOI 10.1056/NEJMc0804021; Arias CA, 2011, NEW ENGL J MED, V365, P892, DOI 10.1056/NEJMoa1011138; Arias CA, 2009, ANTIMICROB AGENTS CH, V53, P4240, DOI 10.1128/AAC.00242-09; ARTHUR M, 1993, J BACTERIOL, V175, P117, DOI 10.1128/JB.175.1.117-127.1993; Azimian A, 2012, J CLIN MICROBIOL, V50, P3581, DOI 10.1128/JCM.01727-12; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; DUTKAMALEN S, 1995, J CLIN MICROBIOL, V33, P24, DOI 10.1128/JCM.33.1.24-27.1995; Kos VN, 2012, MBIO, V3, DOI 10.1128/mBio.00112-12; Limbago BM, 2014, J CLIN MICROBIOL, V52, P998, DOI 10.1128/JCM.02187-13; Lozano C, 2012, APPL ENVIRON MICROB, V78, P5948, DOI 10.1128/AEM.00870-12; Martineau F, 2000, ANTIMICROB AGENTS CH, V44, P231, DOI 10.1128/AAC.44.2.231-238.2000; McCarthy AJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-104; Jimenez JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038576; O'Brien FG, 2009, J ANTIMICROB CHEMOTH, V64, P684, DOI 10.1093/jac/dkp285; Reyes J, 2009, CLIN INFECT DIS, V49, P1861, DOI 10.1086/648426; Rodriguez-Noriega E, 2010, INT J INFECT DIS, V14, pE560, DOI 10.1016/j.ijid.2009.08.018; Saha B, 2008, J MED MICROBIOL, V57, P72, DOI 10.1099/jmm.0.47144-0; Tomita H, 2002, J CLIN MICROBIOL, V40, P3326, DOI 10.1128/JCM.40.9.3326-3333.2002; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Woo PCY, 2001, J CLIN PATHOL-MOL PA, V54, P244, DOI 10.1136/mp.54.4.244; Zhu WM, 2013, ANTIMICROB AGENTS CH, V57, P212, DOI 10.1128/AAC.01587-12; Zhu WM, 2010, ANTIMICROB AGENTS CH, V54, P4314, DOI 10.1128/AAC.00185-10	26	108	112	1	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 17	2014	370	16					1524	1531		10.1056/NEJMoa1303359	http://dx.doi.org/10.1056/NEJMoa1303359			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF3HE	24738669	Green Accepted, Bronze			2022-12-28	WOS:000334601600009
J	Aune, D; Saugstad, OD; Henriksen, T; Tonstad, S				Aune, Dagfinn; Saugstad, Ola Didrik; Henriksen, Tore; Tonstad, Serena			Maternal Body Mass Index and the Risk of Fetal Death, Stillbirth, and Infant Death A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVERSE PREGNANCY OUTCOMES; GESTATIONAL WEIGHT-GAIN; PREPREGNANCY WEIGHT; NEONATAL OUTCOMES; EXTREME OBESITY; OVERWEIGHT; POPULATION; WOMEN; COMPLICATIONS; ASSOCIATION	IMPORTANCE Evidence suggests that maternal obesity increases the risk of fetal death, stillbirth, and infant death; however, the optimal body mass index (BMI) for prevention is not known. OBJECTIVE To conduct a systematic review and meta-analysis of cohort studies of maternal BMI and risk of fetal death, stillbirth, and infant death. DATA SOURCES The PubMed and Embase databases were searched from inception to January 23, 2014. STUDY SELECTION Cohort studies reporting adjusted relative risk (RR) estimates for fetal death, stillbirth, or infant death by at least 3 categories of maternal BMI were included. DATA EXTRACTION Data were extracted by 1 reviewer and checked by the remaining reviewers for accuracy. Summary RRs were estimated using a random-effects model. MAIN OUTCOMES AND MEASURES Fetal death, stillbirth, and neonatal, perinatal, and infant death. RESULTS Thirty eight studies (44 publications) with more than 10 147 fetal deaths, more than 16 274 stillbirths, more than 4311 perinatal deaths, 11 294 neonatal deaths, and 4983 infant deaths were included. The summary RR per 5-unit increase in maternal BMI for fetal death was 1.21 (95% CI, 1.09-1.35; l(2) = 77.6%; n = 7 studies); for stillbirth, 1.24 (95% CI, 1.18-1.30; l(2) = 80%; n = 18 studies); for perinatal death, 1.16 (95% CI, 1.00-1.35; l(2) = 93.7%; n = 11 studies); for neonatal death, 1.15 (95% CI, 1.07-1.23; l(2) = 78.5%; n = 12 studies); and for infant death, 1.18 (95% CI, 1.09-1.28; l(2) = 79%; n = 4 studies). The test for nonlinearity was significant in all analyses but was most pronounced for fetal death. For women with a BMI of 20 (reference standard for all outcomes), 25, and 30, absolute risks per 10 000 pregnancies for fetal death were 76, 82 (95% CI, 76-88), and 102 (95% CI, 93-112); for stillbirth, 40, 48 (95% CI, 46-51), and 59 (95% CI, 55-63); for perinatal death, 66, 73 (95% CI, 67-81), and 86 (95% CI, 76-98); for neonatal death, 20, 21 (95% CI, 19-23), and 24 (95% CI, 22-27); and for infant death, 33, 37 (95% CI, 34-39), and 43 (95% CI, 40-47), respectively. CONCLUSIONS AND RELEVANCE Even modest increases in maternal BMI were associated with increased risk of fetal death, stillbirth, and neonatal, perinatal, and infant death. Weight management guidelines for women who plan pregnancies should take these findings into consideration to reduce the burden of fetal death, stillbirth, and infant death.	[Aune, Dagfinn] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London W2 1PG, England; [Aune, Dagfinn; Tonstad, Serena] Univ Oslo, Ulleval Hosp, Dept Prevent Cardiol, Oslo, Norway; [Aune, Dagfinn] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Fac Med, N-7034 Trondheim, Norway; [Saugstad, Ola Didrik] Univ Oslo, Rikshosp, Dept Pediat Res, Oslo Univ Hosp, N-0027 Oslo, Norway; [Henriksen, Tore] Oslo Univ Hosp, Rikshosp, Sect Obstet, Women & Childrens Div, Oslo, Norway; [Tonstad, Serena] Loma Linda Univ, Dept Hlth Promot & Educ, Loma Linda, CA 92350 USA	Imperial College London; University of Oslo; Norwegian University of Science & Technology (NTNU); University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; Loma Linda University	Aune, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, St Marys Campus,Norfolk Pl, London W2 1PG, England.	d.aune@imperial.ac.uk	Saugstad, Ola/AAS-9041-2021	Saugstad, Ola/0000-0002-3166-5254; Aune, Dagfinn/0000-0002-4533-1722	Norwegian SIDS; Stillbirth Society, Oslo, Norway [554.04/12]	Norwegian SIDS; Stillbirth Society, Oslo, Norway	This project was supported by a grant from the Norwegian SIDS and Stillbirth Society (554.04/12), Oslo, Norway.	Abenhaim Haim A., 2007, Archives of Gynecology and Obstetrics, V275, P39, DOI 10.1007/s00404-006-0219-y; Addo V N, 2010, Ghana Med J, V44, P64; Baeten JM, 2001, AM J PUBLIC HEALTH, V91, P436, DOI 10.2105/AJPH.91.3.436; Balchin I, 2007, BRIT MED J, V334, P833, DOI 10.1136/bmj.39132.482025.80; Bhattacharya S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-168; Bodnar LM, 2007, EPIDEMIOLOGY, V18, P234, DOI 10.1097/01.ede.0000254119.99660.e7; Boulet SL, 2003, AM J OBSTET GYNECOL, V188, P1372, DOI 10.1067/mob.2003.302; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2459, DOI 10.1001/jama.2011.1823; Campbell S, 2011, AUST NZ J PUBL HEAL, V35, P343, DOI 10.1111/j.1753-6405.2011.00729.x; CATTANACH S, 1993, AUST NZ J OBSTET GYN, V33, P45, DOI 10.1111/j.1479-828X.1993.tb02051.x; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Choi SK, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-6; Chu SY, 2007, AM J OBSTET GYNECOL, V197, P223, DOI 10.1016/j.ajog.2007.03.027; Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a; Cnattingius S, 2002, SEMIN PERINATOL, V26, P286, DOI 10.1053/sper.2002.34771; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Conde-Agudelo A, 2000, ACTA OBSTET GYN SCAN, V79, P371, DOI 10.1034/j.1600-0412.2000.079005371.x; Craven C, 2002, SEMIN PERINATOL, V26, P36, DOI 10.1053/sper.2002.29836; Cresswell JA, 2012, LANCET, V380, P1325, DOI 10.1016/S0140-6736(12)60869-1; Davis RR, 2014, AM J PUBLIC HEALTH, V104, pS90, DOI 10.2105/AJPH.2013.301425; Denison FC, 2014, BJOG-INT J OBSTET GY, V121, P72, DOI 10.1111/1471-0528.12443; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dodd JM, 2011, AUST NZ J OBSTET GYN, V51, P136, DOI 10.1111/j.1479-828X.2010.01272.x; Drysdale H, 2012, MED J AUSTRALIA, V197, P278, DOI 10.5694/mja12.10125; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eldor A, 2001, J THROMB THROMBOLYS, V12, P23, DOI 10.1023/A:1012730325902; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Fretts RC, 2005, AM J OBSTET GYNECOL, V193, P1923, DOI 10.1016/j.ajog.2005.03.074; Gardosi J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f108; Getahun D, 2007, AM J OBSTET GYNECOL, V196, P499, DOI 10.1016/j.ajog.2006.09.017; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; HAMILTONFAIRLEY D, 1992, BRIT J OBSTET GYNAEC, V99, P128, DOI 10.1111/j.1471-0528.1992.tb14470.x; Hamling J, 2008, STAT MED, V27, P954, DOI 10.1002/sim.3013; Hauger MS, 2008, ACTA OBSTET GYN SCAN, V87, P953, DOI 10.1080/00016340802303349; Jensen DM, 2003, AM J OBSTET GYNECOL, V189, P239, DOI 10.1067/mob.2003.441; Joshi S, 2011, INT J GYNECOL OBSTET, V114, P82, DOI 10.1016/j.ijgo.2011.01.020; Khashan AS, 2009, EUR J EPIDEMIOL, V24, P697, DOI 10.1007/s10654-009-9375-2; Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172; Kristensen J, 2005, BJOG-INT J OBSTET GY, V112, P403, DOI 10.1111/j.1471-0528.2005.00437.x; Langford A, 2011, MATERN CHILD HLTH J, V15, P860, DOI 10.1007/s10995-008-0318-4; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Leung TY, 2008, BJOG-INT J OBSTET GY, V115, P1529, DOI 10.1111/j.1471-0528.2008.01931.x; Liu XM, 2011, ARCH GYNECOL OBSTET, V283, P65, DOI 10.1007/s00404-009-1288-5; Lumme Riitta, 1995, Journal of Obstetrics and Gynaecology (Abingdon), V15, P69, DOI 10.3109/01443619509020659; Magann EF, 2013, AUST NZ J OBSTET GYN, V53, P250, DOI 10.1111/ajo.12047; Galan SM, 2012, J MATERN-FETAL NEO M, V25, P308, DOI 10.3109/14767058.2011.575905; McIntyre HD, 2012, MED J AUSTRALIA, V196, P184, DOI 10.5694/mja11.11120; Moldenhauer JS, 2003, AM J OBSTET GYNECOL, V189, P1173, DOI 10.1067/S0002-9378(03)00576-3; Narchi H, 2010, J OBSTET GYNAECOL, V30, P679, DOI 10.3109/01443615.2010.509824; Nohr EA, 2005, OBSTET GYNECOL, V106, P250, DOI 10.1097/01.AOG.0000172422.81496.57; Nohr EA, 2007, OBSTET GYNECOL, V110, P1083, DOI 10.1097/01.AOG.0000286760.46679.f8; Nohr EA, 2012, ACTA OBSTET GYN SCAN, V91, P363, DOI 10.1111/j.1600-0412.2011.01331.x; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Ovesen P, 2011, OBSTET GYNECOL, V118, P305, DOI 10.1097/AOG.0b013e3182245d49; Persson M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000601; Raatikainen K, 2006, OBESITY, V14, P165, DOI 10.1038/oby.2006.20; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; Reddy UM, 2010, OBSTET GYNECOL, V116, P1119, DOI 10.1097/AOG.0b013e3181f903f8; Royston P, 2000, STAT MED, V19, P1831, DOI 10.1002/1097-0258(20000730)19:14<1831::AID-SIM502>3.0.CO;2-1; Salihu HM, 2008, OBSTET GYNECOL, V111, P1410, DOI 10.1097/AOG.0b013e318173ecd4; Salihu HM, 2007, OBSTET GYNECOL, V110, P552, DOI 10.1097/01.AOG.0000270159.80607.10; Scott-Pillai R, 2013, BJOG-INT J OBSTET GY, V120, P932, DOI 10.1111/1471-0528.12193; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Smith GCS, 2007, AM J PUBLIC HEALTH, V97, P157, DOI 10.2105/AJPH.2005.074294; STONE JL, 1994, OBSTET GYNECOL, V83, P357; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Stringer EM, 2011, OBSTET GYNECOL, V117, P1151, DOI 10.1097/AOG.0b013e3182167627; Syngelaki A, 2011, FETAL DIAGN THER, V30, P250, DOI 10.1159/000328083; Tennant PWG, 2011, HUM REPROD, V26, P1501, DOI 10.1093/humrep/der052; Thompson DR, 2008, PUBLIC HEALTH REP, V123, P487, DOI 10.1177/003335490812300410; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; Wallace JM, 2012, PLACENTA, V33, P611, DOI 10.1016/j.placenta.2012.05.006; Wells G., NEWCASTLE OTTAWA SCA; Whiteman VE, 2011, GYNECOL OBSTET INVES, V72, P192, DOI 10.1159/000324375; Zhang J, 2008, AM J OBSTET GYNECOL, V199, pS51, DOI 10.1016/j.ajog.2008.09.161	76	365	381	4	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2014	311	15					1536	1546		10.1001/jama.2014.2269	http://dx.doi.org/10.1001/jama.2014.2269			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9DX	24737366	Bronze			2022-12-28	WOS:000334306000021
J	Chatterjee, P				Chatterjee, Patralekha			ELECTIONS 2014 An activist doctor joins the electoral fray in Rajasthan	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												patralekha.chatterjee@gmail.com						[Anonymous], 2014, BUSINESS STANDARD; Mishra S, 2013, MAIL ONLINE IND 1210	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2014	348								g2814	10.1136/bmj.g2814	http://dx.doi.org/10.1136/bmj.g2814			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF5GN	24736643				2022-12-28	WOS:000334742100024
J	Selvin, E; Parrinello, CM; Sacks, DB; Coresh, J				Selvin, Elizabeth; Parrinello, Christina M.; Sacks, David B.; Coresh, Josef			Trends in Prevalence and Control of Diabetes in the United States, 1988-1994 and 1999-2010	ANNALS OF INTERNAL MEDICINE			English	Article							FASTING PLASMA-GLUCOSE; NATIONAL-HEALTH; ATHEROSCLEROSIS RISK; GLYCATED HEMOGLOBIN; ADULTS; US; MELLITUS; A1C; CLASSIFICATION; COMORBIDITIES	Background: Trends in the prevalence and control of diabetes defined by hemoglobin A(1c) (HbA(1c)) levels are important for health care policy and planning. Objective: To update trends in the prevalence of diabetes, prediabetes, and glycemic control. Design: Cross-sectional. Setting: NHANES (National Health and Nutrition Examination Survey) in 1988-1994 and 1999-2010. Participants: Adults aged 20 years or older. Measurements: We used calibrated HbA(1c) levels to define undiagnosed diabetes (>= 6.5%); prediabetes (5.7% to 6.4%); and, among persons with diagnosed diabetes, glycemic control (<7.0% or <8.0%). Trends in HbA(1c) categories were compared with fasting glucose levels (>= 7.0 mmol/L [>= 126 mg/dL] and 5.6 to 6.9 mmol/L [100 to 125 mg/dL]). Results: In 2010, approximately 21 million U. S. adults aged 20 years or older had total confirmed diabetes (self-reported diabetes or diagnostic levels for both fasting glucose and calibrated HbA(1c)). During 2 decades, the prevalence of total confirmed diabetes in-creased, but the prevalence of undiagnosed diabetes remained fairly stable, reducing the proportion of total diabetes cases that are undiagnosed to 11% in 2005-2010. The prevalence of prediabetes was lower when defined by calibrated HbA(1c) levels than when defined by fasting glucose levels but has increased from 5.8% in 1988-1994 to 12.4% in 2005-2010 when defined by HbA(1c) levels. Glycemic control improved overall, but total diabetes prevalence was greater and diabetes was less controlled among non-Hispanic blacks and Mexican Americans compared with non-Hispanic whites. Limitation: Cross-sectional design. Conclusion: Over the past 2 decades, the prevalence of total diabetes has increased substantially. However, the proportion of undiagnosed diabetes cases decreased, suggesting improvements in screening and diagnosis. Among the growing number of persons with diagnosed diabetes, glycemic control improved but remains a challenge, particularly among non-Hispanic blacks and Mexican Americans.	[Selvin, Elizabeth] Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21287 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA; Johns Hopkins Univ, Baltimore, MD USA; NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; National Institutes of Health (NIH) - USA	Selvin, E (corresponding author), Welch Ctr Prevent Epidemiol & Clin Res, 2024 East Monument St,Suite 2-600, Baltimore, MD 21287 USA.	lselvin@jhsph.edu		Sacks, David/0000-0003-3100-0735	National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK089174]; National Heart, Lung, and Blood Institute [T32 HL007024]; Intramural Program of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089174] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By the National Institute of Diabetes and Digestive and Kidney Diseases (grant R01 DK089174) to Dr. Selvin. Ms. Parrinello was supported by the National Heart, Lung, and Blood Institute (grant T32 HL007024). Dr. Sacks was supported by the Intramural Program of the National Institutes of Health.	Abraham TM, 2013, DIABETES CARE, V36, P2139, DOI 10.2337/dc13-0792; Albano A., 2014, PACKAGE EQUATE; Albano AD, 2011, EQUATE R PACKAGE OBS; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; American Diabetes Association, 2010, DIABETES CARE S1, V33, P692, DOI [10.2337/dc10-S011, DOI 10.2337/DC10-S011]; [Anonymous], 2010, DATA DOC COD FREQ PL; [Anonymous], 2008, DATA DOC COD FREQ PL; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Bower JK, 2013, DIABETES CARE, V36, P569, DOI 10.2337/dc12-0404; Bullard KM, 2013, DIABETES CARE, V36, P2286, DOI 10.2337/dc12-2563; Centers for Disease Control and Prevention, 2012, UPDAT ADVIS NHANES H; Centers for Disease Control and Prevention, 2011, MAPS TRENDS DIAGN DI; Centers for Disease Control and Prevention, 1996, LAB PROC USES 3 NAT; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1014; Christman AL, 2011, DIABETOLOGIA, V54, P1645, DOI 10.1007/s00125-011-2095-7; Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI [10.1056/NEJMoa1215740, 10.1056/NEJMc1311765]; Debnath S, 2012, CLIN NEPHROL, V77, P332, DOI 10.5414/CN107487; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Gross AL, 2012, J CLIN EXP NEUROPSYC, V34, P758, DOI 10.1080/13803395.2012.681628; Heianza Y, 2011, LANCET, V378, P147, DOI 10.1016/S0140-6736(11)60472-8; Kalyani RR, 2010, DIABETES CARE, V33, P1055, DOI 10.2337/dc09-1597; Lee JWR, 2011, DIABETES CARE, V34, P353, DOI 10.2337/dc10-0746; Mann DM, 2010, DIABETES CARE, V33, P2190, DOI 10.2337/dc10-0752; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; National Center for Health Statistics, 2013, NAT HLTH NUTR EX SUR; National Center for Health Statistics, 1996, ANAL REP GUID 3 NAT; Pankow JS, 2007, DIABETES CARE, V30, P325, DOI 10.2337/dc06-1457; PERNEGER TV, 1994, ANN INTERN MED, V121, P912, DOI 10.7326/0003-4819-121-12-199412150-00002; Rejeski WJ, 2012, NEW ENGL J MED, V366, P1209, DOI 10.1056/NEJMoa1110294; Ryerson B, 2003, DIABETES CARE, V26, P206, DOI 10.2337/diacare.26.1.206; Saydah SH, 2004, ANN EPIDEMIOL, V14, P507, DOI 10.1016/j.annepidem.2003.09.016; Schneider ALC, 2013, DIABETES CARE, V36, P1153, DOI 10.2337/dc12-1168; Schneider ALC, 2012, AM J EPIDEMIOL, V176, P738, DOI 10.1093/aje/kws156; Selvin E, 2007, ARCH INTERN MED, V167, P1545, DOI 10.1001/archinte.167.14.1545; Selvin E, 2011, DIABETES CARE, V34, P84, DOI 10.2337/dc10-1235; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Tarver-Carr ME, 2002, J AM SOC NEPHROL, V13, P2363, DOI 10.1097/01.ASN.0000026493.18542.6A; Vincent G. K., 2010, CURRENT POPULATION R, VP25, P1; World Health Organization, 2011, USE GLYC HACM HBA1C; World Health Organization, 2008, WAIST CIRC WAIST FLI; Zhang XZ, 2010, J AM GERIATR SOC, V58, P724, DOI 10.1111/j.1532-5415.2010.02786.x	43	382	387	1	45	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 15	2014	160	8					517	+		10.7326/M13-2411	http://dx.doi.org/10.7326/M13-2411			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG0ZE	24733192	Green Accepted			2022-12-28	WOS:000335143700001
J	Seo, J; Giusti-Rodriguez, P; Zhou, Y; Rudenko, A; Cho, S; Ota, KT; Park, C; Patzke, H; Madabhushi, R; Pan, L; Mungenast, AE; Guan, JS; Delalle, I; Tsai, LH				Seo, Jinsoo; Giusti-Rodriguez, Paola; Zhou, Ying; Rudenko, Andrii; Cho, Sukhee; Ota, Kristie T.; Park, Christine; Patzke, Holger; Madabhushi, Ram; Pan, Ling; Mungenast, Alison E.; Guan, Ji-Song; Delalle, Ivana; Tsai, Li-Huei			Activity-Dependent p25 Generation Regulates Synaptic Plasticity and A beta-Induced Cognitive Impairment	CELL			English	Article							ALZHEIMERS-DISEASE; MEMORY FORMATION; TRANSGENIC MICE; AMPA RECEPTORS; CDK5; PROTEIN; P35; ACTIVATION; PHOSPHORYLATION; NEURODEGENERATION	Cyclin-dependent kinase 5 regulates numerous neuronal functions with its activator, p35. Under neurotoxic conditions, p35 undergoes proteolytic cleavage to liberate p25, which has been implicated in various neurodegenerative diseases. Here, we show that p25 is generated following neuronal activity under physiological conditions in a GluN2B- and CaMKII alpha-dependent manner. Moreover, we developed a knockin mouse model in which endogenous p35 is replaced with a calpain-resistant mutant p35 (Delta p35KI) to prevent p25 generation. The Dp35KI mice exhibit impaired long-term depression and defective memory extinction, likely mediated through persistent GluA1 phosphorylation at Ser845. Finally, crossing the Dp35KI mice with the 5XFAD mouse model of Alzheimer's disease ( AD) resulted in an amelioration of beta-amyloid (Ab)-induced synaptic depression and cognitive impairment. Together, these results reveal a physiological role of p25 production in synaptic plasticity and memory and provide new insights into the function of p25 in A beta-associated neurotoxicity and AD-like pathology.	[Seo, Jinsoo; Giusti-Rodriguez, Paola; Zhou, Ying; Rudenko, Andrii; Cho, Sukhee; Ota, Kristie T.; Park, Christine; Patzke, Holger; Madabhushi, Ram; Pan, Ling; Mungenast, Alison E.; Guan, Ji-Song; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Seo, Jinsoo; Giusti-Rodriguez, Paola; Zhou, Ying; Rudenko, Andrii; Cho, Sukhee; Ota, Kristie T.; Park, Christine; Patzke, Holger; Madabhushi, Ram; Pan, Ling; Mungenast, Alison E.; Guan, Ji-Song; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Delalle, Ivana] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Tsai, Li-Huei] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; [Tsai, Li-Huei] MIT, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Tsai, LH (corresponding author), MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Rudenko, Andrey/AAG-4696-2020; Seo, Jinsoo/AAD-4950-2019	Rudenko, Andrey/0000-0001-6858-3650; Seo, Jinsoo/0000-0001-6432-6964; Guan, Ji-Song/0000-0001-5219-0289; Delalle, Ivana/0000-0002-1873-3064; Mungenast, Alison/0000-0003-1020-0471	National Institutes of Health [R01 NS051874, F31GM80055-03]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM080055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051874] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Neve for packaging the recombinant herpes simplex viruses; J. Giraud and E. Cornejo for early observations; Z. Xie for assistance in developing the cloning strategy to generate the Delta p35KI mouse; W. Xu, S. Su, A. Nott, and A. Bero for helpful comments on the manuscript; and members of the Tsai lab for fruitful advice and discussions. We also thank M. Taylor for animal maintenance. This work was partially supported by the National Institutes of Health (grants R01 NS051874 to L.-H.T. and F31GM80055-03 to P.G.-R.) and the Howard Hughes Medical Institute.	Angelo M, 2003, EUR J NEUROSCI, V18, P423, DOI 10.1046/j.1460-9568.2003.02746.x; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chen RQ, 2012, CELL REP, V2, P1329, DOI 10.1016/j.celrep.2012.09.030; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Crews L, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.2; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; Dalton GL, 2008, NEUROPSYCHOPHARMACOL, V33, P2416, DOI 10.1038/sj.npp.1301642; Dhavan R, 2002, J NEUROSCI, V22, P7879; Engmann O, 2011, BIOL PSYCHIAT, V70, P159, DOI 10.1016/j.biopsych.2011.04.011; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Guan JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025735; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; HALPAIN S, 1990, NATURE, V343, P369, DOI 10.1038/343369a0; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; Jawhar S., 2012, NEUROBIOL AGING, V33, pe129, DOI [DOI 10.1016/J.NEUR0BI0LAGING.2010.05.027, DOI 10.1016/j.neurobiolaging.2010.05.027]; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kesavapany Sashi, 2007, Biotechnology Journal, V2, P978, DOI 10.1002/biot.200700057; Kim J, 2007, P NATL ACAD SCI USA, V104, P20955, DOI 10.1073/pnas.0710548105; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Kimura R, 2009, NEUROBIOL DIS, V33, P229, DOI 10.1016/j.nbd.2008.10.006; Ko J, 2001, J NEUROSCI, V21, P6758; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Mitra A, 2012, NAT NEUROSCI, V15, P250, DOI 10.1038/nn.3004; Mukerjee N, 2000, ARCH BIOCHEM BIOPHYS, V379, P337, DOI 10.1006/abbi.2000.1889; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ohshima T, 2005, J NEUROCHEM, V94, P917, DOI 10.1111/j.1471-4159.2005.03233.x; Otth C, 2002, J ALZHEIMERS DIS, V4, P417, DOI 10.3233/JAD-2002-4508; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Sadleir KR, 2012, J BIOL CHEM, V287, P7224, DOI 10.1074/jbc.M111.333914; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Shuai YC, 2010, CELL, V140, P579, DOI 10.1016/j.cell.2009.12.044; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Swatton JE, 2004, EUR J NEUROSCI, V19, P2711, DOI 10.1111/j.0953-816X.2004.03365.x; Szapiro G, 2003, HIPPOCAMPUS, V13, P53, DOI 10.1002/hipo.10043; Tronson NC, 2012, TRENDS NEUROSCI, V35, P145, DOI 10.1016/j.tins.2011.10.003; Verkhratsky A, 2010, NEUROTHERAPEUTICS, V7, P399, DOI 10.1016/j.nurt.2010.05.017; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Yang T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003604; Yoo BC, 2001, NATURE, V411, P763, DOI 10.1038/35081146; Zhang M, 2011, J NEUROSCI, V31, P10174, DOI 10.1523/JNEUROSCI.0009-11.2011; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	60	59	60	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					486	498		10.1016/j.cell.2014.01.065	http://dx.doi.org/10.1016/j.cell.2014.01.065			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725413	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000334304500020
J	Slager, J; Kjos, M; Attaiech, L; Veening, JW				Slager, Jelle; Kjos, Morten; Attaiech, Laetitia; Veening, Jan-Willem			Antibiotic-Induced Replication Stress Triggers Bacterial Competence by Increasing Gene Dosage near the Origin	CELL			English	Article							DNA-DAMAGE RESPONSE; STREPTOCOCCUS-PNEUMONIAE; BACILLUS-SUBTILIS; TRANSCRIPTOME ANALYSIS; SOS RESPONSE; CELL-DEATH; TRANSFORMATION; EXPRESSION; PHEROMONE; EVOLUTION	Streptococcus pneumoniae (pneumococcus) kills nearly 1 million children annually, and the emergence of antibiotic-resistant strains poses a serious threat to human health. Because pneumococci can take up DNA from their environment by a process called competence, genes associated with antibiotic resistance can rapidly spread. Remarkably, competence is activated in response to several antibiotics. Here, we demonstrate that antibiotics targeting DNA replication cause an increase in the copy number of genes proximal to the origin of replication (oriC). As the genes required for competence initiation are located near oriC, competence is thereby activated. Transcriptome analyses show that antibiotics targeting DNA replication also upregulate origin-proximal gene expression in other bacteria. This mechanism is a direct, intrinsic consequence of replication fork stalling. Our data suggest that evolution has conserved the oriC-proximal location of important genes in bacteria to allow for a robust response to replication stress without the need for complex gene-regulatory pathways.	[Slager, Jelle; Kjos, Morten; Attaiech, Laetitia; Veening, Jan-Willem] Univ Groningen, Ctr Synthet Biol, Groningen Biomol Sci & Biotechnol Inst, Mol Genet Grp, NL-9747 AG Groningen, Netherlands	University of Groningen	Veening, JW (corresponding author), Univ Groningen, Ctr Synthet Biol, Groningen Biomol Sci & Biotechnol Inst, Mol Genet Grp, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	j.w.veening@rug.nl	Attaiech, Laetitia/M-6593-2014	Attaiech, Laetitia/0000-0002-6188-1839; Kjos, Morten/0000-0003-4448-9082; Slager, Jelle/0000-0002-8226-4303; Veening, Jan-Willem/0000-0002-3162-6634	FEBS long-term fellowship; EMBO long-term fellowship; EMBO Young Investigator Program; VIDI fellowship from the Netherlands Organisation for Scientific Research, Earth and Life Sciences (NWO-ALW); ERC [337399-PneumoCell]	FEBS long-term fellowship; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); VIDI fellowship from the Netherlands Organisation for Scientific Research, Earth and Life Sciences (NWO-ALW)(Netherlands Organization for Scientific Research (NWO)); ERC(European Research Council (ERC)European Commission)	We thank George Wright for providing HPUra and HBEMAU and Jean-Pierre Claverys for plasmids. We thank Anne de Jong for bioinformatics support and Antoine van Oijen, Jan Kok, and Oscar Kuipers for comments. M.K. is supported by a FEBS long-term fellowship, and L.A. is supported by an EMBO long-term fellowship. Work in the Veening lab is supported by the EMBO Young Investigator Program, a VIDI fellowship (864.12.001) from the Netherlands Organisation for Scientific Research, Earth and Life Sciences (NWO-ALW), and ERC starting grant 337399-PneumoCell.	Alloing G, 1998, MOL MICROBIOL, V29, P75, DOI 10.1046/j.1365-2958.1998.00904.x; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Boutry C, 2013, J BACTERIOL, V195, P696, DOI 10.1128/JB.01605-12; BROWN NC, 1970, P NATL ACAD SCI USA, V67, P1454, DOI 10.1073/pnas.67.3.1454; Cassone M, 2012, J BIOL CHEM, V287, P38449, DOI 10.1074/jbc.M112.391482; Charpentier X, 2012, CURR OPIN MICROBIOL, V15, P570, DOI 10.1016/j.mib.2012.08.001; Charpentier X, 2011, J BACTERIOL, V193, P1114, DOI 10.1128/JB.01146-10; Cirz RT, 2007, J BACTERIOL, V189, P531, DOI 10.1128/JB.01464-06; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; Claverys JP, 2000, MOL MICROBIOL, V35, P251, DOI 10.1046/j.1365-2958.2000.01718.x; Cornick JE, 2012, MICROBES INFECT, V14, P573, DOI 10.1016/j.micinf.2012.01.012; Couturier E, 2006, MOL MICROBIOL, V59, P1506, DOI 10.1111/j.1365-2958.2006.05046.x; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Dagkessamanskaia A, 2004, MOL MICROBIOL, V51, P1071, DOI 10.1111/j.1365-2958.2003.03892.x; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; de Jong IG, 2011, JOVE-J VIS EXP, DOI 10.3791/3145; Eldar A, 2009, NATURE, V460, P510, DOI 10.1038/nature08150; Engelmoer DJP, 2011, EVOLUTION, V65, P3475, DOI 10.1111/j.1558-5646.2011.01402.x; Gmuender H, 2001, GENOME RES, V11, P28, DOI 10.1101/gr.157701; Goranov AI, 2005, P NATL ACAD SCI USA, V102, P12932, DOI 10.1073/pnas.0506174102; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Johnsborg O, 2009, FEMS MICROBIOL REV, V33, P627, DOI 10.1111/j.1574-6976.2009.00167.x; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kerkhoven R, 2004, BIOINFORMATICS, V20, P1812, DOI 10.1093/bioinformatics/bth159; Khil PP, 2002, MOL MICROBIOL, V44, P89, DOI 10.1046/j.1365-2958.2002.02878.x; Kjos M, 2014, MOL MICROBIOL, V91, P1088, DOI 10.1111/mmi.12517; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee MS, 1998, APPL ENVIRON MICROB, V64, P4796; Lewis RJ, 1996, BIOESSAYS, V18, P661, DOI 10.1002/bies.950180810; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marrer E, 2006, ANTIMICROB AGENTS CH, V50, P269, DOI 10.1128/AAC.50.1.269-278.2006; MARTIN B, 1995, MOL MICROBIOL, V15, P367, DOI 10.1111/j.1365-2958.1995.tb02250.x; Martin B, 2013, MOL MICROBIOL, V87, P394, DOI 10.1111/mmi.12104; Martin B, 2010, MOL MICROBIOL, V75, P1513, DOI 10.1111/j.1365-2958.2010.07071.x; Martin-Galiano AJ, 2003, ANTIMICROB AGENTS CH, V47, P1257, DOI 10.1128/AAC.47.4.1257-1261.2003; McClure R, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt444; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Odsbu I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007617; Pestova EV, 1996, MOL MICROBIOL, V21, P853, DOI 10.1046/j.1365-2958.1996.501417.x; Peterson SN, 2004, MOL MICROBIOL, V51, P1051, DOI 10.1046/j.1365-2958.2003.03907.x; Price MN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-19; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; Prudhomme M, 2005, MOL BIOL STREPTOCOCC, P519; Prudhomme M, 2006, SCIENCE, V313, P89, DOI 10.1126/science.1127912; Sangurdekar DP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-583; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Stevens KE, 2011, MBIO, V2, DOI 10.1128/mBio.00071-11; Su'etsugu M, 2011, MOL CELL, V41, P720, DOI 10.1016/j.molcel.2011.02.024; Tarantino PM, 1999, J MED CHEM, V42, P2035, DOI 10.1021/jm980693i; TOMASZ A, 1966, P NATL ACAD SCI USA, V55, P58, DOI 10.1073/pnas.55.1.58; van der Veen S, 2010, MICROBIOL-SGM, V156, P374, DOI 10.1099/mic.0.035196-0; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; Wecke T, 2011, J ANTIMICROB CHEMOTH, V66, P2689, DOI 10.1093/jac/dkr373; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Yamane T, 2012, INT J UROL, V19, P360, DOI 10.1111/j.1442-2042.2011.02933.x	58	138	143	3	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					395	406		10.1016/j.cell.2014.01.068	http://dx.doi.org/10.1016/j.cell.2014.01.068			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725406	Bronze, Green Published			2022-12-28	WOS:000334304500013
J	Kazi, DS; Garber, AM; Shah, RU; Dudley, RA; Mell, MW; Rhee, C; Moshkevich, S; Boothroyd, DB; Owens, DK; Hlatky, MA				Kazi, Dhruv S.; Garber, Alan M.; Shah, Rashmee U.; Dudley, R. Adams; Mell, Matthew W.; Rhee, Ceron; Moshkevich, Solomon; Boothroyd, Derek B.; Owens, Douglas K.; Hlatky, Mark A.			Cost-Effectiveness of Genotype-Guided and Dual Antiplatelet Therapies in Acute Coronary Syndrome	ANNALS OF INTERNAL MEDICINE			English	Article							SIROLIMUS-ELUTING STENTS; PLATO PLATELET INHIBITION; ARTERY-BYPASS SURGERY; TIMI 38 TRIAL; CYP2C19 GENOTYPE; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; CLINICAL-OUTCOMES; FOCUSED UPDATE; CLOPIDOGREL	Background: The choice of antiplatelet therapy after acute coronary syndrome (ACS) is complicated: Ticagrelor and prasugrel are novel alternatives to clopidogrel, patients with some genotypes may not respond to clopidogrel, and low-cost generic formulations of clopidogrel are available. Objective: To determine the most cost-effective strategy for dual antiplatelet therapy after percutaneous coronary intervention for ACS. Design: Decision-analytic model. Data Sources: Published literature, Medicare claims, and life tables. Target Population: Patients having percutaneous coronary intervention for ACS. Time Horizon: Lifetime. Perspective: Societal. Intervention: Five strategies were examined: generic clopidogrel, prasugrel, ticagrelor, and genotyping for polymorphisms of CYP2C19 with carriers of loss-of-function alleles receiving either ticagrelor (genotyping with ticagrelor) or prasugrel (genotyping with prasugrel) and noncarriers receiving clopidogrel. Outcome Measures: Direct medical costs, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios (ICERs). Results of Base-Case Analysis: The clopidogrel strategy produced $179301 in costs and 9.428 QALYs. Genotyping with prasugrel was superior to prasugrel alone, with an ICER of $35 800 per QALY relative to clopidogrel. Genotyping with ticagrelor was more effective than genotyping with prasugrel ($30 200 per QALY relative to clopidogrel). Ticagrelor was the most effective strategy ($52 600 per QALY relative to genotyping with ticagrelor).. Results of Sensitivity Analysis: Stronger associations between genotype and thrombotic outcomes rendered ticagrelor substantially less cost-effective ($104 800 per QALY). Genotyping with prasugrel was the preferred therapy among patients who could not tolerate ticagrelor. Limitation: No randomized trials have directly compared genotyping strategies or prasugrel with ticagrelor. Conclusion: Genotype-guided personalization may improve the cost-effectiveness of prasugrel and ticagrelor after percutaneous coronary intervention for ACS, but ticagrelor for all patients may be an economically reasonable alternative in some settings.	Univ Calif San Francisco, San Francisco Gen Hosp, San Francisco, CA USA; Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; Harvard Univ, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; Ctr Primary Care Outcomes Res, Grad Sch Business, Stanford, CA USA; Ctr Hlth Policy, Stanford, CA USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Kazi, DS (corresponding author), San Francisco Gen Hosp, Div Cardiol, 1001 Potrero Ave,Room 5G1, San Francisco, CA 94110 USA.	kazi@alumni.stanford.edu		Hlatky, Mark/0000-0003-4686-9441; Boothroyd, Derek Brian/0000-0001-5387-6995; Shah, Rashmee/0000-0002-7823-8540	American Heart Association; U.S. Department of Veterans Affairs; Stanford University; University of California San Francisco	American Heart Association(American Heart Association); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); Stanford University(Stanford University); University of California San Francisco(University of California System)	American Heart Association, U.S. Department of Veterans Affairs, Stanford University, and University of California San Francisco.	Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Anderson JL, 2011, J AM COLL CARDIOL, V57, pE215, DOI 10.1016/j.jacc.2011.02.011; Angiolillo DJ, 2007, J AM COLL CARDIOL, V49, P1505, DOI 10.1016/j.jacc.2006.11.044; [Anonymous], 2010, TOP 20 GLOB HLTH PRO; Arias Elizabeth, 2010, Natl Vital Stat Rep, V58, P1; Bamezai A, 2005, ANN EMERG MED, V45, P483, DOI 10.1016/j.annemergmed.2004.08.029; Bhatt DL, 2007, NEW ENGL J MED, V357, P2078, DOI 10.1056/NEJMe0706859; Bhatt DL, 2013, CHARISMA GENOMICS; Brandt JT, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.10.010; Cannon CP, 2010, LANCET, V375, P283, DOI 10.1016/S0140-6736(09)62191-7; Centers for Medicare & Medicaid Services, MED AN REV MEDPAR FI; Centers for Medicare & Medicaid Services, DEN FIL; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; Chieffo A, 2007, CIRCULATION, V116, P158, DOI 10.1161/CIRCULATIONAHA.107.692178; COHEN DJ, 1994, CIRCULATION, V89, P1859, DOI 10.1161/01.CIR.89.4.1859; Coleman CI, 2012, CURR MED RES OPIN, V28, P49, DOI 10.1185/03007995.2011.639752; Committee on the Assessment of the US Drug Safety System, 2007, FUT DRUG SAF PROM PR; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Davies Andrew, 2013, J Med Econ, V16, P510, DOI 10.3111/13696998.2013.768998; de la Torre-Hernandez JM, 2008, J AM COLL CARDIOL, V51, P986, DOI 10.1016/j.jacc.2007.10.057; Fox KAA, 2004, CIRCULATION, V110, P1202, DOI 10.1161/01.CIR.0000140675.85342.1B; Fox KAA, 2010, EUR HEART J, V31, P2755, DOI 10.1093/eurheartj/ehq326; Freeman JV, 2011, ANN INTERN MED, V154, P1, DOI 10.7326/0003-4819-154-1-201101040-00289; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; Garber AM, 2009, NEW ENGL J MED, V360, P1925, DOI 10.1056/NEJMp0901355; Garg P, 2008, J AM COLL CARDIOL, V51, P1844, DOI 10.1016/j.jacc.2008.01.042; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Gurbel PA, 2012, CIRCULATION, V125, P1276, DOI 10.1161/CIRCULATIONAHA.111.031195; Harmsze AM, 2012, PHARMACOGENET GENOM, V22, P169, DOI 10.1097/FPC.0b013e32834ff6e3; Healthcare Cost and Utilization Project, 2008, OV NAT INP SAMPL; Held C, 2011, J AM COLL CARDIOL, V57, P672, DOI 10.1016/j.jacc.2010.10.029; Hlatky MA, 1997, NEW ENGL J MED, V336, P92, DOI 10.1056/NEJM199701093360203; Hlatky MA, 2013, J AM COLL CARDIOL, V61, P295, DOI 10.1016/j.jacc.2012.10.018; Holmes MV, 2011, JAMA-J AM MED ASSOC, V306, P2704, DOI 10.1001/jama.2011.1880; Kaul Sanjay, 2010, Arch Intern Med, V170, P1010, DOI 10.1001/archinternmed.2010.139; King 3rd SB, 2008, J AM COLL CARDIOL, V51, P172; Ko DT, 2010, CIRCULATION, V121, P2635, DOI 10.1161/CIRCULATIONAHA.109.926881; Ko DT, 2010, CIRC-CARDIOVASC INTE, V3, P140, DOI 10.1161/CIRCINTERVENTIONS.109.928721; Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Lemos PA, 2004, CIRCULATION, V109, P190, DOI 10.1161/01.CIR.0000109138.84579.FA; Li Y, 2012, J THROMB HAEMOST, V10, P199, DOI 10.1111/j.1538-7836.2011.04570.x; Lipscomb J., 1996, COST EFFECTIVENESS H, P214; Longworth Louise, 2005, Eur J Health Econ, V6, P347, DOI 10.1007/s10198-005-0309-y; Lopez-Jimenez F, 2002, AM HEART J, V144, P687, DOI 10.1067/mhj.2002.124835; Machecourt J, 2007, J AM COLL CARDIOL, V50, P501, DOI 10.1016/j.jacc.2007.04.051; Mahaffey KW, 2011, CIRCULATION, V124, P544, DOI 10.1161/CIRCULATIONAHA.111.047498; Mahoney EM, 2010, CIRCULATION, V121, P71, DOI 10.1161/CIRCULATIONAHA.109.900704; Mauskopf Josephine A, 2012, J Med Econ, V15, P166, DOI 10.3111/13696998.2011.637590; Mega JL, 2010, LANCET, V376, P1312, DOI 10.1016/S0140-6736(10)61273-1; Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543; Mega JL, 2009, CIRCULATION, V119, P2553, DOI 10.1161/CIRCULATIONAHA.109.851949; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Mehran R, 2011, TRANSC CARD THER C S; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; New Drug Application (NDA), NEW DRUG APPL NDA; Nikolic E, 2013, EUR HEART J, V34, P220, DOI 10.1093/eurheartj/ehs149; Orford JL, 2002, J AM COLL CARDIOL, V40, P1567, DOI 10.1016/S0735-1097(02)02374-4; Panattoni L, 2012, PHARMACOECONOMICS, V30, P1067, DOI 10.2165/11595080-000000000-00000; Pare G, 2010, NEW ENGL J MED, V363, P1704, DOI 10.1056/NEJMoa1008410; Park DW, 2011, J AM COLL CARDIOL, V58, P2630, DOI 10.1016/j.jacc.2011.08.057; Parodi G, 2011, JAMA-J AM MED ASSOC, V306, P1215, DOI 10.1001/jama.2011.1332; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Reese ES, 2012, PHARMACOTHERAPY, V32, P323, DOI 10.1002/j.1875-9114.2012.01048; Roberts JD, 2012, LANCET, V379, P1705, DOI 10.1016/S0140-6736(12)60161-5; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; Saia F, 2006, J AM COLL CARDIOL, V48, P1312, DOI 10.1016/j.jacc.2006.03.063; Schleinitz MD, 2005, ANN INTERN MED, V142, P251, DOI 10.7326/0003-4819-142-4-200502150-00007; Schleinitz MD, 2004, AM J MED, V116, P797, DOI 10.1016/j.amjmed.2004.01.014; Scirica BM, 2011, J AM COLL CARDIOL, V57, P1908, DOI 10.1016/j.jacc.2010.11.056; Scott SA, 2011, CLIN PHARMACOL THER, V90, P328, DOI 10.1038/clpt.2011.132; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Smith-Spangler CM, 2010, ANN INTERN MED, V152, P481, DOI 10.7326/0003-4819-152-8-201004200-00212; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Sorich MJ, 2013, CLIN PHARMACOL THER, V94, P376, DOI 10.1038/clpt.2013.100; Storey RF, 2010, J AM COLL CARDIOL, V56, P185, DOI 10.1016/j.jacc.2010.01.062; Thomson R, 2000, LANCET, V355, P956, DOI 10.1016/S0140-6736(00)90012-6; Torrance GW., 1996, COST EFFECTIVENESS H, P54; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; U.S. Department of Commerce Bureau of Economic Analysis, 2013, NAT EC ACC GROSS DOM; Urban P, 2006, CIRCULATION, V113, P1434, DOI 10.1161/CIRCULATIONAHA.104.532242; van Werkum JW, 2009, J AM COLL CARDIOL, V53, P1399, DOI 10.1016/j.jacc.2008.12.055; Varenhorst C, 2009, EUR HEART J, V30, P1744, DOI 10.1093/eurheartj/ehp157; Wallentin L, 2010, LANCET, V376, P1320, DOI 10.1016/S0140-6736(10)61274-3; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Williams DO, 2006, CIRCULATION, V114, P2154, DOI 10.1161/CIRCULATIONAHA.106.667915; Wiviott SD, 2008, LANCET, V371, P1353, DOI 10.1016/S0140-6736(08)60422-5; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Woodward C, 2009, CAN MED ASSOC J, V180, P807, DOI 10.1503/cmaj.090483; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Zabalza M, 2012, HEART, V98, P100, DOI 10.1136/hrt.2011.227652	95	66	66	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2014	160	4					221	232		10.7326/M13-1999	http://dx.doi.org/10.7326/M13-1999			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB3BO	24727840	Green Published			2022-12-28	WOS:000331666500002
J	Kim, CA; Rasania, SP; Afilalo, J; Popma, JJ; Lipsitz, LA; Kim, DH				Kim, Caroline A.; Rasania, Suraj P.; Afilalo, Jonathan; Popma, Jeffrey J.; Lipsitz, Lewis A.; Kim, Dae Hyun			Functional Status and Quality of Life After Transcatheter Aortic Valve Replacement A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							HIGH-RISK PATIENTS; PROSTHESIS-PATIENT MISMATCH; CORONARY-ARTERY-DISEASE; 6-MINUTE WALK TEST; ONE-YEAR OUTCOMES; EDWARDS-SAPIEN; ELDERLY-PATIENTS; FOLLOW-UP; HEALTH-STATUS; HEMODYNAMIC OUTCOMES	Background: The functional and quality-of-life benefits of transcatheter aortic valve replacement (TAVR) have not been established. Purpose: To evaluate the changes in functional status and quality of life after TAVR. Data Sources: MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials from 1 January 2002 to 30 September 2013. Study Selection: Studies of TAVR that reported the New York Heart Association (NYHA) class, Short Form-12/36 Health Survey physical and mental component summary (points), or other measures of functional status. Data Extraction: Two reviewers independently extracted the mean change (follow-up minus baseline) in primary outcomes. Because of substantial heterogeneity, data were not pooled; the range of mean change was summarized. Data Synthesis: We identified 60 observational studies (56 pre- post comparison and 4 head-to-head comparative studies) and 2 randomized, controlled trials (11 205 patients). Most studies showed a clinically important decrease in NYHA class at 6 to 11 months (range, -0.8 to -2.1 classes) and 12 to 23 months (range, -0.8 to -2.1 classes). The improvement in the Short Form-12/36 Health Survey physical component score was clinically important over 12 months (range, 4.9 to 26.9 points), and the change in mental component score was smaller (range, 1.0 to 8.9 points). Clinically important improvements were seen in other disease-specific measures but were less consistently seen in general health measures. Limitations: Comparative evidence is limited by few head-to-head studies. Survivor bias may have overestimated the benefits. Conclusion: Transcatheter aortic valve replacement provides clinically important benefits in physical function and disease-specific measures of quality of life but modest benefits in psychological and general health measures. More comparative studies on functional status and quality of life are needed for informed treatment decision making.	Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Inst Aging Res,Hebrew SeniorLife, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; McGill Univ, Montreal, PQ, Canada; Geisinger Med Ctr, Danville, PA 17822 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Hebrew SeniorLife; Harvard University; Harvard T.H. Chan School of Public Health; McGill University; McGill University; Geisinger Medical Center	Kim, DH (corresponding author), Beth Israel Deaconess Med Ctr, Div Gerontol, 110 Francis St,Suite 1B, Boston, MA 02215 USA.	dkim2@bidmc.harvard.edu			Health Resources and Services Administration; Health Resources in Action; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG025037] Funding Source: NIH RePORTER	Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Health Resources in Action; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Health Resources and Services Administration and Health Resources in Action.	Abdel-Wahab M, 2012, AM J CARDIOL, V109, P581, DOI 10.1016/j.amjcard.2011.09.053; Afilalo J, 2012, CIRC-CARDIOVASC QUAL, V5, P222, DOI 10.1161/CIRCOUTCOMES.111.963157; Ahmed A, 2006, AM HEART J, V151, P444, DOI 10.1016/j.ahj.2005.03.066; Akin I, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-80; Attias D, 2010, ARCH CARDIOVASC DIS, V103, P236, DOI 10.1016/j.acvd.2010.03.006; Bach DS, 2009, CIRC-CARDIOVASC QUAL, V2, P533, DOI 10.1161/CIRCOUTCOMES.109.848259; Bagur R, 2011, AM J CARDIOL, V108, P258, DOI 10.1016/j.amjcard.2011.03.031; Bagur R, 2011, AM HEART J, V161, P726, DOI 10.1016/j.ahj.2010.12.024; Bedogni F, 2011, JACC-CARDIOVASC INTE, V4, P1228, DOI 10.1016/j.jcin.2011.10.002; Bekeredjian R, 2010, AM J CARDIOL, V106, P1777, DOI 10.1016/j.amjcard.2010.08.017; Bleiziffer S, 2012, J THORAC CARDIOV SUR, V143, P310, DOI 10.1016/j.jtcvs.2011.10.060; Boothroyd LJ, 2013, CAN J CARDIOL, V29, P718, DOI 10.1016/j.cjca.2012.09.002; Buellesfeld L, 2011, J AM COLL CARDIOL, V57, P1650, DOI 10.1016/j.jacc.2010.11.044; Cao C, 2013, ANN CARDIOTHORAC SUR, V2, P10, DOI 10.3978/j.issn.2225-319X.2012.11.09; Chodor P, 2010, KARDIOL POL, V68, P1124; Clark MA, 2012, CIRC-CARDIOVASC QUAL, V5, P697, DOI 10.1161/CIRCOUTCOMES.112.966002; D'Onofrio A, 2012, EUR J CARDIO-THORAC, V41, P1271, DOI 10.1093/ejcts/ezr236; D'Onofrio A, 2011, J THORAC CARDIOV SUR, V142, P768, DOI 10.1016/j.jtcvs.2011.06.026; de Brito FS, 2012, ARQ BRAS CARDIOL, V99, P697, DOI 10.1590/S0066-782X2012005000063; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dvir D, 2013, CATHETER CARDIO INTE, V81, P871, DOI 10.1002/ccd.24623; Dvir D, 2012, CIRCULATION, V126, P2335, DOI 10.1161/CIRCULATIONAHA.112.104505; Ewe SH, 2011, J AM COLL CARDIOL, V58, P1910, DOI 10.1016/j.jacc.2011.08.027; Fairbairn TA, 2012, J AM COLL CARDIOL, V59, P1672, DOI 10.1016/j.jacc.2012.01.035; Gautier M, 2011, EUROINTERVENTION, V7, P549, DOI 10.4244/EIJV7I5A90; Genereux P, 2012, J AM COLL CARDIOL, V59, P2317, DOI 10.1016/j.jacc.2012.02.022; Georgiadou P, 2011, AM HEART J, V162, P232, DOI 10.1016/j.ahj.2011.06.004; Gilard M, 2012, NEW ENGL J MED, V366, P1705, DOI 10.1056/NEJMoa1114705; GOLDMAN L, 1981, CIRCULATION, V64, P1227, DOI 10.1161/01.CIR.64.6.1227; Goncalves A, 2013, INT J CARDIOL, V162, P117, DOI 10.1016/j.ijcard.2011.05.050; Gotzmann M, 2012, CATHETER CARDIO INTE, V79, P693, DOI 10.1002/ccd.23240; Gotzmann M, 2011, AM HEART J, V162, P238, DOI 10.1016/j.ahj.2011.05.011; Gotzmann M, 2011, AM J CARDIOL, V107, P1687, DOI 10.1016/j.amjcard.2011.01.058; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Green P, 2013, AM J CARDIOL, V112, P700, DOI 10.1016/j.amjcard.2013.04.046; Grimaldi A, 2013, INT J CARDIOL, V168, P281, DOI 10.1016/j.ijcard.2012.09.079; Gurvitch R, 2010, CIRCULATION, V122, P1319, DOI 10.1161/CIRCULATIONAHA.110.948877; Himbert D, 2012, AM J CARDIOL, V110, P877, DOI 10.1016/j.amjcard.2012.04.064; Himbert D, 2009, J AM COLL CARDIOL, V54, P303, DOI 10.1016/j.jacc.2009.04.032; HLATKY MA, 1989, AM J CARDIOL, V64, P651, DOI 10.1016/0002-9149(89)90496-7; Hutter A, 2013, ANN THORAC SURG, V95, P77, DOI 10.1016/j.athoracsur.2012.08.030; Jilaihawi H, 2012, CATHETER CARDIO INTE, V80, P128, DOI 10.1002/ccd.23368; Kalavrouziotis D, 2011, J AM COLL CARDIOL, V58, P1016, DOI 10.1016/j.jacc.2011.05.026; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Khatri PJ, 2013, ANN INTERN MED, V158, P35, DOI 10.7326/0003-4819-158-1-201301010-00007; Khawaja MZ, 2012, CIRCULATION, V126, pE189, DOI 10.1161/CIRCULATIONAHA.112.103127; Kind P., 1996, QUAL LIFE PHARMACOEC, V25, P3110, DOI [10.1097/00007632-200012150-00005, DOI 10.1097/00007632-200012150-00005]; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Kodali SK, 2011, AM J CARDIOL, V107, P1058, DOI 10.1016/j.amjcard.2010.11.034; Krane M, 2012, AM J CARDIOL, V109, P1774, DOI 10.1016/j.amjcard.2012.02.021; Latib A, 2012, EUROINTERVENTION, V7, P1275, DOI 10.4244/EIJV7I11A202; Lefevre T, 2011, EUR HEART J, V32, P148, DOI 10.1093/eurheartj/ehq427; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Li XB, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-168; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Messori A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001770; Muller-Nordhorn J, 2004, HEART, V90, P523, DOI 10.1136/hrt.2003.013995; Munoz-Garcia AJ, 2012, AM HEART J, V163, P288, DOI 10.1016/j.ahj.2011.11.013; Nemec P, 2012, COR VASA, V54, pE76, DOI 10.1016/j.crvasa.2012.02.003; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Osnabrugge RLJ, 2013, J AM COLL CARDIOL, V62, P1002, DOI 10.1016/j.jacc.2013.05.015; Osten MD, 2010, CATHETER CARDIO INTE, V75, P475, DOI 10.1002/ccd.22291; Panchal HB, 2013, AM J CARDIOL, V112, P850, DOI 10.1016/j.amjcard.2013.05.015; Pasic M, 2011, J THORAC CARDIOV SUR, V142, P270, DOI 10.1016/j.jtcvs.2010.09.049; Puls M, 2012, CLIN RES CARDIOL, V101, P553, DOI 10.1007/s00392-012-0426-4; Raphael C, 2007, HEART, V93, P476, DOI 10.1136/hrt.2006.089656; Rasekaba T, 2009, INTERN MED J, V39, P495, DOI 10.1111/j.1445-5994.2008.01880.x; Rector T S, 1995, J Card Fail, V1, P201, DOI 10.1016/1071-9164(95)90025-X; Rector TS, 1987, HEART FAIL, V3, P198; Reynolds MR, 2012, J AM COLL CARDIOL, V60, P548, DOI 10.1016/j.jacc.2012.03.075; Reynolds MR, 2011, CIRCULATION, V124, P1964, DOI 10.1161/CIRCULATIONAHA.111.040022; Schoenenberger AW, 2013, EUR HEART J, V34, P684, DOI 10.1093/eurheartj/ehs304; Schueler R, 2012, J AM SOC ECHOCARDIOG, V25, P827, DOI 10.1016/j.echo.2012.04.023; SCHWARZ F, 1982, CIRCULATION, V66, P1105, DOI 10.1161/01.CIR.66.5.1105; Seiffert M, 2012, J THORAC CARDIOV SUR, V143, P617, DOI 10.1016/j.jtcvs.2011.11.004; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Spertus J, 2005, AM HEART J, V150, P707, DOI 10.1016/j.ahj.2004.12.010; Stortecky S, 2012, EUROINTERVENTION, V8, P437, DOI 10.4244/EIJV8I4A69; Stortecky S, 2011, ANN THORAC SURG, V92, P1324, DOI 10.1016/j.athoracsur.2011.05.106; Sundermann S, 2011, EUR J CARDIO-THORAC, V39, P33, DOI 10.1016/j.ejcts.2010.04.013; Sundt TM, 2000, CIRCULATION, V102, P70; Takagi H, 2013, ANN THORAC SURG, V96, P513, DOI 10.1016/j.athoracsur.2013.04.049; Takagi H, 2011, INT J CARDIOL, V153, P207, DOI 10.1016/j.ijcard.2011.07.081; Taramasso M, 2012, EUROINTERVENTION, V8, P429, DOI 10.4244/EIJV8I4A68; Thielmann M, 2009, ANN THORAC SURG, V88, P1468, DOI 10.1016/j.athoracsur.2009.07.033; Thomas M, 2011, CIRCULATION, V124, P425, DOI 10.1161/CIRCULATIONAHA.110.001545; Treede H, 2010, J THORAC CARDIOV SUR, V140, P897, DOI 10.1016/j.jtcvs.2010.01.017; Tzikas A, 2010, AM J CARDIOL, V106, P255, DOI 10.1016/j.amjcard.2010.02.036; Ussia GP, 2013, INT J CARDIOL, V167, P943, DOI 10.1016/j.ijcard.2012.03.089; Ussia GP, 2012, EUR HEART J, V33, P969, DOI 10.1093/eurheartj/ehr491; Ussia GP, 2011, AM J CARDIOL, V108, P1772, DOI 10.1016/j.amjcard.2011.07.049; Ussia GP, 2011, EUROINTERVENTION, V7, P573, DOI 10.4244/EIJV7I5A93; Ussia GP, 2010, CATHETER CARDIO INTE, V76, P440, DOI 10.1002/ccd.22595; van Geldorp MWA, 2013, NETH HEART J, V21, P21, DOI 10.1007/s12471-012-0364-9; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Webb JG, 2007, CIRCULATION, V116, P755, DOI 10.1161/CIRCULATIONAHA.107.698258; Webb JG, 2009, CIRCULATION, V119, P3009, DOI 10.1161/CIRCULATIONAHA.108.837807; Wells G., 2013, NEWCASTLE OTTAWA SCA; Wenaweser P, 2011, J AM COLL CARDIOL, V58, P2151, DOI 10.1016/j.jacc.2011.05.063; Wilbring M, 2012, ANN THORAC SURG, V93, P734, DOI 10.1016/j.athoracsur.2011.11.008; Wu YC, 2013, CHINESE MED J-PEKING, V126, P1171, DOI 10.3760/cma.j.issn.0366-6999.20123100; Wyrwich KW, 2004, AM HEART J, V147, P615, DOI 10.1016/j.ahj.2003.10.039; Yamamoto M, 2012, AM J CARDIOL, V110, P1156, DOI 10.1016/j.amjcard.2012.05.058; Ye J, 2010, J THORAC CARDIOV SUR, V139, P1107, DOI 10.1016/j.jtcvs.2009.10.056; Ye J, 2009, J THORAC CARDIOV SUR, V137, P167, DOI 10.1016/j.jtcvs.2008.08.028	106	52	52	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2014	160	4					243	254		10.7326/M13-1316	http://dx.doi.org/10.7326/M13-1316			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB3BO	24727842	Green Accepted			2022-12-28	WOS:000331666500004
J	Solow, EB; Kazi, S; Makris, UE				Solow, E. Blair; Kazi, Salahuddin; Makris, Una E.			Update in Rheumatology: Evidence Published in 2013	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kazi, Salahuddin] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; Dallas Vet Affairs Med Ctr, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Kazi, S (corresponding author), Univ Texas SW Med Ctr Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	salahuddin.kazi@utsouthwestern.edu		Makris, Una/0000-0003-4750-0777				Eriksson JK, 2013, JAMA INTERN MED, V173, P1407, DOI 10.1001/jamainternmed.2013.7801; Hare KB, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-71; Harrington JT, 2007, CLIN EXP RHEUMATOL, V25, pS55; Solomon DH, 2013, ARTHRITIS CARE  1210	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2014	161	3					200	U151		10.7326/M14-0287	http://dx.doi.org/10.7326/M14-0287			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3KH	24722650				2022-12-28	WOS:000340486000005
J	Pregler, JP; Crandall, CJ				Pregler, Janet P.; Crandall, Carolyn J.			Update in Women's Health: Evidence Published in 2013	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							AMERICAN-CANCER-SOCIETY; BREAST; PREVENTION; GUIDELINES; SURGERY; THERAPY; RISKS; BRCA1		[Pregler, Janet P.; Crandall, Carolyn J.] Univ Calif Los Angeles, David Geffen Sch Med, Iris Cantor UCLA Womens Hlth Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Pregler, JP (corresponding author), Iris Cantor UCLA Womens Hlth Ctr, 100 UCLA Med Plaza,Suite 250, Los Angeles, CA 90095 USA.	japregler@mednet.ucla.edu						American College of Radiology, 2013, ACR OFF RES PHYS BRE; [Anonymous], 2013, Obstet Gynecol, V121, P1407, DOI 10.1097/01.AOG.0000431053.33593.2d; [Anonymous], 2013, OBS GYNECOL, V122, P931, DOI [DOI 10.1097/01.AOG.0000435416.21944.54, 10.1097/01.AOG.0000435416.21944.54]; Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI 10.1200/JOP.000082; Calonge N, 2011, ANN INTERN MED, V154, P356, DOI 10.7326/0003-4819-154-5-201103010-00307; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237; Fda US FDA, 2013, FDA DRUG SAF COMM VA; Gourlay ML, 2012, NEW ENGL J MED, V366, P225, DOI 10.1056/NEJMoa1107142; Gray R, 2013, J CLIN ONCOL S, V31; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Kjaer MM, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.046; Maggard MA, 2008, JAMA-J AM MED ASSOC, V300, P2286, DOI 10.1001/jama.2008.641; Mandelblatt JS, 2013, JAMA-J AM MED ASSOC, V310, P376, DOI 10.1001/jama.2013.8273; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Meador KJ, 2013, JAMA-J AM MED ASSOC, V309, P1730, DOI 10.1001/jama.2013.4001; MOYER VA, ANN INTERN MED; Moyer VA, 2013, ANN INTERN MED, V158, P47, DOI 10.7326/0003-4819-158-1-201301010-00553; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Saslow D, 2012, CA-CANCER J CLIN, V62, P147, DOI 10.3322/caac.21139; U.S. Food and Drug Administration, HIGHL PRESCR INF MIR; U.S. Preventive Services Task Force, 2014, SCREEN BREAST CANC	23	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 6	2014	160	9					627	+		10.7326/M14-0257	http://dx.doi.org/10.7326/M14-0257			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V44NW	24722675				2022-12-28	WOS:000209756700002
J	Bowes, O; Baxter, K; Elsey, T; Snead, M; Cox, T				Bowes, Oliver; Baxter, Kim; Elsey, Terry; Snead, Martin; Cox, Timothy			Hereditary hyperferritinaemia cataract syndrome	LANCET			English	Editorial Material									[Bowes, Oliver; Baxter, Kim; Elsey, Terry; Snead, Martin; Cox, Timothy] Addenbrookes Hosp, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Bowes, O (corresponding author), Addenbrookes Hosp, Dept Ophthalmol, Hills Rd, Cambridge CB2 0QQ, England.	obowes@nhs.net		Bowes, Oliver/0000-0001-8919-5366; snead, martin/0000-0003-0042-8659				GIRELLI D, 1995, BRIT J HAEMATOL, V90, P931, DOI 10.1111/j.1365-2141.1995.tb05218.x; Levi S, 1998, BLOOD, V91, P4180, DOI 10.1182/blood.V91.11.4180.411k38_4180_4187; Luscieti S, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-30	3	15	16	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2014	383	9927					1520	1520		10.1016/S0140-6736(14)60484-0	http://dx.doi.org/10.1016/S0140-6736(14)60484-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG3NI	24766965				2022-12-28	WOS:000335325800033
J	Bercovici, D; Ricard, Y				Bercovici, David; Ricard, Yanick			Plate tectonics, damage and inheritance	NATURE			English	Article							2-PHASE GRAIN-DAMAGE; DYNAMIC RECRYSTALLIZATION; MANTLE CONVECTION; GROWTH; GENERATION; MODEL; SIZE; EVOLUTION; FLOW; MECHANISMS	The initiation of plate tectonics on Earth is a critical event in our planet's history. The time lag between the first proto-subduction (about 4 billion years ago) and global tectonics (approximately 3 billion years ago) suggests that plates and plate boundaries became widespread over a period of 1 billion years. The reason for this time lag is unknown but fundamental to understanding the origin of plate tectonics. Here we suggest that when sufficient lithospheric damage (which promotes shear localization and long-lived weak zones) combines with transient mantle flow and migrating proto-subduction, it leads to the accumulation of weak plate boundaries and eventually to fully formed tectonic plates driven by subduction alone. We simulate this process using a grain evolution and damage mechanism with a composite rheology (which is compatible with field and laboratory observations of polycrystalline rocks(1,2)), coupled to an idealized model of pressure-driven lithospheric flow in which a low-pressure zone is equivalent to the suction of convective downwellings. In the simplest case, for Earth-like conditions, a few successive rotations of the driving pressure field yield relic damaged weak zones that are inherited by the lithospheric flow to forma nearly perfect plate, with passive spreading and strike-slip margins that persist and localize further, even though flow is driven only by subduction. But for hotter surface conditions, such as those on Venus, accumulation and inheritance of damage is negligible; hence only subduction zones survive and plate tectonics does not spread, which corresponds to observations. After plates have developed, continued changes in driving forces, combined with inherited damage and weak zones, promote increased tectonic complexity, such as oblique subduction, strike-slip boundaries that are subparallel to plate motion, and spalling of minor plates.	[Bercovici, David] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Ricard, Yanick] Univ Lyon 1, CNRS, ENS Lyon, Lab Geol Lyon, F-69622 Villeurbanne, France	Yale University; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Bercovici, D (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06520 USA.	david.bercovici@yale.edu	ricard, yanick/AAW-5649-2021; ricard, yanick/C-6287-2009	ricard, yanick/0000-0002-0998-4670; ricard, yanick/0000-0002-0998-4670; Bercovici, David/0000-0003-1993-0016	National Science Foundation; Agence Nationale de la Recherche; Directorate For Geosciences [1015229] Funding Source: National Science Foundation; Division Of Earth Sciences [1344538, 1135382] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	D. B. acknowledges support from the National Science Foundation; Y.R. acknowledges support from the Agence Nationale de la Recherche. This work benefitted from discussions with S. Karato, G. Hirth, N. Coltice and B. J. Foley.	ARGUS DF, 1991, GEOPHYS RES LETT, V18, P2039, DOI 10.1029/91GL01532; Austin NJ, 2007, GEOLOGY, V35, P343, DOI 10.1130/G23244A.1; Bercovici D, 2003, EARTH PLANET SC LETT, V205, P107, DOI 10.1016/S0012-821X(02)01009-9; Bercovici D, 2001, J GEOPHYS RES-SOL EA, V106, P8887, DOI 10.1029/2000JB900430; BERCOVICI D, 1993, GEOPHYS J INT, V114, P635, DOI 10.1111/j.1365-246X.1993.tb06993.x; Bercovici D, 2013, EARTH PLANET SC LETT, V365, P275, DOI 10.1016/j.epsl.2013.02.002; Bercovici D, 2012, PHYS EARTH PLANET IN, V202, P27, DOI 10.1016/j.pepi.2012.05.003; Condie K., 2008, DID PLATE TECTONICS, P281; Evans B, 2001, INT J EARTH SCI, V90, P88, DOI 10.1007/s005310000150; Faul UH, 2006, CONTRIB MINERAL PETR, V151, P101, DOI 10.1007/s00410-005-0048-1; Foley BJ, 2012, EARTH PLANET SC LETT, V331, P281, DOI 10.1016/j.epsl.2012.03.028; Foley BJ, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002378; Gurnis M., 2000, GEOPHYS MONOGR SER, V121, P73, DOI DOI 10.1029/GM121P0073; Harrison TM, 2005, SCIENCE, V310, P1947, DOI 10.1126/science.1117926; HILLERT M, 1988, ACTA METALL MATER, V36, P3177, DOI 10.1016/0001-6160(88)90053-3; Hiraga T, 2010, EARTH PLANET SC LETT, V291, P10, DOI 10.1016/j.epsl.2009.12.026; Hopkins MD, 2010, EARTH PLANET SC LETT, V298, P367, DOI 10.1016/j.epsl.2010.08.010; KARATO S, 1989, TECTONOPHYSICS, V168, P255, DOI 10.1016/0040-1951(89)90221-7; Karato SI, 2008, DEFORMATION OF EARTH MATERIALS: AN INTRODUCTION TO THE RHEOLOGY OF SOLID EARTH, P1, DOI 10.1017/CBO9780511804892; KARATO SI, 1980, GEOPHYS RES LETT, V7, P649, DOI 10.1029/GL007i009p00649; Korenaga J, 2013, ANNU REV EARTH PL SC, V41, P117, DOI 10.1146/annurev-earth-050212-124208; Krajcinovic D., 1996, DAMAGE MECH; Landuyt W, 2009, EARTH PLANET SC LETT, V277, P29, DOI 10.1016/j.epsl.2008.09.034; Lenardic A, 2008, EARTH PLANET SC LETT, V271, P34, DOI 10.1016/j.epsl.2008.03.031; Linckens J, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008119; Paczkowski K, 2012, GEOPHYS J INT, V189, P717, DOI 10.1111/j.1365-246X.2012.05398.x; Polat A, 2011, GONDWANA RES, V20, P255, DOI 10.1016/j.gr.2011.01.007; Ricard Y, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2007JB005491; Rozel A, 2011, GEOPHYS J INT, V184, P719, DOI 10.1111/j.1365-246X.2010.04875.x; SCHUBERT G, 1995, ICARUS, V117, P173, DOI 10.1006/icar.1995.1150; Sharp WD, 2006, SCIENCE, V313, P1281, DOI 10.1126/science.1128489; Shirey S., 2008, DID PLATE TECTONICS, P1; Shirey SB, 2011, SCIENCE, V333, P434, DOI 10.1126/science.1206275; Skemer P, 2010, J PETROL, V51, P43, DOI 10.1093/petrology/egp057; SMITH CS, 1948, T AM I MIN MET ENG, V175, P15; Trompert R, 1998, NATURE, V395, P686, DOI 10.1038/27185; van Heck HJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035190; van Hunen J, 2012, ANNU REV EARTH PL SC, V40, P195, DOI [10.1146/annurev-earth-842711-105255, 10.1146/annurev-earth-042711-105255]; Warren JM, 2006, EARTH PLANET SC LETT, V248, P438, DOI 10.1016/j.epsl.2006.06.006; Zhong SJ, 1998, J GEOPHYS RES-SOL EA, V103, P15255, DOI 10.1029/98JB00605	40	164	169	7	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					513	+		10.1038/nature13072	http://dx.doi.org/10.1038/nature13072			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24717430				2022-12-28	WOS:000334741600034
J	Suva, ML; Rheinbay, E; Gillespie, SM; Patel, AP; Wakimoto, H; Rabkin, SD; Riggi, N; Chi, AS; Cahill, DP; Nahed, BV; Curry, WT; Martuza, RL; Rivera, MN; Rossetti, N; Kasif, S; Beik, S; Kadri, S; Tirosh, I; Wortman, I; Shalek, AK; Rozenblatt-Rosen, O; Regev, A; Louis, DN; Bernstein, BE				Suva, Mario L.; Rheinbay, Esther; Gillespie, Shawn M.; Patel, Anoop P.; Wakimoto, Hiroaki; Rabkin, Samuel D.; Riggi, Nicolo; Chi, Andrew S.; Cahill, Daniel P.; Nahed, Brian V.; Curry, William T.; Martuza, Robert L.; Rivera, Miguel N.; Rossetti, Nikki; Kasif, Simon; Beik, Samantha; Kadri, Sabah; Tirosh, Itay; Wortman, Ivo; Shalek, Alex K.; Rozenblatt-Rosen, Orit; Regev, Aviv; Louis, David N.; Bernstein, Bradley E.			Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells	CELL			English	Article							INITIATING CELLS; CHROMATIN STATE; SELF-RENEWAL; CANCER; ENHANCERS; GLIOMA; TUMORIGENICITY; PLURIPOTENCY; LEUKEMIA; GENOME	Developmental fate decisions are dictated by master transcription factors (TFs) that interact with cis-regulatory elements to direct transcriptional programs. Certain malignant tumors may also depend on cellular hierarchies reminiscent of normal development but superimposed on underlying genetic aberrations. In glioblastoma (GBM), a subset of stem-like tumorpropagating cells (TPCs) appears to drive tumor progression and underlie therapeutic resistance yet remain poorly understood. Here, we identify a core set of neurodevelopmental TFs (POU3F2, SOX2, SALL2, and OLIG2) essential for GBM propagation. These TFs coordinately bind and activate TPC-specific regulatory elements and are sufficient to fully reprogram differentiated GBM cells to "induced'' TPCs, recapitulating the epigenetic landscape and phenotype of native TPCs. We reconstruct a network model that highlights critical interactions and identifies candidate therapeutic targets for eliminating TPCs. Our study establishes the epigenetic basis of a developmental hierarchy in GBM, provides detailed insight into underlying gene regulatory programs, and suggests attendant therapeutic strategies.	[Suva, Mario L.; Rheinbay, Esther; Gillespie, Shawn M.; Patel, Anoop P.; Regev, Aviv; Bernstein, Bradley E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Suva, Mario L.; Rheinbay, Esther; Gillespie, Shawn M.; Riggi, Nicolo; Rivera, Miguel N.; Rossetti, Nikki; Louis, David N.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Suva, Mario L.; Rheinbay, Esther; Gillespie, Shawn M.; Riggi, Nicolo; Rivera, Miguel N.; Rossetti, Nikki; Louis, David N.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Suva, Mario L.; Rheinbay, Esther; Gillespie, Shawn M.; Patel, Anoop P.; Wakimoto, Hiroaki; Rabkin, Samuel D.; Riggi, Nicolo; Chi, Andrew S.; Cahill, Daniel P.; Nahed, Brian V.; Curry, William T.; Martuza, Robert L.; Rivera, Miguel N.; Rossetti, Nikki; Louis, David N.; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Suva, Mario L.; Rheinbay, Esther; Gillespie, Shawn M.; Riggi, Nicolo; Rivera, Miguel N.; Rossetti, Nikki; Beik, Samantha; Kadri, Sabah; Tirosh, Itay; Wortman, Ivo; Rozenblatt-Rosen, Orit; Regev, Aviv; Bernstein, Bradley E.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Patel, Anoop P.; Wakimoto, Hiroaki; Rabkin, Samuel D.; Cahill, Daniel P.; Nahed, Brian V.; Curry, William T.; Martuza, Robert L.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Chi, Andrew S.] Massachusetts Gen Hosp, Div Neurooncol, Boston, MA 02114 USA; [Chi, Andrew S.] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA; [Chi, Andrew S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Kasif, Simon] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Kasif, Simon] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Shalek, Alex K.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02140 USA	Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University; Boston University; Harvard University; Massachusetts Institute of Technology (MIT)	Suva, ML (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	suva.mario@mgh.harvard.edu; bernstein.bradley@mgh.harvard.edu	Shalek, Alex/Y-2434-2019; rabkin, samuel/C-2443-2012; Suva, Mario/AAY-7798-2020; Wakimoto, Hiroaki/H-4533-2019; Rozenblatt-Rosen, Orit/HDN-4182-2022; Nahed, Brian/E-4239-2014	Shalek, Alex/0000-0001-5670-8778; rabkin, samuel/0000-0003-2344-2795; Suva, Mario/0000-0001-9898-5351; Wakimoto, Hiroaki/0000-0001-8225-241X; Kadri, Sabah/0000-0003-0365-6550; Gillespie, Shawn/0000-0003-1913-0860; Cahill, Daniel/0000-0003-2552-6546; Nahed, Brian/0000-0001-8537-106X	Oncosuisse [BIL-KFS02590- 02-2010]; National Brain Tumor Society [NS032677]; HHMI; Howard Hughes Medical Institute; Starr Cancer Consortium; Harvard Stem Cell Institute; Klarman Family Foundation; NATIONAL CANCER INSTITUTE [R01CA160762, K12CA090354, P50CA165962] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032677] Funding Source: NIH RePORTER	Oncosuisse; National Brain Tumor Society; HHMI(Howard Hughes Medical Institute); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Starr Cancer Consortium; Harvard Stem Cell Institute; Klarman Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Timothy Durham, Noam Shoresh, Mia Caplan Uziel, and Jing Gao for computational assistance and Charles Epstein, Meital Hatan, and the Broad Institute Genome Sequencing Platform for help with data production.We thank Leslie Gaffney and Bang Wong for graphical work; David Dombkowski for flow cytometry; James Kim for histology sections; Erica Shefler, Dave Gennert, and John Trombetta for support; and Pinky Bautista and Yukako Yagi for slide scanning.We thank Rahul Satija, Leah Escalante, Brian Liau, Richard Koche, and Russel Ryan for fruitful discussions and Stephen Elledge for the pINDUCER vectors.M.L.S.is supported by Oncosuisse grant BIL-KFS02590- 02-2010, the Medic Foundation, and a grant from the National Brain Tumor Society.R.L.M.is supported by R01 grant NS032677.M.N.R.is supported by awards from the Burroughs Wellcome Fund and HHMI.This research was supported by funds from the Howard Hughes Medical Institute, the Starr Cancer Consortium, the Burroughs Wellcome Fund, the Harvard Stem Cell Institute, and the Klarman Family Foundation.	Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barrett LE, 2012, CANCER CELL, V21, P11, DOI 10.1016/j.ccr.2011.11.025; Binda E, 2012, CANCER CELL, V22, P765, DOI 10.1016/j.ccr.2012.11.005; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Chudnovsky Y, 2014, CELL REP, V6, P313, DOI 10.1016/j.celrep.2013.12.032; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hon GC, 2009, HUM MOL GENET, V18, pR195, DOI 10.1093/hmg/ddp409; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Janiszewska M, 2012, GENE DEV, V26, P1926, DOI 10.1101/gad.188292.112; Jansen M, 2010, LANCET NEUROL, V9, P717, DOI 10.1016/S1474-4422(10)70105-8; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Lodato MA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003288; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Mehta S, 2011, CANCER CELL, V19, P359, DOI 10.1016/j.ccr.2011.01.035; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mimasu S, 2010, BIOCHEMISTRY-US, V49, P6494, DOI 10.1021/bi100299r; Morris SA, 2013, CELL RES, V23, P33, DOI 10.1038/cr.2013.1; Natsume A, 2013, CANCER RES, V73, P4559, DOI 10.1158/0008-5472.CAN-13-0109; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rheinbay E, 2013, CELL REP, V3, P1567, DOI 10.1016/j.celrep.2013.04.021; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Stricker SH, 2013, GENE DEV, V27, P654, DOI 10.1101/gad.212662.112; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wakimoto H, 2009, CANCER RES, V69, P3472, DOI 10.1158/0008-5472.CAN-08-3886; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Yang P, 2011, STEM CELLS, V29, P791, DOI 10.1002/stem.634; Yoon OK, 2010, RNA, V16, P1256, DOI 10.1261/rna.2038810; Zhang XM, 2013, CELL REP, V5, P445, DOI 10.1016/j.celrep.2013.09.018; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	54	556	566	4	97	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					580	594		10.1016/j.cell.2014.02.030	http://dx.doi.org/10.1016/j.cell.2014.02.030			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24726434	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000335392100009
J	Kruse, E; Agol, E				Kruse, Ethan; Agol, Eric			KOI-3278: A Self-Lensing Binary Star System	SCIENCE			English	Article							WHITE-DWARFS; NLTT 11748; KEPLER; EVOLUTION	Over 40% of Sun-like stars are bound in binary or multistar systems. Stellar remnants in edge-on binary systems can gravitationally magnify their companions, as predicted 40 years ago. By using data from the Kepler spacecraft, we report the detection of such a "self-lensing" system, in which a 5-hour pulse of 0.1% amplitude occurs every orbital period. The white dwarf stellar remnant and its Sun-like companion orbit one another every 88.18 days, a long period for a white dwarf-eclipsing binary. By modeling the pulse as gravitational magnification (microlensing) along with Kepler's laws and stellar models, we constrain the mass of the white dwarf to be similar to 63% of the mass of our Sun. Further study of this system, and any others discovered like it, will help to constrain the physics of white dwarfs and binary star evolution.	[Kruse, Ethan; Agol, Eric] Univ Washington, Dept Astron, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Kruse, E (corresponding author), Univ Washington, Dept Astron, Box 351580, Seattle, WA 98195 USA.	eakruse@uw.edu		Kruse, Ethan/0000-0002-0493-1342; Agol, Eric/0000-0002-0802-9145	NSF; NSF [AST 0645416]; NASA [NNH05ZDA001C, 12-OSS12-0011]	NSF(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	E.K. was funded by an NSF Graduate Student Research Fellowship. E. A. acknowledges funding by NSF Career grant AST 0645416; NASA Astrobiology Institute's Virtual Planetary Laboratory, supported by NASA under cooperative agreement NNH05ZDA001C; and NASA Origins of Solar Systems grant 12-OSS12-0011. Solar image courtesy of NASA/Solar Dynamics Observatory (SDO) and the Helioseismic and Magnetic Imager (HMI) science teams. The Kepler data presented in this paper were obtained from the Mikulski Archive for Space Telescopes (MAST). The code used for analysis is provided in a repository at https://github.com/ethankruse/koi3278. The authors welcome requests for additional information regarding the material presented in this paper.	Agol E, 2003, ASTROPHYS J, V594, P449, DOI 10.1086/376833; Agol E, 2002, ASTROPHYS J, V579, P430, DOI 10.1086/342880; Bergeron P, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/1/28; Bressan A, 2012, MON NOT R ASTRON SOC, V427, P127, DOI 10.1111/j.1365-2966.2012.21948.x; Burke CJ, 2014, ASTROPHYS J SUPPL S, V210, DOI 10.1088/0067-0049/210/2/19; Carter JA, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/2/132; Davidson C., 1920, PHILOS T R SOC A, V220, P291, DOI DOI 10.1098/RSTA.1920.0009; Einstein A, 1936, Science, V84, P506, DOI 10.1126/science.84.2188.506; Farmer AJ, 2003, ASTROPHYS J, V592, P1151, DOI 10.1086/375806; Holberg JB, 2013, MON NOT R ASTRON SOC, V435, P2077, DOI 10.1093/mnras/stt1433; Ivanova N, 2013, ASTRON ASTROPHYS REV, V21, DOI 10.1007/s00159-013-0059-2; Kaplan DL, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/2/167; Kepler SO, 2007, MON NOT R ASTRON SOC, V375, P1315, DOI 10.1111/j.1365-2966.2006.11388.x; MAEDER A, 1973, ASTRON ASTROPHYS, V26, P215; Marsh TR, 2001, MON NOT R ASTRON SOC, V324, P547, DOI 10.1046/j.1365-8711.2001.04293.x; Muirhead PS, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/111; Paczynski B, 1996, ANNU REV ASTRON ASTR, V34, P419, DOI 10.1146/annurev.astro.34.1.419; Parsons SG, 2012, MON NOT R ASTRON SOC, V420, P3281, DOI 10.1111/j.1365-2966.2011.20251.x; Perryman MAC, 2001, ASTRON ASTROPHYS, V369, P339, DOI 10.1051/0004-6361:20010085; Provencal JL, 1998, ASTROPHYS J, V494, P759, DOI 10.1086/305238; Rebassa-Mansergas A, 2012, MON NOT R ASTRON SOC, V423, P320, DOI 10.1111/j.1365-2966.2012.20880.x; Rowe JF, 2010, ASTROPHYS J LETT, V713, pL150, DOI 10.1088/2041-8205/713/2/L150; Sahu KC, 2003, ASTROPHYS J, V584, P1042, DOI 10.1086/345776; Schneider P., 2006, SAAS FEE ADVANCED CO, V33; Steinfadt JDR, 2010, ASTROPHYS J LETT, V716, pL146, DOI 10.1088/2041-8205/716/2/L146; Tenenbaum P, 2014, ASTROPHYS J SUPPL S, V211, DOI 10.1088/0067-0049/211/1/6; Wambsganss Joachim, 1998, Living Rev Relativ, V1, P12, DOI 10.12942/lrr-1998-12; Zorotovic M, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201220321	28	44	44	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					275	277		10.1126/science.1251999	http://dx.doi.org/10.1126/science.1251999			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744369	Green Submitted			2022-12-28	WOS:000334474500028
J	Inouye, SK; Kosar, CM; Tommet, D; Schmitt, EM; Puelle, MR; Saczynski, JS; Marcantonio, ER; Jones, RN				Inouye, Sharon K.; Kosar, Cyrus M.; Tommet, Douglas; Schmitt, Eva M.; Puelle, Margaret R.; Saczynski, Jane S.; Marcantonio, Edward R.; Jones, Richard N.			The CAM-S: Development and Validation of a New Scoring System for Delirium Severity in 2 Cohorts	ANNALS OF INTERNAL MEDICINE			English	Article							CONFUSION ASSESSMENT METHOD; MINI-MENTAL-STATE; RATING-SCALE; OLDER-ADULTS; INTERVENTION; PROGRAM; CARE	Background: Quantifying the severity of delirium is essential to advancing clinical care by improved understanding of delirium effect, prognosis, pathophysiology, and response to treatment. Objective: To develop and validate a new delirium severity measure (CAM-S) based on the Confusion Assessment Method. Design: Validation analysis in 2 independent cohorts. Setting: Three academic medical centers. Patients: The first cohort included 300 patients aged 70 years or older scheduled for major surgery. The second included 919 medical patients aged 70 years or older. Measurements: A 4-item short form and a 10-item long form were developed. Association of the maximum CAM-S score during hospitalization with hospital and posthospital outcomes related to delirium was evaluated. Results: Representative results included adjusted mean length of stay, which increased across levels of short-form severity from 6.5 days (95% CI, 6.2 to 6.9 days) to 12.7 days (CI, 11.2 to 14.3 days) P for trend < 0.001) and across levels of long-form severity from 5.6 days (CI, 5.1 to 6.1 days) to 11.9 days (CI, 10.8 to 12.9 days) (P for trend < 0.001). Representative results for the composite outcome of adjusted relative risk of death or nursing home residence at 90 days increased progressively across levels of short-form severity from 1.0 (referent) to 2.5 (CI, 1.9 to 3.3) (P for trend < 0.001) and across levels of long-form severity from 1.0 (referent) to 2.5 (CI, 1.6 to 3.7) (P for trend < 0.001). Limitation: Data on clinical outcomes were measured in an older data set limited to patients aged 70 years or older. Conclusion: The CAM-S provides a new delirium severity measure with strong psychometric properties and strong associations with important clinical outcomes.	Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; Hebrew SeniorLife, Boston, MA 02459 USA; Univ Massachusetts, Sch Med, Worcester, MA USA; Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Hebrew SeniorLife; University of Massachusetts System; University of Massachusetts Worcester; Brown University	Inouye, SK (corresponding author), Hebrew SeniorLife, Inst Aging Res, Aging Brain Ctr, 1200 Ctr St, Boston, MA 02459 USA.	AgingBrainCenter@hsl.harvard.edu	Marcantonio, Edward R/U-3929-2017; Inouye, Sharon/R-7216-2019; Jones, Richard Norman/J-3488-2013	Marcantonio, Edward R/0000-0002-2911-4250; Jones, Richard Norman/0000-0002-1049-218X; Kosar, Cyrus/0000-0003-0533-7529	National Institute on Aging [P01AG031720, K07AG041835, R01AG030618, K24AG035075, K01AG033643]; Milton and Shirley F. Levy Family Chair; NATIONAL INSTITUTE ON AGING [K07AG041835, K01AG033643, P01AG031720, R01AG030618, K24AG035075] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Milton and Shirley F. Levy Family Chair; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By National Institute on Aging grants P01AG031720 and K07AG041835 (Dr. Inouye), R01AG030618 and K24AG035075 (Dr. Marcantonio), and K01AG033643 (Dr. Saczynski). Dr. Inouye holds the Milton and Shirley F. Levy Family Chair.	Breitbart W, 1997, J PAIN SYMPTOM MANAG, V13, P128, DOI 10.1016/S0885-3924(96)00316-8; BUJA A, 1992, MULTIVAR BEHAV RES, V27, P509, DOI 10.1207/s15327906mbr2704_2; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Greer N, 2011, DELIRIUM SCREENING P; Inouye S. K., 2003, CONFUSION ASSESSMENT; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Inouye SK, 2005, J AM GERIATR SOC, V53, P312, DOI 10.1111/j.1532-5415.2005.53120.x; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Inouye SK, 2000, J AM GERIATR SOC, V48, P1697; Inouye SK, 2013, LANCET; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Lacasse H, 2006, ANN PHARMACOTHER, V40, P1966; Leslie DL, 2005, J AM GERIATR SOC, V53, P405, DOI 10.1111/j.1532-5415.2005.53156.x; Leslie DL, 2008, ARCH INTERN MED, V168, P27, DOI 10.1001/archinternmed.2007.4; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; McDonald RP, 1999, TEST THEORY UNIFIED; Milisen K, 2001, J AM GERIATR SOC, V49, P523, DOI 10.1046/j.1532-5415.2001.49109.x; National Institute for Health and Care Excellence, 2010, 103 NICE CLIN GUID; Schmitt EM, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2012.08.004; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; TRZEPACZ PT, 1988, PSYCHIAT RES, V23, P89, DOI 10.1016/0165-1781(88)90037-6; Wachter RM, 2012, UNDERSTANDING PATIEN; Wei LA, 2008, J AM GERIATR SOC, V56, P823, DOI 10.1111/j.1532-5415.2008.01674.x; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Wong CL, 2010, JAMA-J AM MED ASSOC, V304, P779, DOI 10.1001/jama.2010.1182	29	189	197	2	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 15	2014	160	8					526	+		10.7326/M13-1927	http://dx.doi.org/10.7326/M13-1927			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG0ZE	24733193	Green Submitted, Green Accepted			2022-12-28	WOS:000335143700002
J	Jofre, S				Jofre, Shelley			GSK faces accusations of bribing doctors in Poland The company may have broken US and UK laws on bribery, says Shelley Jofre	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												shelley.jofre@bbc.co.uk						Almashat S, 2012, PHARMACETICAL IND CR; Kmietowicz Z, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7579; Parry J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4791; Reuters, 2014, REUTERS; Roehr B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4568	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2014	348								g2768	10.1136/bmj.g2768	http://dx.doi.org/10.1136/bmj.g2768			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF5GH	24733722				2022-12-28	WOS:000334741500001
J	Qiu, ZZ; Dubin, AE; Mathur, J; Tu, B; Reddy, K; Miraglia, LJ; Reinhardt, J; Orth, AP; Patapoutian, A				Qiu, Zhaozhu; Dubin, Adrienne E.; Mathur, Jayanti; Tu, Buu; Reddy, Kritika; Miraglia, Loren J.; Reinhardt, Juergen; Orth, Anthony P.; Patapoutian, Ardem			SWELL1, a Plasma Membrane Protein, Is an Essential Component of Volume-Regulated Anion Channel	CELL			English	Article							ENDOTHELIAL-CELLS; CHLORIDE CHANNELS; CL-CHANNEL; LYMPHOCYTES; PHYSIOLOGY; PANNEXINS; INCREASE; TAURINE; CALCIUM; EFFLUX	Maintenance of a constant cell volume in response to extracellular or intracellular osmotic changes is critical for cellular homeostasis. Activation of a ubiquitous volume-regulated anion channel (VRAC) plays a key role in this process; however, its molecular identity in vertebrates remains unknown. Here, we used a cell-based fluorescence assay and performed a genome-wide RNAi screen to find components of VRAC. We identified SWELL1 (LRRC8A), a member of a four-transmembrane protein family with unknown function, as essential for hypotonicity-induced iodide influx. SWELL1 is localized to the plasma membrane, and its knockdown dramatically reduces endogenous VRAC currents and regulatory cell volume decrease in various cell types. Furthermore, point mutations in SWELL1 cause a significant change in VRAC anion selectivity, demonstrating that SWELL1 is an essential VRAC component. These findings enable further molecular characterization of the VRAC channel complex and genetic studies for understanding the function of VRAC in normal physiology and disease.	[Qiu, Zhaozhu; Mathur, Jayanti; Tu, Buu; Reddy, Kritika; Miraglia, Loren J.; Orth, Anthony P.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Qiu, Zhaozhu; Dubin, Adrienne E.; Patapoutian, Ardem] Scripps Res Inst, Howard Hughes Med Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA; [Reinhardt, Juergen] Novartis Inst Biomed Res, CH-4056 Basel, Switzerland	Novartis; Howard Hughes Medical Institute; Scripps Research Institute; Novartis	Patapoutian, A (corresponding author), Scripps Res Inst, Howard Hughes Med Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA.	ardem@scripps.edu			NIH [R01 DE022115]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022115] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Paul Groot-Kormelink for information on the HEK-YFP cell line; Yingyao Zhou and Jeff Janes for help with RNAi screen data analysis; Michael Bandell, Jie Xu, Swetha Murthy, Matt Petrus, Albert Parker, Angelica Romero, and Myleen Medina for technical assistance; Qiangfeng Zhang for 3D structural modeling; and members of the Patapoutian lab for valuable discussions. This work was supported by a grant from the NIH (R01 DE022115 to A.P.). A.P. is a Howard Hughes Medical Institute investigator.	Abascal F, 2012, BIOESSAYS, V34, P551, DOI 10.1002/bies.201100173; ACKERMAN MJ, 1994, J GEN PHYSIOL, V103, P153, DOI 10.1085/jgp.103.2.153; Cahalan M D, 1988, Soc Gen Physiol Ser, V43, P281; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Chien LT, 2007, J GEN PHYSIOL, V130, P513, DOI 10.1085/jgp.200709795; Decher T, 2001, BRIT J PHARMACOL, V134, P1467; DOROSHENKO P, 1992, J PHYSIOL-LONDON, V449, P197, DOI 10.1113/jphysiol.1992.sp019082; Dubin AE, 2012, CELL REP, V2, P511, DOI 10.1016/j.celrep.2012.07.014; Falktoft B, 2004, J MEMBRANE BIOL, V201, P59, DOI 10.1007/s00232-004-0705-6; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; GRINSTEIN S, 1982, J GEN PHYSIOL, V80, P801, DOI 10.1085/jgp.80.6.801; Helix N, 2003, J MEMBRANE BIOL, V196, P83, DOI 10.1007/s00232-003-0627-x; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Jackson PS, 1996, KIDNEY INT, V49, P1695, DOI 10.1038/ki.1996.250; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kaczmarek LK, 1997, PHYSIOL REV, V77, P627, DOI 10.1152/physrev.1997.77.3.627; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kubota K, 2004, FEBS LETT, V564, P147, DOI 10.1016/S0014-5793(04)00332-1; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; LEWIS RS, 1993, J GEN PHYSIOL, V101, P801, DOI 10.1085/jgp.101.6.801; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Manolopoulos VG, 1997, AM J PHYSIOL-CELL PH, V273, pC214, DOI 10.1152/ajpcell.1997.273.1.C214; Minier F, 2004, TRENDS PHARMACOL SCI, V25, P499, DOI 10.1016/j.tips.2004.07.005; NILIUS B, 1994, J GEN PHYSIOL, V103, P787, DOI 10.1085/jgp.103.5.787; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; Okada Y, 1998, J GEN PHYSIOL, V112, P365, DOI 10.1085/jgp.112.3.365; Okada Y, 2009, J PHYSIOL-LONDON, V587, P2141, DOI 10.1113/jphysiol.2008.165076; Sawada A, 2003, J CLIN INVEST, V112, P1707, DOI 10.1172/JCI18937; Schmidt M, 2009, NEURON, V64, P498, DOI 10.1016/j.neuron.2009.09.030; Shen MR, 2000, J PHYSIOL-LONDON, V529, P385, DOI 10.1111/j.1469-7793.2000.00385.x; Siebert AP, 2013, J BIOL CHEM, V288, P6140, DOI 10.1074/jbc.M112.409789; Stotz SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046865; Strange K, 1996, AM J PHYSIOL-CELL PH, V270, pC711, DOI 10.1152/ajpcell.1996.270.3.C711; Wang JJ, 2010, J GEN PHYSIOL, V136, P515, DOI 10.1085/jgp.201010440; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	36	354	363	0	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					447	458		10.1016/j.cell.2014.03.024	http://dx.doi.org/10.1016/j.cell.2014.03.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725410	Green Accepted, Bronze			2022-12-28	WOS:000334304500017
J	Revesz, RL; Howard, PH; Arrow, K; Goulder, LH; Kopp, RE; Livermore, MA; Oppenheimer, M; Sterner, T				Revesz, Richard L.; Howard, Peter H.; Arrow, Kenneth; Goulder, Lawrence H.; Kopp, Robert E.; Livermore, Michael A.; Oppenheimer, Michael; Sterner, Thomas			Improve economic models of climate change	NATURE			English	Editorial Material									[Revesz, Richard L.; Howard, Peter H.] NYU, Sch Law, New York, NY 10003 USA; [Arrow, Kenneth; Goulder, Lawrence H.] Stanford Univ, Dept Econ, Stanford, CA 94305 USA; [Kopp, Robert E.] Rutgers State Univ, Dept Earth & Planetary Sci, New Brunswick, NJ 08903 USA; [Livermore, Michael A.] Univ Virginia, Sch Law, Charlottesville, VA 22903 USA; [Oppenheimer, Michael] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Oppenheimer, Michael] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Sterner, Thomas] Univ Gothenburg, Dept Econ, Gothenburg, Sweden	New York University; Stanford University; Rutgers State University New Brunswick; University of Virginia; Princeton University; Princeton University; University of Gothenburg	Revesz, RL (corresponding author), NYU, Sch Law, New York, NY 10003 USA.	richard.revesz@nyu.edu	Sterner, Thomas/AGZ-2537-2022	Kopp, Robert/0000-0003-4016-9428; Livermore, Michael/0000-0002-2403-1173; Oppenheimer, Michael/0000-0002-9708-5914				[Anonymous], 2013, TECHN UPD SOC COST C; [Anonymous], 2010, SOC COST CARB REG IM; Fankhauser S, 2005, RESOUR ENERGY ECON, V27, P1, DOI 10.1016/j.reseneeco.2004.03.003; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Kopp RE, 2012, ECONOMICS-KIEL, V6, DOI 10.5018/economics-ejournal.ja.2012-15; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Sherwood SC, 2010, P NATL ACAD SCI USA, V107, P9552, DOI 10.1073/pnas.0913352107; Sterner T, 2008, REV ENV ECON POLICY, V2, P61, DOI 10.1093/reep/rem024; Weitzman M. L., 1998, ENV EC MGMT, V36, P201	10	128	130	4	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					173	175		10.1038/508173a	http://dx.doi.org/10.1038/508173a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE4UK	24724186	Bronze			2022-12-28	WOS:000333979900016
J	Viana-Tejedor, A; Nunez-Gil, IJ				Viana-Tejedor, Ana; Javier Nunez-Gil, Ivan			Isolated Uvular Angioedema	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 59-year-old man was admitted to the coronary care unit with an inferior ST-segment elevation MI. Physical examination uvular angioedema, which resolved within 24 hours after treatment with antihistamines and glucocorticoids. Videos show the angioedema and its resolution. A 59-year-old man was admitted to the coronary care unit with an inferior ST-segment elevation myocardial infarction. He took no medications and had no history of allergies or angioedema. A primary percutaneous coronary intervention was performed, and a bare-metal stent was successfully implanted in the circumflex coronary artery. Treatment with 6.25 mg of captopril was started 6 hours after completion of the procedure, and 30 minutes after administration he reported difficulty swallowing and throat pain; lung sounds were normal, and he had no breathing difficulties. On examination, the uvula was markedly edematous and erythematous (Panel A and Video 1). Uvular ...	[Viana-Tejedor, Ana; Javier Nunez-Gil, Ivan] Hosp Clin San Carlos, Madrid, Spain	Hospital Clinico San Carlos	Viana-Tejedor, A (corresponding author), Hosp Clin San Carlos, Madrid, Spain.	ana_viana_tejedor@hotmail.com	nunez, ivan/AAD-6950-2020	Nunez Gil, Ivan Javier/0000-0002-1779-3102					0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 10	2014	370	15							e24	10.1056/NEJMicm1309447	http://dx.doi.org/10.1056/NEJMicm1309447			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6IW	24716702				2022-12-28	WOS:000334095200001
J	Joseph, M; Robinson, A				Joseph, Mathai; Robinson, Andrew			Free Indian science	NATURE			English	Editorial Material									[Joseph, Mathai] Tata Inst Fundamental Res, Bombay 400005, Maharashtra, India; [Joseph, Mathai] Univ Warwick, Coventry CV4 7AL, W Midlands, England; [Joseph, Mathai] Tata Consultancy Serv, Bombay, Maharashtra, India	Tata Institute of Fundamental Research (TIFR); University of Warwick; Tata Sons; Tata Consultancy Services Limited (TCS)	Joseph, M (corresponding author), Univ Warwick, Coventry CV4 7AL, W Midlands, England.	andrew.robinson33@virgin.net						Adams J, 2012, NATURE, V490, P335, DOI 10.1038/490335a; Desiraju GR, 2012, NATURE, V484, P159, DOI 10.1038/484159a; Jayaraman K.S., 2012, NATURE; Joseph M., 2013, DIGITAL REPUBLIC IND; Krishna V.V, 2014, HINDU; Parameswaran U. C. V., 2011, CV RAMAN BIOGRAPHY 2, P224; Varma G, 2014, SCIENCE; World Bank World Development Indicators, WORLD DEV IND RES DE; World Intellectual Property Organization, 2012, 2012 WIPO IP FACTS F	9	13	14	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					36	38		10.1038/508036a	http://dx.doi.org/10.1038/508036a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD9UL	24707526	Bronze			2022-12-28	WOS:000333609900028
J	Maret, D; Telmon, N; Treil, J; Caron, P; Nabet, C				Maret, Delphine; Telmon, Norbert; Treil, Jacques; Caron, Philippe; Nabet, Cathy			Pituitary Adenoma as an Incidental Finding in Dental Radiology: A Case Report	ANNALS OF INTERNAL MEDICINE			English	Letter									[Maret, Delphine] Univ Toulouse 3, Ctr Hosp Univ, Lab Anthropol Mol & Imagerie Synth, F-31062 Toulouse, France; [Telmon, Norbert] Univ Toulouse 3, Hop Rangueil, Ctr Hosp Univ, Lab Anthropol Mol & Imagerie Synth, F-31062 Toulouse, France; [Treil, Jacques] Univ Toulouse 3, Lab Anthropol Mol & Imagerie Synth, F-31062 Toulouse, France; [Caron, Philippe] Ctr Hosp Univ Larrey, Toulouse, France; [Nabet, Cathy] Univ Toulouse 3, Ctr Hosp Univ, F-31062 Toulouse, France	CHU de Toulouse; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Maret, D (corresponding author), Univ Toulouse 3, Ctr Hosp Univ, Lab Anthropol Mol & Imagerie Synth, F-31062 Toulouse, France.		Nabet, Cathy/AAC-4008-2019; Maret, Delphine/AFT-1061-2022					Freda PU, 2011, J CLIN ENDOCR METAB, V96, P894, DOI 10.1210/jc.2010-1048; Scarfe WC, 2006, J AM DENT ASS S3, V72, P75	2	3	3	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2014	160	4					290	291		10.7326/L14-5004-4	http://dx.doi.org/10.7326/L14-5004-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB3BO	24727848				2022-12-28	WOS:000331666500013
J	Haraldsdottir, S; Shah, MH				Haraldsdottir, Sigurdis; Shah, Manisha H.			New era for treatment in differentiated thyroid cancer	LANCET			English	Editorial Material							PHASE-II TRIAL; SORAFENIB		[Haraldsdottir, Sigurdis; Shah, Manisha H.] Ohio State Univ, Div Med Oncol, Dept Internal Med, Ctr Comprehens Canc, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Shah, MH (corresponding author), Ohio State Univ, Div Med Oncol, Dept Internal Med, Ctr Comprehens Canc, Columbus, OH 43210 USA.	manisha.shah@osumc.edu		Haraldsdottir, Sigurdis/0000-0002-5050-3699				Ahmed M, 2011, EUR J ENDOCRINOL, V165, P315, DOI 10.1530/EJE-11-0129; Brose M.S., 2014, LANCET; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; Durante C, 2006, J CLIN ENDOCR METAB, V91, P2892, DOI 10.1210/jc.2005-2838; European Medicines Agency, EU3131999 EUR MED AG; GOTTLIEB JA, 1974, NEW ENGL J MED, V290, P193, DOI 10.1056/NEJM197401242900404; Gupta-Abramson V, 2008, J CLIN ONCOL, V26, P4714, DOI 10.1200/JCO.2008.16.3279; Haraldsdottir S, 2014, CURR OPIN ONCOL, V26, P36, DOI 10.1097/CCO.0000000000000029; Hoftijzer H, 2009, EUR J ENDOCRINOL, V161, P923, DOI 10.1530/EJE-09-0702; Howlader N, 2013, SEER CANC STAT REV 1; Keefe SM, 2011, J CLIN ONCOL, V29; Kloos RT, 2009, J CLIN ONCOL, V27, P1675, DOI 10.1200/JCO.2008.18.2717; U.S. Food and Drug Administration, FDA APPR NEX TREAT T	13	5	5	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2014	384	9940					286	288		10.1016/S0140-6736(14)60663-2	http://dx.doi.org/10.1016/S0140-6736(14)60663-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3AE	24768111				2022-12-28	WOS:000339722400006
J	Calderon, AJ; Newman, JS; Winawer, NH				Calderon, Aaron J.; Newman, James S.; Winawer, Neil H.			Update in Hospital Medicine: Evidence Published in 2013	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CLINICAL-PRACTICE GUIDELINE		[Winawer, Neil H.] Emory Univ, Atlanta, GA 30303 USA; Mayo Clin, Rochester, MN 55905 USA; Exempla St Joseph Hosp, Denver, CO 80218 USA	Emory University; Mayo Clinic	Winawer, NH (corresponding author), Emory Univ, 49 Jessie Hill Jr Dr SE, Atlanta, GA 30303 USA.	nwinawe@emory.edu						Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Global Initiative for Chronic Obstructive Lung Disease, 2013, GLOBAL STRATEGY FOR; Horner C, 2012, J ANTIMICROB CHEMOTH, V67, P2547, DOI 10.1093/jac/dks284; Johnston BC, 2012, ANN INTERN MED, V157, P878, DOI 10.7326/0003-4819-157-12-201212180-00563; Mentzelopoulos SD, 2009, ARCH INTERN MED, V169, P15, DOI 10.1001/archinternmed.2008.509; Patel JB, 2009, CLIN INFECT DIS, V49, P935, DOI 10.1086/605495; Pereira TV, 2012, JAMA-J AM MED ASSOC, V308, P1676, DOI 10.1001/jama.2012.13444; Sud S, 2010, INTENS CARE MED, V36, P585, DOI 10.1007/s00134-009-1748-1; Umpierrez GE, 2012, J CLIN ENDOCR METAB, V97, P16, DOI 10.1210/jc.2011-2098	10	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2					139	+		10.7326/M14-0266	http://dx.doi.org/10.7326/M14-0266			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	24722702				2022-12-28	WOS:000339764600023
J	Orentlicher, D; Pope, TM; Rich, BA				Orentlicher, David; Pope, Thaddeus Mason; Rich, Ben A.			The Changing Legal Climate for Physician Aid in Dying	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Orentlicher, David] Indiana Univ, Hall Ctr Law & Hlth, Robert H McKinney Sch Law, Indianapolis, IN 46202 USA; [Pope, Thaddeus Mason] Hamline Univ, Sch Law, Hlth Law Inst, St Paul, MN USA; [Rich, Ben A.] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Mitchell Hamline School of Law; University of California System; University of California Davis	Orentlicher, D (corresponding author), Indiana Univ, Hall Ctr Law & Hlth, Robert H McKinney Sch Law, 530 W New York St, Indianapolis, IN 46202 USA.	dorentli@iu.edu	Pope, Thaddeus/K-9452-2019	Pope, Thaddeus/0000-0002-7163-505X				American Public Health Association, POL STAT DAT; CANTOR NL, 1977, RUTGERS LAW REV, V30, P243; Ganzini L, 2009, J PAIN SYMPTOM MANAG, V38, P807, DOI 10.1016/j.jpainsymman.2009.04.026; GELFAND G, 1987, WISC LAW REV, P737; Hall M. A., 2013, HLTH CARE LAW ETHICS; Orentlicher D, 1996, NEW ENGL J MED, V335, P663, DOI 10.1056/NEJM199608293350912	6	12	12	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2014	311	19					1961	1962		10.1001/jama.2014.4117	http://dx.doi.org/10.1001/jama.2014.4117			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH4UA	24733479	Green Published			2022-12-28	WOS:000336122800011
J	Thing, J; Coates, C; Bundy, M				Thing, James; Coates, Chris; Bundy, Mike			An adolescent athlete with groin pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AVULSION FRACTURES; LESSER TROCHANTER; INJURIES; PELVIS; HIP; CHILDREN		[Thing, James] Cranleigh Sch, Med Ctr, Cranleigh GU6 8QQ, England; [Coates, Chris] Royal Surrey Cty Hosp, Guildford, Surrey, England; [Bundy, Mike] Cranleigh Sch, Cranleigh GU6 8QQ, England	Royal Surrey County Hospital	Thing, J (corresponding author), Cranleigh Sch, Med Ctr, Cranleigh GU6 8QQ, England.	thing.james@gmail.com						Anderson K, 2001, AM J SPORT MED, V29, P521, DOI 10.1177/03635465010290042501; GAMBLE JG, 1993, J PEDIATR ORTHOP B, V2, P188, DOI 10.1097/01202412-199302020-00018; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P170, DOI 10.1016/j.cppeds.2010.06.003; Karlin LI., 1986, THE LOWER EXTREMITY, V2; MARTIN T A, 1957, Clin Orthop, V10, P108; McKinney BI, 2009, ORTHOPEDICS, V32, P42, DOI 10.3928/01477447-20090101-12; METZMAKER JN, 1985, AM J SPORT MED, V13, P349, DOI 10.1177/036354658501300510; Rossi F, 2001, SKELETAL RADIOL, V30, P127, DOI 10.1007/s002560000319; Stevens MA, 1999, RADIOGRAPHICS, V19, P655, DOI 10.1148/radiographics.19.3.g99ma05655; Theologis TN, 1997, INJURY, V28, P363, DOI 10.1016/S0020-1383(97)00017-X; Vandervliet EJM, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036921; Weiss JM, 2006, OPER TECHN SPORT MED, V14, P212, DOI 10.1053/j.otsm.2006.04.002	12	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2014	348								g2766	10.1136/bmj.g2766	http://dx.doi.org/10.1136/bmj.g2766			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5PN	24776121				2022-12-28	WOS:000335471000018
J	Baldauf, D; Desimone, R				Baldauf, Daniel; Desimone, Robert			Neural Mechanisms of Object-Based Attention	SCIENCE			English	Article							TOP-DOWN MODULATION; VISUAL-CORTEX; NEURONAL SYNCHRONIZATION; SELECTIVE ATTENTION; PREFRONTAL CORTEX; FACE PERCEPTION; WORKING-MEMORY; OSCILLATIONS; AREA; REPRESENTATION	How we attend to objects and their features that cannot be separated by location is not understood. We presented two temporally and spatially overlapping streams of objects, faces versus houses, and used magnetoencephalography and functional magnetic resonance imaging to separate neuronal responses to attended and unattended objects. Attention to faces versus houses enhanced the sensory responses in the fusiform face area (FFA) and parahippocampal place area (PPA), respectively. The increases in sensory responses were accompanied by induced gamma synchrony between the inferior frontal junction, IFJ, and either FFA or PPA, depending on which object was attended. The IFJ appeared to be the driver of the synchrony, as gamma phases were advanced by 20 ms in IFJ compared to FFA or PPA. Thus, the IFJ may direct the flow of visual processing during object-based attention, at least in part through coupled oscillations with specialized areas such as FFA and PPA.	[Baldauf, Daniel; Desimone, Robert] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Baldauf, D (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	baldauf@mit.edu	Desimone, Robert/G-1121-2018; Baldauf, Daniel/K-6717-2012	Baldauf, Daniel/0000-0001-5764-506X	NIH [P30EY2621]; NSF [CCF-1231216]; NATIONAL EYE INSTITUTE [P30EY002621] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Liang, D. Pantazis, M. Hamalainen, D. Dilks, D. Osher, Y. Zhang, C. Triantafyllou, S. Shannon, S. Arnold, C. Jennings. Supported by NIH (P30EY2621) and NSF (CCF-1231216), both to R.D.	Barcelo F, 2000, NAT NEUROSCI, V3, P399, DOI 10.1038/73975; Brass M, 2005, TRENDS COGN SCI, V9, P314, DOI 10.1016/j.tics.2005.05.001; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Ciaramitaro VM, 2011, J NEUROPHYSIOL, V105, P1258, DOI 10.1152/jn.00680.2010; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fedorenko E, 2012, CURR BIOL, V22, P2059, DOI 10.1016/j.cub.2012.09.011; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; HARI R, 1989, J ACOUST SOC AM, V86, P1033, DOI 10.1121/1.398093; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; Parkkonen L, 2008, P NATL ACAD SCI USA, V105, P20500, DOI 10.1073/pnas.0810966105; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Saygin ZM, 2012, NAT NEUROSCI, V15, P321, DOI 10.1038/nn.3001; Schoenfeld MA, 2014, NAT NEUROSCI, V17, P619, DOI 10.1038/nn.3656; Serences JT, 2007, NEURON, V55, P301, DOI 10.1016/j.neuron.2007.06.015; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Tsao DY, 2008, P NATL ACAD SCI USA, V105, P19514, DOI 10.1073/pnas.0809662105; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Zanto TP, 2011, NAT NEUROSCI, V14, P656, DOI 10.1038/nn.2773	31	254	257	10	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					424	427		10.1126/science.1247003	http://dx.doi.org/10.1126/science.1247003			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763592				2022-12-28	WOS:000334867800044
J	Du, JN; Skubi, KL; Schultz, DM; Yoon, TP				Du, Juana; Skubi, Kazimer L.; Schultz, Danielle M.; Yoon, Tehshik P.			A Dual-Catalysis Approach to Enantioselective [2+2] Photocycloadditions Using Visible Light	SCIENCE			English	Article							LEWIS-ACID CATALYSIS; PHOTOCHEMICAL-REACTIONS; CHIRAL SENSITIZER; ORGANIC-SYNTHESIS; COMPLEXES; CHEMISTRY	In contrast to the wealth of catalytic systems that are available to control the stereochemistry of thermally promoted cycloadditions, few similarly effective methods exist for the stereocontrol of photochemical cycloadditions. A major unsolved challenge in the design of enantioselective catalytic photocycloaddition reactions has been the difficulty of controlling racemic background reactions that occur by direct photoexcitation of substrates while unbound to catalyst. Here, we describe a strategy for eliminating the racemic background reaction in asymmetric [2 + 2] photocycloadditions of alpha, beta-unsaturated ketones to the corresponding cyclobutanes by using a dual-catalyst system consisting of a visible light-absorbing transition-metal photocatalyst and a stereocontrolling Lewis acid cocatalyst. The independence of these two catalysts enables broader scope, greater stereochemical flexibility, and better efficiency than previously reported methods for enantioselective photochemical cycloadditions.	[Du, Juana; Skubi, Kazimer L.; Schultz, Danielle M.; Yoon, Tehshik P.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Yoon, TP (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	tyoon@chem.wisc.edu		Skubi, Kazimer/0000-0002-9689-1842	NIH [GM095666, GM105149]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095666, F32GM105149] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. S. Dolinar and I. A. Guzei for determining absolute stereochemistry by x-ray crystallography. Metrical parameters for the structures of 3c and S3 are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC-988977 and 988978, respectively. Funding for this work was provided by an NIH research grant (GM095666) and a postdoctoral fellowship to D. M. S. (GM105149).	Allen AE, 2012, CHEM SCI, V3, P633, DOI 10.1039/c2sc00907b; Aspinall HC, 2002, CHEM REV, V102, P1807, DOI 10.1021/cr010288q; Bach T, 2000, ANGEW CHEM INT EDIT, V39, P2302, DOI 10.1002/1521-3773(20000703)39:13<2302::AID-ANIE2302>3.0.CO;2-6; Brimioulle R, 2013, SCIENCE, V342, P840, DOI 10.1126/science.1244809; DEMUTH M, 1986, ANGEW CHEM INT EDIT, V25, P1117, DOI 10.1002/anie.198611171; Du J, 2009, J AM CHEM SOC, V131, P14604, DOI 10.1021/ja903732v; FOURNIER F, 1986, CAN J CHEM, V64, P881, DOI 10.1139/v86-146; Guo H, 2010, ANGEW CHEM INT EDIT, V49, P7782, DOI 10.1002/anie.201003619; Hoffmann N, 2008, CHEM REV, V108, P1052, DOI 10.1021/cr0680336; Hoveyda AH, 1998, CHEM BIOL, V5, pR187, DOI 10.1016/S1074-5521(98)90155-7; HUBERT AJ, 1967, J CHEM SOC C, P1984, DOI 10.1039/j39670001984; INOUE Y, 1992, CHEM REV, V92, P741, DOI 10.1021/cr00013a001; Iriondo-Alberdi J, 2007, EUR J ORG CHEM, V2007, P4801, DOI 10.1002/ejoc.200700239; Ischay MA, 2008, J AM CHEM SOC, V130, P12886, DOI 10.1021/ja805387f; Kacprzynski MA, 2004, J AM CHEM SOC, V126, P10676, DOI 10.1021/ja0478779; KALYANASUNDARAM K, 1982, COORDIN CHEM REV, V46, P159, DOI 10.1016/0010-8545(82)85003-0; Kuhn W, 1930, NATURWISSENSCHAFTEN, V18, P183, DOI 10.1007/BF01501575; Le Bel JA, 1874, B SOC CHIM FR, V22, P337; Maturi MM, 2013, CHEM-EUR J, V19, P7461, DOI 10.1002/chem.201300203; Mikami K, 2002, ANGEW CHEM INT EDIT, V41, P3555, DOI 10.1002/1521-3773(20021004)41:19<3554::AID-ANIE3554>3.0.CO;2-P; Muller C, 2011, J AM CHEM SOC, V133, P16689, DOI 10.1021/ja207480q; Muller C, 2009, ANGEW CHEM INT EDIT, V48, P6640, DOI 10.1002/anie.200901603; Ojima I., 2010, CATALYTIC ASYMMETRIC; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; RAU H, 1983, CHEM REV, V83, P535, DOI 10.1021/cr00057a003; TODA F, 1995, J CHEM SOC CHEM COMM, P621, DOI 10.1039/c39950000621; TOLBERT LM, 1982, J AM CHEM SOC, V104, P1742, DOI 10.1021/ja00370a053; Yamamoto H., 2000, LEWIS ACIDS ORGANIC, V1	28	392	394	14	380	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					392	396		10.1126/science.1251511	http://dx.doi.org/10.1126/science.1251511			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763585	Green Accepted			2022-12-28	WOS:000334867800035
J	Auerbach, E				Auerbach, Elise			Iran needs to present a united front on science	NATURE			English	Editorial Material									Amnesty Int USA, Chicago, IL USA		Auerbach, E (corresponding author), Amnesty Int USA, Chicago, IL USA.	aiis@uchicago.edu							0	0	0	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					433	433		10.1038/508433a	http://dx.doi.org/10.1038/508433a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF5GI	24759380	Bronze			2022-12-28	WOS:000334741600004
J	Bellott, DW; Hughes, JF; Skaletsky, H; Brown, LG; Pyntikova, T; Cho, TJ; Koutseva, N; Zaghlul, S; Graves, T; Rock, S; Kremitzki, C; Fulton, RS; Dugan, S; Ding, Y; Morton, D; Khan, Z; Lewis, L; Buhay, C; Wang, QY; Watt, J; Holder, M; Lee, S; Nazareth, L; Rozen, S; Muzny, DM; Warren, WC; Gibbs, RA; Wilson, RK; Page, DC				Bellott, Daniel W.; Hughes, Jennifer F.; Skaletsky, Helen; Brown, Laura G.; Pyntikova, Tatyana; Cho, Ting-Jan; Koutseva, Natalia; Zaghlul, Sara; Graves, Tina; Rock, Susie; Kremitzki, Colin; Fulton, Robert S.; Dugan, Shannon; Ding, Yan; Morton, Donna; Khan, Ziad; Lewis, Lora; Buhay, Christian; Wang, Qiaoyan; Watt, Jennifer; Holder, Michael; Lee, Sandy; Nazareth, Lynne; Rozen, Steve; Muzny, Donna M.; Warren, Wesley C.; Gibbs, Richard A.; Wilson, Richard K.; Page, David C.			Mammalian Y chromosomes retain widely expressed dosage-sensitive regulators	NATURE			English	Article							SEX-DETERMINING REGION; X-CHROMOSOMES; SHORT ARM; EMBRYONIC-DEVELOPMENT; GENE CONVERSION; 2 DAUGHTERS; INACTIVATION; PHENOTYPE; EVOLUTION; SEQUENCE	The human X and Y chromosomes evolved from an ordinary pair of autosomes, but millions of years ago genetic decay ravaged the Y chromosome, and only three per cent of its ancestral genes survived. We reconstructed the evolution of the Y chromosome across eight mammals to identify biases in gene content and the selective pressures that preserved the surviving ancestral genes. Our findings indicate that survival was nonrandom, and in two cases, convergent across placental and marsupial mammals. We conclude that the gene content of the Y chromosome became specialized through selection to maintain the ancestral dosage of homologous X-Y gene pairs that function as broadly expressed regulators of transcription, translation and protein stability. We propose that beyond its roles in testis determination and spermatogenesis, the Y chromosome is essential for male viability, and has unappreciated roles in Turner's syndrome and in phenotypic differences between the sexes in health and disease.	[Bellott, Daniel W.; Hughes, Jennifer F.; Skaletsky, Helen; Brown, Laura G.; Pyntikova, Tatyana; Cho, Ting-Jan; Koutseva, Natalia; Zaghlul, Sara; Rozen, Steve; Page, David C.] MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA; [Bellott, Daniel W.; Hughes, Jennifer F.; Skaletsky, Helen; Brown, Laura G.; Pyntikova, Tatyana; Cho, Ting-Jan; Koutseva, Natalia; Zaghlul, Sara; Rozen, Steve; Page, David C.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Graves, Tina; Rock, Susie; Kremitzki, Colin; Fulton, Robert S.; Warren, Wesley C.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Dugan, Shannon; Ding, Yan; Morton, Donna; Khan, Ziad; Lewis, Lora; Buhay, Christian; Wang, Qiaoyan; Watt, Jennifer; Holder, Michael; Lee, Sandy; Nazareth, Lynne; Muzny, Donna M.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); Baylor College of Medicine	Bellott, DW (corresponding author), MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA.	bellott@wi.mit.edu	Wilson, Richard K./AAF-4139-2019; Rozen, Steven G./J-5939-2013	Wilson, Richard K./0000-0002-1992-1358; Kremitzki, Colin/0000-0001-9175-3136; Rozen, Steven G./0000-0002-4288-0056	National Institutes of Health; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR013986] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, U54HG003079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank W. J. Murphy, E. Owens and J. E. Womak for generating radiation hybrid panels and for assistance in mapping; L. Lyons and W. J. M. for providing the rhesus radiation hybrid panel; A. Kaur for a rhesus cell line; S. Austad, P. Hornsby and S. Tardif for marmoset cell lines; M. Brown for rat cell lines; J. E. W. for bull fibroblasts; W. Johnson and S. O'Neil for rhesus tissues samples; W. J., S.O. and S. T. for marmoset tissue samples; M. Turner for rat tissue samples; J. E. W. for bull tissue samples; P. Samollow for opossum tissue samples; E. Vallender for Tamarin DNA; B. Chowdhary and T. Raudsepp for FISH experiments in the bull; C. Friedman and B. Trask for flow-sorted marmoset Y chromosomes; B. T. for sizing rat Y chromosomes; C. Burge for permission to assemble transcriptome data from SRR594455, SRR594463 and SRR594508; J. Alfoldi for permission to assemble transcriptome data from SRR500909; R. B. Norgren for permission to assemble transcriptome data from SRR544870; and A. Godfrey, Y. Hu and B. Lesch for comments on the manuscript. Supported by National Institutes of Health and Howard Hughes Medical Institute.	Adachi M, 2000, HUM GENET, V106, P306, DOI 10.1007/s004390051042; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Bachtrog D, 2008, GENETICS, V179, P1513, DOI 10.1534/genetics.107.084012; Bellott DW, 2010, NATURE, V466, P612, DOI 10.1038/nature09172; BURGOYNE PS, 1983, J REPROD FERTIL, V68, P381, DOI 10.1530/jrf.0.0680381; BURGOYNE PS, 1983, J REPROD FERTIL, V68, P387, DOI 10.1530/jrf.0.0680387; BURGOYNE PS, 1981, J REPROD FERTIL, V61, P207, DOI 10.1530/jrf.0.0610207; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chocholska S, 2006, AM J MED GENET A, V140A, P604, DOI 10.1002/ajmg.a.31145; COCKWELL A, 1991, J MED GENET, V28, P151, DOI 10.1136/jmg.28.3.151; Dal Zotto L, 1998, HUM MOL GENET, V7, P489, DOI 10.1093/hmg/7.3.489; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fisher RA, 1931, BIOL REV BIOL P CAMB, V6, P345, DOI 10.1111/j.1469-185X.1931.tb01030.x; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Froyen G, 2012, AM J HUM GENET, V91, P252, DOI 10.1016/j.ajhg.2012.06.010; Good CD, 2003, BRAIN, V126, P2431, DOI 10.1093/brain/awg242; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; HASSOLD T, 1988, AM J HUM GENET, V42, P534; HAYASHIDA H, 1992, J MOL EVOL, V35, P181, DOI 10.1007/BF00183228; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; HOOK EB, 1983, HUM GENET, V64, P24, DOI 10.1007/BF00289473; Huang LL, 2012, AM J HUM GENET, V91, P694, DOI 10.1016/j.ajhg.2012.08.011; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Hughes JF, 2012, NATURE, V483, P82, DOI 10.1038/nature10843; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Hughes JF, 2005, NATURE, V437, P101, DOI 10.1038/nature04101; Iwase M, 2003, P NATL ACAD SCI USA, V100, P5258, DOI 10.1073/pnas.0635848100; James RS, 1998, HUM GENET, V102, P507, DOI 10.1007/s004390050733; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; Jobling MA, 2007, HUM MOL GENET, V16, P307, DOI 10.1093/hmg/ddl465; Jones MH, 1996, HUM MOL GENET, V5, P1695, DOI 10.1093/hmg/5.11.1695; Kaiser VB, 2011, GENOME BIOL EVOL, V3, P1329, DOI 10.1093/gbe/evr103; Karere GM, 2008, GENOMICS, V92, P210, DOI 10.1016/j.ygeno.2008.05.013; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; LAU EC, 1989, GENOMICS, V4, P162, DOI 10.1016/0888-7543(89)90295-4; Lawson-Yuen A, 2008, EUR J HUM GENET, V16, P614, DOI 10.1038/sj.ejhg.5202006; Lee S, 2012, DEV CELL, V22, P25, DOI 10.1016/j.devcel.2011.11.009; Lindgren AM, 2013, HUM GENET, V132, P537, DOI 10.1007/s00439-013-1263-x; Marais G, 2003, CURR BIOL, V13, pR641, DOI 10.1016/S0960-9822(03)00570-0; MASSA G, 1992, EUR J PEDIATR, V151, P893, DOI 10.1007/BF01954124; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mueller JL, 2013, NAT GENET, V45, P1083, DOI 10.1038/ng.2705; Murtagh VJ, 2012, GENOME RES, V22, P498, DOI 10.1101/gr.120790.111; Ohno S., 1967, SEX CHROMOSOMES SEX; Ramocki MB, 2010, AM J MED GENET A, V152A, P1079, DOI 10.1002/ajmg.a.33184; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Rozen S, 2009, AM J HUM GENET, V85, P923, DOI 10.1016/j.ajhg.2009.11.011; Rujirabanjerd S, 2010, EUR J HUM GENET, V18, P330, DOI 10.1038/ejhg.2009.175; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Sekiguchi T, 2004, EXP CELL RES, V300, P213, DOI 10.1016/j.yexcr.2004.07.005; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Slonim D, 1997, J COMPUT BIOL, V4, P487, DOI 10.1089/cmb.1997.4.487; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Wang X, 2014, GENOME RES, V24, P70, DOI 10.1101/gr.161919.113; WATANABE M, 1993, NAT GENET, V4, P268, DOI 10.1038/ng0793-268; WATSON JM, 1990, P NATL ACAD SCI USA, V87, P7125, DOI 10.1073/pnas.87.18.7125; Welstead GG, 2012, P NATL ACAD SCI USA, V109, P13004, DOI 10.1073/pnas.1210787109; Xie D, 2010, GENOME RES, V20, P804, DOI 10.1101/gr.100594.109; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zinn AR, 1998, AM J HUM GENET, V63, P1757, DOI 10.1086/302152; Zinn AR, 1997, CLIN GENET, V52, P235	69	388	393	3	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					494	+		10.1038/nature13206	http://dx.doi.org/10.1038/nature13206			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24759411	Green Accepted, Green Published			2022-12-28	WOS:000334741600030
J	Birbeck, GL; Hanna, MG; Griggs, RC				Birbeck, Gretchen L.; Hanna, Michael G.; Griggs, Robert C.			Global Opportunities and Challenges for Clinical Neuroscience	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Birbeck, Gretchen L.; Griggs, Robert C.] Univ Rochester, Dept Neurol, Rochester, NY 14642 USA; [Birbeck, Gretchen L.] Chikankata Hosp, Epilepsy Care Team, Mazabuka, Zambia; [Hanna, Michael G.] UCL, Inst Neurol, London, England	University of Rochester; University of London; University College London	Birbeck, GL (corresponding author), Univ Rochester, Dept Neurol, 265 Crittenden Blvd, Rochester, NY 14642 USA.	gretchen_birbeck@urmc.rochester.edu		Griggs, Robert/0000-0001-7988-4854; Hanna, Michael/0000-0003-0825-4075	Medical Research Council [MR/K000608/1] Funding Source: Medline; MRC [MR/K000608/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Birbeck GL, 2013, BMC MED, V11, DOI [10.1186/1741-7015-11-223, 10.1186/1741-7015-11-226]; Dorsey ER, 2010, JAMA-J AM MED ASSOC, V303, P137, DOI 10.1001/jama.2009.1987; Griggs RC, 2009, MOL GENET METAB, V96, P20, DOI 10.1016/j.ymgme.2008.10.003; Minisman G, 2012, J NEUROL SCI, V313, P1, DOI 10.1016/j.jns.2011.10.004; National Institutes of Health (NIH), NIH GRANTS POL CONS; Sun GH, 2012, NEW ENGL J MED, V367, P687, DOI 10.1056/NEJMp1206643; World Health Organization (WHO), 17 NEGL TROP DIS	8	7	7	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2014	311	16					1609	1610		10.1001/jama.2014.2744	http://dx.doi.org/10.1001/jama.2014.2744			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF4OU	24756506				2022-12-28	WOS:000334693900016
J	Rosenberg, RN; Saver, JL				Rosenberg, Roger N.; Saver, Jeffrey L.			Advancing Neurotherapeutics in the 21st Century	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rosenberg, Roger N.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Rosenberg, Roger N.] Alzheimers Dis Ctr, Dallas, TX 75390 USA; [Saver, Jeffrey L.] Univ Calif Los Angeles, Los Angeles, CA USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Los Angeles	Rosenberg, RN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	roger.rosenberg@utsouthwestern.edu		Saver, Jeffrey/0000-0001-9141-2251	NIA NIH HHS [P30 AG012300] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bargmann CI, 2014, JAMA NEUROL, V71, P675, DOI 10.1001/jamaneurol.2014.411; Birbeck GL, 2014, JAMA-J AM MED ASSOC, V311, P1609, DOI 10.1001/jama.2014.2744; Callaghan BC, 2014, JAMA-J AM MED ASSOC, V311, P1607, DOI 10.1001/jama.2014.1021; Chamberlain JM, 2014, JAMA-J AM MED ASSOC, V311, P1652, DOI 10.1001/jama.2014.2625; Connolly BS, 2014, JAMA-J AM MED ASSOC, V311, P1670, DOI 10.1001/jama.2014.3654; Ebinger M, 2014, JAMA-J AM MED ASSOC, V311, P1622, DOI 10.1001/jama.2014.2850; Fonarow GC, 2014, JAMA-J AM MED ASSOC, V311, P1632, DOI 10.1001/jama.2014.3203; Hyman SE, 2014, SCIENCE, V343, P1177, DOI 10.1126/science.1252603; Pedley TA, 2014, JAMA-J AM MED ASSOC, V311, P1611, DOI 10.1001/jama.2014.4081; Salman RAS, 2014, JAMA-J AM MED ASSOC, V311, P1661, DOI 10.1001/jama.2014.3200; Wall M, 2014, JAMA-J AM MED ASSOC, V311, P1641, DOI 10.1001/jama.2014.3312	11	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2014	311	16					1620	1621		10.1001/jama.2014.4084	http://dx.doi.org/10.1001/jama.2014.4084			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF4OU	24756511	Green Accepted			2022-12-28	WOS:000334693900021
J	Quintana, EV; Barclay, T; Raymond, SN; Rowe, JF; Bolmont, E; Caldwell, DA; Howell, SB; Kane, SR; Huber, D; Crepp, JR; Lissauer, JJ; Ciardi, DR; Coughlin, JL; Everett, ME; Henze, CE; Horch, E; Isaacson, H; Ford, EB; Adams, FC; Still, M; Hunter, RC; Quarles, B; Selsis, F				Quintana, Elisa V.; Barclay, Thomas; Raymond, Sean N.; Rowe, Jason F.; Bolmont, Emeline; Caldwell, Douglas A.; Howell, Steve B.; Kane, Stephen R.; Huber, Daniel; Crepp, Justin R.; Lissauer, Jack J.; Ciardi, David R.; Coughlin, Jeffrey L.; Everett, Mark E.; Henze, Christopher E.; Horch, Elliott; Isaacson, Howard; Ford, Eric B.; Adams, Fred C.; Still, Martin; Hunter, Roger C.; Quarles, Billy; Selsis, Franck			An Earth-Sized Planet in the Habitable Zone of a Cool Star	SCIENCE			English	Article							LOW-MASS STARS; MAIN-SEQUENCE STARS; M-DWARF STARS; SUN-LIKE STAR; SUPER-EARTHS; ECLIPSING BINARY; GLIESE 581D; SYSTEMS; VALIDATION; RADII	The quest for Earth-like planets is a major focus of current exoplanet research. Although planets that are Earth-sized and smaller have been detected, these planets reside in orbits that are too close to their host star to allow liquid water on their surfaces. We present the detection of Kepler-186f, a 1.11 +/- 0.14 Earth-radius planet that is the outermost of five planets, all roughly Earth-sized, that transit a 0.47 +/- 0.05 solar-radius star. The intensity and spectrum of the star's radiation place Kepler-186f in the stellar habitable zone, implying that if Kepler-186f has an Earth-like atmosphere and water at its surface, then some of this water is likely to be in liquid form.	[Quintana, Elisa V.; Rowe, Jason F.; Caldwell, Douglas A.; Huber, Daniel; Coughlin, Jeffrey L.] SETI Inst, Mountain View, CA 94043 USA; [Quintana, Elisa V.; Barclay, Thomas; Rowe, Jason F.; Caldwell, Douglas A.; Howell, Steve B.; Huber, Daniel; Lissauer, Jack J.; Coughlin, Jeffrey L.; Henze, Christopher E.; Hunter, Roger C.; Quarles, Billy] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Barclay, Thomas; Still, Martin] Bay Area Environm Res Inst, West Sonoma, CA 95476 USA; [Raymond, Sean N.; Bolmont, Emeline; Selsis, Franck] Univ Bordeaux, Lab Astrophys Bordeaux, UMR 5804, F-33270 Floirac, France; [Raymond, Sean N.; Bolmont, Emeline; Selsis, Franck] CNRS, Lab Astrophys Bordeaux, UMR 5804, F-33270 Floirac, France; [Kane, Stephen R.] San Francisco State Univ, San Francisco, CA 94132 USA; [Crepp, Justin R.] Univ Notre Dame, Notre Dame, IN 46556 USA; [Lissauer, Jack J.] Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA; [Ciardi, David R.] CALTECH, NASA Exoplanet Sci Inst, Pasadena, CA 91125 USA; [Everett, Mark E.] Natl Opt Astron Observ, Tucson, AZ 85719 USA; [Horch, Elliott] So Connecticut State Univ, New Haven, CT 06515 USA; [Isaacson, Howard] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Ford, Eric B.] Penn State Univ, Davey Lab 525, Ctr Exoplanets & Habitable, University Pk, PA 16802 USA; [Ford, Eric B.] Penn State Univ, Davey Lab 525, Dept Astron & Astrophys, University Pk, PA 16802 USA; [Adams, Fred C.] Univ Michigan, Dept Phys, Michigan Ctr Theoret Phys, Ann Arbor, MI 48109 USA; [Adams, Fred C.] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux; California State University System; San Francisco State University; University of Notre Dame; Stanford University; California Institute of Technology; National Aeronautics & Space Administration (NASA); National Optical Astronomy Observatory; Connecticut State University System; Southern Connecticut State University; University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Quintana, EV (corresponding author), SETI Inst, 189 Bernardo Ave,Suite 100, Mountain View, CA 94043 USA.	elisa.quintana@nasa.gov	Quarles, Billy/AAI-3920-2020; Ford, Eric B./AAB-5479-2019; Caldwell, Douglas A/L-7911-2014; Huber, Daniel/AAE-9440-2019	Quarles, Billy/0000-0002-9644-8330; Ford, Eric B./0000-0001-6545-639X; Caldwell, Douglas A/0000-0003-1963-9616; Huber, Daniel/0000-0001-8832-4488; Barclay, Thomas/0000-0001-7139-2724; Rowe, Jason/0000-0002-5904-1865; Ciardi, David/0000-0002-5741-3047; Bolmont, Emeline/0000-0001-5657-4503; Selsis, Franck/0000-0001-9619-5356; Coughlin, Jeffrey/0000-0003-1634-9672; Raymond, Sean/0000-0001-8974-0758	Research Opportunities in Space and Earth Sciences Kepler Participating Scientist Program [NNX12AD21G]; NASA [NNA13AA93A, NAS5-26555]; NASA Postdoctoral Program at the Ames Research Center; Kepler Participating Scientist Program; Pennsylvania State University; Eberly College of Science; Pennsylvania Space Grant Consortium; European Research Council [209622: E3ARTHs]; NASA Science Mission directorate; NASA Office of Space Science [NNX13AC07G]; National Science Foundation (NSF); National Research Council (Canada); Comision Nacional de Investigacion Cientifica y Tecnologica (Chile); Australian Research Council (Australia); Ministerio da Ciencia, Tecnologia e Inovacao (Brazil); Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Argentina)	Research Opportunities in Space and Earth Sciences Kepler Participating Scientist Program; NASA(National Aeronautics & Space Administration (NASA)); NASA Postdoctoral Program at the Ames Research Center; Kepler Participating Scientist Program; Pennsylvania State University; Eberly College of Science; Pennsylvania Space Grant Consortium; European Research Council(European Research Council (ERC)European Commission); NASA Science Mission directorate(National Aeronautics & Space Administration (NASA)); NASA Office of Space Science(National Aeronautics & Space Administration (NASA)); National Science Foundation (NSF)(National Science Foundation (NSF)); National Research Council (Canada); Comision Nacional de Investigacion Cientifica y Tecnologica (Chile); Australian Research Council (Australia)(Australian Research Council); Ministerio da Ciencia, Tecnologia e Inovacao (Brazil); Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Argentina)	The authors working at NASA Ames thank the SETI Institute for hosting them during the U. S. government shutdown. E. V. Q. and J.F.R. acknowledge support from the Research Opportunities in Space and Earth Sciences Kepler Participating Scientist Program Grant NNX12AD21G. S.N.R.'s contribution was performed as part of the NASA Astrobiology Institute's Virtual Planetary Laboratory Lead Team, supported by NASA under cooperative agreement no. NNA13AA93A. D. H. acknowledges support by an appointment to the NASA Postdoctoral Program at the Ames Research Center, administered by Oak Ridge Associated Universities through a contract with NASA, and the Kepler Participating Scientist Program. The Center for Exoplanets and Habitable Worlds is supported by the Pennsylvania State University, the Eberly College of Science, and the Pennsylvania Space Grant Consortium. F. S. acknowledges support from the European Research Council (Starting Grant 209622: E3ARTHs). This paper includes data collected by the Kepler mission. Funding for the Kepler mission is provided by the NASA Science Mission directorate. This research also made use of NASA's Astrophysics Data System. Some of the data presented in this paper were obtained from the Mikulski Archive for Space Telescopes (MAST). The Space Telescope Science Institute is operated by the Association of Universities for Research in Astronomy, under NASA contract NAS5-26555. Support for MAST for non-Hubble Space Telescope data is provided by the NASA Office of Space Science via grant NNX13AC07G and by other grants and contracts. This research made use of the NASA Exoplanet Archive, which is operated by the California Institute of Technology, under contract with NASA under the Exoplanet Exploration Program. The Gemini Observatory is operated by the Association of Universities for Research in Astronomy, under a cooperative agreement with the National Science Foundation (NSF) on behalf of the Gemini partnership: NSF (United States), the National Research Council (Canada), the Comision Nacional de Investigacion Cientifica y Tecnologica (Chile), the Australian Research Council (Australia), the Ministerio da Ciencia, Tecnologia e Inovacao (Brazil), and the Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Argentina).	Andrews SM, 2007, ASTROPHYS J, V671, P1800, DOI 10.1086/522885; Barclay T, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/101; Bayless AJ, 2006, ASTROPHYS J, V651, P1155, DOI 10.1086/507981; Borucki WJ, 2013, SCIENCE, V340, P587, DOI 10.1126/science.1234702; Chiang E, 2013, MON NOT R ASTRON SOC, V431, P3444, DOI 10.1093/mnras/stt424; Cossou C., 2014, IAU S, V299, P360; David EM, 2003, PUBL ASTRON SOC PAC, V115, P825, DOI 10.1086/376395; Ferraz-Mello S, 2008, CELEST MECH DYN ASTR, V101, P171, DOI 10.1007/s10569-008-9133-x; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Goodman J, 2010, COMM APP MATH COM SC, V5, P65, DOI 10.2140/camcos.2010.5.65; Heller R, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201015809; Holman MJ, 2010, SCIENCE, V330, P51, DOI 10.1126/science.1195778; HUT P, 1981, ASTRON ASTROPHYS, V99, P126; Irwin J, 2009, ASTROPHYS J, V701, P1436, DOI 10.1088/0004-637X/701/2/1436; Kane SR, 2012, PUBL ASTRON SOC PAC, V124, P323, DOI 10.1086/665271; KROUPA P, 1993, MON NOT R ASTRON SOC, V262, P545, DOI 10.1093/mnras/262.3.545; Lissauer JJ, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/44; Lopez ED, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/1/59; Lopez-Morales M, 2007, ASTROPHYS J, V660, P732, DOI 10.1086/513142; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; Muirhead PS, 2012, ASTROPHYS J LETT, V750, DOI 10.1088/2041-8205/750/2/L37; Raymond S. N., 2014, MON NOT R ASTRON SOC; Raymond SN, 2007, ASTROPHYS J, V669, P606, DOI 10.1086/521587; Rowe JF, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/45; Selsis F, 2007, ASTRON ASTROPHYS, V476, P1373, DOI 10.1051/0004-6361:20078091; Tarter JC, 2007, ASTROBIOLOGY, V7, P30, DOI 10.1089/ast.2006.0124; Terquem C, 2007, ASTROPHYS J, V654, P1110, DOI 10.1086/509497; Torres G, 2004, ASTROPHYS J, V614, P979, DOI 10.1086/423734; Udry S, 2007, ASTRON ASTROPHYS, V469, pL43, DOI 10.1051/0004-6361:20077612; von Paris P, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/201015329; Wang J, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/1/4; Wordsworth RD, 2011, ASTROPHYS J LETT, V733, DOI 10.1088/2041-8205/733/2/L48	37	156	158	3	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					277	280		10.1126/science.1249403	http://dx.doi.org/10.1126/science.1249403			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744370	Green Submitted			2022-12-28	WOS:000334474500029
J	Wang, P; Xue, YQ; Han, YM; Lin, L; Wu, C; Xu, S; Jiang, ZP; Xu, JF; Liu, QY; Cao, XT				Wang, Pin; Xue, Yiquan; Han, Yanmei; Lin, Li; Wu, Cong; Xu, Sheng; Jiang, Zhengping; Xu, Junfang; Liu, Qiuyan; Cao, Xuetao			The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation	SCIENCE			English	Article							TRANSCRIPTION; EXPRESSION; REPRESSION; MICRORNAS; DISEASE; STAT3; PU.1; PTEN	Long noncoding RNAs (lncRNAs) play important roles in diverse biological processes; however, few have been identified that regulate immune cell differentiation and function. Here, we identified lnc-DC, which was exclusively expressed in human conventional dendritic cells (DCs). Knockdown of lnc-DC impaired DC differentiation from human monocytes in vitro and from mouse bone marrow cells in vivo and reduced capacity of DCs to stimulate T cell activation. lnc-DC mediated these effects by activating the transcription factor STAT3 (signal transducer and activator of transcription 3). lnc-DC bound directly to STAT3 in the cytoplasm, which promoted STAT3 phosphorylation on tyrosine-705 by preventing STAT3 binding to and dephosphorylation by SHP1. Our work identifies a lncRNA that regulates DC differentiation and also broadens the known mechanisms of lncRNA action.	[Wang, Pin; Xue, Yiquan; Han, Yanmei; Xu, Sheng; Jiang, Zhengping; Liu, Qiuyan; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Wang, Pin; Xue, Yiquan; Han, Yanmei; Xu, Sheng; Jiang, Zhengping; Liu, Qiuyan; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Wang, Pin; Lin, Li; Cao, Xuetao] Chinese Acad Med Sci, Natl Key Lab Mol Biol, Beijing 100005, Peoples R China; [Wang, Pin; Lin, Li; Cao, Xuetao] Chinese Acad Med Sci, Dept Immunol, Inst Basic Med Sci, Beijing 100005, Peoples R China; [Wu, Cong; Xu, Junfang; Cao, Xuetao] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China	Naval Medical University; Naval Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Zhejiang University	Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China.	caoxt@immunol.org	Han, Yanmei/D-8995-2016; Xu, Junfang/ABC-6562-2021	wu, cong/0000-0003-4943-8786; xu, sheng/0000-0002-9547-8052	National Key Basic Research Program of China [2013CB530502]; National Natural Science Foundation of China [31390431, 81230074, 81123006]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank M. Jin and P. Ma for technical assistance; W. Ge, P. Zhang, and X. Xu for helpful discussions; and Q. Li of Genminix Informatics for bioinformatics assistance. The data presented in this paper are tabulated in the main paper and in the supplementary materials. Our transcriptome microarray data and RNA-seq data are deposited in Gene Expression Omnibus (GEO) under the accession nos. GSE54143 and GSE54401, respectively, and our ChIP-seq data are deposited in GEO under the accession no. GSE43036. This work is supported by grants from the National Key Basic Research Program of China (2013CB530502) and the National Natural Science Foundation of China (31390431, 81230074, and 81123006). X. C. and P. W. designed the experiments; P. W., Y.X., Y.H., L. L., C. W., S. X., Z.J., J.X., and Q. L. performed the experiments; X. C. and P. W. analyzed data and wrote the paper; and X. C. was responsible for research supervision, coordination, and strategy. We declare no competing financial interests.	Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guermonprez P, 2013, NAT MED, V19, P730, DOI 10.1038/nm.3197; Guerriero A, 2000, BLOOD, V95, P879, DOI 10.1182/blood.V95.3.879.003k13_879_885; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hu GQ, 2013, NAT IMMUNOL, V14, P1190, DOI 10.1038/ni.2712; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Johnsson P, 2014, BBA-GEN SUBJECTS, V1840, P1063, DOI 10.1016/j.bbagen.2013.10.035; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Li ZH, 2014, P NATL ACAD SCI USA, V111, P1002, DOI 10.1073/pnas.1313768111; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001	27	753	823	8	343	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					310	313		10.1126/science.1251456	http://dx.doi.org/10.1126/science.1251456			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744378				2022-12-28	WOS:000334474500039
J	McManus, IC; Wakeford, R				McManus, I. C.; Wakeford, Richard			PLAB and UK graduates' performance on MRCP(UK) and MRCGP examinations: data linkage study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICAL-SCHOOL; ACADEMIC-PERFORMANCE; JUDGES USE; PART 1; ASSESSMENTS; ETHNICITY; STUDENTS; DOCTORS; SCORES; IMPACT	Objectives To assess whether international medical graduates passing the two examinations set by the Professional and Linguistic Assessments Board (PLAB1 and PLAB2) of the General Medical Council (GMC) are equivalent to UK graduates at the end of the first foundation year of medical training (F1), as the GMC requires, and if not, to assess what changes in the PLAB pass marks might produce equivalence. Design Data linkage of GMC PLAB performance data with data from the Royal Colleges of Physicians and the Royal College of General Practitioners on performance of PLAB graduates and UK graduates at the MRCP(UK) and MRCGP examinations. Setting Doctors in training for internal medicine or general practice in the United Kingdom. Participants 7829, 5135, and 4387 PLAB graduates on their first attempt at MRCP(UK) Part 1, Part 2, and PACES assessments from 2001 to 2012 compared with 18 532, 14 094, and 14 376 UK graduates taking the same assessments; 3160 PLAB1 graduates making their first attempt at the MRCGP AKT during 2007-12 compared with 14 235 UK graduates; and 1411 PLAB2 graduates making their first attempt at the MRCGP CSA during 2010-12 compared with 6935 UK graduates. Main outcome measures Performance at MRCP(UK) Part 1, Part 2, and PACES assessments, and MRCGP AKT and CSA assessments in relation to performance on PLAB1 and PLAB2 assessments, as well as to International English Language Testing System (IELTS) scores. MRCP(UK), MRCGP, and PLAB results were analysed as marks relative to the pass mark at the first attempt. Results PLAB1 marks were a valid predictor of MRCP(UK) Part 1, MRCP(UK) Part 2, and MRCGP AKT (r=0.521, 0.390, and 0.490; all P<0.001). PLAB2 marks correlated with MRCP(UK) PACES and MRCGP CSA (r=0.274, 0.321; both P<0.001). PLAB graduates had significantly lower MRCP(UK) and MRCGP assessments (Glass's Delta=0.94, 0.91, 1.40, 1.01, and 1.82 for MRCP(UK) Part 1, Part 2, and PACES and MRCGP AKT and CSA), and were more likely to fail assessments and to progress more slowly than UK medical graduates. IELTS scores correlated significantly with later performance, multiple regression showing that the effect of PLAB1 (beta=0.496) was much stronger than the effect of IELTS (beta=0.086). Changes to PLAB pass marks that would result in international medical graduate and UK medical graduate equivalence were assessed in two ways. Method 1 adjusted PLAB pass marks to equate median performance of PLAB and UK graduates. Method 2 divided PLAB graduates into 12 equally spaced groups according to PLAB performance, and compared these with mean performance of graduates from individual UK medical schools, assessing which PLAB groups were equivalent in MRCP(UK) and MRCGP performance to UK graduates. The two methods produced similar results. To produce equivalent performance on the MRCP and MRGP examinations, the pass mark for PLAB1 would require raising by about 27 marks (13%) and for PLAB2 by about 15-16 marks (20%) above the present standard. Conclusions PLAB is a valid assessment of medical knowledge and clinical skills, correlating well with performance at MRCP(UK) and MRCGP. PLAB graduates' knowledge and skills at MRCP(UK) and MRCGP are over one standard deviation below those of UK graduates, although differences in training quality cannot be taken into account. Equivalent performance in MRCGP(UK) and MRCGP would occur if the pass marks of PLAB1 and PLAB2 were raised considerably, but that would also reduce the pass rate, with implications for medical workforce planning. Increasing IELTS requirements would have less impact on equivalence than raising PLAB pass marks.	[McManus, I. C.] UCL, UCL Med Sch, London WC1E 6BT, England; [McManus, I. C.] UCL, Res Dept Clin Educ & Hlth Psychol, London WC1E 6BT, England; [Wakeford, Richard] Univ Cambridge, Cambridge CB1 2EW, England	University of London; University College London; University of London; University College London; University of Cambridge	McManus, IC (corresponding author), UCL, UCL Med Sch, Mortimer St, London WC1E 6BT, England.	i.mcmanus@ucl.ac.uk		McManus, Ian/0000-0003-3510-4814	GMC	GMC	Both authors have completed the Unified Competing Interest form at ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: ICM is a member of the General Medical Council's Working Party on the PLAB assessment and has received attendance fees from the GMC, and is educational advisor to the MRCP(UK); RW has been an educational advisor to the MRCGP since 1984.	[Anonymous], 2013, MRCGP ANN REP; Bowhay AR, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-38; Bramley T., 2007, TECHNIQUES MONITORIN, P246; Clauser BE, 2009, J EDUC MEAS, V46, P390, DOI 10.1111/j.1745-3984.2009.00089.x; Cleland J., 2012, IDENTIFYING BEST PRA; Denney ML, 2013, BRIT J GEN PRACT, V63, pE718, DOI 10.3399/bjgp13X674396; Dewhurst NG, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-8; Downing SM, 2006, TEACH LEARN MED, V18, P50, DOI 10.1207/s15328015tlm1801_11; Elder A, 2011, CLIN MED, V11, P231, DOI 10.7861/clinmedicine.11-3-231; Esmail A, 2013, INDEPENDENT REV MEMB; Esmail A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5662; General Medical Council, 2012, REV ROUT GP SPEC REG; General Medical Council, 2011, ANN SPEC REP 2010 11; General Medical Council, 2013, BROAD THEM REV MEMB; General Medical Council, 1999, STEER GROUP REV PLAB; KANE M, 1994, REV EDUC RES, V64, P425, DOI 10.2307/1170678; Kolen M.J., 1995, TEST EQUATING METHOD; Margolis MJ, 2014, EDUC MEAS-ISSUES PRA, V33, P15, DOI 10.1111/emip.12025; McManus IC, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-5; McManus IC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-242; McManus IC, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-60; McManus IC, BMC MED ED IN PRESS; Mee J, 2013, EDUC MEAS-ISSUES PRA, V32, P27, DOI 10.1111/emip.12013; MRCP(UK), 2013, MRCP UK ANN REV 2011; Patel Lord, 2004, FIN REP; Practical assessment of clinical examination skills (PACES), 2000, J ROY COLL PHYS LOND, V34, P57; Ricker KL, 2013, ALBERTA J EDUC RES, V52, P53; ROGERS JL, 1993, PSYCHOL BULL, V113, P553, DOI 10.1037/0033-2909.113.3.553; Rushd S, 2013, EUR J OBSTET GYN R B, V166, P124, DOI 10.1016/j.ejogrb.2012.10.004; Rushd S, 2012, POSTGRAD MED J, V88, P249, DOI 10.1136/postgradmedj-2011-130479; Tiffin PA, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2622; Tighe J, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-40; Tyrer SP., 2002, PSYCHIATR BULL, V26, P257, DOI [DOI 10.1192/PB.26.7.257, 10.1192/pb.26.7.257]; Verheggen MM, 2008, ADV HEALTH SCI EDUC, V13, P203, DOI 10.1007/s10459-006-9035-1; WAKEFORD R, 1993, BRIT MED J, V307, P542, DOI 10.1136/bmj.307.6903.542-a; Wakeford R, BMC MED ED UNPUB; Wakeford R, 2012, EDUC PRIM CARE, V23, P148, DOI 10.1080/14739879.2012.11494097; Wembridge HA, 1923, J AM STAT ASSOC, V18, P600, DOI 10.2307/2277500; Williams David Innes, 1986, REP WORK PART PLAB T; Woolf K, BR J ED PSY IN PRESS; Woolf K, 2012, MED TEACH, V34, P577, DOI 10.3109/0142159X.2012.669082; Woolf K, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d901	42	40	40	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2014	348								g2621	10.1136/bmj.g2621	http://dx.doi.org/10.1136/bmj.g2621			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AF5HJ	24742473	Green Published, hybrid			2022-12-28	WOS:000334744300001
J	Scully, T				Scully, Tony			SOCIETY AT LARGE	NATURE			English	Editorial Material																			0	34	34	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					S50	S51		10.1038/508S50a	http://dx.doi.org/10.1038/508S50a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF0KP	24740125	Bronze			2022-12-28	WOS:000334403000002
J	Bannuru, RR; Flavin, NE; Vaysbrot, E; Harvey, W; McAlindon, T				Bannuru, Raveendhara R.; Flavin, Nina E.; Vaysbrot, Elizaveta; Harvey, William; McAlindon, Timothy			High-Energy Extracorporeal Shock-Wave Therapy for Treating Chronic Calcific Tendinitis of the Shoulder	ANNALS OF INTERNAL MEDICINE			English	Review							ROTATOR-CUFF; SINGLE-BLIND; SUPRASPINATUS TENDINITIS; CLINICAL-TRIAL; ESWT; RADIOTHERAPY; MANAGEMENT	Background: Calcific and noncalcific tendinitis of the shoulder can be unresponsive to conventional therapies. Extracorporeal shock-wave therapy (ESWT) has been suggested as an alternative treatment. Purpose: To assess the efficacy of ESWT in patients with calcific and noncalcific tendinitis. Data Sources: MEDLINE, Cochrane Central Register of Controlled Trials, EMBASE, Web of Science, and Google Scholar were searched up to 1 November 2013. Study Selection: Randomized, controlled trials (RCTs) comparing high-energy versus low-energy ESWT or placebo for treatment of calcific or noncalcific tendinitis of the shoulder. Outcome measures included pain (visual analogue scale score), functional assessment (Constant-Murley score), and resolution of calcifications. Data Extraction: Three independent reviewers abstracted data and determined eligibility and quality by consensus. Data Synthesis: Twenty-eight RCTs met the inclusion criteria. Studies were heterogeneous. Twenty RCTs compared ESWT energy levels and placebo and consistently showed that high-energy ESWT was significantly better than placebo in decreasing pain and improving function and resorption of calcifications in calcific tendinitis. No significant difference was found between ESWT and placebo in treatment of noncalcific tendinitis. Limitation: The number of RCTs was small, and the studies were heterogeneous. Conclusion: High-energy ESWT is effective for improving pain and shoulder function in chronic calcific shoulder tendinitis and can result in complete resolution of calcifications. This therapy may be underutilized for a condition that can be difficult to manage.	Tufts Med Ctr, Ctr Treatment Comparison & Integrat Anal, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Tufts Univ, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA; Tufts Univ, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts University; Tufts University	Bannuru, RR (corresponding author), Tufts Med Ctr, Div Rheumatol, Ctr Treatment Comparison & Integrat Anal, 800 Washington St,Box 406, Boston, MA 02111 USA.	rbannuru@tuftsmedicalcenter.org	Bannuru, Raveendhara/G-2601-2011	Bannuru, Raveendhara/0000-0002-8069-5783	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS021396] Funding Source: NIH RePORTER; AHRQ HHS [F32 HS021396] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Albert JD, 2007, J BONE JOINT SURG BR, V89B, P335, DOI 10.1302/0301-620X.89B3.18249; [Anonymous], 2002, P010039 SIEM SONOCUR; [Anonymous], 2005, P040026 ORTH EXTR SH; Avancini-Dobrovic V, 2011, COLLEGIUM ANTROPOL, V35, P221; Bosworth BM, 1941, J AMER MED ASSOC, V116, P2477, DOI 10.1001/jama.1941.02820220019004; Cacchio A, 2006, PHYS THER, V86, P672, DOI 10.1093/ptj/86.5.672; Chang KV, 2012, ARCH PHYS MED REHAB, V93, P1259, DOI 10.1016/j.apmr.2012.02.023; Chaudhury S, 2010, NAT REV RHEUMATOL, V6, P217, DOI 10.1038/nrrheum.2010.25; CONSTANT CR, 1987, CLIN ORTHOP RELAT R, P160; Cosentino R, 2003, ANN RHEUM DIS, V62, P248, DOI 10.1136/ard.62.3.248; Cosentino R, 2004, CLIN RHEUMATOL, V23, P475, DOI 10.1007/s10067-004-0883-x; Daecke W, 2002, J SHOULDER ELB SURG, V11, P476, DOI 10.1067/mse.2002.126614; Daecke W, 2002, ORTHOPADE, V31, P645, DOI 10.1007/s00132-002-0324-y; Engebretsen K, 2011, PHYS THER, V91, P37, DOI 10.2522/ptj.20090338; Engebretsen K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3360; Farin PU, 1996, INVEST RADIOL, V31, P300, DOI 10.1097/00004424-199605000-00010; Farr S, 2011, KNEE SURG SPORT TR A, V19, P2085, DOI 10.1007/s00167-011-1479-z; Galasso O, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-86; GARTNER J, 1993, Z ORTHOP GRENZGEB, V131, P461, DOI 10.1055/s-2008-1040055; Gerdesmeyer L, 2003, JAMA-J AM MED ASSOC, V290, P2573, DOI 10.1001/jama.290.19.2573; Green S, 1998, BRIT MED J, V316, P354, DOI 10.1136/bmj.316.7128.354; Gross M. W., 2001, International Journal of Radiation Oncology Biology Physics, V51, P364, DOI 10.1016/S0360-3016(01)02497-X; Gross MW, 2002, STRAHLENTHER ONKOL, V178, P314, DOI 10.1007/s00066-002-0905-z; Haake M, 2002, CLIN ORTHOP RELAT R, P323; Haake M, 2001, BIOMED TECH, V46, P69, DOI 10.1515/bmte.2001.46.3.69; Haake M, 2001, Z ORTHOP GRENZGEB, V139, P397, DOI 10.1055/s-2001-17981; Harniman Elaine, 2004, J Hand Ther, V17, P132, DOI 10.1197/j.jht.2004.02.003; Hearnden A, 2009, ACTA ORTHOP BELG, V75, P25; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hsu CJ, 2008, J SHOULDER ELB SURG, V17, P55, DOI 10.1016/j.jse.2007.03.023; Huisstede BMA, 2011, MANUAL THER, V16, P419, DOI 10.1016/j.math.2011.02.005; Ioppolo F, 2013, ARCH PHYS MED REHAB, V94, P1699, DOI 10.1016/j.apmr.2013.01.030; Ioppolo F, 2012, PHYS THER, V92, P1376, DOI 10.2522/ptj.20110252; Krasny C, 2005, J BONE JOINT SURG BR, V87B, P501, DOI 10.1302/0301-620X.87B4; Lee SY, 2011, J SHOULDER ELB SURG, V20, P845, DOI 10.1016/j.jse.2010.10.024; Loew M, 1999, J BONE JOINT SURG BR, V81B, P863, DOI 10.1302/0301-620X.81B5.9374; Loew M, 1995, J Shoulder Elbow Surg, V4, P101, DOI 10.1016/S1058-2746(05)80062-X; Mouzopoulos G, 2007, SKELETAL RADIOL, V36, P803, DOI 10.1007/s00256-007-0297-3; Ogden JA, 2001, CLIN ORTHOP RELAT R, P22; Pan PJ, 2003, ARCH PHYS MED REHAB, V84, P988, DOI 10.1016/S0003-9993(03)00010-8; Papatheodorou A, 2006, RADIOGRAPHICS, V26, DOI 10.1148/rg.e23; Perlick Lars, 2003, J Orthop Sci, V8, P777, DOI 10.1007/s00776-003-0720-0; Peters J, 2004, SKELETAL RADIOL, V33, P712, DOI 10.1007/s00256-004-0849-8; Pleiner J, 2004, WIEN KLIN WOCHENSCHR, V116, P536, DOI 10.1007/BF03217707; Rompe JD, 1998, J BONE JOINT SURG BR, V80B, P546, DOI 10.1302/0301-620X.80B3.8434; Rompe JD, 1997, ORTHOPADE, V26, P215; Rompe JD, 1998, J SHOULDER ELB SURG, V7, P505, DOI 10.1016/S1058-2746(98)90203-8; Rompe JD, 2001, CLIN ORTHOP RELAT R, P72; Sabeti M, 2007, WIEN KLIN WOCHENSCHR, V119, P124, DOI 10.1007/s00508-006-0723-x; Sabeti-Aschraf M, 2005, AM J SPORT MED, V33, P1365, DOI 10.1177/0363546504273052; Schmitt J, 2002, ORTHOPADE, V31, P652, DOI 10.1007/s00132-002-0325-x; Schmitt J, 2001, J BONE JOINT SURG BR, V83B, P873, DOI 10.1302/0301-620X.83B6.11591; Schofer MD, 2009, ACTA ORTHOP BELG, V75, P452; Seil R, 1999, Z ORTHOP GRENZGEB, V137, P310, DOI 10.1055/s-2008-1039717; Speed CA, 2004, J BONE JOINT SURG BR, V86B, P165, DOI 10.1302/0301-620X.86B2.14253; Speed CA, 2002, J BONE JOINT SURG BR, V84B, P509, DOI 10.1302/0301-620X.84B4.12318; Speed CA, 1999, NEW ENGL J MED, V340, P1582, DOI 10.1056/NEJM199905203402011; Tornese D, 2011, CLIN REHABIL, V25, P731, DOI 10.1177/0269215510396740; Vavken P, 2009, SPORTS HEALTH, V1, P137, DOI 10.1177/1941738108331197; Wang CJ, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-11; Wang CJ, 2001, CLIN ORTHOP RELAT R, P83	61	58	67	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 15	2014	160	8					542	+		10.7326/M13-1982	http://dx.doi.org/10.7326/M13-1982			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG0ZE	24733195				2022-12-28	WOS:000335143700004
J	O'Dowd, A				O'Dowd, Adrian			BMJ AWARDS 2014 Diabetes Team of the Year: adaptable and supportive	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												adrianodowd@hotmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2014	348								g2708	10.1136/bmj.g2708	http://dx.doi.org/10.1136/bmj.g2708			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF5GN	24736317				2022-12-28	WOS:000334742100025
J	Maconochie, IK; Bingham, R				Maconochie, Ian K.; Bingham, Robert			ABC of Resuscitation, 6th Edition Paediatric Resuscitation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LIFE-SUPPORT		[Maconochie, Ian K.] St Marys Hosp London, London, England; Great Ormond St Childrens Hosp London, London, England	Imperial College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Maconochie, IK (corresponding author), St Marys Hosp London, London, England.			Maconochie, Ian/0000-0001-6319-8550				Biarent D, 2010, RESUSCITATION, V81, P1364, DOI 10.1016/j.resuscitation.2010.08.012; de Caen AR, 2010, RESUSCITATION, V81, pE213, DOI 10.1016/j.resuscitation.2010.08.028	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2014	348								g1732					12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SD	24714205				2022-12-28	WOS:000334348500011
J	Pringsheim, T; Becker, WJ				Pringsheim, Tamara; Becker, Werner J.			Triptans for symptomatic treatment of migraine headache	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EFFICACY; SAFETY		[Pringsheim, Tamara] Univ Calgary, Dept Clin Neurosci Psychiat Pediat & Community Hl, Alberta Childrens Hosp, Calgary, AB T3B 6A8, Canada; [Becker, Werner J.] Univ Calgary, Dept Clin Neurosci, Foothills Med Ctr, Calgary, AB T3B 6A8, Canada	Alberta Childrens Hospital; University of Calgary; University of Calgary	Pringsheim, T (corresponding author), Univ Calgary, Dept Clin Neurosci Psychiat Pediat & Community Hl, Alberta Childrens Hosp, Calgary, AB T3B 6A8, Canada.	tmprings@ucalgary.ca	Pringsheim, Tamara/L-5955-2019	Pringsheim, Tamara/0000-0002-8229-8431				[Anonymous], 2013, MICR; BATES D, 1994, NEUROLOGY, V44, P1587, DOI 10.1212/WNL.44.9.1587; Chen LC, 2007, HEADACHE, V47, P1169, DOI 10.1111/j.1526-4610.2007.00884.x; Derry CJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009665; Derry CJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008615.pub2; DERRY CJ, 2012, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD009663; Dodick D, 2004, HEADACHE, V44, P414, DOI 10.1111/j.1526-4610.2004.04078.x; Dowson A, 1996, EUR NEUROL, V36, P28, DOI 10.1159/000119101; Evans RW, 2010, HEADACHE, V50, P1089, DOI 10.1111/j.1526-4610.2010.01691.x; Hutchinson S, 2013, HEADACHE, V53, P614, DOI 10.1111/head.12064; Law S, 2013, COCHRANE DB SYST REV, V10; Law S, 2013, COCHRANE DB SYST REV, V10; National Institute for Health and Care Excellence, 2012, 120 CG NAT I HLTH CA; Oldman AD, 2002, PAIN, V97, P247, DOI 10.1016/S0304-3959(02)00024-6; Olesen J, 2004, EUR J NEUROL, V11, P671, DOI 10.1111/j.1468-1331.2004.00914.x; Poolsup N, 2005, J CLIN PHARM THER, V30, P521, DOI 10.1111/j.1365-2710.2005.00677.x; Tepper SJ, 2002, ARCH NEUROL-CHICAGO, V59, P1084, DOI 10.1001/archneur.59.7.1084; Thorlund K, 2014, CEPHALALGIA, V34, P258, DOI 10.1177/0333102413508661; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Worthington I, 2013, CAN J NEUROL SCI, V40, pS10; Worthington I, 2013, CAN J NEUROL SCI, V40, pS33	21	10	11	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2014	348								g2285	10.1136/bmj.g2285	http://dx.doi.org/10.1136/bmj.g2285			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SB	24711666				2022-12-28	WOS:000334348300010
J	Hsu, A; Malik, O; Johnson, L; Esty, DC				Hsu, Angel; Malik, Omar; Johnson, Laura; Esty, Daniel C.			Mobilize citizens to track sustainability	NATURE			English	Editorial Material							FISHERIES; US		[Hsu, Angel] Yale Univ, Yale Ctr Environm Law & Policy, Environm Performance Measurement Program, New Haven, CT 06520 USA; [Malik, Omar; Johnson, Laura] Yale Univ, Yale Ctr Environm Law & Policy, New Haven, CT USA; [Esty, Daniel C.] Yale Univ, New Haven, CT USA	Yale University; Yale University; Yale University	Hsu, A (corresponding author), Yale Univ, Yale Ctr Environm Law & Policy, Environm Performance Measurement Program, New Haven, CT 06520 USA.	angel.hsu@yale.edu		, Omar/0000-0002-9446-0002				Friess DA, 2011, ENVIRON CONSERV, V38, P1, DOI 10.1017/S0376892911000026; Froese R, 2012, MAR BIOL, V159, P1283, DOI 10.1007/s00227-012-1909-6; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; KPMG, 2013, KPMG SURV CORP SUST; Pauly D, 2012, MAR POLICY, V36, P746, DOI 10.1016/j.marpol.2011.10.021; Rodell M, 2002, J HYDROL, V263, P245, DOI 10.1016/S0022-1694(02)00060-4	6	16	16	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					33	35		10.1038/508033a	http://dx.doi.org/10.1038/508033a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD9UL	24707525	Bronze			2022-12-28	WOS:000333609900027
J	Jayson, GC; Kohn, EC; Kitchener, HC; Ledermann, JA				Jayson, Gordon C.; Kohn, Elise C.; Kitchener, Henry C.; Ledermann, Jonathan A.			Ovarian cancer	LANCET			English	Article							PHASE-III TRIAL; RECURRENT EPITHELIAL OVARIAN; PEGYLATED LIPOSOMAL DOXORUBICIN; PLACEBO-CONTROLLED TRIAL; GRADE SEROUS CARCINOMA; BRCA2 MUTATIONS; PRIMARY PERITONEAL; INTERGROUP TRIAL; DOUBLE-BLIND; OPEN-LABEL	Epithelial ovarian cancer is the commonest cause of gynaecological cancer-associated death. The disease typically presents in postmenopausal women, with a few months of abdominal pain and distension. Most women have advanced disease (International Federation of Gynecology and Obstetrics [FIGO] stage III), for which the standard of care remains surgery and platinum-based cytotoxic chemotherapy. Although this treatment can be curative for most patients with early stage disease, most women with advanced disease will develop many episodes of recurrent disease with progressively shorter disease-free intervals. These episodes culminate in chemoresistance and ultimately bowel obstruction, the most frequent cause of death. For women whose disease continues to respond to platinum-based drugs, the disease can often be controlled for 5 years or more. Targeted treatments such as antiangiogenic drugs or poly (ADP-ribose) polymerase inhibitors off er potential for improved survival. The efficacy of screening, designed to detect the disease at an earlier and curable stage remains unproven, with key results expected in 2015.	[Jayson, Gordon C.] Christie Hosp, Inst Canc Studies, Manchester M20 4BX, Lancs, England; [Jayson, Gordon C.; Kitchener, Henry C.] Univ Manchester, Manchester, Lancs, England; [Kohn, Elise C.] NCI, Ctr Canc Res, Bethesda, MD 20892 USA; [Kitchener, Henry C.] St Marys Hosp, Inst Canc Studies, Manchester M13 0JH, Lancs, England; [Ledermann, Jonathan A.] UCL, Inst Canc, London, England	Christie NHS Foundation Trust; Christie Hospital; University of Manchester; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Manchester; University of London; University College London	Jayson, GC (corresponding author), Christie Hosp, Manchester M20 4BX, Lancs, England.	Gordon.Jayson@Manchester.ac.uk	Jayson, Gordon C/O-8224-2015	Jayson, Gordon C/0000-0002-8515-8944	Intramural Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA	Intramural Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA	The authors would like to thank Andrew Clamp for his review and comments on the manuscript. ECK was supported by the Intramural Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA. We also thank Richard Fitzmaurice for the photographs in figure 1, and James O'Connor for the images in figure 4.	Aghajanian C, 2012, J CLIN ONCOL, V30, P2039, DOI 10.1200/JCO.2012.42.0505; AHLGREN JD, 1993, J CLIN ONCOL, V11, P1957, DOI 10.1200/JCO.1993.11.10.1957; Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Aletti GD, 2006, GYNECOL ONCOL, V100, P33, DOI 10.1016/j.ygyno.2005.07.123; Alsop K, 2012, J CLIN ONCOL, V30, P2654, DOI 10.1200/JCO.2011.39.8545; Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Anglesio MS, 2011, CLIN CANCER RES, V17, P2538, DOI 10.1158/1078-0432.CCR-10-3314; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Anttila M, 1999, GYNECOL ONCOL, V72, P337, DOI 10.1006/gyno.1998.5264; Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Ayhan A, 2009, AM J SURG PATHOL, V33, P1220, DOI 10.1097/PAS.0b013e3181a24354; Banerjee S, 2013, CLIN CANCER RES, V19, P961, DOI 10.1158/1078-0432.CCR-12-2243; Bankhead CR, 2008, BJOG-INT J OBSTET GY, V115, P1008, DOI 10.1111/j.1471-0528.2008.01772.x; Behbakht K, 2011, GYNECOL ONCOL, V123, P19, DOI 10.1016/j.ygyno.2011.06.022; Beral V, 2012, LANCET ONCOL, V13, P946, DOI [10.1016/S1470-2045(12)70322-4, 10.1016/S1470-2045(12)70365-0]; Berek J, 2009, J CLIN ONCOL, V27, P418, DOI 10.1200/JCO.2008.17.8400; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Bolis G, 1996, CANCER, V77, P128, DOI 10.1002/(SICI)1097-0142(19960101)77:1<128::AID-CNCR21>3.0.CO;2-6; Bolton KL, 2012, JAMA-J AM MED ASSOC, V307, P382, DOI 10.1001/jama.2012.20; Bookman MA, 2009, J CLIN ONCOL, V27, P1419, DOI 10.1200/JCO.2008.19.1684; Bowman A, 2002, CLIN CANCER RES, V8, P2233; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Burstein HJ, 2011, J CLIN ONCOL, V29, P3328, DOI 10.1200/JCO.2011.36.0354; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cannistra SA, 2007, J CLIN ONCOL, V25, P5180, DOI 10.1200/JCO.2007.12.0782; Chittenden BG, 2009, REPROD BIOMED ONLINE, V19, P398, DOI 10.1016/S1472-6483(10)60175-7; Couch FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003212; Cree IA, 2007, ANTI-CANCER DRUG, V18, P1093, DOI 10.1097/CAD.0b013e3281de727e; De Placido S, 2004, J CLIN ONCOL, V22, P2635, DOI 10.1200/JCO.2004.09.088; Du Bois A, 2013, J CLIN ONCOL, V31, DOI 10.1200/jco.2013.31.18_suppl.lba5503; DUBOIS A, 2009, CANCER, V115, P1234, DOI DOI 10.1002/CNCR.24149; EELES RA, 1991, BRIT MED J, V302, P259, DOI 10.1136/bmj.302.6771.259; Eisenhauer EA, 1997, ANN ONCOL, V8, P963, DOI 10.1023/A:1008240421028; Farley J, 2013, LANCET ONCOL, V14, P134, DOI 10.1016/S1470-2045(12)70572-7; Folkins AK, 2013, HISTOPATHOLOGY, V62, P2, DOI 10.1111/his.12028; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; GCIG, GCIG CRIT CA125 OV C; Gershenson DM, 2009, GYNECOL ONCOL, V114, P48, DOI 10.1016/j.ygyno.2009.03.001; Gertig DM, 2000, J NATL CANCER I, V92, P249, DOI 10.1093/jnci/92.3.249; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Goff BA, 2004, JAMA-J AM MED ASSOC, V291, P2705, DOI 10.1001/jama.291.22.2705; Gonzalez-Martin AJ, 2005, ANN ONCOL, V16, P749, DOI 10.1093/annonc/mdi147; Gordon AN, 2001, J CLIN ONCOL, V19, P3312, DOI 10.1200/JCO.2001.19.14.3312; Gotlieb WH, 2012, LANCET ONCOL, V13, P154, DOI 10.1016/S1470-2045(11)70338-2; Gourley C, 2010, J CLIN ONCOL, V28, P2505, DOI 10.1200/JCO.2009.25.1082; Griffiths RW, 2011, INT J GYNECOL CANCER, V21, P58, DOI 10.1097/IGC.0b013e3182049273; Guidozzi F, 1999, CANCER-AM CANCER SOC, V86, P1013, DOI 10.1002/(SICI)1097-0142(19990915)86:6<1013::AID-CNCR17>3.0.CO;2-1; Hannibal CG, 2012, GYNECOL ONCOL, V125, P655, DOI 10.1016/j.ygyno.2012.02.028; Harter P, 2011, INT J GYNECOL CANCER, V21, P289, DOI 10.1097/IGC.0b013e31820aaafd; Herzog TJ, 2011, GYNECOL ONCOL, V122, P350, DOI 10.1016/j.ygyno.2011.04.005; Hong DS, 2012, CLIN CANCER RES, V18, P4173, DOI 10.1158/1078-0432.CCR-12-0714; International Agency for Research on Cancer, 2008, GLOB CANC STAT; JACOBS I, 1990, BRIT J OBSTET GYNAEC, V97, P922, DOI 10.1111/j.1471-0528.1990.tb02448.x; Jacobs IJ, 1999, LANCET, V353, P1207, DOI 10.1016/S0140-6736(98)10261-1; Jelovac D, 2011, CA-CANCER J CLIN, V61, P183, DOI 10.3322/caac.20113; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Junor EJ, 1999, BRIT J OBSTET GYNAEC, V106, P1130, DOI 10.1111/j.1471-0528.1999.tb08137.x; Karlan BY, 2012, J CLIN ONCOL, V30, P362, DOI 10.1200/JCO.2010.34.3178; Katsumata N, 2013, LANCET ONCOL, V14, P1020, DOI 10.1016/S1470-2045(13)70363-2; Katsumata N, 2009, LANCET, V374, P1331, DOI 10.1016/S0140-6736(09)61157-0; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; Kaye SB, 2012, J CLIN ONCOL, V30, P372, DOI 10.1200/JCO.2011.36.9215; KEHOE S, 1994, J SURG ONCOL, V57, P205, DOI 10.1002/jso.2930570314; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Kobel M, 2010, J PATHOL, V222, P191, DOI 10.1002/path.2744; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Konner JA, 2010, CLIN CANCER RES, V16, P5288, DOI 10.1158/1078-0432.CCR-10-0700; Ledermann J., 2013, P ASCO ANN M, V31, P5505; Ledermann JA, 2013, EUR CANC C 2012 AMST; Ledermann J, 2012, NEW ENGL J MED, V366, P1382, DOI 10.1056/NEJMoa1105535; Ledermann JA, 2011, J CLIN ONCOL, V29, P3798, DOI 10.1200/JCO.2010.33.5208; LoRusso PM, 2012, J CLIN ONCOL, V30, P4011, DOI 10.1200/JCO.2011.41.4946; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Markman B, 2012, ANN ONCOL, V23, P2399, DOI 10.1093/annonc/mds011; MARKMAN M, 1991, J CLIN ONCOL, V9, P389, DOI 10.1200/JCO.1991.9.3.389; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Medeiros F, 2006, AM J SURG PATHOL, V30, P230, DOI 10.1097/01.pas.0000180854.28831.77; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Meyer T, 2001, ANN ONCOL, V12, P1705, DOI 10.1023/A:1013558501425; Mobus V, 2007, J CLIN ONCOL, V25, P4187, DOI 10.1200/JCO.2006.09.7527; Monk BJ, 2013, GYNECOL ONCOL, V128, P573, DOI 10.1016/j.ygyno.2012.11.038; Munksgaard PS, 2012, GYNECOL ONCOL, V124, P164, DOI 10.1016/j.ygyno.2011.10.001; National Institute for Health and Care Excellence (NICE), 2011, OV CANC REC IN MAN O; Naumann R, 2011, J CLIN ONCOL S15, V29, P5045; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Pal T, 2012, BRIT J CANCER, V107, P1783, DOI 10.1038/bjc.2012.452; Panici PB, 2005, JNCI-J NATL CANCER I, V97, P560, DOI 10.1093/jnci/dji102; Parmar MKB, 2003, LANCET, V361, P2099; Pearce CL, 2012, LANCET ONCOL, V13, P385, DOI 10.1016/S1470-2045(11)70404-1; Pecorelli S, 2009, J CLIN ONCOL, V27, P4642, DOI 10.1200/JCO.2009.21.9691; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Pfisterer J, 2006, J CLIN ONCOL, V24, P4699, DOI 10.1200/JCO.2006.06.0913; Pharoah PDP, 2013, NAT GENET, V45, P362, DOI 10.1038/ng.2564; Powless CA, 2011, GYNECOL ONCOL, V122, P536, DOI 10.1016/j.ygyno.2011.05.001; Prat J, 2014, INT J GYNECOL OBSTET, V124, P1, DOI 10.1016/j.ijgo.2013.10.001; Press JZ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-17; Pujade-Lauraine E, 2012, 2012 ANN M AM SOC CL; Pujade-Lauraine E, 2010, J CLIN ONCOL, V28, P3323, DOI 10.1200/JCO.2009.25.7519; Rose PG, 2004, NEW ENGL J MED, V351, P2489, DOI 10.1056/NEJMoa041125; Rosenthal AN, 2013, J CLIN ONCOL, V31, P49, DOI 10.1200/JCO.2011.39.7638; Rustin GJS, 2006, J CLIN ONCOL, V24, P45, DOI 10.1200/JCO.2005.01.2757; Rustin GJS, 1996, J CLIN ONCOL, V14, P1545, DOI 10.1200/JCO.1996.14.5.1545; Rustin GJS, 2010, LANCET, V376, P1155, DOI 10.1016/S0140-6736(10)61268-8; Sharma R, 2009, BRIT J CANCER, V100, P707, DOI 10.1038/sj.bjc.6604914; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Sieh W, 2013, INT J EPIDEMIOL, V42, P579, DOI 10.1093/ije/dyt042; Simchoni S, 2006, P NATL ACAD SCI USA, V103, P3770, DOI 10.1073/pnas.0511301103; Smyth JF, 2007, CLIN CANCER RES, V13, P3617, DOI 10.1158/1078-0432.CCR-06-2878; Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; Stark D, 2013, LANCET ONCOL, V14, P236, DOI 10.1016/S1470-2045(12)70567-3; Stewart LM, 2013, GYNECOL ONCOL, V129, P372, DOI 10.1016/j.ygyno.2013.01.027; Stone RL, 2012, NEW ENGL J MED, V366, P610, DOI 10.1056/NEJMoa1110352; Swart AC, AM SOC CLIN ONC ASCO, P5509; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Trimbos B, 2010, J NATL CANCER I, V102, P982, DOI 10.1093/jnci/djq149; Trimbos JB, 2003, JNCI-J NATL CANCER I, V95, P105; Trimbos JB, 2003, JNCI-J NATL CANCER I, V95, P113, DOI 10.1093/jnci/95.2.113; Tsilidis KK, 2011, BRIT J CANCER, V105, P1436, DOI 10.1038/bjc.2011.371; UK Cancer Research, 2013, OV CANC SURV STAT; UK Cancer Research, 2013, OV CANC INC STAT; UK Cancer Research, 2013, CANC SURV RAT TRENDS; van der Burg MEL, 2002, BRIT J CANCER, V86, P19, DOI 10.1038/sj/bjc/6600002; VANDERBURG MEL, 1995, NEW ENGL J MED, V332, P629, DOI 10.1056/NEJM199503093321002; Vasey PA, 2004, JNCI-J NATL CANCER I, V96, P1682, DOI 10.1093/jnci/djh323; Whitworth MK, 2004, J CLIN ONCOL, V22, P199, DOI 10.1200/JCO.2004.02.056; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Yee KWL, 2006, CLIN CANCER RES, V12, P5165, DOI 10.1158/1078-0432.CCR-06-0764	130	1214	1265	12	60	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2014	384	9951					1376	1388		10.1016/S0140-6736(13)62146-7	http://dx.doi.org/10.1016/S0140-6736(13)62146-7			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NH	24767708				2022-12-28	WOS:000343004000028
J	Birchall, MA; Seifalian, AM				Birchall, Martin A.; Seifalian, Alexander M.			Tissue engineering's green shoots of disruptive innovation	LANCET			English	Editorial Material									[Birchall, Martin A.] Royal Natl Throat Nose & Ear Hosp, UCL Ear Inst, London WC1X 8DA, England; [Seifalian, Alexander M.] Royal Free London NHS Fdn Trust Hosp, Univ Coll London, Div Surg & Intervent Sci, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust	Birchall, MA (corresponding author), Royal Natl Throat Nose & Ear Hosp, UCL Ear Inst, Grays Inn Rd, London WC1X 8DA, England.	m.birchall@ucl.ac.uk		seifalian, Alexander/0000-0002-8334-9376	MRC [MR/K026453/1, G1001539] Funding Source: UKRI; Medical Research Council [G1001539, MR/K026453/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743; Bhargava S, 2008, EUR UROL, V53, P1263, DOI 10.1016/j.eururo.2008.01.061; Centanni JM, 2011, ANN SURG, V253, P672, DOI 10.1097/SLA.0b013e318210f3bd; Christensen Clayton, 2003, INNOVATORS SOLUTION; Christensen CM, 2000, HARVARD BUS REV, V78, P102; de Mel A, 2012, MACROMOL BIOSCI, V12, P1010, DOI 10.1002/mabi.201200039; Delaere PR, 2009, LANCET, V373, P717, DOI 10.1016/S0140-6736(09)60429-3; Fulco I, 2014, LANCET; Jabir S, 2014, BURNS, V40, P1059, DOI 10.1016/j.burns.2014.01.008; Olausson M, 2012, LANCET, V380, P230, DOI 10.1016/S0140-6736(12)60633-3; Raya-Rivera A. M., 2014, LANCET	12	9	9	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2014	384	9940					288	290		10.1016/S0140-6736(14)60533-x	http://dx.doi.org/10.1016/S0140-6736(14)60533-x			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM3AE	24726476				2022-12-28	WOS:000339722400007
J	Butkus, R; Doherty, R; Daniel, H				Butkus, Renee; Doherty, Robert; Daniel, Hilary		Amer Coll Phys	Reducing Firearm-Related Injuries and Deaths in the United States: Executive Summary of a Policy Position Paper From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							STORAGE PRACTICES; GUN VIOLENCE; ADOLESCENT SUICIDE; MENTAL-ILLNESS; RISK; HOMICIDE; OWNERSHIP; PREVENTION; RATES; CARE		[Butkus, Renee; Doherty, Robert; Daniel, Hilary; Amer Coll Phys] Amer Coll Physicians, Washington, DC 20001 USA	American College of Physicians	Butkus, R (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.	rbutkus@acponline.org			ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	*AGCY HEAT RES, 2010, MENTAL DISORDERS SUB; Albright TL, 2003, J AM BOARD FAM PRACT, V16, P40, DOI 10.3122/jabfm.16.1.40; ALPERS P, 2014, GUNS US TOTAL NUMBER; *AM BAR ASS, 2011, REGULATION FIREARMS; *AM PSY ASS, 2013, FIREARM ACCESS ACTS; Anglemyer A, 2014, ANN INTERN MED, V160, P101, DOI 10.7326/M13-1301; [Anonymous], 2013, NONF INJ REP 2001 20; [Anonymous], 2014, INJ PREV CONTR DAT S; Bangalore S, 2013, AM J MED, V126, P873, DOI 10.1016/j.amjmed.2013.04.012; Barber C, 2011, ACCIDENT ANAL PREV, V43, P724, DOI 10.1016/j.aap.2010.10.018; BERGER SE, 2009, TARASOFF DUTY WARN C; Beronio K, 2013, ASPE ISSUE BRIEF AFF; *BRADY HENDGUN, 1993, BRADY HANDGUN VIOLEN; BRENT DA, 1988, ARCH GEN PSYCHIAT, V45, P581, DOI 10.1001/archpsyc.1988.01800300079011; BRENT DA, 1991, JAMA-J AM MED ASSOC, V266, P2989, DOI 10.1001/jama.266.21.2989; BRENT DA, 1993, AM J DIS CHILD, V147, P1066, DOI 10.1001/archpedi.1993.02160340052013; Butkus R, 2014, ANN INTERN MED, V160, P821, DOI 10.7326/M13-1960; Carbone PS, 2005, ARCH PEDIAT ADOL MED, V159, P1049, DOI 10.1001/archpedi.159.11.1049; *CDCP, 2013, FASTSTATS SUICIDE SE; *CDCP, 2013, NONFATAL INJURY REPO; Centers for Disease Control and Prevention, 2013, FASTSTATS SUIC SELF; *CNN, 2011, POLL AM OVERWHELMING; Cook P.J., 1997, GUNS AM NATL SURVEY; COOK PJ, 2013, REDUCING GUN VIOLENC, V22, P31; COOPER A, 2011, HOMICIDE TRENDS US; Corrigan PW, 2005, PSYCHIAT RES, V136, P153, DOI 10.1016/j.psychres.2005.06.005; Cummings P, 1997, AM J PUBLIC HEALTH, V87, P974, DOI 10.2105/AJPH.87.6.974; Cummings P, 1998, JAMA-J AM MED ASSOC, V280, P471, DOI 10.1001/jama.280.5.471; DANIELS A, 2014, SMART PHONES SMART T; DuRant RH, 2007, PEDIATRICS, V119, pE1271, DOI 10.1542/peds.2006-1485; DUTTON S, 2013, BACKGROUND CHECK SUP; Fazel S, 2010, ARCH GEN PSYCHIAT, V67, P931, DOI 10.1001/archgenpsychiatry.2010.97; *FED BUR INVES, 2010, NATL INSTANT CRIMINA; *FIR INJ CTR, 2014, FIREARM INJURY US PH; Fisher CE, 2013, ANN INTERN MED, V159, P423, DOI 10.7326/0003-4819-159-5-201309030-00679; Frattaroli S, 2013, ANN INTERN MED, V158, P697, DOI 10.7326/0003-4819-158-9-201305070-00597; Friedman RA, 2006, NEW ENGL J MED, V355, P2064, DOI 10.1056/NEJMp068229; Gardner HG, 2012, PEDIATRICS, V130, pE1416, DOI 10.1542/peds.2012-2481; Gardner W, 2010, PEDIATRICS, V125, P945, DOI 10.1542/peds.2009-1964; GREENBERG A, 2013, LIBERATOR TEST FIRIN; Grossman DC, 2005, JAMA-J AM MED ASSOC, V293, P707, DOI 10.1001/jama.293.6.707; Hepburn L, 2004, J TRAUMA, V56, P676, DOI 10.1097/01.TA.0000068996.01096.39; Herbert PB, 2002, J AM ACAD PSYCHIATRY, V30, P275; Hoyert DL, 2012, NATL VITAL STAT REPO, V61, P40; HOYERT DL, 2012, REPORT, V2, P1; Institute of Medicine and National Research Council, 2013, PRIORITIES RES REDUC; *INTELLIGUN, 2014, KODIAK INDUSTRIES WE; Johnson RM, 2006, ARCH PEDIAT ADOL MED, V160, P788, DOI 10.1001/archpedi.160.8.788; KAISER HJ FAM FDN, 2014, NUMBER DEATHS DUE IN; Kapp MB, 2013, ANN INTERN MED, V159, P421, DOI 10.7326/0003-4819-159-5-201309030-00682; Karp A, 2007, SMALL ARMS SURVEY 20; KEATING D, 2013, GUN DEATHS SHAPED RA; KELLERMANN AL, 1992, NEW ENGL J MED, V327, P467, DOI 10.1056/NEJM199208133270705; Kellermann AL, 1998, J TRAUMA, V45, P263, DOI 10.1097/00005373-199808000-00010; KELLERMANN AL, 1986, NEW ENGL J MED, V314, P1557, DOI 10.1056/NEJM198606123142406; KELLERMANN AL, 1992, J TRAUMA, V33, P1, DOI 10.1097/00005373-199207000-00001; KELLERMANN AL, 1993, NEW ENGL J MED, V329, P1084, DOI 10.1056/NEJM199310073291506; Kleck G, 1998, JAMA-J AM MED ASSOC, V280, P473, DOI 10.1001/jama.280.5.473; Koper CS, 2004, UPDATED ASSESSMENT F; Koper CS, 2007, CRIME GUN RISK FACTO; KOPER CS, 2013, REDUCING GUN VIOLENC, P160; KROUSE WJ, 2012, HOW MANY GUNS ARE US, V8, P9; Laine C, 2013, ANN INTERN MED, V158, P493, DOI 10.7326/0003-4819-158-6-201303190-00586; Large M, 2009, SCHIZOPHRENIA BULL, V35, P1012, DOI 10.1093/schbul/sbn040; *LAW CTR PREV GUN, 2013, CAL MODEL TWENTY YEA; *LAW CTR PREV GUN, 2013, 2013 STATE SCORECARD; LEE AD, 2013, BACKGROUND CHECKS FI; LIU EC, 2013, SUBMISSION MENTAL HE; LoConte NK, 2008, AM J ALZHEIMERS DIS, V23, P313, DOI 10.1177/1533317508317061; LUO M, 2013, NEW YORK TIMES 0928, pA1; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; *MAY AGA ILL, 2013, REPORTING LOST STOLE; *MAY AGA ILL GUN, 2011, FATAL GAPS HOW MISSI; *MAY AGAIN ILL GUN, 2013, COALITION REPORT MOV; MAY JP, 1993, J GEN INTERN MED, V8, P380, DOI 10.1007/BF02600078; MCGONIGAL MD, 1993, J TRAUMA, V35, P532, DOI 10.1097/00005373-199310000-00006; Miller M, 2006, INJURY PREV, V12, P178, DOI 10.1136/ip.2005.010850; Miller M, 2005, ACCIDENT ANAL PREV, V37, P661, DOI 10.1016/j.aap.2005.02.003; MILLER TR, 2012, CHILDRENS SAFETY NET; Mozaffarian D, 2013, JAMA-J AM MED ASSOC, V309, P551, DOI 10.1001/jama.2013.38; Mulvey EP, 2006, J CONSULT CLIN PSYCH, V74, P743, DOI 10.1037/0022-006X.74.4.743; Nance ML, 1997, J PEDIATR SURG, V32, P949, DOI 10.1016/S0022-3468(97)90375-4; Nelson DE, 1996, JAMA-J AM MED ASSOC, V275, P1744, DOI 10.1001/jama.275.22.1744; *NICS IMPR AMEN, 2007, NICS IMPROVEMENT AME; Nordstrom D L, 2001, Inj Prev, V7, P112, DOI 10.1136/ip.7.2.112; *NY STAT PSY ASS, 2013, NYSPA ISSUES PRESS R; Parker GF, 2010, PSYCHIAT SERV, V61, P478, DOI 10.1176/appi.ps.61.5.478; PEREZ E, 2013, ATF TEST SHOWS 3D GU; *PEW RES CTR PEOP, 2013, GUN CONTROL DEBATE; Phillips CD, 2013, AM J PUBLIC HEALTH, V103, P86, DOI 10.2105/AJPH.2012.300807; *POL EXECUT RES, 2010, GUNS CRIME BREAKING; Preventing firearm violence: a public health imperative, 1995, ANN INTERN MED, V122, P311; *PUB SAF SEC AMEN, 2013, HR 1565; *QUINN UN, 2013, OVERWHELMING SUPPORT; Richardson EG, 2011, J TRAUMA, V70, P238, DOI 10.1097/TA.0b013e3181dbaddf; Richmond TS, 2004, J TRAUMA, V57, P1356, DOI 10.1097/01.TA.0000141886.22472.F5; Romero M, 2003, INJURY PREV, V9, P367, DOI 10.1136/ip.9.4.367; Rosengart M, 2005, INJURY PREV, V11, P77, DOI 10.1136/ip.2004.007062; Roth J, 1997, IMPACT EVALUATION PU; Simpson JR, 2007, J AM ACAD PSYCHIATRY, V35, P330; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001; SPERRY T, 2013, US REQUIRES GRP REMO; Steadman HJ, 1998, ARCH GEN PSYCHIAT, V55, P393, DOI 10.1001/archpsyc.55.5.393; SWANSON JW, 1994, VIOLENCE MENTAL DISO; Torrey E, 2008, SHORTAGE PUBLIC HOSP; *TREAT ADV CTR, 2005, TREATMENT ADVOCACY C; Umhau JC, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-146; *UND FIR, 1988, UNDETECTABLE FIREARM; *UND FIR MOD, 2013, UNDETECTABLE FIREARM; *US BUR ALC, 2014, DONT LIE FOR OTHER G; *US BUR ALC, 2013, 3D PRINTING TECHNOL; *US BUR ALC, 2000, FOLLOWING GUN ENFORC; *US CENS BUR, 2011, US CENSUS BUR POPUL; *US DEPT JUST, 2012, FIREARMS STOLEN DURI; *US GOV ACC, 2012, GUN CONTROL SHARING; *VIOL POL CTR, 2011, GUN DEATHS OUTPACE M; *WASH POST ABC NEW, 2013, WOULD YOU SUPPORT OP; Weinberger SE, 2012, NEW ENGL J MED, V367, P1557, DOI 10.1056/NEJMsb1209858; West BA, 2013, MMWR-MORBID MORTAL W, V62, P176; Wintemute GJ, 1999, NEW ENGL J MED, V341, P1583, DOI 10.1056/NEJM199911183412106; WINTEMUTE GJ, 2013, INJURY PREV, P1; WINTEMUTE GJ, 2013, J URBAN HEALTH; WYOM DEPT HLTH, 2012, REPORT SUICIDE WYOMI	123	46	46	0	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12					858	+		10.7326/M14-0216	http://dx.doi.org/10.7326/M14-0216			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24722815				2022-12-28	WOS:000337374900021
J	Woo, SH; Ranade, S; Weyer, AD; Dubin, AE; Baba, Y; Qiu, ZZ; Petrus, M; Miyamoto, T; Reddy, K; Lumpkin, EA; Stucky, CL; Patapoutian, A				Woo, Seung-Hyun; Ranade, Sanjeev; Weyer, Andy D.; Dubin, Adrienne E.; Baba, Yoshichika; Qiu, Zhaozhu; Petrus, Matt; Miyamoto, Takashi; Reddy, Kritika; Lumpkin, Ellen A.; Stucky, Cheryl L.; Patapoutian, Ardem			Piezo2 is required for Merkel-cell mechanotransduction	NATURE			English	Article							SELECTIVE PHOTOTOXIC DESTRUCTION; HAIRY SKIN; CUTANEOUS MECHANORECEPTORS; SENSORY NEURONS; TOUCH; RESPONSES; CHANNELS; RECEPTOR; CURRENTS; TRANSMISSION	How we sense touch remains fundamentally unknown(1,2). The Merkel cell-neurite complex is a gentle touch receptor in the skin that mediates slowly adapting responses of A beta sensory fibres to encode fine details of objects(3-6). This mechanoreceptor complex was recognized to have an essential role in sensing gentle touch nearly 50 years ago(3,4). However, whether Merkel cells or afferent fibres themselves sense mechanical force is still debated, and the molecular mechanism of mechanotransduction is unknown(1,2,7-12). Synapse-like junctions are observed between Merkel cells and associated afferents(6,13-15), and yet it is unclear whether Merkel cells are inherently mechanosensitive or whether they can rapidly transmit such information to the neighbouring nerve(1,2,16,17). Here we show that Merkel cells produce touch-sensitive currents in vitro. Piezo2, a mechanically activated cation channel, is expressed in Merkel cells. We engineered mice deficient in Piezo2 in the skin, but not in sensory neurons, and show that Merkel-cell mechanosensitivity completely depends on Piezo2. In these mice, slowly adapting responses in vivo mediated by the Merkel cell-neurite complex show reduced static firing rates, and moreover, the mice display moderately decreased behavioural responses to gentle touch. Our results indicate that Piezo2 is the Merkel-cell mechanotransduction channel and provide the first line of evidence that Piezo channels have a physiological role in mechanosensation in mammals. Furthermore, our data present evidence for a two-receptor-site model, in which both Merkel cells and innervating afferents act together as mechanosensors. The two-receptor system could provide this mechanoreceptor complex with a tuning mechanism to achieve highly sophisticated responses to a given mechanical stimulus(15,18,19).	[Woo, Seung-Hyun; Ranade, Sanjeev; Dubin, Adrienne E.; Qiu, Zhaozhu; Miyamoto, Takashi; Patapoutian, Ardem] Scripps Res Inst, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Weyer, Andy D.; Stucky, Cheryl L.] Med Coll Wisconsin, Dept Cell Biol, Milwaukee, WI 53226 USA; [Weyer, Andy D.; Stucky, Cheryl L.] Med Coll Wisconsin, Dept Neurobiol, Milwaukee, WI 53226 USA; [Weyer, Andy D.; Stucky, Cheryl L.] Med Coll Wisconsin, Dept Anat, Milwaukee, WI 53226 USA; [Baba, Yoshichika; Lumpkin, Ellen A.] Columbia Univ, Dept Dermatol, New York, NY 10032 USA; [Baba, Yoshichika; Lumpkin, Ellen A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Qiu, Zhaozhu; Petrus, Matt; Reddy, Kritika] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Howard Hughes Medical Institute; Scripps Research Institute; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Columbia University; Columbia University; Novartis	Patapoutian, A (corresponding author), Scripps Res Inst, Howard Hughes Med Inst, La Jolla, CA 92037 USA.	ardem@scripps.edu		Ranade, Sanjeev/0000-0001-8601-3563; Lumpkin, Ellen/0000-0002-1166-3374; Weyer, Andy/0000-0003-4485-9530	Howard Hughes Medical Institute; NIH [R01DE022358, R01AR051219]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051219, P30AR044535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070711, R01NS040538] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank S. Murthy and B. Coste for suggestions. Research was supported by the Howard Hughes Medical Institute (to A. P.) and NIH grants R01DE022358 (to A. P.) and R01AR051219 (to E.A.L.).	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Cahusac PMB, 2009, NEUROSCIENCE, V163, P933, DOI 10.1016/j.neuroscience.2009.07.015; CHAMBERS MR, 1967, J PHYSIOL-LONDON, V192, pP26; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dassule HR, 2000, DEVELOPMENT, V127, P4775; DIAMOND J, 1986, J PHYSIOL-LONDON, V376, P101, DOI 10.1113/jphysiol.1986.sp016144; Dubin AE, 2012, CELL REP, V2, P511, DOI 10.1016/j.celrep.2012.07.014; Fagan BM, 2001, NEUROREPORT, V12, P341, DOI 10.1097/00001756-200102120-00032; Faucherre A, 2013, J NEUROSCI, V 33, P17089, DOI 10.1523/JNEUROSCI.0522-13.2013; GU J, 1981, AM J PATHOL, V104, P63; Halata Z, 2003, ANAT REC PART A, V271A, P225, DOI 10.1002/ar.a.10029; HARTSCHUH W, 1980, J INVEST DERMATOL, V75, P159, DOI 10.1111/1523-1747.ep12522555; IGGO A, 1969, J PHYSIOL-LONDON, V200, P763, DOI 10.1113/jphysiol.1969.sp008721; IKEDA I, 1994, J PHYSIOL-LONDON, V479, P247, DOI 10.1113/jphysiol.1994.sp020292; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Kinkelin I, 1999, EUR J NEUROSCI, V11, P3963, DOI 10.1046/j.1460-9568.1999.00822.x; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Lesniak DR, 2014, ELIFE, V3, DOI 10.7554/eLife.01488; Maksimovic S, 2013, ANN NY ACAD SCI, V1279, P13, DOI 10.1111/nyas.12057; Maricich SM, 2012, J NEUROSCI, V32, P3296, DOI 10.1523/JNEUROSCI.5307-11.2012; Maricich SM, 2009, SCIENCE, V324, P1580, DOI 10.1126/science.1172890; Milenkovic N, 2008, J NEUROPHYSIOL, V100, P2771, DOI 10.1152/jn.90799.2008; MILLS LR, 1995, J NEUROCYTOL, V24, P117, DOI 10.1007/BF01181555; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Piskorowski R, 2008, PFLUG ARCH EUR J PHY, V457, P197, DOI 10.1007/s00424-008-0496-3; Press D, 2010, SOMATOSENS MOT RES, V27, P174, DOI 10.3109/08990220.2010.516670; Rose MF, 2009, NEURON, V64, P341, DOI 10.1016/j.neuron.2009.10.023; Senok SS, 1996, EXP BRAIN RES, V110, P325; Stucky CL, 1999, J NEUROSCI, V19, P8509; Wellnitz SA, 2010, J NEUROPHYSIOL, V103, P3378, DOI 10.1152/jn.00810.2009; Woo SH, 2010, DEVELOPMENT, V137, P3965, DOI 10.1242/dev.055970; YAMASHITA Y, 1992, J PHYSIOL-LONDON, V450, P143, DOI 10.1113/jphysiol.1992.sp019120; YAMASHITA Y, 1991, SOMATOSENS MOT RES, V8, P87, DOI 10.3109/08990229109144732	35	404	422	7	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					622	626		10.1038/nature13251	http://dx.doi.org/10.1038/nature13251			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24717433	Green Accepted			2022-12-28	WOS:000336457100049
J	Jones, DK; Singer, PM; Ayanian, JZ				Jones, David K.; Singer, Phillip M.; Ayanian, John Z.			The Changing Landscape of Medicaid Practical and Political Considerations for Expansion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Jones, David K.; Singer, Phillip M.] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48104 USA; [Ayanian, John Z.] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Inst Healthcare Policy & Innovat,Div Gen Med,Med, Ann Arbor, MI 48104 USA; [Ayanian, John Z.] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48104 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Singer, PM (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, 1415 Washington Hts, Ann Arbor, MI 48104 USA.	pmsinger@umich.edu						Ayanian JZ, 2013, NEW ENGL J MED, V369, P1773, DOI 10.1056/NEJMp1310910; Berwick DM, 2013, JAMA-J AM MED ASSOC, V310, P1921, DOI 10.1001/jama.2013.281965; Blumenthal KJ, 2013, HEALTH AFFAIR, V32, P497, DOI 10.1377/hlthaff.2012.0431; Jones DK, 2014, J HEALTH POLIT POLIC, V39, P97, DOI 10.1215/03616878-2395190; Kaiser Family Foundation (KFF), 2013, KFF ISS BRIEF IMP CO; Kaiser Family Foundation (KFF), 2013, KFF FACT SHEET MED E; Kaiser Family Foundation (KFF), 2014, STAT HLTH FACTS HLTH; McDonough JE, 2014, JAMA-J AM MED ASSOC, V311, P569, DOI 10.1001/jama.2013.286067	8	22	22	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2014	311	19					1965	1966		10.1001/jama.2014.3700	http://dx.doi.org/10.1001/jama.2014.3700			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UA	24710968				2022-12-28	WOS:000336122800013
J	Molofsky, AV; Kelley, KW; Tsai, HH; Redmond, SA; Chang, SM; Madireddy, L; Chan, JR; Baranzini, SE; Ullian, EM; Rowitch, DH				Molofsky, Anna V.; Kelley, Kevin W.; Tsai, Hui-Hsin; Redmond, Stephanie A.; Chang, Sandra M.; Madireddy, Lohith; Chan, Jonah R.; Baranzini, Sergio E.; Ullian, Erik M.; Rowitch, David H.			Astrocyte-encoded positional cues maintain sensorimotor circuit integrity	NATURE			English	Article							DEVELOPING SPINAL-CORD; MOTOR-NEURONS; SEMAPHORIN-III; BRAIN-DEVELOPMENT; SENSORY AXONS; ADULT-MOUSE; SPECIFICATION; GENERATION; EXPRESSION; IDENTIFICATION	Astrocytes, the most abundant cells in the central nervous system, promote synapse formation and help to refine neural connectivity. Although they are allocated to spatially distinct regional domains during development, it is unknown whether region-restricted astrocytes are functionally heterogeneous. Here we show that postnatal spinal cord astrocytes express several region-specific genes, and that ventral astrocyte-encoded semaphorin 3a (Sema3a) is required for proper motor neuron and sensory neuron circuit organization. Loss of astrocyte-encoded Sema3a leads to dysregulated alpha-motor neuron axon initial segment orientation, markedly abnormal synaptic inputs, and selective death of alpha- but not of adjacent gamma-motor neurons. In addition, a subset of TrkA(+) sensory afferents projects to ectopic ventral positions. These findings demonstrate that stable maintenance of a positional cue by developing astrocytes influences multiple aspects of sensorimotor circuit formation. More generally, they suggest that regional astrocyte heterogeneity may help to coordinate postnatal neural circuit refinement.	[Molofsky, Anna V.; Kelley, Kevin W.; Tsai, Hui-Hsin; Chang, Sandra M.; Rowitch, David H.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Molofsky, Anna V.; Kelley, Kevin W.; Tsai, Hui-Hsin; Chang, Sandra M.; Rowitch, David H.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Molofsky, Anna V.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Kelley, Kevin W.; Tsai, Hui-Hsin; Rowitch, David H.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Kelley, Kevin W.] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94143 USA; [Kelley, Kevin W.; Redmond, Stephanie A.] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA; [Redmond, Stephanie A.; Madireddy, Lohith; Chan, Jonah R.; Baranzini, Sergio E.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Ullian, Erik M.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Rowitch, David H.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rowitch, DH (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	rowitchd@peds.ucsf.edu	Molofsky, Anna Victoria/P-2506-2018; Ritter, Stefanie L/D-9312-2012	Molofsky, Anna Victoria/0000-0002-4709-2411; Baranzini, Sergio/0000-0003-0067-194X; Rowitch, David/0000-0002-0079-0060; Redmond, Stephanie/0000-0002-5580-6269	NIMH [5T32MH089920-04, R01MH099595-01]; APA/Pfizer MD/PhD Psychiatric Research Fellowship; California Institute for Regenerative Medicine [TG2-01153]; Ruth L. Kirschstein NRSA [FNS081905A]; NINDS [R01 NS059893]; NIH [1DP2OD006507-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099595, T32MH089920, K08MH104417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059893, R01NS062796, F31NS081905] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006507] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); APA/Pfizer MD/PhD Psychiatric Research Fellowship; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Ruth L. Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Flanagan, T. Jessell, J. de Nooj, N. Balaskas, M. Hancock, S. Ohata and R. Krencik for comments on the manuscript and technical suggestions. We are grateful to K. Sabeur, M. Wong and the UCSF Flow Cytometry and Genomics core facilities for expert technical help, A. Kolodkin for Sema3a probe construct, L. Reichardt for the TrkA antibody, J. Dasen for FoxP1 and Scip antibodies, and N. Heintz and J. Dougherty for Aldh1L1-cre mice. A. V. M. is supported by an NIMH Training Grant (5T32MH089920-04) and an APA/Pfizer MD/PhD Psychiatric Research Fellowship. K. W. K is supported by the California Institute for Regenerative Medicine (TG2-01153). S. A. R. is supported by a Ruth L. Kirschstein NRSA FNS081905A. This work was supported by grants from the NINDS (to D. H. R. (R01 NS059893) and J. R. C.), E. M. U. is supported by NIMH (R01MH099595-01), an NIH New Innovator Award (1DP2OD006507-01) and That Man May See. D. H. R. is a HHMI Investigator.	Alvarez FJ, 2004, J COMP NEUROL, V472, P257, DOI 10.1002/cne.20012; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Ashrafi S, 2012, J NEUROSCI, V32, P8725, DOI 10.1523/JNEUROSCI.1160-12.2012; AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x; Barros CS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005108; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Brumovsky P, 2007, NEUROSCIENCE, V147, P469, DOI 10.1016/j.neuroscience.2007.02.068; Brumovsky P. R., 2013, NEUROLOGY, V2013; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CAMU W, 1992, J NEUROSCI METH, V44, P59, DOI 10.1016/0165-0270(92)90114-S; Chen AI, 2006, NEURON, V49, P395, DOI 10.1016/j.neuron.2005.12.028; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Cohen S, 2005, EUR J NEUROSCI, V21, P1767, DOI 10.1111/j.1460-9568.2005.04021.x; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Duflocq A, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-66; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Freeman MR, 2013, NEURON, V80, P613, DOI 10.1016/j.neuron.2013.10.034; Friese A, 2009, P NATL ACAD SCI USA, V106, P13588, DOI 10.1073/pnas.0906809106; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hochstim C, 2008, CELL, V133, P510, DOI 10.1016/j.cell.2008.02.046; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Liu Y, 2011, CURR OPIN NEUROBIOL, V21, P52, DOI 10.1016/j.conb.2010.09.003; Magavi S, 2012, J NEUROSCI, V32, P4762, DOI 10.1523/JNEUROSCI.3560-11.2012; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Mitra P, 2012, J NEUROPHYSIOL, V107, P728, DOI 10.1152/jn.00558.2011; Molofsky AV, 2013, GLIA, V61, P1518, DOI 10.1002/glia.22538; Muroyama Y, 2005, NATURE, V438, P360, DOI 10.1038/nature04139; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nishiyama M, 2011, NAT CELL BIOL, V13, P676, DOI 10.1038/ncb2255; Ozaki S, 1997, J COMP NEUROL, V380, P215; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Shelly M, 2011, NEURON, V71, P433, DOI 10.1016/j.neuron.2011.06.041; Surmeli G, 2011, CELL, V147, P653, DOI 10.1016/j.cell.2011.10.012; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Tien AC, 2012, DEVELOPMENT, V139, P2477, DOI 10.1242/dev.077214; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	44	186	189	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					189	+		10.1038/nature13161	http://dx.doi.org/10.1038/nature13161			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24776795	Green Accepted, Green Submitted			2022-12-28	WOS:000335454300031
J	Gislason, SR; Oelkers, EH				Gislason, Sigurdur R.; Oelkers, Eric H.			Carbon Storage in Basalt	SCIENCE			English	Editorial Material							SEQUESTRATION		[Gislason, Sigurdur R.] Univ Iceland, Inst Earth Sci, IS-101 Reykjavik, Iceland; [Oelkers, Eric H.] Univ Paul Sabatier IRD, GET UMR CNRS 5563, F-31400 Toulouse, France; [Oelkers, Eric H.] UCL, London WC1E 6BT, England	University of Iceland; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of London; University College London	Gislason, SR (corresponding author), Univ Iceland, Inst Earth Sci, Sturlugata 7, IS-101 Reykjavik, Iceland.	sigrg@hi.is; eric.oelkers@get.obs-mip.fr	Oelkers, Eric/ABI-6279-2020	Oelkers, Eric/0000-0002-5759-524X				Aradottir ESP, 2012, INT J GREENH GAS CON, V9, P24, DOI 10.1016/j.ijggc.2012.02.006; Archer D, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002625; Gilfillan SMV, 2009, NATURE, V458, P614, DOI 10.1038/nature07852; Gislason S. R., 2013, MIN MAG-LONDON, V77, P1178; Gislason SR, 2010, INT J GREENH GAS CON, V4, P537, DOI 10.1016/j.ijggc.2009.11.013; Global CCS Institute, 2011, ECONOMIC ASSESSMENT; Goldberg DS, 2008, P NATL ACAD SCI USA, V105, P9920, DOI 10.1073/pnas.0804397105; Matter J. M., 2013, AMERICAN GEOPHYSICAL; McGrail BP, 2012, INT J GREENH GAS CON, V9, P91, DOI 10.1016/j.ijggc.2012.03.009; McGrail BP, 2011, ENRGY PROCED, V4, P5653, DOI 10.1016/j.egypro.2011.02.557; Metz B, 2005, IPCC SPECIAL REPORT, P195; Ragnheidardottir E, 2011, INT J GREENH GAS CON, V5, P1065, DOI 10.1016/j.ijggc.2010.11.010; Rosenbauer RJ, 2012, GEOCHIM COSMOCHIM AC, V89, P116, DOI 10.1016/j.gca.2012.04.042; Schaef HT, 2010, INT J GREENH GAS CON, V4, P249, DOI 10.1016/j.ijggc.2009.10.009; Wiese F., 2008, TECH REP ISOR 2008 0	15	148	158	11	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					373	374		10.1126/science.1250828	http://dx.doi.org/10.1126/science.1250828			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763582				2022-12-28	WOS:000334867800030
J	Watanabe, J; Hattori, M; Berriman, M; Lehane, MJ; Hall, N; Solano, P; Hide, W; Toure, Y; Attardo, GM; Darby, AC; Toyoda, A; Hertz-Fowler, C; Larkin, DM; Cotton, JA; Watanabe, J; Sanders, MJ; Swain, MT; Hattori, M; Berriman, M; Quail, MA; Inoue, N; Ravel, S; Taylor, TD; Srivastava, TP; Sharma, V; Warren, W; Wilson, RK; Suzuki, Y; Lawson, D; Hughes, DST; Megy, K; Masiga, DK; Mireji, PO; Attardo, GM; Hansen, IA; Van den Abbeele, J; Benoit, JB; Bourtzis, K; Lehane, MJ; Masiga, DK; Obiero, GFO; Robertson, HM; Jones, JW; Zhou, JJ; Field, LM; Friedrich, M; Mireji, PO; Nyanjom, SRG; Telleria, EL; Caljon, G; Van den Abbeele, J; Ribeiro, JMC; Acosta-Serrano, A; Benoit, JB; Ooi, CP; Rose, C; Price, DP; Haines, LR; Lehane, MJ; Christoffels, A; Sim, C; Pham, DQD; Denlinger, DL; Geiser, DL; Omedo, IA; Benoit, JB; Winzerling, JJ; Peyton, JT; Marucha, KK; Jonas, M; Meuti, ME; Rawlings, ND; Mireji, PO; Zhang, QR; Macharia, RW; Michalkova, V; Dashti, ZJS; Baumann, AA; Gade, G; Marco, HG; Hansen, IA; Caers, J; Schoofs, L; Riehle, MA; Hu, WQ; Tu, ZJ; Tarone, AM; Malacrida, AR; Kibet, CK; Benoit, JB; Scolari, F; Attardo, GM; Koekemoer, JJO; Willis, J; Gomulski, LM; Falchetto, M; Scott, MJ; Fu, SH; Sze, SH; Luiz, T; Weiss, B; Walshe, DP; Wang, JW; Benoit, JB; Attardo, GM; Wamalwa, M; Mwangi, S; Ramphul, UN; Snyder, AK; Brelsfoard, CL; Thomas, GH; Tsiamis, G; Bourtzis, K; Arensburger, P; Rio, RVM; Macdonald, SJ; Panji, S; Kruger, A; Christoffels, A; Benkahla, A; Balyeidhusa, ASP; Msangi, A; Ooi, CP; Okoro, CK; Masiga, DK; Stephens, D; Walshe, DP; Stanley, EJ; Mpondo, F; Wamwiri, F; Mramba, F; Attardo, GM; Siwo, G; Obiero, GFO; Githinji, G; Harkins, G; Murilla, G; Lehvaslaiho, H; Malele, I; Koekemoer, JJO; Auma, JE; Kinyua, JK; Ouma, J; Watanabe, J; Megy, K; Okedi, L; Manga, L; Jonas, M; Wamalwa, M; Aslett, M; Koffi, M; Berriman, M; Lehane, MJ; Gaunt, MW; Makgamathe, M; Hall, N; Mulder, N; Manangwa, O; Abila, PP; Wincker, P; Mireji, PO; Gregory, R; Rio, RVM; Bateta, R; Sakate, R; Aksoy, S; Ommeh, S; Lehane, S; Nyanjom, SRG; Imanishi, T; Taylor, TD; Osamor, VC; Sharma, V; Hide, W; Kawahara, Y; Benoit, JB				Watanabe, Junichi; Hattori, Masahira; Berriman, Matthew; Lehane, Michael J.; Hall, Neil; Solano, Philippe; Hide, Winston; Toure, Yeya; Attardo, Geoffrey M.; Darby, Alistair C.; Toyoda, Atsushi; Hertz-Fowler, Christiane; Larkin, Denis M.; Cotton, James A.; Watanabe, Junichi; Sanders, Mandy J.; Swain, Martin T.; Hattori, Masahira; Berriman, Matthew; Quail, Michael A.; Inoue, Noboru; Ravel, Sophie; Taylor, Todd D.; Srivastava, Tulika P.; Sharma, Vineet; Warren, Wesley; Wilson, Richard K.; Suzuki, Yutaka; Lawson, Daniel; Hughes, Daniel S. T.; Megy, Karyn; Masiga, Daniel K.; Mireji, Paul O.; Attardo, Geoffrey M.; Hansen, Imma A.; Van den Abbeele, Jan; Benoit, Joshua B.; Bourtzis, Kostas; Lehane, Michael J.; Masiga, Daniel K.; Obiero, George F. O.; Robertson, Hugh M.; Jones, Jeffery W.; Zhou, Jing-Jiang; Field, Linda M.; Friedrich, Markus; Mireji, Paul O.; Nyanjom, Steven R. G.; Telleria, Erich L.; Caljon, Guy; Van den Abbeele, Jan; Ribeiro, Jose M. C.; Acosta-Serrano, Alvaro; Benoit, Joshua B.; Ooi, Cher-Pheng; Rose, Clair; Price, David P.; Haines, Lee R.; Lehane, Michael J.; Christoffels, Alan; Sim, Cheolho; Pham, Daphne Q. D.; Denlinger, David L.; Geiser, Dawn L.; Omedo, Irene A.; Benoit, Joshua B.; Winzerling, Joy J.; Peyton, Justin T.; Marucha, Kevin K.; Jonas, Mario; Meuti, Megan E.; Rawlings, Neil D.; Mireji, Paul O.; Zhang, Qirui; Macharia, Rosaline W.; Michalkova, Veronika; Dashti, Zahra Jalali Sefid; Baumann, Aaron A.; Gaede, Gerd; Marco, Heather G.; Hansen, Immo A.; Caers, Jelle; Schoofs, Liliane; Riehle, Michael A.; Hu, Wanqi; Tu, Zhijian; Tarone, Aaron M.; Malacrida, Anna R.; Kibet, Caleb K.; Benoit, Joshua B.; Scolari, Francesca; Attardo, Geoffrey M.; Koekemoer, Jacobus J. O.; Willis, Judith; Gomulski, Ludvik M.; Falchetto, Marco; Scott, Maxwell J.; Fu, Shuhua; Sze, Sing-Hoi; Luiz, Thiago; Weiss, Brian; Walshe, Deirdre P.; Wang, Jingwen; Benoit, Joshua B.; Attardo, Geoffrey M.; Wamalwa, Mark; Mwangi, Sarah; Ramphul, Urvashi N.; Snyder, Anna K.; Brelsfoard, Corey L.; Thomas, Gavin H.; Tsiamis, George; Bourtzis, Kostas; Arensburger, Peter; Rio, Rita V. M.; Macdonald, Sandy J.; Panji, Sumir; Kruger, Adele; Christoffels, Alan; Benkahla, Alia; Balyeidhusa, Apollo S. P.; Msangi, Atway; Ooi, Cher-Pheng; Okoro, Chinyere K.; Masiga, Daniel K.; Stephens, Dawn; Walshe, Deirdre P.; Stanley, Eleanor J.; Mpondo, Feziwe; Wamwiri, Florence; Mramba, Furaha; Attardo, Geoffrey M.; Siwo, Geoffrey; Obiero, George F. O.; Githinji, George; Harkins, Gordon; Murilla, Grace; Lehvaeslaiho, Heikki; Malele, Imna; Koekemoer, Jacobus J. O.; Auma, Joanna E.; Kinyua, Johnson K.; Ouma, Johnson; Watanabe, Junichi; Megy, Karyn; Okedi, Loyce; Manga, Lucien; Jonas, Mario; Wamalwa, Mark; Aslett, Martin; Koffi, Mathurin; Berriman, Matthew; Lehane, Michael J.; Gaunt, Michael W.; Makgamathe, Mmule; Hall, Neil; Mulder, Nicola; Manangwa, Oliver; Abila, Patrick P.; Wincker, Patrick; Mireji, Paul O.; Gregory, Richard; Rio, Rita V. M.; Bateta, Rosemary; Sakate, Ryuichi; Aksoy, Serap; Ommeh, Sheila; Lehane, Stella; Nyanjom, Steven R. G.; Imanishi, Tadashi; Taylor, Todd D.; Osamor, Victor C.; Sharma, Vineet; Hide, Winston; Kawahara, Yoshihiro; Benoit, Joshua B.		IGGI	Genome Sequence of the Tsetse Fly (Glossina morsitans): Vector of African Trypanosomiasis	SCIENCE			English	Article							IMMUNE-RESPONSES; AQUAPORINS; PROTEINS; DIPTERA	Tsetse flies are the sole vectors of human African trypanosomiasis throughout sub-Saharan Africa. Both sexes of adult tsetse feed exclusively on blood and contribute to disease transmission. Notable differences between tsetse and other disease vectors include obligate microbial symbioses, viviparous reproduction, and lactation. Here, we describe the sequence and annotation of the 366-megabase Glossina morsitans morsitans genome. Analysis of the genome and the 12,308 predicted protein-encoding genes led to multiple discoveries, including chromosomal integrations of bacterial (Wolbachia) genome sequences, a family of lactation-specific proteins, reduced complement of host pathogen recognition proteins, and reduced olfaction/ chemosensory associated genes. These genome data provide a foundation for research into trypanosomiasis prevention and yield important insights with broad implications for multiple aspects of tsetse biology.	[Lehvaeslaiho, Heikki] KAUST, Thuwal 239556900, Saudi Arabia; [Arensburger, Peter] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA; [Bourtzis, Kostas] Alexander Fleming Biomed Sci Res Ctr, Biomed Sci Res Ctr, Vari 16672, Greece; [Wincker, Patrick] CEA, F-91507 Evry, France; [Macharia, Rosaline W.] Univ Nairobi, Ctr Biotechnol & Bioinformat, Nairobi 00100, Kenya; [Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Ctr Om & Bioinformat, Kashiwa, Chiba 2778561, Japan; [Toyoda, Atsushi] Natl Inst Genet, Comparat Genom Lab, Mishima, Shizuoka 4118540, Japan; [Panji, Sumir; Mulder, Nicola] Univ Cape Town, Fac Hlth Sci, IIDMM, Computat Biol Grp, ZA-7925 Cape Town, South Africa; [Fu, Shuhua] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Marucha, Kevin K.; Bateta, Rosemary] Egerton Univ, Dept Biochem & Mol Biol, Njoro, Kenya; [Kinyua, Johnson K.] JKUAT, Dept Biochem, Nairobi, Kenya; [Hu, Wanqi; Tu, Zhijian] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA; [Zhou, Jing-Jiang; Field, Linda M.] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden AL5 2JQ, Herts, England; [Benoit, Joshua B.] Univ Cincinnati, McMicken Coll Arts & Sci, Dept Biol Sci, Cincinnati, OH 45221 USA; [Gaede, Gerd; Marco, Heather G.] Univ Cape Town, Dept Biol Sci, ZA-7700 Rondebosch, South Africa; [Pham, Daphne Q. D.] Univ Wisconsin Parkside, Dept Biol Sci, Kenosha, WI 53144 USA; [Jones, Jeffery W.; Friedrich, Markus] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Malacrida, Anna R.; Scolari, Francesca; Gomulski, Ludvik M.; Falchetto, Marco] Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy; [Sim, Cheolho] Baylor Univ, Dept Biol, Waco, TX 76798 USA; [Caers, Jelle; Schoofs, Liliane] Katholieke Univ Leuven, Dept Biol, B-3000 Louvain, Belgium; [Hansen, Imma A.; Price, David P.; Hansen, Immo A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Thomas, Gavin H.; Macdonald, Sandy J.] Univ York, Dept Biol, York Y010 5DD, N Yorkshire, England; [Snyder, Anna K.; Rio, Rita V. M.] W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA; [Van den Abbeele, Jan; Caljon, Guy] Inst Trop Med Antwerp, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Willis, Judith] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Omedo, Irene A.] CGMRC, KEMRI Wellcome Trust Programme, Dept Clin Res, Kilifi, Kenya; [Osamor, Victor C.] Covenant Univ, Coll Sci & Technol, Dept Comp & Informat Sci, Ota, Ogun State, Nigeria; [Sze, Sing-Hoi] Texas A&M Univ, Dept Biochem & Biophys, Dept Comp Sci & Engn, College Stn, TX 77843 USA; [Scott, Maxwell J.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Tarone, Aaron M.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Denlinger, David L.; Zhang, Qirui] Ohio State Univ, Dept Entomol, Aronoff Lab 400, Columbus, OH 43210 USA; [Riehle, Michael A.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Robertson, Hugh M.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; Joint FAO IAEA Programme Nucl Tech Food & Agr, Insect Pest Control Lab, A-1220 Vienna, Austria; [Tsiamis, George] Univ Patras, Dept Environm & Nat Resources Management, Agrinion 30100, Greece; [Telleria, Erich L.; Michalkova, Veronika; Luiz, Thiago; Weiss, Brian; Wang, Jingwen; Aksoy, Serap] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, 60 Coll St, New Haven, CT 06520 USA; [Peyton, Justin T.] Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Aronoff Lab 300, Columbus, OH 43210 USA; [Brelsfoard, Corey L.] St Catharine Coll, Dept Nat Sci, St Catharine, KY 40061 USA; [Winzerling, Joy J.] Univ Arizona, Coll Agr & Life Sci, Dept Nutr Sci, Career Serv, Tucson, AZ 85721 USA; [Winzerling, Joy J.] Univ Arizona, Coll Agr & Life Sci, Dept Nutr Sci, Acad Serv, Tucson, AZ 85721 USA; [Geiser, Dawn L.] Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA; [Gaunt, Michael W.] Univ London London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1E 7HT, England; [Acosta-Serrano, Alvaro; Rose, Clair] Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England; [Acosta-Serrano, Alvaro; Haines, Lee R.; Walshe, Deirdre P.; Ramphul, Urvashi N.; Lehane, Stella] Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England; [Koekemoer, Jacobus J. O.] Onderstepoort Vet Inst, Entomol Sect, ZA-110 Onderstepoort, South Africa; [Siwo, Geoffrey] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; Univ Pretoria, Dept Vet Trop Dis, ZA-110 Onderstepoort, South Africa; [Lawson, Daniel; Hughes, Daniel S. T.; Stanley, Eleanor J.] European Bioinformat Inst EMBL EBI, European Mol Biol Labs, Cambridge CB10 1SA, Cambs, England; [Benkahla, Alia] Inst Pasteur Tunis, Lab Med Parasitol Biotechnol & Biomol, Grp Bioinformat & Modeling, Tunis 1002, Tunisia; [Solano, Philippe; Koffi, Mathurin] CIRDES Bobo Dioulasso, UMR IRD CIRAD INTERTRYP 177, IRD, Bobo Dioulasso, Burkina Faso; [Ravel, Sophie] LRCT Campus Int Baillarguet, UMR IRD CIRAD INTERTRYP 177, IRD, Montpellier, France; [Larkin, Denis M.; Swain, Martin T.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3FG, Ceredigion, Wales; [Ommeh, Sheila] JKUAT, Biotechnol Res Inst, Nairobi, Kenya; [Darby, Alistair C.; Gregory, Richard] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England; [Michalkova, Veronika] Slovak Acad Sci, Inst Zool, Bratislava 84506, Slovakia; [Sakate, Ryuichi; Imanishi, Tadashi; Kawahara, Yoshihiro] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Integrated Database Team, Koto Ku, Tokyo 1350064, Japan; [Wamwiri, Florence; Murilla, Grace; Auma, Joanna E.; Ouma, Johnson] Kenya Agr Res Inst, Trypanosomiasis Res Ctr, Kikuyu 902, Kenya; [Ribeiro, Jose M. C.] NIAID, Lab Malaria & Vector Res, Rockville, MD 20852 USA; [Stephens, Dawn; Makgamathe, Mmule] Technol Innovat Agcy, Natl Genom Platform, ZA-4058 Durban, South Africa; [Balyeidhusa, Apollo S. P.] Makerere Univ, Dept Biochem & Sports Sci, Kampala, Uganda; [Rawlings, Neil D.] EMBL European Bioinformat Inst, Wellcome Trust Sanger Inst, Bateman Grp, Cambridge CB10 1SA, Cambs, England; [Obiero, George F. O.; Kibet, Caleb K.] Int Ctr Insect Physiol & Ecol, Mol Biol & Bioinformat Unit, Nairobi, Kenya; [Okedi, Loyce; Abila, Patrick P.] Natl Livestock Resources Res Inst NaLIRRI, Tororo, Uganda; [Inoue, Noboru] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan; [Hertz-Fowler, Christiane; Cotton, James A.; Sanders, Mandy J.; Quail, Michael A.; Aslett, Martin] Wellcome Trust Sanger Inst, Parasite Genom Grp, Cambridge CB10 1SA, Cambs, England; [Baumann, Aaron A.] Howard Hughes Med Inst, Riddiford Lab, Ashburn, VA 20147 USA; [Srivastava, Tulika P.; Sharma, Vineet; Sharma, Vineet] RIKEN Ctr Integrat Med Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Christoffels, Alan; Macharia, Rosaline W.; Dashti, Zahra Jalali Sefid; Wamalwa, Mark; Mwangi, Sarah; Panji, Sumir; Kruger, Adele; Mpondo, Feziwe; Harkins, Gordon] Univ Western Cape, South African MRC Bioinformat Unit, South African Natl Bioinformat Inst, ZA-7530 Bellville, South Africa; [Toure, Yeya] WHO, Special Programme Res & Training Trop Dis TDR, CH-1211 Geneva 27, Switzerland; [Warren, Wesley; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63110 USA; [Msangi, Atway; Mramba, Furaha; Malele, Imna; Manangwa, Oliver] TTRI, Tanga, Tanzania; [Ouma, Johnson] Vector Hlth Int, Arusha, Tanzania; [Okoro, Chinyere K.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, Cambs, England; [Manga, Lucien] WHO, WHO Reg Off Africa, Brazzaville, Rep Congo; [Srivastava, Tulika P.] Indian Inst Technol, Sch Basic Sci, Mandi 175001, Himachal Prades, India; [Githinji, George] CGMRC, KEMRI Wellcome Trust Programme, Dept Parasite Vector & Human Biol, Kilifi, Kenya; [Watanabe, Junichi] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; Kenyatta Univ, Dept Biochem & Biotechnol, Nairobi, Kenya; [Sharma, Vineet; Sharma, Vineet] Indian Inst Sci Educ & Res, Dept Biol Sci, Bhopal 462066, Madhya Pradesh, India; King Abdulaziz Univ, Fac Sci, Jeddah 21589, Saudi Arabia; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02461 USA; [Kawahara, Yoshihiro] Natl Inst Agrobiol Sci, Agrogen Res Ctr, Bioinformat Res Unit, Tsukuba, Ibaraki 3058602, Japan	King Abdullah University of Science & Technology; California State University System; California State Polytechnic University Pomona; Alexander Fleming Biomedical Sciences Research Center; CEA; University of Nairobi; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Cape Town; Texas A&M University System; Texas A&M University College Station; Egerton University; Jomo Kenyatta University of Agriculture & Technology; Virginia Polytechnic Institute & State University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University System of Ohio; University of Cincinnati; University of Cape Town; University of Wisconsin System; University of Wisconsin Parkside; Wayne State University; University of Pavia; Baylor University; KU Leuven; New Mexico State University; University of York - UK; West Virginia University; Institute of Tropical Medicine (ITM); University System of Georgia; University of Georgia; Covenant University; Texas A&M University System; Texas A&M University College Station; University of North Carolina; North Carolina State University; Texas A&M University System; Texas A&M University College Station; University System of Ohio; Ohio State University; University of Arizona; University of Illinois System; University of Illinois Urbana-Champaign; International Atomic Energy Agency; University of Patras; Yale University; University System of Ohio; Ohio State University; University of Arizona; University of Arizona; University of Arizona; University of London; London School of Hygiene & Tropical Medicine; Liverpool School of Tropical Medicine; University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; University of Notre Dame; University of Pretoria; European Molecular Biology Laboratory (EMBL); Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; CIRAD; Institut de Recherche pour le Developpement (IRD); CIRAD; Institut de Recherche pour le Developpement (IRD); Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Jomo Kenyatta University of Agriculture & Technology; University of Liverpool; Slovak Academy of Sciences; National Institute of Advanced Industrial Science & Technology (AIST); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Makerere University; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; International Centre of Insect Physiology & Ecology (ICIPE); Obihiro University of Agriculture & Veterinary Medicine; Wellcome Trust Sanger Institute; Howard Hughes Medical Institute; RIKEN; University of the Western Cape; World Health Organization; Washington University (WUSTL); Wellcome Trust Sanger Institute; World Health Organization; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Mandi; University of Tokyo; Kenyatta University; Indian Institute of Science Education & Research (IISER) - Bhopal; King Abdulaziz University; Harvard University; Harvard T.H. Chan School of Public Health; National Institute of Agrobiological Sciences - Japan	Aksoy, S (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, 60 Coll St, New Haven, CT 06520 USA.	geoffrey.attardo@yale.edu; mb4@sanger.ac.uk; serap.aksoy@yale.edu	Abila, Patrick P'Odyek/T-1294-2018; solano, philippe/B-2328-2010; Imanishi, Tadashi/R-3076-2019; Hattori, Masahira/AAD-3785-2019; Quail, michael/ABE-6131-2020; Thomas, Gavin H/E-5753-2011; Ooi, Cher-Pheng/Q-9635-2018; Haines, Lee/K-9264-2017; Murilla, Grace/AAI-8944-2020; Scolari, Francesca/ABC-2285-2020; Scott, Maxwell J/J-1935-2015; Acosta-Serrano, Alvaro/L-5503-2015; Gomulski, Ludvik/AFK-3930-2022; Hide, Winston A/V-2727-2017; Larkin, Denis/AAB-1633-2022; Osamor, Victor/P-1264-2019; Ouma, Johnson/AAS-5044-2020; Zhang, Qirui/C-6579-2011; Darby, Alistair/I-6485-2012; Hide, Winston Hide/C-7217-2009; Marco, Heather/AAN-6213-2020; Larkin, Denis/AAB-2249-2022; Riehle, Michael A/O-2852-2017; Gomulski, Ludvik/AAG-2709-2022; Walshe, Deirdre/AAD-7716-2019; LA Silva, Thiago/L-7699-2016; Berriman, Matthew/A-7618-2011; Christoffels, Alan/C-3269-2014; schoofs, liliane/ABD-2943-2020; Hattori, Masahira/C-6958-2016; Geiser, Dawn L/J-9923-2012; Wang, Jingwen/E-6932-2018; Aksoy, Serap/K-2244-2019; Ribeiro, Jose/J-7011-2015; Attardo, Geoffrey Michael/I-3320-2019; Mireji, Paul/M-3830-2019; Obiero, George F. O./ABF-9688-2020; Caljon, Guy/E-1310-2017; Cotton, James A/B-8806-2008; Wilson, Richard K./AAF-4139-2019; Telleria, Erich L/F-1580-2015; Ommeh, Sheila C/H-1505-2015; Hide, Winston/R-3815-2019; Taylor, Todd/A-7121-2009; Rawlings, Neil/M-5566-2013; Schoofs, Liliane/F-2815-2010	Abila, Patrick P'Odyek/0000-0002-4487-1217; solano, philippe/0000-0002-4351-3506; Thomas, Gavin H/0000-0002-9763-1313; Ooi, Cher-Pheng/0000-0002-1503-1155; Haines, Lee/0000-0001-8821-6479; Murilla, Grace/0000-0002-4753-2819; Scolari, Francesca/0000-0003-3085-9038; Scott, Maxwell J/0000-0001-6536-4735; Acosta-Serrano, Alvaro/0000-0002-2576-7959; Hide, Winston A/0000-0002-8621-3271; Larkin, Denis/0000-0001-7859-6201; Zhang, Qirui/0000-0002-2749-9740; Darby, Alistair/0000-0002-3786-6209; Hide, Winston Hide/0000-0002-8621-3271; Marco, Heather/0000-0003-3000-3010; Walshe, Deirdre/0000-0001-5531-2368; LA Silva, Thiago/0000-0002-8520-5405; Berriman, Matthew/0000-0002-9581-0377; Christoffels, Alan/0000-0002-0420-2916; Hattori, Masahira/0000-0001-9467-0344; Geiser, Dawn L/0000-0002-6004-8407; Wang, Jingwen/0000-0002-6794-2604; Aksoy, Serap/0000-0001-9941-143X; Attardo, Geoffrey Michael/0000-0001-6265-2969; Mireji, Paul/0000-0002-7965-2428; Obiero, George F. O./0000-0001-5628-7002; Caljon, Guy/0000-0002-4870-3202; Cotton, James A/0000-0001-5475-3583; Wilson, Richard K./0000-0002-1992-1358; Telleria, Erich L/0000-0003-0006-0057; Ommeh, Sheila C/0000-0002-0780-0399; Hide, Winston/0000-0002-8621-3271; Taylor, Todd/0000-0003-4247-6253; Hall, Neil/0000-0003-2808-0009; Van Den Abbeele, Jan/0000-0002-4533-4480; Githinji, George/0000-0001-9640-7371; Kibet, Caleb/0000-0002-0312-4282; Malele, Imna/0000-0002-9343-7150; Benkahla, Alia/0000-0001-9988-3250; Rawlings, Neil/0000-0001-5557-7665; Field, Linda/0000-0002-3328-2513; Macdonald, Sandy/0000-0002-4112-0987; Bateta, Rosemary/0000-0002-2793-4837; Wamalwa, Mark/0000-0001-7714-2697; Hertz-Fowler, Christiane/0000-0002-0729-6479; malacrida, anna/0000-0003-4566-8795; Ribeiro, Jose/0000-0002-9107-0818; harkins, gordon w/0000-0003-0041-8047; Auma, Joanna/0000-0002-0717-5554; Osamor, Victor/0000-0003-1868-0967; Nyanjom, Steven/0000-0002-6290-991X; Lawson, Daniel/0000-0001-7765-983X; Marucha, Kevin/0000-0003-1438-2735; K. Sharma, Vineet/0000-0002-2958-6215; Gade, Gerd/0000-0002-7048-9660; Masiga, Daniel/0000-0001-7513-0887; Megy, Karyn/0000-0002-2826-3879; Koekemoer, Otto/0000-0003-3223-9078; Okoro, Chinyere/0000-0002-2466-304X; Baumann, Aaron/0000-0002-7410-8482; Schoofs, Liliane/0000-0002-1673-432X; Imanishi, Tadashi/0000-0002-1182-9127; GOMULSKI, LUDVIK/0000-0002-1506-7051; Tarone, Aaron/0000-0003-0965-7634; Mulder, Nicola J/0000-0003-4905-0941; Riehle, Michael/0000-0001-9747-3872	Wellcome Trust [085775/Z/08/Z, 098051]; World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR) [A90088]; Ambrose Monell Foundation; Food and Agriculture Organization/International Atomic Energy Agency Coordinated Research Program "Improving SIT for Tsetse Flies through Research on their Symbionts"; European Union Cooperation in Science and Technology (COST) Action [FA0701]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; BBSRC [BB/J017698/1, BBS/E/C/00005193, BBS/E/C/00005194] Funding Source: UKRI; MRC [MR/K002279/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005194, BBS/E/C/00005193, BB/J017698/1] Funding Source: researchfish; Medical Research Council [MR/K002279/1] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [D43TW007391, R03TW008413, R03TW009444] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [F32CA091768] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081774, R01AI051584] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR); Ambrose Monell Foundation; Food and Agriculture Organization/International Atomic Energy Agency Coordinated Research Program "Improving SIT for Tsetse Flies through Research on their Symbionts"; European Union Cooperation in Science and Technology (COST) Action; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The public release and future updates of the genome sequence and associated information are hosted at VectorBase (www.vectorbase.org). The genome sequence can also be found at GenBank under the accession no. CCAG010000000. The Glossina morsitans genome project was funded by the Wellcome Trust (grants 085775/Z/08/Z and 098051) and World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR) (project no. A90088) and the Ambrose Monell Foundation. Authors also acknowledge support by the Food and Agriculture Organization/International Atomic Energy Agency Coordinated Research Program "Improving SIT for Tsetse Flies through Research on their Symbionts," the European Union Cooperation in Science and Technology (COST) Action FA0701 "Arthropod Symbiosis: From Fundamental Studies to Pest and Disease Management," and a grant-in-aid for Scientific Research on Priority Areas "Comprehensive Genomics" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. H.). BAC libraries were generated through National Institute of Allergy and Infectious Diseases resources, and sequencing was supported by RIKEN Japan. We thank the staff in the library construction, sequence production, and informatics support groups at the Wellcome Trust Sanger Institute.	Abd-Alla AMM, 2008, J VIROL, V82, P4595, DOI 10.1128/JVI.02588-07; Aksoy S, 2005, TRENDS PARASITOL, V21, P107, DOI 10.1016/j.pt.2005.01.006; Alam U, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002415; Alves-Silva J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-213; Attardo GM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002645; Benoit JB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003874; Benoit JB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002517; Bosco-Drayon V, 2012, CELL HOST MICROBE, V12, P153, DOI 10.1016/j.chom.2012.06.002; BRADY J, 1991, PHYSIOL ENTOMOL, V16, P153, DOI 10.1111/j.1365-3032.1991.tb00551.x; Brelsfoard C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002728; Caljon G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047233; Campbell EM, 2008, J COMP PHYSIOL B, V178, P935, DOI 10.1007/s00360-008-0288-2; Dolezal T, 2005, PLOS BIOL, V3, P1213, DOI 10.1371/journal.pbio.0030201; Dyer NA, 2013, TRENDS PARASITOL, V29, P188, DOI 10.1016/j.pt.2013.02.003; Elsik CG, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-106; Friedrich M., 2010, ELS, DOI [10.1002/9780470015902.a0022898, DOI 10.1002/9780470015902.A0022898]; Gibson G, 1999, MED VET ENTOMOL, V13, P2, DOI 10.1046/j.1365-2915.1999.00163.x; HARDIE R, 1989, J INSECT PHYSIOL, V35, P423, DOI 10.1016/0022-1910(89)90117-0; Hens K, 2004, INSECT MOL BIOL, V13, P615, DOI 10.1111/j.0962-1075.2004.00520.x; KAMINKER JS, 2002, GENOME BIOL, V0003; Lehane MJ, 2004, TRENDS PARASITOL, V20, P433, DOI 10.1016/j.pt.2004.07.002; Lehane MJ, 1997, ANNU REV ENTOMOL, V42, P525, DOI 10.1146/annurev.ento.42.1.525; Lindh JM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001661; Liu R, 2012, INSECT MOL BIOL, V21, P41, DOI 10.1111/j.1365-2583.2011.01114.x; Michalkova V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087554; NORDEN DA, 1969, COMP BIOCHEM PHYSIOL, V31, P819, DOI 10.1016/0010-406X(69)92082-9; Obiero GFO, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002663; Petersen FT, 2007, MOL PHYLOGENET EVOL, V45, P111, DOI 10.1016/j.ympev.2007.04.023; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Rio RVM, 2012, MBIO, V3, DOI 10.1128/mBio.00240-11; Rose C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002691; Schmitt A, 2005, J EXP BIOL, V208, P1247, DOI 10.1242/jeb.01527; Telleria EL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002649; Van Den Abbeele J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000926; Weiss BL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003318; Weiss BL, 2012, J IMMUNOL, V188, P3395, DOI 10.4049/jimmunol.1103691; Welburn SC, 2009, PARASITOLOGY, V136, P1943, DOI 10.1017/S0031182009006416; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108	38	171	173	5	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					380	386		10.1126/science.1249656	http://dx.doi.org/10.1126/science.1249656			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763584	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000334867800033
J	Ma, QF				Ma, Qiufu			Merkel Cells Are a Touchy Subject	CELL			English	Editorial Material							COMPONENTS	How the Merkel cell-neurite complex transduces and encodes touch remains unclear. Ikeda et al. now implicate Merkel cells as the primary sites of tactile transduction and the ion channel Piezo2 as the chief mechanotransducer. Surprisingly, Merkel cells also mediate allodynia, providing a new cellular target for chronic pain treatment.	[Ma, Qiufu] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Ma, Qiufu] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Ma, QF (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 450 Brookline St, Boston, MA 02115 USA.	qiufu_ma@dfci.harvard.edu			NIDCR NIH HHS [R01 DE018025] Funding Source: Medline; NINDS NIH HHS [P01 NS072040] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS072040] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; GOTTSCHALDT KM, 1981, SCIENCE, V214, P183, DOI 10.1126/science.7280690; IGGO A, 1969, J PHYSIOL-LONDON, V200, P763, DOI 10.1113/jphysiol.1969.sp008721; Ikeda R, 2014, CELL, V157, P664, DOI 10.1016/j.cell.2014.02.026; Lou S, 2013, J NEUROSCI, V33, P870, DOI 10.1523/JNEUROSCI.3942-12.2013; Maksimovic S, 2013, ANN NY ACAD SCI, V1279, P13, DOI 10.1111/nyas.12057; Maricich SM, 2009, SCIENCE, V324, P1580, DOI 10.1126/science.1172890; Niu JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092027; Ogawa H, 1996, PROG NEUROBIOL, V49, P317, DOI 10.1016/0301-0082(96)00018-4; TOREBJORK HE, 1992, J PHYSIOL-LONDON, V448, P765, DOI 10.1113/jphysiol.1992.sp019069	10	6	9	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					531	533		10.1016/j.cell.2014.04.010	http://dx.doi.org/10.1016/j.cell.2014.04.010			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766802	Bronze			2022-12-28	WOS:000335392100004
J	Letourneau, A; Santoni, FA; Bonilla, X; Sailani, MR; Gonzalez, D; Kind, J; Chevalier, C; Thurman, R; Sandstrom, RS; Hibaoui, Y; Garieri, M; Popadin, K; Falconnet, E; Gagnebin, M; Gehrig, C; Vannier, A; Guipponi, M; Farinelli, L; Robyr, D; Migliavacca, E; Borel, C; Deutsch, S; Feki, A; Stamatoyannopoulos, JA; Herault, Y; van Steensel, B; Guigo, R; Antonarakis, SE				Letourneau, Audrey; Santoni, Federico A.; Bonilla, Ximena; Sailani, M. Reza; Gonzalez, David; Kind, Jop; Chevalier, Claire; Thurman, Robert; Sandstrom, Richard S.; Hibaoui, Youssef; Garieri, Marco; Popadin, Konstantin; Falconnet, Emilie; Gagnebin, Maryline; Gehrig, Corinne; Vannier, Anne; Guipponi, Michel; Farinelli, Laurent; Robyr, Daniel; Migliavacca, Eugenia; Borel, Christelle; Deutsch, Samuel; Feki, Anis; Stamatoyannopoulos, John A.; Herault, Yann; van Steensel, Bas; Guigo, Roderic; Antonarakis, Stylianos E.			Domains of genome-wide gene expression dysregulation in Down's syndrome	NATURE			English	Article							PARTIAL TRISOMY; CELL-TYPE; CHROMATIN; BIOTINYLATION; TRANSCRIPTOME; PROLIFERATION; CHROMOSOME; PLASTICITY; PHENOTYPES; PACKAGE	Trisomy 21 is the most frequent genetic cause of cognitive impairment. To assess the perturbations of gene expression in trisomy 21, and to eliminate the noise of genomic variability, we studied the transcriptome of fetal fibroblasts from a pair of monozygotic twins discordant for trisomy 21. Here we show that the differential expression between the twins is organized in domains along all chromosomes that are either upregulated or downregulated. These gene expression dysregulation domains (GEDDs)can be defined by the expression level of their gene content, and are well conserved in induced pluripotent stem cells derived from the twins' fibroblasts. Comparison of the transcriptome of the Ts65Dn mouse model of Down's syndrome and normal littermate mouse fibroblasts also showed GEDDs along the mouse chromosomes that were syntenic in human. The GEDDs correlate with the lamina- associated (LADs)and replication domains of mammalian cells. The overall position of LADs was not altered in trisomic cells; however, the H3K4me3 profile of the trisomic fibroblasts was modified and accurately followed the GEDD pattern. These results indicate that the nuclear compartments of trisomic cells undergo modifications of the chromatin environment influencing the overall transcriptome, and that GEDDs may therefore contribute to some trisomy 21 phenotypes.	[Letourneau, Audrey; Santoni, Federico A.; Bonilla, Ximena; Sailani, M. Reza; Garieri, Marco; Popadin, Konstantin; Falconnet, Emilie; Gagnebin, Maryline; Gehrig, Corinne; Vannier, Anne; Guipponi, Michel; Robyr, Daniel; Migliavacca, Eugenia; Borel, Christelle; Antonarakis, Stylianos E.] Univ Hosp Geneva, Univ Geneva Med Sch, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Gonzalez, David; Guigo, Roderic] Univ Pompeu Fabra, Ctr Genom Regulat, Barcelona 08003, Spain; [Kind, Jop; van Steensel, Bas] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [Chevalier, Claire; Herault, Yann] Univ Strasbourg, INSERM, CNRS, Translat Med & Neurosci Program,IGBMC,ICS,PHENOMI, F-67404 Illkirch Graffenstaden, France; [Thurman, Robert; Sandstrom, Richard S.; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Hibaoui, Youssef; Feki, Anis] Univ Hosp Geneva, Dept Obstet & Gynecol, Stem Cell Res Lab, CH-1211 Geneva, Switzerland; [Farinelli, Laurent] FASTERIS SA, CH-1228 Plan Les Ouates, Switzerland; [Migliavacca, Eugenia] Swiss Inst Bioinfomat, CH-1211 Geneva, Switzerland; [Deutsch, Samuel] DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; [Antonarakis, Stylianos E.] iGE3 Inst Genet & Genom Geneva, CH-1211 Geneva, Switzerland	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Netherlands Cancer Institute; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Washington; University of Washington Seattle; University of Geneva; Swiss Institute of Bioinformatics; United States Department of Energy (DOE)	Antonarakis, SE (corresponding author), Univ Hosp Geneva, Univ Geneva Med Sch, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	Stylianos.Antonarakis@unige.ch	Guigo, Roderic/D-1303-2010; Herault, Yann/B-5500-2012; Antonarakis, Stylianos E/N-8866-2014; Bonilla, Ximena/AAI-7910-2021; borel, christelle/AAC-9645-2019; Popadin, Konstantin/L-7459-2017	Guigo, Roderic/0000-0002-5738-4477; Herault, Yann/0000-0001-7049-6900; Antonarakis, Stylianos E/0000-0001-8907-5823; Deutsch, Samuel/0000-0001-9456-7101; Sandstrom, Richard/0000-0002-3356-1547; Santoni, Federico/0000-0002-3258-4747; Feki, Anis/0000-0002-9817-9445; Bonilla, Ximena/0000-0002-4950-6825	Swiss National Science Foundation [SNF-144082]; European Research Council [ERC-249968]; AnEUploidy grant; Lejeune foundation; ChildCare foundation; Spanish MICINN [BIO2011-26205, ERC-294653]; NWO-ALW-VICI; CNRS; INSERM; University of Strasbourg; NIH [U54HG007010]; Genico and Ernest Boninchi foundation; BluePrint EU grant;  [ANR-10-INBS-07]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007010] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); AnEUploidy grant; Lejeune foundation; ChildCare foundation; Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NWO-ALW-VICI(Netherlands Organization for Scientific Research (NWO)); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Strasbourg; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genico and Ernest Boninchi foundation; BluePrint EU grant; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the Swiss National Science Foundation (SNF-144082), the European Research Council (ERC-249968), AnEUploidy and BluePrint EU grants, the Lejeune, and ChildCare foundations for supporting the S.E.A. laboratory. The laboratories of R.G. were supported by Spanish MICINN (BIO2011-26205) and ERC-294653, B.v.S. by NWO-ALW-VICI, Y. He. by CNRS, INSERM, University of Strasbourg and ANR-10-INBS-07, J.A.S. by NIH U54HG007010, and A.F. by Genico and Ernest Boninchi foundation. Wethank S. Dahoun and J.L. Blouin for the discordant twins sample collection.	Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R87, 10.1186/gb-2012-13-10-r87]; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Bakshi R, 2010, J CELL PHYSIOL, V225, P569, DOI 10.1002/jcp.22240; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Canzonetta C, 2008, AM J HUM GENET, V83, P388, DOI 10.1016/j.ajhg.2008.08.012; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Chrast R, 2000, HUM MOL GENET, V9, P1853, DOI 10.1093/hmg/9.12.1853; Contestabile A, 2007, HIPPOCAMPUS, V17, P665, DOI 10.1002/hipo.20308; Costa V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018493; Dahoun S, 2008, AM J MED GENET A, V146A, P2086, DOI 10.1002/ajmg.a.32431; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Deutsch S, 2005, HUM MOL GENET, V14, P3741, DOI 10.1093/hmg/ddi404; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Duchon A, 2011, MAMM GENOME, V22, P674, DOI 10.1007/s00335-011-9356-0; Esposito G, 2008, HUM MOL GENET, V17, P440, DOI 10.1093/hmg/ddm322; Gierman HJ, 2007, GENOME RES, V17, P1286, DOI 10.1101/gr.6276007; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; Grad I, 2011, Eur Cell Mater, V22, P258; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hibaoui Y, 2014, EMBO MOL MED, V6, P259, DOI 10.1002/emmm.201302848; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang H, 2003, DEV DYNAM, V227, P608, DOI 10.1002/dvdy.10344; John Sam, 2013, Curr Protoc Mol Biol, VChapter 27, DOI 10.1002/0471142727.mb2127s103; Knowles DG, 2013, BIOINFORMATICS, V29, P614, DOI 10.1093/bioinformatics/btt016; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Letourneau A, 2012, PROG BRAIN RES, V197, P15, DOI 10.1016/B978-0-444-54299-1.00002-9; Lockstone HE, 2007, GENOMICS, V90, P647, DOI 10.1016/j.ygeno.2007.08.005; Lyle R, 2009, EUR J HUM GENET, V17, P454, DOI 10.1038/ejhg.2008.214; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Narang MA, 2004, HUM MOL GENET, V13, P15, DOI 10.1093/hmg/ddh006; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pestinger V, 2011, J NUTR BIOCHEM, V22, P328, DOI 10.1016/j.jnutbio.2010.02.011; Pope BD, 2012, HUM MOL GENET, V21, P4162, DOI 10.1093/hmg/dds232; Postnikov Y, 2010, BBA-GENE REGUL MECH, V1799, P62, DOI 10.1016/j.bbagrm.2009.11.016; Prandini P, 2007, AM J HUM GENET, V81, P252, DOI 10.1086/519248; Pritchard MA, 1999, J NEURAL TRANSM-SUPP, P293; Ram G, 2011, CLIN EXP IMMUNOL, V164, P9, DOI 10.1111/j.1365-2249.2011.04335.x; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SHAPIRO BL, 1983, AM J MED GENET, V14, P241, DOI 10.1002/ajmg.1320140206; Singh MP, 2013, ARCH BIOCHEM BIOPHYS, V529, P105, DOI 10.1016/j.abb.2012.11.005; Sommer CA, 2008, GENOME, V51, P19, DOI [10.1139/G07-100, 10.1139/g07-100]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Voss TC, 2014, NAT REV GENET, V15, P69, DOI 10.1038/nrg3623; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Zhu N, 2010, BBA-GENE REGUL MECH, V1799, P74, DOI 10.1016/j.bbagrm.2009.11.006; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	57	190	193	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					345	+		10.1038/nature13200	http://dx.doi.org/10.1038/nature13200			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24740065				2022-12-28	WOS:000334403000042
J	Lacasse, Y				Lacasse, Yves			Review: Exercise programs after pulmonary rehabilitation preserve short-term exercise capacity in COPD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DISEASE		Univ Laval, Hop Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada	Laval University	Lacasse, Y (corresponding author), Univ Laval, Hop Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.							Keating A, 2011, CHRON RESP DIS, V8, P89, DOI 10.1177/1479972310393756; Lacasse Y, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub2; Maltais F, 2008, ANN INTERN MED, V149, P869, DOI 10.7326/0003-4819-149-12-200812160-00006	3	0	0	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2014	160	8							JC4	10.7326/0003-4819-160-8-201404150-02004	http://dx.doi.org/10.7326/0003-4819-160-8-201404150-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW3QU	24733221				2022-12-28	WOS:000364907600003
J	Angus-Leppan, H				Angus-Leppan, Heather			First seizures in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							UNPROVOKED SEIZURE; TRANSIENT LOSS; AMERICAN-ACADEMY; EARLY EPILEPSY; RECURRENCE; RISK; MANAGEMENT; EEG; CONSCIOUSNESS; MISDIAGNOSIS		[Angus-Leppan, Heather] Royal Free London NHS Fdn Trust, London, England; [Angus-Leppan, Heather] Barnet Chase Farm Hosp NHS Trust, London, England; [Angus-Leppan, Heather] UCL, Inst Neurol, London WC1E 6BT, England; [Angus-Leppan, Heather] Imperial Coll London, Ctr Restorat Neurosci, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London; Imperial College London	Angus-Leppan, H (corresponding author), Royal Free Hosp, Pond St, London NW3 2QG, England.	heather.angus-leppan@nhs.net	Angus-Leppan, Heather/AAF-5168-2019	Angus-Leppan, Heather/0000-0001-7004-3848				All Party Parliamentary Group on Epilepsy, 2007, WAST MON WAST LIV HU; Almeida MDG, 2007, EPILEPSIA, V48, P851, DOI 10.1111/j.1528-1167.2007.01045.x; Angus-Leppan H, 2010, EUR J NEUROL, V17, pe26, DOI 10.1111/j.1468-1331.2008.02904.x; Angus-Leppan H, 2008, SEIZURE-EUR J EPILEP, V17, P431, DOI 10.1016/j.seizure.2007.12.010; Angus-Leppan H, 2007, CLIN NEUROPHYSIOL, V118, P22, DOI 10.1016/j.clinph.2006.08.014; Angus-Leppan Heather, 2013, Pract Neurol, V13, P308, DOI 10.1136/practneurol-2012-000502; [Anonymous], 1993, EPILEPSIA, V34, P592; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; [Anonymous], 1960, BRIT MED J, V2, P416; BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x; Beghi E, 2010, EPILEPSIA, V51, P671, DOI 10.1111/j.1528-1167.2009.02285.x; Bellon M, 2013, EPILEPSY BEHAV, V27, P251, DOI 10.1016/j.yebeh.2013.01.016; Bellon M, 2013, EPILEPSY BEHAV, V26, P7, DOI 10.1016/j.yebeh.2012.10.019; BERAN R G, 1985, Neuroepidemiology, V4, P82, DOI 10.1159/000110218; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; BERG AT, 1991, NEUROLOGY, V41, P965, DOI 10.1212/WNL.41.7.965; Burns CM, 2008, PEDIATRICS, V122, P65, DOI 10.1542/peds.2007-2822; Burt J, 2008, LEARNING DISABILITY, V11, P12; Camfield P, 2000, EPILEPSIA, V41, P1230, DOI 10.1111/j.1528-1157.2000.tb00331.x; Carpio A, 2009, CURR NEUROL NEUROSCI, V9, P319, DOI 10.1007/s11910-009-0048-z; Caviness JN, 2004, LANCET NEUROL, V3, P598, DOI 10.1016/S1474-4422(04)00880-4; Chung SS, 2006, NEUROLOGY, V66, P1730, DOI 10.1212/01.wnl.0000218160.31537.87; Cole C, 2010, SEIZURE-EUR J EPILEP, V19, P592, DOI 10.1016/j.seizure.2010.09.005; DAY SC, 1982, AM J MED, V73, P15, DOI 10.1016/0002-9343(82)90913-5; Duncan S, 1999, EPILEPSIA, V40, P197, DOI 10.1111/j.1528-1157.1999.tb02075.x; Dunn MJG, 2005, EMERG MED J, V22, P237, DOI 10.1136/emj.2004.015651; EAGLE KA, 1985, AM J MED, V79, P455, DOI 10.1016/0002-9343(85)90032-4; Eckart RE, 2004, ANN INTERN MED, V141, P829, DOI 10.7326/0003-4819-141-11-200412070-00005; FENWICK PBC, 1985, ACTA NEUROL SCAND, V71, P428; FORSGREN L, 1990, EPILEPSIA, V31, P292, DOI 10.1111/j.1528-1157.1990.tb05379.x; Ganzeboom KS, 2006, J CARDIOVASC ELECTR, V17, P1172, DOI 10.1111/j.1540-8167.2006.00595.x; Harden CL, 2007, NEUROLOGY, V69, P1772, DOI 10.1212/01.wnl.0000285083.25882.0e; HART YM, 1990, LANCET, V336, P1271, DOI 10.1016/0140-6736(90)92960-P; Hauser WA, 2008, EPILEPSIA, V49, P8, DOI 10.1111/j.1528-1167.2008.01443.x; Hauser WA, 1996, MAYO CLIN PROC, V71, P576, DOI 10.4065/71.6.576; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; HAUSER WA, 1990, NEUROLOGY, V40, P1163, DOI 10.1212/WNL.40.8.1163; HAUSER WA, 1982, NEW ENGL J MED, V307, P522, DOI 10.1056/NEJM198208263070903; Haut SR, 2008, SEMIN NEUROL, V28, P289, DOI 10.1055/s-2008-1079333; Helen Cross J, 2009, PAEDIAT CHILD HLTH, V19, P199; HOEFNAGELS WAJ, 1991, J NEUROL, V238, P39, DOI 10.1007/BF00319709; JACOBY A, 1993, EPILEPSY RES, V16, P83, DOI 10.1016/0920-1211(93)90042-6; Jallon P, 1997, EPILEPSIA, V38, P547, DOI 10.1111/j.1528-1157.1997.tb01139.x; Kho LK, 2006, NEUROLOGY, V67, P1047, DOI 10.1212/01.wnl.0000237555.12146.66; Kim LG, 2006, LANCET NEUROL, V5, P317, DOI 10.1016/S1474-4422(06)70383-0; King MA, 1998, LANCET, V352, P1007, DOI 10.1016/S0140-6736(98)03543-0; Krumholz A, 2007, NEUROLOGY, V69, P1996, DOI 10.1212/01.wnl.0000285084.93652.43; Lambert MV, 2001, SEIZURE-EUR J EPILEP, V10, P319, DOI 10.1053/seiz.2000.0512; LAVADOS J, 1992, ACTA NEUROL SCAND, V85, P249; Leach JP, 2005, SEIZURE-EUR J EPILEP, V14, P514, DOI 10.1016/j.seizure.2005.08.008; Lempert T, 1997, NERVENARZT, V68, P620, DOI 10.1007/s001150050171; LEMPERT T, 1994, ANN NEUROL, V36, P233, DOI 10.1002/ana.410360217; Leone M, 2002, J NEUROL NEUROSUR PS, V73, P495, DOI 10.1136/jnnp.73.5.495; Leone MA, 2006, NEUROLOGY, V67, P2227, DOI 10.1212/01.wnl.0000249309.80510.63; LEWIS HM, 1979, ARCH DIS CHILD, V54, P869, DOI 10.1136/adc.54.11.869; Logroscino G, 2002, NEUROLOGY, V58, P537, DOI 10.1212/WNL.58.4.537; LOISEAU J, 1990, EPILEPSIA, V31, P391, DOI 10.1111/j.1528-1157.1990.tb05493.x; LOISEAU J, 1990, ANN NEUROL, V27, P232, DOI 10.1002/ana.410270304; Marini C, 2003, J NEUROL NEUROSUR PS, V74, P192, DOI 10.1136/jnnp.74.2.192; Marson A, 2005, LANCET, V365, P2007, DOI 10.1016/S0140-6736(05)66694-9; Meinardi H, 2001, EPILEPSIA, V42, P136, DOI 10.1046/j.1528-1157.2001.32800.x; Morton B, 2006, J NEUROL NEUROSUR PS, V77, P199, DOI 10.1136/jnnp.2005.066852; National Institute for Health and Clinical Excellence, 2010, TRANS LOSS CONSC BLA; National Institute for Health and Clinical Excellence: Guidance, 2012, EP DIAGN MAN EP AD C; Neligan A, 2012, NEUROLOGY, V78, P1166, DOI 10.1212/WNL.0b013e31824f807a; NG SKC, 1988, NEW ENGL J MED, V319, P666; Ng YS, 2013, J NEUROL NEUROSUR PS, V84, pe2; PANAYIOTOPOULOS CP, 1992, J NEUROL NEUROSUR PS, V55, P1002, DOI 10.1136/jnnp.55.11.1002; PANAYIOTOPOULOS CP, 2002, CLIN GUIDE EPILEPTIC; PLACENCIA M, 1992, NEUROEPIDEMIOLOGY, V11, P74, DOI 10.1159/000110915; Reuber M, 2003, ANN NEUROL, V53, P305, DOI 10.1002/ana.3000; Reuber M, 2011, EPILEPSIA, V52, P2028, DOI 10.1111/j.1528-1167.2011.03162.x; Rossetti AO, 2006, J NEUROL NEUROSUR PS, V77, P611, DOI 10.1136/jnnp.2005.080887; Sander JW, 2013, LANCET, V382, P1618, DOI 10.1016/S0140-6736(13)61136-8; Sander JW, 2005, EUR J NEUROL, V12, P3, DOI 10.1111/j.1468-1331.2005.01326.x; Seneviratne U, 2009, POSTGRAD MED J, V85, P667, DOI 10.1136/pgmj.2009.082883; Sheldon R, 2002, J AM COLL CARDIOL, V40, P142, DOI 10.1016/S0735-1097(02)01940-X; SHINNAR S, 1990, PEDIATRICS, V85, P1076; Smith D, 1999, QJM-INT J MED, V92, P15, DOI 10.1093/qjmed/92.1.15; Smith SJM, 2005, J NEUROL NEUROSUR PS, V76, P2, DOI 10.1136/jnnp.2005.069245; Soteriades ES, 2002, NEW ENGL J MED, V347, P878, DOI 10.1056/NEJMoa012407; Szaflarski JP, 2008, EPILEPSIA, V49, P974, DOI 10.1111/j.1528-1167.2007.01513.x; Taylor J, 1996, J NEUROL NEUROSUR PS, V60, P621, DOI 10.1136/jnnp.60.6.621; Thijs RD, 2008, NEUROLOGY, V71, P1713, DOI 10.1212/01.wnl.0000335165.68893.b0; van Breemen MSM, 2007, LANCET NEUROL, V6, P421, DOI 10.1016/S1474-4422(07)70103-5; Velissaris SL, 2012, EPILEPSIA, V53, P1774, DOI 10.1111/j.1528-1167.2012.03658.x; Zaidi A, 2000, J AM COLL CARDIOL, V36, P181, DOI 10.1016/S0735-1097(00)00700-2; ZIELINSKI JJ, 1974, EPIDEMIOLOGY MEDICOS; ZIVIN L, 1968, BRAIN, V91, P751, DOI 10.1093/brain/91.4.751	89	17	18	2	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2014	348								g2470	10.1136/bmj.g2470	http://dx.doi.org/10.1136/bmj.g2470			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF5GN	24736280				2022-12-28	WOS:000334742100019
J	Gough, EK; Moodie, EEM; Prendergast, AJ; Johnson, SMA; Humphrey, JH; Stoltzfus, RJ; Walker, AS; Trehan, I; Gibb, DM; Goto, R; Tahan, S; de Morais, MB; Manges, AR				Gough, Ethan K.; Moodie, Erica E. M.; Prendergast, Andrew J.; Johnson, Sarasa M. A.; Humphrey, Jean H.; Stoltzfus, Rebecca J.; Walker, A. Sarah; Trehan, Indi; Gibb, Diana M.; Goto, Rie; Tahan, Soraia; de Morais, Mauro Batista; Manges, Amee R.			The impact of antibiotics on growth in children in low and middle income countries: systematic review and meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DOUBLE-BLIND; PERSISTENT DIARRHEA; GUT MICROBIOTA; CLINICAL-TRIAL; ANTI-GIARDIA; MALNUTRITION; NUTRITION; EFFICACY; HEALTH; INFECTION	Objectives To determine whether antibiotic treatment leads to improvements in growth in prepubertal children in low and middle income countries, to determine the magnitude of improvements in growth, and to identify moderators of this treatment effect. Design Systematic review and meta-analysis. Data sources Medline, Embase, Scopus, the Cochrane central register of controlled trials, and Web of Science. Study selection Randomised controlled trials conducted in low or middle income countries in which an orally administered antibacterial agent was allocated by randomisation or minimisation and growth was measured as an outcome. Participants aged 1 month to 12 years were included. Control was placebo or non-antimicrobial intervention. Results Data were pooled from 10 randomised controlled trials representing 4316 children, across a variety of antibiotics, indications for treatment, treatment regimens, and countries. In random effects models, antibiotic use increased height by 0.04 cm/month (95% confidence interval 0.00 to 0.07) and weight by 23.8 g/month (95% confidence interval 4.3 to 43.3). After adjusting for age, effects on height were larger in younger populations and effects on weight were larger in African studies compared with other regions. Conclusion Antibiotics have a growth promoting effect in prepubertal children in low and middle income countries. This effect was more pronounced for ponderal than for linear growth. The antibiotic growth promoting effect may be mediated by treatment of clinical or subclinical infections or possibly by modulation of the intestinal microbiota. Better definition of the mechanisms underlying this effect will be important to inform optimal and safe approaches to achieving healthy growth in vulnerable populations.	[Gough, Ethan K.; Moodie, Erica E. M.; Johnson, Sarasa M. A.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Prendergast, Andrew J.; Humphrey, Jean H.] Zvitambo Inst Maternal Child Hlth Res, Harare, Zimbabwe; [Prendergast, Andrew J.] Queen Mary Univ London, Blizard Inst, Ctr Paediat, London, England; [Prendergast, Andrew J.; Walker, A. Sarah; Gibb, Diana M.] MRC, Clin Trials Unit, London, England; [Humphrey, Jean H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Stoltzfus, Rebecca J.] Cornell Univ, Div Nutr Sci, Program Int Nutr, Ithaca, NY 14853 USA; [Trehan, Indi] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Trehan, Indi] Univ Malawi, Blantyre, Malawi; [Goto, Rie] Univ Cambridge, Dept Archaeol & Anthropol, Div Biol Anthropol, Cambridge CB2 1TN, England; [Tahan, Soraia; de Morais, Mauro Batista] Univ Fed Sao Paulo, Escola Paulista Med, Sao Paulo, Brazil; [Manges, Amee R.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V6T 1Z3, Canada	McGill University; University of London; Queen Mary University London; Medical Research Council Clinical Trials Unit; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Cornell University; Washington University (WUSTL); University of Malawi; University of Cambridge; Universidade Federal de Sao Paulo (UNIFESP); University of British Columbia	Manges, AR (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V6T 1Z3, Canada.	amee.manges@ubc.ca	Walker, Sarah/HDM-8717-2022; MORAIS, MAURO B/I-7995-2014	Batista de Morais, Mauro/0000-0003-4014-5549; Prendergast, Andrew/0000-0001-7904-7992; Gough, Ethan/0000-0001-5265-7731	Vanier Canada Graduate Scholarship	Vanier Canada Graduate Scholarship	EKG was supported by the Vanier Canada Graduate Scholarship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ANU, 2006, PEDIATR INFECT DIS J, V25, P1137, DOI 10.1097/01.inf.0000245105.99934.5f; Alcoba G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053184; Amza A, 2013, AM J TROP MED HYG, V88, P138, DOI 10.4269/ajtmh.2012.12-0284; Angelakis E, 2013, LANCET INFECT DIS, V13, P889, DOI 10.1016/S1473-3099(13)70179-8; Bahl R, 1996, ACTA PAEDIATR, V85, P1290, DOI 10.1111/j.1651-2227.1996.tb13913.x; Montovani PAB, 2009, BRAZ J PHARM SCI, V45, P687, DOI 10.1590/S1984-82502009000400011; BHATNAGAR S, 1992, J PEDIATR GASTR NUTR, V15, P117, DOI 10.1097/00005176-199208000-00003; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 1996, ACTA PAEDIATR SCAND, V374, P133; Bosi P, 2011, J ANIM SCI, V89, P4043, DOI 10.2527/jas.2010-3311; BRIEND A, 1989, LANCET, V2, P319; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; Chung HC, 2010, CURR OPIN IMMUNOL, V22, P455, DOI 10.1016/j.coi.2010.06.008; CROFTON J, 1950, Postgrad Med J, V26, P368; de Onis M, 2013, MATERN CHILD NUTR, V9, P6, DOI 10.1111/mcn.12075; Dewey KG, 2011, MATERN CHILD NUTR, V7, P129, DOI 10.1111/j.1740-8709.2011.00357.x; Dickson R, 2000, BMJ-BRIT MED J, V320, P1697, DOI 10.1136/bmj.320.7251.1697; Dritz SS, 2002, J AM VET MED ASSOC, V220, P1690, DOI 10.2460/javma.2002.220.1690; Dutta S, 2006, J TROP PEDIATRICS, V52, P103, DOI 10.1093/tropej/fmi070; Francois F, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-37; GARCIADEOLARTE D, 1974, AM J DIS CHILD, V127, P379, DOI 10.1001/archpedi.1974.02110220077011; GARROD LP, 1960, BRIT MED J, V1, P527, DOI 10.1136/bmj.1.5172.527; Gerber GK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002624; Giannakopoulos CG, 2001, J VET MED A, V48, P257, DOI 10.1046/j.1439-0442.2001.00364.x; Goto R, 2009, T ROY SOC TROP MED H, V103, P520, DOI 10.1016/j.trstmh.2008.07.020; Greenland S, 2008, MODERN EPIDEMIOLOGY, P652; Guay DRP, 2000, ANN PHARMACOTHER, V34, P1469; Gueimonde M, 2012, CLIN MICROBIOL INFEC, V18, P32, DOI 10.1111/j.1469-0691.2012.03873.x; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; GUPTA MC, 1982, AM J CLIN NUTR, V36, P79, DOI 10.1093/ajcn/36.1.79; GUZMAN MA, 1958, AM J CLIN NUTR, V6, P430, DOI 10.1093/ajcn/6.4.430; HEIKENS GT, 1993, EUR J CLIN NUTR, V47, P160; HIRSCHHORN N, 1971, AM J CLIN NUTR, V24, P872; Hooper LV, 2009, NAT REV MICROBIOL, V7, P367, DOI 10.1038/nrmicro2114; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Isanaka S., 2013, EFFECT ROUTINE ANTIB; Kantas D, 1998, J VET MED A, V45, P525, DOI 10.1111/j.1439-0442.1998.tb00856.x; KHINMAUNGU, 1990, LANCET, V336, P1090, DOI 10.1016/0140-6736(90)92569-4; Lazzerini M, 2011, B WORLD HEALTH ORGAN, V89, P593, DOI 10.2471/BLT.10.084715; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lopriore C, 2004, AM J CLIN NUTR, V80, P973, DOI 10.1093/ajcn/80.4.973; LOUGHLIN E H, 1957, Antibiot Annu, V5, P95; Lunn PG, 2000, P NUTR SOC, V59, P147, DOI 10.1017/S0029665100000173; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Million M, 2013, CLIN MICROBIOL INFEC, V19, P305, DOI 10.1111/1469-0691.12172; Packer EL, 2011, AUST VET J, V89, P338, DOI 10.1111/j.1751-0813.2011.00802.x; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Parks CW, 2005, POULTRY SCI, V84, P1967, DOI 10.1093/ps/84.12.1967; Prendergast A, 2012, AM J TROP MED HYG, V86, P756, DOI 10.4269/ajtmh.2012.11-0743; Prendergast A, 2011, CLIN INFECT DIS, V52, P953, DOI 10.1093/cid/cir029; Rafii Fatemeh, 2008, Ther Clin Risk Manag, V4, P1343; Rerat M, 2012, PREV VET MED, V103, P265, DOI 10.1016/j.prevetmed.2011.09.003; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Riley RD, 2008, STAT MED, V27, P1870, DOI 10.1002/sim.3165; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Rodriguez L, 2011, INT J ENV RES PUB HE, V8, P1174, DOI 10.3390/ijerph8041174; ROSENBERG IH, 1974, AM J CLIN NUTR, V27, P304, DOI 10.1093/ajcn/27.3.304; Roy SK, 1998, T ROY SOC TROP MED H, V92, P460, DOI 10.1016/S0035-9203(98)91094-X; Salvo F, 2009, EXPERT OPIN DRUG SAF, V8, P111, DOI [10.1517/14740330802527984 , 10.1517/14740330802527984]; Scarpignato C, 2005, CHEMOTHERAPY, V51, P36, DOI 10.1159/000081990; SCRIMSHAW N S, 1953, Bol Oficina Sanit Panam, V34, P551; SCRIMSHAW NS, 1968, ARCH ENVIRON HEALTH, V16, P223, DOI 10.1080/00039896.1968.10665048; Smith C L, 2000, Pediatr Rev, V21, P368; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Sullivan A, 2001, Lancet Infect Dis, V1, P101, DOI 10.1016/S1473-3099(01)00066-4; Tahan S, 2007, BRAZ J MED BIOL RES, V40, P209, DOI 10.1590/S0100-879X2006005000064; TALLY FP, 1978, ANTIMICROB AGENTS CH, V13, P460, DOI 10.1128/AAC.13.3.460; Taylor-Robinson DC, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000371.pub3; Trehan I, 2013, NEW ENGL J MED, V368, P425, DOI 10.1056/NEJMoa1202851; Trehan I, 2010, TROP MED INT HEALTH, V15, P1022, DOI 10.1111/j.1365-3156.2010.02580.x; Trehan I, 2009, AM J GASTROENTEROL, V104, P2326, DOI 10.1038/ajg.2009.270; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; United Nations, 2013, MILL DEV GOALS REP; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Weber TE, 2001, J ANIM SCI, V79, P2542; WHO, 2006, ACTA PAEDIATR, P76, DOI DOI 10.1111/J.1651-2227.2006.TB02378.X; WOLFSDORF J, 1973, S AFR MED J, V47, P1887; World Health Organization and United Nations Children's Fund, 2012, COTR PROPH HIV EXP H; Zavascki AP, 2007, J ANTIMICROB CHEMOTH, V60, P1206, DOI 10.1093/jac/dkm357	84	84	84	1	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2014	348								g2267	10.1136/bmj.g2267	http://dx.doi.org/10.1136/bmj.g2267			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF5GN	24735883	Green Published, hybrid			2022-12-28	WOS:000334742100001
J	Crawley, SW; Shifrin, DA; Grega-Larson, NE; McConnell, RE; Benesh, AE; Mao, SL; Zheng, YX; Zheng, QY; Nam, KT; Millis, BA; Kachar, B; Tyska, MJ				Crawley, Scott W.; Shifrin, David A., Jr.; Grega-Larson, Nathan E.; McConnell, Russell E.; Benesh, Andrew E.; Mao, Suli; Zheng, Yuxi; Zheng, Qing Yin; Nam, Ki Taek; Millis, Bryan A.; Kachar, Bechara; Tyska, Matthew J.			Intestinal Brush Border Assembly Driven by Protocadherin-Based Intermicrovillar Adhesion	CELL			English	Article							USHER-SYNDROME PROTEINS; SENSORY HAIR-CELLS; IN-VIVO; CADHERIN; LOCALIZATION; MECHANOTRANSDUCTION; ORGANIZATION; HARMONIN; DOMAIN; GENE	Transporting epithelial cells build apical microvilli to increase membrane surface area and enhance absorptive capacity. The intestinal brush border provides an elaborate example with tightly packed microvilli that function in nutrient absorption and host defense. Although the brush border is essential for physiological homeostasis, its assembly is poorly understood. We found that brush border assembly is driven by the formation of Ca2+-dependent adhesion links between adjacent microvilli. Intermicrovillar links are composed of protocadherin-24 and mucin-like protocadherin, which target to microvillar tips and interact to form a trans-heterophilic complex. The cytoplasmic domains of microvillar protocadherins interact with the scaffolding protein, harmonin, and myosin-7b, which promote localization to microvillar tips. Finally, a mouse model of Usher syndrome lacking harmonin exhibits microvillar protocadherin mislocalization and severe defects in brush border morphology. These data reveal an adhesion-based mechanism for brush border assembly and illuminate the basis of intestinal pathology in patients with Usher syndrome.	[Crawley, Scott W.; Shifrin, David A., Jr.; Grega-Larson, Nathan E.; McConnell, Russell E.; Benesh, Andrew E.; Mao, Suli; Tyska, Matthew J.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Zheng, Yuxi; Zheng, Qing Yin] Case Western Reserve Univ, Dept Otolaryngol HNS, Cleveland, OH 44106 USA; [Nam, Ki Taek] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul 120752, South Korea; [Millis, Bryan A.; Kachar, Bechara] NIDCD, NIH, Bethesda, MD 20892 USA	Vanderbilt University; Case Western Reserve University; Yonsei University; Yonsei University Health System; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Tyska, MJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA.	matthew.tyska@vanderbilt.edu		/0000-0001-5063-8502; Millis, Bryan/0000-0002-5770-627X	NIDCD; NIH; American Heart Association (AHA); AHA [12GRNT12050314]; VUMC Digestive Diseases Research Center [NIH P30DK058404]; Vanderbilt University IDEAS award; NIH [DC009246, DK075555, DK095811]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007502] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA119925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095811, R01DK075555, R56DK095811, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009246, ZIADC000002, ZIADC000009] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012324] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); AHA(American Heart Association); VUMC Digestive Diseases Research Center; Vanderbilt University IDEAS award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank all members of the M.J.T. laboratory and the Vanderbilt Epithelial Biology Center for advice and support. Electron and light microscopy was performed in part through the use of the VUMC Cell Imaging Shared Resource. This work was supported by Intramural Programs of NIDCD, NIH (to B.K.), American Heart Association (AHA) predoctoral fellowships (to D.A.S. and R.E.M.), AHA postdoctoral fellowship (to S.W.C.), AHA grant-in-aid 12GRNT12050314 (to M.J.T.), the VUMC Digestive Diseases Research Center (NIH P30DK058404), a Vanderbilt University IDEAS award (to M.J.T.), and NIH DC009246 (to Q.Y.Z.), DK075555, and DK095811 (to M.J.T.).	Alagramam KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019183; BAILEY DS, 1989, GUT, V30, P78, DOI 10.1136/gut.30.1.78; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; BERNDORFF D, 1994, J CELL BIOL, V125, P1353, DOI 10.1083/jcb.125.6.1353; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; BOLLER K, 1985, J CELL BIOL, V100, P327, DOI 10.1083/jcb.100.1.327; BOUGHMAN JA, 1983, J CHRON DIS, V36, P595, DOI 10.1016/0021-9681(83)90147-9; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Chan YHM, 2012, SCIENCE, V337, P1186, DOI 10.1126/science.1223539; Chang J, 2008, J PROTEOMICS, V71, P530, DOI 10.1016/j.jprot.2008.08.003; D'Alterio C, 2005, J CELL BIOL, V171, P549, DOI 10.1083/jcb.200507072; Elledge HM, 2010, P NATL ACAD SCI USA, V107, P10708, DOI 10.1073/pnas.1006284107; Emond MR, 2011, J CELL BIOL, V195, P1115, DOI 10.1083/jcb.201108115; Ferrary E, 1999, J CELL BIOL, V146, P819, DOI 10.1083/jcb.146.4.819; Goldberg M, 2000, J BIOL CHEM, V275, P24622, DOI 10.1074/jbc.M000234200; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; Grillet N, 2009, NEURON, V62, P375, DOI 10.1016/j.neuron.2009.04.006; Grimm-Gunter EMS, 2009, MOL BIOL CELL, V20, P2549, DOI 10.1091/mbc.E08-10-1030; Guillot C, 2013, SCIENCE, V340, P1185, DOI 10.1126/science.1235249; Henn A, 2005, J BIOL CHEM, V280, P39665, DOI 10.1074/jbc.M507667200; Jeejeebhoy KN, 2002, CAN MED ASSOC J, V166, P1297; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Khubchandani SR, 2011, ULTRASTRUCT PATHOL, V35, P87, DOI 10.3109/01913123.2010.537438; Kobayashi I, 1999, GASTROENTEROLOGY, V117, P823, DOI 10.1016/S0016-5085(99)70340-9; Mariadason JM, 2005, GASTROENTEROLOGY, V128, P1081, DOI 10.1053/j.gastro.2005.01.054; MAROUX S, 1988, BIOCHIMIE, V70, P1297, DOI 10.1016/0300-9084(88)90198-8; McConnell RE, 2011, AM J PHYSIOL-GASTR L, V300, pG914, DOI 10.1152/ajpgi.00005.2011; MOOSEKER MS, 1985, ANNU REV CELL BIOL, V1, P209, DOI 10.1146/annurev.cellbio.1.1.209; Mukherjee S, 2008, CELL MOL LIFE SCI, V65, P3019, DOI 10.1007/s00018-008-8182-3; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; Pan LF, 2012, PHYSIOLOGY, V27, P25, DOI 10.1152/physiol.00037.2011; PETERSON MD, 1992, J CELL SCI, V102, P581; Revenu C, 2012, MOL BIOL CELL, V23, P324, DOI 10.1091/mbc.E11-09-0765; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Schlichting K, 2006, J CELL SCI, V119, P1184, DOI 10.1242/jcs.02831; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Shifrin DA, 2012, GUT MICROBES, V3, P460, DOI 10.4161/gmic.21247; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; Sotomayor M, 2012, NATURE, V492, P128, DOI 10.1038/nature11590; Sotomayor M, 2010, NEURON, V66, P85, DOI 10.1016/j.neuron.2010.03.028; Tian C, 2010, BRAIN RES, V1328, P57, DOI 10.1016/j.brainres.2010.02.079; Tyska MJ, 2005, MOL BIOL CELL, V16, P2443, DOI 10.1091/mbc.E04-12-1116; Tyska MJ, 2004, J CELL BIOL, V165, P395, DOI 10.1083/jcb.200310031; Vallance BA, 2002, CAN J GASTROENTEROL, V16, P771, DOI 10.1155/2002/410980; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Widmark Jill M, 2007, Proc (Bayl Univ Med Cent), V20, P408	50	104	111	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					433	446		10.1016/j.cell.2014.01.067	http://dx.doi.org/10.1016/j.cell.2014.01.067			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725409	Green Accepted, Bronze			2022-12-28	WOS:000334304500016
J	Liu, BY; Chen, W; Evavold, BD; Zhu, C				Liu, Baoyu; Chen, Wei; Evavold, Brian D.; Zhu, Cheng			Accumulation of Dynamic Catch Bonds between TCR and Agonist Peptide-MHC Triggers T Cell Signaling	CELL			English	Article							LIGAND BINDING-KINETICS; CUTTING EDGE; ADHESION; REQUIRE; SURFACES; AFFINITY; WASP; ZETA	TCR-pMHC interactions initiate adaptive immune responses, but the mechanism of how such interactions under force induce T cell signaling is unclear. We show that force prolongs lifetimes of single TCR-pMHC bonds for agonists (catch bonds) but shortens those for antagonists (slip bonds). Both magnitude and duration of force are important, as the highest Ca2+ responses were induced by 10 pN via both pMHC catch bonds whose lifetime peaks at this force and anti-TCR slip bonds whose maximum lifetime occurs at 0 pN. High Ca2+ levels require early and rapid accumulation of bond lifetimes, whereas short-lived bonds that slow early accumulation of lifetimes correspond to low Ca2+ responses. Our data support a model in which force on the TCR induces signaling events depending on its magnitude, duration, frequency, and timing, such that agonists form catch bonds that trigger the T cell digitally, whereas antagonists form slip bonds that fail to activate.	[Liu, Baoyu; Chen, Wei; Zhu, Cheng] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Zhu, Cheng] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Zhu, Cheng] Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Evavold, Brian D.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Emory University	Zhu, C (corresponding author), Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	cheng.zhu@bme.gatech.edu	Liu, Baoyu/C-4911-2009; Chen, Wei/C-4823-2009	Liu, Baoyu/0000-0002-0798-6314; Evavold, Brian/0000-0002-3561-3494; Chen, Wei/0000-0001-5366-7253; Zhu, Cheng/0000-0002-1718-565X	NIH [AI38282, GM096187, NS071518, AI096879]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007610, R01AI096879, R01AI038282, R56AI038282, R29AI038282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the NIH Tetramer Core Facility at Emory University for providing pMHC monomers, John Altman for providing the H2-K<SUP>b</SUP>alpha 3A2 construct, Larissa Doudy for purifying T cells, Michelle Krogsgaard for advice on Ca<SUP>2+</SUP> imaging, Lining Ju for constructing the BFP-2, Jin-sung Hong for initial design of the Ca<SUP>2+</SUP> imaging system, Yunfeng Chen for designing the temperature control unit, Qinghua Ji for designing the cell chamber, Li Gu for help on statistical analysis, and Rodger P. McEver, Ellis L. Reinherz, Michelle Krogsgaard, Hai-Tao He, and Jeffrey A. Donnell for helpful comments. This work was supported by NIH grants AI38282 and GM096187 (to C.Z.) and NS071518 and AI096879 (to B.D.E.). The authors declare no competing financial interests.	Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Aleksic M, 2010, IMMUNITY, V32, P163, DOI 10.1016/j.immuni.2009.11.013; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Chen W, 2008, BIOPHYS J, V94, P694, DOI 10.1529/biophysj.107.117895; Chen W, 2008, CELL MOL BIOENG, V1, P276, DOI 10.1007/s12195-008-0024-8; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Dushek O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000578; EVANS E, 1995, BIOPHYS J, V68, P2580, DOI 10.1016/S0006-3495(95)80441-8; Gascoigne N R, 2001, Expert Rev Mol Med, V2001, P1, DOI 10.1017/S1462399401002502; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Ilani T, 2009, NAT IMMUNOL, V10, P531, DOI 10.1038/ni.1723; James JR, 2012, NATURE, V487, P64, DOI 10.1038/nature11220; Jansson Andreas, 2011, Self Nonself, V2, P1; Jiang N, 2011, IMMUNITY, V34, P13, DOI 10.1016/j.immuni.2010.12.017; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Kilgore NE, 2003, J IMMUNOL, V170, P4891, DOI 10.4049/jimmunol.170.10.4891; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Li YC, 2010, J IMMUNOL, V184, P5959, DOI 10.4049/jimmunol.0900775; Liu BY, 2014, EUR J IMMUNOL, V44, P239, DOI 10.1002/eji.201343774; Majstoravich S, 2004, BLOOD, V104, P1396, DOI 10.1182/blood-2004-02-0437; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; McMahan RH, 2006, J CLIN INVEST, V116, P2543, DOI 10.1172/JCI26936; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Mukhopadhyay H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003004; Puech PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022344; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sabatino JJ, 2011, J EXP MED, V208, P81, DOI 10.1084/jem.20101574; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Wang JH, 2012, IMMUNOL REV, V250, P102, DOI 10.1111/j.1600-065X.2012.01161.x; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yao DK, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021907; Zarnitsyna VI, 2007, P NATL ACAD SCI USA, V104, P18037, DOI 10.1073/pnas.0704811104; Zhang H, 2011, P NATL ACAD SCI USA, V108, P19323, DOI 10.1073/pnas.1108052108; Zhu C, 2013, IMMUNOL REV, V251, P49, DOI 10.1111/imr.12016	47	328	335	7	89	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					357	368		10.1016/j.cell.2014.02.053	http://dx.doi.org/10.1016/j.cell.2014.02.053			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725404	Green Accepted, Bronze			2022-12-28	WOS:000334304500010
J	Das, RR; Singh, M				Das, Rashmi Ranjan; Singh, Meenu			Oral Zinc for the Common Cold (Withdrawn Publication. See vol. 316, pg. 2678, 2016) (Withdrawn Publication. See vol. 316, pg. 2678, 2016) (Withdrawn Publication. See vol. 316, pg. 2678, 2016)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material; Withdrawn Publication								CLINICAL QUESTION: Is oral zinc associated with a shorter duration, decreased severity, and reduced incidence of the common cold compared with placebo? BOTTOM LINE: When initiated within 24 hours of symptom onset, oral zinc is associated with a shorter duration of the common cold in healthy people. However, there is no association between oral zinc and symptom severity, and the prevalence of adverse effects with zinc lozenges is high. Given the high heterogeneity of data, these results should be interpreted with caution. Used prophylactically, oral zinc is associated with a reduced cold incidence in children. Prophylactic use has not been studied in adults.	[Das, Rashmi Ranjan] All India Inst Med Sci, Dept Pediat, Bhubaneswar, Orissa, India; [Singh, Meenu] Postgrad Inst Med Educ & Res, Dept Pediat, Chandigarh 160012, India	All India Institute of Medical Sciences (AIIMS) Bhubaneswar; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Singh, M (corresponding author), Postgrad Inst Med Educ & Res, Chandigarh 160012, India.	meenusingh4@gmail.com						Eby GA, 2010, MED HYPOTHESES, V74, P482, DOI 10.1016/j.mehy.2009.10.017; Fashner J, 2012, AM FAM PHYSICIAN, V86, P153; National Institutes of Health, ZINC FACT SHEET CONS; Rerksuppaphol S, 2013, PAEDIATR INT CHILD H, V33, P145, DOI 10.1179/2046905513Y.0000000064; Singh M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001364.pub4; Whiteman SC, 2003, J BIOL CHEM, V278, P11954, DOI 10.1074/jbc.M205329200	6	11	11	1	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2014	311	14					1440	1441		10.1001/jama.2014.1404	http://dx.doi.org/10.1001/jama.2014.1404			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4EP	24715076				2022-12-28	WOS:000333935000021
J	Yamada, M; Johannesson, B; Sagi, I; Burnett, LC; Kort, DH; Prosser, RW; Paull, D; Nestor, MW; Freeby, M; Greenberg, E; Goland, RS; Leibel, RL; Solomon, SL; Benvenisty, N; Sauer, MV; Egli, D				Yamada, Mitsutoshi; Johannesson, Bjarki; Sagi, Ido; Burnett, Lisa Cole; Kort, Daniel H.; Prosser, Robert W.; Paull, Daniel; Nestor, Michael W.; Freeby, Matthew; Greenberg, Ellen; Goland, Robin S.; Leibel, Rudolph L.; Solomon, Susan L.; Benvenisty, Nissim; Sauer, Mark V.; Egli, Dieter			Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells	NATURE			English	Article							IN-VITRO; MOUSE; MATURATION; STABILITY; HOTSPOTS; PROTEIN; MEMORY; MODEL; ES	The transfer of somatic cell nuclei into oocytes can give rise to pluripotent stem cells that are consistently equivalent to embryonic stem cells(1-3), holding promise for autologous cell replacement therapy(4,5). Although methods to induce pluripotent stem cells from somatic cells by transcription factors(6) are widely used in basic research, numerous differences between induced pluripotent stem cells and embryonic stem cells have been reported(7-11), potentially affecting their clinical use. Because of the therapeutic potential of diploid embryonic stem-cell lines derived from adult cells of diseased human subjects, we have systematically investigated the parameters affecting efficiency of blastocyst development and stem-cell derivation. Here we show that improvements to the oocyte activation protocol, including the use of both kinase and translation inhibitors, and cell culture in the presence of histone deacetylase inhibitors, promote development to the blastocyst stage. Developmental efficiency varied between oocyte donors, and was inversely related to the number of days of hormonal stimulation required for oocyte maturation, whereas the daily dose of gonadotropin or the total number of metaphase II oocytes retrieved did not affect developmental outcome. Because the use of concentrated Sendai virus for cell fusion induced an increase in intracellular calcium concentration, causing premature oocyte activation, we used diluted Sendai virus in calcium-free medium. Using this modified nuclear transfer protocol, we derived diploid pluripotent stem-cell lines from somatic cells of a newborn and, for the first time, an adult, a female with type 1 diabetes.	[Yamada, Mitsutoshi; Johannesson, Bjarki; Paull, Daniel; Nestor, Michael W.; Solomon, Susan L.; Egli, Dieter] New York Stem Cell Fdn Res Inst, New York, NY 10032 USA; [Sagi, Ido; Benvenisty, Nissim] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Genet, Stem Cell Unit, IL-91904 Jerusalem, Israel; [Burnett, Lisa Cole; Freeby, Matthew; Greenberg, Ellen; Goland, Robin S.; Leibel, Rudolph L.] Columbia Univ, Coll Phys & Surg, Dept Pediat, Naomi Berrie Diabet Ctr, New York, NY 10032 USA; [Kort, Daniel H.; Prosser, Robert W.; Sauer, Mark V.] Columbia Univ, Coll Phys & Surg, Ctr Womens Reprod Care, New York, NY 10019 USA; [Kort, Daniel H.; Prosser, Robert W.; Sauer, Mark V.] Columbia Univ, Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10019 USA	Hebrew University of Jerusalem; Columbia University; Columbia University; Columbia University	Egli, D (corresponding author), New York Stem Cell Fdn Res Inst, New York, NY 10032 USA.	d.egli@nyscf.org			New York Stem Cell Foundation (NYSCF); New York State Stem Cell Science (NYSTEM) IIRP [C026184]; Russell Berrie Foundation Program in Cellular Therapies of Diabetes; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007647] Funding Source: NIH RePORTER	New York Stem Cell Foundation (NYSCF); New York State Stem Cell Science (NYSTEM) IIRP; Russell Berrie Foundation Program in Cellular Therapies of Diabetes; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported the New York Stem Cell Foundation (NYSCF) and a New York State Stem Cell Science (NYSTEM) IIRP Award no. C026184, and the Russell Berrie Foundation Program in Cellular Therapies of Diabetes. We thank S. Mitalipov for helpful discussions and providing reagents, S. Micucci for counting cells in S-phase, and Z. Hall for critical reading of the manuscript. D.E. is a NYSCF-Robertson Investigator.	Bar-Hava I, 2005, GYNECOL ENDOCRINOL, V21, P232, DOI 10.1080/09513590500282331; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Choudhary M, 2012, CELL STEM CELL, V10, P239, DOI 10.1016/j.stem.2012.02.001; Cohen MA, 1999, HUM REPROD, V14, P2755, DOI 10.1093/humrep/14.11.2755; Daley GQ, 2007, SCIENCE, V315, P603, DOI 10.1126/science.1139337; Egli D., 2014, PROTOCOL EXCH; Egli D, 2011, CELL STEM CELL, V9, P293, DOI 10.1016/j.stem.2011.08.002; Egli D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1503; Egli Dieter, 2006, J Vis Exp, P116, DOI 10.3791/116; Ethics Comm Amer Soc Reprod Med, 2007, FERTIL STERIL, V88, P305, DOI 10.1016/j.fertnstert2007.01.104; Fan Y, 2011, STEM CELLS DEV, V20, P1951, DOI 10.1089/scd.2010.0451; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hua H, 2013, J CLIN INVEST, V123, P3146, DOI 10.1172/JCI67638; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Klitzman R, 2009, REPROD BIOMED ONLINE, V18, P603, DOI 10.1016/S1472-6483(10)60002-8; Koyanagi-Aoi M, 2013, P NATL ACAD SCI USA, V110, P20569, DOI 10.1073/pnas.1319061110; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu L, 2000, NAT BIOTECHNOL, V18, P223, DOI 10.1038/72692; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; Pick M, 2009, STEM CELLS, V27, P2686, DOI 10.1002/stem.205; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Ruiz S, 2012, P NATL ACAD SCI USA, V109, P16196, DOI 10.1073/pnas.1202352109; Shang LS, 2014, DIABETES, V63, P923, DOI 10.2337/db13-0717; STERN S, 1972, BIOL REPROD, V7, P341, DOI 10.1093/biolreprod/7.3.341; Tabar V, 2008, NAT MED, V14, P379, DOI 10.1038/nm1732; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Tachibana M, 2010, NAT PROTOC, V5, P1138, DOI 10.1038/nprot.2010.75; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Van Thuan N, 2009, REPRODUCTION, V138, P309, DOI 10.1530/REP-08-0299; Wakayama S, 2006, STEM CELLS, V24, P2023, DOI 10.1634/stemcells.2005-0537; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wang T, 2013, NAT CELL BIOL, V15, P700, DOI 10.1038/ncb2748; Winston NJ, 1997, BIOL CELL, V89, P211, DOI 10.1016/S0248-4900(97)80037-8	38	123	131	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					533	+		10.1038/nature13287	http://dx.doi.org/10.1038/nature13287			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24776804				2022-12-28	WOS:000337806300046
J	Crombie, AT; Murrell, JC				Crombie, Andrew T.; Murrell, J. Colin			Trace-gas metabolic versatility of the facultative methanotroph Methylocella silvestris	NATURE			English	Article							METHANE MONOOXYGENASE; PROPANE; OXIDATION; ETHANE; SYSTEM	The climate-active gas methane is generated both by biological processes and by thermogenic decomposition of fossil organic material, which forms methane and short-chain alkanes, principally ethane, propane and butane(1,2). In addition to natural sources, environments are exposed to anthropogenic inputs of all these gases from oil and gas extraction and distribution. The gases provide carbon and/or energy for a diverse range of microorganisms that can metabolize them in both anoxic(3) and oxic zones. Aerobic methanotrophs, which can assimilate methane, have been considered to be entirely distinct from utilizers of short-chain alkanes, and studies of environments exposed to mixtures of methane and multi-carbon alkanes have assumed that disparate groups of microorganisms are responsible for the metabolism of these gases. Here we describe the mechanism by which a single bacterial strain, Methylocella silvestris, can use methane or propane as a carbon and energy source, documenting a methanotroph that can utilize a short-chain alkane as an alternative to methane. Furthermore, during growth on a mixture of these gases, efficient consumption of both gases occurred at the same time. Two soluble di-iron centre monooxygenase (SDIMO) gene clusters were identified and were found to be differentially expressed during bacterial growth on these gases, although both were required for efficient propane utilization. This report of a methanotroph expressing an additional SDIMO that seems to be uniquely involved in short-chain alkane metabolism suggests that such metabolic flexibility may be important in many environments where methane and short-chain alkanes co-occur.	[Crombie, Andrew T.; Murrell, J. Colin] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Murrell, JC (corresponding author), Univ E Anglia, Sch Environm Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	j.c.murrell@uea.ac.uk	Crombie, Andrew/C-9167-2012; Murrell, John C/B-1443-2012	Crombie, Andrew/0000-0002-8577-2602	Natural Environmental Research Council (NERC) [NE/E016855/1]; University of East Anglia; Earth and Life Systems Alliance of the Norwich Research Park; Natural Environment Research Council [NE/E016855/1, NER/A/S/2002/00876] Funding Source: researchfish; NERC [NE/E016855/1] Funding Source: UKRI	Natural Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of East Anglia; Earth and Life Systems Alliance of the Norwich Research Park; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a Natural Environmental Research Council (NERC) grant (NE/E016855/1) and a NERC studentship to A.T.C. Additional funding was provided by the University of East Anglia and the Earth and Life Systems Alliance of the Norwich Research Park. We thank A. Johnston for critical reading of the manuscript.	ANTHONY C, 1964, BIOCHEM J, V92, P614, DOI 10.1042/bj0920614; ASHRAF W, 1994, FEMS MICROBIOL LETT, V122, P1, DOI 10.1111/j.1574-6968.1994.tb07134.x; Barrios H, 1999, NUCLEIC ACIDS RES, V27, P4305, DOI 10.1093/nar/27.22.4305; Chen Y, 2010, J BACTERIOL, V192, P3840, DOI 10.1128/JB.00506-10; COLBY J, 1977, BIOCHEM J, V165, P395, DOI 10.1042/bj1650395; Coleman NV, 2006, ENVIRON MICROBIOL, V8, P1228, DOI 10.1111/j.1462-2920.2006.01015.x; Cooley RB, 2009, MICROBIOL-SGM, V155, P2086, DOI 10.1099/mic.0.028175-0; Crombie A, 2011, METHOD ENZYMOL, P119, DOI 10.1016/B978-0-12-386905-0.00008-5; Dedysh SN, 2005, J BACTERIOL, V187, P4665, DOI 10.1128/JB.187.13.4665-4670.2005; Etiope G, 2013, MAR PETROL GEOL, V43, P178, DOI 10.1016/j.marpetgeo.2013.02.009; Etiope G, 2010, GLOBAL PLANET CHANGE, V72, P265, DOI 10.1016/j.gloplacha.2010.01.002; Etiope G, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033623; Etiope G, 2009, SCIENCE, V323, P478, DOI 10.1126/science.1165904; Furuya T, 2011, APPL ENVIRON MICROB, V77, P1214, DOI 10.1128/AEM.02316-10; Gilbert B, 2000, APPL ENVIRON MICROB, V66, P966, DOI 10.1128/AEM.66.3.966-975.2000; GREEN MJ, 1984, METHOD ENZYMOL, V105, P3; Guerlava P, 1998, CURR MICROBIOL, V36, P131, DOI 10.1007/PL00006756; Hamamura N, 2000, FEMS MICROBIOL LETT, V186, P21, DOI 10.1111/j.1574-6968.2000.tb09076.x; Heider J, 1998, FEMS MICROBIOL REV, V22, P459, DOI 10.1111/j.1574-6976.1998.tb00381.x; Hinrichs KU, 2006, P NATL ACAD SCI USA, V103, P14684, DOI 10.1073/pnas.0606535103; Johnson EL, 2006, APPL ENVIRON MICROB, V72, P950, DOI 10.1128/AEM.72.1.950-952.2006; Kotani T, 2003, J BACTERIOL, V185, P7120, DOI 10.1128/JB.185.24.7120-7128.2003; Kotani T, 2006, J BIOSCI BIOENG, V102, P184, DOI 10.1263/jbb.102.184; Leahy JG, 2003, FEMS MICROBIOL REV, V27, P449, DOI 10.1016/S0168-6445(03)00023-8; MACKAY D, 1981, J PHYS CHEM REF DATA, V10, P1175, DOI 10.1063/1.555654; MANGO FD, 1994, NATURE, V368, P536, DOI 10.1038/368536a0; Marx CJ, 2002, BIOTECHNIQUES, V33, P1062, DOI 10.2144/02335rr01; Mason OU, 2012, ISME J, V6, P1715, DOI 10.1038/ismej.2012.59; McDonald IR, 2008, APPL ENVIRON MICROB, V74, P1305, DOI 10.1128/AEM.02233-07; Osborn SG, 2011, P NATL ACAD SCI USA, V108, P8172, DOI 10.1073/pnas.1100682108; Patel NA, 2012, J PROTEOME RES, V11, P4755, DOI 10.1021/pr300253s; Patel VJ, 2009, J PROTEOME RES, V8, P3752, DOI 10.1021/pr900080y; PRIOR SD, 1985, FEMS MICROBIOL LETT, V29, P105; Rahman MT, 2011, ISME J, V5, P1061, DOI 10.1038/ismej.2010.190; Reddy CM, 2012, P NATL ACAD SCI USA, V109, P20229, DOI 10.1073/pnas.1101242108; Reeburgh W.S., 2003, TREATISE GEOCHEM, V4, P347; Sambrook J., 2001, MOL CLONING LAB MANU, Vthird edition; Semrau JD, 2011, FEMS MICROBIOL LETT, V323, P1, DOI 10.1111/j.1574-6968.2011.02315.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Theisen AR, 2005, MOL MICROBIOL, V58, P682, DOI 10.1111/j.1365-2958.2005.04861.x	40	57	60	3	78	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					148	+		10.1038/nature13192	http://dx.doi.org/10.1038/nature13192			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24776799	Green Accepted			2022-12-28	WOS:000336768900046
J	Brady, DC; Crowe, MS; Turski, ML; Hobbs, GA; Yao, XJ; Chaikuad, A; Knapp, S; Xiao, KH; Campbell, SL; Thiele, DJ; Counter, CM				Brady, Donita C.; Crowe, Matthew S.; Turski, Michelle L.; Hobbs, G. Aaron; Yao, Xiaojie; Chaikuad, Apirat; Knapp, Stefan; Xiao, Kunhong; Campbell, Sharon L.; Thiele, Dennis J.; Counter, Christopher M.			Copper is required for oncogenic BRAF signalling and tumorigenesis	NATURE			English	Article							CATALYZED OXIDATION REACTIONS; MEK INHIBITION; IN-VIVO; BETA(2)-ADRENERGIC RECEPTOR; MASS-SPECTROMETRY; RAS ONCOGENESIS; CANCER; MUTATIONS; ACTIVATION; MELANOMA	The BRAF kinase is mutated, typically Val 600 -> Glu (V600E), to induce an active oncogenic state in a large fraction of melanomas, thyroid cancers, hairy cell leukaemias and, to a smaller extent, a wide spectrum of other cancers(1,2). BRAF(V600E) phosphorylates and activates the MEK1 andMEK2 kinases, which in turn phosphorylate and activate the ERK1 and ERK2 kinases, stimulating the mitogen-activated protein kinase (MAPK) pathway to promote cancer(3). Targeting MEK1/2 is proving to be an important therapeutic strategy, given that a MEK1/2 inhibitor provides a survival advantage in metastatic melanoma(4), an effect that is increased when administered together with a BRAF(V600E) inhibitor(5). We previously found that copper (Cu) influx enhances MEK1 phosphorylation of ERK1/2 through a Cu-MEK1 interaction(6). Here we show decreasing the levels of CTR1 (Cu transporter 1), or mutations in MEK1 that disrupt Cu binding, decreased BRAF(V600E)-driven signalling and tumorigenesis in mice and human cell settings. Conversely, a MEK1-MEK5 chimaera that phosphorylated ERK1/2 independently of Cu or an active ERK2 restored the tumour growth of murine cells lacking Ctrl1. Cu chelators used in the treatment of Wilson disease(7) decreased tumour growth of human or murine cells transformed by BRAF(V600E) or engineered to be resistant to BRAF inhibition. Taken together, these results suggest that Cu-chelation therapy could be repurposed to treat cancers containing the BRAF(V600E) mutation.	[Brady, Donita C.; Crowe, Matthew S.; Turski, Michelle L.; Thiele, Dennis J.; Counter, Christopher M.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Hobbs, G. Aaron; Campbell, Sharon L.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Yao, Xiaojie; Xiao, Kunhong] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Chaikuad, Apirat; Knapp, Stefan] Univ Oxford, Target Discovery Inst, Nuffield Dept Clin Med, Oxford OX3 7DQ, England; [Chaikuad, Apirat; Knapp, Stefan] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Counter, Christopher M.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of Oxford; University of Oxford; Duke University	Counter, CM (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	chris.counter@duke.edu	Xiao, Kunhong/AAG-4275-2020; Knapp, Stefan/AAG-2347-2019	Xiao, Kunhong/0000-0002-1069-1226; Knapp, Stefan/0000-0001-5995-6494; Counter, Christopher M/0000-0003-0748-3079; campbell, sharon/0000-0003-0311-409X; Chaikuad, Apirat/0000-0003-1120-2209; Hobbs, Aaron/0000-0002-4751-9681; Crowe, Matthew/0000-0001-5251-0238	National Institutes of Health [CA178145, HL075443, DK074192, CA094184, CA172104]; Structural Genomics Consortium (Welcome Trust) [092809/Z/10/Z]; FP7 grant [278568]; Stewart Trust; Edward Spiegel Fund of the Lymphoma Foundation; NATIONAL CANCER INSTITUTE [R01CA094184, R21CA172104, R01CA089614, P30CA014236, P30CA016086, K01CA178145] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008570, T32GM007184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Structural Genomics Consortium (Welcome Trust); FP7 grant; Stewart Trust; Edward Spiegel Fund of the Lymphoma Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. McMahon, C. Cronin, E. Johnson, A. Stewart, D. S. Tyler and D. G. Kirsch for reagents, and C. Cronin, L. E. Crose, A. M. Jaeger, M. A. Luftig, E. Johnson, D. F. Kashatus, B. L. Lampson, J. P. Madigan, N. I. Nicely, Y. Nose, C. W. Pemble, N. L. K. Pershing, A. Stewart and J. D. Weyandt for technical support, discussions and/or review of the manuscript. This work was supported by National Institutes of Health grants CA178145 (D. C. B.), HL075443 (Proteomic Core K. X.), DK074192 (D. J. T.), CA094184 and CA172104 (C. M. C.), the Structural Genomics Consortium (Welcome Trust 092809/Z/10/Z), FP7 grant 278568 'PRIMES' (S. K. and A. C.), the Stewart Trust (C. M. C.), the Edward Spiegel Fund of the Lymphoma Foundation (C. M. C.), and donations made in memory of Linda Woolfenden (C.M.C.).	Ala A, 2007, LANCET, V369, P397, DOI 10.1016/S0140-6736(07)60196-2; Augustine CK, 2010, MOL CANCER THER, V9, P2090, DOI 10.1158/1535-7163.MCT-10-0073; Bertinato J, 2003, J BIOL CHEM, V278, P35071, DOI 10.1074/jbc.M302242200; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bric A, 2009, CANCER CELL, V16, P324, DOI 10.1016/j.ccr.2009.08.015; Bridgewater JD, 2005, ANAL BIOCHEM, V341, P122, DOI 10.1016/j.ab.2005.02.034; Bridgewater JD, 2006, J AM SOC MASS SPECTR, V17, P1552, DOI 10.1016/j.jasms.2006.06.003; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; English JM, 1999, J BIOL CHEM, V274, P31588, DOI 10.1074/jbc.274.44.31588; Fischmann TO, 2009, BIOCHEMISTRY-US, V48, P2661, DOI 10.1021/bi801898e; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; HUANG WD, 1995, MOL BIOL CELL, V6, P237, DOI 10.1091/mbc.6.3.237; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Lampson BL, 2012, CANCER RES, V72, P4472, DOI 10.1158/0008-5472.CAN-12-0057; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Levin-Salomon V, 2008, J BIOL CHEM, V283, P34500, DOI 10.1074/jbc.M806443200; Nakamura K, 2006, MOL CELL BIOL, V26, P2065, DOI 10.1128/MCB.26.6.2065-2079.2006; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; O'Hayer KM, 2006, METHOD ENZYMOL, V407, P637, DOI 10.1016/S0076-6879(05)07050-3; O'Hayer KM, 2009, CARCINOGENESIS, V30, P1841, DOI 10.1093/carcin/bgp198; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Scholl FA, 2004, CANCER RES, V64, P6035, DOI 10.1158/0008-5472.CAN-04-0017; Solit DB, 2011, NEW ENGL J MED, V364, P772, DOI 10.1056/NEJMcibr1013704; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Tsai CY, 2012, BIOCHEM PHARMACOL, V84, P1007, DOI 10.1016/j.bcp.2012.07.014; Turski ML, 2012, MOL CELL BIOL, V32, P1284, DOI 10.1128/MCB.05722-11; Turski ML, 2009, J BIOL CHEM, V284, P717, DOI 10.1074/jbc.R800055200; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Zipfel PA, 2010, ONCOGENE, V29, P4859, DOI 10.1038/onc.2010.224	42	302	312	10	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					492	+		10.1038/nature13180	http://dx.doi.org/10.1038/nature13180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24717435	Green Accepted, Green Submitted			2022-12-28	WOS:000336126000039
J	Durruthy-Durruthy, R; Gottlieb, A; Hartman, BH; Waldhaus, J; Laske, RD; Altman, R; Heller, S				Durruthy-Durruthy, Robert; Gottlieb, Assaf; Hartman, Byron H.; Waldhaus, Joerg; Laske, Roman D.; Altman, Russ; Heller, Stefan			Reconstruction of the Mouse Otocyst and Early Neuroblast Lineage at Single-Cell Resolution	CELL			English	Article							MAMMALIAN INNER-EAR; AUDITORY-SYSTEM DEVELOPMENT; SENSORY EPITHELIA; GENE-EXPRESSION; MORPHOGENESIS; NEURONS; MICE; SPECIFICATION; INSIGHTS; EMBRYO	The otocyst harbors progenitors for most cell types of the mature inner ear. Developmental lineage analyses and gene expression studies suggest that distinct progenitor populations are compartmentalized to discrete axial domains in the early otocyst. Here, we conducted highly parallel quantitative RT-PCR measurements on 382 individual cells from the developing otocyst and neuroblast lineages to assay 96 genes representing established otic markers, signaling-pathway-associated transcripts, and novel otic-specific genes. By applying multivariate cluster, principal component, and network analyses to the data matrix, we were able to readily distinguish the delaminating neuroblasts and to describe progressive states of gene expression in this population at single-cell resolution. It further established a three-dimensional model of the otocyst in which each individual cell can be precisely mapped into spatial expression domains. Our bioinformatic modeling revealed spatial dynamics of different signaling pathways active during early neuroblast development and prosensory domain specification.	[Durruthy-Durruthy, Robert; Hartman, Byron H.; Waldhaus, Joerg; Laske, Roman D.; Heller, Stefan] Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA; [Durruthy-Durruthy, Robert; Hartman, Byron H.; Waldhaus, Joerg; Laske, Roman D.; Heller, Stefan] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Gottlieb, Assaf; Altman, Russ] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Gottlieb, Assaf; Altman, Russ] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Heller, S (corresponding author), Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA.	hellers@stanford.edu			NIH [DC006167, DC012250, DC013210]; P30 core support [DC010363]; Stanford Initiative to Cure Hearing Loss; FP7-Health-2013-Innovation; Deutsche Forschungsgemeinschaft [WA3420/1]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006167, F32DC013210, R01DC012250, R01DC004563, P30DC010363] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); P30 core support; Stanford Initiative to Cure Hearing Loss; FP7-Health-2013-Innovation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the staff at the Stanford Shared FACS Facility for their help and support; Patrick Raphael for his help with implementing movies; and all members of the Heller laboratory for comments on the manuscript. This work was supported by NIH grants DC006167 and DC012250 to S.H., by P30 core support (DC010363), by the Stanford Initiative to Cure Hearing Loss, and, in part, by FP7-Health-2013-Innovation, a cooperative grant by the European Commission. B.H.H. is supported by NIH F32 grant DC013210. J.W. is supported, in part, by a fellowship (WA3420/1) from the Deutsche Forschungsgemeinschaft.	Abello G, 2007, MECH DEVELOP, V124, P631, DOI 10.1016/j.mod.2007.04.002; Alsina B, 2004, DEV BIOL, V267, P119, DOI 10.1016/j.ydbio.2003.11.012; Alsina B, 2009, INT J DEV BIOL, V53, P1503, DOI 10.1387/ijdb.072422ba; Basch ML, 2011, J NEUROSCI, V31, P8046, DOI 10.1523/JNEUROSCI.6671-10.2011; Brigande JV, 2000, P NATL ACAD SCI USA, V97, P11700, DOI 10.1073/pnas.97.22.11700; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; Brown AS, 2011, DEVELOPMENT, V138, P3967, DOI 10.1242/dev.066126; Chang WS, 1999, DEV BIOL, V216, P369, DOI 10.1006/dbio.1999.9457; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; CORWIN JT, 1989, J COMP NEUROL, V288, P529, DOI 10.1002/cne.902880402; Daudet N, 2007, DEVELOPMENT, V134, P2369, DOI 10.1242/dev.001842; Depew MJ, 1999, DEVELOPMENT, V126, P3831; Fekete DM, 2002, CURR OPIN NEUROBIOL, V12, P35, DOI 10.1016/S0959-4388(02)00287-8; Fritzsch B, 2005, HEARING RES, V206, P52, DOI 10.1016/j.heares.2004.11.025; Fritzsch B, 2002, J NEUROBIOL, V53, P143, DOI 10.1002/neu.10098; Fritzsch B, 2003, BRAIN RES BULL, V60, P423, DOI 10.1016/S0361-9230(03)00048-0; Gerlach LM, 2000, DEVELOPMENT, V127, P45; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Groves AK, 2012, DEVELOPMENT, V139, P245, DOI 10.1242/dev.067074; Hamada Y, 1999, DEVELOPMENT, V126, P3415; Hartman BH, 2010, P NATL ACAD SCI USA, V107, P15792, DOI 10.1073/pnas.1002827107; Hatch EP, 2007, DEVELOPMENT, V134, P3615, DOI 10.1242/dev.006627; Hidalgo-Sanchez M, 2000, MECH DEVELOP, V95, P225, DOI 10.1016/S0925-4773(00)00332-4; Holley M, 2010, DEV BIOL, V340, P547, DOI 10.1016/j.ydbio.2010.02.004; Hurd EA, 2010, DEVELOPMENT, V137, P3139, DOI 10.1242/dev.047894; Jolliffe I. T., 2002, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kalisky T, 2011, NAT METHODS, V8, P311, DOI 10.1038/nmeth0411-311; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kim WY, 2001, DEVELOPMENT, V128, P417; Koo SK, 2009, DEV BIOL, V333, P14, DOI 10.1016/j.ydbio.2009.06.016; Li HW, 2004, J COMP NEUROL, V477, P1, DOI 10.1002/cne.20190; Lin ZS, 2005, DEVELOPMENT, V132, P2309, DOI 10.1242/dev.01804; Liu M, 2000, GENE DEV, V14, P2839, DOI 10.1101/gad.840500; Lu CC, 2011, J NEUROSCI, V31, P10903, DOI 10.1523/JNEUROSCI.2358-11.2011; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Merlo GR, 2002, DEV BIOL, V248, P157, DOI 10.1006/dbio.2002.0713; Morsli H, 1998, J NEUROSCI, V18, P3327; Murata J, 2006, J COMP NEUROL, V497, P502, DOI 10.1002/cne.20997; Murata J, 2012, ADV EXP MED BIOL, V727, P161, DOI 10.1007/978-1-4614-0899-4_12; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Neves J, 2011, DEVELOPMENT, V138, P735, DOI 10.1242/dev.060657; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Radde-Gallwitz K, 2004, J COMP NEUROL, V477, P412, DOI 10.1002/cne.20257; Riccomagno MM, 2005, GENE DEV, V19, P1612, DOI 10.1101/gad.1303905; Riccomagno MM, 2002, GENE DEV, V16, P2365, DOI 10.1101/gad.1013302; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; SWANSON GJ, 1990, DEV BIOL, V137, P243, DOI 10.1016/0012-1606(90)90251-D; Tischler J, 2013, CURR OPIN BIOTECH, V24, P69, DOI 10.1016/j.copbio.2012.09.013; Verpy E, 1999, P NATL ACAD SCI USA, V96, P529, DOI 10.1073/pnas.96.2.529; Wu DK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008409; Zheng WM, 2003, DEVELOPMENT, V130, P3989, DOI 10.1242/dev.00628	52	99	101	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					964	978		10.1016/j.cell.2014.03.036	http://dx.doi.org/10.1016/j.cell.2014.03.036			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24768691	Green Accepted, Bronze			2022-12-28	WOS:000335765500022
J	Mooers, AO				Mooers, Arne O.			BIODIVERSITY Supply and demand	NATURE			English	Editorial Material							DIVERSIFICATION RATES; MOLECULAR PHYLOGENIES; EVOLUTION; SPECIATION; BIRDS		[Mooers, Arne O.] Simon Fraser Univ, Dept Biol, Burnaby, BC V5A 1S6, Canada; [Mooers, Arne O.] Simon Fraser Univ, Human Evolutionary Studies Program, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Mooers, AO (corresponding author), Simon Fraser Univ, Dept Biol, Burnaby, BC V5A 1S6, Canada.	amooers@sfu.ca						Darwin C., 1877, ORIGIN SPECIES; Etienne RS, 2012, SYST BIOL, V61, P204, DOI 10.1093/sysbio/syr091; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Morlon H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000493; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Price TD, 2014, NATURE, V509, P222, DOI 10.1038/nature13272; Purvis Andy, 2009, P278; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2013, P NATL ACAD SCI USA, V110, P15354, DOI 10.1073/pnas.1305529110; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Revell LJ, 2005, SYST BIOL, V54, P973, DOI 10.1080/10635150500354647; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Svensson EI, 2012, ORG DIVERS EVOL, V12, P229, DOI 10.1007/s13127-012-0082-6	14	1	1	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					171	173		10.1038/nature13332	http://dx.doi.org/10.1038/nature13332			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24776802				2022-12-28	WOS:000335454300026
J	de Iongh, A				de Iongh, Anya			Patients need support to self manage their long term conditions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												anya.deiongh@cantab.net						Health Foundation, 2014, CLOS DOORS; NHS Confederation, 2012, INV EM PSYCH WELLB P; NHS England, DOM 2 ENH QUAL LIF P; The Health Foundation, 2013, SUST SPREAD SELF MAN	4	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2014	348								g2973	10.1136/bmj.g2973	http://dx.doi.org/10.1136/bmj.g2973			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5PN	24778324	Green Published, Bronze			2022-12-28	WOS:000335471000011
J	Neier, R				Neier, Reinhard			A Two-Catalyst Photochemistry Route to Homochiral Rings	SCIENCE			English	Editorial Material							CATALYSIS; LIGHT		Univ Neuchatel, Dept Chem, CH-2000 Neuchatel, Switzerland	University of Neuchatel	Neier, R (corresponding author), Univ Neuchatel, Dept Chem, Rue Emile Argand 11, CH-2000 Neuchatel, Switzerland.	reinhard.neier@unine.ch						Ahrendt KA, 2000, J AM CHEM SOC, V122, P4243, DOI 10.1021/ja000092s; Blaser HU, 2003, CHEM COMMUN, P293, DOI 10.1039/b209968n; Brimioulle R, 2013, SCIENCE, V342, P840, DOI 10.1126/science.1244809; Ciamician G, 1908, BER DTSCH CHEM GES, V41, P1928, DOI 10.1002/cber.19080410272; Du JN, 2014, SCIENCE, V344, P392, DOI 10.1126/science.1251511; EDER U, 1971, ANGEW CHEM INT EDIT, V10, P496, DOI 10.1002/anie.197104961; HAJOS ZG, 1974, J ORG CHEM, V39, P1615, DOI 10.1021/jo00925a003; KATSUKI T, 1980, J AM CHEM SOC, V102, P5974, DOI 10.1021/ja00538a077; Kuhn W, 1930, Z PHYS CHEM B-CHEM E, V7, P292; MIYASHITA A, 1980, J AM CHEM SOC, V102, P7932, DOI 10.1021/ja00547a020; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Sibi MP, 1999, ACCOUNTS CHEM RES, V32, P163, DOI 10.1021/ar9600547; Vineyard B. D., 1972, CHEM COMMUN, V1972, P10; Wessig P, 2006, ANGEW CHEM INT EDIT, V45, P2168, DOI 10.1002/anie.200503908	14	9	9	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					368	369		10.1126/science.1252965	http://dx.doi.org/10.1126/science.1252965			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763578				2022-12-28	WOS:000334867800026
J	Jewison, AC; Tilliridou, V; Skelton, E; Howlett, DC; Evans, G				Jewison, Amanda Catherine; Tilliridou, Vicky; Skelton, Emily; Howlett, David C.; Evans, George			PICTURE QUIZ A man with a palpable abdominal mass and night sweats	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AORTIC-ANEURYSM		[Jewison, Amanda Catherine; Skelton, Emily; Howlett, David C.] Eastbourne Dist Gen Hosp, Dept Radiol, Eastbourne BN21 2UD, England; [Tilliridou, Vicky] Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Evans, George] Eastbourne Dist Gen Hosp, Dept Vasc Surg, Eastbourne BN21 2UD, England	University of Brighton; University of Sussex	Jewison, AC (corresponding author), Eastbourne Dist Gen Hosp, Dept Radiol, Eastbourne BN21 2UD, England.	ajewison@doctors.org.uk		Skelton, Emily/0000-0003-0132-7948				Haug ES, 2003, J VASC SURG, V38, P492, DOI 10.1016/S0741-5214(03)00340-9; Hellmann DB, 2007, JAMA-J AM MED ASSOC, V297, P395, DOI 10.1001/jama.297.4.395; Jego C, 2000, J MAL VASCUL, V25, P132; Nitecki SS, 1996, J VASC SURG, V23, P860, DOI 10.1016/S0741-5214(96)70249-5; Paravastu SCV, 2009, EUR J VASC ENDOVASC, V38, P291, DOI 10.1016/j.ejvs.2009.05.005; Stone WM, 2012, J VASC SURG, V56, P951, DOI 10.1016/j.jvs.2012.03.253; Stotter AT, 1990, EUR J VASCULAR SURG, V4, p201e5; Sumino H, 1999, J MED, V30, P67; WALKER DI, 1972, BRIT J SURG, V59, P609, DOI 10.1002/bjs.1800590807	9	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2014	348								g2834	10.1136/bmj.g2834	http://dx.doi.org/10.1136/bmj.g2834			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG1DI	24764570				2022-12-28	WOS:000335154900004
J	Zeuzem, S; Jacobson, IM; Baykal, T; Marinho, RT; Poordad, F; Bourliere, M; Sulkowski, MS; Wedemeyer, H; Tam, E; Desmond, P; Jensen, DM; Di Bisceglie, AM; Varunok, P; Hassanein, T; Xiong, JY; Pilot-Matias, T; DaSilva-Tillmann, B; Larsen, L; Podsadecki, T; Bernstein, B				Zeuzem, Stefan; Jacobson, Ira M.; Baykal, Tolga; Marinho, Rui T.; Poordad, Fred; Bourliere, Marc; Sulkowski, Mark S.; Wedemeyer, Heiner; Tam, Edward; Desmond, Paul; Jensen, Donald M.; Di Bisceglie, Adrian M.; Varunok, Peter; Hassanein, Tarek; Xiong, Junyuan; Pilot-Matias, Tami; DaSilva-Tillmann, Barbara; Larsen, Lois; Podsadecki, Thomas; Bernstein, Barry			Retreatment of HCV with ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC HEPATITIS-C; SUSTAINED VIROLOGICAL RESPONSE; TREATMENT-NAIVE SUBJECTS; GENOTYPE 1 INFECTION; VIRUS-INFECTION; 3-DAY MONOTHERAPY; PLUS RIBAVIRIN; TRIAL; TELAPREVIR; PEGINTERFERON/RIBAVIRIN	Background In this phase 3 trial we evaluated the efficacy and safety of the interferon-free combination of ABT-450 with ritonavir (ABT-450/r), ombitasvir (also known as ABT-267), dasabuvir (also known as ABT-333), and ribavirin for the retreatment of HCV in patients who were previously treated with peginterferon-ribavirin. Methods We enrolled patients with HCV genotype 1 infection and no cirrhosis who had previously been treated with peginterferon-ribavirin and had a relapse, a partial response, or a null response. Patients were randomly assigned in a 3: 1 ratio to receive coformulated ABT-450/r-ombitasvir (at a once-daily dose of 150 mg of ABT-450, 100 mg of ritonavir, and 25 mg of ombitasvir) and dasabuvir (250 mg twice daily) with ribavirin (1000 or 1200 mg daily) or matching placebos during the 12-week double-blind period. The primary end point was the rate of sustained virologic response 12 weeks after the end of study treatment. The primary efficacy analysis compared this rate among patients assigned to the active regimen with a historical response rate (65%) among previously treated patients with HCV genotype 1 infection and no cirrhosis who had received retreatment with telaprevir and peginterferon-ribavirin. Results A total of 394 patients received at least one study-drug dose. In the active-regimen group, 286 of 297 patients had a sustained virologic response at post-treatment week 12, for an overall rate of 96.3% (95% confidence interval, 94.2 to 98.4). This rate was non-inferior and superior to the historical control rate. Rates were 95.3% among patients with a prior relapse (82 of 86 patients), 100% among patients with a prior partial response (65 of 65 patients), and 95.2% among patients with a prior null response (139 of 146 patients). Pruritus occurred more frequently with the active regimen (in 13.8% of patients) than with placebo (5.2%, P = 0.03). Three patients in the active-regimen group (1.0%) discontinued the study drugs owing to adverse events. Hemoglobin values of grade 2 (8.0 to <10.0 g per deciliter) and grade 3 (6.5 to <8.0 g per deciliter) occurred in 4.7% and 0.3% of patients in the active-regimen group, respectively. Conclusions Rates of response to a 12-week interferon-free combination regimen were more than 95% among previously treated patients with HCV genotype 1 infection, including patients with a prior null response. (Funded by AbbVie; SAPPHIRE-II ClinicalTrials.gov number, NCT01715415.)	[Zeuzem, Stefan] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany; [Wedemeyer, Heiner] Hannover Med Sch, D-30623 Hannover, Germany; [Jacobson, Ira M.] Weill Cornell Med Coll, New York, NY USA; [Varunok, Peter] Premier Med Grp Hudson Valley, Poughkeepsie, NY USA; [Baykal, Tolga; Xiong, Junyuan; Pilot-Matias, Tami; DaSilva-Tillmann, Barbara; Larsen, Lois; Podsadecki, Thomas; Bernstein, Barry] AbbVie, N Chicago, IL USA; [Jensen, Donald M.] Univ Chicago, Med Ctr, Ctr Liver Dis, Chicago, IL 60637 USA; [Marinho, Rui T.] Ctr Hosp Lisboa Norte, Lisbon, Portugal; [Marinho, Rui T.] Univ Lisbon, Lisbon, Portugal; [Poordad, Fred] Univ Texas Hlth Sci Ctr San Antonio, Texas Liver Inst, San Antonio, TX 78229 USA; [Bourliere, Marc] Hop St Joseph, Marseille, France; [Sulkowski, Mark S.] Johns Hopkins Univ, Baltimore, MD USA; [Tam, Edward] Liver & Intestinal Res Ctr, Vancouver, BC, Canada; [Desmond, Paul] St Vincents Hosp Melbourne, Fitzroy, Vic, Australia; [Di Bisceglie, Adrian M.] St Louis Univ, St Louis, MO 63103 USA; [Hassanein, Tarek] Southern Calif Liver Ctr, Coronado, CA USA; [Hassanein, Tarek] Southern Calif Res Ctr, Coronado, CA USA	Goethe University Frankfurt; Hannover Medical School; Cornell University; AbbVie; University of Chicago; University of Chicago Medical Center; Universidade de Lisboa; Universidade de Lisboa; University of Texas System; University of Texas Health San Antonio; Johns Hopkins University; St Vincent's Hospital Melbourne; Saint Louis University	Zeuzem, S (corresponding author), Johann Wolfgang Goethe Univ Hosp, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	zeuzem@em.uni-frankfurt.de	Zeuzem, Stefan/AAE-7435-2019	TAM, EDWARD/0000-0002-8306-3968	AbbVie	AbbVie(AbbVie)	Supported by AbbVie.	[Anonymous], INC TEL FILM COAT TA; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Chen Stephen L, 2006, Int J Med Sci, V3, P47; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hsu CS, 2013, NEW ENGL J MED, V369, P678, DOI 10.1056/NEJMc1307641; Jacobson I, 2013, J HEPATOL, V58, pS574, DOI 10.1016/S0168-8278(13)61424-5; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kowdley KV, 2014, NEW ENGL J MED, V370, P222, DOI 10.1056/NEJMoa1306227; Lawitz E, 2012, J HEPATOL, V56, pS469, DOI 10.1016/S0168-8278(12)61198-2; Lok AS, 2014, J HEPATOL, V60, P490, DOI 10.1016/j.jhep.2013.10.019; Manns MP, 2011, J HEPATOL, V54, P1114, DOI 10.1016/j.jhep.2010.08.040; Marinho RT, 2013, WORLD J GASTROENTERO, V19, P6703, DOI 10.3748/wjg.v19.i40.6703; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Menon RM, 2009, ANN M HEPDART KOH CO; Poordad F, 2012, J HEPATOL, V56, pS478, DOI 10.1016/S0168-8278(12)61218-5; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Zeuzem S, 2011, J HEPATOL, V54, pS3, DOI 10.1016/S0168-8278(11)60007-X; Zeuzem S, 2014, GASTROENTEROLOGY, V146, p[430, e6]; Zeuzem S, 2012, HEPATOLOGY, V55, P749, DOI 10.1002/hep.24744; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	24	461	487	1	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 24	2014	370	17					1604	1614		10.1056/NEJMoa1401561	http://dx.doi.org/10.1056/NEJMoa1401561			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4TG	24720679				2022-12-28	WOS:000336120500007
J	Heremans, JP				Heremans, Joseph P.			The ugly duckling	NATURE			English	Editorial Material							THERMOELECTRICS		[Heremans, Joseph P.] Ohio State Univ, Dept Mech & Aerosp Engn, Columbus, OH 43210 USA; [Heremans, Joseph P.] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Heremans, JP (corresponding author), Ohio State Univ, Dept Mech & Aerosp Engn, Columbus, OH 43210 USA.	heremans.1@osu.edu	Heremans, Joseph P./D-3298-2015	Heremans, Joseph P./0000-0003-3996-2744				Biswas K, 2012, NATURE, V489, P414, DOI 10.1038/nature11439; Callen, 1960, THERMODYNAMICS INTRO, V28, P684; Heremans JP, 2013, NAT NANOTECHNOL, V8, P471, DOI 10.1038/nnano.2013.129; Nielsen MD, 2013, ENERG ENVIRON SCI, V6, P570, DOI 10.1039/c2ee23391f; Seebeck T.J., 1825, MAGNETISCHE POLARISA, P265; Zhao LD, 2014, NATURE, V508, P373, DOI 10.1038/nature13184	6	75	77	3	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					327	328		10.1038/508327a	http://dx.doi.org/10.1038/508327a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24740062				2022-12-28	WOS:000334403000037
J	Linn, MC; Gerard, L; Ryoo, K; McElhaney, K; Liu, OL; Rafferty, AN				Linn, Marcia C.; Gerard, Libby; Ryoo, Kihyun; McElhaney, Kevin; Liu, Ou Lydia; Rafferty, Anna N.			Computer-Guided Inquiry to Improve Science Learning	SCIENCE			English	Editorial Material							TUTOR		[Linn, Marcia C.; Gerard, Libby] Univ Calif Berkeley, Grad Sch Educ, Berkeley, CA 94720 USA; [Ryoo, Kihyun] Univ N Carolina, Sch Educ, Chapel Hill, NC 27599 USA; [McElhaney, Kevin] SRI Int, Menlo Pk, CA 94025 USA; [Liu, Ou Lydia] Educ Testing Serv, Princeton, NJ 08541 USA; [Rafferty, Anna N.] Univ Calif Berkeley, Comp Sci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of North Carolina; University of North Carolina Chapel Hill; SRI International; Educational Testing Service (ETS); University of California System; University of California Berkeley	Linn, MC (corresponding author), Univ Calif Berkeley, Grad Sch Educ, Berkeley, CA 94720 USA.	mclinn@berkeley.edu		Gerard, Libby/0000-0002-2708-5409	Direct For Education and Human Resources [0822388, 1119670] Funding Source: National Science Foundation	Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))		Achieve Inc, 2013, NEXT GEN SCI STAND; Graesser AC, 2004, BEHAV RES METH INS C, V36, P180, DOI 10.3758/BF03195563; Linn M. C., 2011, SCI LEARNING INSTRUC; Liu OL, 2014, EDUC MEAS-ISSUES PRA, V33, P19, DOI 10.1111/emip.12028; Osborne J, 2010, SCIENCE, V328, P463, DOI 10.1126/science.1183944; Rafferty A. N., 2013, P WORKSH 16 INT C AR, V8, P612; Razzaq L, 2009, FRONT ARTIF INTEL AP, V200, P457, DOI 10.3233/978-1-60750-028-5-457; Roscoe RD, 2013, J EDUC PSYCHOL, V105, P1010, DOI 10.1037/a0032340; Ryoo K, 2014, J RES SCI TEACH, V51, P147, DOI 10.1002/tea.21128; Segedy JR, 2013, ETR&D-EDUC TECH RES, V61, P71, DOI 10.1007/s11423-012-9275-0; Shouse R. A, 2007, COMMITTEE SCI LEARNI; Sisk-Hilton S., 2009, TEACHING LEARNING PU; Uttal DH, 2013, CURR DIR PSYCHOL SCI, V22, P367, DOI 10.1177/0963721413484756; VanLehn K, 2011, EDUC PSYCHOL-US, V46, P197, DOI 10.1080/00461520.2011.611369; Wineburg S., 2012, SOC EDUC, V76, P288	15	37	37	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					155	156		10.1126/science.1245980	http://dx.doi.org/10.1126/science.1245980			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6JD	24723599				2022-12-28	WOS:000334096300021
J	Mahony, C				Mahony, Chris			Gastroenterology Team of the Year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												chris.mahony@cjmedia.biz			MDDUS	MDDUS	I have read and understood the BMJ policy on declaration of interests and have no relevant interests to declare. The BMJ Awards are sponsored by MDDUS. The awards ceremony will take place on 8 May at the Park Plaza Hotel, Westminster. To find out more go to http://thebmjawards.bmj.com.		0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2014	348								g2677	10.1136/bmj.g2677	http://dx.doi.org/10.1136/bmj.g2677			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SI	24727180				2022-12-28	WOS:000334349200011
J	Bernstein, R				Bernstein, Rachel			Shifting Ground for Big Data Researchers	CELL			English	Editorial Material																			0	4	4	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					283	284		10.1016/j.cell.2014.03.028	http://dx.doi.org/10.1016/j.cell.2014.03.028			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725396	Bronze			2022-12-28	WOS:000334304500001
J	Reperant, LA; Kuiken, T; Grenfell, BT; Osterhaus, ADME				Reperant, Leslie A.; Kuiken, Thijs; Grenfell, Bryan T.; Osterhaus, Albert D. M. E.			The immune response and within-host emergence of pandemic influenza virus	LANCET			English	Article							DIVERSE MALARIA INFECTIONS; RESPIRATORY DROPLET; TRANSMISSION; HUMANS; COMPETITION; DYNAMICS; FERRETS	Zoonotic influenza viruses that are a few mutations away from pandemic viruses circulate in animals, and can evolve into airborne-transmissible viruses in human beings. Paradoxically, such viruses only occasionally emerge in people; the four influenza pandemics that occurred in the past 100 years were caused by zoonotic viruses that acquired efficient transmissibility. Emergence of a pandemic virus in people can happen when transmissible viruses evolve in individuals with zoonotic influenza and replicate to titres allowing transmission. We postulate that this step in the genesis of a pandemic virus only occasionally occurs in human beings, because the immune response triggered by zoonotic influenza virus also controls transmissible mutants that emerge during infection. Therefore, an impaired immune response might be needed for within-host emergence of a pandemic virus and replication to titres allowing transmission. Immunocompromised individuals-eg, those with comorbidities, of advanced age, or receiving immunosuppressive treatment-could be at increased risk of generating transmissible viruses and initiating chains of human-to-human infection.	[Reperant, Leslie A.; Kuiken, Thijs; Osterhaus, Albert D. M. E.] Erasmus MC, Dept Virosci, NL-3000 CA Rotterdam, Netherlands; [Reperant, Leslie A.; Osterhaus, Albert D. M. E.] Artemis Res Inst One Hlth Europe, Utrecht, Netherlands; [Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Erasmus University Rotterdam; Erasmus MC; Princeton University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Reperant, LA (corresponding author), Erasmus MC, Dept Virosci, POB 2040, NL-3000 CA Rotterdam, Netherlands.	l.reperant@erasmusmc.nl		Kuiken, Thijs/0000-0001-5501-9049; Reperant, Leslie/0000-0002-7212-1595	EU [302060, 278976, 223498]; RAPIDD program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, NIH, Department of Homeland Security contract [HSHQDC-12-C-00058]; Bill & Melinda Gates Foundation	EU(European Commission); RAPIDD program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, NIH, Department of Homeland Security contract; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	We thank Guus Rimmelzwaan (Department of Viroscience, Erasmus Medical Centre, Netherlands), and Derek Smith and Judy Fonville (Department of Zoology, University of Cambridge, UK) for productive discussions. LAR was supported by EU FP7 Marie-Curie International Incoming Fellowship #302060; TK by EU FP7 ANTIGONE project #278976; BTG by the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, NIH, Department of Homeland Security contract HSHQDC-12-C-00058, and the Bill & Melinda Gates Foundation; and ADMEO by EU FP7 EMPERIE project #223498 and EU FP7 ANTIGONE project #278976. The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Cheng VCC, 2011, J INFECTION, V62, P394, DOI 10.1016/j.jinf.2011.02.007; Chutinimitkul S, 2010, J VIROL, V84, P6825, DOI 10.1128/JVI.02737-09; de Roode JC, 2005, AM NAT, V166, P531, DOI 10.1086/491659; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Doherty PC, 2000, ANNU REV IMMUNOL, V18, P561, DOI 10.1146/annurev.immunol.18.1.561; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Raberg L, 2006, AM NAT, V168, P41, DOI 10.1086/505160; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Reperant LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043115; Reperant LA, 2012, VACCINE, V30, P4419, DOI 10.1016/j.vaccine.2012.04.049; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Thornburg NJ, 2013, J CLIN INVEST, V123, P4405, DOI 10.1172/JCI69377; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; van der Vries E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003343; Wodarz D, 2004, P ROY SOC B-BIOL SCI, V271, P1101, DOI 10.1098/rspb.2003.2664; Xiong XL, 2013, NATURE, V499, P496, DOI 10.1038/nature12372; Zhang Y, 2013, SCIENCE, V340, P1459, DOI 10.1126/science.1229455	22	16	17	0	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2014	384	9959					2077	2081		10.1016/S0140-6736(13)62425-3	http://dx.doi.org/10.1016/S0140-6736(13)62425-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW6BD	24767965				2022-12-28	WOS:000346353600029
J	Baize, S; Pannetier, D; Oestereich, L; Rieger, T; Koivogui, L; Magassouba, N; Soropogui, B; Sow, MS; Keita, S; De Clerck, H; Tiffany, A; Dominguez, G; Loua, M; Traore, A; Kolie, M; Malano, ER; Heleze, E; Bocquin, A; Mely, S; Raoul, H; Caro, V; Cadar, D; Gabriel, M; Pahlmann, M; Tappe, D; Schmidt-Chanasit, J; Impouma, B; Diallo, AK; Formenty, P; Van Herp, M; Gunther, S				Baize, Sylvain; Pannetier, Delphine; Oestereich, Lisa; Rieger, Toni; Koivogui, Lamine; Magassouba, N'Faly; Soropogui, Barre; Sow, Mamadou Saliou; Keita, Sakoba; De Clerck, Hilde; Tiffany, Amanda; Dominguez, Gemma; Loua, Mathieu; Traore, Alexis; Kolie, Moussa; Malano, Emmanuel Roland; Heleze, Emmanuel; Bocquin, Anne; Mely, Stephane; Raoul, Herve; Caro, Valerie; Cadar, Daniel; Gabriel, Martin; Pahlmann, Meike; Tappe, Dennis; Schmidt-Chanasit, Jonas; Impouma, Benido; Diallo, Abdoul Karim; Formenty, Pierre; Van Herp, Michel; Guenther, Stephan			Emergence of Zaire Ebola Virus Disease in Guinea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LASSA-VIRUS; FILOVIRUSES; INFECTION; ASSAY	In March 2014, the World Health Organization was notified of an outbreak of a communicable disease characterized by fever, severe diarrhea, vomiting, and a high fatality rate in Guinea. Virologic investigation identified Zaire ebolavirus (EBOV) as the causative agent. Full-length genome sequencing and phylogenetic analysis showed that EBOV from Guinea forms a separate clade in relationship to the known EBOV strains from the Democratic Republic of Congo and Gabon. Epidemiologic investigation linked the laboratory-confirmed cases with the presumed first fatality of the outbreak in December 2013. This study demonstrates the emergence of a new EBOV strain in Guinea.	[Baize, Sylvain; Pannetier, Delphine; Bocquin, Anne; Mely, Stephane] Univ Lyon 1, Natl Reference Ctr Viral Hemorrhag Fevers, F-69365 Lyon, France; [Baize, Sylvain] Univ Lyon 1, Inst Pasteur, Unite Biol Infect Virales Emergentes, F-69365 Lyon, France; [Baize, Sylvain] Univ Lyon 1, CIRI, Ecole Normale Super Lyon, INSERM,U1111, F-69365 Lyon, France; [Pannetier, Delphine; Bocquin, Anne; Mely, Stephane; Raoul, Herve] INSERM Jean Merieux, Lab P4, Lyon, France; [Tiffany, Amanda] Epictr, Paris, France; [Caro, Valerie] Inst Pasteur, Unite Rech & Expertise Environm & Risques Infect, Paris, France; [Oestereich, Lisa; Rieger, Toni; Cadar, Daniel; Gabriel, Martin; Tappe, Dennis; Schmidt-Chanasit, Jonas; Guenther, Stephan] World Hlth Org WHO, Bernhard Nocht Inst Trop Med, Collaborating Ctr Arbovirus & Hemorrhag Fever Ref, Hamburg, Germany; [Oestereich, Lisa; Rieger, Toni; Cadar, Daniel; Gabriel, Martin; Pahlmann, Meike; Tappe, Dennis; Schmidt-Chanasit, Jonas; Guenther, Stephan] German Ctr Infect Res DZIF, Hamburg, Germany; [Koivogui, Lamine] Inst Natl Sante Publ, Conakry, Guinea; [Magassouba, N'Faly; Soropogui, Barre] Univ Gamal Abdel Nasser Conakry, Lab Fievres Hemorrag Guinee, Conakry, Guinea; [Sow, Mamadou Saliou] Hop Natl Donka, Serv Malad Infect & Trop, Conakry, Guinea; [Keita, Sakoba] Minist Hlth Guinea, Conakry, Guinea; [Malano, Emmanuel Roland; Heleze, Emmanuel; Diallo, Abdoul Karim] WHO, Conakry, Guinea; [Loua, Mathieu] Direct Reg Sante Nzerekore, Sect Prevent & Lutte Malad, Nzerekore, Guinea; [Traore, Alexis] Direct Prefectorale Sante Gueckedou, Sect Prevent & Lutte Malad, Gueckedou, Guinea; [Kolie, Moussa] Hop Prefectoral Gueckedou, Gueckedou, Guinea; [De Clerck, Hilde; Van Herp, Michel] Med Frontieres, Brussels, Belgium; [Tiffany, Amanda; Dominguez, Gemma] Med Frontieres, Geneva, Switzerland; [Formenty, Pierre] WHO, Geneva, Switzerland; [Impouma, Benido] African Reg Off, Brazzaville, DEM REP CONGO	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Bernhard Nocht Institut fur Tropenmedizin; World Health Organization; German Center for Infection Research; World Health Organization; World Health Organization	Gunther, S (corresponding author), Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	guenther@bni.uni-hamburg.de	Daniel, Cadar/AAN-2658-2021	Cadar, Daniel/0000-0002-8063-2766; Gunther, Stephan/0000-0002-6562-0230; MELY, Stephane/0000-0002-3278-3455; Baize, Sylvain/0000-0002-3234-7477; Oestereich, Lisa/0000-0003-0098-7485; Rieger, Toni/0000-0002-7863-1916	European Community [228292]; Institut National de Veille Sanitaire	European Community(European Commission); Institut National de Veille Sanitaire	Supported by a grant (228292, to the European Virus Archive) from the European Community. The National Reference Center for Viral Hemorrhagic Fevers in Lyons, France, is supported by the Institut National de Veille Sanitaire.	Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Formenty P, 1999, J INFECT DIS, V179, pS48, DOI 10.1086/514285; Gibb TR, 2001, J CLIN MICROBIOL, V39, P4125, DOI 10.1128/JCM.39.11.4125-4130.2001; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hartman AL, 2010, CLIN LAB MED, V30, P161, DOI 10.1016/j.cll.2009.12.001; Huang Yi, 2012, Virologica Sinica, V27, P273, DOI 10.1007/s12250-012-3252-y; Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306; Kortepeter MG, 2011, J INFECT DIS, V204, pS810, DOI 10.1093/infdis/jir299; Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Miranda ME, 1999, J INFECT DIS, V179, pS115, DOI 10.1086/514314; Olschlager S, 2010, J CLIN MICROBIOL, V48, P2009, DOI 10.1128/JCM.02351-09; Panning M, 2007, J INFECT DIS, V196, pS199, DOI 10.1086/520600; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanchez A, 1999, J INFECT DIS, V179, pS164, DOI 10.1086/514282; Smith O, 2014, SCI REP-UK, V4, DOI 10.1038/srep04003; Vieth S, 2007, T ROY SOC TROP MED H, V101, P1253, DOI 10.1016/j.trstmh.2005.03.018	19	897	966	2	526	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2014	371	15					1418	1425		10.1056/NEJMoa1404505	http://dx.doi.org/10.1056/NEJMoa1404505			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3FJ	24738640	Bronze			2022-12-28	WOS:000342674800010
J	Fulco, I; Miot, S; Haug, MD; Barbero, A; Wixmerten, A; Feliciano, S; Wolf, F; Jundt, G; Marsano, A; Farhadi, J; Heberer, M; Jakob, M; Schaefer, DJ; Martin, I				Fulco, Ilario; Miot, Sylvie; Haug, Martin D.; Barbero, Andrea; Wixmerten, Anke; Feliciano, Sandra; Wolf, Francine; Jundt, Gernot; Marsano, Anna; Farhadi, Jian; Heberer, Michael; Jakob, Marcel; Schaefer, Dirk J.; Martin, Ivan			Engineered autologous cartilage tissue for nasal reconstruction after tumour resection: an observational first-in-human trial	LANCET			English	Article							ANATOMY; GRAFTS; DIFFERENTIATION; TRANSPLANTATION; SUBUNITS; SHAPE; EAR	Background Autologous native cartilage from the nasal septum, ear, or rib is the standard material for surgical reconstruction of the nasal alar lobule after two-layer excision of non-melanoma skin cancer. We assessed whether engineered autologous cartilage grafts allow safe and functional alar lobule restoration. Methods In a first-in-human trial, we recruited five patients at the University Hospital Basel (Basel, Switzerland). To be eligible, patients had to be aged at least 18 years and have a two-layer defect (>= 50% size of alar subunit) after excision of non-melanoma skin cancer on the alar lobule. Chondrocytes (isolated from a 6 mm cartilage biopsy sample from the nasal septum harvested under local anaesthesia during collection of tumour biopsy sample) were expanded, seeded, and cultured with autologous serum onto collagen type I and type III membranes in the course of 4 weeks. The resulting engineered cartilage grafts (25 mm x 25 mm x 2 mm) were shaped intra-operatively and implanted after tumour excision under paramedian forehead or nasolabial flaps, as in standard reconstruction with native cartilage. During flap refinement after 6 months, we took biopsy samples of repair tissues and histologically analysed them. The primary outcomes were safety and feasibility of the procedure, assessed 12 months after reconstruction. At least 1 year after implantation, when reconstruction is typically stabilised, we assessed patient satisfaction and functional outcomes (alar cutaneous sensibility, structural stability, and respiratory flow rate). Findings Between Dec 13, 2010, and Feb 6, 2012, we enrolled two women and three men aged 76-88 years. All engineered grafts contained a mixed hyaline and fibrous cartilage matrix. 6 months after implantation, reconstructed tissues displayed fibromuscular fatty structures typical of the alar lobule. After 1 year, all patients were satisfied with the aesthetic and functional outcomes and no adverse events had been recorded. Cutaneous sensibility and structural stability of the reconstructed area were clinically satisfactory, with adequate respiratory function. Interpretation Autologous nasal cartilage tissues can be engineered and clinically used for functional restoration of alar lobules. Engineered cartilage should now be assessed for other challenging facial reconstructions.	[Fulco, Ilario; Miot, Sylvie; Haug, Martin D.; Barbero, Andrea; Wixmerten, Anke; Feliciano, Sandra; Wolf, Francine; Marsano, Anna; Heberer, Michael; Jakob, Marcel; Schaefer, Dirk J.; Martin, Ivan] Univ Basel, Univ Basel Hosp, Dept Surg, CH-4031 Basel, Switzerland; [Fulco, Ilario; Miot, Sylvie; Haug, Martin D.; Barbero, Andrea; Wixmerten, Anke; Feliciano, Sandra; Wolf, Francine; Marsano, Anna; Heberer, Michael; Jakob, Marcel; Schaefer, Dirk J.; Martin, Ivan] Univ Basel, Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Jundt, Gernot] Univ Basel, Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland; [Farhadi, Jian] Guys & St Thomas Hosp, Dept Plast Surg, London SE1 9RT, England	University of Basel; University of Basel; University of Basel; Guy's & St Thomas' NHS Foundation Trust	Martin, I (corresponding author), Univ Basel, Univ Basel Hosp, Dept Surg, CH-4031 Basel, Switzerland.	martin.haug@usb.ch; ivan.martin@usb.ch	Fulco, Ilario/Y-3177-2019; Jakob, Marcel/AAI-6122-2021; Martin, Ivan/K-9286-2016	Jakob, Marcel/0000-0002-9021-0890; Martin, Ivan/0000-0001-6493-0432; Barbero, Andrea/0000-0001-5252-789X; Marsano, Anna/0000-0002-3084-0823	Hospital Pharmacy (University Hospital Basel); Foundation of the Department of Surgery, University Hospital Basel; Krebsliga beider Basel [22-2008]	Hospital Pharmacy (University Hospital Basel); Foundation of the Department of Surgery, University Hospital Basel; Krebsliga beider Basel	We acknowledge the support of the Hospital Pharmacy (University Hospital Basel), especially Christoph Hilker and Stefanie Deuster for help with establishment of a quality management system and for the access to the clean room for graft manufacturing. We also thank Katja Martin from Geistlich for providing Chondro-Gide collagen scaffolds; Marcus Mumme for clinical monitoring of the study; Gerhard Unteregger for mycoplasma tests; Reno Frei for microbiology tests; and Daniel Baumhoer for assistance with histology. This study was funded by the Foundation of the Department of Surgery, University Hospital Basel; and by the Krebsliga beider Basel (contract number 22-2008).	Albrecht C, 2011, OSTEOARTHR CARTILAGE, V19, P1219, DOI 10.1016/j.joca.2011.07.004; Ali-Salaam P, 2002, PLAST RECONSTR SURG, V110, P261, DOI 10.1097/00006534-200207000-00044; American Cancer Society, 2012, CANC FACTS FIG 2012; Becker DG, 1997, ARCH OTOLARYNGOL, V123, P789; Bell-Krotoski J, 1993, J Hand Ther, V6, P114; BURGET GC, 1985, PLAST RECONSTR SURG, V76, P239, DOI 10.1097/00006534-198508000-00010; Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001; Chun KW, 2008, J PLAST RECONSTR AES, V61, P400, DOI 10.1016/j.bjps.2007.06.029; Clement PAR, 2005, RHINOLOGY, V43, P169; Daniel RK, 2013, AESTHET SURG J, V33, P222, DOI 10.1177/1090820X12472695; Driscoll B P, 2001, Arch Facial Plast Surg, V3, P91, DOI 10.1001/archfaci.3.2.91; European Medicines Agency, 1995, CLIN SAF DAT MAN DEF; Farhadi J, 2006, ANN SURG, V244, P978, DOI 10.1097/01.sla.0000247057.16710.be; Haug MD, 2009, ANN PLAS SURG, V63, P171, DOI 10.1097/SAP.0b013e318189a9c4; HOLLANDER AP, 1994, J CLIN INVEST, V93, P1722, DOI 10.1172/JCI117156; Homicz Mark R, 2003, Arch Facial Plast Surg, V5, P53; Kafienah W, 2002, TISSUE ENG, V8, P817, DOI 10.1089/10763270260424178; Lawson W, 2007, OPER TECH OTOLAYNGOL, V18, P315, DOI [10.1016/j.otot.2007.09.004, DOI 10.1016/J.OTOT.2007.09.004]; Lomas A, 2012, BRIT J DERMATOL, V166, P1069, DOI 10.1111/j.1365-2133.2012.10830.x; Lovice DB, 1999, OTOLARYNG CLIN N AM, V32, P113, DOI 10.1016/S0030-6665(05)70118-3; Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001; Martin I, SCI TRANSL IN PRESS; Martin I, 2009, TRENDS BIOTECHNOL, V27, P495, DOI 10.1016/j.tibtech.2009.06.002; Menick FJ, 2002, PLAST RECONSTR SURG, V109, P1839, DOI 10.1097/00006534-200205000-00010; Moretti M, 2005, TISSUE ENG, V11, P1421, DOI 10.1089/ten.2005.11.1421; Rettinger G, 2007, GMS CURR TOP OTORHIN, V6, P1; Reuther MS, 2013, OTOLARYNG HEAD NECK, V148, P753, DOI 10.1177/0194599813478921; Rohrich RJ, 2004, PLAST RECONSTR SURG, V114, P1405, DOI 10.1097/01.PRS.0000138596.57393.05; Santoro R, 2010, BIOMATERIALS, V31, P8946, DOI 10.1016/j.biomaterials.2010.08.009; Sivayoham E, 2012, CURR OPIN OTOLARYNGO, V20, P287, DOI 10.1097/MOO.0b013e328355b1d9; Stoll W, 1997, Facial Plast Surg, V13, P45, DOI 10.1055/s-2008-1064464; Tay AG, 2004, TISSUE ENG, V10, P762, DOI 10.1089/1076327041348572; von Bomhard A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071667; Wettstein R, 2008, SCAND J PLAST RECONS, V42, P92, DOI 10.1080/02844310701694811; Wolf F, 2008, EUR CELLS MATER, V15, P1; Yanaga H, 2009, AESTHET PLAST SURG, V33, P795, DOI 10.1007/s00266-009-9399-8; Zemek A, 2010, LARYNGOSCOPE, V120, P1089, DOI 10.1002/lary.20891; Zopf DA, 2012, ARCH FACIAL PLAST S, V3, P1	38	115	122	2	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2014	384	9940					337	346		10.1016/S0140-6736(14)60544-4	http://dx.doi.org/10.1016/S0140-6736(14)60544-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3AE	24726477				2022-12-28	WOS:000339722400031
J	van Galen, P; Kreso, A; Mbong, N; Kent, DG; Fitzmaurice, T; Chambers, JE; Xie, S; Laurenti, E; Hermans, K; Eppert, K; Marciniak, SJ; Goodall, JC; Green, AR; Wouters, BG; Wienholds, E; Dick, JE				van Galen, Peter; Kreso, Antonija; Mbong, Nathan; Kent, David G.; Fitzmaurice, Timothy; Chambers, Joseph E.; Xie, Stephanie; Laurenti, Elisa; Hermans, Karin; Eppert, Kolja; Marciniak, Stefan J.; Goodall, Jane C.; Green, Anthony R.; Wouters, Bradly G.; Wienholds, Erno; Dick, John E.			The unfolded protein response governs integrity of the haematopoietic stem-cell pool during stress	NATURE			English	Article							ER-STRESS; MESSENGER-RNA; IDENTIFICATION; TRANSLATION; DEPHOSPHORYLATION; REINITIATION; INHIBITOR; HIERARCHY; DEATH; IRE1	The blood system is sustained by a pool of haematopoietic stem cells (HSCs) that are long-lived due to their capacity for self-renewal. A consequence of longevity is exposure to stress stimuli including reactive oxygen species (ROS), nutrient fluctuation and DNA damage(1,2). Damage that occurs within stressed HSCs must be tightly controlled to prevent either loss of function or the clonal persistence of oncogenic mutations that increase the risk of leukaemogenesis(3,4). Despite the importance of maintaining cell integrity throughout life, how the HSC pool achieves this and how individual HSCs respond to stress remain poorly understood. Many sources of stress cause misfolded protein accumulation in the endoplasmic reticulum (ER), and subsequent activation of the unfolded protein response (UPR) enables the cell to either resolve stress or initiate apoptosis(5,6). Here we show that human HSCs are predisposed to apoptosis through strong activation of the PERK branch of the UPR after ER stress, whereas closely related progenitors exhibit an adaptive response leading to their survival. Enhanced ER protein folding by overexpression of the cochaperone ERDJ4 (also called DNAJB9) increases HSC repopulation capacity in xenograft assays, linking the UPR to HSC function. Because the UPR is a focal point where different sources of stress converge, our study provides a framework for understanding how stress signalling is coordinated within tissue hierarchies and integrated with stemness. Broadly, these findings reveal that the HSC pool maintains clonal integrity by clearance of individual HSCs after stress to prevent propagation of damaged stem cells.	[van Galen, Peter; Kreso, Antonija; Mbong, Nathan; Xie, Stephanie; Laurenti, Elisa; Hermans, Karin; Wienholds, Erno; Dick, John E.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [van Galen, Peter; Kreso, Antonija; Mbong, Nathan; Xie, Stephanie; Laurenti, Elisa; Hermans, Karin; Wienholds, Erno; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Kent, David G.; Chambers, Joseph E.; Marciniak, Stefan J.; Green, Anthony R.] Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust, MRC Stem Cell Inst, Cambridge CB2 0XY, England; [Kent, David G.; Green, Anthony R.] Univ Cambridge, Dept Haematol, Cambridge CB2 0XY, England; [Fitzmaurice, Timothy; Goodall, Jane C.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Sch Clin Med, Cambridge CB2 0QQ, England; [Eppert, Kolja] McGill Univ, Dept Pediat, Westmount, PQ H3Z 2Z3, Canada; [Eppert, Kolja] McGill Univ, Ctr Hlth, Res Inst, Westmount, PQ H3Z 2Z3, Canada; [Wouters, Bradly G.] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada; [Wouters, Bradly G.] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; McGill University; McGill University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Dick, JE (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada.	jdick@uhnresearch.ca	Chambers, Joseph/Z-5212-2019; Wouters, Bradly/T-1525-2017; Kent, David/AAZ-4916-2021	Chambers, Joseph/0000-0003-4675-0053; Wouters, Bradly/0000-0002-8187-592X; Kent, David/0000-0001-7871-8811; Marciniak, Stefan/0000-0001-8472-7183; Green, Anthony/0000-0002-9795-0218; Eppert, Kolja/0000-0001-9061-8856; Fitzmaurice, Tim/0000-0003-1403-2495; Xie, Stephanie/0000-0002-0284-494X; Dick, John/0000-0002-9527-8317; Laurenti, Elisa/0000-0002-9917-9092; van Galen, Peter/0000-0002-0735-1570; Goodall, Jane/0000-0002-3761-161X	Canadian Institutes for Health Research; Canadian Cancer Society; Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute; Ontario Institute for Cancer Research; province of Ontario; Canada Research Chair; Ontario Ministry of Health and Long Term Care (OMOHLTC); Leukemia and Lymphoma Research; Cancer Research UK; Kay Kendall Leukaemia Fund; NIHR Cambridge Biomedical Research Centre; Cambridge Experimental Cancer Medicine Centre; Leukemia & Lymphoma Society of America; Arthritis Research UK; Medical Research Council (UK); Terry Fox New Frontiers Research Program [PPG09-020005]; Canadian Institute for Health Research (CIHR) [201592]; Medical Research Council [G0601840, G1001765, G1002610] Funding Source: researchfish; Versus Arthritis [19639] Funding Source: researchfish; MRC [G0601840, G1001765, G1002610] Funding Source: UKRI	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Institute for Cancer Research; province of Ontario; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario); Leukemia and Lymphoma Research; Cancer Research UK(Cancer Research UK); Kay Kendall Leukaemia Fund; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge Experimental Cancer Medicine Centre; Leukemia & Lymphoma Society of America(Leukemia and Lymphoma Society); Arthritis Research UK(Versus Arthritis); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Terry Fox New Frontiers Research Program; Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank D. Ron and D. Rubinsztein for critical assessment of this work; all members of the Dick laboratory, especially O. I. Gan and E. Lechman, for experimental support and advice; A. Khandani, P. Penttila and the SickKids-UHN flow facility for technical support; N. Jamal for providing bone marrow samples; J. Heijmans for providing the pLV-ca-GADD34 vector; and L. Naldini for providing the MA1 vector. Work in the Dick laboratory is supported by grants from the Canadian Institutes for Health Research, Canadian Cancer Society, Terry Fox Foundation, Genome Canada through the Ontario Genomics Institute, Ontario Institute for Cancer Research with funds from the province of Ontario, a Canada Research Chair and the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC. A. R. G. and D. G. K. are supported by Leukemia and Lymphoma Research, Cancer Research UK, the Kay Kendall Leukaemia Fund, the NIHR Cambridge Biomedical Research Centre, the Cambridge Experimental Cancer Medicine Centre, and the Leukemia & Lymphoma Society of America. J. C. G. and T. F. are supported by Arthritis Research UK. S. J. M. and J. E. C. are supported by the Medical Research Council (UK). B. G. W. is supported by the Terry Fox New Frontiers Research Program (PPG09-020005), the Ontario Institute for Cancer Research, and the Canadian Institute for Health Research (CIHR grant 201592).	Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; DuRose JB, 2006, MOL BIOL CELL, V17, P3095, DOI 10.1091/mbc.E06-01-0055; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Heijmans J, 2013, CELL REP, V3, P1128, DOI 10.1016/j.celrep.2013.02.031; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Kurisu J, 2003, GENES CELLS, V8, P189, DOI 10.1046/j.1365-2443.2003.00625.x; Lai CW, 2012, J BIOL CHEM, V287, P7969, DOI 10.1074/jbc.M111.311290; Laurenti E, 2013, NAT IMMUNOL, V14, P756, DOI 10.1038/ni.2615; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rouault-Pierre K, 2013, CELL STEM CELL, V13, P549, DOI 10.1016/j.stem.2013.08.011; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Shen Y, 2002, J BIOL CHEM, V277, P15947, DOI 10.1074/jbc.M112214200; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; van Galen P, 2014, CELL STEM CELL, V14, P94, DOI 10.1016/j.stem.2013.11.021; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Warner JK, 2005, LEUKEMIA, V19, P1794, DOI 10.1038/sj.leu.2403917; Wey S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039047; Yahata T, 2011, BLOOD, V118, P2941, DOI 10.1182/blood-2011-01-330050; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	39	226	229	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					268	+		10.1038/nature13228	http://dx.doi.org/10.1038/nature13228			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24776803	Green Submitted			2022-12-28	WOS:000337032400050
J	Rosas, M; Davies, LC; Giles, PJ; Liao, CT; Kharfan, B; Stone, TC; O'Donnell, VB; Fraser, DJ; Jones, SA; Taylor, PR				Rosas, Marcela; Davies, Luke C.; Giles, Peter J.; Liao, Chia-Te; Kharfan, Bashar; Stone, Timothy C.; O'Donnell, Valerie B.; Fraser, Donald J.; Jones, Simon A.; Taylor, Philip R.			The Transcription Factor Gata6 Links Tissue Macrophage Phenotype and Proliferative Renewal	SCIENCE			English	Article							RESIDENT MACROPHAGES; IN-VIVO; INFLAMMATION; RECEPTOR; MICE; EXPRESSION; MONOCYTES; LINEAGES; DECTIN-1; HEART	Tissue-resident macrophages are heterogeneous as a consequence of anatomical niche-specific functions. Many populations self-renew independently of bone marrow in the adult, but the molecular mechanisms of this are poorly understood. We determined a transcriptional profile for the major self-renewing population of peritoneal macrophages in mice. These cells specifically expressed the transcription factor Gata6. Selective deficiency of Gata6 in myeloid cells caused substantial alterations in the transcriptome of peritoneal macrophages. Gata6 deficiency also resulted in dysregulated peritoneal macrophage proliferative renewal during homeostasis and in response to inflammation, which was associated with delays in the resolution of inflammation. Our investigations reveal that the tissue macrophage phenotype is under discrete tissue-selective transcriptional control and that this is fundamentally linked to the regulation of their proliferation renewal.	[Rosas, Marcela; Davies, Luke C.; Liao, Chia-Te; Kharfan, Bashar; O'Donnell, Valerie B.; Jones, Simon A.; Taylor, Philip R.] Cardiff Univ, Cardiff Inst Infect & Immun, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Giles, Peter J.; Stone, Timothy C.] Cardiff Univ, Cent Biotechnol Serv, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Fraser, Donald J.] Cardiff Univ, Inst Mol Med, Sch Med, Cardiff CF14 4XN, S Glam, Wales	Cardiff University; Cardiff University; Cardiff University	Taylor, PR (corresponding author), Cardiff Univ, Cardiff Inst Infect & Immun, Sch Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	taylorpr@cf.ac.uk	Rosas Nexticapa, Marcela/HGU-1088-2022; Jones, Simon Arnett/Q-7017-2018	Jones, Simon Arnett/0000-0001-7297-9711; Fraser, Donald/0000-0003-0102-9342; /0000-0003-4089-8460; Davies, Luke/0000-0001-7767-4060; Taylor, Philip/0000-0003-0163-1421	Medical Research Council (MRC) UK [G0601617]; MRC project grant [MR/J002151/1]; Wellcome Trust Programme Grant; MRC Doctoral Training Grant; Medical Research Council [MR/J002151/1, G0601617, 984199, MR/K02003X/1] Funding Source: researchfish; MRC [G0601617, MR/K02003X/1, MR/J002151/1] Funding Source: UKRI	Medical Research Council (MRC) UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC project grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Programme Grant(Wellcome Trust); MRC Doctoral Training Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the staff of our animal facilities for the care of the animals. We also thank C. Pepper, J. Fisher, C. Watkins, and M. Musson for their help with cell purifications and Affymetrix analysis. P. R. T conceived and designed the project and wrote the manuscript; M. R., L. C. D, P. J. G, C.-T.L., B. K., T. C. S., and P. R. T designed and conducted the experiments; and all authors contributed to the analysis and interpretation of the data. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Microarray data has been deposited in the Gene Expression Omnibus (accession nos. GSE28621 and GSE47049). P. R. T. is a Medical Research Council (MRC) UK Senior Non-Clinical Fellow (grant G0601617). This work was also supported by an MRC project grant (MR/J002151/1). V.O.D. is supported by a Wellcome Trust Programme Grant. L. C. D. is an MRC Doctoral Training Grant recipient, Cardiff University 125 for 125 scholar, and MRC Centenary Award holder. All animal work was conducted in accordance with institutional and UK Home Office guidelines. The authors declare no conflicts of interest.	Capo-Chichi CD, 2009, MOL CELL BIOL, V29, P4766, DOI 10.1128/MCB.00087-09; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; Davies LC, 2011, EUR J IMMUNOL, V41, P2155, DOI 10.1002/eji.201141817; Dioszeghy V, 2008, J IMMUNOL, V181, P6514, DOI 10.4049/jimmunol.181.9.6514; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; GORDON S, 1971, J EXP MED, V133, P321, DOI 10.1084/jem.133.2.321; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; McDonald JU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045781; Mullaly SC, 2007, EUR J IMMUNOL, V37, P224, DOI 10.1002/eji.200636405; Pfau JC, 2004, AM J PHYSIOL-LUNG C, V286, pL354, DOI 10.1152/ajplung.00380.2002; Rosas M, 2008, J IMMUNOL, V181, P3549, DOI 10.4049/jimmunol.181.5.3549; Rosas M, 2007, EUR J IMMUNOL, V37, P2518, DOI 10.1002/eji.200636892; Rosas M, 2010, J LEUKOCYTE BIOL, V88, P169, DOI 10.1189/jlb.0809548; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Sodhi CP, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-19; Taylor PR, 2003, EUR J IMMUNOL, V33, P2090, DOI 10.1002/eji.200324003; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhao RO, 2005, MOL CELL BIOL, V25, P2622, DOI 10.1128/MCB.25.7.2622-2631.2005	23	255	261	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					645	648		10.1126/science.1251414	http://dx.doi.org/10.1126/science.1251414			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24762537	Green Accepted			2022-12-28	WOS:000335537400047
J	Kashtan, N; Roggensack, SE; Rodrigue, S; Thompson, JW; Biller, SJ; Coe, A; Ding, HM; Marttinen, P; Malmstrom, RR; Stocker, R; Follows, MJ; Stepanauskas, R; Chisholm, SW				Kashtan, Nadav; Roggensack, Sara E.; Rodrigue, Sebastien; Thompson, Jessie W.; Biller, Steven J.; Coe, Allison; Ding, Huiming; Marttinen, Pekka; Malmstrom, Rex R.; Stocker, Roman; Follows, Michael J.; Stepanauskas, Ramunas; Chisholm, Sallie W.			Single-Cell Genomics Reveals Hundreds of Coexisting Subpopulations in Wild Prochlorococcus	SCIENCE			English	Article							ECOTYPES; MICROORGANISMS; PREDATION; DIVERSITY; ATLANTIC; PATTERNS	Extensive genomic diversity within coexisting members of a microbial species has been revealed through selected cultured isolates and metagenomic assemblies. Yet, the cell-by-cell genomic composition of wild uncultured populations of co-occurring cells is largely unknown. In this work, we applied large-scale single-cell genomics to study populations of the globally abundant marine cyanobacterium Prochlorococcus. We show that they are composed of hundreds of subpopulations with distinct "genomic backbones," each backbone consisting of a different set of core gene alleles linked to a small distinctive set of flexible genes. These subpopulations are estimated to have diverged at least a few million years ago, suggesting ancient, stable niche partitioning. Such a large set of coexisting subpopulations may be a general feature of free-living bacterial species with huge populations in highly mixed habitats.	[Kashtan, Nadav; Roggensack, Sara E.; Rodrigue, Sebastien; Thompson, Jessie W.; Biller, Steven J.; Coe, Allison; Ding, Huiming; Stocker, Roman; Chisholm, Sallie W.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Rodrigue, Sebastien] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Ding, Huiming; Chisholm, Sallie W.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Marttinen, Pekka] Aalto Univ, Helsinki Inst Informat Technol, Dept Informat & Comp Sci, FI-00076 Aalto, Finland; [Malmstrom, Rex R.] Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA; [Follows, Michael J.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Stepanauskas, Ramunas] Bigelow Lab Ocean Sci, East Boothbay, ME 04544 USA	Massachusetts Institute of Technology (MIT); University of Sherbrooke; Massachusetts Institute of Technology (MIT); Aalto University; University of Helsinki; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Massachusetts Institute of Technology (MIT); Bigelow Laboratory for Ocean Sciences	Kashtan, N (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	nadav.kashtan@gmail.com; chisholm@mit.edu	Marttinen, Pekka E/N-6234-2015; Biller, Steven/CAG-2216-2022; t, lf/AAJ-4924-2020; Stocker, Roman/T-9456-2017; Stocker, Roman/N-8987-2019; Biller, Steven/CAI-9174-2022	Marttinen, Pekka E/0000-0001-7078-7927; Stocker, Roman/0000-0002-3199-0508; Stepanauskas, Ramunas/0000-0003-4458-3108; Kashtan, Nadav/0000-0002-7475-1363; Malmstrom, Rex/0000-0002-4758-7369; Chisholm, Sallie/0000-0003-1480-2445	NSF Evolutionary Biology Section and Biological Oceanography Section; NSF Center for Microbial Oceanography Research and Education (C-MORE); U.S. Department of Energy (DOE)-GTL; Gordon and Betty Moore Foundation Marine Microbiology Initiative; NSF Biological Oceanography Section; DOE [DE-AC02-05CH11231]; Division Of Ocean Sciences [1232982] Funding Source: National Science Foundation	NSF Evolutionary Biology Section and Biological Oceanography Section; NSF Center for Microbial Oceanography Research and Education (C-MORE)(National Science Foundation (NSF)); U.S. Department of Energy (DOE)-GTL(United States Department of Energy (DOE)); Gordon and Betty Moore Foundation Marine Microbiology Initiative(Gordon and Betty Moore Foundation); NSF Biological Oceanography Section(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); DOE(United States Department of Energy (DOE)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank S. Itzkovitz, P. H. R. Calil, D. Sher, R. Milo, P. M. Berube, A. P. Yelton, R. Braakman, and particularly M. F. Polz for comments on the manuscript. We thank the Bermuda Atlantic Time-series Study for sample collection, the Bigelow Laboratory Single Cell Genomics Center for single-cell sorting and whole-genome amplification, and the BioMicroCenter facility at MIT for their contributions to the generation of genomic data. N.K. acknowledges the Rothschild Foundation (Yad Hanadiv) and the National Oceanic and Atmospheric Administration "Climate and Global Change" Postdoctoral Research Fellowships. This work was supported by grants to S. W. C. from the NSF Evolutionary Biology Section and Biological Oceanography Section, the NSF Center for Microbial Oceanography Research and Education (C-MORE), the U.S. Department of Energy (DOE)-GTL, and the Gordon and Betty Moore Foundation Marine Microbiology Initiative; to R. Stepanauskas from the NSF Biological Oceanography Section; and to R. R. M from the DOE (contract number DE-AC02-05CH11231). Genomic data have been deposited in National Center for Biotechnology Information GenBank under accession numbers KJ477896 to KJ479276 and JFKN00000000 to JFOE00000000. Additional data files have been deposited to Dryad (doi:10.5061/dryad.9r0p6).	Avrani S, 2011, NATURE, V474, P604, DOI 10.1038/nature10172; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Barton AD, 2010, SCIENCE, V327, P1509, DOI 10.1126/science.1184961; Cadillo-Quiroz H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001265; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Gonzaga A, 2012, GENOME BIOL EVOL, V4, P1360, DOI 10.1093/gbe/evs112; Grote J, 2012, MBIO, V3, DOI 10.1128/mBio.00252-12; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kalisky T, 2011, ANNU REV GENET, V45, P431, DOI 10.1146/annurev-genet-102209-163607; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Lasken RS, 2012, NAT REV MICROBIOL, V10, P631, DOI 10.1038/nrmicro2857; Malfatti F, 2009, AQUAT MICROB ECOL, V58, P1, DOI 10.3354/ame01355; Malmstrom RR, 2010, ISME J, V4, P1252, DOI 10.1038/ismej.2010.60; Mehra-Chaudhary R, 2011, J BACTERIOL, V193, P4081, DOI 10.1128/JB.00418-11; MICHAELS AF, 1994, DEEP-SEA RES PT I, V41, P1013, DOI 10.1016/0967-0637(94)90016-7; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Muhling M, 2012, ENVIRON MICROBIOL, V14, P567, DOI 10.1111/j.1462-2920.2011.02589.x; Nei M, 1982, Prog Clin Biol Res, V103 Pt A, P167; Papke RT, 2007, P NATL ACAD SCI USA, V104, P14092, DOI 10.1073/pnas.0706358104; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Simmons SL, 2008, PLOS BIOL, V6, P1427, DOI 10.1371/journal.pbio.0060177; Stepanauskas R, 2012, CURR OPIN MICROBIOL, V15, P613, DOI 10.1016/j.mib.2012.09.001; Thompson CC, 2013, MICROB ECOL, V66, P752, DOI 10.1007/s00248-013-0270-8; Wurtzel O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015628	29	319	328	6	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					416	420		10.1126/science.1248575	http://dx.doi.org/10.1126/science.1248575			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763590	Green Submitted			2022-12-28	WOS:000334867800042
J	Feld, JJ; Kowdley, KV; Coakley, E; Sigal, S; Nelson, DR; Crawford, D; Weiland, O; Aguilar, H; Xiong, JY; Pilot-Matias, T; DaSilva-Tillmann, B; Larsen, L; Podsadecki, T; Bernstein, B				Feld, Jordan J.; Kowdley, Kris V.; Coakley, Eoin; Sigal, Samuel; Nelson, David R.; Crawford, Darrell; Weiland, Ola; Aguilar, Humberto; Xiong, Junyuan; Pilot-Matias, Tami; DaSilva-Tillmann, Barbara; Larsen, Lois; Podsadecki, Thomas; Bernstein, Barry			Treatment of HCV with ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOTYPE 1 INFECTION; TREATMENT-NAIVE PATIENTS; C VIRUS-INFECTION; HEPATITIS-C; SIMEPREVIR TMC435; PLUS SOFOSBUVIR; INTERFERON-FREE; PHASE 2B; TRIAL; DACLATASVIR	BACKGROUND The interferon-free combination of the protease inhibitor ABT-450 with ritonavir (ABT-450/r) and the NS5A inhibitor ombitasvir (also known as ABT-267) plus the nonnucleoside polymerase inhibitor dasabuvir (also known as ABT-333) and ribavirin has shown efficacy against the hepatitis C virus (HCV) in patients with HCV genotype 1 infection. In this phase 3 trial, we evaluated this regimen in previously untreated patients with HCV genotype 1 infection and no cirrhosis. METHODS In this multicenter, randomized, double-blind, placebo-controlled trial, we assigned previously untreated patients with HCV genotype 1 infection, in a 3: 1 ratio, to an active regimen consisting of a single-tablet coformulation of ABT-450/r-ombitasvir (at a once-daily dose of 150 mg of ABT-450, 100 mg of ritonavir, and 25 mg of ombitasvir), and dasabuvir (250 mg twice daily) with ribavirin (in doses determined according to body weight) (group A) or matching placebos (group B). The patients received the study treatment during a 12-week double-blind period. The primary end point was sustained virologic response at 12 weeks after the end of treatment. The primary analysis compared the response rate in group A with the response rate (78%) in a historical control group of previously untreated patients without cirrhosis who received telaprevir with peginterferon and ribavirin. Adverse events occurring during the double-blind period were compared between group A and group B. RESULTS A total of 631 patients received at least one dose of the study drugs. The rate of sustained virologic response in group A was 96.2% (95% confidence interval, 94.5 to 97.9), which was superior to the historical control rate. Virologic failure during treatment and relapse after treatment occurred in 0.2% and 1.5%, respectively, of the patients in group A. The response rates in group A were 95.3% among patients with HCV genotype 1a infection and 98.0% among those with HCV genotype 1b infection. The rate of discontinuation due to adverse events was 0.6% in each study group. Nausea, pruritus, insomnia, diarrhea, and asthenia occurred in significantly more patients in group A than in group B (P<0.05 for all comparisons). Reductions in the hemoglobin level were all of grade 1 or 2; reductions of grade 1 and 2 occurred in 47.5% and 5.8%, respectively, of the patients in group A, whereas grade 1 reductions occurred in 2.5% of the patients in group B. CONCLUSIONS In previously untreated patients with HCV genotype 1 infection and no cirrhosis, a 12-week multitargeted regimen of ABT-450/r-ombitasvir and dasabuvir with ribavirin was highly effective and was associated with a low rate of treatment discontinuation. (Funded by AbbVie; SAPPHIRE-I ClinicalTrials.gov number, NCT01716585.)	[Feld, Jordan J.] Toronto Western Hosp, Ctr Liver, Toronto, ON M5T 2S8, Canada; [Kowdley, Kris V.] Virginia Mason Med Ctr, Digest Dis Inst, Seattle, WA 98101 USA; [Coakley, Eoin; Xiong, Junyuan; Pilot-Matias, Tami; DaSilva-Tillmann, Barbara; Larsen, Lois; Podsadecki, Thomas; Bernstein, Barry] AbbVie, N Chicago, IL USA; [Sigal, Samuel] NYU, Sch Med, New York, NY USA; [Nelson, David R.] Univ Florida, Coll Med, Gainesville, FL USA; [Crawford, Darrell] Gallipoli Med Res Fdn, Brisbane, Qld, Australia; [Crawford, Darrell] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Weiland, Ola] Karolinska Inst, Karolinska Univ Hosp Huddinge, Stockholm, Sweden; [Aguilar, Humberto] Louisiana Res Ctr, Shreveport, LA USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Virginia Mason Medical Center; AbbVie; New York University; State University System of Florida; University of Florida; University of Queensland; Karolinska Institutet; Karolinska University Hospital; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Feld, JJ (corresponding author), Toronto Western Hosp, Ctr Liver, 399 Bathurst St,6B Fell Pavil, Toronto, ON M5T 2S8, Canada.	jordan.feld@uhn.ca	Feld, Jordan/AAH-5628-2020; Kowdley, Kris/AAF-5202-2019; Sigal, Samuel/AGF-2841-2022; Crawford, Darrell HG/F-2157-2010	Feld, Jordan/0000-0003-2640-2211; Crawford, Darrell/0000-0001-8480-5954; Weiland, Ola/0000-0002-6934-9724	Boehringer Ingelheim; Gilead Sciences; Vertex Pharmaceuticals; Achillion Pharmaceuticals; Bristol-Myers Squibb; Idenix Pharmaceuticals; Janssen Pharmaceuticals; Merck; Roche; Santaris Pharma; Ikaria Pharmaceuticals; Trio Health; Pharmasset; Tekmira Pharmaceuticals; Novartis; Beckman Coulter; Intercept Pharmaceuticals; Mochida Pharmaceutical; Conatus Pharmaceuticals; Genentech; GlaxoSmithKline; Otsuka Pharmaceutical; Salix Pharmaceuticals; Hyperion Therapeutics; AbbVie; Kadmon Pharmaceuticals; Medivir; Johnson Johnson; Ironwood Pharmaceuticals	Boehringer Ingelheim(Boehringer Ingelheim); Gilead Sciences(Gilead Sciences); Vertex Pharmaceuticals(Vertex Pharmaceuticals); Achillion Pharmaceuticals; Bristol-Myers Squibb(Bristol-Myers Squibb); Idenix Pharmaceuticals; Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Roche(Roche Holding); Santaris Pharma; Ikaria Pharmaceuticals; Trio Health; Pharmasset; Tekmira Pharmaceuticals; Novartis(Novartis); Beckman Coulter; Intercept Pharmaceuticals; Mochida Pharmaceutical; Conatus Pharmaceuticals; Genentech(Roche HoldingGenentech); GlaxoSmithKline(GlaxoSmithKline); Otsuka Pharmaceutical(Otsuka Pharmaceutical); Salix Pharmaceuticals; Hyperion Therapeutics; AbbVie(AbbVie); Kadmon Pharmaceuticals; Medivir; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Ironwood Pharmaceuticals	Dr. Feld reports receiving consulting fees from Boehringer Ingelheim, Gilead Sciences, Vertex Pharmaceuticals, Achillion Pharmaceuticals, Bristol-Myers Squibb, Idenix Pharmaceuticals, Janssen Pharmaceuticals, and Merck; and grant support from Roche, Boehringer Ingelheim, Gilead Sciences, Santaris Pharma, and Vertex Pharmaceuticals. Dr. Kowdley reports receiving fees for serving on advisory boards from Boehringer Ingelheim, Gilead Sciences, Ikaria Pharmaceuticals, Janssen Pharmaceuticals, Merck, Vertex Pharmaceuticals, Trio Health, Pharmasset, and Tekmira Pharmaceuticals; consulting fees from Novartis; and grant support from Beckman Coulter, Bristol-Myers Squibb, Intercept Pharmaceuticals, Mochida Pharmaceutical, Conatus Pharmaceuticals, Genentech, GlaxoSmithKline, Boehringer Ingelheim, Gilead Sciences, Ikaria Pharmaceuticals, Janssen Pharmaceuticals, Merck, Vertex Pharmaceuticals, and Pharmasset. Dr. Coakley, Ms. Xiong, Dr. Pilot-Matias, Dr. DaSilva-Tillmann, Dr. Larsen, Dr. Podsadecki, and Dr. Bernstein report being employees of and holding stock or stock options in AbbVie. Dr. Sigal reports receiving fees for serving on an advisory board and lecture fees from Gilead Sciences; consulting fees from Otsuka Pharmaceutical and GlaxoSmithKline; and grant support from Gilead Sciences, Boehringer Ingelheim, Otsuka Pharmaceutical, Salix Pharmaceuticals, GlaxoSmithKline, Ikaria Pharmaceuticals, Hyperion Therapeutics, and Vertex Pharmaceuticals. Dr. Nelson reports receiving grant support from AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, Gilead Sciences, Idenix Pharmaceuticals, Kadmon Pharmaceuticals, Merck, and Vertex Pharmaceuticals; and participating in continuing medical education activities with Clinical Care Options, Projects in Knowledge, and Practice Point Communications. Dr. Crawford reports receiving fees for serving on an advisory board from Bristol-Myers Squibb, Janssen Pharmaceuticals, and Gilead Sciences. Dr. Weiland reports receiving fees for serving on an advisory board and lecture fees from Gilead Sciences, Bristol-Myers Squibb, Medivir, Johnson & Johnson, and Merck. Dr. Aguilar reports receiving lecture fees from Santaris Pharma and Ironwood Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.	American Association for the Study of Liver Diseases and Infectious Diseases Society of America, REC TEST MAN TREAT H; [Anonymous], 2012, HEP C FACT SHEET; [Anonymous], 2013, INC TEL FILM COAT TA; Chopra A, 2013, LIVER INT, V33, P30, DOI 10.1111/liv.12080; Everson GT, 2013, HEPATOLOGY, V58, p1377A; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hezode C, 2012, HEPATOLOGY, V56, p553A; Hsu CS, 2013, NEW ENGL J MED, V369, P678, DOI 10.1056/NEJMc1307641; Jacobson I, 2013, J HEPATOL, V58, pS574, DOI 10.1016/S0168-8278(13)61424-5; Jacobson IM, 2013, HEPATOLOGY, V58, p1379A; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kowdley KV, 2014, NEW ENGL J MED, V370, P222, DOI 10.1056/NEJMoa1306227; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Manns MP, 2011, J HEPATOL, V54, P1114, DOI 10.1016/j.jhep.2010.08.040; Menon RM, 2009, HEPDART 2009 KOH COA; Poordad F, 2012, GASTROENTEROLOGY, V143, P608, DOI 10.1053/j.gastro.2012.05.011; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Zeuzem S, 2013, AS PAC ASS STUD LIV; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561; Zeuzem S, 2013, NEW ENGL J MED, V369, P630, DOI 10.1056/NEJMoa1213557; Zeuzem S, 2012, HEPATOLOGY, V55, P749, DOI 10.1002/hep.24744	22	684	717	1	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 24	2014	370	17					1594	1603		10.1056/NEJMoa1315722	http://dx.doi.org/10.1056/NEJMoa1315722			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4TG	24720703				2022-12-28	WOS:000336120500006
J	Gulland, A				Gulland, Anne			BMJ AWARDS 2014 Cancer Care Team	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												annecgulland@yahoo.co.uk						Health & Social Care Information Centre, 2012, STATISTICS ON SMOKIN	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2014	348								g2824	10.1136/bmj.g2824	http://dx.doi.org/10.1136/bmj.g2824			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG1DI	24764571				2022-12-28	WOS:000335154900003
J	Li, CW; Ciston, J; Kanan, MW				Li, Christina W.; Ciston, Jim; Kanan, Matthew W.			Electroreduction of carbon monoxide to liquid fuel on oxide-derived nanocrystalline copper	NATURE			English	Article							ELECTROCHEMICAL REDUCTION; CO2 ELECTROREDUCTION; CONVERSION; HYDROCARBONS; CATALYSTS; ELECTRODE; INSIGHTS; DIOXIDE	The electrochemical conversion of CO2 and H2O into liquid fuel is ideal for high-density renewable energy storage and could provide an incentive for CO2 capture. However, efficient electrocatalysts for reducing CO2 and its derivatives into a desirable fuel(1-3) are not available at present. Although many catalysts(4-11) can reduce CO2 to carbon monoxide (CO), liquid fuel synthesis requires that CO is reduced further, using H2O as a H+ source. Copper (Cu) is the only known material with an appreciable CO electroreduction activity, but in bulk form its efficiency and selectivity for liquid fuel are far too low for practical use. In particular, H2O reduction to H-2 outcompetes CO reduction on Cu electrodes unless extreme overpotentials are applied, at which point gaseous hydrocarbons are the major CO reduction products(12,13). Here we show that nanocrystalline Cu prepared from Cu2O ('oxide-derivedCu') produces multi-carbon oxygenates (ethanol, acetate and n-propanol) with up to 57% Faraday efficiency at modest potentials (-0.25 volts to -0.5 volts versus the reversible hydrogen electrode) in CO-saturated alkaline H2O. By comparison, when prepared by traditional vapour condensation, Cu nanoparticles with an average crystallite size similar to that of oxide-derived copper produce nearly exclusive H-2 (96% Faraday efficiency) under identical conditions. Our results demonstrate the ability to change the intrinsic catalytic properties of Cu for this notoriously difficult reaction by growing interconnected nanocrystallites from the constrained environment of an oxide lattice. The selectivity for oxygenates, with ethanol as the major product, demonstrates the feasibility of a two-step conversion of CO2 to liquid fuel that could be powered by renewable electricity.	[Li, Christina W.; Kanan, Matthew W.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Ciston, Jim] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Natl Ctr Electron Microscopy, Berkeley, CA 94720 USA	Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kanan, MW (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	mkanan@stanford.edu		Li, Christina/0000-0002-3538-9955; Kanan, Matthew/0000-0002-5932-6289	Stanford University; NSF [CHE-1266401]; Office of Science, Office of Basic Energy Sciences of the US Department of Energy [DE-AC02-05CH11231]; Direct For Mathematical & Physical Scien [1266401] Funding Source: National Science Foundation	Stanford University(Stanford University); NSF(National Science Foundation (NSF)); Office of Science, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank Stanford University and the NSF (CHE-1266401) for support of this work. C. W. L. gratefully acknowledges an NSF Predoctoral Fellowship. A portion of this work was performed at NCEM, which is supported by the Office of Science, Office of Basic Energy Sciences of the US Department of Energy under contract number DE-AC02-05CH11231. We thank M. Toney and B. Shyam for assistance with grazing incidence X-ray diffraction performed at SSRL, a national user facility operated by Stanford University on behalf of the Office of Basic Energy Sciences of the US Department of Energy.	Appel AM, 2013, CHEM REV, V113, P6621, DOI 10.1021/cr300463y; Benson EE, 2009, CHEM SOC REV, V38, P89, DOI 10.1039/b804323j; Calle-Vallejo F, 2013, ANGEW CHEM INT EDIT, V52, P7282, DOI 10.1002/anie.201301470; Chen YH, 2012, J AM CHEM SOC, V134, P19969, DOI 10.1021/ja309317u; Cole E.B., 2010, CARBON DIOXIDE CHEM, ppp. 291; Costentin C, 2013, CHEM SOC REV, V42, P2423, DOI 10.1039/c2cs35360a; Costentin C, 2012, SCIENCE, V338, P90, DOI 10.1126/science.1224581; CRC, 2013, HDB CHEM PHYS; DiMeglio JL, 2013, J AM CHEM SOC, V135, P8798, DOI 10.1021/ja4033549; Ebbesen SD, 2009, J POWER SOURCES, V193, P349, DOI 10.1016/j.jpowsour.2009.02.093; Gattrell M, 2006, J ELECTROANAL CHEM, V594, P1, DOI 10.1016/j.jelechem.2006.05.013; Gavrilov AN, 2007, PHYS CHEM CHEM PHYS, V9, P5476, DOI 10.1039/b707598g; Gileadi E., 1993, ELECTRODES KINETICS, P1; Gupta M, 2011, ACS CATAL, V1, P641, DOI 10.1021/cs2001048; HORI Y, 1987, J AM CHEM SOC, V109, P5022, DOI 10.1021/ja00250a044; HORI Y, 1989, J CHEM SOC FARAD T 1, V85, P2309, DOI 10.1039/f19898502309; Hori Y, 2008, MOD ASP ELECTROCHEM, P89; Hori Y, 2002, J PHYS CHEM B, V106, P15, DOI 10.1021/jp013478d; HORI Y, 1991, J CHEM SOC FARADAY T, V87, P125, DOI 10.1039/ft9918700125; Hori Y, 1997, J PHYS CHEM B, V101, P7075, DOI 10.1021/jp970284i; Jhong HR, 2013, CURR OPIN CHEM ENG, V2, P191, DOI 10.1016/j.coche.2013.03.005; Koga O, 2005, ELECTROCHIM ACTA, V50, P2475, DOI 10.1016/j.electacta.2004.10.076; Kuhl KP, 2012, ENERG ENVIRON SCI, V5, P7050, DOI 10.1039/c2ee21234j; Li CW, 2012, J AM CHEM SOC, V134, P7231, DOI 10.1021/ja3010978; MILLS GA, 1994, FUEL, V73, P1243, DOI 10.1016/0016-2361(94)90301-8; Montoya JH, 2013, CHEMCATCHEM, V5, P737, DOI 10.1002/cctc.201200564; Radetic T, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.085502; Schouten KJP, 2012, J AM CHEM SOC, V134, P9864, DOI 10.1021/ja302668n; Shaw SK, 2011, PHYS CHEM CHEM PHYS, V13, P5242, DOI 10.1039/c0cp02064h; Tornow CE, 2012, J AM CHEM SOC, V134, P19520, DOI 10.1021/ja308217w; Wang SY, 2009, J PHYS CHEM C, V113, P18935, DOI 10.1021/jp906923z; WASZCZUK P, 1995, ELECTROCHIM ACTA, V40, P1717, DOI 10.1016/0013-4686(95)00088-V	32	1057	1069	60	1822	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					504	+		10.1038/nature13249	http://dx.doi.org/10.1038/nature13249			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24717429				2022-12-28	WOS:000334741600032
J	Moberly, T				Moberly, Tom			ETHNIC DISCRIMINATION Minority report: how the UK's treatment of foreign and ethnic minority doctors needs to change	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PERFORMANCE					tmoberly@bmj.com						Equality and Diversity Committee, 2014, BMA; Esmail A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5662; McManus IC, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2621; Tiffin PA, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2622	4	6	6	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2014	348								g2838	10.1136/bmj.g2838	http://dx.doi.org/10.1136/bmj.g2838			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG1DB	24755052				2022-12-28	WOS:000335154200013
J	Kostarelos, K; Novoselov, KS				Kostarelos, Kostas; Novoselov, Kostya S.			Exploring the Interface of Graphene and Biology	SCIENCE			English	Editorial Material							OXIDE; CELLS; INTERNALIZATION; NANOPLATELETS; CYTOTOXICITY; PROSPECTS		[Kostarelos, Kostas] Univ Manchester, Fac Med & Human Sci, Nanomed Lab, Manchester, Lancs, England; [Novoselov, Kostya S.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Kostarelos, Kostas; Novoselov, Kostya S.] Univ Manchester, Natl Graphene Inst, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Kostarelos, K (corresponding author), Univ Manchester, Fac Med & Human Sci, Nanomed Lab, Manchester, Lancs, England.	kostas.kostarelos@manchester.ac.uk; kostya@manchester.ac.uk	Novoselov, Kostya S/G-9581-2014; Kostarelos, Kostas/AAP-6879-2021	Novoselov, Kostya S/0000-0003-4972-5371; Kostarelos, Kostas/0000-0002-2224-6672; hai yan, he/0000-0003-0366-6185				Akhavan O, 2010, ACS NANO, V4, P5731, DOI 10.1021/nn101390x; Ali-Boucetta H, 2013, ADV HEALTHC MATER, V2, P433, DOI 10.1002/adhm.201200248; Bitounis D, 2013, ADV MATER, V25, P2258, DOI 10.1002/adma.201203700; Blake P, 2008, NANO LETT, V8, P1704, DOI 10.1021/nl080649i; Bussy C, 2013, ACCOUNTS CHEM RES, V46, P692, DOI 10.1021/ar300199e; First PN, 2010, MRS BULL, V35, P296, DOI 10.1557/mrs2010.552; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Girish CM, 2013, ADV HEALTHC MATER, V2, P1489, DOI 10.1002/adhm.201200489; Hernandez Y, 2008, NAT NANOTECHNOL, V3, P563, DOI 10.1038/nnano.2008.215; Hu WB, 2010, ACS NANO, V4, P4317, DOI 10.1021/nn101097v; Kotchey GP, 2011, ACS NANO, V5, P2098, DOI 10.1021/nn103265h; Lammel T, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-27; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Li YF, 2013, P NATL ACAD SCI USA, V110, P12295, DOI 10.1073/pnas.1222276110; Liu SB, 2012, LANGMUIR, V28, P12364, DOI 10.1021/la3023908; Liu SB, 2011, ACS NANO, V5, P6971, DOI 10.1021/nn202451x; Na HK, 2013, NANOSCALE, V5, P1669, DOI 10.1039/c2nr33800a; Novoselov KS, 2012, NATURE, V490, P192, DOI 10.1038/nature11458; Novoselov KS, 2011, REV MOD PHYS, V83, P837, DOI 10.1103/RevModPhys.83.837; Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/NNANO.2009.58, 10.1038/nnano.2009.58]; Ruiz ON, 2011, ACS NANO, V5, P8100, DOI 10.1021/nn202699t; Russier J, 2013, NANOSCALE, V5, P11234, DOI 10.1039/c3nr03543c; Schinwald A, 2014, NANOTOXICOLOGY, V8, P824, DOI 10.3109/17435390.2013.831502; Schinwald A, 2012, ACS NANO, V6, P736, DOI 10.1021/nn204229f; Tu YS, 2013, NAT NANOTECHNOL, V8, P594, DOI [10.1038/nnano.2013.125, 10.1038/NNANO.2013.125]	25	252	258	3	326	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					261	263		10.1126/science.1246736	http://dx.doi.org/10.1126/science.1246736			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744363				2022-12-28	WOS:000334474500022
J	Anthes, E				Anthes, Emily			Marginal gains	NATURE			English	Editorial Material							UNITED-STATES; OBESITY; METAANALYSIS; WEIGHT; TRIAL											Daniel TO, 2013, PSYCHOL SCI, V24, P2339, DOI 10.1177/0956797613488780; Haines J, 2013, JAMA PEDIATR, V167, P1072, DOI 10.1001/jamapediatrics.2013.2356; Hampp C, 2013, PHARMACOTHERAPY, V33, P1299, DOI 10.1002/phar.1342; Hart CN, 2013, PEDIATRICS, V132, pE1473, DOI 10.1542/peds.2013-1274; Ho M, 2012, PEDIATRICS, V130, pE1647, DOI 10.1542/peds.2012-1176; Jensen MD, 2013, J AM COLL CARDIOL; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Rucker D, 2007, BMJ-BRIT MED J, V335, P1194, DOI 10.1136/bmj.39385.413113.25; Svetkey LP, 2008, JAMA-J AM MED ASSOC, V299, P1139, DOI 10.1001/jama.299.10.1139; Yanovski SZ, 2014, JAMA-J AM MED ASSOC, V311, P74, DOI 10.1001/jama.2013.281361	10	5	5	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					S54	S56		10.1038/508S54a	http://dx.doi.org/10.1038/508S54a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF0KP	24740127	Bronze			2022-12-28	WOS:000334403000004
J	Morken, JP				Morken, James P.			Catalysis marches on	NATURE			English	Editorial Material							SUBSTITUTION-REACTIONS; CONJUGATE ADDITION; PALLADIUM; REAGENTS; OLEFINS; ARYL		Boston Coll, Dept Chem, Chestnut Hill, MA 02467 USA	Boston College	Morken, JP (corresponding author), Boston Coll, Dept Chem, Chestnut Hill, MA 02467 USA.	morken@bc.edu						Alexakis A, 2008, CHEM REV, V108, P2796, DOI 10.1021/cr0683515; Das JP, 2011, CHEM COMMUN, V47, P4593, DOI 10.1039/c0cc05222a; Du XL, 2001, ORG LETT, V3, P3313, DOI 10.1021/ol016529y; Harutyunyan SR, 2008, CHEM REV, V108, P2824, DOI 10.1021/cr068424k; HECK RF, 1972, J ORG CHEM, V37, P2320, DOI 10.1021/jo00979a024; Hoveyda AH, 2004, CHEM COMMUN, P1779, DOI 10.1039/b401123f; JOHNSON LK, 1995, J AM CHEM SOC, V117, P6414, DOI 10.1021/ja00128a054; Kochi T, 2012, J AM CHEM SOC, V134, P16544, DOI 10.1021/ja308377u; Lu Z, 2008, ANGEW CHEM INT EDIT, V47, P258, DOI 10.1002/anie.200605113; Mei TS, 2014, NATURE, V508, P340, DOI 10.1038/nature13231; MIZOROKI T, 1971, B CHEM SOC JPN, V44, P581, DOI 10.1246/bcsj.44.581; Zhang P, 2011, J AM CHEM SOC, V133, P9716, DOI 10.1021/ja2039248	12	4	4	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					324	325		10.1038/nature13225	http://dx.doi.org/10.1038/nature13225			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24717440				2022-12-28	WOS:000334403000035
J	Pitt, B; Pfeffer, MA; Assmann, SF; Boineau, R; Anand, IS; Claggett, B; Clausell, N; Desai, AS; Diaz, R; Fleg, JL; Gordeev, I; Harty, B; Heitner, JF; Kenwood, CT; Lewis, EF; O'Meara, E; Probstfield, JL; Shaburishvili, T; Shah, SJ; Solomon, SD; Sweitzer, NK; Yang, S; McKinlay, SM				Pitt, Bertram; Pfeffer, Marc A.; Assmann, Susan F.; Boineau, Robin; Anand, Inder S.; Claggett, Brian; Clausell, Nadine; Desai, Akshay S.; Diaz, Rafael; Fleg, Jerome L.; Gordeev, Ivan; Harty, Brian; Heitner, John F.; Kenwood, Christopher T.; Lewis, Eldrin F.; O'Meara, Eileen; Probstfield, Jeffrey L.; Shaburishvili, Tamaz; Shah, Sanjiv J.; Solomon, Scott D.; Sweitzer, Nancy K.; Yang, Song; McKinlay, Sonja M.		Topcat Investigators	Spironolactone for Heart Failure with Preserved Ejection Fraction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; VENTRICULAR DYSFUNCTION; TASK-FORCE; MORTALITY; HOSPITALIZATION; MANAGEMENT; REDUCTION; OUTCOMES; TRIAL; PERINDOPRIL	BackgroundMineralocorticoid-receptor antagonists improve the prognosis for patients with heart failure and a reduced left ventricular ejection fraction. We evaluated the effects of spironolactone in patients with heart failure and a preserved left ventricular ejection fraction. MethodsIn this randomized, double-blind trial, we assigned 3445 patients with symptomatic heart failure and a left ventricular ejection fraction of 45% or more to receive either spironolactone (15 to 45 mg daily) or placebo. The primary outcome was a composite of death from cardiovascular causes, aborted cardiac arrest, or hospitalization for the management of heart failure. ResultsWith a mean follow-up of 3.3 years, the primary outcome occurred in 320 of 1722 patients in the spironolactone group (18.6%) and 351 of 1723 patients in the placebo group (20.4%) (hazard ratio, 0.89; 95% confidence interval [CI], 0.77 to 1.04; P=0.14). Of the components of the primary outcome, only hospitalization for heart failure had a significantly lower incidence in the spironolactone group than in the placebo group (206 patients [12.0%] vs. 245 patients [14.2%]; hazard ratio, 0.83; 95% CI, 0.69 to 0.99, P=0.04). Neither total deaths nor hospitalizations for any reason were significantly reduced by spironolactone. Treatment with spironolactone was associated with increased serum creatinine levels and a doubling of the rate of hyperkalemia (18.7%, vs. 9.1% in the placebo group) but reduced hypokalemia. With frequent monitoring, there were no significant differences in the incidence of serious adverse events, a serum creatinine level of 3.0 mg per deciliter (265 mol per liter) or higher, or dialysis. ConclusionsIn patients with heart failure and a preserved ejection fraction, treatment with spironolactone did not significantly reduce the incidence of the primary composite outcome of death from cardiovascular causes, aborted cardiac arrest, or hospitalization for the management of heart failure. (Funded by the National Heart, Lung, and Blood Institute; TOPCAT ClinicalTrials.gov number, NCT00094302.) In this trial, 3445 patients with heart failure and a preserved ejection fraction were assigned to spironolactone or placebo. At a mean of 3.3 years, there was no significant difference in death from cardiovascular causes, aborted cardiac arrest, or hospitalization for heart failure. Many patients with heart failure have a normal or near-normal left ventricular ejection fraction.(1)-(4) Such patients share common signs and symptoms, as well as an impaired quality of life and a poor prognosis, with patients who have heart failure and a reduced ejection fraction.(5)-(8) However, the benefit of most medical therapies for heart failure is limited to those with a reduced ejection fraction, generally 40% or less.(1),(2),(9) The lack of favorable evidence from clinical-outcome trials involving patients with heart failure and a preserved left ventricular ejection fraction is reflected in current guidelines, which offer no specific ...	[Pitt, Bertram] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Pfeffer, Marc A.; Claggett, Brian; Desai, Akshay S.; Lewis, Eldrin F.; Solomon, Scott D.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Assmann, Susan F.; Harty, Brian; Kenwood, Christopher T.; McKinlay, Sonja M.] New England Res Inst, Watertown, MA USA; [Boineau, Robin; Fleg, Jerome L.; Yang, Song] NHLBI, Bethesda, MD 20892 USA; [Anand, Inder S.] Vet Affairs Med Ctr, Minneapolis, MN USA; [Anand, Inder S.] Univ Minnesota, Minneapolis, MN USA; [Clausell, Nadine] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Diaz, Rafael] Estudios Clin Latinoamer, Rosario, Santa Fe, Argentina; [Gordeev, Ivan] Pirogov Russian Natl Res Med Univ, Moscow, Russia; [Heitner, John F.] New York Methodist Hosp, Brooklyn, NY USA; [O'Meara, Eileen] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Probstfield, Jeffrey L.] Univ Washington, Med Ctr, Seattle, WA 98195 USA; [Shaburishvili, Tamaz] Serv Clin, Tbilisi, Georgia; [Shah, Sanjiv J.] Northwestern Univ, Chicago, IL 60611 USA; [Sweitzer, Nancy K.] Univ Wisconsin, Madison, WI 53706 USA	University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; HealthCore, Inc; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; Pirogov Russian National Research Medical University; NewYork-Presbyterian Brooklyn Methodist Hospital; NewYork-Presbyterian Hospital; Universite de Montreal; University of Washington; University of Washington Seattle; Northwestern University; University of Wisconsin System; University of Wisconsin Madison	Pfeffer, MA (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	mpfeffer@rics.bwh.harvard.edu	Clausell, Nadine Oliveira/C-7813-2016; Gordeev, Ivan/AAB-5950-2022; Boineau, Robin/AAR-4452-2021; Desai, Akshay/ABE-7250-2020; Shah, Sanjiv J./AFQ-9480-2022; Nedogoda, Sergey V/O-4656-2014	Clausell, Nadine Oliveira/0000-0003-4207-3809; Nedogoda, Sergey V/0000-0001-5981-1754; Joseph, Jacob/0000-0002-7279-4896; Zile, Michael/0000-0001-7076-221X; Anand, Inder/0000-0003-1308-4963	National Heart, Lung, and Blood Institute, National Institutes of Health [HHSN268200425207C]	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by a contract from the National Heart, Lung, and Blood Institute, National Institutes of Health (HHSN268200425207C).	Abrahamsson P, 2013, EUR J HEART FAIL, V15, P885, DOI 10.1093/eurjhf/hft032; Ahmed A, 2006, EUR HEART J, V27, P178, DOI 10.1093/eurheartj/ehi687; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Blair JEA, 2008, J AM COLL CARDIOL, V52, P1640, DOI 10.1016/j.jacc.2008.07.056; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Braunwald E, 2013, CLIN PHARMACOL THER, V94, P430, DOI 10.1038/clpt.2013.149; Campbell RT, 2012, J AM COLL CARDIOL, V60, P2349, DOI 10.1016/j.jacc.2012.04.064; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; Desai AS, 2011, AM HEART J, V162, P966, DOI 10.1016/j.ahj.2011.09.007; Domanski M, 2004, CONTROL CLIN TRIALS, V25, P553, DOI 10.1016/j.cct.2004.08.005; Edelmann F, 2013, JAMA-J AM MED ASSOC, V309, P781, DOI 10.1001/jama.2013.905; Fonarow GC, 2007, J AM COLL CARDIOL, V50, P768, DOI 10.1016/j.jacc.2007.04.064; Fox KM, 2003, LANCET, V362, P782; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Hoekstra T, 2011, EUR J HEART FAIL, V13, P1013, DOI 10.1093/eurjhf/hfr072; Lam CSP, 2011, EUR J HEART FAIL, V13, P18, DOI 10.1093/eurjhf/hfq121; Lewis EF, 2007, EUR J HEART FAIL, V9, P83, DOI 10.1016/j.ejheart.2006.10.012; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; McMurray J, 2003, EUR J HEART FAIL, V5, P261, DOI 10.1016/S1388-9842(03)00052-7; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mottram PM, 2004, CIRCULATION, V110, P558, DOI 10.1161/01.CIR.0000138680.89536.A9; O'Connor CM, 2011, J AM COLL CARDIOL, V58, P915, DOI 10.1016/j.jacc.2011.03.057; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Paulus WJ, 2010, J AM COLL CARDIOL, V55, P526, DOI 10.1016/j.jacc.2009.06.067; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pitt B, 2010, INT J CARDIOL, V143, P309, DOI 10.1016/j.ijcard.2009.03.036; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Shah SJ, 2008, JAMA-J AM MED ASSOC, V300, P431, DOI 10.1001/jama.300.4.431; Shah SJ, 2013, CIRC-HEART FAIL, V6, P184, DOI 10.1161/CIRCHEARTFAILURE.112.972794; Solomon SD, 2007, CIRCULATION, V116, P1482, DOI 10.1161/CIRCULATIONAHA.107.696906; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	36	1436	1481	5	74	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 10	2014	370	15					1383	1392		10.1056/NEJMoa1313731	http://dx.doi.org/10.1056/NEJMoa1313731			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6IW	24716680				2022-12-28	WOS:000334095200006
J	Stender, J; Gosseries, O; Bruno, MA; Charland-Verville, V; Vanhaudenhuyse, A; Demertzi, A; Chatelle, C; Thonnard, M; Thibaut, A; Heine, L; Soddu, A; Boly, M; Schnakers, C; Gjedde, A; Laureys, S				Stender, Johan; Gosseries, Olivia; Bruno, Marie-Aurelie; Charland-Verville, Vanessa; Vanhaudenhuyse, Audrey; Demertzi, Athena; Chatelle, Camille; Thonnard, Marie; Thibaut, Aurore; Heine, Lizette; Soddu, Andrea; Boly, Melanie; Schnakers, Caroline; Gjedde, Albert; Laureys, Steven			Diagnostic precision of PET imaging and functional MRI in disorders of consciousness: a clinical validation study	LANCET			English	Article							REGIONAL CEREBRAL METABOLISM; BRAIN-DAMAGED PATIENTS; VEGETATIVE STATE; RECOVERY; SCALE; COMA; AWARENESS; NETWORKS; INJURY; RECOMMENDATIONS	Background Bedside clinical examinations can have high rates of misdiagnosis of unresponsive wakefulness syndrome (vegetative state) or minimally conscious state. The diagnostic and prognostic usefulness of neuroimaging-based approaches has not been established in a clinical setting. We did a validation study of two neuroimaging-based diagnostic methods: PET imaging and functional MRI (fMRI). Methods For this clinical validation study, we included patients referred to the University Hospital of Lige, Belgium, between January, 2008, and June, 2012, who were diagnosed by our unit with unresponsive wakefulness syndrome, locked-in syndrome, or minimally conscious state with traumatic or non-traumatic causes. We did repeated standardised clinical assessments with the Coma Recovery Scale-Revised (CRS-R), cerebral F-18 -fluorodeoxyglucose (FDG) PET, and fMRI during mental activation tasks. We calculated the diagnostic accuracy of both imaging methods with CRS-R diagnosis as reference. We assessed outcome after 12 months with the Glasgow Outcome Scale-Extended. Findings We included 41 patients with unresponsive wakefulness syndrome, four with locked-in syndrome, and 81 in a minimally conscious state (48=traumatic, 78=non-traumatic; 110=chronic, 16=subacute). F-18-FDG PET had high sensitivity for identification of patients in a minimally conscious state (93%, 95% CI 85-98) and high congruence (85%, 77-90) with behavioural CRS-R scores. The active fMRI method was less sensitive at diagnosis of a minimally conscious state (45%, 30-61) and had lower overall congruence with behavioural scores (63%, 51-73) than PET imaging. F-18-FDG PET correctly predicted outcome in 75 of 102 patients (74%, 64-81), and fMRI in 36 of 65 patients (56%, 43-67). 13 of 41 (32%) of the behaviourally unresponsive patients (ie, diagnosed as unresponsive with CRS-R) showed brain activity compatible with (minimal) consciousness (ie, activity associated with consciousness, but diminished compared with fully conscious individuals) on at least one neuroimaging test; 69% of these (9 of 13) patients subsequently recovered consciousness. Interpretation Cerebral F-18-FDG PET could be used to complement bedside examinations and predict long-term recovery of patients with unresponsive wakefulness syndrome. Active fMRI might also be useful for differential diagnosis, but seems to be less accurate.	[Stender, Johan; Gosseries, Olivia; Bruno, Marie-Aurelie; Charland-Verville, Vanessa; Vanhaudenhuyse, Audrey; Demertzi, Athena; Chatelle, Camille; Thonnard, Marie; Thibaut, Aurore; Heine, Lizette; Boly, Melanie; Schnakers, Caroline; Laureys, Steven] Univ Liege, Cyclotron Res Ctr, Coma Sci Grp, B-4000 Liege, Belgium; [Stender, Johan; Gosseries, Olivia; Bruno, Marie-Aurelie; Charland-Verville, Vanessa; Vanhaudenhuyse, Audrey; Demertzi, Athena; Chatelle, Camille; Thonnard, Marie; Thibaut, Aurore; Heine, Lizette; Boly, Melanie; Schnakers, Caroline; Laureys, Steven] Univ Liege, Dept Neurol, B-4000 Liege, Belgium; [Stender, Johan; Gosseries, Olivia; Bruno, Marie-Aurelie; Charland-Verville, Vanessa; Vanhaudenhuyse, Audrey; Demertzi, Athena; Chatelle, Camille; Thonnard, Marie; Thibaut, Aurore; Heine, Lizette; Boly, Melanie; Schnakers, Caroline; Laureys, Steven] Univ Hosp Liege, Liege, Belgium; [Soddu, Andrea] Univ Western Ontario, Brain & Mind Inst, Dept Phys & Astron, London, ON, Canada; [Stender, Johan; Gjedde, Albert] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark	University of Liege; University of Liege; University of Liege; Western University (University of Western Ontario); University of Copenhagen	Laureys, S (corresponding author), Univ Liege, Cyclotron Res Ctr, Coma Sci Grp, B-4000 Liege, Belgium.	steven.laureys@ulg.ac.be	Soddu, Andrea/K-7087-2014; Thibaut, Aurore/U-8101-2019; Laureys, Steven/AAN-2097-2021; Gjedde, Albert/I-2452-2019; Gosseries, Olivia/AAB-6469-2020; Gjedde, Albert/U-3751-2019; Demertzi, Athena/I-1251-2019; Vanhaudenhuyse, Audrey/AAP-2455-2020; Laureys, Steven/A-3349-2011	Soddu, Andrea/0000-0001-6833-745X; Laureys, Steven/0000-0002-3096-3807; Gosseries, Olivia/0000-0001-9011-7496; Gjedde, Albert/0000-0002-3756-7401; Demertzi, Athena/0000-0001-8021-3759; Boly, Melanie/0000-0001-9584-0907; Heine, Lizette/0000-0003-1369-8199; Chatelle, Camille/0000-0002-7526-2107	Belgian National Funds for Scientific Research (FNRS); Fonds Leon Fredericq; European Commission; James McDonnell Foundation; Mind Science Foundation; French Speaking Community Concerted Research Action; University of Copenhagen; University of Liege	Belgian National Funds for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds Leon Fredericq; European Commission(European CommissionEuropean Commission Joint Research Centre); James McDonnell Foundation; Mind Science Foundation; French Speaking Community Concerted Research Action; University of Copenhagen; University of Liege(University of Liege)	The Belgian National Funds for Scientific Research (FNRS), Fonds Leon Fredericq, the European Commission, the James McDonnell Foundation, the Mind Science Foundation, the French Speaking Community Concerted Research Action, the University of Copenhagen, and the University of Liege.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Boly M, 2007, NEUROIMAGE, V36, P979, DOI 10.1016/j.neuroimage.2007.02.047; Boly M, 2008, LANCET NEUROL, V7, P1013, DOI 10.1016/S1474-4422(08)70219-9; Chatelle C, 2012, J NEUROL NEUROSUR PS, V83, P1233, DOI 10.1136/jnnp-2012-302987; Childs NL, 1996, BRIT MED J, V313, P944; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; Cruse D, 2012, NEUROLOGY, V78, P816, DOI 10.1212/WNL.0b013e318249f764; Cruse D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-18; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Demertzi A, 2013, CURR OPIN NEUROBIOL, V23, P239, DOI 10.1016/j.conb.2012.12.003; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Ferreira N, 2007, MED LAW, V26, P387; Fins JJ, 2008, AM J BIOETHICS, V8, P3, DOI 10.1080/15265160802318113; Fins JJ, 2010, HASTINGS CENT REP, V40, P21, DOI 10.1353/hcr.0.0257; Gevers S, 2005, EUR J HEALTH LAW, V12, P347, DOI 10.1163/157180905775088513; Giacino JT, 2009, PROG BRAIN RES, V177, P33, DOI 10.1016/S0079-6123(09)17704-X; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; Gosseries O, BRAIN INJ IN PRESS; Grill E, 2013, ARCH PHYS MED REHAB, V94, P1870, DOI 10.1016/j.apmr.2012.10.040; Hirschberg R, 2011, NEUROL CLIN, V29, P773, DOI 10.1016/j.ncl.2011.07.009; Langsjo JW, 2012, J NEUROSCI, V32, P4935, DOI 10.1523/JNEUROSCI.4962-11.2012; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 1999, J NEUROL NEUROSUR PS, V67, P121, DOI 10.1136/jnnp.67.1.121; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lochlainn MN, 2013, IRISH J MED SCI, V182, P7, DOI 10.1007/s11845-012-0825-6; Lovstad M, 2010, J HEAD TRAUMA REHAB, V25, P349, DOI 10.1097/HTR.0b013e3181cec841; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Manning J, 2012, J LAW MED, V19, P430; Maquet P, 2000, J SLEEP RES, V9, P207; Monti MM, 2012, ANNU REV CLIN PSYCHO, V8, P431, DOI 10.1146/annurev-clinpsy-032511-143050; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Overgaard M, 2011, LANCET, V378, P2052, DOI 10.1016/S0140-6736(11)61591-2; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Perry JE, 2005, ANN INTERN MED, V143, P744, DOI 10.7326/0003-4819-143-10-200511150-00012; Pisa FE, 2014, J HEAD TRAUMA REHAB, V29, pE23, DOI 10.1097/HTR.0b013e3182a4469f; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schnakers C, 2008, BRAIN INJURY, V22, P786, DOI 10.1080/02699050802403557; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Schnakers C, 2009, NEUROCASE, V15, P271, DOI 10.1080/13554790902724904; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shulman RG, 2009, P NATL ACAD SCI USA, V106, P11096, DOI 10.1073/pnas.0903941106; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thibaut A, 2012, J REHABIL MED, V44, P487, DOI 10.2340/16501977-0940; TOMMASINO C, 1995, J NEUROSURG ANESTH, V7, P109, DOI 10.1097/00008506-199504000-00006; Vanhaudenhuyse A, 2011, J COGNITIVE NEUROSCI, V23, P570, DOI 10.1162/jocn.2010.21488; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313	51	263	272	3	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2014	384	9942					514	522		10.1016/S0140-6736(14)60042-8	http://dx.doi.org/10.1016/S0140-6736(14)60042-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM9JR	24746174				2022-12-28	WOS:000340198300030
J	Maisonneuve, E; Gerdes, K				Maisonneuve, Etienne; Gerdes, Kenn			Molecular Mechanisms Underlying Bacterial Persisters	CELL			English	Review							ESCHERICHIA-COLI K-12; MEDIATE ANTIBIOTIC TOLERANCE; MESSENGER-RNA INTERFERASES; MULTIDRUG TOLERANCE; STRINGENT RESPONSE; AFFECTS LETHALITY; AFFECTS FREQUENCY; BETA-LACTAM; TOXIN; HIPA	All bacteria form persisters, cells that are multidrug tolerant and therefore able to survive antibiotic treatment. Due to the low frequencies of persisters in growing bacterial cultures and the complex underlying molecular mechanisms, the phenomenon has been challenging to study. However, recent technological advances in microfluidics and reporter genes have improved this scenario. Here, we summarize recent progress in the field, revealing the ubiquitous bacterial stress alarmone ppGpp as an emerging central regulator of multidrug tolerance and persistence, both in stochastically and environmentally induced persistence. In several different organisms, toxin-antitoxin modules function as effectors of ppGpp-induced persistence.	[Maisonneuve, Etienne; Gerdes, Kenn] Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Gerdes, Kenn] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark	Newcastle University - UK; University of Copenhagen	Gerdes, K (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Richardson Rd, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.	kenn.gerdes@ncl.ac.uk	Gerdes, Kenn/AAS-5548-2021; Gerdes, Kenn/M-2420-2014	Gerdes, Kenn/0000-0002-7462-4612; Gerdes, Kenn/0000-0002-7462-4612; maisonneuve, Etienne/0000-0003-3451-1223	European Research Council Advanced Investigator [294517 "PERSIST']; Laureate Research; Novo Nordisk Fonden [NNF12OC0000638] Funding Source: researchfish	European Research Council Advanced Investigator; Laureate Research; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by a European Research Council Advanced Investigator Grant (294517 "PERSIST'') and by a Laureate Research Grant Award from Novo Nordisk to K.G. We thank David Holden and Namiko Mitarai for critical reading of the manuscript. We further thank the members of the Gerdes group and members of the Centre for Bacterial Cell Biology for stimulating discussions.	Abraham EP, 1940, NATURE, V146, P837, DOI 10.1038/146837a0; Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; Al Mamun AM, 2012, SCIENCE, V338, P1344, DOI 10.1126/science.1226683; Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; Bernier SP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003144; Bigger JW, 1944, LANCET, V2, P497; BLACK DS, 1994, J BACTERIOL, V176, P4081, DOI 10.1128/JB.176.13.4081-4091.1994; BLACK DS, 1991, J BACTERIOL, V173, P5732, DOI 10.1128/jb.173.18.5732-5739.1991; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Castro-Roa D, 2013, NAT CHEM BIOL, V9, P811, DOI [10.1038/NCHEMBIO.1364, 10.1038/nchembio.1364]; Cataudella I, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003174; Cataudella I, 2012, NUCLEIC ACIDS RES, V40, P6424, DOI 10.1093/nar/gks297; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Dandekar T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00164; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ezraty B, 2013, SCIENCE, V340, P1583, DOI 10.1126/science.1238328; Falla TJ, 1998, ANTIMICROB AGENTS CH, V42, P3282, DOI 10.1128/AAC.42.12.3282; Fasani RA, 2013, P NATL ACAD SCI USA, V110, pE2528, DOI 10.1073/pnas.1301023110; Fung DKC, 2010, ANTIMICROB AGENTS CH, V54, P1082, DOI 10.1128/AAC.01218-09; Gaca AO, 2013, MBIO, V4, DOI 10.1128/mBio.00646-13; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Geiger T, 2014, J BACTERIOL, V196, P894, DOI 10.1128/JB.01201-13; Gelens L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003190; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; Germain E, 2013, MOL CELL, V52, P248, DOI 10.1016/j.molcel.2013.08.045; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; Hansen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039185; Harrison JJ, 2005, MICROBIOL-SGM, V151, P3181, DOI 10.1099/mic.0.27794-0; Helaine S, 2014, SCIENCE, V343, P204, DOI 10.1126/science.1244705; Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107; Jiang Y, 2002, MOL MICROBIOL, V44, P971, DOI 10.1046/j.1365-2958.2002.02921.x; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Kaspy I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4001; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kim JS, 2011, ANTIMICROB AGENTS CH, V55, P5380, DOI 10.1128/AAC.00708-11; Kim Y, 2010, BIOCHEM BIOPH RES CO, V391, P209, DOI 10.1016/j.bbrc.2009.11.033; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; LaFleur MD, 2010, ANTIMICROB AGENTS CH, V54, P39, DOI 10.1128/AAC.00860-09; Leung V, 2012, J BACTERIOL, V194, P2265, DOI 10.1128/JB.06707-11; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Lou CB, 2008, J THEOR BIOL, V255, P205, DOI 10.1016/j.jtbi.2008.07.035; Mahoney TF, 2013, J BACTERIOL, V195, P1869, DOI 10.1128/JB.02197-12; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Masuda H, 2012, MOL MICROBIOL, V84, P979, DOI 10.1111/j.1365-2958.2012.08068.x; MOYED HS, 1986, J BACTERIOL, V166, P399, DOI 10.1128/jb.166.2.399-403.1986; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; Nystrom T, 2003, MOL MICROBIOL, V48, P17, DOI 10.1046/j.1365-2958.2003.03385.x; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Overgaard M, 2009, J MOL BIOL, V394, P183, DOI 10.1016/j.jmb.2009.09.006; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; Shyp V, 2012, EMBO REP, V13, P835, DOI 10.1038/embor.2012.106; Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x; Unoson C, 2008, MOL MICROBIOL, V70, P258, DOI 10.1111/j.1365-2958.2008.06416.x; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Vega NM, 2013, P NATL ACAD SCI USA, V110, P14420, DOI 10.1073/pnas.1308085110; Vega NM, 2012, NAT CHEM BIOL, V8, P431, DOI [10.1038/NCHEMBIO.915, 10.1038/nchembio.915]; Wang XX, 2012, NAT CHEM BIOL, V8, P855, DOI 10.1038/NCHEMBIO.1062; Wexselblatt E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002925; Winther KS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3796; Winther KS, 2012, NUCLEIC ACIDS RES, V40, P4347, DOI 10.1093/nar/gks029; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; WOLFSON JS, 1990, ANTIMICROB AGENTS CH, V34, P1938, DOI 10.1128/AAC.34.10.1938; Wu YX, 2012, ANTIMICROB AGENTS CH, V56, P4922, DOI 10.1128/AAC.00921-12; Zhang JJ, 2003, J BIOL CHEM, V278, P32300, DOI 10.1074/jbc.M304767200	95	416	432	13	270	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					539	548		10.1016/j.cell.2014.02.050	http://dx.doi.org/10.1016/j.cell.2014.02.050			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766804	Bronze			2022-12-28	WOS:000335392100006
J	Ebinger, M; Winter, B; Wendt, M; Weber, JE; Waldschmidt, C; Rozanski, M; Kunz, A; Koch, P; Kellner, PA; Gierhake, D; Villringer, K; Fiebach, JB; Grittner, U; Hartmann, A; Mackert, BM; Endres, M; Audebert, HJ				Ebinger, Martin; Winter, Benjamin; Wendt, Matthias; Weber, Joachim E.; Waldschmidt, Carolin; Rozanski, Michal; Kunz, Alexander; Koch, Peter; Kellner, Philipp A.; Gierhake, Daniel; Villringer, Kersten; Fiebach, Jochen B.; Grittner, Ulrike; Hartmann, Andreas; Mackert, Bruno-Marcel; Endres, Matthias; Audebert, Heinrich J.		STEMO Consortium	Effect of the Use of Ambulance-Based Thrombolysis on Time to Thrombolysis in Acute Ischemic Stroke A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; PHANTOM-S; ALTEPLASE; CARE; MANAGEMENT; THERAPY; UNIT	IMPORTANCE Time to thrombolysis is crucial for outcome in acute ischemic stroke. OBJECTIVE To determine if starting thrombolysis in a specialized ambulance reduces delays. DESIGN, SETTING, AND PARTICIPANTS In the Prehospital Acute Neurological Treatment and Optimization of Medical care in Stroke Study (PHANTOM-S), conducted in Berlin, Germany, we randomly assigned weeks with and without availability of the Stroke Emergency Mobile (STEMO) from May 1, 2011, to January 31, 2013. Berlin has an established stroke care infrastructure with 14 stroke units. We included 6182 adult patients (STEMO weeks: 44.3% male, mean [SD] age, 73.9 [15.0] y; control weeks: 45.2% male, mean [SD] age, 74.3 [14.9] y) for whom a stroke dispatch was activated. INTERVENTIONS The intervention comprised an ambulance (STEMO) equipped with a CT scanner, point-of-care laboratory, and telemedicine connection; a stroke identification algorithm at dispatcher level; and a prehospital stroke team. Thrombolysis was started before transport to hospital if ischemic stroke was confirmed and contraindications excluded. MAIN OUTCOMES AND MEASURES Primary outcome was alarm-to-thrombolysis time. Secondary outcomes included thrombolysis rate, secondary intracerebral hemorrhage after thrombolysis, and 7-day mortality. RESULTS Time reduction was assessed in all patients with a stroke dispatch from the entire catchment area in STEMO weeks (3213 patients) vs control weeks (2969 patients) and in patients in whom STEMO was available and deployed (1804 patients) vs control weeks (2969 patients). Compared with thrombolysis during control weeks, there was a reduction of 15 minutes (95% CI, 11-19) in alarm-to-treatment times in the catchment area during STEMO weeks (76.3 min; 95% CI, 73.2-79.3 vs 61.4 min; 95% CI, 58.7-64.0; P < .001). Among patients for whom STEMO was deployed, mean alarm-to-treatment time (51.8 min; 95% CI, 49.0-54.6) was shorter by 25 minutes (95% CI, 20-29; P < .001) than during control weeks. Thrombolysis rates in ischemic stroke were 29% (310/1070) during STEMO weeks and 33% (200/614) after STEMO deployment vs 21% (220/1041) during control weeks (differences, 8%; 95% CI, 4%-12%; P < .001, and 12%, 95% CI, 7%-16%; P < .001, respectively). STEMO deployment incurred no increased risk for intracerebral hemorrhage (STEMO deployment: 7/200; conventional care: 22/323; adjusted odds ratio [OR], 0.42, 95% CI, 0.18-1.03; P = .06) or 7-day mortality (9/199 vs 15/323; adjusted OR, 0.76; 95% CI, 0.31-1.82; P = .53). CONCLUSIONS AND RELEVANCE Compared with usual care, the use of ambulance-based thrombolysis resulted in decreased time to treatment without an increase in adverse events. Further studies are needed to assess the effects on clinical outcomes.	[Ebinger, Martin; Winter, Benjamin; Wendt, Matthias; Weber, Joachim E.; Waldschmidt, Carolin; Rozanski, Michal; Kunz, Alexander; Koch, Peter; Endres, Matthias; Audebert, Heinrich J.] Charite, Dept Neurol, D-10117 Berlin, Germany; [Ebinger, Martin; Winter, Benjamin; Rozanski, Michal; Kunz, Alexander; Gierhake, Daniel; Villringer, Kersten; Fiebach, Jochen B.; Grittner, Ulrike; Endres, Matthias; Audebert, Heinrich J.] Charite, Ctr Stroke Res Berlin CSB, D-10117 Berlin, Germany; [Kellner, Philipp A.] Vivantes Klinikum Friedrichshain, Rettungsstelle, Berlin, Germany; [Grittner, Ulrike] Charite, Dept Biostat & Clin Epidemiol, D-10117 Berlin, Germany; [Hartmann, Andreas] Rhon Klinikum Klinikum Frankfurt Oder, Frankfurt, Oder, Germany; [Mackert, Bruno-Marcel] Vivantes Auguste Viktoria Klinikum, Berlin, Germany; [Endres, Matthias] Charite, ExcellenceCluster NeuroCure, D-10117 Berlin, Germany; [Endres, Matthias] German Ctr Neurodegenerat Dis DZNE, Berlin, Germany; [Endres, Matthias] German Ctr Cardiovasc Res DZHK, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); German Centre for Cardiovascular Research	Ebinger, M (corresponding author), Charite, Klin & Hsch Ambulanz Neurol, Charitepl 1, D-10117 Berlin, Germany.	martin.ebinger@charite.de	Weber, Joachim/AAL-2799-2020; Grittner, Ulrike/I-2026-2019	Weber, Joachim/0000-0002-1666-6021; Grittner, Ulrike/0000-0003-2595-0224; Fiebach, Jochen B./0000-0002-7936-6958; Endres, Matthias/0000-0001-6520-3720; Audebert, Heinrich J./0000-0002-4785-0366	Zukunftsfonds Berlin; Technology Foundation Berlin; EU; European Regional Development Fund (ERDF)	Zukunftsfonds Berlin; Technology Foundation Berlin; EU(European Commission); European Regional Development Fund (ERDF)(European Commission)	PHANTOM-S was funded by the Zukunftsfonds Berlin and the Technology Foundation Berlin with EU co-financing by the European Regional Development Fund (ERDF).	Audebert HJ, 2013, NEUROLOGY, V81, P501, DOI 10.1212/WNL.0b013e31829e0fdd; Ebinger M, 2012, INT J STROKE, V7, P348, DOI 10.1111/j.1747-4949.2011.00756.x; Fassbender K, 2013, LANCET NEUROL, V12, P585, DOI 10.1016/S1474-4422(13)70100-5; Fonarow GC, 2011, CIRCULATION, V123, P750, DOI 10.1161/CIRCULATIONAHA.110.974675; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kohrmann M, 2011, INT J STROKE, V6, P493, DOI 10.1111/j.1747-4949.2011.00585.x; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Koennecke HC, 2012, BERLINER SCHLAGANFAL; Krebes S, 2012, STROKE, V43, P776, DOI 10.1161/STROKEAHA.111.634980; Lansberg MG, 2009, STROKE, V40, P2079, DOI 10.1161/STROKEAHA.108.540708; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Meretoja A, 2012, NEUROLOGY, V79, P306, DOI 10.1212/WNL.0b013e31825d6011; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Schwamm LH, 2013, NEUROLOGY, V80, P130, DOI 10.1212/WNL.0b013e31827d44ca; Stroke Study Group National Institute of Neurological Disorders, 1995, NEW ENGL J MED, V333, P1581, DOI [10.1056/NEJM199512143332401, DOI 10.1056/NEJM199512143332401]; Wahlgren N, 2008, LANCET, V372, P1303, DOI 10.1016/S0140-6736(08)61339-2; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Walter S, 2012, LANCET NEUROL, V11, P397, DOI 10.1016/S1474-4422(12)70057-1; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; Weber JE, 2013, NEUROLOGY, V80, P163, DOI 10.1212/WNL.0b013e31827b90e5	23	287	306	1	43	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2014	311	16					1622	1631		10.1001/jama.2014.2850	http://dx.doi.org/10.1001/jama.2014.2850			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF4OU	24756512	Bronze			2022-12-28	WOS:000334693900022
J	Friedman, AK; Walsh, JJ; Juarez, B; Ku, SM; Chaudhury, D; Wang, J; Li, XT; Dietz, DM; Pan, NN; Vialou, VF; Neve, RL; Yue, ZY; Han, MH				Friedman, Allyson K.; Walsh, Jessica J.; Juarez, Barbara; Ku, Stacy M.; Chaudhury, Dipesh; Wang, Jing; Li, Xianting; Dietz, David M.; Pan, Nina; Vialou, Vincent F.; Neve, Rachael L.; Yue, Zhenyu; Han, Ming-Hu			Enhancing Depression Mechanisms in Midbrain Dopamine Neurons Achieves Homeostatic Resilience	SCIENCE			English	Article							VENTRAL TEGMENTAL AREA; SOCIAL DEFEAT STRESS; REWARD CIRCUIT; I-H; CHANNELS; SUSCEPTIBILITY; INHIBITION; BDNF	Typical therapies try to reverse pathogenic mechanisms. Here, we describe treatment effects achieved by enhancing depression-causing mechanisms in ventral tegmental area (VTA) dopamine (DA) neurons. In a social defeat stress model of depression, depressed (susceptible) mice display hyperactivity of VTA DA neurons, caused by an up-regulated hyperpolarization-activated current (I-h). Mice resilient to social defeat stress, however, exhibit stable normal firing of these neurons. Unexpectedly, resilient mice had an even larger Ih, which was observed in parallel with increased potassium (K+) channel currents. Experimentally further enhancing Ih or optogenetically increasing the hyperactivity of VTA DA neurons in susceptible mice completely reversed depression-related behaviors, an antidepressant effect achieved through resilience-like, projection-specific homeostatic plasticity. These results indicate a potential therapeutic path of promoting natural resilience for depression treatment.	[Friedman, Allyson K.; Walsh, Jessica J.; Juarez, Barbara; Ku, Stacy M.; Chaudhury, Dipesh; Han, Ming-Hu] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Walsh, Jessica J.; Juarez, Barbara; Ku, Stacy M.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, Neurosci Program, New York, NY 10029 USA; [Wang, Jing; Li, Xianting; Pan, Nina; Yue, Zhenyu] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Dietz, David M.; Vialou, Vincent F.; Yue, Zhenyu; Han, Ming-Hu] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Dietz, David M.; Vialou, Vincent F.; Yue, Zhenyu; Han, Ming-Hu] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Neve, Rachael L.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Massachusetts Institute of Technology (MIT)	Han, MH (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	ming-hu.han@mssm.edu	Dietz, David/J-9458-2015; vialou, vincent/F-2968-2013; Dietz, David/AAW-4574-2021; Han, Ming-Hu/G-8836-2012	Dietz, David/0000-0002-6927-9236; vialou, vincent/0000-0002-8212-751X; Dietz, David/0000-0002-6927-9236; Li, Xianting/0000-0002-3153-0931; Juarez, Barbara/0000-0001-7897-8031; Walsh, Jessica/0000-0001-8466-8451	National Institute of Mental Health [R01 MH092306]; National Research Service Award [F31 MH095425, T32 MH 087004, F32 MH096464]; Johnson & Johnson-International Mental Health Research Organization (IMHRO) Rising Star Translational Research Award; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH096464, T32MH020016, T32MH087004, F31MH095425, F31MH108326, T32MH096678, P50MH096890, R01MH092306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022445] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson & Johnson-International Mental Health Research Organization (IMHRO) Rising Star Translational Research Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank E. J. Nestler for his continuing support of this work. We also thank S. J. Russo, H. P. Xu, J. L. Cao, F. Henn, and E. J. Nestler for their helpful discussion and G. R. Tibbs and P. A. Goldstein from Weill Cornell Medical College for providing the HCN2 plasmid. This work was supported by the National Institute of Mental Health (R01 MH092306: S. M. K., D. C., M.-H. H.), National Research Service Award (F31 MH095425 to J. J. W.; T32 MH 087004 to B. J.; F32 MH096464 to A. K. F.), and Johnson & Johnson-International Mental Health Research Organization (IMHRO) Rising Star Translational Research Award (M.-H.H.).	Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Carey TA, 2011, CLIN PSYCHOL REV, V31, P236, DOI 10.1016/j.cpr.2010.04.004; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Dickman DK, 2009, SCIENCE, V326, P1127, DOI 10.1126/science.1179685; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; Frye MA, 2011, NEW ENGL J MED, V364, P51, DOI 10.1056/NEJMcp1000402; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Koo JW, 2012, SCIENCE, V338, P124, DOI 10.1126/science.1222265; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Kumar S, 2008, COGNITIVE THER RES, V32, P734, DOI 10.1007/s10608-008-9190-1; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Nakatani Y, 2013, J PHARMACOL SCI, V123, P203, DOI 10.1254/jphs.13116SC; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Russo SJ, 2012, NAT NEUROSCI, V15, P1475, DOI 10.1038/nn.3234; Southwick SM, 2012, SCIENCE, V338, P79, DOI 10.1126/science.1222942; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Walsh JJ, 2014, NAT NEUROSCI, V17, P27, DOI 10.1038/nn.3591; Wanat MJ, 2008, J PHYSIOL-LONDON, V586, P2157, DOI 10.1113/jphysiol.2007.150078; Whalley K, 2013, NAT REV NEUROSCI, V14, DOI 10.1038/nrn3637; Wilkinson MB, 2011, J NEUROSCI, V31, P9084, DOI 10.1523/JNEUROSCI.0039-11.2011; Zhang J, 2012, NEURON, V76, P1133, DOI 10.1016/j.neuron.2012.10.019	33	267	281	6	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					313	319		10.1126/science.1249240	http://dx.doi.org/10.1126/science.1249240			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744379	Green Accepted			2022-12-28	WOS:000334474500040
J	Tanne, JH				Tanne, Janice Hopkins			Some progress and some missed targets in the TB epidemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Alami NN, 2014, MMWR-MORBID MORTAL W, V63, P229; World Health Organization, GLOB TUB REP 2013	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2014	348								g2626	10.1136/bmj.g2626	http://dx.doi.org/10.1136/bmj.g2626			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF5GS	24740907				2022-12-28	WOS:000334742600008
J	Gonzales, G				Gonzales, Gilbert			Same-Sex Marriage - A Prescription for Better Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Research suggests that discriminatory environments and bans on same-sex marriage are detrimental to health and that legalizing same-sex marriage contributes to better health for LGBT people, as well as improving access to insurance for LGBT people and their children. The past year has proved to be a pivotal one for lesbian, gay, bisexual, and transgender (LGBT) Americans. When 2013 began, same-sex couples were allowed to marry only in 9 states plus Washington, D.C., and even when they were legally married by states, the federal government did not recognize their relationships, in accordance with the Defense of Marriage Act (DOMA). As of February 2014, same-sex couples can legally wed in 17 states (and enter civil unions or domestic partnerships in 3 others), and their unions are federally recognized, thanks to a set of court decisions and new laws passed by ...	[Gonzales, Gilbert] Univ Minnesota, Div Hlth Policy & Management, Minneapolis, MN 55455 USA; [Gonzales, Gilbert] Univ Minnesota, State Hlth Access Data Assistance Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Gonzales, G (corresponding author), Univ Minnesota, Div Hlth Policy & Management, Minneapolis, MN 55455 USA.							Gonzales G, 2014, AM J PUBLIC HEALTH, V104, pE95, DOI 10.2105/AJPH.2013.301577; Gonzales G, 2013, PEDIATRICS, V132, P703, DOI 10.1542/peds.2013-0988; Hatzenbuehler ML, 2012, AM J PUBLIC HEALTH, V102, P285, DOI 10.2105/AJPH.2011.300382; Hatzenbuehler ML, 2010, AM J PUBLIC HEALTH, V100, P452, DOI 10.2105/AJPH.2009.168815; Wight RG, 2013, AM J PUBLIC HEALTH, V103, P339, DOI 10.2105/AJPH.2012.301113	5	22	22	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 10	2014	370	15					1373	1376		10.1056/NEJMp1400254	http://dx.doi.org/10.1056/NEJMp1400254			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE6IW	24716677				2022-12-28	WOS:000334095200003
J	Meyer, G; Vicaut, E; Danays, T; Agnelli, G; Becattini, C; Beyer-Westendorf, J; Bluhmki, E; Bouvaist, H; Brenner, B; Couturaud, F; Dellas, C; Empen, K; Franca, A; Galie, N; Geibel, A; Goldhaber, SZ; Jimenez, D; Kozak, M; Kupatt, C; Kucher, N; Lang, IM; Lankeit, M; Meneveau, N; Pacouret, G; Palazzini, M; Petris, A; Pruszczyk, P; Rugolotto, M; Salvi, A; Schellong, S; Sebbane, M; Sobkowicz, B; Stefanovic, BS; Thiele, H; Torbicki, A; Verschuren, F; Konstantinides, SV				Meyer, Guy; Vicaut, Eric; Danays, Thierry; Agnelli, Giancarlo; Becattini, Cecilia; Beyer-Westendorf, Jan; Bluhmki, Erich; Bouvaist, Helene; Brenner, Benjamin; Couturaud, Francis; Dellas, Claudia; Empen, Klaus; Franca, Ana; Galie, Nazzareno; Geibel, Annette; Goldhaber, Samuel Z.; Jimenez, David; Kozak, Matija; Kupatt, Christian; Kucher, Nils; Lang, Irene M.; Lankeit, Mareike; Meneveau, Nicolas; Pacouret, Gerard; Palazzini, Massimiliano; Petris, Antoniu; Pruszczyk, Piotr; Rugolotto, Matteo; Salvi, Aldo; Schellong, Sebastian; Sebbane, Mustapha; Sobkowicz, Bozena; Stefanovic, Branislav S.; Thiele, Holger; Torbicki, Adam; Verschuren, Franck; Konstantinides, Stavros V.		Peitho Investigators	Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RIGHT-VENTRICULAR ENLARGEMENT; THROMBOLYTIC THERAPY; VENOUS THROMBOEMBOLISM; PROGNOSTIC ROLE; ECHOCARDIOGRAPHY; COMPLICATIONS; MANAGEMENT; ELEVATION	BackgroundThe role of fibrinolytic therapy in patients with intermediate-risk pulmonary embolism is controversial. MethodsIn a randomized, double-blind trial, we compared tenecteplase plus heparin with placebo plus heparin in normotensive patients with intermediate-risk pulmonary embolism. Eligible patients had right ventricular dysfunction on echocardiography or computed tomography, as well as myocardial injury as indicated by a positive test for cardiac troponin I or troponin T. The primary outcome was death or hemodynamic decompensation (or collapse) within 7 days after randomization. The main safety outcomes were major extracranial bleeding and ischemic or hemorrhagic stroke within 7 days after randomization. ResultsOf 1006 patients who underwent randomization, 1005 were included in the intention-to-treat analysis. Death or hemodynamic decompensation occurred in 13 of 506 patients (2.6%) in the tenecteplase group as compared with 28 of 499 (5.6%) in the placebo group (odds ratio, 0.44; 95% confidence interval, 0.23 to 0.87; P=0.02). Between randomization and day 7, a total of 6 patients (1.2%) in the tenecteplase group and 9 (1.8%) in the placebo group died (P=0.42). Extracranial bleeding occurred in 32 patients (6.3%) in the tenecteplase group and 6 patients (1.2%) in the placebo group (P<0.001). Stroke occurred in 12 patients (2.4%) in the tenecteplase group and was hemorrhagic in 10 patients; 1 patient (0.2%) in the placebo group had a stroke, which was hemorrhagic (P=0.003). By day 30, a total of 12 patients (2.4%) in the tenecteplase group and 16 patients (3.2%) in the placebo group had died (P=0.42). ConclusionsIn patients with intermediate-risk pulmonary embolism, fibrinolytic therapy prevented hemodynamic decompensation but increased the risk of major hemorrhage and stroke. (Funded by the Programme Hospitalier de Recherche Clinique in France and others; PEITHO EudraCT number, 2006-005328-18; ClinicalTrials.gov number, NCT00639743.) In a randomized trial, 1006 patients with intermediate-risk pulmonary embolism were assigned to tenecteplase or placebo in addition to standard heparin therapy. The tenecteplase group had a lower rate of hemodynamic decompensation but more frequent major hemorrhage and stroke. Acute pulmonary embolism occurs frequently and may cause death or serious disability.(1) Case fatality rates vary widely,(2),(3) but approximately 10% of all patients with acute pulmonary embolism die within 3 months after the diagnosis.(4),(5) Acute right ventricular pressure overload at diagnosis is an important determinant of the severity and early clinical outcome of pulmonary embolism.(6) High-risk pulmonary embolism(7) is characterized by overt hemodynamic instability and warrants immediate advanced therapy, including consideration of fibrinolysis. In contrast, for patients presenting without systemic hypotension or hemodynamic compromise, standard anticoagulation is generally considered adequate treatment.(8) However, patients who have acute right ventricular ...	[Meyer, Guy] Univ Paris 05, AP HP, Sorbonne Paris Cite, Paris, France; [Meyer, Guy] INSERM, UMR S 970 GIRC Thrombose, Paris, France; [Vicaut, Eric] AP HP, Paris, France; [Vicaut, Eric] Univ Diderot Paris 7, Paris, France; [Danays, Thierry] Boehringer Ingelheim GmbH & Co KG, Grenoble, France; [Bouvaist, Helene] Univ Grenoble, Serv Cardiol, Hop Michallon Ctr Hosp, Grenoble, France; [Couturaud, Francis] Univ Bretagne Occidentale, Dept Med Interne & Pneumol, EA 3878, CIC INSERM 0502,Hop Cavale Blanche, Brest, France; [Meneveau, Nicolas] Univ Hosp Jean Minjoz, Dept Cardiol, EA 3920, SFR 4234, Besancon, France; [Pacouret, Gerard] Ctr Hosp Reg Univ Tours, Hop Trousseau, Serv Cardiol A, Tours, France; [Sebbane, Mustapha] Hop Arnaud Villeneuve, Serv Accueil Urgences, Montpellier, France; [Agnelli, Giancarlo; Becattini, Cecilia] Univ Perugia, Dept Internal & Cardiovasc Med, Stroke Unit, I-06100 Perugia, Italy; [Galie, Nazzareno; Palazzini, Massimiliano] Bologna Univ Hosp, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Rugolotto, Matteo] Osped Foncello, Treviso, Italy; [Salvi, Aldo] Univ Osped Riuniti Ancona, Azienda Osped, Ancona, Italy; [Beyer-Westendorf, Jan] Tech Univ Dresden, Ctr Vasc Dis, Div Thrombosis Res, D-01062 Dresden, Germany; [Schellong, Sebastian] Univ Klinikum, Dresden, Germany; [Beyer-Westendorf, Jan] Carl Gustav Carus Univ Hosp, Dresden, Germany; Tech Univ Dresden, D-01062 Dresden, Germany; [Bluhmki, Erich] Boehringer Ingelheim GmbH & Co KG, Bieberach, Germany; [Dellas, Claudia; Lankeit, Mareike] Univ Gottingen, Abt Kardiol & Pneumol, D-37073 Gottingen, Germany; [Geibel, Annette] Univ Freiburg, Abt Innere Med 3, D-79106 Freiburg, Germany; [Empen, Klaus] Ernst Moritz Arndt Univ Greifswald, Klinikum Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany; [Kupatt, Christian] Univ Munich, Klinikum Grosshadern, D-80539 Munich, Germany; [Lankeit, Mareike; Konstantinides, Stavros V.] Univ Med Ctr, Ctr Thrombosis & Hemostasis, Mainz, Germany; [Thiele, Holger] Univ Leipzig, Dept Internal Med, D-04109 Leipzig, Germany; [Brenner, Benjamin] Rambam Hlth Care Campus, Haifa, Israel; [Franca, Ana] Hosp Garcia Orta, Almada, Portugal; [Goldhaber, Samuel Z.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Goldhaber, Samuel Z.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Jimenez, David] Hosp Ramon & Cajal, Dept Resp Dis, Inst Ramon y Cajal Invest, E-28034 Madrid, Spain; [Kozak, Matija] Univ Med Ctr, Ljubljana, Slovenia; [Kucher, Nils] Univ Hosp Bern, Dept Angiol & Cardiol, CH-3010 Bern, Switzerland; [Lang, Irene M.] Med Univ Vienna, Allgemeines Krankenhaus Stadt Wien, Vienna, Austria; [Petris, Antoniu] Univ Med & Pharm Grigore T Popa, Cardiol Clin, Spitalul Clin Judetean Urgenta Sf Spiridon, Iasi, Romania; [Pruszczyk, Piotr] Med Univ Warsaw, Dept Internal Med & Cardiol, Warsaw, Poland; [Sobkowicz, Bozena] Med Univ Bialystok, Bialystok, Poland; [Torbicki, Adam] European Hlth Ctr Otwock, Dept Pulm Circulat & Thromboembol Dis, Ctr Postgraduate Med Educ, Otwock, Poland; [Stefanovic, Branislav S.] Univ Belgrade, Sch Med, Cardiol Clin, Emergency Ctr,Clin Ctr Serbia, Belgrade, Serbia; [Verschuren, Franck] Catholic Univ Louvain, Clin Univ St Luc, Serv Urgences, B-1200 Brussels, Belgium; [Konstantinides, Stavros V.] Democritus Univ Thrace, Dept Cardiol, Alexandroupolis, Greece	Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Boehringer Ingelheim; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Universite de Franche-Comte; CHU Besancon; CHU Tours; Universite de Montpellier; CHU de Montpellier; University of Perugia; IRCCS Azienda Ospedaliero-Universitaria di Bologna; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Boehringer Ingelheim; University of Gottingen; University of Freiburg; Ernst Moritz Arndt Universitat Greifswald; University of Munich; Johannes Gutenberg University of Mainz; Leipzig University; Rambam Health Care Campus; Hospital Garcia de Orta; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Hospital Universitario Ramon y Cajal; University Medical Centre Ljubljana; University of Bern; University Hospital of Bern; Medical University of Vienna; Grigore T Popa University of Medicine & Pharmacy; Medical University of Warsaw; Medical University of Bialystok; Clinical Centre of Serbia; University of Belgrade; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Democritus University of Thrace	Konstantinides, SV (corresponding author), Univ Med Ctr Mainz, Ctr Thrombosis & Hemostasis, Langenbeckstr 1, D-55131 Mainz, Germany.	konstantinides@unimedizin-mainz.de	Beyer-Westendorf, Jan/K-7569-2019; Becattini, Cecilia/L-1739-2018; nechita, alexandru cristian/AAM-8914-2021; Couturaud, Francis/Q-1366-2019; Octavian, Petris Antoniu/AAV-9211-2021; Quere, Isabelle/AAB-8519-2020; Konstantinides, Stavros/AAL-3174-2021; Kostrubiec, Maciej/O-4136-2018; Ferrari, Emile/R-2917-2016; Thiele, Holger/ABE-6792-2020; Galie, Nazzareno/F-7004-2014; Pruszczyk, Piotr/AAA-3523-2019; Palazzini, Massimiliano/AFM-3353-2022	Beyer-Westendorf, Jan/0000-0002-6983-9993; nechita, alexandru cristian/0000-0001-6481-1046; Couturaud, Francis/0000-0002-1855-8032; Quere, Isabelle/0000-0002-1492-9764; Konstantinides, Stavros/0000-0001-6359-7279; Kostrubiec, Maciej/0000-0002-1207-749X; Thiele, Holger/0000-0002-0169-998X; Galie, Nazzareno/0000-0003-4271-8670; Sobkowicz, Bozena/0000-0002-3297-3320; salvi, aldo/0000-0002-5601-8790; Franca, Ana/0000-0001-6925-0196; Petris, Antoniu/0000-0002-4150-9271; SANCHEZ, Olivier/0000-0003-1633-8391; Lang, Irene/0000-0003-0485-2692; PALAZZINI, MASSIMILIANO/0000-0002-6778-1994; Kupatt, Christian/0000-0002-3611-1218; BECATTINI, Cecilia/0000-0002-8343-4888; Van de Werf, Frans/0000-0001-9479-7767; Lankeit, Mareike/0000-0001-5211-7997; Torbicki, Adam/0000-0003-3475-8832	Programme Hospitalier de Recherche Clinique in France [AOM 03063, AOM 08231, AOM 10171]; Federal Ministry of Education and Research in Germany [01KG0802, 01EO1003]; Boehringer Ingelheim; Programme Hospitalier de Recherche Clinique in France [AOM 03063, AOM 08231, AOM 10171]; Federal Ministry of Education and Research in Germany [01KG0802, 01EO1003]; Boehringer Ingelheim	Programme Hospitalier de Recherche Clinique in France; Federal Ministry of Education and Research in Germany; Boehringer Ingelheim(Boehringer Ingelheim); Programme Hospitalier de Recherche Clinique in France; Federal Ministry of Education and Research in Germany; Boehringer Ingelheim(Boehringer Ingelheim)	Supported by grants from Programme Hospitalier de Recherche Clinique (AOM 03063, AOM 08231, and AOM 10171) in France, the Federal Ministry of Education and Research (01KG0802 and 01EO1003) in Germany, and Boehringer Ingelheim.	Armstrong PW, 2013, NEW ENGL J MED, V368, P1379, DOI 10.1056/NEJMoa1301092; Aujesky D, 2009, CIRCULATION, V119, P962, DOI 10.1161/CIRCULATIONAHA.108.824292; Becattini C, 2007, CIRCULATION, V116, P427, DOI 10.1161/CIRCULATIONAHA.106.680421; Binder L, 2005, CIRCULATION, V112, P1573, DOI 10.1161/CIRCULATIONAHA.105.552216; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Jaff MR, 2012, CIRCULATION, V125, pE495, DOI 10.1161/CIR.0b013e318250efb9; Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f; Kanter DS, 1997, CHEST, V111, P1241, DOI 10.1378/chest.111.5.1241; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Konstantinides S, 2003, J THROMB HAEMOST, V1, P1127, DOI 10.1046/j.1538-7836.2003.00335.x; Konstantinides S, 2012, EUR HEART J, V33, P3014, DOI 10.1093/eurheartj/ehs258; Konstantinides S, 2008, NEW ENGL J MED, V359, P2804, DOI 10.1056/NEJMcp0804570; Kucher N, 2005, ARCH INTERN MED, V165, P1777, DOI 10.1001/archinte.165.15.1777; Kucher N, 2014, CIRCULATION, V129, P479, DOI 10.1161/CIRCULATIONAHA.113.005544; Laporte S, 2008, CIRCULATION, V117, P1711, DOI 10.1161/CIRCULATIONAHA.107.726232; LEVINE MN, 1995, CLIN CHEST MED, V16, P321; MEYER G, 1992, J AM COLL CARDIOL, V19, P239, DOI 10.1016/0735-1097(92)90472-Y; Mikkola KM, 1997, AM HEART J, V134, P69, DOI 10.1016/S0002-8703(97)70108-X; Quiroz R, 2004, CIRCULATION, V109, P2401, DOI 10.1161/01.CIR.0000129302.90476.BC; Sanchez O, 2010, AM J RESP CRIT CARE, V181, P168, DOI 10.1164/rccm.200906-0970OC; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Scridon T, 2005, AM J CARDIOL, V96, P303, DOI 10.1016/j.amjcard.2005.03.062; Sharifi M, 2013, AM J CARDIOL, V111, P273, DOI 10.1016/j.amjcard.2012.09.027; Steering Committee, 2012, AM HEART J, V163, p33e1; Stein PD, 2012, AM J MED, V125, P465, DOI 10.1016/j.amjmed.2011.10.015; SUDLOW MF, 1992, LANCET, V340, P873; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; Wan S, 2004, CIRCULATION, V110, P744, DOI 10.1161/01.CIR.0000137826.09715.9C	28	823	858	1	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 10	2014	370	15					1402	1411		10.1056/NEJMoa1302097	http://dx.doi.org/10.1056/NEJMoa1302097			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6IW	24716681	Green Published			2022-12-28	WOS:000334095200008
J	Eapen, ZJ; Lauer, MS; Temple, RJ				Eapen, Zubin J.; Lauer, Michael S.; Temple, Robert J.			The Imperative of Overcoming Barriers to the Conduct of Large, Simple Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Eapen, Zubin J.] Duke Clin Res Inst, Durham, NC 27715 USA; [Lauer, Michael S.] NHLBI, Div Cardiovasc Sci, Bethesda, MD 20892 USA; [Temple, Robert J.] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	Duke University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); US Food & Drug Administration (FDA)	Eapen, ZJ (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	zubin.eapen@duke.edu			FOOD AND DRUG ADMINISTRATION [U19FD003800] Funding Source: NIH RePORTER; FDA HHS [U19FD003800] Funding Source: Medline	FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); FDA HHS		Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789; Getz K., 2012, CLINICAL TRIAL COMPL; Hess CN, 2013, AM HEART J, V166, P421, DOI 10.1016/j.ahj.2013.06.013; US FDA, 2012, GUIDANCE FOR INDUSTR; US Food and Drug Administration (FDA), 2013, OVERSIGHT OF CLINICA	5	62	66	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2014	311	14					1397	1398		10.1001/jama.2014.1030	http://dx.doi.org/10.1001/jama.2014.1030			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4EP	24715072				2022-12-28	WOS:000333935000012
J	Woodward, A; Smith, KR; Campbell-Lendrum, D; Chadee, DD; Honda, Y; Liu, QY; Olwoch, J; Revich, B; Sauerborn, R; Chafe, Z; Confalonieri, U; Haines, A				Woodward, Alistair; Smith, Kirk R.; Campbell-Lendrum, Diarmid; Chadee, Dave D.; Honda, Yasushi; Liu, Qiyong; Olwoch, Jane; Revich, Boris; Sauerborn, Rainer; Chafe, Zoe; Confalonieri, Ulisses; Haines, Andy			Climate change and health: on the latest IPCC report	LANCET			English	Editorial Material									[Woodward, Alistair] Univ Auckland, Sch Populat Hlth, Auckland 1142, New Zealand; [Smith, Kirk R.; Chafe, Zoe] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Campbell-Lendrum, Diarmid] WHO, Dept Publ Hlth Environm & Social Determinants Hlt, CH-1211 Geneva, Switzerland; [Chadee, Dave D.] Univ W Indies, Dept Life Sci, St Augustine, Trinidad Tobago; [Honda, Yasushi] Univ Tsukuba, Fac Hlth & Sports Sci, Tsukuba, Ibaraki, Japan; [Liu, Qiyong] China Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Olwoch, Jane] South African Natl Space Agcy, SANSA Earth Observat, Pretoria, South Africa; [Revich, Boris] Russian Acad Sci, Inst Forecasting, Moscow, Russia; [Sauerborn, Rainer] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Confalonieri, Ulisses] FIOCRUZ Oswaldo Cruz Fdn, Lab Hlth Educ, Belo Horizonte, MG, Brazil; [Haines, Andy] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England	University of Auckland; University of California System; University of California Berkeley; World Health Organization; University West Indies Mona Jamaica; University West Indies Saint Augustine; University of Tsukuba; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Russian Academy of Sciences; Umea University; Fundacao Oswaldo Cruz; University of London; London School of Hygiene & Tropical Medicine	Woodward, A (corresponding author), Univ Auckland, Sch Populat Hlth, Auckland 1142, New Zealand.	a.woodward@auckland.ac.nz	Olwoch, Jane/AAC-5073-2020	Haines, Andy/0000-0002-8053-4605; Chafe, Zoe/0000-0001-6670-6979; Woodward, Alistair/0000-0001-5425-6018				Anenberg SC, 2012, ENVIRON HEALTH PERSP, V120, P831, DOI 10.1289/ehp.1104301; Barros VR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1133; Ebi KL, 2012, CLIMATIC CHANGE, V114, P417, DOI 10.1007/s10584-012-0442-4; Hosking J, 2012, ENVIRON HEALTH PERSP, V120, P1076, DOI 10.1289/ehp.1104093; Kirtman B., 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Mastrandrea MD, 2011, CLIMATIC CHANGE, V108, P675, DOI 10.1007/s10584-011-0178-6; Parry ML, 2007, CLIMATE CHANGE 2007; Shaposhnikov D, 2014, EPIDEMIOLOGY, V25, P359, DOI 10.1097/EDE.0000000000000090; Teague B., 2010, 2009 VICTORIAN BUSHF; The World Bank,, 2012, TURN HEAT WHY 4C WAR	10	150	157	4	93	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 5	2014	383	9924					1185	1189		10.1016/S0140-6736(14)60576-6	http://dx.doi.org/10.1016/S0140-6736(14)60576-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE6LO	24703554				2022-12-28	WOS:000334104600004
J	Lo Re, V; Kallan, MJ; Tate, JP; Localio, AR; Lim, JK; Goetz, MB; Klein, MB; Rimland, D; Rodriguez-Barradas, MC; Butt, AA; Gibert, CL; Brown, ST; Park, L; Dubrow, R; Reddy, KR; Kostman, JR; Strom, BL; Justice, AC				Lo Re, Vincent, III; Kallan, Michael J.; Tate, Janet P.; Localio, A. Russell; Lim, Joseph K.; Goetz, Matthew Bidwell; Klein, Marina B.; Rimland, David; Rodriguez-Barradas, Maria C.; Butt, Adeel A.; Gibert, Cynthia L.; Brown, Sheldon T.; Park, Lesley; Dubrow, Robert; Reddy, K. Rajender; Kostman, Jay R.; Strom, Brian L.; Justice, Amy C.			Hepatic Decompensation in Antiretroviral-Treated Patients Co-Infected With HIV and Hepatitis C Virus Compared With Hepatitis C Virus-Monoinfected Patients A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CHRONIC LIVER-DISEASE; POLYMERASE CHAIN-REACTION; SIMPLE NONINVASIVE INDEX; VETERANS AGING COHORT; PROTEIN-S DEFICIENCY; SOCIETY-USA PANEL; FIBROSIS PROGRESSION; HEPATOCELLULAR-CARCINOMA; HIV/HCV COINFECTION	Background: The incidence and determinants of hepatic decompensation have been incompletely examined among patients co-infected with HIV and hepatitis C virus (HCV) in the antiretroviral therapy (ART) era, and few studies have compared outcome rates with those of patients with chronic HCV alone. Objective: To compare the incidence of hepatic decompensation between antiretroviral-treated patients co-infected with HIV and HCV and HCV-monoinfected patients and to evaluate factors associated with decompensation among co-infected patients receiving ART. Design: Retrospective cohort study. Setting: Veterans Health Administration. Patients: 4280 co-infected patients who initiated ART and 6079 HCV-monoinfected patients receiving care between 1997 and 2010. All patients had detectable HCV RNA and were HCV treatment-naive. Measurements: Incident hepatic decompensation, determined by diagnoses of ascites, spontaneous bacterial peritonitis, or esophageal variceal hemorrhage. Results: The incidence of hepatic decompensation was greater among co-infected than monoinfected patients (7.4% vs. 4.8% at 10 years; P < 0.001). Compared with HCV-monoinfected patients, co-infected patients had a higher rate of hepatic decompensation (hazard ratio [HR] accounting for competing risks, 1.56 [95% CI, 1.31 to 1.86]). Co-infected patients who maintained HIV RNA levels less than 1000 copies/mL still had higher rates of decompensation than HCV-monoinfected patients (HR, 1.44 [CI, 1.05 to 1.99]). Baseline advanced hepatic fibrosis (FIB-4 score >3.25) (HR, 5.45 [CI, 3.79 to 7.84]), baseline hemoglobin level less than 100 g/L (HR, 2.24 [CI, 1.20 to 4.20]), diabetes mellitus (HR, 1.88 [CI, 1.38 to 2.56]), and nonblack race (HR, 2.12 [CI, 1.65 to 2.72]) were each associated with higher rates of decompensation among co-infected patients. Limitation: Observational study of predominantly male patients. Conclusion: Despite receiving ART, patients co-infected with HIV and HCV had higher rates of hepatic decompensation than HCV-monoinfected patients. Rates of decompensation were higher for co-infected patients with advanced liver fibrosis, severe anemia, diabetes, and nonblack race.	Univ Penn, Philadelphia, PA 19104 USA; Philadelphia VA Med Ctr, Philadelphia, PA USA; VA Connecticut Healthcare Syst, West Haven, CT 06516 USA; Yale Univ, Sch Med, West Haven, CT 06516 USA; Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA; VA Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; McGill Univ, Ctr Hlth, Montreal, PQ, Canada; Atlanta VA Med Ctr, Atlanta, GA 30033 USA; Emory Univ, Sch Med, Atlanta, GA USA; Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; Baylor Coll Med, Houston, TX 77030 USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA; Sheikh Khalifa Med City, Abu Dhabi, U Arab Emirates; Washington DC VA Med Ctr, Washington, DC 20422 USA; George Washington Univ, Med Ctr, Washington, DC 20037 USA; James J Peters VA Med Ctr, New York, NY USA; Mt Sinai Sch Med, New York, NY USA; Rutgers State Univ, Newark, NJ 07103 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; McGill University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Emory University; Baylor College of Medicine; Baylor College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; George Washington University; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; Rutgers State University Newark; Rutgers State University New Brunswick	Lo Re, V (corresponding author), Univ Penn, Penn Ctr AIDS Res, Ctr Clin Epidemiol & Biostat, Div Infect Dis,Dept Med,Perelman Sch Med, 836 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	vincentl@mail.med.upenn.edu	Goetz, Matthew Bidwell/GPX-4090-2022; Re, Vincent Lo/N-7817-2015	Goetz, Matthew/0000-0003-4542-992X; Butt, Adeel/0000-0002-1118-1826; Klein, Marina/0000-0002-3063-8430; Park, Lesley S./0000-0002-3848-7753	National Institute of Allergy and Infectious Diseases [K01 AI070001]; National Institute on Alcohol Abuse and Alcoholism [U01 AA13566]; National Institute of Mental Health [T32 MH020031]; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI070001, P30AI045008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA020794, U01AA013566, U24AA022001, U01AA020790] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	National Institutes of Health.	Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Berenguer J, 2009, HEPATOLOGY, V50, P407, DOI 10.1002/hep.23020; Bissell DM, 1999, HEPATOLOGY, V29, P988, DOI 10.1002/hep.510290351; BISSUEL F, 1992, J ACQ IMMUN DEF SYND, V5, P484; Blanco F, 2011, J VIRAL HEPATITIS, V18, P11, DOI 10.1111/j.1365-2893.2009.01261.x; Brau N, 2006, J HEPATOL, V44, P47, DOI 10.1016/j.jhep.2005.07.006; Butt AA, 2004, HEPATOLOGY, V40, P115, DOI 10.1002/hep.20289; Butt AA, 2009, AIDS, V23, P1227, DOI 10.1097/QAD.0b013e32832bd7af; Cain LE, 2009, STAT MED, V28, P1725, DOI 10.1002/sim.3585; Chu C, 2011, J URBAN HEALTH, V88, P507, DOI 10.1007/s11524-010-9540-7; Cole SR, 2010, AM J EPIDEMIOL, V171, P198, DOI 10.1093/aje/kwp347; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; Fanning L, 1999, HEPATOLOGY, V29, P904, DOI 10.1002/hep.510290310; FEFFER SE, 1995, SOUTHERN MED J, V88, P1126, DOI 10.1097/00007611-199511000-00008; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Frederick T, 2009, AIDS PATIENT CARE ST, V23, P915, DOI 10.1089/apc.2009.0111; FREEDMAN VA, 1995, DEMOGRAPHY, V32, P459, DOI 10.2307/2061691; Freiberg MS, 2011, CIRC-CARDIOVASC QUAL, V4, P425, DOI 10.1161/CIRCOUTCOMES.110.957415; Fultz SL, 2006, MED CARE, V44, pS25, DOI 10.1097/01.mlr.0000223670.00890.74; Gandhi NR, 2013, PHARMACOEPIDEM DR S, V22, P1019, DOI 10.1002/pds.3476; Garcia-Tsao G, 2010, HEPATOLOGY, V51, P1445, DOI 10.1002/hep.23478; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; GRETCH D, 1994, J INFECT DIS, V169, P1219, DOI 10.1093/infdis/169.6.1219; Hisada M, 2005, HEPATOLOGY, V42, P1446, DOI 10.1002/hep.20938; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hui JM, 2003, GASTROENTEROLOGY, V125, P1695, DOI 10.1053/j.gastro.2003.08.032; Justice AC, 2004, AIDS, V18, pS49, DOI 10.1097/00002030-200401001-00008; Justice AC, 2012, CLIN INFECT DIS, V54, P984, DOI 10.1093/cid/cir989; KATO N, 1993, HEPATOLOGY, V18, P16, DOI 10.1002/hep.1840180104; Kazis LE, 1998, ARCH INTERN MED, V158, P626, DOI 10.1001/archinte.158.6.626; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Kramer JR, 2005, AM J GASTROENTEROL, V100, P56, DOI 10.1111/j.1572-0241.2005.40670.x; LAU JYN, 1993, LANCET, V341, P1501, DOI 10.1016/0140-6736(93)90635-T; Limketkai BN, 2012, JAMA-J AM MED ASSOC, V308, P370, DOI 10.1001/jama.2012.7844; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Lin WY, 2013, J INFECT DIS, V207, pS13, DOI 10.1093/infdis/jis926; LITTLE RJA, 1982, AM STAT, V36, P38, DOI 10.2307/2684091; Lo Re V, 2011, PHARMACOEPIDEM DR S, V20, P689, DOI 10.1002/pds.2148; Lo Re V, 2009, AIDS, V23, P2191, DOI 10.1097/QAD.0b013e32832ec258; MITA E, 1994, J HEPATOL, V21, P468, DOI 10.1016/S0168-8278(05)80330-7; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2011, GUID US ANT AG HIV 1, P1, DOI DOI 10.1016/S0735-1097(03)00232-8; Paradis V, 2001, HEPATOLOGY, V34, P738, DOI 10.1053/jhep.2001.28055; Pineda JA, 2005, HEPATOLOGY, V41, P779, DOI 10.1002/hep.20626; Pineda JA, 2007, HEPATOLOGY, V46, P622, DOI 10.1002/hep.21757; Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0; Qurishi N, 2003, LANCET, V362, P1708, DOI 10.1016/S0140-6736(03)14844-1; Raymond HF, 2011, SEX TRANSM DIS, V38, P219, DOI 10.1097/OLQ.0b013e3181f68ed4; Royston P, 2005, STATA J, V5, P188, DOI 10.1177/1536867X0500500204; Sathiakumar N, 1998, J OCCUP ENVIRON MED, V40, P808, DOI 10.1097/00043764-199809000-00010; Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042; SORICE M, 1994, THROMB RES, V73, P165, DOI 10.1016/0049-3848(94)90095-7; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Sugerman RW, 1996, PEDIATR INFECT DIS J, V15, P106, DOI 10.1097/00006454-199602000-00003; Sulkowski M, 2013, LANCET INFECT DIS, V13, P597, DOI 10.1016/S1473-3099(13)70149-X; Sulkowski MS, 2007, AIDS, V21, P2209, DOI 10.1097/QAD.0b013e3282f10de9; Sulkowski MS, 2013, ANN INTERN MED, V159, P86, DOI 10.7326/0003-4819-159-2-201307160-00654; Sulkowski MS, 2004, AIDS, V18, P2277, DOI 10.1097/00002030-200411190-00008; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; van Sighem A, 2008, JAIDS-J ACQ IMM DEF, V48, P104, DOI 10.1097/QAI.0b013e31816a1d4f; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222; Youssef Wael, 2002, Semin Gastrointest Dis, V13, P17; Zarski JP, 2003, J HEPATOL, V38, P307, DOI 10.1016/S0168-8278(02)00387-2; Zeuzem S, 1996, HEPATOLOGY, V24, P1003	67	192	193	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2014	160	6					369	+		10.7326/M13-1829	http://dx.doi.org/10.7326/M13-1829			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MW	24723077	Green Accepted			2022-12-28	WOS:000333521300013
J	Michaleff, ZA; Maher, CG; Lin, CWC; Rebbeck, T; Jull, G; Latimer, J; Connelly, L; Sterling, M				Michaleff, Zoe A.; Maher, Chris G.; Lin, Chung-Wei Christine; Rebbeck, Trudy; Jull, Gwendolen; Latimer, Jane; Connelly, Luke; Sterling, Michele			Comprehensive physiotherapy exercise programme or advice for chronic whiplash (PROMISE): a pragmatic randomised controlled trial	LANCET			English	Article							THERAPEUTIC INTERVENTIONS; DISORDER WAD; CLINICAL-TRIAL; PAIN; DISABILITY; SCALE; NECK; RESPONSIVENESS; VALIDATION; EDUCATION	Background Evidence suggests that brief physiotherapy programmes are as effective for acute whiplash-associated disorders as more comprehensive programmes; however, whether this also holds true for chronic whiplash-associated disorders is unknown. We aimed to estimate the effectiveness of a comprehensive exercise programme delivered by physiotherapists compared with advice in people with a chronic whiplash-associated disorder. Methods PROMISE is a two group, pragmatic randomised controlled trial in patients with chronic (>3 months and <5 years) grade 1 or 2 whiplash-associated disorder. Participants were randomly assigned by a computer-generated randomisation schedule to receive either the comprehensive exercise programme (20 sessions) or advice (one session and telephone support). Sealed opaque envelopes were used to conceal allocation. The primary outcome was pain intensity measured on a 0-10 scale. Outcomes were measured at baseline, 14 weeks, 6 months, and 12 months by a masked assessor. Analysis was by intention to treat, and treatment effects were calculated with linear mixed models. The trial is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12609000825257. Findings 172 participants were allocated to either the comprehensive exercise programme (n=86) or advice group (n=86); 157 (91%) were followed up at 14 weeks, 145 (84%) at 6 months, and 150 (87%) at 12 months. A comprehensive exercise programme was not more effective than advice alone for pain reduction in the participants. At 14 weeks the treatment effect on a 0-10 pain scale was 0. 0 (95% CI -0.7 to 0.7), at 6 months 0.2 (-0.5 to 1.0), and at 12 months -0.1 (-0.8 to 0.6). CNS hyperexcitability and symptoms of post-traumatic stress did not modify the eff ect of treatment. We recorded no serious adverse events. Interpretation We have shown that simple advice is equally as effective as a more intense and comprehensive physiotherapy exercise programme. The need to identify effective and affordable strategies to prevent and treat acute through to chronic whiplash associated disorders is an important health priority. Future avenues of research might include improving understanding of the mechanisms responsible for persistent pain and disability, investigating the effectiveness and timing of drugs, and study of content and delivery of education and advice. Funding The National Health and Medical Research Council of Australia, Motor Accidents Authority of New South Wales, and Motor Accident Insurance Commission of Queensland.	[Michaleff, Zoe A.; Maher, Chris G.; Lin, Chung-Wei Christine; Latimer, Jane] George Inst Global Hlth, Sydney, NSW, Australia; [Michaleff, Zoe A.; Maher, Chris G.; Lin, Chung-Wei Christine; Latimer, Jane] Sydney Med Sch, Sydney, NSW, Australia; [Rebbeck, Trudy] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2050, Australia; [Connelly, Luke; Sterling, Michele] Univ Queensland, Ctr Natl Res Disabil & Rehabil Med, Brisbane, Qld, Australia; [Jull, Gwendolen] Univ Queensland, Sch Hlth & Rehabil Sci, Div Physiotherapy, Brisbane, Qld, Australia; [Connelly, Luke] Univ Queensland, Hlth Sch Econ, Australian Ctr Econ Res, Brisbane, Qld, Australia; [Connelly, Luke] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia	George Institute for Global Health; University of Sydney; University of Sydney; University of Sydney; University of Queensland; University of Queensland; University of Queensland; University of Queensland	Michaleff, ZA (corresponding author), Univ Sydney, George Inst Global Hlth, Sydney, NSW 2050, Australia.	zmichaleff@georgeinstitute.org.au	Jull, Gwendolen/F-4233-2010; Rebbeck, Trudy/AAF-6300-2021; Maher, Christopher/AAC-6267-2019; Lin, Chung-Wei Christine/S-8840-2019; Sterling, Michele/F-1679-2010	Jull, Gwendolen/0000-0003-2670-1318; Rebbeck, Trudy/0000-0002-4453-4739; Maher, Christopher/0000-0002-1628-7857; Lin, Chung-Wei Christine/0000-0001-6192-7238; Sterling, Michele/0000-0003-1772-2248; Connelly, Luke/0000-0002-1734-4809; Michaleff, Zoe/0000-0002-0360-4956; Sterling, Michele/0000-0001-8242-2685	National Health and Medical Research Council - the Motor Accidents Authority of New South Wales; Motor Accidents Insurance Commission Queensland; Australian Research Council; National Health and Medical Research Council; Motor Accidents Authority of New South Wales	National Health and Medical Research Council - the Motor Accidents Authority of New South Wales; Motor Accidents Insurance Commission Queensland; Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Motor Accidents Authority of New South Wales	This investigator-initiated trial was funded by the National Health and Medical Research Council with supplementary funding from the Motor Accidents Authority of New South Wales and the Motor Accidents Insurance Commission Queensland. CGM and JL's research fellowships are funded by the Australian Research Council. C-WCL, TR, MS's research fellowships are funded by the National Health and Medical Research Council. Assistance with recruitment was provided by the Motor Accidents Authority of New South Wales, the Motor Accidents Insurance Commission Queensland, QBE Insurance, Allianz Insurance, Dr Clive Sun Consultant in Rehabilitation Medicine and Pain Medicine, and the Sydney Specialist Physiotherapy Centre. We thank the treating physiotherapy centres in New South Wales: Bay Active Physio, Dora Street Physiotherapy, Macarthur Physiotherapy and Sports Injury Centre, North Ryde Physiotherapy, Park Central Physiotherapy, Penrith Physiotherapy Sports Centre, Spine Care Centre, Special Spinal Rehab, Sydney Specialist Physiotherapy Centre, Sydney Spine Physio, and Queensland: Axis Physiotherapy, Bracken Ridge Physio, Brisbane City Physiotherapy, Carina Central Physiotherapy, Indooroopilly Physiotherapy, Milton Physiotherapy, Performance Rehab, Physiotherapy Sports and Rehab Clinic, Physiomatic.	Australian Bureau of Statistics, 1995, NAT HLTH SURV SF 36; Bennett MI, 2005, J PAIN, V6, P149, DOI 10.1016/j.jpain.2004.11.007; Blincoe L, 2000, EC IMPACT MOTOR VEHI; Boudreau S, 2007, PAIN, V132, P169, DOI 10.1016/j.pain.2007.07.019; Gross A, 2012, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD005106.PUB4; Hole D E, 1995, Man Ther, V1, P36, DOI 10.1054/math.1995.0248; Jull G, 2007, PAIN, V129, P28, DOI 10.1016/j.pain.2006.09.030; Jull G., WHIPLASH INJURY RECO; Jull G, 2013, PAIN, V154, P1798, DOI 10.1016/j.pain.2013.05.041; Jull GA, 2011, SPINE, V36, pS173, DOI 10.1097/BRS.0b013e31823883e6; Kamper SJ, 2008, PAIN, V138, P617, DOI 10.1016/j.pain.2008.02.019; Kamper SJ, 2011, CLIN J PAIN, V27, P495, DOI 10.1097/AJP.0b013e31820e1185; Kamper SJ, 2009, J MAN MANIP THER, V17, P163, DOI 10.1179/jmt.2009.17.3.163; Lamb SE, 2013, LANCET, V381, P546, DOI 10.1016/S0140-6736(12)61304-X; Lord SM, 1996, NEW ENGL J MED, V335, P1721, DOI 10.1056/NEJM199612053352302; Maxwell S, 2013, MANUAL THER, V18, P172, DOI 10.1016/j.math.2012.07.004; McCarthy S, 2008, OCCUP MED-OXFORD, V58, P379, DOI 10.1093/occmed/kqn062; Meeus M, 2012, PAIN PHYSICIAN, V15, P351; Michaleff ZA, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-149; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nicholas M., 2004, MUSCULOSKELETAL PHYS, V2nd; Pengel LHM, 2004, SPINE, V29, P879, DOI 10.1097/00007632-200404150-00011; Rushton A, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000265; Scholten-Peeters GGM, 2006, SPINE, V31, P723, DOI 10.1097/01.brs.0000206381.15224.0f; Soderlund Anne, 2001, Physiotherapy Theory and Practice, V17, P229; Stewart MJ, 2007, PAIN, V128, P59, DOI 10.1016/j.pain.2006.08.030; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Teasell RW, 2010, PAIN RES MANAG, V15, P313, DOI 10.1155/2010/487279; Teasell RW, 2010, PAIN RES MANAG, V15, P305, DOI 10.1155/2010/108685; Teasell RW, 2010, PAIN RES MANAG, V15, P323, DOI 10.1155/2010/914358; Teasell RW, 2010, PAIN RES MANAG, V15, P295, DOI 10.1155/2010/640164; Thompson WR, 2010, ACSMS GUIDELINES EXE, V8th; TRACsa: trauma and injury recovery, 2008, TRACSA TRAUMA INJURY; Verhagen AP, 2007, COCHRANE DB SYST REV, V4; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Walton DM, 2013, CLIN J PAIN, V29, P499, DOI 10.1097/AJP.0b013e318269569c; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Westaway MD, 1998, J ORTHOP SPORT PHYS, V27, P331, DOI 10.2519/jospt.1998.27.5.331; Willis C, 2004, PAIN, V110, P681, DOI 10.1016/j.pain.2004.05.008	39	105	108	1	30	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					133	141		10.1016/S0140-6736(14)60457-8	http://dx.doi.org/10.1016/S0140-6736(14)60457-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL1YC	24703832				2022-12-28	WOS:000338921500032
J	Sedrakyan, A				Sedrakyan, Art			Precarious innovation of anti-infective coated devices	LANCET			English	Editorial Material							CENTRAL VENOUS CATHETERS; FRAMEWORK; TERM		[Sedrakyan, Art] Cornell Univ, Weill Cornell Med Coll, Dept Hlth Policy & Res, Patient Ctr Comparat Effectiveness Program, New York, NY 10065 USA; [Sedrakyan, Art] Cornell Univ, Weill Cornell Med Coll, Dept Cardiac Surg, New York, NY 10065 USA	Cornell University; Cornell University	Sedrakyan, A (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Hlth Policy & Res, Patient Ctr Comparat Effectiveness Program, New York, NY 10065 USA.	ars2013@med.cornell.edu						Ardaugh BM, 2013, NEW ENGL J MED, V368, P97, DOI 10.1056/NEJMp1211581; Cook JA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2820; Darouiche RO, 1999, NEW ENGL J MED, V340, P1, DOI 10.1056/NEJM199901073400101; Deierhoi RJ, 2013, J AM COLL SURGEONS, V217, P763, DOI 10.1016/j.jamcollsurg.2013.07.003; Diener MK, 2014, LANCET; Hockenhull JC, 2008, HEALTH TECHNOL ASSES, V12, P1; Namba RS, 2013, J BONE JOINT SURG AM, V95A, P775, DOI 10.2106/JBJS.L.00211; Pickard R, 2012, LANCET, V380, P1927, DOI 10.1016/S0140-6736(12)61380-4; Pople I, 2012, NEUROSURGERY, V71, P6, DOI 10.1227/NEU.0b013e3182544e31; Rome BN, 2014, JAMA-J AM MED ASSOC, V311, P385, DOI 10.1001/jama.2013.284986; Sedrakyan A, 2012, LANCET, V379, P1174, DOI 10.1016/S0140-6736(12)60372-9; Sedrakyan A, 2010, MED CARE, V48, pS121, DOI 10.1097/MLR.0b013e3181d991c4; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Zheng H, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003978	14	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					111	113		10.1016/S0140-6736(14)60577-8	http://dx.doi.org/10.1016/S0140-6736(14)60577-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1YC	24718271				2022-12-28	WOS:000338921500011
J	Harris, R				Harris, Russell			Screening Is Only Part of the Answer to Breast Cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MAMMOGRAPHY		[Harris, Russell] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Res Ctr Excellence Clin Prevent Serv, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Harris, R (corresponding author), Univ N Carolina, Sheps Ctr Hlth Serv Res, 725 Martin Luther King Blvd,CB 7590, Chapel Hill, NC 27599 USA.	rharris@med.unc.edu						Ahn J, 2007, ARCH INTERN MED, V167, P2091, DOI 10.1001/archinte.167.19.2091; Bardia A, 2006, ARCH INTERN MED, V166, P2478, DOI 10.1001/archinte.166.22.2478; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Esserman L, 2014, ANN INTERN MED; Kalager M, 2012, ANN INTERN MED, V156, P491, DOI 10.7326/0003-4819-156-7-201204030-00005; Miller Anthony B, 2014, BMJ, V348, pg366, DOI 10.1136/bmj.g366; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Singer Natasha, 2011, NEW YORK TIMES  0206, pBU1	9	5	5	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12					861	863		10.7326/M14-0616	http://dx.doi.org/10.7326/M14-0616			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24711098				2022-12-28	WOS:000337374900023
J	Igarashi, KM; Lu, L; Colgin, LL; Moser, MB; Moser, EI				Igarashi, Kei M.; Lu, Li; Colgin, Laura L.; Moser, May-Britt; Moser, Edvard I.			Coordination of entorhinal-hippocampal ensemble activity during associative learning	NATURE			English	Article							GAMMA-OSCILLATIONS; SPATIAL REPRESENTATION; OLFACTORY-BULB; BEHAVING RAT; CORTEX; SYNCHRONIZATION; DISCRIMINATION; INFORMATION; MEMORY; FREQUENCY	Accumulating evidence points to cortical oscillations as a mechanism for mediating interactions among functionally specialized neurons in distributed brain circuits(1-6). A brain function that may use such interactions is declarative memory-that is, memory that can be consciously recalled, such as episodes and facts. Declarative memory is enabled by circuits in the entorhinal cortex that interface the hippocampus with the neocortex(7,8). During encoding and retrieval of declarative memories, entorhinal and hippocampal circuits are thought to interact via theta and gamma oscillations(4,6,8), which in awake rodents predominate frequency spectra in both regions(9-12). In favour of this idea, theta-gamma coupling has been observed between entorhinal cortex and hippocampus under steady-state conditions inwell-trained rats(12); however, the relationship between interregional coupling and memory formation remains poorly understood. Here we show, by multisite recording at successive stages of associative learning, that the coherence of firing patterns in directly connected entorhinal-hippocampus circuits evolves as rats learn to use an odour cue to guide navigational behaviour, and that such coherence is invariably linked to the development of ensemble representations for unique trial outcomes in each area. Entorhinal-hippocampal coupling was observed specifically in the 20-40-hertz frequency band and specifically between the distal part of hippocampal area CA1 and the lateral part of entorhinal cortex, the subfields that receive the predominant olfactory input to the hippocampal region(13). Collectively, the results identify 20-40-hertz oscillations as a mechanism for synchronizing evolving representations in dispersed neural circuits during encoding and retrieval of olfactory-spatial associative memory.	[Igarashi, Kei M.; Lu, Li; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7491 Trondheim, Norway; [Igarashi, Kei M.; Lu, Li; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Ctr Neural Computat, N-7491 Trondheim, Norway; [Colgin, Laura L.] Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Texas System; University of Texas Austin	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, Olav Kyrres Gate 9,MTFS,7491, N-7491 Trondheim, Norway.	kei.igarashi@ntnu.no; edvard.moser@ntnu.no	Igarashi, Kei M/AAL-7116-2020; Igarashi, Kei/V-9383-2018	Igarashi, Kei M/0000-0002-5635-169X; Igarashi, Kei/0000-0001-5477-574X; Colgin, Laura/0000-0002-4853-8913	European Research Council [232608, 268598]; Kavli Foundation; Centre of Excellence scheme of the Research Council of Norway (Centre for the Biology of Memory and Centre for Neural Computation); Mishima Kaiun Memorial Foundation; Japan Society for the Promotion of Science	European Research Council(European Research Council (ERC)European Commission); Kavli Foundation; Centre of Excellence scheme of the Research Council of Norway (Centre for the Biology of Memory and Centre for Neural Computation); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank A. M. Amundsgard, K. Haugen, K. Jenssen, E. Krakvik, R. Skjerpeng and H. Waade for technical assistance, and M. Witter and members of the Moser laboratory for discussions. This work was supported by two Advanced Investigator grants from the European Research Council ('CIRCUIT', Grant Agreement no. 232608; 'ENSEMBLE', Grant Agreement no. 268598), the Kavli Foundation, the Centre of Excellence scheme of the Research Council of Norway (Centre for the Biology of Memory and Centre for Neural Computation), the Mishima Kaiun Memorial Foundation, and the Japan Society for the Promotion of Science.	Ahmed OJ, 2012, J NEUROSCI, V32, P7373, DOI 10.1523/JNEUROSCI.5110-11.2012; Berke JD, 2008, HIPPOCAMPUS, V18, P519, DOI 10.1002/hipo.20435; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BRAGIN A, 1995, J NEUROSCI, V15, P47; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; Buzsaki G., 2006, RHYTHMS BRAIN; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Colgin LL, 2013, ANNU REV NEUROSCI, V36, P295, DOI 10.1146/annurev-neuro-062012-170330; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Day M, 2003, NATURE, V424, P205, DOI 10.1038/nature01769; EICHENBAUM H, 1987, J NEUROSCI, V7, P716; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; FREEMAN WJ, 1978, ELECTROEN CLIN NEURO, V44, P586, DOI 10.1016/0013-4694(78)90126-8; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Henriksen EJ, 2010, NEURON, V68, P127, DOI 10.1016/j.neuron.2010.08.042; Howe MW, 2011, P NATL ACAD SCI USA, V108, P16801, DOI 10.1073/pnas.1113158108; Igarashi KM, 2012, J NEUROSCI, V32, P7970, DOI 10.1523/JNEUROSCI.0154-12.2012; Jezek K, 2011, NATURE, V478, P246, DOI 10.1038/nature10439; Kepecs A, 2007, J NEUROPHYSIOL, V98, P205, DOI 10.1152/jn.00071.2007; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Macmillan N. A., 1991, DETECTION THEORY USE; Martin C, 2007, J NEUROPHYSIOL, V98, P2196, DOI 10.1152/jn.00524.2007; MCNAUGHTON BL, 1978, BRAIN RES, V157, P277, DOI 10.1016/0006-8993(78)90030-6; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; Naya Y, 2011, SCIENCE, V333, P773, DOI 10.1126/science.1206773; Ravel N, 2003, EUR J NEUROSCI, V17, P350, DOI 10.1046/j.1460-9568.2003.02445.x; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Witter M., 2004, RAT NERVOUS SYSTEM, V3, P635, DOI [10.1016/B978-012547638-6/50022-5, DOI 10.1016/B978-012547638-6/50022-5]	45	226	230	4	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					143	+		10.1038/nature13162	http://dx.doi.org/10.1038/nature13162			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24739966	Green Accepted			2022-12-28	WOS:000336768900045
J	Gharib, H				Gharib, Hossein			Update in Endocrinology: Evidence Published in 2013	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Gharib, Hossein] Mayo Clin, Coll Med, 200 First St, Rochester, MN 55905 USA	Mayo Clinic	Gharib, H (corresponding author), Mayo Clin, Coll Med, 200 First St, Rochester, MN 55905 USA.	gharib.hossein@mayo.edu						Romeo S, 2012, DIABETES CARE, V35, P2613, DOI 10.2337/dc12-0193	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 3	2014	160	11					785	790		10.7326/M14-0047	http://dx.doi.org/10.7326/M14-0047			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V44NY	24723208				2022-12-28	WOS:000209756900001
J	Deuse, T; Hua, XQ; Wang, D; Maegdefessel, L; Heeren, J; Scheja, L; Bolanos, JP; Rakovic, A; Spin, JM; Stubbendorff, M; Ikeno, F; Langer, F; Zeller, T; Schulte-Uentrop, L; Stoehr, A; Itagaki, R; Haddad, F; Eschenhagen, T; Blankenberg, S; Kiefmann, R; Reichenspurner, H; Velden, J; Klein, C; Yeung, A; Robbins, RC; Tsao, PS; Schrepfer, S				Deuse, Tobias; Hua, Xiaoqin; Wang, Dong; Maegdefessel, Lars; Heeren, Joerg; Scheja, Ludger; Bolanos, Juan P.; Rakovic, Aleksandar; Spin, Joshua M.; Stubbendorff, Mandy; Ikeno, Fumiaki; Laenger, Florian; Zeller, Tanja; Schulte-Uentrop, Leonie; Stoehr, Andrea; Itagaki, Ryo; Haddad, Francois; Eschenhagen, Thomas; Blankenberg, Stefan; Kiefmann, Rainer; Reichenspurner, Hermann; Velden, Joachim; Klein, Christine; Yeung, Alan; Robbins, Robert C.; Tsao, Philip S.; Schrepfer, Sonja			Dichloroacetate prevents restenosis in preclinical animal models of vessel injury	NATURE			English	Article							MITOCHONDRIA; APOPTOSIS; MECHANISMS; DISEASE; CELLS	Despite the introduction of antiproliferative drug-eluting stents, coronary heart disease remains the leading cause of death in the United States(1). In-stent restenosis and bypass graft failure are characterized by excessive smooth muscle cell (SMC) proliferation(2,3) and concomitant myointima formation with luminal obliteration. Here we show that during the development of myointimal hyperplasia in human arteries, SMCs show hyperpolarization of their mitochondrial membrane potential (Delta Psi m) and acquire a temporary state with a high proliferative rate and resistance to apoptosis. Pyruvate dehydrogenase kinase isoform 2 (PDK2) was identified as a key regulatory protein, and its activation proved necessary for relevant myointima formation. Pharmacologic PDK2 blockade with dichloroacetate or lentiviral PDK2 knockdown prevented Delta Psi m hyperpolarization, facilitated apoptosis and reduced myointima formation in injured human mammary and coronary arteries, rat aortas, rabbit iliac arteries and swine (pig) coronary arteries. In contrast to several commonly used antiproliferative drugs, dichloroacetate did not prevent vessel re-endothelialization. Targeting myointimal Delta Psi m and alleviating apoptosis resistance is a novel strategy for the prevention of proliferative vascular diseases.	[Deuse, Tobias; Hua, Xiaoqin; Wang, Dong; Stubbendorff, Mandy; Itagaki, Ryo; Schrepfer, Sonja] Univ Heart Ctr Hamburg, TSI Lab, D-20246 Hamburg, Germany; [Deuse, Tobias; Hua, Xiaoqin; Wang, Dong; Stubbendorff, Mandy; Zeller, Tanja; Schulte-Uentrop, Leonie; Stoehr, Andrea; Itagaki, Ryo; Eschenhagen, Thomas; Blankenberg, Stefan; Kiefmann, Rainer; Reichenspurner, Hermann; Schrepfer, Sonja] Univ Med Ctr Hamburg Eppendorf, Cardiovasc Res Ctr Hamburg CVRC, D-20246 Hamburg, Germany; [Deuse, Tobias; Hua, Xiaoqin; Wang, Dong; Stubbendorff, Mandy; Zeller, Tanja; Schulte-Uentrop, Leonie; Stoehr, Andrea; Itagaki, Ryo; Eschenhagen, Thomas; Blankenberg, Stefan; Kiefmann, Rainer; Reichenspurner, Hermann; Schrepfer, Sonja] Univ Med Ctr Hamburg Eppendorf, Partner Site Hamburg Kiel Luebeck, DZHK German Ctr Cardiovasc Res, D-20246 Hamburg, Germany; [Deuse, Tobias; Reichenspurner, Hermann; Schrepfer, Sonja] Univ Heart Ctr Hamburg, D-20246 Hamburg, Germany; [Maegdefessel, Lars] Karolinska Inst, Dept Med, Atherosclerosis Res Unit, S-17176 Stockholm, Sweden; [Heeren, Joerg; Scheja, Ludger] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, D-20246 Hamburg, Germany; [Bolanos, Juan P.] Univ Salamanca, CSIC, Inst Funct Biol & Genom, Salamanca 37007, Spain; [Rakovic, Aleksandar; Klein, Christine] Med Univ Lubeck, Inst Neurogenet, D-23562 Lubeck, Germany; [Spin, Joshua M.; Ikeno, Fumiaki; Haddad, Francois; Yeung, Alan; Tsao, Philip S.] Stanford Univ, Stanford, CA 94305 USA; [Spin, Joshua M.; Ikeno, Fumiaki; Haddad, Francois; Yeung, Alan; Robbins, Robert C.; Tsao, Philip S.; Schrepfer, Sonja] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Laenger, Florian] Hannover Med Sch, Inst Pathol, D-30625 Hannover, Germany; [Zeller, Tanja; Blankenberg, Stefan] Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, D-20246 Hamburg, Germany; [Schulte-Uentrop, Leonie; Kiefmann, Rainer] Univ Med Ctr Hamburg Eppendorf, Dept Anaesthesiol, D-20246 Hamburg, Germany; [Stoehr, Andrea; Eschenhagen, Thomas] Univ Med Ctr Hamburg Eppendorf, Inst Expt Pharmacol & Toxicol, D-20246 Hamburg, Germany; [Velden, Joachim] Univ Hosp Erlangen, Inst Pathol, Dept Nephropathol, D-91054 Erlangen, Germany; [Robbins, Robert C.; Schrepfer, Sonja] Stanford Univ, Dept Cardiothorac Surg, Stanford, CA 94305 USA; [Tsao, Philip S.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Karolinska Institutet; University of Hamburg; University Medical Center Hamburg-Eppendorf; Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca; University of Lubeck; Stanford University; Stanford University; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Erlangen Nuremberg; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Schrepfer, S (corresponding author), Univ Heart Ctr Hamburg, TSI Lab, Martinistr 52, D-20246 Hamburg, Germany.	schrepfer@stanford.edu	Klein, Christine/AGK-8003-2022; Bolaños, Juan Pedro/M-9518-2019; Maegdefessel, Lars/AAW-8243-2020; Stoehr, Andrea/F-7452-2018; Maegdefessel, Lars/C-2955-2015	Bolaños, Juan Pedro/0000-0002-3949-6862; Stoehr, Andrea/0000-0003-3573-1818; Maegdefessel, Lars/0000-0001-5228-2634; Spin, Joshua/0000-0002-4256-9161; Klein, Christine/0000-0003-2102-3431; Zeller, Tanja/0000-0003-3379-2641; IKENO, FUMIAKI/0000-0003-2905-0311; Laenger, Florian/0000-0003-1191-4855	German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) [SCHR992/3-1, SCHR992/4-1]; International Society for Heart and Lung Transplantation (ISHLT); Forderverein des Universitaren Herzzentrums Hamburg; Hermann and Lilly Schilling Foundation; MINECO [SAF2013-41177-R]; NIH [NIH 1R01HL105299]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105299] Funding Source: NIH RePORTER	German Research Foundation (Deutsche Forschungsgemeinschaft (DFG))(German Research Foundation (DFG)); International Society for Heart and Lung Transplantation (ISHLT); Forderverein des Universitaren Herzzentrums Hamburg; Hermann and Lilly Schilling Foundation; MINECO(Spanish Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank C. Pahrmann for performing all cell cultures and for her technical assistance. We thank J. Thoms for performing immunoblots, H. Wiebold for assistance in organ chamber experiments, J. Lyons and her team for her assistance with the swine study, and S. Ehret, A. Deng and M. Resch for their technical assistance. We thank the UKE Imaging Facility (UMIF, B. Zobiak) and the UKE Animal Facility. Ethicon (Norderstedt, Germany) provided surgical suture materials. We also thank A. Treszl and G. Schoen for their statistical analyses. This study was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG), SCHR992/3-1 and SCHR992/4-1 to S.S.), the International Society for Heart and Lung Transplantation (ISHLT, to S. S.), the Forderverein des Universitaren Herzzentrums Hamburg ( to S. S.), the Hermann and Lilly Schilling Foundation ( to C. K.), the MINECO (SAF2013-41177-R, to J. P. B.) and the NIH (NIH 1R01HL105299, to P.S.T.).	Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Bernal-Mizrachi C, 2005, NATURE, V435, P502, DOI 10.1038/nature03527; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Mitra AK, 2005, CAN J PHYSIOL PHARM, V83, P701, DOI 10.1139/Y05-080; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Novak K, 1998, NAT MED, V4, P989, DOI 10.1038/1965; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073	16	64	67	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					641	+		10.1038/nature13232	http://dx.doi.org/10.1038/nature13232			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24747400	Green Published, Green Accepted			2022-12-28	WOS:000336457100053
J	Kowdley, KV; Gordon, SC; Reddy, KR; Rossaro, L; Bernstein, DE; Lawitz, E; Shiffman, ML; Schiff, E; Ghalib, R; Ryan, M; Rustgi, V; Chojkier, M; Herring, R; Di Bisceglie, AM; Pockros, PJ; Subramanian, GM; An, D; Svarovskaia, E; Hyland, RH; Pang, PS; Symonds, WT; McHutchison, JG; Muir, AJ; Pound, D; Fried, MW				Kowdley, Kris V.; Gordon, Stuart C.; Reddy, K. Rajender; Rossaro, Lorenzo; Bernstein, David E.; Lawitz, Eric; Shiffman, Mitchell L.; Schiff, Eugene; Ghalib, Reem; Ryan, Michael; Rustgi, Vinod; Chojkier, Mario; Herring, Robert; Di Bisceglie, Adrian M.; Pockros, Paul J.; Subramanian, G. Mani; An, Di; Svarovskaia, Evguenia; Hyland, Robert H.; Pang, Phillip S.; Symonds, William T.; McHutchison, John G.; Muir, Andrew J.; Pound, David; Fried, Michael W.		ION-3 Investigators	Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC HEPATITIS-C; NS5A INHIBITOR	BACKGROUND High rates of sustained virologic response were observed among patients with hepatitis C virus (HCV) infection who received 12 weeks of treatment with the nucleotide polymerase inhibitor sofosbuvir combined with the NS5A inhibitor ledipasvir. This study examined 8 weeks of treatment with this regimen. METHODS In this phase 3, open-label study, we randomly assigned 647 previously untreated patients with HCV genotype 1 infection without cirrhosis to receive ledipasvir and sofosbuvir (ledipasvir-sofosbuvir) for 8 weeks, ledipasvir-sofosbuvir plus ribavirin for 8 weeks, or ledipasvir-sofosbuvir for 12 weeks. The primary end point was sustained virologic response at 12 weeks after the end of therapy. RESULTS The rate of sustained virologic response was 94% (95% confidence interval [CI], 90 to 97) with 8 weeks of ledipasvir-sofosbuvir, 93% (95% CI, 89 to 96) with 8 weeks of ledipasvir-sofosbuvir plus ribavirin, and 95% (95% CI, 92 to 98) with 12 weeks of ledipasvir-sofosbuvir. As compared with the rate of sustained virologic response in the group that received 8 weeks of ledipasvir-sofosbuvir, the rate in the 12-week group was 1 percentage point higher (97.5% CI, -4 to 6) and the rate in the group that received 8 weeks of ledipasvir-sofosbuvir with ribavirin was 1 percentage point lower (95% CI, -6 to 4); these results indicated noninferiority of the 8-week ledipasvir-sofosbuvir regimen, on the basis of a noninferiority margin of 12 percentage points. Adverse events were more common in the group that received ribavirin than in the other two groups. No patient who received 8 weeks of only ledipasvir-sofosbuvir discontinued treatment owing to adverse events. CONCLUSIONS Ledipasvir-sofosbuvir for 8 weeks was associated with a high rate of sustained virologic response among previously untreated patients with HCV genotype 1 infection without cirrhosis. No additional benefit was associated with the inclusion of ribavirin in the regimen or with extension of the duration of treatment to 12 weeks.	[Kowdley, Kris V.] Virginia Mason Med Ctr, Inst Digest Dis, Seattle, WA 98101 USA; [Gordon, Stuart C.] Henry Ford Hlth Syst, Detroit, MI USA; [Reddy, K. Rajender] Univ Penn, Philadelphia, PA 19104 USA; [Rossaro, Lorenzo] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA; [Chojkier, Mario] Univ Calif San Diego, Med Ctr, San Diego, CA 92103 USA; [Pockros, Paul J.] Scripps Clin, La Jolla, CA 92037 USA; [Subramanian, G. Mani; An, Di; Svarovskaia, Evguenia; Hyland, Robert H.; Pang, Phillip S.; Symonds, William T.; McHutchison, John G.] Gilead Sci, Foster City, CA USA; [Bernstein, David E.] Hofstra North Shore Long Isl Jewish Sch Med, Manhasset, NY USA; [Lawitz, Eric] Texas Liver Inst, San Antonio, TX USA; [Lawitz, Eric] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Ghalib, Reem] Texas Clin Res Inst, Arlington, TX USA; [Shiffman, Mitchell L.] Bon Secours Hlth Syst, Liver Inst Virginia, Richmond, VA USA; [Shiffman, Mitchell L.] Bon Secours Hlth Syst, Liver Inst Virginia, Newport News, VA USA; [Ryan, Michael] Digest & Liver Dis Specialists, Norfolk, VA USA; [Rustgi, Vinod] Metropolitan Liver Dis, Fairfax, VA USA; [Schiff, Eugene] Univ Miami, Sch Med, Ctr Liver Dis, Miami, FL USA; [Herring, Robert] Qual Med Res, Nashville, TN USA; [Di Bisceglie, Adrian M.] St Louis Univ, St Louis, MO 63103 USA; [Muir, Andrew J.] Duke Univ, Med Ctr, Durham, NC USA; [Fried, Michael W.] Univ N Carolina, Chapel Hill, NC USA; [Pound, David] Indianapolis Gastroenterol Res Fdn, Indianapolis, IN USA	Virginia Mason Medical Center; Henry Ford Health System; Henry Ford Hospital; University of Pennsylvania; University of California System; University of California Davis; University of California System; University of California San Diego; Scripps Research Institute; Gilead Sciences; Hofstra University; University of Texas System; University of Texas Health San Antonio; University of Miami; Saint Louis University; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Kowdley, KV (corresponding author), Virginia Mason Med Ctr, Inst Digest Dis, 1100 Ninth Ave, Seattle, WA 98101 USA.	kris.kowdley@vmmc.org	Kowdley, Kris/AAF-5202-2019		Gilead Sciences; Boehringer Ingelheim; Ikaria Pharmaceuticals; Janssen; Merck; Vertex Pharmaceuticals; Trio Health; Pharmasset; Tekmira Pharmaceuticals; Novartis; Beckman Coulter; Bristol-Myers Squibb; Intercept Pharmaceuticals; Mochida; Conatus Pharmaceuticals; Genentech; GlaxoSmithKline; Janssen-Cilag; AbbVie; Amgen; CVS Caremark; ViralEd; Genfit; Hyperion Therapeutics; Achillion Pharmaceuticals; Salix Pharmaceuticals; Bayer; Gen-Probe; Lumena Pharmaceuticals; Idenix Pharmaceuticals; Idera Pharmaceuticals; Takeda Pharmaceuticals; ViroChem Pharma; Inhibitex; ZymoGenetics; Biolex Therapeutics; Anadys Pharmaceuticals; GlobeImmune; Transgene; Roche	Gilead Sciences(Gilead Sciences); Boehringer Ingelheim(Boehringer Ingelheim); Ikaria Pharmaceuticals; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Vertex Pharmaceuticals(Vertex Pharmaceuticals); Trio Health; Pharmasset; Tekmira Pharmaceuticals; Novartis(Novartis); Beckman Coulter; Bristol-Myers Squibb(Bristol-Myers Squibb); Intercept Pharmaceuticals; Mochida; Conatus Pharmaceuticals; Genentech(Roche HoldingGenentech); GlaxoSmithKline(GlaxoSmithKline); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); AbbVie(AbbVie); Amgen(Amgen); CVS Caremark; ViralEd; Genfit; Hyperion Therapeutics; Achillion Pharmaceuticals; Salix Pharmaceuticals; Bayer(Bayer AG); Gen-Probe; Lumena Pharmaceuticals; Idenix Pharmaceuticals; Idera Pharmaceuticals; Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); ViroChem Pharma(Dexcel Pharma); Inhibitex; ZymoGenetics; Biolex Therapeutics; Anadys Pharmaceuticals; GlobeImmune; Transgene(Transgene SA); Roche(Roche Holding)	Supported by Gilead Sciences.; Dr. Kowdley reports receiving fees for serving on advisory boards through his institution from Boehringer Ingelheim, Gilead Sciences, Ikaria Pharmaceuticals, Janssen, Merck, Vertex Pharmaceuticals, Trio Health, Pharmasset, and Tekmira Pharmaceuticals, consulting fees through his institution from Novartis, and grant support through his institution from Beckman Coulter, Bristol-Myers Squibb, Boehringer Ingelheim, Gilead Sciences, Ikaria Pharmaceuticals, Intercept Pharmaceuticals, Janssen, Merck, Mochida, Vertex Pharmaceuticals, Pharmasset, Conatus Pharmaceuticals, Genentech, and GlaxoSmithKline. Dr. Gordon reports receiving fees for serving on a data monitoring board from Janssen-Cilag, consulting fees from AbbVie, Bristol-Myers Squibb, Amgen, CVS Caremark, Merck, Novartis, and Vertex Pharmaceuticals, and grant support through his institution from AbbVie, Bristol-Myers Squibb, Merck, Vertex Pharmaceuticals, GlaxoSmithKline, and Intercept Pharmaceuticals. Dr. Reddy reports receiving fees for serving on advisory boards from Idenix Pharmaceuticals and Novartis, fees for serving on advisory boards through his institution from Bristol-Myers Squibb, Merck, Vertex Pharmaceuticals, Janssen, Genentech, and AbbVie, fees for the preparation of education material and participation in continuing medical education meetings from ViralEd, and grant support through his institution from Bristol-Myers Squibb, Merck, Vertex Pharmaceuticals, Janssen, Genentech, AbbVie, Genfit, Ikaria Pharmaceuticals, and Hyperion Therapeutics. Dr. Rossaro reports receiving fees for serving on advisory boards from Gilead Sciences, Vertex Pharmaceuticals, Merck, Janssen, Genentech, Novartis, and AbbVie, lecture fees from Gilead Sciences, Vertex Pharmaceuticals, Merck, Janssen, and Genentech, and grant support from Gilead Sciences, Vertex Pharmaceuticals, Merck, Genentech, Bristol-Myers Squibb, Novartis, and AbbVie. Dr. Bernstein reports receiving personal fees from Gilead Sciences, AbbVie, Vertex Pharmaceuticals, and Merck, and grant support from Gilead Sciences, AbbVie, Janssen, Vertex Pharmaceuticals, Merck, and Bristol-Myers Squibb. Dr. Lawitz reports receiving personal fees and grant support from Gilead Sciences. Dr. Shiffman reports receiving fees for serving on advisory boards from AbbVie, Achillion Pharmaceuticals, Bristol-Myers Squibb, Boehringer Ingelheim, GlaxoSmithKline, Janssen, Merck, and Salix Pharmaceuticals, lecture fees from Bayer, GlaxoSmithKline, Janssen, Genentech, Salix Pharmaceuticals, and Vertex Pharmaceuticals, and grant support from AbbVie, Achillion Pharmaceuticals, Beckman Coulter, Bristol-Myers Squibb, Boehringer Ingelheim, Gen-Probe, Intercept Pharmaceuticals, Lumena Pharmaceuticals, and Novartis. Dr. Schiff reports receiving fees for serving on an advisory board and grant support from Gilead Sciences. Dr. Ghalib reports receiving grant support from Gilead Sciences, Pharmasset, Bristol-Myers Squibb, Idenix Pharmaceuticals, Idera Pharmaceuticals, Merck, Novartis, Boehringer Ingelheim, Salix Pharmaceuticals, Takeda Pharmaceuticals, Janssen, Vertex Pharmaceuticals, ViroChem Pharma, Achillion Pharmaceuticals, Inhibitex, ZymoGenetics, Biolex Therapeutics, and Anadys Pharmaceuticals. Dr. Rustgi reports receiving fees for serving on advisory boards from AbbVie and Merck, lecture fees from Janssen and Genentech, and grant support from AbbVie, Vertex Pharmaceuticals, and Bristol-Myers Squibb. Dr.; Di Bisceglie reports receiving personal fees from Genentech, Gilead Sciences, Vertex Pharmaceuticals, AbbVie, Bayer, Salix Pharmaceuticals, and Janssen, and grant support from Genentech, Gilead Sciences, Idenix Pharmaceuticals, Vertex Pharmaceuticals, Bristol-Myers Squibb, AbbVie, GlobeImmune, Transgene, Salix Pharmaceuticals, and Janssen. Dr. Pockros reports receiving fees for serving on an advisory board, lecture fees, and grant support from Gilead Sciences. Drs. Subramanian, An, Svarovskaia, Hyland, Pang, Symonds, and McHutchison report being employees of and owning stock in Gilead Sciences. Dr. Muir reports receiving personal fees from AbbVie, Achillion Pharmaceuticals, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck, and Vertex Pharmaceuticals, and grant support from AbbVie, Achillion Pharmaceuticals, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck, Roche, and Vertex Pharmaceuticals. Dr. Fried reports receiving personal fees and grant support from Gilead Sciences, AbbVie, Bristol-Myers Squibb, Janssen, Merck, Vertex Pharmaceuticals, and Genentech. No other potential conflict of interest relevant to this article was reported.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; [Anonymous], 2013, SCREEN HEP C VIR INF; [Anonymous], 2003, REB RIB CAPS US PRES; Aronsohn A, 2014, HEPATOLOGY, V59, P13, DOI 10.1002/hep.26590; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Gane EJ, 2014, GASTROENTEROLOGY, V146, P736, DOI 10.1053/j.gastro.2013.11.007; Holmberg SD, 2013, NEW ENGL J MED, V368, P1859, DOI 10.1056/NEJMp1302973; Institute of Medicine, 2010, HEP LIV CANC NAT STR; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kohli A, 2013, 64 ANN M AM ASS STUD; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Lawitz EJ, 2012, J HEPATOL, V57, P24, DOI 10.1016/j.jhep.2011.12.029; Mayne Pharma, 2021, NEXTST EST DROSP TAB; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Rein DB, 2011, DIGEST LIVER DIS, V43, P66, DOI 10.1016/j.dld.2010.05.006; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1	17	925	955	1	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2014	370	20					1879	1888		10.1056/NEJMoa1402355	http://dx.doi.org/10.1056/NEJMoa1402355			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UH	24720702				2022-12-28	WOS:000336123600004
J	O'Leary, T; Marder, E				O'Leary, Timothy; Marder, Eve			Mapping Neural Activation onto Behavior in an Entire Animal	SCIENCE			English	Editorial Material									[O'Leary, Timothy] Brandeis Univ, Volen Ctr, Waltham, MA 02453 USA; Brandeis Univ, Dept Biol, Waltham, MA 02453 USA	Brandeis University; Brandeis University	O'Leary, T (corresponding author), Brandeis Univ, Volen Ctr, Waltham, MA 02453 USA.	marder@brandeis.edu		O'Leary, Timothy/0000-0002-1029-0158				Bargmann CI, 2013, NAT METHODS, V10, P483, DOI 10.1038/NMETH.2451; Fiala A, 2010, CURR BIOL, V20, pR897, DOI 10.1016/j.cub.2010.08.053; KUPFERMANN I, 1978, BEHAV BRAIN SCI, V1, P3, DOI 10.1017/S0140525X00059057; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Vogelstein JT, 2014, SCIENCE, V344, P386, DOI 10.1126/science.1250298; WIERSMA CAG, 1964, COMP BIOCHEM PHYSIOL, V12, P509, DOI 10.1016/0010-406X(64)90153-7	7	12	12	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					372	373		10.1126/science.1253853	http://dx.doi.org/10.1126/science.1253853			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763581				2022-12-28	WOS:000334867800029
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Care. data doesn't care enough about consent	BMJ-BRITISH MEDICAL JOURNAL			English	Letter												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Cooper C, 2014, INDEPENDENT; NHS, NHS BREAST SCREEN HE; NHS England, 2014, NHS UK ACTS RESP CON; NHS Information Centre awards Atos contract for new General Practice Extraction Service, 2011, ATOS 2011; Ramesh R., 2014, GUARDIAN 2014; Thompson SG, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2307; Vallance C., 2014, BBC NEWS; [No title captured]	8	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2014	348								g2831	10.1136/bmj.g2831	http://dx.doi.org/10.1136/bmj.g2831			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG1DB	24755982				2022-12-28	WOS:000335154200012
J	Jacob, KS; Patel, V				Jacob, K. S.; Patel, Vikram			Classification of mental disorders: a global mental health perspective	LANCET			English	Editorial Material							PRIMARY-CARE; DEPRESSION; RECOGNITION; MANAGEMENT; ANXIETY		[Jacob, K. S.] Christian Med Coll & Hosp, Vellore 632002, Tamil Nadu, India; [Patel, Vikram] London Sch Hyg & Trop Med, Ctr Global Mental Hlth, London WC1E 7HT, England; [Patel, Vikram] Publ Hlth Fdn India, Ctr Mental Hlth, New Delhi, India	Christian Medical College & Hospital (CMCH) Vellore; University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India	Patel, V (corresponding author), London Sch Hyg & Trop Med, Ctr Global Mental Hlth, Keppel St, London WC1E 7HT, England.	vikram.patel@lshtm.ac.uk		Patel, Vikram/0000-0003-1066-8584				American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Croudace T, 2003, BRIT J PSYCHIAT, V182, P20, DOI 10.1192/bjp.182.1.20; Das-Munshi J, 2008, BRIT J PSYCHIAT, V192, P171, DOI 10.1192/bjp.bp.107.036707; Goldberg DJ, 2011, J COSMET LASER THER, V13, P1, DOI 10.3109/14764172.2011.557620; Heath I, 1999, BRIT MED J, V318, P439; Jacob KS, 2010, CRITICAL MED PRACTIC, P311; Jacob KS, 2010, DIAGNOSTIC ISSUES DE, P191; Kauye F, 2013, PSYCHOL MED, V31, P1; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Kuruvilla A, 2012, NATL MED J INDIA, V25, P332; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Medicine PLoS, 2013, PLOS MED, V10; Patel V, 1996, LANCET, V347, P742, DOI 10.1016/S0140-6736(96)90083-5; Patel V, 2011, BEHAV RES THER, V49, P523, DOI 10.1016/j.brat.2011.06.012; PAYKEL ES, 1992, BRIT MED J, V305, P1198, DOI 10.1136/bmj.305.6863.1198; WHO, 2008, MENT HLTH GAP ACT PR; World Health Organization, 1996, INT CLASS DIS 10 DIA; World Organization of Family Doctors Wonca, INT CLASS PRIM CAR	19	61	64	1	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2014	383	9926					1433	1435		10.1016/S0140-6736(13)62382-X	http://dx.doi.org/10.1016/S0140-6736(13)62382-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG3LI	24759250				2022-12-28	WOS:000335318400029
J	Rowland, K				Rowland, Kate			Review: Nicotine replacement therapy increases CVD events; bupropion and varenicline do not	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							METAANALYSIS; RISK		Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Rowland, K (corresponding author), Univ Chicago, Chicago, IL 60637 USA.		Rowland, Kate/Q-6256-2019	Rowland, Kate/0000-0002-1383-0279				Moore D, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1024; Prochaska JJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2856; Singh S, 2011, CAN MED ASSOC J, V183, P1359, DOI 10.1503/cmaj.110218	3	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2014	160	8							JC2	10.7326/0003-4819-160-8-201404150-02002	http://dx.doi.org/10.7326/0003-4819-160-8-201404150-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW3QU	24733219				2022-12-28	WOS:000364907600001
J	Harrison, DM				Harrison, Daniel M.			Multiple Sclerosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PLACEBO-CONTROLLED TRIAL; AMERICAN ACADEMY; GLATIRAMER ACETATE; INTERFERON BETA-1B; NATURAL-HISTORY; PLASMA-EXCHANGE; RISK; BRAIN; CORTICOSTEROIDS; SUBCOMMITTEE						Harrison, Daniel M/AAG-4218-2021	Harrison, Daniel M/0000-0001-8707-2004				BECK RW, 1992, NEW ENGL J MED, V326, P581, DOI 10.1056/NEJM199202273260901; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bloomgren G, 2012, NEW ENGL J MED, V366, P1870, DOI 10.1056/NEJMoa1107829; Comi G, 2009, LANCET, V374, P1503, DOI 10.1016/S0140-6736(09)61259-9; Comi G, 2013, MULT SCLER J, V19, P1074, DOI 10.1177/1352458512469695; Correale J, 2010, J IMMUNOL, V185, P4948, DOI 10.4049/jimmunol.1000588; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Farez MF, 2011, J NEUROL, V258, P1197, DOI 10.1007/s00415-011-5984-2; Flechter S, 2002, J NEUROL SCI, V197, P51, DOI 10.1016/S0022-510X(02)00047-3; Garcia-Martin E, 2012, OPHTHALMOLOGY, V119, P1705, DOI 10.1016/j.ophtha.2012.01.046; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Greenberg BM, 2007, NEUROLOGY, V68, P1614, DOI 10.1212/01.wnl.0000260970.63493.c8; Gronseth GS, 2000, NEUROLOGY, V54, P1720, DOI 10.1212/WNL.54.9.1720; Hauser SL, 2012, ANN NEUROL, V71, pA5, DOI 10.1002/ana.23608; Islam T, 2006, ANN NEUROL, V60, P56, DOI 10.1002/ana.20871; Jacobs L D, 1995, Mult Scler, V1, P118; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kappos L, 2009, LANCET NEUROL, V8, P987, DOI 10.1016/S1474-4422(09)70237-6; Kremenchutzky M, 2006, BRAIN, V129, P584, DOI 10.1093/brain/awh721; Langer-Gould AM, 2013, NEUROLOGY, V81, P1004, DOI 10.1212/WNL.0b013e31828aab14; Lassmann H, 2011, BRAIN, V134, P2772, DOI 10.1093/brain/awr197; Lee P, 2013, J CLIN VIROL, V57, P141, DOI 10.1016/j.jcv.2013.02.002; Lublin FD, 2013, ANN NEUROL, V73, P327, DOI 10.1002/ana.23863; Marriott JJ, 2010, NEUROLOGY, V74, P1463, DOI 10.1212/WNL.0b013e3181dc1ae0; Morrow SA, 2004, NEUROLOGY, V63, P1079, DOI 10.1212/01.WNL.0000138572.82125.F5; Mowry EM, 2012, ANN NEUROL, V72, P234, DOI 10.1002/ana.23591; Niedziela N, 2013, INT J NEUROSCI; Noyes K, 2011, NEUROLOGY, V77, P355, DOI 10.1212/WNL.0b013e3182270402; O'Connor P, 2011, NEW ENGL J MED, V365, P1293, DOI 10.1056/NEJMoa1014656; O'Riordan JI, 1998, BRAIN, V121, P495, DOI 10.1093/brain/121.3.495; Parisi V, 1999, INVEST OPHTH VIS SCI, V40, P2520; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; RAMOTELLO C, 2013, MULT SCLER; Rocca MA, 2013, J NEUROL, V260, P929, DOI 10.1007/s00415-012-6788-8; Runia TF, 2012, NEUROLOGY, V79, P261, DOI 10.1212/WNL.0b013e31825fdec7; Rutschmann OT, 2002, NEUROLOGY, V59, P1837, DOI 10.1212/WNL.59.12.1837; SIMPSON S, 2010, ANN NEUROL, V193, P68; Simsarian JP, 2011, DRUG DES DEV THER, V5, P381, DOI 10.2147/DDDT.S19331; Soilu-Hanninen M, 2012, J NEUROL NEUROSUR PS, V83, P566, DOI 10.1136/jnnp-2011-301876; Stangel M, 2013, NAT REV NEUROL, V9, P267, DOI 10.1038/nrneurol.2013.41; Trebst C, 2009, BLOOD PURIFICAT, V28, P108, DOI 10.1159/000224630; van der Mei IAF, 2003, BRIT MED J, V327, P316, DOI 10.1136/bmj.327.7410.316; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133	45	9	9	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	2014	160	7							ITC4	10.7326/0003-4819-160-7-201404010-01004	http://dx.doi.org/10.7326/0003-4819-160-7-201404010-01004			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6IL	24763702				2022-12-28	WOS:000334093800020
J	Raju, TNK				Raju, Tonse N. K.			Delayed cord clamping: does gravity matter?	LANCET			English	Editorial Material							MIDWIVES; BIRTH		Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Raju, TNK (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA.	rajut@mail.nih.gov						Bhatt S, 2013, J PHYSIOL-LONDON, V591, P2113, DOI 10.1113/jphysiol.2012.250084; Bolisetty S, 2014, PEDIATRICS, V133, P55, DOI 10.1542/peds.2013-0372; Farrar D, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-23; GUNTHER M, 1957, LANCET, V1, P1277, DOI 10.1016/S0140-6736(57)92302-4; Hutchon DJR, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5447; McAdams RM, 2014, OBSTET GYNECOL, V123, P549, DOI 10.1097/AOG.0000000000000122; McDonald Susan J, 2013, Cochrane Database Syst Rev, pCD004074, DOI 10.1002/14651858.CD004074.pub3; Rabe H, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003248.pub4, 10.1002/14651858.CD003248.pub3]; Raju TNK, 2013, CURR OPIN PEDIATR, V25, P180, DOI 10.1097/MOP.0b013e32835d2a9e; Vain NE, 2014, LANCET; World Health Organization,, 2012, GUID BAS NEWB RES	11	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2014	384	9939					213	214		10.1016/S0140-6736(14)60411-6	http://dx.doi.org/10.1016/S0140-6736(14)60411-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL8JI	24746756				2022-12-28	WOS:000339384100006
J	Geva, T; Martins, JD; Wald, RM				Geva, Tal; Martins, Jose D.; Wald, Rachel M.			Atrial septal defects	LANCET			English	Article							PATENT FORAMEN OVALE; CONGENITAL HEART-DISEASE; RIGHT-VENTRICULAR VOLUME; ATRIOVENTRICULAR-CONDUCTION DISTURBANCE; SINUS VENOSUS DEFECTS; TRANSCATHETER CLOSURE; DEVICE CLOSURE; PERCUTANEOUS CLOSURE; MAGNETIC-RESONANCE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY	Atrial septal defects are the third most common type of congenital heart disease. Included in this group of malformations are several types of atrial communications that allow shunting of blood between the systemic and the pulmonary circulations. Most children with isolated atrial septal defects are free of symptoms, but the rates of exercise intolerance, atrial tachyarrhythmias, right ventricular dysfunction, and pulmonary hypertension increase with advancing age and life expectancy is reduced in adults with untreated defects. The risk of development of pulmonary vascular disease, a potentially lethal complication, is higher in female patients and in older adults with untreated defects. Surgical closure is safe and effective and when done before age 25 years is associated with normal life expectancy. Transcatheter closure offers a less invasive alternative for patients with a secundum defect who fulfil anatomical and size criteria. In this Seminar we review the causes, anatomy, pathophysiology, treatment, and outcomes of atrial septal defects in children and adult patients in whom this defect is the primary cardiac anomaly.	[Geva, Tal] Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Geva, Tal] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Martins, Jose D.] Ctr Hosp Lisboa Cent, Hosp Santa Marta, Dept Pediat Cardiol, Lisbon, Portugal; [Wald, Rachel M.] Univ Toronto, Toronto Congenital Cardiac Ctr Adults, Peter Munk Cardiac Ctr, Toronto, ON, Canada	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; University of Toronto; Peter Munk Cardiac Centre; Toronto Congenital Cardiac Centre for Adults	Geva, T (corresponding author), Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA.	tal.geva@cardio.chboston.org	Martins, Jose/AAC-3826-2020	Martins, Jose/0000-0002-0163-3139				Abaci A, 2013, CATHETER CARDIO INTE, V82, P1123, DOI 10.1002/ccd.24875; Alverson CJ, 2011, PEDIATRICS, V127, pE647, DOI 10.1542/peds.2010-1399; Amin Z, 2004, CATHETER CARDIO INTE, V63, P496, DOI 10.1002/ccd.20211; Anderson RH, 2002, HEART, V88, P104, DOI 10.1136/heart.88.1.104; Andrews R, 2002, PEDIATR CARDIOL, V23, P528, DOI 10.1007/PL00021008; Attie F, 2001, J AM COLL CARDIOL, V38, P2035, DOI 10.1016/S0735-1097(01)01635-7; Aynaci FM, 1997, GENET COUNSEL, V8, P145; Bakker MK, 2010, BIRTH DEFECTS RES A, V88, P94, DOI 10.1002/bdra.20641; Balint OH, 2008, HEART, V94, P1189, DOI 10.1136/hrt.2006.114660; Balzer J, 2010, EUR J ECHOCARDIOGR, V11, P1, DOI 10.1093/ejechocard/jep116; Banka P, 2011, J THORAC CARDIOV SUR, V142, P517, DOI 10.1016/j.jtcvs.2011.01.031; Baumgartner H, 2010, EUR HEART J, V31, P2915, DOI 10.1093/eurheartj/ehq249; Bedard E, 2009, EUR HEART J, V30, P256, DOI 10.1093/eurheartj/ehn597; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Berger F, 1999, ANN THORAC SURG, V68, P75, DOI 10.1016/S0003-4975(99)00478-6; Bjornstad PG, 2009, CARDIOL YOUNG, V19, P40, DOI 10.1017/S1047951108003387; Blom NA, 2001, AM J CARDIOL, V87, P305, DOI 10.1016/S0002-9149(00)01363-1; Botto LD, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e32; Burd Larry, 2007, Congenit Heart Dis, V2, P250, DOI 10.1111/j.1747-0803.2007.00105.x; Butera G, 2006, AM HEART J, V151, P228, DOI 10.1016/j.ahj.2005.02.051; CAMPBELL M, 1970, BRIT HEART J, V32, P820; Caputo S, 2005, EUR HEART J, V26, P2179, DOI 10.1093/eurheartj/ehi378; Chen Y, 2010, J THORAC CARDIOV SUR, V140, P684, DOI 10.1016/j.jtcvs.2010.01.013; CHIN AJ, 1992, AM HEART J, V124, P1655, DOI 10.1016/0002-8703(92)90098-G; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; Connuck D, 2002, AM J CARDIOL, V89, P244, DOI 10.1016/S0002-9149(01)02214-7; Correa A, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.028; Cottens D, 2011, ACTA CARDIOL, V66, P309, DOI 10.1080/AC.66.3.2114130; Cunningham ET, 1998, ARCH OPHTHALMOL-CHIC, V116, P78, DOI 10.1001/archopht.116.1.78; D'Amato E, 2010, DIABETIC MED, V27, P1195, DOI 10.1111/j.1464-5491.2010.03046.x; DALGLEISH AE, 1976, J MORPHOL, V149, P369, DOI 10.1002/jmor.1051490306; Di Salvo G, 2005, J AM SOC ECHOCARDIOG, V18, P930, DOI 10.1016/j.echo.2005.01.029; Diegeler A, 1997, EUR J CARDIO-THORAC, V12, P501, DOI 10.1016/S1010-7940(97)00183-8; Diller GP, 2005, CIRCULATION, V112, P828, DOI 10.1161/CIRCULATIONAHA.104.529800; Divekar A, 2005, J AM COLL CARDIOL, V45, P1213, DOI 10.1016/j.jacc.2004.12.072; Drenthen W, 2007, J AM COLL CARDIOL, V49, P2303, DOI 10.1016/j.jacc.2007.03.027; Du ZD, 2001, AM J CARDIOL, V88, P1450, DOI 10.1016/S0002-9149(01)02135-X; Elliott DA, 2003, J AM COLL CARDIOL, V41, P2072, DOI 10.1016/S0735-1097(03)00420-0; Engelfriet P, 2008, INT J CARDIOL, V126, P379, DOI 10.1016/j.ijcard.2007.04.044; Everett AD, 2009, PEDIATR CARDIOL, V30, P240, DOI 10.1007/s00246-008-9325-x; FISHER DC, 1995, CHEST, V107, P1504, DOI 10.1378/chest.107.6.1504; Freeman SB, 2008, GENET MED, V10, P173, DOI 10.1097/GIM.0b013e3181634867; Fuse S, 2001, AM J CARDIOL, V88, P1447, DOI 10.1016/S0002-9149(01)02134-8; Gaithersburg H., 2012, FDA EXECUTIVE SUMMAR; Ganie MA, 2010, J PEDIATR ENDOCR MET, V23, P1087, DOI 10.1515/jpem.2010.172; Gatzoulis MA, 1999, NEW ENGL J MED, V340, P839, DOI 10.1056/NEJM199903183401103; Gelemter-Yaniv L, 2007, ACTA PAEDIATR, V96, P726, DOI 10.1111/j.1651-2227.2007.00240.x; Geva T, 2009, ECHOCARDIOGRAPHY PED, P158; Giardini A, 2004, J AM COLL CARDIOL, V43, P1886, DOI 10.1016/j.jacc.2003.10.067; Goetschmann S, 2008, AM J CARDIOL, V102, P340, DOI 10.1016/j.amjcard.2008.03.061; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; Hanninen M, 2011, CAN J CARDIOL, V27, P698, DOI 10.1016/j.cjca.2011.04.003; Hanslik A, 2006, PEDIATRICS, V118, P1560, DOI 10.1542/peds.2005-3037; Helgason H, 1999, PEDIATR CARDIOL, V20, P195, DOI 10.1007/s002469900439; Hirayama-Yamada K, 2005, AM J MED GENET A, V135A, P47, DOI 10.1002/ajmg.a.30684; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; HOLT M, 1960, BRIT HEART J, V22, P236; Hosoda T, 1999, JPN CIRC J, V63, P425, DOI 10.1253/jcj.63.425; Humenberger M, 2011, EUR HEART J, V32, P553, DOI 10.1093/eurheartj/ehq352; Ikeda Y, 2002, CIRC J, V66, P561, DOI 10.1253/circj.66.561; Jones TK, 2007, J AM COLL CARDIOL, V49, P2215, DOI 10.1016/j.jacc.2006.11.053; Jost CHA, 2005, CIRCULATION, V112, P1953, DOI 10.1161/CIRCULATIONAHA.104.493775; Khan AA, 2010, JACC-CARDIOVASC INTE, V3, P276, DOI 10.1016/j.jcin.2009.12.011; KHOURY GH, 1967, J PEDIATR-US, V70, P432, DOI 10.1016/S0022-3476(67)80143-4; Kim YH, 2010, ANN THORAC SURG, V89, P1629, DOI 10.1016/j.athoracsur.2009.10.027; KING TD, 1976, JAMA-J AM MED ASSOC, V235, P2506, DOI 10.1001/jama.235.23.2506; Kleinman CS, 2005, PEDIATR CARDIOL, V26, P128, DOI 10.1007/s00246-004-0957-1; KONSTANTINIDES S, 1995, NEW ENGL J MED, V333, P469, DOI 10.1056/NEJM199508243330801; Kutty S, 2012, AM J CARDIOL, V109, P1348, DOI 10.1016/j.amjcard.2011.12.031; Lammers A, 2005, J THORAC CARDIOV SUR, V129, P1353, DOI 10.1016/j.jtcvs.2004.10.007; Lee LJ, 2013, PEDIATR CARDIOL, V34, P398, DOI 10.1007/s00246-012-0470-x; Lee SA, 2007, J GENET, V86, P241, DOI 10.1007/s12041-007-0031-x; Lee YS, 2009, PEDIATR PULM, V44, P1025, DOI 10.1002/ppul.21100; LEWIS FJ, 1953, SURGERY, V33, P52; Lindsey JB, 2007, LANCET, V369, P1244, DOI 10.1016/S0140-6736(07)60576-5; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; Maitra M, 2009, DEV BIOL, V326, P368, DOI 10.1016/j.ydbio.2008.11.004; Majunke N, 2009, AM J CARDIOL, V103, P550, DOI 10.1016/j.amjcard.2008.10.018; Masutani S, 2012, HEART VESSELS, V27, P71, DOI 10.1007/s00380-011-0122-8; Masutani S, 2011, J CARD FAIL, V17, P957, DOI 10.1016/j.cardfail.2011.07.003; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; McElhinney DB, 2003, J AM COLL CARDIOL, V42, P1650, DOI 10.1016/j.jacc.2003.05.004; McMahon CJ, 2002, HEART, V87, P256, DOI 10.1136/heart.87.3.256; Meier B, 2005, CATHETER CARDIO INTE, V66, P397, DOI 10.1002/ccd.20509; Miller A, 2011, AM J MED GENET A, V155A, P2137, DOI 10.1002/ajmg.a.34130; Mommersteeg MTM, 2006, CIRC RES, V99, P351, DOI 10.1161/01.RES.0000238360.33284.a0; Monfredi O, 2013, INT J CARDIOL, V167, P1578, DOI 10.1016/j.ijcard.2012.04.081; MURPHY JG, 1990, NEW ENGL J MED, V323, P1645, DOI 10.1056/NEJM199012133232401; MURRAY G, 1948, ANN SURG, V128, P843, DOI 10.1097/00000658-194810000-00016; Nakagawa K, 2012, CATHETER CARDIO INTE, V80, P84, DOI 10.1002/ccd.23457; Nouira S, 2008, ARCH MED RES, V39, P429, DOI 10.1016/j.arcmed.2008.01.002; Nyboe C, 2013, EUR J CARDIO-THORAC, V43, P752, DOI 10.1093/ejcts/ezs405; Okubo A, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.018895; Opotowsky AR, 2008, JAMA-J AM MED ASSOC, V299, P521, DOI 10.1001/jama.299.5.521; Opotowsky AR, 2009, AM HEART J, V157, P867, DOI 10.1016/j.ahj.2009.02.019; Parker SE, 2012, AM J EPIDEMIOL, V176, P1110, DOI 10.1093/aje/kws201; Polen KND, 2013, BIRTH DEFECTS RES A, V97, P28, DOI 10.1002/bdra.23096; Powell AJ, 2003, AM J CARDIOL, V91, P1523, DOI 10.1016/S0002-9149(03)00417-X; RAGHIB G, 1965, CIRCULATION, V31, P906, DOI 10.1161/01.CIR.31.6.906; Reefhuis J, 2009, HUM REPROD, V24, P360, DOI 10.1093/humrep/den387; Rhee EK, 2000, AM J CARDIOL, V85, P1472, DOI 10.1016/S0002-9149(00)00797-9; Rhodes J, 2002, AM J CARDIOL, V90, P803, DOI 10.1016/S0002-9149(02)02620-6; Rifai L, 2007, CARDIOL YOUNG, V17, P107, DOI 10.1017/S1047951106001338; Rosenzweig BP, 2001, J AM SOC ECHOCARDIOG, V14, P155, DOI 10.1067/mje.2001.108249; Sachweh JS, 2006, ANN THORAC SURG, V81, P207, DOI 10.1016/j.athoracsur.2005.07.053; Sadiq M, 2012, CARDIOL YOUNG, V22, P71, DOI 10.1017/S104795111100093X; Salehian O, 2005, J AM COLL CARDIOL, V45, P499, DOI 10.1016/j.jacc.2004.10.052; Saxena Anita, 2005, Indian Heart J, V57, P35; Schneider B, 1996, AM J CARDIOL, V77, P1202, DOI 10.1016/S0002-9149(96)00163-4; Schoen SP, 2006, HEART, V92, P821, DOI 10.1136/hrt.2005.070060; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Schussler JM, 2005, AM J CARDIOL, V95, P993, DOI 10.1016/j.amjcard.2004.12.046; Shimizu K, 1997, J CARDIAC SURG, V12, P198, DOI 10.1111/j.1540-8191.1997.tb00123.x; Silversides CK, 2008, AM J CARDIOL, V101, P683, DOI 10.1016/j.amjcard.2007.10.035; STEELE PM, 1987, CIRCULATION, V76, P1037, DOI 10.1161/01.CIR.76.5.1037; Strauss RM, 2005, PEDIATR DERMATOL, V22, P373, DOI 10.1111/j.1525-1470.2005.22424.x; Suchon E, 2009, MED SCI MONITOR, V15, pCR612; Suematsu Y, 2007, EUR J CARDIO-THORAC, V32, P573, DOI 10.1016/j.ejcts.2007.06.026; Sugimoto M, 2011, CIRC J, V75, P2213, DOI 10.1253/circj.CJ-10-1211; Taggart NW, 2011, J THORAC CARDIOV SUR, V142, P221, DOI 10.1016/j.jtcvs.2011.03.006; Takaya Y, 2013, J INTERV CARDIOL, V26, P195, DOI 10.1111/joic.12002; Teo KS, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-44; Thilen U, 2009, INT J CARDIOL, V132, P364, DOI 10.1016/j.ijcard.2007.11.101; Thomas VC, 2012, CONGENIT HEART DIS, V7, P204, DOI 10.1111/j.1747-0803.2010.00442.x; Valente AM, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2007.01.001; Valente AM, 2007, PEDIATR CARDIOL, V28, P51, DOI 10.1007/s00246-006-1477-y; Valverde I, 2010, PEDIATR CARDIOL, V31, P1244, DOI 10.1007/s00246-010-9782-x; Van De Bruaene A, 2011, J CARDIOPULM REHABIL, V31, P308, DOI 10.1097/HCR.0b013e318220a805; van den Bosch AE, 2006, J AM SOC ECHOCARDIOG, V19, P815, DOI 10.1016/j.echo.2006.01.016; VANPRAAGH S, 1994, AM HEART J, V128, P365, DOI 10.1016/0002-8703(94)90491-X; Vecht JA, 2010, HEART, V96, P1789, DOI 10.1136/hrt.2010.204933; Veldtman GR, 2001, J AM COLL CARDIOL, V37, P2108, DOI 10.1016/S0735-1097(01)01305-5; Vitarelli A, 2012, INT J CARDIOVAS IMAG, V28, P1905, DOI 10.1007/s10554-012-0022-8; Walker RE, 2004, AM J CARDIOL, V93, P1374, DOI 10.1016/j.amjcard.2004.02.033; Warnes CA, 2008, CIRCULATION, V118, P2395, DOI [10.1161/CIRCULATIONAHA.108.190811, 10.1016/j.jacc.2008.10.001]; Wertman B, 2006, J AM COLL CARDIOL, V47, P1226, DOI 10.1016/j.jacc.2005.12.017; Wessels A, 2000, ANAT REC, V259, P288, DOI 10.1002/1097-0185(20000701)259:3<288::AID-AR60>3.0.CO;2-D; Yalonetsky S, 2009, CONGENIT HEART DIS, V4, P17, DOI 10.1111/j.1747-0803.2008.00245.x; Yap SC, 2009, BJOG-INT J OBSTET GY, V116, P1593, DOI 10.1111/j.1471-0528.2009.02301.x; Yoshihara K, 1999, Kyobu Geka, V52, P134; Zaqout M, 2010, PEDIATR CARDIOL, V31, P1171, DOI 10.1007/s00246-010-9778-6	141	151	182	2	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2014	383	9932					1921	1932		10.1016/S0140-6736(13)62145-5	http://dx.doi.org/10.1016/S0140-6736(13)62145-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI4PR	24725467				2022-12-28	WOS:000336847800033
J	Cummings, SR; Studenski, S; Ferrucci, L				Cummings, Steven R.; Studenski, Stephanie; Ferrucci, Luigi			A Diagnosis of Dismobility-Giving Mobility Clinical Visibility A Mobility Working Group Recommendation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SUBSEQUENT DISABILITY; PHYSICAL PERFORMANCE; OLDER-ADULTS; GAIT SPEED		[Cummings, Steven R.] Calif Pacific Med Ctr, Res Inst, San Francisco Coordinating Ctr, San Francisco, CA 94107 USA; [Studenski, Stephanie; Ferrucci, Luigi] NIA, Intramural Program, Baltimore, MD 21224 USA	California Pacific Medical Center; California Pacific Medical Center Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Cummings, SR (corresponding author), Calif Pacific Med Ctr, Res Inst, San Francisco Coordinating Ctr, 185 Berry St,Ste 5700, San Francisco, CA 94107 USA.	scummings@sfcc-cpmc.net			NATIONAL INSTITUTE ON AGING [ZIAAG000015] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AG000015-49] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Brown CJ, 2013, JAMA-J AM MED ASSOC, V310, P1168, DOI 10.1001/jama.2013.276566; Cawthon PM, 2009, J AM GERIATR SOC, V57, P1411, DOI 10.1111/j.1532-5415.2009.02366.x; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; Hardy SE, 2011, J GEN INTERN MED, V26, P130, DOI 10.1007/s11606-010-1543-2; Pahor M, 2006, J GERONTOL A-BIOL, V61, P1157; Rydwik E., 2012, Physiotherapy Theory and Practice, V28, P238, DOI 10.3109/09593985.2011.601804; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Vermeulen J, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-33	10	165	168	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 28	2014	311	20					2061	2062		10.1001/jama.2014.3033	http://dx.doi.org/10.1001/jama.2014.3033			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8MQ	24763978	Green Accepted			2022-12-28	WOS:000336392400016
J	Siegel, AM; Sisti, DA; Caplan, AL				Siegel, Andrew M.; Sisti, Dominic A.; Caplan, Arthur L.			Pediatric Euthanasia in Belgium Disturbing Developments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Siegel, Andrew M.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sisti, Dominic A.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Caplan, Arthur L.] NYU, Div Med Eth, Langone Med Ctr, New York, NY USA	University of Pennsylvania; University of Pennsylvania; New York University; NYU Langone Medical Center	Siegel, AM (corresponding author), Univ Penn, Dept Psychiat, Perelman Sch Med, 3535 Market St,Second Floor, Philadelphia, PA 19104 USA.	andrew.siegel@uphs.upenn.edu		Siegel, Andrew/0000-0002-8605-2519; Sisti, Dominic/0000-0002-2282-9253				Casell, 2004, NATURE SUFFERING GOA; Dan B, 2014, LANCET, V383, P671, DOI 10.1016/S0140-6736(14)60110-0; Jennings B, 2013, HASTINGS CTR GUIDELI; Orentlicher D, 2014, JAMA-J AM MED ASSOC, V311, P1961, DOI 10.1001/jama.2014.4117; Pousset G, 2011, ARCH DIS CHILD, V96, P948, DOI 10.1136/adc.2009.182139; Quill TE, 1997, JAMA-J AM MED ASSOC, V278, P2099, DOI 10.1001/jama.278.23.2099; Verhagen E, 2005, NEW ENGL J MED, V352, P959, DOI 10.1056/NEJMp058026	7	30	32	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2014	311	19					1963	1964		10.1001/jama.2014.4257	http://dx.doi.org/10.1001/jama.2014.4257			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UA	24743867				2022-12-28	WOS:000336122800012
J	Chambers, JQ; Roberts, DA				Chambers, Jeffrey Q.; Roberts, Dar A.			ECOLOGY Drought in the Congo Basin	NATURE			English	Editorial Material							CLIMATE; FOREST; VARIABILITY; GREENNESS		[Chambers, Jeffrey Q.] Univ Calif Berkeley, Dept Geog, Berkeley, CA 94720 USA; [Roberts, Dar A.] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA	University of California System; University of California Berkeley; University of California System; University of California Santa Barbara	Chambers, JQ (corresponding author), Univ Calif Berkeley, Dept Geog, Berkeley, CA 94720 USA.	jqchambers@berkeley.edu	Chambers, Jeffrey Q/J-9021-2014; Chambers, Jeffrey Q/AAU-7097-2021	Chambers, Jeffrey Q/0000-0003-3983-7847; 				Brando PM, 2010, P NATL ACAD SCI USA, V107, P14685, DOI 10.1073/pnas.0908741107; Galvao LS, 2011, REMOTE SENS ENVIRON, V115, P2350, DOI 10.1016/j.rse.2011.04.035; Goulden ML, 2004, ECOL APPL, V14, pS42, DOI 10.1890/02-6008; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Hutyra LR, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000365; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Marengo JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047436; McDowell NG, 2011, TRENDS ECOL EVOL, V26, P523, DOI 10.1016/j.tree.2011.06.003; Morton DC, 2014, NATURE, V506, P221, DOI 10.1038/nature13006; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Saatchi S, 2013, P NATL ACAD SCI USA, V110, P565, DOI 10.1073/pnas.1204651110; Samanta A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042154; Toomey M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049041; Xu LA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046824; Zhou LM, 2014, NATURE, V509, P86, DOI 10.1038/nature13265	15	6	6	2	37	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					34	37		10.1038/nature13330	http://dx.doi.org/10.1038/nature13330			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24759323				2022-12-28	WOS:000335199100031
J	Song, F; Chen, P; Sun, DP; Wang, MZ; Dong, LP; Liang, D; Xu, RM; Zhu, P; Li, GH				Song, Feng; Chen, Ping; Sun, Dapeng; Wang, Mingzhu; Dong, Liping; Liang, Dan; Xu, Rui-Ming; Zhu, Ping; Li, Guohong			Cryo-EM Study of the Chromatin Fiber Reveals a Double Helix Twisted by Tetranucleosomal Units	SCIENCE			English	Article							HIGHER-ORDER STRUCTURE; LINKER HISTONE H5; X-RAY-DIFFRACTION; NUCLEOSOME; ORGANIZATION; MICROSCOPY; RESOLUTION; FILAMENT; LOCATION; OCTAMER	The hierarchical packaging of eukaryotic chromatin plays a central role in transcriptional regulation and other DNA-related biological processes. Here, we report the 11-angstrom-resolution cryogenic electron microscopy (cryo-EM) structures of 30-nanometer chromatin fibers reconstituted in the presence of linker histone H1 and with different nucleosome repeat lengths. The structures show a histone H1-dependent left-handed twist of the repeating tetranucleosomal structural units, within which the four nucleosomes zigzag back and forth with a straight linker DNA. The asymmetric binding and the location of histone H1 in chromatin play a role in the formation of the 30-nanometer fiber. Our results provide mechanistic insights into how nucleosomes compact into higher-order chromatin fibers.	[Song, Feng; Chen, Ping; Sun, Dapeng; Wang, Mingzhu; Dong, Liping; Liang, Dan; Xu, Rui-Ming; Zhu, Ping; Li, Guohong] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Song, Feng; Sun, Dapeng; Dong, Liping; Liang, Dan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhu, P (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	zhup@ibp.ac.cn; liguohong@ibp.ac.cn	liang, dy/GZA-4770-2022; xu, rui/GRX-5734-2022	sun, dapeng/0000-0003-0220-8844; Chen, Ping/0000-0003-0295-0846	National Basic Research Program of China [2010CB912400, 2011CB966300, 2009CB825500]; National Natural Science Foundation of China [91219202, 31230018, 91019007, 21261130090, 31000566]; Strategic Priority Research Program from the Chinese Academy of Sciences [XDA01010304, XDB08010100]; Key Research Program from the Chinese Academy of Sciences [KJZD-EW-L05]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program from the Chinese Academy of Sciences; Key Research Program from the Chinese Academy of Sciences; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by grants from the National Basic Research Program of China (2010CB912400 to P.Z., 2011CB966300 to G. L., and 2009CB825500 to R. M. X. and P.Z.); the National Natural Science Foundation of China (91219202 to G. L., 31230018 to P.Z., 91019007 to G. L., 21261130090 to P.Z., and 31000566 to P. C.); Strategic Priority Research Program (XDA01010304 to G. L. and XDB08010100 to P.Z. and R. M. X.) and Key Research Program (KJZD-EW-L05 to P.Z., G. L., and R. M. X.) from the Chinese Academy of Sciences; and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, to P. C. All EM data were collected and processed at the Center for Bio-imaging, Institute of Biophysics, Chinese Academy of Sciences. We thank G. Ji and X. Huang for their technical help and support with electron microscopy and L. Ling for technical help and support with the data processing in the High Performance Computing Service Station. We are also indebted to the colleagues whose work could not be cited because of the limitation of space. The cryo-EM maps for the 12 x 177 bp, 12 x 187 bp and 24 x 177 bp chromatin fibers were deposited into the Electron Microscopy Data Bank with the accession codes EMD-2600, EMD-2601 and EMD-2602, respectively. The authors declare no conflicts of interest.	ALLAN J, 1980, NATURE, V288, P675, DOI 10.1038/288675a0; BATES DL, 1981, NUCLEIC ACIDS RES, V9, P5883, DOI 10.1093/nar/9.22.5883; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Carruthers LM, 1999, METHOD ENZYMOL, V304, P19; Carter GJ, 1998, BIOCHEMISTRY-US, V37, P12477, DOI 10.1021/bi980716v; DAVIES HG, 1968, NATURE, V217, P1122, DOI 10.1038/2171122a0; Fan L, 2006, P NATL ACAD SCI USA, V103, P8384, DOI 10.1073/pnas.0508951103; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; Frouws TD, 2009, BIOPHYS J, V96, P3363, DOI 10.1016/j.bpj.2008.10.075; GERCHMAN SE, 1987, P NATL ACAD SCI USA, V84, P7802, DOI 10.1073/pnas.84.22.7802; Ghirlando R, 2008, J MOL BIOL, V376, P1417, DOI 10.1016/j.jmb.2007.12.051; GRAZIANO V, 1994, NATURE, V368, P351, DOI 10.1038/368351a0; LANGMORE JP, 1983, J CELL BIOL, V96, P1120, DOI 10.1083/jcb.96.4.1120; Leuba SH, 1998, BIOPHYS J, V74, P2830, DOI 10.1016/S0006-3495(98)77990-1; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; PEARSON EC, 1983, EMBO J, V2, P1367, DOI 10.1002/j.1460-2075.1983.tb01593.x; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Staynov DZ, 2008, BIOESSAYS, V30, P1003, DOI 10.1002/bies.20816; STAYNOV DZ, 1988, EMBO J, V7, P3685, DOI 10.1002/j.1460-2075.1988.tb03250.x; Syed SH, 2010, P NATL ACAD SCI USA, V107, P9620, DOI 10.1073/pnas.1000309107; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Thomas JO, 1999, CURR OPIN CELL BIOL, V11, P312, DOI 10.1016/S0955-0674(99)80042-8; WIDOM J, 1985, CELL, V43, P207, DOI 10.1016/0092-8674(85)90025-X; WILLIAMS SP, 1986, BIOPHYS J, V49, P233, DOI 10.1016/S0006-3495(86)83637-2; WOODCOCK CLF, 1984, J CELL BIOL, V99, P42, DOI 10.1083/jcb.99.1.42; Zhou BR, 2013, P NATL ACAD SCI USA, V110, P19390, DOI 10.1073/pnas.1314905110	28	380	406	2	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					376	380		10.1126/science.1251413	http://dx.doi.org/10.1126/science.1251413			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763583				2022-12-28	WOS:000334867800032
J	Carvunis, AR; Ideker, T				Carvunis, Anne-Ruxandra; Ideker, Trey			Siri of the Cell: What Biology Could Learn from the iPhone	CELL			English	Article							GENE ONTOLOGY; SYSTEMS; NETWORK	Modern genomics is very efficient at mapping genes and gene networks, but how to transform these maps into predictive models of the cell remains unclear. Recent progress in computer science, embodied by intelligent agents such as Siri, inspires an approach for moving from networks to multiscale models able to predict a range of cellular phenotypes and answer biological questions.	[Carvunis, Anne-Ruxandra; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Ideker, T (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	trey@bioeng.ucsd.edu		Carvunis, Anne-Ruxandra/0000-0002-6474-6413; Ideker, Trey/0000-0002-1708-8454	National Institutes of General Medical Sciences [P41 GM103504, P50 GM085764]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764, P41GM103504] Funding Source: NIH RePORTER	National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge Janusz Dutkowski, Michael Yu, Michael Kramer, Hannah Carter, Salvatore Loguercio, Benjamin Good, Bing Ren, Andrew Su, Gary Siuzdak, Benjamin Kellman, Heidi Kayser, and our anonymous reviewers for important discussions and comments in preparation for this Essay. This work was supported by the National Institutes of General Medical Sciences grants P41 GM103504 and P50 GM085764.	Alterovitz G, 2010, NAT BIOTECHNOL, V28, P128, DOI 10.1038/nbt0210-128; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Berner ES., 2007, CLIN DECISION SUPPOR; Brachman R.J., 2004, KNOWLEDGE REPRESENTA, P336; Bray, 2009, WETWARE COMPUTER EVE; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; Cohen K Bretonnel, 2013, Proc Conf Assoc Comput Linguist Meet, V2013, P3; Dutkowski J, 2013, NAT BIOTECHNOL, V31, P38, DOI 10.1038/nbt.2463; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fung YC., 2013, BIOMECHANICS MECH PR; Gruber TR, 1995, INT J HUM-COMPUT ST, V43, P907, DOI 10.1006/ijhc.1995.1081; Guzzoni D, 2006, 2006 IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE AND INTELLIGENT AGENT TECHNOLOGY, WORKSHOPS PROCEEDINGS, P417, DOI 10.1109/WI-IATW.2006.27; Hooke Robert, 1665, MICROGRAPHIA SOME PH; Kauffman Stuart A., 1993; King RD, 2009, SCIENCE, V324, P85, DOI 10.1126/science.1165620; Koller D., 2009, PROBABILISTIC GRAPHI; MATHEWS CK, 1993, J BACTERIOL, V175, P6377, DOI 10.1128/jb.175.20.6377-6381.1993; McPherson A, 2009, INTRO MACROMOLECULAR; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Pollack G.H., 2001, CELLS GELS ENGINES L; REDDY GPV, 1977, P NATL ACAD SCI USA, V74, P3152, DOI 10.1073/pnas.74.8.3152; Robinson P.N., 2011, INTRO BIOONTOLOGIES; Spaulding A, 2011, LECT NOTES ARTIF INT, V6738, P627, DOI 10.1007/978-3-642-21869-9_128; Thompson D. W., 1917, GROWTH FORM; Walhout A.J.M., 2013, HDB SYSTEMS BIOL CON; Wren JD, 2011, BIOINFORMATICS, V27, P2025, DOI 10.1093/bioinformatics/btr327	28	22	22	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					534	538		10.1016/j.cell.2014.03.009	http://dx.doi.org/10.1016/j.cell.2014.03.009			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766803	Bronze, Green Accepted			2022-12-28	WOS:000335392100005
J	Sadat, MA; Moir, S; Chun, TW; Lusso, P; Kaplan, G; Wolfe, L; Memoli, MJ; He, M; Vega, H; Kim, LJY; Huang, Y; Hussein, N; Nievas, E; Mitchell, R; Garofalo, M; Louie, A; Ireland, DC; Grunes, C; Cimbro, R; Patel, V; Holzapfel, G; Salahuddin, D; Bristol, T; Adams, D; Marciano, BE; Hegde, M; Li, YX; Calvo, KR; Stoddard, J; Justement, JS; Jacques, J; Priel, DAL; Murray, D; Sun, P; Kuhns, DB; Boerkoel, CF; Chiorini, JA; Di Pasquale, G; Verthelyi, D; Rosenzweig, SD				Sadat, Mohammed A.; Moir, Susan; Chun, Tae-Wook; Lusso, Paolo; Kaplan, Gerardo; Wolfe, Lynne; Memoli, Matthew J.; He, Miao; Vega, Hugo; Kim, Leo J. Y.; Huang, Yan; Hussein, Nadia; Nievas, Elma; Mitchell, Raquel; Garofalo, Mary; Louie, Aaron; Ireland, Derek C.; Grunes, Claire; Cimbro, Raffaello; Patel, Vyomesh; Holzapfel, Genevieve; Salahuddin, Daniel; Bristol, Tyler; Adams, David; Marciano, Beatriz E.; Hegde, Madhuri; Li, Yuxing; Calvo, Katherine R.; Stoddard, Jennifer; Justement, J. Shawn; Jacques, Jerome; Priel, Debra A. Long; Murray, Danielle; Sun, Peter; Kuhns, Douglas B.; Boerkoel, Cornelius F.; Chiorini, John A.; Di Pasquale, Giovanni; Verthelyi, Daniela; Rosenzweig, Sergio D.			Glycosylation, Hypogammaglobulinemia, and Resistance to Viral Infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OTITIS-MEDIA; HIV; EFFICACY; ENTRY; CD4	Genetic defects in MOGS, the gene encoding mannosyl-oligosaccharide glucosidase (the first enzyme in the processing pathway of N-linked oligosaccharide), cause the rare congenital disorder of glycosylation type IIb (CDG-IIb), also known as MOGS-CDG. MOGS is expressed in the endoplasmic reticulum and is involved in the trimming of N-glycans. We evaluated two siblings with CDG-IIb who presented with multiple neurologic complications and a paradoxical immunologic phenotype characterized by severe hypogammaglobulinemia but limited clinical evidence of an infectious diathesis. A shortened immunoglobulin half-life was determined to be the mechanism underlying the hypogammaglobulinemia. Impaired viral replication and cellular entry may explain a decreased susceptibility to infections.	[Sadat, Mohammed A.; Hussein, Nadia; Nievas, Elma; Mitchell, Raquel; Garofalo, Mary; Rosenzweig, Sergio D.] NIAID, Infect Dis Susceptibil Unit, Lab Host Def, NIH, Bethesda, MD 20892 USA; [Moir, Susan; Chun, Tae-Wook; Lusso, Paolo; Kim, Leo J. Y.; Louie, Aaron; Cimbro, Raffaello; Justement, J. Shawn; Murray, Danielle] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Memoli, Matthew J.; Bristol, Tyler] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Marciano, Beatriz E.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Holzapfel, Genevieve; Salahuddin, Daniel; Sun, Peter] NIAID, Lab Immunogenet, NIH, Bethesda, MD 20892 USA; [Rosenzweig, Sergio D.] NIAID, Primary Immunodeficiency Clin, NIH, Bethesda, MD 20892 USA; [Wolfe, Lynne; Vega, Hugo; Huang, Yan; Adams, David; Boerkoel, Cornelius F.] Natl Human Res Genome Inst, Undiagnosed Dis Program, NIH, Bethesda, MD USA; [Calvo, Katherine R.; Stoddard, Jennifer] Natl Inst Dent & Craniofacial Res, Dept Lab Med, Clin Ctr, NIH, Bethesda, MD USA; [Patel, Vyomesh] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA; [Chiorini, John A.; Di Pasquale, Giovanni] Natl Inst Dent & Craniofacial Res, Adeno Associated Virus Biol Sect, NIH, Bethesda, MD USA; [Kaplan, Gerardo; Jacques, Jerome] Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Ireland, Derek C.; Grunes, Claire; Verthelyi, Daniela] Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Priel, Debra A. Long; Kuhns, Douglas B.] US FDA, Clin Serv Program, Silver Spring, MD USA; [Priel, Debra A. Long; Kuhns, Douglas B.] Frederick Natl Lab Canc Res, SAIC Frederick, Frederick, MD USA; [He, Miao; Hegde, Madhuri] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Li, Yuxing] Ctr Neutralizing Antibodies TSRI, IAVI Int AIDS Vaccine Initiat, La Jolla, CA USA; [Li, Yuxing] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Emory University; International AIDS Vaccine Initiative; Scripps Research Institute	Rosenzweig, SD (corresponding author), CC, Serv Immunol, DLM, 10 Ctr Dr,Bldg 10 2C410F, Bethesda, MD 20892 USA.	srosenzweig@cc.nih.gov	Boerkoel, Cornelius Franciscus/AFW-4948-2022; Chun, Tae-Wook/AAC-3101-2020; Chun, Tae-Wook/W-9187-2019; Moir, Susan/AAC-3676-2020	Boerkoel, Cornelius Franciscus/0000-0003-3097-241X; Chun, Tae-Wook/0000-0001-5153-7340; Hussein, Nadia/0000-0001-7999-0278; Kim, Leo/0000-0002-1790-9136; kaplan, gerardo/0000-0003-3303-7259; Ireland, Derek/0000-0001-5829-4206; Calvo, Katherine/0000-0002-0771-4191; Cimbro, Raffaello/0000-0002-6251-5160	Intramural Research Program of the National Institutes of Health; National Cancer Institute [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000851, ZIAAI000880, ZIAAI000976, ZIAAI001122, ZIAAI001041, ZIAAI000825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000695] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090025] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); CLINICAL CENTER	Supported by the Intramural Research Program of the National Institutes of Health and by a grant from the National Cancer Institute (HHSN261200800001E).	AHMED SP, 1995, BIOCHEM BIOPH RES CO, V208, P267, DOI 10.1006/bbrc.1995.1333; Buckner CM, 2013, J VIROL, V87, P5800, DOI 10.1128/JVI.00094-13; Chonmaitree T, 2008, CLIN INFECT DIS, V46, P815, DOI 10.1086/528685; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Chun TW, 2010, AIDS, V24, P2803, DOI 10.1097/QAD.0b013e328340a239; De Praeter CM, 2000, AM J HUM GENET, V66, P1744, DOI 10.1086/302948; Di Pasquale G, 2003, EMBO J, V22, P1716, DOI 10.1093/emboj/cdg153; Faid V, 2007, PROTEOMICS, V7, P1800, DOI 10.1002/pmic.200600977; Fields B. N., 2007, FIELDS VIROLOGY; Fischer PB, 1996, J VIROL, V70, P7153, DOI 10.1128/JVI.70.10.7153-7160.1996; FISCHL MA, 1994, J ACQ IMMUN DEF SYND, V7, P139; Gorry PR, 2001, J VIROL, V75, P10073, DOI 10.1128/JVI.75.21.10073-10089.2001; HENDERSON FW, 1982, NEW ENGL J MED, V306, P1377, DOI 10.1056/NEJM198206103062301; Moir S, 1999, J VIROL, V73, P7972, DOI 10.1128/JVI.73.10.7972-7980.1999; Moss B, 2006, VIROLOGY, V344, P48, DOI 10.1016/j.virol.2005.09.037; Obaro SK, 2004, LANCET INFECT DIS, V4, P510, DOI 10.1016/S1473-3099(04)01106-5; Qu XW, 2011, ANTIMICROB AGENTS CH, V55, P1036, DOI 10.1128/AAC.01319-10; Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310; Stiehm ER, 1997, PEDIATR INFECT DIS J, V16, P696, DOI 10.1097/00006454-199707000-00012; Szretter KJ, 2006, CURR PROTOC MICROBIO, V15, p15G1; Varki A., 2009, ESSENTIALS GLYCOBIOL; Winkelstein JA, 2006, MEDICINE, V85, P193, DOI 10.1097/01.md.0000229482.27398.ad	22	82	84	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 24	2014	370	17					1615	1625		10.1056/NEJMoa1302846	http://dx.doi.org/10.1056/NEJMoa1302846			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4TG	24716661	Green Accepted			2022-12-28	WOS:000336120500008
J	Butt, CA				Butt, Carrie A.			Cabeza (Back of Head) Salomon Huerta	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2014	311	16					1592	1593		10.1001/jama.2013.279460	http://dx.doi.org/10.1001/jama.2013.279460			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF4OU	24756490				2022-12-28	WOS:000334693900001
J	Chamberlain, JM; Okada, P; Holsti, M; Mahajan, P; Brown, KM; Vance, C; Gonzalez, V; Lichenstein, R; Stanley, R; Brousseau, DC; Grubenhoff, J; Zemek, R; Johnson, DW; Clemons, TE; Baren, J				Chamberlain, James M.; Okada, Pamela; Holsti, Maija; Mahajan, Prashant; Brown, Kathleen M.; Vance, Cheryl; Gonzalez, Victor; Lichenstein, Richard; Stanley, Rachel; Brousseau, David C.; Grubenhoff, Joseph; Zemek, Roger; Johnson, David W.; Clemons, Traci E.; Baren, Jill		PECARN	Lorazepam vs Diazepam for Pediatric Status Epilepticus A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONVULSIVE STATUS EPILEPTICUS; INTRAVENOUS LORAZEPAM; MANAGEMENT; SEIZURES; CHILDHOOD; CHILDREN; THERAPY	IMPORTANCE Benzodiazepines are considered first-line therapy for pediatric status epilepticus. Some studies suggest that lorazepam may be more effective or safer than diazepam, but lorazepam is not Food and Drug Administration approved for this indication. OBJECTIVE To test the hypothesis that lorazepam has better efficacy and safety than diazepam for treating pediatric status epilepticus. DESIGN, SETTING, AND PARTICIPANTS This double-blind, randomized clinical trial was conducted from March 1, 2008, to March 14, 2012. Patients aged 3 months to younger than 18 years with convulsive status epilepticus presenting to 1 of 11 US academic pediatric emergency departments were eligible. There were 273 patients; 140 randomized to diazepam and 133 to lorazepam. INTERVENTIONS Patients received either 0.2 mg/kg of diazepam or 0.1 mg/kg of lorazepam intravenously, with half this dose repeated at 5 minutes if necessary. If status epilepticus continued at 12 minutes, fosphenytoin was administered. MAIN OUTCOMES AND MEASURES The primary efficacy outcome was cessation of status epilepticus by 10 minutes without recurrence within 30 minutes. The primary safety outcome was the performance of assisted ventilation. Secondary outcomes included rates of seizure recurrence and sedation and times to cessation of status epilepticus and return to baseline mental status. Outcomes were measured 4 hours after study medication administration. RESULTS Cessation of status epilepticus for 10 minutes without recurrence within 30 minutes occurred in 101 of 140 (72.1%) in the diazepam group and 97 of 133 (72.9%) in the lorazepam group, with an absolute efficacy difference of 0.8%(95% CI, -11.4% to 9.8%). Twenty-six patients in each group required assisted ventilation (16.0% given diazepam and 17.6% given lorazepam; absolute risk difference, 1.6%; 95% CI, -9.9% to 6.8%). There were no statistically significant differences in secondary outcomes except that lorazepam patients were more likely to be sedated (66.9% vs 50%, respectively; absolute risk difference, 16.9%; 95% CI, 6.1% to 27.7%). CONCLUSIONS AND RELEVANCE Among pediatric patients with convulsive status epilepticus, treatment with lorazepam did not result in improved efficacy or safety compared with diazepam. These findings do not support the preferential use of lorazepam for this condition.	[Chamberlain, James M.; Brown, Kathleen M.] Childrens Natl Med Ctr, Div Emergency Med, Washington, DC 20010 USA; [Okada, Pamela] Univ Texas Dallas, Dallas, TX 75230 USA; [Holsti, Maija] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Mahajan, Prashant] Childrens Hosp Michigan, Dept Pediat, Detroit, MI 48201 USA; [Vance, Cheryl] Univ Calif Davis, Sacramento, CA 95817 USA; [Gonzalez, Victor] Baylor Coll Med, Houston, TX 77030 USA; [Lichenstein, Richard] Univ Baltimore, Dept Pediat, Baltimore, MD 21201 USA; [Stanley, Rachel] Univ Michigan, Ann Arbor, MI 48109 USA; [Brousseau, David C.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Grubenhoff, Joseph] Childrens Hosp Colorado, Denver, CO USA; [Zemek, Roger] Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON K1H 8L1, Canada; [Johnson, David W.] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada; [Clemons, Traci E.] EMMES Corp, Rockville, MD USA; [Baren, Jill] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA	Children's National Health System; University of Texas System; University of Texas Dallas; Utah System of Higher Education; University of Utah; Children's Hospital of Michigan; University of California System; University of California Davis; Baylor College of Medicine; University System of Maryland; University of Baltimore; University of Michigan System; University of Michigan; Medical College of Wisconsin; Children's Hospital Colorado; University of Ottawa; Children's Hospital of Eastern Ontario; Alberta Childrens Hospital; University of Calgary; Emmes Corporation; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Chamberlain, JM (corresponding author), Childrens Natl Med Ctr, Div Emergency Med, 111 Michigan Ave NW, Washington, DC 20010 USA.	jchamber@childrensnational.org	Grubenhoff, A/H-9994-2019; Zemek, Roger/H-1039-2018	Grubenhoff, A/0000-0001-5072-4064; Holubkov, Richard/0000-0003-0431-3381	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [HHSN275201100017C]; Emergency Medical Services for Children (EMSC) program of the Maternal and Child Health Bureau (MCHB), Health Resources and Services Administration, Department of Health and Human Services [U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC00008]; NICHD	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Emergency Medical Services for Children (EMSC) program of the Maternal and Child Health Bureau (MCHB), Health Resources and Services Administration, Department of Health and Human Services; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by grant HHSN275201100017C from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The Pediatric Emergency Care Applied Research Network (PECARN) is supported by cooperative agreements U03MC00001, U03MC00003, U03MC00006, U03MC00007, and U03MC00008 from the Emergency Medical Services for Children (EMSC) program of the Maternal and Child Health Bureau (MCHB), Health Resources and Services Administration, Department of Health and Human Services. The Best Pharmaceuticals for Children Act Data Coordinating Center for this study was the EMMES Corp and was funded by the NICHD under a separate contract.	Alldredge BK, 2001, NEW ENGL J MED, V345, P631, DOI 10.1056/NEJMoa002141; Appleton R, 2000, ARCH DIS CHILD, V83, P415; APPLETON R, 1995, DEV MED CHILD NEUROL, V37, P682; Bleck TP, 1999, EPILEPSIA, V40, pS59, DOI 10.1111/j.1528-1157.1999.tb00880.x; Chamberlain JM, 2012, J PEDIATR-US, V160, P667, DOI 10.1016/j.jpeds.2011.09.048; Chamberlain JM, 2012, J PEDIATR, V160, pe2; Chen YHJ, 2004, STAT MED, V23, P1023, DOI 10.1002/sim.1688; Chin RF, 2008, LANCET NEUROL, V7, P771, DOI DOI 10.1016/51474-4422(08)70141-8; Chin RFM, 2008, LANCET NEUROL, V7, P696, DOI 10.1016/S1474-4422(08)70141-8; CHIULLI D A, 1991, Journal of Emergency Medicine, V9, P13, DOI 10.1016/0736-4679(91)90525-K; Cock HR, 2002, QJM-INT J MED, V95, P225, DOI 10.1093/qjmed/95.4.225; De Negri M, 2001, Paediatr Drugs, V3, P411, DOI 10.2165/00128072-200103060-00002; Food and Drug Administration, 2011, GUIDANCE FOR INSTITU; GIANG DW, 1988, PEDIATR NEUROL, V4, P358, DOI 10.1016/0887-8994(88)90083-5; Krug SE, 2007, PEDIATRICS, V120, P1367, DOI 10.1542/peds.2007-2902; LEPPIK IE, 1983, JAMA-J AM MED ASSOC, V249, P1452, DOI 10.1001/jama.249.11.1452; Lowenstein, 1999, EPILEPSIA, V40, pS21; Lowenstein DH, 1999, EPILEPSIA, V40, pS3, DOI 10.1111/j.1528-1157.1999.tb00872.x; Manno EM, 2003, MAYO CLIN PROC, V78, P508, DOI 10.4065/78.4.508; Martland T, 1998, DEV MED CHILD NEUROL, V40, P286; Mitchell WG, 1996, EPILEPSIA, V37, pS74, DOI 10.1111/j.1528-1157.1996.tb06025.x; Qureshi A, 2002, SEIZURE-EUR J EPILEP, V11, P141, DOI 10.1053/seiz.2001.0635; Riker RR, 1999, CRIT CARE MED, V27, P1325, DOI 10.1097/00003246-199907000-00022; Sabo-Graham T, 1998, Pediatr Rev, V19, P306, DOI 10.1542/pir.19-9-306; Sabo-Graham T, 1998, PEDIATR REV, V19, P310; Shinnar S, 1996, PEDIATRICS, V98, P216; Silbergleit R, 2012, NEW ENGL J MED, V366, P591, DOI 10.1056/NEJMoa1107494; TREIMAN DM, 1990, NEUROLOGY, V40, P32; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; US Department of Health and Human Services, 2010, 2010 NATIONAL STATIS; Woods D, 2005, PEDIATRICS, V115, P155, DOI 10.1542/peds.2004-0410	31	111	113	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2014	311	16					1652	1660		10.1001/jama.2014.2625	http://dx.doi.org/10.1001/jama.2014.2625			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF4OU	24756515	Bronze			2022-12-28	WOS:000334693900025
J	Davison, SA; Strasser, SI				Davison, Scott A.; Strasser, Simone I.			Ordering and interpreting hepatitis B serology	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VIRUS INFECTION; MANAGEMENT		[Davison, Scott A.] Liverpool Hosp, Dept Gastroenterol, Sydney, NSW, Australia; [Strasser, Simone I.] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Camperdown, NSW 2050, Australia; [Strasser, Simone I.] Univ Sydney, Cent Clin Sch, Sydney, NSW 2006, Australia	Liverpool Hospital; University of Sydney; University of Sydney	Strasser, SI (corresponding author), Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Camperdown, NSW 2050, Australia.	simone.strasser@sswahs.nsw.gov.au		Davison, Scott/0000-0002-5872-2044				[Anonymous], 2011, HEP B ANT SCREEN NEW; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chan HLY, 2009, J VIRAL HEPATITIS, V16, P36, DOI 10.1111/j.1365-2893.2008.01037.x; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; McMahon BJ, 2010, CLIN LIVER DIS, V14, P381, DOI 10.1016/j.cld.2010.05.007; National Hepatitis B testing policy, 2012, NAT HEP B TEST POL; National Institute for Health and Care Excellence, 2013, HEP B CHRON DIAGN MA; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Sokal EM, 2013, J HEPATOL, V59, P814, DOI 10.1016/j.jhep.2013.05.016; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882	11	6	6	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2014	348								g2522	10.1136/bmj.g2522	http://dx.doi.org/10.1136/bmj.g2522			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF5HJ	24742733				2022-12-28	WOS:000334744300008
J	Macilwain, C				Macilwain, Colin			Beware of backroom deals in the name of 'science'	NATURE			English	Editorial Material												cfmworldview@gmail.com							0	3	3	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					289	289		10.1038/508289a	http://dx.doi.org/10.1038/508289a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF0KP	24740030	Bronze			2022-12-28	WOS:000334403000013
J	Stojchevska, L; Vaskivskyi, I; Mertelj, T; Kusar, P; Svetin, D; Brazovskii, S; Mihailovic, D				Stojchevska, L.; Vaskivskyi, I.; Mertelj, T.; Kusar, P.; Svetin, D.; Brazovskii, S.; Mihailovic, D.			Ultrafast Switching to a Stable Hidden Quantum State in an Electronic Crystal	SCIENCE			English	Article							INDUCED SUPERCONDUCTIVITY; DENSITY; TRANSITIONS; MICROSCOPY	Hidden states of matter may be created if a system out of equilibrium follows a trajectory to a state that is inaccessible or does not exist under normal equilibrium conditions. We found such a hidden (H) electronic state in a layered dichalcogenide crystal of 1T-TaS2 (the trigonal phase of tantalum disulfide) reached as a result of a quench caused by a single 35-femtosecond laser pulse. In comparison to other states of the system, the H state exhibits a large drop of electrical resistance, strongly modified single-particle and collective-mode spectra, and a marked change of optical reflectivity. The H state is stable until a laser pulse, electrical current, or thermal erase procedure is applied, causing it to revert to the thermodynamic ground state.	[Stojchevska, L.; Vaskivskyi, I.; Mertelj, T.; Kusar, P.; Svetin, D.; Mihailovic, D.] Jozef Stefan Inst, Dept Complex Matter, Jamova 39, SI-1000 Ljubljana, Slovenia; [Stojchevska, L.; Mihailovic, D.] Jozef Stefan Int Postgrad Sch, SI-1000 Ljubljana, Slovenia; [Brazovskii, S.] Univ Paris Sud, LPTMS, CNRS, UMR8626, F-91405 Orsay, France; [Brazovskii, S.] Int Inst Phys, BR-59078400 Natal, RN, Brazil; [Mihailovic, D.] CENN Nanoctr, SI-1000 Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay	Mihailovic, D (corresponding author), Jozef Stefan Inst, Dept Complex Matter, Jamova 39, SI-1000 Ljubljana, Slovenia.	dragan.mihailovic@ijs.si	Mihailovic, Dragan/H-6753-2014; Brazovskii, Serguei/A-9608-2012; Vaskivskyi, Igor/N-6388-2019	Mihailovic, Dragan/0000-0003-2074-2899; Brazovskii, Serguei/0000-0001-8147-9655; Vaskivskyi, Igor/0000-0003-4090-1471	Slovenian Research Agency; European restructuring funds (CENN Nanocenter); European Research Council advanced grant TRAJECTORY	Slovenian Research Agency(Slovenian Research Agency - Slovenia); European restructuring funds (CENN Nanocenter); European Research Council advanced grant TRAJECTORY	Supported by the Slovenian Research Agency, European restructuring funds (CENN Nanocenter), and European Research Council advanced grant TRAJECTORY. A European patent application PCT/SI2013/000056 has been submitted. We thank L. Forro, V. V. Kabanov, N. Kirova, P. Monceau, E. Tossatti, and E. Tutis for valuable discussions.	BAK P, 1982, REP PROG PHYS, V45, P587, DOI 10.1088/0034-4885/45/6/001; Cavalleri A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.237401; Clerc F, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/35/355002; Dean N, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.016401; Demsar J, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.041101; Eichberger M, 2010, NATURE, V468, P799, DOI 10.1038/nature09539; Fausti D, 2011, SCIENCE, V331, P189, DOI 10.1126/science.1197294; Hellmann S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.187401; ISHIGURO T, 1991, PHYS REV B, V44, P2046, DOI 10.1103/PhysRevB.44.2046; KOSHIHARA S, 1990, PHYS REV B, V42, P6853, DOI 10.1103/PhysRevB.42.6853; Li LJ, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/67005; MCMILLAN WL, 1976, PHYS REV B, V14, P1496, DOI 10.1103/PhysRevB.14.1496; NAKANISHI K, 1977, J PHYS SOC JPN, V43, P1839, DOI 10.1143/JPSJ.43.1839; Nasu K, 2001, J PHYS-CONDENS MAT, V13, pR693, DOI 10.1088/0953-8984/13/35/201; Okamoto H, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.165202; Perfetti L, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/5/053019; Petersen JC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.177402; Rossnagel K, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.073106; Sipos B, 2008, NAT MATER, V7, P960, DOI 10.1038/nmat2318; Takubo N, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.017404; THOMSON RE, 1994, PHYS REV B, V49, P16899, DOI 10.1103/PhysRevB.49.16899; Tomimoto S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.035106; Tosatti E., 1976, J PHYS, V37; YU G, 1991, PHYS REV LETT, V67, P2581, DOI 10.1103/PhysRevLett.67.2581; Zakery A., 2007, OPTICAL NONLINEARITI	26	377	381	11	284	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					177	180		10.1126/science.1241591	http://dx.doi.org/10.1126/science.1241591			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24723607	Green Submitted			2022-12-28	WOS:000334096300029
J	Palucka, K; Banchereau, J				Palucka, Karolina; Banchereau, Jacques			SnapShot: Cancer Vaccines	CELL			English	Editorial Material							DENDRITIC CELLS		[Palucka, Karolina] Baylor Res Inst, Baylor Inst Immunol Res, Ralph M Steinman Ctr Canc Vaccines, Dallas, TX 75204 USA; [Banchereau, Jacques] Jackson Lab, Farmington, CT 06030 USA	Baylor Scott & White Health; Baylor University Medical Center; Jackson Laboratory	Palucka, K (corresponding author), Baylor Res Inst, Baylor Inst Immunol Res, Ralph M Steinman Ctr Canc Vaccines, Dallas, TX 75204 USA.							Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Le DT, 2012, SEMIN ONCOL, V39, P311, DOI 10.1053/j.seminoncol.2012.02.008; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Sousa CRE, 2011, SEMIN IMMUNOL, V23, P1, DOI 10.1016/j.smim.2011.02.003; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010	8	15	15	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					516	516		10.1016/j.cell.2014.03.044	http://dx.doi.org/10.1016/j.cell.2014.03.044			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725415	Bronze			2022-12-28	WOS:000334304500023
J	Chinthapalli, K				Chinthapalli, Krishna			Exporting disease, disability, and death The tobacco epidemic is only just starting in most of the world	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COMPANIES					kchinthapalli@bmj.com	Chinthapalli, Krishna/P-8428-2019	Chinthapalli, Krishna/0000-0003-4136-4882				Borzekowski DLG, 2013, PEDIATRICS, V132, pE825, DOI 10.1542/peds.2013-1150; Connolly G., 1987, TOBACCO TRADE WARS; He P, 2013, ENVIRON HEALTH PREV, V18, P85, DOI 10.1007/s12199-012-0288-4; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Lee K, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-2; Levy D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1134; Mackay J, 1996, BRIT MED B; Mackay J., 1995, TOBACCO HLTH; Malone R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1453; New York Times, 1988, NY TIMES; Patel Preeti, 2007, Tob Control, V16, pe1, DOI 10.1136/tc.2006.016071; Tavernise S, 2013, NY TIMES; Wall E, 2013, DAILY TELEGRAPH; Warren CW, 2006, LANCET, V367, P749, DOI 10.1016/S0140-6736(06)68192-0; Wen CP, 2005, TOB CONTROL, V14, pI38, DOI 10.1136/tc.2004.007971; World Health Organization-WHO, 2013, WHO REP GLOB TOB EP; Yang JL, 2010, TOB CONTROL, V19, DOI 10.1136/tc.2009.029710	17	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2014	348								g2221	10.1136/bmj.g2221	http://dx.doi.org/10.1136/bmj.g2221			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SD	24714368				2022-12-28	WOS:000334348500008
J	Kmietowicz, Z				Kmietowicz, Zosia			Innovation in Healthcare Award: change from the front line	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London, England		Kmietowicz, Z (corresponding author), BMJ, London, England.	zkmietowicz@bmj.com						Clarkesmith DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074037; Poole R, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-139; Smith DJ, 2011, BIPOLAR DISORD, V13, P571, DOI 10.1111/j.1399-5618.2011.00949.x	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2014	348								g2487	10.1136/bmj.g2487	http://dx.doi.org/10.1136/bmj.g2487			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SD	24714133				2022-12-28	WOS:000334348500010
J	Quinn, K				Quinn, Kevin			After the Revolution: DRGs at Age 30	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PROSPECTIVE PAYMENT; PERFORMANCE; HOSPITALS	1 October 2013 marked 30 years since Medicare began paying hospitals by diagnosis-related group (DRG), arguably the most influential innovation in the history of health care financing. Initially developed as a tool for hospital management, DRGs became the basis of the inpatient prospective payment system that Medicare implemented in 1983. The strong incentives were revolutionary in their impact. Medicare spending growth slowed sharply, and, more remarkable, hospitals posted record profits. After the link between cost and payment was broken, hospitals moved quickly to cut costs. Nevertheless, a literature survey concluded that none of the worst fears about adverse effects on patients were realized. Diagnosis-related groups have also come to define "the product of a hospital" for purposes of benchmarking and risk adjustment. The acceptance of DRG algorithms owes much to their categorical approach, clinical focus, and transparency. The 2 most commonly used algorithms, Medicare DRGs and All Patient Refined (DRGs, typically explain more than 40% of cost variance in inpatient stays, although with considerable range by care category. Because Medicare DRGs are unsuitable for obstetrics, pediatrics, and neonatology, some payers prefer APR DRGs. Diagnosis-related groups have proven to be a suitable basis for payment, as evidenced by widespread use. Common issues include mitigation of adverse incentives, appropriate payment for extremely costly stays, applicability to certain hospitals and care categories, and growing complexity. The DRG experience offers lessons about the effectiveness of financial incentives, the likelihood of adverse effects, the usefulness of case-mix measures, the risks of growing complexity, and the example that sensible policy need not be the domain of any one political party or other entity.	Xerox Corp, Helena, MT 59601 USA	Xerox	Quinn, K (corresponding author), Xerox Corp, 34 North Last Chance Gulch, Helena, MT 59601 USA.	kevin.quinn@xerox.com						Averill RF., 2013, 3M APR DRG CLASSIFIC; Averill RF, 2013, MEDICARE SEVERITY DI; Averill RF, 1999, PHYS PROFILING RISK, P391; Averill Richard F., 1991, DRGS THEIR DESIGN DE; Calikoglu S, 2012, HEALTH AFFAIR, V31, P2649, DOI 10.1377/hlthaff.2012.0357; Centers for Medicare & Medicaid Services, 2014, NAT HLTH EXP TYP SER; Centers for Medicare & Medicaid Services, BUNDL PAYM CAR IN BP; Centers for Medicare & Medicaid Services (CMS) HHS, 2004, FED REGISTER, V69, P48915; Codman EA, 1914, SURG GYNECOL OBSTET, V18, P491; Coulam R. F., 1991, HLTH CARE FINANCIN S, V12, P45; Fetter RB, 1991, DRGS THEIR DESIGN DE; Florida Agency for Health Care Administration, 2014, HOSPITALS; Goldfield Norbert, 2010, Qual Manag Health Care, V19, P3, DOI 10.1097/QMH.0b013e3181ccbcc3; GUTERMAN S, 1990, HEALTH AFFAIR, V9, P125, DOI 10.1377/hlthaff.9.1.125; Health Forum, 2011, AHA HOSP STAT; IGLEHART JK, 1983, NEW ENGL J MED, V308, P1428, DOI 10.1056/NEJM198306093082331; Mayes R, 2006, MEDICARE PROSPECTIVE; Medicare Payment Advisory Commission, 2013, PAYM BAS HOSP AC INP; Medicare Payment Advisory Commission, 2013, DAT BOOK HLTH CAR SP; Medicare Payment Advisory Commission, 2013, PAYM BAS CRIT ACC HO; Meier B., 2013, NY TIMES; Muldoon J H, 1999, Pediatrics, V103, P302; Quentin W, 2013, HEALTH AFFAIR, V32, P713, DOI 10.1377/hlthaff.2012.0876; Quinn K, 2008, HEALTH AFFAIR, V27, P269, DOI 10.1377/hlthaff.27.1.269; RUSSELL LB, 1989, NEW ENGL J MED, V320, P439, DOI 10.1056/NEJM198902163200706; Russell LB, 1989, MEDICARES NEW HOSP P; SMITH DG, 1992, PAYING MEDICARE POLI; Starr P, 1982, SOCIAL TRANSFORMATIO; U.S. Department of Health and Human Services, 1982, C HOSP PROSP PAYM ME; U.S. Government Accountability Office, 2013, GAO13334; Utah Department of Health, 2010, READM UT HOSP YEARS; Wynn BO, 2007, EVALUATION SEVERITY; Xerox State Healthcare, 2013, MED DRG PROJ POL DES	33	24	29	8	50	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2014	160	6					426	+		10.7326/M13-2115	http://dx.doi.org/10.7326/M13-2115			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MW	24723081				2022-12-28	WOS:000333521300021
J	Davies, SC; Winpenny, E; Ball, S; Fowler, T; Rubin, J; Nolte, E				Davies, Sally C.; Winpenny, Eleanor; Ball, Sarah; Fowler, Tom; Rubin, Jennifer; Nolte, Ellen			For debate: a new wave in public health improvement	LANCET			English	Article							CORONARY HEART-DISEASE; FINANCIAL INCENTIVES; PHYSICAL-ACTIVITY; OUTLET DENSITY; FOOD; SMOKING; MORTALITY; PROMOTION; OBESITY; STROKE	The rising burden of chronic disease poses a challenge for all public health systems and requires innovative approaches to effectively improve population health. Persisting inequalities in health are of particular concern. Disadvantage because of education, income, or social position is associated with a larger burden of disease and, in particular, multimorbidity. Although much has been achieved to enhance population health, challenges remain, and approaches need to be revisited. In this paper, we join the debate about how a new wave of public health improvement might look. We start from the premise that population health improvement is conditional on a health-promoting societal context. It is characterised by a culture in which healthy behaviours are the norm, and in which the institutional, social, and physical environment support this mindset. Achievement of this ambition will require a positive, holistic, eclectic, and collaborative effort, involving a broad range of stakeholders. We emphasise three mechanisms: maximisation of the value of health and incentives for healthy behaviour; promotion of healthy choices as default; and minimisation of factors that create a culture and environment which promote unhealthy behaviour. We give examples of how these mechanisms might be achieved.	[Davies, Sally C.; Fowler, Tom] Dept Hlth, Off Chief Med Officer, London SE1 6TE, England; [Winpenny, Eleanor; Ball, Sarah; Rubin, Jennifer; Nolte, Ellen] RAND Europe, Cambridge CB4 1YG, England; [Fowler, Tom] Publ Hlth England, Field Epidemiol Serv West Midlands, Birmingham, W Midlands, England; [Fowler, Tom] Univ Birmingham, Birmingham, W Midlands, England	RAND Corporation; RAND Europe; Public Health England; University of Birmingham	Nolte, E (corresponding author), RAND Europe, Westbrook Ctr, Milton Rd, Cambridge CB4 1YG, England.	enolte@rand.org	Winpenny, Eleanor/AAF-1595-2020; Fowler, Tom/AGT-1933-2022	Winpenny, Eleanor/0000-0003-1933-0168; Fowler, Tom/0000-0002-7258-2279; Nolte, Ellen/0000-0002-2289-117X	Policy Research Programme of the Department of Health [111/0001]	Policy Research Programme of the Department of Health	This paper is based on The St Andrews American Medical Alumni Lecture given by the Chief Medical Officer Prof Dame Sally C Davies, at St Andrews University, St Andrews, UK, on Nov 16, 2012. The contribution by EW, SB, JR, and EN to this work was supported, in part, by a grant funded by the Policy Research Programme of the Department of Health (contract number 111/0001).	Anderson P, 2011, J HEALTH COMMUN, V16, P107, DOI 10.1080/10810730.2011.601531; Anderson P, 2009, ALCOHOL ALCOHOLISM, V44, P229, DOI 10.1093/alcalc/agn115; Ashcroft RE, 2011, HEALTH EXPECT, V14, P191, DOI 10.1111/j.1369-7625.2011.00664.x; Azetsop J, 2013, PHILOS ETHICS HUM ME, V8, DOI 10.1186/1747-5341-8-16; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Baynes C, 2013, CROYDON COUNCIL SET; Beaglehole R, 2001, INT J EPIDEMIOL, V30, P1495, DOI 10.1093/ije/30.6.1495; Berkman L.F., 2000, SOCIAL EPIDEMIOLOGY, P3; Blecher E, 2013, TOB CONTROL, V22, DOI 10.1136/tobaccocontrol-2012-050575; Bleich SN, 2012, ANNU REV PUBL HEALTH, V33, P7, DOI 10.1146/annurev-publhealth-031811-124658; Buck D., 2012, IMPLICATIONS POLICY; Burton H, 2013, NAT GENET, V45, P349, DOI 10.1038/ng.2582; Cahill K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004307.pub3; Calman K, 1998, BRIT MED J, V317, P596, DOI 10.1136/bmj.317.7158.596; Campbell CA, 2009, AM J PREV MED, V37, P556, DOI 10.1016/j.amepre.2009.09.028; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Communities and Local Government Committee, 2013, ROL LOC AUTH HLTH IS; Concern A, 2012, MAKING IMPRESSION RE; Confederation NHS, 2011, ILLN WELLN ACH EFF I; Culley D., 2011, LESSONS LEARNED PLAN; Davies S. C., 2012, ANN REPORT CHIEF MED, V1; Davies S. C, 2014, ANN REPORT CHIEF MED; Davies SC, 2012, LANCET, V380, P1793, DOI 10.1016/S0140-6736(12)61955-2; Ding D, 2012, HEALTH PLACE, V18, P100, DOI 10.1016/j.healthplace.2011.08.021; DOLL R, 1954, BMJ-BRIT MED J, V1, P1451, DOI 10.1136/bmj.1.4877.1451; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Eyles H, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001353; Ferdinand AO, 2012, AM J PUBLIC HEALTH, V102, pE7, DOI 10.2105/AJPH.2012.300740; Fitzgerald JL, 2013, AUST HEALTH REV, V37, P199, DOI 10.1071/AH12238; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Hammond D, 2011, TOB CONTROL, V20, P327, DOI 10.1136/tc.2010.037630; Hanlon P, 2011, PUBLIC HEALTH, V125, P30, DOI 10.1016/j.puhe.2010.09.004; Hanlon P, 2012, PERSPECT PUBLIC HEAL, V132, P313, DOI 10.1177/1757913912440781; Harris F, 2006, TOB CONTROL, V15, P26, DOI 10.1136/tc.2005.013110; Harris JL, 2009, ANNU REV PUBL HEALTH, V30, P211, DOI 10.1146/annurev.publhealth.031308.100304; Harrison O, 2011, J HEALTH COMMUN, V16, P158, DOI 10.1080/10810730.2011.596608; Hassan E., 2009, HLTH WELLBEING WORK; Hawkes C, 2011, INT J PEDIATR OBES, V6, P83, DOI 10.3109/17477166.2010.486836; Hruschka DJ, 2008, J EPIDEMIOL COMMUN H, V62, P947, DOI 10.1136/jech.2008.076729; Illo J, 1996, MED HIST, V40, P373, DOI 10.1017/S0025727300061354; Johnston V, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008645.pub2; Kullgren JT, 2013, ANN INTERN MED, V158, P505, DOI 10.7326/0003-4819-158-7-201304020-00002; Lomas J, 1998, SOC SCI MED, V47, P1181, DOI 10.1016/S0277-9536(98)00190-7; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marmot M, 2010, FAIR SOC HLTH LIVES; Marmot M., 2013, HLTH ALL POLICIES SE; MARMOT MG, 1978, J EPIDEMIOL COMMUN H, V32, P244, DOI 10.1136/jech.32.4.244; Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918; Moodie C, 2012, PLAIN TOBACCO PACKAG; Nnoaham KE, 2009, INT J EPIDEMIOL, V38, P1324, DOI 10.1093/ije/dyp214; O'Donoghue T, 2000, J BEHAV DECIS MAKING, V13, P233, DOI 10.1002/(SICI)1099-0771(200004/06)13:2<233::AID-BDM325>3.0.CO;2-U; Patel D, 2011, AM J HEALTH PROMOT, V25, P341, DOI 10.4278/ajhp.100603-QUAN-172; Porter R., 1997, GREATEST BENEFIT MAN; Powell LM, 2013, OBES REV, V14, P110, DOI 10.1111/obr.12002; Promberger M, 2012, SOC SCI MED, V75, P2509, DOI 10.1016/j.socscimed.2012.09.033; PUSKA P, 1989, ANN MED, V21, P169, DOI 10.3109/07853898909149928; Reitzel LR, 2011, AM J PUBLIC HEALTH, V101, P315, DOI 10.2105/AJPH.2010.191676; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Rose G., 1992, STRATEGY PREVENTIVE; Rosen George, 1958, HIST PUBLIC HLTH; Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228; Saffer H, 2000, J HEALTH ECON, V19, P1117, DOI 10.1016/S0167-6296(00)00054-0; SAKULA A, 1982, THORAX, V37, P246, DOI 10.1136/thx.37.4.246; Sheard S, 2006, NATIONS DOCTOR ROLE; Stockwell Tim, 2012, Am J Public Health, V102, pe103, DOI 10.2105/AJPH.2012.301094; Stokes 3rd J, 1989, HYPERTENSION S1, V13, pI13; Tolman E.C., 1932, PURPOSIVE BEHAV ANIM; WILSON PW, 1980, AM J CARDIOL, V46, P649, DOI 10.1016/0002-9149(80)90516-0; WOLF PA, 1988, JAMA-J AM MED ASSOC, V259, P1025, DOI 10.1001/jama.259.7.1025; World Health Organization, 1986, OTT CHART GES	72	38	39	2	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2014	384	9957					1889	1895		10.1016/S0140-6736(13)62341-7	http://dx.doi.org/10.1016/S0140-6736(13)62341-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7LA	24703631				2022-12-28	WOS:000345116800029
J	Diener, MK; Knebel, P; Kieser, M; Schuler, P; Schiergens, TS; Atanassov, V; Neudecker, J; Stein, E; Thielemann, H; Kunz, R; von Frankenberg, M; Schernikau, U; Bunse, J; Jansen-Winkeln, B; Partecke, LI; Prechtl, G; Pochhammer, J; Bouchard, R; Hodina, R; Beckurts, KTE; Leissner, L; Lemmens, HP; Kallinowski, F; Thomusch, O; Seehofer, D; Simon, T; Hyhlik-Durr, A; Seiler, CM; Hackert, T; Reissfelder, C; Hennig, R; Doerr-Harim, C; Klose, C; Ulrich, A; Buchler, MW				Diener, Markus K.; Knebel, Phillip; Kieser, Meinhard; Schueler, Philipp; Schiergens, Tobias S.; Atanassov, Vladimir; Neudecker, Jens; Stein, Erwin; Thielemann, Henryk; Kunz, Reiner; von Frankenberg, Moritz; Schernikau, Utz; Bunse, Joerg; Jansen-Winkeln, Boris; Partecke, Lars I.; Prechtl, Gerald; Pochhammer, Julius; Bouchard, Ralf; Hodina, Rene; Beckurts, K. Tobias E.; Leissner, Lothar; Lemmens, Hans-Peter; Kallinowski, Friedrich; Thomusch, Oliver; Seehofer, Daniel; Simon, Thomas; Hyhlik-Duerr, Alexander; Seiler, Christoph M.; Hackert, Thilo; Reissfelder, Christoph; Hennig, Rene; Doerr-Harim, Colette; Klose, Christina; Ulrich, Alexis; Buechler, Markus W.			Effectiveness of triclosan-coated PDS Plus versus uncoated PDS II sutures for prevention of surgical site infection after abdominal wall closure: the randomised controlled PROUD trial	LANCET			English	Article							COLORECTAL SURGERY; WOUND INFECTIONS; METAANALYSIS; EFFICACY; REDUCE	Background Postoperative surgical site infections are one of the most frequent complications after open abdominal surgery, and triclosan-coated sutures were developed to reduce their occurrence. The aim of the PROUD trial was to obtain reliable data for the effectiveness of triclosan-coated PDS Plus sutures for abdominal wall closure, compared with non-coated PDS II sutures, in the prevention of surgical site infections. Methods This multicentre, randomised controlled group-sequential superiority trial was done in 24 German hospitals. Adult patients (aged >= 18 years) who underwent elective midline abdominal laparotomy for any reason were eligible for inclusion. Exclusion criteria were impaired mental state, language problems, and participation in another intervention trial that interfered with the intervention or outcome of this trial. A central web-based randomisation tool was used to randomly assign eligible participants by permuted block randomisation with a 1:1 allocation ratio and block size 4 before mass closure to either triclosan-coated sutures (PDS Plus) or uncoated sutures (PDS II) for abdominal fascia closure. The primary endpoint was the occurrence of superficial or deep surgical site infection according to the Centers for Disease Control and Prevention criteria within 30 days after the operation. Patients, surgeons, and the outcome assessors were masked to group assignment. Interim and final analyses were by modified intention to treat. This trial is registered with the German Clinical Trials Register, number DRKS00000390. Findings Between April 7, 2010, and Oct 19, 2012, 1224 patients were randomly assigned to intervention groups (607 to PDS Plus, and 617 to PDS II), of whom 1185 (587 PDS Plus and 598 PDS II) were analysed by intention to treat. The study groups were well balanced in terms of patient and procedure characteristics. The occurrence of surgical site infections did not differ between the PDS Plus group (87 [14.8%] of 587) and the PDS II group (96 [16.1%] of 598; OR 0.91, 95% CI 0.66-1.25; p=0.64). Serious adverse events also did not differ between the groups-146 of 583 (25.0%) patients treated with PDS Plus had at least one serious adverse event, compared with 138 of 602 (22.9%) patients treated with PDS II; p=0.39). Interpretation Triclosan-coated PDS Plus did not reduce the occurrence of surgical site infection after elective midline laparotomy. Innovative, multifactorial strategies need to be developed and assessed in future trials to reduce surgical site infections. Funding Johnson & Johnson Medical Limited.	[Diener, Markus K.; Doerr-Harim, Colette] Heidelberg Univ, German Surg Soc, Study Ctr, D-69120 Heidelberg, Germany; [Diener, Markus K.; Knebel, Phillip; Hackert, Thilo; Ulrich, Alexis; Buechler, Markus W.] Heidelberg Univ, Dept Gen Visceral & Transplantat Surg, D-69120 Heidelberg, Germany; [Kieser, Meinhard; Klose, Christina] Heidelberg Univ, Inst Med Biometry & Informat, D-69120 Heidelberg, Germany; [Hyhlik-Duerr, Alexander] Heidelberg Univ, Dept Vasc & Endovasc Surg, D-69120 Heidelberg, Germany; [Schueler, Philipp] Univ Gottingen, Univ Med Ctr, Dept Gen & Visceral Surg, D-37073 Gottingen, Germany; [Schiergens, Tobias S.] Univ Munich, Dept Gen Visceral Transplantat Vasc & Thorac Surg, Munich, Germany; [Atanassov, Vladimir] Vivantes Klinikum Neukolln, Berlin, Germany; [Neudecker, Jens] Campus Charite Mitte, Dept Gen Visceral Vasc & Thorac Surg, Berlin, Germany; [Stein, Erwin] St Josefs Hosp Dortmund Horde, Dept Gen Visceral & Trauma Surg, Dortmund, Germany; [Thielemann, Henryk] Unfallkrankenhaus Berlin, Clin Gen & Visceral Surg, Berlin, Germany; [Kunz, Reiner] St Joseph Hosp Berlin Tempelhof, Clin Gen & Visceral Surg, Berlin, Germany; [von Frankenberg, Moritz] Krankenhaus Salem, Dept Surg, Dept Gen Abdominal & Minimal Invas Surg, Heidelberg, Germany; [Schernikau, Utz] Pk Klin Weissensee, Dept Gen Visceral & Minimal Invas Surg, Berlin, Germany; [Bunse, Joerg] Sana Klinikum Lichtenberg, Dept Gen & Visceral Surg, Berlin, Germany; [Jansen-Winkeln, Boris] Univ Med Mainz, Clin Gen Visceral & Transplantat Surg, Mainz, Germany; [Partecke, Lars I.] Univ Med Greifswald, Dept Gen Visceral Thorac & Vasc Surg, Greifswald, Germany; [Prechtl, Gerald] Kliniken Landkreises Neumarkt ID Oberpfalz, Surg Clin, Neumarkt, Germany; [Pochhammer, Julius] Marienhosp Stuttgart, Clin Gen Visceral & Thorac Surg, Stuttgart, Germany; [Bouchard, Ralf] Univ Clin Schleswig Holstein, Surg Clin, Lubeck, Germany; [Hodina, Rene] Klinikum Steinenberg Reutlingen, Clin Gen Visceral & Thorax Surg, Reutlingen, Germany; [Beckurts, K. Tobias E.] Krankenhaus Augustinerinnen, Dept Gen Visceral & Trauma Surg, Cologne, Germany; [Leissner, Lothar] Univ Klinikum Schleswig Holstein, Clin Gen Visceral Thorac Transplantat & Pediat Su, Kiel, Germany; [Lemmens, Hans-Peter] Gemeinschaftskrankenhaus Havelhohe, Dept Surg, Berlin, Germany; [Kallinowski, Friedrich] Asklepios Klin Harburg, Dept Gen & Visceral Surg, Hamburg, Germany; [Thomusch, Oliver] Univ Freiburg, Dept Gen & Visceral Surg, D-79106 Freiburg, Germany; [Seehofer, Daniel] Charite Campus Virchow Klinikum, Dept Gen Visceral & Transplantat Surg, Berlin, Germany; [Simon, Thomas] GRN Klin Sinsheim, Dept Gen & Visceral Surg, Sinsheim, Germany; [Seiler, Christoph M.] Josephs Hosp Warendorf, Dept Gen Visceral & Vasc Surg, Warendorf, Germany; [Reissfelder, Christoph] Univ Hosp Carl Gustav Carus, Dept Visceral Thorac & Vasc Surg, Dresden, Germany; [Hennig, Rene] Katharinen Hosp, Dept Gen & Visceral Surg, D-70174 Stuttgart, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Gottingen; University of Munich; VIivantes Klinikum Neukolln; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Johannes Gutenberg University of Mainz; Greifswald Medical School; St. Marien Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Freiburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Klinikum Stuttgart	Buchler, MW (corresponding author), Heidelberg Univ, Dept Gen Visceral & Transplantat Surg, Neuenheimer Feld 110, D-69120 Heidelberg, Germany.	markus.buechler@med.uni-heidelberg.de	Jansen-Winkeln, Boris/AAI-9550-2021; Atanassov, Vladimir/AAM-6993-2021; Seehofer, Daniel/X-1933-2019; Seiler, Christoph/AAG-7056-2021	Jansen-Winkeln, Boris/0000-0002-3996-9391; Reissfelder, Christoph/0000-0003-4591-1046	Johnson & Johnson Medical Limited	Johnson & Johnson Medical Limited	This trial was funded by a grant from Johnson & Johnson Medical Limited. We thank the staff of all participating centres of the PROUD trial Group and the German Surgical Research Network (CHIR-Net)-a network for clinical research in surgery-for their outstanding engagement and support of the trial.	Baracs J, 2011, SURG INFECT, V12, P483, DOI 10.1089/sur.2011.001; BAUER P, 1994, BIOMETRICS, V50, P1029, DOI 10.2307/2533441; Brannath W, 2002, J AM STAT ASSOC, V97, P236, DOI 10.1198/016214502753479374; Chang WK, 2012, ANN SURG, V255, P854, DOI 10.1097/SLA.0b013e31824e7005; Cheadle William G, 2006, Surg Infect (Larchmt), V7 Suppl 1, pS7, DOI 10.1089/sur.2006.7.s-7; de Lissovoy G, 2009, AM J INFECT CONTROL, V37, P387, DOI 10.1016/j.ajic.2008.12.010; Diana M, 2011, WORLD J SURG, V35, P280, DOI 10.1007/s00268-010-0862-0; Heger U, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-245; Higgins JPT, 2008, CLIN TRIALS, V5, P225, DOI 10.1177/1740774508091600; HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606; Justinger C, 2013, SURGERY, V154, P589, DOI 10.1016/j.surg.2013.04.011; Justinger C, 2011, LANGENBECK ARCH SURG, V396, P845, DOI 10.1007/s00423-011-0786-7; Justinger C, 2009, SURGERY, V145, P330, DOI 10.1016/j.surg.2008.11.007; KATZ S, 1981, ANN SURG, V194, P35, DOI 10.1097/00000658-198107000-00007; Kirkland KB, 1999, INFECT CONT HOSP EP, V20, P725, DOI 10.1086/501572; Malone DL, 2002, J SURG RES, V103, P89, DOI 10.1006/jsre.2001.6343; Masini BD, 2011, J SURG EDUC, V68, P101, DOI 10.1016/j.jsurg.2010.09.015; McCulloch P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3012; Ming XT, 2008, SURG INFECT, V9, P451, DOI 10.1089/sur.2007.061; Nakamura T, 2013, SURGERY, V153, P576, DOI 10.1016/j.surg.2012.11.018; Neumayer L, 2007, J AM COLL SURGEONS, V204, P1178, DOI 10.1016/j.jamcollsurg.2007.03.022; NICE Guidance, SURG SIT INF CG74; Rasic Z, 2011, COLLEGIUM ANTROPOL, V35, P439; Rubin D. B., 2004, MULTIPLE IMPUTATION; Seiler CM, 2009, ANN SURG, V249, P576, DOI 10.1097/SLA.0b013e31819ec6c8; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.3.CO;2-S; Wacha H., 2010, CHEMOTHER J, V19, P70; Wang ZX, 2013, BRIT J SURG, V100, P465, DOI 10.1002/bjs.9062	28	108	110	2	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					142	152		10.1016/S0140-6736(14)60238-5	http://dx.doi.org/10.1016/S0140-6736(14)60238-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL1YC	24718270				2022-12-28	WOS:000338921500033
J	Masha, L; Bernard, S				Masha, Luke; Bernard, Sheilah			Grey Turner's sign suggesting retroperitoneal haemorrhage	LANCET			English	Editorial Material									[Masha, Luke; Bernard, Sheilah] Boston Univ, Boston, MA 02118 USA	Boston University	Masha, L (corresponding author), Boston Univ, 72 East Concord St Evans 124, Boston, MA 02118 USA.	luke.masha@BMC.org							0	4	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2014	383	9932					1920	1920		10.1016/S0140-6736(13)61943-1	http://dx.doi.org/10.1016/S0140-6736(13)61943-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI4PR	24767964				2022-12-28	WOS:000336847800032
J	Jordan-Young, RM; Sonksen, PH; Karkazis, K				Jordan-Young, Rebecca M.; Soenksen, Peter H.; Karkazis, Katrina			Sex, health, and athletes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OUT-OF-BOUNDS; ANDROGEN EXCESS; HYPERANDROGENISM; MANAGEMENT; DISORDERS; CRITIQUE; POLICIES; WOMEN		[Jordan-Young, Rebecca M.] Columbia Univ, Barnard Coll, New York, NY USA; [Soenksen, Peter H.] St Thomas Hosp, London, England; [Soenksen, Peter H.] Kings Coll London, London WC2R 2LS, England; [Soenksen, Peter H.] Univ Southampton, Southampton, Hants, England; [Karkazis, Katrina] Stanford Univ, Stanford, CA 93405 USA	Columbia University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Southampton; Stanford University	Karkazis, K (corresponding author), Stanford Univ, 1215 Welch Rd, Stanford, CA 93405 USA.	karkazis@stanford.edu	Karkazis, Katrina/AAE-7276-2019	Karkazis, Katrina/0000-0001-9103-2881	Divn Of Social and Economic Sciences [1331123] Funding Source: National Science Foundation	Divn Of Social and Economic Sciences(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Achermann JC, 2011, WILLIAMS TXB ENDOCRI, V12th, P868; [Anonymous], SPORT TRANS MAK SPOR; [Anonymous], 2010, GUARDIAN; Archer JS, 2004, BEST PRACT RES CL OB, V18, P737, DOI 10.1016/j.bpobgyn.2004.05.007; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P453, DOI 10.1210/jc.2003-031122; Bermon S., 2012, GEND VER; Bermon S, 2013, AM J BIOETHICS, V13, P63, DOI 10.1080/15265161.2013.776129; Carmina E, 2006, J CLIN ENDOCR METAB, V91, P2, DOI 10.1210/jc.2005-1457; Cook CJ, 2013, PHYSIOL BEHAV, V116, P8, DOI 10.1016/j.physbeh.2013.03.013; Fenichel P, 2013, J CLIN ENDOCR METAB, V98, pE1055, DOI 10.1210/jc.2012-3893; FIFA, 2011, GEND VER; Genel M, 2010, PEDIATR RES, V68, P149, DOI 10.1203/00006450-201011001-00289; Goodman N F, 2001, Endocr Pract, V7, P120; Government of India Ministry of Youth and Sports, 2013, STAND OP PROC ID CIR; Healy ML, 2014, CLIN ENDOCRINOL; International Association of Athletics Federations, 2011, IAAF REG GOV ELIG FE; International Association of Athletics Federations, 2011, HYP REG EXPL NOT; International Olympic Committee, 2014, IOC REG FEM HYP; Karkazis K, 2012, AM J BIOETHICS, V12, P3, DOI 10.1080/15265161.2012.680533; King NMP, 2013, AM J BIOETHICS, V13, P13, DOI 10.1080/15265161.2013.828126; Ljungqvist A, 2012, GENDER VER SPORT; Riepe FG, 2002, HORM RES, V58, P196, DOI 10.1159/000065492; Wunsch L, 2012, BJU INT, V110, pE958, DOI 10.1111/j.1464-410X.2012.11181.x; Xavier NA, 2012, J CLIN ENDOCR METAB, V97, P3902, DOI 10.1210/jc.2012-2792	24	25	25	2	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2014	348								g2926	10.1136/bmj.g2926	http://dx.doi.org/10.1136/bmj.g2926			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5PN	24776640				2022-12-28	WOS:000335471000005
J	McCartney, M				McCartney, Margaret			Research press releases need better policing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2014, ITV NEWS        0401; Lynch CD, 2014, HUM REPROD, V29, P1067, DOI 10.1093/humrep/deu032; Oyebode O., 2014, J EPIDEMIOL COMMUNIT; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Stephens P., 2014, BBC NEWS; Yavchitz A, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001308	6	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2014	348								g2868	10.1136/bmj.g2868	http://dx.doi.org/10.1136/bmj.g2868			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5PN	24776381				2022-12-28	WOS:000335471000003
J	Kress, JP; Hall, JB				Kress, John P.; Hall, Jesse B.			CRITICAL CARE MEDICINE ICU-Acquired Weakness and Recovery from Critical Illness	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RESPIRATORY-DISTRESS-SYNDROME; INTENSIVE INSULIN THERAPY; ILL PATIENTS; MECHANICAL VENTILATION; FUNCTIONAL DISABILITY; RISK-FACTORS; MYOPATHY; MUSCLE; UNIT; POLYNEUROPATHY		[Kress, John P.; Hall, Jesse B.] Univ Chicago, Dept Med, Sect Pulm & Crit Care, Chicago, IL 60637 USA	University of Chicago	Kress, JP (corresponding author), Univ Chicago, Dept Med, Sect Pulm & Crit Care, 5841 S Maryland Ave,MC 6026, Chicago, IL 60637 USA.	jkress@medicine.bsd.uchicago.edu			Hospira; France Foundation	Hospira; France Foundation	Dr. Kress reports receiving lecture fees from Hospira and the France Foundation and fees for expert testimony in medical malpractice cases. Dr. Hall reports receiving fees for expert testimony in a patent case (Hospira v. Sandoz) and in medical malpractice cases on behalf of a patient, physicians, and hospitals. No other potential conflict of interest relevant to this article was reported.	Bailey P, 2007, CRIT CARE MED, V35, P139, DOI 10.1097/01.CCM.0000251130.69568.87; Bednarik J, 2005, J NEUROL, V252, P343, DOI 10.1007/s00415-005-0654-x; Bednarik J, 2003, INTENS CARE MED, V29, P1505, DOI 10.1007/s00134-003-1858-0; Bolton CF, 2005, MUSCLE NERVE, V32, P140, DOI 10.1002/mus.20304; BOLTON CF, 1984, J NEUROL NEUROSUR PS, V47, P1223, DOI 10.1136/jnnp.47.11.1223; BURNS JR, 1975, CHEST, V68, P608; Burtin C, 2009, CRIT CARE MED, V37, P2499, DOI 10.1097/CCM.0b013e3181a38937; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; Clavet H, 2011, DISABIL REHABIL, V33, P105, DOI 10.3109/09638288.2010.486468; De Jonghe B, 2004, INTENS CARE MED, V30, P1117, DOI 10.1007/s00134-004-2174-z; De Jonghe B, 2003, CRIT CARE MED, V31, P2344, DOI 10.1097/01.CCM.0000084850.16444.94; De Jonghe B, 2002, JAMA-J AM MED ASSOC, V288, P2859, DOI 10.1001/jama.288.22.2859; Derde S, 2012, CRIT CARE MED, V40, P79, DOI 10.1097/CCM.0b013e31822d7c18; Dock W, 1944, J AMER MED ASSOC, V125, P1083, DOI 10.1001/jama.1944.02850340009004; Druschky A, 2001, INTENS CARE MED, V27, P686, DOI 10.1007/s001340100890; Fenzi F, 2003, ACTA NEUROPATHOL, V106, P75, DOI 10.1007/s00401-003-0704-3; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finfer S, 2012, NEW ENGL J MED, V367, P1108, DOI 10.1056/NEJMoa1204942; Fletcher SN, 2003, CRIT CARE MED, V31, P1012, DOI 10.1097/01.CCM.0000053651.38421.D9; Garnacho-Montero J, 2001, INTENS CARE MED, V27, P1288, DOI 10.1007/s001340101009; Griffiths RD, 1995, NUTRITION, V11, P428; Hermans G, 2007, AM J RESP CRIT CARE, V175, P480, DOI 10.1164/rccm.200605-665OC; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Hopkins RO, 2009, CLIN CHEST MED, V30, P143, DOI 10.1016/j.ccm.2008.11.001; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jaber S, 2011, AM J RESP CRIT CARE, V183, P364, DOI 10.1164/rccm.201004-0670OC; KLEYWEG RP, 1991, MUSCLE NERVE, V14, P1103, DOI 10.1002/mus.880141111; Koch S, 2011, J NEUROL NEUROSUR PS, V82, P287, DOI 10.1136/jnnp.2009.192997; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Latronico N, 2003, INTENS CARE MED, V29, P1411, DOI 10.1007/s00134-003-1884-y; Latronico N, 1996, LANCET, V347, P1579, DOI 10.1016/S0140-6736(96)91074-0; Leatherman JW, 1996, AM J RESP CRIT CARE, V153, P1686, DOI 10.1164/ajrccm.153.5.8630621; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Levine S, 2011, AM J RESP CRIT CARE, V183, P483, DOI 10.1164/rccm.200910-1487OC; MACFARLANE IA, 1977, LANCET, V2, P615; Morris C, 2002, CRIT CARE MED, V30, P2612, DOI 10.1097/00003246-200211000-00048; Morris PE, 2008, CRIT CARE MED, V36, P2238, DOI 10.1097/CCM.0b013e318180b90e; Morris PE, 2011, AM J MED SCI, V341, P373, DOI 10.1097/MAJ.0b013e31820ab4f6; Needham DM, 2010, ARCH PHYS MED REHAB, V91, P536, DOI 10.1016/j.apmr.2010.01.002; OLSEN CW, 1956, JAMA-J AM MED ASSOC, V160, P39, DOI 10.1001/jama.1956.02960360041008; Osler W, 1915, PRINCIPLES PRACTICE, P114; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Pohlman MC, 2010, CRIT CARE MED, V38, P2089, DOI 10.1097/CCM.0b013e3181f270c3; Powers SK, 2002, J APPL PHYSIOL, V92, P1851, DOI 10.1152/japplphysiol.00881.2001; Reid MB, 2011, J PHYSIOL-LONDON, V589, P2171, DOI 10.1113/jphysiol.2010.203356; Rich MM, 2003, J PHYSIOL-LONDON, V547, P555, DOI 10.1113/jphysiol.2002.035188; Rich MM, 2002, CARDIOLOGY, V97, P187, DOI 10.1159/000063120; Sacanella E, 2011, CRIT CARE, V15, DOI 10.1186/cc10121; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Slutsky AS, 2010, NEW ENGL J MED, V363, P1176, DOI 10.1056/NEJMe1007136; Stevens Robert D, 2009, Crit Care Med, V37, pS299, DOI 10.1097/CCM.0b013e3181b6ef67; Trojaborg W, 2001, CLIN NEUROPHYSIOL, V112, P1586, DOI 10.1016/S1388-2457(01)00572-7; Turner DA, 2011, CRIT CARE MED, V39, P2593, DOI 10.1097/CCM.0b013e3182282bbe; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; ZOCHODNE DW, 1987, BRAIN, V110, P819, DOI 10.1093/brain/110.4.819	57	397	445	8	71	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 24	2014	370	17					1626	1635		10.1056/NEJMra1209390	http://dx.doi.org/10.1056/NEJMra1209390			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4TG	24758618				2022-12-28	WOS:000336120500009
J	Gregg, EW; Li, YF; Wang, J; Burrows, NR; Ali, MK; Rolka, D; Williams, DE; Geiss, L				Gregg, Edward W.; Li, Yanfeng; Wang, Jing; Burrows, Nilka Rios; Ali, Mohammed K.; Rolka, Deborah; Williams, Desmond E.; Geiss, Linda			Changes in Diabetes-Related Complications in the United States, 1990-2010	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOWER-EXTREMITY AMPUTATIONS; US ADULTS; PUBLIC-HEALTH; LONG-TERM; TRENDS; INDIVIDUALS; DISEASE; RATES; RISK	Background: Preventive care for adults with diabetes has improved substantially in recent decades. We examined trends in the incidence of diabetes-related complications in the United States from 1990 through 2010. Methods: We used data from the National Health Interview Survey, the National Hospital Discharge Survey, the U.S. Renal Data System, and the U.S. National Vital Statistics System to compare the incidences of lower-extremity amputation, end-stage renal disease, acute myocardial infarction, stroke, and death from hyperglycemic crisis between 1990 and 2010, with age standardized to the U.S. population in the year 2000. Results: Rates of all five complications declined between 1990 and 2010, with the largest relative declines in acute myocardial infarction (-67.8%; 95% confidence interval [CI], -76.2 to -59.3) and death from hyperglycemic crisis (-64.4%; 95% CI, -68.0 to -60.9), followed by stroke and amputations, which each declined by approximately half (-52.7% and -51.4%, respectively); the smallest decline was in end-stage renal disease (-28.3%; 95% CI, -34.6 to -21.6). The greatest absolute decline was in the number of cases of acute myocardial infarction (95.6 fewer cases per 10,000 persons; 95% CI, 76.6 to 114.6), and the smallest absolute decline was in the number of deaths from hyperglycemic crisis (-2.7; 95% CI, -2.4 to -3.0). Rate reductions were larger among adults with diabetes than among adults without diabetes, leading to a reduction in the relative risk of complications associated with diabetes. When expressed as rates for the overall population, in which a change in prevalence also affects complication rates, there was a decline in rates of acute myocardial infarction and death from hyperglycemic crisis (2.7 and 0.1 fewer cases per 10,000, respectively) but not in rates of amputation, stroke, or end-stage renal disease. Conclusions: Rates of diabetes-related complications have declined substantially in the past two decades, but a large burden of disease persists because of the continued increase in the prevalence of diabetes. (Funded by the Centers for Disease Control and Prevention.)	[Gregg, Edward W.; Li, Yanfeng; Wang, Jing; Burrows, Nilka Rios; Ali, Mohammed K.; Rolka, Deborah; Williams, Desmond E.; Geiss, Linda] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30341 USA; [Ali, Mohammed K.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health	Gregg, EW (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy, Atlanta, GA 30341 USA.	edg7@cdc.gov	li, yan/GTI-4638-2022; Ali, Mohammed K/N-9833-2013	Gregg, Edward/0000-0003-2381-6822; Ali, Mohammed/0000-0001-7266-2503				Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; Angell SY, 2012, ANN INTERN MED, V157, P81, DOI 10.7326/0003-4819-157-2-201207170-00004; [Anonymous], 2000, Vital Health Stat 2, P1; [Anonymous], 2013, NAT DIAB SURV SYST; [Anonymous], 2011, NAT DIAB FACT SHEET; Booth GL, 2006, DIABETES CARE, V29, P32, DOI 10.2337/diacare.29.1.32; Booth GL, 2005, DIABETES CARE, V28, P1045, DOI 10.2337/diacare.28.5.1045; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P986; Cowie CC, 2011, DIABETES CARE, V34, P2338; Dennison C, 2000, Vital Health Stat 1, P1; Diabet Control Complications Trial DCCT Res Grp, 1995, AM J CARDIOL, V75, P894; Epstein AJ, 2011, JAMA-J AM MED ASSOC, V305, P1769, DOI 10.1001/jama.2011.551; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Ford ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065228; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Geiss LS, 2006, AM J PREV MED, V30, P371, DOI 10.1016/j.amepre.2005.12.009; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Gregg EW, 2012, DIABETES CARE, V35, P1252, DOI 10.2337/dc11-1162; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; Ikonen TS, 2010, DIABETES CARE, V33, P2598, DOI 10.2337/dc10-0462; Kennon B, 2012, DIABETES CARE, V35, P2588, DOI 10.2337/dc12-0511; Kitabchi AE, 2009, DIABETES CARE, V32, P1335, DOI 10.2337/dc09-9032; Li YF, 2012, DIABETES CARE, V35, P273, DOI 10.2337/dc11-1360; Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144; McKinlay J, 2000, LANCET, V356, P757, DOI 10.1016/S0140-6736(00)02641-6; Murphy Sherry L, 2013, Natl Vital Stat Rep, V61, P1; Myerson M, 2009, CIRCULATION, V119, P503, DOI 10.1161/CIRCULATIONAHA.107.693879; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; U. S. Renal Data System Coordinating Center, 2012, USRDS 2012 RES GUID; UK Prospective Diabetes Study Group, 1999, BMJ-BRIT MED J, V318, P29; Vamos EP, 2010, DIABETES CARE, V33, P2592, DOI 10.2337/dc10-0989; VINICOR F, 1994, DIABETES CARE, V17, P22; Wang J, 2011, DIABETES CARE, V34, P1579, DOI 10.2337/dc11-0178; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610	41	1073	1109	4	75	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 17	2014	370	16					1514	1523		10.1056/NEJMoa1310799	http://dx.doi.org/10.1056/NEJMoa1310799			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF3HE	24738668	Bronze			2022-12-28	WOS:000334601600008
J	Cox, JF				Cox, John F.			Review: Exercise reduces mortality compared with drugs in stroke but not in CHD, HF, or prediabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Rochester, Sch Med, Rochester, NY USA	University of Rochester	Cox, JF (corresponding author), Univ Rochester, Sch Med, Rochester, NY USA.							Lian XQ, 2014, PREV MED, V58, P64, DOI 10.1016/j.ypmed.2013.10.020	1	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2014	160	8							JC3	10.7326/0003-4819-160-8-201404150-02003	http://dx.doi.org/10.7326/0003-4819-160-8-201404150-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW3QU	24733220				2022-12-28	WOS:000364907600002
J	Kaw, R				Kaw, Roop			In patients with obstructive sleep apnea and resistant hypertension, CPAP reduced 24-hour blood pressure	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Cleveland Clin, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Kaw, R (corresponding author), Cleveland Clin, Cleveland, OH 44106 USA.		Kaw, Roop/A-7877-2009	Kaw, Roop/0000-0001-7712-7729				Fagard RH, 2008, HYPERTENSION, V51, P55, DOI 10.1161/HYPERTENSIONAHA.107.100727; Logan AG, 2003, EUR RESPIR J, V21, P241, DOI 10.1183/09031936.03.00035402; Lozano L, 2010, J HYPERTENS, V28, P2161, DOI 10.1097/HJH.0b013e32833b9c63; Seif F, 2014, J HYPERTENS, V32, P267, DOI 10.1097/HJH.0000000000000011; Weaver Terri E, 2008, Proc Am Thorac Soc, V5, P173, DOI 10.1513/pats.200708-119MG	5	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2014	160	8							JC10	10.7326/0003-4819-160-8-201404150-02010	http://dx.doi.org/10.7326/0003-4819-160-8-201404150-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW3QU	24733215				2022-12-28	WOS:000364907600009
J	Feehally, J; Couser, W; Dupuis, S; Finkelstein, F; Harden, P; Harris, D; Lameire, N; Naicker, S; Remuzzi, G; Segantini, L; Tonelli, M				Feehally, John; Couser, William; Dupuis, Sophie; Finkelstein, Fredric; Harden, Paul; Harris, David; Lameire, Norbert; Naicker, Sarala; Remuzzi, Giuseppe; Segantini, Luca; Tonelli, Marcello			Nephrology in developing countries: the ISN's story	LANCET			English	Editorial Material							CHRONIC KIDNEY-DISEASE		[Feehally, John; Couser, William; Dupuis, Sophie; Finkelstein, Fredric; Harden, Paul; Harris, David; Lameire, Norbert; Naicker, Sarala; Remuzzi, Giuseppe; Segantini, Luca; Tonelli, Marcello] Int Soc Nephrol, B-1000 Brussels, Belgium		Feehally, J (corresponding author), Int Soc Nephrol, B-1000 Brussels, Belgium.	jf27@le.ac.uk	; Remuzzi, Giuseppe/V-9766-2017	Naicker, Saraladevi/0000-0002-7058-9725; Segantini, Luca/0000-0003-4949-8623; Remuzzi, Giuseppe/0000-0002-6194-3446				Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Harden PN, 2012, QJM-INT J MED, V105, P389, DOI 10.1093/qjmed/hcs007; Harris DCH, 2012, KIDNEY INT SUPPL, V2, P275, DOI 10.1038/kisup.2012.32; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9	6	10	10	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 12	2014	383	9925					1271	1272		10.1016/S0140-6736(13)62711-7	http://dx.doi.org/10.1016/S0140-6736(13)62711-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE6LQ	24725563				2022-12-28	WOS:000334104900004
J	Holmes, D				Holmes, David			Diana Farmer: pioneer of fetal surgery	LANCET			English	Biographical-Item																			0	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 12	2014	383	9925					1287	1287		10.1016/S0140-6736(14)60633-4	http://dx.doi.org/10.1016/S0140-6736(14)60633-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6LQ	24725566				2022-12-28	WOS:000334104900013
J	Cheetham, CE; Belluscio, L				Cheetham, Claire E.; Belluscio, Leonardo			An Olfactory Critical Period	SCIENCE			English	Editorial Material							RESTORATION		[Cheetham, Claire E.; Belluscio, Leonardo] NINDS, Dev Neural Plast Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Cheetham, CE (corresponding author), NINDS, Dev Neural Plast Sect, NIH, 35 Convent Dr, Bethesda, MD 20892 USA.	belluscl@ninds.nih.gov	Cheetham, Claire/A-2612-2017	Cheetham, Claire/0000-0002-4038-1501	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003002] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Cheng N, 2013, J NEUROSCI, V33, P12208, DOI 10.1523/JNEUROSCI.0291-13.2013; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Ma LM, 2014, SCIENCE, V344, P194, DOI 10.1126/science.1248805; Nguyen MQ, 2010, J NEUROSCI, V30, P9271, DOI 10.1523/JNEUROSCI.1502-10.2010; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Tsai L, 2014, SCIENCE, V344, P197, DOI 10.1126/science.1248806; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	8	7	7	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					157	158		10.1126/science.1253136	http://dx.doi.org/10.1126/science.1253136			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24723600				2022-12-28	WOS:000334096300022
J	Gong, JP				Gong, Jian Ping			Materials both Tough and Soft	SCIENCE			English	Editorial Material							HYDROGELS; RECOVERY		Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan	Hokkaido University	Gong, JP (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan.	gong@mail.sci.hokudai.ac.jp	Gong, Jian Ping/B-7019-2009	Gong, Jian Ping/0000-0003-2228-2750				Ducrot E, 2014, SCIENCE, V344, P186, DOI 10.1126/science.1248494; Gong JP, 2010, SOFT MATTER, V6, P2583, DOI 10.1039/b924290b; Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907; Haque MA, 2011, MACROMOLECULES, V44, P8916, DOI 10.1021/ma201653t; Henderson KJ, 2010, MACROMOLECULES, V43, P6193, DOI 10.1021/ma100963m; Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409; Sun TL, 2013, NAT MATER, V12, P932, DOI [10.1038/NMAT3713, 10.1038/nmat3713]; Thompson JB, 2001, NATURE, V414, P773, DOI 10.1038/414773a; Zhao XH, 2014, SOFT MATTER, V10, P672, DOI 10.1039/c3sm52272e	9	269	276	20	456	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					161	162		10.1126/science.1252389	http://dx.doi.org/10.1126/science.1252389			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24723604				2022-12-28	WOS:000334096300026
J	Bidaye, SS; Machacek, C; Wu, Y; Dickson, BJ				Bidaye, Salil S.; Machacek, Christian; Wu, Yang; Dickson, Barry J.			Neuronal Control of Drosophila Walking Direction	SCIENCE			English	Article							STICK INSECT; JOINT COORDINATION; THORACIC REFLEXES; BACKWARD WALKING; DESCENDING INPUT; COCKROACH; EXPRESSION; MARKER; PATTERNS; LIGHT	Most land animals normally walk forward but switch to backward walking upon sensing an obstacle or danger in the path ahead. A change in walking direction is likely to be triggered by descending "command" neurons from the brain that act upon local motor circuits to alter the timing of leg muscle activation. Here we identify descending neurons for backward walking in Drosophila-the MDN neurons. MDN activity is required for flies to walk backward when they encounter an impassable barrier and is sufficient to trigger backward walking under conditions in which flies would otherwise walk forward. We also identify ascending neurons, MAN, that promote persistent backward walking, possibly by inhibiting forward walking. These findings provide an initial glimpse into the circuits and logic that control walking direction in Drosophila.	[Bidaye, Salil S.; Machacek, Christian; Wu, Yang; Dickson, Barry J.] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Dickson, BJ (corresponding author), Res Inst Mol Pathol IMP, Dr Bohrgasse 7, A-1030 Vienna, Austria.	dicksonb@janelia.hhmi.org	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Bidaye, Salil/0000-0001-9494-6531; Wu, Yang/0000-0002-7782-8290	Boehringer Ingelheim GmbH	Boehringer Ingelheim GmbH(Boehringer Ingelheim)	We thank L. Tirian and the entire VT project team for generating and staining VT GAL4 and split-GAL4 lines; A. Buschges and M. Palfreyman for insightful discussions and comments on the manuscript; M. Columbini and D. Kummerer for constructing the various assay chambers; K. Heinze for help with the laser sheet setup; and H. Grasberger and W. Li for help in developing the tracker. Basic research at the IMP is funded in part by Boehringer Ingelheim GmbH.	Akay T, 2007, J NEUROSCI, V27, P3285, DOI 10.1523/JNEUROSCI.5202-06.2007; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; Burdohan JA, 1996, J NEUROSCI, V16, P5830; BUSCHGES A, 1995, J EXP BIOL, V198, P435; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHRACHRI A, 1987, NEUROSCI LETT, V77, P49, DOI 10.1016/0304-3940(87)90605-7; GRAHAM D, 1985, J EXP BIOL, V118, P287; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; Mu LY, 2008, J COMP PHYSIOL A, V194, P283, DOI 10.1007/s00359-007-0307-x; Mu LY, 2008, J COMP PHYSIOL A, V194, P299, DOI 10.1007/s00359-007-0309-8; Nicolai LJJ, 2010, P NATL ACAD SCI USA, V107, P20553, DOI 10.1073/pnas.1010198107; PEARSON KG, 1972, J EXP BIOL, V56, P173; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Rosenbaum P, 2010, J NEUROPHYSIOL, V104, P1681, DOI 10.1152/jn.00362.2010; Schoneich S, 2011, J COMP NEUROL, V519, P1677, DOI 10.1002/cne.22594; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Toth TI, 2012, J NEUROPHYSIOL, V107, P3267, DOI 10.1152/jn.01124.2011; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	21	103	103	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					97	101		10.1126/science.1249964	http://dx.doi.org/10.1126/science.1249964			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700860				2022-12-28	WOS:000333746100061
J	Zhao, QM; Ma, XJ; Ge, XL; Liu, F; Yan, WL; Wu, L; Ye, M; Liang, XC; Zhang, J; Gao, Y; Jia, B; Huang, GY				Zhao, Qu-ming; Ma, Xiao-jing; Ge, Xiao-ling; Liu, Fang; Yan, Wei-li; Wu, Lin; Ye, Ming; Liang, Xue-cun; Zhang, Jing; Gao, Yan; Jia, Bing; Huang, Guo-ying		Neonatal Congenital Heart Dis	Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a prospective study	LANCET			English	Article							NEWBORN-INFANTS; DEFECTS; PREVALENCE; METAANALYSIS	Background Several pioneering studies have provided evidence for the introduction of universal pulse oximetry screening for critical congenital heart disease. However, whether the benefits of screening reported in studies from high-income countries would translate with similar success to low-income countries is unknown. We assessed the feasibility and reliability of pulse oximetry plus clinical assessment for detection of major congenital heart disease, especially critical congenital heart disease, in China. Methods We did a pilot study at three hospitals in Shanghai to assess the accuracy of pulse oximetry plus clinical assessment for detection of congenital heart disease. We made a data collection plan before recruitment. We then undertook a large, prospective, and multicentre screening study in which we screened all consecutive newborn babies (aged 6-72 h) born at 18 hospitals in China between Aug 1, 2011, and Nov 30, 2012. Newborn babies with positive screen results (either an abnormal pulse oximetry or abnormal clinical assessment) were referred for echocardiography within 24 h of screening. We identified false-negative results by clinical follow-up and parents' feedback. We calculated sensitivity, specificity, positive and negative predictive values, and positive and negative likelihood ratios for pulse oximetry alone, and in combination with clinical assessment, for detection of major and critical congenital heart disease. Findings In the pilot study, 6785 consecutive newborn babies were screened; 46 of 49 (94%) cases of asymptomatic major congenital heart disease and eight of eight (100%) cases of asymptomatic critical disease were detected by pulse oximetry and clinical assessment. In the prospective multicentre study, we screened 122 738 consecutive newborn babies (120 707 asymptomatic and 2031 symptomatic), and detected congenital heart disease in 1071 (157 critical and 330 major). In asymptomatic newborn babies, the sensitivity of pulse oximetry plus clinical assessment was 93 2% (95% CI 87 9-96 2) for critical congenital heart disease and 90 2% (86.4-93.0) for major disease. The addition of pulse oximetry to clinical assessment improved sensitivity for detection of critical congenital heart disease from 77.4% (95% CI 70 0-83.4) to 93 2% (87 9-96.2). The false-positive rate for detection of critical disease was 2.7% (3298 of 120 392) for clinical assessment alone and 0 3% (394 of 120 561) for pulse oximetry alone. Interpretation Pulse oximetry plus clinical assessment is feasible and reliable for the detection of major congenital heart disease in newborn babies in China. This simple and accurate combined method should be used in maternity hospitals to screen for congenital heart disease. Funding Key Clinical Research Project sponsored by Ministry of Health, Shanghai Public Health Three-Year Action Plan sponsored by Shanghai Municipal Government, and National Basic Research Project of China.	[Zhao, Qu-ming; Ma, Xiao-jing; Ge, Xiao-ling; Liu, Fang; Yan, Wei-li; Wu, Lin; Ye, Ming; Liang, Xue-cun; Zhang, Jing; Gao, Yan; Jia, Bing; Huang, Guo-ying] Fudan Univ, Childrens Hosp, Pediat Heart Ctr, Shanghai 201102, Peoples R China; [Ma, Xiao-jing; Ge, Xiao-ling; Yan, Wei-li; Huang, Guo-ying] Shanghai Key Lab Birth Defects, Shanghai, Peoples R China	Fudan University	Huang, GY (corresponding author), Fudan Univ, Childrens Hosp, Pediat Heart Ctr, Shanghai 201102, Peoples R China.	jiabing2012@hotmail.com; gyhuang@shmu.edu.cn	Yan, Weili/AAS-9448-2021; MA, XIAO/HHN-5611-2022	Yan, Weili/0000-0002-7633-7449; 	Ministry of Health, Shanghai Public Health Three-Year Action Plan - Shanghai Municipal Government; National Basic Research Project of China; Key Clinical Research Project - Ministry of Health [2010-239]; Shanghai Public Health Three-Year Action Plan - Shanghai Municipal Government [20155]; National Basic Research Project of China [2010CB529504]	Ministry of Health, Shanghai Public Health Three-Year Action Plan - Shanghai Municipal Government; National Basic Research Project of China(National Basic Research Program of China); Key Clinical Research Project - Ministry of Health; Shanghai Public Health Three-Year Action Plan - Shanghai Municipal Government; National Basic Research Project of China(National Basic Research Program of China)	Key Clinical Research Project sponsored by Ministry of Health, Shanghai Public Health Three-Year Action Plan sponsored by Shanghai Municipal Government, and National Basic Research Project of China.; Our study was funded by the Key Clinical Research Project Sponsored by Ministry of Health (BJ and G-yH, number 2010-239), Shanghai Public Health Three-Year Action Plan Sponsored by Shanghai Municipal Government (G-yH, number 20155), and National Basic Research Project of China (G-yH, number 2010CB529504). We thank all professionals involved in the Neonatal Congenital Heart Disease Screening Project; Wyman W Lai (Morgan Stanley Children's Hospital of New York Presbyterian, NY, USA) and Yiu-fai Cheung (University of Hong Kong, Hong Kong, China) for their comments and review of the report; Jian-feng Xu (Wake Forest School of Medicine, Winston-Salem, NC, USA) and Duo-lao Wang (University of London, London, UK) for their valuable comments on the revision of the report; and Anne de-Wahl Granelli from Queen Silvia Children's Hospital (Gothenburg, Sweden) for serving as our advisory board.	Arlettaz R, 2006, EUR J PEDIATR, V165, P94, DOI 10.1007/s00431-005-0006-y; Chang RKR, 2008, ARCH PEDIAT ADOL MED, V162, P969, DOI 10.1001/archpedi.162.10.969; Ewer AK, 2013, CURR OPIN CARDIOL, V28, P92, DOI 10.1097/HCO.0b013e32835d7e42; Ewer AK, 2012, EARLY HUM DEV, V88, P915, DOI 10.1016/j.earlhumdev.2012.09.013; Ewer AK, 2011, LANCET, V378, P785, DOI 10.1016/S0140-6736(11)60753-8; Granelli AD, 2009, BRIT MED J, V338, DOI 10.1136/bmj.a3037; Ho TC, 2011, PEDIATR CARDIOL, V32, P811, DOI 10.1007/s00246-011-9991-y; Hoffman JIE, 2011, NEONATOLOGY, V99, P1, DOI 10.1159/000311216; Kemper AR, 2011, PEDIATRICS, V128, pE1259, DOI 10.1542/peds.2011-1317; Kuelling B, 2009, SWISS MED WKLY, V139, P699, DOI smw-12880; Lindinger A, 2010, KLIN PADIATR, V222, P321, DOI 10.1055/s-0030-1254155; Meberg A, 2008, J PEDIATR-US, V152, P761, DOI 10.1016/j.jpeds.2007.12.043; Ministry of Health of the People's Republic of China, 2012, NAT BIRTH DEF CONTR; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Riede FT, 2010, EUR J PEDIATR, V169, P975, DOI 10.1007/s00431-010-1160-4; Saxena Anita, 2009, Expert Rev Cardiovasc Ther, V7, P1621, DOI 10.1586/erc.09.141; Sendelbach DM, 2008, PEDIATRICS, V122, pE815, DOI 10.1542/peds.2008-0781; Singh A, 2013, LANCET, V381, P535, DOI 10.1016/S0140-6736(13)60278-0; Thangaratinam S, 2012, LANCET, V379, P2459, DOI 10.1016/S0140-6736(12)60107-X; Turska Kmiec A, 2012, KARDIOL POL, V70, P370; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Wren C, 1999, ARCH DIS CHILD-FETAL, V80, pF49, DOI 10.1136/fn.80.1.F49; Wu KH, 2006, CHINESE MED J-PEKING, V119, P2005, DOI 10.1097/00029330-200612010-00011	23	126	163	4	60	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 30	2014	384	9945					747	754		10.1016/S0140-6736(14)60198-7	http://dx.doi.org/10.1016/S0140-6736(14)60198-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5DD	24768155				2022-12-28	WOS:000341361500035
J	Jones, A; Cremin, I; Abdullah, F; Idoko, J; Cherutich, P; Kilonzo, N; Rees, H; Hallett, T; O'Reilly, K; Koechlin, F; Schwartlander, B; de Zalduondo, B; Kim, S; Jay, J; Huh, J; Piot, P; Dybul, M				Jones, Alexandra; Cremin, Ide; Abdullah, Fareed; Idoko, John; Cherutich, Peter; Kilonzo, Nduku; Rees, Helen; Hallett, Timothy; O'Reilly, Kevin; Koechlin, Florence; Schwartlander, Bernhard; de Zalduondo, Barbara; Kim, Susan; Jay, Jonathan; Huh, Jacqueline; Piot, Peter; Dybul, Mark			Transformation of HIV from pandemic to low-endemic levels: a public health approach to combination prevention	LANCET			English	Article							SUB-SAHARAN AFRICA; HUMAN-IMMUNODEFICIENCY-VIRUS; RANDOMIZED CONTROLLED-TRIAL; POSTTRIAL FOLLOW-UP; REPORTED CONDOM USE; MALE CIRCUMCISION; ANTIRETROVIRAL THERAPY; PREEXPOSURE PROPHYLAXIS; BEHAVIOR-CHANGE; SOUTH-AFRICA	Large declines in HIV incidence have been reported since 2001, and scientific advances in HIV prevention provide strong hope to reduce incidence further. Now is the time to replace the quest for so-called silver bullets with a public health approach to combination prevention that understands that risk is not evenly distributed and that effective interventions can vary by risk profile. Different countries have different microepidemics, with very different levels of transmission and risk groups, changing over time. Therefore, focus should be on high-transmission geographies, people at highest risk for HIV, and the package of interventions that are most likely to have the largest effect in each different microepidemic. Building on the backbone of behaviour change, condom use, and medical male circumcision, as well as expanded use of antiretroviral drugs for infected people and pre-exposure prophylaxis for uninfected people at high risk of infection, it is now possible to consider the prospect of what would be one of the most remarkable achievements in the history of public health: reduction of HIV transmission from a pandemic to low-level endemicity.	[Jones, Alexandra; Kim, Susan; Jay, Jonathan; Huh, Jacqueline; Dybul, Mark] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Cremin, Ide; Hallett, Timothy] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Abdullah, Fareed] SANAC, Pretoria, South Africa; [Idoko, John] Natl Agcy Control AIDS, Abuja, Nigeria; [Cherutich, Peter] Natl AIDS STD Control Programme NASCOP, Nairobi, Kenya; [Kilonzo, Nduku] Liverpool Voluntary Counselling & Testing Care &, Nairobi, Kenya; [Rees, Helen] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, ZA-2050 Johannesburg, South Africa; [O'Reilly, Kevin; Koechlin, Florence] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland; [Schwartlander, Bernhard] UNAIDS, Dept Evidence Strategy & Results, Geneva, Switzerland; [de Zalduondo, Barbara] UNAIDS, Off Deputy Execut Director Programme, Geneva, Switzerland; [Piot, Peter] London Sch Hyg & Trop Med, Directors Off, London WC1, England; [Dybul, Mark] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland	Georgetown University; Imperial College London; University of Witwatersrand; World Health Organization; UNAIDS; UNAIDS; University of London; London School of Hygiene & Tropical Medicine	Dybul, M (corresponding author), Geneva Secretariat, Global Fund Fight AIDS TB & Malaria, Chemin Blandonnet 8, CH-1214 Geneva, Switzerland.	mark.dybul@theglobalfund.org		Cremin, Ide/0000-0003-2560-6247; Abdullah, Fareed/0000-0002-1118-9430; Jay, Jonathan/0000-0002-7543-4247; Hallett, Timothy/0000-0002-9681-0424; Rees, Helen/0000-0003-1442-6734; Jones, Alexandra/0000-0001-5039-144X	Bill & Melinda Gates Foundation; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1B, MR/K010174/1] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Bill & Melinda Gates Foundation provided grant support for some of the activities described in this paper. No funding bodies had any role in the design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Stephen Becker, Blair Hanewall, Salif Sow, and Wilson Mok of the Bill & Melinda Gates Foundation for their support, insights, review, and comment on early versions of the manuscript.	Agot KE, 2007, JAIDS-J ACQ IMM DEF, V44, P66, DOI 10.1097/01.qai.0000242455.05274.20; Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; [Anonymous], 2012, TELEGRAPH; [Anonymous], 2017, 2013 UNAIDS REP GLOB; Atun R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001045; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Barnighausen T, 2012, P NATL ACAD SCI USA, V109, P21271, DOI 10.1073/pnas.1209017110; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Beksinska M, 2011, CONTRACEPTION, V83, P316, DOI 10.1016/j.contraception.2010.07.022; Bellan SE, 2013, LANCET, V381, P1561, DOI 10.1016/S0140-6736(12)61960-6; Bertozzi SM, 2008, LANCET, V372, P831, DOI 10.1016/S0140-6736(08)60889-2; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Buchbinder SP, 2005, JAIDS-J ACQ IMM DEF, V39, P82, DOI 10.1097/01.qai.0000134740.41585.f4; Buse K, 2008, J ROY SOC MED, V101, P572, DOI 10.1258/jrsm.2008.08k036; Carey RF, 1999, SEX TRANSM DIS, V26, P216, DOI 10.1097/00007435-199904000-00006; *CDCP, 2012, CDC FACT SHEET NEW I; Chang LW, 2013, LANCET INFECT DIS, V13, P65, DOI 10.1016/S1473-3099(12)70273-6; Coffey PS, 2006, CONTRACEPTION, V73, P588, DOI 10.1016/j.contraception.2005.10.017; Cohen J, 2011, SCIENCE, V334, P1338, DOI 10.1126/science.334.6061.1338; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cremin I, 2013, AIDS, V27, P447, DOI 10.1097/QAD.0b013e32835ca2dd; Cuadros DF, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-28; Dickson KE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001133; Dybul M, 2002, J INFECT DIS, V185, P1818, DOI 10.1086/340650; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238; Foege WH, 2011, CAL MILBANK BOOK HEA, V21, P1; Foss AM, 2004, BRIT MED J, V329, P185, DOI 10.1136/bmj.329.7459.185; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Ghys PD, 2006, SEX TRANSM INFECT, V82, pI52, DOI 10.1136/sti.2005.016428; Ghys PD, 2010, SEX TRANSM INFECT, V86, pI1, DOI [10.1136/sti.2010.047852, 10.1136/sti.2010.044933]; *GLOB IND AN, 2012, COND GLOB STRAT BUS; Gomez GB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001323; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Green EC, 2006, AIDS BEHAV, V10, P335, DOI 10.1007/s10461-006-9073-y; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gregson S, 2010, INT J EPIDEMIOL, V39, P1311, DOI 10.1093/ije/dyq055; Grulich AE, 2001, AIDS, V15, P1188, DOI 10.1097/00002030-200106150-00020; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Haberer JE, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001511; Hallett TB, 2007, SEX TRANSM INFECT, V83, pI50, DOI 10.1136/sti.2006.023606; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; Hankins C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001127; Heffron R, 2012, JAIDS-J ACQ IMM DEF, V61, P116, DOI 10.1097/QAI.0b013e31825da73f; Hurt CB, 2011, CLIN INFECT DIS, V53, P1265, DOI 10.1093/cid/cir684; *INT PLANN PAR FED, 2012, PEOPL LIV HIV STIGM; International Partnership for Microbicides, RING STUD; Jegede AS, 2007, PLOS MED, V4, P417, DOI 10.1371/journal.pmed.0040073; Johnson LF, 2012, J R SOC INTERFACE, V9, P1544, DOI 10.1098/rsif.2011.0826; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; *KEN NAT AIDS CONT, 2009, AN HIV PREV RESP MOD; Kenya National Bureau of Statistics, 2010, KEN DEM HLTH SURV 20; Kong XR, 2012, AM J EPIDEMIOL, V176, P875, DOI 10.1093/aje/kws179; Kurth Ann E, 2011, Curr HIV/AIDS Rep, V8, P62, DOI 10.1007/s11904-010-0063-3; Marrazzo J.M., 2015, C RETR OPP INF ATL M, P509; Mattson CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002443; McIntyre JA, 2011, JAIDS-J ACQ IMM DEF, V58, P506, DOI 10.1097/QAI.0b013e318237af5d; *MEAS DHS INT ICF, DHS OV; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Mugglin C, 2012, 19 C RETR OPP INF SE; NACC and NASCOP, 2012, KEN AIDS EP UPD 2012; Nel AM, 2011, J WOMENS HEALTH, V20, P1207, DOI 10.1089/jwh.2010.2476; Ng M, 2011, LANCET, V378, P1643, DOI 10.1016/S0140-6736(11)61390-1; NGUGI EN, 1988, LANCET, V2, P887, DOI 10.1016/S0140-6736(88)92480-4; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Padian NS, 2011, JAIDS-J ACQ IMM DEF, V58, pE23, DOI 10.1097/QAI.0b013e318227af37; Padian NS, 2011, JAIDS-J ACQ IMM DEF, V56, P199, DOI 10.1097/QAI.0b013e31820bb448; Parikh UM, 2012, CLIN INFECT DIS, V55, P303, DOI 10.1093/cid/cis373; Pinkerton SD, 1997, SOC SCI MED, V44, P1303, DOI 10.1016/S0277-9536(96)00258-4; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Pretorius C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013646; Rojanapithayalkorn W, 2006, REPROD HEALTH MATTER, V14, P41, DOI 10.1016/S0968-8080(06)28270-3; Schackman BR, 2010, JAIDS-J ACQ IMM DEF, V55, pS27, DOI 10.1097/QAI.0b013e3181f9c1da; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Shelton JD, 2010, LANCET, V375, P964, DOI 10.1016/S0140-6736(10)60416-3; Shisana O., 2009, S AFRICAN NATL HIV P; SIGALL H, 1970, J EXP SOC PSYCHOL, V6, P1, DOI 10.1016/0022-1031(70)90072-7; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Smith MK, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001260; STOVER J, 2013, 17 INT C AIDS STIS A; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; TANSER F, 2011, 18 C RETR OPP INF BO; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; The United States President's Emergency Plan for AIDS Relief (PEPFAR), 2012, PEPFAR BLUEPR CREAT; Umalusi, 2008, STAT INF REP SIRI; UNAIDS, 2010, COMB HIV PREV TAIL C; UNAIDS, 2012, TOG WE WILL END AIDS; UNAIDS, 2010, GLOB REP REP GLOB AI, P120; van de Vijver DAMC, 2013, AIDS, V27, P2943, DOI 10.1097/01.aids.0000433237.63560.20; Weir SS, 1999, J EPIDEMIOL COMMUN H, V53, P417, DOI 10.1136/jech.53.7.417; WELLER S, 2002, COCHRANE DB SYST REV, V1; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; Wheelock A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001234; WHO, 2013, GLOB UPD HIV TREATM; WHO UNODC UNAIDS, 2012, TECHN GUID COUNTR TA; WHO (World Health Organization), 2009, COUNTR EXP SCAL UP M; Woosley RL, 2007, CLIN PHARMACOL THER, V81, P129, DOI 10.1038/sj.clpt.6100014; World Health Organization, 2008, OP GUID SCAL MAL CIR; Zaba B, 2000, AIDS, V14, P1633, DOI 10.1097/00002030-200007280-00020; ZABA B, 2008, 17 INT AIDS C MEX AU; ZENILMAN JM, 1995, SEX TRANSM DIS, V22, P15, DOI 10.1097/00007435-199501000-00003	108	83	84	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2014	384	9939					272	279		10.1016/S0140-6736(13)62230-8	http://dx.doi.org/10.1016/S0140-6736(13)62230-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL8JI	24740087				2022-12-28	WOS:000339384100029
J	McLellan, AT				McLellan, A. Thomas			Should at-risk patients be paid to receive interventions?	LANCET			English	Editorial Material							PERCEPTION; CARE		Treatment Res Inst, Philadelphia, PA 19106 USA		McLellan, AT (corresponding author), Treatment Res Inst, Philadelphia, PA 19106 USA.	TMcLellan@tresearch.org						Aspinall EJ, 2011, OCCUP MED-OXFORD, V61, P531, DOI 10.1093/occmed/kqr136; Black N, 2010, NEW ENGL J MED, V363, P1103, DOI 10.1056/NEJMp1009188; Boden-Albala B, 2011, NEUROEPIDEMIOLOGY, V37, P83, DOI 10.1159/000329522; Hogarth RM, 2011, J BEHAV DECIS MAKING, V24, P202, DOI 10.1002/bdm.689; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Pozgar, 2014, LEGAL ETHICAL ISSUES; Weaver T., 2014, LANCET	7	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					113	114		10.1016/S0140-6736(14)60490-6	http://dx.doi.org/10.1016/S0140-6736(14)60490-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1YC	24725466	hybrid			2022-12-28	WOS:000338921500012
J	Stillman, MD				Stillman, Michael D.			Training for the 21st Century?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INTERNAL-MEDICINE; ACCREDITATION		[Stillman, Michael D.] Univ Louisville, Sch Med, Louisville, KY 40292 USA	University of Louisville	Stillman, MD (corresponding author), Ambulatory Internal Med Clin, Ambulatory Care Bldg,550 South Jackson St, Louisville, KY 40202 USA.	michael.stillman@louisville.edu						Fitzgibbons JP, 2006, ANN INTERN MED, V144, P920, DOI 10.7326/0003-4819-144-12-200606200-00010; Goroll AH, 2004, ANN INTERN MED, V140, P902, DOI 10.7326/0003-4819-140-11-200406010-00012; Green Michael L, 2009, J Grad Med Educ, V1, P5, DOI 10.4300/01.01.0003; Holmboe ES, 2005, J GEN INTERN MED, V20, P1165, DOI 10.1111/j.1525-1497.2005.0249.x; Nasca TJ, 2012, NEW ENGL J MED, V366, P1051, DOI 10.1056/NEJMsr1200117; Weinberger SE, 2006, ANN INTERN MED, V144, P927, DOI 10.7326/0003-4819-144-12-200606200-00124; Woolf SH, 2013, US HLTH INT PERSPECT	7	6	6	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 3	2014	160	11					800	+		10.7326/M13-2358	http://dx.doi.org/10.7326/M13-2358			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MT	24711077				2022-12-28	WOS:000337348700007
J	Biller-Andorno, N; Juni, P; Kalager, M				Biller-Andorno, Nikola; Jueni, Peter; Kalager, Mette			Abolishing Mammography Screening Programs? A View from the Swiss Medical Board	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BENEFITS		[Biller-Andorno, Nikola] Univ Zurich, Inst Biomed Eth, Zurich, Switzerland; [Jueni, Peter] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Jueni, Peter] Univ Bern, Clin Trials Unit Bern, Dept Clin Res, Bern, Switzerland; [Biller-Andorno, Nikola] Harvard Univ, Sch Med, Div Med Eth, Dept Global Hlth & Social Med, Boston, MA USA	University of Zurich; University of Bern; University of Bern; Harvard University; Harvard Medical School	Biller-Andorno, N (corresponding author), Univ Zurich, Inst Biomed Eth, Zurich, Switzerland.		Juni, Peter/Q-8700-2016	Juni, Peter/0000-0002-5985-0670; Biller-Andorno, Nikola/0000-0001-7661-1324				Domenighetti G, 2003, INT J EPIDEMIOL, V32, P816, DOI 10.1093/ije/dyg257; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Miller Anthony B, 2014, BMJ, V348, pg366, DOI 10.1136/bmj.g366; Welch HG, 2014, JAMA INTERN MED, V174, P448, DOI 10.1001/jamainternmed.2013.13635	5	182	192	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 22	2014	370	21					1965	1967		10.1056/NEJMp1401875	http://dx.doi.org/10.1056/NEJMp1401875			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH4UZ	24738641	Green Published			2022-12-28	WOS:000336125500002
J	Olszak, T; Neves, JF; Dowds, CM; Baker, K; Glickman, J; Davidson, NO; Lin, CS; Jobin, C; Brand, S; Sotlar, K; Wada, K; Katayama, K; Nakajima, A; Mizuguchi, H; Kawasaki, K; Nagata, K; Muller, W; Snapper, SB; Schreiber, S; Kaser, A; Zeissig, S; Blumberg, RS				Olszak, Torsten; Neves, Joana F.; Dowds, C. Marie; Baker, Kristi; Glickman, Jonathan; Davidson, Nicholas O.; Lin, Chyuan-Sheng; Jobin, Christian; Brand, Stephan; Sotlar, Karl; Wada, Koichiro; Katayama, Kazufumi; Nakajima, Atsushi; Mizuguchi, Hiroyuki; Kawasaki, Kunito; Nagata, Kazuhiro; Mueller, Werner; Snapper, Scott B.; Schreiber, Stefan; Kaser, Arthur; Zeissig, Sebastian; Blumberg, Richard S.			Protective mucosal immunity mediated by epithelial CD1d and IL-10	NATURE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TRIGLYCERIDE TRANSFER PROTEIN; KILLER T-CELLS; ULCERATIVE-COLITIS; CYTOPLASMIC TAIL; BARRIER FUNCTION; MICE; GENE; EXPRESSION; MOLECULES	The mechanisms by which mucosal homeostasis is maintained are of central importance to inflammatory bowel disease. Critical to these processes is the intestinal epithelial cell (IEC), which regulates immune responses at the interface between the commensal microbiota and the host(1,2). CD1d presents self and microbial lipid antigens to natural killer T (NKT) cells, which are involved in the pathogenesis of colitis in animal models and human inflammatory bowel disease(3-8). As CD1d crosslinking on model IECs results in the production of the important regulatory cytokine interleukin (IL)-10 (ref. 9), decreased epithelial CD1d expression-as observed ininflammatory bowel disease(10,11)-may contribute substantially to intestinal inflammation. Here we show in mice that whereas bone-marrow-derived CD1d signals contribute to NKT-cell-mediated intestinal inflammation, engagement of epithelial CD1 delicits protective effects through the activation of STAT3 and STAT3-dependent transcription of IL-10, heat shock protein 110 (HSP110; also known as HSP105), and CD1d itself. All of these epithelial elements are critically involved in controlling CD1d-mediated intestinal inflammation. This is demonstrated by severe NKT-cell-mediated colitis upon IEC-specific deletion of IL-10, CD1d, and its critical regulator microsomal triglyceride transfer protein (MTP)(12,13), as well as deletion of HSP110 in the radioresistant compartment. Our studies thus uncover a novel pathway of IEC-dependent regulation of mucosal homeostasis and highlight a critical role of IL-10 in the intestinal epithelium, with broad implications for diseases such as inflammatory bowel disease.	[Olszak, Torsten; Neves, Joana F.; Baker, Kristi; Snapper, Scott B.; Zeissig, Sebastian; Blumberg, Richard S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA; [Dowds, C. Marie; Schreiber, Stefan; Zeissig, Sebastian] Univ Med Ctr Schleswig Holstein, Dept Internal Med 1, D-24105 Kiel, Germany; [Glickman, Jonathan] GI Pathol, Miraca Life Sci, Newton, MA 02464 USA; [Davidson, Nicholas O.] Washington Univ, Sch Med, Div Gastroenterol, St Louis, MO 63110 USA; [Lin, Chyuan-Sheng] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Jobin, Christian] Univ Florida, Dept Med, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA; [Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, D-81377 Munich, Germany; [Sotlar, Karl] Univ Munich, Inst Pathol, D-80377 Munich, Germany; [Wada, Koichiro; Katayama, Kazufumi] Osaka Univ, Dept Pharmacol, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Nakajima, Atsushi] Yokohama City Univ, Div Gastroenterol, Sch Med, Yokohama, Kanagawa 2360027, Japan; [Mizuguchi, Hiroyuki] Osaka Univ, Lab Biochem & Mol Biol, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Kawasaki, Kunito; Nagata, Kazuhiro] Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kita Ku, Kyoto 6038555, Japan; [Mueller, Werner] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England; [Snapper, Scott B.] Childrens Hosp, Dept Med, Div Pediat Gastroenterol Hepatol & Nutr, Boston, MA 02115 USA; [Kaser, Arthur] Univ Cambridge, Addenbrooke Hosp, Div Gastroenterol, Cambridge CB2 0QQ, England	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Kiel; Schleswig Holstein University Hospital; Washington University (WUSTL); Columbia University; State University System of Florida; University of Florida; University of Munich; University of Munich; Osaka University; Yokohama City University; Osaka University; Kyoto Sangyo University; University of Manchester; Harvard University; Boston Children's Hospital; University of Cambridge	Blumberg, RS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA.	szeissig@1med.uni-kiel.de; rblumberg@partners.org	Muller, Werner/B-9044-2008; Zeissig, Sebastian/B-6297-2012; Neves, Joana F/J-9406-2014	Muller, Werner/0000-0002-1297-9725; Zeissig, Sebastian/0000-0001-5124-0897; Neves, Joana F/0000-0001-5842-4162; Baker, Kristi/0000-0002-2993-3889; Mizuguchi, Hiroyuki/0000-0003-0594-8178; Dowds, C Marie/0000-0002-7170-0667	National Institutes of Health (NIH) [DK044319, DK051362, DK053056, DK088199]; Harvard Digestive Diseases Center [DK0034854]; European Research Council (ERC Starting Grant) [336528]; Deutsche Forschungsgemeinschaft (DFG) [ZE 814/4-1, ZE 814/5-1, ZE 814/6-1]; Crohn's and Colitis Foundation of America; European Commission (Marie Curie International Reintegration Grant) [256363]; DFG Excellence Cluster "Inflammation at Interfaces"; DFG [OL 324/1-1, BR 1912/6-1]; Washington University DDRCC [HL38180, DK56260, P30DK52574]; HDDC Pilot and Feasibility Grant; NCI [P30CA013696]; Else Kroener-Fresenius-Stiftung (Else Kroener-Exzellenzstipendium) [2010_EKES.32]; Japan Society for Promotion of Science [24659823]; ERC under the European Community's Seventh Framework Programme (FP7/ERC) [260961]; National Institute for Health Research Cambridge Biomedical Research Centre; Austrian Science Fund; START [Y446-B18]; Innsbruck Medical University [MFI 2007-407]; Addenbrooke's Charitable Trust, CiCRA; European Community's Seventh Framework Programme (FP7) under grant agreement SysmedIBD [305564]; NIH [HL59561, DK034854, AI50950]; Helmsley Charitable Trust; Wolpow Family Chair in IBD Treatment and Research; Ministry of Science [P21530-B18]; Austrian Science Fund (FWF) [P 21530] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA013696] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038180, R37HL038180, P01HL059561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI050950, R01AI050950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051362, R37DK044319, R01DK053056, P30DK034854, R01DK088199, P30DK052574, R01DK044319, R01DK056260] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center; European Research Council (ERC Starting Grant)(European Research Council (ERC)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Crohn's and Colitis Foundation of America; European Commission (Marie Curie International Reintegration Grant); DFG Excellence Cluster "Inflammation at Interfaces"(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Washington University DDRCC; HDDC Pilot and Feasibility Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Else Kroener-Fresenius-Stiftung (Else Kroener-Exzellenzstipendium); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ERC under the European Community's Seventh Framework Programme (FP7/ERC); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Austrian Science Fund(Austrian Science Fund (FWF)); START(Austrian Science Fund (FWF)); Innsbruck Medical University; Addenbrooke's Charitable Trust, CiCRA; European Community's Seventh Framework Programme (FP7) under grant agreement SysmedIBD; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmsley Charitable Trust; Wolpow Family Chair in IBD Treatment and Research; Ministry of Science(Ministry of Science, ICT & Future Planning, Republic of Korea); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank H.-C. Hung for technical assistance with microinjection, Y. Xie for performing osmium staining, A. Bedynek and M. Friedrich for performing immunohistochemistry of the human biopsies, F. A. Zhu for assistance with antigen presentation assays, D. Shouval, M. Sablon and D. Perez for animal care and husbandry, K. Tashiro for technical assistance with adenovirus preparation, V. M. Thiele for technical assistance, J. Cusick for help with manuscript preparation, and S. E. Plevy for discussions and reagents. This work was supported by: National Institutes of Health (NIH) (grants DK044319, DK051362, DK053056, DK088199) and the Harvard Digestive Diseases Center (DK0034854) (R. S. B.); the European Research Council (ERC Starting Grant agreement no. 336528), the Deutsche Forschungsgemeinschaft (DFG) (ZE 814/4-1, ZE 814/5-1, ZE 814/6-1), the Crohn's and Colitis Foundation of America (Postdoctoral Fellowship Award), the European Commission (Marie Curie International Reintegration Grant no. 256363) and the DFG Excellence Cluster "Inflammation at Interfaces" (S.Z.); the DFG (OL 324/1-1) (T.O.); HL38180, DK56260, Washington University DDRCC P30DK52574 (morphology core) (N.O.D.); HDDC Pilot and Feasibility Grant (K. B.); NCI P30CA013696 (C.-S.L.), the DFG (BR 1912/6-1) and the Else Kroener-Fresenius-Stiftung (Else Kroener-Exzellenzstipendium 2010_EKES.32) (S. B.); Grant-in-Aid for Challenging Exploratory Research 24659823 from Japan Society for Promotion of Science (K. W.); the ERC under the European Community's Seventh Framework Programme (FP7/2007-2013/ERC Grant agreement no. 260961), the National Institute for Health Research Cambridge Biomedical Research Centre, the Austrian Science Fund and Ministry of Science P21530-B18 and START Y446-B18, Innsbruck Medical University (MFI 2007-407) and the Addenbrooke's Charitable Trust, CiCRA (A. K.); the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement SysmedIBD (no. 305564) (W. M., S. S.); the NIH (grants HL59561, DK034854, AI50950), the Helmsley Charitable Trust and the Wolpow Family Chair in IBD Treatment and Research (S. B. S.). PBS57-loaded and unloaded mouse CD1d tetramer was obtained through the NIH Tetramer Facility. The authors thank M. A. Exley and S. P. Colgan for discussions.	Behar SM, 1999, J IMMUNOL, V162, P161; BLUMBERG RS, 1991, J IMMUNOL, V147, P2518; Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chen ZG, 2008, J IMMUNOL, V180, P6085, DOI 10.4049/jimmunol.180.9.6085; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Colgan SP, 1999, P NATL ACAD SCI USA, V96, P13938, DOI 10.1073/pnas.96.24.13938; Colgan SP, 2003, J CLIN INVEST, V112, P745, DOI 10.1172/JC1200317241; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Furuta GT, 2005, AM J PHYSIOL-GASTR L, V289, pG890, DOI 10.1152/ajpgi.00015.2005; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Katayama K, 2003, GASTROENTEROLOGY, V124, P1315, DOI 10.1016/S0016-5085(03)00262-2; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Liao CM, 2012, GASTROENTEROLOGY, V142, P326, DOI 10.1053/j.gastro.2011.10.030; Mizuguchi H, 1999, HUM GENE THER, V10, P2013, DOI 10.1089/10430349950017374; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nakamura J, 2008, STROKE, V39, P2853, DOI 10.1161/STROKEAHA.107.506188; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Park SH, 1998, J IMMUNOL, V160, P3128; Perera L, 2007, INFLAMM BOWEL DIS, V13, P298, DOI 10.1002/ibd.20026; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; VIDAL K, 1993, J IMMUNOL METHODS, V166, P63, DOI 10.1016/0022-1759(93)90329-6; Wingender G, 2008, AM J PHYSIOL-GASTR L, V294, pG1, DOI 10.1152/ajpgi.00437.2007; Yamagishi N, 2009, FEBS J, V276, P5870, DOI 10.1111/j.1742-4658.2009.07311.x; Yue SC, 2005, P NATL ACAD SCI USA, V102, P11811, DOI 10.1073/pnas.0503366102; Zeissig S, 2012, NAT MED, V18, P1060, DOI 10.1038/nm.2811; Zeissig S, 2010, J CLIN INVEST, V120, P2889, DOI 10.1172/JCI42703	38	139	146	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					497	+		10.1038/nature13150	http://dx.doi.org/10.1038/nature13150			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24717441	Green Published, Green Accepted			2022-12-28	WOS:000336126000040
J	van Groenigen, KJ; Qi, X; Osenberg, CW; Luo, YQ; Hungate, BA				van Groenigen, Kees Jan; Qi, Xuan; Osenberg, Craig W.; Luo, Yiqi; Hungate, Bruce A.			Faster Decomposition Under Increased Atmospheric CO2 Limits Soil Carbon Storage	SCIENCE			English	Article							ELEVATED CO2; ORGANIC-MATTER; GLOBAL CHANGE; ENRICHMENT; ROOTS; PLANT; GRASSLANDS; COMMUNITY; ADDITIONS; MODEL	Soils contain the largest pool of terrestrial organic carbon (C) and are a major source of atmospheric carbon dioxide (CO2). Thus, they may play a key role in modulating climate change. Rising atmospheric CO2 is expected to stimulate plant growth and soil C input but may also alter microbial decomposition. The combined effect of these responses on long-term C storage is unclear. Combining meta-analysis with data assimilation, we show that atmospheric CO2 enrichment stimulates both the input (+19.8%) and the turnover of C in soil (+16.5%). The increase in soil C turnover with rising CO2 leads to lower equilibrium soil C stocks than expected from the rise in soil C input alone, indicating that it is a general mechanism limiting C accumulation in soil.	[van Groenigen, Kees Jan; Hungate, Bruce A.] No Arizona Univ, Ctr Ecosyst Sci & Soc, Flagstaff, AZ 86011 USA; [van Groenigen, Kees Jan] Univ Dublin Trinity Coll, Sch Nat Sci, Dept Bot, Dublin 2, Ireland; [Qi, Xuan; Luo, Yiqi] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Osenberg, Craig W.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Luo, Yiqi] Tsinghua Univ, Ctr Earth Syst Sci, Beijing 100084, Peoples R China; [Hungate, Bruce A.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA	Northern Arizona University; Trinity College Dublin; University of Oklahoma System; University of Oklahoma - Norman; State University System of Florida; University of Florida; Tsinghua University; Northern Arizona University	van Groenigen, KJ (corresponding author), No Arizona Univ, Ctr Ecosyst Sci & Soc, Flagstaff, AZ 86011 USA.	cjvangroenigen@nau.edu	van Groenigen, Kees Jan/Q-7081-2018; van groenigen, kees jan/ABF-2075-2021	van Groenigen, Kees Jan/0000-0002-9165-3925; van groenigen, kees jan/0000-0002-9165-3925; Osenberg, Craig/0000-0003-1918-7904	Biological and Environmental Research program, Office of Science, U.S. Department of Energy; Western Regional Center of the National Institute for Climatic Change Research; Irish Research Council; Marie Curie Actions under the Seventh Framework Program (FP7); U.S. Department of Energy, Terrestrial Ecosystem Sciences [DE SC0008270]	Biological and Environmental Research program, Office of Science, U.S. Department of Energy; Western Regional Center of the National Institute for Climatic Change Research; Irish Research Council(Irish Research Council for Science, Engineering and Technology); Marie Curie Actions under the Seventh Framework Program (FP7); U.S. Department of Energy, Terrestrial Ecosystem Sciences(United States Department of Energy (DOE))	This research was supported by the Biological and Environmental Research program, Office of Science, U.S. Department of Energy; the Western Regional Center of the National Institute for Climatic Change Research; and the Irish Research Council, cofunded by Marie Curie Actions under the Seventh Framework Program (FP7). X.Q. and Y.L. received financial support from the U.S. Department of Energy, Terrestrial Ecosystem Sciences grant DE SC0008270. We thank M. Hoosbeek, K. Sturner, A. Talhelm, and D. Zak for sharing unpublished data with us. Many thanks go to T. Xu for assisting us with writing the Matlab code. The data reported in this paper are available online as supplementary materials.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Arora VK, 2013, J CLIMATE, V26, P5289, DOI 10.1175/JCLI-D-12-00494.1; Blagodatskaya E, 2008, BIOL FERT SOILS, V45, P115, DOI 10.1007/s00374-008-0334-y; Carney KM, 2007, P NATL ACAD SCI USA, V104, P4990, DOI 10.1073/pnas.0610045104; DALENBERG JW, 1989, SOIL BIOL BIOCHEM, V21, P443, DOI 10.1016/0038-0717(89)90157-0; Davidson EA, 2000, NATURE, V408, P789, DOI 10.1038/35048672; Dijkstra FA, 2007, ECOL LETT, V10, P1046, DOI 10.1111/j.1461-0248.2007.01095.x; Drake JE, 2011, ECOL LETT, V14, P349, DOI 10.1111/j.1461-0248.2011.01593.x; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Hungate BA, 1996, PLANT SOIL, V187, P135, DOI 10.1007/BF00017086; Hungate BA, 2009, GLOBAL CHANGE BIOL, V15, P2020, DOI 10.1111/j.1365-2486.2009.01866.x; Luo YQ, 2011, GLOBAL CHANGE BIOL, V17, P843, DOI 10.1111/j.1365-2486.2010.02265.x; Norby RJ, 2001, OECOLOGIA, V127, P153, DOI 10.1007/s004420000615; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; PARTON WJ, 1987, SOIL SCI SOC AM J, V51, P1173, DOI 10.2136/sssaj1987.03615995005100050015x; Paterson E, 2008, SOIL BIOL BIOCHEM, V40, P2434, DOI 10.1016/j.soilbio.2008.06.005; Pendall E, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001821; Perveen N, 2014, GLOBAL CHANGE BIOL, V20, P1174, DOI 10.1111/gcb.12493; Phillips RP, 2012, ECOL LETT, V15, P1042, DOI 10.1111/j.1461-0248.2012.01827.x; Sayer EJ, 2011, NAT CLIM CHANGE, V1, P304, DOI 10.1038/NCLIMATE1190; Sillen WMA, 2012, BIOGEOSCIENCES, V9, P2247, DOI 10.5194/bg-9-2247-2012; Smith P, 2004, SOIL USE MANAGE, V20, P264, DOI 10.1079/SUM2004239; Thornton PE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002868; van Groenigen KJ, 2011, NATURE, V475, P214, DOI 10.1038/nature10176; van Groenigen KJ, 2006, P NATL ACAD SCI USA, V103, P6571, DOI 10.1073/pnas.0509038103; Wullschleger SD, 2002, PLANT CELL ENVIRON, V25, P319, DOI 10.1046/j.1365-3040.2002.00796.x; Zak DR, 2000, NEW PHYTOL, V147, P201, DOI 10.1046/j.1469-8137.2000.00687.x	28	206	215	24	596	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					508	509		10.1126/science.1249534	http://dx.doi.org/10.1126/science.1249534			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24762538				2022-12-28	WOS:000335157700040
J	Richardson, B				Richardson, Ben			Clinical examination is essential to reduce overdiagnosis and overtreatment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Leeds Gen Infirm, Leeds LS1 3EX, W Yorkshire, England	Leeds General Infirmary; University of Leeds	Richardson, B (corresponding author), Leeds Gen Infirm, Leeds LS1 3EX, W Yorkshire, England.	benmrichardson@gmail.com						Fesmire FM, 1998, ANN EMERG MED, V31, P3, DOI 10.1016/S0196-0644(98)70274-4; Patel K, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3442; Verghese A, 2011, TED GLOBAL 2011; Wiener RS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3368	4	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2014	348								g2920	10.1136/bmj.g2920	http://dx.doi.org/10.1136/bmj.g2920			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5PN	24778191				2022-12-28	WOS:000335471000004
J	Clark, AG				Clark, Andrew G.			The vital Y chromosome	NATURE			English	Editorial Material							DEGENERATION	Comparisons of Y-chromosome sequences in various mammals reveal abundant gene loss early in the chromosome's evolution but remarkable gene stability across the Y chromosomes of extant species. See Articles p.488 & p.494	Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Clark, AG (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	ac347@cornell.edu		Clark, Andrew/0000-0001-7159-8511				Bachtrog D, 2013, NAT REV GENET, V14, P113, DOI 10.1038/nrg3366; Bellott DW, 2014, NATURE, V508, P494, DOI 10.1038/nature13206; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Cortez D, 2014, NATURE, V508, P488, DOI 10.1038/nature13151; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Sayres MAW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004064; Sayres MAW, 2013, MOL BIOL EVOL, V30, P781, DOI 10.1093/molbev/mss267; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722	8	10	12	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					463	465		10.1038/508463a	http://dx.doi.org/10.1038/508463a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24759407				2022-12-28	WOS:000334741600023
J	Ram, J; Agarwal, A				Ram, Jagat; Agarwal, Aniruddha			Giant Papillae in Vernal Keratoconjunctivitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ram, Jagat; Agarwal, Aniruddha] Postgrad Inst Med Educ & Res, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Ram, J (corresponding author), Postgrad Inst Med Educ & Res, Chandigarh, India.	drjagatram@gmail.com							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 24	2014	370	17					1636	1636		10.1056/NEJMicm1307657	http://dx.doi.org/10.1056/NEJMicm1307657			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4TG	24758619				2022-12-28	WOS:000336120500010
J	Schneider, R				Schneider, Ralph			Sea levels from ancient seashells	NATURE			English	Editorial Material							TEMPERATURE	The isotopic composition of oxygen in sea water correlates with changes in global mean sea level. Microfossils carrying oxygen-isotope signals have been used to extend sea-level records as far back as 5 million years ago. SEE ARTICLE p. 477	Univ Kiel, Inst Geosci, D-24118 Kiel, Germany	University of Kiel	Schneider, R (corresponding author), Univ Kiel, Inst Geosci, Olshaussenstr 40, D-24118 Kiel, Germany.	schneider@gpi.uni-kiel.de						Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; EMILIANI C, 1957, SCIENCE, V125, P383, DOI 10.1126/science.125.3244.383; Etourneau J, 2010, EARTH PLANET SC LETT, V297, P103, DOI 10.1016/j.epsl.2010.06.010; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Rohling EJ, 2014, NATURE, V508, P477, DOI 10.1038/nature13230; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008	8	2	2	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					465	466		10.1038/nature13328	http://dx.doi.org/10.1038/nature13328			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24739964				2022-12-28	WOS:000334741600024
J	Fields, RD				Fields, R. Douglas			Myelin-More than Insulation	SCIENCE			English	Editorial Material							CORTEX		Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Fields, RD (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bldg 35,Room 2A211,MSC 3713, Bethesda, MD 20892 USA.	fieldsd@mail.nih.gov			Intramural NIH HHS [Z01 HD000713-13] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000713] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bakiri Y, 2011, J PHYSIOL-LONDON, V589, P559, DOI 10.1113/jphysiol.2010.201376; Bukalo O, 2013, P NATL ACAD SCI USA, V110, P5175, DOI 10.1073/pnas.1210735110; Fields RD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001128; Kole MHP, 2012, NEURON, V73, P235, DOI 10.1016/j.neuron.2012.01.007; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Schwab ME, 2014, CURR OPIN NEUROBIOL, V27, P53, DOI 10.1016/j.conb.2014.02.011; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Sun WZ, 2009, P NATL ACAD SCI USA, V106, P17986, DOI 10.1073/pnas.0903962106; Tomassy GS, 2014, SCIENCE, V344, P319, DOI 10.1126/science.1249766; WAXMAN SG, 1972, J CELL BIOL, V53, P210, DOI 10.1083/jcb.53.1.210; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006	12	43	43	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					264	266		10.1126/science.1253851	http://dx.doi.org/10.1126/science.1253851			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744365	Green Accepted			2022-12-28	WOS:000334474500024
J	Trivedi, BP				Trivedi, Bijal P.			Dissecting appetite	NATURE			English	Editorial Material							NEURAL CIRCUIT; NUCLEUS; HUNGER											Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Carter ME, 2013, NATURE, V503, P111, DOI 10.1038/nature12596; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022	8	8	9	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					S64	S65		10.1038/508S64a	http://dx.doi.org/10.1038/508S64a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF0KP	24740131				2022-12-28	WOS:000334403000008
J	Hudson, MP				Hudson, Michael P.			Review: In stable obstructive CAD, PCI plus medical therapy (MT) does not differ from MT alone	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DISEASE		Henry Ford Hosp, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Hudson, MP (corresponding author), Henry Ford Hosp, Detroit, MI 48202 USA.							Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Pursnani S, 2012, CIRC-CARDIOVASC INTE, V5, P476, DOI 10.1161/CIRCINTERVENTIONS.112.970954	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2014	160	8							JC8	10.7326/0003-4819-160-8-201404150-02008	http://dx.doi.org/10.7326/0003-4819-160-8-201404150-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW3QU	24733225				2022-12-28	WOS:000364907600007
J	Bourke, J				Bourke, Joanna			Childbirth in the UK: suffering and citizenship before the 1950s	LANCET			English	Editorial Material									Univ London, Birkbeck Coll, Dept Hist, London WC1E 7HX, England	University of London; Birkbeck University London	Bourke, J (corresponding author), Univ London, Birkbeck Coll, Dept Hist, London WC1E 7HX, England.	j.bourke@bbk.ac.uk						Bourke Joanna, 2014, STORY PAIN; Cassidy T, 2007, BIRTH HIST; Epstein RH, 2011, GET ME OUT HERE HIST; Marland H, 1999, OUTSIDE WALLS ASYLUM; Wolf JH, DELIVER ME PAIN ANES	5	8	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 12	2014	383	9925					1288	1289		10.1016/S0140-6736(14)60634-6	http://dx.doi.org/10.1016/S0140-6736(14)60634-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE6LQ	24734291				2022-12-28	WOS:000334104900014
J	Kainulainen, J; Federrath, C; Henning, T				Kainulainen, Jouni; Federrath, Christoph; Henning, Thomas			Unfolding the Laws of Star Formation: The Density Distribution of Molecular Clouds	SCIENCE			English	Article							FORMATION RATES; MACH NUMBER; TURBULENCE; GAS; UNIVERSALITY; SIMULATIONS; VARIANCE; GALAXIES	The formation of stars shapes the structure and evolution of entire galaxies. The rate and efficiency of this process are affected substantially by the density structure of the individual molecular clouds in which stars form. The most fundamental measure of this structure is the probability density function of volume densities (rho-PDF), which determines the star formation rates predicted with analytical models. This function has remained unconstrained by observations. We have developed an approach to quantify rho-PDFs and establish their relation to star formation. The rho-PDFs instigate a density threshold of star formation and allow us to quantify the star formation efficiency above it. The rho-PDFs provide new constraints for star formation theories and correctly predict several key properties of the star-forming interstellar medium.	[Kainulainen, Jouni; Henning, Thomas] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Federrath, Christoph] Monash Univ, Sch Math Sci, Monash Ctr Astrophys, Clayton, Vic 3800, Australia	Max Planck Society; Monash University	Kainulainen, J (corresponding author), Max Planck Inst Astron, Konigstuhl 17, D-69117 Heidelberg, Germany.	jtkainul@mpia.de	Henning, Thomas K/O-4372-2018	Henning, Thomas K/0000-0002-1493-300X; Federrath, Christoph/0000-0002-0706-2306; Kainulainen, Jouni/0000-0001-7764-3109	Deutsche Forschungsgemeinschaft [1573]; Australian Research Council [DP110102191]; Leibniz-Rechenzentrum [pr32lo]; Julich Supercomputing Centre [hhd20]; Partnership for Advanced Computing in Europe [pr89mu]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Australian Research Council(Australian Research Council); Leibniz-Rechenzentrum; Julich Supercomputing Centre; Partnership for Advanced Computing in Europe	We thank H. Beuther, P. Clark, and A. Stutz for discussions. J.K. acknowledges the Deutsche Forschungsgemeinschaft priority program 1573 ("ISM-SPP"), and C. F. acknowledges the Discovery Projects Fellowship from the Australian Research Council (grant DP110102191). We acknowledge supercomputing time at Leibniz-Rechenzentrum (grant pr32lo), Julich Supercomputing Centre (grant hhd20), and Partnership for Advanced Computing in Europe (grant pr89mu). This work is based on publicly available data from the 2 Micron All Sky Survey (http://irsa.ipac.caltech.edu/Missions/2mass.html).	Brunt CM, 2010, MON NOT R ASTRON SOC, V405, pL56, DOI 10.1111/j.1745-3933.2010.00858.x; Diehl R, 2006, NATURE, V439, P45, DOI 10.1038/nature04364; Evans NJ, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/2/114; Evans NJ, 2009, ASTROPHYS J SUPPL S, V181, P321, DOI 10.1088/0067-0049/181/2/321; Federrath C, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/156; Fischera J, 2004, ASTROPHYS J, V611, P919, DOI 10.1086/422184; Ginsburg A, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/50; Heiderman A, 2010, ASTROPHYS J, V723, P1019, DOI 10.1088/0004-637X/723/2/1019; Hennebelle P, 2012, ASTRON ASTROPHYS REV, V20, DOI 10.1007/s00159-012-0055-y; Hennebelle P, 2011, ASTROPHYS J LETT, V743, DOI 10.1088/2041-8205/743/2/L29; Heyer MH, 2004, ASTROPHYS J, V615, pL45, DOI 10.1086/425978; Kainulainen J, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201219526; Kainulainen J, 2009, ASTRON ASTROPHYS, V508, pL35, DOI 10.1051/0004-6361/200913605; Krumholz MR, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/69; Krumholz MR, 2005, ASTROPHYS J, V630, P250, DOI 10.1086/431734; Lada CJ, 2010, ASTROPHYS J, V724, P687, DOI 10.1088/0004-637X/724/1/687; Launhardt R, 2010, ASTROPHYS J SUPPL S, V188, P139, DOI 10.1088/0067-0049/188/1/139; Murray N, 2010, ASTROPHYS J, V709, P424, DOI 10.1088/0004-637X/709/1/424; Padoan P, 1997, MON NOT R ASTRON SOC, V288, P145, DOI 10.1093/mnras/288.1.145; Padoan P., U ARIZONA SPACE SCI; Padoan P, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/1/40; Robitaille TP, 2010, ASTROPHYS J LETT, V710, pL11, DOI 10.1088/2041-8205/710/1/L11; Roman-Duval J, 2010, ASTROPHYS J, V723, P492, DOI 10.1088/0004-637X/723/1/492; Scalo J, 1998, ASTROPHYS J, V504, P835, DOI 10.1086/306099; Vazquez-Semadeni E., 1994, MON NOT R ASTRON SOC, V423, P681	28	89	89	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					183	185		10.1126/science.1248724	http://dx.doi.org/10.1126/science.1248724			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24723608	Green Submitted			2022-12-28	WOS:000334096300031
J	Tsai, L; Barnea, G				Tsai, Lulu; Barnea, Gilad			A Critical Period Defined by Axon-Targeting Mechanisms in the Murine Olfactory Bulb	SCIENCE			English	Article							RECEPTOR GENE-EXPRESSION; ODORANT RECEPTORS; TOPOGRAPHIC MAP; SELF-AVOIDANCE; SENSORY MAP; ORGANIZATION; EPITHELIUM; NEURONS; SYSTEM; BRAIN	The olfactory system remains plastic throughout life because of continuous neurogenesis of sensory neurons in the nose and inhibitory interneurons in the olfactory bulb. Here, we reveal that transgenic expression of an odorant receptor has non-cell autonomous effects on axons expressing this receptor from the endogenous gene. Perinatal expression of transgenic odorant receptor causes rerouting of like axons to new glomeruli, whereas expression after the sensory map is established does not lead to rerouting. Further, chemical ablation of the map after rerouting does not restore the normal map, even when the transgenic receptor is no longer expressed. Our results reveal that glomeruli are designated as targets for sensory neurons expressing specific odorant receptors during a critical period in the formation of the olfactory sensory map.	[Tsai, Lulu; Barnea, Gilad] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Barnea, G (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	gilad_barnea@brown.edu		Korsak, Lulu/0000-0001-7662-3448	NIH [T32GM007601, 5R01MH086920]; Pew Scholar in the Biomedical Sciences program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103410, T32GM007601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086920] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholar in the Biomedical Sciences program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank R. Axel, E. Morrow, and members of the Barnea laboratory for critical reading of the manuscript. We thank R. Y. Korsak and M. Talay for artwork for the figures. This work was supported by NIH grants T32GM007601 (L. T.) and 5R01MH086920 (G. B.), as well as by funds from the Pew Scholar in the Biomedical Sciences program.	Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; BRITTEBO EB, 1995, PHARMACOL TOXICOL, V76, P76, DOI 10.1111/j.1600-0773.1995.tb00107.x; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Fleischmann A, 2008, NEURON, V60, P1068, DOI 10.1016/j.neuron.2008.10.046; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Nakashima A, 2013, CELL, V154, P1314, DOI 10.1016/j.cell.2013.08.033; Nguyen MQ, 2007, CELL, V131, P1009, DOI 10.1016/j.cell.2007.10.050; Nguyen MQ, 2010, J NEUROSCI, V30, P9271, DOI 10.1523/JNEUROSCI.1502-10.2010; RAMING K, 1993, NATURE, V361, P353, DOI 10.1038/361353a0; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Tsuboi A, 1999, J NEUROSCI, V19, P8409; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zipursky SL, 2013, ANNU REV NEUROSCI, V36, P547, DOI 10.1146/annurev-neuro-062111-150414	26	39	39	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					197	200		10.1126/science.1248806	http://dx.doi.org/10.1126/science.1248806			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24723611	Green Accepted			2022-12-28	WOS:000334096300035
J	Shaw, JE				Shaw, Jane E.			Alejandro Zaffaroni (1923-2014) OBITUARY	NATURE			English	Biographical-Item												janeeshaw@comcast.net						ZAFFARONI A, PUBLICATION LIST	1	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					187	187		10.1038/508187a	http://dx.doi.org/10.1038/508187a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE4UK	24717508	Bronze			2022-12-28	WOS:000333979900029
J	Willis, NA; Chandramouly, G; Huang, B; Kwok, A; Follonier, C; Deng, CX; Scully, R				Willis, Nicholas A.; Chandramouly, Gurushankar; Huang, Bin; Kwok, Amy; Follonier, Cindy; Deng, Chuxia; Scully, Ralph			BRCA1 controls homologous recombination at Tus/Ter-stalled mammalian replication forks	NATURE			English	Article							STRAND BREAK REPAIR; EPSTEIN-BARR-VIRUS; SISTER-CHROMATID RECOMBINATION; TRACT GENE CONVERSION; DNA-DAMAGE RESPONSE; ESCHERICHIA-COLI; IN-VITRO; CELLS; PROTEIN; ORIP	Replication fork stalling can promote genomic instability, predisposing to cancer and other diseases(1-3). Stalled replication forks may be processed by sister chromatid recombination (SCR), generating error-free or error-prone homologous recombination (HR) outcomes(4-8). In mammalian cells, a long-standing hypothesis proposes that the major hereditary breast/ovarian cancer predisposition gene products, BRCA1 and BRCA2, control HR/SCR at stalled replication forks(9). Although BRCA1 and BRCA2 affect replication fork processing(10-12), direct evidence that BRCA gene products regulate homologous recombination at stalled chromosomal replication forks is lacking, due to a dearth of tools for studying this process. Here we report that the Escherichia coli Tus/Ter complex(13-16) can be engineered to induce site-specific replication fork stalling and chromosomal HR/SCR in mouse cells. Tus/Ter-induced homologous recombination entails processing of bidirectionally arrested forks. We find that the Brca1 carboxy (C)-terminal tandem BRCT repeat and regions of Brca1 encoded by exon 11-two Brca1 elements implicated in tumour suppression-control Tus/Ter-induced homologous recombination. Inactivation of either Brca1 or Brca2 increases the absolute frequency of 'long-tract' gene conversions at Tus/Ter-stalled forks, an outcome not observed in response to a site-specific endonuclease-mediated chromosomal double-strand break. Therefore, homologous recombination at stalled forks is regulated differently from homologous recombination at double-strand breaks arising independently of a replication fork. We propose that aberrant long-tract homologous recombination at stalled replication forks contributes to genomic instability and breast/ovarian cancer predisposition in BRCA mutant cells.	[Willis, Nicholas A.; Chandramouly, Gurushankar; Huang, Bin; Kwok, Amy; Scully, Ralph] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Willis, Nicholas A.; Chandramouly, Gurushankar; Huang, Bin; Kwok, Amy; Scully, Ralph] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Follonier, Cindy] Princeton Univ, Lewis Thomas Lab 101, Princeton, NJ 08544 USA; [Deng, Chuxia] NIDDK, NIH, Bethesda, MD 20814 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Princeton University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Scully, R (corresponding author), Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02215 USA.	rscully@bidmc.harvard.edu	Scully, Ralph/F-5008-2013; deng, chuxia/N-6713-2016		NIH [R01CA095175, R01GM073894, R21CA144017, R37GM26938]; NIH/NCI [5T32CA081156]; ACS [PF-12-248-01-DMC]; NATIONAL CANCER INSTITUTE [R01CA095175, R21CA144017, T32CA081156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056011, ZIADK056009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026938, R01GM073894, R37GM026938, R01GM043265] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ACS(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Michel for reagents and advice; D. Livingston, K. Marians, J. Walter, I. Hickson, S. Powell, V. Zakian and members of the Scully laboratory for helpful discussions; I. Hickson and S. Powell for sharing their unpublished data on Tus/Ter replication blocks in eukaryotes; R. Baer for antibodies and A. Ashworth for Brca1 conditional ES cell line 11C0/47T. This work was supported by NIH grants R01CA095175, R01GM073894 and R21CA144017 (to R.S.). N.A.W. was supported by an NIH/NCI postdoctoral fellowship (5T32CA081156) and an ACS postdoctoral research fellowship (PF-12-248-01-DMC). C.F. was supported by NIH grant R37GM26938 (to V.A.Z.).	AMIN AA, 1992, J BIOL CHEM, V267, P18612; Bidnenko V, 2002, EMBO J, V21, P3898, DOI 10.1093/emboj/cdf369; Carr AM, 2013, J MOL BIOL, V425, P4733, DOI 10.1016/j.jmb.2013.04.023; Castor D, 2013, MOL CELL, V52, P221, DOI 10.1016/j.molcel.2013.08.036; Chandramouly G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3404; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Dhar SK, 2001, CELL, V106, P287, DOI 10.1016/S0092-8674(01)00458-5; Follonier C, 2014, METHODS MOL BIOL, V1094, P209, DOI 10.1007/978-1-62703-706-8_16; GAHN TA, 1989, CELL, V58, P527, DOI 10.1016/0092-8674(89)90433-9; Garner E, 2013, CELL REP, V5, P207, DOI 10.1016/j.celrep.2013.08.041; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; HILL TM, 1990, P NATL ACAD SCI USA, V87, P2481, DOI 10.1073/pnas.87.7.2481; Huber LJ, 2001, MOL CELL BIOL, V21, P4005, DOI 10.1128/MCB.21.12.4005-4015.2001; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; KIRCHMAIER AL, 1995, J VIROL, V69, P1280, DOI 10.1128/JVI.69.2.1280-1283.1995; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Lambert S, 2010, MOL CELL, V39, P346, DOI 10.1016/j.molcel.2010.07.015; Llorente B, 2008, CELL CYCLE, V7, P859, DOI 10.4161/cc.7.7.5613; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Mulcair MD, 2006, CELL, V125, P1309, DOI 10.1016/j.cell.2006.04.040; Nagaraju G, 2007, DNA REPAIR, V6, P1018, DOI 10.1016/j.dnarep.2007.02.020; Nagaraju G, 2006, MOL CELL BIOL, V26, P8075, DOI 10.1128/MCB.01235-06; Pathania S, 2011, MOL CELL, V44, P235, DOI 10.1016/j.molcel.2011.09.002; Puget N, 2005, DNA REPAIR, V4, P149, DOI 10.1016/j.dnarep.2004.08.010; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Saini N, 2013, NATURE, V502, P389, DOI 10.1038/nature12584; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743	33	100	102	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					556	+		10.1038/nature13295	http://dx.doi.org/10.1038/nature13295			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24776801	Green Accepted, Green Submitted			2022-12-28	WOS:000337806300051
J	Yamamoto, J; Suh, J; Takeuchi, D; Tonegawa, S				Yamamoto, Jun; Suh, Junghyup; Takeuchi, Daigo; Tonegawa, Susumu			Successful Execution of Working Memory Linked to Synchronized High-Frequency Gamma Oscillations	CELL			English	Article							CAT VISUAL-CORTEX; TEMPORAL ASSOCIATION MEMORY; ENTORHINAL CORTEX; BEHAVING RAT; PREFRONTAL CORTEX; SINGLE NEURONS; HIPPOCAMPUS; INFORMATION; TASK; PERFORMANCE	Neuronal oscillations have been hypothesized to play an important role in cognition and its ensuing behavior, but evidence that links a specific neuronal oscillation to a discrete cognitive event is largely lacking. We measured neuronal activity in the entorhinal- hippocampal circuit while mice performed a reward-based spatial working memory task. During the memory retention period, a transient burst of high gamma synchronization preceded an animal's correct choice in both prospective planning and retrospective mistake correction, but not an animal's incorrect choice. Optogenetic inhibition of the circuit targeted to the choice point area resulted in a coordinated reduction in both high gamma synchrony and correct execution of a working-memory-guided behavior. These findings suggest that transient high gamma synchrony contributes to the successful execution of spatial working memory. Furthermore, our data are consistent with an association between transient high gamma synchrony and explicit awareness of the working memory content.	[Yamamoto, Jun; Suh, Junghyup; Takeuchi, Daigo; Tonegawa, Susumu] MIT, RIKEN Ctr Neural Circuit Genet, Picower Inst Learning & Memory, Dept Biol, Cambridge, MA 02139 USA; [Yamamoto, Jun; Suh, Junghyup; Takeuchi, Daigo; Tonegawa, Susumu] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Tonegawa, Susumu] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Tonegawa, S (corresponding author), MIT, RIKEN Ctr Neural Circuit Genet, Picower Inst Learning & Memory, Dept Biol, Cambridge, MA 02139 USA.	tonegawa@mit.edu	Suh, Junghyup/AAO-8265-2020	Yamamoto, Jun/0000-0002-9681-2841	RIKEN Brain Science Institute; Picower Institute Innovation Fund; Human Frontier Science Program (HFSP) fellowship	RIKEN Brain Science Institute; Picower Institute Innovation Fund; Human Frontier Science Program (HFSP) fellowship(Human Frontier Science Program)	We thank G. Das for the viral construction; C. Lovett, M. Serock, C. Ragion, N. Nayyar, and K. Kajikawa for help with the viral injections and histology; J. Young, C. MacDonald, M. Pignatelli, T. Kitamura, and C. Yokoyama for comments and discussions on the manuscript; and other members of the Tonegawa lab for their support. This work was supported by the RIKEN Brain Science Institute (to S.T.), the Picower Institute Innovation Fund (to S T.), and the Human Frontier Science Program (HFSP) fellowship (to D.T.).	Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; BRAGIN A, 1995, J NEUROSCI, V15, P47; Carr MF, 2012, NEURON, V75, P700, DOI 10.1016/j.neuron.2012.06.014; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Dolleman-Van Der Weel M. J., 1996, Journal of Comparative Neurology, V364, P637, DOI 10.1002/(SICI)1096-9861(19960122)364:4<637::AID-CNE3>3.0.CO;2-4; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; FREEMAN JA, 1975, J NEUROPHYSIOL, V38, P369, DOI 10.1152/jn.1975.38.2.369; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hirabayashi T, 2013, NEURON, V77, P192, DOI 10.1016/j.neuron.2012.10.031; Hirabayashi T, 2010, J NEUROSCI, V30, P10407, DOI 10.1523/JNEUROSCI.0135-10.2010; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Jutras MJ, 2009, J NEUROSCI, V29, P12521, DOI 10.1523/JNEUROSCI.0640-09.2009; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Kitamura T, 2014, SCIENCE, V343, P896, DOI 10.1126/science.1244634; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Melzer S, 2012, SCIENCE, V335, P1506, DOI 10.1126/science.1217139; MITZDORF U, 1978, EXP BRAIN RES, V33, P371; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; OTTO T, 1992, BEHAV NEUROSCI, V106, P762, DOI 10.1037/0735-7044.106.5.762; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; PERKEL DH, 1967, BIOPHYS J, V7, P391, DOI 10.1016/S0006-3495(67)86596-2; Quilichini P, 2010, J NEUROSCI, V30, P11128, DOI 10.1523/JNEUROSCI.1327-10.2010; Resulaj A, 2009, NATURE, V461, P263, DOI 10.1038/nature08275; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; Van Der Werf YD, 2003, CORTEX, V39, P1047, DOI 10.1016/S0010-9452(08)70877-3; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081	41	212	215	1	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					845	857		10.1016/j.cell.2014.04.009	http://dx.doi.org/10.1016/j.cell.2014.04.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24768692	Bronze, Green Submitted			2022-12-28	WOS:000335765500013
J	Kilpatrick, ES; Atkin, SL				Kilpatrick, Eric S.; Atkin, Stephen L.			RATIONAL TESTING Using haemoglobin A(1c) to diagnose type 2 diabetes or to identify people at high risk of diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE		[Kilpatrick, Eric S.] Hull Royal Infirm, Dept Clin Biochem, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Kilpatrick, Eric S.] Hull York Med Sch, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Atkin, Stephen L.] Weill Cornell Med Coll Qatar, Doha, Qatar	University of Hull; University of Hull; University of York - UK; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Kilpatrick, ES (corresponding author), Hull Royal Infirm, Dept Clin Biochem, Kingston Upon Hull HU3 2JZ, N Humberside, England.	Eric.Kilpatrick@hey.nhs.uk	Atkin, stephen/ABE-7047-2020					Hamilton W, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4259; John WG, 2012, DIABETIC MED, V29, P1350, DOI 10.1111/j.1464-5491.2012.03762.x; Kilpatrick ES, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4432; Lenters-Westra E, 2010, CLIN CHEM, V56, P44, DOI 10.1373/clinchem.2009.130641; Lowe LP, 2012, DIABETES CARE, V35, P574, DOI 10.2337/dc11-1687; National Institute for Health and Care Excellence, 2014, PREVENTING TYPE 2 DI; Selvin E, 2007, ARCH INTERN MED, V167, P1545, DOI 10.1001/archinte.167.14.1545; World Health Organisation, 1999, DEFINITION DIAGNOSIS; World Health Organization, 2011, USE OF GLYCATED HAEM	9	12	12	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2014	348								g2867	10.1136/bmj.g2867	http://dx.doi.org/10.1136/bmj.g2867			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG1DN	24769658				2022-12-28	WOS:000335155400005
J	Bendall, SC; Davis, KL; Amir, ED; Tadmor, MD; Simonds, EF; Chen, TJ; Shenfeld, DK; Nolan, GP; Pe'er, D				Bendall, Sean C.; Davis, Kara L.; Amir, El-ad David; Tadmor, Michelle D.; Simonds, Erin F.; Chen, Tiffany J.; Shenfeld, Daniel K.; Nolan, Garry P.; Pe'er, Dana			Single-Cell Trajectory Detection Uncovers Progression and Regulatory Coordination in Human B Cell Development	CELL			English	Article							MASS CYTOMETRY; IMMUNOGLOBULIN; LYMPHOCYTES; MURINE; STAT5	Tissue regeneration is an orchestrated progression of cells from an immature state to amature one, conventionally represented as distinctive cell subsets. A continuum of transitional cell states exists between these discrete stages. We combine the depth of single-cell mass cytometry and an algorithm developed to leverage this continuumby aligning single cells of a given lineage onto a unified trajectory that accurately predicts the developmental path de novo. Applied to human B cell lymphopoiesis, the algorithm (termed Wanderlust) constructed trajectories spanning from hematopoietic stem cells through to naive B cells. This trajectory revealed nascent fractions of B cell progenitors and aligned them with developmentally cued regulatory signaling including IL-7/STAT5 and cellular events such as immunoglobulin rearrangement, highlighting checkpoints across which regulatory signals are rewired paralleling changes in cellular state. This study provides a comprehensive analysis of human B lymphopoiesis, laying a foundation to apply this approach to other tissues and "corrupted'' developmental processes including cancer.	[Bendall, Sean C.; Davis, Kara L.; Simonds, Erin F.; Chen, Tiffany J.; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Bendall, Sean C.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Davis, Kara L.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Amir, El-ad David; Tadmor, Michelle D.; Shenfeld, Daniel K.; Pe'er, Dana] Columbia Univ, Dept Biol Sci, Dept Syst Biol, New York, NY 10027 USA; [Chen, Tiffany J.] Stanford Univ, Program Biomed Informat, Stanford, CA 94305 USA; [Chen, Tiffany J.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Columbia University; Stanford University; Stanford University	Nolan, GP (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA.	gnolan@stanford.edu; dpeer@biology.columbia.edu	Nolan, Garry/AAE-7903-2019; Bendall, Sean/AGG-0126-2022	Nolan, Garry/0000-0002-8862-9043; Bendall, Sean/0000-0003-1341-2453; Pe'er, Dana/0000-0002-9259-8817; Simonds, Erin/0000-0002-3497-4861	St. Baldrick's Foundation Scholar Award; Alex's Lemonade Stand Young Investigator Award; Lucile Packard Foundation for Children's Health; NIH-NCATS-CTSA [UL1 TR001085]; Child Health Research Institute of Stanford University; Damon Runyon Cancer Research Foundation Fellowship [DRG-2017-09]; NIH [K99GM104148-01, S10 SIG S10RR027582-01, 152175.5041015.0412, DP2-OD002414-01, U54CA121852-01A1]; National Defense Science & Engineering Graduate Fellowship Program; Stanford University Graduate Fellowship; Google Anita Borg Memorial Scholarship; William Lawrence and Blanche Hughes Foundation; Entertainment Industry Foundation; Northrup-Grumman Corp; Alliance for Lupus Research; Lymphoma Research Foundation; Bill and Melinda Gates Foundation; NSF [MCB-1149728]; Packard Fellowship for Science and Engineering;  [0158 G KB065];  [1R01CA130826];  [5U54CA143907NIH];  [CIRM: DR1-01477];  [HEALTH.2010.1.2-1];  [HHSF223201210194C - FDA: BAA-12-00118];  [HHSN272200700038C];  [N01-HV-00242];  [NIH 41000411217];  [NIH 5-24927];  [P01 CA034233-22A1];  [PN2EY018228];  [RB2-01592];  [U19 AI057229];  [U54CA149145];  [W81XWH-12-1-0591]; Direct For Biological Sciences [1149728] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA130826, U54CA143907, U54CA121852, R01CA164729, P01CA034233, U54CA149145] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744, S10RR027582] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229, U19AI100627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM104148, K99GM104148] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002414] Funding Source: NIH RePORTER	St. Baldrick's Foundation Scholar Award; Alex's Lemonade Stand Young Investigator Award; Lucile Packard Foundation for Children's Health; NIH-NCATS-CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Child Health Research Institute of Stanford University; Damon Runyon Cancer Research Foundation Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science & Engineering Graduate Fellowship Program; Stanford University Graduate Fellowship(Stanford University); Google Anita Borg Memorial Scholarship(Google Incorporated); William Lawrence and Blanche Hughes Foundation; Entertainment Industry Foundation; Northrup-Grumman Corp; Alliance for Lupus Research; Lymphoma Research Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NSF(National Science Foundation (NSF)); Packard Fellowship for Science and Engineering; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Omer Angel, Antonio de-la-Hera, Astraea Jager, Ulf Klein, Smita Krishnaswamy, Jacob Levine, Eva Sanz, Peter Sims, and Angelica Trejo for their intellectual and technical contributions. K.L.D. is supported by a St. Baldrick's Foundation Scholar Award, Alex's Lemonade Stand Young Investigator Award and the Lucile Packard Foundation for Children's Health, Stanford NIH-NCATS-CTSA UL1 TR001085 and Child Health Research Institute of Stanford University. S.C.B. is supported by the Damon Runyon Cancer Research Foundation Fellowship (DRG-2017-09) and the NIH K99GM104148-01. E.D.A. is a Howard Hughes Medical Institute International Student Research Fellow. T.J.C. is supported by National Defense Science & Engineering Graduate Fellowship Program, Stanford University Graduate Fellowship, and the Google Anita Borg Memorial Scholarship. This work was supported by 0158 G KB065; 1R01CA130826; 5U54CA143907NIH; CIRM: DR1-01477; HEALTH.2010.1.2-1; HHSF223201210194C - FDA: BAA-12-00118; HHSN272200700038C; N01-HV-00242; NIH 41000411217; NIH 5-24927; P01 CA034233-22A1; PN2EY018228; RB2-01592; U19 AI057229; U54CA149145; W81XWH-12-1-0591 OCRP-TIA NWC; NIH S10 SIG S10RR027582-01, William Lawrence and Blanche Hughes Foundation, Entertainment Industry Foundation, Northrup-Grumman Corp, Alliance for Lupus Research, Lymphoma Research Foundation, Bill and Melinda Gates Foundation, NIH 152175.5041015.0412 and the Rachford and Carlota A. Harris Endowment to G.P.N. This work was supported by NSF MCB-1149728, NIH DP2-OD002414-01, NIH U54CA121852-01A1 to D.P. D.P. holds a Packard Fellowship for Science and Engineering. G.P.N. has personal financial interest in and S.C.B. is a paid consultant for the company DVS Sciences, the manufacturers that produced some of the reagents and instrumentation used in this manuscript.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Cobaleda C, 2009, BIOESSAYS, V31, P600, DOI 10.1002/bies.200800234; Fienberg HG, 2012, CYTOM PART A, V81A, P467, DOI 10.1002/cyto.a.22067; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; HARDY RR, 1984, J EXP MED, V159, P1169, DOI 10.1084/jem.159.4.1169; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Johnson SE, 2005, J IMMUNOL, V175, P7325, DOI 10.4049/jimmunol.175.11.7325; Kang JS, 2004, CURR OPIN IMMUNOL, V16, P180, DOI 10.1016/j.coi.2004.02.002; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Rolink AG, 1999, IMMUNOL LETT, V68, P89, DOI 10.1016/S0165-2478(99)00035-8; Sanz E, 2010, P NATL ACAD SCI USA, V107, P5925, DOI 10.1073/pnas.0907942107; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202	16	546	558	5	100	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					714	725		10.1016/j.cell.2014.04.005	http://dx.doi.org/10.1016/j.cell.2014.04.005			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766814	Green Accepted, Bronze			2022-12-28	WOS:000335392100019
J	Brzezniak, C; Szabo, E				Brzezniak, Christina; Szabo, Eva			Sunitinib-Associated Hair Depigmentation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Brzezniak, Christina] Walter Reed Natl Mil Med Ctr, Bethesda, MD 20889 USA; [Szabo, Eva] NIH, Bethesda, MD 20892 USA	Walter Reed National Military Medical Center; National Institutes of Health (NIH) - USA	Brzezniak, C (corresponding author), Walter Reed Natl Mil Med Ctr, Bethesda, MD 20889 USA.	christina.e.brzezniak.mil@health.mil		Brzezniak, Christina/0000-0002-4937-8202; Szabo, Eva/0000-0003-3891-0942					0	10	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 24	2014	370	17					E27	E27		10.1056/NEJMicm1309906	http://dx.doi.org/10.1056/NEJMicm1309906			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4TG	24758639				2022-12-28	WOS:000336120500001
J	Gronych, J; Pfister, SM; Jones, DTW				Gronych, Jan; Pfister, Stefan M.; Jones, David T. W.			Connect Four with Glioblastoma Stem Cell Factors	CELL			English	Editorial Material								Hierarchical cell state models, wherein a few stem-like tumor-propagating cells repopulate the tumor after therapy, are often invoked in cancer. Suvaet al. demonstrate a plastic developmental hierarchy in glioma cell populations by characterizing the epigenetic states of phenotypically distinct cells and identifying four factors sufficient to reprogram differentiated cells into a tumorigenic stem-like state.	[Gronych, Jan] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany; [Pfister, Stefan M.; Jones, David T. W.] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Hematol & Oncol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Pfister, SM (corresponding author), German Canc Res Ctr, Div Pediat Neurooncol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	s.pfister@dkfz.de; david.jones@dkfz.de	Jones, David T. W./Z-1963-2019; Pfister, Stefan M/F-6860-2013	Pfister, Stefan M/0000-0002-5447-5322				Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stricker SH, 2013, GENE DEV, V27, P654, DOI 10.1101/gad.212662.112; Sturm D, 2014, NAT REV CANCER, V14, P92, DOI 10.1038/nrc3655; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024	10	10	12	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					525	527		10.1016/j.cell.2014.04.001	http://dx.doi.org/10.1016/j.cell.2014.04.001			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766799	Bronze			2022-12-28	WOS:000335392100001
J	Chapman, EG; Costantino, DA; Rabe, JL; Moon, SL; Wilusz, J; Nix, JC; Kieft, JS				Chapman, Erich G.; Costantino, David A.; Rabe, Jennifer L.; Moon, Stephanie L.; Wilusz, Jeffrey; Nix, Jay C.; Kieft, Jeffrey S.			The Structural Basis of Pathogenic Subgenomic Flavivirus RNA (sfRNA) Production	SCIENCE			English	Article							JAPANESE ENCEPHALITIS-VIRUS; MESSENGER-RNA; WEST-NILE; MOSQUITO CELLS; DENGUE; RESISTANT; XRN1	Flaviviruses are emerging human pathogens and worldwide health threats. During infection, pathogenic subgenomic flaviviral RNAs (sfRNAs) are produced by resisting degradation by the 5'-> 3' host cell exonuclease Xrn1 through an unknown RNA structure-based mechanism. Here, we present the crystal structure of a complete Xrn1-resistant flaviviral RNA, which contains interwoven pseudoknots within a compact structure that depends on highly conserved nucleotides. The RNA's three-dimensional topology creates a ringlike conformation, with the 5' end of the resistant structure passing through the ring from one side of the fold to the other. Disruption of this structure prevents formation of sfRNA during flaviviral infection. Thus, sfRNA formation results from an RNA fold that interacts directly with Xrn1, presenting the enzyme with a structure that confounds its helicase activity.	[Chapman, Erich G.; Costantino, David A.; Rabe, Jennifer L.; Kieft, Jeffrey S.] Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Chapman, Erich G.; Costantino, David A.; Kieft, Jeffrey S.] Univ Colorado Denver, Sch Med, Howard Hughes Med Inst, Aurora, CO 80045 USA; [Moon, Stephanie L.; Wilusz, Jeffrey] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Nix, Jay C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Mol Biol Consortium, Berkeley, CA 94720 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kieft, JS (corresponding author), Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	jeffrey.kieft@ucdenver.edu		Moon, Stephanie/0000-0002-4989-0150	University of Colorado Cancer Center [P30CA046934]; NIH award through the Rocky Mountain Regional Center of Excellence [U54 AI-065357]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM108257] Funding Source: NIH RePORTER	University of Colorado Cancer Center; NIH award through the Rocky Mountain Regional Center of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Kieft Lab for discussions and A. Ferre-d'Amare, M. Johnston, and R. Batey for critical reading of this manuscript. The University of Colorado Denver X-ray Facility is supported by University of Colorado Cancer Center Support Grant P30CA046934. J.S.K. is an Early Career Scientist of the Howard Hughes Medical Institute. J.W. was supported by a NIH award through the Rocky Mountain Regional Center of Excellence, U54 AI-065357. Coordinates and structure factors have been deposited with Protein Data Bank accession code 4PQV.	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892; Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10; Jinek M, 2011, MOL CELL, V41, P600, DOI 10.1016/j.molcel.2011.02.004; Jones CI, 2012, WIRES RNA, V3, P455, DOI 10.1002/wrna.1109; Lescoute A, 2006, RNA, V12, P83, DOI 10.1261/rna.2208106; Lin KC, 2004, J VIROL, V78, P5133, DOI 10.1128/JVI.78.10.5133-5138.2004; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112; NAEVE CW, 1978, J VIROL, V25, P535, DOI 10.1128/JVI.25.2.535-545.1978; Normile D, 2013, SCIENCE, V342, P415, DOI 10.1126/science.342.6157.415; Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007; Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404; Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12; Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12; Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10; TAKEDA H, 1978, J GEN VIROL, V38, P281, DOI 10.1099/0022-1317-38-2-281; Urosevic N, 1997, J GEN VIROL, V78, P23, DOI 10.1099/0022-1317-78-1-23; WENGLER G, 1978, VIROLOGY, V89, P423, DOI 10.1016/0042-6822(78)90185-X	19	167	170	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					307	310		10.1126/science.1250897	http://dx.doi.org/10.1126/science.1250897			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744377	Green Accepted			2022-12-28	WOS:000334474500038
J	Minteer, BA; Collins, JP; Love, KE; Puschendorf, R				Minteer, Ben A.; Collins, James P.; Love, Karen E.; Puschendorf, Robert			Avoiding (Re) extinction	SCIENCE			English	Editorial Material							POPULATIONS; FROGS; DNA		[Minteer, Ben A.; Collins, James P.; Love, Karen E.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Puschendorf, Robert] Univ Plymouth, Sch Biol Sci, Plymouth PL4 8AA, Devon, England	Arizona State University; Arizona State University-Tempe; University of Plymouth	Minteer, BA (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	ben.minteer@asu.edu	Puschendorf, Robert/B-6280-2011	Puschendorf, Robert/0000-0002-8105-171X				Athreya Ramana, 2006, Indian Birds, V2, P82; Bolanos F, 2002, AMBIENTICO, V107, P12; Brengtson S. A., 1984, AUK, V101, P1; Collar NJ, 1999, IBIS, V141, P358, DOI 10.1111/j.1474-919X.1999.tb04406.x; Collins J.P., 2009, EXTINCTION OUR TIMES; Fuller Errol, 2003, GREAT AUK EXTINCTION; Garcia-Rodriguez A, 2012, DIVERS DISTRIB, V18, P204, DOI 10.1111/j.1472-4642.2011.00862.x; Mendoza AM, 2012, MOL ECOL RESOUR, V12, P470, DOI 10.1111/j.1755-0998.2011.03107.x; Nishida K., 2006, BRENESIA, V66, P78; NORTON DA, 1994, TAXON, V43, P181, DOI 10.2307/1222876; Phillips BL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1290; Prunier J, 2012, MOL ECOL RESOUR, V12, P524, DOI 10.1111/j.1755-0998.2012.03116.x; Rodriguez-Estrella R, 2006, BIODIVERS CONSERV, V15, P1621, DOI 10.1007/s10531-004-4308-6; Scheffers BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022531	14	73	81	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					260	261		10.1126/science.1250953	http://dx.doi.org/10.1126/science.1250953			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744362				2022-12-28	WOS:000334474500021
J	Katz, DL				Katz, D. L.			Obesity is not a disease	NATURE			English	Editorial Material									[Katz, D. L.] Yale Univ, Prevent Res Ctr, New Haven, CT 06520 USA	Yale University	Katz, DL (corresponding author), Yale Univ, Prevent Res Ctr, New Haven, CT 06520 USA.	davkatz7@gmail.com		Katz, David/0000-0001-6845-6192				Cannon C. P., 2009, CLIN CORNERSTONE, V9, P69; Cannon Christopher P, 2009, Clin Cornerstone, V9, P55; Diamond J., 1999, NY TIMES; Gill T P, 1999, Asia Pac J Clin Nutr, V8, P75, DOI 10.1046/j.1440-6047.1999.00060.x; Katz D. L., 2013, US NEWS WORLD REPORT; Katz DL, 2014, CHILD OBES, V10, P1, DOI 10.1089/chi.2014.1012; Kraschnewski JL, 2013, MED CARE, V51, P186, DOI 10.1097/MLR.0b013e3182726c33; Moss M., 2013, NEW YORK TIMES MAGAZ; Nawaz H, 2001, AM J PREV MED, V21, P73, DOI 10.1016/S0749-3797(01)00317-8; Nawaz H, 1999, AM J PUBLIC HEALTH, V89, P764, DOI 10.2105/AJPH.89.5.764	10	24	25	1	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					S57	S57		10.1038/508S57a	http://dx.doi.org/10.1038/508S57a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF0KP	24740128				2022-12-28	WOS:000334403000005
J	Pop, IM; Geerlings, K; Catelani, G; Schoelkopf, RJ; Glazman, LI; Devoret, MH				Pop, Ioan M.; Geerlings, Kurtis; Catelani, Gianluigi; Schoelkopf, Robert J.; Glazman, Leonid I.; Devoret, Michel H.			Coherent suppression of electromagnetic dissipation due to superconducting quasiparticles	NATURE			English	Article							JOSEPHSON; FLUCTUATIONS; DEPENDENCE; JUNCTIONS; QUBIT	Owing to the low-loss propagation of electromagnetic signals in superconductors, Josephson junctions constitute ideal building blocks for quantum memories, amplifiers, detectors and high-speed processing units, operating over a wide band of microwave frequencies. Nevertheless, although transport in superconducting wires is perfectly lossless for direct current, transport of radio-frequency signals can be dissipative in the presence of quasiparticle excitations above the superconducting gap(1). Moreover, the exact mechanism of this dissipation in Josephson junctions has never been fully resolved experimentally. In particular, Josephson's key theoretical prediction that quasiparticle dissipation should vanish in transport through a junction when the phase difference across the junction is pi ( ref. 2) has never been observed(3). This subtle effect can be understood as resulting from the destructive interference of two separate dissipative channels involving electron-like and hole-like quasiparticles. Here we report the experimental observation of this quantum coherent suppression of quasiparticle dissipation across a Josephson junction. As the average phase bias across the junction is swept through p, we measure an increase of more than one order of magnitude in the energy relaxation time of a superconducting artificial atom. This striking suppression of dissipation, despite the presence of lossy quasiparticle excitations above the superconducting gap, provides a powerful tool for minimizing decoherence in quantum electronic systems and could be directly exploited in quantum information experiments with superconducting quantum bits.	[Pop, Ioan M.; Geerlings, Kurtis; Catelani, Gianluigi; Schoelkopf, Robert J.; Glazman, Leonid I.; Devoret, Michel H.] Yale Univ, Dept Appl Phys, New Haven, CT 06511 USA; [Catelani, Gianluigi] Peter Grunberg Inst PGI 2, Forschungszentrum Julich, D-52425 Julich, Germany	Yale University; Helmholtz Association; Research Center Julich	Pop, IM (corresponding author), Yale Univ, Dept Appl Phys, 15 Prospect St, New Haven, CT 06511 USA.	ioan.pop@yale.edu	Schoelkopf, Robert J/J-8178-2012; Pop, Ioan M/S-2354-2017; Catelani, Gianluigi/E-7134-2011; Pop, Ioan/ABE-6678-2020	Pop, Ioan M/0000-0002-6776-9792; Catelani, Gianluigi/0000-0002-0421-7325; Pop, Ioan/0000-0002-0660-6543	YINQE; NSF MRSEC DMR [1119826]; IARPA [W911NF-09-1-0369]; ARO [W911NF-09-1-0514]; NSF [DMR-1006060, DMR-0653377]; DOE [DE-FG02-08ER46482]; EU under REA [CIG-618258]	YINQE; NSF MRSEC DMR(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); IARPA; ARO; NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE)); EU under REA	We acknowledge discussions with L. Frunzio, A. Kamal, N. Masluk and U. Vool. Facilities use was supported by YINQE and NSF MRSEC DMR 1119826. This research was supported by IARPA under grant no. W911NF-09-1-0369, ARO under grant no. W911NF-09-1-0514, the NSF under grants nos DMR-1006060 and DMR-0653377, DOE contract no. DE-FG02-08ER46482 (L.I.G.), and the EU under REA grant agreement CIG-618258 (G.C.).	Aumentado J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.066802; Barends R, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3638063; Barone A., 2005, PHYS APPL JOSEPHSON; Beenakker C, 1992, TRANSPORT PHENOMENA; BEENAKKER CWJ, 1991, PHYS REV LETT, V67, P3836, DOI 10.1103/PhysRevLett.67.3836; Bell MT, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.137003; BRAGINSKY VB, 1987, PHYS LETT A, V120, P300, DOI 10.1016/0375-9601(87)90676-1; Bretheau L, 2013, NATURE, V499, P312, DOI 10.1038/nature12315; Catelani G, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.064517; Catelani G, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.077002; Clarke J., 2004, SQUID HDB FUNDAMENTA; Corcoles AD, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3658630; DOLAN GJ, 1977, APPL PHYS LETT, V31, P337, DOI 10.1063/1.89690; Ferguson AJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.106603; Giazotto F, 2012, NATURE, V492, P401, DOI 10.1038/nature11702; HARRIS RE, 1974, PHYS REV B, V10, P84, DOI 10.1103/PhysRevB.10.84; JOSEPHSON BD, 1962, PHYS LETT, V1, P251, DOI 10.1016/0031-9163(62)91369-0; Kos F, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.174521; LANGENBERG DN, 1974, REV PHYS APPL, V9, P35, DOI 10.1051/rphysap:019740090103500; Lecocq F, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/31/315302; Leppakangas J, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.060505; Manucharyan VE, 2009, SCIENCE, V326, P113, DOI 10.1126/science.1175552; Masluk N.A., 2012, THESIS YALE U; Masluk NA, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.137002; MATTIS DC, 1958, PHYS REV, V111, P412, DOI 10.1103/PhysRev.111.412; Paik H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.240501; PEDERSEN NF, 1972, PHYS REV B-SOLID ST, V6, P4151, DOI 10.1103/PhysRevB.6.4151; Pop IM, 2012, J VAC SCI TECHNOL B, V30, DOI 10.1116/1.3673790; Rigetti C, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.100506; Riste D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2936; Santavicca DF, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/8/087001; Schoelkopf R. J., 2002, QUANTUM NOISE MESOSC, P175; Shaw MD, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.024503; SOERENSEN OH, 1977, PHYS REV LETT, V39, P1018, DOI 10.1103/PhysRevLett.39.1018; Sun L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.230509; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Zhu GY, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.024510	39	154	160	0	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					369	+		10.1038/nature13017	http://dx.doi.org/10.1038/nature13017			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24740067				2022-12-28	WOS:000334403000046
J	Prindle, A; Selimkhanov, J; Li, H; Razinkov, I; Tsimring, LS; Hasty, J				Prindle, Arthur; Selimkhanov, Jangir; Li, Howard; Razinkov, Ivan; Tsimring, Lev S.; Hasty, Jeff			Rapid and tunable post-translational coupling of genetic circuits	NATURE			English	Article							PROTEIN; LOGIC; ULTRASENSITIVITY; DEGRADATION; PROTEOLYSIS; SIGMA(S); BIOLOGY; RSSB	One promise of synthetic biology is the creation of genetic circuitry that enables the execution of logical programming in living cells. Such 'wet programming'is positioned to transform a wide and diverse swathe of biotechnology ranging from therapeutics and diagnostics to water treatment strategies. Although progress in the development of a library of genetic modules continues apace(1-4), a major challenge for their integration into larger circuits is the generation of sufficiently fast and precise communication between modules(5,6). Anattractive approach is to integrate engineered circuits with host processes that facilitate robust cellular signalling(7). In this context, recent studies have demonstrated that bacterial protein degradation can trigger a precise response to stress by overloading a limited supply of intracellular proteases(8-10). Here we use protease competition to engineer rapid and tunable coupling of genetic circuits across multiple spatial and temporal scales. We characterize coupling delay times that are more than an order of magnitude faster than standard transcription factor- based coupling methods (less than 1 min compared with 2040 min) and demonstrate tunability through manipulation of the linker between the protein and its degradation tag. We use this mechanism as a platform to couple genetic clocks at the intracellular and colony level, then synchronize the multi-colony dynamics to reduce variability in both clocks. We show how the coupled clock network can be used to encode independent environmental inputs into a single time series output, thus enabling frequency multiplexing (information transmitted on a common channel by distinct frequencies) in a genetic circuit context. Our results establish a general framework for the rapid and tunable coupling of genetic circuits through the use of native `queueing' processes such as competitive protein degradation.	[Prindle, Arthur; Selimkhanov, Jangir; Li, Howard; Razinkov, Ivan; Hasty, Jeff] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Tsimring, Lev S.; Hasty, Jeff] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA; [Hasty, Jeff] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Hasty, J (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	hasty@bioeng.ucsd.edu			National Science Foundation [MCB-1121748]; San Diego Center for Systems Biology (NIH) [P50 GM085764]; US Department of Defense National Defense Science and Engineering Graduate Fellowship; Div Of Molecular and Cellular Bioscience [1121748] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); San Diego Center for Systems Biology (NIH); US Department of Defense National Defense Science and Engineering Graduate Fellowship; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation (MCB-1121748) and by the San Diego Center for Systems Biology (NIH Grant P50 GM085764) and the US Department of Defense National Defense Science and Engineering Graduate Fellowship (A.P.). We would like to thank T. Danino, M. Jin, C. Rivera, O. Din and J. De Friel for critical reading of the manuscript.	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Buchler NE, 2008, J MOL BIOL, V384, P1106, DOI 10.1016/j.jmb.2008.09.079; Burger A, 2010, P NATL ACAD SCI USA, V107, P4016, DOI 10.1073/pnas.0915138107; Cookson NA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.94; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Ferry M. S., METHODS ENZYMOL, V497, P295; Fredriksson A, 2007, GENE DEV, V21, P862, DOI 10.1101/gad.409407; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Griffith KL, 2008, MOL MICROBIOL, V70, P1012, DOI 10.1111/j.1365-2958.2008.06467.x; Grunberg R, 2010, NUCLEIC ACIDS RES, V38, P2663, DOI 10.1093/nar/gkq139; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; McGinness KE, 2006, MOL CELL, V22, P701, DOI 10.1016/j.molcel.2006.04.027; Merrikh H, 2009, P NATL ACAD SCI USA, V106, P611, DOI 10.1073/pnas.0803665106; Mika F, 2005, GENE DEV, V19, P2770, DOI 10.1101/gad.353705; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Nandagopal N, 2011, SCIENCE, V333, P1244, DOI 10.1126/science.1207084; Prindle A, 2012, NATURE, V481, P39, DOI 10.1038/nature10722; Pruteanu M, 2002, MOL MICROBIOL, V45, P1701, DOI 10.1046/j.1365-2958.2002.03123.x; Rosenfeld N, 2003, J MOL BIOL, V329, P645, DOI 10.1016/S0022-2836(03)00506-0; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Strogatz S. H., 2001, NONLINEAR DYNAMICS C; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527	30	111	112	0	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					387	+		10.1038/nature13238	http://dx.doi.org/10.1038/nature13238			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24717442	Green Accepted			2022-12-28	WOS:000334403000050
J	Rawlins, MD				Rawlins, Michael D.			MEDICAL LEGISLATION The "Saatchi bill" will allow responsible innovation in treatment	BMJ-BRITISH MEDICAL JOURNAL			English	News Item									Royal Soc Med, London W1G 0AE, England		Rawlins, MD (corresponding author), Royal Soc Med, London W1G 0AE, England.	m.d.rawlins@ncl.ac.uk						Department of Health, 1959, LEG ENC MED INN; Fialova J, 2014, DERMATOL THER, V27, P105, DOI 10.1111/dth.12065	2	9	10	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2014	348								g2771	10.1136/bmj.g2771	http://dx.doi.org/10.1136/bmj.g2771			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF5GN	24735990				2022-12-28	WOS:000334742100018
J	Romani, RW				Romani, Roger W.			Pulsar Beams-Big and Bright	SCIENCE			English	Editorial Material							GAMMA-RAY PULSARS		[Romani, Roger W.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Romani, Roger W.] Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA	Stanford University; Stanford University	Romani, RW (corresponding author), Stanford Univ, Dept Phys, 382 Via Pueblo Mall, Stanford, CA 94305 USA.	rwr@astro.stanford.edu						Abdo AA, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/17; Abdo AA, 2009, SCIENCE, V325, P840, DOI 10.1126/science.1175558; Bai XN, 2010, ASTROPHYS J, V715, P1282, DOI 10.1088/0004-637X/715/2/1282; HALPERN JP, 1992, NATURE, V357, P222, DOI 10.1038/357222a0; ROMANI RW, 1995, ASTROPHYS J, V438, P314, DOI 10.1086/175076; Watters KP, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/2/123	6	3	3	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					159	160		10.1126/science.1251943	http://dx.doi.org/10.1126/science.1251943			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24723602				2022-12-28	WOS:000334096300024
J	O'Sullivan, ED; Moran, SM				O'Sullivan, Eoin Daniel; Moran, Sarah Margaret			Transsternal Gastric Hernia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 55-year-old man with diabetes presented with severe reflux, chronic cough, and aspiration pneumonia. An easily reducible hernia was noted in the area of the sternal defect. A 55-year-old man with diabetes presented with severe reflux, chronic cough, and aspiration pneumonia. An easily reducible hernia measuring 10 cm by 15 cm was noted in the area of the sternal defect (Panel A). Three years earlier, he had undergone coronary-artery bypass grafting, which was complicated by impaired sternal wound healing. Debridement was performed, sternotomy wires were removed, and care was provided for the open wound until an omental flap could be placed to achieve wound closure. Computed tomography of the thorax revealed anterior gastric herniation through the defect (Panel B). Given the complexity of the surgical repair required ...	[O'Sullivan, Eoin Daniel; Moran, Sarah Margaret] Cork Univ Hosp, Cork, Ireland	University College Cork	O'Sullivan, ED (corresponding author), Cork Univ Hosp, Cork, Ireland.		O'Sullivan, Eoin/AAL-2550-2020	O'Sullivan, Eoin/0000-0002-7709-6595; Moran, Sarah/0000-0001-9377-4133					0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 10	2014	370	15					1440	1440		10.1056/NEJMicm1309719	http://dx.doi.org/10.1056/NEJMicm1309719			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6IW	24716683				2022-12-28	WOS:000334095200012
J	Jefferson, T; Doshi, P				Jefferson, Tom; Doshi, Peter			Multisystem failure: the story of anti-influenza drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; NEURAMINIDASE INHIBITORS; ACUTE INFLUENZA; HEALTHY-ADULTS; OSELTAMIVIR; COMPLICATIONS; EFFICACY; SAFETY		[Jefferson, Tom] Cochrane Acute Resp Infect Grp, I-00187 Rome, Italy; [Doshi, Peter] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Jefferson, T (corresponding author), Cochrane Acute Resp Infect Grp, I-00187 Rome, Italy.	Jefferson.tom@gmail.com			Department of Health [10/80/01] Funding Source: Medline; National Institute for Health Research [10/80/01] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		[Anonymous], COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD008965; [Anonymous], 2005, HHS PAND INFL PLAN; Centers for Drug Evaluation and Research, 1999, APPL OS; Chan M, 2009, SWINE INFLUENZA; Cohen D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5387; Doshi Peter, 2013, BMJ Open, V3, DOI 10.1136/bmjopen-2012-002496; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Doshi P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7898; Doshi P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5164; FDA, 1999, DIV DIR MEM ZAN; Groves T., 2013, BMJ-BRIT MED J, V347, pf4687; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; La Roche Hoffman, 2014, PROD LAB TAM OS PHOS; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Smith J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5374; Thomas K., 2013, NY TIMES; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; UK Department of Health, 2005, UK INFL PAND CONT PL; US Centers for Disease Control and Prevention, 2012, INFL ANT MED SUMM CL; US Centers for Disease Control and Prevention, 2012, CDC NEWSROOM    0207; *WHO, WHO INT PROT RAP OP; World Health Organization, 2013, WHO MOD LIST ESS MED	24	30	32	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2014	348									10.1136/bmj.g2263	http://dx.doi.org/10.1136/bmj.g2263			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SE	24721793				2022-12-28	WOS:000334348700014
J	Devauchelle-Pensec, V; Mariette, X; Jousse-Joulin, S; Berthelot, JM; Perdriger, A; Puechal, X; Le Guern, V; Sibilia, J; Gottenberg, JE; Chiche, L; Hachulla, E; Hatron, PY; Goeb, V; Hayem, G; Morel, J; Zarnitsky, C; Dubost, JJ; Pers, JO; Nowak, E; Saraux, A				Devauchelle-Pensec, Valerie; Mariette, Xavier; Jousse-Joulin, Sandrine; Berthelot, Jean-Marie; Perdriger, Aleth; Puechal, Xavier; Le Guern, Veronique; Sibilia, Jean; Gottenberg, Jacques-Eric; Chiche, Laurent; Hachulla, Eric; Hatron, Pierre Yves; Goeb, Vincent; Hayem, Gilles; Morel, Jacques; Zarnitsky, Charles; Dubost, Jean Jacques; Pers, Jacques Olivier; Nowak, Emmanuel; Saraux, Alain			Treatment of Primary Sjogren Syndrome With Rituximab A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							SALIVARY-GLAND BIOPSY; DOUBLE-BLIND; B-CELLS; EFFICACY; DISEASE; INFLIXIMAB; ANTI-CD20; RATIOS; RISK; GENE	Background: Primary Sjogren syndrome (pSS) is an autoimmune disorder characterized by ocular and oral dryness or systemic manifestations. Objective: To evaluate efficacy and harms of rituximab in adults with recent-onset or systemic pSS. Design: Randomized, placebo-controlled, parallel-group trial conducted between March 2008 and January 2011. Study personnel (except pharmacists), investigators, and patients were blinded to treatment group. (ClinicalTrials.gov: NCT00740948) Setting: 14 university hospitals in France. Patients: 120 patients with scores of 50 mm or greater on at least 2 of 4 visual analogue scales (VASs) (global disease, pain, fatigue, and dryness) and recent-onset (<10 years) biologically active or systemic pSS. Intervention: Randomization (1:1 ratio) to rituximab (1 g at weeks 0 and 2) or placebo. Measurements: Primary end point was improvement of at least 30 mm in 2 of 4 VASs by week 24. Results: No significant difference between groups in the primary end point was found (difference, 1.0% [95% CI, -16.7% to 18.7%]). The proportion of patients with at least 30-mm decreases in at least two of the four VAS scores was higher in the rituximab group at week 6 (22.4% vs. 9.1%; P=0.036). An improvement of at least 30 mm in VAS fatigue score was more common with rituximab at weeks 6 (P<0.001) and 16 (P=0.012),and improvement in fatigue from baseline to week 24 was greater with rituximab. Adverse events were similar between groups except for a higher rate of infusion reactions with rituximab. Limitation: Low disease activity at baseline and a primary outcome that may have been insensitive to detect clinically important changes. Conclusion: Rituximab did not alleviate symptoms or disease activity in patients with pSS at week 24, although it alleviated some symptoms at earlier time points.	Univ Bretagne Occidentale, Ctr Hosp Univ Morvan, Ctr Hosp Univ Cavale Blanche, Brest, France; CHU Brest, INSERM, Ctr Invest Clin 0502, F-29285 Brest, France; Univ Paris 11, Hop Univ Paris Sud, AP HP, INSERM,U1012, Le Kremlin Bicetre, France; CHU Nantes, Hotel Dieu, F-44035 Nantes 01, France; Ctr Hosp Univ Hop Sud, Rennes, France; Ctr Hosp Mans, Le Mans, France; Hop Cochin, F-75674 Paris, France; Hop Bichat Claude Bernard, F-75877 Paris, France; Univ Strasbourg, Hop Univ Strasbourg, Strasbourg, France; Hop Conception, Marseille, France; Univ Lille 2, Claude Huriez Hosp, Lille, France; Ctr Hosp Rouen, Bois Guillaume, France; Ctr Hosp Univ Lapeyronie, Montpellier, France; Ctr Hosp Monod, Montivilliers, France; Gabriel Montpied Teaching Hosp, Clermont Ferrand, France	CHU Brest; Universite de Bretagne Occidentale; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Nantes Universite; CHU de Nantes; CHU Rennes; Centre Hospitalier Le Mans; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Montpellier; CHU de Montpellier; CHU Clermont Ferrand	Saraux, A (corresponding author), Hop Cavale Blanche, Rheumatol Unit, BP 824, F-29609 Brest, France.	alain.saraux@chu-brest.fr	Puéchal, Xavier/P-1555-2017; HACHULLA, ERIC/R-8488-2018; Pers, Jacques-Olivier/AGG-7221-2022	Puéchal, Xavier/0000-0003-3573-9203; HACHULLA, ERIC/0000-0001-7432-847X; Sibilia, Jean/0000-0002-1601-4795; Goeb, Vincent/0000-0002-3807-545X	Programme Hospitalier de Recherche Clinique	Programme Hospitalier de Recherche Clinique	Programme Hospitalier de Recherche Clinique 2010.	BJERRUM K, 1990, CLIN EXP RHEUMATOL, V8, P283; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; CHISHOLM DM, 1968, J CLIN PATHOL, V21, P656, DOI 10.1136/jcp.21.5.656; Daridon C, 2006, ARTHRITIS RHEUM-US, V54, P2280, DOI 10.1002/art.21936; Dass S, 2008, ANN RHEUM DIS, V67, P1541, DOI 10.1136/ard.2007.083865; Devauchelle-Pensec V, 2007, ARTHRIT RHEUM-ARTHR, V57, P310, DOI 10.1002/art.22536; Devauchelle-Pensec V, 2010, ARTHRITIS RHEUM-US, V62, P2262, DOI 10.1002/art.27509; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Gottenberg JE, 2006, P NATL ACAD SCI USA, V103, P2770, DOI 10.1073/pnas.0510837103; Guellec D, 2013, AUTOIMMUN REV, V12, P416, DOI 10.1016/j.autrev.2012.08.001; Jonsson MV, 2005, J CLIN IMMUNOL, V25, P189, DOI 10.1007/s10875-005-4091-5; Kuijpers TW, 2010, J CLIN INVEST, V120, P214, DOI 10.1172/JCI40231; Le Pottier L, 2009, J IMMUNOL, V182, P3540, DOI 10.4049/jimmunol.0803588; Mariette X, 2004, ARTHRITIS RHEUM, V50, P1270, DOI 10.1002/art.20146; Meijer JM, 2010, ARTHRITIS RHEUM-US, V62, P960, DOI 10.1002/art.27314; Meiners PM, 2012, ANN RHEUM DIS, V71, P1297, DOI 10.1136/annrheumdis-2011-200460; Mekinian A, 2012, ANN RHEUM DIS, V71, P84, DOI 10.1136/annrheumdis-2011-200086; Peri Y, 2012, BEST PRACT RES CL RH, V26, P105, DOI 10.1016/j.berh.2012.01.012; Pets JO, 2007, ARTHRITIS RHEUM, V56, P1464; Pijpe J, 2005, ARTHRITIS RHEUM-US, V52, P2740, DOI 10.1002/art.21260; Ramos-Casals M, 2010, JAMA-J AM MED ASSOC, V304, P452, DOI 10.1001/jama.2010.1014; Ray A, 2012, J IMMUNOL, V188, P3188, DOI 10.4049/jimmunol.1103354; Rovin BH, 2012, ARTHRITIS RHEUM-US, V64, P1215, DOI 10.1002/art.34359; Sankar V, 2004, ARTHRITIS RHEUM-US, V50, P2240, DOI 10.1002/art.20299; Seror R, 2010, ANN RHEUM DIS, V69, P1103, DOI 10.1136/ard.2009.110619; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Steinfeld SD, 2001, ARTHRITIS RHEUM, V44, P2371, DOI 10.1002/1529-0131(200110)44:10<2371::AID-ART401>3.0.CO;2-W; TALAL N, 1974, J CLIN INVEST, V53, P180, DOI 10.1172/JCI107536; VANBIJSTERVELD OP, 1974, ARCH OPHTHALMOL-CHIC, V91, P432, DOI 10.1001/archopht.1974.03900060446002; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; WACHOLDER S, 1986, AM J EPIDEMIOL, V123, P174, DOI 10.1093/oxfordjournals.aje.a114212	31	252	273	1	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2014	160	4					233	242		10.7326/M13-1085	http://dx.doi.org/10.7326/M13-1085			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB3BO	24727841				2022-12-28	WOS:000331666500003
J	Weinberger, SE; Johnson, BH; Ness, DL				Weinberger, Steven E.; Johnson, Beverley H.; Ness, Debra L.			Patient- and Family-Centered Medical Education: The Next Revolution in Medical Education?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Weinberger, Steven E.] Amer Coll Physicians, Philadelphia, PA 19106 USA; [Johnson, Beverley H.] Inst Patient & Family Ctr Care, Bethesda, MD 20814 USA; [Ness, Debra L.] Natl Partnership Women & Families, Washington, DC 20009 USA	American College of Physicians	Weinberger, SE (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	sweinberger@acponline.org						Accreditation Council for Graduate Medical Education, 2013, ACGME PROGR REQ GRAD; American Academy of Family Physicians American Academy of Pediatrics American College of Physicians American Osteopathic Association, 2010, JOINT PRINC MED ED P; DELBANCO TL, 1992, ANN INTERN MED, V116, P414, DOI 10.7326/0003-4819-116-5-414; Gonzalo JD, 2010, J GEN INTERN MED, V25, P792, DOI 10.1007/s11606-010-1344-7; Institute for Patient-and Family-Centered Care, 2012, APPL PAT FAM CTR CON; Institute of Medicine, 2012, BEST CAR LOW COST PA; Laine C, 1996, JAMA-J AM MED ASSOC, V275, P152, DOI 10.1001/jama.275.2.152; Sudore Rebecca L, 2009, J Clin Outcomes Manag, V16, P20; The Health Foundation, 2011, CAN PAT BE TEACH INV; Ubel PA, 2013, NEW ENGL J MED, V369, P1484, DOI 10.1056/NEJMp1306826	10	22	22	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2014	161	1					73	+		10.7326/M13-2993	http://dx.doi.org/10.7326/M13-2993			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK4UN	24756416				2022-12-28	WOS:000338419700008
J	Asangani, IA; Dommeti, VL; Wang, XJ; Malik, R; Cieslik, M; Yang, RD; Escara-Wilke, J; Wilder-Romans, K; Dhanireddy, S; Engelke, C; Iyer, MK; Jing, XJ; Wu, YM; Cao, XH; Qin, ZHS; Wang, SM; Feng, FY; Chinnaiyan, AM				Asangani, Irfan A.; Dommeti, Vijaya L.; Wang, Xiaoju; Malik, Rohit; Cieslik, Marcin; Yang, Rendong; Escara-Wilke, June; Wilder-Romans, Kari; Dhanireddy, Sudheer; Engelke, Carl; Iyer, Mathew K.; Jing, Xiaojun; Wu, Yi-Mi; Cao, Xuhong; Qin, Zhaohui S.; Wang, Shaomeng; Feng, Felix Y.; Chinnaiyan, Arul M.			Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer	NATURE			English	Article							SELECTIVE-INHIBITION; INCREASED SURVIVAL; CHIP-SEQ; P-TEFB; BRD4; ANTIANDROGEN; RECRUITMENT; ABIRATERONE; GENE; TRANSCRIPTION	Men who develop metastatic castration-resistant prostate cancer(CRPC) invariably succumb to the disease. Progression to CRPC after androgen ablation therapy is predominantly driven by deregulated and rogen receptor (AR) signalling(1-3). Despite the success of recently approved therapies targeting AR signalling, such as abiraterone(4-6) and second generation anti-androgens including MDV3100 (also known as enzalutamide) 7,8, durable responses are limited, presumably owing to acquired resistance. Recently, JQ1 and I-BET762 two selective small-molecule inhibitors that target the amino-terminal bromodomains of BRD4, have been shown to exhibit anti-proliferative effects in a range of malignancies(9-12). Here we show that AR-signalling-competent human CRPC cell lines are preferentially sensitive to bromodomain and extraterminal (BET) inhibition. BRD4 physically interacts with the N-terminal domain of AR and can bedisrupted by JQ1(refs 11, 13). Like the direct AR antagonist MDV3100, JQ1 disrupted AR recruitment to target gene loci. By contrast with MDV3100, JQ1 functions downstream of AR, and more potently abrogated BRD4 localization to AR target loci and AR-mediated gene transcription, including induction of the TMPRSS2-ERG gene fusion and its oncogenic activity. In vivo, BET bromodomain inhibition was more efficacious than direct AR antagonism in CRPC xenograft mouse models. Taken together, these studies provide a novel epigenetic approach for the concerted blockade of oncogenic drivers in advanced prostate cancer.	[Asangani, Irfan A.; Dommeti, Vijaya L.; Wang, Xiaoju; Malik, Rohit; Cieslik, Marcin; Escara-Wilke, June; Dhanireddy, Sudheer; Engelke, Carl; Iyer, Mathew K.; Jing, Xiaojun; Wu, Yi-Mi; Cao, Xuhong; Feng, Felix Y.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Asangani, Irfan A.; Wang, Xiaoju; Malik, Rohit; Wu, Yi-Mi; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Yang, Rendong; Qin, Zhaohui S.] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30329 USA; [Wilder-Romans, Kari; Feng, Felix Y.] Univ Michigan, Sch Med, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Cao, Xuhong; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Wang, Shaomeng] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Wang, Shaomeng] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Wang, Shaomeng] Univ Michigan, Sch Med, Dept Med Chem, Ann Arbor, MI 48109 USA; [Wang, Shaomeng; Feng, Felix Y.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Emory University; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Qin, Zhaohui/Q-3133-2019	Qin, Zhaohui/0000-0002-1583-146X; asangani, irfan/0000-0001-5381-1702; Wang, Shaomeng/0000-0002-8782-6950	Movember-Prostate Cancer Foundation Challenge Award; Early Detection Research Network [UO1 CA111275]; NCI Prostate SPORE [P50CA69568]; Doris Duke Charitable Foundation; American Cancer Society; A. Alfred-Taubman Institute; PCF Young Investigator Award; NATIONAL CANCER INSTITUTE [U01CA111275, P50CA069568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER	Movember-Prostate Cancer Foundation Challenge Award; Early Detection Research Network; NCI Prostate SPORE; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); American Cancer Society(American Cancer Society); A. Alfred-Taubman Institute; PCF Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Paliakov, T. Barrette, Y. Qiao, P. Vats, R. Stender, X. Jiang, M. Pranithi and S. Han for technical assistance; C. Kumar-Sinha, M. Dhanasekaran, N. Palanisamy and P. Kunju for helpful discussions; J. Athanikar and K. Giles for critically reading the manuscript and submission of documents. This work was supported by a Movember-Prostate Cancer Foundation Challenge Award and in part by the Early Detection Research Network (UO1 CA111275) and the NCI Prostate SPORE (P50CA69568) to A. M. C. A. M. C. is also supported by the Doris Duke Charitable Foundation, American Cancer Society, and A. Alfred-Taubman Institute. I. A. A. and R. A. are supported by a PCF Young Investigator Award.	Asangani IA, 2013, MOL CELL, V49, P80, DOI 10.1016/j.molcel.2012.10.008; Attard G, 2011, CLIN CANCER RES, V17, P1649, DOI 10.1158/1078-0432.CCR-10-0567; Balbas MD, 2013, ELIFE, V2, DOI 10.7554/eLife.00499; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Devaiah BN, 2012, P NATL ACAD SCI USA, V109, P6927, DOI 10.1073/pnas.1120422109; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gao LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063563; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lin TH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.270; Lockwood WW, 2012, P NATL ACAD SCI USA, V109, P19408, DOI 10.1073/pnas.1216363109; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Matzuk MM, 2012, CELL, V150, P673, DOI 10.1016/j.cell.2012.06.045; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Mukherji D, 2012, EXPERT OPIN INV DRUG, V21, P227, DOI 10.1517/13543784.2012.651125; Pickrell JK, 2011, BIOINFORMATICS, V27, P2144, DOI 10.1093/bioinformatics/btr354; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Qin ZHS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-369; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reid AHM, 2010, J CLIN ONCOL, V28, P1489, DOI 10.1200/JCO.2009.24.6819; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Stein MN, 2012, CLIN CANCER RES, V18, P1848, DOI 10.1158/1078-0432.CCR-11-1805; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Taplin ME, 1999, CANCER RES, V59, P2511; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; van der Horst EH, 2004, BIOTECHNIQUES, V37, P940, DOI 10.2144/04376ST02; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wu SY, 2013, MOL CELL, V49, P843, DOI 10.1016/j.molcel.2012.12.006; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029	42	634	670	9	180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					278	+		10.1038/nature13229	http://dx.doi.org/10.1038/nature13229			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24759320	Green Accepted			2022-12-28	WOS:000337032400052
J	Godinho, SA; Picone, R; Burute, M; Dagher, R; Su, Y; Leung, CT; Polyak, K; Brugge, JS; Thery, M; Pellman, D				Godinho, Susana A.; Picone, Remigio; Burute, Mithila; Dagher, Regina; Su, Ying; Leung, Cheuk T.; Polyak, Kornelia; Brugge, Joan S.; Thery, Manuel; Pellman, David			Oncogene-like induction of cellular invasion from centrosome amplification	NATURE			English	Article							HUMAN BREAST-CANCER; CENTRIOLE DUPLICATION; CHROMOSOMAL INSTABILITY; SPINDLE CHECKPOINT; JUNCTION FORMATION; CELLS; EXPRESSION; ROLES; RAC; TUMORIGENESIS	Centrosome amplification has long been recognized as a feature of human tumours; however, its role in tumorigenesis remains unclear(1). Centrosome amplification is poorly tolerated by non-transformed cells and, in the absence of selection, extra centrosomes are spontaneously lost(2). Thus, the high frequency of centrosome amplification, particularly in more aggressive tumours(3), raises the possibility that extra centrosomes could, in some contexts, confer advantageous characteristics that promote tumour progression. Using a three-dimensional model system and other approaches to culture human mammary epithelial cells, we find that centrosome amplification triggers cell invasion. This invasive behaviour is similar to that induced by overexpression of the breast cancer oncogene ERBB2 (ref.4) and indeed enhances invasiveness triggered by ERBB2. Our data indicate that, through increased centrosomal microtubule nucleation, centrosome amplification increases Rac1 activity, which disrupts normal cell-cell adhesion and promotes invasion. These findings demonstrate that centrosome amplification, a structural alteration of the cytoskeleton, can promote features of malignant transformation.	[Godinho, Susana A.; Picone, Remigio; Dagher, Regina; Pellman, David] Childrens Hosp, Howard Hughes Med Inst, Dept Pediat Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Godinho, Susana A.; Picone, Remigio; Dagher, Regina; Pellman, David] Childrens Hosp, Boston, MA 02115 USA; [Godinho, Susana A.; Picone, Remigio; Dagher, Regina; Leung, Cheuk T.; Brugge, Joan S.; Pellman, David] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Burute, Mithila; Thery, Manuel] UMR5168 CEA UJF INRA CNRS, Inst Rech Technol & Sci Vivant, Grenoble, France; [Burute, Mithila; Thery, Manuel] U1160 INSERM AP HP Univ Paris Diderot, Inst Univ Hematol, Hop St Louis, F-75010 Paris, France; [Burute, Mithila] CYTOO SA, F-38054 Grenoble, France; [Su, Ying; Polyak, Kornelia] Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Godinho, SA (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Dept Pediat Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA.	s.godinho@qmul.ac.uk; david_pellman@dfci.harvard.edu		Godinho, Susana/0000-0003-0638-065X; Leung, Cheuk/0000-0002-5838-5535; Su, Ying/0000-0003-0462-3865	FCT [HMSP-CT/SAU-ICT/0075/2009]; ERC [310472]; ISI program of BPIFrance; NIH [GM083299-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083299] Funding Source: NIH RePORTER	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); ERC(European Research Council (ERC)European Commission); ISI program of BPIFrance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to S. Jhaveri-Schneider, S. Muthuswamy, M. Bettencourt-Dias, R. Basto, D. Calado, N. Ganem, A. Spektor, M. Kwon and B. Atkins for comments or discussion of the manuscript; the Nikon Imaging Center at Harvard Medical School; J. Waters, J. Rosenberg and H. Elliott from the Image and Data Analysis Core at Harvard Medical School for their help with FRET microscopy and analysis; L. Cameron of the Confocal and Light Microcopy Facility at Dana-Farber Cancer Institute; H. Li of SNP analysis; A. Bui for help establishing the 3D cultures; Q. Tseng for establishing MCF 10A doublets on micropatterns; and C. Sproat and J. Marshall for help with the organotypic cultures. Reagents were kindly provided by L. Pelletier, J. Locarek, M. Matsuda, A. Hall and J. Marshall. S. A. G. is supported by an FCT grant HMSP-CT/SAU-ICT/0075/2009. M. T. is supported by the ERC grant 310472 and the ISI program of BPIFrance. D.P. is an HHMI investigator and is supported by an NIH grant GM083299-1.	Azioune A, 2010, METHOD CELL BIOL, V97, P133, DOI 10.1016/S0091-679X(10)97008-8; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chan JY, 2011, INT J BIOL SCI, V7, P1122, DOI 10.7150/ijbs.7.1122; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fogg VC, 2005, J CELL SCI, V118, P2859, DOI 10.1242/jcs.02412; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Guderian G, 2010, J CELL SCI, V123, P2163, DOI 10.1242/jcs.068502; Gunawardane RN, 2005, CANCER RES, V65, P11572, DOI 10.1158/0008-5472.CAN-05-1196; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; Holland AJ, 2012, GENE DEV, V26, P2684, DOI 10.1101/gad.207027.112; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Mack NA, 2011, CELL CYCLE, V10, P1571, DOI 10.4161/cc.10.10.15612; Mahjoub MR, 2012, CURR BIOL, V22, P1628, DOI 10.1016/j.cub.2012.06.057; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Nystrom ML, 2005, J PATHOL, V205, P468, DOI 10.1002/path.1716; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; PALACIOS J, 1995, VIRCHOWS ARCH, V427, P259; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Sluder G, 2004, CURR OPIN CELL BIOL, V16, P49, DOI 10.1016/j.ceb.2003.11.006; Sonnen KF, 2013, J CELL SCI, V126, P3223, DOI 10.1242/jcs.129502; Stehbens S, 2012, J CELL BIOL, V198, P481, DOI 10.1083/jcb.201206050; Tseng QZ, 2012, P NATL ACAD SCI USA, V109, P1506, DOI 10.1073/pnas.1106377109; Wallace SW, 2011, MOL CELL BIOL, V31, P81, DOI 10.1128/MCB.01001-10; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Xiang B, 2006, METHOD ENZYMOL, V406, P692, DOI 10.1016/S0076-6879(06)06054-X; Xue B, 2013, NAT CELL BIOL, V15, P189, DOI 10.1038/ncb2663; Yuan K, 2010, J HISTOCHEM CYTOCHEM, V58, P857, DOI 10.1369/jhc.2010.955856; Zhan LX, 2006, CANCER RES, V66, P5201, DOI 10.1158/0008-5472.CAN-05-4081; Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055; Zyss D, 2009, TRENDS CELL BIOL, V19, P334, DOI 10.1016/j.tcb.2009.04.001	46	271	276	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					167	+		10.1038/nature13277	http://dx.doi.org/10.1038/nature13277			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24739973	Green Accepted			2022-12-28	WOS:000336768900050
J	Kumazaki, K; Chiba, S; Takemoto, M; Furukawa, A; Nishiyama, K; Sugano, Y; Mori, T; Dohmae, N; Hirata, K; Nakada-Nakura, Y; Maturana, AD; Tanaka, Y; Mori, H; Sugita, Y; Arisaka, F; Ito, K; Ishitani, R; Tsukazaki, T; Nureki, O				Kumazaki, Kaoru; Chiba, Shinobu; Takemoto, Mizuki; Furukawa, Arata; Nishiyama, Ken-ichi; Sugano, Yasunori; Mori, Takaharu; Dohmae, Naoshi; Hirata, Kunio; Nakada-Nakura, Yoshiko; Maturana, Andres D.; Tanaka, Yoshiki; Mori, Hiroyuki; Sugita, Yuji; Arisaka, Fumio; Ito, Koreaki; Ishitani, Ryuichiro; Tsukazaki, Tomoya; Nureki, Osamu			Structural basis of Sec-independent membrane protein insertion by YidC	NATURE			English	Article							ESCHERICHIA-COLI YIDC; MOLECULAR-DYNAMICS; SUBUNIT; TRANSLOCATION; BIOGENESIS; VALIDATION; REQUIRES; RECEPTOR; FEATURES; REGIONS	Newly synthesized membrane proteins must be accurately inserted into the membrane, folded and assembled for proper functioning. The protein YidC inserts its substrates into the membrane, thereby facilitating membrane protein assembly in bacteria; the homologous proteins Oxa1 and Alb3 have the same function in mitochondria and chloroplasts, respectively(1,2). In the bacterial cytoplasmic membrane, YidC functions as an independent insertase and a membrane chaperone in cooperation with the translocon SecYEG(3-5). Here we present the crystal structure of YidC from Bacillus halodurans, at 2.4 angstrom resolution. The structure reveals a novel fold, in which five conserved transmembrane helices form a positively charged hydrophilic groove that is open towards both the lipid bilayer and the cytoplasm but closed on the extracellular side. Structure-based in vivo analyses reveal that a conserved arginine residue in the groove is important for the insertion of membrane proteins by YidC. We propose an insertion mechanism for single-spanning membrane proteins, in which the hydrophilic environment generated by the groove recruits the extracellular regions of substrates into the low-dielectric environment of the membrane.	[Kumazaki, Kaoru; Takemoto, Mizuki; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kumazaki, Kaoru; Takemoto, Mizuki; Dohmae, Naoshi; Ishitani, Ryuichiro; Nureki, Osamu] RIKEN, Global Res Cluster, Wako, Saitama 3510198, Japan; [Chiba, Shinobu; Ito, Koreaki] Kyoto Sangyo Univ, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan; [Furukawa, Arata; Sugano, Yasunori; Tanaka, Yoshiki; Tsukazaki, Tomoya] Nara Inst Sci & Technol, Dept Syst Biol, Grad Sch Biol Sci, Nara 6300192, Japan; [Nishiyama, Ken-ichi] Iwate Univ, Fac Agr, Cryobiofrontier Res Ctr, Morioka, Iwate 0208550, Japan; [Sugano, Yasunori; Mori, Takaharu; Sugita, Yuji] RIKEN, Theoret Mol Sci Lab, Wako, Saitama 3510198, Japan; [Hirata, Kunio] RIKEN SPring 8 Ctr, SR Life Sci Instrumentat Unit, Sayo, Hyogo 6795148, Japan; [Nakada-Nakura, Yoshiko] Kyoto Univ, Dept Cell Biol, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; [Maturana, Andres D.] Nagoya Univ, Grad Sch Bioagr Sci, Dept Bioengn Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Mori, Hiroyuki] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan; [Arisaka, Fumio] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Tsukazaki, Tomoya] PRESTO, JST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; RIKEN; Kyoto Sangyo University; Nara Institute of Science & Technology; Iwate University; RIKEN; RIKEN; Kyoto University; Nagoya University; Kyoto University; Tokyo Institute of Technology; Japan Science & Technology Agency (JST)	Nureki, O (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ttsukaza@bs.naist.jp; nureki@bs.s.u-tokyo.ac.jp	NUREKI, OSAMU/G-4960-2014; Sugita, Yuji/L-6726-2014; Dohmae, Naoshi/C-2040-2011; Tsukazaki, Tomoya/N-2299-2019; Mori, Takaharu/AAH-1234-2021	Sugita, Yuji/0000-0001-9738-9216; Dohmae, Naoshi/0000-0002-5242-9410; Tsukazaki, Tomoya/0000-0002-6386-723X; Tanaka, Yoshiki/0000-0001-6960-5276; Chiba, Shinobu/0000-0003-3485-3477; Mori, Takaharu/0000-0002-8717-2926; Mori, Hiroyuki/0000-0002-0429-1269; Takemoto, Mizuki/0000-0002-6339-6431; Hirata, Kunio/0000-0002-1491-6509	Platform for Drug Discovery, Informatics and Structural Life Science by the Ministry of Education, Culture, Sports, Science and Technology (MEXT); JSPS KAKENHI [20247020, 20523517, 24687016, 24102503, 24121704, 24227004, 24657095, 25291006, 25291009, 25660073]; FIRST; PRESTO; JST; MEXT; Private University Strategic Research Foundation Support Program (MEXT); Nagase Science and Technology Foundation; Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research [13J08353, 24117003, 26102532, 26119701, 26102703] Funding Source: KAKEN	Platform for Drug Discovery, Informatics and Structural Life Science by the Ministry of Education, Culture, Sports, Science and Technology (MEXT); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); FIRST; PRESTO; JST(Japan Science & Technology Agency (JST)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Private University Strategic Research Foundation Support Program (MEXT); Nagase Science and Technology Foundation; Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We wish to thank K. Watanabe from Shoko Scientific for assistance with the SEC-MALLS experiments; T. Nishizawa, T. Higuchi, H. E. Kato, M. Hattori, R. Ishii and H. Nishimasu for discussions; A. Kurabayashi, H. Nakamura, S. Hibino, T. Takino and C. Tsutsumi for technical support; A. Nakashima and R. Yamazaki for secretarial assistance; the RIKEN BioResource Center for providing B. halodurans genomic DNA; the RIKEN Integrated Cluster of Clusters (RICC) for providing computational resources; and the beamline staff members at BL32XU of SPring-8 for technical assistance during data collection. The synchrotron radiation experiments were performed at BL32XU of SPring-8 (proposal no. 2011A1125, 2011A1139, 2011B1062, 2011B1280, 2012A1093, 2012A1201, 2012B1146, 2012B1162 and 2013A1128), with approval from RIKEN. This work was supported by the Platform for Drug Discovery, Informatics and Structural Life Science by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), by JSPS KAKENHI (grant no. 20247020, 20523517, 24687016, 24102503, 24121704, 24227004, 24657095, 25291006, 25291009 and 25660073), by the FIRST program, by PRESTO, by the JST, by a Grant-in-Aid for JSPS Fellows, by a grant for the HPCI STRATEGIC PROGRAM Computational Life Science and Application in Drug Discovery and Medical Development from MEXT, and by grants from the Private University Strategic Research Foundation Support Program (MEXT), the Nagase Science and Technology Foundation, and the Astellas Foundation for Research on Metabolic Disorders.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Caffrey M, 2009, ANNU REV BIOPHYS, V38, P29, DOI 10.1146/annurev.biophys.050708.133655; Chen MY, 2002, J BIOL CHEM, V277, P7670, DOI 10.1074/jbc.M110644200; Chiba S, 2012, MOL CELL, V47, P863, DOI 10.1016/j.molcel.2012.06.034; Chiba S, 2011, P NATL ACAD SCI USA, V108, P6073, DOI 10.1073/pnas.1018343108; Chiba S, 2009, EMBO J, V28, P3461, DOI 10.1038/emboj.2009.280; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; du Plessis DJF, 2006, J BIOL CHEM, V281, P12248, DOI 10.1074/jbc.M600048200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Funes S, 2011, BIOL CHEM, V392, P13, DOI 10.1515/BC.2011.013; HAYASHI Y, 1989, METHOD ENZYMOL, V172, P514; Hirata K, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/1/012002; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kedrov A, 2013, J MOL BIOL, V425, P4112, DOI 10.1016/j.jmb.2013.07.042; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Kruger V, 2012, J BIOL CHEM, V287, P33314, DOI 10.1074/jbc.M112.387563; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lotz M, 2008, J MOL BIOL, V375, P901, DOI 10.1016/j.jmb.2007.10.089; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Nishizawa T, 2013, SCIENCE, V341, P168, DOI 10.1126/science.1239002; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Price CE, 2010, J BIOL CHEM, V285, P3575, DOI 10.1074/jbc.M109.051128; Rubio A, 2005, J BACTERIOL, V187, P5000, DOI 10.1128/JB.187.14.5000-5002.2005; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Saller MJ, 2012, BIOL CHEM, V393, P1279, DOI 10.1515/hsz-2012-0199; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Seitl I, 2014, MOL MICROBIOL, V91, P408, DOI 10.1111/mmi.12465; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Strop P, 2005, PROTEIN SCI, V14, P2207, DOI 10.1110/ps.051543805; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wagner S, 2008, J BIOL CHEM, V283, P17881, DOI 10.1074/jbc.M801481200; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h; Zhu L, 2013, J BIOL CHEM, V288, P7704, DOI 10.1074/jbc.M112.429431	50	135	139	2	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					516	+		10.1038/nature13167	http://dx.doi.org/10.1038/nature13167			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24739968				2022-12-28	WOS:000336126000044
J	Baker, AW; Forest, KT				Baker, Anna W.; Forest, Katrina T.			STRUCTURAL BIOLOGY Action at a distance in a light receptor	NATURE			English	Editorial Material							PHYTOCHROME; BACTERIOPHYTOCHROME; DOMAIN		[Baker, Anna W.; Forest, Katrina T.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Baker, AW (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	awbaker@wisc.edu; forest@bact.wisc.edu						Anders K, 2013, J BIOL CHEM, V288, P35714, DOI 10.1074/jbc.M113.510461; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Giraud E, 2005, J BIOL CHEM, V280, P32389, DOI 10.1074/jbc.M506890200; Mandalari C, 2013, PHOTOCH PHOTOBIO SCI, V12, P1144, DOI 10.1039/c3pp25404f; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Takala H, 2014, NATURE, V509, P245, DOI 10.1038/nature13310; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang XJ, 2011, NATURE, V479, P428, DOI 10.1038/nature10506	11	1	1	1	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					174	175		10.1038/nature13331	http://dx.doi.org/10.1038/nature13331			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24776796				2022-12-28	WOS:000335454300028
J	Price, TD; Hooper, DM; Buchanan, CD; Johansson, US; Tietze, DT; Alstrom, P; Olsson, U; Ghosh-Harihar, M; Ishtiaq, F; Gupta, SK; Martens, J; Harr, B; Singh, P; Mohan, D				Price, Trevor D.; Hooper, Daniel M.; Buchanan, Caitlyn D.; Johansson, Ulf S.; Tietze, D. Thomas; Alstroem, Per; Olsson, Urban; Ghosh-Harihar, Mousumi; Ishtiaq, Farah; Gupta, Sandeep K.; Martens, Jochen; Harr, Bettina; Singh, Pratap; Mohan, Dhananjai			Niche filling slows the diversification of Himalayan songbirds	NATURE			English	Article							SPECIES RICHNESS; ECOLOGICAL OPPORTUNITY; RANGE LIMITS; DIVERSITY; EVOLUTION; SPECIATION; BIRDS; PATTERNS; RADIATION; GRADIENT	Speciation generally involves a three-step process-range expansion, range fragmentation and the development of reproductive isolation between spatially separated populations(1,2). Speciation relies on cycling through these three steps and each may limit the rate at which new species form(1,3). We estimate phylogenetic relationships among all Himalayan songbirds to ask whether the development of reproductive isolation and ecological competition, both factors that limit range expansions(4), set an ultimate limit on speciation. Based on a phylogeny for all 358 species distributed along the eastern elevational gradient, here we show that body size and shape differences evolved early in the radiation, with the elevational band occupied by a species evolving later. These results are consistent with competition for niche space limiting species accumulation(5). Even the elevation dimension seems to be approaching ecological saturation, because the closest relatives both inside the assemblage and elsewhere in the Himalayas are on average separated by more than five million years, which is longer than it generally takes for reproductive isolation to be completed(2,3,6); also, elevational distributions are well explained by resource availability, notably the abundance of arthropods, and not by differences in diversification rates in different elevational zones. Our results imply that speciation rate is ultimately set by niche filling(that is, ecological competition for resources), rather than by the rate of acquisition of reproductive isolation.	[Price, Trevor D.; Hooper, Daniel M.; Buchanan, Caitlyn D.; Johansson, Ulf S.; Tietze, D. Thomas] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Johansson, Ulf S.] Swedish Museum Nat Hist, Dept Zool, S-10405 Stockholm, Sweden; [Tietze, D. Thomas] Heidelberg Univ, Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany; [Alstroem, Per] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing 100101, Peoples R China; [Alstroem, Per] Swedish Univ Agr Sci, Swedish Species Informat Ctr, S-75007 Uppsala, Sweden; [Olsson, Urban] Univ Gothenburg, Dept Biol & Environm Sci, S-40530 Gothenburg, Sweden; [Ghosh-Harihar, Mousumi; Ishtiaq, Farah; Gupta, Sandeep K.; Singh, Pratap; Mohan, Dhananjai] Wildlife Inst India, Dehra Dun 248001, Uttar Pradesh, India; [Martens, Jochen] Johannes Gutenberg Univ Mainz, Inst Zool, D-55099 Mainz, Germany; [Harr, Bettina] Max Planck Inst Evolutionary Biol, D-24306 Plon, Germany	University of Chicago; Swedish Museum of Natural History; Ruprecht Karls University Heidelberg; Chinese Academy of Sciences; Institute of Zoology, CAS; Swedish University of Agricultural Sciences; University of Gothenburg; Wildlife Institute of India; Johannes Gutenberg University of Mainz; Max Planck Society	Price, TD (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	pricet@uchicago.edu	Tietze, Dieter Thomas/AAG-4714-2021; Ghosh-Harihar, Mousumi/AGJ-8900-2022; GUPTA, SANDEEP KUMAR/AAD-9882-2021; Alström, Per/C-1619-2015; Tietze, Dieter Thomas/A-1366-2011	Tietze, Dieter Thomas/0000-0001-6868-227X; GUPTA, SANDEEP KUMAR/0000-0001-6295-0210; Alström, Per/0000-0001-7182-2763; Tietze, Dieter Thomas/0000-0001-6868-227X; Johansson, Ulf/0000-0002-2544-8528; Ishtiaq, Farah/0000-0002-6762-7014	US NSF; National Geographic Society; Jornvall Foundation, a Chinese Academy of Sciences Visiting Professorship; Swedish Research Council; Wenner-Gren Foundation; Feldbausch Foundation of Mainz University; German DFG [Ti679/1-1]	US NSF(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Jornvall Foundation, a Chinese Academy of Sciences Visiting Professorship; Swedish Research Council(Swedish Research CouncilEuropean Commission); Wenner-Gren Foundation; Feldbausch Foundation of Mainz University; German DFG(German Research Foundation (DFG))	We thank the government of India and the Chief Wildlife Wardens of the six Indian Himalayan states for permits. We also thank S. Dalvi, K. Jamdar, N. Jamdar, E. Scordato and D. Wheatcroft for help in the field, U. Borthakur and V. Mathur in the laboratory and E. Goldberg, R. Hudson, J. Kennedy, M. McPeek, A. Phillimore, D. Schluter, T. Tyrberg and J. Weir for advice. Tissue and toe pads for this project were provided by J. Cracraft (American Museum of Natural History), N. Rice (Academy of Natural Sciences, Philadelphia), M. Adams (The Natural History Museum, Tring), J. Dumbacher and M. Flannery (California Academy of Sciences), J. Bates and D. Willard (Field Museum of Natural History, Chicago), Herman Mays (Cincinnatti Museum); M. Wink (Institut fur Pharmazie und Molekulare Biotechnologie, Heidelberg); R. Brumfeld and D. Dittmann (Lousiana State Museum of Zoology); S. Edwards (Museum of Natural History, Harvard); G. Frisk (Swedish Museum of Natural History, Stockholm); J. Dean and J. Rappole (National Museum of Natural History Smithsonian); S. Birks (Burke Museum, University of Washington); the Zoologisches Forschungmuseum Alexander Koenig, Bonn; J. Bolding Kristensen and J. Fjeldsa (Zoological Museum, Copenhagen); the Zoologische Staatssammlung Munchen, Munich; and K. Zyskowski (Yale University). This work was supported in part by grants from the US NSF and the National Geographic Society (TDP), the Jornvall Foundation, a Chinese Academy of Sciences Visiting Professorship (to P. A.), the Swedish Research Council (grants to U.O. and P. A.), the Wenner-Gren Foundation (a grant to U. S. J.), the Feldbausch Foundation of Mainz University (a grant to J. M.) and the German DFG (grants to B. H. and D. T. T., grant number Ti679/1-1). We thank D. Tautz for making laboratory facilities available in Germany.	Acharya BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029097; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Badgley C, 2008, P NATL ACAD SCI USA, V105, P12145, DOI 10.1073/pnas.0805592105; Beaulieu JM, 2012, EVOLUTION, V66, P2369, DOI 10.1111/j.1558-5646.2012.01619.x; Bivand RS, 2008, USE R, P1; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Colwell RK, 2005, AM NAT, V166, pE149, DOI 10.1086/491689; Cornell HV, 2013, BIOL REV, V88, P140, DOI 10.1111/j.1469-185X.2012.00245.x; Coyne JA, 2000, EVOLUTION, V54, P2166; Dong F, 2010, MOL PHYLOGENET EVOL, V57, P1268, DOI 10.1016/j.ympev.2010.09.023; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Endler J.A., 1977, Monographs in Population Biology, pi; Etienne RS, 2012, SYST BIOL, V61, P204, DOI 10.1093/sysbio/syr091; Ghosh-Harihar M, 2014, J ANIM ECOL, V83, P628, DOI 10.1111/1365-2656.12157; Ghosh-Harihar M, 2013, ECOL RES, V28, P125, DOI 10.1007/s11284-012-1000-2; GILL FB, 1971, AUK, V88, P35, DOI 10.2307/4083960; Goldberg EE, 2006, EVOLUTION, V60, P1344, DOI 10.1111/j.0014-3820.2006.tb01214.x; Grant P. R., 2008, WHY SPECIES MULTIPLY; Gross SJ, 2000, J BIOGEOGR, V27, P869, DOI 10.1046/j.1365-2699.2000.00440.x; Groth JG, 1999, MOL PHYLOGENET EVOL, V12, P115, DOI 10.1006/mpev.1998.0603; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; Grytnes JA, 2008, BASIC APPL ECOL, V9, P373, DOI 10.1016/j.baae.2007.05.001; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HARVEY PH, 1994, EVOLUTION, V48, P523, DOI 10.1111/j.1558-5646.1994.tb01341.x; Harvey PH, 2000, PHILOS T ROY SOC B, V355, P1599, DOI 10.1098/rstb.2000.0721; Hawkins BA, 2005, AM NAT, V166, pE140, DOI 10.1086/491686; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Helmus MR, 2012, ECOLOGY, V93, pS31, DOI 10.1890/11-0435.1; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2011, RASTER GEOGRAPHIC AN; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Johansson US, 2007, EVOLUTION, V61, P324, DOI 10.1111/j.1558-5646.2007.00024.x; Jonsson KA, 2011, P NATL ACAD SCI USA, V108, P2328, DOI 10.1073/pnas.1018956108; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kennedy JD, 2012, EVOLUTION, V66, P2599, DOI 10.1111/j.1558-5646.2012.01618.x; Kraatz BP, 2010, GEOLOGY, V38, P111, DOI 10.1130/G30619.1; Laliberte E., 2011, FD MEASURING FUNCTIO; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Linder HP, 2005, MOL PHYLOGENET EVOL, V35, P569, DOI 10.1016/j.ympev.2004.12.006; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; Mahler DL, 2010, EVOLUTION, V64, P2731, DOI 10.1111/j.1558-5646.2010.01026.x; MAYR E., 1942, Systematics and the origin of species from the viewpoint of a zoologist.; Mayr E., 2001, BIRDS NO MELANESIA S; Mayr G, 2013, SYST BIODIVERS, V11, P7, DOI 10.1080/14772000.2013.765521; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; McCain CM, 2004, J BIOGEOGR, V31, P19, DOI 10.1046/j.0305-0270.2003.00992.x; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Packert M, 2012, J BIOGEOGR, V39, P556, DOI 10.1111/j.1365-2699.2011.02606.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pebesma E.J., 2005, R NEWS, V5, P9; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Phillimore Albert B., 2009, P240; Price T, 1997, PHILOS T ROY SOC B, V352, P519, DOI 10.1098/rstb.1997.0036; Price T, 2008, SPECIATION BIRDS; Price TD, 2002, EVOLUTION, V56, P2083; Price Trevor, 2003, Journal of the Bombay Natural History Society, V100, P394; Price TD, 2011, AM NAT, V178, pS97, DOI 10.1086/661926; Price TD, 2010, PHILOS T R SOC B, V365, P1749, DOI 10.1098/rstb.2009.0269; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Rabosky DL, 2013, ANNU REV ECOL EVOL S, V44, P481, DOI 10.1146/annurev-ecolsys-110512-135800; Rabosky DL, 2013, P NATL ACAD SCI USA, V110, P15354, DOI 10.1073/pnas.1305529110; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rambaut A., 2007, TRACER V1 4; Rasmussen PC., 2005, BIRDS S ASIA RIPLEY; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; RICHMAN AD, 1992, NATURE, V355, P817, DOI 10.1038/355817a0; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Ricklefs RE, 2004, NATURE, V430, P338, DOI 10.1038/nature02700; Ricklefs RE, 2012, P NATL ACAD SCI USA, V109, P14482, DOI 10.1073/pnas.1212079109; Rosenzweig Michael L., 1993, P52; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Sanders NJ, 2012, ECOGRAPHY, V35, P1, DOI 10.1111/j.1600-0587.2011.07338.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schnute J. T., 2004, CAN TECH REP FISH AQ, V2549, P126; Swofford D. L., 1998, PAUP PHYLOGENETIC AN; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; TERBORGH JW, 1980, AM NAT, V116, P178, DOI 10.1086/283621; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Weir JT, 2006, EVOLUTION, V60, P842; Weir JT, 2011, AM NAT, V177, P462, DOI 10.1086/658910; White EP, 2010, AM NAT, V175, pE35, DOI 10.1086/649578; Wiens JJ, 2007, P ROY SOC B-BIOL SCI, V274, P919, DOI 10.1098/rspb.2006.0301; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x; Zapata FA, 2005, AM NAT, V166, pE144, DOI 10.1086/491685	93	253	264	9	281	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					222	+		10.1038/nature13272	http://dx.doi.org/10.1038/nature13272			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24776798				2022-12-28	WOS:000335454300038
J	Bowler, C; Scanlan, DJ				Bowler, Chris; Scanlan, David J.			GENETICS Being Selective in the Prochlorococcus Collective	SCIENCE			English	Editorial Material							ECOTYPES; SYNECHOCOCCUS		[Bowler, Chris] Ecole Normale Super, CNRS, UMR8197, Inst Biol, F-75005 Paris, France; [Scanlan, David J.] Univ Warwick, Sch Life Sci, Coventry CV8 1FN, W Midlands, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Warwick	Bowler, C (corresponding author), Ecole Normale Super, CNRS, UMR8197, Inst Biol, F-75005 Paris, France.	cbowler@biologie.ens.fr; d.j.scanlan@warwick.ac.uk	Scanlan, David J/G-4080-2016; Bowler, Chris/AAC-6256-2019	Scanlan, David J/0000-0003-3093-4245; Bowler, Chris/0000-0003-3835-6187	NERC [NE/I00985X/1] Funding Source: UKRI; Natural Environment Research Council [NE/I00985X/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Barton AD, 2010, SCIENCE, V327, P1509, DOI 10.1126/science.1184961; Chow CET, 2014, ISME J, V8, P816, DOI 10.1038/ismej.2013.199; Coleman M, 2007, IEEE CONTR SYST MAG, V27, P15, DOI 10.1109/MCS.2007.284503; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kashtan N, 2014, SCIENCE, V344, P416, DOI 10.1126/science.1248575; Malmstrom RR, 2010, ISME J, V4, P1252, DOI 10.1038/ismej.2010.60; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Tirichine L, 2011, PLANT J, V66, P45, DOI 10.1111/j.1365-313X.2011.04540.x; Zwirglmaier K, 2009, ENVIRON MICROBIOL, V11, P1767, DOI 10.1111/j.1462-2920.2009.01902.x	12	2	2	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					366	367		10.1126/science.1253817	http://dx.doi.org/10.1126/science.1253817			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763577				2022-12-28	WOS:000334867800025
J	Travers, A				Travers, Andrew			The 30-nm Fiber Redux	SCIENCE			English	Editorial Material							CHROMATIN FIBER; NUCLEOSOME; REVEALS; COMPACT		[Travers, Andrew] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Travers, Andrew] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	MRC Laboratory Molecular Biology; University of Cambridge	Travers, A (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	aat@mrc-lmb.cam.ac.uk			MRC [MC_U105178783] Funding Source: UKRI; Medical Research Council [MC_U105178783] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Cui Y, 2000, P NATL ACAD SCI USA, V97, P127, DOI 10.1073/pnas.97.1.127; Fan L, 2006, P NATL ACAD SCI USA, V103, P8384, DOI 10.1073/pnas.0508951103; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; Fussner E, 2011, TRENDS BIOCHEM SCI, V36, P1, DOI 10.1016/j.tibs.2010.09.002; LENNARD AC, 1985, EMBO J, V4, P3455, DOI 10.1002/j.1460-2075.1985.tb04104.x; Livolant F, 2006, PHILOS T R SOC A, V364, P2615, DOI 10.1098/rsta.2006.1843; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Recouvreux P, 2011, BIOPHYS J, V100, P2726, DOI 10.1016/j.bpj.2011.03.064; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Scheffer MP, 2012, J STRUCT BIOL, V178, P207, DOI 10.1016/j.jsb.2011.11.020; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; STAYNOV DZ, 1988, EMBO J, V7, P3685, DOI 10.1002/j.1460-2075.1988.tb03250.x; Staynov DZ, 2000, NUCLEIC ACIDS RES, V28, P3092, DOI 10.1093/nar/28.16.3092; Syed SH, 2010, P NATL ACAD SCI USA, V107, P9620, DOI 10.1073/pnas.1000309107	15	9	12	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					370	372		10.1126/science.1253852	http://dx.doi.org/10.1126/science.1253852			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763580				2022-12-28	WOS:000334867800028
J	Cavanaugh, DJ; Geratowski, JD; Wooltorton, JRA; Spaethling, JM; Hector, CE; Zheng, XZ; Johnson, EC; Eberwine, JH; Sehgal, A				Cavanaugh, Daniel J.; Geratowski, Jill D.; Wooltorton, Julian R. A.; Spaethling, Jennifer M.; Hector, Clare E.; Zheng, Xiangzhong; Johnson, Erik C.; Eberwine, James H.; Sehgal, Amita			Identification of a Circadian Output Circuit for Rest: Activity Rhythms in Drosophila	CELL			English	Article							CHANNEL-BINDING-PROTEIN; PARS INTERCEREBRALIS; LOCOMOTOR BEHAVIOR; CLOCK NEURONS; ABLATION; GENE; ACTIVATION; EXPRESSION; PACEMAKER; RESPONSES	Though much is known about the cellular and molecular components of the circadian clock, output pathways that couple clock cells to overt behaviors have not been identified. We conducted a screen for circadian-relevant neurons in the Drosophila brain and report here that cells of the pars intercerebralis (PI), a functional homolog of the mammalian hypothalamus, comprise an important component of the circadian output pathway for rest: activity rhythms. GFP reconstitution across synaptic partners (GRASP) analysis demonstrates that PI cells are connected to the clock through a polysynaptic circuit extending from pacemaker cells to PI neurons. Molecular profiling of relevant PI cells identified the corticotropin-releasing factor (CRF) homolog, DH44, as a circadian output molecule that is specifically expressed by PI neurons and is required for normal rest: activity rhythms. Notably, selective activation or ablation of just six DH44+ PI cells causes arrhythmicity. These findings delineate a circuit through which clock cells can modulate locomotor rhythms.	[Cavanaugh, Daniel J.; Geratowski, Jill D.; Wooltorton, Julian R. A.; Zheng, Xiangzhong; Sehgal, Amita] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Spaethling, Jennifer M.; Eberwine, James H.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Spaethling, Jennifer M.; Eberwine, James H.] Univ Penn, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA; [Hector, Clare E.; Johnson, Erik C.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Sehgal, Amita] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Wake Forest University; Howard Hughes Medical Institute; University of Pennsylvania	Sehgal, A (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu		Wooltorton, Julian/0000-0003-0778-0196	NIH [5F32GM100555, 2R01NS048471, U24NS057631]; NARSAD Young Investigator Award; NSF [IOS 092931]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM100555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS048471, U24NS057631, R01NS048471] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD Young Investigator Award(NARSAD); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Wen-Feng Chen for the modified pattB plasmid; Dr. Ana Lia Obaid for help with the PI cell harvesting; Dr. Jan Veenstra for the SIFa antibody; Drs. Justin Blau, Leslie Griffith, Ralph Greenspan, Michael Rosbash, Kristin Scott, Paul Taghert, Scott Waddell, and Ben White for fly stocks; and members of the Sehgal laboratory for helpful discussions. This work was supported by NIH grant 5F32GM100555 to D.J.C., 2R01NS048471 to A.S., U24NS057631 to J.R.A.W, a 2010 NARSAD Young Investigator Award to X.Z., and NSF grant IOS 092931 to E.C.J.A.S. is an Investigator of the HHMI.	Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Belgacem YH, 2002, P NATL ACAD SCI USA, V99, P15154, DOI 10.1073/pnas.232244199; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Buckley PT, 2011, NEURON, V69, P877, DOI 10.1016/j.neuron.2011.02.028; Cabrero P, 2002, J EXP BIOL, V205, P3799; Chang DC, 2006, BEHAV PROCESS, V71, P211, DOI 10.1016/j.beproc.2005.12.008; Collins B, 2012, NEURON, V74, P706, DOI 10.1016/j.neuron.2012.02.034; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; de Velasco B, 2007, DEV BIOL, V302, P309, DOI 10.1016/j.ydbio.2006.09.035; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; Eberwine J, 2011, PHARMACOL THERAPEUT, V129, P241, DOI 10.1016/j.pharmthera.2010.09.010; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Feng YF, 2004, J NEUROGENET, V18, P377, DOI 10.1080/01677060490894522; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Gatti S, 2000, CURR BIOL, V10, P667, DOI 10.1016/S0960-9822(00)00517-0; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hall JC, 2003, ADV GENET, V48, P1, DOI 10.1016/S0065-2660(03)48000-0; HANDLER AM, 1979, NATURE, V279, P236, DOI 10.1038/279236a0; Jaramillo AM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-3; Kaneko H, 2012, CURR BIOL, V22, P1851, DOI 10.1016/j.cub.2012.08.006; Lear BC, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000154; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Luo WY, 2012, CELL, V148, P765, DOI 10.1016/j.cell.2011.12.024; Matsui T, 2009, PHYSIOL BEHAV, V96, P548, DOI 10.1016/j.physbeh.2008.12.009; Morris J, 2011, JOVE-J VIS EXP, DOI 10.3791/2634; Murad A, 2007, NEURON, V53, P689, DOI 10.1016/j.neuron.2007.01.034; Nicolai LJJ, 2010, P NATL ACAD SCI USA, V107, P20553, DOI 10.1073/pnas.1010198107; Park D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001896; Picot M, 2007, PLOS BIOL, V5, P2513, DOI 10.1371/journal.pbio.0050315; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; RAJASHEKHAR KP, 1994, J COMP NEUROL, V349, P633, DOI 10.1002/cne.903490410; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Shafer OT, 2008, NEURON, V58, P223, DOI 10.1016/j.neuron.2008.02.018; Shahidullah M, 2009, J NEUROSCI, V29, P13328, DOI 10.1523/JNEUROSCI.3024-09.2009; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; SOKOLOVE PG, 1975, J INSECT PHYSIOL, V21, P785, DOI 10.1016/0022-1910(75)90009-8; Son GH, 2011, FRONT NEUROENDOCRIN, V32, P451, DOI 10.1016/j.yfrne.2011.07.003; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Terhzaz S, 2007, BIOCHEM BIOPH RES CO, V352, P305, DOI 10.1016/j.bbrc.2006.11.030; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Yoshii T, 2009, J NEUROSCI, V29, P2597, DOI 10.1523/JNEUROSCI.5439-08.2009; Zhang Y, 2010, CURR BIOL, V20, P600, DOI 10.1016/j.cub.2010.02.044; Zhao Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009141	49	141	141	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					689	701		10.1016/j.cell.2014.02.024	http://dx.doi.org/10.1016/j.cell.2014.02.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766812	Green Accepted, Bronze			2022-12-28	WOS:000335392100017
J	Susaki, EA; Tainaka, K; Perrin, D; Kishino, F; Tawara, T; Watanabe, TM; Yokoyama, C; Onoe, H; Eguchi, M; Yamaguchi, S; Abe, T; Kiyonari, H; Shimizu, Y; Miyawaki, A; Yokota, H; Ueda, HR				Susaki, Etsuo A.; Tainaka, Kazuki; Perrin, Dimitri; Kishino, Fumiaki; Tawara, Takehiro; Watanabe, Tomonobu M.; Yokoyama, Chihiro; Onoe, Hirotaka; Eguchi, Megumi; Yamaguchi, Shun; Abe, Takaya; Kiyonari, Hiroshi; Shimizu, Yoshihiro; Miyawaki, Atsushi; Yokota, Hideo; Ueda, Hiroki R.			Whole-Brain Imaging with Single-Cell Resolution Using Chemical Cocktails and Computational Analysis	CELL			English	Article							LIGHT-SHEET MICROSCOPY; MOUSE-BRAIN; IN-VIVO; ULTRAMICROSCOPY; RECONSTRUCTION; CONNECTIONS; PROJECTIONS; EXPRESSION; MICE; VISUALIZATION	Systems-level identification and analysis of cellular circuits in the brain will require the development of whole-brain imaging with single-cell resolution. To this end, we performed comprehensive chemical screening to develop a whole-brain clearing and imaging method, termed CUBIC (clear, unobstructed brain imaging cocktails and computational analysis). CUBIC is a simple and efficient method involving the immersion of brain samples in chemical mixtures containing aminoalcohols, which enables rapid whole-brain imaging with single-photon excitation microscopy. CUBIC is applicable to multicolor imaging of fluorescent proteins or immunostained samples in adult brains and is scalable from a primate brain to subcellular structures. We also developed a whole-brain cell-nuclear counterstaining protocol and a computational image analysis pipeline that, together with CUBIC reagents, enable the visualization and quantification of neural activities induced by environmental stimulation. CUBIC enables time-course expression profiling of whole adult brains with single-cell resolution.	[Susaki, Etsuo A.; Tainaka, Kazuki; Ueda, Hiroki R.] RIKEN Quantitat Biol Ctr, Lab Synthet Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Susaki, Etsuo A.; Perrin, Dimitri; Ueda, Hiroki R.] RIKEN Ctr Dev Biol, Lab Syst Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Susaki, Etsuo A.; Tainaka, Kazuki; Ueda, Hiroki R.] Univ Tokyo, Grad Sch Med, Dept Syst Pharmacol, Bunkyo Ku, Tokyo 1130033, Japan; [Susaki, Etsuo A.; Tainaka, Kazuki; Ueda, Hiroki R.] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Kishino, Fumiaki] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; [Tawara, Takehiro; Yokota, Hideo] RIKEN Ctr Adv Photon, Image Proc Res Team, Wako, Saitama 3510198, Japan; [Watanabe, Tomonobu M.] Osaka Univ, OLABB, RIKEN Quantitat Biol Ctr, Lab Comprehens Bioimaging, Suita, Osaka 5650874, Japan; [Yokoyama, Chihiro; Onoe, Hirotaka] RIKEN Ctr Life Sci Technol, Biofunct Imaging Team, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Eguchi, Megumi; Yamaguchi, Shun] Gifu Univ, Grad Sch Med, Div Morphol Neurosci, Gifu 5011194, Japan; [Yamaguchi, Shun] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Abe, Takaya; Kiyonari, Hiroshi] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Shimizu, Yoshihiro] RIKEN Quantitat Biol Ctr, Lab Cell Free Prot Synth, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Miyawaki, Atsushi] RIKEN Brain Sci Inst, Lab Cell Funct Dynam, Wako, Saitama 3510198, Japan	RIKEN; RIKEN; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; RIKEN; Osaka University; RIKEN; RIKEN; Gifu University; Japan Science & Technology Agency (JST); RIKEN; RIKEN; RIKEN	Ueda, HR (corresponding author), RIKEN Quantitat Biol Ctr, Lab Synthet Biol, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	uedah-tky@umin.ac.jp	Yokoyama, Chihiro/C-6035-2017; Ueda, Hiroki R/C-5037-2014; Shimizu, Yoshihiro/A-6472-2016; Miyawaki, Atsushi/K-3569-2014; Kiyonari, Hiroshi/N-7936-2015; Perrin, Dimitri/H-8630-2013; Watanabe, Tomonobu/J-4812-2013	Yokoyama, Chihiro/0000-0002-1910-3750; Ueda, Hiroki R/0000-0001-8342-9176; Shimizu, Yoshihiro/0000-0003-3499-1394; Miyawaki, Atsushi/0000-0002-2329-3235; Perrin, Dimitri/0000-0002-4007-5256; Watanabe, Tomonobu/0000-0002-2420-4230; Susaki, Etsuo/0000-0001-5621-7311; Tainaka, Kazuki/0000-0002-5943-8723	Program for Innovative Cell Biology by Innovative Technology; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT/Japan Society for the Promotion of Science (JSPS) [25221004, 23115006]; strategic programs for R&D (President's discretionary fund) of RIKEN; RIKEN Center for Developmental Biology and RIKEN Quantitative Biology Center; Core Research for Evolutional Science and Technology (CREST); Precursory Research for Embryonic Science and Technology (PRESTO) of Japan Science and Technology Agency (JST); RIKEN Special Postdoctoral Research Program; Japan Foundation for Applied Enzymology; Shimabara Science Promotion Foundation; RIKEN Foreign Postdoctoral Researcher Program	Program for Innovative Cell Biology by Innovative Technology; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT/Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); strategic programs for R&D (President's discretionary fund) of RIKEN; RIKEN Center for Developmental Biology and RIKEN Quantitative Biology Center; Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Precursory Research for Embryonic Science and Technology (PRESTO) of Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); RIKEN Special Postdoctoral Research Program; Japan Foundation for Applied Enzymology; Shimabara Science Promotion Foundation; RIKEN Foreign Postdoctoral Researcher Program	We thank the lab members at RIKEN CDB and QBiC, in particular, S. Hirahara, J. Hara, H. Ukai, N. Koide, J. Yoshida, C. Imai, and Y. Niwa for their kind help in preparing the materials and C. Jolley for helpful advice. We also thank T. Imai for sharing the SeeDB protocol before its publication, H. Hama for testing Scale protocol with our samples before its publication, H. Niwa for providing a vector with a CAG promoter, H. Sekiya for supporting two-photon imaging experiments, the LARGE, RIKEN CDB for housing the mice, Emi Kosano for illustrating the mouse in Figure 6, and Olympus and Olympus Engineering for optimizing the Ultramicroscope setup. This work was supported by the Program for Innovative Cell Biology by Innovative Technology from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, a Grant-in-Aid for Scientific Research (S) (Grant No. 25221004) and a Grant-in-Aid for Scientific Research on Innovative Areas (Grant No. 23115006) from MEXT/Japan Society for the Promotion of Science (JSPS), the strategic programs for R&D (President's discretionary fund) of RIKEN, an intramural Grant-in-Aid from the RIKEN Center for Developmental Biology and RIKEN Quantitative Biology Center, a grant from Core Research for Evolutional Science and Technology (CREST) and Precursory Research for Embryonic Science and Technology (PRESTO) of Japan Science and Technology Agency (JST), the RIKEN Special Postdoctoral Research Program, a Grant-in-Aid from Japan Foundation for Applied Enzymology, a Grant-in-Aid from the Shimabara Science Promotion Foundation, and by the RIKEN Foreign Postdoctoral Researcher Program.	Abe T, 2011, GENESIS, V49, P579, DOI 10.1002/dvg.20753; Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; CORMACK AM, 1973, PHYS MED BIOL, V18, P195, DOI 10.1088/0031-9155/18/2/003; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Eguchi M, 2009, NEUROIMAGE, V44, P1274, DOI 10.1016/j.neuroimage.2008.10.046; Emmenlauer M, 2009, J MICROSC-OXFORD, V233, P42, DOI 10.1111/j.1365-2818.2008.03094.x; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gong H, 2013, NEUROIMAGE, V74, P87, DOI 10.1016/j.neuroimage.2013.02.005; Hagerling R, 2013, EMBO J, V32, P629, DOI 10.1038/emboj.2012.340; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Johnson GA, 2010, NEUROIMAGE, V53, P365, DOI 10.1016/j.neuroimage.2010.06.067; Kalchmair S, 2010, OPT LETT, V35, P79, DOI 10.1364/OL.35.000079; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; LAUTERBUR PC, 1973, NATURE, V242, P190, DOI 10.1038/242190a0; Leischner U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005785; Li AA, 2010, SCIENCE, V330, P1404, DOI 10.1126/science.1191776; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; Mertz J, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3324890; MILLER MW, 1984, J COMP NEUROL, V226, P184, DOI 10.1002/cne.902260204; Murphy K, 2011, IEEE T MED IMAGING, V30, P1901, DOI 10.1109/TMI.2011.2158349; NAVONE F, 1984, SCIENCE, V226, P1209, DOI 10.1126/science.6438799; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pitrone PG, 2013, NAT METHODS, V10, P598, DOI 10.1038/nmeth.2507; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Reep RL, 1996, EXP BRAIN RES, V111, P215; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; SLONIEWSKI P, 1986, J COMP NEUROL, V246, P467, DOI 10.1002/cne.902460405; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Tomer R, 2011, CURR OPIN GENET DEV, V21, P558, DOI 10.1016/j.gde.2011.07.003; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	41	756	827	10	189	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					726	739		10.1016/j.cell.2014.03.042	http://dx.doi.org/10.1016/j.cell.2014.03.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24746791	Bronze			2022-12-28	WOS:000335392100020
J	Callaghan, BC; Burke, JF; Feldman, EL				Callaghan, Brian C.; Burke, James F.; Feldman, Eva L.			How Neurologists Can Choose (Even More) Wisely Prioritizing Waste Reduction Targets and Identifying Gaps in Knowledge	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AMERICAN ACADEMY; HEADACHE		[Callaghan, Brian C.; Burke, James F.] Univ Michigan, Hlth Serv Res Program, Dept Neurol, Ann Arbor, MI 48104 USA; [Feldman, Eva L.] Univ Michigan, A Alfred Taubman Med Res Inst, Dept Neurol, Ann Arbor, MI 48104 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Feldman, EL (corresponding author), Univ Michigan, A Alfred Taubman Med Res Inst, Dept Neurol, 109 Zina Pitcher Pl,5017 BSRB, Ann Arbor, MI 48104 USA.	efeldman@med.umich.edu		Feldman, Eva/0000-0002-9162-2694	NIDDK NIH HHS [R24 DK082841, UO1 DK076160, U01 DK076160, R24 DK082841-01] Funding Source: Medline; NINDS NIH HHS [K08 NS082597, K23 NS079417] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK082841, U01DK076160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS079417, K08NS082597] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Callaghan BC, 2014, JAMA INTERN MED, V174, P819, DOI 10.1001/jamainternmed.2014.173; GRONSETH GS, 1995, NEUROLOGY, V45, P1263, DOI 10.1212/WNL.45.7.1263; Institute of Medicine, THE HEALTHCARE IMPER; Langer-Gould AM, 2013, NEUROLOGY, V81, P1004, DOI 10.1212/WNL.0b013e31828aab14; Lipitz-Snyderman A, 2013, JAMA INTERN MED, V173, P1277, DOI 10.1001/jamainternmed.2013.6181; Sandrini G, 2011, EUR J NEUROL, V18, P373, DOI 10.1111/j.1468-1331.2010.03212.x; Silberstein SD, 2000, NEUROLOGY, V55, P754, DOI 10.1212/WNL.55.6.754	7	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2014	311	16					1607	1608		10.1001/jama.2014.1021	http://dx.doi.org/10.1001/jama.2014.1021			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF4OU	24756505	Green Accepted			2022-12-28	WOS:000334693900015
J	Pedley, TA				Pedley, Timothy A.			Neurology at a Crossroads Opportunities and Challenges	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Columbia Univ, Med Ctr, Neurol Inst New York, Dept Neurol, New York, NY 10032 USA	Columbia University	Pedley, TA (corresponding author), Columbia Univ, Med Ctr, Neurol Inst New York, Dept Neurol, 710 W 168th St, New York, NY 10032 USA.	tap2@columbia.edu						Dall TM, 2013, NEUROLOGY, V81, P470, DOI 10.1212/WNL.0b013e318294b1cf; Fisher ES, HLTH CARE SPENDING Q; Freedman Mark S, 2013, Continuum (Minneap Minn), V19, P968, DOI 10.1212/01.CON.0000433288.30715.e3; Freeman WD, 2013, NEUROLOGY, V81, P479, DOI 10.1212/WNL.0b013e31829d8783; National Institutes of Health, 2013, IMP SEQ NAT I HLTH; Organisation for Economic Cooperation and Development, OECD HLTH DAT 2013 D; Sigsbee B, 2013, JAMA NEUROL, V70, P1097, DOI 10.1001/jamaneurol.2013.3299; Zuliani L, 2012, J NEUROL NEUROSUR PS, V83, P638, DOI 10.1136/jnnp-2011-301237	8	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2014	311	16					1611	1612		10.1001/jama.2014.4081	http://dx.doi.org/10.1001/jama.2014.4081			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF4OU	24756507				2022-12-28	WOS:000334693900017
J	Mailankody, S; Prasad, V				Mailankody, Sham; Prasad, Vinay			Comparative Effectiveness Questions in Oncology	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INCREASED SURVIVAL; PROSTATE-CANCER		[Mailankody, Sham; Prasad, Vinay] NCI, Med Oncol Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mailankody, S (corresponding author), NCI, Med Oncol Serv, Bethesda, MD 20892 USA.			Prasad, Vinayak/0000-0002-6110-8221				De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Experts in Chronic Myeloid Leukemia, 2013, BLOOD, V121, P4439; Hall S. S., 2013, NEW YORK MAGAZINE; Small EJ, 2004, J CLIN ONCOL, V22, P1025, DOI 10.1200/JCO.2004.06.037; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369	5	34	34	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 17	2014	370	16					1478	1481		10.1056/NEJMp1400104	http://dx.doi.org/10.1056/NEJMp1400104			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AF3HE	24738667				2022-12-28	WOS:000334601600004
J	Sarpatwari, A; Avorn, J; Kesselheim, AS				Sarpatwari, Ameet; Avorn, Jerry; Kesselheim, Aaron S.			Using a Drug-Safety Tool to Prevent Competition	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sarpatwari, Ameet] Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sarpatwari, A (corresponding author), Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Regulations.gov, 2013, Prometheus Laboratories Inc.-citizen petition, Patent No. 7141018; Thomas Katie, 2013, NY TIMES, pB1	2	24	25	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 17	2014	370	16					1476	1478		10.1056/NEJMp1400488	http://dx.doi.org/10.1056/NEJMp1400488			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AF3HE	24738666				2022-12-28	WOS:000334601600003
J	Tiffin, PA; Illing, J; Kasim, AS; McLachlan, JC				Tiffin, Paul A.; Illing, Jan; Kasim, Adetayo S.; McLachlan, John C.			Annual Review of Competence Progression (ARCP) performance of doctors who passed Professional and Linguistic Assessments Board (PLAB) tests compared with UK medical graduates: national data linkage study	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MULTIPLE IMPUTATION; ACADEMIC-PERFORMANCE; MRCGP EXAMINATIONS; EXAMINERS; ETHNICITY; MRCP(UK); OUTCOMES; PACES; SEX	Objective To determine whether use of the Professional and Linguistic Assessments Board (PLAB) examination system used to grant registration for international medical graduates results in equivalent postgraduate medical performance, as evaluated at Annual Review of Competence Progression (ARCP), between UK based doctors who qualified overseas and those who obtained their primary medical qualification from UK universities. Design Observational study linking ARCP outcome data from the UK deaneries with PLAB test performance and demographic data held by the UK General Medical Council (GMC). Setting Doctors in postgraduate training for a medical specialty or general practice in the UK and doctors obtaining GMC registration via the PLAB system. Participants 53 436 UK based trainee doctors with at least one competency related ARCP outcome reported during the study period, of whom 42 017 were UK medical graduates and 11 419 were international medical graduates who were registered following a pass from the PLAB route. Main outcome measure Probability of obtaining a poorer versus a more satisfactory category of outcome at ARCP following successful registration as a doctor in the UK. Results International medical graduates were more likely to obtain a less satisfactory outcome at ARCP compared with UK graduates. This finding persisted even after adjustment for the potential influence of sex, age, years of UK based practice, and ethnicity and exclusion of outcomes associated with postgraduate examination failure (odds ratio 1.63, 95% confidence interval 1.30 to 2.06). However, international medical graduates who scored in the highest twelfth at part 1 of the PLAB (at least 32 points above the pass mark) had ARCP outcomes that did not differ significantly from those of UK graduates. Conclusions These findings suggest that the PLAB test used for registration of international medical graduates is not generally equivalent to the requirements for UK graduates. The differences in postgraduate performance, as captured at ARCP, following the two routes to registration might be levelled out by raising the standards of English language competency required as well as the pass marks for the two parts of the PLAB test. An alternative might be to introduce a different testing system.	[Tiffin, Paul A.] Univ Durham, Wolfson Res Inst Hlth & Wellbeing, Sch Med Pharm & Hlth, Stockton On Tees TS17 6BH, England; [Illing, Jan; McLachlan, John C.] Ctr Med Educ Res, Durham DH1 1TA, England; [Kasim, Adetayo S.] Univ Durham, Wolfson Res Inst Hlth & Wellbeing, Stockton On Tees TS17 6BH, England	Durham University	Tiffin, PA (corresponding author), Univ Durham, Wolfson Res Inst Hlth & Wellbeing, Sch Med Pharm & Hlth, Queens Campus, Stockton On Tees TS17 6BH, England.	p.a.tiffin@durham.ac.uk	McLachlan, John/AAF-4203-2021; Tiffin, Paul/AAO-1834-2020	Tiffin, Paul/0000-0003-1770-5034; McLachlan, John/0000-0001-5493-2645; Kasim, Adetayo Safiriyu/0000-0002-0411-3059; Illing, Jan/0000-0001-6218-9775	General Medical Council (GMC); Higher Education Funding Council for England (HEFCE)	General Medical Council (GMC); Higher Education Funding Council for England (HEFCE)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE))	This study was funded by the General Medical Council (GMC) via an open tendering process. All authors are independent of the GMC. PAT is supported in his research by a Higher Education Funding Council for England (HEFCE) clinical senior lecturer fellowship.	Baker D, 2012, CLIN TEACH, V9, P325, DOI 10.1111/j.1743-498X.2012.00555.x; British Council, 2014, WHAT IS IELTS; British Medical Association, 2014, EX EQ SURV ROYAL COL; Carr A, 2013, BMJ CAREERS; Clark PF, 2006, INT LABOUR REV, V145, P37, DOI 10.1111/j.1564-913X.2006.tb00009.x; Conference of Postgraduate Medical Deans of the United Kingdom, 1998, OR GUID; Denney ML, 2013, BRIT J GEN PRACT, V63, pE718, DOI 10.3399/bjgp13X674396; Esmail A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5662; General Medical Council, 2012, REV ROUT GP SPEC REG; General Medical Council, 2014, PLAB 2; General Medical Council, 2014, SPONS BOD UK; General Medical Council, 2013, STAT MED ED PRACT UK; General Medical Council, 2013, ARCP RITA DAT COLL 2; General Medical Council, 2014, ARCP RITA REP GUID M; General Medical Council, 2012, ANN REV COMP PROGR A; General Medical Council, 2014, APPR SPEC SUBSP TRAI; General Medical Council, 2014, LIST REG MED PRACT; General Medical Council, 2013, BROAD THEM REV MEMB; General Medical Council, 2014, SPEC SPEC GUID CESR; Humphrey C, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1817; Information Comissioners Office, 2012, AN MAN DAT PROT RISK; MacLellan AM, 2010, CAN FAM PHYSICIAN, V56, P912; McLachlan JC, 2012, DEV EVIDENCE BASE PR; McManus IC, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-5; McManus IC, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2621; McManus IC, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-103; McManus IC, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-60; Medical Council of Canada, 2013, ANN REP 2012; National Deanery Data Group, 2011, NAT DEAN DAT GROUP N; Rothman AI, 2000, ACAD MED, V75, P1206, DOI 10.1097/00001888-200012000-00018; Rothwell C, 2013, INT J MED EDUC, V4, P75, DOI 10.5116/ijme.515a.2231; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Tyrer SP., 2002, PSYCHIATR BULL, V26, P257, DOI [DOI 10.1192/PB.26.7.257, 10.1192/pb.26.7.257]; UK Departments of Health, 2007, GUID POSTGR SPEC TRA; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Woolf K, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d901; World Health Organization, 2014, WORLD DIR MED SCH; Zieky MJ, 2001, SETTING PERFORMANCE STANDARDS, P19	39	50	50	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2014	348								g2622	10.1136/bmj.g2622	http://dx.doi.org/10.1136/bmj.g2622			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF5HJ	24742539	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000334744300002
J	Glod, SA				Glod, Susan A.			Miracle	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Penn State Univ, Milton S Hershey Med Ctr, Dept Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Glod, SA (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Med, Hershey, PA 17033 USA.	sglod@hmc.psu.edu							0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2014	311	15					1499	1499		10.1001/jama.2014.2159	http://dx.doi.org/10.1001/jama.2014.2159			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9DX	24737365				2022-12-28	WOS:000334306000016
J	McTaggart, MP; Newall, RG; Hirst, JA; Bankhead, CR; Lamb, EJ; Roberts, NW; Price, CP				McTaggart, Malcolm P.; Newall, Ronald G.; Hirst, Jennifer A.; Bankhead, Clare R.; Lamb, Edmund J.; Roberts, Nia W.; Price, Christopher P.			Diagnostic Accuracy of Point-of-Care Tests for Detecting Albuminuria	ANNALS OF INTERNAL MEDICINE			English	Review							GLOMERULAR-FILTRATION-RATE; KIDNEY-DISEASE MEASURES; STAGE RENAL-DISEASE; URINARY ALBUMIN; CREATININE RATIO; COLLABORATIVE METAANALYSIS; CLINITEK MICROALBUMIN; SYSTEMATIC REVIEWS; REAGENT STRIP; ALL-CAUSE	Background: Experts recommend screening for albuminuria in patients at risk for kidney disease. Purpose: To systematically review evidence about the diagnostic accuracy of point-of-care (POC) tests for detecting albuminuria in individuals for whom guidelines recommend such detection. Data Sources: Cochrane Library, EMBASE, Medion database, MEDLINE, and Science Citation Index from 1963 through 5 December 2013; hand searches of other relevant journals; and reference lists. Study Selection: Cross-sectional studies, published in any language, that compared the accuracy of machine-read POC tests of urinary albumin-creatinine ratio with that of laboratory measurement. Data Extraction: Two independent reviewers extracted study data and assessed study quality using the QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies 2) tool. Data Synthesis: Sixteen studies (n = 3356 patients) that evaluated semiquantitative or quantitative POC tests and used random urine samples collected in primary or secondary ambulatory care settings met inclusion criteria. Pooling results from a bivariate randomeffects model gave sensitivity and specificity estimates of 76% (95% CI, 63% to 86%) and 93% (CI, 84% to 97%), respectively, for the semiquantitative test. Sensitivity and specificity estimates for the quantitative test were 96% (CI, 78% to 99%) and 98% (CI, 93% to 99%), respectively. The negative likelihood ratios for the semiquantitative and quantitative tests were 0.26 (CI, 0.16 to 0.40) and 0.04 (CI, 0.01 to 0.25), respectively. Limitation: Accuracy estimates were based on data from single-sample urine measurement, but guidelines require that diagnosis of albuminuria be based on at least 2 of 3 samples collected in a 6-month period. Conclusion: A negative semiquantitative POC test result does not rule out albuminuria, whereas quantitative POC testing meets required performance standards and can be used to rule out albuminuria.	East Kent Hosp Univ NHS Fdn Trust, Canterbury, Kent, England; Univ Oxford, Oxford OX2 6GG, England	University of Oxford	Price, CP (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Radcliffe Observ Quarter, Woodstock Rd, Oxford OX2 6GG, England.		Roberts, Nia W/F-9842-2010	Roberts, Nia W/0000-0002-1142-6440; Hirst, Jennifer/0000-0002-8416-2159	National Institute for Health Research Diagnostic Evidence Cooperative Oxford at Oxford Health NHS Foundation Trust	National Institute for Health Research Diagnostic Evidence Cooperative Oxford at Oxford Health NHS Foundation Trust	Ms. Roberts and Professor Price are supported by the National Institute for Health Research Diagnostic Evidence Cooperative Oxford at Oxford Health NHS Foundation Trust.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Bachmann LM, 2014, CLIN CHEM, V60, P471, DOI 10.1373/clinchem.2013.210302; Bossuyt PMM, 2012, CLIN CHEM, V58, P1636, DOI 10.1373/clinchem.2012.182576; Boyd JC, 2012, CLIN CHEM, V58, P1273, DOI 10.1373/clinchem.2012.192252; Croal BL, 2001, CLIN CHIM ACTA, V307, P15, DOI 10.1016/S0009-8981(01)00450-8; Davidson EM, 2003, POINT CARE, V2, P89; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Dwamena B., 2007, MIDAS STATA MODULE M; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Fraser CG, 2001, BIOL VARIATION PRINC; Fu R, 2008, CONDUCTING QUANTITAT; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Graziani MS, 2009, NEPHROL DIAL TRANSPL, V24, P1490, DOI 10.1093/ndt/gfn639; Guy M, 2009, CLIN CHIM ACTA, V399, P54, DOI 10.1016/j.cca.2008.09.006; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Harbord RM, 2009, STATA J, V9, P211, DOI 10.1177/1536867X0900900203; HOWEY JEA, 1989, AM J KIDNEY DIS, V13, P35, DOI 10.1016/S0272-6386(89)80112-X; Kania K, 2010, ANN CLIN BIOCHEM, V47, P151, DOI 10.1258/acb.2009.009247; Kazmierczak SC, 2011, CLIN CHEM, V57, P1219, DOI 10.1373/clinchem.2011.171538; KEEN H, 1963, LANCET, V2, P913; Khawali C, 2002, BRAZ J MED BIOL RES, V35, P337, DOI 10.1590/S0100-879X2002000300008; Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013, KIDNEY INT S, V3, P1, DOI [DOI 10.1038/KISUP.2012.73, 10.1038/kisup.2012.48]; Knottnerus JA, 2003, J CLIN EPIDEMIOL, V56, P1118, DOI 10.1016/S0895-4356(03)00206-3; Knudsen ST, 2012, DAN MED J, V59; Kouri T, 2009, SCAND J CLIN LAB INV, V69, P52, DOI 10.1080/00365510802322419; Lamb EJ, 2013, CLIN CHEM, V59, P462, DOI 10.1373/clinchem.2012.184259; Laurence CO, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-165; Le Floch JP, 2001, DIABETES METAB, V27, P36; Lieske JC, 2013, CLIN CHEM LAB MED, V51, P981, DOI 10.1515/cclm-2012-0768; Linnet K, 2012, CLIN CHEM, V58, P1292, DOI 10.1373/clinchem.2012.182543; Lloyd MM, 2011, S AFR FAM PRACT, V53, P281, DOI 10.1080/20786204.2011.10874100; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mahmoodi BK, 2012, LANCET, V380, P1649, DOI 10.1016/S0140-6736(12)61272-0; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; McTaggart MP, 2012, AM J KIDNEY DIS, V60, P787, DOI 10.1053/j.ajkd.2012.05.009; Miller WG, 2009, CLIN CHEM, V55, P24, DOI 10.1373/clinchem.2008.106567; MOGENSEN CE, 1985, UREMIA INVEST, V9, P85, DOI 10.3109/08860228509088195; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moons KGM, 2012, CLIN CHEM, V58, P1408, DOI 10.1373/clinchem.2012.182550; National Institute for Health and Care Excellence, 2009, 66 NICE; National Institute for Health and Care Excellence, 2010, 15 NICE; National Institute for Health and Care Excellence, 2008, 73 NICE; Newman DJ, 2000, CLIN CHIM ACTA, V294, P139, DOI 10.1016/S0009-8981(00)00181-9; Parsons M, 1999, CLIN NEPHROL, V51, P220; Parsons MP, 1999, CLIN CHEM, V45, P414; Pickersgill A, 2001, DIABETIC MED, V18, P937, DOI 10.1046/j.0742-3071.2001.00590.x; POULSEN PL, 1992, DIABETES METAB, V18, P395; Poulsen PL, 1998, DIABETES CARE, V21, P97, DOI 10.2337/diacare.21.1.97; Pugia MJ, 1998, J CLIN LAB ANAL, V12, P280, DOI 10.1002/(SICI)1098-2825(1998)12:5<280::AID-JCLA5>3.0.CO;2-A; Reitsma JB, 2012, CLIN CHEM, V58, P1534, DOI 10.1373/clinchem.2012.182568; Sacks DB, 2011, CLIN CHEM, V57, P793, DOI 10.1373/clinchem.2011.163634; Shephard MDS, 1999, ANN CLIN BIOCHEM, V36, P393, DOI 10.1177/000456329903600315; Shephard MDS, 2005, ANN CLIN BIOCHEM, V42, P208, DOI 10.1258/0004563053857806; Stengel D, 2003, J MED SCREEN, V10, P47, DOI 10.1258/096914103321610806; The Health and Social Care Information Centre, 2012, 1 CAR PROC TREATM TA; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	58	23	24	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 15	2014	160	8					550	+		10.7326/M13-2331	http://dx.doi.org/10.7326/M13-2331			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG0ZE	24733196				2022-12-28	WOS:000335143700005
J	Dauer, WT; Guo, M				Dauer, William T.; Guo, Ming			Multiplying Messages LRRK beneath Parkinson Disease	CELL			English	Editorial Material							TRANSLATION		[Dauer, William T.] Univ Michigan, Sch Med, Dept Neurol, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Guo, Ming] Univ Calif Los Angeles, UCLA David Geffen Sch Med, Dept Neurol, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Guo, M (corresponding author), Univ Calif Los Angeles, UCLA David Geffen Sch Med, Dept Neurol, Dept Mol & Med Pharmacol, 695 Charles Young Dr South, Los Angeles, CA 90095 USA.	mingfly@ucla.edu		Dauer, William/0000-0003-1775-7504				Cookson MR, 2010, HUM MOL GENET, V19, pR21, DOI 10.1093/hmg/ddq167; Demetriades C, 2014, CELL, V156, P786, DOI 10.1016/j.cell.2014.01.024; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Kennedy BK, 2009, AGING CELL, V8, P617, DOI 10.1111/j.1474-9726.2009.00522.x; Martin I, 2014, CELL, V157, P472, DOI 10.1016/j.cell.2014.01.064; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Rouquette J, 2005, EMBO J, V24, P2862, DOI 10.1038/sj.emboj.7600752; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Trinh J, 2013, NAT REV NEUROL, V9, P445, DOI 10.1038/nrneurol.2013.132	10	0	0	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					291	293		10.1016/j.cell.2014.03.043	http://dx.doi.org/10.1016/j.cell.2014.03.043			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725399	Bronze			2022-12-28	WOS:000334304500004
J	Watts, S				Watts, Susan			Society needs more than wonder to respect science	NATURE			English	Editorial Material												susan.watts@susanwatts.org							0	6	6	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					151	151		10.1038/508151a	http://dx.doi.org/10.1038/508151a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE4UK	24717473	Bronze			2022-12-28	WOS:000333979900004
J	Wennberg, DE; Sharp, SM; Bevan, G; Skinner, JS; Gottlieb, DJ; Wennberg, JE				Wennberg, David E.; Sharp, Sandra M.; Bevan, Gwyn; Skinner, Jonathan S.; Gottlieb, Daniel J.; Wennberg, John E.			A population health approach to reducing observational intensity bias in health risk adjustment: cross sectional analysis of insurance claims	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PROFILING HOSPITAL PERFORMANCE; GENERAL PRACTICES; MORTALITY; RATES; FORMULA; DEATH; MODEL	Objective To compare the performance of two new approaches to risk adjustment that are free of the influence of observational intensity with methods that depend on diagnoses listed in administrative databases. Setting Administrative data from the US Medicare program for services provided in 2007 among 306 US hospital referral regions. Design Cross sectional analysis. Participants 20% sample of fee for service Medicare beneficiaries residing in one of 306 hospital referral regions in the United States in 2007 (n=5 153 877). Main outcome measures The effect of health risk adjustment on age, sex, and race adjusted mortality and spending rates among hospital referral regions using four indices: the standard Centers for Medicare and Medicaid Services-Hierarchical Condition Categories (HCC) index used by the US Medicare program (calculated from diagnoses listed in Medicare's administrative database); a visit corrected HCC index (to reduce the effects of observational intensity on frequency of diagnoses); a poverty index (based on US census); and a population health index calculated using data on incidence of hip fractures and strokes, and responses from a population based annual survey of health from the Centers for Disease Control and Prevention). Results Estimated variation in age, sex, and race adjusted mortality rates across hospital referral regions was reduced using the indices based on population health, poverty, and visit corrected HCC, but increased using the standard HCC index. Most of the residual variation in age, sex, and race adjusted mortality was explained (in terms of weighted R2) by the population health index: R2=0.65. The other indices explained less: R2=0.20 for the visit corrected HCC index; 0.19 for the poverty index, and 0.02 for the standard HCC index. The residual variation in age, sex, race, and price adjusted spending per capita across the 306 hospital referral regions explained by the indices (in terms of weighted R2) were 0.50 for the standard HCC index, 0.21 for the population health index, 0.12 for the poverty index, and 0.07 for the visit corrected HCC index, implying that only a modest amount of the variation in spending can be explained by factors most closely related to mortality. Further, once the HCC index is visit corrected it accounts for almost none of the residual variation in age, sex, and race adjusted spending. Conclusion Health risk adjustment using either the poverty index or the population health index performed substantially better in terms of explaining actual mortality than the indices that relied on diagnoses from administrative databases; the population health index explained the majority of residual variation in age, sex, and race adjusted mortality. Owing to the influence of observational intensity on diagnoses from administrative databases, the standard HCC index over-adjusts for regional differences in spending. Research to improve health risk adjustment methods should focus on developing measures of risk that do not depend on observation influenced diagnoses recorded in administrative databases.	[Wennberg, David E.; Sharp, Sandra M.; Skinner, Jonathan S.; Gottlieb, Daniel J.; Wennberg, John E.] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA; [Bevan, Gwyn] Univ London London Sch Econ & Polit Sci, Dept Management, London WC2A 2AE, England; [Skinner, Jonathan S.] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA; [Skinner, Jonathan S.] Natl Bur Econ Res, Hanover, NH USA	Dartmouth College; University of London; London School Economics & Political Science; Dartmouth College; National Bureau of Economic Research	Wennberg, DE (corresponding author), Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, 35 Centerra Pkwy, Lebanon, NH 03766 USA.	David.E.Wennberg@Dartmouth.edu			National Institute on Aging [PO1-AG19783]; Robert Wood Johnson Foundation; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was partially supported by the National Institute on Aging (grant PO1-AG19783) and the Robert Wood Johnson Foundation. The funders had no role in the design and conduct of the study; the collection, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.	[Anonymous], 2003, IHI INN SER WHIT P 1; Bevan G, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6732; Bevan G, 2009, FINANC ACCOUNT MANAG, V25, P391, DOI 10.1111/j.1468-0408.2009.00484.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dixon J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6608; Gottlieb DJ, 2010, HEALTH AFFAIR, V29, P537, DOI 10.1377/hlthaff.2009.0609; Heijink R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-73; IEZZONI LI, 1994, HEALTH SERV RES, V29, P435; Institute of Medicine, 2013, VAR HLTH CAR SPEND T; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Koster M, 2008, LAKARTIDNINGEN; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Medicare Payment Advisory Commission The (MedPac), 2009, REP C IMPR INC MED P; Ong MK, 2009, CIRC-CARDIOVASC QUAL, V2, P548, DOI 10.1161/CIRCOUTCOMES.108.825612; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Romley JA, 2013, AM J MANAG CARE, V19, pE46; Romley JA, 2011, ANN INTERN MED, V154, P160, DOI 10.7326/0003-4819-154-3-201102010-00005; Rosenthal T, 2012, ANNU REV MED, V63, P493, DOI 10.1146/annurev-med-050710-134438; Schmidt M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e356; Silber JH, 2010, HEALTH SERV RES, V45, P1872, DOI 10.1111/j.1475-6773.2010.01180.x; Sirovich B, 2008, HEALTH AFFAIR, V27, P813, DOI 10.1377/hlthaff.27.3.813; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; The Canadian Institute for Health Information, 2007, HSMR NEW APPR MEAS H; van de Ven WPMM, 2008, HEALTH AFFAIR, V27, P771, DOI 10.1377/hlthaff.27.3.771; Van de Ven WPMM, 2011, HEALTH ECON POLICY L, V6, P147, DOI 10.1017/S1744133110000319; Weiner JP, 2012, HEALTH AFFAIR, V31, P306, DOI 10.1377/hlthaff.2011.0420; Welch HG, 2011, JAMA-J AM MED ASSOC, V305, P1113, DOI 10.1001/jama.2011.307; Wennberg JE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f549; Whittington J, 2005, IHI INN SER WHIT P 2	30	19	19	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 10	2014	348								g2392	10.1136/bmj.g2392	http://dx.doi.org/10.1136/bmj.g2392			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE9SG	24721838	Green Published, hybrid			2022-12-28	WOS:000334348900001
J	Gliwa, C; Pearson, SD				Gliwa, Catherine; Pearson, Steven D.			Evidentiary Rationales for the Choosing Wisely Top 5 Lists	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Gliwa, Catherine; Pearson, Steven D.] NIH, Dept Bioeth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Pearson, SD (corresponding author), NIH, 10 Ctr Dr,Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	pearsonsd@cc.nih.gov			Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		American Board of Internal Medicine Foundation, CHOOSING WISELY; Hoffman A, 2009, HEALTH AFFAIR, V28, pW710, DOI 10.1377/hlthaff.28.4.w710	2	29	29	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2014	311	14					1443	1444		10.1001/jama.2013.285362	http://dx.doi.org/10.1001/jama.2013.285362			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4EP	24715077				2022-12-28	WOS:000333935000022
J	Rothberg, MB; Pekow, PS; Priya, A; Lindenauer, PK				Rothberg, Michael B.; Pekow, Penelope S.; Priya, Aruna; Lindenauer, Peter K.			Variation in Diagnostic Coding of Patients With Pneumonia and Its Association With Hospital Risk-Standardized Mortality Rates A Cross-sectional Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							COMORBIDITY MEASURES; ACUTE EXACERBATIONS; PERFORMANCE; MODELS; CARE	Background: Most U.S. hospitals publicly report 30-day risk-standardized mortality rates for pneumonia. Rates exclude severe cases, which may be assigned a secondary diagnosis of pneumonia and a principal diagnosis of sepsis or respiratory failure. By assigning sepsis and respiratory failure codes more liberally, hospitals might improve their reported performance. Objective: To examine the effect of the definition of pneumonia on hospital mortality rates. Design: Cross-sectional study. Setting: 329 U. S. hospitals. Patients: Adults hospitalized for pneumonia (as a principal diagnosis or secondary diagnosis paired with a principal diagnosis of sepsis or respiratory failure) between 2007 and 2010. Measurements: Proportion of patients with pneumonia coded with a principal diagnosis of sepsis or respiratory failure and risk-standardized mortality rates excluding versus including a principal diagnosis of sepsis or respiratory failure. Results: When the definition of pneumonia was limited to patients with a principal diagnosis of pneumonia, the risk-standardized mortality rate was significantly better than the mean in 4.3% of hospitals and significantly worse in 6.4%. When the definition was broadened to include patients with a principal diagnosis of sepsis or respiratory failure, this rate was better than the mean in 11.9% of hospitals and worse in 22.8% and the outlier status of 28.3% of hospitals changed. Among hospitals in the highest quintile of proportion of patients coded with a principal diagnosis of sepsis or respiratory failure, outlier status under the broader definition improved in 7.6% and worsened in 40.9%. Among those in the lowest quintile, 20.0% improved and none worsened. Limitation: Only inpatient mortality was studied. Conclusion: Variation in use of the principal diagnosis of sepsis or respiratory failure may bias efforts to compare hospital performance regarding pneumonia outcomes.	Cleveland Clin, Inst Med, Cleveland, OH 44195 USA; Baystate Med Ctr, Ctr Qual Care Res, Springfield, MA 01199 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Univ Massachusetts, Amherst, MA 01003 USA	Cleveland Clinic Foundation; Baystate Medical Center; Tufts University; University of Massachusetts System; University of Massachusetts Amherst	Rothberg, MB (corresponding author), Cleveland Clin, Dept Med, Inst Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.	rothbem@ccf.org			Agency for Healthcare Research and Quality; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018723] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	[Anonymous], 1985, Fed Regist, V50, P31038; Borzecki AM, 2010, MED CARE, V48, P1117, DOI 10.1097/MLR.0b013e3181ef9d53; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Centers for Disease Control and Prevention, 2011, ICD 9 CM OFF GUID CO; Centers for Medicare & Medicaid Services, 2012, 30 DAY DEATH READM M; Drye EE, 2012, ANN INTERN MED, V156, P19, DOI 10.7326/0003-4819-156-1-201201030-00004; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Ettinger WH, 2008, AM J MED QUAL, V23, P90, DOI 10.1177/1062860607313141; Fonarow GC, 2012, JAMA-J AM MED ASSOC, V308, P257, DOI 10.1001/jama.2012.7870; Goldman LE, 2011, HEALTH SERV RES, V46, P1946, DOI 10.1111/j.1475-6773.2011.01300.x; Krumholz H, 2007, RISK ADJUSTMENT MODE; Kupfer JM, 2013, JAMA-J AM MED ASSOC, V309, P2213, DOI 10.1001/jama.2013.5009; Li PX, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-245; Lindenauer PK, 2006, ANN INTERN MED, V144, P894, DOI 10.7326/0003-4819-144-12-200606200-00006; Lindenauer PK, 2012, JAMA-J AM MED ASSOC, V307, P1405, DOI 10.1001/jama.2012.384; Rahn Ada C, 2011, Med Econ, V88, P26; Rothberg MB, 2010, JAMA-J AM MED ASSOC, V303, P2035, DOI 10.1001/jama.2010.672; Ryan AM, 2009, INQUIRY-J HEALTH CAR, V46, P274, DOI 10.5034/inquiryjrnl_46.03.274; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694	19	48	49	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2014	160	6					380	+		10.7326/M13-1419	http://dx.doi.org/10.7326/M13-1419			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MW	24723078	Green Accepted			2022-12-28	WOS:000333521300014
J	Reyes-Fox, M; Steltzer, H; Trlica, MJ; McMaster, GS; Andales, AA; LeCain, DR; Morgan, JA				Reyes-Fox, Melissa; Steltzer, Heidi; Trlica, M. J.; McMaster, Gregory S.; Andales, Allan A.; LeCain, Dan R.; Morgan, Jack A.			Elevated CO2 further lengthens growing season under warming conditions	NATURE			English	Article							CLIMATE-CHANGE; FLOWERING TIME; CARBON-DIOXIDE; PHENOLOGY; GRASSLAND; RESPONSES; PLANTS	Observations of a longer growing season through earlier plant growth in temperate to polar regions have been thought to be a response to climate warming(1-5). However, data from experimental warming studies indicate that many species that initiate leaf growth and flowering earlier also reach seed maturation and senesce earlier, shortening their active and reproductive periods(6-10). A conceptual model to explain this apparent contradiction(11), and an analysis of the effect of elevated CO2-which can delay annual life cycle events(12-14)-on changing season length, have not been tested. Here we show that experimental warming in a temperate grassland led to a longer growing season through earlier leaf emergence by the first species to leaf, often a grass, and constant or delayed senescence by other species that were the last to senesce, supporting the conceptual model. Elevated CO2 further extended growing, but not reproductive, season length in the warmed grassland by conserving water, which enabled most species to remain active longer. Our results suggest that a longer growing season, especially in years or biomes where water is a limiting factor, is not due to warming alone, but also to higher atmospheric CO2 concentrations that extend the active period of plant annual life cycles.	[Reyes-Fox, Melissa] ARS, USDA, Soil Plant Nutrient Res Unit, Ft Collins, CO 80526 USA; [Reyes-Fox, Melissa; McMaster, Gregory S.] Northern Plains Area, Ft Collins, CO 80526 USA; [Steltzer, Heidi] Ft Lewis Coll, Dept Biol, Durango, CO 81301 USA; [Trlica, M. J.] Colorado State Univ, Dept Forest & Rangeland Stewardship, Ft Collins, CO 80523 USA; [McMaster, Gregory S.] ARS, USDA, Agr Syst Res Unit, Ft Collins, CO 80526 USA; [Andales, Allan A.] Colorado State Univ, Dept Soil & Crop Sci, Ft Collins, CO 80523 USA; [LeCain, Dan R.; Morgan, Jack A.] ARS, USDA, Rangeland Resources Res Unit, Ft Collins, CO 80526 USA	United States Department of Agriculture (USDA); Colorado State University; United States Department of Agriculture (USDA); Colorado State University; United States Department of Agriculture (USDA)	Steltzer, H (corresponding author), Ft Lewis Coll, Dept Biol, Durango, CO 81301 USA.	Melissa.reyes@ars.usda.gov; steltzer_h@fortlewis.edu	Andales, Allan A/M-8328-2013		US Department of Agriculture Agricultural Research Center (USDA-ARS) Climate Change, Soils & Emissions Program; US Department of Energy's Office of Science through the Terrestrial Ecosystem Science Program; National Science Foundation (DEB) [1021559]; Colorado State University; Direct For Biological Sciences [1021559] Funding Source: National Science Foundation	US Department of Agriculture Agricultural Research Center (USDA-ARS) Climate Change, Soils & Emissions Program; US Department of Energy's Office of Science through the Terrestrial Ecosystem Science Program; National Science Foundation (DEB)(National Science Foundation (NSF)); Colorado State University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The following individuals contributed to the installation and maintenance of the Prairie Heating and CO<INF>2</INF> Enrichment (PHACE) project: D. Smith, D. Blumenthal, E. Pendall, E. Hardy, L. Griffith, A. Hansen, K. Corp, V. Banuelos, G. Tinnin, M. West, C. Brooks, M. Busick, D. Milchunas, G. Dunn and L. Ahuja. Funding for this work was supported by the US Department of Agriculture Agricultural Research Center (USDA-ARS) Climate Change, Soils & Emissions Program, by the US Department of Energy's Office of Science through the Terrestrial Ecosystem Science Program, by the National Science Foundation (DEB no. 1021559) and by Colorado State University. D. Inouye provided comments that improved the manuscript.	Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Aldridge G, 2011, J ECOL, V99, P905, DOI 10.1111/j.1365-2745.2011.01826.x; Ball JT., 1987, PROGR PHOTOSYNTHESIS, P221; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Cleland EE, 2006, P NATL ACAD SCI USA, V103, P13740, DOI 10.1073/pnas.0600815103; Fay PA, 2012, NAT CLIM CHANGE, V2, P742, DOI [10.1038/nclimate1573, 10.1038/NCLIMATE1573]; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Hoffmann AA, 2010, J ECOL, V98, P927, DOI 10.1111/j.1365-2745.2010.01667.x; Hollister RD, 2005, ECOLOGY, V86, P1562, DOI 10.1890/04-0520; Hovenden MJ, 2008, NEW PHYTOL, V178, P815, DOI 10.1111/j.1469-8137.2008.02419.x; Hoye TT, 2013, NAT CLIM CHANGE, V3, P759, DOI [10.1038/nclimate1909, 10.1038/NCLIMATE1909]; Kim Y, 2012, REMOTE SENS ENVIRON, V121, P472, DOI 10.1016/j.rse.2012.02.014; Kimball BA, 2008, GLOBAL CHANGE BIOL, V14, P309, DOI 10.1111/j.1365-2486.2007.01486.x; Korner C, 2006, NEW PHYTOL, V172, P393, DOI 10.1111/j.1469-8137.2006.01886.x; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Miglietta F, 2001, NEW PHYTOL, V150, P465, DOI 10.1046/j.1469-8137.2001.00115.x; Morgan JA, 2011, NATURE, V476, P202, DOI 10.1038/nature10274; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Post ES, 2008, ECOLOGY, V89, P363, DOI 10.1890/06-2138.1; Richardson AD, 2013, AGR FOREST METEOROL, V169, P156, DOI 10.1016/j.agrformet.2012.09.012; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Sherry RA, 2007, P NATL ACAD SCI USA, V104, P198, DOI 10.1073/pnas.0605642104; Springer CJ, 2007, NEW PHYTOL, V176, P243, DOI 10.1111/j.1469-8137.2007.02196.x; Steltzer H, 2009, SCIENCE, V324, P886, DOI 10.1126/science.1171542; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P9892, DOI 10.1073/pnas.1732012100	27	115	122	6	267	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					259	+		10.1038/nature13207	http://dx.doi.org/10.1038/nature13207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24759322	Green Published			2022-12-28	WOS:000337032400048
J	Vazquez-Laslop, N; Mankin, AS				Vazquez-Laslop, Nora; Mankin, Alexander S.			Protein Accounting in the Cellular Economy	CELL			English	Editorial Material								Knowing the copy number of cellular proteins is critical for understanding cell physiology. By being able to measure the absolute synthesis rates of the majority of cellular proteins, Li et al. gain insights into key aspects of translation regulation and fundamental principles of cellular strategies to adjust protein synthesis according to the functional needs.	[Vazquez-Laslop, Nora; Mankin, Alexander S.] Univ Illinois, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Vazquez-Laslop, N (corresponding author), Univ Illinois, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA.	nvazquez@uic.edu; shura@uic.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104370, R01GM106386] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM104370, R01 GM104370, R01 GM106386, GM106386] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342	5	3	3	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					529	531		10.1016/j.cell.2014.04.002	http://dx.doi.org/10.1016/j.cell.2014.04.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766801	Green Accepted, Bronze			2022-12-28	WOS:000335392100003
J	Sibbald, V				Sibbald, Vanessa			Emergency Medicine Team of the Year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, Evidence Ctr, London WC1H 9JR, England		Sibbald, V (corresponding author), BMJ, Evidence Ctr, London WC1H 9JR, England.	vsibbald@bmj.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2014	348								g2861	10.1136/bmj.g2861	http://dx.doi.org/10.1136/bmj.g2861			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG1DH	24760160				2022-12-28	WOS:000335154800005
J	Adli, M; Hegerl, U				Adli, Mazda; Hegerl, Ulrich			Do we underestimate the benefits of antidepressants?	LANCET			English	Editorial Material							INITIAL SEVERITY; DEPRESSION; EFFICACY; METAANALYSIS		[Adli, Mazda] Charite, Dept Psychiat & Psychotherapy, D-10117 Berlin, Germany; [Adli, Mazda] Fliedner Klin Berlin, D-10117 Berlin, Germany; [Hegerl, Ulrich] Univ Leipzig, Dept Psychiat & Psychotherapy, D-04109 Leipzig, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University	Adli, M (corresponding author), Charite, Dept Psychiat & Psychotherapy, D-10117 Berlin, Germany.	mazda.adli@charite.de	Adli, Mazda/GYV-2083-2022	Hegerl, Ulrich/0000-0002-3039-7470				Cuijpers P, 2012, CLIN PSYCHOL REV, V32, P280, DOI 10.1016/j.cpr.2012.01.003; Fountoulakis KN, 2013, ANN GEN PSYCHIATR, V12, DOI 10.1186/1744-859X-12-26; Guideline Group Unipolar Depression, 2009, S3 GUIDELINE NATIONA; Hegerl U, 2012, J AFFECT DISORDERS, V138, P183, DOI 10.1016/j.jad.2011.05.015; Hegerl U, 2010, INT J NEUROPSYCHOPH, V13, P31, DOI 10.1017/S1461145709000224; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Kleinman A, 2012, LANCET, V379, P608, DOI 10.1016/S0140-6736(12)60258-X; Kobak KA, 2010, J CLIN PSYCHOPHARM, V30, P193, DOI 10.1097/JCP.0b013e3181d20912; Leucht S, 2012, BRIT J PSYCHIAT, V200, P97, DOI 10.1192/bjp.bp.111.096594; NICE, 2004, CLINICAL PRACTICE GU; NICE, 2009, NATIONAL CLINICAL PR, V90	11	6	6	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2014	383	9926					1361	1362		10.1016/S0140-6736(14)60534-1	http://dx.doi.org/10.1016/S0140-6736(14)60534-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG3LI	24759238				2022-12-28	WOS:000335318400004
J	Hawkes, N				Hawkes, Nigel			The role of NHS gatekeeping in delayed diagnosis	BMJ-BRITISH MEDICAL JOURNAL			English	News Item												nigel.hawkes1@btinternet.com						MATHERS N, 1989, BRIT MED J, V298, P172, DOI 10.1136/bmj.298.6667.172; Vedsted P, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X588484	2	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2014	348								g2633	10.1136/bmj.g2633	http://dx.doi.org/10.1136/bmj.g2633			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF5HJ	24742882				2022-12-28	WOS:000334744300007
J	Gallus, A				Gallus, Alex			Review: Dabigatran does not differ from vitamin K antagonists for mortality or major bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							WARFARIN		SA Pathol Flinders Med Ctr, Adelaide, SA, Australia	Flinders Medical Centre; SA Pathology	Gallus, A (corresponding author), SA Pathol Flinders Med Ctr, Adelaide, SA, Australia.			Gallus, Alexander/0000-0001-7347-9989				Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Majeed A, 2013, CIRCULATION, V128, P2325, DOI 10.1161/CIRCULATIONAHA.113.002332; Wasserlauf G, 2013, AM J CARDIOL, V112, P454, DOI 10.1016/j.amjcard.2013.03.054	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2014	160	8							JC5	10.7326/0003-4819-160-8-201404150-02005	http://dx.doi.org/10.7326/0003-4819-160-8-201404150-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW3QU	24733222				2022-12-28	WOS:000364907600004
J	Moayyedi, P				Moayyedi, Paul			Review: Calprotectin testing differentiates inflammatory bowel disease from the irritable bowel syndrome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DIAGNOSIS		McMaster Univ, Hamilton, ON, Canada	McMaster University	Moayyedi, P (corresponding author), McMaster Univ, Hamilton, ON, Canada.		Moayyedi, Paul/M-6178-2014	Moayyedi, Paul/0000-0002-3616-9292				Ford AC, 2008, AM J GASTROENTEROL, V103, P1229, DOI 10.1111/j.1572-0241.2007.01740.x; Ford AC, 2013, GASTROENTEROLOGY, V145, P1262, DOI 10.1053/j.gastro.2013.08.048; ROSETH AG, 1993, SCAND J GASTROENTERO, V28, P1073, DOI 10.3109/00365529309098312	3	1	1	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2014	160	8							JC13	10.7326/0003-4819-160-8-201404150-02013	http://dx.doi.org/10.7326/0003-4819-160-8-201404150-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW3QU	24733218				2022-12-28	WOS:000364907600012
J	Miller, MS; Palese, P				Miller, Matthew S.; Palese, Peter			Peering into the Crystal Ball: Influenza Pandemics and Vaccine Efficacy	CELL			English	Article							ANTIBODY-RESPONSES; SYSTEMS BIOLOGY; VIRUS VACCINES; HUMANS; TRANSMISSION; IMMUNIZATION; PATTERNS; H5N1; HA	The looming threat of a new influenza virus pandemic has fueled ambitious efforts to devise more predictive parameters for assessing the risks associated with emergent virus strains. At the same time, a comprehensive understanding of critical factors that can accurately predict the outcome of vaccination is sorely needed in order to improve the effectiveness of influenza virus vaccines. Will new studies aimed at identifying adaptations required for virus transmissibility and systems-level analyses of influenza virus vaccine responses provide an improved framework for predictive models of viral adaptation and vaccine efficacy?	[Miller, Matthew S.; Palese, Peter] Icahn Sch Med Mt Sinai, Dept Microbiol, Div Infect Dis, New York, NY 10029 USA; [Palese, Peter] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Miller, MS (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, Div Infect Dis, New York, NY 10029 USA.	matthew.miller@mssm.edu; peter.palese@mssm.edu		Miller, Matthew/0000-0003-3426-5069; Palese, Peter/0000-0002-0337-5823	Canadian Institutes of Health Research Postdoctoral Fellowship; NIH [P01 AI097092-01, HHSN266200700010C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI097092] Funding Source: NIH RePORTER	Canadian Institutes of Health Research Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We apologize to our colleagues whose work could not be cited due to space limitations. M.S.M. is supported, in part, by a Canadian Institutes of Health Research Postdoctoral Fellowship. P.P. is supported, in part, by NIH P01 AI097092-01 and HHSN266200700010C.	Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Julien JP, 2012, IMMUNOL REV, V250, P180, DOI 10.1111/imr.12005; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kimble JB, 2011, P NATL ACAD SCI USA, V108, P12084, DOI 10.1073/pnas.1108058108; Krammer F, 2014, NAT IMMUNOL, V15, P3, DOI 10.1038/ni.2761; Linster M, 2014, CELL, V157, DOI 10.1016/j.cell.2014.02.040; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nayak JL, 2013, J INFECT DIS, V207, P297, DOI 10.1093/infdis/jis684; Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Sasaki S, 2007, J VIROL, V81, P215, DOI 10.1128/JVI.01957-06; Spensieri F, 2013, P NATL ACAD SCI USA, V110, P14330, DOI 10.1073/pnas.1311998110; Stern AM, 2005, HEALTH AFFAIR, V24, P611, DOI 10.1377/hlthaff.24.3.611; To KKW, 2013, LANCET INFECT DIS, V13, P809, DOI 10.1016/S1473-3099(13)70167-1; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Wolinetz CD, 2012, SCIENCE, V336, P1525, DOI 10.1126/science.1223995; Zaraket H, 2013, J VIROL, V87, P4826, DOI 10.1128/JVI.03110-12	23	20	21	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					294	299		10.1016/j.cell.2014.03.023	http://dx.doi.org/10.1016/j.cell.2014.03.023			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725400	Bronze			2022-12-28	WOS:000334304500005
J	Denniston, MM; Jiles, RB; Drobeniuc, J; Klevens, RM; Ward, JW; McQuillan, GM; Holmberg, SD				Denniston, Maxine M.; Jiles, Ruth B.; Drobeniuc, Jan; Klevens, R. Monina; Ward, John W.; McQuillan, Geraldine M.; Holmberg, Scott D.			Chronic Hepatitis C Virus Infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010	ANNALS OF INTERNAL MEDICINE			English	Article							PREVALENCE; MORTALITY; TYPE-2	Background: Knowledge of the number of persons with chronic hepatitis C virus (HCV) infection in the United States is critical for public health and policy planning. Objective: To estimate the prevalence of chronic HCV infection between 2003 and 2010 and to identify factors associated with this condition. Design: Nationally representative household survey. Setting: U.S. noninstitutionalized civilian population. Participants: 30 074 NHANES (National Health and Nutrition Examination Survey) participants between 2003 and 2010. Measurements: Interviews to ascertain demographic characteristics and possible risks and exposures for HCV infection. Serum samples from participants aged 6 years or older were tested for antibody to HCV; if results were positive or indeterminate, the samples were tested for HCV RNA, which indicates current chronic infection. Results: Based on 273 participants who tested positive for HCV RNA, the estimated prevalence of HCV infection was 1.0% (95% CI, 0.8% to 1.2%), corresponding to 2.7 million chronically infected persons (CI, 2.2 to 3.2 million persons) in the U. S. noninstitutionalized civilian population. Infected persons were more likely to be aged 40 to 59 years, male, and non-Hispanic black and to have less education and lower family income. Factors significantly associated with chronic HCV infection were illicit drug use (including injection drugs) and receipt of a blood transfusion before 1992; 49% of persons with HCV infection did not report either risk factor. Limitation: Incarcerated and homeless persons were not surveyed. Conclusion: This analysis estimated that approximately 2.7 million U. S. residents in the population sampled by NHANES have chronic HCV infection, about 500 000 fewer than estimated in a similar analysis between 1999 and 2002. These data underscore the urgency of identifying the millions of persons who remain infected and linking them to appropriate care and treatment.	Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Holmberg, SD (corresponding author), 1600 Clifton Rd NE,Mail Stop G37, Atlanta, GA 30333 USA.	sdh1@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Denniston MM, 2012, HEPATOLOGY, V55, P1652, DOI 10.1002/hep.25556; El-Kamary SS, 2011, CLIN INFECT DIS, V53, P150, DOI 10.1093/cid/cir306; Fox AN, 2012, CLIN INFECT DIS, V55, pS16, DOI 10.1093/cid/cis391; Gottlieb SL, 2004, J INFECT DIS, V190, P1059, DOI 10.1086/423323; Grant WC, 2005, HEPATOLOGY, V42, P1406, DOI 10.1002/hep.20941; Holmberg SD, 2013, NEW ENGL J MED, V368, P1859, DOI 10.1056/NEJMp1302973; Institute of Medicine, 2010, HEP LIV CANC NAT STR; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Mahajan R., 2013, IDWEEK 2013 SAN FRAN; North CS, 2013, GEN HOSP PSYCHIAT, V35, P122, DOI 10.1016/j.genhosppsych.2012.11.002; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Pyenson B., 2009, CONSEQUENCES HEPATIT; *RES TRIANGL I, 2008, SUDAAN LANG MAN REL; Sie L, 2013, J VIRAL HEPATITIS, V20, P628, DOI 10.1111/jvh.12086; Smith BD, 2012, ANN INTERN MED, V157, P817, DOI 10.7326/0003-4819-157-9-201211060-00529; Spradling PR, 2012, CLIN INFECT DIS, V55, P1047, DOI 10.1093/cid/cis616; Tohme RA, 2010, HEPATOLOGY, V52, P1497, DOI 10.1002/hep.23808; Wald A, 2001, JAMA-J AM MED ASSOC, V285, P3100, DOI 10.1001/jama.285.24.3100	21	562	566	0	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2014	160	5					293	+		10.7326/M13-1133	http://dx.doi.org/10.7326/M13-1133			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC8OT	24737271	Green Accepted			2022-12-28	WOS:000332793900001
J	Chong, JJH; Yang, XL; Don, CW; Minami, E; Liu, YW; Weyers, JJ; Mahoney, WM; Van Biber, B; Cook, SM; Palpant, NJ; Gantz, JA; Fugate, JA; Muskheli, V; Gough, GM; Vogel, KW; Astley, CA; Hotchkiss, CE; Baldessari, A; Pabon, L; Reinecke, H; Gill, EA; Nelson, V; Kiem, HP; Laflamme, MA; Murry, CE				Chong, James J. H.; Yang, Xiulan; Don, Creighton W.; Minami, Elina; Liu, Yen-Wen; Weyers, Jill J.; Mahoney, William M., Jr.; Van Biber, Benjamin; Cook, Savannah M.; Palpant, Nathan J.; Gantz, Jay A.; Fugate, James A.; Muskheli, Veronica; Gough, G. Michael; Vogel, Keith W.; Astley, Cliff A.; Hotchkiss, Charlotte E.; Baldessari, Audrey; Pabon, Lil; Reinecke, Hans; Gill, Edward A.; Nelson, Veronica; Kiem, Hans-Peter; Laflamme, Michael A.; Murry, Charles E.			Human embryonic-stem-cell-derived cardiomyocytesregenerate non-humanprimate hearts	NATURE			English	Article							LARGE ANIMAL-MODELS; ENGRAFT	Pluripotent stem cells provide a potential solution to current epidemic rates of heart failure(1) by providing human cardiomyocytes to support heart regeneration(2). Studies of human embryonic-stem-cell-derived cardiomyocytes (hESC-CMs) in small-animal models have shown favourable effects of this treatment(3-7). However, it remains unknown whether clinical-scale hESC-CM transplantation is feasible, safe or can provide sufficient myocardial regeneration. Here we show that hESC-CMs can be produced at a clinical scale (more than one billion cells per batch) and cryopreserved with good viability. Using a non-human primate model of myocardial ischaemia followed by reperfusion, we show that cryopreservation and intramyocardial delivery of one billion hESC-CMs generates extensive remuscularization of the infarctedheart. The hESC-CMs showed progressive but incomplete maturation over a 3-month period. Grafts were perfused by host vasculature, and electromechanical junctions between graft and host myocytes were present within 2 weeks of engraftment. Importantly, grafts showed regular calcium transients that were synchronized to the host electrocardiogram, indicating electromechanical coupling. In contrast to small-animal models(7), nonfatal ventricular arrhythmias were observed in hESC-CM-engrafted primates. Thus, hESC-CMs can remuscularize substantial amounts of the infarcted monkey heart. Comparable remuscularization of a human heart should be possible, but potential arrhythmic complications need to be overcome.	[Chong, James J. H.; Yang, Xiulan; Minami, Elina; Liu, Yen-Wen; Weyers, Jill J.; Mahoney, William M., Jr.; Van Biber, Benjamin; Palpant, Nathan J.; Gantz, Jay A.; Fugate, James A.; Muskheli, Veronica; Pabon, Lil; Reinecke, Hans; Laflamme, Michael A.; Murry, Charles E.] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98109 USA; [Chong, James J. H.; Yang, Xiulan; Minami, Elina; Liu, Yen-Wen; Weyers, Jill J.; Mahoney, William M., Jr.; Van Biber, Benjamin; Palpant, Nathan J.; Gantz, Jay A.; Fugate, James A.; Muskheli, Veronica; Pabon, Lil; Reinecke, Hans; Laflamme, Michael A.; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA; [Chong, James J. H.] Westmead Hosp, Dept Cardiol, Westmead, NSW 2145, Australia; [Chong, James J. H.] Univ Sydney, Sch Med, Sydney, NSW 2006, Australia; [Chong, James J. H.; Yang, Xiulan; Minami, Elina; Liu, Yen-Wen; Weyers, Jill J.; Mahoney, William M., Jr.; Van Biber, Benjamin; Palpant, Nathan J.; Gantz, Jay A.; Fugate, James A.; Muskheli, Veronica; Pabon, Lil; Reinecke, Hans; Kiem, Hans-Peter; Laflamme, Michael A.; Murry, Charles E.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Don, Creighton W.; Minami, Elina; Gill, Edward A.; Murry, Charles E.] Univ Washington, Dept Med Cardiol, Seattle, WA 98195 USA; [Cook, Savannah M.] Univ Washington, Inst Stem Cell & Regenerat Med, Dept Comparat Med, Seattle, WA 98109 USA; [Gantz, Jay A.; Murry, Charles E.] Univ Washington, Dept Bioengn, Seattle, WA 98109 USA; [Gough, G. Michael; Vogel, Keith W.; Astley, Cliff A.; Hotchkiss, Charlotte E.; Baldessari, Audrey] Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; [Nelson, Veronica; Kiem, Hans-Peter] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Sydney; University of Sydney; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Murry, CE (corresponding author), Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98109 USA.	murry@uw.edu	Mahoney, William/GQB-0802-2022; Chong, James/E-2924-2018; Gantz, Jay A/B-3581-2009; Laflamme, Michael/AAV-6791-2021; Weyers, Jill/AGX-7536-2022; Palpant, Nathan/B-1641-2017	Chong, James/0000-0002-5201-4856; Laflamme, Michael/0000-0001-5908-880X; Weyers, Jill/0000-0003-2358-1162; Palpant, Nathan/0000-0002-9334-8107	National Institutes of Health [P01HL094374, R01HL084642, U01HL100405, P01GM081619]; Institute of Translational Health Sciences/Primate Center Ignition Award; National Health and Medical Research Council of Australia; Australian-American Fulbright Commission; American Heart Association [12POST11940060, 12POST9330030]; Jose Carreras/E.D. Thomas Chair for Cancer Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117991, R01HL084642, P01HL094374, U01HL100405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619, T32GM007266, T32GM008619] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Translational Health Sciences/Primate Center Ignition Award; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian-American Fulbright Commission; American Heart Association(American Heart Association); Jose Carreras/E.D. Thomas Chair for Cancer Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Dupras, B. Brown, D. Rocha, E. Wilson, C. English, J. Randolph-Habecker and T. Goodpaster for assistance with these experiments. This work was supported by National Institutes of Health grants P01HL094374, R01HL084642, U01HL100405 and P01GM081619 and an Institute of Translational Health Sciences/Primate Center Ignition Award. J. J. H. C. was supported by National Health and Medical Research Council of Australia Overseas Training and Australian-American Fulbright Commission Fellowships. X.Y. is supported by an American Heart Association post-doctoral scholarship 12POST11940060. J. J. W. is supported by an American Heart Association post-doctoral scholarship 12POST9330030. H.-P. K. is a Markey Molecular Medicine investigator and the recipient of the Jose Carreras/E.D. Thomas Chair for Cancer Research.	Bel A, 2010, CIRCULATION, V122, pS118, DOI 10.1161/CIRCULATIONAHA.109.927293; Biermann M, 1998, J CARDIOVASC ELECTR, V9, P1348, DOI 10.1111/j.1540-8167.1998.tb00110.x; Blin G, 2010, J CLIN INVEST, V120, P1125, DOI 10.1172/JCI40120; Bretzner F, 2011, CELL STEM CELL, V8, P468, DOI 10.1016/j.stem.2011.04.012; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Chen HSV, 2009, CIRCULATION, V120, P2496, DOI 10.1161/CIRCULATIONAHA.107.751412; Chong JJH, 2013, STEM CELLS DEV, V22, P1932, DOI 10.1089/scd.2012.0542; Dixon JA, 2009, CIRC-HEART FAIL, V2, P262, DOI 10.1161/CIRCHEARTFAILURE.108.814459; Fernandes S, 2010, J MOL CELL CARDIOL, V49, P941, DOI 10.1016/j.yjmcc.2010.09.008; Gandolfi F, 2011, THERIOGENOLOGY, V75, P1416, DOI 10.1016/j.theriogenology.2011.01.026; Gantz JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046971; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; HOSHINO T, 1983, CIRCULATION, V67, P1109, DOI 10.1161/01.CIR.67.5.1109; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Laurita KR, 2001, AM J PHYSIOL-HEART C, V280, pH2053, DOI 10.1152/ajpheart.2001.280.5.H2053; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mauritz C, 2011, EUR HEART J, V32, P2634, DOI 10.1093/eurheartj/ehr166; Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; van der Spoel TIG, 2011, CARDIOVASC RES, V91, P649, DOI 10.1093/cvr/cvr113; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; Weyers JJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000202; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu CH, 2011, REGEN MED, V6, P53, DOI 10.2217/RME.10.91; Yang XL, 2014, CIRC RES, V114, P511, DOI 10.1161/CIRCRESAHA.114.300558; Zhu WZ, 2011, METHODS MOL BIOL, V767, P419, DOI 10.1007/978-1-61779-201-4_31	30	859	898	4	195	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					273	+		10.1038/nature13233	http://dx.doi.org/10.1038/nature13233			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24776797	Green Accepted			2022-12-28	WOS:000337032400051
J	Henderson, JT; Whitlock, EP; O'Connor, E; Senger, CA; Thompson, JH; Rowland, MG				Henderson, Jillian T.; Whitlock, Evelyn P.; O'Connor, Elizabeth; Senger, Caitlyn A.; Thompson, Jamie H.; Rowland, Maya G.			Low-Dose Aspirin for Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							PREGNANCY-INDUCED HYPERTENSION; ACETYLSALICYLIC-ACID; DOPPLER ULTRASOUND; GROWTH RESTRICTION; UNITED-STATES; RISK-FACTORS; WOMEN; UTERINE; METAANALYSIS; DISORDERS	Background: Preeclampsia is a leading cause of maternal and perinatal morbidity and mortality. Purpose: To systematically review benefits and harms of low-dose aspirin for preventing morbidity and mortality from preeclampsia. Data Sources: MEDLINE, Database of Abstracts of Reviews of Effects, PubMed, and Cochrane Central Register of Controlled Trials (January 2006 to June 2013); previous systematic reviews, clinical trial registries, and surveillance searches for large studies (June 2013 to February 2014). Study Selection: Randomized, controlled trials (RCTs) to assess benefits among women at high preeclampsia risk and RCTs or large cohort studies of harms among women at any risk level. English-language studies of fair or good quality were included. Data Extraction: Dual quality assessment and abstraction of studies. Data Synthesis: Two large, multisite RCTs and 13 smaller RCTs of high-risk women (8 good-quality) were included, in addition to 6 RCTs and 2 observational studies of average-risk women to assess harms (7 good-quality). Depending on baseline risk, aspirin use was associated with absolute risk reductions of 2% to 5% for preeclampsia (relative risk [RR], 0.76 [95% CI, 0.62 to 0.95]), 1% to 5% for intrauterine growth restriction (RR, 0.80 [CI, 0.65 to 0.99]), and 2% to 4% for preterm birth (RR, 0.86 [CI, 0.76 to 0.98]). No significant perinatal or maternal harms were identified, but rare harms could not be ruled out. Evidence on long-term outcomes was sparse, but 18-month follow-up from the largest trial found no developmental harms. Limitations: Benefits may have been overestimated due to small-study effects. Predictive intervals were not statistically significant. Future studies could shift findings toward the null. Conclusion: Daily low-dose aspirin beginning as early as the second trimester prevented clinically important health outcomes. No harms were identified, but long-term evidence was limited.	[Henderson, Jillian T.; Whitlock, Evelyn P.; O'Connor, Elizabeth; Senger, Caitlyn A.; Thompson, Jamie H.; Rowland, Maya G.] Kaiser Permanente Northwest, Portland, OR USA	Kaiser Permanente	Henderson, JT (corresponding author), Kaiser Permanente Ctr Hlth Res, 3800 North Interstate Ave, Portland, OR 97227 USA.				AHRQ [HHS-290-2012-00015-I]	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By contract HHS-290-2012-00015-I, task order 3, from AHRQ.	ACOG Committee on Practice Bulletins--Obstetrics, 2002, Obstet Gynecol, V99, P159; Adeney KL, 2006, HEADACHE, V46, P794, DOI 10.1111/j.1526-4610.2006.00432.x; American Congress of Obstetricians and Gynecologists, 2013, HYPERTENSION PREGNAN; American Congress of Obstetricians and Gynecologists. Intrauterine Growth Restriction, 2000, ACOG PRACTICE B; Ananth CV, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6564; [Anonymous], 2008, US PREV SERV TASK FO; Askie LM, 2007, LANCET, V369, P1791, DOI 10.1016/S0140-6736(07)60712-0; Audibert F, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.014; Ayala DE, 2013, CHRONOBIOL INT, V30, P260, DOI 10.3109/07420528.2012.717455; Basso O, 2006, JAMA-J AM MED ASSOC, V296, P1357, DOI 10.1001/jama.296.11.1357; Beck CT, 2011, J MIDWIFERY WOM HEAL, V56, P427, DOI 10.1111/j.1542-2011.2011.00090.x; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; BENIGNI A, 1989, NEW ENGL J MED, V321, P357, DOI 10.1056/NEJM198908103210604; Berg CJ, 2010, OBSTET GYNECOL, V116, P1302, DOI 10.1097/AOG.0b013e3181fdfb11; BEROYZ G, 1994, LANCET, V343, P619; Borenstein M, 2009, INTRO META ANAL; Bower SJ, 1996, BRIT J OBSTET GYNAEC, V103, P625, DOI 10.1111/j.1471-0528.1996.tb09829.x; Bradburn MJ, 1998, METAANALYSIS STATA U, P3; Bujold E, 2010, OBSTET GYNECOL, V116, P402, DOI 10.1097/AOG.0b013e3181e9322a; Bushnell CD, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b664; Caritis S, 1998, NEW ENGL J MED, V338, P701, DOI 10.1056/NEJM199803123381101; CASPI E, 1994, AM J REPROD IMMUNOL, V31, P19, DOI 10.1111/j.1600-0897.1994.tb00842.x; Cetin I, 2011, PLACENTA, V32, pS4, DOI 10.1016/j.placenta.2010.11.022; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; Czerwinski S, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/858097; DAVIES NJ, 1995, HYPERTENS PREGNANCY, V14, P49, DOI 10.3109/10641959509058050; Davis EF, 2012, PEDIATRICS, V129, pE1552, DOI 10.1542/peds.2011-3093; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dombrowski MP, 2006, OBSTET GYNECOL, V108, P667, DOI 10.1097/01.AOG.0000235059.84188.9c; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Engelhard IM, 2002, GEN HOSP PSYCHIAT, V24, P260, DOI 10.1016/S0163-8343(02)00189-5; Facchinetti F, 2009, CEPHALALGIA, V29, P286, DOI 10.1111/j.1468-2982.2008.01704.x; Fe RW, 2011, J CLIN EPIDEMIOL, V64, P1187, DOI 10.1016/j.jclinepi.2010.08.010; Gallery EDM, 1997, HYPERTENS PREGNANCY, V16, P229, DOI 10.3109/10641959709031640; Gaugler-Senden IPM, 2012, J MATERN-FETAL NEO M, V25, P272, DOI 10.3109/14767058.2011.573829; Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011; Grab D, 2000, ULTRASOUND OBST GYN, V15, P19, DOI 10.1046/j.1469-0705.2000.00009.x; Grill S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-70; Harbord RM, 2009, STATA J, V9, P197, DOI 10.1177/1536867X0900900202; HAUTH JC, 1993, AM J OBSTET GYNECOL, V168, P1083, DOI 10.1016/0002-9378(93)90351-I; Henderson J, 2014, LOW DOSE AS IN PRESS; Hermida RC, 1997, HYPERTENSION, V30, P589, DOI 10.1161/01.HYP.30.3.589; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hoedjes M, 2011, BIRTH-ISS PERINAT C, V38, P246, DOI 10.1111/j.1523-536X.2011.00477.x; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006; Jensen MS, 2010, EPIDEMIOLOGY, V21, P779, DOI 10.1097/EDE.0b013e3181f20bed; Keim SA, 2006, EPIDEMIOLOGY, V17, P435, DOI 10.1097/01.ede.0000221693.72971.b3; Lain KY, 2002, JAMA-J AM MED ASSOC, V287, P3183, DOI 10.1001/jama.287.24.3183; Lykke JA, 2009, HYPERTENSION, V53, P944, DOI 10.1161/HYPERTENSIONAHA.109.130765; Malacrida C, 2014, HEALTH-LONDON, V18, P41, DOI 10.1177/1363459313476964; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; MCPARLAND P, 1990, LANCET, V335, P1552, DOI 10.1016/0140-6736(90)91377-M; Mendola P, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.007; National Institute for Health and Care Excellence, 2006, GUID MAN; NEWNHAM JP, 1995, AUST NZ J OBSTET GYN, V35, P370, DOI 10.1111/j.1479-828X.1995.tb02144.x; Poon LCY, 2010, J HUM HYPERTENS, V24, P104, DOI 10.1038/jhh.2009.45; Rep A, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.045; Roberts JM, 2013, J REPROD IMMUNOL, V99, P1, DOI 10.1016/j.jri.2013.05.003; Rotchell YE, 1998, BRIT J OBSTET GYNAEC, V105, P286, DOI 10.1111/j.1471-0528.1998.tb10088.x; Rowe-Murray HJ, 2001, BRIT J OBSTET GYNAEC, V108, P1068, DOI 10.1111/j.1471-0528.2001.00242.x; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; SCHIFF E, 1989, NEW ENGL J MED, V321, P351, DOI 10.1056/NEJM198908103210603; SIBAI BM, 1993, NEW ENGL J MED, V329, P1213, DOI 10.1056/NEJM199310213291701; Soet JE, 2003, BIRTH-ISS PERINAT C, V30, P36, DOI 10.1046/j.1523-536X.2003.00215.x; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Stepan H, 2007, HYPERTENSION, V49, P818, DOI 10.1161/01.HYP.0000258404.21552.a3; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Subtil D, 2003, BJOG-INT J OBSTET GY, V110, P475, DOI 10.1016/S1470-0328(03)02996-3; Thangaratinam S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2088; Trivedi NA, 2011, J POSTGRAD MED, V57, P91, DOI 10.4103/0022-3859.81858; Trogstad L, 2011, BEST PRACT RES CL OB, V25, P329, DOI 10.1016/j.bpobgyn.2011.01.007; Vainio M, 2002, BJOG-INT J OBSTET GY, V109, P161, DOI 10.1111/j.1471-0528.2002.01046.x; Valdiviezo C, 2012, CLIN CARDIOL, V35, P160, DOI 10.1002/clc.21965; VIINIKKA L, 1993, BRIT J OBSTET GYNAEC, V100, P809, DOI 10.1111/j.1471-0528.1993.tb14304.x; Villa PM, 2013, BJOG-INT J OBSTET GY, V120, P64, DOI 10.1111/j.1471-0528.2012.03493.x; WALLENBURG HCS, 1986, LANCET, V1, P1; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089; Wells G., 2013, NEWCASTLE OTTAWA SCA; Wen Shi Wu, 2004, Semin Fetal Neonatal Med, V9, P429, DOI 10.1016/j.siny.2004.04.002; Yu CKH, 2003, ULTRASOUND OBST GYN, V22, P233, DOI 10.1002/uog.218	82	227	250	1	35	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2014	160	10					695	+		10.7326/M13-2844	http://dx.doi.org/10.7326/M13-2844			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MJ	24711050				2022-12-28	WOS:000337347100016
J	Czuczman, MA; Fattouh, R; van Rijn, JM; Canadien, V; Osborne, S; Muise, AM; Kuchroo, VK; Higgins, DE; Brumell, JH				Czuczman, Mark A.; Fattouh, Ramzi; van Rijn, Jorik M.; Canadien, Veronica; Osborne, Suzanne; Muise, Aleixo M.; Kuchroo, Vijay K.; Higgins, Darren E.; Brumell, John H.			Listeria monocytogenes exploits efferocytosis to promote cell-to-cell spread	NATURE			English	Article							PLASMA-MEMBRANE; HOST-CELLS; PHOSPHOLIPASES-C; INFECTION; CLEARANCE; SURVIVAL; ROLES; ACTIN; MICE	Efferocytosis, the process by which dying or dead cells are removed by phagocytosis, has an important role in development, tissue homeostasis and innate immunity(1). Efferocytosis is mediated, in part, by receptors that bind to exofacial phosphatidylserine (PS) on cells or cellular debris after loss of plasma membrane asymmetry. Here we show that a bacterial pathogen, Listeria monocytogenes, can exploit efferocytosis to promote cell-to-cell spread during infection. These bacteria can escape the phagosome in host cells by using the poreforming toxin listeriolysin O (LLO) and two phospholipase C enzymes(2). Expression of the cell surface protein ActA allows L. monocytogenes to activate host actin regulatory factors and undergo actin-based motility in the cytosol, eventually leading to formation of actin-rich protrusions at the cell surface. Here we show that protrusion formation is associated with plasma membrane damage due to LLO's poreforming activity. LLO also promotes the release of bacteria-containing protrusions from the host cell, generating membrane-derived vesicles with exofacial PS. The PS-binding receptor TIM-4 (encoded by the Timd4 gene) contributes to efficient cell-to-cell spread by L. monocytogenes in macrophages in vitro and growth of these bacteria is impaired in Timd4(-/-) mice. Thus, L. monocytogenes promotes its dissemination in a host by exploiting efferocytosis. Our results indicate that PS-targeted therapeutics may be useful in the fight against infections by L. monocytogenes and other bacteria that use similar strategies of cell-to-cell spread during infection.	[Czuczman, Mark A.; Fattouh, Ramzi; Canadien, Veronica; Osborne, Suzanne; Muise, Aleixo M.; Brumell, John H.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 0A4, Canada; [Czuczman, Mark A.; Brumell, John H.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [van Rijn, Jorik M.] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; [van Rijn, Jorik M.] Univ Med Ctr Utrecht, Inst Biomembranes, NL-3584 CX Utrecht, Netherlands; [Muise, Aleixo M.] Hosp Sick Children, Dept Paediat, Div Gastroenterol Hepatol & Nutr, Toronto, ON M5G 1X8, Canada; [Muise, Aleixo M.; Brumell, John H.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Muise, Aleixo M.; Brumell, John H.] Hosp Sick Children, Sickkids IBD Ctr, Toronto, ON M5G 1X8, Canada; [Kuchroo, Vijay K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Higgins, Darren E.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Brumell, JH (corresponding author), Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 0A4, Canada.	john.brumell@sickkids.ca	van Rijn, Jorik/ABF-4613-2020	van Rijn, Jorik/0000-0003-2865-4455; Fattouh, Ramzi/0000-0001-6573-6367	Canadian Foundation for Innovation; Ontario Innovation Trust; Canadian Institutes of Health Research; Canadian Association of Gastroenterology; Crohn's and Colitis Foundation of Canada; Research Training Committee at the Hospital for Sick Children; Arthritis Society of Canada [RG11/013]; US Public Health Service grant from the National Institutes of Health [AI053669]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096138] Funding Source: NIH RePORTER	Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Association of Gastroenterology; Crohn's and Colitis Foundation of Canada; Research Training Committee at the Hospital for Sick Children; Arthritis Society of Canada; US Public Health Service grant from the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to S. Gray-Owen, S. Grinstein and D. Portnoy for providing reagents and advice and to D. Holmyard for help with electron microscopy. J.H.B. holds the Pitblado Chair in Cell Biology. Infrastructure for the Brumell laboratory was provided by a Leader's Opportunity Fund grant from the Canadian Foundation for Innovation and the Ontario Innovation Trust. R. F. was supported by a postdoctoral fellowship from the Canadian Institutes of Health Research in partnership with the Canadian Association of Gastroenterology and the Crohn's and Colitis Foundation of Canada. S.O. was supported by a postdoctoral fellowship from the Research Training Committee at the Hospital for Sick Children. This work was supported by an operating grant from The Arthritis Society of Canada (#RG11/013) to J.H.B. and a US Public Health Service grant (AI053669) from the National Institutes of Health to D.E.H.	Alberti-Segui C, 2007, CELL MICROBIOL, V9, P179, DOI 10.1111/j.1462-5822.2006.00780.x; Appelberg R, 2000, INFECT IMMUN, V68, P912, DOI 10.1128/IAI.68.2.912-914.2000; Babiychuk EB, 2011, CELL DEATH DIFFER, V18, P80, DOI 10.1038/cdd.2010.81; BISHOP DK, 1987, J IMMUNOL, V139, P2005; Brumell JH, 2001, CELL MICROBIOL, V3, P75, DOI 10.1046/j.1462-5822.2001.00087.x; Cassidy SKB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002628; Draeger A, 2011, BIOCHEM PHARMACOL, V81, P703, DOI 10.1016/j.bcp.2010.12.027; Drevets DA, 1999, INFECT IMMUN, V67, P3512, DOI 10.1128/IAI.67.7.3512-3517.1999; Fadeel B, 2009, CRIT REV BIOCHEM MOL, V44, P264, DOI 10.1080/10409230903193307; Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x; Friedrich N, 2012, MICROBIOL MOL BIOL R, V76, P707, DOI 10.1128/MMBR.00024-12; Gedde MM, 2000, INFECT IMMUN, V68, P999, DOI 10.1128/IAI.68.2.999-1003.2000; Glomski IJ, 2002, J CELL BIOL, V156, P1029, DOI 10.1083/jcb.200201081; Grundling A, 2003, J BACTERIOL, V185, P6295, DOI 10.1128/JB.185.21.6295-6307.2003; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; Hamon MA, 2012, TRENDS MICROBIOL, V20, P360, DOI 10.1016/j.tim.2012.04.006; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Idone V, 2008, TRENDS CELL BIOL, V18, P552, DOI 10.1016/j.tcb.2008.09.001; JONES S, 1994, INFECT IMMUN, V62, P5608, DOI 10.1128/IAI.62.12.5608-5613.1994; Keyel PA, 2011, J CELL SCI, V124, P2414, DOI 10.1242/jcs.076182; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Martin CJ, 2012, CELL HOST MICROBE, V12, P289, DOI 10.1016/j.chom.2012.06.010; Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Mostowy S, 2012, ADV IMMUNOL, V113, P19, DOI 10.1016/B978-0-12-394590-7.00007-5; Munsie LN, 2009, NAT METHODS, V6, P317, DOI 10.1038/nmeth0509-317; Nomura T, 2007, MICROBIOL-SGM, V153, P2250, DOI 10.1099/mic.0.2007/005843-0; Pust S, 2005, EMBO J, V24, P1287, DOI 10.1038/sj.emboj.7600595; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Robbins JR, 1999, J CELL BIOL, V146, P1333, DOI 10.1083/jcb.146.6.1333; Rodriguez-Manzanet R, 2008, J IMMUNOL, V180, P4706, DOI 10.4049/jimmunol.180.7.4706; Rodriguez-Manzanet R, 2010, P NATL ACAD SCI USA, V107, P8706, DOI 10.1073/pnas.0910359107; Schnupf P, 2006, CELL MICROBIOL, V8, P353, DOI 10.1111/j.1462-5822.2005.00631.x; Schnupf P, 2007, MICROBES INFECT, V9, P1176, DOI 10.1016/j.micinf.2007.05.005; Shen A, 2005, MOL MICROBIOL, V57, P1460, DOI 10.1111/j.1365-2958.2005.04780.x; Skoble J, 2000, J CELL BIOL, V150, P527, DOI 10.1083/jcb.150.3.527; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; Waite JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001326	39	90	95	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					230	+		10.1038/nature13168	http://dx.doi.org/10.1038/nature13168			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24739967	Green Accepted, Green Submitted			2022-12-28	WOS:000335454300040
J	Balachandran, JS; Hall, JB				Balachandran, Jay S.; Hall, Jesse B.			Update in Pulmonary, Sleep, and Critical Care Medicine: Evidence Published in 2013	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Balachandran, Jay S.; Hall, Jesse B.] Univ Chicago, Med Ctr, Chicago, IL 60637 USA	University of Chicago; University of Chicago Medical Center	Balachandran, JS (corresponding author), Univ Chicago, Dept Med, Sect Pulm & Crit Care, Med Ctr, 5841 South Maryland Ave,MC6076, Chicago, IL 60637 USA.	jsbalach@uchicago.edu		Balachandran, Jay/0000-0001-5574-4662				Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Agnelli G, 2013, NEW ENGL J MED, V368, P699, DOI 10.1056/NEJMoa1207541; Briel M, 2010, JAMA-J AM MED ASSOC, V303, P865, DOI 10.1001/jama.2010.218; Carson JL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub3; Clement A, 2006, THORAX, V61, P895, DOI 10.1136/thx.2005.057950; Galiatsou E, 2006, AM J RESP CRIT CARE, V174, P187, DOI 10.1164/rccm.200506-899OC; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Mentzelopoulos SD, 2009, ARCH INTERN MED, V169, P15, DOI 10.1001/archinternmed.2008.509; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Neto AS, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2013.09.031; Roberts I, 1998, BMJ-BRIT MED J, V317, P235; Serisier DJ, 2013, JAMA-J AM MED ASSOC, V309, P1260, DOI 10.1001/jama.2013.2290; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP	13	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 6	2014	160	9					621	+	PMID 24722730	10.7326/M14-0209	http://dx.doi.org/10.7326/M14-0209			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V44NW	24722730				2022-12-28	WOS:000209756700001
J	Glass, JM				Glass, Jonathan M.			PERSONAL VIEW Competency based training is a framework for incompetence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Guys & St Thomas NHS Fdn Trust, Dept Urol, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust	Glass, JM (corresponding author), Guys & St Thomas NHS Fdn Trust, Dept Urol, London SE1 9RT, England.	jonathan.glass@gstt.nhs.uk							0	24	25	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2014	348								g2909	10.1136/bmj.g2909	http://dx.doi.org/10.1136/bmj.g2909			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG1DN	24769452				2022-12-28	WOS:000335155400010
J	Karaca, E; Weitzer, S; Pehlivan, D; Shiraishi, H; Gogakos, T; Hanada, T; Jhangiani, SN; Wiszniewski, W; Withers, M; Campbell, IM; Erdin, S; Isikay, S; Franco, LM; Gonzaga-Jauregui, C; Gambin, T; Gelowani, V; Hunter, JV; Yesil, G; Koparir, E; Yilmaz, S; Brown, M; Briskin, D; Hafner, M; Morozov, P; Farazi, TA; Bernreuther, C; Glatzel, M; Trattnig, S; Friske, J; Kronnerwetter, C; Bainbridge, MN; Gezdirici, A; Seven, M; Muzny, DM; Boerwinkle, E; Ozen, M; Clausen, T; Tuschl, T; Yuksel, A; Hess, A; Gibbs, RA; Martinez, J; Penninger, JM; Lupski, JR				Karaca, Ender; Weitzer, Stefan; Pehlivan, Davut; Shiraishi, Hiroshi; Gogakos, Tasos; Hanada, Toshikatsu; Jhangiani, Shalini N.; Wiszniewski, Wojciech; Withers, Marjorie; Campbell, Ian M.; Erdin, Serkan; Isikay, Sedat; Franco, Luis M.; Gonzaga-Jauregui, Claudia; Gambin, Tomasz; Gelowani, Violet; Hunter, Jill V.; Yesil, Gozde; Koparir, Erkan; Yilmaz, Sarenur; Brown, Miguel; Briskin, Daniel; Hafner, Markus; Morozov, Pavel; Farazi, Thalia A.; Bernreuther, Christian; Glatzel, Markus; Trattnig, Siegfried; Friske, Joachim; Kronnerwetter, Claudia; Bainbridge, Matthew N.; Gezdirici, Alper; Seven, Mehmet; Muzny, Donna M.; Boerwinkle, Eric; Ozen, Mustafa; Clausen, Tim; Tuschl, Thomas; Yuksel, Adnan; Hess, Andreas; Gibbs, Richard A.; Martinez, Javier; Penninger, Josef M.; Lupski, James R.		Baylor Hopkins Ctr Mendelian	Human CLP1 Mutations Alter tRNA Biogenesis, Affecting Both Peripheral and Central Nervous System Function	CELL			English	Article							CAUSE PONTOCEREBELLAR HYPOPLASIA; SYNTHETASE MUTATIONS; PROTEIN FUNCTION; GENE; DISEASE; NEUROPATHY; COMPLEX	CLP1 is a RNA kinase involved in tRNA splicing. Recently, CLP1 kinase-dead mice were shown to display a neuromuscular disorder with loss of motor neurons and muscle paralysis. Human genome analyses now identified a CLP1 homozygous missense mutation (p. R140H) in five unrelated families, leading to a loss of CLP1 interaction with the tRNA splicing endonuclease (TSEN) complex, largely reduced pretRNA cleavage activity, and accumulation of linear tRNA introns. The affected individuals develop severe motor-sensory defects, cortical dysgenesis, and microcephaly. Mice carrying kinase-dead CLP1 also displayed microcephaly and reduced cortical brain volume due to the enhanced cell death of neuronal progenitors that is associated with reduced numbers of cortical neurons. Our data elucidate a neurological syndrome defined by CLP1 mutations that impair tRNA splicing. Reduction of a founder mutation to homozygosity illustrates the importance of rare variations in disease and supports the clan genomics hypothesis.	[Karaca, Ender; Pehlivan, Davut; Wiszniewski, Wojciech; Withers, Marjorie; Campbell, Ian M.; Franco, Luis M.; Gonzaga-Jauregui, Claudia; Gambin, Tomasz; Gelowani, Violet; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Dept Human Mol Genet, Dept Mol & Human Genet, Houston, TX 77030 USA; [Karaca, Ender; Weitzer, Stefan; Shiraishi, Hiroshi; Hanada, Toshikatsu; Martinez, Javier; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol IMBA, A-1030 Vienna, Austria; [Gogakos, Tasos; Brown, Miguel; Briskin, Daniel; Hafner, Markus; Morozov, Pavel; Farazi, Thalia A.; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA; [Jhangiani, Shalini N.; Bainbridge, Matthew N.; Muzny, Donna M.; Boerwinkle, Eric; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Erdin, Serkan] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Isikay, Sedat] Gaziantep Childrens Hosp, TR-27560 Gaziantep, Turkey; [Franco, Luis M.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Hunter, Jill V.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA; [Yesil, Gozde] Bezmialem Univ, Dept Med Genet, D-52425 Istanbul, Turkey; [Koparir, Erkan; Gezdirici, Alper; Seven, Mehmet; Ozen, Mustafa; Yuksel, Adnan] Istanbul Univ, Cerrahpasa Med Sch, Dept Med Genet, D-52425 Istanbul, Turkey; [Yilmaz, Sarenur] Istanbul Medeniyet Univ, Fac Med, Dept Med Genet, D-52425 Istanbul, Turkey; [Bernreuther, Christian; Glatzel, Markus] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, D-20246 Hamburg, Germany; [Trattnig, Siegfried; Friske, Joachim; Kronnerwetter, Claudia] Med Univ Vienna, MR Ctr Excellence, Dept Radiobiol, A-1090 Vienna, Austria; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Clausen, Tim] Inst Mol Pathol, A-1030 Vienna, Austria; [Hess, Andreas] Univ Erlangen Nurnberg, Inst Expt Pharmacol, D-91054 Erlangen, Germany; [Hess, Andreas] Vienna BioCtr, CSF, A-1030 Vienna, Austria; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Hanada, Toshikatsu] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto 6068507, Japan	Baylor College of Medicine; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Howard Hughes Medical Institute; Rockefeller University; Baylor College of Medicine; Harvard University; Massachusetts General Hospital; Cengiz Gokcek Obstetrics & Gynecology Hospital; Gaziantep Children's Hospital; Baylor College of Medicine; Baylor College of Medicine; Bezmialem Vakif University; Istanbul University; Istanbul University - Cerrahpasa; Istanbul Medeniyet University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Medical University of Vienna; University of Texas System; University of Texas Health Science Center Houston; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Erlangen Nuremberg; Vienna Biocenter (VBC); Baylor College of Medicine; Baylor College of Medicine; Kyoto University	Martinez, J (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol IMBA, A-1030 Vienna, Austria.	javier.martinez@imba.oeaw.ac.at; josef.penninger@imba.oeaw.ac.at; jlupski@bcm.edu	YESIL, GOZDE/ABE-1615-2020; Glatzel, Markus/V-8844-2019; Gezdirici, Alper/AAG-5480-2019; Seven, Mehmet/E-1017-2019; Penninger, Josef M/I-6860-2013; Glatzel, Markus/G-3356-2011; Erdin, Serkan/B-4988-2008; Gambin, Tomasz/HDN-5840-2022; Gonzaga-Jauregui, Claudia/H-4752-2019; Pehlivan, Davut/I-3235-2019; Erdin, Serkan/AAE-4288-2019; ışıkay, sedat/AAA-9993-2020; Morozov, Pavel/GQP-7206-2022; Hafner, Markus/O-7100-2018; Gezdirici, Alper/W-8459-2018	YESIL, GOZDE/0000-0003-1964-6306; Glatzel, Markus/0000-0002-7720-8817; Gezdirici, Alper/0000-0002-2432-9279; Seven, Mehmet/0000-0001-7878-2039; Penninger, Josef M/0000-0002-8194-3777; Glatzel, Markus/0000-0002-7720-8817; Erdin, Serkan/0000-0001-6587-2625; Gambin, Tomasz/0000-0002-0941-4571; Gonzaga-Jauregui, Claudia/0000-0002-4667-3679; ışıkay, sedat/0000-0003-0103-9612; Hafner, Markus/0000-0002-4336-6518; Gezdirici, Alper/0000-0002-2432-9279; Trattnig, Siegfried/0000-0003-1623-3303; Ozen, Mustafa/0000-0002-6142-5294; Martinez, Javier/0000-0001-9152-7323; Campbell, Ian/0000-0002-3749-2884; Clausen, Tim/0000-0003-1582-6924; Yuksel, Adnan/0000-0002-7275-8254	US National Institute of Neurological Disorders and Stroke (NINDS) [R01NS058529]; US National Human Genome Research Institute (NHGRI) [U54HG006542]; Astellas Foundation for Research on Metabolic Disorders and The Mochida Memorial Foundation for Medical and Pharmaceutical Research; NINDS [K23NS078056]; DFG [FG885, GRK 1459]; IMBA; Advanced ERC grant; NIAID [1K23AI087821- 01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI087821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529, K23NS078056] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Astellas Foundation for Research on Metabolic Disorders and The Mochida Memorial Foundation for Medical and Pharmaceutical Research; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DFG(German Research Foundation (DFG)); IMBA; Advanced ERC grant; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the patients and families who participated in this study. We thank the CSF/PIF MRI imaging facility at the campus Vienna BioCenter. This work was supported in part by US National Institute of Neurological Disorders and Stroke (NINDS) grant R01NS058529 and US National Human Genome Research Institute (NHGRI) grant U54HG006542 to J.R.L.H.S. is supported in part by the fellowship of Astellas Foundation for Research on Metabolic Disorders and The Mochida Memorial Foundation for Medical and Pharmaceutical Research. W.W. is supported by a K23NS078056 grant from the NINDS. M.G. is supported by grants from the DFG (FG885 and GRK 1459). J.M. and S.W. are supported by IMBA. J.M.P. is supported by an Advanced ERC grant and IMBA. L.M.F. is supported by a Career Development Award (1K23AI087821- 01) from the NIAID. J.R.L. is a paid consultant for Athena Diagnostics, has stock ownership in 23andMe and Ion Torrent Systems, and is a coinventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from the clinical exome sequencing offered in the Medical Genetics Laboratory.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204; Cassandrini D, 2010, NEUROLOGY, V75, P1459, DOI 10.1212/WNL.0b013e3181f88173; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Cooper DN, 1998, NUCLEIC ACIDS RES, V26, P285, DOI 10.1093/nar/26.1.285; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Gonzaga-Jauregui C, 2013, JAMA NEUROL, V70, P1491, DOI 10.1001/jamaneurol.2013.4598; Hanada T, 2013, NATURE, V495, P474, DOI 10.1038/nature11923; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008; Noble CG, 2007, NUCLEIC ACIDS RES, V35, P87, DOI 10.1093/nar/gkl1010; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pehlivan D, 2012, GENET MED, V14, P313, DOI 10.1038/gim.2011.13; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Renbaum P, 2009, AM J HUM GENET, V85, P281, DOI 10.1016/j.ajhg.2009.07.006; ROCHE AF, 1987, PEDIATRICS, V79, P706; Schaffer AE, 2014, CELL, V157, P651, DOI 10.1016/j.cell.2014.03.049; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shiraishi H, 2010, BBA-GEN SUBJECTS, V1800, P405, DOI 10.1016/j.bbagen.2009.11.008; Siepel A, 2006, LECT NOTES COMPUT SC, V3909, P190; Valbuena A, 2006, MOL CELL BIOL, V26, P4782, DOI 10.1128/MCB.00069-06; Valbuena A, 2011, CELL SIGNAL, V23, P1267, DOI 10.1016/j.cellsig.2011.04.002; Vester A, 2013, HUM MUTAT, V34, P191, DOI 10.1002/humu.22210; Wan JJ, 2012, NAT GENET, V44, P704, DOI 10.1038/ng.2254; Weitzer S, 2007, NATURE, V447, P222, DOI 10.1038/nature05777	33	136	140	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					636	650		10.1016/j.cell.2014.02.058	http://dx.doi.org/10.1016/j.cell.2014.02.058			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766809	Green Accepted, Bronze			2022-12-28	WOS:000335392100013
J	Riddell, J; Gazit, R; Garrison, BS; Guo, GJ; Saadatpour, A; Mandal, PK; Ebina, W; Volchkov, P; Yuan, GC; Orkin, SH; Rossi, DJ				Riddell, Jonah; Gazit, Roi; Garrison, Brian S.; Guo, Guoji; Saadatpour, Assieh; Mandal, Pankaj K.; Ebina, Wataru; Volchkov, Pavel; Yuan, Guo-Cheng; Orkin, Stuart H.; Rossi, Derrick J.			Reprogramming Committed Murine Blood Cells to Induced Hematopoietic Stem Cells with Defined Factors	CELL			English	Article							SELF-RENEWAL; B-CELLS; PROGENITORS; DIFFERENTIATION; FIBROBLASTS; PRECURSORS; CONVERSION; INDUCTION; LEUKEMIA; LMO2	Hematopoietic stem cells (HSCs) sustain blood formation throughout life and are the functional units of bone marrow transplantation. We show that transient expression of six transcription factors Run1t1,Hlf, Lmo2, Prdm5, Pbx1, and Zfp37 imparts multilineage transplantation potential onto otherwise committed lymphoid and myeloid progenitors and myeloid effector cells. Inclusion of Mycn and Meis1 and use of polycistronic viruses increase reprogramming efficacy. The reprogrammed cells designated induced-HSCs (iHSCs) possess clonal multilineage differentiation potential reconstitute stem/progenitor compartments and are serially transplantable. Single-cell analysis revealed that iHSCs derived under optimal conditions exhibit a gene expression profile that is highly similar to endogenous HSCs. These findings demonstrate that expression of a set of defined factors is sufficient to activate the gene networks governing HSC functional identity in committed blood cells. Our results raise the prospect that blood cell reprogramming may be a strategy for derivation of transplantable stem cells for clinical application.	[Riddell, Jonah; Gazit, Roi; Garrison, Brian S.; Mandal, Pankaj K.; Ebina, Wataru; Volchkov, Pavel; Rossi, Derrick J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Orkin, Stuart H.; Rossi, Derrick J.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Riddell, Jonah; Gazit, Roi; Garrison, Brian S.; Mandal, Pankaj K.; Ebina, Wataru; Volchkov, Pavel; Rossi, Derrick J.] Boston Childrens Hosp, Div Hematol Oncol, Program Cellular & Mol Med, Boston, MA 02116 USA; [Guo, Guoji; Orkin, Stuart H.] Dana Farber Boston Childrens Hosp, Canc & Blood Disorders Ctr, Boston, MA 02116 USA; [Saadatpour, Assieh; Yuan, Guo-Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Saadatpour, Assieh; Yuan, Guo-Cheng] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Orkin, Stuart H.] Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Orkin, Stuart H.; Rossi, Derrick J.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Howard Hughes Medical Institute; Harvard University	Rossi, DJ (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	derrick.rossi@childrens.harvard.edu	Volchkov, Pavel Y/H-4743-2013; mandal, pankaj/B-4885-2016; Gazit, Roi/J-3352-2017	Gazit, Roi/0000-0002-0548-2147; Guo, Guoji/0000-0002-1716-4621; Mandal, Pankaj/0000-0003-1993-9918	National Institutes of Health [RO1HL107630, R00AG029760, U01HL107440, U01HL100001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL010000, R01HL107630, U01HL107440, U01HL100001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG029760, R00AG029760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We wish to thank Isabel Beerman, Lydia Fang, Mike Bamberg, Ana Zguro, Rab Prinjha, and Duane Wesemann for expertise, input and assistance.This work was supported by the National Institutes of Health RO1HL107630 (D.J.R.), R00AG029760 (D.J.R.), U01HL107440 (D.J.R.), and U01HL100001 (S.H.O.) and grants from GlaxoSmithKline (D.J.R.), The Leona M.and Harry B.Helmsley Charitable Trust (D.J.R.), The New York Stem Cell Foundation (D.J.R.), and The Harvard Stem Cell Institute (D.J.R., S.H.O., G.C.- Y.).S.H.O.is an Investigator of the Howard Hughes Medical Institute.D.J.R.is a New York Stem Cell Foundation Robertson Investigator.	Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; CHOI J, 1990, P NATL ACAD SCI USA, V87, P7988, DOI 10.1073/pnas.87.20.7988; Choi KD, 2009, J CLIN INVEST, V119, P2818, DOI 10.1172/JCI38591; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Doulatov S, 2013, CELL STEM CELL, V13, P459, DOI 10.1016/j.stem.2013.09.002; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Gazit R, 2013, STEM CELL REP, V1, P266, DOI 10.1016/j.stemcr.2013.07.004; Gratwohl A, 2010, JAMA-J AM MED ASSOC, V303, P1617, DOI 10.1001/jama.2010.491; Guo GJ, 2013, CELL STEM CELL, V13, P492, DOI 10.1016/j.stem.2013.07.017; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; Kocabas F, 2012, BLOOD, V120, P4963, DOI 10.1182/blood-2012-05-432260; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; McCormack MP, 2010, SCIENCE, V327, P879, DOI 10.1126/science.1182378; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Nakorn TN, 2002, J CLIN INVEST, V109, P1579, DOI 10.1172/JCI200215272; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Sturgeon CM, 2013, NAT BIOTECHNOL, V31, P416, DOI 10.1038/nbt.2571; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Taghon T, 2007, NAT IMMUNOL, V8, P845, DOI 10.1038/ni1486; Unnisa Z, 2012, BLOOD, V120, P4973, DOI 10.1182/blood-2012-06-435800; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890	31	233	247	0	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					549	564		10.1016/j.cell.2014.04.006	http://dx.doi.org/10.1016/j.cell.2014.04.006			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766805	Green Accepted, Bronze			2022-12-28	WOS:000335392100007
J	Holmes, D				Holmes, David			Abdisalan Noor: mapping malaria	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2014	383	9926					1375	1375		10.1016/S0140-6736(14)60669-3	http://dx.doi.org/10.1016/S0140-6736(14)60669-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG3LI	24759240				2022-12-28	WOS:000335318400012
J	Pope, BD; Gilbert, DM				Pope, Benjamin D.; Gilbert, David M.			Up and down in Down's syndrome	NATURE			English	Editorial Material							CHROMATIN		[Pope, Benjamin D.; Gilbert, David M.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Pope, BD (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	pope@bio.fsu.edu; gilbert@bio.fsu.edu	Pope, Ben/Y-4326-2019	Pope, Ben/0000-0003-1847-9163	NCI NIH HHS [F31 CA165863] Funding Source: Medline; NIGMS NIH HHS [R01 GM083337] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F31CA165863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083337] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Catez F, 2002, EMBO REP, V3, P760, DOI 10.1093/embo-reports/kvf156; Dahoun S, 2008, AM J MED GENET A, V146A, P2086, DOI 10.1002/ajmg.a.32431; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P602; Letourneau A, 2014, NATURE, V508, P345, DOI 10.1038/nature13200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu XW, 2007, J BIOL CHEM, V282, P20868, DOI 10.1074/jbc.M702547200; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024	11	8	9	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					323	324		10.1038/508323a	http://dx.doi.org/10.1038/508323a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24740061				2022-12-28	WOS:000334403000034
J	Hirsch, C				Hirsch, Calvin			Review: Cholinesterase inhibitors do not prevent dementia in patients with mild cognitive impairment	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ALZHEIMERS-DISEASE		Univ Calif Davis, Davis Med Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis	Hirsch, C (corresponding author), Univ Calif Davis, Davis Med Ctr, Sacramento, CA 95817 USA.							Buschert VC, 2011, J ALZHEIMERS DIS, V25, P679, DOI 10.3233/JAD-2011-100999; Doody RS, 2009, NEUROLOGY, V72, P1555, DOI 10.1212/01.wnl.0000344650.95823.03; Russ TC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009132.pub2; Winblad B, 2006, DEMENT GERIATR COGN, V21, P353, DOI 10.1159/000091790	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2014	160	8							JC11	10.7326/0003-4819-160-8-201404150-02011	http://dx.doi.org/10.7326/0003-4819-160-8-201404150-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW3QU	24733216				2022-12-28	WOS:000364907600010
J	Eikermann, M; Velmahos, G; Abbara, S; Huang, PL; Fagan, SP; Hirschberg, RE; Kwon, JY; Nose, V				Eikermann, Matthias; Velmahos, George; Abbara, Suhny; Huang, Paul L.; Fagan, Shawn P.; Hirschberg, Ronald E.; Kwon, John Y.; Nose, Vania			Case 11-2014: A Man with Traumatic Injuries after a Bomb Explosion at the Boston Marathon	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OPERATION ENDURING FREEDOM; CRITICALLY-ILL PATIENTS; CORONARY-ARTERY; IRAQI FREEDOM; RETRIEVAL; MIGRATION; WOUNDS; PELLET; HEART; VEIN	A 34-year-old man was brought to the emergency department because of injuries sustained when a bomb exploded at the Boston Marathon. His right leg had been amputated below the knee and his left leg was burned. Imaging showed metallic foreign bodies in the legs, pelvis, and chest. Presentation of CaseDr. John T. Nagurney (Emergency Medicine): A 34-year-old man was brought to the emergency department at this hospital because of multiple traumatic injuries that he sustained when a bomb exploded while he was watching the 2013 Boston Marathon. At the scene, the patient reportedly lost consciousness, had a complete amputation of his right leg directly below the knee, and had copious blood loss. A tourniquet had been applied to the right upper leg. He was placed on a backboard, immobilized, and transported to this hospital by ambulance, arriving at 3:20 p.m., 31 minutes after the explosion. He ...	[Eikermann, Matthias] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Velmahos, George] Massachusetts Gen Hosp, Dept Trauma Emergency Surg & Surg Crit Care, Boston, MA 02114 USA; [Abbara, Suhny] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Huang, Paul L.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Fagan, Shawn P.] Massachusetts Gen Hosp, Dept Burns, Boston, MA 02114 USA; [Hirschberg, Ronald E.] Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Kwon, John Y.] Massachusetts Gen Hosp, Dept Orthoped, Boston, MA 02114 USA; [Nose, Vania] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Eikermann, Matthias] Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA; [Velmahos, George; Fagan, Shawn P.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Kwon, John Y.] Harvard Univ, Sch Med, Dept Orthoped, Boston, MA USA; [Nose, Vania] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Eikermann, M (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA.			Huang, Paul/0000-0002-5436-8658; Abbara, Suhny/0000-0003-2552-7362	Trimed	Trimed	Dr. Kwon reports receiving consulting fees from Trimed. No other potential conflict of interest relevant to this article was reported.	AKHRAS F, 1983, EUR HEART J, V4, P815, DOI 10.1093/oxfordjournals.eurheartj.a061403; Benirschke Stephen K, 2013, Instr Course Lect, V62, P79; Biocina B, 1997, EUR J CARDIO-THORAC, V11, P399, DOI 10.1016/S1010-7940(96)01124-4; Carroll MI, 2013, J VASC SURG, V57, P459, DOI 10.1016/j.jvs.2012.01.092; Eikermann M, 2013, INTENS CARE MED, V39, P2200, DOI 10.1007/s00134-013-3132-4; Feldman T, 2011, CATHETER CARDIO INTE, V77, P901, DOI 10.1002/ccd.23124; Garzon-Serrano J, 2011, PM&R, V3, P307, DOI 10.1016/j.pmrj.2010.12.022; Greaves N, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-36; Ikonomidis JS, 1998, ANN THORAC SURG, V66, P562, DOI 10.1016/S0003-4975(98)00475-5; Jeffery S L A, 2009, Eplasty, V9, pe28; Kasotakis G, 2012, CRIT CARE MED, V40, P1122, DOI 10.1097/CCM.0b013e3182376e6d; King DR, 2012, J SPEC OPER MED, V12, P33; Koirala B, 2012, EUR J CARDIO-THORAC, V42, P584, DOI 10.1093/ejcts/ezs267; Kragh JF, 2008, J TRAUMA, V64, pS38, DOI 10.1097/TA.0b013e31816086b1; LOWE JE, 1983, ANN THORAC SURG, V36, P295, DOI 10.1016/S0003-4975(10)60132-4; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Ramasamy A, 2009, INJURY, V40, P493, DOI 10.1016/j.injury.2008.03.028; RICH NM, 1978, J TRAUMA, V18, P236, DOI 10.1097/00005373-197804000-00002; Richey Stephen L, 2007, World J Emerg Surg, V2, P28, DOI 10.1186/1749-7922-2-28; Ritenour AE, 2008, J TRAUMA, V64, pS174, DOI 10.1097/TA.0b013e318160773e; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; VANEEDEN AF, 1980, S AFR MED J, V57, P1052; Watson TS, 2010, J AM ACAD ORTHOP SUR, V18, P718, DOI 10.5435/00124635-201012000-00002; Welling DR, 2006, J AM COLL SURGEONS, V203, P106, DOI 10.1016/j.jamcollsurg.2006.02.034; Zimmerman JL, 2013, CHEST, V144, P1058, DOI 10.1378/chest.12-2016	25	13	13	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 10	2014	370	15					1441	1451		10.1056/NEJMcpc1314240	http://dx.doi.org/10.1056/NEJMcpc1314240			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6IW	24716684				2022-12-28	WOS:000334095200013
J	van den Brink, W; Mann, K; Gual, A; Aubin, HJ				van den Brink, Wim; Mann, Karl; Gual, Antoni; Aubin, Henri-Jean			Wim van den Brink and colleagues reply to Des Spence and Alain Braillon	BMJ-BRITISH MEDICAL JOURNAL			English	Letter							AS-NEEDED NALMEFENE; ALCOHOL DEPENDENCE; EFFICACY; MISUSE		[van den Brink, Wim] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Mann, Karl] Heidelberg Univ, Heidelberg, Germany; [Gual, Antoni] Hosp Clin Barcelona, Addict Unit Clin, Barcelona, Spain; [Aubin, Henri-Jean] Univ Paris 11, Paris, France	University of Amsterdam; Academic Medical Center Amsterdam; Ruprecht Karls University Heidelberg; University of Barcelona; Hospital Clinic de Barcelona; UDICE-French Research Universities; Universite Paris Saclay	van den Brink, W (corresponding author), Univ Amsterdam, Acad Med Ctr, Meibergdreef 5, NL-1105 AZ Amsterdam, Netherlands.	w.vandenbrink@amc.uva.nl	Aubin, Henri-Jean/AAP-8605-2021; , Aubin/AAT-9739-2021	Aubin, Henri-Jean/0000-0002-6604-6672; Gual, Antoni/0000-0002-7130-981X				Braillon A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2017; Gual A, 2013, EUR NEUROPSYCHOPHARM, V23, P1432, DOI 10.1016/j.euroneuro.2013.02.006; Leucht S, 2012, BRIT J PSYCHIAT, V200, P97, DOI 10.1192/bjp.bp.111.096594; Mann K, 2013, BIOL PSYCHIAT, V73, P706, DOI 10.1016/j.biopsych.2012.10.020; Spence D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1531; van den Brink W, 2013, ALCOHOL ALCOHOLISM, V48, P570, DOI 10.1093/alcalc/agt061	6	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2014	348								g2605	10.1136/bmj.g2605	http://dx.doi.org/10.1136/bmj.g2605			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SB	24711667				2022-12-28	WOS:000334348300015
J	Hocevar, SN; Paddock, CD; Spak, CW; Rosenblatt, R; Diaz-Luna, H; Castillo, I; Luna, S; Friedman, GC; Antony, S; Stoddard, RA; Tiller, RV; Peterson, T; Blau, DM; Sriram, RR; da Silva, A; de Almeida, M; Benedict, T; Goldsmith, CS; Zaki, SR; Visvesvara, GS; Kuehnert, MJ				Hocevar, Susan N.; Paddock, Christopher D.; Spak, Cedric W.; Rosenblatt, Randall; Diaz-Luna, Hector; Castillo, Isabel; Luna, Sergio; Friedman, Glen C.; Antony, Suresh; Stoddard, Robyn A.; Tiller, Rebekah V.; Peterson, Tammie; Blau, Dianna M.; Sriram, Rama R.; da Silva, Alexandre; de Almeida, Marcos; Benedict, Theresa; Goldsmith, Cynthia S.; Zaki, Sherif R.; Visvesvara, Govinda S.; Kuehnert, Matthew J.		Microsporidia Transplant Transmiss	Microsporidiosis Acquired Through Solid Organ Transplantation A Public Health Investigation	ANNALS OF INTERNAL MEDICINE			English	Article							POLYMERASE-CHAIN-REACTION; SUBUNIT RIBOSOMAL-RNA; IN-VITRO CULTURE; ENCEPHALITOZOON-CUNICULI; ENTEROCYTOZOON-BIENEUSI; IMMUNOCOMPETENT SUBJECTS; PATIENT; AIDS; BRUCELLA; INFECTION	Background: Encephalitozoon cuniculi, a microsporidial species most commonly recognized as a cause of renal, respiratory, and central nervous system, infections in immunosuppressed patients, was identified as the cause of a temporally associated cluster of febrile illness among 3 solid organ transplant recipients from a common donor. Objective: To confirm the source of the illness, assess donor and recipient risk factors, and provide therapy recommendations for ill recipients. Design: Public health investigation. Setting: Two transplant hospitals and community interview with the deceased donor's family. Patients: Three transplant recipients and the organ donor. Measurements: Specimens were tested for microsporidia by using culture, immunofluorescent antibody, polymerase chain reaction, immunohistochemistry, and electron microscopy. Donor medical records were reviewed and a questionnaire was developed to assess for microsporidial infection. Results: Kidneys and lungs were procured from the deceased donor and transplanted to 3 recipients who became ill with fever 7 to 10 weeks after the transplant. Results of urine culture, serologic, and polymerase chain reaction testing were positive for E. cuniculi of genotype III in each recipient; the organism was also. identified in biopsy or autopsy specimens in all recipients. The donor had positive serologic test results for E. cuniculi. Surviving recipients received albendazole. Donor assessment did not identify factors for suspected E. cuniculi infection. Limitation: Inability to detect organism by culture or polymerase chain reaction in donor due to lack of autopsy specimens. Conclusion: Microsporidiosis is now recognized as an emerging transplant-associated disease and should be considered in febrile transplant recipients when tests for routinely encountered agents are unrevealing. Donor-derived disease is critical to assess when multiple recipients from a common donor are ill.	[Hocevar, Susan N.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Baylor Univ, Med Ctr, Dallas, TX USA; Southwest Transplant Alliance, Dallas, TX USA; Las Palmas Med Ctr, El Paso, TX USA	Centers for Disease Control & Prevention - USA; Baylor University; Baylor University Medical Center	Hocevar, SN (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS A35, Atlanta, GA 30333 USA.	lgc7@cdc.gov	Tiller, Rebekah/GRJ-1844-2022		Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Ambrosioni J, 2010, BONE MARROW TRANSPL, V45, P1249, DOI 10.1038/bmt.2009.315; Anane S, 2010, GASTROEN CLIN BIOL, V34, P450, DOI 10.1016/j.gcb.2010.07.003; BROWN SL, 1981, J CLIN MICROBIOL, V13, P398, DOI 10.1128/JCM.13.2.398-400.1981; BUCHANAN TM, 1980, J CLIN MICROBIOL, V11, P691, DOI 10.1128/JCM.11.6.691-693.1980; Carlson James R, 2004, Arch Pathol Lab Med, V128, pe41; Carrington M, 2012, J CLIN MICROBIOL, V50, P2173, DOI 10.1128/JCM.00573-12; Croppo GP, 1997, J PARASITOL, V83, P66, DOI 10.2307/3284318; da Silva AJ, 1999, MOL DIAGN, V4, P57, DOI 10.1016/S1084-8592(99)80050-2; daSilva AJ, 1997, ARCH PATHOL LAB MED, V121, P874; DaSilva AJ, 1996, J CLIN MICROBIOL, V34, P986, DOI 10.1128/JCM.34.4.986-987.1996; Decraene V, 2012, EPIDEMIOL INFECT, V140, P519, DOI 10.1017/S095026881100077X; DEGROOTE MA, 1995, J INFECT DIS, V171, P1375, DOI 10.1093/infdis/171.5.1375; Del Aguila C, 2001, J EUKARYOT MICROBIOL, p75S; del Aguila C, 2001, J CLIN MICROBIOL, V39, P1105, DOI 10.1128/JCM.39.3.1105-1108.2001; Desoubeaux G, 2013, TRANSPL INFECT DIS, V15, pE250, DOI 10.1111/tid.12158; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; Didier ES, 2011, CURR OPIN INFECT DIS, V24, P490, DOI 10.1097/QCO.0b013e32834aa152; Didier ES, 2000, MICROBES INFECT, V2, P709, DOI 10.1016/S1286-4579(00)00354-3; Didier ES, 2005, ACTA TROP, V94, P61, DOI 10.1016/j.actatropica.2005.01.010; Didier ES, 2004, VET PARASITOL, V126, P145, DOI 10.1016/j.vetpar.2004.09.006; Didier ES, 1998, CLIN INFECT DIS, V27, P1, DOI 10.1086/514607; Didier ES, 1996, J CLIN MICROBIOL, V34, P2835, DOI 10.1128/JCM.34.11.2835-2837.1996; Dither ES, 2005, EXPERT REV ANTI-INFE, V3, P419; Franzen C, 1995, CLIN INFECT DIS, V21, P1480, DOI 10.1093/clinids/21.6.1480; Galvan AL, 2011, J CLIN MICROBIOL, V49, P1301, DOI 10.1128/JCM.01833-10; Garcia LS, 2002, J CLIN MICROBIOL, V40, P1892, DOI 10.1128/JCM.40.6.1892-1901.2002; Gross U, 2003, PARASITOL RES, V90, pS14, DOI 10.1007/s00436-002-0753-x; Hinic V, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-22; Kakrania R, 2006, EYE, V20, P1314, DOI 10.1038/sj.eye.6702178; Kucerova-Pospisilova Z, 1998, FOLIA PARASIT, V45, P108; Lanternier F, 2009, TRANSPL INFECT DIS, V11, P83, DOI 10.1111/j.1399-3062.2008.00347.x; Lobo ML, 2012, INT J PARASITOL, V42, P197, DOI 10.1016/j.ijpara.2011.12.002; Meissner EG, 2012, EMERG INFECT DIS, V18, P1155, DOI 10.3201/eid1807.120047; Mofenson Lynne M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Nagpal A, 2013, TRANSPL INFECT DIS, V15, P526, DOI 10.1111/tid.12119; Pragle A., 2008, Morbidity and Mortality Weekly Report, V57, P603; Sak B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001162; Sak B, 2011, J CLIN MICROBIOL, V49, P1064, DOI 10.1128/JCM.01147-10; Sak B, 2010, EMERG INFECT DIS, V16, P335, DOI 10.3201/eid1602.090964; Scaglia M, 1998, CLIN INFECT DIS, V26, P174, DOI 10.1086/516264; vanGool T, 1997, J INFECT DIS, V175, P1020, DOI 10.1086/513963; VISVESVARA GS, 1995, J CLIN MICROBIOL, V33, P930, DOI 10.1128/JCM.33.4.930-936.1995; Vrioni G, 2008, CLIN INFECT DIS, V46, pE131, DOI 10.1086/588482	43	38	41	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2014	160	4					213	220		10.7326/M13-2226	http://dx.doi.org/10.7326/M13-2226			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB3BO	24727839	Green Accepted			2022-12-28	WOS:000331666500001
J	Weisman, A; Lewis, GF				Weisman, Alanna; Lewis, Gary F.			Low-Level Laser Liposuction and Hypertriglyceridemia	ANNALS OF INTERNAL MEDICINE			English	Letter							THERAPY		[Weisman, Alanna; Lewis, Gary F.] Toronto Gen Hosp, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Weisman, A (corresponding author), Toronto Gen Hosp, Toronto, ON, Canada.		Weisman, Alanna/AAR-7255-2020	Weisman, Alanna/0000-0003-3778-653X				Caruso-Davis MK, 2011, OBES SURG, V21, P722, DOI 10.1007/s11695-010-0126-y; Jacskon RF, 2010, AM J COSMET SURG, V27, P177; LEWIS GF, 1991, J CLIN ENDOCR METAB, V72, P934, DOI 10.1210/jcem-72-4-934; Mulholland RS, 2011, CLIN PLAST SURG, V38, P503, DOI 10.1016/j.cps.2011.05.002	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2014	160	4					289	290		10.7326/L14-5004-3	http://dx.doi.org/10.7326/L14-5004-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB3BO	24727847				2022-12-28	WOS:000331666500012
J	Lee, H; Kim, DW; Remedios, R; Anthony, TE; Chang, A; Madisen, L; Zeng, HK; Anderson, DJ				Lee, Hyosang; Kim, Dong-Wook; Remedios, Ryan; Anthony, Todd E.; Chang, Angela; Madisen, Linda; Zeng, Hongkui; Anderson, David J.			Scalable control of mounting and attack by Esr1(+) neurons in the ventromedial hypothalamus	NATURE			English	Article							ESTROGEN-RECEPTOR-ALPHA; MEDIAL AMYGDALA; AGGRESSION; NUCLEUS; IDENTIFICATION; MICE	Social behaviours, such as aggression or mating, proceed through a series of appetitive and consummatory phases(1) that are associated with increasing levels of arousal(2). How such escalation is encoded in the brain, and linked to behavioural action selection, remains an unsolved problem in neuroscience. The ventrolateral subdivision of the murine ventromedial hypothalamus(VMHvl) contains neurons whose activity increases during male-male and male-female social encounters. Non-cell-type-specific optogenetic activation of this region elicited attack behaviour, but not mounting(3). We have identified a subset of VMHvl neurons marked by the oestrogen receptor 1 (Esr1), and investigated their role in male social behaviour. Optogenetic manipulations indicated that Esr1(+) (but not Esr1(-)) neurons are sufficient to initiate attack, and that their activity is continuously required during ongoing agonistic behaviour. Surprisingly, weaker optogenetic activation of these neurons promoted mounting behaviour, rather than attack, towards both males and females, as well as sniffing and close investigation. Increasing photostimulation intensity could promote a transition from close investigation and mounting to attack, within a single social encounter. Importantly, time-resolved optogenetic inhibition experiments revealed requirements for Esr1(+) neurons in both the appetitive (investigative) and the consummatory phases of social interactions. Combined optogenetic activation and calcium imaging experiments in vitro, as well as c-Fos analysis in vivo, indicated that increasing photostimulation intensity increases both the number of active neurons and the average level of activity per neuron. These data suggest that Esr1(+) neurons in VMHvl control the progression of a social encounter from its appetitive through its consummatory phases, in a scalable manner that reflects the number or type of active neurons in the population.	[Lee, Hyosang; Remedios, Ryan; Anthony, Todd E.; Chang, Angela; Anderson, David J.] CALTECH, Div Biol & Biol Engn 156 29, Pasadena, CA 91125 USA; [Lee, Hyosang; Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Kim, Dong-Wook; Anderson, David J.] CALTECH, Pasadena, CA 91125 USA; [Madisen, Linda; Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA 98103 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Allen Institute for Brain Science	Anderson, DJ (corresponding author), CALTECH, Div Biol & Biol Engn 156 29, Pasadena, CA 91125 USA.	wuwei@caltech.edu	Remedios, Ryan/AAA-2389-2020	Remedios, Ryan/0000-0001-6004-808X	NIH [R01MH070053, 1K99NS074077, 1F32HD055198-01]; Gordon Moore Foundation; Ellison Medical Research Foundation; Beckman Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD055198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070053, R01MH085082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS074077] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon Moore Foundation; Ellison Medical Research Foundation(Lawrence Ellison Foundation); Beckman Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Park for behavioural scoring, R. Robertson for behavioural scoring and MATLAB programming, L. Lo for testing Cre-mediated recombination in Esr1<SUP>cre/+</SUP> male mice, C. Chiu and X. Wang for histology, M. McCardle for genotyping, J. S. Chang for technical assistance, S. Pease for generation of knock-in mice, H. Cai for training in slice electrophysiology, A. Wong for assistance with two-photon imaging, K. Deisseroth and J. Harris for AAV constructs, E. Boyden for advice on ferrule fibre fabrication, D. Lin and M. Boyle for their contributions to early stages of this project, W. Hong and R. Axel for comments on the manuscript, C. Chiu for laboratory management and G. Mancuso for administrative assistance. D. J. A. is an Investigator of the Howard Hughes Medical Institute and a Paul G. Allen Distinguished Investigator. This work was supported in part by NIH grant no. R01MH070053, and grants from the Gordon Moore Foundation and Ellison Medical Research Foundation. H. L. was supported by the NIH Pathway to Independence Award 1K99NS074077. T. E. A. was supported by NIH NRSA postdoctoral fellowship grant 1F32HD055198-01 and a Beckman Fellowship.	Anderson DJ, 2012, BIOL PSYCHIAT, V71, P1081, DOI 10.1016/j.biopsych.2011.11.012; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; BENTLEY D, 1978, ANNU REV NEUROSCI, V1, P35, DOI 10.1146/annurev.ne.01.030178.000343; BLANCHARD DC, 1988, ANNU REV PSYCHOL, V39, P43, DOI 10.1146/annurev.ps.39.020188.000355; Blanchard RJ, 2003, HORM BEHAV, V44, P161, DOI 10.1016/S0018-506X(03)00127-2; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chan E, 2007, NEUROSCIENCE, V144, P604, DOI 10.1016/j.neuroscience.2006.08.080; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; COHEN RS, 1992, PROG NEUROBIOL, V38, P423, DOI 10.1016/0301-0082(92)90045-G; Devidze N, 2006, PHYSIOL BEHAV, V88, P283, DOI 10.1016/j.physbeh.2006.05.030; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Harris JA., 2012, CURR PROTOC NEUROSCI, V20, P21, DOI [10.1002/0471142301.ns0120-59, DOI 10.1002/0471142301.NS0120-59, 10.1002/0471142301.ns0120s59, DOI 10.1002/0471142301.NS0120S59]; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Kow LM, 2005, BRAIN RES, V1043, P124, DOI 10.1016/j.brainres.2005.02.068; Kristan WB, 2008, CURR BIOL, V18, pR928, DOI 10.1016/j.cub.2008.07.081; KRUK MR, 1983, BRAIN RES, V260, P61, DOI 10.1016/0006-8993(83)90764-3; Kvitsiani D, 2013, NATURE, V498, P363, DOI 10.1038/nature12176; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lerchner W, 2007, NEURON, V54, P35, DOI 10.1016/j.neuron.2007.02.030; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Musatov S, 2006, P NATL ACAD SCI USA, V103, P10456, DOI 10.1073/pnas.0603045103; Sano K, 2013, EUR J NEUROSCI, V37, P1308, DOI 10.1111/ejn.12131; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Spiteri T, 2010, BEHAV BRAIN RES, V210, P211, DOI 10.1016/j.bbr.2010.02.033; Spiteri T, 2010, NEUROENDOCRINOLOGY, V91, P142, DOI 10.1159/000255766; TINBERGEN N, 1950, SYM SOC EXP BIOL, V4, P305; Vrontou S, 2013, NATURE, V493, P669, DOI 10.1038/nature11810; WALTER P, 1985, P NATL ACAD SCI USA, V82, P7889, DOI 10.1073/pnas.82.23.7889; Wu MV, 2011, CURR OPIN NEUROBIOL, V21, P116, DOI 10.1016/j.conb.2010.09.014; Wu YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008054; Xu XH, 2012, CELL, V148, P596, DOI 10.1016/j.cell.2011.12.018; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017	36	251	252	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					627	+		10.1038/nature13169	http://dx.doi.org/10.1038/nature13169			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24739975	Green Accepted			2022-12-28	WOS:000336457100050
J	Olsen, Y; Sharfstein, JM				Olsen, Yngvild; Sharfstein, Joshua M.			Chronic Pain, Addiction, and Zohydro	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Olsen, Yngvild] Inst Behav Resources, Baltimore, MD 21205 USA; [Sharfstein, Joshua M.] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA	Maryland Department of Health & Mental Hygiene	Olsen, Y (corresponding author), Inst Behav Resources, Baltimore, MD 21205 USA.							Centers for Disease Control and Prevention (CDC), 2013, POL IMP PRESCR PAINK; Centers for Disease Control and Prevention (CDC), 2011, PUBL HLTH GRAND ROUN; FDA Commissioner Margaret A, 2014, COMMUNICATION   0403; Federation of State Medical Boards of the United States, 2014, PAIN MAN POL BOARD B; Severtson SG, 2013, J PAIN, V14, P1122, DOI 10.1016/j.jpain.2013.04.011	5	20	20	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 29	2014	370	22					2061	2063		10.1056/NEJMp1404181	http://dx.doi.org/10.1056/NEJMp1404181			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH9BM	24758596				2022-12-28	WOS:000336434000002
J	Marks, PW				Marks, Peter W.			Update in Hematology and Oncology: Evidence Published in 2013	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Marks, Peter W.] US FDA, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Marks, PW (corresponding author), US FDA, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	peter.marks@fda.hhs.gov						Agnelli G, 2013, NEW ENGL J MED, V368, P699, DOI 10.1056/NEJMoa1207541; Blade J, 2010, J CLIN ONCOL, V28, P690, DOI 10.1200/JCO.2009.22.2257; Carson JL, 2013, JAMA-J AM MED ASSOC, V309, P83, DOI 10.1001/jama.2012.50429; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Dennis M, 2013, STROKE, V44, P1075, DOI 10.1161/STROKEAHA.111.680298; Dispenzieri A, 2013, BLOOD, V122, P4172, DOI 10.1182/blood-2013-08-520890; Douketis JD, 2012, CHEST S, V141; Gonsalves WI, 2013, MAYO CLIN PROC, V88, P495, DOI 10.1016/j.mayocp.2013.03.006; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hicks LK, 2013, BLOOD, V122, P3879, DOI 10.1182/blood-2013-07-518423; Lam JS, 2006, J UROLOGY, V175, P27, DOI 10.1016/S0022-5347(05)00034-0; O'Brien J, 2000, LANCET, V355, P1295; Paz-Ares L, 2012, LANCET ONCOL, V13, P247, DOI 10.1016/S1470-2045(12)70063-3; Schnipper LE, 2013, J CLIN ONCOL, V31, P4362, DOI 10.1200/JCO.2013.53.3943; Shaw AT, 2013, J CLIN ONCOL, V31, P1105, DOI 10.1200/JCO.2012.44.5353; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Wells PS, 2006, JAMA-J AM MED ASSOC, V295, P199, DOI 10.1001/jama.295.2.199; Zelenetz AD, 2011, J NATL COMPR CANC NE, V9, P484, DOI 10.6004/jnccn.2011.0046	18	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2014	160	10					712	718		10.7326/M14-0092	http://dx.doi.org/10.7326/M14-0092			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V44NX	24722624				2022-12-28	WOS:000209756800001
J	Carter, M				Carter, Meg			MEDICINE AND THE MEDIA The not so independent tobacco experts	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												meg@megcarter.com						BBC News, 2013, BBC NEWS; Brown K, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2060; Davies E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7366; Drazen Jeffrey M, 2010, BMJ, V340, pc3239, DOI 10.1136/bmj.c3239; Gornall G., 2014, BMJ-BRIT MED J, V348, pf7646; McColl K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e833; Monbiot George, 2014, GUARDIAN; Monbiot George, 2013, GUARDIAN	8	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2014	348								g2908	10.1136/bmj.g2908	http://dx.doi.org/10.1136/bmj.g2908			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG1DN	24769792				2022-12-28	WOS:000335155400009
J	Ikeda, R; Cha, M; Ling, J; Jia, ZF; Coyle, D; Gu, JGG				Ikeda, Ryo; Cha, Myeounghoon; Ling, Jennifer; Jia, Zhanfeng; Coyle, Dennis; Gu, Jianguo G.			Merkel Cells Transduce and Encode Tactile Stimuli to Drive A beta-Afferent Impulses	CELL			English	Article							SEROTONIN-LIKE IMMUNOREACTIVITY; DORSAL-ROOT GANGLION; CAENORHABDITIS-ELEGANS; MECHANOSENSORY TRANSDUCTION; MECHANICAL ALLODYNIA; HAIRY SKIN; SNOUT SKIN; RAT; NEURONS; RESPONSES	Sensory systems for detecting tactile stimuli have evolved from touch-sensing nerves in invertebrates to complicated tactile end organs in mammals. Merkel discs are tactile end organs consisting of Merkel cells and A beta-afferent nerve endings and are localized in fingertips, whisker hair follicles, and other touch-sensitive spots. Merkel discs transduce touch into slowly adapting impulses to enable tactile discrimination, but their transduction and encoding mechanisms remain unknown. Using rat whisker hair follicles, we show that Merkel cells rather than Ab-afferent nerve endings are primary sites of tactile transduction and identify the Piezo2 ion channel as the Merkel cell mechanical transducer. Piezo2 transduces tactile stimuli into Ca2+-action potentials in Merkel cells, which drive Ab-afferent nerve endings to fire slowly adapting impulses. We further demonstrate that Piezo2 and Ca2+-action potentials in Merkel cells are required for behavioral tactile responses. Our findings provide insights into how tactile end-organs function and have clinical implications for tactile dysfunctions.	[Ikeda, Ryo; Cha, Myeounghoon; Ling, Jennifer; Jia, Zhanfeng; Coyle, Dennis; Gu, Jianguo G.] Univ Cincinnati, Coll Med, Dept Anesthesiol, Pain Res Ctr, Cincinnati, OH 45267 USA; [Ikeda, Ryo] Jikei Univ, Sch Med, Dept Orthopaed Surg, Minato Ku, Tokyo 1058461, Japan	University System of Ohio; University of Cincinnati; Jikei University	Gu, JGG (corresponding author), Univ Cincinnati, Coll Med, Dept Anesthesiol, Pain Res Ctr, POB 670531,231 Albert Sabin Way, Cincinnati, OH 45267 USA.	gujo@uc.edu	Cha, Myeounghoon/ABI-2748-2020	cha, myeounghoon/0000-0002-7993-672X; Ikeda, Ryo/0000-0001-6603-7146	NIH [DE018661, DE023090]; Mochida Memorial Foundation for Medical and Pharmaceutical Research of Japan; NSF of China (NSFC) [31000376]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023090, R01DE018661] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mochida Memorial Foundation for Medical and Pharmaceutical Research of Japan; NSF of China (NSFC)(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Drs. A. MacDermott, M. Salter, J. Strong, and M. Baccei for comments on an earlier version of this manuscript. This work was supported by NIH grants DE018661 and DE023090 to J.G.G, a travel fellowship to R.I. from The Mochida Memorial Foundation for Medical and Pharmaceutical Research of Japan, and a scholarship to Z.J. from NSF of China (NSFC, 31000376).	Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Baumann KI, 1996, NEUROSCI LETT, V213, P1, DOI 10.1016/0304-3940(96)12813-5; Blake DT, 1997, J NEUROPHYSIOL, V78, P2503, DOI 10.1152/jn.1997.78.5.2503; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; CROWE R, 1978, CELL TISSUE RES, V190, P273; Drew LJ, 2004, J PHYSIOL-LONDON, V556, P691, DOI 10.1113/jphysiol.2003.058693; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Ebara S, 2002, J COMP NEUROL, V449, P103, DOI 10.1002/cne.10277; Eijkelkamp N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2673; ENGLISH KB, 1992, ANAT REC, V232, P112, DOI 10.1002/ar.1092320112; Fricke B, 2000, CELL TISSUE RES, V299, P327; GARCIACABALLERO T, 1989, ANAT REC, V225, P267, DOI 10.1002/ar.1092250402; GOTTSCHALDT KM, 1981, SCIENCE, V214, P183, DOI 10.1126/science.7280690; Haeberle H, 2004, P NATL ACAD SCI USA, V101, P14503, DOI 10.1073/pnas.0406308101; Halata Z, 2003, ANAT REC PART A, V271A, P225, DOI 10.1002/ar.a.10029; HASHIMOTO K, 1972, J ANAT, V111, P99; Hogg RC, 1999, J PHARMACOL EXP THER, V289, P1502; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; IGGO A, 1969, J PHYSIOL-LONDON, V200, P763, DOI 10.1113/jphysiol.1969.sp008721; IKEDA I, 1994, J PHYSIOL-LONDON, V479, P247, DOI 10.1113/jphysiol.1994.sp020292; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Lou S, 2013, J NEUROSCI, V33, P870, DOI 10.1523/JNEUROSCI.3942-12.2013; Maricich SM, 2012, J NEUROSCI, V32, P3296, DOI 10.1523/JNEUROSCI.5307-11.2012; Maricich SM, 2009, SCIENCE, V324, P1580, DOI 10.1126/science.1172890; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; MUNGER BL, 1965, J CELL BIOL, V26, P79, DOI 10.1083/jcb.26.1.79; Ogawa H, 1988, Prog Brain Res, V74, P63; Sang CN, 1996, ANESTHESIOLOGY, V85, P491, DOI 10.1097/00000542-199609000-00007; Senok SS, 1996, NEUROSCI LETT, V214, P167, DOI 10.1016/0304-3940(96)12906-2; Shoykhet M, 2000, SOMATOSENS MOT RES, V17, P171; Tachibana T, 2005, ARCH HISTOL CYTOL, V68, P383, DOI 10.1679/aohc.68.383; TOREBJORK HE, 1992, J PHYSIOL-LONDON, V448, P765, DOI 10.1113/jphysiol.1992.sp019069; YAMASHITA Y, 1992, J PHYSIOL-LONDON, V450, P143, DOI 10.1113/jphysiol.1992.sp019120; Yan ZQ, 2013, NATURE, V493, P221, DOI 10.1038/nature11685; Yu HW, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-63; ZACCONE G, 1986, HISTOCHEMISTRY, V85, P29, DOI 10.1007/BF00508650; ZACCONE G, 1995, NEUROPEPTIDES, V28, P257, DOI 10.1016/0143-4179(95)90041-1; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	45	193	198	2	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					664	675		10.1016/j.cell.2014.02.026	http://dx.doi.org/10.1016/j.cell.2014.02.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24746027	Bronze, Green Accepted			2022-12-28	WOS:000335392100015
J	Kemmeren, P; Sameith, K; van de Pasch, LAL; Benschop, JJ; Lenstra, TL; Margaritis, T; O'Duibhir, E; Apweiler, E; van Wageningen, S; Ko, CW; van Heesch, S; Kashani, MM; Ampatziadis-Michailidis, G; Brok, MO; Brabers, NACH; Miles, AJ; Bouwmeester, D; van Hooff, SR; van Bakel, H; Sluiters, E; Bakker, LV; Snel, B; Lijnzaad, P; van Leenen, D; Koerkamp, MJAG; Holstege, FCP				Kemmeren, Patrick; Sameith, Katrin; van de Pasch, Loes A. L.; Benschop, Joris J.; Lenstra, Tineke L.; Margaritis, Thanasis; O'Duibhir, Eoghan; Apweiler, Eva; van Wageningen, Sake; Ko, Cheuk W.; van Heesch, Sebastiaan; Kashani, Mehdi M.; Ampatziadis-Michailidis, Giannis; Brok, Mariel O.; Brabers, Nathalie A. C. H.; Miles, Anthony J.; Bouwmeester, Diane; van Hooff, Sander R.; van Bakel, Harm; Sluiters, Erik; Bakker, Linda V.; Snel, Berend; Lijnzaad, Philip; van Leenen, Dik; Koerkamp, Marian J. A. Groot; Holstege, Frank C. P.			Large-Scale Genetic Perturbations Reveal Regulatory Networks and an Abundance of Gene-Specific Repressors	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; EXPRESSION PROFILES; EUKARYOTIC GENOME; YEAST; MECHANISMS; PATHWAYS; INTERACTOME; CIRCUITRY; TARGETS	To understand regulatory systems, it would be useful to uniformly determine how different components contribute to the expression of all other genes. We therefore monitored mRNA expression genome-wide, for individual deletions of one-quarter of yeast genes, focusing on (putative) regulators. The resulting genetic perturbation signatures reflect many different properties. These include the architecture of protein complexes and pathways, identification of expression changes compatible with viability, and the varying responsiveness to genetic perturbation. The data are assembled into a genetic perturbation network that shows different connectivities for different classes of regulators. Four feed-forward loop (FFL) types are overrepresented, including incoherent type 2 FFLs that likely represent feedback. Systematic transcription factor classification shows a surprisingly high abundance of gene-specific repressors, suggesting that yeast chromatin is not as generally restrictive to transcription as is often assumed. The data set is useful for studying individual genes and for discovering properties of an entire regulatory system.	[Kemmeren, Patrick; Sameith, Katrin; van de Pasch, Loes A. L.; Benschop, Joris J.; Lenstra, Tineke L.; Margaritis, Thanasis; O'Duibhir, Eoghan; Apweiler, Eva; van Wageningen, Sake; Ko, Cheuk W.; van Heesch, Sebastiaan; Kashani, Mehdi M.; Ampatziadis-Michailidis, Giannis; Brok, Mariel O.; Brabers, Nathalie A. C. H.; Miles, Anthony J.; Bouwmeester, Diane; van Hooff, Sander R.; van Bakel, Harm; Sluiters, Erik; Bakker, Linda V.; Lijnzaad, Philip; van Leenen, Dik; Koerkamp, Marian J. A. Groot; Holstege, Frank C. P.] Univ Med Ctr Utrecht, NL-3584 CG Utrecht, Netherlands; [Snel, Berend] Univ Utrecht, Dept Biol, NL-3584 CG Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University	Holstege, FCP (corresponding author), Univ Med Ctr Utrecht, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.	f.c.p.holstege@umcutrecht.nl	Lijnzaad, Philip/ABE-4205-2021; Lenstra, Tineke/L-3958-2016; van Bakel, Harm/N-9561-2017; Holstege, Frank/AAM-9944-2021; Snel, Berend/B-8886-2011; Benschop, Joris j/C-7809-2012; van Heesch, Sebastiaan/AAT-6595-2020	Lijnzaad, Philip/0000-0002-7535-583X; Lenstra, Tineke/0000-0002-4440-9962; van Bakel, Harm/0000-0002-1376-6916; Snel, Berend/0000-0002-5804-8547; van Heesch, Sebastiaan/0000-0001-9593-1980; Groot Koerkamp, Marian JA/0000-0002-0867-0821; Kemmeren, Patrick/0000-0003-2237-7354; Sameith, Katrin/0000-0003-4306-930X	Netherlands Bioinformatics Centre and the Netherlands Organization of Scientific Research [016108607, 81702015, 05071057, 91106009, 021002035, 863.07.007, 864.11.010, 70057407]	Netherlands Bioinformatics Centre and the Netherlands Organization of Scientific Research	This study was supported by the Netherlands Bioinformatics Centre and the Netherlands Organization of Scientific Research (grants 016108607, 81702015, 05071057, 91106009, and 021002035 to T.L.L.; grants 863.07.007 and 864.11.010 to P.K.; and grant 70057407 to J.J.B.).	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Benschop JJ, 2010, MOL CELL, V38, P916, DOI 10.1016/j.molcel.2010.06.002; Bonke M, 2013, G3-GENES GENOM GENET, V3, P75, DOI 10.1534/g3.112.004283; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Chua G, 2006, P NATL ACAD SCI USA, V103, P12045, DOI 10.1073/pnas.0605140103; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Fisk DG, 2006, YEAST, V23, P857, DOI 10.1002/yea.1400; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Hughes TR, 2013, GENETICS, V195, P9, DOI 10.1534/genetics.113.153262; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; MacNeil LT, 2011, GENOME RES, V21, P645, DOI 10.1101/gr.097378.109; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Margaritis T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002952; Margaritis T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.21; McIsaac RS, 2012, MOL BIOL CELL, V23, P2993, DOI 10.1091/mbc.E12-03-0232; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; SAVAGEAU MA, 1977, P NATL ACAD SCI USA, V74, P5647, DOI 10.1073/pnas.74.12.5647; Sharan R, 2006, NAT BIOTECHNOL, V24, P427, DOI 10.1038/nbt1196; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Steinfeld I, 2007, NAT GENET, V39, P303, DOI 10.1038/ng1965; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Teng X, 2013, MOL CELL, V52, P485, DOI 10.1016/j.molcel.2013.09.026; van Bakel H, 2004, EMBO REP, V5, P964, DOI 10.1038/sj.embor.7400253; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; van de Peppel J, 2003, EMBO REP, V4, P387, DOI 10.1038/sj.embor.embor798; van Wageningen S, 2010, CELL, V143, P991, DOI 10.1016/j.cell.2010.11.021; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Walhout AJM, 2001, NAT REV MOL CELL BIO, V2, P55, DOI 10.1038/35048107; Weiner A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001369; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	54	161	163	1	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					740	752		10.1016/j.cell.2014.02.054	http://dx.doi.org/10.1016/j.cell.2014.02.054			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766815	Bronze			2022-12-28	WOS:000335392100021
J	Rohling, EJ; Foster, GL; Grant, KM; Marino, G; Roberts, AP; Tamisiea, ME; Williams, F				Rohling, E. J.; Foster, G. L.; Grant, K. M.; Marino, G.; Roberts, A. P.; Tamisiea, M. E.; Williams, F.			Sea-level and deep-sea-temperature variability over the past 5.3 million years	NATURE			English	Article							EASTERN MEDITERRANEAN PYCNOCLINE; ICE-VOLUME; WATER TEMPERATURE; OXYGEN ISOTOPE; SOUTHERN-OCEAN; POLAR OCEAN; CLIMATE; GLACIATION; SALINITY; DELTA-O-18	Ice volume (and hence sea level) and deep-sea temperature are key measures of global climate change. Sea level has been documented using several independent methods over the past 0.5 million years (Myr). Older periods, however, lack such independent validation; all existing records are related to deep-sea oxygen isotope (delta O-18) data that are influenced by processes unrelated to sea level. For deep-sea temperature, only one continuous high-resolution (Mg/Ca-based) record exists, with related sea-level estimates, spanning the past 1.5 Myr. Here we present a novel sea-level reconstruction, with associated estimates of deep-sea temperature, which independently validates the previous 0-1.5 Myr reconstruction and extends it back to 5.3 Myr ago. We find that deep-sea temperature and sea level generally decreased through time, but distinctly out of synchrony, which is remarkable given the importance of ice-albedo feedbacks on the radiative forcing of climate. In particular, we observe a large temporal offset during the onset of Plio-Pleistocene ice ages, between a marked cooling step at 2.73 Myr ago and the first major glaciation at 2.15 Myr ago. Last, we tentatively infer that ice sheets may have grown largest during glacials with more modest reductions in deep-sea temperature.	[Rohling, E. J.; Grant, K. M.; Marino, G.; Roberts, A. P.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Foster, G. L.; Williams, F.] Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; [Tamisiea, M. E.] Natl Oceanog Ctr, Liverpool L3 5DA, Merseyside, England	Australian National University; NERC National Oceanography Centre; University of Southampton; NERC National Oceanography Centre	Rohling, EJ (corresponding author), Australian Natl Univ, Res Sch Earth Sci, GPO Box 4, Canberra, ACT 0200, Australia.	eelco.rohling@anu.edu.au	Foster, Gavin/W-5968-2019; Rohling, Eelco J/B-9736-2008; Foster, Gavin/CAF-4654-2022; Roberts, Andrew P/E-6422-2010; Marino, Gianluca/AAN-3969-2020	Rohling, Eelco J/0000-0001-5349-2158; Foster, Gavin/0000-0003-3688-9668; Roberts, Andrew P/0000-0003-0566-8117; Marino, Gianluca/0000-0001-9795-5337; Williams, Felicity/0000-0003-1222-6587; Grant, Katharine/0000-0003-4299-5504	Australian Laureate Fellowship [FL120100050]; UK Natural Environment Research Council (NERC) consortium project iGlass; Menzies Centre for Australian Studies, King's College London; Natural Environment Research Council [noc010012, bosc01001, 1233832, NE/H006273/1, NE/I009906/1, NE/I008365/1] Funding Source: researchfish; NERC [NE/I008365/1, bosc01001, NE/I009906/1, NE/H006273/1] Funding Source: UKRI	Australian Laureate Fellowship; UK Natural Environment Research Council (NERC) consortium project iGlass; Menzies Centre for Australian Studies, King's College London; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank M. Raymo for discussion of Pliocene sea-level estimates (notably PLIOMAX) at the PALSEA2 workshop in Rome, October 2013, and all colleagues who made their data available-for example, via the PANGAEA and NOAA-NCDC Palaeoclimate data centres, or directly. This study was supported by 2012 Australian Laureate Fellowship FL120100050 (E.J.R.) and UK Natural Environment Research Council (NERC) consortium project iGlass (E.J.R., M. T., F. W., A. P. R.). F. W. acknowledges an Australian Bicentennial Scholarship Award from the Menzies Centre for Australian Studies, King's College London.	Adkins JF, 2002, SCIENCE, V298, P1769, DOI 10.1126/science.1076252; ALLEN CP, 1991, P OC DRILL PROGR SCI, V0114; Bailey I, 2013, QUATERNARY SCI REV, V75, P181, DOI 10.1016/j.quascirev.2013.06.004; Bailey I, 2012, EARTH PLANET SC LETT, V341, P222, DOI 10.1016/j.epsl.2012.05.034; Bailey I, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001736; Balco G, 2010, GEOLOGY, V38, P795, DOI 10.1130/G30946.1; Biton E, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001431; BRYDEN HL, 1991, DEEP-SEA RES, V38, pS445, DOI 10.1016/S0198-0149(12)80020-3; Butt FA, 2000, MAR GEOL, V169, P373, DOI 10.1016/S0025-3227(00)00088-8; Casford JSL, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2007PA001422; Casford JSL, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000601; Casford JSL, 2003, PALAEOGEOGR PALAEOCL, V190, P103, DOI 10.1016/S0031-0182(02)00601-6; Clark PU, 1998, PALEOCEANOGRAPHY, V13, P1, DOI 10.1029/97PA02660; de Boer B, 2010, ANN GLACIOL, V51, P23, DOI 10.3189/172756410791392736; De Lange GJ, 2008, NAT GEOSCI, V1, P606, DOI 10.1038/ngeo283; Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; Elderfield H, 2010, QUATERNARY SCI REV, V29, P160, DOI 10.1016/j.quascirev.2009.07.013; Emeis KC, 2000, PALAEOGEOGR PALAEOCL, V158, P371, DOI 10.1016/S0031-0182(00)00059-6; Foster GL, 2013, P NATL ACAD SCI USA, V110, P1209, DOI 10.1073/pnas.1216073110; Garcia-Castellanos D, 2011, NATURE, V480, P359, DOI 10.1038/nature10651; Gebhardt A. C., QUAT SCI REV; Govers R, 2009, GEOLOGY, V37, P167, DOI 10.1130/G25141A.1; Grant KM, 2012, NATURE, V491, P744, DOI 10.1038/nature11593; Haley BA, 2008, NAT GEOSCI, V1, P68, DOI 10.1038/ngeo.2007.5; Haug GH, 2005, NATURE, V433, P821, DOI 10.1038/nature03332; Haug GH, 1998, NATURE, V393, P673, DOI 10.1038/31447; Hayes A, 2005, QUATERNARY SCI REV, V24, P999, DOI 10.1016/j.quascirev.2004.02.018; Herbert TD, 2010, SCIENCE, V328, P1530, DOI 10.1126/science.1185435; Hernandez-Molina FJ, 2014, GEOLOGY, V42, P227, DOI 10.1130/G35083.1; Hillenbrand CD, 2006, PALAEOGEOGR PALAEOCL, V242, P240, DOI 10.1016/j.palaeo.2006.06.001; Hodell D.A., 1991, Proceedings of the Ocean Drilling Program Scientific Results, V114, P409, DOI 10.2973/odp.proc.sr.114.150.1991; Hodell DA, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001211; JANSEN E, 1991, NATURE, V349, P600, DOI 10.1038/349600a0; Jimenez-Moreno G, 2013, GEOL SOC AM BULL, V125, P432, DOI 10.1130/B30663.1; Jorissen FJ, 1999, MAR GEOL, V153, P91, DOI 10.1016/S0025-3227(98)00088-7; Kendall RA, 2005, GEOPHYS J INT, V161, P679, DOI 10.1111/j.1365-246X.2005.02553.x; Kleiven HF, 2002, PALAEOGEOGR PALAEOCL, V184, P213; Knies J, 2009, QUATERNARY SCI REV, V28, P812, DOI 10.1016/j.quascirev.2008.12.002; Kroon D., 1998, ARCTIC, V160, P181, DOI DOI 10.2973/ODP.PROC.SR.160.071.1998(CHAPTER14)160; Lawrence KT, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001669; Lisiecki L.E., 2005, PALEOCEANOGRAPHY, V20, DOI [10.1029/2004PA001071, DOI 10.1029/2004PA001071]; Lisiecki LE, 2007, QUATERNARY SCI REV, V26, P56, DOI 10.1016/j.quascirev.2006.09.005; Loget N, 2006, SEDIMENT GEOL, V188, P341, DOI 10.1016/j.sedgeo.2006.03.012; Lourens LJ, 1996, PALEOCEANOGRAPHY, V11, P391, DOI 10.1029/96PA01125; Lourens LJ, 2001, NATURE, V409, P1029, DOI 10.1038/35059062; Marino G, 2007, GEOLOGY, V35, P675, DOI 10.1130/G23831A.1; Marino G, 2009, QUATERNARY SCI REV, V28, P3246, DOI 10.1016/j.quascirev.2009.08.011; Martinez-Garcia A, 2010, SCIENCE, V328, P1550, DOI 10.1126/science.1184480; Matthiesen S, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000880; Mattingsdal R., QUAT SCI REV; McKay R, 2012, P NATL ACAD SCI USA, V109, P6423, DOI 10.1073/pnas.1112248109; Medina-Elizalde M, 2008, EARTH PLANET SC LETT, V269, P584, DOI 10.1016/j.epsl.2008.03.014; Mercone D, 2001, MAR GEOL, V177, P25, DOI 10.1016/S0025-3227(01)00122-0; Mikolajewicz U, 2011, CLIM PAST, V7, P161, DOI 10.5194/cp-7-161-2011; Miller KG, 2012, GEOLOGY, V40, P407, DOI 10.1130/G32869.1; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Mudelsee M, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001153; Myers PG, 1998, PALEOCEANOGRAPHY, V13, P586, DOI 10.1029/98PA02736; Naafs BDA, 2013, QUATERNARY SCI REV, V80, P1, DOI 10.1016/j.quascirev.2013.08.014; Naafs BDA, 2012, EARTH PLANET SC LETT, V317, P8, DOI 10.1016/j.epsl.2011.11.026; Naish T, 2009, NATURE, V458, P322, DOI 10.1038/nature07867; Nykjaer L, 2009, CLIM RES, V39, P11, DOI 10.3354/cr00794; Osborne AH, 2010, QUATERNARY SCI REV, V29, P2473, DOI 10.1016/j.quascirev.2010.05.015; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Rabineau M, 2014, EARTH PLANET SC LETT, V388, P353, DOI 10.1016/j.epsl.2013.11.059; Ravelo AC, 2004, NATURE, V429, P263, DOI 10.1038/nature02567; Raymo ME, 1989, PALEOCEANOGRAPHY, V4, P413, DOI 10.1029/PA004i004p00413; Raymo ME, 2011, NAT GEOSCI, V4, P328, DOI [10.1038/ngeo1118, 10.1038/NGEO1118]; Rogerson M, 2012, CLIM DYNAM, V39, P589, DOI 10.1007/s00382-011-1148-4; Rohling EJ, 2010, EARTH PLANET SC LETT, V291, P97, DOI 10.1016/j.epsl.2009.12.054; Rohling EJ, 2009, NAT GEOSCI, V2, P500, DOI 10.1038/ngeo557; Rohling EJ, 2013, QUATERNARY SCI REV, V70, P63, DOI 10.1016/j.quascirev.2013.03.013; Rohling EJ, 1991, PALEOCEANOGRAPHY, V6, P747, DOI 10.1029/91PA02455; Rohling EJ, 1991, PALEOCEANOGRAPHY, V6, P537, DOI 10.1029/91PA01328; Rohling EJ, 1998, NATURE, V394, P162, DOI 10.1038/28134; Rohling EJ, 2004, MAR MICROPALEONTOL, V50, P89, DOI 10.1016/S0377-8398(03)00068-9; Rohling EJ, 2003, CLIM DYNAM, V20, P257, DOI 10.1007/s00382-002-0266-4; ROHLING EJ, 1994, MAR GEOL, V122, P1, DOI 10.1016/0025-3227(94)90202-X; Rohling EJ, 2002, CLIM DYNAM, V18, P587, DOI 10.1007/s00382-001-0194-8; Rohling EJ, 1999, PALEOCEANOGRAPHY, V14, P706, DOI 10.1029/1999PA900042; ROHLING EJ, 1994, P K NED AKAD WETENSC, V97, P201; Schrag DP, 1996, SCIENCE, V272, P1930, DOI 10.1126/science.272.5270.1930; Seki O, 2010, EARTH PLANET SC LETT, V292, P201, DOI 10.1016/j.epsl.2010.01.037; SHACKLETON NJ, 1984, NATURE, V307, P620, DOI 10.1038/307620a0; SHACKLETON NJ, 1977, NATURE, V270, P216, DOI 10.1038/270216a0; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Siddall M, 2004, EARTH PLANET SC LETT, V225, P421, DOI 10.1016/j.epsl.2004.06.008; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Sigman DM, 2004, NATURE, V428, P59, DOI 10.1038/nature02357; Sosdian S, 2009, SCIENCE, V325, P306, DOI 10.1126/science.1169938; STANEV EV, 1989, OCEANOL ACTA, V12, P141; Thomson J, 1999, MAR GEOL, V153, P77, DOI 10.1016/S0025-3227(98)00089-9; TIEDEMANN R, 1994, PALEOCEANOGRAPHY, V9, P619, DOI 10.1029/94PA00208; TOLMAZIN D, 1985, PROG OCEANOGR, V15, P217, DOI 10.1016/0079-6611(85)90038-2; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Wang PX, 2010, EARTH PLANET SC LETT, V290, P319, DOI 10.1016/j.epsl.2009.12.028; Yu J., 2010, SCIENCE, V328, p1480c	97	353	369	10	288	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					477	+		10.1038/nature13230	http://dx.doi.org/10.1038/nature13230			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24739960				2022-12-28	WOS:000334741600027
J	Wassarman, PM				Wassarman, Paul M.			Sperm protein finds its mate	NATURE			English	Editorial Material							MAMMALIAN FERTILIZATION; FOLATE RECEPTORS; MEMBRANE BLOCK; FUSION; RECOGNITION; POLYSPERMY; IZUMO; EGGS	Knowledge of the sperm-specific protein that is required for the attachment of sperm to eggs during fertilization in mammals has led to the identification of the protein's receptor on the egg's plasma membrane. SEE ARTICLE P.483	Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Wassarman, PM (corresponding author), Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	paul.wassarman@mssm.edu						Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; Chen C, 2013, NATURE, V500, P486, DOI 10.1038/nature12327; Ellerman DA, 2009, MOL REPROD DEV, V76, P1188, DOI 10.1002/mrd.21092; Gardner AJ, 2006, REPROD FERT DEVELOP, V18, P53, DOI 10.1071/RD05122; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Inoue N, 2013, DEVELOPMENT, V140, P3221, DOI 10.1242/dev.094854; Jegou A, 2011, P NATL ACAD SCI USA, V108, P10946, DOI 10.1073/pnas.1017400108; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; Wang M, 2009, MOL REPROD DEV, V76, P794, DOI 10.1002/mrd.21027; Wassarman Paul M., 2008, V475, P99, DOI 10.1007/978-1-59745-250-2_6; Wibowo AS, 2013, P NATL ACAD SCI USA, V110, P15180, DOI 10.1073/pnas.1308827110; Wortzman-Show GB, 2007, MOL HUM REPROD, V13, P557, DOI 10.1093/molehr/gam042; Wright GJ, 2009, MOL BIOSYST, V5, P1405, DOI [10.1039/B903580J, 10.1039/b903580j]	14	9	10	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					466	467		10.1038/nature13227	http://dx.doi.org/10.1038/nature13227			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24739970				2022-12-28	WOS:000334741600025
J	Smith, JM				Smith, Jeanette M.			Our English Coasts (Strayed Sheep)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2014	311	15					1482	1483		10.1001/jama.2013.279446	http://dx.doi.org/10.1001/jama.2013.279446			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9DX	24737353				2022-12-28	WOS:000334306000001
J	Ryan, AM; Press, MJ				Ryan, Andrew M.; Press, Matthew J.			Value-Based Payment for Physicians in Medicare: Small Step or Giant Leap?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							QUALITY; INCENTIVES		[Ryan, Andrew M.; Press, Matthew J.] Weill Cornell Med Coll, New York, NY 10021 USA	Cornell University	Ryan, AM (corresponding author), Weill Cornell Med Coll, Dept Publ Hlth, 402 East 67th St,Room LA-215, New York, NY 10021 USA.	amr2015@med.cornell.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K01HS018546] Funding Source: NIH RePORTER; AHRQ HHS [K01 HS018546-01] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Alexander JA, 2013, HEALTH SERV RES, V48, P376, DOI 10.1111/j.1475-6773.2012.01454.x; Berenson RA, 2010, HEALTH AFFAIR, V29, P699, DOI 10.1377/hlthaff.2009.0715; Bishop TF, 2012, AM J MANAG CARE, V18, pE126; Carey MA, 2014, KAISER HLTH NEW 0207; Centers for Medicare & Medicaid Services, 2012, FED REG, V77, P68892; Centers for Medicare & Medicaid Services, 2013, FED REG, V78, P43282; Centers for Medicare & Medicaid Services, 2013, PHYS QUAL REP SYST P; Muhlestein D, 2013, HLTH AFFAIRS BL 0219; Ryan AM, 2012, HEALTH AFFAIR, V31, P585, DOI 10.1377/hlthaff.2011.0719; VanLare JM, 2012, JAMA-J AM MED ASSOC, V308, P2089, DOI 10.1001/jama.2012.14834	10	8	8	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 15	2014	160	8					565	U175		10.7326/M13-1715	http://dx.doi.org/10.7326/M13-1715			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG0ZE	24733199				2022-12-28	WOS:000335143700007
J	Evans, T; Wade, CM; Chapman, FA; Johnson, AD; Loose, M				Evans, Teri; Wade, Christopher M.; Chapman, Frank A.; Johnson, Andrew D.; Loose, Matthew			Acquisition of Germ Plasm Accelerates Vertebrate Evolution	SCIENCE			English	Article							CELL DEVELOPMENT; URODELE AMPHIBIANS; EMBRYOS; SPECIFICATION; MAMMALS; ORIGIN; TURTLE; GENES; VASA	Primordial germ cell (PGC) specification occurs either by induction from pluripotent cells (epigenesis) or by a cell-autonomous mechanism mediated by germ plasm (preformation). Among vertebrates, epigenesis is basal, whereas germ plasm has evolved convergently across lineages and is associated with greater speciation. We compared protein-coding sequences of vertebrate species that employ preformation with their sister taxa that use epigenesis and demonstrate that genes evolve more rapidly in species containing germ plasm. Furthermore, differences in rates of evolution appear to cause phylogenetic incongruence in protein-coding sequence comparisons between vertebrate taxa. Our results support the hypothesis that germ plasm liberates constraints on somatic development and that enhanced evolvability drives the evolution of germ plasm.	[Evans, Teri; Wade, Christopher M.; Johnson, Andrew D.; Loose, Matthew] Univ Nottingham, Sch Life Sci, Nottingham NG7 2UH, England; [Chapman, Frank A.] Univ Florida, Program Fisheries & Aquat Sci, Gainesville, FL 32653 USA	University of Nottingham; State University System of Florida; University of Florida	Johnson, AD (corresponding author), Univ Nottingham, Sch Life Sci, Nottingham NG7 2UH, England.	andrew.d.johnson@nottingham.ac.uk; matt.loose@nottingham.ac.uk		Loose, Matthew/0000-0002-5264-0929; Wade, Christopher/0000-0002-1269-9694; Forey, Teri/0000-0001-5663-9821; Johnson, Andrew/0000-0002-5183-2072	Biotechnology and Biological Sciences Research Council, Medical Research Council; University of Nottingham; Biotechnology and Biological Sciences Research Council [974247] Funding Source: researchfish; Medical Research Council [G1100025, G0700078, MR/L001047/1] Funding Source: researchfish; MRC [G1100025, G0700078, MR/L001047/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, Medical Research Council; University of Nottingham; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	All data are available from the authors' Web site at www.nottingham.ac.uk/similar to plzloose/phyloinc and are deposited at http://datadryad.org (DOI: 10.5061/dryad.rd70f). The authors thank B. Crother, G. Morgan, and M. Blythe for helpful discussion. Sequencing was carried out at the Genome Centre, Queen Mary, University of London by L. Bhaw-Rosun and M. Struegbig. This work was supported by the Biotechnology and Biological Sciences Research Council, Medical Research Council, and University of Nottingham.	Bachvarova RF, 2009, EVOL DEV, V11, P603, DOI 10.1111/j.1525-142X.2009.00366.x; Bachvarova RF, 2009, EVOL DEV, V11, P525, DOI 10.1111/j.1525-142X.2009.00360.x; Crother BI, 2007, J THEOR BIOL, V248, P322, DOI 10.1016/j.jtbi.2007.05.035; Davalos LM, 2012, BIOL REV, V87, P991, DOI 10.1111/j.1469-185X.2012.00240.x; Dixon JE, 2010, DEVELOPMENT, V137, P2973, DOI 10.1242/dev.049262; Fan X, 2007, DEV GENES EVOL, V217, P807, DOI 10.1007/s00427-007-0191-y; Frankenberg S, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-56; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hubert J., 1985, Biology of Reptilia, V14, P41; Hughes S, 2001, J MOL EVOL, V53, P70, DOI 10.1007/s002390010194; Johnson AD, 2003, EVOL DEV, V5, P414, DOI 10.1046/j.1525-142X.2003.03048.x; Johnson AD, 2003, PHILOS T ROY SOC B, V358, P1371, DOI 10.1098/rstb.2003.1331; Johnson AD, 2011, REPRODUCTION, V141, P291, DOI 10.1530/REP-10-0474; Leitch HG, 2013, CURR TOP DEV BIOL, V104, P149, DOI 10.1016/B978-0-12-416027-9.00005-X; Loose M, 2004, DEV BIOL, V271, P467, DOI 10.1016/j.ydbio.2004.04.014; Raz E, 2003, NAT REV GENET, V4, P690, DOI 10.1038/nrg1154; Roux J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000311; Sutasurya L. A., 1979, PRIMORDIAL GERM CELL; Swiers G, 2010, DEV BIOL, V343, P138, DOI 10.1016/j.ydbio.2010.04.002; Telford MJ, 2005, CURR BIOL, V15, pR296, DOI 10.1016/j.cub.2005.04.001; Tsunekawa N, 2000, DEVELOPMENT, V127, P2741; Wang Z, 2013, NAT GENET, V45, P701, DOI 10.1038/ng.2615	23	35	35	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					200	203		10.1126/science.1249325	http://dx.doi.org/10.1126/science.1249325			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24723612				2022-12-28	WOS:000334096300036
J	Groschel, S; Sanders, MA; Hoogenboezem, R; de Wit, E; Bouwman, BAM; Erpelinck, C; van der Velden, VHJ; Havermans, M; Avellino, R; van Lom, K; Rombouts, EJ; van Duin, M; Dohner, K; Beverloo, HB; Bradner, JE; Dohner, H; Lowenberg, B; Valk, PJM; Bindels, EMJ; de Laat, W; Delwel, R				Groeschel, Stefan; Sanders, Mathijs A.; Hoogenboezem, Remco; de Wit, Elzo; Bouwman, Britta A. M.; Erpelinck, Claudia; van der Velden, Vincent H. J.; Havermans, Marije; Avellino, Roberto; van Lom, Kirsten; Rombouts, Elwin J.; van Duin, Mark; Doehner, Konstanze; Beverloo, H. Berna; Bradner, James E.; Doehner, Hartmut; Lowenberg, Bob; Valk, Peter J. M.; Bindels, Eric M. J.; de Laat, Wouter; Delwel, Ruud			A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia	CELL			English	Article							HEMATOPOIETIC-CELLS; MUTATIONS; ACTIVATION; LOCUS; HAPLOINSUFFICIENCY; ABNORMALITIES; LANDSCAPE	Chromosomal rearrangements without gene fusions have been implicated in leukemogenesis by causing deregulation of proto-oncogenes via relocation of cryptic regulatory DNA elements. AML with inv(3)/t(3;3) is associated with aberrant expression of the stem-cell regulator EVI1. Applying functional genomics and genome-engineering, we demonstrate that both 3q rearrangements reposition a distal GATA2 enhancer to ectopically activate EVI1 and simultaneously confer GATA2 functional haploinsufficiency, previously identified as the cause of sporadic familial AML/MDS and MonoMac/Emberger syndromes. Genomic excision of the ectopic enhancer restored EVI1 silencing and led to growth inhibition and differentiation of AML cells, which could be replicated by pharmacologic BET inhibition. Our data show that structural rearrangements involving the chromosomal repositioning of a single enhancer can cause deregulation of two unrelated distal genes, with cancer as the outcome.	[Groeschel, Stefan; Sanders, Mathijs A.; Hoogenboezem, Remco; Erpelinck, Claudia; Havermans, Marije; Avellino, Roberto; van Lom, Kirsten; Rombouts, Elwin J.; van Duin, Mark; Lowenberg, Bob; Valk, Peter J. M.; Bindels, Eric M. J.; Delwel, Ruud] Erasmus Univ, Med Ctr, Dept Hematol, NL-3015 GE Rotterdam, Netherlands; [Groeschel, Stefan; Doehner, Konstanze; Doehner, Hartmut] Ulm Univ Hosp, Dept Internal Med 2, D-89081 Ulm, Germany; [de Wit, Elzo; Bouwman, Britta A. M.; de Laat, Wouter] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [de Wit, Elzo; Bouwman, Britta A. M.; de Laat, Wouter] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [van der Velden, Vincent H. J.] Erasmus Univ, Med Ctr, Dept Immunol, NL-3015 CN Rotterdam, Netherlands; [Beverloo, H. Berna] Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3015 GE Rotterdam, Netherlands; [Beverloo, H. Berna] Dutch Working Grp Hematooncol Genome Diagnost, NL-3015 GE Rotterdam, Netherlands; [Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Bradner, James E.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Erasmus University Rotterdam; Erasmus MC; Ulm University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Delwel, R (corresponding author), Erasmus Univ, Med Ctr, Dept Hematol, NL-3015 GE Rotterdam, Netherlands.	h.delwel@erasmusmc.nl	Valk, Peter/AAX-2823-2020; Döhner, Hartmut/C-8933-2016	Döhner, Hartmut/0000-0003-2116-5536; de Laat, Wouter/0000-0002-6393-595X; de Wit, Elzo/0000-0003-2883-1415; Bouwman, Britta/0000-0002-9827-9497	Deutsche Forschungsgemeinschaft [GR 3955/1-1]; Lady Tata Memorial Trust; Association for International Cancer Research; Center for Translational Molecular Medicine (CTMM) [GR03O-102]; EHA Research Fellowship; Worldwide Cancer Research [12-1309] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Lady Tata Memorial Trust; Association for International Cancer Research; Center for Translational Molecular Medicine (CTMM); EHA Research Fellowship; Worldwide Cancer Research	We thank J. Qi for providing JQ1; I. P. Touw, P. van Strien, K. Eiwen, J. van Galen, A. C. Bijkerk, P. Hogenbirk-Hupkes, J. Koenders, F. Cornelissen, H. van de Werken, and other members of the Department of Hematology at the Erasmus MC for their support; E. Simons for editorial assistance. We thank L. Cong and F. Zhang from the Broad Institute for their support with the CRISPR/Cas9 toolbox. This work was financially supported by grants from the Deutsche Forschungsgemeinschaft (GR 3955/1-1, S. Groschel), the Lady Tata Memorial Trust, Association for International Cancer Research (E. Bindels), the Center for Translational Molecular Medicine (CTMM; GR03O-102, M. Sanders) and an EHA Research Fellowship (S. Groschel).	BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; de Pater E, 2013, J EXP MED, V210, P2843, DOI 10.1084/jem.20130751; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Frohling S, 2008, NEW ENGL J MED, V359, P722, DOI 10.1056/NEJMra0803109; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Grass JA, 2006, MOL CELL BIOL, V26, P7056, DOI 10.1128/MCB.01033-06; Hahn CN, 2011, NAT GENET, V43, P1012, DOI 10.1038/ng.913; Hsu AP, 2013, BLOOD, V121, P3830, DOI 10.1182/blood-2012-08-452763; Hsu AP, 2011, BLOOD, V118, P2653, DOI 10.1182/blood-2011-05-356352; Kataoka K, 2011, J EXP MED, V208, P2402, DOI 10.1084/jem.20110447; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lugthart S, 2010, J CLIN ONCOL, V28, P3890, DOI 10.1200/JCO.2010.29.2771; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mitelman F, 2004, NAT GENET, V36, P331, DOI 10.1038/ng1335; Mitelman F, 2013, MITELMAN DATABASE CH; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; ORLIC D, 1995, P NATL ACAD SCI USA, V92, P4601, DOI 10.1073/pnas.92.10.4601; Ostergaard P, 2011, NAT GENET, V43, P929, DOI 10.1038/ng.923; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; POLACK A, 1993, EMBO J, V12, P3913, DOI 10.1002/j.1460-2075.1993.tb06069.x; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Spinner MA, 2014, BLOOD, V123, P809, DOI 10.1182/blood-2013-07-515528; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; van Dongen JJM, 2012, LEUKEMIA, V26, P1908, DOI 10.1038/leu.2012.120; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wieser R, 2003, HAEMATOLOGICA, V88, P25	35	395	409	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					369	381		10.1016/j.cell.2014.02.019	http://dx.doi.org/10.1016/j.cell.2014.02.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24703711	Bronze			2022-12-28	WOS:000334304500011
J	Rasberry, L				Rasberry, Lane			Wikipedia: what it is and why it matters for healthcare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												lrasberry@consumer.org		Rasberry, Lane/0000-0002-9485-6146				Wikimedia, WIK ID REL SOURC MED; Wikipedia, WIK VER; Wikipedia, LOW BACK PAIN; Wikipedia, WIK WIKIPROJECT MED; Wikipedia, WIK MAN STYL MED REL	5	7	7	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2014	348								g2478	10.1136/bmj.g2478	http://dx.doi.org/10.1136/bmj.g2478			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SD	24714406				2022-12-28	WOS:000334348500009
J	Chowdhury, R; Warnakula, S; Kunutsor, S; Crowe, F; Ward, HA; Johnson, L; Franco, OH; Butterworth, AS; Forouhi, NG; Thompson, SG; Khaw, KT; Mozaffarian, D; Danesh, J; Di Angelantonio, E				Chowdhury, Rajiv; Warnakula, Samantha; Kunutsor, Setor; Crowe, Francesca; Ward, Heather A.; Johnson, Laura; Franco, Oscar H.; Butterworth, Adam S.; Forouhi, Nita G.; Thompson, Simon G.; Khaw, Kay-Tee; Mozaffarian, Dariush; Danesh, John; Di Angelantonio, Emanuele			Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary Risk A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							FOOD FREQUENCY QUESTIONNAIRE; CARDIOVASCULAR-DISEASE; SATURATED FAT; HEART-DISEASE; LIFE-STYLE; PREVENTION; VALIDITY; COHORT; BLOOD; BIAS	Background: Guidelines advocate changes in fatty acid consumption to promote cardiovascular health. Purpose: To summarize evidence about associations between fatty acids and coronary disease. Data Sources: MEDLINE, Science Citation Index, and Cochrane Central Register of Controlled Trials through July 2013. Study Selection: Prospective, observational studies and randomized, controlled trials. Data Extraction: Investigators extracted data about study characteristics and assessed study biases. Data Synthesis: There were 32 observational studies (512 420 participants) of fatty acids from dietary intake; 17 observational studies (25 721 participants) of fatty acid biomarkers; and 27 randomized, controlled trials (105 085 participants) of fatty acid supplementation. In observational studies, relative risks for coronary disease were 1.03 (95% CI, 0.98 to 1.07) for saturated, 1.00 (CI, 0.91 to 1.10) for monounsaturated, 0.87 (CI, 0.78 to 0.97) for long-chain omega-3 polyunsaturated, 0.98 (CI, 0.90 to 1.06) for omega-6 polyunsaturated, and 1.16 (CI, 1.06 to 1.27) for trans fatty acids when the top and bottom thirds of baseline dietary fatty acid intake were compared. Corresponding estimates for circulating fatty acids were 1.06 (CI, 0.86 to 1.30), 1.06 (CI, 0.97 to 1.17), 0.84 (CI, 0.63 to 1.11), 0.94 (CI, 0.84 to 1.06), and 1.05 (CI, 0.76 to 1.44), respectively. There was heterogeneity of the associations among individual circulating fatty acids and coronary disease. In randomized, controlled trials, relative risks for coronary disease were 0.97 (CI, 0.69 to 1.36) for alpha-linolenic, 0.94 (CI, 0.86 to 1.03) for long-chain omega-3 polyunsaturated, and 0.86 (CI, 0.69 to 1.07) for omega-6 polyunsaturated fatty acid supplementations. Limitation: Potential biases from preferential publication and selective reporting. Conclusion: Current evidence does not clearly support cardiovascular guidelines that encourage high consumption of polyunsaturated fatty acids and low consumption of total saturated fats.	Univ Cambridge, Cambridge CB1 8RN, England; MRC, Cambridge, England; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Univ Oxford, Oxford, England; Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London SW7 2AZ, England; Univ Bristol, Ctr Exercise Nutr & Hlth Sci, Bristol BS8 1TZ, Avon, England; Erasmus Univ, Med Ctr, NL-3000 CA Rotterdam, Netherlands	University of Cambridge; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; Imperial College London; University of Bristol; Erasmus University Rotterdam; Erasmus MC	Chowdhury, R (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, 2 Worts Causeway, Cambridge CB1 8RN, England.	rajiv.chowdhury@phpc.cam.ac.uk	DiAngelantonio, Emanuele/ABE-6852-2020; Khaw, Kay-Tee/AAZ-3209-2021; Franco, Óscar H/ABE-2305-2020; Kunutsor, Setor K/H-9807-2019; Mozaffarian, Dariush/ABC-2822-2020; Chowdhury, Rajiv/AHB-1253-2022	Franco, Óscar H/0000-0002-4606-4929; Kunutsor, Setor K/0000-0002-2625-0273; Johnson, Laura/0000-0001-8985-3154; Butterworth, Adam/0000-0002-6915-9015; Crowe, Francesca/0000-0003-4026-1726; Forouhi, Nita/0000-0002-5041-248X; Di Angelantonio, Emanuele/0000-0001-8776-6719	British Heart Foundation; Medical Research Council; Cambridge National Institute for Health Research Biomedical Research Centre; Gates Cambridge; MRC [MC_UP_A100_1003, MR/L003120/1, MC_UU_12015/5] Funding Source: UKRI; British Heart Foundation [RG/13/13/30194, RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MC_UP_A100_1003, MR/L003120/1, G0401527, G1000143, MC_UU_12015/5] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114, NF-SI-0512-10165] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Gates Cambridge; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	British Heart Foundation, Medical Research Council, Cambridge National Institute for Health Research Biomedical Research Centre, and Gates Cambridge.	Baylin A, 2006, CURR OPIN LIPIDOL, V17, P22, DOI 10.1097/01.mol.0000199814.46720.83; Bingham SA, 2003, LANCET, V362, P212, DOI 10.1016/S0140-6736(03)13913-X; Campbell MK, 2006, BIOCHEMISTRY; Clarke R, 1997, BRIT MED J, V314, P112, DOI 10.1136/bmj.314.7074.112; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Degirolamo C, 2009, J LIPID RES, V50, pS434, DOI 10.1194/jlr.R800076-JLR200; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Erkkila A, 2008, PROG LIPID RES, V47, P172, DOI 10.1016/j.plipres.2008.01.004; Forsythe CE, 2008, LIPIDS, V43, P65, DOI 10.1007/s11745-007-3132-7; Forsythe CE, 2010, LIPIDS, V45, P947, DOI 10.1007/s11745-010-3467-3; Frayn K, 2005, CARDIOVASCULAR DISEASE: DIET, NUTRITION AND EMERGING RISK FACTORS, P1; Gidding SS, 2009, CIRCULATION, V119, P1161, DOI 10.1161/CIRCULATIONAHA.109.191856; Gillingham LG, 2011, LIPIDS, V46, P209, DOI 10.1007/s11745-010-3524-y; Goris AHC, 2000, AM J CLIN NUTR, V71, P130; HEBERT JR, 1995, INT J EPIDEMIOL, V24, P389, DOI 10.1093/ije/24.2.389; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Johansson L, 1998, AM J CLIN NUTR, V68, P266, DOI 10.1093/ajcn/68.2.266; Joint WHO/FAO Expert Consultation, DIET NUTR PREV CHRON; Khaw KT, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001255; Kobayashi M, 2003, J EPIDEMIOL, V13, pS64; Lucas L, 2011, CURR PHARM DESIGN, V17, P754, DOI 10.2174/138161211795428911; Manson JE, 2012, CONTEMP CLIN TRIALS, V33, P159, DOI 10.1016/j.cct.2011.09.009; McNaught AD, 1997, COMPENDIUM CHEM TERM, DOI DOI 10.1351/GOLDBOOK; Merchant AT, 2008, AM J CLIN NUTR, V87, P168, DOI 10.1093/ajcn/87.1.168; Mozaffarian D, 2008, CIRCULATION, V117, P3031, DOI 10.1161/CIRCULATIONAHA.107.738732; Mozaffarian D, 2011, ANN INTERN MED, V155, P160, DOI 10.7326/0003-4819-155-3-201108020-00006; National Institute for Health and Care Excellence, 2013, PH25 PREV CARD DIS; Parks EJ, 2000, AM J CLIN NUTR, V71, P412; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Poppitt SD, 1998, INT J OBESITY, V22, P303, DOI 10.1038/sj.ijo.0800584; Ramsden CE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8707; Ratnayake WMN, 2009, ANN NUTR METAB, V55, P8, DOI 10.1159/000228994; RIBOLI E, 1987, CANCER SURV, V6, P685; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rimm EB, 1992, AM J EPIDEMIOL, V135, P1127, DOI [DOI 10.1093/OXFORDJOURNALS.AJE.A116211, DOI 10.1093/OXFORDJOUMALS.AJE.A116211]; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Siri Patty W, 2005, Curr Atheroscler Rep, V7, P455, DOI 10.1007/s11883-005-0062-9; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P535, DOI 10.3945/ajcn.2009.27725; Smit LA, 2009, ANN NUTR METAB, V55, P44, DOI 10.1159/000228995; Wells G., NEWCASTLE OTTAWA SCA; Wennberg M, 2009, PUBLIC HEALTH NUTR, V12, P1477, DOI 10.1017/S1368980008004503; Willett WC, 2000, EPIDEMIOL REV, V22, P82, DOI 10.1093/oxfordjournals.epirev.a018029; Wolk A, 1998, AM J CLIN NUTR, V68, P291, DOI 10.1093/ajcn/68.2.291	45	825	842	11	299	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2014	160	6					398	+		10.7326/M13-1788	http://dx.doi.org/10.7326/M13-1788			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MW	24723079				2022-12-28	WOS:000333521300016
J	Joy, TR; Monjed, A; Zou, GY; Hegele, RA; McDonald, CG; Mahon, JL				Joy, Tisha R.; Monjed, Alaa; Zou, Guang Yong; Hegele, Robert A.; McDonald, Charlotte G.; Mahon, Jeffrey L.			N-of-1 (Single-Patient) Trials for Statin-Related Myalgia	ANNALS OF INTERNAL MEDICINE			English	Article							MYOPATHY; PAIN; OUTCOMES; VALIDITY; SAFETY; SERIES	Background: Statin-related myalgia is difficult to distinguish from other conditions causing myalgia and may often lead to statin discontinuation. Objective: To compare the effect of statin rechallenge with placebo in patients with prior statin-related myalgia and to determine whether patients resumed statin therapy after evaluating the results. Design: N-of-1 trial with 3 double-blind, crossover comparisons separated by 3-week washout periods. (Clinicaltrials.gov: NCT01259791) Setting: Tertiary care lipid clinic. Patients: Patients with prior statin-related myalgia with or without mild elevation of creatine kinase levels. Intervention: Rechallenge with the statin that was previously associated with myalgia within 3 weeks of open-label use versus matching placebo. Measurements: Weekly visual analogue scale (VAS) scores for myalgia and specific symptoms (VAS myalgia score and symptom-specific VAS score, respectively), pain interference scores, and pain severity scores were recorded during the 3-week periods when patients were receiving placebo or statin. The primary outcome was the VAS myalgia score (range, 0 to 100 mm). Results: Eight patients (mean age, 66 years [SD, 8 years]; 88% women, all with high 10-year Framingham cardiovascular risk) participated in n-of-1 trials. Seven patients completed 3 treatment pairs, and 1 completed 2 treatment pairs. For each n-of-1 trial, no statistically significant differences were seen between statin and placebo in the VAS myalgia score, symptom-specific VAS score, pain interference score, and pain severity score. Five patients resumed open-label statin treatment, with a median posttrial follow-up of 10 months. Limitation: Results are limited by the small sample size and cannot be extended to patients with longer onset of myalgia after statin initiation. Conclusion: In selected patients with a history of statin-related myalgia whose symptoms are difficult to evaluate, n-of-1 trials may be a useful method for determining statin tolerability.	[Joy, Tisha R.] Western Univ, Schulich Sch Med & Dent, London, ON N6A 4V2, Canada; Western Univ, Robarts Res Inst, London, ON N6A 4V2, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Joy, TR (corresponding author), Western Univ, Schulich Sch Med & Dent, B5-107,268 Grosvenor St, London, ON N6A 4V2, Canada.	tisjoy@hotmail.com	Joy, Tisha/X-3564-2019; Mahon, Jeff/G-3324-2011; Zou, Guangyong/K-6408-2013; Hegele, Robert/G-3301-2011; Hegele, Robert/AAF-6482-2020; Joy, Tisha/G-3311-2011	Zou, Guangyong/0000-0001-5773-4185; Hegele, Robert/0000-0003-2861-5325; 	Western University, London, Ontario, Canada	Western University, London, Ontario, Canada	Primary Funding Source: Western University, London, Ontario, Canada.	Ballantyne CM, 2003, ARCH INTERN MED, V163, P553, DOI 10.1001/archinte.163.5.553; Bays H, 2006, AM J CARDIOL, V97, p6C, DOI 10.1016/j.amjcard.2005.12.006; Bellosta S, 2012, EXPERT OPIN DRUG SAF, V11, P933, DOI 10.1517/14740338.2012.712959; Breivik H, 2008, BRIT J ANAESTH, V101, P17, DOI 10.1093/bja/aen103; Cham S, 2010, PHARMACOTHERAPY, V30, P541, DOI 10.1592/phco.30.6.541; Cohen JD, 2012, J CLIN LIPIDOL, V6, P208, DOI 10.1016/j.jacl.2012.03.003; Duan NH, 2013, J CLIN EPIDEMIOL, V66, pS21, DOI 10.1016/j.jclinepi.2013.04.006; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Fung EC, 2012, CARDIOVASC THER, V30, pe212, DOI 10.1111/j.1755-5922.2011.00267.x; Gallagher EJ, 2001, ANN EMERG MED, V38, P633, DOI 10.1067/mem.2001.118863; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Guyatt G, 2008, USERS GUIDES MED LIT, P179; Ho PM, 2008, AM HEART J, V155, P772, DOI 10.1016/j.ahj.2007.12.011; JOHANNESSEN T, 1991, FAM PRACT, V8, P384, DOI 10.1093/fampra/8.4.384; Joy TR, 2009, ANN INTERN MED, V150, P858, DOI 10.7326/0003-4819-150-12-200906160-00009; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; Lamperti C, 2005, ARCH NEUROL-CHICAGO, V62, P1709, DOI 10.1001/archneur.62.11.1709; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; Lillie EO, 2011, PERS MED, V8, P161, DOI 10.2217/PME.11.7; Mahon J, 1996, BRIT MED J, V312, P1069; Mahon JL, 1999, CHEST, V115, P38, DOI 10.1378/chest.115.1.38; Mohaupt MG, 2009, CAN MED ASSOC J, V181, pE11, DOI 10.1503/cmaj.081785; Nikles CJ, 2006, PEDIATRICS, V117, P2040, DOI 10.1542/peds.2005-1328; Parker BA, 2013, J CLIN LIPIDOL, V7, P187, DOI 10.1016/j.jacl.2013.02.002; Pasternak RC, 2002, J AM COLL CARDIOL, V40, P567, DOI 10.1016/S0735-1097(02)02030-2; Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Todd KH, 1996, ANN EMERG MED, V27, P485, DOI 10.1016/S0196-0644(96)70238-X; *U TX MD AND CANC, 2013, BRIEF PAIN INV BPI; Wei L, 2002, HEART, V88, P229, DOI 10.1136/heart.88.3.229; Williams VSL, 2006, J PAIN SYMPTOM MANAG, V31, P48, DOI 10.1016/j.jpainsymman.2005.06.008; Yelland MJ, 2007, RHEUMATOLOGY, V46, P135, DOI 10.1093/rheumatology/kel195; Yelland MJ, 2009, PAIN MED, V10, P754, DOI 10.1111/j.1526-4637.2009.00615.x; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004; Zucker DR, 2010, J CLIN EPIDEMIOL, V63, P1312, DOI 10.1016/j.jclinepi.2010.04.020	36	85	86	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2014	160	5					301	+		10.7326/M13-1921	http://dx.doi.org/10.7326/M13-1921			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC8OT	24737272				2022-12-28	WOS:000332793900002
J	Roumelioti, ME; Unruh, M				Roumelioti, Maria-Eleni; Unruh, Mark			Update in Nephrology: Evidence Published in 2013	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Roumelioti, Maria-Eleni; Unruh, Mark] Univ New Mexico, MSC 10-5550,1 Univ New Mexico, Albuquerque, NM 87131 USA	University of New Mexico	Unruh, M (corresponding author), Univ New Mexico, Dept Internal Med, Div Nephrol, MSC 10-5550,1 Univ New Mexico, Albuquerque, NM 87131 USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2014	161	1					54	+		10.7326/M14-0263	http://dx.doi.org/10.7326/M14-0263			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V44NZ	24723262				2022-12-28	WOS:000209757000001
J	Rajkumar, R; Conway, PH; Tavenner, M				Rajkumar, Rahul; Conway, Patrick H.; Tavenner, Marilyn			CMS-Engaging Multiple Payers in Payment Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rajkumar, Rahul; Conway, Patrick H.; Tavenner, Marilyn] Ctr Medicare & Medicaid Serv, Washington, DC 20201 USA; [Rajkumar, Rahul] Brigham & Womens Hosp, Boston, MA 02115 USA; [Conway, Patrick H.] Cincinnati Childrens Hosp, Cincinnati, OH USA	Centers for Medicare & Medicaid Services; Harvard University; Brigham & Women's Hospital; Cincinnati Children's Hospital Medical Center	Rajkumar, R (corresponding author), Ctr Medicare & Medicaid Serv, 200 Independence Ave SW, Washington, DC 20201 USA.	rahul.rajkumar@cms.hhs.gov						Cavanaugh S, 2010, MULTIPAYER APPROACH; Mayes R, 2008, MEDICARE PROSPECTIVE; Song ZR, 2013, JAMA-J AM MED ASSOC, V309, P35, DOI 10.1001/jama.2012.96870; Toussaint J, 2013, JAMA-J AM MED ASSOC, V310, P1341, DOI 10.1001/jama.2013.279149	4	82	82	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2014	311	19					1967	1968		10.1001/jama.2014.3703	http://dx.doi.org/10.1001/jama.2014.3703			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UA	24752342				2022-12-28	WOS:000336122800014
J	Meunier, E; Dick, MS; Dreier, RF; Schurmann, N; Broz, DK; Warming, S; Roose-Girma, M; Bumann, D; Kayagaki, N; Takeda, K; Yamamoto, M; Broz, P				Meunier, Etienne; Dick, Mathias S.; Dreier, Roland F.; Schuermann, Nura; Broz, Daniela Kenzelmann; Warming, Soren; Roose-Girma, Merone; Bumann, Dirk; Kayagaki, Nobuhiko; Takeda, Kiyoshi; Yamamoto, Masahiro; Broz, Petr			Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases	NATURE			English	Article							NONCANONICAL INFLAMMASOME ACTIVATION; TOXOPLASMA-GONDII; HOST-DEFENSE; IMMUNITY; SALMONELLA; INFECTION; AUTOPHAGY; NLRP3; RESISTANCE; PROTECTS	Lipopolysaccharide from Gram-negative bacteria is sensed in the host cell cytoplasm by a non-canonical inflammasome pathway that ultimately results in caspase-11 activation and cell death(1-3). In mouse macrophages, activation of this pathway requires the production of type-I interferons(4,5), indicating that interferon-induced genes have a critical role in initiating this pathway. Here we report that a cluster of small interferon-inducible GTPases, the so-called guanylate-binding proteins, is required for the full activity of the non-canonical caspase-11 inflammasome during infections with vacuolar Gram-negative bacteria. We show that guanylate-binding proteins are recruited to intracellular bacterial pathogens and are necessary to induce the lysis of the pathogen-containing vacuole. Lysis of the vacuole releases bacteria into the cytosol, thus allowing the detection of their lipopolysaccharide by a yet unknown lipopolysaccharide sensor. Moreover, recognition of the lysed vacuole by the danger sensor galectin-8 initiates the uptake of bacteria into autophagosomes, which results in a reduction of caspase-11 activation. These results indicate that host-mediated lysis of pathogen-containing vacuoles is an essential immune function and is necessary for efficient recognition of pathogens by inflammasome complexes in the cytosol.	[Meunier, Etienne; Dick, Mathias S.; Dreier, Roland F.; Schuermann, Nura; Bumann, Dirk; Broz, Petr] Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland; [Broz, Daniela Kenzelmann] Univ Basel, Dept Biomed, CH-4056 Basel, Switzerland; [Warming, Soren; Roose-Girma, Merone; Kayagaki, Nobuhiko] Genentech Inc, San Francisco, CA 94080 USA; [Takeda, Kiyoshi; Yamamoto, Masahiro] Osaka Univ, Dept Microbiol & Immunol, Suita, Osaka 5650871, Japan	University of Basel; University of Basel; Roche Holding; Genentech; Osaka University	Broz, P (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland.	petr.broz@unibas.ch	Broz, Petr/AAC-7940-2019; Takeda, Kiyoshi/C-9331-2009; Warming, Soren/ABD-5729-2021	Broz, Petr/0000-0002-2334-7790; Warming, Soren/0000-0002-5721-0741; Takeda, Kiyoshi/0000-0002-1778-6332; Dick, Mathias/0000-0002-4070-9749	SNSF [PP00P3_139120/1]; University of Basel [ID2153162]; Marie Heim-Voegtlin Fellowship [145516]	SNSF(Swiss National Science Foundation (SNSF)); University of Basel; Marie Heim-Voegtlin Fellowship	We thank N. Mizushima and S. Virgin for Atg5-deficient BMDMs, K. Pfeffer for Gbp2-deficient BMDMs, J. Frey for B. thailandensis, the Biozentrum Proteomics and Imaging Core Facilities for technical assistance, K. Anderson, T. Soukup, R. Schwingendorf, J. C. Cox, V. M. Dixit for reagents and N. Personnic for discussions. This work was supported by an SNSF Professorship PP00P3_139120/1, University of Basel project grant ID2153162 to P. B. and a Marie Heim-Voegtlin Fellowship 145516 to D.K.B.	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Burton NA, 2014, CELL HOST MICROBE, V15, P72, DOI 10.1016/j.chom.2013.12.006; Case CL, 2013, P NATL ACAD SCI USA, V110, P1851, DOI 10.1073/pnas.1211521110; Casson CN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003400; Coers J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003538; Degrandi D, 2013, P NATL ACAD SCI USA, V110, P294, DOI 10.1073/pnas.1205635110; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Haldar AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003414; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Lima DS, 2013, NAT MED, V19, P909, DOI 10.1038/nm.3221; MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Paetzold S, 2007, INFECT IMMUN, V75, P4826, DOI 10.1128/IAI.00454-07; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Traver MK, 2011, J BIOL CHEM, V286, P30471, DOI 10.1074/jbc.M111.251967; VanCott JL, 1998, NAT MED, V4, P1247, DOI 10.1038/3227; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	26	316	327	3	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					366	+		10.1038/nature13157	http://dx.doi.org/10.1038/nature13157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24739961				2022-12-28	WOS:000336121200040
J	Armstrong, AC; Evans, GD				Armstrong, Anne C.; Evans, Gareth D.			Management of women at high risk of breast cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BRCA2 MUTATION CARRIERS; REDUCING SALPINGO-OOPHORECTOMY; CONTRALATERAL MASTECTOMY; REDUCTION; SURVIVAL; UK; METAANALYSIS; MAMMOGRAPHY; POPULATION; TIME		[Armstrong, Anne C.] Christie Hosp Manchester, Dept Oncol, Manchester, Lancs, England; [Evans, Gareth D.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester Ctr Genom Med, Manchester, Lancs, England; [Evans, Gareth D.] Cent Manchester Fdn Trust, St Marys Hosp, Dept Med Genet, Manchester, Lancs, England	Christie NHS Foundation Trust; Christie Hospital; University of Manchester; University of Manchester	Armstrong, AC (corresponding author), Christie Hosp Manchester, Dept Oncol, Manchester, Lancs, England.	anne.armstrong@christie.nhs.uk	Evans, D Gareth/AAB-4308-2022	Evans, D Gareth/0000-0002-8482-5784; Armstrong, Anne/0000-0002-0774-7006				Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2008, J MED GENET, V45, P425, DOI 10.1136/jmg.2007.056556; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; de Gonzalez A, 2009, JNCI-J NATL CANCER I, V101, P205, DOI 10.1093/jnci/djn440; Cancer Research UK, 2012, BREAST CANCER INCIDE; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Cuzick J, 2014, LANCET, V383, P1041, DOI 10.1016/S0140-6736(13)62292-8; Cuzick J, 2013, LANCET, V381, P1827, DOI 10.1016/S0140-6736(13)60140-3; Evans DGR, 2009, J MED GENET, V46, P811, DOI 10.1136/jmg.2009.067850; Evans DG, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-155; Evans DGR, 2013, APPL CLIN GENET, V6, P53, DOI 10.2147/TACG.S35605; Evans DGR, 2013, BREAST CANCER RES TR, V140, P135, DOI 10.1007/s10549-013-2583-1; Fakkert IE, 2012, CANCER PREV RES, V5, P1291, DOI 10.1158/1940-6207.CAPR-12-0190; Hallowell N, 2012, FAM CANCER, V11, P215, DOI 10.1007/s10689-011-9504-4; Harris H, 2011, FAM CANCER, V10, P501, DOI 10.1007/s10689-011-9434-1; Heemskerk-Gerritsen BAM, 2013, ANN ONCOL, V24, P2029, DOI 10.1093/annonc/mdt134; Ingham SL, 2013, BREAST CANCER RES TR, V142, P611, DOI 10.1007/s10549-013-2765-x; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; Lalloo F, 2012, CLIN GENET, V82, P105, DOI 10.1111/j.1399-0004.2012.01859.x; Leach MO, 2005, LANCET, V365, P1769, DOI 10.1016/S0140-6736(05)66481-1; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Mavaddat N, 2012, CANCER EPIDEM BIOMAR, V21, P134, DOI 10.1158/1055-9965.EPI-11-0775; Metcalfe K, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g226; Montgomery LL, 1999, ANN SURG ONCOL, V6, P546, DOI 10.1007/s10434-999-0542-1; Moyer VA, 2013, ANN INTERN MED, V159, P698, DOI [10.7326/0003-4819-159-10-201311190-00717, 10.7326/0003-4819-159-10-201311190-00718]; National Institute for Health and Care Excellence, 2013, CLIN GUID; Papelard H, 2000, BRIT J CANCER, V83, P719, DOI 10.1054/bjoc.2000.1331; Parkin DM, 2011, BRIT J CANCER, V105, pS77, DOI 10.1038/bjc.2011.489; Ralleigh G, 2004, CLIN RADIOL, V59, P647, DOI 10.1016/j.crad.2004.04.003; Rebbeck TR, 2009, JNCI-J NATL CANCER I, V101, P80, DOI 10.1093/jnci/djn442; Rebbeck TR, 2005, J CLIN ONCOL, V23, P7804, DOI 10.1200/JCO.2004.00.8151; Rebbeck TR, 2004, J CLIN ONCOL, V22, P1055, DOI 10.1200/JCO.2004.04.188; Reid DM, 2008, CANCER TREAT REV, V34, pS3, DOI 10.1016/j.ctrv.2008.03.007; Rubinstein Wendy S, 2004, Fam Cancer, V3, P249, DOI 10.1007/s10689-004-9550-2; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Swerdlow AJ, 2012, J CLIN ONCOL, V30, P2745, DOI 10.1200/JCO.2011.38.8835; Turkoz FP, 2013, BREAST, V22, P344, DOI 10.1016/j.breast.2012.08.005; Tyrer J, 2004, STAT MED, V23, P1111, DOI 10.1002/sim.1668; Warner E, 2008, ANN INTERN MED, V148, P671, DOI 10.7326/0003-4819-148-9-200805060-00007; Waters EA, 2012, BREAST CANCER RES TR, V134, P875, DOI 10.1007/s10549-012-2089-2	40	21	21	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2014	348								g2756	10.1136/bmj.g2756	http://dx.doi.org/10.1136/bmj.g2756			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5PN	24778341				2022-12-28	WOS:000335471000002
J	Berndt, A; Lee, SY; Ramakrishnan, C; Deisseroth, K				Berndt, Andre; Lee, Soo Yeun; Ramakrishnan, Charu; Deisseroth, Karl			Structure-Guided Transformation of Channelrhodopsin into a Light-Activated Chloride Channel	SCIENCE			English	Article							POTASSIUM CHANNELS; GREEN-ALGAE; HALOBACTERIUM-HALOBIUM; ION SELECTIVITY; OPTICAL CONTROL; CATION CHANNEL; K+ CHANNEL; OPTOGENETICS; INHIBITION; EXCITATION	Using light to silence electrical activity in targeted cells is a major goal of optogenetics. Available optogenetic proteins that directly move ions to achieve silencing are inefficient, pumping only a single ion per photon across the cell membrane rather than allowing many ions per photon to flow through a channel pore. Building on high-resolution crystal-structure analysis, pore vestibule modeling, and structure-guided protein engineering, we designed and characterized a class of channelrhodopsins (originally cation-conducting) converted into chloride-conducting anion channels. These tools enable fast optical inhibition of action potentials and can be engineered to display step-function kinetics for stable inhibition, outlasting light pulses and for orders-of-magnitude-greater light sensitivity of inhibited cells. The resulting family of proteins defines an approach to more physiological, efficient, and sensitive optogenetic inhibition.	[Berndt, Andre; Lee, Soo Yeun; Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Ritter, Stefanie L/D-9312-2012	Berndt, Andre/0000-0003-4758-5598	National Institute of Mental Health; Simons Foundation Autism Research Initiative; National Institute on Drug Abuse; Defense Advanced Research Projects Agency; Gatsby Charitable Foundation; Wiegers Family Fund; German Academic Exchange Service (DAAD); Fidelity Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086373, R01MH075957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA035377, R01DA020794] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation Autism Research Initiative; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Gatsby Charitable Foundation; Wiegers Family Fund; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Fidelity Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank C. Perry and H. Swanson for technical assistance, the entire Deisseroth laboratory for helpful discussions, and T. Jardetzky for use of a Biotek Synergy4 plate reader. K. D. is supported by the National Institute of Mental Health, the Simons Foundation Autism Research Initiative, the National Institute on Drug Abuse, the Defense Advanced Research Projects Agency, the Gatsby Charitable Foundation, and the Wiegers Family Fund. A. B. received support from the German Academic Exchange Service (DAAD), and S.Y.L. received support from the Fidelity Foundation. Optogenetic tools and methods reported in this paper are distributed and supported freely (www.optogenetics.org).	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Andrews-Zwilling Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040555; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2010, BIOPHYS J, V98, P753, DOI 10.1016/j.bpj.2009.10.052; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bichet D, 2006, P NATL ACAD SCI USA, V103, P14355, DOI 10.1073/pnas.0606660103; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Clapham DE, 2003, PHARMACOL REV, V55, P591, DOI 10.1124/pr.55.4.6; Deisseroth K, 2014, NATURE, V505, P309, DOI 10.1038/nature12982; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; Geibel S, 2001, BIOPHYS J, V81, P2059, DOI 10.1016/S0006-3495(01)75855-9; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; Herman AM, 2014, ELIFE, V3, DOI 10.7554/eLife.01481; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Liske H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03110; MATSUNOYAGI A, 1977, BIOCHEM BIOPH RES CO, V78, P237, DOI 10.1016/0006-291X(77)91245-1; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nimigean CM, 2003, BIOCHEMISTRY-US, V42, P9263, DOI 10.1021/bi0348720; Nonnengasser C, 1996, BIOPHYS J, V70, P932, DOI 10.1016/S0006-3495(96)79636-4; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; Packer AM, 2013, NAT NEUROSCI, V16, P805, DOI 10.1038/nn.3427; Prakash R, 2012, NAT METHODS, V9, P1171, DOI 10.1038/NMETH.2215; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Sauer DB, 2011, P NATL ACAD SCI USA, V108, P16634, DOI 10.1073/pnas.1111688108; Seki A, 2007, BIOPHYS J, V92, P2559, DOI 10.1529/biophysj.106.093153; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	41	251	288	2	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					420	424		10.1126/science.1252367	http://dx.doi.org/10.1126/science.1252367			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763591	Green Accepted			2022-12-28	WOS:000334867800043
J	Quimby, RM; Oguri, M; More, A; More, S; Moriya, TJ; Werner, MC; Tanaka, M; Folatelli, G; Bersten, MC; Maeda, K; Nomoto, K				Quimby, Robert M.; Oguri, Masamune; More, Anupreeta; More, Surhud; Moriya, Takashi J.; Werner, Marcus C.; Tanaka, Masayuki; Folatelli, Gaston; Bersten, Melina C.; Maeda, Keiichi; Nomoto, Ken'ichi			Detection of the Gravitational Lens Magnifying a Type Ia Supernova	SCIENCE			English	Article							LUMINOUS SUPERNOVAE; SUPERLUMINOUS SUPERNOVA; LIGHT CURVES; GALAXIES; PS1-10AFX; MASSES	Objects of known brightness, like type la supernovae (SNIa), can be used to measure distances. If a massive object warps spacetime to form multiple images of a background SNIa, a direct test of cosmic expansion is also possible. However, these lensing events must first be distinguished from other rare phenomena. Recently, a supernova was found to shine much brighter than normal for its distance, which resulted in a debate: Was it a new type of superluminous supernova or a normal SNIa magnified by a hidden gravitational lens? Here, we report that a spectrum obtained after the supernova faded away shows the presence of a foreground galaxy-the first found to strongly magnify a SNIa. We discuss how more lensed SNIa can be found than previously predicted.	[Quimby, Robert M.; Oguri, Masamune; More, Anupreeta; More, Surhud; Werner, Marcus C.; Folatelli, Gaston; Bersten, Melina C.; Nomoto, Ken'ichi] Univ Tokyo, Kavli Inst Phys & Math Universe WPI, Todai Inst Adv Study, Kashiwa, Chiba 2778583, Japan; [Oguri, Masamune] Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; [Moriya, Takashi J.] Univ Bonn, Argelander Inst Astron, D-53121 Bonn, Germany; [Moriya, Takashi J.] Univ Tokyo, Res Ctr Early Universe, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Werner, Marcus C.] Duke Univ, Dept Math, Durham, NC 27708 USA; [Tanaka, Masayuki] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Maeda, Keiichi] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan	University of Tokyo; University of Tokyo; University of Bonn; University of Tokyo; Duke University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Kyoto University	Quimby, RM (corresponding author), Univ Tokyo, Kavli Inst Phys & Math Universe WPI, Todai Inst Adv Study, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778583, Japan.	robert.quimby@ipmu.jp	Werner, Marcus/G-2688-2011; More, Surhud/AAX-3636-2021; Oguri, Masamune/C-6230-2011; More, Surhud/A-5049-2013	More, Surhud/0000-0002-2986-2371; More, Surhud/0000-0002-2986-2371; Folatelli, Gaston/0000-0001-5247-1486; Moriya, Takashi/0000-0003-1169-1954; Maeda, Keiichi/0000-0003-2611-7269	Japan Society for the Promotion of Science (JSPS) [24740118]; World Premier International Research Center Initiative, Ministry of Education, Culture, Sports, Science and Technology, Japan; FIRST program; Subaru Measurements of Images and Redshifts project; JSPS [23-5929]; W. M. Keck Foundation; Grants-in-Aid for Scientific Research [12F02322] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); World Premier International Research Center Initiative, Ministry of Education, Culture, Sports, Science and Technology, Japan; FIRST program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Subaru Measurements of Images and Redshifts project; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); W. M. Keck Foundation(W.M. Keck Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Kakenhi Grant-in-Aid for Young Scientists (B)(24740118) from the Japan Society for the Promotion of Science (JSPS); the World Premier International Research Center Initiative, Ministry of Education, Culture, Sports, Science and Technology, Japan; the FIRST program; the Subaru Measurements of Images and Redshifts project; and the JSPS Research Fellowship for Young Scientists (23-5929). The data presented herein were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California, and NASA. The Observatory was made possible by the generous financial support of the W. M. Keck Foundation. The data presented in this paper are available from the Weizmann Interactive Supernova Data Repository (www.weizmann.ac.il/astrophysics/wiserep).	BARKAT Z, 1967, PHYS REV LETT, V18, P379, DOI 10.1103/PhysRevLett.18.379; Blanton MR, 2005, ASTRON J, V129, P2562, DOI 10.1086/429803; Chevalier RA, 2011, ASTROPHYS J LETT, V729, DOI 10.1088/2041-8205/729/1/L6; Chornock R, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/162; Erb DK, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/26; Gal-Yam A, 2012, SCIENCE, V337, P927, DOI 10.1126/science.1203601; Hicken M, 2009, ASTROPHYS J, V700, P1097, DOI 10.1088/0004-637X/700/2/1097; Kasen D, 2010, ASTROPHYS J, V717, P245, DOI 10.1088/0004-637X/717/1/245; Kauffmann G, 2003, MON NOT R ASTRON SOC, V341, P33, DOI 10.1046/j.1365-8711.2003.06291.x; Moriya TJ, 2013, MON NOT R ASTRON SOC, V428, P1020, DOI 10.1093/mnras/sts075; Oguri M, 2003, MON NOT R ASTRON SOC, V338, pL25, DOI 10.1046/j.1365-8711.2003.06290.x; Oguri M, 2010, MON NOT R ASTRON SOC, V405, P2579, DOI 10.1111/j.1365-2966.2010.16639.x; OKE JB, 1995, PUBL ASTRON SOC PAC, V107, P375, DOI 10.1086/133562; Quimby RM, 2013, ASTROPHYS J LETT, V768, DOI 10.1088/2041-8205/768/1/L20; RAKAVY G, 1967, ASTROPHYS J, V150, P131, DOI 10.1086/149318; REFSDAL S, 1964, MON NOT R ASTRON SOC, V128, P307, DOI 10.1093/mnras/128.4.307; Rockosi C., 2010, SPIE C SERIES, V7735; Woosley SE, 2007, NATURE, V450, P390, DOI 10.1038/nature06333; Woosley SE, 2010, ASTROPHYS J LETT, V719, pL204, DOI 10.1088/2041-8205/719/2/L204	22	66	66	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					396	399		10.1126/science.1250903	http://dx.doi.org/10.1126/science.1250903			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763586	Green Submitted, Green Published			2022-12-28	WOS:000334867800036
J	Franz, HB; Kim, ST; Farquhar, J; Day, JMD; Economos, RC; McKeegan, KD; Schmitt, AK; Irving, AJ; Hoek, J; Dottin, J				Franz, Heather B.; Kim, Sang-Tae; Farquhar, James; Day, James M. D.; Economos, Rita C.; McKeegan, Kevin D.; Schmitt, Axel K.; Irving, Anthony J.; Hoek, Joost; Dottin, James, III			Isotopic links between atmospheric chemistry and the deep sulphur cycle on Mars	NATURE			English	Article							LOS-ANGELES; PETROGENESIS; METEORITE; NAKHLITES; ASSEMBLAGES; COMPONENTS; REGOLITH; ALH84001; SULFATE	The geochemistry of Martian meteorites provides a wealth of information about the solid planet and the surface and atmospheric processes that occurred on Mars. The degree to which Martian magmas may have assimilated crustal material, thus altering the geochemical signatures acquired from their mantle sources, is unclear(1). This issue features prominently in efforts to understand whether the source of light rare-earth elements in enriched shergottites lies in crustal material incorporated into melts(1,2) or in mixing between enriched and depleted mantle reservoirs(3). Sulphur isotope systematics offer insight into some aspects of crustal assimilation. The presence of igneous sulphides in Martian meteorites with sulphur isotope signatures indicative of mass-independent fractionation suggests the assimilation of sulphur both during passage of magmas through the crust of Mars and at sites of emplacement. Here we report isotopic analyses of 40 Martian meteorites that represent more than half of the distinct known Martian meteorites, including 30 shergottites (28 plus 2 pairs, where pairs are separate fragments of a single meteorite), 8 nakhlites (5 plus 3 pairs), Allan Hills 84001 and Chassigny. Our data provide strong evidence that assimilation of sulphur into Martian magmas was a common occurrence throughout much of the planet's history. The signature of mass-independent fractionation observed also indicates that the atmospheric imprint of photochemical processing preserved in Martian meteoritic sulphide and sulphate is distinct from that observed in terrestrial analogues, suggesting fundamental differences between the dominant sulphur chemistry in the atmosphere of Mars and that in the atmosphere of Earth(4).	[Franz, Heather B.] NASA, Goddard Space Flight Ctr, Ctr Res & Explorat Space Sci & Technol, Greenbelt, MD 20771 USA; [Franz, Heather B.; Farquhar, James; Hoek, Joost; Dottin, James, III] Univ Maryland, Dept Geol, College Pk, MD 20742 USA; [Franz, Heather B.; Farquhar, James; Hoek, Joost; Dottin, James, III] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; [Kim, Sang-Tae] McMaster Univ, Sch Geog & Earth Sci, Hamilton, ON L8S 4K1, Canada; [Day, James M. D.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Economos, Rita C.; McKeegan, Kevin D.; Schmitt, Axel K.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Irving, Anthony J.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; McMaster University; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle	Franz, HB (corresponding author), NASA, Goddard Space Flight Ctr, Ctr Res & Explorat Space Sci & Technol, Greenbelt, MD 20771 USA.	heather.b.franz@nasa.gov	McKeegan, Kevin D/A-4107-2008; Franz, Heather B/F-3508-2012; Kim, Sang-Tae/A-1406-2008; Kim, Sang-Tae/C-2768-2013; Day, James/A-5099-2010	McKeegan, Kevin D/0000-0002-1827-729X; Kim, Sang-Tae/0000-0002-5639-3750; Schmitt, Axel/0000-0002-9029-4211; Day, James/0000-0001-9520-3465	US National Science Foundation Instrumentation and Facilities Program; NASA Cosmochemistry grants [NNX09AF72G, NNX13AL13G]	US National Science Foundation Instrumentation and Facilities Program; NASA Cosmochemistry grants	We acknowledge the Meteorite Working Group, L. Welzenbach, T. McCoy, S. Ralew, M. N. Rao, L. Nyquist, J. Zipfel, C. Smith, H. Kojima, A. Treiman, T. Bunch and B. Zanda for providing meteorite samples analysed in this study. We also thank P. Piccoli for assistance with electron microprobe analyses. The manuscript benefited from independent reviews by M. Thiemens, P. Cartigny, S. Ono, D. Johnston and B. Wing during revision. The UCLA ion microprobe facility is partly supported by a grant from the US National Science Foundation Instrumentation and Facilities Program. This work was supported by NASA Cosmochemistry grants NNX09AF72G and NNX13AL13G to J.F.	[Anonymous], 1989, P 19 LUN PLAN SCI C; [Anonymous], MARTIAN SURFACE COMP; Baroni M, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010185; Borg LE, 1997, GEOCHIM COSMOCHIM AC, V61, P4915, DOI 10.1016/S0016-7037(97)00276-7; Bridges JC, 2000, EARTH PLANET SC LETT, V176, P267, DOI 10.1016/S0012-821X(00)00019-4; Day JMD, 2006, METEORIT PLANET SCI, V41, P581, DOI 10.1111/j.1945-5100.2006.tb00484.x; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2000, NATURE, V404, P50, DOI 10.1038/35003517; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; Farquhar J, 2007, EARTH PLANET SC LETT, V264, P1, DOI 10.1016/j.epsl.2007.08.006; FORREST J, 1977, ANAL CHEM, V49, P1579, DOI 10.1021/ac50019a030; GAO X, 1993, GEOCHIM COSMOCHIM AC, V57, P3159, DOI 10.1016/0016-7037(93)90300-L; Gao X., 1991, GEOCHIM COSMOCHIM AC, V55, P2671, DOI DOI 10.1016/0016-7037(91)90381-E; Greenwood JP, 2000, EARTH PLANET SC LETT, V184, P23, DOI 10.1016/S0012-821X(00)00301-0; Gross J, 2013, METEORIT PLANET SCI, V48, P854, DOI 10.1111/maps.12092; Hallis LJ, 2011, METEORIT PLANET SCI, V46, P1787, DOI 10.1111/j.1945-5100.2011.01293.x; Herd CDK, 2002, GEOCHIM COSMOCHIM AC, V66, P2025, DOI 10.1016/S0016-7037(02)00828-1; HULSTON JR, 1965, J GEOPHYS RES, V70, P3475, DOI 10.1029/JZ070i014p03475; Irving A. J., 2011, METEORIT PLANET SCI, V46, pA108; Jambon A., 2010, P LUNAR PLANET SCI C, V41, P1696; Labidi J, 2013, NATURE, V501, P208, DOI 10.1038/nature12490; Labidi J, 2012, CHEM GEOL, V334, P189, DOI 10.1016/j.chemgeo.2012.10.028; Mayer B., 2004, HDB STABLE ISOTOPE A, P538, DOI [10.1016/B978-044451114-0/50028-4, DOI 10.1016/B978-044451114-0/50028-4]; MCSWEEN HY, 1994, METEORITICS, V29, P757, DOI 10.1111/j.1945-5100.1994.tb01092.x; Mikouchi T., 2002, P LUNAR PLANET SCI C, V31; Mikouchi T., 2004, ANTARCT METEORITE RE, V17, P13; Mikouchi T., 2006, P LUNAR PLANET SCI C, V37; MITTLEFEHLDT DW, 1994, METEORITICS, V29, P214, DOI 10.1111/j.1945-5100.1994.tb00673.x; Rai VK, 2007, GEOCHIM COSMOCHIM AC, V71, P1341, DOI 10.1016/j.gca.2006.11.033; Rai VK, 2005, SCIENCE, V309, P1062, DOI 10.1126/science.1112954; Rubin AE, 2000, GEOLOGY, V28, P1011, DOI 10.1130/0091-7613(2000)28<1011:LATMDB>2.0.CO;2; Sarbadhikari AB, 2009, GEOCHIM COSMOCHIM AC, V73, P2190, DOI 10.1016/j.gca.2009.01.012; Shearer CK, 1996, GEOCHIM COSMOCHIM AC, V60, P2921, DOI 10.1016/0016-7037(96)00165-2; Shih C.-Y., 2010, P LUNAR PLANET SCI C, V41, P1367; Shirai N., 2008, P LUNAR PLANET SCI C, V39, P1643; THODE HG, 1961, GEOCHIM COSMOCHIM AC, V25, P159, DOI 10.1016/0016-7037(61)90074-6; Udry A, 2012, METEORIT PLANET SCI, V47, P1575, DOI 10.1111/j.1945-5100.2012.01420.x; Warren PH, 2004, METEORIT PLANET SCI, V39, P137, DOI 10.1111/j.1945-5100.2004.tb00054.x	38	85	88	1	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					364	+		10.1038/nature13175	http://dx.doi.org/10.1038/nature13175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24740066	Green Published			2022-12-28	WOS:000334403000045
J	Sole, R; Macia, J				Sole, Ricard; Macia, Javier			Biocircuits in synchrony	NATURE			English	Editorial Material									[Sole, Ricard; Macia, Javier] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona 08003, Spain	Pompeu Fabra University	Sole, R (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona 08003, Spain.	ricard.sole@upf.edu; javier.macia@upf.edu	Solé, Ricard/I-3379-2015	Sole, Ricard/0000-0001-6974-1008				Cookson NA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.94; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Kwok R, 2010, NATURE, V463, P288, DOI 10.1038/463288a; Oklobdzija V., 2003, DIGITAL SYSTEM CLOCK; Prindle A, 2014, NATURE, V508, P387, DOI 10.1038/nature13238; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Sole RV, 2013, NAT COMPUT, V12, P485, DOI 10.1007/s11047-013-9380-y; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565	10	2	2	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					326	327		10.1038/nature13224	http://dx.doi.org/10.1038/nature13224			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24717436				2022-12-28	WOS:000334403000036
J	Ladizinski, B; Lee, KC				Ladizinski, Barry; Lee, Kachiu C.			A Nodular Protuberance on the Hard Palate	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TORUS PALATINUS		[Ladizinski, Barry] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21201 USA; [Lee, Kachiu C.] Brown Univ, Dept Dermatol, Providence, RI 02912 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Brown University	Ladizinski, B (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 300 N Charles St,Ste 304, Baltimore, MD 21201 USA.	barryladizinski@gmail.com						Beena JP, 2012, J DENT CHILD, V79, P181; Cantin M, 2011, CLIN ANAT, V24, P789, DOI 10.1002/ca.21202; Garcia-Garcia AS, 2010, MED ORAL PATOL ORAL, V15, pE353, DOI 10.4317/medoral.15.e353	3	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2014	311	15					1558	1559		10.1001/jama.2014.271	http://dx.doi.org/10.1001/jama.2014.271			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9DX	24737369				2022-12-28	WOS:000334306000024
J	McLeod, DSA; Caturegli, P; Cooper, DS; Matos, PG; Hutfless, S				McLeod, Donald S. A.; Caturegli, Patrizio; Cooper, David S.; Matos, Peter G.; Hutfless, Susan			Variation in Rates of Autoimmune Thyroid Disease by Race/Ethnicity in US Military Personnel	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							SURVEY NHANES-III; NATIONAL-HEALTH; PREVALENCE		[McLeod, Donald S. A.] QIMR Berghofer Med Res Inst, Dept Populat Hlth, Herston, Qld, Australia; [Caturegli, Patrizio] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Cooper, David S.] Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, Baltimore, MD USA; [Matos, Peter G.] US Army, Joint Munit Command Headquarters AMSJM HRS, Rock Isl, IL USA; [Hutfless, Susan] Johns Hopkins Univ, Sch Med, Div Gastroenterol & Hepatol, Baltimore, MD USA	QIMR Berghofer Medical Research Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	McLeod, DSA (corresponding author), Royal Brisbane Hosp, QIMR Berghofer Med Res Inst, QIMR Locked Bag 2000, Herston, Qld 4029, Australia.	donald.mcleod@qimrberghofer.edu.au	McLeod, Donald/ABC-6047-2021; McLeod, Donald/O-1051-2019; McLeod, Donald S. A./C-4242-2014	McLeod, Donald/0000-0003-1131-020X; McLeod, Donald S. A./0000-0003-1131-020X; Hutfless, Susan/0000-0002-6311-2611				Belin RM, 2004, J CLIN ENDOCR METAB, V89, P6077, DOI 10.1210/jc.2004-0431; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Holm IA, 2005, ARCH INTERN MED, V165, P1606, DOI 10.1001/archinte.165.14.1606; McLeod DSA, 2012, ENDOCRINE, V42, P252, DOI 10.1007/s12020-012-9703-2; Nelson JP, 2008, NICOTINE TOB RES, V10, P775, DOI 10.1080/14622200802027123; US Census Bureau, NAT INT EST 2000 201	6	60	65	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2014	311	15					1563	1565		10.1001/jama.2013.285606	http://dx.doi.org/10.1001/jama.2013.285606			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9DX	24737370				2022-12-28	WOS:000334306000025
J	Forth, S; Hsia, KC; Shimamoto, Y; Kapoor, TM				Forth, Scott; Hsia, Kuo-Chiang; Shimamoto, Yuta; Kapoor, Tarun M.			Asymmetric Friction of Nonmotor MAPs Can Lead to Their Directional Motion in Active Microtubule Networks	CELL			English	Article							PLUS-END TRACKING; CYTOPLASMIC DYNEIN; SELF-ORGANIZATION; NUCLEOTIDE STATE; MEIOTIC SPINDLE; CROSS-LINKERS; IN-VITRO; NUMA; BINDING; PROTEIN	Diverse cellular processes require microtubules to be organized into distinct structures, such as asters or bundles. Within these dynamic motifs, microtubule-associated proteins (MAPs) are frequently under load, but how force modulates these proteins' function is poorly understood. Here, we combine optical trapping with TIRF-based microscopy to measure the force dependence of microtubule interaction for three nonmotor MAPs ( NuMA, PRC1, and EB1) required for cell division. We find that frictional forces increase nonlinearly with MAP velocity across microtubules and depend on filament polarity, with NuMA's friction being lower when moving toward minus ends, EB1's lower toward plus ends, and PRC1's exhibiting no directional preference. Mathematical models predict, and experiments confirm, that MAPs with asymmetric friction can move directionally within actively moving microtubule pairs they crosslink. Our findings reveal how nonmotor MAPs can generate frictional resistance in dynamic cytoskeletal networks via micromechanical adaptations whose anisotropy may be optimized for MAP localization and function within cellular structures.	[Forth, Scott; Hsia, Kuo-Chiang; Shimamoto, Yuta; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA	Rockefeller University	Kapoor, TM (corresponding author), Rockefeller Univ, Lab Chem & Cell Biol, 1230 York Ave, New York, NY 10065 USA.	kapoor@rockefeller.edu	Shimamoto, Yuta/AAH-3281-2019; Hsia, Kuo-Chiang/AAS-8056-2021	Shimamoto, Yuta/0000-0003-0935-2793; Hsia, Kuo-Chiang/0000-0002-4409-6732; Forth, Scott/0000-0002-2630-8017	National Institutes of Health (NIH) [1S10RR023748-01]; NIH National Research Service Award Fellowship [F32GM099380]; Leukemia & Lymphoma Society; NIH [GM65933]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM099380, R01GM065933] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service Award Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank R. Subramanian for assistance with protein construct design, expression, and purification; D. Compton for the gift of NuMA cDNA; and K. Sato and M. Magnasco for helpful discussions about theoretical calculations. The SEC-LS/UV/RI instrumentation used for light-scattering analysis was supported by a National Institutes of Health (NIH) award (1S10RR023748-01). S.F. acknowledges postdoctoral support from an NIH National Research Service Award Fellowship (F32GM099380). K.-C.H. is supported by a Special Fellow Award from The Leukemia & Lymphoma Society. T.M.K. acknowledges support from the NIH (GM65933).	Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bieling P, 2010, CELL, V142, P420, DOI 10.1016/j.cell.2010.06.033; Bormuth V, 2009, SCIENCE, V325, P870, DOI 10.1126/science.1174923; Braun M, 2011, NAT CELL BIOL, V13, P1259, DOI 10.1038/ncb2323; Buey RM, 2011, MOL BIOL CELL, V22, P2912, DOI 10.1091/mbc.E11-01-0017; Bustamante C, 2001, ACCOUNTS CHEM RES, V34, P412, DOI 10.1021/ar0001719; COMPTON DA, 1992, J CELL BIOL, V116, P1395, DOI 10.1083/jcb.116.6.1395; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; GAGLIO T, 1995, J CELL BIOL, V131, P693, DOI 10.1083/jcb.131.3.693; Gaglio T, 1996, J CELL BIOL, V135, P399, DOI 10.1083/jcb.135.2.399; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Haren L, 2002, J CELL SCI, V115, P1815; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; Heald R, 1997, J CELL BIOL, V138, P615, DOI 10.1083/jcb.138.3.615; Hentrich C, 2010, J CELL BIOL, V189, P465, DOI 10.1083/jcb.200910125; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Jiang K, 2012, CURR BIOL, V22, P1800, DOI 10.1016/j.cub.2012.07.047; Jiang K, 2011, CURR OPIN CELL BIOL, V23, P94, DOI 10.1016/j.ceb.2010.08.008; Kisurina-Evgenieva O, 2004, J CELL SCI, V117, P6391, DOI 10.1242/jcs.01568; MAGNASCO MO, 1993, PHYS REV LETT, V71, P1477, DOI 10.1103/PhysRevLett.71.1477; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Mitchison TJ, 2013, MOL BIOL CELL, V24, P1559, DOI 10.1091/mbc.E12-12-0850; Mitchison TJ, 2001, NAT CELL BIOL, V3, pE17, DOI 10.1038/35050656; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Peterman EJG, 2009, CURR BIOL, V19, pR1089, DOI 10.1016/j.cub.2009.10.047; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Subramanian R, 2013, CELL, V154, P377, DOI 10.1016/j.cell.2013.06.021; Subramanian R, 2012, DEV CELL, V23, P874, DOI 10.1016/j.devcel.2012.10.011; Subramanian R, 2010, CELL, V142, P433, DOI 10.1016/j.cell.2010.07.012; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uemura S, 2002, P NATL ACAD SCI USA, V99, P5977, DOI 10.1073/pnas.092546199; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Vogel SK, 2009, PLOS BIOL, V7, P918, DOI 10.1371/journal.pbio.1000087; Weinger JS, 2011, CURR BIOL, V21, P154, DOI 10.1016/j.cub.2010.12.038; Wollman R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.23; Yang G, 2008, J CELL BIOL, V182, P631, DOI 10.1083/jcb.200801105; Yang G, 2007, NAT CELL BIOL, V9, P1233, DOI 10.1038/ncb1643; Zanic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007585	45	50	50	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					420	432		10.1016/j.cell.2014.02.018	http://dx.doi.org/10.1016/j.cell.2014.02.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725408	Green Accepted, Bronze			2022-12-28	WOS:000334304500015
J	Tiecke, TG; Thompson, JD; de Leon, NP; Liu, LR; Vuletic, V; Lukin, MD				Tiecke, T. G.; Thompson, J. D.; de Leon, N. P.; Liu, L. R.; Vuletic, V.; Lukin, M. D.			Nanophotonic quantum phase switch with a single atom	NATURE			English	Article							PHOTON; CAVITY; STATE; NETWORK; SHIFTS; LOGIC; LIGHT	By analogy to transistors in classical electronic circuits, quantum optical switches are important elements of quantum circuits and quantum networks(1-3). Operated at the fundamental limit where a single quantum of light or matter controls another field or material system(4), such a switch may enable applications such as long-distance quantum communication(5), distributed quantum information processing(2) and metrology(6), and the exploration of novel quantum states of matter(7). Here, by strongly coupling a photon to a single atom trapped in the near field of a nanoscale photonic crystal cavity, we realize a system in which a single atom switches the phase of a photon and a single photon modifies the atom's phase. We experimentally demonstrate an atom-induced optical phase shift(8) that is nonlinear at the two-photon level(9), a photon number router that separates individual photons and photon pairs into different output modes(10), and a single-photon switch in which a single 'gate' photon controls the propagation of a subsequent probe field(11,12). These techniques pave the way to integrated quantum nanophotonic networks involving multiple atomic nodes connected by guided light.	[Tiecke, T. G.; Thompson, J. D.; de Leon, N. P.; Liu, L. R.; Lukin, M. D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Tiecke, T. G.; Vuletic, V.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Tiecke, T. G.; Vuletic, V.] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [de Leon, N. P.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University	Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	vuletic@mit.edu; lukin@fas.harvard.edu	LIU, LEE/AAE-2624-2021; Vuletic, Vladan/M-8736-2019	de Leon, Nathalie/0000-0003-1324-1412; Thompson, Jeff/0000-0001-8673-052X	US NSF; Center for Ultracold Atoms; Natural Sciences and Engineering Research Council of Canada; Air Force Office of Scientific Research Multidisciplinary University Research Initiative; Packard Foundation; Fannie and John Hertz Foundation; NSF Graduate Research Fellowship Program; NSF [ECS-0335765]; Division Of Physics [1125846] Funding Source: National Science Foundation	US NSF(National Science Foundation (NSF)); Center for Ultracold Atoms; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Air Force Office of Scientific Research Multidisciplinary University Research Initiative(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); Packard Foundation(The David & Lucile Packard Foundation); Fannie and John Hertz Foundation; NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank T. Peyronel, A. Kubanek, A. Zibrov for discussions and experimental assistance. Financial support was provided by the US NSF, the Center for Ultracold Atoms, the Natural Sciences and Engineering Research Council of Canada, the Air Force Office of Scientific Research Multidisciplinary University Research Initiative and the Packard Foundation. J.D.T. acknowledges support from the Fannie and John Hertz Foundation and the NSF Graduate Research Fellowship Program. This work was performed in part at the Center for Nanoscale Systems (CNS), a member of the National Nanotechnology Infrastructure Network, which is supported by the NSF under award no. ECS-0335765. The CNS is part of Harvard University.	Aoki T, 2006, NATURE, V443, P671, DOI 10.1038/nature05147; Aoki T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.083601; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Carusotto I, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.299; Chang DE, 2007, NAT PHYS, V3, P807, DOI 10.1038/nphys708; Chen W, 2013, SCIENCE, V341, P768, DOI 10.1126/science.1238169; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; Deleglise S, 2008, NATURE, V455, P510, DOI 10.1038/nature07288; Devoret MH, 2013, SCIENCE, V339, P1169, DOI 10.1126/science.1231930; Duan LM, 2010, REV MOD PHYS, V82, P1209, DOI 10.1103/RevModPhys.82.1209; Duan LM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.127902; Fushman I, 2008, SCIENCE, V320, P769, DOI 10.1126/science.1154643; Gleyzes S, 2007, NATURE, V446, P297, DOI 10.1038/nature05589; Haroche S., 2006, EXPLORING QUANTUM; Kim H, 2013, NAT PHOTONICS, V7, P373, DOI [10.1038/NPHOTON.2013.48, 10.1038/nphoton.2013.48]; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Komar P, 2013, PREPRINT; O'Shea D, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.193601; Reiserer A, 2013, SCIENCE, V342, P1349, DOI 10.1126/science.1246164; Ritter S, 2012, NATURE, V484, P195, DOI 10.1038/nature11023; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; Schuster I, 2008, NAT PHYS, V4, P382, DOI 10.1038/nphys940; Thompson JD, 2013, SCIENCE, V340, P1202, DOI 10.1126/science.1237125; Thompson JD, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.133001; TURCHETTE QA, 1995, PHYS REV LETT, V75, P4710, DOI 10.1103/PhysRevLett.75.4710; Volz J, 2011, NATURE, V475, P210, DOI 10.1038/nature10225; Volz T, 2012, NAT PHOTONICS, V6, P605, DOI [10.1038/nphoton.2012.181, 10.1038/NPHOTON.2012.181]; Waks E, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.041803; Wang B, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.022320	30	395	405	6	273	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					241	244		10.1038/nature13188	http://dx.doi.org/10.1038/nature13188			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE4UK	24717513	Green Submitted			2022-12-28	WOS:000333979900043
J	Riol-Blanco, L; Ordovas-Montanes, J; Perro, M; Naval, E; Thiriot, A; Alvarez, D; Paust, S; Wood, JN; von Andrian, UH				Riol-Blanco, Lorena; Ordovas-Montanes, Jose; Perro, Mario; Naval, Elena; Thiriot, Aude; Alvarez, David; Paust, Silke; Wood, John N.; von Andrian, Ulrich H.			Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation	NATURE			English	Article							DELTA T-CELLS; PERIPHERAL LYMPHOID ORGANS; DENDRITIC CELLS; PLAQUE-FORMATION; NERVOUS-SYSTEM; RECEPTOR; MICE; IDENTIFICATION; MONOCYTES; CYTOKINE	The skin has a dual function as a barrier and a sensory interface between the body and the environment. To protect against invading pathogens, the skin harbours specialized immune cells, including dermal dendritic cells (DDCs) and interleukin (IL)-17-producing gamma delta T (gamma delta T17) cells, the aberrant activation of which by IL-23 can provoke psoriasis-like inflammation(1-4). The skin is also innervated by a meshwork of peripheral nerves consisting of relatively sparse autonomic and abundant sensory fibres. Interactions between the autonomic nervous system and immune cells in lymphoid organs are known to contribute to systemic immunity, but how peripheral nerves regulate cutaneous immune responses remains unclear(5,6). We exposed the skin of mice to imiquimod, which induces IL-23-dependent psoriasis-like inflammation(7,8). Hereweshowthat a subset of sensory neurons expressing the ion channels TRPV1 and Na(v)1.8 is essential to drive this inflammatory response. Imaging of intact skin revealed that a large fraction of DDCs, the principal source of IL-23, is in close contact with these nociceptors. Upon selective pharmacological or genetic ablation of nociceptors(9-11), DDCs failed to produce IL-23 in imiquimod-exposed skin. Consequently, the local production of IL-23-dependent inflammatory cytokines by dermal gamma delta T17 cells and the subsequent recruitment of inflammatory cells to the skin were markedly reduced. Intradermal injection of IL-23 bypassed the requirement for nociceptor communicationwithDDCs and restored the inflammatory response(12). These findings indicate that TRPV1(+)Na(v)1.8(+) nociceptors, by interacting with DDCs, regulate the IL-23/IL-17 pathway andcontrol cutaneousimmune responses.	[Riol-Blanco, Lorena; Ordovas-Montanes, Jose; Perro, Mario; Naval, Elena; Thiriot, Aude; Alvarez, David; Paust, Silke; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA; [Wood, John N.] UCL, Inst Biomed Res, London WC1E 6BT, England	Harvard University; Harvard Medical School; University of London; University College London	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA.	uva@hms.harvard.edu	Perro, Mario/AAB-5554-2021	Perro, Mario/0000-0003-1375-8155; Paust, Silke/0000-0002-0526-3999; Ordovas-Montanes, Jose/0000-0001-5444-5601	National Institutes of Health (NIH) [AI069259, AI078897, AI095261, AI111595]; NIH [5F31AR063546-02]; Human Frontiers Science Program; Charles A. King Trust; National Psoriasis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI111595, U19AI095261, P01AI112521, R01AI069259, P01AI078897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F31AR063546] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F000227/1] Funding Source: researchfish; Medical Research Council [G0901905] Funding Source: researchfish; Wellcome Trust [101054/Z/13/Z] Funding Source: researchfish; BBSRC [BB/F000227/1] Funding Source: UKRI; MRC [G0901905] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); Charles A. King Trust; National Psoriasis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank G. Cheng, M. Flynn and S. Omid for technical support; M. Perdue, L. Jones and E. Nigro for secretarial assistance; E. Gray for providing detailed protocols for flow cytometry of skin samples; J. Harris for discussion and providing detailed RNA isolation protocols of skin samples; R. T. Roderick for histopathology analysis; T. Liu and J. Ru-Rong for providing the RTX denervation protocol; M. Ghebremichael for statistical advice; F. Winau and J. L. Rodriguez-Fernandez for critical reading of the manuscript and members of the von Andrian laboratory for discussion and advice. This work was supported by National Institutes of Health (NIH) grants AI069259, AI078897, AI095261 and AI111595 (to U.H.v.A.), NIH 5F31AR063546-02 (to J.O.-M.) and the Human Frontiers Science Program, Charles A. King Trust and National Psoriasis Foundation (to L.R.-B.).	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Chiu I.M., 2013, NATURE; Chiu IM, 2012, NAT NEUROSCI, V15, P1063, DOI 10.1038/nn.3144; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; FARBER EM, 1990, INT J DERMATOL, V29, P418, DOI 10.1111/j.1365-4362.1990.tb03825.x; Flutter B, 2013, EUR J IMMUNOL, V43, P3138, DOI 10.1002/eji.201343801; Gray EE, 2013, NAT IMMUNOL, V14, P584, DOI 10.1038/ni.2585; Gray EE, 2011, J IMMUNOL, V186, P6091, DOI 10.4049/jimmunol.1100427; Grebe KM, 2009, P NATL ACAD SCI USA, V106, P5300, DOI 10.1073/pnas.0808851106; Guilliams M, 2010, EUR J IMMUNOL, V40, P2089, DOI 10.1002/eji.201040498; Guo LY, 2012, TRENDS IMMUNOL, V33, P598, DOI 10.1016/j.it.2012.07.006; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; MULLER G, 1995, J IMMUNOL, V155, P4661; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Ostrowski SM, 2011, J INVEST DERMATOL, V131, P1530, DOI 10.1038/jid.2011.60; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Sandor K, 2009, NEUROSCI LETT, V451, P204, DOI 10.1016/j.neulet.2009.01.016; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Weninger W, 2000, IMMUNITY, V12, P665, DOI 10.1016/S1074-7613(00)80217-4; Wohn C, 2013, P NATL ACAD SCI USA, V110, P10723, DOI 10.1073/pnas.1307569110; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	36	305	314	5	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					157	+		10.1038/nature13199	http://dx.doi.org/10.1038/nature13199			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24759321	Green Accepted, Green Submitted			2022-12-28	WOS:000336768900048
J	Poordad, F; Hezode, C; Trinh, R; Kowdley, KV; Zeuzem, S; Agarwal, K; Shiffman, ML; Wedemeyer, H; Berg, T; Yoshida, EM; Forns, X; Lovell, SS; Da Silva-Tillmann, B; Collins, CA; Campbell, AL; Podsadecki, T; Bernstein, B				Poordad, Fred; Hezode, Christophe; Trinh, Roger; Kowdley, Kris V.; Zeuzem, Stefan; Agarwal, Kosh; Shiffman, Mitchell L.; Wedemeyer, Heiner; Berg, Thomas; Yoshida, Eric M.; Forns, Xavier; Lovell, Sandra S.; Da Silva-Tillmann, Barbara; Collins, Christine A.; Campbell, Andrew L.; Podsadecki, Thomas; Bernstein, Barry			ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; GENOTYPE 1 INFECTION; ALL-CAUSE MORTALITY; VIRUS-INFECTION; HCV INFECTION; UNITED-STATES; BOCEPREVIR; TELAPREVIR; EPIDEMIOLOGY; THERAPY	BACKGROUND Interferon-containing regimens for the treatment of hepatitis C virus (HCV) infection are associated with increased toxic effects in patients who also have cirrhosis. We evaluated the interferon-free combination of the protease inhibitor ABT-450 with ritonavir (ABT-450/r), the NS5A inhibitor ombitasvir (ABT-267), the nonnucleoside polymerase inhibitor dasabuvir (ABT-333), and ribavirin in an open-label phase 3 trial involving previously untreated and previously treated adults with HCV genotype 1 infection and compensated cirrhosis. METHODS We randomly assigned 380 patients with Child-Pugh class A cirrhosis to receive either 12 or 24 weeks of treatment with ABT-450/r-ombitasvir (at a once-daily dose of 150 mg of ABT-450, 100 mg of ritonavir, and 25 mg of ombitasvir), dasabuvir (250 mg twice daily), and ribavirin administered according to body weight. The primary efficacy end point was a sustained virologic response 12 weeks after the end of treatment. The rate of sustained virologic response in each group was compared with the estimated rate with a telaprevir-based regimen (47%; 95% confidence interval [CI], 41 to 54). A noninferiority margin of 10.5 percentage points established 43% as the noninferiority threshold; the superiority threshold was 54%. RESULTS A total of 191 of 208 patients who received 12 weeks of treatment had a sustained virologic response at post-treatment week 12, for a rate of 91.8% (97.5% CI, 87.6 to 96.1). A total of 165 of 172 patients who received 24 weeks of treatment had a sustained virologic response at post-treatment week 12, for a rate of 95.9% (97.5% CI, 92.6 to 99.3). These rates were superior to the historical control rate. The three most common adverse events were fatigue (in 32.7% of patients in the 12-week group and 46.5% of patients in the 24-week group), headache (in 27.9% and 30.8%, respectively), and nausea (in 17.8% and 20.3%, respectively). The hemoglobin level was less than 10 g per deciliter in 7.2% and 11.0% of patients in the respective groups. Overall, 2.1% of patients discontinued treatment owing to adverse events. CONCLUSIONS In this phase 3 trial of an oral, interferon-free regimen evaluated exclusively in patients with HCV genotype 1 infection and cirrhosis, multitargeted therapy with the use of three new antiviral agents and ribavirin resulted in high rates of sustained virologic response. Drug discontinuations due to adverse events were infrequent.	[Poordad, Fred] Univ Texas Hlth Sci Ctr San Antonio, Texas Liver Inst, San Antonio, TX 78215 USA; [Hezode, Christophe] Univ Paris Est, Henri Mondor Hosp, AP HP, INSERM,U955, Creteil, France; [Trinh, Roger; Lovell, Sandra S.; Da Silva-Tillmann, Barbara; Collins, Christine A.; Campbell, Andrew L.; Podsadecki, Thomas; Bernstein, Barry] AbbVie, N Chicago, IL USA; [Kowdley, Kris V.] Virginia Mason Med Ctr, Inst Digest Dis, Seattle, WA 98101 USA; [Zeuzem, Stefan] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany; [Wedemeyer, Heiner] Hannover Med Sch, D-30623 Hannover, Germany; [Berg, Thomas] Univ Klinikum Leipzig, Leipzig, Germany; [Agarwal, Kosh] Kings Coll Hosp London, Inst Liver Studies, London SE5 8RX, England; [Shiffman, Mitchell L.] Liver Inst Virginia, Newport News, VA USA; [Yoshida, Eric M.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Forns, Xavier] Hosp Clin Barcelona, Liver Unit, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Forns, Xavier] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain	University of Texas System; University of Texas Health San Antonio; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); AbbVie; Virginia Mason Medical Center; Goethe University Frankfurt; Hannover Medical School; Leipzig University; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of British Columbia; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Poordad, F (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Texas Liver Inst, 607 Camden St,Suite 101, San Antonio, TX 78215 USA.	poordad@uthscsa.edu	Zeuzem, Stefan/AAE-7435-2019; Hezode, Christophe/U-4659-2018; Kowdley, Kris/AAF-5202-2019; Agarwal, Kosh/ABH-8721-2020	Agarwal, Kosh/0000-0002-4754-828X; Berg, Thomas/0000-0003-0003-6241; Forns, Xavier/0000-0002-8188-1764	AbbVie	AbbVie(AbbVie)	Supported by AbbVie.	[Anonymous], 2013, INC TEL; [Anonymous], 2014, INC TEL SUMM PROD CH; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bourliere M, 2012, LIVER INT, V32, P113, DOI 10.1111/j.1478-3231.2011.02702.x; Bruno S, 2010, HEPATOLOGY, V51, P2069, DOI 10.1002/hep.23528; Butt AA, 2009, HEPATOLOGY, V50, P387, DOI 10.1002/hep.23000; Carrion AF, 2014, EXPERT OPIN PHARMACO, V15, P711, DOI 10.1517/14656566.2014.889116; Colombo M, 2013, GUT; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hezode C, 2013, J HEPATOL, V59, P434, DOI 10.1016/j.jhep.2013.04.035; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kowdley KV, 2014, NEW ENGL J MED, V370, P222, DOI 10.1056/NEJMoa1306227; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Monteagudo E, 2010, XENOBIOTICA, V40, P826, DOI 10.3109/00498254.2010.519061; Morgan RL, 2013, ANN INTERN MED, V158, P329, DOI 10.7326/0003-4819-158-5-201303050-00005; Noureddin M, 2013, HEPATOLOGY, V58, P1548, DOI 10.1002/hep.26506; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Razavi H, 2013, HEPATOLOGY, V57, P2164, DOI 10.1002/hep.26218; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Vierling JM, 2014, J HEPATOL, V60, P748, DOI 10.1016/j.jhep.2013.12.013; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	27	707	730	2	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 22	2014	370	21					1973	1982		10.1056/NEJMoa1402869	http://dx.doi.org/10.1056/NEJMoa1402869			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UZ	24725237	Bronze, Green Published			2022-12-28	WOS:000336125500005
J	Petrillo, E; Herz, MAG; Fuchs, A; Reifer, D; Fuller, J; Yanovsky, MJ; Simpson, C; Brown, JWS; Barta, A; Kalyna, M; Kornblihtt, AR				Petrillo, Ezequiel; Godoy Herz, Micaela A.; Fuchs, Armin; Reifer, Dominik; Fuller, John; Yanovsky, Marcelo J.; Simpson, Craig; Brown, John W. S.; Barta, Andrea; Kalyna, Maria; Kornblihtt, Alberto R.			A Chloroplast Retrograde Signal Regulates Nuclear Alternative Splicing	SCIENCE			English	Article							GENE-EXPRESSION; ARABIDOPSIS; LIGHT; PROTEINS; TRANSCRIPTS; PLANTS	Light is a source of energy and also a regulator of plant physiological adaptations. We show here that light/dark conditions affect alternative splicing of a subset of Arabidopsis genes preferentially encoding proteins involved in RNA processing. The effect requires functional chloroplasts and is also observed in roots when the communication with the photosynthetic tissues is not interrupted, suggesting that a signaling molecule travels through the plant. Using photosynthetic electron transfer inhibitors with different mechanisms of action, we deduce that the reduced pool of plastoquinones initiates a chloroplast retrograde signaling that regulates nuclear alternative splicing and is necessary for proper plant responses to varying light conditions.	[Petrillo, Ezequiel; Godoy Herz, Micaela A.; Kornblihtt, Alberto R.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Lab Fisiol & Biol Mol,IFIBYNE,CONICET, Buenos Aires, DF, Argentina; [Fuchs, Armin; Reifer, Dominik; Barta, Andrea; Kalyna, Maria] Med Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Fuller, John; Simpson, Craig; Brown, John W. S.] James Hutton Inst, Dundee, Scotland; [Yanovsky, Marcelo J.] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, IIBBA, RA-1033 Buenos Aires, DF, Argentina; [Brown, John W. S.] Univ Dundee, Div Plant Sci, James Hutton Inst, Dundee, Scotland	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); James Hutton Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; James Hutton Institute; University of Dundee	Kornblihtt, AR (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Lab Fisiol & Biol Mol,IFIBYNE,CONICET, Ciudad Univ,Pabellon 2,C1428EHA, Buenos Aires, DF, Argentina.	ark@fbmc.fcen.uba.ar	Kalyna, Maria/N-7051-2017	Kalyna, Maria/0000-0003-4702-7625; Kornblihtt, Alberto/0000-0003-4322-0831; Simpson, Craig/0000-0002-1723-1492; Petrillo, Ezequiel/0000-0002-0025-3708; Barta, Andrea/0000-0002-8851-406X	Agencia Nacional de Promocion de Ciencia y Tecnologia of Argentina; University of Buenos Aires; King Abdulaziz University; European Network on Alternative Splicing; Austrian Science Fund FWF [P26333, DK W1207, SFBF43-P10, ERA-NET I254]; U.K. Biotechnology and Biological Sciences Research Council; Scottish Government Rural and Environment Science and Analytical Services division; BBSRC [BB/G024979/1] Funding Source: UKRI; Austrian Science Fund (FWF) [I 254] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/G024979/1] Funding Source: researchfish	Agencia Nacional de Promocion de Ciencia y Tecnologia of Argentina(ANPCyT); University of Buenos Aires(University of Buenos Aires); King Abdulaziz University; European Network on Alternative Splicing; Austrian Science Fund FWF(Austrian Science Fund (FWF)); U.K. Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Government Rural and Environment Science and Analytical Services division; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank J. Casal, J. Estevez, N. Iusem, J. Palermo, G. Cabrera, G. Siless, N. Carrillo, F. Rolland, J. Chory, J.-S. Jeon, R. Hausler, J. Sheen, A. Kohler, A. Trebst, and S. Smeekens for materials and advice. This work was supported by the Agencia Nacional de Promocion de Ciencia y Tecnologia of Argentina, the University of Buenos Aires, the King Abdulaziz University, the European Network on Alternative Splicing, the Austrian Science Fund FWF (P26333 to M. K.; DK W1207, SFBF43-P10, ERA-NET I254 to A. B.), the U.K. Biotechnology and Biological Sciences Research Council, and the Scottish Government Rural and Environment Science and Analytical Services division. M. G. H. is a fellow and A. R. K. is a career investigator from the Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina. E. P. is an EMBO postdoctoral fellow. A. R. K. is a senior international research scholar of the Howard Hughes Medical Institute (for detailed acknowledgments, see the supplementary text).	Casal JJ, 2005, INT J DEV BIOL, V49, P501, DOI 10.1387/ijdb.051973jc; Dijkwel PP, 1997, PLANT CELL, V9, P583, DOI 10.1105/tpc.9.4.583; Domon C, 1998, J BIOL CHEM, V273, P34603, DOI 10.1074/jbc.273.51.34603; ELICH TD, 1993, EMBO J, V12, P4857, DOI 10.1002/j.1460-2075.1993.tb06175.x; Finazzi G, 2001, J BIOL CHEM, V276, P9770, DOI 10.1074/jbc.M010092200; Gyula N, 2003, CURR OPIN PLANT BIOL, V6, P446, DOI 10.1016/S1369-5266(03)00082-7; Hanson J, 2009, CURR OPIN PLANT BIOL, V12, P562, DOI 10.1016/j.pbi.2009.07.014; Kalyna M, 2006, NUCLEIC ACIDS RES, V34, P4395, DOI 10.1093/nar/gkl570; Khandelwal A, 2008, PLANT PHYSIOL, V148, P2050, DOI 10.1104/pp.108.128488; Kim SH, 2009, PLANT CELL, V21, P2045, DOI 10.1105/tpc.109.067736; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Lopato S, 1996, PLANT CELL, V8, P2255, DOI 10.1105/tpc.8.12.2255; Ruckle ME, 2012, PLANT PHYSIOL, V159, P366, DOI 10.1104/pp.112.193599; Schansker G, 2005, BBA-BIOENERGETICS, V1706, P250, DOI 10.1016/j.bbabio.2004.11.006; Sellaro R, 2009, CURR BIOL, V19, P1216, DOI 10.1016/j.cub.2009.05.062; Simpson CG, 2008, PLANT J, V53, P1035, DOI 10.1111/j.1365-313X.2007.03392.x; Syed NH, 2012, TRENDS PLANT SCI, V17, P616, DOI 10.1016/j.tplants.2012.06.001	17	130	138	6	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					427	430		10.1126/science.1250322	http://dx.doi.org/10.1126/science.1250322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763593	Green Accepted			2022-12-28	WOS:000334867800045
J	Guillen, N				Guillen, Nancy			Nibbled to death	NATURE			English	Editorial Material							ENTAMOEBA-HISTOLYTICA; MEMBRANE-FRAGMENTS; TARGET-CELLS; TROGOCYTOSIS; CAPTURE	Trogocytosis, a process in which one cell 'takes a bite' out of another, had previously been seen only in immune cells. But the phenomenon has now been found in Entamoeba histolytica, as a way for this parasite to kill host cells. See Letter p. 526	Inst Pasteur, Dept Cell Biol & Infect, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Guillen, N (corresponding author), Inst Pasteur, Dept Cell Biol & Infect, F-75015 Paris, France.	nguillen@pasteur.fr						Aucher A, 2008, BLOOD, V111, P5621, DOI 10.1182/blood-2008-01-134155; Blazquez S, 2008, CELL MICROBIOL, V10, P1676, DOI 10.1111/j.1462-5822.2008.01158.x; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Daubeuf S, 2010, J IMMUNOL, V184, P1897, DOI 10.4049/jimmunol.0901570; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Faust DM, 2012, MICROBES INFECT, V14, P1428, DOI 10.1016/j.micinf.2012.05.013; Hudrisier D, 2001, J IMMUNOL, V166, P3645, DOI 10.4049/jimmunol.166.6.3645; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Ralston KS, 2014, NATURE, V508, P526, DOI 10.1038/nature13242; Thibeaux R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003824	10	5	5	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					462	463		10.1038/nature13223	http://dx.doi.org/10.1038/nature13223			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24717438				2022-12-28	WOS:000334741600022
J	Ralston, KS; Solga, MD; Mackey-Lawrence, NM; Somlata; Bhattacharya, A; Petri, WA				Ralston, Katherine S.; Solga, Michael D.; Mackey-Lawrence, Nicole M.; Somlata; Bhattacharya, Alok; Petri, William A., Jr.			Trogocytosis by Entamoeba histolytica contributes to cell killing and tissue invasion	NATURE			English	Article							CYTOPATHOGENIC MECHANISMS; TARGET-CELLS; PHAGOCYTOSIS; ADHERENCE; INTERNALIZATION; MICROSCOPY; ANTIBODIES; SYNAPSE	Entamoeba histolytica is the causative agent of amoebiasis, a potentially fatal diarrhoeal disease in the developing world. The parasite was named "histolytica'' for its ability to destroy host tissues, which is probably driven by direct killing of human cells. The mechanism of human cell killing has been unclear, although the accepted model was that the parasites use secreted toxic effectors to kill cells before ingestion(1). Here we report the discovery that amoebae kill by ingesting distinct pieces of living human cells, resulting in intracellular calcium elevation and eventual cell death. After cell killing, amoebae detach and cease ingestion. Ingestion of human cell fragments is required for cell killing, and also contributes to invasion of intestinal tissue. The internalization of fragments of living human cells is reminiscent of trogocytosis (from Greek trogo, nibble) observed between immune cells(2-6), but amoebic trogocytosis differs because it results in death. The ingestion of live cell material and the rejection of corpses illuminate a stark contrast to the established model of dead cell clearance in multicellular organisms(7). These findings change the model for tissue destruction in amoebiasis and suggest an ancient origin of trogocytosis as a form of intercellular exchange.	[Ralston, Katherine S.; Mackey-Lawrence, Nicole M.; Petri, William A., Jr.] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Solga, Michael D.; Petri, William A., Jr.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Somlata; Bhattacharya, Alok] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Petri, William A., Jr.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; Jawaharlal Nehru University, New Delhi; University of Virginia	Petri, WA (corresponding author), Univ Virginia, Dept Med, Charlottesville, VA 22908 USA.	wap3g@virginia.edu	Petri, William/AAL-3642-2020; Petri, William A./D-3639-2019	Petri, William/0000-0002-7268-1218; Ralston, Katherine/0000-0002-1604-7634; , SOMLATA/0000-0003-1928-5280	Howard Hughes Medical Institute from the Life Sciences Research Foundation; Hartwell Foundation; NIH [AI07046-32, 5R01 AI-26649]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026649, T32AI007046, T32AI055432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007769] Funding Source: NIH RePORTER	Howard Hughes Medical Institute from the Life Sciences Research Foundation; Hartwell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. A. Redick and S. J. Guillot for assistance with sample preparation for electron microscopy and D. A. Zemo of Olympus for assistance with multiphoton microscopy. We thank the University of Virginia Research Histology Core for assistance with preparation of frozen sections. We thank J. E. Casanova, J. D. Castle, J. Lannigan, K. S. Ravichandran and R. P. Taylor for helpful discussions. The artwork (Extended Data Fig. 1) was prepared by A. Impagliazzo. K. S. R. was supported by a Howard Hughes Medical Institute Postdoctoral Fellowship from the Life Sciences Research Foundation, and a Postdoctoral Fellowship from the Hartwell Foundation. N.M.M.-L. was supported by NIH Training Grant AI07046-32. This work was supported by NIH grant 5R01 AI-26649 to W.A.P.	Bansal D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000551; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Boettner DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040008; BROWN T, 1979, J MED MICROBIOL, V12, P363, DOI 10.1099/00222615-12-3-363; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; GONZALEZRUIZ A, 1994, J CLIN PATHOL, V47, P236, DOI 10.1136/jcp.47.3.236; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hudrisier D, 2001, J IMMUNOL, V166, P3645, DOI 10.4049/jimmunol.166.6.3645; HUDSON L, 1974, NATURE, V251, P60, DOI 10.1038/251060a0; Huston CD, 2003, INFECT IMMUN, V71, P964, DOI 10.1128/IAI.71.2.964-972.2003; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Korpe PS, 2013, CLIN INFECT DIS, V56, P988, DOI 10.1093/cid/cis1044; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; LEJEUNE A, 1987, BIOL CELL, V59, P239, DOI 10.1111/j.1768-322X.1987.tb00536.x; LEJEUNE A, 1992, BIOL CELL, V74, P211, DOI 10.1016/0248-4900(92)90027-X; Mann BJ, 2002, INT REV CYTOL, V216, P59; Martinez-Martin N, 2011, IMMUNITY, V35, P208, DOI 10.1016/j.immuni.2011.06.003; MCCOY JJ, 1994, GLYCOCONJUGATE J, V11, P432, DOI 10.1007/BF00731279; Mondal D, 2006, T ROY SOC TROP MED H, V100, P1032, DOI 10.1016/j.trstmh.2005.12.012; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakada-Tsukui K, 2009, CELL MICROBIOL, V11, P1471, DOI 10.1111/j.1462-5822.2009.01341.x; Ralston KS, 2011, TRENDS PARASITOL, V27, P253, DOI 10.1016/j.pt.2011.02.006; RAVDIN JI, 1980, J EXP MED, V152, P377, DOI 10.1084/jem.152.2.377; RAVDIN JI, 1981, J CLIN INVEST, V68, P1305, DOI 10.1172/JCI110377; SAFFER LD, 1991, INFECT IMMUN, V59, P4681, DOI 10.1128/IAI.59.12.4681-4683.1991; Sateriale A, 2012, INFECT IMMUN, V80, P4456, DOI 10.1128/IAI.00671-12; Somlata, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1199; Williams M, 2012, DEV DYNAM, V241, P270, DOI 10.1002/dvdy.23711	28	137	140	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					526	+		10.1038/nature13242	http://dx.doi.org/10.1038/nature13242			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24717428	Green Accepted			2022-12-28	WOS:000334741600037
J	Stroka, KM; Jiang, HY; Chen, SH; Tong, ZQ; Wirtz, D; Sun, SX; Konstantopoulos, K				Stroka, Kimberly M.; Jiang, Hongyuan; Chen, Shih-Hsun; Tong, Ziqiu; Wirtz, Denis; Sun, Sean X.; Konstantopoulos, Konstantinos			Water Permeation Drives Tumor Cell Migration in Confined Microenvironments	CELL			English	Article							ACTIN-POLYMERIZATION; NA+/H+ ANTIPORTER; INTRACELLULAR PH; MOTILITY DRIVEN; ION CHANNELS; CANCER; VOLUME; LOCALIZATION; INVASION; TRANSPORTERS	Cell migration is a critical process for diverse (patho) physiological phenomena. Intriguingly, cell migration through physically confined spaces can persist even when typical hallmarks of 2D planar migration, such as actin polymerization and myosin II-mediated contractility, are inhibited. Here, we present an integrated experimental and theoretical approach ("Osmotic Engine Model") and demonstrate that directed water permeation is a major mechanism of cell migration in confined microenvironments. Using microfluidic and imaging techniques along with mathematical modeling, we show that tumor cells confined in a narrow channel establish a polarized distribution of Na+/H+ pumps and aquaporins in the cell membrane, which creates a net inflow of water and ions at the cell leading edge and a net outflow of water and ions at the trailing edge, leading to net cell displacement. Collectively, this study presents an alternate mechanism of cell migration in confinement that depends on cell-volume regulation via water permeation.	[Stroka, Kimberly M.; Tong, Ziqiu; Wirtz, Denis; Sun, Sean X.; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Inst NanoBioTechnol, Baltimore, MD 21218 USA; [Stroka, Kimberly M.; Tong, Ziqiu; Wirtz, Denis; Sun, Sean X.; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD 21218 USA; [Stroka, Kimberly M.; Chen, Shih-Hsun; Tong, Ziqiu; Wirtz, Denis; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Jiang, Hongyuan; Sun, Sean X.] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Sun, Sean X.; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Jiang, Hongyuan] Univ Sci & Technol China, CAS Key Lab Mech Behav & Design Mat, Hefei 230026, Anhui, Peoples R China	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Sun, SX (corresponding author), Johns Hopkins Univ, Johns Hopkins Inst NanoBioTechnol, Baltimore, MD 21218 USA.	ssun@jhu.edu; konstant@jhu.edu	Tong, Ziqiu/AAR-6182-2020	Tong, Ziqiu/0000-0003-4183-1858	National Science Foundation [NSF-1159823]; National Cancer Institute [U54-CA143868, RO1GM075305, RO1CA174388, T32-CA130840, F32-CA177756]; Kleberg Foundation; National Natural Science Foundation of China [NSFC 11342010]; Div Of Chem, Bioeng, Env, & Transp Sys [1159823] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [T32CA130840, F32CA177756, R01CA174388, U54CA143868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075305] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kleberg Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jean Paul Thiery for providing S180 cells, Antonio LLombart-Bosch for CH2879 cells, Ramana Sidhaye for AQP5 siRNA adenovirus, and Helim Aranda-Espinoza for use of the Micro-Osmometer. This work was supported by awards from the National Science Foundation (NSF-1159823 to K.K.), the National Cancer Institute (U54-CA143868 to D.W., K.K., and S.X.S.; RO1GM075305 to S.X.S.; RO1CA174388 to D. W.; T32-CA130840 to K.M.S.; and F32-CA177756 to K.M.S.), the Kleberg Foundation (to K. K. and S.X.S.), and the National Natural Science Foundation of China (NSFC 11342010 to H.J.).	Alexander S, 2008, HISTOCHEM CELL BIOL, V130, P1147, DOI 10.1007/s00418-008-0529-1; Atzberger PJ, 2009, PHYSICA D, V238, P1168, DOI 10.1016/j.physd.2009.03.018; Balzer EM, 2012, FASEB J, V26, P4045, DOI 10.1096/fj.12-211441; Beltran AR, 2008, PFLUG ARCH EUR J PHY, V455, P799, DOI 10.1007/s00424-007-0333-0; Chae YK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002162; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Chung HJ, 2006, P NATL ACAD SCI USA, V103, P8870, DOI 10.1073/pnas.0603376103; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; GOSS GG, 1994, J BIOL CHEM, V269, P8741; GRINSTEIN S, 1993, EMBO J, V12, P5209, DOI 10.1002/j.1460-2075.1993.tb06216.x; Grunnet M, 2002, PFLUG ARCH EUR J PHY, V444, P167, DOI 10.1007/s00424-002-0782-4; Hung WC, 2013, J CELL BIOL, V202, P807, DOI 10.1083/jcb.201302132; Iwasaki T, 2008, BIOPHYS J, V94, pL35, DOI 10.1529/biophysj.107.124479; Jaeger M, 1999, BIOPHYS J, V77, P1257, DOI 10.1016/S0006-3495(99)76977-8; Jiang HY, 2013, BIOPHYS J, V105, P609, DOI 10.1016/j.bpj.2013.06.021; Jung HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028492; Keren K, 2009, NAT CELL BIOL, V11, P1219, DOI 10.1038/ncb1965; Klein M, 2000, J GEN PHYSIOL, V115, P599, DOI 10.1085/jgp.115.5.599; Konstantopoulos K, 2013, BIOPHYS J, V104, P279, DOI 10.1016/j.bpj.2012.12.016; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Mazzochi C, 2006, J BIOL CHEM, V281, P6528, DOI 10.1074/jbc.M509386200; Mingle LA, 2005, J CELL SCI, V118, P2425, DOI 10.1242/jcs.02371; Mitchison TJ, 2008, SEMIN CELL DEV BIOL, V19, P215, DOI 10.1016/j.semcdb.2008.01.008; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; OSTER GF, 1987, J CELL SCI, P35; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; Pathak A, 2012, P NATL ACAD SCI USA, V109, P10334, DOI 10.1073/pnas.1118073109; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prentice-Mott HV, 2013, P NATL ACAD SCI USA, V110, P21006, DOI 10.1073/pnas.1317441110; Ritter M, 1998, BRIT J PHARMACOL, V124, P627, DOI 10.1038/sj.bjp.0701864; Schwab A, 2001, NEWS PHYSIOL SCI, V16, P29, DOI 10.1152/physiologyonline.2001.16.1.29; Schwab A, 2007, PFLUG ARCH EUR J PHY, V453, P421, DOI 10.1007/s00424-006-0138-6; Schwab A, 2012, PHYSIOL REV, V92, P1865, DOI 10.1152/physrev.00018.2011; Sidhaye VK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038717; Spagnolie SE, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3469786; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; Stroka KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061377; Taber LA, 2011, J MECH MATER STRUCT, V6, P569, DOI 10.2140/jomms.2011.6.569; Tong ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029211; WAKABAYASHI S, 1992, P NATL ACAD SCI USA, V89, P2424, DOI 10.1073/pnas.89.6.2424; Wehner F, 2004, REV PHYSIOL BIOCH P, V148, P1, DOI 10.1007/s10254-003-0009-x; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Yadav S, 2009, MOL BIOL CELL, V20, P1728, DOI 10.1091/mbc.E08-10-1077	45	302	308	7	168	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					611	623		10.1016/j.cell.2014.02.052	http://dx.doi.org/10.1016/j.cell.2014.02.052			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24726433	Bronze, Green Accepted			2022-12-28	WOS:000335392100011
J	Aisen, PS				Aisen, Paul S.			Serum Brain-Derived Neurotrophic Factor and the Risk for Dementia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ALZHEIMERS-DISEASE	IMPORTANCE In animal studies, brain-derived neurotrophic factor (BDNF) has been shown to impact neuronal survival and function and improve synaptic plasticity and long-term memory. Circulating BDNF levels increase with physical activity and caloric restriction, thus BDNF may mediate some of the observed associations between lifestyle and the risk for dementia. Some prior studies showed lower circulating BDNF in persons with Alzheimer disease (AD) compared with control participants; however, it remains uncertain whether reduced levels precede dementia onset. OBJECTIVE To examine whether higher serum BDNF levels in cognitively healthy adults protect against the future risk for dementia and AD and to identify potential modifiers of this association. DESIGN, SETTING, AND PARTICIPANTS Framingham Study original and offspring participants were followed up from 1992 and 1998, respectively, for up to 10 years. We used Cox models to relate BDNF levels to the risk for dementia and AD and adjusted for potential confounders. We also ran sensitivity analyses stratified by sex, age, and education, as well as related BDNF genetic variants to AD risk. This community-based, prospective cohort study involved 2131 dementia-free participants aged 60 years and older (mean [SD] age, 72 [7] years; 56% women). MAIN OUTCOMES AND MEASURES Ten-year incidence of dementia and AD. RESULTS During follow-up, 140 participants developed dementia, 117 of whom had AD. Controlling for age and sex, each standard-deviation increment in BDNF was associated with a 33% lower risk for dementia and AD(P = .006 and P = .01, respectively) and these associations persisted after additional adjustments. Compared with the bottom quintile, BDNF levels in the top quintile were associated with less than half the risk for dementia and AD(hazard ratio, 0.49; 95% CI, 0.28-0.85; P = .01; and hazard ratio, 0.46; 95% CI, 0.24-0.86; P = .02, respectively). These associations were apparent only among women, persons aged 80 years and older, and those with college degrees (hazard ratios for AD: 0.65, [95% CI, 0.50-0.85], P = .001; 0.63 [95% CI, 0.47-0.85], P = .002; and 0.27 [95% CI, 0.11-0.65], P = .003, respectively). Brain-derived neurotrophic factor genetic variants were not associated with AD risk. CONCLUSIONS AND RELEVANCE Higher serum BDNF levels may protect against future occurrence of dementia and AD. Our findings suggest a role for BDNF in the biology and possibly in the prevention of dementia and AD, especially in select subgroups of women and older and more highly educated persons.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Aisen, PS (corresponding author), Univ Calif San Diego, Dept Neurosci, 9500 Gilman Dr,M-C 0949, La Jolla, CA 92093 USA.	paisen@ucsd.edu						Aisen PS, 2008, JAMA-J AM MED ASSOC, V300, P1774, DOI 10.1001/jama.300.15.1774; Cummings Jeffrey L, 2011, Alzheimers Dement, V7, pe13, DOI 10.1016/j.jalz.2010.06.004; Lu B, 1997, REV NEUROSCIENCE, V8, P1; Lyketsos CG, 2007, NEUROLOGY, V68, P1800; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Oliff HS, 1998, MOL BRAIN RES, V61, P147, DOI 10.1016/S0169-328X(98)00222-8; Sperling RA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002609; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Weinstein G, 2014, JAMA NEUROL, V71, P55, DOI 10.1001/jamaneurol.2013.4781; Weinstein G, 2013, J ALZHEIMERS DIS, V33, pS439, DOI 10.3233/JAD-2012-129040	10	11	11	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2014	311	16					1684	1685		10.1001/jama.2014.3120	http://dx.doi.org/10.1001/jama.2014.3120			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF4OU	24756518				2022-12-28	WOS:000334693900028
J	Klose, CSN; Flach, M; Mohle, L; Rogell, L; Hoyler, T; Ebert, K; Fabiunke, C; Pfeifer, D; Sexl, V; Fonseca-Pereira, D; Domingues, RG; Veiga-Fernandes, H; Arnold, SJ; Busslinger, M; Dunay, IR; Tanriver, Y; Diefenbach, A				Klose, Christoph S. N.; Flach, Melanie; Moehle, Luisa; Rogell, Leif; Hoyler, Thomas; Ebert, Karolina; Fabiunke, Carola; Pfeifer, Dietmar; Sexl, Veronika; Fonseca-Pereira, Diogo; Domingues, Rita G.; Veiga-Fernandes, Henrique; Arnold, Sebastian J.; Busslinger, Meinrad; Dunay, Ildiko R.; Tanriver, Yakup; Diefenbach, Andreas			Differentiation of Type 1 ILCs from a Common Progenitor to All Helper-like Innate Lymphoid Cell Lineages	CELL			English	Article							NATURAL-KILLER-CELL; ROR-GAMMA-T; TRANSCRIPTION FACTOR GATA3; TISSUE INDUCER CELLS; TOXOPLASMA-GONDII; INFLAMMATORY MONOCYTES; INTERFERON-GAMMA; NKP46(+) CELLS; ID PROTEINS; BET	Innate lymphoid cells (ILCs) are a recently recognized group of lymphocytes that have important functions in protecting epithelial barriers against infections and in maintaining organ homeostasis. ILCs have been categorized into three distinct groups, transcriptional circuitry and effector functions of which strikingly resemble the various T helper cell subsets. Here, we identify a common, Id2-expressing progenitor to all interleukin 7 receptor-expressing, "helper-like" ILC lineages, the CHILP. Interestingly, the CHILP differentiated into ILC2 and ILC3 lineages, but not into conventional natural killer (cNK) cells that have been considered an ILC1 subset. Instead, the CHILP gave rise to a peculiar NKp46(+) IL-7R alpha(+) ILC lineage that required T-bet for specification and was distinct of cNK cells or other ILC lineages. Such ILC1s coproduced high levels of IFN-gamma and TNF and protected against infections with the intracellular parasite Toxoplasma gondii. Our data significantly advance our understanding of ILC differentiation and presents evidence for a new ILC lineage that protects barrier surfaces against intracellular infections.	[Klose, Christoph S. N.; Flach, Melanie; Rogell, Leif; Hoyler, Thomas; Ebert, Karolina; Fabiunke, Carola; Diefenbach, Andreas] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Med Microbiol & Hyg, D-55131 Mainz, Germany; [Klose, Christoph S. N.; Flach, Melanie; Rogell, Leif; Hoyler, Thomas; Ebert, Karolina; Fabiunke, Carola; Tanriver, Yakup] Univ Freiburg, Med Ctr, Inst Med Microbiol & Hyg, Dept Med Microbiol & Hyg, D-79104 Freiburg, Germany; [Moehle, Luisa; Dunay, Ildiko R.] Univ Magdeburg, Inst Med Microbiol, D-39120 Magdeburg, Germany; [Rogell, Leif] Max Planck Inst Immunbiol & Epigenet, D-79108 Freiburg, Germany; [Pfeifer, Dietmar] Univ Med Ctr Freiburg, Genom Lab, Dept Hematol Oncol & Stem Cell Transplantat, D-79106 Freiburg, Germany; [Sexl, Veronika] Univ Vet Med Vienna, Inst Pharmacol & Toxicol, A-1210 Vienna, Austria; [Fonseca-Pereira, Diogo; Domingues, Rita G.; Veiga-Fernandes, Henrique] Fac Med Lisbon, Inst Mol Med, P-1649028 Lisbon, Portugal; [Klose, Christoph S. N.; Ebert, Karolina; Fabiunke, Carola; Arnold, Sebastian J.; Tanriver, Yakup] Univ Freiburg, Med Ctr, Div Renal, D-79106 Freiburg, Germany; [Arnold, Sebastian J.] Univ Freiburg, Ctr Biol Signalling Studies, BIOSS, D-79104 Freiburg, Germany; [Busslinger, Meinrad] Vienna Bioctr, Res Inst Mol Pathol, A-1020 Vienna, Austria	Johannes Gutenberg University of Mainz; University of Freiburg; Otto von Guericke University; Max Planck Society; University of Freiburg; University of Veterinary Medicine Vienna; Universidade de Lisboa; University of Freiburg; University of Freiburg; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Diefenbach, A (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Inst Med Microbiol & Hyg, Obere Zahlbacher Str 67, D-55131 Mainz, Germany.	diefenbach@uni-mainz.de	Tanriver, Yakup/AAU-7064-2020; da Fonseca Pereira, Diogo/O-9894-2019; Diefenbach, Andreas/T-2589-2018; Fonseca-Pereira, Diogo/U-1275-2018; Busslinger, Meinrad J./J-1249-2016; Klose, Christoph/ABE-6396-2020; Sexl, Veronika/B-8657-2016	Diefenbach, Andreas/0000-0002-9176-9530; Fonseca-Pereira, Diogo/0000-0002-7400-9804; Busslinger, Meinrad J./0000-0002-9111-9351; Sexl, Veronika/0000-0001-9363-0412; Veiga-Fernandes, Henrique/0000-0001-6216-1836; Mohle, Luisa/0000-0002-4535-9952; Hoyler, Thomas/0000-0003-4798-3692; Tanriver, Yakup/0000-0002-4806-2548; Arnold, Sebastian J./0000-0002-2688-9210	ERC [311377, 207057]; EMBO; Deutsche Forschungsgemeinschaft [SFB992/B02, SPP1646-DI764/3, TA436/2-1, TA436/3-1]; Deutsche Forschungsgemeinschaft (Emmy Noether Stipend) [AR732/1-1]; Boehringer Ingelheim Fonds; Fundacao para a Ciencia e Tecnologia, Portugal; MOTIVATE Promotionskolleg; Else-Kroner-Fresenius Stiftung; Boehringer Ingelheim;  [FWF-SFB28]	ERC(European Research Council (ERC)European Commission); EMBO(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (Emmy Noether Stipend)(German Research Foundation (DFG)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); MOTIVATE Promotionskolleg; Else-Kroner-Fresenius Stiftung; Boehringer Ingelheim(Boehringer Ingelheim); 	We thank G. Hacker for support; the members of the Diefenbach laboratory and M. Hofmann for valuable discussions, A. Triantafyllopoulou for critically reading and commenting on the manuscript, K. Oberle, N. Goppert, and D. Kautz for excellent technical assistance. We are thankful to C. Johner for providing mouse lines. We are grateful to D. Herchenbach, K. Geiger, and M. Follo for cell sorting. The work was supported by ERC Starting Grants (#311377 to A.D. and #207057 to H.V.F.), EMBO (to H.V.F.), the Deutsche Forschungsgemeinschaft (SFB992/B02, SPP1646-DI764/3 to A.D., TA436/2-1, TA436/3-1 to Y.T., and an Emmy Noether Stipend AR732/1-1 to S.J.A.), the Boehringer Ingelheim Fonds (to M.F.), the Fundacao para a Ciencia e Tecnologia, Portugal (D.F.P., R.D.G and H.V.F.), the FWF-SFB28 (to V.S.), MOTIVATE Promotionskolleg funded by the Else-Kroner-Fresenius Stiftung (to C.F.), and by Boehringer Ingelheim (to M.B.).	Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Carotta S, 2011, BLOOD, V117, P5449, DOI 10.1182/blood-2010-11-318956; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Constantinides M.G., 2014, NATURE; DENKERS EY, 1993, J EXP MED, V178, P1465, DOI 10.1084/jem.178.5.1465; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Diefenbach A, 2013, EUR J MICROBIOL IMMU, V3, P143, DOI 10.1556/EuJMI.3.2013.3.1; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; GAZZINELLI RT, 1993, P NATL ACAD SCI USA, V90, P6115, DOI 10.1073/pnas.90.13.6115; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Magri G, 2014, NAT IMMUNOL, V15, P354, DOI 10.1038/ni.2830; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Schulthess J, 2012, IMMUNITY, V37, P108, DOI 10.1016/j.immuni.2012.05.013; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stewart CA, 2007, EUR J IMMUNOL, V37, P1442, DOI 10.1002/eji.200737354; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Verykokakis M, 2013, J IMMUNOL, V191, P5973, DOI 10.4049/jimmunol.1301521; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812	45	734	755	1	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					340	356		10.1016/j.cell.2014.03.030	http://dx.doi.org/10.1016/j.cell.2014.03.030			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725403	Bronze			2022-12-28	WOS:000334304500009
J	Krauss, BS; Krauss, BA; Green, SM				Krauss, Baruch S.; Krauss, Benjamin A.; Green, Steven M.			Procedural Sedation and Analgesia in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EMERGENCY-DEPARTMENT; ADVERSE EVENTS	This video shows the technique of procedural sedation and analgesia in children, reviewing indications, patient assessment, the use of sedative and analgesic drugs, potential adverse events, recovery, and discharge from the hospital.	[Krauss, Baruch S.] Brigham & Womens Hosp, Div Emergency Med, Boston, MA 02115 USA; [Krauss, Benjamin A.] Univ Massachusetts, Boston, MA 02125 USA; [Green, Steven M.] Loma Linda Univ, Med Ctr, Dept Emergency Med, Loma Linda, CA USA	Harvard University; Brigham & Women's Hospital; University of Massachusetts System; University of Massachusetts Boston; Loma Linda University	Krauss, BS (corresponding author), Brigham & Womens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA.	baruch.krauss@childrens.harvard.edu			Oridion Medical	Oridion Medical	Dr. Krauss reports receiving consulting fees from Oridion Medical and being named in four patents held by Boston Children's Hospital - one patent related to respiratory analysis with capnography (U.S. patent 6,648,833), two patents related to a waveform interpreter for respiratory analysis (U.S. patents 6,997,880 and 6,428,483), and one patent related to an automated interpretive medical care system and methodology (U.S. patent 8,147,419). No other potential conflict of interest relevant to this article was reported.	Agrawal D, 2003, ANN EMERG MED, V42, P636, DOI 10.1016/S0196-0644(03)00516-X; Bhatt M, 2009, ANN EMERG MED, V53, P426, DOI 10.1016/j.annemergmed.2008.09.030; Green SM, 2002, ACAD EMERG MED, V9, P35, DOI 10.1197/aemj.9.1.35; Green SM, 2007, ANN EMERG MED, V49, P454, DOI 10.1016/j.annemergmed.2006.08.017; Green SM, 2011, ANN EMERG MED, V57, P449, DOI 10.1016/j.annemergmed.2010.11.030; Krauss B, 2006, LANCET, V367, P766, DOI 10.1016/S0140-6736(06)68230-5; Krauss B, 2000, NEW ENGL J MED, V342, P938, DOI 10.1056/NEJM200003303421306; Krauss B, 2007, ANN EMERG MED, V50, P172, DOI 10.1016/j.annemergmed.2006.10.016	8	17	18	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 10	2014	370	15							e23	10.1056/NEJMvcm1108559	http://dx.doi.org/10.1056/NEJMvcm1108559			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6IW	24716701				2022-12-28	WOS:000334095200002
J	Veale, D; Roberts, A				Veale, David; Roberts, Alison			Obsessive-compulsive disorder	BMJ-BRITISH MEDICAL JOURNAL			English	Review							COGNITIVE-BEHAVIORAL THERAPY; DSM-IV DISORDERS; ANXIETY DISORDERS; COMORBIDITY; PREVALENCE; METAANALYSIS; PANDAS; RISK		[Veale, David; Roberts, Alison] South London & Maudsley NHS Fdn Trust, Ctr Anxiety Disorders & Trauma, London SE5 8AZ, England; [Veale, David] Kings Coll London, South London & Maudsley NHS Fdn Trust, Anxiety Disorders Residential Unit, London WC2R 2LS, England; [Veale, David] Kings Coll London, Inst Psychiat, London WC2R 2LS, England	South London & Maudsley NHS Trust; University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; University of London; King's College London	Veale, D (corresponding author), South London & Maudsley NHS Fdn Trust, Ctr Anxiety Disorders & Trauma, London SE5 8AZ, England.	david.veale@kcl.ac.uk	; Veale, David/F-5670-2010	Roberts, Alison/0000-0002-8003-2285; Veale, David/0000-0002-1717-4766				Abramowitz JS, 2006, CAN J PSYCHIAT, V51, P407, DOI 10.1177/070674370605100702; Achim AM, 2011, SCHIZOPHRENIA BULL, V37, P811, DOI 10.1093/schbul/sbp148; American Psychiatric Association, 2013, DSM 5; Bobes J, 2001, EUR PSYCHIAT, V16, P239, DOI 10.1016/S0924-9338(01)00571-5; Foa E. B., 1983, FAILURES BEHAV THERA; Frost R, 1997, BEHAV RES THER, V35, P667; Grisham JR, 2011, PSYCHOL MED, V41, P2495, DOI 10.1017/S0033291711000894; Herbst N, 2012, CLIN PSYCHOL REV, V32, P454, DOI 10.1016/j.cpr.2012.04.005; Heyman I, 2001, BRIT J PSYCHIAT, V179, P324, DOI 10.1192/bjp.179.4.324; Hollander E, 1997, CNS SPECTRUMS, V2, P15; Kalra SK, 2009, J CLIN INVEST, V119, P737, DOI 10.1172/JCI37563; Kaye WH, 2004, AM J PSYCHIAT, V161, P2215, DOI 10.1176/appi.ajp.161.12.2215; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Komossa K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008141.pub2; Lovell K, 2011, J MENT HEALTH, V20, P525, DOI 10.3109/09638237.2011.608745; Murphy Dennis L, 2010, Dialogues Clin Neurosci, V12, P131; National Institute for Health and Care Excellence, 2013, OBS COMP DIS EV UPD; National Institute for Health and Clinical Excellence, 2005, OBS COMP DIS COR INT; Olatunji BO, 2013, J PSYCHIATR RES, V47, P33, DOI 10.1016/j.jpsychires.2012.08.020; Oldfield VB, 2011, BRIT J CLIN PSYCHOL, V50, P7, DOI 10.1348/014466510X490073; Pace SM, 2011, CLIN PSYCHOL REV, V31, P361, DOI 10.1016/j.cpr.2011.01.007; Pallanti Stefano, 2011, Front Psychiatry, V2, P70, DOI 10.3389/fpsyt.2011.00070; Palumbo Donna, 2007, Neuropsychiatr Dis Treat, V3, P687; Pauls David L, 2010, Dialogues Clin Neurosci, V12, P149; Perlmutter SJ, 1999, LANCET, V354, P1153, DOI 10.1016/S0140-6736(98)12297-3; Roth A., 1996, WHAT WORKS WHOM CRIT; Russell AJ, 2005, BRIT J PSYCHIAT, V186, P525, DOI 10.1192/bjp.186.6.525; Russell EJ, 2013, J CLIN PSYCHIAT, V74, P377, DOI 10.4088/JCP.12r07917; Simpson HB, 2013, JAMA PSYCHIAT, V70, P1190, DOI 10.1001/jamapsychiatry.2013.1932; Singer HS, 2012, J PEDIATR-US, V160, P725, DOI 10.1016/j.jpeds.2011.11.040; Swedo S., 2012, PEDIAT THERAPEUTICS, V2, P1, DOI [DOI 10.4172/2161-0665.1000113, 10.4172/2161-0665.1000113]; Swedo SE, 2004, PEDIATRICS, V113, P907, DOI 10.1542/peds.113.4.907; Veale D, 2002, BEHAV RES THER, V40, P383, DOI 10.1016/S0005-7967(01)00016-X; Veale D, 2009, ADV PSYCHIAT TREATME, V15, P332, DOI DOI 10.1192/APT.BP.107.004705; Wittchen HU, 2005, EUR NEUROPSYCHOPHARM, V15, P357, DOI 10.1016/j.euroneuro.2005.04.012; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd	37	78	86	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2014	348								g2183	10.1136/bmj.g2183	http://dx.doi.org/10.1136/bmj.g2183			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE9SB	24709802	Green Accepted			2022-12-28	WOS:000334348300008
J	Ewer, AK				Ewer, Andrew K.			Pulse oximetry screening: do we have enough evidence now?	LANCET			English	Editorial Material							CONGENITAL HEART-DISEASE; DEFECTS; PROGRAM; IMPACT		Univ Birmingham, Birmingham Womens Hosp, Sch Clin & Expt Med, Birmingham B15 2TG, W Midlands, England	Birmingham Women's Hospital; University of Birmingham	Ewer, AK (corresponding author), Univ Birmingham, Birmingham Womens Hosp, Sch Clin & Expt Med, Birmingham B15 2TG, W Midlands, England.	a.k.ewer@bham.ac.uk	Ewer, Andrew K/B-1050-2013	Ewer, Andrew/0000-0002-3825-4781				Acharya G, 2004, ACTA OBSTET GYN SCAN, V83, P1124, DOI 10.1111/j.0001-6349.2004.00404.x; de-Wahl GA, 2009, BMJ-BRIT MED J, V338, pa3037, DOI DOI 10.1136/BMJ.A3037; Ewer AK, 2012, EARLY HUM DEV, V88, P915, DOI 10.1016/j.earlhumdev.2012.09.013; Ewer AK, 2011, LANCET, V378, P785, DOI 10.1016/S0140-6736(11)60753-8; Garg LF, 2013, PEDIATRICS, V132, pE314, DOI 10.1542/peds.2013-0269; Mahle WT, 2012, PEDIATRICS, V129, P190, DOI 10.1542/peds.2011-3211; Peterson C, 2014, JAMA PEDIATR, V168, P361, DOI 10.1001/jamapediatrics.2013.4779; Riede FT, 2010, EUR J PEDIATR, V169, P975, DOI 10.1007/s00431-010-1160-4; Singh A, 2014, ARCH DIS CHILD-FETAL, V99, pF297, DOI [10.1136/archdischild-2013-303968, 10.1136/archdischild-2013-305657]; Singh AS, 2014, ARCH DIS CHILD FETAL; Thangaratinam S, 2012, LANCET, V379, P2459, DOI 10.1016/S0140-6736(12)60107-X; Turska-Kmiec A, 2012, KARDIOL POL, V70, P370; Zhao Q-m, 2014, LANCET	13	17	18	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 30	2014	384	9945					725	726		10.1016/S0140-6736(14)60575-4	http://dx.doi.org/10.1016/S0140-6736(14)60575-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5DD	24768154				2022-12-28	WOS:000341361500010
J	Sammons, JS				Sammons, Julia Shaklee			Ready or Not: Responding to Measles in the Postelimination Era	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Sammons, Julia Shaklee] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sammons, Julia Shaklee] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; [Sammons, Julia Shaklee] Childrens Hosp Philadelphia, Dept Infect Prevent & Control, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Sammons, JS (corresponding author), Childrens Hosp Philadelphia, 34th St & Civ Ctr Blvd,Main Bldg,A Level, Philadelphia, PA 19104 USA.	sammonsj@email.chop.edu						[Anonymous], 2012, RED BOOK REPORT COMM; [Anonymous], MANUAL SURVEILLANCE; [Anonymous], EP PREV VACC PREV DI; Asma S, 2014, MMWR-MORBID MORTAL W, V63, P277; Black CL, 2013, MMWR-MORBID MORTAL W, V62, P733; McLean HQ, 2013, MMWR RECOMM REP, V62, P1; Perry RT, 2004, J INFECT DIS, V189, pS4, DOI 10.1086/377712; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Smith PJ, 2004, PEDIATRICS, V114, P187, DOI 10.1542/peds.114.1.187; Wallace G, 2013, MMWR-MORBID MORTAL W, V62, P741	10	4	4	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2					145	+		10.7326/M14-0892	http://dx.doi.org/10.7326/M14-0892			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	24763975				2022-12-28	WOS:000339764600024
J	Butkus, R; Weissman, A				Butkus, Renee; Weissman, Arlene			Internists' Attitudes Toward Prevention of Firearm Injury	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICIANS	Background: Professional organizations have called for the medical community's attention to the prevention of firearm injury. However, little is known about physicians' attitudes and practices in preventing firearm injury. Objective: To determine internists' attitudes and practices about firearms and to assess whether opinions differ according to whether there are gun owners in a physician's home. Design: Cross-sectional survey. Setting: Internal medicine practices. Participants: 573 internists representative of American College of Physicians' members. Measures: Respondents' experiences and reported practice behaviors related to firearms and their opinions about contributors and public policies related to firearm violence, as well as physician education and training in firearm safety. Results: The survey response rate was 56.5%. Eighty-five percent of respondents believed that firearm injury is a public health issue, and 71% believed that it is a bigger problem today than a decade ago. Seventy-six percent of respondents believed that stricter gun control legislation would help reduce the risks for gun-related injuries or deaths. Although 66% of respondents believed that physicians should have the right to counsel patients on preventing deaths and injuries from firearms, 58% reported never asking whether patients have guns in their homes. Limitations: The generalizability of these findings to non-American College of Physicians' member internists and other physicians is unknown. Responses may not reflect actual behavior. Conclusion: Most respondents believed that firearm-related violence is a public health issue and favored policy initiatives aimed at reducing it. Although most internists supported a physician's right to counsel patients about gun safety, few reported currently doing it.	[Butkus, Renee] Amer Coll Physicians, Washington, DC 20001 USA; Amer Coll Physicians, Philadelphia, PA USA	American College of Physicians; American College of Physicians	Butkus, R (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW, Washington, DC 20001 USA.	rbutkus@acponline.org						Albright TL, 2003, J AM BOARD FAM PRACT, V16, P40, DOI 10.3122/jabfm.16.1.40; American Academy of Orthopaedic Surgeons, 1996, AM AC ORTH SURG B; American Public Health Association, 1998, POL STAT HANDG INJ R; [Anonymous], 2014, INJ PREV CONTR DAT S; Bronson DL., 2012, STAT ACP RED FIR REL; Bronson DL., 2013, COMMUNICATION   0405; Carbone PS, 2005, ARCH PEDIAT ADOL MED, V159, P1049, DOI 10.1001/archpedi.159.11.1049; Cassel CK, 1998, ANN INTERN MED, V128, P224, DOI 10.7326/0003-4819-128-3-199802010-00009; Centers for Disease Control and Prevention, 2013, FASTSTATS SUIC SELF; Gardner W, 2010, PEDIATRICS, V125, P945, DOI 10.1542/peds.2009-1964; Hoyert Donna L, 2012, Natl Vital Stat Rep, V61, P1; Laine C, 2013, ANN INTERN MED, V158, P493, DOI 10.7326/0003-4819-158-6-201303190-00586; Pew Research Center for the People and the Press, 2013, GUN CONTR DEB SEV OP; Richardson EG, 2011, J TRAUMA, V70, P238, DOI 10.1097/TA.0b013e3181dbaddf	14	35	35	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12					821	U33		10.7326/M13-1960	http://dx.doi.org/10.7326/M13-1960			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24722784				2022-12-28	WOS:000337374900015
J	Handley, AJ				Handley, Anthony J.			Drowning	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GUIDELINES											BIERENS J, 2006, HDB DROWNING; Idris AH, 2003, CIRCULATION, V108, P2565, DOI 10.1161/01.CIR.0000099581.70012.68; Layon AJ, 2009, ANESTHESIOLOGY, V110, P1390, DOI 10.1097/ALN.0b013e3181a4c3b8; Soar J, 2010, RESUSCITATION, V81, P1400, DOI 10.1016/j.resuscitation.2010.08.015; Szpilman D, 2012, NEW ENGL J MED, V366, P2102, DOI 10.1056/NEJMra1013317	5	1	2	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2014	348								g1734	10.1136/bmj.g1734	http://dx.doi.org/10.1136/bmj.g1734			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH5BW	24740929				2022-12-28	WOS:000336144400001
J	Gibson, EM; Purger, D; Mount, CW; Goldstein, AK; Lin, GL; Wood, LS; Inema, I; Miller, SE; Bieri, G; Zuchero, JB; Barres, BA; Woo, PJ; Vogel, H; Monje, M				Gibson, Erin M.; Purger, David; Mount, Christopher W.; Goldstein, Andrea K.; Lin, Grant L.; Wood, Lauren S.; Inema, Ingrid; Miller, Sarah E.; Bieri, Gregor; Zuchero, J. Bradley; Barres, Ben A.; Woo, Pamelyn J.; Vogel, Hannes; Monje, Michelle			Neuronal Activity Promotes Oligodendrogenesis and Adaptive Myelination in the Mammalian Brain	SCIENCE			English	Article							WHITE-MATTER; ADULT BRAIN; ELECTRICAL-ACTIVITY; PROGENITOR CELLS; PRECURSOR CELLS; TRANSGENIC MICE; MICROGLIA; PROTEIN; DIFFERENTIATION; NEUROGENESIS	Myelination of the central nervous system requires the generation of functionally mature oligodendrocytes from oligodendrocyte precursor cells (OPCs). Electrically active neurons may influence OPC function and selectively instruct myelination of an active neural circuit. In this work, we use optogenetic stimulation of the premotor cortex in awake, behaving mice to demonstrate that neuronal activity elicits a mitogenic response of neural progenitor cells and OPCs, promotes oligodendrogenesis, and increases myelination within the deep layers of the premotor cortex and subcortical white matter. We further show that this neuronal activity-regulated oligodendrogenesis and myelination is associated with improved motor function of the corresponding limb. Oligodendrogenesis and myelination appear necessary for the observed functional improvement, as epigenetic blockade of oligodendrocyte differentiation and myelin changes prevents the activity-regulated behavioral improvement.	[Gibson, Erin M.; Purger, David; Mount, Christopher W.; Goldstein, Andrea K.; Lin, Grant L.; Wood, Lauren S.; Inema, Ingrid; Miller, Sarah E.; Woo, Pamelyn J.; Monje, Michelle] Stanford Univ, Dept Neurol, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Gibson, Erin M.; Purger, David; Mount, Christopher W.; Goldstein, Andrea K.; Lin, Grant L.; Wood, Lauren S.; Inema, Ingrid; Miller, Sarah E.; Woo, Pamelyn J.; Monje, Michelle] Stanford Univ, Dept Neurosurg, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Gibson, Erin M.; Purger, David; Mount, Christopher W.; Goldstein, Andrea K.; Lin, Grant L.; Wood, Lauren S.; Inema, Ingrid; Miller, Sarah E.; Woo, Pamelyn J.; Monje, Michelle] Stanford Univ, Dept Pediat, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Purger, David] Stanford Univ, Sch Med, Grad Program Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Mount, Christopher W.; Lin, Grant L.; Bieri, Gregor] Stanford Univ, Sch Med, Grad Program Neurosci, Stanford, CA 94305 USA; [Zuchero, J. Bradley; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Zuchero, J. Bradley; Barres, Ben A.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Vogel, Hannes] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Monje, M (corresponding author), Stanford Univ, Dept Neurol, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	mmonje@stanford.edu		Miller, Sarah/0000-0002-5558-1813; Gibson, Erin/0000-0001-9749-3814; Lin, Grant/0000-0001-6888-2140; Vogel, Otto Hannes/0000-0002-0960-3508; Monje, Michelle/0000-0002-3547-237X; Mount, Christopher/0000-0003-1635-2492; Zuchero, J. Bradley/0000-0002-4706-2538	National Institute of Neurological Disorders and Stroke [NINDS K08NS070926, R01 EY10257]; California Institute for Regenerative Medicine [CIRM RB4-06093, RN3-06510]; Alex's Lemonade Stand Foundation; McKenna Claire Foundation; Cure Starts Now; Lyla Nsouli Foundation; Dylan Jewett Fund; Connor Johnson Fund; Zoey Ganesh Fund; Dylan Frick Fund; Abigail Jensen Fund; Wayland Villars Fund; Jennifer Kranz Memorial Fund; Ludwig Foundation; Price Family Charitable Fund; Stanford Medical Scientist Training Program; Stanford Institute for Neuro-Innovation and Translational Neurosciences; Child Health Research Institute; Lucile Packard Foundation for Children's Health, Stanford University Clinical & Translation Science Award [UL1 RR025744]; Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation; Bezos Family Foundation; Child Health Research Institute at Stanford University, Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases; NIH [1S10RR02678001]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS070926] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Alex's Lemonade Stand Foundation; McKenna Claire Foundation; Cure Starts Now; Lyla Nsouli Foundation; Dylan Jewett Fund; Connor Johnson Fund; Zoey Ganesh Fund; Dylan Frick Fund; Abigail Jensen Fund; Wayland Villars Fund; Jennifer Kranz Memorial Fund; Ludwig Foundation; Price Family Charitable Fund; Stanford Medical Scientist Training Program; Stanford Institute for Neuro-Innovation and Translational Neurosciences; Child Health Research Institute; Lucile Packard Foundation for Children's Health, Stanford University Clinical & Translation Science Award; Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation(Howard Hughes Medical Institute); Bezos Family Foundation; Child Health Research Institute at Stanford University, Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We gratefully acknowledge support from the National Institute of Neurological Disorders and Stroke (NINDS K08NS070926 to M. M.; R01 EY10257 to B. A. B.); California Institute for Regenerative Medicine (CIRM RB4-06093 and RN3-06510 to M. M.); Alex's Lemonade Stand Foundation (M. M.); McKenna Claire Foundation (M. M.); The Cure Starts Now (M. M.); Lyla Nsouli Foundation (M. M.); the Dylan Jewett, Connor Johnson, Zoey Ganesh, Dylan Frick, Abigail Jensen, Wayland Villars, and Jennifer Kranz Memorial Funds (M. M.); Ludwig Foundation (M. M.); Price Family Charitable Fund (M. M.); Stanford Medical Scientist Training Program (D. P., C. W. M., G. L. L.); Stanford Institute for Neuro-Innovation and Translational Neurosciences (M. M.); the Child Health Research Institute (M. M. and E. M. G.); Lucile Packard Foundation for Children's Health, Stanford University Clinical & Translation Science Award (UL1 RR025744 to E. M. G.); Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation (J.B.Z.); the Bezos Family Foundation (I. I.); and the Child Health Research Institute at Stanford University, Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases (M. M.). We give special thanks to J. Perrino of the Electron Microscopy Core of the Stanford University Cell Sciences Imaging Facility for technical support with transmission electron microscopy NIH Shared Instrumentation Grant 1S10RR02678001; to S. Chen for the illustration accompanying the print summary of this work; and to J. Lennon, K. Lechtenberg, H. Venkatesh, and M. E. Freret for critical reading of the manuscript.	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; BENES FM, 1989, SCHIZOPHRENIA BULL, V15, P585, DOI 10.1093/schbul/15.4.585; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brazel CY, 2005, AGING CELL, V4, P197, DOI 10.1111/j.1474-9726.2005.00158.x; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; De Biase LM, 2011, J NEUROSCI, V31, P12650, DOI 10.1523/JNEUROSCI.2455-11.2011; De Biase LM, 2010, J NEUROSCI, V30, P3600, DOI 10.1523/JNEUROSCI.6000-09.2010; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Franklin B. J., 2008, THE MOUSE BRAIN; Fruttiger M, 2000, CURR BIOL, V10, P1283, DOI 10.1016/S0960-9822(00)00757-0; Goldsberry G, 2011, EPILEPSY BEHAV, V22, P391, DOI 10.1016/j.yebeh.2011.06.025; GRAEBER MB, 1990, J NEUROIMMUNOL, V27, P121, DOI 10.1016/0165-5728(90)90061-Q; Gremel CM, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00110; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Hill RA, 2013, J NEUROSCI, V33, P14558, DOI 10.1523/JNEUROSCI.2001-12.2013; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Kingham PJ, 1999, J NEUROCHEM, V73, P538, DOI 10.1046/j.1471-4159.1999.0730538.x; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Li Q, 2010, NEUROSCI LETT, V479, P128, DOI 10.1016/j.neulet.2010.05.043; Lin SC, 2005, NEURON, V46, P773, DOI 10.1016/j.neuron.2005.04.025; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Mangin JM, 2008, J NEUROSCI, V28, P7610, DOI 10.1523/JNEUROSCI.1355-08.2008; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Monje M, 2011, P NATL ACAD SCI USA, V108, P4453, DOI 10.1073/pnas.1101657108; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Morris MJ, 2013, J NEUROSCI, V33, P6401, DOI 10.1523/JNEUROSCI.1001-12.2013; Pajevic S, 2014, NEUROSCIENCE, V276, P135, DOI 10.1016/j.neuroscience.2013.11.007; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; Schlegel AA, 2012, J COGNITIVE NEUROSCI, V24, P1664, DOI 10.1162/jocn_a_00240; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Shi P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1518; SMITH RS, 1970, AM J PHYSIOL, V219, P1256, DOI 10.1152/ajplegacy.1970.219.5.1256; Stevens B, 1998, J NEUROSCI, V18, P9303; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Wu MZ, 2012, J NEUROSCI, V32, P6651, DOI 10.1523/JNEUROSCI.4876-11.2012; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Yue T, 2006, J NEUROSCI, V26, P1275, DOI 10.1523/JNEUROSCI.4717-05.2006; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854; Zuccaro E, 2013, NAT CELL BIOL, V15, P572, DOI 10.1038/ncb2750	57	766	777	7	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					487	+	1252304	10.1126/science.1252304	http://dx.doi.org/10.1126/science.1252304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24727982	Green Accepted			2022-12-28	WOS:000335157700034
J	Anand, M				Anand, Mahesh			PLANETARY SCIENCE Analyzing Moon Rocks	SCIENCE			English	Editorial Material							LUNAR VOLCANIC GLASSES; MELT INCLUSIONS; WATER; HYDROGEN; SAMPLES		Open Univ, Milton Keynes MK7 6AA, Bucks, England	Open University - UK	Anand, M (corresponding author), Open Univ, Milton Keynes MK7 6AA, Bucks, England.	mahesh.anand@open.ac.uk	Anand, Mahesh/E-9259-2013					Barnes JJ, 2014, EARTH PLANET SC LETT, V390, P244, DOI 10.1016/j.epsl.2014.01.015; Boyce JW, 2014, SCIENCE, V344, P400, DOI 10.1126/science.1250398; Boyce JW, 2010, NATURE, V466, P466, DOI 10.1038/nature09274; Hauri EH, 2011, SCIENCE, V333, P213, DOI 10.1126/science.1204626; Hui HJ, 2013, NAT GEOSCI, V6, P177, DOI 10.1038/ngeo1735; McCubbin FM, 2010, P NATL ACAD SCI USA, V107, P11223, DOI 10.1073/pnas.1006677107; Mortimer J. I., 2014, LUNAR PLANET SCI, V45; Nakajima M., 2014, LUNAR PLANET SCI, V45; Saal AE, 2008, NATURE, V454, P192, DOI 10.1038/nature07047; Saal AE, 2013, SCIENCE, V340, P1317, DOI 10.1126/science.1235142; Tartese R, 2014, GEOLOGY, V42, P363, DOI 10.1130/G35288.1; Tartese R, 2013, GEOCHIM COSMOCHIM AC, V122, P58, DOI 10.1016/j.gca.2013.08.014; Wetzel D. T., 2014, LUNAR PLANET SCI, V45	13	3	3	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					365	366		10.1126/science.1253266	http://dx.doi.org/10.1126/science.1253266			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763576				2022-12-28	WOS:000334867800024
J	Leslie, NR; den Hertog, J				Leslie, Nick R.; den Hertog, Jeroen			Mutant PTEN in Cancer: Worse Than Nothing	CELL			English	Editorial Material							TUMOR; MICE	Tumor suppressors block the development of cancer and are often lost during tumor development. Papa et al. show that partial loss of normal PTEN tumor suppressor function can be compounded by additional disruption caused by the expression of inactive mutant PTEN protein. This has significant implications for patients with PTEN gene mutations.	[Leslie, Nick R.] Heriot Watt Univ, Inst Biol Chem Biophys & Bioengn, Edinburgh EH14 4AS, Midlothian, Scotland; [den Hertog, Jeroen] Koninklijke Nederlandse Akad Wetenschappen, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [den Hertog, Jeroen] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [den Hertog, Jeroen] Inst Biol Leiden, NL-2333 BE Leiden, Netherlands	Heriot Watt University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Leiden University	Leslie, NR (corresponding author), Heriot Watt Univ, Inst Biol Chem Biophys & Bioengn, Edinburgh EH14 4AS, Midlothian, Scotland.	n.r.leslie@hw.ac.uk		LESLIE, Nicholas/0000-0001-5131-0541	MRC [G0801865] Funding Source: UKRI; Medical Research Council [G0801865] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Carracedo A, 2011, CANCER RES, V71, P629, DOI 10.1158/0008-5472.CAN-10-2488; Freeman D, 2006, CANCER RES, V66, P6492, DOI 10.1158/0008-5472.CAN-05-4143; Knobbe CB, 2008, ONCOGENE, V27, P5398, DOI 10.1038/onc.2008.238; Leslie NR, 2011, TRENDS PHARMACOL SCI, V32, P131, DOI 10.1016/j.tips.2010.12.005; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Odriozola L, 2007, J BIOL CHEM, V282, P23306, DOI 10.1074/jbc.M611240200; Papa A, 2014, CELL, V157, P595, DOI 10.1016/j.cell.2014.03.027; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Wang H, 2010, P NATL ACAD SCI USA, V107, P5142, DOI 10.1073/pnas.0912524107	10	12	13	1	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					527	529		10.1016/j.cell.2014.04.008	http://dx.doi.org/10.1016/j.cell.2014.04.008			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766800	Bronze			2022-12-28	WOS:000335392100002
J	Dornelas, M; Gotelli, NJ; McGill, B; Shimadzu, H; Moyes, F; Sievers, C; Magurran, AE				Dornelas, Maria; Gotelli, Nicholas J.; McGill, Brian; Shimadzu, Hideyasu; Moyes, Faye; Sievers, Caya; Magurran, Anne E.			Assemblage Time Series Reveal Biodiversity Change but Not Systematic Loss	SCIENCE			English	Article							PLANET; SCALE; ECOSYSTEMS; DIVERSITY	The extent to which biodiversity change in local assemblages contributes to global biodiversity loss is poorly understood. We analyzed 100 time series from biomes across Earth to ask how diversity within assemblages is changing through time. We quantified patterns of temporal alpha diversity, measured as change in local diversity, and temporal beta diversity, measured as change in community composition. Contrary to our expectations, we did not detect systematic loss of alpha diversity. However, community composition changed systematically through time, in excess of predictions from null models. Heterogeneous rates of environmental change, species range shifts associated with climate change, and biotic homogenization may explain the different patterns of temporal alpha and beta diversity. Monitoring and understanding change in species composition should be a conservation priority.	[Dornelas, Maria; Shimadzu, Hideyasu; Moyes, Faye; Sievers, Caya; Magurran, Anne E.] Univ St Andrews, Ctr Biol Divers, St Andrews KY16 9TH, Fife, Scotland; [Dornelas, Maria; Shimadzu, Hideyasu; Moyes, Faye; Sievers, Caya; Magurran, Anne E.] Univ St Andrews, Scottish Oceans Inst, Sch Biol, St Andrews KY16 9TH, Fife, Scotland; [Gotelli, Nicholas J.] Univ Vermont, Dept Biol, Burlington, VT 05405 USA; [McGill, Brian] Univ Maine, Sch Biol & Ecol, Sustainabil Solut Initiat, Orono, ME 04469 USA; [Shimadzu, Hideyasu] Keio Univ, Dept Math, Yokohama, Kanagawa 2238522, Japan	University of St Andrews; University of St Andrews; University of Vermont; University of Maine System; University of Maine Orono; Keio University	Dornelas, M (corresponding author), Univ St Andrews, Ctr Biol Divers, St Andrews KY16 9TH, Fife, Scotland.	maadd@st-andrews.ac.uk	Dornelas, Marcelo C/A-6104-2013; McGill, Brian J/A-3476-2008; Shimadzu, Hideyasu/E-5649-2010; Moyes, Faye/AAE-8480-2019; Dornelas, Maria/E-3595-2010	Dornelas, Marcelo C/0000-0002-6710-3050; McGill, Brian J/0000-0002-0850-1913; Shimadzu, Hideyasu/0000-0003-0919-8829; Moyes, Faye/0000-0001-9687-0593; Dornelas, Maria/0000-0003-2077-7055; Magurran, Anne/0000-0002-0036-2795	European Research Council [BioTIME 250189]; Scottish Funding Council (MASTS) [HR09011]; Royal Society; Belspo (Belgian Science Policy); NSF; NOAA Marine Fisheries Service [NA11NMF4540174]; Fisheries and Oceans Canada; Government of Nunavut; Nunavut Wildlife Management Board; Nunavut Tunngavik Inc.; Nunavut Emerging Fisheries Fund; Makivik Corporation; Smithsonian Institution; Atherton Seidell Grant Program; NSF [BSR-8811902, DEB 9411973, DEB 0080538, DEB 0218039, DEB 0620910, DEB 0963447]; Luquillo Long-Term Ecological Research Program; University of Puerto Rico; NSF's Long-Term Ecological Research program and Fishery Administration Agency; Council of Agriculture, Taiwan; Azores Fisheries Observer Program; Center of the Institute of Marine Research (IMAR) of the University of the Azores; NSF's Long-Term Ecological Research Program [DEB 08-23380]; U.S. Forest Service Pacific Northwest Research Station, and Oregon State University; Directorate For Geosciences [1236905] Funding Source: National Science Foundation	European Research Council(European Research Council (ERC)European Commission); Scottish Funding Council (MASTS); Royal Society(Royal Society of London); Belspo (Belgian Science Policy)(Belgian Federal Science Policy Office); NSF(National Science Foundation (NSF)); NOAA Marine Fisheries Service; Fisheries and Oceans Canada; Government of Nunavut; Nunavut Wildlife Management Board; Nunavut Tunngavik Inc.; Nunavut Emerging Fisheries Fund; Makivik Corporation; Smithsonian Institution(Smithsonian Institution); Atherton Seidell Grant Program; NSF(National Science Foundation (NSF)); Luquillo Long-Term Ecological Research Program; University of Puerto Rico; NSF's Long-Term Ecological Research program and Fishery Administration Agency; Council of Agriculture, Taiwan; Azores Fisheries Observer Program; Center of the Institute of Marine Research (IMAR) of the University of the Azores; NSF's Long-Term Ecological Research Program; U.S. Forest Service Pacific Northwest Research Station, and Oregon State University; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Supported by the European Research Council (BioTIME 250189), the Scottish Funding Council (MASTS, grant reference HR09011) (M. D.), and the Royal Society (A. E. M.). We are grateful to all the data providers for making data publicly available and to their funders: Belspo (Belgian Science Policy); NSF; NOAA Marine Fisheries Service (grant NA11NMF4540174); Fisheries and Oceans Canada; Government of Nunavut, Nunavut Wildlife Management Board, Nunavut Tunngavik Inc., and Nunavut Emerging Fisheries Fund; Makivik Corporation; Smithsonian Institution; Atherton Seidell Grant Program; grants BSR-8811902, DEB 9411973, DEB 0080538, DEB 0218039, DEB 0620910, and DEB 0963447 from NSF to the Institute for Tropical Ecosystem Studies, University of Puerto Rico, and to the International Institute of Tropical Forestry, U. S. Forest Service, as part of the Luquillo Long-Term Ecological Research Program; University of Puerto Rico; NSF's Long-Term Ecological Research program and Fishery Administration Agency; Council of Agriculture, Taiwan; Azores Fisheries Observer Program; and the Center of the Institute of Marine Research (IMAR) of the University of the Azores. In addition, data were provided by the H. J. Andrews Experimental Forest research program, funded by NSF's Long-Term Ecological Research Program (DEB 08-23380), P. Henderson (Pisces Conservation), U.S. Forest Service Pacific Northwest Research Station, and Oregon State University. Cruise data were collected through the logistical efforts of the Australian Antarctic Division and approved by the Australian Antarctic Research Advisory Committee (projects 2208 and 2953), the Australian Antarctic Data Centre of the Australian Antarctic Division, Tasmania. We are also grateful to the databases that compile these data: OBIS, Ecological Data Wiki, DATRAS, and LTER. Finally, we thank O. Mendivil-Ramos for advice on database design, L. Antao, and M. Barbosa and three anonymous referees for comments on earlier versions of the manuscript. The rarefied time series used in our analysis are included as Databases S1 and S2.	Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Butchart SHM, 2005, PHILOS T R SOC B, V360, P255, DOI 10.1098/rstb.2004.1583; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Ellis EC, 2013, P NATL ACAD SCI USA, V110, P7978, DOI 10.1073/pnas.1217241110; Elton C S., 1958, THE ECOLOGY OF INVAS; Erasmus BFN, 1999, P ROY SOC B-BIOL SCI, V266, P315, DOI 10.1098/rspb.1999.0640; Ferrier S, 2004, BIOSCIENCE, V54, P1101, DOI 10.1641/0006-3568(2004)054[1101:MMOTBF]2.0.CO;2; Graham NAJ, 2014, CURR OPIN ENV SUST, V7, P9, DOI 10.1016/j.cosust.2013.11.023; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Loh J, 2005, PHILOS T R SOC B, V360, P289, DOI 10.1098/rstb.2004.1584; Magurran AE, 2010, PHILOS T R SOC B, V365, P3611, DOI 10.1098/rstb.2010.0285; Millennium Ecosystem Assessment, 2006, ECOSYSTEMS AND HUMAN; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Rahel FJ, 2002, ANNU REV ECOL SYST, V33, P291, DOI 10.1146/annurev.ecolsys.33.010802.150429; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Vellend M, 2013, P NATL ACAD SCI USA, V110, P19456, DOI 10.1073/pnas.1312779110; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563	21	728	740	27	649	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					296	299		10.1126/science.1248484	http://dx.doi.org/10.1126/science.1248484			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744374	Green Accepted, Green Published			2022-12-28	WOS:000334474500035
J	Nishimura, MT; Dangl, JL				Nishimura, Marc T.; Dangl, Jeffery L.			PLANT SCIENCE Paired Plant Immune Receptors	SCIENCE			English	Editorial Material							CELL-DEATH; PROTEIN; ARABIDOPSIS; CHS1		[Nishimura, Marc T.] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Nishimura, MT (corresponding author), Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	marcusn@email.unc.edu; dangl@email.unc.edu		Nishimura, Marc Tad/0000-0003-4666-6900	Division Of Integrative Organismal Systems [1257373] Funding Source: National Science Foundation; Howard Hughes Medical Institute Funding Source: Medline	Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Birker D, 2009, PLANT J, V60, P602, DOI 10.1111/j.1365-313X.2009.03984.x; Cesari S, 2013, PLANT CELL, V25, P1463, DOI 10.1105/tpc.112.107201; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Narusaka M, 2009, PLANT J, V60, P218, DOI 10.1111/j.1365-313X.2009.03949.x; Noutoshi Y, 2005, PLANT J, V43, P873, DOI 10.1111/j.1365-313X.2005.02500.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Takken FLW, 2012, CURR OPIN PLANT BIOL, V15, P375, DOI 10.1016/j.pbi.2012.05.001; Tasset C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001202; Wang YC, 2013, PLANT J, V75, P553, DOI 10.1111/tpj.12232; Williams SJ, 2014, SCIENCE, V344, P299, DOI 10.1126/science.1247357; Zbierzak AM, 2013, PLANT J, V75, P539, DOI 10.1111/tpj.12219	12	10	10	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					267	268		10.1126/science.1253849	http://dx.doi.org/10.1126/science.1253849			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744367				2022-12-28	WOS:000334474500026
J	Suzuki, H; Nishizawa, T; Tani, K; Yamazaki, Y; Tamura, A; Ishitani, R; Dohmae, N; Tsukita, S; Nureki, O; Fujiyoshi, Y				Suzuki, Hiroshi; Nishizawa, Tomohiro; Tani, Kazutoshi; Yamazaki, Yuji; Tamura, Atsushi; Ishitani, Ryuichiro; Dohmae, Naoshi; Tsukita, Sachiko; Nureki, Osamu; Fujiyoshi, Yoshinori			Crystal Structure of a Claudin Provides Insight into the Architecture of Tight Junctions	SCIENCE			English	Article							MEMBRANE-PROTEINS; MUTATIONS; TRANSPORT; CHANNELS; OCCLUDIN; STRANDS	Tight junctions are cell-cell adhesion structures in epithelial cell sheets that surround organ compartments in multicellular organisms and regulate the permeation of ions through the intercellular space. Claudins are the major constituents of tight junctions and form strands that mediate cell adhesion and function as paracellular barriers. We report the structure of mammalian claudin-15 at a resolution of 2.4 angstroms. The structure reveals a characteristic beta-sheet fold comprising two extracellular segments, which is anchored to a transmembrane four-helix bundle by a consensus motif. Our analyses suggest potential paracellular pathways with distinctive charges on the extracellular surface, providing insight into the molecular basis of ion homeostasis across tight junctions.	[Suzuki, Hiroshi; Tani, Kazutoshi; Fujiyoshi, Yoshinori] Nagoya Univ, Cellular & Struct Physiol Inst, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Nishizawa, Tomohiro; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan; [Nishizawa, Tomohiro; Ishitani, Ryuichiro; Dohmae, Naoshi; Nureki, Osamu] RIKEN, Global Res Cluster, Wako, Saitama 3510198, Japan; [Yamazaki, Yuji; Tamura, Atsushi; Tsukita, Sachiko] Osaka Univ, Lab Biol Sci, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Yamazaki, Yuji; Tamura, Atsushi; Tsukita, Sachiko] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; [Fujiyoshi, Yoshinori] Nagoya Univ, Grad Sch Pharmaceut Sci, Dept Basic Med Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University; University of Tokyo; RIKEN; Osaka University; Osaka University; Nagoya University	Nureki, O (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan.	nureki@bs.s.u-tokyo.ac.jp; yoshi@cespi.nagoya-u.ac.jp	Suzuki, Hiroshi/D-5428-2013; Fujiyoshi, Yoshinori/E-5989-2012; Dohmae, Naoshi/C-2040-2011; Tani, Kazutoshi/B-3705-2008; NUREKI, OSAMU/G-4960-2014	Suzuki, Hiroshi/0000-0001-5371-6385; Fujiyoshi, Yoshinori/0000-0002-8070-1493; Dohmae, Naoshi/0000-0002-5242-9410; Tani, Kazutoshi/0000-0003-4835-154X; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [22227004, 24227004]; Japan New Energy and Industrial Technology Development Organization (NEDO); National Institute of Biomedical Innovation; Grants-in-Aid for Scientific Research [26440024] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Uji for technical support, T. Suzuki for mass spectrometry, T. Imasaki and Y. Takagi for sharing their unpublished protocol for SeMet incorporation and their technical advice, the beamline staff members at BL32XU of SPring-8 (Hyogo, Japan) for technical help during data collection, and T. Walz for critical reading of the manuscript. Supported by Grants-in-Aid for Scientific Research (S) (22227004, Y. F.; 24227004, O.N.) and (A) (S. T.), Grants-in-Aid for Scientific Research on Innovative Areas (S. T.), Grants-in-Aid for Young Scientists (B) (K. T.), and Platform for Drug Discovery, Information, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and the Japan New Energy and Industrial Technology Development Organization (NEDO) and the National Institute of Biomedical Innovation (Y.F.). H. S., Y.Y., and A. T. screened claudin genes; H. S. performed protein expression, purification, and electron microscopic studies; T.N. crystallized the mCldn15 protein in lipidic cubic phase, collected and processed diffraction data, and solved and refined the structure; K. T. analyzed the structure; R. I. assisted with x-ray data collection and structure determination; N.D. performed mass spectrometric analyses; H. S., T.N., K. T., S. T., O.N., and Y.F. wrote the manuscript; and S. T., O.N., and Y.F. supervised the research. The authors declare no competing financial interests. Coordinates and structure factors have been deposited in the Protein Data Bank under accession number 4P79.	Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Angelow S, 2008, AM J PHYSIOL-RENAL, V295, pF867, DOI 10.1152/ajprenal.90264.2008; Colegio OR, 2002, AM J PHYSIOL-CELL PH, V283, pC142, DOI 10.1152/ajpcell.00038.2002; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Hadj-Rabia S, 2004, GASTROENTEROLOGY, V127, P1386, DOI 10.1053/j.gastro.2004.07.022; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hirata K, 2010, AIP CONF PROC, V1234, P901, DOI 10.1063/1.3463362; Krug SM, 2012, ANN NY ACAD SCI, V1257, P20, DOI 10.1111/j.1749-6632.2012.06555.x; Li JH, 2013, AM J PHYSIOL-CELL PH, V305, pC190, DOI 10.1152/ajpcell.00074.2013; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; POWELL DW, 1981, AM J PHYSIOL, V241, pG275, DOI 10.1152/ajpgi.1981.241.4.G275; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; SCHNEEBERGER EE, 1992, AM J PHYSIOL, V262, pL647, DOI 10.1152/ajplung.1992.262.6.L647; Schulz GE, 2000, CURR OPIN STRUC BIOL, V10, P443, DOI 10.1016/S0959-440X(00)00120-2; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; STAEHELIN LA, 1973, J CELL SCI, V13, P763; Tamura A, 2011, GASTROENTEROLOGY, V140, P913, DOI 10.1053/j.gastro.2010.08.006; Tang VW, 2003, BIOPHYS J, V84, P1660, DOI 10.1016/S0006-3495(03)74975-3; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wada M, 2013, GASTROENTEROLOGY, V144, P369, DOI 10.1053/j.gastro.2012.10.035; White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]; Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154	28	234	239	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					304	307		10.1126/science.1248571	http://dx.doi.org/10.1126/science.1248571			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744376				2022-12-28	WOS:000334474500037
J	Scully, T				Scully, Tony			Obesity	NATURE			English	Editorial Material																			0	14	15	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					S49	S49		10.1038/508S49a	http://dx.doi.org/10.1038/508S49a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24740124	Bronze			2022-12-28	WOS:000334403000001
J	Engel, CC				Engel, Charles C.			Review: In neuropathy, fibromyalgia, or chronic pain, duloxetine reduces pain but increases adverse events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Engel, Charles C.] RAND Corp, Arlington, VA USA; [Engel, Charles C.] Uniformed Serv Univ Hlth Sci, Arlington, VA USA	RAND Corporation	Engel, CC (corresponding author), RAND Corp, Arlington, VA USA.			Engel, Charles/0000-0002-9232-3389					0	2	2	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2014	160	8							JC12	10.7326/0003-4819-160-8-201404150-02012	http://dx.doi.org/10.7326/0003-4819-160-8-201404150-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW3QU	24733217				2022-12-28	WOS:000364907600011
J	Liapis, K; Chung, Y; Akhtar, W; Taussig, D				Liapis, Konstantinos; Chung, Yooyun; Akhtar, Waqas; Taussig, David			PICTURE QUIZ A patient with rheumatoid arthritis, cryoglobulinaemia, and an "accidental" finding	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NECROSIS FACTOR THERAPY; VISCERAL LEISHMANIASIS; UNITED-KINGDOM; DISEASE; EUROPE; LUPUS; RISK		[Liapis, Konstantinos; Akhtar, Waqas; Taussig, David] Barts & London NHS Trust, St Bartholomews Hosp, Dept Haematol Oncol, London EC1A 7BE, England; [Chung, Yooyun] Barts & London NHS Trust, Trauma Ctr, Royal London Hosp, London EC1A 7BE, England	Barts Health NHS Trust; Barts Health NHS Trust; Royal London Hospital	Liapis, K (corresponding author), Barts & London NHS Trust, St Bartholomews Hosp, Dept Haematol Oncol, London EC1A 7BE, England.	kosliapis@hotmail.com	Akhtar, Waqas/GRJ-5030-2022	Akhtar, Waqas/0000-0001-7563-7346				Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; ARGOV S, 1989, CLIN EXP IMMUNOL, V76, P190; Berman JD, 1999, CLIN INFECT DIS, V28, P49, DOI 10.1086/515086; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Casato M, 1999, ARTHRITIS RHEUM, V42, P2007, DOI 10.1002/1529-0131(199909)42:9&lt;2007::AID-ANR30&gt;3.0.CO;2-X; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; COHEN MG, 1987, ANN RHEUM DIS, V46, P853, DOI 10.1136/ard.46.11.853; Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8; Dixon WG, 2006, ARTHRITIS RHEUM-US, V54, P2368, DOI 10.1002/art.21978; Galanakis E, 1997, LANCET, V350, P368, DOI 10.1016/S0140-6736(05)63428-9; Gkolfinopoulou K, 2013, Euro Surveill, V18, P20532, DOI 10.2807/1560-7917.ES2013.18.29.20532; Khan A, 2010, BMJ CASE REP; Lockwood DNJ, 2006, BMJ-BRIT MED J, V333, P711, DOI 10.1136/bmj.38989.567083.BE; Malik ANJ, 2006, EMERG INFECT DIS, V12, P1257, DOI 10.3201/eid1708.050486; Moore EM, 2011, CLIN MED, V11, P492, DOI 10.7861/clinmedicine.11-5-492; Morra Enrica, 2005, Hematology Am Soc Hematol Educ Program, P368; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Murray HW, 2000, BMJ-BRIT MED J, V320, P490, DOI 10.1136/bmj.320.7233.490; Neumayr ALC, 2013, TRAVEL MED INFECT DI, V11, P412, DOI 10.1016/j.tmaid.2013.05.003; Ramos-Casals M, 2012, LANCET, V379, P348, DOI 10.1016/S0140-6736(11)60242-0; Ready PD, 2010, EUROSURVEILLANCE, V15, P29; Wall EC, 2012, AM J TROP MED HYG, V86, P115, DOI 10.4269/ajtmh.2012.10-0558; Williams EL, 2009, RHEUMATOLOGY, V48, P716, DOI 10.1093/rheumatology/kep080; Xynos ID, 2009, EMERG INFECT DIS, V15, P956, DOI 10.3201/eid1506.090101; Zanger P, 2013, EUROSURVEILLANCE, V18, P49, DOI 10.2807/1560-7917.ES2013.18.30.20542	25	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2014	348								g2701	10.1136/bmj.g2701	http://dx.doi.org/10.1136/bmj.g2701			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF5GH	24733745				2022-12-28	WOS:000334741500017
J	Ducrot, E; Chen, YL; Bulters, M; Sijbesma, RP; Creton, C				Ducrot, Etienne; Chen, Yulan; Bulters, Markus; Sijbesma, Rint P.; Creton, Costantino			Toughening Elastomers with Sacrificial Bonds and Watching Them Break	SCIENCE			English	Article							DOUBLE-NETWORK HYDROGELS; BIMODAL ELASTOMERS; FRACTURE ENERGY; STRENGTH; GELS; TOUGHNESS; POLYMERS; RUBBER; MODEL	Elastomers are widely used because of their large-strain reversible deformability. Most unfilled elastomers suffer from a poor mechanical strength, which limits their use. Using sacrificial bonds, we show how brittle, unfilled elastomers can be strongly reinforced in stiffness and toughness (up to 4 megapascals and 9 kilojoules per square meter) by introducing a variable proportion of isotropically prestretched chains that can break and dissipate energy before the material fails. Chemoluminescent cross-linking molecules, which emit light as they break, map in real time where and when many of these internal bonds break ahead of a propagating crack. The simple methodology that we use to introduce sacrificial bonds, combined with the mapping of where bonds break, has the potential to stimulate the development of new classes of unfilled tough elastomers and better molecular models of the fracture of soft materials.	[Ducrot, Etienne; Creton, Costantino] Ecole Super Phys & Chim Ind Ville Paris ESPCI, UMR 7615, F-75231 Paris 05, France; [Ducrot, Etienne; Creton, Costantino] CNRS, UMR 7615, F-75231 Paris 05, France; [Ducrot, Etienne; Creton, Costantino] Univ Paris 06, Sorbonne Univ, UMR 7615, F-75231 Paris 05, France; [Chen, Yulan; Sijbesma, Rint P.] Eindhoven Univ Technol, Inst Complex Mol Syst, NL-5600 MB Eindhoven, Netherlands; [Bulters, Markus] DSM Ahead, NL-6167 RD Geleen, Netherlands	UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Eindhoven University of Technology; DSM NV	Creton, C (corresponding author), Ecole Super Phys & Chim Ind Ville Paris ESPCI, UMR 7615, 10 Rue Vauquelin, F-75231 Paris 05, France.	costantino.creton@espci.fr	Ducrot, Etienne/O-2418-2014; chen, yulan/ABB-3014-2020; CRETON, COSTANTINO/B-4077-2008	Ducrot, Etienne/0000-0002-8737-8668; CRETON, COSTANTINO/0000-0002-0177-9680; chen, yulan/0000-0001-6017-8888	DSM Ahead, Geleen, Netherlands	DSM Ahead, Geleen, Netherlands	We gratefully acknowledge the financial support of DSM Ahead, Geleen, Netherlands and many helpful discussions with the researchers of their Materials Science Center. We also thank E.J. Kramer and H.R. Brown for their insightful comments and critical reading of the manuscript, and D. Martina for his friendly and efficient help in setting up the camera for the chemoluminescence experiments. Last, we thank W. Fresquet from Andor Technology for lending us the camera.	BROWN HR, 1991, MACROMOLECULES, V24, P2752, DOI 10.1021/ma00010a018; Brown HR, 2007, MACROMOLECULES, V40, P3815, DOI 10.1021/ma062642y; Chen YL, 2012, NAT CHEM, V4, P559, DOI [10.1038/nchem.1358, 10.1038/NCHEM.1358]; Dieter G.E., 1976, MECH METALLURGY VOL; Genesky GD, 2008, MACROMOLECULES, V41, P8231, DOI 10.1021/ma801065x; Genesky GD, 2010, POLYMER, V51, P4152, DOI 10.1016/j.polymer.2010.06.054; Gent AN, 1996, LANGMUIR, V12, P4492, DOI 10.1021/la950887q; Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907; Greensmith H.W., 1963, J APPL POLYM SCI, V7, P993, DOI [10.1002/app.1963.070070316, DOI 10.1002/APP.1963.070070316]; Heinrich G, 2002, CURR OPIN SOLID ST M, V6, P195, DOI 10.1016/S1359-0286(02)00030-X; Kramer E.J., 1990, ADV POLYM SCI, V91, P1; LAKE GJ, 1967, PROC R SOC LON SER-A, V300, P108, DOI 10.1098/rspa.1967.0160; LAKE GJ, 1965, J APPL POLYM SCI, V9, P1233, DOI 10.1002/app.1965.070090405; LECHTKEN P, 1976, CHEM BER-RECL, V109, P2862, DOI 10.1002/cber.19761090818; Na YH, 2006, MACROMOLECULES, V39, P4641, DOI 10.1021/ma060568d; Nakajima T, 2013, SOFT MATTER, V9, P1955, DOI 10.1039/c2sm27232f; Persson BNJ, 2005, J PHYS-CONDENS MAT, V17, pR1071, DOI 10.1088/0953-8984/17/44/R01; Sakulkaew K, 2011, POLYM TEST, V30, P163, DOI 10.1016/j.polymertesting.2010.11.014; Singh NK, 2011, MACROMOLECULES, V44, P1480, DOI 10.1021/ma1028054; Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409; Tanaka Y, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/56005; Tanaka Y, 2005, J PHYS CHEM B, V109, P11559, DOI 10.1021/jp0500790; Viers BD, 2007, J MACROMOL SCI A, V44, P131, DOI 10.1080/10601320601030657; Wang X, 2011, SOFT MATTER, V7, P8576, DOI 10.1039/c1sm05787a; Webber RE, 2007, MACROMOLECULES, V40, P2919, DOI 10.1021/ma062924y; Yu QM, 2009, MACROMOLECULES, V42, P3852, DOI 10.1021/ma900622s	26	647	653	46	973	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					186	189		10.1126/science.1248494	http://dx.doi.org/10.1126/science.1248494			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24723609	Green Submitted			2022-12-28	WOS:000334096300032
J	Southwell, DG; Nicholas, CR; Basbaum, AI; Stryker, MP; Kriegstein, AR; Rubenstein, JL; Alvarez-Buylla, A				Southwell, Derek G.; Nicholas, Cory R.; Basbaum, Allan I.; Stryker, Michael P.; Kriegstein, Arnold R.; Rubenstein, John L.; Alvarez-Buylla, Arturo			Interneurons from Embryonic Development to Cell-Based Therapy	SCIENCE			English	Review							MEDIAL GANGLIONIC EMINENCE; EXPERIENCE-DEPENDENT PLASTICITY; STEM-CELLS; VISUAL-CORTEX; CORTICAL INTERNEURONS; GABAERGIC INTERNEURONS; DIRECTED DIFFERENTIATION; FUNCTIONAL MATURATION; NEURAL PRECURSORS; MIGRATORY STREAM		[Southwell, Derek G.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Nicholas, Cory R.; Kriegstein, Arnold R.; Rubenstein, John L.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Nicholas, Cory R.; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Basbaum, Allan I.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Stryker, Michael P.] Univ Calif San Francisco, Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Stryker, Michael P.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Rubenstein, John L.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	abuylla@stemcell.ucsf.edu		Southwell, Derek/0000-0001-6465-3869; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Stryker, Michael/0000-0003-1546-5831	NIH [R01-EY02874, HD032116, NS28478, MH049428, NS78326, NS14627]; California Institute of Regenerative Medicine [RC1-00346, TR3-05606, RB2-01602, TR2-01749]; JG Bowes Foundation; M.S. Scientific Advisory Board of the Allen Institute for Brain Science; National Institutes of Health; National Institute of Mental Health; California Institute for Regenerative Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY002162, R01EY002874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049428, R37MH049428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028478, R37NS014627, R01NS078326, R29NS028478, R01NS028478, R01NS014627] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); JG Bowes Foundation; M.S. Scientific Advisory Board of the Allen Institute for Brain Science; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Baraban for comments on the manuscript. We apologize to colleagues whose work we could not include because of space limitations. This work was supported by the NIH (R01-EY02874 to M.P.S., HD032116, NS28478 to A.A.-B., MH049428 to J.L.R., NS78326 and NS14627 to A.I.B.), by the California Institute of Regenerative Medicine (RC1-00346 and TR3-05606 to A.R.K., RB2-01602 to J.L.R., and TR2-01749 to A.A.-B.) and by the JG Bowes Foundation. A.A.-B., A.R.K., J.L.R., C.R.N.; Founders and shareholders, Neurona Therapeutics; M.S. Scientific Advisory Board of the Allen Institute for Brain Science. Related research in the authors' laboratories is funded by the National Institutes of Health (A.I.B., M.P.S., A.R.K., J.L.R., A.A.-B.), National Institute of Mental Health (J.L.R.), and California Institute for Regenerative Medicine (C.R.N., A.I.B., M.P.S., A.R.K., J.L.R., A.A.-B.). Patents related to this work: 20020151066 (UC Regents, issued 2000, Production of GABAergic Cells)-J.L.R., M. Mione, S. Anderson, T. Stuehmer, K. Yun; 20090311222 (UC Regents, 2006-pending, Transplantation of Neural Cells)-S. Baraban, J.L.R., A.A.-B.; 20130202568 (UC Regents, 2008-pending, Ameliorating Nervous System Disorders)-A.R.K., J.L.R., S. Baraban, A.A.-B.; 2013155222 A2 (UC Regents, 2012-pending, Brain-Specific Enhancers for Cell-Based Therapy)-V. Axel, J.L.R., Y.-J. Chen, L. Pennacchio, D. Vogt, A.R.K.; 61783594 (UC Regents, 2013-pending, In Vitro Production of Medial Ganglionic Eminence Precursor Cells)-C.R.N., J.L.R., A.R.K.	ALTMAN J, 1963, ANAT REC, V145, P573, DOI 10.1002/ar.1091450409; Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Au E, 2013, NEURON, V80, P1145, DOI 10.1016/j.neuron.2013.09.022; Baraban SC, 2009, P NATL ACAD SCI USA, V106, P15472, DOI 10.1073/pnas.0900141106; Bartolini G, 2013, NEURON, V79, P849, DOI 10.1016/j.neuron.2013.08.014; Ben-Ari Y, 2008, TRENDS NEUROSCI, V31, P626, DOI 10.1016/j.tins.2008.09.002; Braz JM, 2012, NEURON, V74, P663, DOI 10.1016/j.neuron.2012.02.033; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Calcagnotto ME, 2010, EPILEPSIA, V51, P71, DOI 10.1111/j.1528-1167.2010.02614.x; Cambray S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1817; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chen YJJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061956; Danjo T, 2011, J NEUROSCI, V31, P1919, DOI 10.1523/JNEUROSCI.5128-10.2011; De la Cruz E, 2011, NEUROTHERAPEUTICS, V8, P763, DOI 10.1007/s13311-011-0058-9; Dekkers MPJ, 2013, SCIENCE, V340, P39, DOI 10.1126/science.1236152; Du TG, 2008, DEVELOPMENT, V135, P1559, DOI 10.1242/dev.015123; Dunnett SB, 2012, PROG BRAIN RES, V201, P3, DOI 10.1016/B978-0-444-59544-7.00017-2; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Failor S, 2010, J NEUROSCI, V30, P81, DOI 10.1523/JNEUROSCI.5656-08.2010; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Gage FH, 2012, PROG BRAIN RES, V200, P7, DOI 10.1016/B978-0-444-59575-1.00001-6; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Gordon JA, 1996, J NEUROSCI, V16, P3274; Goulburn AL, 2012, STEM CELL RES, V8, P416, DOI 10.1016/j.scr.2011.12.002; Goulburn AL, 2011, STEM CELLS, V29, P462, DOI 10.1002/stem.587; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; GRAYBIEL AM, 1989, J NEUROSCI, V9, P3250; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hansen DV, 2013, NAT NEUROSCI, V16, P1576, DOI 10.1038/nn.3541; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hoch RV, 2009, SEMIN CELL DEV BIOL, V20, P378, DOI 10.1016/j.semcdb.2009.02.005; Hunt RF, 2013, NAT NEUROSCI, V16, P692, DOI 10.1038/nn.3392; Inan M, 2012, CEREB CORTEX, V22, P820, DOI 10.1093/cercor/bhr148; ISACSON O, 1987, NEUROSCIENCE, V22, P481, DOI 10.1016/0306-4522(87)90348-4; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kato M, 2005, J CHILD NEUROL, V20, P392, DOI 10.1177/08830738050200042001; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; LEVIMONTALCINI R, 1949, J COMP NEUROL, V91, P209, DOI 10.1002/cne.900910204; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Ma T, 2013, NAT NEUROSCI, V16, P1588, DOI 10.1038/nn.3536; Maisano X, 2012, J NEUROSCI, V32, P46, DOI 10.1523/JNEUROSCI.2683-11.2012; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; Maroof AM, 2010, J NEUROSCI, V30, P4667, DOI 10.1523/JNEUROSCI.4255-09.2010; Martinez-Cerdeno V, 2010, CELL STEM CELL, V6, P238, DOI 10.1016/j.stem.2010.01.004; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336; Olsson M, 1997, NEUROSCIENCE, V79, P57, DOI 10.1016/S0306-4522(96)00606-9; OLSSON M, 1995, NEUROSCIENCE, V69, P1169, DOI 10.1016/0306-4522(95)00325-D; PAKZABAN P, 1993, EXP BRAIN RES, V97, P13; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Pencea V, 2001, EXP NEUROL, V172, P1, DOI 10.1006/exnr.2001.7768; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; Richardson RM, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E16; Rossignol E, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/649325; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Southwell DG, 2012, NATURE, V491, P109, DOI 10.1038/nature11523; Southwell DG, 2010, SCIENCE, V327, P1145, DOI 10.1126/science.1183962; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Tanaka DH, 2011, J NEUROSCI, V31, P14116, DOI 10.1523/JNEUROSCI.2786-11.2011; Taniguchi H, 2013, SCIENCE, V339, P70, DOI 10.1126/science.1227622; Valente MF, 2013, CELL TRANSPLANT, V22, P1237, DOI 10.3727/096368912X657422; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Wonders C, 2005, NEUROSCIENTIST, V11, P199, DOI 10.1177/1073858404270968; Wonders CP, 2008, DEV BIOL, V314, P127, DOI 10.1016/j.ydbio.2007.11.018; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Xu Q, 2010, NEURON, V65, P328, DOI 10.1016/j.neuron.2010.01.004; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Yozu M, 2005, J NEUROSCI, V25, P7268, DOI 10.1523/JNEUROSCI.2072-05.2005; Zipancic I, 2010, CELL TRANSPLANT, V19, P549, DOI 10.3727/096368910X491383	93	133	136	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					167	+	1240622	10.1126/science.1240622	http://dx.doi.org/10.1126/science.1240622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7VN	24723614	Green Accepted			2022-12-28	WOS:000349836700001
J	Griggs, D				Griggs, Dave			Streamline IPCC reports	NATURE			English	Editorial Material									[Griggs, Dave] Monash Univ, Monash Sustainabil Inst, Melbourne, Vic 3004, Australia	Monash University	Griggs, D (corresponding author), Monash Univ, Monash Sustainabil Inst, Melbourne, Vic 3004, Australia.	dave.griggs@monash.edu		Griggs, David/0000-0002-9461-9933				Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; IPCC, 2013, CLIMATE CHANGE 2022; Parry ML, 2007, CLIMATE CHANGE 2007; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1	4	5	5	4	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					171	173		10.1038/508171a	http://dx.doi.org/10.1038/508171a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE4UK	24724185	Bronze			2022-12-28	WOS:000333979900015
J	Perez-Vargas, J; Krey, T; Valansi, C; Avinoam, O; Haouz, A; Jamin, M; Raveh-Barak, H; Podbilewicz, B; Rey, FA				Perez-Vargas, Jimena; Krey, Thomas; Valansi, Clari; Avinoam, Ori; Haouz, Ahmed; Jamin, Marc; Raveh-Barak, Hadas; Podbilewicz, Benjamin; Rey, Felix A.			Structural Basis of Eukaryotic Cell-Cell Fusion	CELL			English	Article							VIRUS ENVELOPE PROTEIN; SEMLIKI-FOREST-VIRUS; MEMBRANE-FUSION; CRYSTAL-STRUCTURE; DENGUE VIRUS; C-ELEGANS; ANGSTROM RESOLUTION; ENCEPHALITIS-VIRUS; HOMOTYPIC FUSION; SNARE COMPLEX	Cell-cell fusion proteins are essential in development. Here we show that the C. elegans cell-cell fusion protein EFF-1 is structurally homologous to viral class II fusion proteins. The 2.6 angstrom crystal structure of the EFF-1 trimer displays the same 3D fold and quaternary conformation of postfusion class II viral fusion proteins, although it lacks a nonpolar "fusion loop," indicating that it does not insert into the target membrane. EFF-1 was previously shown to be required in both cells for fusion, and we show that blocking EFF-1 trimerization blocks the fusion reaction. Together, these data suggest that whereas membrane fusion driven by viral proteins entails leveraging of a nonpolar loop, EFF-1-driven fusion of cells entails trans-trimerization such that transmembrane segments anchored in the two opposing membranes are brought into contact at the tip of the EFF-1 trimer to then, analogous to SNARE-mediated vesicle fusion, zip the two membranes into one.	[Perez-Vargas, Jimena; Krey, Thomas; Rey, Felix A.] Inst Pasteur, Unite Virol Struct, F-75724 Paris 15, France; [Perez-Vargas, Jimena; Krey, Thomas; Rey, Felix A.] CNRS UMR 3569, F-75724 Paris 15, France; [Valansi, Clari; Avinoam, Ori; Raveh-Barak, Hadas; Podbilewicz, Benjamin] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Haouz, Ahmed] Inst Pasteur, Proteopole Plateforme Cristallogenese, CNRS UMR 3528, F-75724 Paris 15, France; [Jamin, Marc] Univ Grenoble Alpes, F-38042 Grenoble 9, France; [Jamin, Marc] CNRS, UVHCI, F-38042 Grenoble 9, France; [Jamin, Marc] Univ Grenoble Alpes, EMBL, CNRS, Unit Virus Host Cell Interact, F-38042 Grenoble 9, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Technion Israel Institute of Technology; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Podbilewicz, B (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	podbilew@technion.ac.il; rey@pasteur.fr	Podbilewicz, Benjamin/N-4825-2014; Avinoam, Ori/AAX-7382-2020; Rey, Felix/B-6497-2012	Avinoam, Ori/0000-0003-3543-168X; Jamin, Marc/0000-0002-8677-2110; Podbilewicz, Benjamin/0000-0002-0411-4182; Rey, Felix/0000-0002-9953-7988; HAOUZ, Ahmed/0000-0003-1196-1635	French "Agence Nationale pour la Recherche" [ANR-2010-BLAN-1211 01]; Institut Pasteur; CNRS; Merck-Serono; ERC [268843]; Israel Science Foundation (ISF) [1542/07, 826/08]	French "Agence Nationale pour la Recherche"(French National Research Agency (ANR)); Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Merck-Serono(Merck & Company); ERC(European Research Council (ERC)European Commission); Israel Science Foundation (ISF)(Israel Science Foundation)	F.A.R. was funded by the French "Agence Nationale pour la Recherche" grant ANR-2010-BLAN-1211 01 and by Institut Pasteur, CNRS, and Merck-Serono. B. P. was funded by the ERC Advanced grant 268843 and the Israel Science Foundation (ISF grants 1542/07 and 826/08). B.P. was a Grass fellow at Radcliffe Institute for Advanced Study, Harvard University. We thank Patrick England, Bertrand Raynal, and Patrick Weber of the Pasteur Proteopole for technical help; the staff of synchrotron beamlines PX-I at the Swiss Light Source, Proxima-1 at SOLEIL, and ID23-1 at the European Synchrotron Radiation Facility for help during data collection; Clemens Vonrhein and Gerard Bricogne from Global Phasing Ltd. for methodological concepts; Tom Rapoport and his lab for discussions and for hosting B. P. at Harvard Medical School; and Jorge Verdin Ramos from Technion and the members of the Rey and Podbilewicz labs for discussions.	Aguilar PS, 2013, TRENDS GENET, V29, P427, DOI 10.1016/j.tig.2013.01.011; Avinoam O, 2011, CURR TOP MEMBR, V68, P209, DOI 10.1016/B978-0-12-385891-7.00009-X; Avinoam O, 2011, SCIENCE, V332, P589, DOI 10.1126/science.1202333; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; del Campo JJ, 2005, CURR BIOL, V15, P413, DOI 10.1016/j.cub.2005.01.054; Dessau M, 2013, P NATL ACAD SCI USA, V110, P1696, DOI 10.1073/pnas.1217780110; DuBois RM, 2013, NATURE, V493, P552, DOI 10.1038/nature11741; Frame IG, 2001, GENE, V263, P219, DOI 10.1016/S0378-1119(00)00567-9; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Klein DE, 2013, J VIROL, V87, P2287, DOI 10.1128/JVI.02957-12; Kozlov MM, 2010, TRENDS BIOCHEM SCI, V35, P699, DOI 10.1016/j.tibs.2010.06.003; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; Liao MF, 2005, J CELL BIOL, V171, P111, DOI 10.1083/jcb.200507075; Luca VC, 2013, J VIROL, V87, P818, DOI 10.1128/JVI.01950-12; Malik HS, 2000, GENOME RES, V10, P1307, DOI 10.1101/gr.145000; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Moss TJ, 2011, TRENDS CELL BIOL, V21, P416, DOI 10.1016/j.tcb.2011.03.009; Nayak V, 2009, J VIROL, V83, P4338, DOI 10.1128/JVI.02574-08; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Sanchez-San Martin C, 2013, J VIROL, V87, P7680, DOI 10.1128/JVI.00814-13; Sapir A, 2007, DEV CELL, V12, P683, DOI 10.1016/j.devcel.2007.03.003; Shemer G, 2004, CURR BIOL, V14, P1587, DOI 10.1016/j.cub.2004.07.059; Shilagardi K, 2013, SCIENCE, V340, P359, DOI 10.1126/science.1234781; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451	38	96	98	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					407	419		10.1016/j.cell.2014.02.020	http://dx.doi.org/10.1016/j.cell.2014.02.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725407	Bronze			2022-12-28	WOS:000334304500014
J	Reiserer, A; Kalb, N; Rempe, G; Ritter, S				Reiserer, Andreas; Kalb, Norbert; Rempe, Gerhard; Ritter, Stephan			A quantum gate between a flying optical photon and a single trapped atom	NATURE			English	Article							PHASE-SHIFTS; COMMUNICATION	The steady increase in control over individual quantum systems supports the promotion of a quantum technology that could provide functionalities beyond those of any classical device. Two particularly promising applications have been explored during the past decade: photon-based quantum communication, which guarantees unbreakable encryption(1) but which still has to be scaled to high rates over large distances, and quantum computation, which will fundamentally enhance computability(2) if it can be scaled to a large number of quantum bits (qubits). It was realized early on that a hybrid system of light qubits and matter qubits(3) could solve the scalability problem of each field-that of communication by use of quantum repeaters4, and that of computation by use of an optical interconnect between smaller quantum processors(5,6). To this end, the development of a robust two-qubit gate that allows the linking of distant computational nodes is "a pressing challenge"(6). Here we demonstrate such a quantum gate between the spin state of a single trapped atom and the polarization state of an optical photon contained in a faint laser pulse. The gate mechanism presented(7,8) is deterministic and robust, and is expected to be applicable to almost any matter qubit. It is based on reflection of the photonic qubit from a cavity that provides strong light-matter coupling. To demonstrate its versatility, we use the quantum gate to create atom-photon, atom-photon-photon and photon-photon entangled states from separable input states. We expect our experiment to enable various applications, including the generation of atomic(9) and photonic(10) cluster states and Schrodinger-cat states(11), deterministic photonic Bell-state measurements(12), scalable quantum computation(7) and quantum communication using a redundant quantum parity code(13).	[Reiserer, Andreas; Kalb, Norbert; Rempe, Gerhard; Ritter, Stephan] Max Planck Inst Quanten Opt, D-85748 Garching, Germany	Max Planck Society	Rempe, G (corresponding author), Max Planck Inst Quanten Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	gerhard.rempe@mpq.mpg.de	Reiserer, Andreas/J-3243-2014; Reiserer, Andreas/G-4980-2017; Ritter, Stephan/F-1579-2010	Reiserer, Andreas/0000-0001-9595-7363; Reiserer, Andreas/0000-0001-9595-7363; Ritter, Stephan/0000-0001-9002-7407	European Union; Bundesministerium fur Bildung und Forschung [IKT 2020]	European Union(European Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by the European Union (Collaborative Project SIQS) and by the Bundesministerium fur Bildung und Forschung via IKT 2020 (QK_QuOReP).	Awschalom DD, 2013, SCIENCE, V339, P1174, DOI 10.1126/science.1231364; Bonato C, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.160503; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Cho JY, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.160501; Dayan B, 2008, SCIENCE, V319, P1062, DOI 10.1126/science.1152261; Duan LM, 2010, REV MOD PHYS, V82, P1209, DOI 10.1103/RevModPhys.82.1209; Duan LM, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.032333; Duan LM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.080503; Duan LM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.127902; Fushman I, 2008, SCIENCE, V320, P769, DOI 10.1126/science.1154643; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; Hu CY, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.125318; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Monroe C, 2013, SCIENCE, V339, P1164, DOI 10.1126/science.1231298; Munro WJ, 2012, NAT PHOTONICS, V6, P777, DOI [10.1038/NPHOTON.2012.243, 10.1038/nphoton.2012.243]; Nolleke C, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.140403; O'Shea D, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.193601; Olmschenk S, 2009, SCIENCE, V323, P486, DOI 10.1126/science.1167209; Rauschenbeutel A, 2000, SCIENCE, V288, P2024, DOI 10.1126/science.288.5473.2024; Rehacek, 2004, QUANTUM STATE ESTIMA; Reiserer A, 2013, SCIENCE, V342, P1349, DOI 10.1126/science.1246164; Reiserer A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.223003; Ritter S, 2012, NATURE, V484, P195, DOI 10.1038/nature11023; Thompson JD, 2013, SCIENCE, V340, P1202, DOI 10.1126/science.1237125; TURCHETTE QA, 1995, PHYS REV LETT, V75, P4710, DOI 10.1103/PhysRevLett.75.4710; van Enk SJ, 1998, SCIENCE, V279, P205, DOI 10.1126/science.279.5348.205; Volz J, 2011, NATURE, V475, P210, DOI 10.1038/nature10225; Wang B, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.022320; Xiao YF, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.042314	30	247	255	5	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					237	+		10.1038/nature13177	http://dx.doi.org/10.1038/nature13177			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE4UK	24717512	Green Submitted			2022-12-28	WOS:000333979900042
J	Perkins, GD; Gates, S				Perkins, Gavin D.; Gates, Simon			Is adrenaline safe and effective as a treatment for out of hospital cardiac arrest?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOPULMONARY-RESUSCITATION; BLOOD-FLOW; EPINEPHRINE; SURVIVAL; TRIAL; OUTCOMES; COUNCIL; PLACEBO; CARE		[Perkins, Gavin D.; Gates, Simon] Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Perkins, Gavin D.] Heart England NHS Fdn Trust, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England	University of Warwick; Heart of England NHS Foundation Trust	Perkins, GD (corresponding author), Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	g.d.perkins@warwick.ac.uk	Perkins, Gavin/E-7613-2010	Perkins, Gavin/0000-0003-3027-7548	Department of Health [12/127/126] Funding Source: Medline; National Institute for Health Research [12/127/126] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Burnett AM, 2012, RESUSCITATION, V83, P1021, DOI 10.1016/j.resuscitation.2012.03.018; Fries M, 2006, RESUSCITATION, V71, P248, DOI 10.1016/j.resuscitation.2006.02.023; Frontanes A, 2011, RESUSCITATION, V82, P427, DOI 10.1016/j.resuscitation.2010.11.020; Hagihara A, 2012, JAMA-J AM MED ASSOC, V307, P1161, DOI 10.1001/jama.2012.294; Hayakawa K, 2011, RESUSCITATION, V82, P874, DOI 10.1016/j.resuscitation.2011.02.045; HERLITZ J, 1995, RESUSCITATION, V29, P195, DOI 10.1016/0300-9572(94)00851-6; Holmberg M, 2002, RESUSCITATION, V54, P37, DOI 10.1016/S0300-9572(02)00048-5; Jacobs IG, 2011, RESUSCITATION, V82, P1138, DOI 10.1016/j.resuscitation.2011.06.029; Koster RW, 2010, RESUSCITATION, V81, P1277, DOI 10.1016/j.resuscitation.2010.08.009; Machida M, 2012, J CARDIOL, V60, P503, DOI 10.1016/j.jjcc.2012.07.001; Nakahara S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6829; Nolan JP, 2010, RESUSCITATION, V81, pE1, DOI 10.1016/j.resuscitation.2010.08.002; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; Olasveengen TM, 2012, RESUSCITATION, V83, P327, DOI 10.1016/j.resuscitation.2011.11.011; Olasveengen TM, 2009, JAMA-J AM MED ASSOC, V302, P2222, DOI 10.1001/jama.2009.1729; Ong MEH, 2007, ANN EMERG MED, V50, P635, DOI 10.1016/j.annemergmed.2007.03.028; Patanwala AE, 2013, MINERVA ANESTESIOL; Ristagno G, 2009, CRIT CARE MED, V37, P1408, DOI 10.1097/CCM.0b013e31819cedc9; SAFAR P, 1964, J Iowa Med Soc, V54, P629; Sasson C, 2011, RESUSCITATION, V82, P674, DOI 10.1016/j.resuscitation.2011.02.002; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Sun SJ, 2010, CRIT CARE MED, V38, P2175, DOI 10.1097/CCM.0b013e3181eedad6; Woodhouse SP, 1995, RESUSCITATION, V30, P243, DOI 10.1016/0300-9572(95)00890-X	23	20	20	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2014	348								g2435	10.1136/bmj.g2435	http://dx.doi.org/10.1136/bmj.g2435			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SB	24709574				2022-12-28	WOS:000334348300009
J	Wood, B				Wood, Bernard			Fifty years after Homo habilis	NATURE			English	Editorial Material									George Washington Univ, Washington, DC 20052 USA	George Washington University	Wood, B (corresponding author), George Washington Univ, Washington, DC 20052 USA.	bwood@gwu.edu						Holliday TW, 2012, CURR ANTHROPOL, V53, pS330, DOI 10.1086/667360; Le Gros Clark W.E., 1955, FOSSIL EVIDENCE HUMA; LEAKEY LSB, 1964, NATURE, V202, P7, DOI 10.1038/202007a0; Leakey MG, 2012, NATURE, V488, P201, DOI 10.1038/nature11322; Lordkipanidze D, 2013, SCIENCE, V342, P326, DOI 10.1126/science.1238484; Tobias P.V., 1991, HOMO HABILIS SKULLS, V4a et 4b; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; WOOD B, 1992, NATURE, V355, P783, DOI 10.1038/355783a0; Wood B., 1991, HOMINID CRANIAL REMA, V4	9	24	24	0	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					31	33		10.1038/508031a	http://dx.doi.org/10.1038/508031a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD9UL	24707524	Bronze			2022-12-28	WOS:000333609900026
J	Mostashari, F; Sanghavi, D; McClellan, M				Mostashari, Farzad; Sanghavi, Darshak; McClellan, Mark			Health Reform and Physician-Led Accountable Care The Paradox of Primary Care Physician Leadership	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COSTS		[Mostashari, Farzad; Sanghavi, Darshak; McClellan, Mark] Brookings Inst, Washington, DC 20036 USA	Brookings Institution	McClellan, M (corresponding author), Brookings Inst, 1775 Massachusetts Ave NW, Washington, DC 20036 USA.	mmcclellan@brookings.edu						Friedberg MW, 2014, JAMA-J AM MED ASSOC, V311, P815, DOI 10.1001/jama.2014.353; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P2572, DOI 10.1001/jama.2013.7103; McClellan M, 2010, HEALTH AFFAIR, V29, P982, DOI 10.1377/hlthaff.2010.0194; Media Editorial Beck M, 2014, WALL STREET J; Muhlenstein D., 2014, HLTH AFFAIRS BL 0129; Tilburt JC, 2013, JAMA-J AM MED ASSOC, V310, P380, DOI 10.1001/jama.2013.8278	6	47	47	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2014	311	18					1855	1856		10.1001/jama.2014.4086	http://dx.doi.org/10.1001/jama.2014.4086			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0GT	24723035	Bronze			2022-12-28	WOS:000335798100014
J	Takala, H; Bjorling, A; Berntsson, O; Lehtivuori, H; Niebling, S; Hoernke, M; Kosheleva, I; Henning, R; Menzel, A; Ihalainen, JA; Westenhoff, S				Takala, Heikki; Bjorling, Alexander; Berntsson, Oskar; Lehtivuori, Heli; Niebling, Stephan; Hoernke, Maria; Kosheleva, Irina; Henning, Robert; Menzel, Andreas; Ihalainen, Janne A.; Westenhoff, Sebastian			Signal amplification and transduction in phytochrome photosensors	NATURE			English	Article							STRUCTURAL DYNAMICS; CRYSTAL-STRUCTURE; BACTERIOPHYTOCHROME; PHOTOCONVERSION; REVEALS; PROTEIN; SIMILARITY; KINASES; BINDING; DOMAIN	Sensory proteins must relay structural signals from the sensory site over large distances to regulatory output domains. Phytochromes are a major family of red-light-sensing kinases that control diverse cellular functions in plants, bacteria and fungi(1-9). Bacterial phytochromes consist of a photosensory core and a carboxy-terminal regulatory domain(10,11). Structures of photosensory cores are reported in the resting state(12-18) and conformational responses to light activation have been proposed in the vicinity of the chromophore(19-23). However, the structure of the signalling state and the mechanism of downstream signal relay through the photosensory core remain elusive. Here we report crystal and solution structures of the resting and activated states of the photosensory core of the bacteriophytochrome from Deinococcus radiodurans. The structures show an open and closed form of the dimeric protein for the activated and resting states, respectively. This nanometre-scale rearrangement is controlled by refolding of an evolutionarily conserved 'tongue', which is in contact with the chromophore. The findings reveal an unusual mechanism in which atomic-scale conformational changes around the chromophore are first amplified into ana angstrom-scale distance change in the tongue, and further grow into a nanometre-scale conformational signal. The structural mechanism is a blueprint for understanding how phytochromes connect to the cellular signalling network.	[Takala, Heikki; Lehtivuori, Heli; Ihalainen, Janne A.] Univ Jyvaskyla, Dept Biol & Environm Sci, Nanosci Ctr, Jyvaskyla 40014, Finland; [Takala, Heikki; Bjorling, Alexander; Berntsson, Oskar; Niebling, Stephan; Hoernke, Maria; Westenhoff, Sebastian] Univ Gothenburg, Dept Chem & Mol Biol, S-40530 Gothenburg, Sweden; [Kosheleva, Irina; Henning, Robert] Univ Chicago, Ctr Adv Radiat Sources, Chicago, IL 60637 USA; [Menzel, Andreas] Paul Scherrer Inst, CH-5232 Villigen, Switzerland	University of Jyvaskyla; University of Gothenburg; University of Chicago; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Ihalainen, JA (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Nanosci Ctr, Jyvaskyla 40014, Finland.	janne.ihalainen@jyu.fi; westenho@chem.gu.se	Menzel, Andreas/C-4388-2012; Takala, Heikki/ABC-9139-2020; Takala, Heikki/GVT-1834-2022	Menzel, Andreas/0000-0002-0489-609X; Takala, Heikki/0000-0003-2518-8583; Takala, Heikki/0000-0003-2518-8583; Hoernke, Maria/0000-0003-2008-411X; Niebling, Stephan/0000-0001-6582-5984; Berntsson, Oskar/0000-0003-1843-6278; Ihalainen, Janne/0000-0002-8741-1587; Lehtivuori, Heli/0000-0002-7450-2578	European Community [312284 CALIPSO]; National Institutes of Health, National Institute of General Medical Sciences [1R24GM111072]; Foundation of Strategic Research, Sweden; Swedish Research Council [279944]; European Research Council [279944]; Finnish Academy [138063]; Finnish Cultural Foundation [0131067]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM111072] Funding Source: NIH RePORTER	European Community(European Commission); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Foundation of Strategic Research, Sweden; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Finnish Academy(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge beamline access at BM29 and ID23-1 at the ESRF, cSAXS at the Swiss Light Source (funded by the European Community's FP7 grant agreement no. 312284 CALIPSO), and BioCARS at the Advanced Photon Source, Argonne National Laboratory (supported by National Institutes of Health, National Institute of General Medical Sciences grant 1R24GM111072 and in part through collaboration with P. Anfinrud). K. Forest and R. Vierstra are acknowledged for the donation of the plasmids. J. Ylanne and his group are acknowledged for advice on crystallography, and H. Hakkanen and A. Liukkonen for their assistance. We thank M.-A. Mroginski for providing force-field parameter files for the biliverdin. We acknowledge V. Chukharev and N. V. Tkachenko for the facilities for transient absorption spectroscopy measurements. We also acknowledge grants to S. W. by the Foundation of Strategic Research, Sweden, and the Swedish and European Research Councils, agreement number 279944, support to J.A.I. by Finnish Academy grant 138063, and to H.T. by the Finnish Cultural Foundation grant 0131067.	Anders K, 2013, J BIOL CHEM, V288, P35714, DOI 10.1074/jbc.M113.510461; Andersson M, 2009, STRUCTURE, V17, P1265, DOI 10.1016/j.str.2009.07.007; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Blumenstein A, 2005, CURR BIOL, V15, P1833, DOI 10.1016/j.cub.2005.08.061; Burgie ES, 2013, STRUCTURE, V21, P88, DOI 10.1016/j.str.2012.11.001; BUTLER WL, 1959, P NATL ACAD SCI USA, V45, P1703, DOI 10.1073/pnas.45.12.1703; Cammarata M, 2008, NAT METHODS, V5, P881, DOI [10.1038/nmeth.1255, 10.1038/NMETH.1255]; Cornilescu G, 2008, J MOL BIOL, V383, P403, DOI 10.1016/j.jmb.2008.08.034; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Evans K, 2006, J MOL BIOL, V364, P655, DOI 10.1016/j.jmb.2006.09.045; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hughes J, 1997, NATURE, V386, P663, DOI 10.1038/386663a0; Jiang ZY, 1999, SCIENCE, V285, P406, DOI 10.1126/science.285.5426.406; Kehoe DM, 1996, SCIENCE, V273, P1409, DOI 10.1126/science.273.5280.1409; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Li H, 2010, P NATL ACAD SCI USA, V107, P10872, DOI 10.1073/pnas.1001908107; Liu HG, 2012, J APPL CRYSTALLOGR, V45, P587, DOI 10.1107/S0021889812015786; Mailliet J, 2011, J MOL BIOL, V413, P115, DOI 10.1016/j.jmb.2011.08.023; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Narikawa R, 2013, P NATL ACAD SCI USA, V110, P918, DOI 10.1073/pnas.1212098110; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song C, 2011, P NATL ACAD SCI USA, V108, P3842, DOI 10.1073/pnas.1013377108; Ulijasz AT, 2010, NATURE, V463, P250, DOI 10.1038/nature08671; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Westenhoff S, 2010, NAT METHODS, V7, P775, DOI 10.1038/nmeth1010-775c; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang XJ, 2011, NATURE, V479, P428, DOI 10.1038/nature10506; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	35	245	248	2	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					245	+		10.1038/nature13310	http://dx.doi.org/10.1038/nature13310			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24776794	Green Accepted			2022-12-28	WOS:000335454300043
J	Bass, C				Bass, Christopher			Complex regional pain syndrome medicalises limb pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LOW-BACK-PAIN; PSYCHOSOCIAL FACTORS; START BACK; MANAGEMENT		John Radcliffe Hosp, Oxford OX3 9DU, England	University of Oxford	Bass, C (corresponding author), John Radcliffe Hosp, Oxford OX3 9DU, England.	Christopher.bass@oxfordhealth.nhs.uk						Atherton K, 2006, EMERG MED J, V23, P195, DOI 10.1136/emj.2005.027102; Beerthuizen A, 2011, EUR J PAIN, V15, P971, DOI 10.1016/j.ejpain.2011.02.008; Blyth FM, 2007, PAIN, V129, P8, DOI 10.1016/j.pain.2007.03.009; Bruehl S, 2007, PAIN, V129, P1, DOI 10.1016/j.pain.2007.02.017; Creed F, 2006, WORLD PSYCHIATRY, V5, P146; Croft P., 2011, CHRONIC PAIN EPIDEMI, DOI 10.1093/acprof:oso/9780199235766.001.0001; de Asla R, 2011, J BONE JOINT SURG AM, V93, p[e116, 1], DOI DOI 10.2106/JBJS.K; Department of Health, 2008, LONG TERM COND POS P; Gupta A, 2007, RHEUMATOLOGY, V46, P666, DOI 10.1093/rheumatology/kel363; Harden RN, 2007, PAIN MED, V8, P326, DOI 10.1111/j.1526-4637.2006.00169.x; Haviland MG, 2010, PSYCHIAT RES, V177, P335, DOI 10.1016/j.psychres.2009.08.017; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; Holm LW, 2008, PLOS MED, V5, P760, DOI 10.1371/journal.pmed.0050105; Kouyanou K, 1997, PSYCHOSOM MED, V59, P597, DOI 10.1097/00006842-199711000-00007; Main CJ, 2012, PHYSIOTHERAPY, V98, P110, DOI 10.1016/j.physio.2011.03.003; Munglani R, 2012, PAIN NEWS, V10, P16; Nicholas MK, 2011, PHYS THER, V91, P737, DOI 10.2522/ptj.20100224; Page LA, 2003, J ROY SOC MED, V96, P223, DOI 10.1258/jrsm.96.5.223; Pearce JMS, 2005, SPINAL CORD, V43, P263, DOI 10.1038/sj.sc.3101709; Ring D, 2010, J HAND SURG-AM, V35A, P1345, DOI 10.1016/j.jhsa.2010.06.007; Roditi D, 2011, PSYCHOL RES BEHAV MA, V4, P41, DOI 10.2147/PRBM.S15375; Schott G D, 2007, Pract Neurol, V7, P145; Singh HP, 2006, J HAND SURG-BRIT EUR, V31B, P611, DOI 10.1016/j.jhsb.2006.08.009; Vranceanu AM, 2011, J HAND THER, V24, P118, DOI 10.1016/j.jht.2010.12.002; Williams Amanda C de C, 2011, Br J Gen Pract, V61, P638, DOI 10.3399/bjgp11X601479	25	3	3	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2014	348								g2631	10.1136/bmj.g2631	http://dx.doi.org/10.1136/bmj.g2631			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5PN	24776533				2022-12-28	WOS:000335471000001
J	Dominici, F; Greenstone, M; Sunstein, CR				Dominici, Francesca; Greenstone, Michael; Sunstein, Cass R.			Particulate Matter Matters	SCIENCE			English	Editorial Material							CLEAN-AIR ACT; CAUSAL INFERENCE; POLLUTION; MORTALITY; HEALTH; IMPACT; REGULATIONS; ASSOCIATION		[Dominici, Francesca] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Greenstone, Michael] MIT, Dept Econ, Cambridge, MA 02142 USA; [Greenstone, Michael] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Sunstein, Cass R.] Harvard Univ, Sch Law, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); National Bureau of Economic Research; Harvard University	Greenstone, M (corresponding author), MIT, Dept Econ, Cambridge, MA 02142 USA.	mgreenst@mit.edu	Sunstein, Cass/AAV-8196-2020		NIEHS NIH HHS [R01 ES012054, R01 ES019560, R21 ES020152, R21 ES02147, R21 ES022585] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES020152, R01ES019560, R01ES012054, R21ES022585] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		[Anonymous], 2009, RES REP HLTH EFF I; ASHENFELTER O, 1994, AM ECON REV, V84, P1157; Bell ML, 2009, AM J RESP CRIT CARE, V179, P1115, DOI 10.1164/rccm.200808-1240OC; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Card D, 2009, Q J ECON, V124, P597, DOI 10.1162/qjec.2009.124.2.597; Chay K, 2003, J RISK UNCERTAINTY, V27, P279, DOI 10.1023/A:1025897327639; Chay K., 2003, NBER WORKING PAPER 1; Chay KY, 2005, J POLIT ECON, V113, P376, DOI 10.1086/427462; Chay KY, 2003, Q J ECON, V118, P1121, DOI 10.1162/00335530360698513; Chen YY, 2013, P NATL ACAD SCI USA, V110, P12936, DOI 10.1073/pnas.1300018110; Clancy L, 2002, LANCET, V360, P1210, DOI 10.1016/S0140-6736(02)11281-5; Deschenes O., 2012, NBER WORKING PAPER 1; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Dominici F, 2010, EPIDEMIOLOGY, V21, P187, DOI 10.1097/EDE.0b013e3181cc86e8; Glass TA, 2013, ANNU REV PUBL HEALTH, V34, P61, DOI 10.1146/annurev-publhealth-031811-124606; Greenstone M, 2002, J POLIT ECON, V110, P1175, DOI 10.1086/342808; Greenstone M, 2009, J ENVIRON ECON MANAG, V57, P21, DOI 10.1016/j.jeem.2008.02.004; Greven S, 2011, J AM STAT ASSOC, V106, P396, DOI 10.1198/jasa.2011.ap09392; Health Effects Institute, 2003, ASSESSING THE HEALTH; HECKMAN JJ, 1989, AM ECON REV, V79, P138; Janes H, 2007, EPIDEMIOLOGY, V18, P416, DOI 10.1097/EDE.0b013e31806462e9; Krewski Daniel, 2009, Res Rep Health Eff Inst, P5; Lee DS, 2010, J ECON LIT, V48, P281, DOI 10.1257/jel.48.2.281; Moore K, 2010, AM J EPIDEMIOL, V171, P1233, DOI 10.1093/aje/kwq064; Office of Management and Budget, 2012, 2012 REPORT TO CONGR; Office of Management and Budget, 2013, 2013 DRAFT REPORT TO, p[14, 18, 19]; Peng RD, 2006, J R STAT SOC A STAT, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x; Pope CA, 2007, EPIDEMIOLOGY, V18, P424, DOI 10.1097/EDE.0b013e318065c008; RANSOM MR, 1995, CONTEMP ECON POLICY, V13, P86, DOI 10.1111/j.1465-7287.1995.tb00745.x; Rich DQ, 2012, JAMA-J AM MED ASSOC, V307, P2068, DOI 10.1001/jama.2012.3488; Rubin DB, 2008, ANN APPL STAT, V2, P808, DOI 10.1214/08-AOAS187; Samet JM, 2011, NEW ENGL J MED, V365, P198, DOI 10.1056/NEJMp1103332; Thomas D., 2009, STATISTICAL METHODS; Wang C, 2012, BIOMETRICS, V68, P661, DOI 10.1111/j.1541-0420.2011.01731.x; Zigler CM, 2012, BIOSTATISTICS, V13, P289, DOI 10.1093/biostatistics/kxr052	35	175	178	3	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					257	259		10.1126/science.1247348	http://dx.doi.org/10.1126/science.1247348			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF1LD	24744361	Green Accepted			2022-12-28	WOS:000334474500020
J	Kayser, MS; Yue, ZF; Sehgal, A				Kayser, Matthew S.; Yue, Zhifeng; Sehgal, Amita			A Critical Period of Sleep for Development of Courtship Circuitry and Behavior in Drosophila	SCIENCE			English	Article							INFANT-DEATH-SYNDROME; TRANSGENE EXPRESSION; TRANSCRIPTION FACTOR; ADULT DROSOPHILA; NEURAL CIRCUITRY; AROUSAL; BRAIN; PLASTICITY; DOPAMINE; IDENTIFICATION	Most animals sleep more early in life than in adulthood, but the function of early sleep is not known. Using Drosophila, we found that increased sleep in young flies was associated with an elevated arousal threshold and resistance to sleep deprivation. Excess sleep results from decreased inhibition of a sleep-promoting region by a specific dopaminergic circuit. Experimental hyperactivation of this circuit in young flies results in sleep loss and lasting deficits in adult courtship behaviors. These deficits are accompanied by impaired development of a single olfactory glomerulus, VA1v, which normally displays extensive sleep-dependent growth after eclosion. Our results demonstrate that sleep promotes normal brain development that gives rise to an adult behavior critical for species propagation and suggest that rapidly growing regions of the brain are most susceptible to sleep perturbations early in life.	[Kayser, Matthew S.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kayser, Matthew S.] Univ Penn, Ctr Sleep & Circadian Neurobiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yue, Zhifeng; Sehgal, Amita] Univ Penn, Howard Hughes Med Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sehgal, Amita] Univ Penn, Dept Neurosci, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Sehgal, A (corresponding author), Univ Penn, Howard Hughes Med Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu		Kayser, Matthew/0000-0003-2359-4967	National Institutes of Health [T32HL07713, R25MH060490]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH060490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Raizen, T. Abel, M. Frank, and members of the Sehgal lab for helpful input and advice. This work was supported by grants T32HL07713 and R25MH060490 from the National Institutes of Health (M. S. K.) and the Howard Hughes Medical Institute (A. S.). M. S. K. and A. S. designed the experiments. M. S. K. and Z.Y. performed the research. M. S. K., Z.Y., and A. S. collected, analyzed, and interpreted the data. M. S. K., Z.Y., and A. S. wrote and edited the paper. The authors have no patents pending or financial conflicts to disclose.	Abel T, 2013, CURR BIOL, V23, pR774, DOI 10.1016/j.cub.2013.07.025; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Devaud JM, 2003, J NEUROBIOL, V56, P13, DOI 10.1002/neu.10215; Devaud JM, 2001, J NEUROSCI, V21, P6274, DOI 10.1523/JNEUROSCI.21-16-06274.2001; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Donlea JM, 2014, NEURON, V81, P860, DOI 10.1016/j.neuron.2013.12.013; Donlea JM, 2011, SCIENCE, V332, P1571, DOI 10.1126/science.1202249; Ednick M, 2009, SLEEP, V32, P1449, DOI 10.1093/sleep/32.11.1449; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Frank MG, 2011, PROG BRAIN RES, V193, P221, DOI 10.1016/B978-0-444-53839-0.00014-4; Frank MG, 1997, AM J PHYSIOL-REG I, V272, pR1792, DOI 10.1152/ajpregu.1997.272.6.R1792; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Halbower AC, 2006, PLOS MED, V3, P1391, DOI 10.1371/journal.pmed.0030301; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; HARPER RM, 1981, SCIENCE, V213, P1030, DOI 10.1126/science.7268406; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Inagaki HK, 2012, CELL, V148, P583, DOI 10.1016/j.cell.2011.12.022; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Jouvet-Mounier D, 1970, Dev Psychobiol, V2, P216; Kim WJ, 2013, NEURON, V80, P1190, DOI 10.1016/j.neuron.2013.09.034; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kondoh Y, 2003, P ROY SOC B-BIOL SCI, V270, P1005, DOI 10.1098/rspb.2003.2331; Kumar S, 2012, GENE DEV, V26, P1224, DOI 10.1101/gad.186338.111; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; KUPFER DJ, 1995, BIOL PSYCHIAT, V38, P391, DOI 10.1016/0006-3223(94)00295-E; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Maret S, 2011, NAT NEUROSCI, V14, P1418, DOI 10.1038/nn.2934; Masuyama K, 2012, J NEUROGENET, V26, P89, DOI 10.3109/01677063.2011.642910; O'Brien LM, 2004, PEDIATRICS, V114, P44, DOI 10.1542/peds.114.1.44; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Pfeiffer BD, 2012, P NATL ACAD SCI USA, V109, P6626, DOI 10.1073/pnas.1204520109; ROFFWARG HP, 1966, SCIENCE, V152, P604, DOI 10.1126/science.152.3722.604; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Sachse S, 2007, NEURON, V56, P838, DOI 10.1016/j.neuron.2007.10.035; SCHECHTMAN VL, 1992, PEDIATRICS, V89, P865; Seugnet L, 2011, SLEEP, V34, P137, DOI 10.1093/sleep/34.2.137; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Tanenhaus AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045130; Ueno T, 2012, NAT NEUROSCI, V15, P1516, DOI 10.1038/nn.3238; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wang LM, 2011, NAT NEUROSCI, V14, P757, DOI 10.1038/nn.2800; Wu M. N., 2012, CURR BIOL; Wu MN, 2008, SLEEP, V31, P465, DOI 10.1093/sleep/31.4.465; Yamamoto D, 2013, NAT REV NEUROSCI, V14, P681, DOI 10.1038/nrn3567; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	55	100	101	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					269	274		10.1126/science.1250553	http://dx.doi.org/10.1126/science.1250553			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744368	Green Accepted			2022-12-28	WOS:000334474500027
J	Williams, SJ; Sohn, KH; Wan, L; Bernoux, M; Sarris, PF; Segonzac, C; Ve, T; Ma, Y; Saucet, SB; Ericsson, DJ; Casey, LW; Lonhienne, T; Winzor, DJ; Zhang, XX; Coerdt, A; Parker, JE; Dodds, PN; Kobe, B; Jones, JDG				Williams, Simon J.; Sohn, Kee Hoon; Wan, Li; Bernoux, Maud; Sarris, Panagiotis F.; Segonzac, Cecile; Ve, Thomas; Ma, Yan; Saucet, Simon B.; Ericsson, Daniel J.; Casey, Lachlan W.; Lonhienne, Thierry; Winzor, Donald J.; Zhang, Xiaoxiao; Coerdt, Anne; Parker, Jane E.; Dodds, Peter N.; Kobe, Bostjan; Jones, Jonathan D. G.			Structural Basis for Assembly and Function of a Heterodimeric Plant Immune Receptor	SCIENCE			English	Article							RESISTANCE PROTEIN; DISEASE RESISTANCE; TIR DOMAIN; CELL-DEATH; ARABIDOPSIS-THALIANA; CRYSTAL-STRUCTURE; BLAST RESISTANCE; MOLECULAR-BASIS; EFFECTOR; BINDING	Cytoplasmic plant immune receptors recognize specific pathogen effector proteins and initiate effector-triggered immunity. In Arabidopsis, the immune receptors RPS4 and RRS1 are both required to activate defense to three different pathogens. We show that RPS4 and RRS1 physically associate. Crystal structures of the N-terminal Toll-interleukin-1 receptor/resistance (TIR) domains of RPS4 and RRS1, individually and as a heterodimeric complex (respectively at 2.05, 1.75, and 2.65 angstrom resolution), reveal a conserved TIR/TIR interaction interface. We show that TIR domain heterodimerization is required to form a functional RRS1/RPS4 effector recognition complex. The RPS4 TIR domain activates effector-independent defense, which is inhibited by the RRS1 TIR domain through the heterodimerization interface. Thus, RPS4 and RRS1 function as a receptor complex in which the two components play distinct roles in recognition and signaling.	[Williams, Simon J.; Wan, Li; Ve, Thomas; Ericsson, Daniel J.; Casey, Lachlan W.; Lonhienne, Thierry; Winzor, Donald J.; Zhang, Xiaoxiao; Kobe, Bostjan] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Williams, Simon J.; Wan, Li; Ve, Thomas; Ericsson, Daniel J.; Casey, Lachlan W.; Lonhienne, Thierry; Winzor, Donald J.; Zhang, Xiaoxiao; Kobe, Bostjan] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia; [Sohn, Kee Hoon; Sarris, Panagiotis F.; Segonzac, Cecile; Ma, Yan; Saucet, Simon B.; Jones, Jonathan D. G.] John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Bernoux, Maud; Dodds, Peter N.] Commonwealth Sci & Ind Res Org Plant Ind, Canberra, ACT 2601, Australia; [Coerdt, Anne; Parker, Jane E.] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld 4072, Australia; [Sohn, Kee Hoon; Segonzac, Cecile] Massey Univ, Inst Agr & Environm, Bioprotect Res Ctr, Palmerston North 4442, New Zealand	University of Queensland; University of Queensland; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Max Planck Society; University of Queensland; Massey University	Williams, SJ (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.	s.williams8@uq.edu.au; k.sohn@massey.ac.nz; b.kobe@uq.edu.au; jonathan.jones@sainsbury-laboratory.ac.uk	Williams, Simon/F-7447-2011; Bernoux, Maud/D-4212-2009; SOHN, KEE HOON/H-5311-2013; Sarris, Panagiotis F./N-9978-2015; Lonhienne, Thierry/A-5828-2011; Ve, Thomas/AEK-1006-2022; Ericsson, Daniel/F-7458-2011; Jones, Jonathan DG/J-5129-2012; Bernoux, Maud/N-1360-2019; Casey, Lachlan/N-3396-2015; Kobe, Bostjan/D-1292-2009; Dodds, Peter/D-1181-2009; Zhang, Xiaoxiao/C-6002-2016	Williams, Simon/0000-0003-4781-6261; Ve, Thomas/0000-0002-0113-1905; Ericsson, Daniel/0000-0001-5101-9244; Jones, Jonathan DG/0000-0002-4953-261X; Casey, Lachlan/0000-0002-4458-0137; Kobe, Bostjan/0000-0001-9413-9166; Bernoux, Maud/0000-0001-5416-4295; Dodds, Peter/0000-0003-0620-5923; Saucet, Simon/0000-0002-0255-3886; Ma, Yan/0000-0003-3663-9060; Zhang, Xiaoxiao/0000-0002-5417-6963; Sarris, Panagiotis/0000-0001-7000-8997; Segonzac, Cecile/0000-0002-5537-7556	Australian Research Council (ARC) [DP120100685]; Rural Development Administration (Korea) [PJ007850201006]; Gatsby Foundation (United Kingdom); ARC Discovery Early Career Award [DE130101292]; European Commission [299621]	Australian Research Council (ARC)(Australian Research Council); Rural Development Administration (Korea)(Rural Development Administration (RDA), Republic of Korea); Gatsby Foundation (United Kingdom); ARC Discovery Early Career Award(Australian Research Council); European Commission(European CommissionEuropean Commission Joint Research Centre)	This research was supported by the Australian Research Council (ARC) Discovery Project (DP120100685), by Rural Development Administration (Korea) Project PJ007850201006, and by the Gatsby Foundation (United Kingdom). M. B. was a recipient of an ARC Discovery Early Career Award (DE130101292). A. C. is an International Max-Planck Research School Ph.D. student. B. K. is a National Health and Medical Research Council Research Fellow (1003325). P. F. S is supported by the European Commission FP7-PEOPLE-2011-Intra-European Fellowships (299621). The x-ray diffraction and small-angle scattering data collection was undertaken on the Micro Crystallography and Small-and Wide-Angle X-Ray Scattering beamlines at the Australian Synchrotron. We thank the Australian Synchrotron beamline scientists for help with x-ray data collection, and we acknowledge the use of the University of Queensland Remote Operation Crystallization and X-ray Diffraction Facility (UQ ROCX). We thank R. Counago for valuable help and suggestions, K. Newell and J. Rajamony for providing excellent technical assistance, Icon Genetics and S. Marillonnet for early access to vectors, and J. Ellis and S. Cesari for critical reading of the manuscript. The coordinate and structure factor data for RPS4TIR, RRS1TIR, and RRS1/RPS4TIR have been deposited to the Protein Data Bank (PDB) with PDB IDs 4c6r, 4c6s, and 4c6t, respectively.	Ashikawa I, 2008, GENETICS, V180, P2267, DOI 10.1534/genetics.108.095034; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Birker D, 2009, PLANT J, V60, P602, DOI 10.1111/j.1365-313X.2009.03984.x; Cesari S, 2013, PLANT CELL, V25, P1463, DOI 10.1105/tpc.112.107201; Chan SL, 2010, PROTEIN SCI, V19, P155, DOI 10.1002/pro.275; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Greenberg JT, 1997, ANNU REV PLANT PHYS, V48, P525, DOI 10.1146/annurev.arplant.48.1.525; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Krasileva KV, 2010, PLANT CELL, V22, P2444, DOI 10.1105/tpc.110.075358; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee SK, 2009, GENETICS, V181, P1627, DOI 10.1534/genetics.108.099226; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Narusaka M, 2009, PLANT J, V60, P218, DOI 10.1111/j.1365-313X.2009.03949.x; Noutoshi Y, 2005, PLANT J, V43, P873, DOI 10.1111/j.1365-313X.2005.02500.x; Okuyama Y, 2011, PLANT J, V66, P467, DOI 10.1111/j.1365-313X.2011.04502.x; Sohn KH, 2009, PLANT J, V57, P1079, DOI 10.1111/j.1365-313X.2008.03751.x; Swiderski MR, 2009, MOL PLANT MICROBE IN, V22, P157, DOI 10.1094/MPMI-22-2-0157; Takken FLW, 2012, CURR OPIN PLANT BIOL, V15, P375, DOI 10.1016/j.pbi.2012.05.001; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tasset C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001202; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; Ve T, 2013, P NATL ACAD SCI USA, V110, P17594, DOI 10.1073/pnas.1307614110; Ve T, 2012, CURR DRUG TARGETS, V13, P1360, DOI 10.2174/138945012803530260; von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944; Wan L, 2013, ACTA CRYSTALLOGR F, V69, P1275, DOI 10.1107/S1744309113026614; Williams SJ, 2011, MOL PLANT MICROBE IN, V24, P897, DOI 10.1094/MPMI-03-11-0052; Yuan B, 2011, THEOR APPL GENET, V122, P1017, DOI 10.1007/s00122-010-1506-3; Zhang Y, 2004, PLANT J, V40, P213, DOI 10.1111/j.1365-313X.2004.02201.x	35	219	226	7	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					299	303		10.1126/science.1247357	http://dx.doi.org/10.1126/science.1247357			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744375				2022-12-28	WOS:000334474500036
J	Allen, L; Brand, A; Scott, J; Altman, M; Hlava, M				Allen, Liz; Brand, Amy; Scott, Jo; Altman, Micah; Hlava, Marjorie			Credit where credit is due	NATURE			English	Editorial Material							AUTHORS		[Allen, Liz; Scott, Jo] Wellcome Trust Res Labs, London, England; [Brand, Amy] Digital Sci, Cambridge, MA USA; [Hlava, Marjorie] Access Innovat, Albuquerque, NM USA; [Altman, Micah] MIT, MIT Lib, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Allen, L (corresponding author), Wellcome Trust Res Labs, London, England.	l.allen@wellcome.ac.uk	Allen, Liz/AAK-3137-2020; , NULL/B-1439-2008	Allen, Liz/0000-0002-9298-3168; , NULL/0000-0001-7382-6960; Brand, Amy/0000-0002-4208-1000				Cleary M, 2012, J CLIN NURS, V21, P809, DOI 10.1111/j.1365-2702.2011.04062.x; Dance A, 2012, NATURE, V489, pS2, DOI 10.1038/489S2a; Einav L, 2006, J ECON PERSPECT, V20, P175, DOI 10.1257/089533006776526085; Frische S, 2012, NATURE, V489, P475, DOI 10.1038/489475a; Hames I, 2012, INT WORKSH CONTR SCH; Karani R, 2013, ACAD MED, V88, P364, DOI 10.1097/ACM.0b013e31827fc6ae; Malicki M, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-189; Matheson A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001072; Rodrigo C., 2011, SCIENTOMETRICS, V88, P145	9	109	113	7	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					312	313		10.1038/508312a	http://dx.doi.org/10.1038/508312a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF0KP	24745070	Bronze			2022-12-28	WOS:000334403000024
J	Cury, RG; Moreira, CH				Cury, Rubens Gisbert; Moreira, Camila Hobi			Occipital Calcification and Celiac Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 24-year-old man presented with a 10-year history of recurrent episodes of throbbing, occipital headache associated with complex visual symptoms, lasting from a few minutes to an hour. He had been treated for migraine, with little response. A 24-year-old man presented with a 10-year history of recurrent episodes of throbbing, occipital headache associated with complex visual symptoms, lasting from a few minutes to an hour. He had been treated for migraine, with little response. Routine blood tests revealed a mildly decreased folate level (2.2 ng per milliliter [5.0 nmol per liter]; reference range, 3.1 to 17.5 ng per milliliter [7.0 to 39.0 nmol per liter]), and a computed tomographic scan of the head revealed bilateral occipital calcification (Panels A and B). Laboratory testing revealed normal cerebrospinal fluid and elevated levels of serum IgA antitransglutaminase antibodies (45 U ...	[Cury, Rubens Gisbert; Moreira, Camila Hobi] Univ Sao Paulo, Sao Paulo, Brazil	Universidade de Sao Paulo	Cury, RG (corresponding author), Univ Sao Paulo, Sao Paulo, Brazil.	rubens_cury@usp.br	Cury, Rubens/J-7210-2015	Cury, Rubens/0000-0001-6305-3327					0	7	7	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 17	2014	370	16							e26	10.1056/NEJMicm1311406	http://dx.doi.org/10.1056/NEJMicm1311406			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF3HE	24738690				2022-12-28	WOS:000334601600001
J	Goldenberg, DL				Goldenberg, Don L.			Fibromyalgia Syndrome An Emerging but Controversial Condition (Reprinted from vol 257, pg 2782, 1987)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		GOLDENBERG DL, 1987, JAMA-J AM MED ASSOC, V257, P2782, DOI 10.1001/jama.257.20.2782	1	5	5	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2014	311	15					1570	1570		10.1001/jama.2013.279453	http://dx.doi.org/10.1001/jama.2013.279453			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9DX	24737378				2022-12-28	WOS:000334306000032
J	Arie, S				Arie, Sophie			Has Britain solved its teenage pregnancy problem? Teenage pregnancy rates have been falling dramatically for several years. Sophie Arie looks at why-and whether the trend will last	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADOLESCENT PREGNANCY; CONTRACEPTIVE USE; UNITED-STATES; COUNTRIES; SERVICES											[Anonymous], VITAL HLTH STAT; [Anonymous], 2014, N DEVON J       0324; Arie S, 2014, BMJ-BRIT MED J, V348, pg1926; Ballinski T, 2011, LIFESITENEWS    0113; Boden JM, 2008, J CHILD PSYCHOL PSYC, V49, P151, DOI 10.1111/j.1469-7610.2007.01830.x; Connolly A, 2013, GUIDELINES PRACTICE, P16; Cromer BA, 1999, FAM PLANN PERSPECT, V31, P287, DOI 10.2307/2991539; Darroch JE, 2001, FAM PLANN PERSPECT, V33, P244, DOI 10.2307/3030191; Grimes D, 2000, 16 WORLD C INT FED G; Guttmacher Institute, 2012, FACTS AM TEENS SOURC; Health Communities, TEEN PREGN; McIvor J, 2014, BBC NEWS; NICE, LONG ACT REV CONTR C; Office for National Statistics Statistics Bulletin, 2012, CONC ENGL WAL; Organisation for Economic Development, 2013, SHAR BIRTHS OUTS WED; Santelli JS, 2007, AM J PUBLIC HEALTH, V97, P150, DOI 10.2105/AJPH.2006.089169; Santelli JS, 2009, J ADOLESCENT HEALTH, V45, P25, DOI 10.1016/j.jadohealth.2009.04.017; Williams R, 2011, GUARDIAN; Wise J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2385	19	3	3	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2014	348								g2561	10.1136/bmj.g2561	http://dx.doi.org/10.1136/bmj.g2561			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AF5GH	24733734	Green Published			2022-12-28	WOS:000334741500002
J	Muijres, FT; Elzinga, MJ; Melis, JM; Dickinson, MH				Muijres, Florian T.; Elzinga, Michael J.; Melis, Johan M.; Dickinson, Michael H.			Flies Evade Looming Targets by Executing Rapid Visually Directed Banked Turns	SCIENCE			English	Article							MEDIATED EQUILIBRIUM REFLEXES; FRUIT-FLY; FLIGHT PERFORMANCE; YAW DYNAMICS; DROSOPHILA; MOTION; MODEL; AVOIDANCE; MANEUVERS; SACCADES	Avoiding predators is an essential behavior in which animals must quickly transform sensory cues into evasive actions. Sensory reflexes are particularly fast in flying insects such as flies, but the means by which they evade aerial predators is not known. Using high-speed videography and automated tracking of flies in combination with aerodynamic measurements on flapping robots, we show that flying flies react to looming stimuli with directed banked turns. The maneuver consists of a rapid body rotation followed immediately by an active counter-rotation and is enacted by remarkably subtle changes in wing motion. These evasive maneuvers of flies are substantially faster than steering maneuvers measured previously and indicate the existence of sensory-motor circuitry that can reorient the fly's flight path within a few wingbeats.	[Muijres, Florian T.; Elzinga, Michael J.; Melis, Johan M.; Dickinson, Michael H.] Univ Washington, Seattle, WA 98195 USA; [Melis, Johan M.] Delft Univ Technol, Fac Aerosp Engn, NL-2600 GB Delft, Netherlands	University of Washington; University of Washington Seattle; Delft University of Technology	Dickinson, MH (corresponding author), Univ Washington, Box 351800,24 Kincaid Hall, Seattle, WA 98195 USA.	flyman@uw.edu	Muijres, Florian Titus/N-6483-2015	Muijres, Florian Titus/0000-0002-5668-0653	Air Force Office of Scientific Research [FA9550-10-1-0368]; Paul G. Allen Family Foundation; Army Research Laboratory [DAAD 19-03-D-0004]; Swedish Research Council; Royal Physiographical Society in Lund	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Paul G. Allen Family Foundation; Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographical Society in Lund(Royal Society of London)	This work was supported by grants from the Air Force Office of Scientific Research (FA9550-10-1-0368) to M. H. D., the Paul G. Allen Family Foundation to M. H. D., Army Research Laboratory (DAAD 19-03-D-0004) to M. H. D., Swedish Research Council to F. T. M., and the Royal Physiographical Society in Lund to F. T. M. We thank S. Safarik, X. Zabala, and J. Liu for their technical support, and B. van Oudheusden for co-supervising J. M. M. The data reported in this paper are tabulated in the supplementary materials: The body and wing kinematics data for all reported flight sequences, as well as forces and torques from the robotic fly experiments, are stored in Database S1, and the Fourier series coefficients required to reconstruct the here analyzed wingbeat kinematics (using eq. S1) are available in table S1.	Bender JA, 2006, J EXP BIOL, V209, P4597, DOI 10.1242/jeb.02583; Bender JA, 2006, J EXP BIOL, V209, P3170, DOI 10.1242/jeb.02369; Bergou AJ, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.148101; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Card G, 2008, CURR BIOL, V18, P1300, DOI 10.1016/j.cub.2008.07.094; Cheng B, 2011, IEEE T ROBOT, V27, P849, DOI 10.1109/TRO.2011.2156170; Combes SA, 2012, J EXP BIOL, V215, P903, DOI 10.1242/jeb.059394; DAVID CT, 1978, PHYSIOL ENTOMOL, V3, P191, DOI 10.1111/j.1365-3032.1978.tb00148.x; de Vries SEJ, 2012, CURR BIOL, V22, P353, DOI 10.1016/j.cub.2012.01.007; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; DICKINSON MH, 1993, J EXP BIOL, V174, P45; Dickinson MH, 1999, PHILOS T ROY SOC B, V354, P903, DOI 10.1098/rstb.1999.0442; Dickson WB, 2010, J EXP BIOL, V213, P3047, DOI 10.1242/jeb.042978; Domenici P, 2011, J EXP BIOL, V214, P2463, DOI 10.1242/jeb.029652; Elzinga MJ, 2012, J R SOC INTERFACE, V9, P1685, DOI 10.1098/rsif.2011.0699; Fontaine EI, 2009, J EXP BIOL, V212, P1307, DOI 10.1242/jeb.025379; Fotowat H, 2011, ANNU REV NEUROSCI, V34, P1, DOI 10.1146/annurev-neuro-061010-113632; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Frye MA, 2001, NEURON, V32, P385, DOI 10.1016/S0896-6273(01)00490-1; GOTZ KG, 1964, KYBERNETIK, V2, P77, DOI 10.1007/BF00288561; GOTZ KG, 1984, BIOL CYBERN, V51, P135, DOI 10.1007/BF00357927; Hedrick TL, 2009, SCIENCE, V324, P252, DOI 10.1126/science.1168431; Lehmann FO, 1997, J EXP BIOL, V200, P1133; Lehmann FO, 2006, MOL B INT U, P230; Reiser MB, 2008, J NEUROSCI METH, V167, P127, DOI 10.1016/j.jneumeth.2007.07.019; Reiser MB, 2013, J EXP BIOL, V216, P719, DOI 10.1242/jeb.074732; Ristroph L, 2010, P NATL ACAD SCI USA, V107, P4820, DOI 10.1073/pnas.1000615107; Ristroph L, 2009, J EXP BIOL, V212, P1324, DOI 10.1242/jeb.025502; Sherman A, 2003, J EXP BIOL, V206, P295, DOI 10.1242/jeb.00075; Tammero LF, 2002, J EXP BIOL, V205, P327; Tu MS, 1996, J COMP PHYSIOL A, V178, P813, DOI 10.1007/BF00225830; van Breugel F, 2012, J EXP BIOL, V215, P1783, DOI 10.1242/jeb.066498; VOGEL S, 1966, J EXP BIOL, V44, P567	33	139	145	7	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					172	177		10.1126/science.1248955	http://dx.doi.org/10.1126/science.1248955			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24723606				2022-12-28	WOS:000334096300028
J	Gilbertson, RJ				Gilbertson, Richard J.			Driving Glioblastoma to Drink	CELL			English	Editorial Material							CELLS; DEATH		[Gilbertson, Richard J.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Gilbertson, Richard J.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Gilbertson, RJ (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	richard.gilbertson@stjude.org	Gilbertson, Richard James/ABE-1346-2021	Gilbertson, Richard James/0000-0001-7539-9472	NATIONAL CANCER INSTITUTE [P01CA096832, R01CA129541] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA129541, P01 CA096832] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Kitambi SS, 2014, CELL, V157, DOI 10.1016/j.cell.2014.02.021; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Overmeyer JH, 2008, MOL CANCER RES, V6, P965, DOI 10.1158/1541-7786.MCR-07-2036; Robinson MW, 2012, J MED CHEM, V55, P1940, DOI 10.1021/jm201006x; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; van den Bent MJ, 2009, J CLIN ONCOL, V27, P1268, DOI 10.1200/JCO.2008.17.5984	8	8	10	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					289	290		10.1016/j.cell.2014.03.034	http://dx.doi.org/10.1016/j.cell.2014.03.034			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725398	Bronze			2022-12-28	WOS:000334304500003
J	Lee, JK; Hahn, S; Kim, DW; Suh, KJ; Keam, B; Kim, TM; Lee, SH; Heo, DS				Lee, June-Koo; Hahn, Seokyung; Kim, Dong-Wan; Suh, Koung Jin; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Heo, Dae Seog			Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non-Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							2ND-LINE TREATMENT; OPEN-LABEL; 1ST-LINE ERLOTINIB; EGFR; GEFITINIB; MUTATIONS; MULTICENTER; DOCETAXEL; TRIAL; GEMCITABINE	IMPORTANCE Current guidelines recommend both epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) and cytotoxic chemotherapy drugs as standard treatment options for patients with wild-type (WT) EGFR who were previously treated for non-small cell lung cancer (NSCLC). However, it is not clear that EGFR TKIs are as efficacious as chemotherapy in patients with WT EGFR. OBJECTIVE To determine the association between first-generation EGFR TKI vs chemotherapy and survival in advanced NSCLC patients with WT EGFR. DATA SOURCES PubMed, EMBASE, Cochrane database, and meeting abstracts of the American Society of Clinical Oncology and European Society of Medical Oncology through December 2013. STUDY SELECTION Eligible studies were randomized controlled trials comparing EGFR TKI with conventional chemotherapy in patients with advanced NSCLC. Out of 1947 retrieved articles, 11 trials incorporating 1605 patients with WT EGFR were included. DATA EXTRACTION AND SYNTHESIS Two reviewers extracted trial characteristics and outcomes. The risk of bias was evaluated using the Cochrane tool. All measures were pooled using random-effects models and 95% CIs were calculated. MAIN OUTCOMES AND MEASURES The primary outcome was progression-free survival (PFS), measured as hazard ratios (HRs). The secondary outcomes were objective response rate and overall survival, expressed as relative risks and HRs, respectively. RESULTS Among patients with WT EGFR tumors, chemotherapy was associated with improvement of PFS, compared with TKI (HR for TKI, 1.41; 95% CI, 1.10-1.81). No statistically significant subgroup difference was identified in terms of line of treatment (first-line vs second-or later-line), experimental drug, dominant ethnicity, or EGFR mutation analysis method. Trials using more sensitive platforms than direct sequencing were associated with a significant PFS benefit with chemotherapy (HR for TKI, 1.84; 95% CI, 1.35-2.52). The association of chemotherapy with improvement in PFS was also significant in second-or later-line trials (HR, 1.34; 95% CI, 1.09-1.65). The objective response rate was higher with chemotherapy (92/549, 16.8%, vs 39/540, 7.2%, for TKI; relative risk for TKI, 1.11; 95% CI, 1.02-1.21); however, no statistically significant difference was observed with respect to overall survival (HR for TKI, 1.08; 95% CI, 0.96-1.22). CONCLUSIONS AND RELEVANCE Among patients with advanced NSCLC harboring WT EGFR, conventional chemotherapy, compared with first-generation EGFR TKI, was associated with improvement in PFS but not overall survival.	[Lee, June-Koo; Kim, Dong-Wan; Suh, Koung Jin; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Heo, Dae Seog] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Hahn, Seokyung] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul 110744, South Korea; [Hahn, Seokyung] Seoul Natl Univ, Coll Med, Dept Med, Seoul, South Korea; [Kim, Dong-Wan; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Heo, Dae Seog] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, DW (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 110744, South Korea.	kimdw@snu.ac.kr	Kim, Dong-Wan/J-5391-2012	Suh, Koung Jin/0000-0002-1881-8738; Lee, June-Koo/0000-0003-1348-4094; Hahn, Seokyung/0000-0002-4684-4917	National Research Foundation of Korea (NRF); Korean government [2010-0009563, 2012-0000994]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government(Korean Government)	This work was supported in part by National Research Foundation of Korea (NRF) grants funded by the Korean government (2010-0009563, 2012-0000994).	[Anonymous], VIRTUAL MEETING OF 2; Brugger W, 2011, J CLIN ONCOL, V29, P4113, DOI 10.1200/JCO.2010.31.8162; Chen YM, 2012, J THORAC ONCOL, V7, P412, DOI 10.1097/JTO.0b013e31823a39e8; Ciuleanu T, 2012, LANCET ONCOL, V13, P300, DOI 10.1016/S1470-2045(11)70385-0; Dacic S, 2008, ADV ANAT PATHOL, V15, P241, DOI 10.1097/PAP.0b013e31817bf5a9; Douillard JY, 2010, J CLIN ONCOL, V28, P744, DOI 10.1200/JCO.2009.24.3030; Eberhard DA, 2008, J CLIN ONCOL, V26, P983, DOI 10.1200/JCO.2007.12.9858; Ettinger DS, 2012, J NATL COMPR CANC NE, V10, P1236, DOI 10.6004/jnccn.2012.0130; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Garassino MC, 2013, LANCET ONCOL, V14, P981, DOI 10.1016/S1470-2045(13)70310-3; Goto K, 2012, ANN ONCOL, V23, P2914, DOI 10.1093/annonc/mds121; Gridelli C, 2012, J CLIN ONCOL, V30, P3002, DOI 10.1200/JCO.2011.41.2056; Han JY, 2012, J CLIN ONCOL, V30, P1122, DOI 10.1200/JCO.2011.36.8456; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirsch FR, 2009, LANCET ONCOL, V10, P432, DOI 10.1016/S1470-2045(09)70110-X; Karampeazis A, 2013, CANCER-AM CANCER SOC, V119, P2754, DOI 10.1002/cncr.28132; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Kimura H, 2006, CANCER SCI, V97, P642, DOI 10.1111/j.1349-7006.2006.00216.x; Laurie SA, 2013, J CLIN ONCOL, V31, P1061, DOI 10.1200/JCO.2012.43.4522; Lee SM, 2012, LANCET ONCOL, V13, P1161, DOI 10.1016/S1470-2045(12)70412-6; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mao C, 2010, LUNG CANCER, V69, P272, DOI 10.1016/j.lungcan.2009.11.020; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Okano Y, 2013, PAPER PRESENTED AT 2; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pan QL, 2005, J MOL DIAGN, V7, P396, DOI 10.1016/S1525-1578(10)60569-7; Pao W, 2007, CLIN CANCER RES, V13, P4954, DOI 10.1158/1078-0432.CCR-07-1387; Peters S, 2012, ANN ONCOL, V23, P56, DOI 10.1093/annonc/mds226; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Sun JM, 2012, CANCER-AM CANCER SOC, V118, P6234, DOI 10.1002/cncr.27630; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Zhao M, 2013, PAPER PRESENTED AT 2; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Zhu CQ, 2008, J CLIN ONCOL, V26, P4268, DOI 10.1200/JCO.2007.14.8924	43	109	116	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2014	311	14					1430	1437		10.1001/jama.2014.3314	http://dx.doi.org/10.1001/jama.2014.3314			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4EP	24715074	Bronze			2022-12-28	WOS:000333935000019
J	Edlow, JA; Rabinstein, A; Traub, SJ; Wijdicks, EFM				Edlow, Jonathan A.; Rabinstein, Alejandro; Traub, Stephen J.; Wijdicks, Eelco F. M.			Diagnosis of reversible causes of coma	LANCET			English	Review							NONCONVULSIVE STATUS EPILEPTICUS; ALTERED MENTAL STATUS; LUMBAR PUNCTURE; IMPAIRED CONSCIOUSNESS; 4 SCORE; INTRACRANIAL HYPERTENSION; COMPUTED-TOMOGRAPHY; CLINICAL-FEATURES; OCULAR ULTRASOUND; VENOUS PULSATION	Because coma has many causes, physicians must develop a structured, algorithmic approach to diagnose and treat reversible causes rapidly. The three main mechanisms of coma are structural brain lesions, diffuse neuronal dysfunction, and, rarely, psychiatric causes. The first priority is to stabilise the patient by treatment of life-threatening conditions, then to use the history, physical examination, and laboratory findings to identify structural causes and diagnose treatable disorders. Some patients have a clear diagnosis. In those who do not, the first decision is whether brain imaging is needed. Imaging should be done in post-traumatic coma or when structural brain lesions are probable or possible causes. Patients who do not undergo imaging should be reassessed regularly. If CT is non-diagnostic, a checklist should be used use to indicate whether advanced imaging is needed or evidence is present of a treatable poisoning or infection, seizures including non-convulsive status epilepticus, endocrinopathy, or thiamine deficiency.	[Edlow, Jonathan A.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Emergency Med, Cambridge, MA 02138 USA; [Rabinstein, Alejandro; Wijdicks, Eelco F. M.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Traub, Stephen J.] Mayo Clin, Dept Emergency Med, Scottsdale, AZ USA	Harvard University; Beth Israel Deaconess Medical Center; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix	Edlow, JA (corresponding author), Beth Israel Deaconess Med Ctr, Dept Emergency Med, 1 Deaconess Pl,CC-2, Boston, MA 02215 USA.	jedlow@bidmc.harvard.edu	Edlow, Jonathan A/F-7128-2016					Akamizu T, 2012, THYROID, V22, P661, DOI 10.1089/thy.2011.0334; Akavipat P, 2009, NEUROL MED-CHIR, V49, P565, DOI 10.2176/nmc.49.565; Angel MJ, 2011, NEUROL CLIN, V29, P837, DOI 10.1016/j.ncl.2011.08.002; Arora Sanjay, 2006, CJEM, V8, P433; Baki SGA, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-36; Bautista RED, 2007, J CLIN NEUROPHYSIOL, V24, P16, DOI 10.1097/WNP.0b013e318030e8cb; Booij H A, 2012, Pract Neurol, V12, P179, DOI 10.1136/practneurol-2011-000152; Brouwer MC, 2012, LANCET, V380, P1684, DOI 10.1016/S0140-6736(12)61185-4; Bruno MA, 2011, NEUROCRIT CARE, V15, P447, DOI 10.1007/s12028-011-9547-2; Cadranel JF, 2001, AM J GASTROENTEROL, V96, P515, DOI 10.1111/j.1572-0241.2001.03552.x; Cammarata G, 2011, J TRAUMA, V71, P779, DOI 10.1097/TA.0b013e3182220673; Churi S, 2012, CHEM PHARM BULL, V60, P859, DOI 10.1248/cpb.c12-00171; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; Donnino MW, 2007, ANN EMERG MED, V50, P715, DOI 10.1016/j.annemergmed.2007.02.007; Donnino MW, 2007, ANN EMERG MED, V50, P722, DOI 10.1016/j.annemergmed.2006.10.022; Dutta P, 2008, CRIT CARE, V12, DOI 10.1186/cc6211; Edlow JA, 2008, J EMERG MED, V34, P237, DOI 10.1016/j.jemermed.2007.10.003; Edlow JA, 2013, LANCET NEUROL, V12, P175, DOI 10.1016/S1474-4422(12)70306-X; Edlow JA, 2011, LANCET NEUROL, V10, P550, DOI 10.1016/S1474-4422(11)70069-2; Fitch MT, 2007, LANCET INFECT DIS, V7, P191, DOI 10.1016/S1473-3099(07)70050-6; Forsberg S, 2009, EMERG MED J, V26, P100, DOI 10.1136/emj.2007.054536; Forsberg S, 2012, AM J EMERG MED, V30, P1986, DOI 10.1016/j.ajem.2012.04.032; Forsberg S, 2012, CLIN TOXICOL, V50, P254, DOI 10.3109/15563650.2012.670245; Galvin R, 2010, EUR J NEUROL, V17, P1408, DOI 10.1111/j.1468-1331.2010.03153.x; Glimaker M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f361; Gofton TE, 2012, NAT REV NEUROL, V8, P557, DOI 10.1038/nrneurol.2012.183; GOWER DJ, 1987, J NEUROL NEUROSUR PS, V50, P1071, DOI 10.1136/jnnp.50.8.1071; Greer DM, 2012, CRIT CARE MED, V40, P1150, DOI 10.1097/CCM.0b013e318237bafb; Hasbun R, 2001, NEW ENGL J MED, V345, P1727, DOI 10.1056/NEJMoa010399; HOFFMAN RS, 1995, JAMA-J AM MED ASSOC, V274, P562, DOI 10.1001/jama.274.7.562; Huff JS, 2012, NEUROCRIT CARE, V17, P54, DOI 10.1007/s12028-012-9755-4; Husain AM, 2003, J NEUROL NEUROSUR PS, V74, P189, DOI 10.1136/jnnp.74.2.189; Jacks AS, 2003, J NEUROL NEUROSUR PS, V74, P7, DOI 10.1136/jnnp.74.1.7; Jayakrishnan B, 2012, Oman Med J, V27, P501, DOI 10.5001/omj.2012.120; Kaplan PW, 2011, NEUROL CLIN, V29, P973, DOI 10.1016/j.ncl.2011.07.010; Kattah JC, 2009, STROKE, V40, P3504, DOI 10.1161/STROKEAHA.109.551234; Keswani SC, 2002, J NEUROL NEUROSUR PS, V73, P83, DOI 10.1136/jnnp.73.1.83; Kevric J, 2011, EMERG MED J, V28, P486, DOI 10.1136/emj.2009.085845; Kim JY, 2013, RESUSCITATION, V84, P1068, DOI 10.1016/j.resuscitation.2013.02.010; Koster-Rasmussen R, 2008, J INFECTION, V57, P449, DOI 10.1016/j.jinf.2008.09.033; Laish-Farkash A, 2011, AM J CARDIOL, V108, P173, DOI 10.1016/j.amjcard.2011.03.021; Lascaratos G, 2010, NEUROLOGY, V75, pE53, DOI 10.1212/WNL.0b013e3181f4d851; Leong LB, 2008, INT J EMERG MED, V1, P179, DOI 10.1007/s12245-008-0049-8; LEVIN BE, 1978, ARCH NEUROL-CHICAGO, V35, P37, DOI 10.1001/archneur.1978.00500250041009; Lewis C, 2012, CURR MED RES OPIN, V28, P1039, DOI 10.1185/03007995.2012.694362; Liman TG, 2012, J NEUROL, V259, P155, DOI 10.1007/s00415-011-6152-4; Mailles A, 2009, CLIN INFECT DIS, V49, P1838, DOI 10.1086/648419; Major R, 2011, EMERG MED J, V28, P679, DOI 10.1136/emj.2009.087353; Marshman LAG, 2001, NEUROSURGERY, V49, P1251, DOI 10.1097/00006123-200111000-00045; Martinez-Ricarte F, 2013, NEUROLOGIA, V28, P41, DOI 10.1016/j.nrl.2010.07.028; Maruya J, 2007, J NEUROL NEUROSUR PS, V78, P102, DOI 10.1136/jnnp.2006.096776; Mathew V, 2011, J THROID RES, V2011, DOI 10.4061/2011/493462; Michael BD, 2013, EMERG MED J, V30, P402, DOI 10.1136/emermed-2012-201248; Modi A, 2012, NEUROL INDIA, V60, P168, DOI 10.4103/0028-3886.96394; MORGAN H, 1973, J NEUROSURG, V38, P698, DOI 10.3171/jns.1973.38.6.0698; Nadvi SS, 2000, S AFR MED J, V90, P609; Nathoo N, 2011, WORLD NEUROSURG, V75, P716, DOI 10.1016/j.wneu.2010.11.043; Oddo M, 2009, CRIT CARE MED, V37, P2051, DOI 10.1097/CCM.0b013e3181a00604; Omurtag A, 2012, INT J EMERG MED, V5, DOI 10.1186/1865-1380-5-35; Pearce JMS, 2006, EUR NEUROL, V55, P230, DOI 10.1159/000093876; Poh Z, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/480309; Posner JB, 2007, PLUM POSNERS DIAGNOS; Proulx N, 2005, QJM-INT J MED, V98, P291, DOI 10.1093/qjmed/hci047; Pruitt AA, 2012, NEUROL CLIN, V30, P129, DOI 10.1016/j.ncl.2011.09.011; Qayyum H, 2013, EUR J EMERG MED, V20, P91, DOI 10.1097/MEJ.0b013e32835105c8; Qureshi AI, 2002, CRIT CARE MED, V30, P2778, DOI 10.1097/00003246-200212000-00029; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Rajasekaran S, 2011, CLIN ENDOCRINOL, V74, P9, DOI 10.1111/j.1365-2265.2010.03913.x; ROPPER AH, 1986, NEW ENGL J MED, V314, P953, DOI 10.1056/NEJM198604103141504; ROPPER AH, 1993, J NEUROL NEUROSUR PS, V56, P932, DOI 10.1136/jnnp.56.8.932; Ross IL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053526; Roth C, 2011, Pract Neurol, V11, P136, DOI 10.1136/practneurol-2011-000010; Shavit L, 2012, EUR J INTERN MED, V23, P701, DOI 10.1016/j.ejim.2012.06.015; Sodhi R, 2012, AM J EMERG MED, V30, DOI 10.1016/j.ajem.2011.05.016; Solomon T, 2012, J INFECTION, V64, P347, DOI 10.1016/j.jinf.2011.11.014; Sporer KA, 2013, EMERG MED J, V30, P243, DOI 10.1136/emermed-2011-200452; Stead LG, 2009, NEUROCRIT CARE, V10, P50, DOI 10.1007/s12028-008-9145-0; Sullivan R, 2012, CLIN TOXICOL, V50, P141, DOI 10.3109/15563650.2011.654209; Sutter R, 2013, CRIT CARE MED, V41, P1124, DOI 10.1097/CCM.0b013e318275882f; TEASDALE G, 1974, LANCET, V2, P81; Tenenbein M, 2009, CLIN TOXICOL, V47, P286, DOI 10.1080/15563650902907798; Tokuda Y, 2003, POSTGRAD MED J, V79, P49, DOI 10.1136/pmj.79.927.49; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; WEINER LP, 1965, NEUROLOGY, V15, P87, DOI 10.1212/WNL.15.1.87; Wijdicks EFM, 2011, NEUROLOGY, V77, P84, DOI 10.1212/WNL.0b013e318220ac06; Wijdicks Eelco F M, 2010, Pract Neurol, V10, P51, DOI 10.1136/jnnp.2009.200097; Wijdicks EF, 2010, PRACTICE EMERGENCY C; Wijdicks EF, 2008, COMATOSE PATIENT; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606; Wong SH, 2013, J NEURO-OPHTHALMOL, V33, P17, DOI 10.1097/WNO.0b013e3182622207; Yong AW, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-139; Young GB, 2011, NEUROL CLIN, V29, P765, DOI 10.1016/j.ncl.2011.07.008; Young GB, 2009, ANN NY ACAD SCI, V1157, P32, DOI 10.1111/j.1749-6632.2009.04471.x; Young JL, 2010, EMERG MED CLIN N AM, V28, P595, DOI 10.1016/j.emc.2010.03.010; Zehtabchi S, 2013, EUR J EMERG MED, V20, P126, DOI 10.1097/MEJ.0b013e32835473b1; Zehtabchi S, 2011, EPILEPSY BEHAV, V22, P139, DOI 10.1016/j.yebeh.2011.06.012	97	49	50	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2014	384	9959					2064	2076		10.1016/S0140-6736(13)62184-4	http://dx.doi.org/10.1016/S0140-6736(13)62184-4			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW6BD	24767707				2022-12-28	WOS:000346353600028
J	Brose, MS; Nutting, CM; Jarzab, B; Elisei, R; Siena, S; Bastholt, L; de la Fouchardiere, C; Pacini, F; Paschke, R; Shong, YK; Sherman, SI; Smit, JWA; Chung, J; Kappeler, C; Pena, C; Molnar, I; Schlumberger, MJ				Brose, Marcia S.; Nutting, Christopher M.; Jarzab, Barbara; Elisei, Rossella; Siena, Salvatore; Bastholt, Lars; de la Fouchardiere, Christelle; Pacini, Furio; Paschke, Ralf; Shong, Young Kee; Sherman, Steven I.; Smit, Johannes W. A.; Chung, John; Kappeler, Christian; Pena, Carol; Molnar, Istvan; Schlumberger, Martin J.		DECISION Investigators	Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial	LANCET			English	Article							PROGNOSTIC INDICATORS; DISTANT METASTASES; TUMOR PROGRESSION; II TRIAL; CARCINOMA; EFFICACY; PAPILLARY; SAFETY; MANAGEMENT; MUTATION	Background Patients with radioactive iodine (I-131)-refractory locally advanced or metastatic differentiated thyroid cancer have a poor prognosis because of the absence of effective treatment options. In this study, we assessed the efficacy and safety of orally administered sorafenib in the treatment of patients with this type of cancer. Methods In this multicentre, randomised, double-blind, placebo-controlled, phase 3 trial (DECISION), we investigated sorafenib (400 mg orally twice daily) in patients with radioactive iodine-refractory locally advanced or metastatic differentiated thyroid cancer that had progressed within the past 14 months. Adult patients (>= 18 years of age) with this type of cancer were enrolled from 77 centres in 18 countries. To be eligible for inclusion, participants had to have at least one measurable lesion by CT or MRI according to Response Evaluation Criteria In Solid Tumors (RECIST); Eastern Cooperative Oncology Group performance status 0-2; adequate bone marrow, liver, and renal function; and serum thyroid-stimulating hormone concentration lower than 0.5 mIU/L. An interactive voice response system was used to randomly allocate participants in a 1: 1 ratio to either sorafenib or matching placebo. Patients, investigators, and the study sponsor were masked to treatment assignment. The primary endpoint was progression-free survival, assessed every 8 weeks by central independent review. Analysis was by intention to treat. Patients in the placebo group could cross over to open-label sorafenib upon disease progression. Archival tumour tissue was examined for BRAF and RAS mutations, and serum thyroglobulin was measured at baseline and at each visit. This study is registered with ClinicalTrials.gov, number NCT00984282, and with the EU Clinical Trials Register, number EudraCT 2009-012007-25. Findings Patients were randomly allocated on a 1: 1 basis to sorafenib or placebo. The intention-to-treat population comprised 417 patients (207 in the sorafenib group and 210 in the placebo group) and the safety population was 416 patients (207 in the sorafenib group and 209 in the placebo group). Median progression-free survival was significantly longer in the sorafenib group (10 . 8 months) than in the placebo group (5 . 8 months; hazard ratio [HR] 0.59, 95% CI 0.45-0.76; p < 0.0001). Progression-free survival improved in all prespecified clinical and genetic biomarker subgroups, irrespective of mutation status. Adverse events occurred in 204 of 207 (98.6%) patients receiving sorafenib during the double-blind period and in 183 of 209 (87.6%) patients receiving placebo. Most adverse events were grade 1 or 2. The most frequent treatment-emergent adverse events in the sorafenib group were hand-foot skin reaction (76.3%), diarrhoea (68.6%), alopecia (67.1%), and rash or desquamation (50.2%). Interpretation Sorafenib significantly improved progression-free survival compared with placebo in patients with progressive radioactive iodine-refractory differentiated thyroid cancer. Adverse events were consistent with the known safety profile of sorafenib. These results suggest that sorafenib is a new treatment option for patients with progressive radioactive iodine-refractory differentiated thyroid cancer.	[Brose, Marcia S.] Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; [Brose, Marcia S.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Nutting, Christopher M.] Royal Marsden Hosp, London SW3 6JJ, England; [Jarzab, Barbara] Maria Sklodowska Curie Mem Canc Ctr, Gliwice, Poland; [Jarzab, Barbara] Inst Oncol, Gliwice, Poland; [Elisei, Rossella] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Siena, Salvatore] Osped Niguarda Ca Granda, Niguarda Canc Ctr, Milan, Italy; [Bastholt, Lars] Odense Univ Hosp, Dept Oncol, DK-5000 Odense C, Denmark; [de la Fouchardiere, Christelle] Hosp Civils, Ctr Anticanc, Consortium Canc Thyroidien, Lyon, France; [Pacini, Furio] Univ Siena, Unit Endocrinol, I-53100 Siena, Italy; [Paschke, Ralf] Univ Leipzig, Dept Endocrinol & Nephrol, D-04109 Leipzig, Germany; [Shong, Young Kee] Asan Med Ctr, Div Endocrinol, Seoul, South Korea; [Sherman, Steven I.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Smit, Johannes W. A.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Chung, John; Pena, Carol; Molnar, Istvan] Bayer HealthCare Pharmaceut, Whippany, NJ USA; [Kappeler, Christian] Bayer Pharma AG, Berlin, Germany; [Schlumberger, Martin J.] Gustave Roussy, Villejuif, France; [Schlumberger, Martin J.] Univ Paris 11, Villejuif, France	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Royal Marsden NHS Foundation Trust; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; University of Pisa; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Southern Denmark; Odense University Hospital; CHU Lyon; University of Siena; Leipzig University; University of Ulsan; Asan Medical Center; University of Texas System; UTMD Anderson Cancer Center; Radboud University Nijmegen; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay	Brose, MS (corresponding author), Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Clin Res Bldg,Room 127,415 Curie Blvd, Philadelphia, PA 19104 USA.	brosem@mail.med.upenn.edu	Smit, J.W.A./H-8091-2014; de la Fouchardiere, Christelle/AAW-7887-2021; Jarząb, Barbara/AAI-7942-2020; Provencio, Mariano/ABE-8586-2020; Barbara, Jarzab/I-4654-2019; SIENA, SALVATORE/AAC-5806-2019	Smit, J.W.A./0000-0003-1052-9314; Jarząb, Barbara/0000-0001-9811-9584; Provencio, Mariano/0000-0001-9053-9197; SIENA, SALVATORE/0000-0002-2681-2846; Ando, Yukio/0000-0001-7115-9105; Provencio Pulla, Mariano/0000-0001-6315-7919; Shong, Young Kee/0000-0002-7911-9471; ELISEI, ROSSELLA/0000-0002-5333-9257; Sherman, Steven/0000-0002-3079-5153; Bastholt, Lars/0000-0001-5478-9826; Samuel, Leslie/0000-0002-8402-8670; Eton, Omar/0000-0002-9141-553X; DE LA FOUCHARDIERE, CHRISTELLE/0000-0003-2291-5693	Bayer HealthCare Pharmaceuticals; Onyx Pharmaceuticals (an Amgen subsidiary); NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Bayer HealthCare Pharmaceuticals(Bayer AGBayer Healthcare Pharmaceuticals); Onyx Pharmaceuticals (an Amgen subsidiary); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals (an Amgen subsidiary). We thank the patients, their caregivers, and the investigators who participated in this study; the principal investigators are listed in appendix pp 2-5. We also thank Emma Robinson (7.4 Limited, Oxford, UK), who provided medical writing support, which was funded by Bayer HealthCare Pharmaceuticals.	Ahmed M, 2011, EUR J ENDOCRINOL, V165, P315, DOI 10.1530/EJE-11-0129; Anderson RT, 2013, THYROID, V23, P392, DOI 10.1089/thy.2012.0520; Bible KC, 2010, LANCET ONCOL, V11, P962, DOI 10.1016/S1470-2045(10)70203-5; Brose MS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-349; Carlomagno F, 2006, JNCI-J NATL CANCER I, V98, P326, DOI 10.1093/jnci/djj069; Carr LL, 2010, CLIN CANCER RES, V16, P5260, DOI 10.1158/1078-0432.CCR-10-0994; Cohen EEW, 2008, J CLIN ONCOL, V26, P4708, DOI 10.1200/JCO.2007.15.9566; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Durante C, 2006, J CLIN ENDOCR METAB, V91, P2892, DOI 10.1210/jc.2005-2838; Elisei R, 2008, J CLIN ENDOCR METAB, V93, P3943, DOI 10.1210/jc.2008-0607; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Escudier B, 2009, J CLIN ONCOL, V27, P3312, DOI 10.1200/JCO.2008.19.5511; Gouveia C, 2013, JAMA OTOLARYNGOL, V139, P1164, DOI 10.1001/jamaoto.2013.4501; Gupta-Abramson V, 2008, J CLIN ONCOL, V26, P4714, DOI 10.1200/JCO.2008.16.3279; Hoftijzer H, 2009, EUR J ENDOCRINOL, V161, P923, DOI 10.1530/EJE-09-0702; Kapiteijn E, 2012, ANN ONCOL, V23, P10, DOI 10.1093/annonc/mdr117; Klein M, 2001, J CLIN ENDOCR METAB, V86, P656, DOI 10.1210/jc.86.2.656; Kloos RT, 2009, J CLIN ONCOL, V27, P1675, DOI 10.1200/JCO.2008.18.2717; Leboulleux S, 2012, LANCET ONCOL, V13, P897, DOI 10.1016/S1470-2045(12)70335-2; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Marotta V, 2013, CLIN ENDOCRINOL, V78, P760, DOI 10.1111/cen.12057; National Comprehensive Cancer Network, 2013, NCCN CLIN PRACT GUID; Schlumberger M, 2014, LANCET DIABETES ENDO, V2, P356, DOI 10.1016/S2213-8587(13)70215-8; Schneider TC, 2012, EUR J ENDOCRINOL, V167, P643, DOI 10.1530/EJE-12-0405; Sherman SI, 2008, NEW ENGL J MED, V359, P31, DOI 10.1056/NEJMoa075853; Shoup M, 2003, J AM COLL SURGEONS, V197, P191, DOI 10.1016/S1072-7515(03)00332-6; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Xing MZ, 2013, LANCET, V381, P1058, DOI 10.1016/S0140-6736(13)60109-9; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431; Xing MZ, 2010, MOL CELL ENDOCRINOL, V321, P86, DOI 10.1016/j.mce.2009.10.012	30	907	972	7	120	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2014	384	9940					319	328		10.1016/S0140-6736(14)60421-9	http://dx.doi.org/10.1016/S0140-6736(14)60421-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3AE	24768112	Green Accepted			2022-12-28	WOS:000339722400029
J	Yang, Y; Torchinsky, MB; Gobert, M; Xiong, HZ; Xu, M; Linehan, JL; Alonzo, F; Ng, C; Chen, A; Lin, XY; Sczesnak, A; Liao, JJ; Torres, VJ; Jenkins, MK; Lafaille, JJ; Littman, DR				Yang, Yi; Torchinsky, Miriam B.; Gobert, Michael; Xiong, Huizhong; Xu, Mo; Linehan, Jonathan L.; Alonzo, Francis; Ng, Charles; Chen, Alessandra; Lin, Xiyao; Sczesnak, Andrew; Liao, Jia-Jun; Torres, Victor J.; Jenkins, Marc K.; Lafaille, Juan J.; Littman, Dan R.			Focused specificity of intestinal T(H)17 cells towards commensal bacterial antigens	NATURE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; T-CELLS; MICROBIOTA; TH17; INDUCTION; DIFFERENTIATION; IDENTIFICATION; EXPRESSION; MATURATION; PREDICTION	T-helper-17 (T(H)17) cells have critical roles in mucosal defence and in autoimmune disease pathogenesis(1-3). They are most abundant in the small intestine lamina propria, where their presence requires colonization of mice with microbiota(4-7). Segmented filamentous bacteria (SFB) are sufficient to induce T(H)17 cells and to promote T(H)17-dependent autoimmune disease in animal models(8-14). However, the specificity of T(H)17 cells, the mechanism of their induction by distinct bacteria, and the means by which they foster tissue-specific inflammation remain unknown. Here we show that the T-cell antigen receptor (TCR) repertoire of intestinal T(H)17 cells in SFB-colonized mice has minimal overlap with that of other intestinal CD4(+) T cells and that most T(H)17 cells, but not other T cells, recognize antigens encoded by SFB. T cells with antigen receptors specific for SFB-encoded peptides differentiated into ROR gamma t-expressing T(H)17 cells, even if SFB-colonized mice also harboured a strong T(H)1 cell inducer, Listeria monocytogenes, in their intestine. The match of T-cell effector function with antigen specificity is thus determined by the type of bacteria that produce the antigen. These findings have significant implications for understanding how commensal microbiota contribute to organ-specific autoimmunity and for developing novel mucosal vaccines.	[Yang, Yi; Torchinsky, Miriam B.; Gobert, Michael; Xiong, Huizhong; Xu, Mo; Ng, Charles; Chen, Alessandra; Lin, Xiyao; Sczesnak, Andrew; Liao, Jia-Jun; Lafaille, Juan J.; Littman, Dan R.] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Linehan, Jonathan L.; Jenkins, Marc K.] Univ Minnesota, Sch Med, Dept Microbiol, Ctr Immunol, Minneapolis, MN 55455 USA; [Alonzo, Francis; Torres, Victor J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA	New York University; University of Minnesota System; University of Minnesota Twin Cities; New York University; Howard Hughes Medical Institute; New York University	Littman, DR (corresponding author), NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA.	dan.littman@med.nyu.edu	Jenkins, Marc K/G-1063-2012	Jenkins, Marc K/0000-0001-8009-7655; Torres, Victor/0000-0002-7126-0489; Sczesnak, Andrew/0000-0002-0152-9745	National Center for Advancing Translational Sciences [UL1 TR00038]; National Cancer Institute [5P30CA016087-32]; NIH [R01 AI039614]; Arthritis National Research Foundation; Irvington Institute fellowship program of the Cancer Research Institute; NATIONAL CANCER INSTITUTE [P30CA077598, P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis National Research Foundation(National Research Foundation of Korea); Irvington Institute fellowship program of the Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Yong Kim for generating TCR transgenic mice, A. Viale for 454 pyrosequencing, R. Myers for RNA-seq, N. Freitag for providing the Listeria strain and expression vector, Y. Umesaki for SFB samples, and K. Murphy for providing the 58 alpha<SUP>-</SUP>beta<SUP>-</SUP> hybridoma line. The Immune Monitoring Core New York University (NYU) is supported in part by grant UL1 TR00038 from the National Center for Advancing Translational Sciences and grant 5P30CA016087-32 from the National Cancer Institute; the NYU Histology Core is supported in part by grant 5P30CA016087-32 from the National Cancer Institute. M.K.J. was supported by grant R01 AI039614 from the NIH. Y. Y. was supported by the Arthritis National Research Foundation. M. X. is supported by the Irvington Institute fellowship program of the Cancer Research Institute. D. R. L. is a Howard Hughes Medical Institute Investigator.	Alamyar E., 2012, IMMUNOME RES, V8, P1, DOI [10.4172/1745-7580.1000056, DOI 10.4172/1745-7580.1000056]; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Currier J. R., 2001, CURR PROTOCOLS IMMUN; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Lochner M, 2011, J IMMUNOL, V186, P1531, DOI 10.4049/jimmunol.1001723; McGeachy MJ, 2007, SEMIN IMMUNOL, V19, P372, DOI 10.1016/j.smim.2007.10.012; Monk IR, 2008, APPL ENVIRON MICROB, V74, P3921, DOI 10.1128/AEM.00314-08; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Prakash T, 2011, CELL HOST MICROBE, V10, P273, DOI 10.1016/j.chom.2011.08.007; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; SANDERSON S, 1995, J EXP MED, V182, P1751, DOI 10.1084/jem.182.6.1751; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Schnupf P, 2013, SEMIN IMMUNOL, V25, P342, DOI 10.1016/j.smim.2013.09.001; Sczesnak A, 2011, CELL HOST MICROBE, V10, P260, DOI 10.1016/j.chom.2011.08.005; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Xayarath B, 2009, MOL MICROBIOL, V74, P956, DOI 10.1111/j.1365-2958.2009.06910.x; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	36	325	340	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					152	+		10.1038/nature13279	http://dx.doi.org/10.1038/nature13279			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24739972	Green Accepted			2022-12-28	WOS:000336768900047
J	Palumbi, SR; Barshis, DJ; Traylor-Knowles, N; Bay, RA				Palumbi, Stephen R.; Barshis, Daniel J.; Traylor-Knowles, Nikki; Bay, Rachael A.			Mechanisms of reef coral resistance to future climate change	SCIENCE			English	Article							PORITES-LOBATA; RESILIENCE; RESPONSES; IMPACTS; GROWTH	Reef corals are highly sensitive to heat, yet populations resistant to climate change have recently been identified. To determine the mechanisms of temperature tolerance, we reciprocally transplanted corals between reef sites experiencing distinct temperature regimes and tested subsequent physiological and gene expression profiles. Local acclimatization and fixed effects, such as adaptation, contributed about equally to heat tolerance and are reflected in patterns of gene expression. In less than 2 years, acclimatization achieves the same heat tolerance that we would expect from strong natural selection over many generations for these long-lived organisms. Our results show both short-term acclimatory and longer-term adaptive acquisition of climate resistance. Adding these adaptive abilities to ecosystem models is likely to slow predictions of demise for coral reef ecosystems.	[Palumbi, Stephen R.; Barshis, Daniel J.; Traylor-Knowles, Nikki; Bay, Rachael A.] Stanford Univ, Dept Biol, Hopkins Marine Stn, Pacific Grove, CA 93950 USA	Stanford University	Palumbi, SR (corresponding author), Stanford Univ, Dept Biol, Hopkins Marine Stn, Pacific Grove, CA 93950 USA.	spalumbi@stanford.edu	Traylor-Knowles, Nikki G/D-4354-2012		Gordon and Betty Moore Foundation [GBMF2629]; Schmidt Ocean Institute; NSF	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Schmidt Ocean Institute; NSF(National Science Foundation (NSF))	The transcriptome data are archived at NCBI's Gene Expression Omnibus database (series record GSE56278: www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE56278). Funding was provided by The Gordon and Betty Moore Foundation through grant GBMF2629, the Schmidt Ocean Institute, and a fellowship from the NSF to N.T.K. We thank M. van Oppen, I. Baums, M. De Salvo, L. Bay, M. Morikawa, and O. Hoegh-Guldberg for comments on earlier versions of the manuscript. We also thank the U.S. National Park of American Samoa for permission to work on Ofu reefs and C. Caruso for logistical and research help.	Barshis D. J., 2014, MOL BIOL EVOL; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; COLES SL, 1976, PAC SCI, V30, P159; Craig P, 2001, CORAL REEFS, V20, P185, DOI 10.1007/s003380100159; De Wit P, 2012, MOL ECOL RESOUR, V12, P1058, DOI 10.1111/1755-0998.12003; Endler J.A., 1986, Monographs in Population Biology, pviii; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Honnay O, 2002, ECOL LETT, V5, P525, DOI 10.1046/j.1461-0248.2002.00346.x; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Ladner JT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-217; Ladner JT, 2012, MOL ECOL, V21, P2224, DOI 10.1111/j.1365-294X.2012.05528.x; Logan CA, 2014, GLOBAL CHANGE BIOL, V20, P125, DOI 10.1111/gcb.12390; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Oliver TA, 2011, CORAL REEFS, V30, P241, DOI 10.1007/s00338-010-0696-0; Oliver TA, 2009, MAR ECOL PROG SER, V378, P93, DOI 10.3354/meps07871; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Root TL, 2005, P NATL ACAD SCI USA, V102, P7465, DOI 10.1073/pnas.0502286102; Shamberger KEF, 2014, GEOPHYS RES LETT, V41, P499, DOI 10.1002/2013GL058489; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Smith LW, 2008, PAC SCI, V62, P57, DOI 10.2984/1534-6188(2008)62[57:EVGIOG]2.0.CO;2; Smith LW, 2007, CORAL REEFS, V26, P559, DOI 10.1007/s00338-007-0216-z; Stillman JH, 2003, SCIENCE, V301, P65, DOI 10.1126/science.1083073	30	502	504	24	657	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					895	898		10.1126/science.1251336	http://dx.doi.org/10.1126/science.1251336			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24762535				2022-12-28	WOS:000336233800046
J	Ding, T; Schloss, PD				Ding, Tao; Schloss, Patrick D.			Dynamics and associations of microbial community types across the human body	NATURE			English	Article							VAGINAL MICROBIOME; GUT MICROBIOME; SEX	A primary goal of the Human Microbiome Project (HMP) was to provide a reference collection of 16S ribosomal RNA gene sequences collected from sites across the human body that would allow micro-biologists to better associate changes in the microbiome with changes in health(1). The HMP Consortium has reported the structure and function of the human microbiome in 300 healthy adults at 18 body sites from a single time point(2,3). Using additional data collected over the course of 12-18 months, we used Dirichlet multinomial mixture models(4) to partition the data into community types for each body site and made three important observations. First, there were strong associations between whether individuals had been breastfed as an infant, their gender, and their level of education with their community types at several body sites. Second, although the specific taxonomic compositions of the oral and gut microbiomes were different, the community types observed at these sites were predictive of each other. Finally, over the course of the sampling period, the community types from sites within the oral cavity were the least stable, whereas those in the vagina and gut were the most stable. Our results demonstrate that even with the considerable intra-and interpersonal variation in the human microbiome, this variation can be partitioned into community types that are predictive of each other and are probably the result of life-history characteristics. Understanding the diversity of community types and the mechanisms that result in an individual having a particular type or changing types, will allow us to use their community types to assess disease risk and to personalize therapies.	[Ding, Tao; Schloss, Patrick D.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Schloss, PD (corresponding author), Univ Michigan, Dept Microbiol & Immunol, 1500 W Med Ctr, Ann Arbor, MI 48109 USA.	pschloss@umich.edu		Ding, Tao/0000-0002-2200-0496; Schloss, Patrick/0000-0002-6935-4275	National Institutes of Health [R01HG005975, R01GM099514, P30DK034933]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099514] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Crabtree of the HMP Data Analysis and Coordination Center for his assistance in obtaining the sequencing and metadata files. The analysis described in this study was supported by grants from the National Institutes of Health (R01HG005975, R01GM099514 and P30DK034933).	Aagaard K, 2013, FASEB J, V27, P1012, DOI 10.1096/fj.12-220806; Arumugam M, 2014, NATURE, V506, DOI 10.1038/nature13075; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Brotman RM, 2012, SEX TRANSM DIS, V39, P807, DOI 10.1097/OLQ.0b013e3182631c79; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Moeller AH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2159; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pantoja-Feliciano IG, 2013, ISME J, V7, P1112, DOI 10.1038/ismej.2013.15; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2013, GUT, V62, P952, DOI 10.1136/gutjnl-2012-304214; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Schloss PD, 2013, ISME J, V7, P457, DOI 10.1038/ismej.2012.102; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Statnikov A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02620; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344	32	491	524	9	421	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					357	+		10.1038/nature13178	http://dx.doi.org/10.1038/nature13178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24739969	Green Accepted			2022-12-28	WOS:000336121200038
J	Zollikofer, CPE; de Leon, MSP; Margvelashvili, A; Rightmire, GP; Lordkipanidze, D				Zollikofer, Christoph P. E.; de Leon, Marcia S. Ponce; Margvelashvili, Ann; Rightmire, G. Philip; Lordkipanidze, David			Response to Comment on "A Complete Skull from Dmanisi, Georgia, and the Evolutionary Biology of Early Homo"	SCIENCE			English	Editorial Material							MORPHOLOGICAL VARIATION; PREMOLAR; HOMINID		[Zollikofer, Christoph P. E.; de Leon, Marcia S. Ponce; Margvelashvili, Ann] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland; [Margvelashvili, Ann; Lordkipanidze, David] Georgian Natl Museum, Tbilisi, Georgia; [Rightmire, G. Philip] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA	University of Zurich; Harvard University	Zollikofer, CPE (corresponding author), Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland.	zolli@aim.uzh.ch; dlordkipanidze@museum.ge	Lordkipanidze, David/AAH-6472-2020; Margvelashvili, Ann/AAJ-8955-2020					Darwin C., 1877, ORIGIN SPECIES; Gabounia L, 2002, CR PALEVOL, V1, P243, DOI 10.1016/S1631-0683(02)00032-5; Garman S., 1885, NATURE, V31, P413; Goldschmidt R., 1940, MAT BASIS EVOLUTION; Lordkipanidze D, 2013, SCIENCE, V342, P326, DOI 10.1126/science.1238484; Margvelashvili A, 2013, P NATL ACAD SCI USA, V110, P17278, DOI 10.1073/pnas.1316052110; Moore NC, 2013, AM J PHYS ANTHROPOL, V150, P632, DOI 10.1002/ajpa.22239; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Schwartz JH, 2014, SCIENCE, V344, DOI 10.1126/science.1250056; Schwartz JH, 2000, SCIENCE, V289, P55; Schwartz JH, 2003, SCIENCE, V301, P763; Shields ED, 2005, AM J PHYS ANTHROPOL, V128, P299, DOI 10.1002/ajpa.20110; Spoor F, 2013, NATURE, V502, P452, DOI 10.1038/502452a; White TD, 2003, SCIENCE, V301, P763	14	12	13	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182								10.1126/science.1250081	http://dx.doi.org/10.1126/science.1250081			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763573				2022-12-28	WOS:000334867800020
J	Ginsburg, G				Ginsburg, Geoffrey			Gather and use genetic data in health care	NATURE			English	Editorial Material							GENOMIC MEDICINE; WARFARIN		Duke Univ, Durham, NC 27706 USA	Duke University	Ginsburg, G (corresponding author), Duke Univ, Durham, NC 27706 USA.	geoffrey.ginsburg@duke.edu						Gilfillan RJ, 2010, AM J MANAG CARE, V16, P607; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Kimmel SE, 2013, NEW ENGL J MED, V369, P2283, DOI 10.1056/NEJMoa1310669; Lynch JA, 2013, GENET MED, V15, P630, DOI 10.1038/gim.2013.5; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Manolio TA, 2013, GENET MED, V15, P258, DOI 10.1038/gim.2012.157; Pirmohamed M, 2013, NEW ENGL J MED, V369, P2294, DOI 10.1056/NEJMoa1311386; Van Driest SL, 2014, CLIN PHARMACOL THER, V95, P423, DOI 10.1038/clpt.2013.229; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122	10	35	36	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					451	453		10.1038/508451a	http://dx.doi.org/10.1038/508451a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF5GI	24765668	Bronze			2022-12-28	WOS:000334741600011
J	Papa, A; Wan, LX; Bonora, M; Salmena, L; Song, MS; Hobbs, RM; Lunardi, A; Webster, K; Ng, C; Newton, RH; Knoblauch, N; Guarnerio, J; Ito, K; Turka, LA; Beck, AH; Pinton, P; Bronson, RT; Wei, WY; Pandolfi, PP				Papa, Antonella; Wan, Lixin; Bonora, Massimo; Salmena, Leonardo; Song, Min Sup; Hobbs, Robin M.; Lunardi, Andrea; Webster, Kaitlyn; Ng, Christopher; Newton, Ryan H.; Knoblauch, Nicholas; Guarnerio, Jlenia; Ito, Keisuke; Turka, Laurence A.; Beck, Andy H.; Pinton, Paolo; Bronson, Roderick T.; Wei, Wenyi; Pandolfi, Pier Paolo			Cancer-Associated PTEN Mutants Act in a Dominant-Negative Manner to Suppress PTEN Protein Function	CELL			English	Article							LHERMITTE-DUCLOS-DISEASE; TUMOR-SUPPRESSOR; PHOSPHATASE-ACTIVITY; COWDEN-DISEASE; SOMA SIZE; GENE; MICE; MUTATIONS; PHOSPHORYLATION; SUSCEPTIBILITY	PTEN dysfunction plays a crucial role in the pathogenesis of hereditary and sporadic cancers. Here, we show that PTEN homodimerizes and, in this active conformation, exerts lipid phosphatase activity on PtdIns(3,4,5)P-3. We demonstrate that catalytically inactive cancer-associated PTEN mutants heterodimerize with wild-type PTEN and constrain its phosphatase activity in a dominant-negative manner. To study the consequences of homo-and heterodimerization of wild-type and mutant PTEN in vivo, we generated Pten knockin mice harboring two cancer-associated PTEN mutations (PtenC124S and PtenG129E). Heterozygous Pten(C124S/+) and Pten(G129E/+) cells and tissues exhibit increased sensitivity to PI3-K/Akt activation compared to wild-type and Pten(+/-) counterparts, whereas this difference is no longer apparent between Pten(C124S/-) and Pten(-/-) cells. Notably, Pten KI mice are more tumor prone and display features reminiscent of complete Pten loss. Our findings reveal that PTEN loss and PTEN mutations are not synonymous and define a working model for the function and regulation of PTEN.	[Papa, Antonella; Salmena, Leonardo; Song, Min Sup; Hobbs, Robin M.; Lunardi, Andrea; Webster, Kaitlyn; Ng, Christopher; Guarnerio, Jlenia; Ito, Keisuke; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med,Canc Res Inst, Beth Israel Deaconess Canc Ctr,Dept Med & Pathol, Boston, MA 02215 USA; [Wan, Lixin; Knoblauch, Nicholas; Beck, Andy H.; Wei, Wenyi] Harvard Univ, Dept Pathol, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02115 USA; [Bonora, Massimo; Pinton, Paolo] Univ Ferrara, Dept Morphol, Surg & Expt Med Sect Gen Pathol, I-44124 Ferrara, Italy; [Newton, Ryan H.; Turka, Laurence A.] Harvard Univ, Dept Med, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02115 USA; [Bronson, Roderick T.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Ferrara; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Pandolfi, PP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med,Canc Res Inst, Beth Israel Deaconess Canc Ctr,Dept Med & Pathol, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Pinton, Paolo/J-8025-2012; Bonora, Massimo/AAC-3609-2022; Hobbs, Robin/I-2577-2014	Pinton, Paolo/0000-0001-7108-6508; Bonora, Massimo/0000-0002-5752-3318; Pandolfi, Pier Paolo/0000-0002-5352-5295; Knoblauch, Nicholas/0000-0002-2890-6520; guarnerio, jlenia/0000-0001-7576-7095; Papa, Antonella/0000-0001-8653-7121; Salmena, Leonardo/0000-0003-4023-658X; Ng, Christopher/0000-0001-8815-7958; Hobbs, Robin/0000-0002-3853-2614; Webster, Kaitlyn/0000-0001-9902-0500	American-Italian Cancer Foundation Post-Doctoral Fellowship; Italian Association for Cancer Research [14442]; NIH [U01-CA 141496]; NATIONAL CANCER INSTITUTE [R00CA139009, R01CA082328, U01CA141496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098263, R01DK100689] Funding Source: NIH RePORTER	American-Italian Cancer Foundation Post-Doctoral Fellowship; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank Pandolfi lab members for critical comments and Thomas Garvey for editing the manuscript.The authors are indebted to SuJung Song and Dimitrios Anastosiou for insightful discussion.A.P.was supported in part by the American-Italian Cancer Foundation Post-Doctoral Fellowship.M.B.and P.P.are supported by the Italian Association for Cancer Research (AIRC, grant number 14442).This work was supported by NIH grant U01-CA 141496 to P.P.P.L.A.T.has a family member employed by, and owns equity in, Novartis.	Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; [Anonymous], 2012, J CELL BIOL; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Bai F, 2006, MOL CELL BIOL, V26, P4564, DOI 10.1128/MCB.00266-06; Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Fraser MM, 2004, CANCER RES, V64, P7773, DOI 10.1158/0008-5472.CAN-04-2487; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Hopkins BD, 2013, SCIENCE, V341, P399, DOI 10.1126/science.1234907; Kato H, 2000, CLIN CANCER RES, V6, P3937; Koksal AC, 2011, J BIOL CHEM, V286, P14373, DOI 10.1074/jbc.M111.226357; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Leslie NR, 2011, TRENDS PHARMACOL SCI, V32, P131, DOI 10.1016/j.tips.2010.12.005; Li J, 2013, NAT METHODS, V10, P1046, DOI [10.1038/nmeth.2650, 10.1038/NMETH.2650]; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Putz U, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003084; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Sotelo NS, 2012, J CELL BIOCHEM, V113, P2661, DOI 10.1002/jcb.24141; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Tamura M, 1999, CANCER RES, V59, P442; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Wang H, 2010, P NATL ACAD SCI USA, V107, P5142, DOI 10.1073/pnas.0912524107; Wang X, 2008, ONCOGENE, V27, P5454, DOI 10.1038/onc.2008.242; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309	42	194	203	0	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					595	610		10.1016/j.cell.2014.03.027	http://dx.doi.org/10.1016/j.cell.2014.03.027			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766807	Green Accepted, Bronze			2022-12-28	WOS:000335392100010
J	Tomassy, GS; Berger, DR; Chen, HH; Kasthuri, N; Hayworth, KJ; Vercelli, A; Seung, HS; Lichtman, JW; Arlotta, P				Tomassy, Giulio Srubek; Berger, Daniel R.; Chen, Hsu-Hsin; Kasthuri, Narayanan; Hayworth, Kenneth J.; Vercelli, Alessandro; Seung, H. Sebastian; Lichtman, Jeff W.; Arlotta, Paola			Distinct Profiles of Myelin Distribution Along Single Axons of Pyramidal Neurons in the Neocortex	SCIENCE			English	Article							MOUSE; OLIGODENDROCYTE; SCRAMBLER; CORTEX; BRAIN; MOTOR	Myelin is a defining feature of the vertebrate nervous system. Variability in the thickness of the myelin envelope is a structural feature affecting the conduction of neuronal signals. Conversely, the distribution of myelinated tracts along the length of axons has been assumed to be uniform. Here, we traced high-throughput electron microscopy reconstructions of single axons of pyramidal neurons in the mouse neocortex and built high-resolution maps of myelination. We find that individual neurons have distinct longitudinal distribution of myelin. Neurons in the superficial layers displayed the most diversified profiles, including a new pattern where myelinated segments are interspersed with long, unmyelinated tracts. Our data indicate that the profile of longitudinal distribution of myelin is an integral feature of neuronal identity and may have evolved as a strategy to modulate long-distance communication in the neocortex.	[Tomassy, Giulio Srubek; Chen, Hsu-Hsin; Arlotta, Paola] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Berger, Daniel R.; Kasthuri, Narayanan; Hayworth, Kenneth J.; Lichtman, Jeff W.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Berger, Daniel R.; Seung, H. Sebastian] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Vercelli, Alessandro] Neurosci Inst Turin, Neurosci Inst Cavalieri Ottolenghi, I-10126 Turin, Italy	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT)	Arlotta, P (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	paola_arlotta@harvard.edu	Vercelli, Alessandro/A-1926-2012	Vercelli, Alessandro/0000-0002-5909-2128	Howard Hughes Medical Institute; Human Frontier Science Program; Gatsby Foundation; NIH [NS062849, NS078164]; New York Stem Cell Foundation; Harvard Stem Cell Institute; Conte Centers for Basic and Translational Mental Health Research, National Institute for Mental Health, NIH [1P50MH094271]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB016411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062849, R01NS078164, U01NS090449] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Human Frontier Science Program(Human Frontier Science Program); Gatsby Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; Harvard Stem Cell Institute; Conte Centers for Basic and Translational Mental Health Research, National Institute for Mental Health, NIH; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to S. Lodato, C. Rouaux, B. Sannino, and all members of the Arlotta laboratory for insightful discussions and comments on the manuscript. We thank, in particular, Z. Trayes-Gibson for outstanding technical support; J. Macklis and W. Richardson for sharing riboprobes; and M. Gotz and S. Cappello for sharing tissue from the Emx1-Cre; RhoA<SUP>fl/fl</SUP> line. D. R. B. and H. S. S. were supported by the Howard Hughes Medical Institute, the Human Frontier Science Program, and the Gatsby Foundation. This work was supported by grants from NIH (NS062849 and NS078164), the New York Stem Cell Foundation, and the Harvard Stem Cell Institute to P. A. and Silvio O. Conte Centers for Basic and Translational Mental Health Research, National Institute for Mental Health, NIH (1P50MH094271); P. A. is a New York Stem Cell Foundation-Robertson Investigator.	Barres BA, 1999, J CELL BIOL, V147, P1123, DOI 10.1083/jcb.147.6.1123; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Cappello S, 2012, NEURON, V73, P911, DOI 10.1016/j.neuron.2011.12.030; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; FAIREN A, 1977, J NEUROCYTOL, V6, P311, DOI 10.1007/BF01175194; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; HILDEBRAND C, 1993, PROG NEUROBIOL, V40, P319, DOI 10.1016/0301-0082(93)90015-K; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lang J, 2013, J NEUROSCI, V33, P3113, DOI 10.1523/JNEUROSCI.3467-12.2013; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Molyneaux BJ, 2009, J NEUROSCI, V29, P12343, DOI 10.1523/JNEUROSCI.6108-08.2009; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Ramon y Cajal S, 1995, HISTOLOGY NERVOUS SY; SLOPER JJ, 1979, PHILOS T R SOC B, V285, P173, DOI 10.1098/rstb.1979.0004; SLOPER JJ, 1979, PHILOS T R SOC B, V285, P123, DOI 10.1098/rstb.1979.0002; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; Sweet HO, 1996, MAMM GENOME, V7, P798, DOI 10.1007/s003359900240; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8	25	322	322	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					319	324		10.1126/science.1249766	http://dx.doi.org/10.1126/science.1249766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744380	Green Accepted			2022-12-28	WOS:000334474500041
J	Friedman, LS; Simmons, LH; Goldman, RH; Sohani, AR				Friedman, Lawrence S.; Simmons, Leigh H.; Goldman, Rose H.; Sohani, Aliyah R.			Case 12-2014: A 59-Year-Old Man with Fatigue, Abdominal Pain, Anemia, and Abnormal Liver Function	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD LEAD; HEMOCHROMATOSIS; ASSOCIATION; PORPHYRIAS; POPULATION; EXPOSURE; GENE	A 59-year-old man was admitted to the hospital because of fatigue, abdominal pain, new anemia, arthralgias, abnormal liver function, and emotional lability. A peripheral-blood smear showed polychromasia and coarse basophilic stippling of erythrocytes. Presentation of CaseDr. Laura D. Flannery (Medicine): A 59-year-old man was seen in an outpatient clinic at this hospital because of fatigue, abdominal pain, anemia, arthralgias, and abnormal liver function. The patient had been in his usual state of health until approximately 3 days before presentation, when epigastric distress and ankle edema occurred. He also reported increased personal stress, difficulty sleeping, dysgeusia, and nausea. On presentation in an outpatient clinic at this hospital, he reported epigastric pain that he rated at 6 on a scale of 0 to 10 (with 10 indicating the most severe pain) and no weight ...	[Friedman, Lawrence S.; Simmons, Leigh H.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Sohani, Aliyah R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Friedman, Lawrence S.; Simmons, Leigh H.; Goldman, Rose H.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Sohani, Aliyah R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Friedman, Lawrence S.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Friedman, Lawrence S.] Newton Wellesley Hosp, Dept Med, Newton, MA USA; [Goldman, Rose H.] Cambridge Hlth Alliance, Dept Med, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Tufts University; Newton Wellesley Hospital; Harvard University; Cambridge Health Alliance	Friedman, LS (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Simmons, Leigh/AAQ-3009-2021	Simmons, Leigh/0000-0002-2375-8485	New England Research Institutes	New England Research Institutes	Dr. Simmons reports receiving consulting fees from the New England Research Institutes, and Dr. Goldman serving as a paid expert witness in legal cases related to occupational and environmental health. No other potential conflict of interest relevant to this article was reported.	Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Ahamed M, 2005, SCI TOTAL ENVIRON, V346, P48, DOI 10.1016/j.scitotenv.2004.12.019; Anderson KE, 2005, ANN INTERN MED, V142, P439, DOI 10.7326/0003-4819-142-6-200503150-00010; [Anonymous], 2012, MMWR MORB MORTAL WKL, V61, P641; [Anonymous], 2011, MMWR MORB MORTAL WKL, V60, P841; Bonkovsky HL, 2013, COMPR PHYSIOL, V3, P365, DOI 10.1002/cphy.c120006; Fischbein A, 2007, ENV OCCUPATIONAL MED, P954; Flora Gagan, 2012, Interdiscip Toxicol, V5, P47, DOI 10.2478/v10102-012-0009-2; Fuller SJ, 2013, HEMATOLOGY BASIC PRI, P457; Glassy EF, 1998, COLOR ATLAS HEMATOLO; Goldman RH, 2013, ADULT LEAD POISONING; Kamar N, 2011, EMERG INFECT DIS, V17, P173, DOI 10.3201/eid1702.100856; Khalil N, 2009, NEUROPSYCHOLOGY, V23, P10, DOI 10.1037/a0013757; Lyon E, 2001, CLIN CHEM, V47, P1147; Martin D, 2006, AM J EPIDEMIOL, V163, P467, DOI 10.1093/aje/kwj060; Millham FH, 2010, SEISENGER FORDTRANS, P151; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; Patrick L, 2006, ALTERN MED REV, V11, P2; Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5; Saper RB, 2008, JAMA-J AM MED ASSOC, V300, P915, DOI 10.1001/jama.300.8.915; Sassa S, 1998, SEMIN LIVER DIS, V18, P95, DOI 10.1055/s-2007-1007145; SCHIFFMAN SS, 1983, NEW ENGL J MED, V308, P1275; VALENTINE WN, 1976, J CLIN INVEST, V58, P926, DOI 10.1172/JCI108545; Won KY, 2008, AM J TROP MED HYG, V79, P552, DOI 10.4269/ajtmh.2008.79.552; 2004, MMWR MORB MORTAL WKL, V53, P582	25	10	12	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 17	2014	370	16					1542	1550		10.1056/NEJMcpc1314242	http://dx.doi.org/10.1056/NEJMcpc1314242			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF3HE	24738672				2022-12-28	WOS:000334601600012
J	Clauw, DJ				Clauw, Daniel J.			Fibromyalgia A Clinical Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIALS; CHRONIC PAIN PATIENTS; LOW-DOSE NALTREXONE; DOUBLE-BLIND; CENTRAL SENSITIZATION; RHEUMATOID-ARTHRITIS; DIAGNOSTIC-CRITERIA; SERVICE UTILIZATION; METAANALYSIS; MANAGEMENT	IMPORTANCE Fibromyalgia is present in as much as 2% to 8% of the population, is characterized by widespread pain, and is often accompanied by fatigue, memory problems, and sleep disturbances. OBJECTIVE To review the epidemiology, pathophysiology, diagnosis, and treatment of fibromyalgia. EVIDENCE REVIEW The medical literature on fibromyalgia was reviewed from 1955 to March 2014 via MEDLINE and the Cochrane Central Registry of Controlled Trials, with an emphasis on meta-analyses and contemporary evidence-based treatment guidelines. Treatment recommendations are based on the most recent evidence-based guidelines from the Canadian Pain Society and graded from 1 to 5 based on the level of available evidence. FINDINGS Numerous treatments are available for managing fibromyalgia that are supported by high-quality evidence. These include nonpharmacological therapies (education, exercise, cognitive behavioral therapy) and pharmacological therapies (tricyclics, serotonin norepinephrine reuptake inhibitors, and gabapentinoids). CONCLUSIONS AND RELEVANCE Fibromyalgia and other "centralized" pain states are much better understood now than ever before. Fibromyalgia may be considered as a discrete diagnosis or as a constellation of symptoms characterized by central nervous system pain amplification with concomitant fatigue, memory problems, and sleep and mood disturbances. Effective treatment for fibromyalgia is now possible.	[Clauw, Daniel J.] Univ Michigan, Chron Pain & Fatigue Res Ctr, Ann Arbor, MI 48106 USA	University of Michigan System; University of Michigan	Clauw, DJ (corresponding author), Univ Michigan, 24 Frank Lloyd Wright Dr,POB 385, Ann Arbor, MI 48106 USA.	dclauw@med.umich.edu			Pfizer; Forest; Merck; Nuvo; Cerephex	Pfizer(Pfizer); Forest; Merck(Merck & Company); Nuvo; Cerephex	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Clauw has performed consulting and/or served on scientific advisory boards for Pfizer, Lilly, Forest Laboratories, Johnson & Johnson, Purdue Pharma, Nuvo, Cerephex, Tonix, Iroko, and Takeda. He has received grant support from Pfizer, Forest, Merck, Nuvo, and Cerephex.	Aaron LA, 2001, ANN INTERN MED, V134, P868, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00011; Affaitati G, 2011, EUR J PAIN, V15, P61, DOI 10.1016/j.ejpain.2010.09.002; Allaire S, 2009, ARTHRIT RHEUM-ARTHR, V61, P321, DOI 10.1002/art.24281; Annemans L, 2008, ARTHRITIS RHEUM-US, V58, P895, DOI 10.1002/art.23265; Arnold LM, 2007, PAIN MED, V8, pS63, DOI 10.1111/j.1526-4637.2006.00178.x; Arnold Lesley M, 2009, Prim Care Companion J Clin Psychiatry, V11, P237, DOI 10.4088/PCC.08m00680; Arnold LM, 2012, ARTHRITIS RHEUM-US, V64, P2387, DOI 10.1002/art.34390; Arnold LM, 2000, PSYCHOSOMATICS, V41, P104, DOI 10.1176/appi.psy.41.2.104; Arnold LM, 2004, ARTHRITIS RHEUM-US, V50, P944, DOI 10.1002/art.20042; Arnold LM, 2002, AM J MED, V112, P191, DOI 10.1016/S0002-9343(01)01089-0; Bernardy K, 2010, J RHEUMATOL, V37, P1991, DOI 10.3899/jrheum.100104; Brummett CM, 2013, ANESTHESIOLOGY, V119, P1434, DOI 10.1097/ALN.0b013e3182a8eb1f; Buskila D, 2008, AUTOIMMUN REV, V8, P41, DOI 10.1016/j.autrev.2008.07.023; Caro XJ, 2008, RHEUMATOLOGY, V47, P208, DOI 10.1093/rheumatology/kem345; Chandran AB, 2012, NURS RES, V61, P363, DOI 10.1097/NNR.0b013e318259b6cc; Clauw DJ, 2010, NAT REV RHEUMATOL, V6, P439, DOI 10.1038/nrrheum.2010.120; Cook DB, 2004, J RHEUMATOL, V31, P364; Fishbain D, 2000, ANN MED, V32, P305, DOI 10.3109/07853890008995932; Fitzcharles MA, 2013, J RHEUMATOL, V40, P1388, DOI 10.3899/jrheum.130127; Fitzcharles MA, 2013, PAIN RES MANAG, V18, P119, DOI 10.1155/2013/918216; Fitzcharles MA, 2012, ARTHRITIS RHEUM-US, V64, P2417, DOI 10.1002/art.34522; Foerster BR, 2012, ARTHRITIS RHEUM-US, V64, P579, DOI 10.1002/art.33339; Geisser ME, 2011, PAIN PRACT, V11, P120, DOI 10.1111/j.1533-2500.2010.00403.x; Goldenberg DL, 2004, JAMA-J AM MED ASSOC, V292, P2388, DOI 10.1001/jama.292.19.2388; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; Hadler NM, 1996, SPINE, V21, P2397, DOI 10.1097/00007632-199610150-00021; Hauser W, 2012, CNS DRUGS, V26, P297, DOI 10.2165/11598970-000000000-00000; Hauser W, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3002; Hauser W, 2010, J PAIN, V11, P505, DOI 10.1016/j.jpain.2010.01.002; Hauser W, 2009, PAIN, V145, P69, DOI 10.1016/j.pain.2009.05.014; Hauser W, 2009, ARTHRIT RHEUM-ARTHR, V61, P216, DOI 10.1002/art.24276; Hargrove JB, 2012, PAIN MED, V13, P115, DOI 10.1111/j.1526-4637.2011.01292.x; Harris RE, 2007, J NEUROSCI, V27, P10000, DOI 10.1523/JNEUROSCI.2849-07.2007; Harris RE, 2013, ANESTHESIOLOGY, V119, P1453, DOI 10.1097/ALN.0000000000000017; Harris RE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3136; Harris Richard E, 2006, Curr Pain Headache Rep, V10, P403, DOI 10.1007/s11916-006-0069-0; Holliday KL, 2011, CURR RHEUMATOL REP, V13, P521, DOI 10.1007/s11926-011-0208-4; HUDSON JI, 1994, BAILLIERE CLIN RHEUM, V8, P839, DOI 10.1016/S0950-3579(05)80051-2; Kato K, 2009, PSYCHOL MED, V39, P497, DOI 10.1017/S0033291708003784; Kroenke K, 2009, GEN HOSP PSYCHIAT, V31, P206, DOI 10.1016/j.genhosppsych.2008.12.006; Lee YC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3306; Lewis JD, 2012, NEUROREHABILITATION, V31, P367, DOI 10.3233/NRE-2012-00805; Lynch ME, 2011, BRIT J CLIN PHARMACO, V72, P735, DOI 10.1111/j.1365-2125.2011.03970.x; McBeth J, 2007, BEST PRACT RES CL RH, V21, P403, DOI 10.1016/j.berh.2007.03.003; McLean SA, 2011, J PAIN, V12, P101, DOI 10.1016/j.jpain.2010.05.008; Mist SD, 2013, J PAIN RES, V6, P247, DOI 10.2147/JPR.S32297; Nakao M, 2007, BIOPSYCHOSOC MED, V1, DOI 10.1186/1751-0759-1-17; Phillips K, 2013, ARTHRITIS RHEUM-US, V65, P291, DOI 10.1002/art.37739; Porter NS, 2010, J ALTERN COMPLEM MED, V16, P235, DOI 10.1089/acm.2008.0376; Russell IJ, 2011, PAIN, V152, P1007, DOI 10.1016/j.pain.2010.12.022; Skrabek RQ, 2008, J PAIN, V9, P164, DOI 10.1016/j.jpain.2007.09.002; Tracey I, 2009, J PAIN, V10, P1113, DOI 10.1016/j.jpain.2009.09.001; Tzellos TG, 2010, J CLIN PHARM THER, V35, P639, DOI 10.1111/j.1365-2710.2009.01144.x; Vincent A, 2013, ARTHRIT CARE RES, V65, P786, DOI 10.1002/acr.21896; Warren JW, 2009, UROLOGY, V73, P52, DOI 10.1016/j.urology.2008.06.031; White KP, 2002, ARTHRIT RHEUM-ARTHR, V47, P260, DOI 10.1002/art.10400; Williams DA, 2002, J RHEUMATOL, V29, P1280; Williams DA, 2010, PAIN, V151, P694, DOI 10.1016/j.pain.2010.08.034; Williams DA, 2009, J PAIN, V10, P777, DOI 10.1016/j.jpain.2009.06.001; Williams JA, 2009, J REHABIL MED, V41, P305, DOI 10.2340/16501977-0356; Wolfe F, 1997, ANN RHEUM DIS, V56, P268, DOI 10.1136/ard.56.4.268; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 1997, ARTHRITIS RHEUM, V40, P1560, DOI 10.1002/art.1780400904; Wolfe F, 2011, ARTHRIT CARE RES, V63, P1073, DOI 10.1002/acr.20468; Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Wolfe F, 2009, ARTHRIT RHEUM-ARTHR, V61, P715, DOI 10.1002/art.24553; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Younger J, 2013, ARTHRITIS RHEUM-US, V65, P529, DOI 10.1002/art.37734; Younger J, 2009, PAIN MED, V10, P663, DOI 10.1111/j.1526-4637.2009.00613.x	71	823	861	16	212	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2014	311	15					1547	1555		10.1001/jama.2014.3266	http://dx.doi.org/10.1001/jama.2014.3266			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9DX	24737367				2022-12-28	WOS:000334306000022
J	Lang, E				Lang, Eddy			4F-PCC was noninferior to plasma in patients with acute major bleeding who needed urgent VKA reversal	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calgary, Calgary, AB, Canada	University of Calgary	Lang, E (corresponding author), Univ Calgary, Calgary, AB, Canada.		Lang, Eddy/AAS-2080-2020; Lang, Eddy/I-4759-2014	Lang, Eddy/0000-0003-0850-4337				de Groot NL, 2012, ENDOSCOPY, V44, P731, DOI 10.1055/s-0032-1309361	1	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2014	160	8							JC6	10.7326/0003-4819-160-8-201404150-02006	http://dx.doi.org/10.7326/0003-4819-160-8-201404150-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW3QU	24733223				2022-12-28	WOS:000364907600005
J	Nand, B				Nand, Bela			Doctors should be taught to consider the cost of their practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICIANS; CARE		Advocate Christ Med Ctr, Internal Med Residency Program, Oak Lawn, IL 60453 USA		Nand, B (corresponding author), Advocate Christ Med Ctr, Internal Med Residency Program, Oak Lawn, IL 60453 USA.	belanand@hotmail.com						Brody H, 2012, NEW ENGL J MED, V366, P1949, DOI 10.1056/NEJMp1203365; Brody H, 2010, NEW ENGL J MED, V362, P283, DOI 10.1056/NEJMp0911423; Cooke M, 2006, NEW ENGL J MED, V355, P1339, DOI 10.1056/NEJMra055445; Dine CJ, 2013, ACAD INTERNAL MED IN, V11, P1; Fox S, 2012, MEDSCAPE MED NEWS; JONSEN AR, 1982, CLIN ETHICS; Mechanic R, 1998, JAMA-J AM MED ASSOC, V280, P1015, DOI 10.1001/jama.280.11.1015; Medicare Payment Advisory Commission (MedPAC), 2009, REP C IMPR INC MED P; Roberts John L, 2011, J Grad Med Educ, V3, P155, DOI 10.4300/JGME-D-10-00122.1; Rosenbaum L, 2012, NEW ENGL J MED, V367, P99, DOI 10.1056/NEJMp1205634; Weinberger SE, 2011, ANN INTERN MED, V155, P386, DOI 10.7326/0003-4819-155-6-201109200-00007	11	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2014	348								g2629	10.1136/bmj.g2629	http://dx.doi.org/10.1136/bmj.g2629			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF5GS	24740908				2022-12-28	WOS:000334742600007
J	Spencer, RJ; Sugumar, H; Jones, E; Farouque, O				Spencer, Ryan J.; Sugumar, Hariharan; Jones, Elizabeth; Farouque, Omar			Commotio cordis: a case of ventricular fibrillation caused by a cricket ball strike to the chest	LANCET			English	Editorial Material									[Spencer, Ryan J.; Sugumar, Hariharan; Jones, Elizabeth; Farouque, Omar] Austin Hlth, Dept Cardiol, Heidelberg, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Spencer, RJ (corresponding author), Austin Hlth, Dept Cardiol, Austin Tower,145 Studley Rd, Heidelberg, Vic, Australia.	drryanspencer@gmail.com	Sugumar, Hariharan/AAK-8754-2021					Douglas RJ, 2011, WORLD J EMERG MED, V2, P234, DOI 10.5847/wjem.j.1920-8642.2011.03.015; Link MS, 1998, NEW ENGL J MED, V338, P1805, DOI 10.1056/NEJM199806183382504; Maron BJ, 2013, HEART RHYTHM, V10, P219, DOI 10.1016/j.hrthm.2012.10.034; Maron BJ, 2010, NEW ENGL J MED, V362, P917, DOI 10.1056/NEJMra0910111; McGrath AC, 1996, CRIT REV, V105, P1	5	4	4	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 12	2014	383	9925					1358	1358		10.1016/S0140-6736(14)60486-4	http://dx.doi.org/10.1016/S0140-6736(14)60486-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6LQ	24725579				2022-12-28	WOS:000334104900034
J	Loxterkamp, D				Loxterkamp, David			LETTER FROM NEW ENGLAND Staying ahead of getting behind: reflections on "scarcity"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Seaport Community Hlth Ctr, Belfast, ME 04915 USA		Loxterkamp, D (corresponding author), Seaport Community Hlth Ctr, Belfast, ME 04915 USA.	david.loxterkamp@gmail.com						Mullainathan S., 2013, TIMES BOOKS	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 10	2014	348								g2634	10.1136/bmj.g2634	http://dx.doi.org/10.1136/bmj.g2634			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SG	24721750				2022-12-28	WOS:000334348900006
J	Cole, TB				Cole, Thomas B.			Dazzle-ships in Drydock at Liverpool	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2014	311	14					1382	1383		10.1001/jama.2013.279432	http://dx.doi.org/10.1001/jama.2013.279432			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4EP	24715062				2022-12-28	WOS:000333935000001
J	Weaver, T; Metrebian, N; Hellier, J; Pilling, S; Charles, V; Little, N; Poovendran, D; Mitcheson, L; Ryan, F; Bowden-Jones, O; Dunn, J; Glasper, A; Finch, E; Strang, J				Weaver, Tim; Metrebian, Nicola; Hellier, Jennifer; Pilling, Stephen; Charles, Vikki; Little, Nicholas; Poovendran, Dilkushi; Mitcheson, Luke; Ryan, Frank; Bowden-Jones, Owen; Dunn, John; Glasper, Anthony; Finch, Emily; Strang, John			Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial	LANCET			English	Article							INJECTING DRUG-USERS; USE DISORDERS; TUBERCULOSIS; ADHERENCE; INTERVENTIONS; PREVENTION; OUTREACH; THERAPY; ENGLAND	Background Poor adherence to treatment diminishes its individual and public health benefit. Financial incentives, provided on the condition of treatment attendance, could address this problem. Injecting drug users are a high-risk group for hepatitis B virus (HBV) infection and transmission, but adherence to vaccination programmes is poor. We aimed to assess whether contingency management delivered in routine clinical practice increased the completion of HBV vaccination in individuals receiving opioid substitution therapy. Methods In our cluster randomised controlled trial, we enrolled participants at 12 National Health Service drug treatment services in the UK that provided opioid substitution therapy and nurse-led HBV vaccination with a super-accelerated schedule (vaccination days 0, 7, and 21). Clusters were randomly allocated 1:1:1 to provide vaccination without incentive (treatment as usual), with fixed value contingency management (three 10 pound vouchers), or escalating value contingency management (5 pound, 10 pound, and 15 pound vouchers). Both contingency management schedules rewarded on-time attendance at appointments. The primary outcome was completion of clinically appropriate HBV vaccination within 28 days. We also did sensitivity analyses that examined vaccination completion with full adherence to appointment times and within a 3 month window. The trial is registered with Current Controlled Trials, number ISRCTN72794493. Findings Between March 16, 2011, and April 26, 2012, we enrolled 210 eligible participants. Compared with six (9%) of 67 participants treated as usual, 35 (45%) of 78 participants in the fixed value contingency management group met the primary outcome measure (odds ratio 12.1, 95% CI 3.7-39.9; p<0.0001), as did 32 (49%) of 65 participants in the escalating value contingency management group (14.0,4.2-46.2; p<0.0001). These differences remained significant with sensitivity analyses. Interpretation Modest financial incentives delivered in routine clinical practice significantly improve adherence to, and completion of, HBV vaccination programmes in patients receiving opioid substitution therapy. Achievement of this improvement in routine clinical practice should now prompt actual implementation. Drug treatment providers should employ contingency management to promote adherence to vaccination programmes. The effectiveness of routine use of contingency management to achieve long-term behaviour change remains unknown. Funding National Institute for Health Research (RP-PG-0707-10149).	[Weaver, Tim; Poovendran, Dilkushi] Univ London Imperial Coll Sci Technol & Med, Ctr Mental Hlth, London, England; [Metrebian, Nicola; Charles, Vikki; Strang, John] Kings Coll London, Inst Psychiat, Natl Addict Ctr, London SE5 8BB, England; [Hellier, Jennifer] Kings Coll London, Inst Psychiat, Dept Biostat, Kings Clin Trials Unit, London SE5 8BB, England; [Pilling, Stephen; Little, Nicholas] UCL, Res Dept Clin Educ & Hlth Psychol, London, England; [Mitcheson, Luke; Finch, Emily; Strang, John] South London & Maudsley NHS Fdn Trust, London, England; [Ryan, Frank; Dunn, John] Camden & Islington NHS Fdn Trust, London, England; [Bowden-Jones, Owen] Cent & North West London NHS Fdn Trust, London, England; [Glasper, Anthony] Sussex NHS Fdn Trust, Worthing, England	Imperial College London; University of London; King's College London; University of London; King's College London; University of London; University College London; South London & Maudsley NHS Trust	Strang, J (corresponding author), Kings Coll London, Natl Addict Ctr, Addict Sci Bldg,4 Windsor Walk,Denmark Hill, London SE5 8BB, England.	john.strang@kcl.ac.uk	Strang, John/H-5460-2011	Strang, John/0000-0002-5413-2725; Weaver, Tim/0000-0002-3437-3556; Little, Nicholas/0000-0001-5419-0100; Hellier, Jennifer/0000-0003-1760-3708; Poovendran, Dilkushi/0000-0002-9919-2932	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme [RP-PG-0707-10149]; NIHR Biomedical Research Centre for Mental Health at South London; Maudsley NHS Foundation Trust; Mental Health Research Network; King's College London; National Institute for Health Research [RP-PG-0707-10149] Funding Source: researchfish	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre for Mental Health at South London; Maudsley NHS Foundation Trust; Mental Health Research Network; King's College London; National Institute for Health Research(National Institute for Health Research (NIHR))	This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (grant reference number RP-PG-0707-10149). The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, or the Department of Health. JS and JH are in part supported by the NIHR Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust and King's College London. JH is a member of the King's Clinical Trials Unit. The trial was supported by the Mental Health Research Network and we are extremely grateful for the sterling efforts of all the Clinical Studies Offices from the North and South London Hubs who worked on the trial and helped us achieve our recruitment targets. We also gratefully acknowledge the support and guidance of members of our Trial Steering Committee (Simon Coulton [Chair], Christopher Whiteley, and Soraya Mayet) and our Data Management and Ethics Committee (Louise Sell [Chair], Anne R Lingford-Hughes, and Zoe Hoare). Finally, we thank the patients who took part in the study and all the staff in the participating services who gave their time so generously to recruit patients to the study and of course deliver the intervention.	[Anonymous], 2003, ADHERENCE LONG TERM; Banatvala J, 2000, LANCET, V355, P561, DOI 10.1016/S0140-6736(99)07239-6; Batki SL, 2002, DRUG ALCOHOL DEPEN, V66, P283, DOI 10.1016/S0376-8716(01)00208-3; Brim N, 2007, EXPERT OPIN BIOL TH, V7, P379, DOI 10.1517/14712598.7.3.379; Campbell MK, 2000, FAM PRACT, V17, P192, DOI 10.1093/fampra/17.2.192; Chaisson RE, 2001, AM J MED, V110, P610, DOI 10.1016/S0002-9343(01)00695-7; DARKE S, 1992, BRIT J ADDICT, V87, P733; Department of Health Scottish Government Welsh Assembly Government Northern Ireland Executive, 2007, DRUG MIS DEP UK GUID; Des Jarlais DC, 2001, AM J PUBLIC HEALTH, V91, P1791, DOI 10.2105/AJPH.91.11.1791; Eldridge SM, 2006, INT J EPIDEMIOL, V35, P1292, DOI 10.1093/ije/dyl129; Gossop M, 2001, DRUG ALCOHOL DEPEN, V62, P255, DOI 10.1016/S0376-8716(00)00211-8; Higgins S.T., 2008, CONTINGENCY MANAGEME; Hope VD, 2007, J VIRAL HEPATITIS, V14, P653, DOI 10.1111/j.1365-2893.2007.00856.x; Judd A, 2007, J VIRAL HEPATITIS, V14, P584, DOI 10.1111/j.1365-2893.2007.00844.x; KAZDIN AE, 2000, BEHAV MODIFICATION A; Lamagni T L, 2001, Commun Dis Public Health, V4, P71; Lussier JP, 2006, ADDICTION, V101, P192, DOI 10.1111/j.1360-0443.2006.01311.x; Malotte CK, 2001, AM J PREV MED, V20, P103, DOI 10.1016/S0749-3797(00)00283-X; Marsden J, 2009, LANCET, V374, P1262, DOI 10.1016/S0140-6736(09)61420-3; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; NICE, 2007, DRUG MIS PSYCH INT C; Norton EC, 1996, J CONSULT CLIN PSYCH, V64, P919, DOI 10.1037/0022-006X.64.5.919; Petry NM, 2006, BRIT J PSYCHIAT, V189, P97, DOI 10.1192/bjp.bp.106.022293; Pilling S, 2007, BRIT MED J, V335, P203, DOI 10.1136/bmj.39265.639641.AD; Prendergast M, 2006, ADDICTION, V101, P1546, DOI 10.1111/j.1360-0443.2006.01581.x; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Seal KH, 2003, DRUG ALCOHOL DEPEN, V71, P127, DOI 10.1016/S0376-8716(03)00074-7; Sorensen JL, 2007, DRUG ALCOHOL DEPEN, V88, P54, DOI 10.1016/j.drugalcdep.2006.09.019; Stitzer ML, 2010, DRUG ALCOHOL DEPEN, V107, P76, DOI 10.1016/j.drugalcdep.2009.09.006; Strang J, 2012, LANCET, V379, P71, DOI 10.1016/S0140-6736(11)61674-7; Topp L, 2013, PREV MED, V57, P297, DOI 10.1016/j.ypmed.2013.04.013; Trubatch BN, 2000, AM J PUBLIC HEALTH, V90, P447, DOI 10.2105/AJPH.90.3.447; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; World Health Organization, 2012, PREV CONTR VIR HEP I; World Health Organization, 2012, POL BRIEF GUID PREV	36	59	59	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					153	163		10.1016/S0140-6736(14)60196-3	http://dx.doi.org/10.1016/S0140-6736(14)60196-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1YC	24725468	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000338921500034
J	Moniz, MH; Davis, MM; Chang, T				Moniz, Michelle H.; Davis, Matthew M.; Chang, Tammy			Attitudes About Mandated Coverage of Birth Control Medication and Other Health Benefits in a US National Sample	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Moniz, Michelle H.] Univ Michigan, Robert Wood Johnson Fdn, Clin Scholars Program, Ann Arbor, MI 48109 USA; [Davis, Matthew M.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Chang, Tammy] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA	Robert Wood Johnson Foundation (RWJF); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Moniz, MH (corresponding author), Univ Michigan, Robert Wood Johnson Fdn, Clin Scholars Program, 2800 Plymouth Rd,Bldg 10 G016, Ann Arbor, MI 48109 USA.	mmoniz@med.umich.edu		Chang, Tammy/0000-0002-3580-9438				Butler AS, 2009, REVIEW OF THE HHS FAMILY PLANNING PROGRAM: MISSION, MANAGEMENT, AND MEASUREMENT OF RESULTS, P1; Eckholm E., 2014, NEW YORK TIMES; Eilperin J., 2014, WASHINGTON POST; Gossett DR, 2013, JAMA-J AM MED ASSOC, V309, P1997, DOI 10.1001/jama.2013.4262; Public Religion Research Institute, 2012, SURV MAJ CATH THINK; Zimmer EA, 2013, JAMA-J AM MED ASSOC, V309, P1999, DOI 10.1001/jama.2013.3730	6	7	7	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2014	311	24					2539	2541		10.1001/jama.2014.4766	http://dx.doi.org/10.1001/jama.2014.4766			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ5VE	24756439	Bronze			2022-12-28	WOS:000337757000029
J	Zhou, YX; Zhu, SY; Cai, CZ; Yuan, PF; Li, CM; Huang, YY; Wei, WS				Zhou, Yuexin; Zhu, Shiyou; Cai, Changzu; Yuan, Pengfei; Li, Chunmei; Huang, Yanyi; Wei, Wensheng			High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells	NATURE			English	Article							CAPILLARY MORPHOGENESIS PROTEIN-2; ANTHRAX TOXIN; RECEPTOR; NUCLEASE; LETHALITY; CAS9	Targeted genome editing technologies are powerful tools for studying biology and disease, and have a broad range of research applications(1-7). In contrast to the rapid development of toolkits to manipulate individual genes, large-scale screening methods based on the complete loss of gene expression are only now beginning to be developed(8,9). Here we report the development of a focused CRISPR/Cas-based (clustered regularly interspaced short palindromic repeats/CRISPR-associated) lentiviral library in human cells and a method of gene identification based on functional screening and high-throughput sequencing analysis. Using knockout library screens, we successfully identified the host genes essential for the intoxication of cells by anthrax and diphtheria toxins, which were confirmed by functional validation. The broad application of this powerful genetic screening strategy will not only facilitate the rapid identification of genes important for bacterial toxicity but will also enable the discovery of genes that participate in other biological processes.	[Zhou, Yuexin; Zhu, Shiyou; Cai, Changzu; Yuan, Pengfei; Wei, Wensheng] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Li, Chunmei; Huang, Yanyi] Peking Univ, Biodynam Opt Imaging Ctr BIOPIC, Coll Engn, Beijing 100871, Peoples R China	Peking University; Peking University	Wei, WS (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	wswei@pku.edu.cn	Huang, Yanyi/D-1832-2009; Wei, Wensheng/AAF-1325-2020	Huang, Yanyi/0000-0002-7297-1266; Wei, Wensheng/0000-0002-8053-2423	National Basic Research Program of China [2010CB911800]; National Science Foundation of China [NSFC31170126, NSFC31070115]; Peking-Tsinghua Centre for Life Sciences	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking-Tsinghua Centre for Life Sciences	We thank J. Xi for providing the Cas9-encoding construct, F. Tang for technical advice regarding the high-throughput sequencing analysis, Z. Jiang for aid with the cell lines, Y. Yang for assistance in primer design, Y. Wang for data analysis, and D. Trono for aid with the lentivirus packaging system. We thank Peking University High-throughput Sequencing Center operated by BIOPIC. This work was supported by funds from the National Basic Research Program of China (2010CB911800), the National Science Foundation of China (NSFC31170126, NSFC31070115), and the Peking-Tsinghua Centre for Life Sciences.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Lin BR, 2012, GENE, V497, P200, DOI 10.1016/j.gene.2012.01.041; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wei W, 2006, CELL, V124, P1141, DOI 10.1016/j.cell.2005.12.045; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Yang JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075649; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	26	488	581	11	383	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					487	+		10.1038/nature13166	http://dx.doi.org/10.1038/nature13166			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24717434				2022-12-28	WOS:000336126000038
J	Barrett, KT; Metrano, AJ; Rablen, PR; Miller, SJ				Barrett, Kimberly T.; Metrano, Anthony J.; Rablen, Paul R.; Miller, Scott J.			Spontaneous transfer of chirality in an atropisomerically enriched two-axis system	NATURE			English	Article							TERTIARY AROMATIC AMIDES; KINETIC RESOLUTION; AXIAL CHIRALITY; DRUG DISCOVERY; ROTATION; ENANTIOMERIZATION; BARRIERS; EQUILIBRATION; SEPARATION; CATALYSIS	One of the most well-recognized stereogenic elements in a chiral molecule is an sp(3)-hybridized carbon atom that is connected to four different substituents. Axes of chirality can also exist about bonds with hindered barriers of rotation; molecules containing such axes are known as atropisomers(1). Understanding the dynamics of these systems can be useful, for example, in the design of single-atropisomer drugs(2) or molecular switches and motors(3). For molecules that exhibit a single axis of chirality, rotation about that axis leads to racemization as the system reaches equilibrium. Here we report a two-axis system for which an enantioselective reaction produces four stereoisomers (two enantiomeric pairs): following a catalytic asymmetric transformation, we observe a kinetically controlled product distribution that is perturbed from the system's equilibrium position. As the system undergoes isomerization, one of the diastereomeric pairs drifts spontaneously to a higher enantiomeric ratio. In a compensatory manner, the enantiomeric ratio of the other diastereomeric pair decreases. These observations are made for a class of unsymmetrical amides that exhibits two asymmetric axes-one axis is defined through a benzamide substructure, and the other axis is associated with differentially N,N-disubstituted amides. The stereodynamics of these substrates provides an opportunity to observe a curious interplay of kinetics and thermodynamics intrinsic to a system of stereoisomers that is constrained to a situation of partial equilibrium.	[Barrett, Kimberly T.; Metrano, Anthony J.; Miller, Scott J.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Rablen, Paul R.] Swarthmore Coll, Dept Chem & Biochem, Swarthmore, PA 19081 USA	Yale University; Swarthmore College	Miller, SJ (corresponding author), Yale Univ, Dept Chem, POB 208107, New Haven, CT 06520 USA.	scott.miller@yale.edu	Metrano, Anthony/B-1895-2013; Miller, Scott/N-7761-2017	Metrano, Anthony/0000-0002-2599-8917; Miller, Scott/0000-0001-7817-1318; Rablen, Paul/0000-0002-1300-1999	National Institute of General Medical Sciences of the NIH [GM-068649]; National Science Foundation; Yale University Faculty of Arts and Sciences High Performance Computing Center; National Science Foundation [CNS 08-21132]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068649, R37GM068649] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Yale University Faculty of Arts and Sciences High Performance Computing Center; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the National Institute of General Medical Sciences of the NIH (GM-068649) for support. We also thank L. Guard for X-ray crystallography. A.J.M. was supported by the National Science Foundation Graduate Research Fellowship Program. All computational work was supported by the facilities and staff of the Yale University Faculty of Arts and Sciences High Performance Computing Center, and by the National Science Foundation under grant number CNS 08-21132, which partially funded acquisition of the facilities.	Ahmed A, 1998, TETRAHEDRON, V54, P13277, DOI 10.1016/S0040-4020(98)00814-X; Barrett KT, 2013, J AM CHEM SOC, V135, P2963, DOI 10.1021/ja400082x; Bragg RA, 2002, CHEM-EUR J, V8, P1279, DOI 10.1002/1521-3765(20020315)8:6<1279::AID-CHEM1279>3.3.CO;2-Z; Bringmann G, 2005, ANGEW CHEM INT EDIT, V44, P5384, DOI 10.1002/anie.200462661; Campomanes P, 2002, J PHYS CHEM A, V106, P2623, DOI 10.1021/jp013127z; CHUPP JP, 1967, J ORG CHEM, V32, P2297, DOI 10.1021/jo01282a045; Clayden J, 1998, ANGEW CHEM INT EDIT, V37, P1937, DOI 10.1002/(SICI)1521-3773(19980803)37:13/14<1937::AID-ANIE1937>3.0.CO;2-4; Clayden J, 2009, ANGEW CHEM INT EDIT, V48, P6398, DOI 10.1002/anie.200901719; Cox C, 2000, ACCOUNTS CHEM RES, V33, P849, DOI 10.1021/ar990165g; CUYEGKENG MA, 1987, CHEM BER-RECL, V120, P803, DOI 10.1002/cber.19871200519; Eliel E. L., 1994, STEREOCHEMISTRY ORGA, V425; Erol S, 2012, CHIRALITY, V24, P493, DOI 10.1002/chir.22007; Feringa BL, 2007, J ORG CHEM, V72, P6635, DOI 10.1021/jo070394d; HIRSCH R, 1992, CHEM BER-RECL, V125, P975, DOI 10.1002/cber.19921250432; IWAMURA H, 1988, ACCOUNTS CHEM RES, V21, P175, DOI 10.1021/ar00148a007; Keith JM, 2001, ADV SYNTH CATAL, V343, P5, DOI 10.1002/1615-4169(20010129)343:1<5::AID-ADSC5>3.0.CO;2-I; Kelly TR, 1999, NATURE, V401, P150, DOI 10.1038/43639; Klussmann M, 2006, NATURE, V441, P621, DOI 10.1038/nature04780; LaPlante SR, 2014, J MED CHEM, V57, P1944, DOI 10.1021/jm401202a; LaPlante SR, 2011, J MED CHEM, V54, P7005, DOI 10.1021/jm200584g; LaPlante SR, 2011, CHEMMEDCHEM, V6, P505, DOI 10.1002/cmdc.201000485; Lee WK, 2009, ACCOUNTS CHEM RES, V42, P224, DOI 10.1021/ar8000662; MANNSCHRECK A, 1967, J MOL SPECTROSC, V23, P15, DOI 10.1016/0022-2852(67)90044-6; Oki M., 1983, TOPICS STEREOCHEMIST, V1; Pirkle William H., 1993, Journal of Chromatography, V648, P101, DOI 10.1016/0021-9673(93)83291-Y; Reichert S, 2007, ORG LETT, V9, P899, DOI 10.1021/ol0700660; REIST M, 1995, CHIRALITY, V7, P396, DOI 10.1002/chir.530070603; Wang JB, 2011, SCIENCE, V331, P1429, DOI 10.1126/science.1199844; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x	29	116	118	5	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					71	75		10.1038/nature13189	http://dx.doi.org/10.1038/nature13189			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24747399	Green Accepted, Green Submitted			2022-12-28	WOS:000335199100041
J	Holmes, D				Holmes, David			Susan Desmond-Hellmann: taking charge at the Gates Foundation	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2014	383	9927					1455	1455		10.1016/S0140-6736(14)60706-6	http://dx.doi.org/10.1016/S0140-6736(14)60706-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG3NI	24766954				2022-12-28	WOS:000335325800013
J	Fine, I				Fine, Ione			Do you hear what I see?	NATURE			English	Editorial Material							AUDITORY MOTION; AREA; BLIND; ORGANIZATION; SOUNDS; BRAIN	Researchers have found evidence that the representation of auditory and tactile information in the brains of blind people shows strong similarities to the way in which visual information is represented in sighted people.	Univ Washington, Dept Psychol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Fine, I (corresponding author), Univ Washington, Dept Psychol, Seattle, WA 98195 USA.	ionefine@uw.edu			NATIONAL EYE INSTITUTE [R01EY014645] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY014645] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amedi A, 2007, NAT NEUROSCI, V10, P687, DOI 10.1038/nn1912; Bedny M, 2010, CURR BIOL, V20, P1900, DOI 10.1016/j.cub.2010.09.044; Mahon BZ, 2009, NEURON, V63, P397, DOI 10.1016/j.neuron.2009.07.012; MEIJER PBL, 1992, IEEE T BIO-MED ENG, V39, P112, DOI 10.1109/10.121642; Pascual-Leone A, 2001, PROG BRAIN RES, V134, P427; Poirier C, 2006, NEUROIMAGE, V31, P279, DOI 10.1016/j.neuroimage.2005.11.036; Saenz M, 2008, J NEUROSCI, V28, P5141, DOI 10.1523/JNEUROSCI.0803-08.2008; Striem-Amit E, 2014, CURR BIOL, V24, P687, DOI 10.1016/j.cub.2014.02.010; Striem-Amit E, 2012, NEURON, V76, P640, DOI 10.1016/j.neuron.2012.08.026	9	4	4	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					461	462		10.1038/508461a	http://dx.doi.org/10.1038/508461a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF5GI	24759406	Green Accepted			2022-12-28	WOS:000334741600021
J	Liu, SX; Chistol, G; Hetherington, CL; Tafoya, S; Aathavan, K; Schnitzbauer, J; Grimes, S; Jardine, PJ; Bustamante, C				Liu, Shixin; Chistol, Gheorghe; Hetherington, Craig L.; Tafoya, Sara; Aathavan, K.; Schnitzbauer, Joerg; Grimes, Shelley; Jardine, Paul J.; Bustamante, Carlos			A Viral Packaging Motor Varies Its DNA Rotation and Step Size to Preserve Subunit Coordination as the Capsid Fills	CELL			English	Article							HOMOMERIC RING ATPASE; BACTERIOPHAGE PHI-29; INTERSUBUNIT COORDINATION; OPTICAL TWEEZERS; INTERNAL FORCE; PORTAL MOTOR; EJECTION; PHAGE; MECHANISM; MOLECULE	Multimeric, ring-shaped molecular motors rely on the coordinated action of their subunits to perform crucial biological functions. During these tasks, motors often change their operation in response to regulatory signals. Here, we investigate a viral packaging machine as it fills the capsid with DNA and encounters increasing internal pressure. We find that the motor rotates the DNA during packaging and that the rotation per base pair increases with filling. This change accompanies a reduction in the motor's step size. We propose that these adjustments preserve motor coordination by allowing one subunit to make periodic, specific, and regulatory contacts with the DNA. At high filling, we also observe the downregulation of the ATP-binding rate and the emergence of long-lived pauses, suggesting a throttling-down mechanism employed by the motor near the completion of packaging. This study illustrates how a biological motor adjusts its operation in response to changing conditions, while remaining highly coordinated.	[Liu, Shixin; Chistol, Gheorghe; Hetherington, Craig L.; Tafoya, Sara; Aathavan, K.; Schnitzbauer, Joerg; Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Liu, Shixin; Hetherington, Craig L.; Schnitzbauer, Joerg; Bustamante, Carlos] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Chistol, Gheorghe; Hetherington, Craig L.; Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Tafoya, Sara; Aathavan, K.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Grimes, Shelley; Jardine, Paul J.] Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA; [Grimes, Shelley; Jardine, Paul J.] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu		Jardine, Paul/0000-0002-1090-0550; Chistol, Gheorghe/0000-0003-4868-3667; Bustamante, Carlos/0000-0002-2970-0073	U.S. National Institutes of Health [R01-GM071552, R01-GM059604]; U.S. Department of Energy [DE-AC02-05CH11231]; Howard Hughes Medical Institute; NIH [K99-GM107365]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM107365, R01GM071552, R01GM059604] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Lionberger, N. Liu, J. Moffitt, and M. Sen for critical readings of the manuscript; Z. Bryant, A. Lee, C. Lee, J. Moffitt, M. Nollmann, and D. Reid for help with preliminary experiments and analysis; J. Kittleson for plasmids; and L. Comolli, A. Edelstein, Y. Mejia, M. Morais, and S. Smith for discussions. This work is supported in part by the U.S. National Institutes of Health under grants R01-GM071552 (to C.B.) and R01-GM059604 (to S.G.), the U.S. Department of Energy under contract number DE-AC02-05CH11231 (to C.B.), and the Howard Hughes Medical Institute (to C.B.). S.L. acknowledges support from the NIH Pathway to Independence Award K99-GM107365.	Aathavan K, 2009, NATURE, V461, P669, DOI 10.1038/nature08443; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cao S, 2014, J VIROL, V88, P3986, DOI 10.1128/JVI.03203-13; Casjens Sherwood, 2005, P80; Casjens SR, 2011, NAT REV MICROBIOL, V9, P647, DOI 10.1038/nrmicro2632; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Chistol G, 2012, CELL, V151, P1017, DOI 10.1016/j.cell.2012.10.031; Droege Anja, 2005, P89; EARNSHAW WC, 1980, CELL, V21, P319, DOI 10.1016/0092-8674(80)90468-7; Evilevitch A, 2004, J PHYS CHEM B, V108, P6838, DOI 10.1021/jp0376525; Evilevitch A, 2003, P NATL ACAD SCI USA, V100, P9292, DOI 10.1073/pnas.1233721100; Fuller DN, 2007, J MOL BIOL, V373, P1113, DOI 10.1016/j.jmb.2007.09.011; Gelbart WM, 2009, SCIENCE, V323, P1682, DOI 10.1126/science.1170645; Gonzalez-Huici V, 2004, MOL MICROBIOL, V52, P529, DOI 10.1111/j.1365-2958.2004.03993.x; Happel J., 2012, LOW REYNOLDS NUMBER, V1; HENDRIX RW, 1978, P NATL ACAD SCI USA, V75, P4779, DOI 10.1073/pnas.75.10.4779; Hetherington CL, 2012, MOL MOTORS MOTILITY, P420; Iino R, 2013, CURR OPIN STRUC BIOL, V23, P229, DOI 10.1016/j.sbi.2013.01.004; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Kalafut B, 2008, COMPUT PHYS COMMUN, V179, P716, DOI 10.1016/j.cpc.2008.06.008; Keller D, 2000, BIOPHYS J, V78, P541, DOI 10.1016/S0006-3495(00)76615-X; Kindt J, 2001, P NATL ACAD SCI USA, V98, P13671, DOI 10.1073/pnas.241486298; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Lyubimov AY, 2011, CURR OPIN STRUC BIOL, V21, P240, DOI 10.1016/j.sbi.2011.01.002; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Moffitt JR, 2010, P NATL ACAD SCI USA, V107, P15739, DOI 10.1073/pnas.1006997107; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Molineux IJ, 2013, NAT REV MICROBIOL, V11, P194, DOI 10.1038/nrmicro2988; Morais MC, 2008, STRUCTURE, V16, P1267, DOI 10.1016/j.str.2008.05.010; Morais MC, 2012, ADV EXP MED BIOL, V726, P511, DOI 10.1007/978-1-4614-0980-9_23; Oster G, 2000, BBA-BIOENERGETICS, V1458, P482, DOI 10.1016/S0005-2728(00)00096-7; Purohit PK, 2005, BIOPHYS J, V88, P851, DOI 10.1529/biophysj.104.047134; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rickgauer JP, 2008, BIOPHYS J, V94, P159, DOI 10.1529/biophysj.107.104612; Saleh OA, 2005, NAT STRUCT MOL BIOL, V12, P436, DOI 10.1038/nsmb926; Sao-Jose C, 2007, J MOL BIOL, V374, P346, DOI 10.1016/j.jmb.2007.09.045; Schwartz C, 2013, VIROLOGY, V443, P28, DOI 10.1016/j.virol.2013.04.019; Sen M, 2013, CELL, V155, P636, DOI 10.1016/j.cell.2013.09.022; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Smith SB, 2003, METHOD ENZYMOL, V361, P134; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Spakowitz AJ, 2005, BIOPHYS J, V88, P3912, DOI 10.1529/biophysj.104.052738; Strick T, 1999, PHYSICA A, V263, P392, DOI 10.1016/S0378-4371(98)00540-8; Tolic-Norrelykke IM, 2004, COMPUT PHYS COMMUN, V159, P225, DOI 10.1016/j.cpc.2004.02.012; Van Valen D, 2012, CURR BIOL, V22, P1339, DOI 10.1016/j.cub.2012.05.023; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; WANG JC, 1979, P NATL ACAD SCI USA, V76, P200, DOI 10.1073/pnas.76.1.200; Zhao W, 2008, J MOL BIOL, V383, P520, DOI 10.1016/j.jmb.2008.08.056	50	95	96	1	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					702	713		10.1016/j.cell.2014.02.034	http://dx.doi.org/10.1016/j.cell.2014.02.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766813	Bronze, Green Accepted			2022-12-28	WOS:000335392100018
J	Farrell, M; Buchbinder, R; Hall, W				Farrell, Michael; Buchbinder, Rachelle; Hall, Wayne			Should doctors prescribe cannabinoids?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHEMOTHERAPY-INDUCED NAUSEA; RANDOMIZED CONTROLLED-TRIAL; CENTRAL NEUROPATHIC PAIN; MULTIPLE-SCLEROSIS; DOUBLE-BLIND; CANCER-PATIENTS; SPASTICITY; NABILONE; METAANALYSIS; NABIXIMOLS		[Farrell, Michael] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2031, Australia; [Buchbinder, Rachelle] Cabrini Hosp, Monash Dept Clin Epidemiol, Melbourne, Vic, Australia; [Buchbinder, Rachelle] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Hall, Wayne] Univ Queensland, Clin Res Ctr, Herston, Qld, Australia	University of New South Wales Sydney; Cabrini Health; Monash University; Monash University; University of Queensland	Farrell, M (corresponding author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2031, Australia.	michael.farrell@unsw.edu.au	Farrell, Michael P/A-4769-2012; Hall, Wayne D/A-3283-2008; Buchbinder, Rachelle/G-2952-2011	Farrell, Michael P/0000-0001-7008-8130; Hall, Wayne D/0000-0003-1984-0096; Buchbinder, Rachelle/0000-0002-0597-0933				Amar MB, 2006, J ETHNOPHARMACOL, V105, P1, DOI 10.1016/j.jep.2006.02.001; Christie MJ, 2006, BRIT J PHARMACOL, V148, P385, DOI 10.1038/sj.bjp.0706756; Collin C, 2007, EUR J NEUROL, V14, P290, DOI 10.1111/j.1468-1331.2006.01639.x; Collin C, 2010, NEUROL RES, V32, P451, DOI 10.1179/016164109X12590518685660; Corey-Bloom J, 2012, CAN MED ASSOC J, V184, P1143, DOI 10.1503/cmaj.110837; Dyer O, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4755; Eddy, 2010, 75700 C RES SERV; Guindon J, 2008, BRIT J PHARMACOL, V153, P319, DOI 10.1038/sj.bjp.0707531; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; Institute of Medicine (US). Division of Neuroscience and Behavioral Health, 1999, MARIJUANA MED ASSESS; Johnson JR, 2010, J PAIN SYMPTOM MANAG, V39, P167, DOI 10.1016/j.jpainsymman.2009.06.008; Kalant H, 2001, Pain Res Manag, V6, P80; Langford RM, 2013, J NEUROL, V260, P984, DOI 10.1007/s00415-012-6739-4; Lutge EE, 2013, COCHRANE DB SYST REV, V4; Lynch ME, 2011, BRIT J CLIN PHARMACO, V72, P735, DOI 10.1111/j.1365-2125.2011.03970.x; Martin-Sanchez E, 2009, PAIN MED, V10, P1353, DOI 10.1111/j.1526-4637.2009.00703.x; Nascimento SD, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/149468; Navari RM, 2009, DRUGS, V69, P515, DOI 10.2165/00003495-200969050-00002; Phillips TJC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014433; Pini LA, 2012, J HEADACHE PAIN, V13, P677, DOI 10.1007/s10194-012-0490-1; Podda G, 2012, EXPERT OPIN BIOL TH, V12, P1517, DOI 10.1517/14712598.2012.721765; Portenoy RK, 2012, J PAIN, V13, P438, DOI 10.1016/j.jpain.2012.01.003; Richards BL, 2011, COCHRANE DB SYST REV, V1; Rintala DH, 2010, AM J PHYS MED REHAB, V89, P840, DOI 10.1097/PHM.0b013e3181f1c4ec; Rocha FCM, 2008, EUR J CANCER CARE, V17, P431, DOI 10.1111/j.1365-2354.2008.00917.x; Rog DJ, 2005, NEUROLOGY, V65, P812, DOI 10.1212/01.wnl.0000176753.45410.8b; Russo E, 2006, MED HYPOTHESES, V66, P234, DOI 10.1016/j.mehy.2005.08.026; Selvarajah D, 2010, DIABETES CARE, V33, P128, DOI 10.2337/dc09-1029; Skrabek RQ, 2008, J PAIN, V9, P164, DOI 10.1016/j.jpain.2007.09.002; Snedecor SJ, 2013, J PAIN RES, V6, P539, DOI 10.2147/JPR.S45966; Svendsen KB, 2004, BMJ-BRIT MED J, V329, P31; Toth C, 2012, PAIN, V153, P2073, DOI 10.1016/j.pain.2012.06.024; Tramer MR, 2001, BMJ-BRIT MED J, V323, P16, DOI 10.1136/bmj.323.7303.16; Wade DT, 2010, MULT SCLER J, V16, P707, DOI 10.1177/1352458510367462; Wade DT, 2004, MULT SCLER, V10, P434, DOI 10.1191/1352458504ms1082oa; Wade DT, 2003, CLIN REHABIL, V17, P21, DOI 10.1191/0269215503cr581oa; Ware MA, 2010, ANESTH ANALG, V110, P604, DOI 10.1213/ANE.0b013e3181c76f70	37	9	10	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2014	348								g2737	10.1136/bmj.g2737	http://dx.doi.org/10.1136/bmj.g2737			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG1DH	24760158				2022-12-28	WOS:000335154800003
J	Gurusamy, KS; Davidson, BR				Gurusamy, Kurinchi S.; Davidson, Brian R.			Gallstones	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BILIARY-TRACT CANCER; SYMPTOMATIC GALLSTONES; ABDOMINAL SYMPTOMS; ACUTE-PANCREATITIS; SURGICAL-TREATMENT; RISK-FACTORS; CHOLECYSTECTOMY; CHOLELITHIASIS; EPIDEMIOLOGY; DISSOLUTION		[Gurusamy, Kurinchi S.; Davidson, Brian R.] Royal Free Hosp, UCL Med Sch, Dept Surg, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Gurusamy, KS (corresponding author), Royal Free Hosp, UCL Med Sch, Dept Surg, 9th Floor Royal Free Campus, London, England.	k.gurusamy@ucl.ac.uk		Gurusamy, Kurinchi/0000-0002-0313-9134				ATTILI AF, 1995, HEPATOLOGY, V21, P656, DOI 10.1002/hep.1840210309; Banim PJR, 2011, EUR J GASTROEN HEPAT, V23, P733, DOI 10.1097/MEG.0b013e3283477cc9; Berger MY, 2003, SURG ENDOSC, V17, P1723, DOI 10.1007/s00464-002-9154-6; Berger MY, 2000, SCAND J GASTROENTERO, V35, P70; Bouwense SAW, 2011, ANN SURG, V253, P1053, DOI 10.1097/SLA.0b013e3182172dd7; Carrilho-Riberio L, 2006, SCAND J GASTROENTERO, V41, P338, DOI 10.1080/00365520500483256; Centers for Disease Control and Prevention, 2009, DISCH LEAST ON PROC; Dasari BVM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003327.pub4; DELFAVERO G, 1994, DIGEST DIS SCI, V39, P1704, DOI 10.1007/BF02087780; Department of Health, 2012, NHS REF COSTS 2012 2; Everhart J, 2008, BURDEN DIGESTIVE DIS; Gurusamy KS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006230.pub2; Gurusamy KS, 2013, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD010326.PUB2; Gurusamy KS, 2010, GASTROENTEROL CLIN N, V39, P229, DOI 10.1016/j.gtc.2010.02.004; Gurusamy KS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007088.pub2; Gurusamy KS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005440.pub3; Gutt CN, 2013, ANN SURG, V258, P385, DOI 10.1097/SLA.0b013e3182a1599b; Halldestam I, 2004, BRIT J SURG, V91, P734, DOI 10.1002/bjs.4547; Health and Social Care Information Centre, 2012, HOSP EP STAT ADM PAT; Hsing AW, 2007, BRIT J CANCER, V97, P1577, DOI 10.1038/sj.bjc.6604047; Ishiguro S, 2008, CANCER CAUSE CONTROL, V19, P33, DOI 10.1007/s10552-007-9067-8; Kratzer W, 1999, J CLIN ULTRASOUND, V27, P1, DOI 10.1002/(SICI)1097-0096(199901)27:1<1::AID-JCU1>3.0.CO;2-H; MAY GR, 1993, ALIMENT PHARM THERAP, V7, P139; Mayumi T, 2007, J HEPATO-BILIARY-PAN, V14, P114, DOI 10.1007/s00534-006-1163-8; ODONNELL LDJ, 1988, GUT, V29, P655, DOI 10.1136/gut.29.5.655; Paul A, 1998, SURG ENDOSC-ULTRAS, V12, P856, DOI 10.1007/s004649900729; Portincasa P, 2006, BEST PRACT RES CL GA, V20, P1017, DOI 10.1016/j.bpg.2006.05.005; Qiao T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074887; Ross M, 2011, ACAD EMERG MED, V18, P227, DOI 10.1111/j.1553-2712.2011.01012.x; Rutledge D, 2000, AM J SURG, V180, P466, DOI 10.1016/S0002-9610(00)00520-1; Salek J, 2009, J CLIN GASTROENTEROL, V43, P171, DOI 10.1097/MCG.0b013e318157c62c; Salman B, 2005, DIGEST SURG, V22, P95, DOI 10.1159/000085300; Schafmayer C, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-36; Schmidt M, 2011, DIGEST SURG, V28, P270, DOI 10.1159/000329464; Schmidt M, 2011, SCAND J GASTROENTERO, V46, P1251, DOI 10.3109/00365521.2011.598548; Shaffer Eldon A, 2005, Curr Gastroenterol Rep, V7, P132; Shebl FM, 2011, BRIT J CANCER, V105, P1424, DOI 10.1038/bjc.2011.363; Stinton LM, 2010, GASTROENTEROL CLIN N, V39, P157, DOI 10.1016/j.gtc.2010.02.003; STRASBERG SM, 1993, AM J SURG, V165, P420, DOI 10.1016/S0002-9610(05)80933-X; Sunamura M, 1998, PANCREAS, V16, P243, DOI 10.1097/00006676-199804000-00007; Tornqvist B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6457; TROTMAN BW, 1975, AM J DIG DIS, V20, P735, DOI 10.1007/BF01070831; Trowbridge RL, 2003, JAMA-J AM MED ASSOC, V289, P80, DOI 10.1001/jama.289.1.80; Van Erpecum KJ, 2011, CLIN RES HEPATOL GAS, V35, P281, DOI 10.1016/j.clinre.2011.01.009; Venneman NG, 2006, BEST PRACT RES CL GA, V20, P1063, DOI 10.1016/j.bpg.2006.03.008; Venneman NG, 2006, HEPATOLOGY, V43, P1276, DOI 10.1002/hep.21182; Williams EJ, 2008, GUT, V57, P1004, DOI 10.1136/gut.2007.121657; Yadav D, 2006, PANCREAS, V33, P323, DOI 10.1097/01.mpa.0000236733.31617.52	48	32	33	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2014	348								g2669	10.1136/bmj.g2669	http://dx.doi.org/10.1136/bmj.g2669			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG1DB	24755732				2022-12-28	WOS:000335154200002
J	Kraus, D; Yang, Q; Kong, D; Banks, AS; Zhang, L; Rodgers, JT; Pirinen, E; Pulinilkunnil, TC; Gong, FY; Wang, YC; Cen, YN; Sauve, AA; Asara, JM; Peroni, OD; Monia, BP; Bhanot, S; Alhonen, L; Puigserver, P; Kahn, BB				Kraus, Daniel; Yang, Qin; Kong, Dong; Banks, Alexander S.; Zhang, Lin; Rodgers, Joseph T.; Pirinen, Eija; Pulinilkunnil, Thomas C.; Gong, Fengying; Wang, Ya-chin; Cen, Yana; Sauve, Anthony A.; Asara, John M.; Peroni, Odile D.; Monia, Brett P.; Bhanot, Sanjay; Alhonen, Leena; Puigserver, Pere; Kahn, Barbara B.			Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity	NATURE			English	Article							ADIPOSE-TISSUE; CDNA CLONING; EXPRESSION; MOUSE; LIVER; SIRT1; MICE; METABOLISM; RESISTANCE; CANCER	In obesity and type 2 diabetes, Glut4 glucose transporter expression is decreased selectively in adipocytes(1). Adipose-specific knockout or overexpression of Glut4 alters systemic insulin sensitivity(2). Here we show, using DNA array analyses, that nicotinamide N-methyltransferase (Nnmt) is the most strongly reciprocally regulated gene when comparing gene expression in white adipose tissue(WAT) from adipose-specific Glut4k-nockout or adipose-specific Glut4-overexpressing mice with their respective controls. NNMT methylates nicotinamide (vitamin B3) using S-adenosylmethionine (SAM) as a methyl donor(3,4). Nicotinamide is a precursor of NAD(+), an important cofactor linking cellular redox states with energy metabolism(5). SAM provides propylamine for polyamine biosynthesis and donates a methyl group for histone methylation(6). Polyamine flux including synthesis, catabolism and excretion, is controlled by the rate-limiting enzymes ornithine decarboxylase (ODC) and spermidine-spermine N-1-acetyltransferase (SSAT; encoded by Sat1) and by polyamine oxidase (PAO), and has a major role in energy metabolism(7,8). We report that NNMT expression is increased in WAT and liver of obese and diabetic mice. Nnmt knockdown in WAT and liver protects against diet-induced obesity by augmenting cellular energy expenditure. NNMT inhibition increases adipose SAM and NAD(+) levels and upregulates ODC and SSAT activity as well as expression, owing to the effects of NNMT on histone H3 lysine 4 methylation in adipose tissue. Direct evidence for increased polyamine flux resulting from NNMT inhibition includes elevated urinary excretion and adipocyte secretion of diacetylspermine, a product of polyamine metabolism. NNMT inhibition in adipocytes increases oxygen consumption in an ODC-, SSAT- and PAO-dependent manner. Thus, NNMT is a novel regulator of histone methylation, polyamine flux and NAD(+)-dependent SIRT1 signalling, and is a unique and attractive target for treating obesity and type 2 diabetes.	[Kraus, Daniel; Yang, Qin; Kong, Dong; Zhang, Lin; Pulinilkunnil, Thomas C.; Gong, Fengying; Wang, Ya-chin; Peroni, Odile D.; Kahn, Barbara B.] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Kraus, Daniel; Yang, Qin; Kong, Dong; Zhang, Lin; Pulinilkunnil, Thomas C.; Gong, Fengying; Wang, Ya-chin; Asara, John M.; Peroni, Odile D.; Kahn, Barbara B.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Banks, Alexander S.; Rodgers, Joseph T.; Puigserver, Pere] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Pirinen, Eija; Alhonen, Leena] Univ Eastern Finland, Bioctr Kuopio, AI Virtanen Inst Mol Sci, FI-70211 Kuopio, Finland; [Cen, Yana; Sauve, Anthony A.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Monia, Brett P.; Bhanot, Sanjay] ISIS Pharmaceut, Carlsbad, CA 92008 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Eastern Finland; Cornell University; Harvard University; Beth Israel Deaconess Medical Center; Isis Pharmaceuticals Inc	Kahn, BB (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, 330 Brookline Ave, Boston, MA 02215 USA.	qin.yang@uci.edu; bkahn@bidmc.harvard.edu	Pulinilkunnil, Thomas C/L-5511-2016; Banks, Alexander/B-4832-2012; Cen, Yana/F-4731-2014; Pirinen, Eija/H-9153-2015; Pulinilkunnil, Thomas/H-4387-2019	Pulinilkunnil, Thomas C/0000-0003-1228-893X; Banks, Alexander/0000-0003-1787-6925; Cen, Yana/0000-0001-6436-5744; Pirinen, Eija/0000-0003-1495-3972; Pulinilkunnil, Thomas/0000-0003-1228-893X; Rodgers, Joseph/0000-0002-6598-5520	Deutsche Forschungsgemeinschaft [KR 3475/1-1]; American Heart Association (AHA) [09POST2250499]; NIH [R37 DK43051, P30 DK57521, KO8 DK090149, R01 DK100385, BNORC P30 DK046200, NORCH P30 DK040561]; JPB foundation; AHA [13SDG14620005, PF P30 DK0460200]; Ellison Medical Foundation New Scholar in Aging Award; academy of Finland [118590];  [RO1 DK69966];  [P01CA120964];  [P30CA006516-46]; NATIONAL CANCER INSTITUTE [P01CA120964, P30CA006516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100385, P30DK046200, R01DK069966, K08DK090149, K01DK094943, R37DK043051, P30DK057521, P30DK040561, T32DK007516] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); American Heart Association (AHA)(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB foundation; AHA(American Heart Association); Ellison Medical Foundation New Scholar in Aging Award(Lawrence Ellison Foundation); academy of Finland(Academy of Finland); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Weinshilboum for NNMT antibody; P. Woster for DFMO; M. Yuan for tandem mass spectrometry; A. Karppinen, A. Korhonen, T. Reponen, A. Uimari, S. Pirnes-Karhu and T. Koponen for measurements of ODC and SSAT activity; C. Semenkovich and S. Fried for protocols for FAS activity measurements; and P. Aryal for assistance with real-time qPCR. D. Kr. is supported by the Deutsche Forschungsgemeinschaft (KR 3475/1-1) and American Heart Association (AHA) (09POST2250499); Q.Y. is a Klarman Scholar at the Beth Israel Deaconess Medical Center. This work is supported by grants from the NIH (R37 DK43051, P30 DK57521) and a grant from the JPB foundation to B. B. K.; grants from the NIH (KO8 DK090149, R01 DK100385, BNORC P30 DK046200 and NORCH P30 DK040561) to Q.Y.; grant RO1 DK69966 to P. P.; P01CA120964 and P30CA006516-46 to J.M.A.; AHA 13SDG14620005 and P&F P30 DK0460200 to D.K.; the Ellison Medical Foundation New Scholar in Aging Award to A. A. S.; and academy of Finland grant 118590 to L.A.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; AKSOY S, 1994, J BIOL CHEM, V269, P14835; Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Alexander J, 2006, INT J OBESITY, V30, P50, DOI 10.1038/sj.ijo.0803110; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Bernacki RJ, 1995, CLIN CANCER RES, V1, P847; Bubolz AH, 2012, AM J PHYSIOL-HEART C, V302, pH634, DOI 10.1152/ajpheart.00717.2011; Chen HC, 2002, J LIPID RES, V43, P986; Eguchi J, 2008, CELL METAB, V7, P86, DOI 10.1016/j.cmet.2007.11.002; Endo A, 2006, CONTEMP CLIN TRIALS, V27, P420, DOI 10.1016/j.cct.2006.05.002; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Grubb SC, 2009, NUCLEIC ACIDS RES, V37, pD720, DOI 10.1093/nar/gkn778; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; JANNE J, 1971, J BIOL CHEM, V246, P1725; Jell J, 2007, J BIOL CHEM, V282, P8404, DOI 10.1074/jbc.M610265200; KANGLEE YA, 1983, J NUTR, V113, P215, DOI 10.1093/jn/113.2.215; Kobayashi Y, 2005, INT J MOL MED, V16, P237; Koponen T, 2012, AMINO ACIDS, V42, P427, DOI 10.1007/s00726-011-1013-0; Lee YH, 2005, DIABETOLOGIA, V48, P1776, DOI 10.1007/s00125-005-1867-3; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Pegg AE, 2011, METHODS MOL BIOL, V720, P3, DOI 10.1007/978-1-61779-034-8_1; Pirinen E, 2007, MOL CELL BIOL, V27, P4953, DOI 10.1128/MCB.02034-06; Pulinilkunnil T, 2011, J BIOL CHEM, V286, P8798, DOI 10.1074/jbc.M111.218719; Riederer M, 2009, ATHEROSCLEROSIS, V204, P412, DOI 10.1016/j.atherosclerosis.2008.09.015; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; Sartini D, 2013, CELL BIOCHEM BIOPHYS, V67, P865, DOI 10.1007/s12013-013-9574-z; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Stein S, 2010, EUR HEART J, V31, P2301, DOI 10.1093/eurheartj/ehq107; Svenson KL, 2007, J APPL PHYSIOL, V102, P2369, DOI 10.1152/japplphysiol.01077.2006; Teperino R, 2010, CELL METAB, V12, P321, DOI 10.1016/j.cmet.2010.09.004; Ulanovskaya OA, 2013, NAT CHEM BIOL, V9, P300, DOI [10.1038/NCHEMBIO.1204, 10.1038/nchembio.1204]; Varela-Rey M, 2010, HEPATOLOGY, V52, P105, DOI 10.1002/hep.23639; Williams AC, 2005, QJM-INT J MED, V98, P215, DOI 10.1093/qjmed/hci027; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yaguchi H, 2005, GENOMICS, V85, P591, DOI 10.1016/j.ygeno.2005.01.006; Yan L, 1997, BIOCHEM PHARMACOL, V54, P1139, DOI 10.1016/S0006-2952(97)00325-0; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yang XM, 2011, CANCER RES, V71, P5965, DOI 10.1158/0008-5472.CAN-11-0445	43	306	316	4	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					258	+		10.1038/nature13198	http://dx.doi.org/10.1038/nature13198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE4UK	24717514	Green Accepted			2022-12-28	WOS:000333979900047
J	Olopade, OI				Olopade, Olufunmilayo I.			Janet Davison Rowley 1925-2013	CELL			English	Biographical-Item									Univ Chicago, Ctr Clin Canc Genet & Global Hlth, Chicago, IL 60637 USA	University of Chicago	Olopade, OI (corresponding author), Univ Chicago, Ctr Clin Canc Genet & Global Hlth, 5841 South Maryland Ave,MC 2115, Chicago, IL 60637 USA.	folopade@medicine.bsd.uchicago.edu							0	1	1	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 30	2014	156	3					390	391		10.1016/j.cell.2014.01.015	http://dx.doi.org/10.1016/j.cell.2014.01.015			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	302DD	24757717	Bronze			2022-12-28	WOS:000330580800003
J	Vain, NE; Satragno, DS; Gorenstein, AN; Gordillo, JE; Berazategui, JP; Alda, MG; Prudent, LM				Vain, Nestor E.; Satragno, Daniela S.; Gorenstein, Adriana N.; Gordillo, Juan E.; Berazategui, Juan P.; Guadalupe Alda, M.; Prudent, Luis M.			Effect of gravity on volume of placental transfusion: a multicentre, randomised, non-inferiority trial	LANCET			English	Article							UMBILICAL-CORD; IRON-DEFICIENCY; INFANTS; TERM; LABOR; BIRTH; MANAGEMENT; CONSENSUS; OUTCOMES; BLOOD	Background Delayed cord clamping allows for the passage of blood from the placenta to the baby and reduces the risk of iron deficiency in infancy. To hold the infant for more than 1 min at the level of the vagina (as is presently recommended), on the assumption that gravity affects the volume of placental transfusion, is cumbersome, might result in low compliance, and interferes with immediate contact of the infant with the mother. We aimed to assess whether gravity affects the volume of placental transfusion Methods We did a multicentre non-inferiority trial at three university-affiliated hospitals in Argentina. We obtained informed consent from healthy mothers with normal term pregnancies admitted early in labour. Vigorous babies born vaginally were randomly assigned in a 1: 1 ratio by computer-generated blocks and sequentially numbered sealed opaque envelopes to be held for 2 min before clamping the umbilical cord, at the level of the vagina (introitus group) or on the mother's abdomen or chest (abdomen group). Newborn babies were weighed immediately after birth and after cord clamping. The primary outcome was the difference in weight (as a proxy of placental transfusion volume). The prespecified non-inferiority margin was 18 g (20%). We used t test and chi(2) test for group comparison, and used a multivariable linear regression analysis to control for covariables. This trial is registered with ClinicalTrials.gov, number NCT01497353. Findings Between Aug 1, 2011, and Aug 31, 2012, we allocated 274 newborn babies to the introitus group and 272 to the abdomen group. 77 newborn babies in the introitus group and 78 in the abdomen group were ineligible after randomisation (eg, caesarean section, forceps delivery, short umbilical cord or nuchal cord). Mean weight change was 56 g (SD 47, 95% CI 50-63) for 197 babies in the introitus group compared with 53 g (45, 46-59) for 194 babies in the abdomen group, supporting non-inferiority of the two approaches (difference 3 g, 95% CI -5.8 to 12 8; p=0.45). We did not note any serious adverse events during the study. Interpretation Position of the newborn baby before cord clamping does not seem to affect volume of placental transfusion. Mothers could safely be allowed to hold their baby on their abdomen or chest. This change in practice might increase obstetric compliance with the procedure, enhance maternal-infant bonding, and decrease iron deficiency in infancy.	[Vain, Nestor E.] Univ Buenos Aires, Sch Med, Buenos Aires, DF, Argentina; [Vain, Nestor E.; Satragno, Daniela S.; Gorenstein, Adriana N.; Berazategui, Juan P.; Prudent, Luis M.] Fdn Maternal & Child Hlth FUNDASAMIN, RA-4160 Buenos Aires, DF, Argentina; [Vain, Nestor E.; Gorenstein, Adriana N.; Guadalupe Alda, M.] Trinidad Palermo Private Hosp, Buenos Aires, DF, Argentina; [Gordillo, Juan E.] Inst Matern Our Lady Mercy, San Miguel De Tucuman, Tucuman, Argentina	University of Buenos Aires	Vain, NE (corresponding author), Fdn Maternal & Child Hlth FUNDASAMIN, RA-4160 Buenos Aires, DF, Argentina.	nvain@fundasamin.org			Foundation for Maternal and Child Health (FUNDASAMIN)	Foundation for Maternal and Child Health (FUNDASAMIN)	Foundation for Maternal and Child Health (FUNDASAMIN).	Airey RJ, 2010, COCHRANE DB SYST REV, V6; Alexander JM, 1998, AM J OBSTET GYNECOL, V178, P516, DOI 10.1016/S0002-9378(98)70431-4; Andersson O, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7157; [Anonymous], 2016, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003519.PUB3; Bhatt S, 2013, J PHYSIOL-LONDON, V591, P2113, DOI 10.1113/jphysiol.2012.250084; CALDEYROBARCIA R, 1960, CLIN OBSTET GYNECOL, V3, P386, DOI 10.1097/00003081-196006000-00011; Cernadas JMC, 2010, ARCH ARGENT PEDIATR, V108, P201, DOI 10.1590/S0325-00752010000300005; Cernadas JMC, 2006, PEDIATRICS, V117, pE779, DOI 10.1542/peds.2005-1156; Chaparro CM, 2006, LANCET, V367, P1997, DOI 10.1016/S0140-6736(06)68889-2; Committee on Obstetric Practice American College of Obstetricians and Gynecologists, 2012, Obstet Gynecol, V120, P1522, DOI 10.1097/01.AOG.0000423817.47165.48; Duran P, 2009, ARCH ARGENT PEDIATR, V107, P397, DOI 10.1590/S0325-00752009000500005; Eden AN, 2012, PEDIATR HEMAT ONCOL, V29, P704, DOI 10.3109/08880018.2012.725199; Farrar D, 2011, BJOG-INT J OBSTET GY, V118, P70, DOI 10.1111/j.1471-0528.2010.02781.x; Gleason CA, 2012, AVERYS DIS NEWBORN, P711; GUNTHER M, 1957, LANCET, V1, P1277, DOI 10.1016/S0140-6736(57)92302-4; Hutchon DJR, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5447; Incerti M, 2008, AM J PERINAT, V25, P85, DOI 10.1055/s-2007-1004827; Male C, 2001, ACTA PAEDIATR, V90, P492, DOI 10.1080/080352501750197601; McDonald Susan J, 2013, Cochrane Database Syst Rev, pCD004074, DOI 10.1002/14651858.CD004074.pub3; Nojilana B, 2007, SAMJ S AFR MED J, V97, P741; Perlman JM, 2010, CIRCULATION, V122, P8516, DOI 10.1161/CIRCULATIONAHA.110.971127; PRENDIVILLE WJ, 1988, BMJ-BRIT MED J, V297, P1295, DOI 10.1136/bmj.297.6659.1295; Raju TNK, 2012, CLIN PERINATOL, V39, P889, DOI 10.1016/j.clp.2012.09.006; Royal College of Obstetricians and Gynaecologists, 2009, 14 ROYAL COLL OBST G; Sweet DG, 2010, NEONATOLOGY, V97, P402, DOI 10.1159/000297773; TRUDNOWSKI RJ, 1974, CLIN CHEM, V20, P615; van Rheenen P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7127; YAO AC, 1969, LANCET, V2, P505; YAO AC, 1974, AM J DIS CHILD, V127, P128, DOI 10.1001/archpedi.1974.02110200130021; Zapata Barrios J, 2011, J PERINAT MED, V39, P386	30	70	81	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2014	384	9939					235	240		10.1016/S0140-6736(14)60197-5	http://dx.doi.org/10.1016/S0140-6736(14)60197-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL8JI	24746755				2022-12-28	WOS:000339384100024
J	Pradel, A; Maisey, JG; Tafforeau, P; Mapes, RH; Mallatt, J				Pradel, Alan; Maisey, John G.; Tafforeau, Paul; Mapes, Royal H.; Mallatt, Jon			A Palaeozoic shark with osteichthyan-like branchial arches	NATURE			English	Article							EVOLUTION; JAW; CHONDRICHTHYAN; ORIGIN	The evolution of serially arranged, jointed endoskeletal supports internal to the gills-the visceral branchial arches-represents one of the key events in early jawed vertebrate (gnathostome) history, because it provided the morphological basis for the subsequent evolution of jaws. However, until now little was known about visceral arches in early gnathostomes, and theories about gill arch evolution were driven by information gleaned mostly from both modern cartilaginous (chondrichthyan) and bony (osteichthyan) fishes. New fossil discoveries can profoundly affect our understanding of evolutionary history, by revealing hitherto unseen combinations of primitive and derived characters. Here we describe a 325 million year (Myr)-old Palaeozoic shark-like fossil that represents, to our knowledge, the earliest identified chondrichthyan in which the complete gill skeleton is three-dimensionally preserved in its natural position. Its visceral arch arrangement is remarkably osteichthyan-like, suggesting that this may represent the common ancestral condition for crown gnathostomes. Our findings thus reinterpret the polarity of some arch features of the crown jawed vertebrates and invert the classic hypothesis, in which modern sharks retain the ancestral condition. This study underscores the importance of early chondrichthyans in resolving the evolutionary history of jawed vertebrates.	[Pradel, Alan; Maisey, John G.] Amer Museum Nat Hist, Dept Vertebrate Paleontol, New York, NY 10024 USA; [Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Mapes, Royal H.] Ohio Univ, Dept Geol Sci, Athens, OH 45701 USA; [Mallatt, Jon] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA	American Museum of Natural History (AMNH); European Synchrotron Radiation Facility (ESRF); University System of Ohio; Ohio University; Washington State University	Pradel, A (corresponding author), Amer Museum Nat Hist, Dept Vertebrate Paleontol, Cent Pk West 79th St, New York, NY 10024 USA.	apradel@amnh.org; maisey@amnh.org		Tafforeau, Paul/0000-0002-5962-1683	H. R. & E. Axelrod Research Chair in paleoichthyology at the AMNH	H. R. & E. Axelrod Research Chair in paleoichthyology at the AMNH	We thank staff at the ID19 beamline at the ESRF for assistance, and F. Ippolito (AMNH) for photographs of the specimens. The main work was supported by the H. R. & E. Axelrod Research Chair in paleoichthyology at the AMNH.	Carvalho M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062389; Coates MI, 2001, J VERTEBR PALEONTOL, V21, P438, DOI 10.1671/0272-4634(2001)021[0438:ANSCFT]2.0.CO;2; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; de Beer G., 1937, DEV VERTEBRATE SKULL; DICK J R F, 1978, Transactions of the Royal Society of Edinburgh, V70, P63; Friedman M, 2010, J VERTEBR PALEONTOL, V30, P36, DOI 10.1080/02724630903409071; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; GEGENBAUR C, 1879, ELEMENTS COMPARATIVE; Grogan ED, 2000, J MORPHOL, V243, P219, DOI 10.1002/(SICI)1097-4687(200003)243:3<219::AID-JMOR1>3.0.CO;2-1; Heidtke Ulrich H.J., 2001, Mainzer Geowissenschaftliche Mitteilungen, V30, P105; Holmgren N., 1942, ADA ZOOL [STOCKHOLM], V23, P129; Janvier P., 1996, EARLY VERTEBRATES; JARVIK E, 1980, BASIC STRUCT EVOLUTI, V1; Kuratani S, 2012, EVOL DEV, V14, P76, DOI 10.1111/j.1525-142X.2011.00523.x; Lane JA, 2012, J PALEONTOL, V86, P886, DOI 10.1666/11-139.1; Maisey JG, 2012, J FISH BIOL, V80, P918, DOI 10.1111/j.1095-8649.2012.03245.x; Mallatt J, 1996, ZOOL J LINN SOC-LOND, V117, P329, DOI 10.1111/j.1096-3642.1996.tb01658.x; Mallatt J, 1997, ACTA ZOOL-STOCKHOLM, V78, P279, DOI 10.1111/j.1463-6395.1997.tb01012.x; MAPES RH, 1979, CARBONIFEROUS PERMAI; NELSON G J, 1968, Nobel Symposium, P129; Nelson G. J., 1969, B AM MUS NAT HIST, V141, P477; NIELSEN E, 1942, STUDIES TRIASSIC FIS, V1; PATTERSON C, 1981, ANNU REV ECOL SYST, V12, P195, DOI 10.1146/annurev.es.12.110181.001211; Pradel A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066988; Pradel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024938; Shirai S., 1992, SQUALEAN PHYLOGENY N; Watson D. M. S., 1937, Philosophical Transactions London, V228B, P49, DOI 10.1098/rstb.1937.0009; ZANGERL R, 1975, Palaeontology (Oxford), V18, P333; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617; [No title captured]	30	37	37	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					608	+		10.1038/nature13195	http://dx.doi.org/10.1038/nature13195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24739974				2022-12-28	WOS:000336457100056
J	Groves, T				Groves, Trish			UK Research Paper of the Year: evidence that matters	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIAL		BMJ, London WC1H 9JR, England		Groves, T (corresponding author), BMJ, London WC1H 9JR, England.	tgroves@bmj.com	Groves, Trish/A-9119-2009	Groves, Trish/0000-0001-7915-6419				Allen SJ, 2013, LANCET, V382, P1249, DOI 10.1016/S0140-6736(13)61218-0; George J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6954; Gibb DM, 2013, LANCET, V381, P1391, DOI 10.1016/S0140-6736(12)62198-9; Joshi NV, 2014, LANCET, V383, P705, DOI 10.1016/S0140-6736(13)61754-7; Quint JK, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6650	5	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2014	348								g2944	10.1136/bmj.g2944	http://dx.doi.org/10.1136/bmj.g2944			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5PN	24778269				2022-12-28	WOS:000335471000006
J	Appel, AM				Appel, Aaron M.			Catalysis at the boundaries	NATURE			English	Editorial Material								Copper-based materials have been found that efficiently convert carbon monoxide and water to ethanol using electricity. The discovery is a major advance towards storing renewable energy in the form of a liquid fuel. SEE LETTER p. 504	Pacific NW Natl Lab, Catalysis Sci Grp, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Appel, AM (corresponding author), Pacific NW Natl Lab, Catalysis Sci Grp, Richland, WA 99352 USA.	aaron.appel@pnnl.gov		Appel, Aaron/0000-0002-5604-1253				Appel AM, 2013, CHEM REV, V113, P6621, DOI 10.1021/cr300463y; Cook TR, 2010, CHEM REV, V110, P6474, DOI 10.1021/cr100246c; Hori Y, 2008, MOD ASP ELECTROCHEM, P89; Kondratenko EV, 2013, ENERG ENVIRON SCI, V6, P3112, DOI 10.1039/c3ee41272e; Li CW, 2014, NATURE, V508, P504, DOI 10.1038/nature13249; Li CW, 2012, J AM CHEM SOC, V134, P7231, DOI 10.1021/ja3010978; Olah GA, 2011, J AM CHEM SOC, V133, P12881, DOI 10.1021/ja202642y; Thoi VS, 2013, CHEM SOC REV, V42, P2388, DOI 10.1039/c2cs35272a	8	7	7	0	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					460	461		10.1038/nature13226	http://dx.doi.org/10.1038/nature13226			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24717431				2022-12-28	WOS:000334741600020
J	Bianchi, E; Doe, B; Goulding, D; Wright, GJ				Bianchi, Enrica; Doe, Brendan; Goulding, David; Wright, Gavin J.			Juno is the egg Izumo receptor and is essential for mammalian fertilization	NATURE			English	Article							REGULATORY T-CELLS; MEMBRANE BLOCK; SPERM PENETRATION; PLASMA-MEMBRANE; MYOBLAST FUSION; FOLIC-ACID; FOLATE; POLYSPERMY; CD9; SURFACE	Fertilization occurs when sperm and egg recognize each other and fuse to form a new, genetically distinct organism. The molecular basis of sperm-egg recognition is unknown, but is likely to require interactions between receptor proteins displayed on their surface. Izumo1 is an essential sperm cell-surface protein, but its receptor on the egg has not been described. Here we identify folate receptor 4 (Folr4) as the receptor for Izumo1 on the mouse egg, and propose to rename it Juno. We show that the Izumo1-Juno interaction is conserved within several mammalian species, including humans. Female mice lacking Juno are infertile and Juno-deficient eggs do not fuse with normal sperm. Rapid shedding of Juno from the oolemma after fertilization suggests a mechanism for the membrane block to polyspermy, ensuring eggs normally fuse with just a single sperm. Our discovery of an essential receptor pair at the nexus of conception provides opportunities for the rational development of new fertility treatments and contraceptives.	[Bianchi, Enrica; Wright, Gavin J.] Wellcome Trust Sanger Inst, Cell Surface Signalling Lab, Cambridge CB10 1SA, England; [Doe, Brendan] Wellcome Trust Sanger Inst, Mouse Prod Team, Cambridge CB10 1SA, England; [Goulding, David] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute	Wright, GJ (corresponding author), Wellcome Trust Sanger Inst, Cell Surface Signalling Lab, Cambridge CB10 1SA, England.	gw2@sanger.ac.uk	Bianchi, Enrica/P-2379-2019	Bianchi, Enrica/0000-0001-8124-7328; Wright, Gavin/0000-0003-0537-0863	Wellcome Trust [098051]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust grant number 098051. Juno-deficient mice were generated by the Sanger Institute Mouse Genetics Project. We thank W. Skarnes and J. Bussell for advice on transgenic mice; J. Kerr for construct design; A. Bradley and L. Jovine for helpful comments on the manuscript; and M. Okabe and N. Inoue for the OBF13 antibody.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Alfieri JA, 2003, J CELL SCI, V116, P2149, DOI 10.1242/jcs.00430; Bartholdson SJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003031; Bushell KM, 2008, GENOME RES, V18, P622, DOI 10.1101/gr.7187808; Chen C, 2013, NATURE, V500, P486, DOI 10.1038/nature12327; Coonrod SA, 1999, DEV BIOL, V207, P334, DOI 10.1006/dbio.1998.9161; Crosnier C, 2013, MOL CELL PROTEOMICS, V12, P3976, DOI 10.1074/mcp.O113.028357; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Ellerman DA, 2009, MOL REPROD DEV, V76, P1188, DOI 10.1002/mrd.21092; Gardner AJ, 2006, REPROD FERT DEVELOP, V18, P53, DOI 10.1071/RD05122; Gardner AJ, 2007, REPRODUCTION, V133, P383, DOI 10.1530/REP-06-0304; Golemis E., 2001, PROTEIN PROTEIN INTE; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; HORVATH PM, 1993, MOL REPROD DEV, V34, P65, DOI 10.1002/mrd.1080340111; Ikawa M, 2010, J CLIN INVEST, V120, P984, DOI 10.1172/JCI41585; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Inoue N, 2013, DEVELOPMENT, V140, P3221, DOI 10.1242/dev.094854; JACKOWSKI S, 1979, BIOL REPROD, V20, P150, DOI 10.1095/biolreprod20.2.150; JAFFE LA, 1976, NATURE, V261, P68, DOI 10.1038/261068a0; Jegou A, 2011, P NATL ACAD SCI USA, V108, P10946, DOI 10.1073/pnas.1017400108; Jia ZC, 2009, IMMUNOL INVEST, V38, P718, DOI 10.3109/08820130903171003; Kaji K, 2000, NAT GENET, V24, P279, DOI 10.1038/73502; Kerr JS, 2012, JOVE-J VIS EXP, DOI 10.3791/3881; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Kinoshita M, 2012, J IMMUNOL, V189, P2869, DOI 10.4049/jimmunol.1200420; Kunisawa J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032094; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; Liang SC, 2013, CLIN IMMUNOL, V148, P287, DOI 10.1016/j.clim.2013.05.011; Martin S, 2010, MOL CELL PROTEOMICS, V9, P2654, DOI 10.1074/mcp.M110.004119; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Nagy A., 2003, MANIPULATING MOUSE E; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; Okabe M, 2013, DEVELOPMENT, V140, P4471, DOI 10.1242/dev.090613; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; Powell GT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001216; Runge KE, 2007, DEV BIOL, V304, P317, DOI 10.1016/j.ydbio.2006.12.041; Sabharanjak S, 2004, ADV DRUG DELIVER REV, V56, P1099, DOI 10.1016/j.addr.2004.01.010; Salbaum JM, 2013, BBA-MOL BASIS DIS, V1832, P1653, DOI 10.1016/j.bbadis.2013.04.028; Satouh Y, 2012, J CELL SCI, V125, P4985, DOI 10.1242/jcs.100867; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Sun Y, 2012, ANAL BIOCHEM, V424, P45, DOI 10.1016/j.ab.2012.01.034; Teng MWL, 2010, CANCER RES, V70, P2665, DOI 10.1158/0008-5472.CAN-09-1574; Wibowo AS, 2013, P NATL ACAD SCI USA, V110, P15180, DOI 10.1073/pnas.1308827110; WOLF DP, 1978, DEV BIOL, V64, P1, DOI 10.1016/0012-1606(78)90056-8; Wortzman-Show GB, 2007, MOL HUM REPROD, V13, P557, DOI 10.1093/molehr/gam042; Wright GJ, 2009, MOL BIOSYST, V5, P1405, DOI [10.1039/B903580J, 10.1039/b903580j]; Yamaguchi T, 2007, IMMUNITY, V27, P145, DOI 10.1016/j.immuni.2007.04.017; Zylkiewicz E, 2010, ZYGOTE, V18, P195, DOI 10.1017/S0967199409990189	50	329	346	2	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					483	+		10.1038/nature13203	http://dx.doi.org/10.1038/nature13203			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24739963	Green Accepted			2022-12-28	WOS:000334741600028
J	Faillie, JL; Azoulay, L; Patenaude, V; Hillaire-Buys, D; Suissa, S				Faillie, Jean-Luc; Azoulay, Laurent; Patenaude, Valerie; Hillaire-Buys, Dominique; Suissa, Samy			Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRACTICE RESEARCH DATABASE; EXENATIDE; CANCER; POPULATION; ASSOCIATION; THERAPIES; METFORMIN; MELLITUS	Objectives To determine whether the use of incretin based drugs, compared with sulfonylureas, is associated with an increased risk of acute pancreatitis. Design Population based cohort study. Setting 680 general practices in the United Kingdom contributing to the Clinical Practice Research Datalink. Participants From 1 January 2007 to 31 March 2012, 20 748 new users of incretin based drugs were compared with 51 712 users of sulfonylureas and followed up until 31 March 2013. Main outcome measures Cox proportional hazards models were used to estimate hazard ratios and 95% confidence intervals for acute pancreatitis in users of incretin based drugs compared with users of sulfonylureas. Models were adjusted for tenths of high dimensional propensity score (hdPS). Results The crude incidence rate for acute pancreatitis was 1.45 per 1000 patients per year (95% confidence interval 0.99 to 2.11) for incretin based drug users and 1.47 (1.23 to 1.76) for sulfonylurea users. The rate of acute pancreatitis associated with the use of incretin based drugs was not increased (hdPS adjusted hazard ratio: 1.00, 95% confidence interval 0.59 to 1.70) relative to sulfonylurea use. Conclusions Compared with use of sulfonylureas, the use of incretin based drugs is not associated with an increased risk of acute pancreatitis. While this study is reassuring, it does not preclude a modest increased risk, and thus additional studies are needed to confirm these findings.	[Faillie, Jean-Luc; Azoulay, Laurent; Patenaude, Valerie; Suissa, Samy] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Faillie, Jean-Luc] Univ Toulouse 3, Dept Pharmacoepidemiol, Fac Med, INSERM,U1027, F-31062 Toulouse, France; [Faillie, Jean-Luc; Hillaire-Buys, Dominique] Montpellier Univ Hosp, Dept Med Pharmacol & Toxicol, Montpellier, France; [Azoulay, Laurent] McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; [Hillaire-Buys, Dominique] Univ Montpellier I, Fac Med, INSERM, U1058, Montpellier, France; [Suissa, Samy] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Montpellier; CHU de Montpellier; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; McGill University	Suissa, S (corresponding author), McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada.	samy.suissa@mcgill.ca	Azoulay, Laurent/Z-4421-2019; Faillie, Jean-Luc/AAA-6009-2019	Faillie, Jean-Luc/0000-0003-0100-4073; Azoulay, Laurent/0000-0001-5162-3556	Canadian Institute of Health Research (CIHR); Canada Foundation for Innovation; Societe Francophone du Diabete; Fonds de recherche du Quebec-Sante; James McGill Chair award	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Societe Francophone du Diabete; Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); James McGill Chair award	This study was funded in part by research grants from the Canadian Institute of Health Research (CIHR), and the Canada Foundation for Innovation. The funding sources had no role in the design, analysis, or interpretation of the results, and thus the authors were independent from the funding sources. J-LF receives a grant from the Societe Francophone du Diabete, LA is the recipient of a Chercheur-Boursier career award from the Fonds de recherche du Quebec-Sante, and SS is the recipient of the James McGill Chair award. Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: database acquisitions were funded by the Canadian Institute of Health Research (CIHR) and the Canada Foundation for Innovation; SS has received research grants, participated in advisory board meetings and/or as a speaker at conferences for AstraZeneca, Bayer, Boehringer-Ingelheim, Bristol-Myers-Squibb, Merck, and Novartis, all of which except Bayer are manufacturers of incretin based drugs, though none of these activities were related to diabetes or incretins, with the exception of a single participation in a mock advisory panel for Bristol-Myers-Squibb. Ethical approval: The study protocol was approved by the independent scientific advisory committee of the Clinical Practice Research Datalink and by the research ethics board of the Jewish General Hospital, Montreal, Canada.	Butler AE, 2013, DIABETES, V62, P2595, DOI 10.2337/db12-1686; Butler PC, 2013, DIABETES CARE, V36, P2118, DOI 10.2337/dc12-2713; Cohen D., 2013, BMJ-BRIT MED J, V346, pf1808; Cohen D., 2013, BMJ-BRIT MED J, V347, pf4838; Dore DD, 2011, DIABETES OBES METAB, V13, P559, DOI 10.1111/j.1463-1326.2011.01376.x; Dore DD, 2009, CURR MED RES OPIN, V25, P1019, DOI [10.1185/03007990902820519, 10.1185/03007990902820519 ]; Drucker DJ, 2013, DIABETES, V62, P3316, DOI 10.2337/db13-0822; Drucker DJ, 2002, GASTROENTEROLOGY, V122, P531, DOI 10.1053/gast.2002.31068; Elashoff M, 2011, GASTROENTEROLOGY, V141, P150, DOI 10.1053/j.gastro.2011.02.018; EURICH DT, 2013, BMJ-BRIT MED J, V346, P2267, DOI DOI 10.1136/BMJ.F2267; European Medicines Agency, 2012, SUMM PROD CHAR; Faillie JL, 2014, ACTA DIABETOL, V51, P491, DOI 10.1007/s00592-013-0544-0; Funch D, 2014, DIABETES OBES METAB, V16, P273, DOI 10.1111/dom.12230; Garbe E, 2013, EUR J CLIN PHARMACOL, V69, P549, DOI 10.1007/s00228-012-1334-2; Garg R, 2010, DIABETES CARE, V33, P2349, DOI 10.2337/dc10-0482; Giorda CB, 2014, LANCET DIABETES ENDO, V2, P111, DOI 10.1016/S2213-8587(13)70147-5; Girman CJ, 2010, DIABETES OBES METAB, V12, P766, DOI 10.1111/j.1463-1326.2010.01231.x; Gonzalez-Perez A, 2010, DIABETES CARE, V33, P2580, DOI 10.2337/dc10-0842; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Huberman M, 1999, AM J EPIDEMIOL, V150, P1340; Institute for Safe Medication Practices, 2013, PERSP GLP 1 AGENTS D; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Laferrere B, 2007, DIABETES CARE, V30, P1709, DOI 10.2337/dc06-1549; Monami M, 2014, DIABETES OBES METAB, V16, P48, DOI 10.1111/dom.12176; Monami M, 2014, DIABETES RES CLIN PR, V103, P269, DOI 10.1016/j.diabres.2014.01.010; Noel RA, 2009, DIABETES CARE, V32, P834, DOI 10.2337/dc08-1755; Parsons LS, 2001, P 26 ANN SAS USERS G; Raschi E, 2013, ACTA DIABETOL, V50, P569, DOI 10.1007/s00592-011-0340-7; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Romley JA, 2012, DIABETES TECHNOL THE, V14, P904, DOI 10.1089/dia.2012.0075; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Singh S, 2013, JAMA INTERN MED, V173, P534, DOI 10.1001/jamainternmed.2013.2720; Suissa S, 2012, DIABETES CARE, V35, P2665, DOI 10.2337/dc12-0788; US Food and Drug Administration, 2009, INF HEALTHC PROF ACU; US Food and Drug Administration, 2008, INFORM HEALTHC PROF; US Food and Drug Administration, SAF REQ VIC LIR; Wenten M, 2012, DIABETIC MED, V29, P1412, DOI 10.1111/j.1464-5491.2012.03652.x; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889	40	58	58	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2014	348								g2780	10.1136/bmj.g2780	http://dx.doi.org/10.1136/bmj.g2780			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG1DI	24764569	Green Published, hybrid			2022-12-28	WOS:000335154900002
J	Puente, BN; Kimura, W; Muralidhar, SA; Moon, J; Amatruda, JF; Phelps, KL; Grinsfelder, D; Rothermel, BA; Chen, R; Garcia, JA; Santos, CX; Thet, S; Mori, E; Kinter, MT; Rindler, PM; Zacchigna, S; Mukherjee, S; Chen, DJ; Mahmoud, AI; Giacca, M; Rabinovitch, PS; Aroumougame, A; Shah, AM; Szweda, LI; Sadek, HA				Puente, Bao N.; Kimura, Wataru; Muralidhar, Shalini A.; Moon, Jesung; Amatruda, James F.; Phelps, Kate L.; Grinsfelder, David; Rothermel, Beverly A.; Chen, Rui; Garcia, Joseph A.; Santos, Celio X.; Thet, SuWannee; Mori, Eiichiro; Kinter, Michael T.; Rindler, Paul M.; Zacchigna, Serena; Mukherjee, Shibani; Chen, David J.; Mahmoud, Ahmed I.; Giacca, Mauro; Rabinovitch, Peter S.; Aroumougame, Asaithamby; Shah, Ajay M.; Szweda, Luke I.; Sadek, Hesham A.			The Oxygen-Rich Postnatal Environment Induces Cardiomyocyte Cell-Cycle Arrest through DNA Damage Response	CELL			English	Article							HEART REGENERATION; GROWTH-FACTOR; MYOCARDIAL REGENERATION; MAMMALIAN HEART; HYPOXIA; PROLIFERATION; GENERATION; ZEBRAFISH; DIFFERENTIATION; OVEREXPRESSION	The mammalian heart has a remarkable regenerative capacity for a short period of time after birth, after which the majority of cardiomyocytes permanently exit cell cycle. We sought to determine the primary postnatal event that results in cardiomyocyte cell-cycle arrest. We hypothesized that transition to the oxygen-rich postnatal environment is the upstream signal that results in cell-cycle arrest of cardiomyocytes. Here, we show that reactive oxygen species (ROS), oxidative DNA damage, and DNA damage response (DDR) markers significantly increase in the heart during the first postnatal week. Intriguingly, postnatal hypoxemia, ROS scavenging, or inhibition of DDR all prolong the postnatal proliferative window of cardiomyocytes, whereas hyperoxemia and ROS generators shorten it. These findings uncover a protective mechanism that mediates cardiomyocyte cell-cycle arrest in exchange for utilization of oxygen-dependent aerobic metabolism. Reduction of mitochondrial-dependent oxidative stress should be an important component of cardiomyocyte proliferation-based therapeutic approaches.	[Puente, Bao N.; Kimura, Wataru; Muralidhar, Shalini A.; Amatruda, James F.; Rothermel, Beverly A.; Chen, Rui; Garcia, Joseph A.; Thet, SuWannee; Sadek, Hesham A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Amatruda, James F.; Rothermel, Beverly A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Puente, Bao N.; Moon, Jesung; Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Phelps, Kate L.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Grinsfelder, David] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Mori, Eiichiro; Mukherjee, Shibani; Chen, David J.; Aroumougame, Asaithamby] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Santos, Celio X.; Shah, Ajay M.] Kings Coll London, BHF Ctr Res Excellence, Sch Med, Cardiovasc Div,James Black Ctr, London SE5 9NU, England; [Kinter, Michael T.; Rindler, Paul M.; Szweda, Luke I.] Oklahoma Med Res Fdn, Free Rad Biol & Aging Res Program, Oklahoma City, OK 73104 USA; [Zacchigna, Serena; Giacca, Mauro] Int Ctr Genet Engn & Biotechnol, Mol Med Lab, I-34149 Trieste, Italy; [Rabinovitch, Peter S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Mahmoud, Ahmed I.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Cambridge, MA 02115 USA; [Mahmoud, Ahmed I.] Harvard Univ, Sch Med, Cambridge, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of London; King's College London; Oklahoma Medical Research Foundation; International Center for Genetic Engineering & Biotechnology (ICGEB); University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University	Sadek, HA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	hesham.sadek@utsouthwestern.edu	Giacca, Mauro/J-9287-2016; Mori, Eiichiro/AAY-6830-2020; ZACCHIGNA, SERENA/E-9496-2017	Giacca, Mauro/0000-0003-2927-7225; Mori, Eiichiro/0000-0003-0945-196X; Mahmoud, Ahmed/0000-0003-1528-7393; ZACCHIGNA, SERENA/0000-0001-6705-3076; Shah, Ajay/0000-0002-6547-0631; Kimura, Wataru/0000-0001-6548-6353; Garcia, Joseph/0000-0002-5621-7538; Kinter, Michael/0000-0001-7409-8918	National Aeronautics and Space Administration (NASA) [NNX13AD57G, 20090506]; European Research Council (ERC); British Heart Foundation and a Fondation Leducq Transatlantic Network; American Heart Association; Foundation for Heart Failure Research (NY); NIH [1R01HL115275-01]; British Heart Foundation [RG/13/11/30384] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108104, R01HL072016, R01HL115275, R01HL097768] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000446] Funding Source: NIH RePORTER	National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); European Research Council (ERC)(European Research Council (ERC)European Commission); British Heart Foundation and a Fondation Leducq Transatlantic Network; American Heart Association(American Heart Association); Foundation for Heart Failure Research (NY); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	We thank Dr. James Richardson and John Shelton for their valuable input.This work is supported by National Aeronautics and Space Administration (NASA) grant NNX13AD57G (A.A.), Advanced grant 20090506 from the European Research Council (ERC) (M.G.), the British Heart Foundation and a Fondation Leducq Transatlantic Network (A.M.S.), as well as grants from the American Heart Association (Grant in Aid), Foundation for Heart Failure Research (NY), and the NIH (grant 1R01HL115275- 01) (H.A.S.).	BECKER RO, 1974, NATURE, V248, P145, DOI 10.1038/248145a0; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Birket MJ, 2013, STEM CELL REP, V1, P560, DOI 10.1016/j.stemcr.2013.11.008; Chen JH, 2013, CIRC RES, V112, P1557, DOI 10.1161/CIRCRESAHA.112.300658; Dai DF, 2011, CIRC RES, V108, P837, DOI 10.1161/CIRCRESAHA.110.232306; DAWES GS, 1954, J PHYSIOL-LONDON, V126, P563, DOI 10.1113/jphysiol.1954.sp005227; Dismukes GC, 2001, P NATL ACAD SCI USA, V98, P2170, DOI 10.1073/pnas.061514798; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; FISHER DJ, 1980, AM J PHYSIOL, V238, pH399, DOI 10.1152/ajpheart.1980.238.3.H399; Flink IL, 2002, ANAT EMBRYOL, V205, P235, DOI 10.1007/s00429-002-0249-6; GERTZ EW, 1988, J CLIN INVEST, V82, P2017, DOI 10.1172/JCI113822; Halliwell B.G.J.M.C., 2007, FREE RADICALS BIOL M; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; JACKSON T, 1990, MOL CELL BIOL, V10, P3709, DOI 10.1128/MCB.10.7.3709; Jopling C, 2012, CIRCULATION, V126, P3017, DOI 10.1161/CIRCULATIONAHA.112.107888; Judge S, 2007, AM J PHYSIOL-CELL PH, V292, pC1983, DOI 10.1152/ajpcell.00285.2006; Kirshenbaum R., 1997, J CLIN INVEST, V100, P2722; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Laflamme MA, 2002, CIRC RES, V90, P634, DOI 10.1161/01.RES.0000014822.62629.EB; Lawrence J, 2008, J PHARMACOL EXP THER, V324, P331, DOI 10.1124/jpet.107.132175; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Leslie NR, 2006, ANTIOXID REDOX SIGN, V8, P1765, DOI 10.1089/ars.2006.8.1765; Liao HS, 2001, CIRC RES, V88, P443; Liu ZP, 2010, CIRC RES, V106, P1498, DOI 10.1161/CIRCRESAHA.109.211888; LOPASCHUK GD, 1992, CARDIOVASC RES, V26, P1172, DOI 10.1093/cvr/26.12.1172; LOPASCHUK GD, 1994, BBA-LIPID LIPID MET, V1213, P263, DOI 10.1016/0005-2760(94)00082-4; Mahmoud AI, 2013, NATURE, V497, P249, DOI 10.1038/nature12054; Gonzalez-Rosa JM, 2011, DEVELOPMENT, V138, P1663, DOI 10.1242/dev.060897; Marnett LJ, 2003, J CLIN INVEST, V111, P583, DOI 10.1172/JCI200318022; Marques IJ, 2008, J COMP PHYSIOL B, V178, P77, DOI 10.1007/s00360-007-0201-4; Mills EM, 1998, J BIOL CHEM, V273, P22165, DOI 10.1074/jbc.273.35.22165; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; MITCHELL JA, 1992, ALCOHOL CLIN EXP RES, V16, P308, DOI 10.1111/j.1530-0277.1992.tb01382.x; Moos PJ, 2000, P NATL ACAD SCI USA, V97, P9215, DOI 10.1073/pnas.160241897; Nadal-Ginard B, 2001, REV ESP CARDIOL, V54, P543, DOI 10.1016/S0300-8932(01)76354-3; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Pi Y, 2013, LAB INVEST, V93, P880, DOI 10.1038/labinvest.2013.79; Porrello ER, 2013, P NATL ACAD SCI USA, V110, P187, DOI 10.1073/pnas.1208863110; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Puceat M, 2003, MOL BIOL CELL, V14, P2781, DOI 10.1091/mbc.E02-09-0562; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Rees BB, 2001, J EXP ZOOL, V289, P266, DOI 10.1002/1097-010X(20010401/30)289:4&lt;266::AID-JEZ7&gt;3.0.CO;2-5; Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630; Reynolds JD, 1996, ALCOHOL, V13, P251, DOI 10.1016/0741-8329(95)02051-9; Roesner A, 2006, J EXP BIOL, V209, P2129, DOI 10.1242/jeb.02243; RUDOLPH AM, 1974, ANNU REV PHYSIOL, V36, P187, DOI 10.1146/annurev.ph.36.030174.001155; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Sauer H, 2000, FEBS LETT, V476, P218, DOI 10.1016/S0014-5793(00)01747-6; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Sdek P, 2011, J CELL BIOL, V194, P407, DOI 10.1083/jcb.201012049; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tsatmali M, 2006, MOL CELL NEUROSCI, V33, P345, DOI 10.1016/j.mcn.2006.08.005; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Wang JH, 2011, DEVELOPMENT, V138, P3421, DOI 10.1242/dev.068601; Webster William S., 2007, Birth Defects Research, V81, P215, DOI 10.1002/bdrc.20102; WISNESKI JA, 1985, J CLIN INVEST, V76, P1819, DOI 10.1172/JCI112174; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Yoneyama M, 2010, NEUROCHEM INT, V56, P740, DOI 10.1016/j.neuint.2009.11.018; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102	72	474	484	3	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					565	579		10.1016/j.cell.2014.03.032	http://dx.doi.org/10.1016/j.cell.2014.03.032			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766806	Bronze, Green Accepted			2022-12-28	WOS:000335392100008
J	Schaffer, AE; Eggens, VRC; Caglayan, AO; Reuter, MS; Scott, E; Coufal, NG; Silhavy, JL; Xue, YC; Kayserili, H; Yasuno, K; Rosti, RO; Abdellateef, M; Caglar, C; Kasher, PR; Cazemier, JL; Weterman, MA; Cantagrel, V; Cai, N; Zweier, C; Altunoglu, U; Satkin, NB; Aktar, F; Tuysuz, B; Yalcinkaya, C; Caksen, H; Bilguvar, K; Fu, XD; Trotta, CR; Gabriel, S; Reis, A; Gunel, M; Baas, F; Gleeson, JG				Schaffer, Ashleigh E.; Eggens, Veerle R. C.; Caglayan, Ahmet Okay; Reuter, Miriam S.; Scott, Eric; Coufal, Nicole G.; Silhavy, Jennifer L.; Xue, Yuanchao; Kayserili, Hulya; Yasuno, Katsuhito; Rosti, Rasim Ozgur; Abdellateef, Mostafa; Caglar, Caner; Kasher, Paul R.; Cazemier, J. Leonie; Weterman, Marian A.; Cantagrel, Vincent; Cai, Na; Zweier, Christiane; Altunoglu, Umut; Satkin, N. Bilge; Aktar, Fesih; Tuysuz, Beyhan; Yalcinkaya, Cengiz; Caksen, Huseyin; Bilguvar, Kaya; Fu, Xiang-Dong; Trotta, Christopher R.; Gabriel, Stacey; Reis, Andre; Gunel, Murat; Baas, Frank; Gleeson, Joseph G.			CLP1 Founder Mutation Links tRNA Splicing and Maturation to Cerebellar Development and Neurodegeneration	CELL			English	Article							CAUSE PONTOCEREBELLAR HYPOPLASIA; OXIDATIVE STRESS; IN-VIVO; ENDONUCLEASE; ZEBRAFISH; CLEAVAGE; GENE; IDENTIFICATION; EUKARYOTES; REVEALS	Neurodegenerative diseases can occur so early as to affect neurodevelopment. From a cohort of more than 2,000 consanguineous families with childhood neurological disease, we identified a founder mutation in four independent pedigrees in cleavage and polyadenylation factor I subunit 1 (CLP1). CLP1 is a multifunctional kinase implicated in tRNA, mRNA, and siRNA maturation. Kinase activity of the CLP1 mutant protein was defective, and the tRNA endonuclease complex (TSEN) was destabilized, resulting in impaired pre-tRNA cleavage. Germline clp1 null zebrafish showed cerebellar neurodegeneration that was rescued by wild-type, but not mutant, human CLP1 expression. Patient-derived induced neurons displayed both depletion of mature tRNAs and accumulation of unspliced pre-tRNAs. Transfection of partially processed tRNA fragments into patient cells exacerbated an oxidative stress-induced reduction in cell survival. Our data link tRNA maturation to neuronal development and neurodegeneration through defective CLP1 function in humans.	[Schaffer, Ashleigh E.; Scott, Eric; Coufal, Nicole G.; Silhavy, Jennifer L.; Rosti, Rasim Ozgur; Abdellateef, Mostafa; Cantagrel, Vincent; Cai, Na; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, Neurogenet Lab, La Jolla, CA 92093 USA; [Eggens, Veerle R. C.; Kasher, Paul R.; Cazemier, J. Leonie; Weterman, Marian A.; Baas, Frank] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Amsterdam, Netherlands; [Caglayan, Ahmet Okay; Yasuno, Katsuhito; Caglar, Caner; Bilguvar, Kaya; Gunel, Murat] Yale Univ, Sch Med, Yale Program Neurogenet, Dept Neurosurg, New Haven, CT 06510 USA; [Caglayan, Ahmet Okay; Yasuno, Katsuhito; Caglar, Caner; Bilguvar, Kaya; Gunel, Murat] Yale Univ, Sch Med, Yale Program Neurogenet, Dept Neurobiol, New Haven, CT 06510 USA; [Caglayan, Ahmet Okay; Yasuno, Katsuhito; Caglar, Caner; Bilguvar, Kaya; Gunel, Murat] Yale Univ, Sch Med, Yale Program Neurogenet, Dept Genet, New Haven, CT 06510 USA; [Reuter, Miriam S.; Zweier, Christiane; Reis, Andre] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Xue, Yuanchao; Fu, Xiang-Dong] Univ Calif San Diego, La Jolla, CA 92093 USA; [Kayserili, Hulya; Altunoglu, Umut; Satkin, N. Bilge] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, TR-34093 Fatih Istanbul, Turkey; [Cantagrel, Vincent] Fac Paris Descartes, INSERM, U1163, Inst IMAGINE, F-75015 Paris, France; [Aktar, Fesih] Diyarbakir State Hosp, Dept Pediat, TR-21100 Diyarbakir, Turkey; [Tuysuz, Beyhan] Istanbul Univ, Cerrahpasa Med Sch, Dept Pediat Genet, TR-34098 Istanbul, Turkey; [Yalcinkaya, Cengiz] Istanbul Univ, Cerrahpasa Med Sch, Div Child Neurol, Dept Neurol, TR-34098 Istanbul, Turkey; [Caksen, Huseyin] Necmettin Erbakan Univ, Meram Med Sch, Dept Pediat, TR-42080 Konya, Turkey; [Trotta, Christopher R.] PTC Therapeut, South Plainfield, NJ 07080 USA; [Gabriel, Stacey] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Amsterdam; Academic Medical Center Amsterdam; Yale University; Yale University; Yale University; University of Erlangen Nuremberg; University of California System; University of California San Diego; Istanbul University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Diyarbakir Lice Halis Toprak Foundation State Hospital; Diyarbakir Training & Research Hospital; Saladin Diyarbakir State Hospital; Tigris Memorial Hospital; Istanbul University; Istanbul University - Cerrahpasa; Istanbul University; Istanbul University - Cerrahpasa; Necmettin Erbakan University; Selcuk University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Gleeson, JG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, Neurogenet Lab, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu	Zweier, Christiane/F-2202-2015; Wang, Guilin/G-8794-2018; Yalcinkaya, Cengiz/B-6288-2012; Kayserili, Hülya/AAA-5593-2021; Aktar, Fesih/G-5921-2016; Tüysüz, Beyhan/AAN-4858-2020; Baas, Frank/F-9574-2010; Coufal, Nicole/ABA-9471-2021; Vincent, Cantagrel/H-8698-2017; Reis, André/D-2309-2009; Yasuno, Katsuhito/E-1960-2012; Caglayan, Ahmet O/D-1066-2012; Caglar, Caner/ABE-5815-2021	Zweier, Christiane/0000-0001-8002-2020; Yalcinkaya, Cengiz/0000-0002-3443-8524; Kayserili, Hülya/0000-0003-0376-499X; Aktar, Fesih/0000-0002-0760-5681; Baas, Frank/0000-0003-3912-5428; Vincent, Cantagrel/0000-0002-5180-4848; Reis, André/0000-0002-6301-6363; Yasuno, Katsuhito/0000-0002-3606-532X; Caglayan, Ahmet O/0000-0002-2332-322X; Cazemier, Leonie/0000-0003-2875-6283; caglar, caner/0000-0002-5857-757X; Coufal, Nicole/0000-0001-6547-1733; Tuysuz, Beyhan/0000-0002-9620-5021; Schaffer, Ashleigh/0000-0002-1164-697X; XUE, YUANCHAO/0000-0002-8113-2333; Kasher, Paul/0000-0002-9213-502X; Altunoglu, Umut/0000-0002-3172-5368	National Institutes of Health (NIH) [P01HD070494, R01NS048453, P30NS047101]; Broad Institute [U54HG003067, GM049369]; Yale Center for Mendelian Disorders [U54HG006504, RC2NS070477]; Gregory M. Kiez and Mehmet Kutman Foundation; French National Research Agency [ANRRVP13016KKA]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101, R01NS098004, R01NS052455, RC2NS070477, R01NS048453] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Institute; Yale Center for Mendelian Disorders; Gregory M. Kiez and Mehmet Kutman Foundation; French National Research Agency(French National Research Agency (ANR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (NIH) (P01HD070494, R01NS048453, and P30NS047101 for imaging support to J.G.G., Broad Institute grant U54HG003067 to Eric Lander, GM049369 to X.-D.F., the Yale Center for Mendelian Disorders U54HG006504 to R. Lifton and M.G., RC2NS070477) and the Gregory M. Kiez and Mehmet Kutman Foundation to M.G. We acknowledge M. Gerstein, S. Mane, A.B. Ekici, and S. Uebe for sequencing support and analysis; the Yale Biomedical High Performance Computing Center for data analysis and storage; the Yale Program on Neurogenetics and the Yale Center for Human Genetics andGenomics; the Center for Inherited Disease Research for genotyping; and the Simons Foundation Autism Research Initiative. Consortium for Autosomal Recessive Intellectual Disability (CARID) supported patient ascertainment. We thank E.W.E. Verweij for zebrafish analysis, E. Cuppen and H. van Roekel for support with ENU Tilling, and ZF Health funding for tilling. A.E.S. is the recipient of an A. P. Gianinni Fellowship. V.C. was supported by the French National Research Agency (ANRRVP13016KKA). J.G.G. is an Investigator of the Howard Hughes Medical Institute. We thank patients and parents for participation and J. Lupski, J. Martinez, and S. Weitzer for communicating unpublished results and sharing reagents.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akizu N, 2013, CELL, V154, P505, DOI 10.1016/j.cell.2013.07.005; Boon KL, 2009, HUM MOL GENET, V18, P3615, DOI 10.1093/hmg/ddp310; Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204; CARMICHAEL J, 1987, CANCER RES, V47, P936; Chen HL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009318, 10.1371/journal.pone.0012885]; de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Fassier C, 2010, NAT NEUROSCI, V13, P1380, DOI 10.1038/nn.2662; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; GOUTIERES F, 1977, J NEUROL NEUROSUR PS, V40, P370, DOI 10.1136/jnnp.40.4.370; Hanada T, 2013, NATURE, V495, P474, DOI 10.1038/nature11923; Karaca E, 2014, CELL, V157, P636, DOI 10.1016/j.cell.2014.02.058; Kasher PR, 2011, HUM MOL GENET, V20, P1574, DOI 10.1093/hmg/ddr034; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Namavar Y, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-50; Namavar Y, 2011, BRAIN, V134, P143, DOI 10.1093/brain/awq287; Noble CG, 2007, NUCLEIC ACIDS RES, V35, P87, DOI 10.1093/nar/gkl1010; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; PEEBLES CL, 1983, CELL, V32, P525, DOI 10.1016/0092-8674(83)90472-5; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramirez A, 2008, RNA, V14, P1737, DOI 10.1261/rna.1142908; Renbaum P, 2009, AM J HUM GENET, V85, P281, DOI 10.1016/j.ajhg.2009.07.006; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Sobala A, 2013, RNA BIOL, V10, P553, DOI 10.4161/rna.24285; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Thompson DM, 2009, J CELL BIOL, V185, P43, DOI 10.1083/jcb.200811119; Trotta CR, 2006, NATURE, V441, P375, DOI 10.1038/nature04741; Volta V, 2005, BIOCHEM BIOPH RES CO, V337, P89, DOI 10.1016/j.bbrc.2005.09.012; Wan JJ, 2012, NAT GENET, V44, P704, DOI 10.1038/ng.2254; Weitzer S, 2007, NATURE, V447, P222, DOI 10.1038/nature05777; Wickens M, 2004, SCIENCE, V306, P1299, DOI 10.1126/science.1100137; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; ZILLMANN M, 1991, MOL CELL BIOL, V11, P5410, DOI 10.1128/MCB.11.11.5410	40	164	170	0	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					651	663		10.1016/j.cell.2014.03.049	http://dx.doi.org/10.1016/j.cell.2014.03.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766810	Bronze, Green Accepted			2022-12-28	WOS:000335392100014
J	Lee, H				Lee, Herb			Decisions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									JFK Med Ctr, Dept Anesthesiol, Edison, NJ 08820 USA		Lee, H (corresponding author), JFK Med Ctr, Dept Anesthesiol, Edison, NJ 08820 USA.	herb88@verizon.net						Pollock BE, 2004, J NEUROSURG, V100, P210, DOI 10.3171/jns.2004.100.2.0210	1	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2014	311	16					1613	1614		10.1001/jama.2014.3069	http://dx.doi.org/10.1001/jama.2014.3069			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF4OU	24756508				2022-12-28	WOS:000334693900018
J	Celebi, K; Buchheim, J; Wyss, RM; Droudian, A; Gasser, P; Shorubalko, I; Kye, JI; Lee, C; Park, HG				Celebi, Kemal; Buchheim, Jakob; Wyss, Roman M.; Droudian, Amirhossein; Gasser, Patrick; Shorubalko, Ivan; Kye, Jeong-Il; Lee, Changho; Park, Hyung Gyu			Ultimate Permeation Across Atomically Thin Porous Graphene	SCIENCE			English	Article							GAS SEPARATION; HIGH-SELECTIVITY; HIGH-FLUX; MEMBRANES; TRANSPORT; ULTRAFILTRATION; PERMEABILITY; FLOWS	A two-dimensional (2D) porous layer can make an ideal membrane for separation of chemical mixtures because its infinitesimal thickness promises ultimate permeation. Graphene-with great mechanical strength, chemical stability, and inherent impermeability-offers a unique 2D system with which to realize this membrane and study the mass transport, if perforated precisely. We report highly efficient mass transfer across physically perforated double-layer graphene, having up to a few million pores with narrowly distributed diameters between less than 10 nanometers and 1 micrometer. The measured transport rates are in agreement with predictions of 2D transport theories. Attributed to its atomic thicknesses, these porous graphene membranes show permeances of gas, liquid, and water vapor far in excess of those shown by finite-thickness membranes, highlighting the ultimate permeation these 2D membranes can provide.	[Celebi, Kemal; Buchheim, Jakob; Wyss, Roman M.; Droudian, Amirhossein; Gasser, Patrick; Park, Hyung Gyu] ETH, Dept Mech & Proc Engn, CH-8092 Zurich, Switzerland; [Shorubalko, Ivan] EMPA Swiss Fed Labs Mat Sci & Technol, Lab Elect Metrol Reliabil, CH-8600 Dubendorf, Switzerland; [Kye, Jeong-Il; Lee, Changho] LG Elect Adv Res Inst, Mat & Components R&D Lab, Seoul 137724, South Korea	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); LG Electronics	Park, HG (corresponding author), ETH, Dept Mech & Proc Engn, Sonneggstr 3, CH-8092 Zurich, Switzerland.	parkh@ethz.ch	Park, Hyung Gyu/AAF-7701-2020; Park, Hyung Gyu/F-3056-2013; Buchheim, Jakob/AAH-3700-2019; Shorubalko, Ivan/E-1089-2011; Gasser, Patrick/T-7865-2019; Shorubalko, Ivan/AAT-5887-2021	Park, Hyung Gyu/0000-0001-8121-2344; Park, Hyung Gyu/0000-0001-8121-2344; Buchheim, Jakob/0000-0002-8256-0030; Shorubalko, Ivan/0000-0001-9868-7303; Gasser, Patrick/0000-0002-1054-7558; Shorubalko, Ivan/0000-0001-9868-7303; Wyss, Roman/0000-0001-5246-2096	Binnig Rohrer Nanotechnology Center of ETH Zurich; IBM Zurich; Swiss National Science Foundation [200021-137964]; LG Electronics Advanced Research Institute	Binnig Rohrer Nanotechnology Center of ETH Zurich; IBM Zurich(International Business Machines (IBM)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); LG Electronics Advanced Research Institute	We appreciate the support from Binnig Rohrer Nanotechnology Center of ETH Zurich and IBM Zurich. J.B. and H. G. P. thank Swiss National Science Foundation for financial support (200021-137964). This work was partially supported by LG Electronics Advanced Research Institute, for which K. C., R. M. W. and H. G. P. are grateful. I. S. is thankful to Swiss National Science Foundation for support in equipment procurement (REquip 206021_133823). H. G. P. appreciates P. Jenny at ETH Zurich for his discussion on Knudsen's minimum. J. Patscheider and L. Bernard at Laboratory for Nanoscale Materials Science of EMPA (Swiss Federal Laboratories for Materials Science and Technology), Switzerland, performed x-ray photoelectron spectroscopy and time-of-flight secondary ion mass spectrometry analyses, and C. Bae and H. Shin at the Department of Energy Science of Sungkyunkwan University, Korea, took high-resolution transmission electron microscope images, for which we are grateful.	Bernardo P, 2009, IND ENG CHEM RES, V48, P4638, DOI 10.1021/ie8019032; Berry V, 2013, CARBON, V62, P1, DOI 10.1016/j.carbon.2013.05.052; Brewer SA, 2011, RECENT PAT MAT SCI, V4, P1, DOI DOI 10.2174/1874-464811104010001; Bunch JS, 2008, NANO LETT, V8, P2458, DOI 10.1021/nl801457b; Celebi K, 2013, NANO LETT, V13, P967, DOI 10.1021/nl303934v; de Vos RM, 1998, SCIENCE, V279, P1710, DOI 10.1126/science.279.5357.1710; Dongari N, 2009, MICROFLUID NANOFLUID, V6, P679, DOI 10.1007/s10404-008-0344-y; Elyassi B, 2007, J MEMBRANE SCI, V288, P290, DOI 10.1016/j.memsci.2006.11.027; Freeman B, 2006, MAT SCI MEMBRANES GA; Garaj S, 2010, NATURE, V467, P190, DOI 10.1038/nature09379; Gugliuzza A, 2013, J MEMBRANE SCI, V446, P350, DOI 10.1016/j.memsci.2013.07.014; Guo HL, 2009, J AM CHEM SOC, V131, P1646, DOI 10.1021/ja8074874; Kim HW, 2013, SCIENCE, V342, P91, DOI 10.1126/science.1236098; Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719; KNUDSEN M, 1909, ANN PHYS, V28, P75, DOI DOI 10.1002/ANDP.19093330106; Koenig SP, 2012, NAT NANOTECHNOL, V7, P728, DOI [10.1038/NNANO.2012.162, 10.1038/nnano.2012.162]; Koros WJ, 2000, J MEMBRANE SCI, V175, P181, DOI 10.1016/S0376-7388(00)00418-X; Li H, 2013, SCIENCE, V342, P95, DOI 10.1126/science.1236686; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Li YS, 2010, J MEMBRANE SCI, V354, P48, DOI 10.1016/j.memsci.2010.02.074; LUND LM, 1966, J APPL PHYS, V37, P2489, DOI 10.1063/1.1708841; Mehta A, 2005, J MEMBRANE SCI, V249, P245, DOI 10.1016/j.memsci.2004.09.040; NAGAI K, 1995, J POLYM SCI POL PHYS, V33, P289, DOI 10.1002/polb.1995.090330214; NAKATSUKA S, 1992, J MEMBRANE SCI, V69, P189, DOI 10.1016/0376-7388(92)80039-M; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; O'Hern SC, 2012, ACS NANO, V6, P10130, DOI 10.1021/nn303869m; PRESENT RD, 1949, PHYS REV, V75, P1050, DOI 10.1103/PhysRev.75.1050; Rezac ME, 1999, J MEMBRANE SCI, V156, P211, DOI 10.1016/S0376-7388(98)00346-9; Robeson LM, 2008, J MEMBRANE SCI, V320, P390, DOI 10.1016/j.memsci.2008.04.030; Sampson RA., 1891, PHILOS T R SOC A, V182, P449, DOI [10.1098/rsta.1891.0012, DOI 10.1098/RSTA.1891.0012]; Shekhawata D., 2003, 20031200 DOENETL; Shukla R, 2000, BIOSEPARATION, V9, P7, DOI 10.1023/A:1008194300403; Tang Z, 2009, LANGMUIR, V25, P4848, DOI 10.1021/la900474y; TIO KK, 1994, APPL SCI RES, V52, P1, DOI 10.1007/BF00849164; Yoon T, 2014, NANOSCALE, V6, P151, DOI 10.1039/c3nr03849a	35	605	618	41	971	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					289	292		10.1126/science.1249097	http://dx.doi.org/10.1126/science.1249097			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744372				2022-12-28	WOS:000334474500033
J	Haslam, M				Haslam, Michael			Dating chimpanzees	NATURE			English	Editorial Material							TOOL USE		Univ Oxford, Res Lab Archaeol & Hist Art, Oxford OX1 3QY, England	University of Oxford	Haslam, M (corresponding author), Univ Oxford, Res Lab Archaeol & Hist Art, Oxford OX1 3QY, England.	michael.haslam@rlaha.ox.ac.uk		Haslam, Michael/0000-0001-8234-7806				Biro D, 2003, ANIM COGN, V6, P213, DOI 10.1007/s10071-003-0183-x; Gruber T, 2012, J COMP PSYCHOL, V126, P446, DOI 10.1037/a0028702; Haslam M, 2012, ANTIQUITY, V86, P299, DOI 10.1017/S0003598X00062773; Haslam M, 2009, NATURE, V460, P339, DOI 10.1038/nature08188; Langergraber K. E., 2014, J HUM EVOL; Luncz L. V., 2014, AM J PRIMATOL; MANSON JH, 1991, CURR ANTHROPOL, V32, P369, DOI 10.1086/203974; Prufer K, 2012, NATURE, V486, P527, DOI 10.1038/nature11128; Stout D, 2010, J HUM EVOL, V58, P474, DOI 10.1016/j.jhevol.2010.02.005; Verschuren D, 2000, NATURE, V403, P410, DOI 10.1038/35000179; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415	12	1	1	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					322	323		10.1038/508322a	http://dx.doi.org/10.1038/508322a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24740060				2022-12-28	WOS:000334403000033
J	Bramham, K; Parnell, B; Nelson-Piercy, C; Seed, PT; Poston, L; Chappell, LC				Bramham, Kate; Parnell, Bethany; Nelson-Piercy, Catherine; Seed, Paul T.; Poston, Lucilla; Chappell, Lucy C.			Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ARTERY DOPPLER VELOCIMETRY; ADVERSE PERINATAL OUTCOMES; SUPERIMPOSED PREECLAMPSIA; BLOOD-PRESSURE; ANTIPHOSPHOLIPID ANTIBODIES; NEONATAL OUTCOMES; FETAL-GROWTH; RISK-FACTORS; WOMEN; DISORDERS	Objective To provide an accurate assessment of complications of pregnancy in women with chronic hypertension, including comparison with population pregnancy data (US) to inform pre-pregnancy and antenatal management strategies. Design Systematic review and meta-analysis. Data sources Embase, Medline, and Web of Science were searched without language restrictions, from first publication until June 2013; the bibliographies of relevant articles and reviews were hand searched for additional reports. Study selection Studies involving pregnant women with chronic hypertension, including retrospective and prospective cohorts, population studies, and appropriate arms of randomised controlled trials, were included. Data extraction Pooled incidence for each pregnancy outcome was reported and, for US studies, compared with US general population incidence from the National Vital Statistics Report (2006). Results 55 eligible studies were identified, encompassing 795 221 pregnancies. Women with chronic hypertension had high pooled incidences of superimposed pre-eclampsia (25.9%, 95% confidence interval 21.0% to 31.5 %), caesarean section (41.4%, 35.5% to 47.7%), preterm delivery <37 weeks' gestation (28.1% (22.6 to 34.4%), birth weight <2500 g (16.9%, 13.1% to 21.5%), neonatal unit admission (20.5%, 15.7% to 26.4%), and perinatal death (4.0%, 2.9% to 5.4%). However, considerable heterogeneity existed in the reported incidence of all outcomes (tau(2)=0.286-0.766), with a substantial range of incidences in individual studies around these averages; additional meta-regression did not identify any influential demographic factors. The incidences (the meta-analysis average from US studies) of adverse outcomes in women with chronic hypertension were compared with women from the US national population dataset and showed higher risks in those with chronic hypertension: relative risks were 7.7 (95% confidence interval 5.7 to 10.1) for superimposed pre-eclampsia compared with pre-eclampsia, 1.3 (1.1 to 1.5) for caesarean section, 2.7 (1.9 to 3.6) for preterm delivery 37 weeks' gestation, 2.7 (1.9 to 3.8) for birth weight <2500 g, 3.2 (2.2 to 4.4) for neonatal unit admission, and 4.2 (2.7 to 6.5) for perinatal death. Conclusions This systematic review, reporting meta-analysed data from studies of pregnant women with chronic hypertension, shows that adverse outcomes of pregnancy are common and emphasises a need for heightened antenatal surveillance. A consistent strategy to study women with chronic hypertension is needed, as previous study designs have been diverse. These findings should inform counselling and contribute to optimisation of maternal health, drug treatment, and pre-pregnancy management in women affected by chronic hypertension.	[Chappell, Lucy C.] Kings Coll London, Womens Hlth Acad Ctr, Div Womens Hlth, London SE1 7EH, England; Kings Hlth Partners, St Thomas Hosp, London SE1 7EH, England	University of London; King's College London	Chappell, LC (corresponding author), Kings Coll London, Womens Hlth Acad Ctr, Div Womens Hlth, London SE1 7EH, England.	lucy.chappell@kcl.ac.uk	Seed, Paul T/C-4435-2008	Seed, Paul T/0000-0001-7904-7933; Bramham, Kate/0000-0002-6272-7921; Poston, Lucilla/0000-0003-1100-2821	National Institute for Health Research; Tommy's Charity; National Institute for Health Research [DRF-2009-02-18, 12/25/03] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Tommy's Charity; National Institute for Health Research(National Institute for Health Research (NIHR))	This work is produced by KB under the terms of a doctoral research training fellowship issued by the National Institute for Health Research. The views expressed in this publication are those of the author and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health. PTS's salary is funded by Tommy's Charity.	Aagaard-Tittery KM, 2006, AM J OBSTET GYNECOL, V194, P849, DOI 10.1016/j.ajog.2005.09.017; Abalos E, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002252.pub3; ALES KL, 1989, CLIN EXP HYPERTENS B, V8, P95, DOI 10.3109/10641958909023365; Allen Victoria M, 2004, BMC Pregnancy Childbirth, V4, P17, DOI 10.1186/1471-2393-4-17; American College of Obstetricians and Gynecologists, 2012, Obstet Gynecol, V119, P396, DOI 10.1097/AOG.0b013e318249ff06; ANANTH CV, 1995, EPIDEMIOLOGY, V6, P391, DOI 10.1097/00001648-199507000-00011; Ananth CV, 2007, AM J OBSTET GYNECOL, V197, p273el; Ananth CV, 2007, AM J OBSTET GYNECOL, V197, p273e1; Attolou V., 1998, Cahiers d'Etudes et de Recherches Francophones/Sante, V8, P353; August P, 2004, AM J OBSTET GYNECOL, V191, P1666, DOI 10.1016/j.ajog.2004.03.029; Bagga R, 2007, HYPERTENS PREGNANCY, V26, P139, DOI 10.1080/10641950701204588; Banhidy F, 2010, HYPERTENS RES, V33, P460, DOI 10.1038/hr.2010.17; Bateman BT, 2012, AM J OBSTET GYNECOL, V206; Bateman BT, 2012, AM J OBSTET GYNECOL, V206; Bayliss H, 2002, HYPERTENS PREGNANCY, V21, P161, DOI 10.1081/PRG-120013785; Berg CJ, 2009, OBSTET GYNECOL, V113, P1075, DOI 10.1097/AOG.0b013e3181a09fc0; Broekhuijsen K, 2012, AM J OBSTET GYNECOL, V206, pS344, DOI 10.1016/j.ajog.2011.10.800; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Center for Disease Control and Prevention, 2006, BIRTHS NAT; Chappell L, 1999, BRIT J OBSTET GYNAEC, V106, P983, DOI 10.1111/j.1471-0528.1999.tb08442.x; Chappell LC, 2008, HYPERTENSION, V51, P1002, DOI 10.1161/HYPERTENSIONAHA.107.107565; CHESLEY L C, 1956, West J Surg Obstet Gynecol, V64, P284; Cnossen JS, 2008, BMJ-BRIT MED J, V336, P1117, DOI 10.1136/bmj.39540.522049.BE; COMINODELGADO R, 1986, CLIN EXP HYPERTENS B, V5, P217; CURET LB, 1979, OBSTET GYNECOL, V53, P336; Delmis J, 1993, Lijec Vjesn, V115, P329; DUVEKOT JJ, 1993, AM J OBSTET GYNECOL, V169, P1382, DOI 10.1016/0002-9378(93)90405-8; Ferrazzani S, 2011, EARLY HUM DEV, V87, P445, DOI 10.1016/j.earlhumdev.2011.03.005; Fields SJ, 1996, ANN HUM BIOL, V23, P353, DOI 10.1080/03014469600004602; FLEISCHER A, 1986, AM J OBSTET GYNECOL, V154, P806, DOI 10.1016/0002-9378(86)90462-X; Frusca T, 1998, EUR J OBSTET GYN R B, V79, P47, DOI 10.1016/S0301-2115(98)00045-1; GANT NF, 1977, AM J OBSTET GYNECOL, V127, P369; Giannubilo SR, 2006, EUR J OBSTET GYN R B, V126, P63, DOI 10.1016/j.ejogrb.2005.06.042; Gilbert WM, 2007, J REPROD MED, V52, P1046; Haddad B, 1999, ANN MED, V31, P246, DOI 10.3109/07853899908995887; Hartikainen AL, 1998, HYPERTENS PREGNANCY, V17, P31, DOI 10.3109/10641959809072236; Huusom LD, 2011, BJOG-INT J OBSTET GY, V118, P1, DOI 10.1111/j.1471-0528.2010.02782.x; Inigo Riesgo Carmen Armida, 2008, Ginecol Obstet Mex, V76, P202; Jacquemyn Y, 2006, Clin Exp Obstet Gynecol, V33, P96; Jain L, 1997, J Perinatol, V17, P425; Lecarpentier E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062140; Li DK, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5931; Livingston JC, 2001, OBSTET GYN CLIN N AM, V28, P447, DOI 10.1016/S0889-8545(05)70213-8; Lydakis C, 1998, QJM-INT J MED, V91, P837, DOI 10.1093/qjmed/91.12.837; MABIE WC, 1986, OBSTET GYNECOL, V67, P197, DOI 10.1097/00006250-198602000-00008; Machado M H, 1996, Acta Med Port, V9, P7; Mathews T, 2009, NCHS DATA BRIEF, P21; McCowan LME, 1996, BRIT J OBSTET GYNAEC, V103, P123, DOI 10.1111/j.1471-0528.1996.tb09662.x; National Institute for Health and Clinical Excellence: Guidance, 2010, HYP PREGN MAN HYP DI; Neri I, 2010, J MATERN-FETAL NEO M, V23, P1456, DOI 10.3109/14767051003677962; Ono Y, 2013, J OBSTET GYNAECOL RE, V39, P1142, DOI 10.1111/jog.12041; Onyiriuka A. N., 2005, Annals of African Medicine, V4, P154; Palmsten K, 2010, OBSTET GYNECOL, V116, P858, DOI 10.1097/AOG.0b013e3181f3a1f9; Parry S, 1998, AM J PERINAT, V15, P527, DOI 10.1055/s-2007-994054; PIETRANTONI M, 1994, CLIN EXP HYPERTENS, V16, P479, DOI 10.3109/10641969409067957; Rasmussen Svein, 2006, BMC Pregnancy Childbirth, V6, P16, DOI 10.1186/1471-2393-6-16; Ray JG, 2001, EARLY HUM DEV, V64, P129, DOI 10.1016/S0378-3782(01)00181-5; REY E, 1994, AM J OBSTET GYNECOL, V171, P410, DOI 10.1016/0002-9378(94)90276-3; Rey Evelyne, 1997, Ethnicity and Disease, V7, P5; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Roberts CL, 2008, HYPERTENS PREGNANCY, V27, P285, DOI 10.1080/10641950701826695; Roberts CL, 2005, MED J AUSTRALIA, V182, P332, DOI 10.5694/j.1326-5377.2005.tb06730.x; Roncaglia N, 2008, PRENATAL DIAG, V28, P710, DOI 10.1002/pd.2027; Ruiz Anguas J, 2001, Ginecol Obstet Mex, V69, P143; Sass N, 1990, Rev Paul Med, V108, P261; Seely EW, 2011, NEW ENGL J MED, V365, P439, DOI 10.1056/NEJMcp0804872; Segel S, 2001, AM J OBSTET GYNECOL, V185, pS181, DOI 10.1016/S0002-9378(01)80396-3; Sibai B, 2012, AM J OBSTET GYNECOL, V206, pS57, DOI 10.1016/j.ajog.2011.10.113; Sibai B, 2011, AM J OBSTET GYNECOL, V204, pS294; Sibai BM, 2011, AM J OBSTET GYNECOL, V205, P5, DOI 10.1016/j.ajog.2011.02.078; SIBAI BM, 1983, OBSTET GYNECOL, V61, P571; SIBAI BM, 1986, OBSTET GYNECOL, V67, P517; Sibai BM, 1998, NEW ENGL J MED, V339, P667, DOI 10.1056/NEJM199809033391004; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Su CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053844; Sun Yu, 2007, Zhonghua Fu Chan Ke Za Zhi, V42, P434; Thangaratinam S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2088; Tuuli MG, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.065; Vaz AJV, 2010, HYPERTENS RES, V33, P1012, DOI 10.1038/hr.2010.131; Valsecchi L, 1999, HYPERTENS PREGNANCY, V18, P189, DOI 10.3109/10641959909016192; Vanek M, 2004, INT J GYNECOL OBSTET, V86, P7, DOI 10.1016/j.ijgo.2004.03.006; VELENTGAS P, 1994, EPIDEMIOLOGY, V5, P345, DOI 10.1097/00001648-199405000-00015; Vigil-De Gracia P, 2004, INT J GYNECOL OBSTET, V85, P139, DOI 10.1016/j.ijgo.2003.12.002; von Dadelszen P, 2000, LANCET, V355, P87, DOI 10.1016/S0140-6736(98)08049-0; WEITZ C, 1987, INT J GYNECOL OBSTET, V25, P35, DOI 10.1016/0020-7292(87)90181-0; Wilson K, 2012, AM J OBSTET GYNECOL, V206, pS343, DOI 10.1016/j.ajog.2011.10.797; World Health Organization, 2013, COUNTR EC; Yoder SR, 2009, AM J MED, V122, P890, DOI 10.1016/j.amjmed.2009.03.036; Zeeman G, 2003, AM J OBSTET GYNECOL, V189, pS89, DOI 10.1016/j.ajog.2003.10.083; Zeeman GG, 2004, AM J PERINAT, V21, P275, DOI 10.1055/s-2004-829870; Zetterstrom K, 2008, BJOG-INT J OBSTET GY, V115, P1436, DOI 10.1111/j.1471-0528.2008.01844.x	91	338	351	5	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2014	348								g2301	10.1136/bmj.g2301	http://dx.doi.org/10.1136/bmj.g2301			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF5GN	24735917	hybrid, Green Published			2022-12-28	WOS:000334742100002
J	Lee, AY; St Onge, RP; Proctor, MJ; Wallace, IM; Nile, AH; Spagnuolo, PA; Jitkova, Y; Gronda, M; Wu, Y; Kim, MK; Cheung-Ong, K; Torres, NP; Spear, ED; Han, MKL; Schlecht, U; Suresh, S; Duby, G; Heisler, LE; Surendra, A; Fung, E; Urbanus, ML; Gebbia, M; Lissina, E; Miranda, M; Chiang, JH; Aparicio, AM; Zeghouf, M; Davis, RW; Cherfils, J; Boutry, M; Kaiser, CA; Cummins, CL; Trimble, WS; Brown, GW; Schimmer, AD; Bankaitis, VA; Nislow, C; Bader, GD; Giaever, G				Lee, Anna Y.; St. Onge, Robert P.; Proctor, Michael J.; Wallace, Iain M.; Nile, Aaron H.; Spagnuolo, Paul A.; Jitkova, Yulia; Gronda, Marcela; Wu, Yan; Kim, Moshe K.; Cheung-Ong, Kahlin; Torres, Nikko P.; Spear, Eric D.; Han, Mitchell K. L.; Schlecht, Ulrich; Suresh, Sundari; Duby, Geoffrey; Heisler, Lawrence E.; Surendra, Anuradha; Fung, Eula; Urbanus, Malene L.; Gebbia, Marinella; Lissina, Elena; Miranda, Molly; Chiang, Jennifer H.; Aparicio, Ana Maria; Zeghouf, Mahel; Davis, Ronald W.; Cherfils, Jacqueline; Boutry, Marc; Kaiser, Chris A.; Cummins, Carolyn L.; Trimble, William S.; Brown, Grant W.; Schimmer, Aaron D.; Bankaitis, Vytas A.; Nislow, Corey; Bader, Gary D.; Giaever, Guri			Mapping the Cellular Response to Small Molecules Using Chemogenomic Fitness Signatures	SCIENCE			English	Article							DRUG-INDUCED PHOSPHOLIPIDOSIS; YEAST; DISCOVERY; PATHWAY; PROTEIN; GENOME; GENES	Genome-wide characterization of the in vivo cellular response to perturbation is fundamental to understanding how cells survive stress. Identifying the proteins and pathways perturbed by small molecules affects biology and medicine by revealing the mechanisms of drug action. We used a yeast chemogenomics platform that quantifies the requirement for each gene for resistance to a compound in vivo to profile 3250 small molecules in a systematic and unbiased manner. We identified 317 compounds that specifically perturb the function of 121 genes and characterized the mechanism of specific compounds. Global analysis revealed that the cellular response to small molecules is limited and described by a network of 45 major chemogenomic signatures. Our results provide a resource for the discovery of functional interactions among genes, chemicals, and biological processes.	[Lee, Anna Y.; Wallace, Iain M.; Cheung-Ong, Kahlin; Torres, Nikko P.; Heisler, Lawrence E.; Surendra, Anuradha; Gebbia, Marinella; Lissina, Elena; Brown, Grant W.; Nislow, Corey; Bader, Gary D.; Giaever, Guri] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Lee, Anna Y.; Cheung-Ong, Kahlin; Urbanus, Malene L.; Lissina, Elena; Nislow, Corey; Bader, Gary D.; Giaever, Guri] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [St. Onge, Robert P.; Proctor, Michael J.; Schlecht, Ulrich; Suresh, Sundari; Fung, Eula; Miranda, Molly; Aparicio, Ana Maria; Davis, Ronald W.] Stanford Univ, Dept Biochem, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Nile, Aaron H.; Bankaitis, Vytas A.] Texas A&M Univ, Dept Mol & Cell Med, Coll Med, Hlth Sci Ctr, College Stn, TX 77843 USA; [Spagnuolo, Paul A.] Univ Waterloo, Sch Pharm, Kitchener, ON N2G 1CS, Canada; [Jitkova, Yulia; Gronda, Marcela; Wu, Yan; Schimmer, Aaron D.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Kim, Moshe K.; Torres, Nikko P.; Trimble, William S.; Brown, Grant W.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Kim, Moshe K.; Trimble, William S.] Univ Toronto, Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Spear, Eric D.; Kaiser, Chris A.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Han, Mitchell K. L.; Giaever, Guri] Univ Toronto, Fac Pharm, Dept Pharmaceut Sci, Toronto, ON M5S 3M2, Canada; [Duby, Geoffrey; Boutry, Marc] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain, Belgium; [Chiang, Jennifer H.; Nislow, Corey; Giaever, Guri] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V6T 1Z3, Canada; [Cherfils, Jacqueline] CNRS, Lab Enzymol & Biochim Structur, Gif Sur Yvette, France	University of Toronto; University of Toronto; Stanford University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Waterloo; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Massachusetts Institute of Technology (MIT); University of Toronto; Universite Catholique Louvain; University of British Columbia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Giaever, G (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada.	g.giaever@ubc.ca	Bader, Gary/C-1176-2009; Wallace, Iain/B-9464-2009	Bader, Gary/0000-0003-0185-8861; Heisler, Lawrence/0000-0002-1332-1802; Spagnuolo, Paul/0000-0002-2431-4368; Schimmer, Aaron/0000-0003-4023-3899; Nile, Aaron/0000-0002-7370-8769; Han, Mitchell/0000-0002-9243-1136; Wallace, Iain/0000-0002-9491-7025; Zeghouf, Mahel/0000-0003-3686-2510; Boutry, Marc/0000-0002-2315-6900; Cummins, Carolyn/0000-0001-7603-6577; Brown, Grant/0000-0002-9002-5003	National Human Genome Research Institute [RO1 003317-07]; Canadian Cancer Society Research Institute [020380]; Canadian Institute for Health Research [MOP-81340, MOP-79368, MOP-700724]; Canadian Research Chair; Charles H. Best Institute; Belgian National Fund for Scientific Research; French National Research Agency; Marie Curie Fellowship; Leukemia and Lymphoma Society; Robert A. Welch Foundation; NIH [GM103504, GM44530]; Interuniversity Poles of Attraction Program; NATIONAL CANCER INSTITUTE [R01CA157456] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205, R01HG003317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504, R01GM044530] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Research Chair(Canada Research Chairs); Charles H. Best Institute; Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); French National Research Agency(French National Research Agency (ANR)); Marie Curie Fellowship(European Commission); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Robert A. Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interuniversity Poles of Attraction Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the National Human Genome Research Institute (RO1 003317-07) (C.N., G. G., and R. W. D.); Canadian Cancer Society Research Institute (#020380) (C.N. and G. G.); Canadian Institute for Health Research (MOP-81340) (G. G.), MOP-79368 (G. W. B.), and MOP-700724 (W. S. T.); Canadian Research Chair (G. G.); Charles H. Best Institute (A.Y.L.); Belgian National Fund for Scientific Research and the Interuniversity Poles of Attraction Program (M. B.); French National Research Agency (J.C.); Marie Curie Fellowship (I. M. W.); Leukemia and Lymphoma Society (A. D. S.); Robert A. Welch Foundation (V. A. B.); and NIH grants (GM103504) (G. D. B.) and GM44530 (V. A. B.). The data reported in this paper are tabulated in the supplementary materials, and access to the entire data set is available for query and in a variety of downloadable formats at http://chemogenomics.pharmacy.ubc.ca/HIPHOP/. The raw microarray data are archived in the ArrayExpress database (www.ebi.ac.uk/arrayexpress) under accession no. E-MTAB-2391.	Anderson N, 2006, FEBS LETT, V580, P5533, DOI 10.1016/j.febslet.2006.08.061; Barrett PM, 2012, HUM MOL GENET, V21, pR66, DOI 10.1093/hmg/dds345; Blackman RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029798; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Fang M, 1996, EMBO J, V15, P6447, DOI 10.1002/j.1460-2075.1996.tb01036.x; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hu QC, 2008, J BIOL CHEM, V283, P29563, DOI 10.1074/jbc.M804962200; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Nile AH, 2014, NAT CHEM BIOL, V10, P76, DOI [10.1038/NCHEMBIO.1389, 10.1038/nchembio.1389]; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Rainey MM, 2010, GENETICS, V185, P1221, DOI 10.1534/genetics.110.117846; Reasor MJ, 2001, EXP BIOL MED, V226, P825, DOI 10.1177/153537020122600903; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Torres NP, 2013, ASSAY DRUG DEV TECHN, V11, P299, DOI 10.1089/adt.2012.503; Wallace IM, 2011, CHEM BIOL, V18, P1273, DOI 10.1016/j.chembiol.2011.07.018	22	160	165	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					208	211		10.1126/science.1250217	http://dx.doi.org/10.1126/science.1250217			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24723613	Green Accepted, Green Published			2022-12-28	WOS:000334096300038
J	Bodington, R; Stanley, PRW				Bodington, Richard; Stanley, Paul R. W.			PICTURE QUIZ A man with a mass in the thigh	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SOFT-TISSUE SARCOMA		[Bodington, Richard] Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England; [Stanley, Paul R. W.] Hull & East Yorkshire Hosp NHS Trust, Castle Hill Hosp, Kingston Upon Hull, N Humberside, England	University of Hull; University of York - UK	Bodington, R (corresponding author), Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England.	hy9rb@hyms.ac.uk						Dagan R, 2012, CANCER-AM CANCER SOC, V118, P3199, DOI 10.1002/cncr.26489; Gortzak Y, 2010, CANCER-AM CANCER SOC, V116, P1553, DOI 10.1002/cncr.24949; Ilaslan Hakan, 2010, Cleve Clin J Med, V77 Suppl 1, pS2, DOI 10.3949/ccjm.77.s1.01; National Institute for Health Care and Excellence, 2006, IMPR OUTC PEOPL SARC; Sinha S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c7170	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 10	2014	348								g2483	10.1136/bmj.g2483	http://dx.doi.org/10.1136/bmj.g2483			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SG	24721749				2022-12-28	WOS:000334348900007
J	Weissmueller, S; Manchado, E; Saborowski, M; Morris, JP; Wagenblast, E; Davis, CA; Moon, SH; Pfister, NT; Tschaharganeh, DF; Kitzing, T; Aust, D; Markert, EK; Wu, JM; Grimmond, SM; Pilarsky, C; Prives, C; Biankin, AV; Lowe, SW				Weissmueller, Susann; Manchado, Eusebio; Saborowski, Michael; Morris, John P.; Wagenblast, Elvin; Davis, Carrie A.; Moon, Sung-Hwan; Pfister, Neil T.; Tschaharganeh, Darjus F.; Kitzing, Thomas; Aust, Daniela; Markert, Elke K.; Wu, Jianmin; Grimmond, Sean M.; Pilarsky, Christian; Prives, Carol; Biankin, Andrew V.; Lowe, Scott W.			Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor beta Signaling	CELL			English	Article							TUMOR-SUPPRESSOR P53; LI-FRAUMENI-SYNDROME; NF-Y; MOUSE MODELS; GAIN; INVASION; MUTATION; COMPLEX; P63; P73	Missense mutations in the p53 tumor suppressor inactivate its antiproliferative properties but can also promote metastasis through a gain-of-function activity. We show that sustained expression of mutant p53 is required to maintain the prometastatic phenotype of a murine model of pancreatic cancer, a highly metastatic disease that frequently displays p53 mutations. Transcriptional profiling and functional screening identified the platelet-derived growth factor receptor b (PDGFRb) as both necessary and sufficient to mediate these effects. Mutant p53 induced PDGFRb through a cell-autonomous mechanism involving inhibition of a p73/NF-Y complex that represses PDGFRb expression in p53-deficient, noninvasive cells. Blocking PDGFRb signaling by RNA interference or by small molecule inhibitors prevented pancreatic cancer cell invasion in vitro and metastasis formation in vivo. Finally, high PDGFRb expression correlates with poor disease-free survival in pancreatic, colon, and ovarian cancer patients, implicating PDGFRb as a prognostic marker and possible target for attenuating metastasis in p53 mutant tumors.	[Weissmueller, Susann; Wagenblast, Elvin; Davis, Carrie A.; Lowe, Scott W.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Weissmueller, Susann; Manchado, Eusebio; Saborowski, Michael; Morris, John P.; Tschaharganeh, Darjus F.; Kitzing, Thomas; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10065 USA; [Moon, Sung-Hwan; Pfister, Neil T.; Prives, Carol] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Aust, Daniela; Pilarsky, Christian] Tech Univ Dresden, Dept Visceral Thorac & Vasc Surg, D-01062 Dresden, Germany; [Markert, Elke K.] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA; [Wu, Jianmin; Biankin, Andrew V.] Garvan Inst Med Res, Canc Div, Kinghorn Canc Ctr, Sydney, NSW 2010, Australia; [Wu, Jianmin] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW 2010, Australia; [Grimmond, Sean M.] Univ Queensland, Inst Mol Biosci, Queensland Ctr Med Genom, Santa Lucia, Qld 4072, Australia; [Grimmond, Sean M.; Biankin, Andrew V.] Univ Glasgow, Inst Canc Sci, Wolfson Wohl Canc Res Ctr, Glasgow G61 1BD, Lanark, Scotland; [Lowe, Scott W.] Howard Hughes Med Inst, New York, NY 10065 USA	Cold Spring Harbor Laboratory; Memorial Sloan Kettering Cancer Center; Columbia University; Technische Universitat Dresden; Institute for Advanced Study - USA; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Queensland; University of Glasgow; Howard Hughes Medical Institute	Lowe, SW (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA.	lowes@mskcc.org	Grimmond, Sean/K-3246-2019; Grimmond, Sean M/J-5304-2016; Wu, Jianmin/G-3629-2010	Grimmond, Sean/0000-0002-8102-7998; Grimmond, Sean M/0000-0002-8102-7998; Biankin, Andrew/0000-0002-0362-5597; Wagenblast, Elvin/0000-0002-0709-2759; Wu, Jianmin/0000-0002-8876-128X; Pilarsky, Christian/0000-0002-7968-3283	Annette Kade Fellowship from the Watson School of Biological Sciences; Jane Coffin Childs Memorial Fund for Medical Research; National Cancer Institute [CA 013106]; NATIONAL CANCER INSTITUTE [P01CA129243, P30CA008748, P01CA013106, P01CA087497] Funding Source: NIH RePORTER; Cancer Research UK [17263] Funding Source: researchfish	Annette Kade Fellowship from the Watson School of Biological Sciences; Jane Coffin Childs Memorial Fund for Medical Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	We thank K. Funa for sharing plasmids, A. Lujambio, M. Taylor, J. Ahn, and other members of the Lowe laboratory for critical discussions and/or technical help, APGI for providing clinical data, and J.P. Morton for providing cell lines. We thank C.J. Sherr and L. Dow for their advice on experimental design and for editing the manuscript. S.W. is the recipient of the Annette Kade Fellowship from the Watson School of Biological Sciences. E.M. is supported by The Jane Coffin Childs Memorial Fund for Medical Research. S.W.L. is the Geoffrey Beene Chair of Cancer Biology and a Howard Hughes Medical Institute investigator. This work was supported by a grant from the National Cancer Institute (CA 013106).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; BALLAGI AE, 1995, BIOCHEM BIOPH RES CO, V210, P165, DOI 10.1006/bbrc.1995.1642; Beckerman R, 2009, GENE DEV, V23, P1364, DOI 10.1101/gad.1795709; Dai YJ, 2010, EXPERT OPIN THER PAT, V20, P885, DOI 10.1517/13543776.2010.493559; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Dong P, 2013, ONCOGENE, V32, P3286, DOI 10.1038/onc.2012.334; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Garofalo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067581; Goulimari P, 2005, J BIOL CHEM, V280, P42242, DOI 10.1074/jbc.M508690200; Hackzell A, 2002, J BIOL CHEM, V277, P39769, DOI 10.1074/jbc.M204483200; Hanel W, 2013, CELL DEATH DIFFER, V20, P898, DOI 10.1038/cdd.2013.17; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hoehler T, 2013, BRIT J CANCER, V109, P1408, DOI 10.1038/bjc.2013.409; Ishisaki A, 1997, EUR J BIOCHEM, V246, P142, DOI 10.1111/j.1432-1033.1997.t01-2-00142.x; Joerger AC, 2007, ADV CANCER RES, V97, P1, DOI 10.1016/S0065-230X(06)97001-8; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lehmann BD, 2012, J CLIN ONCOL, V30, P3648, DOI 10.1200/JCO.2012.44.0412; LEVESQUE MA, 1995, CANCER-AM CANCER SOC, V75, P1327, DOI 10.1002/1097-0142(19950315)75:6<1327::AID-CNCR2820750615>3.0.CO;2-P; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lewis NL, 2009, J CLIN ONCOL, V27, P5262, DOI 10.1200/JCO.2009.21.8487; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li Y, 2007, ONCOGENE, V26, P2220, DOI 10.1038/sj.onc.1210311; Liu K, 2011, MOL CELL BIOL, V31, P4464, DOI 10.1128/MCB.05574-11; Longati P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-95; Masciarelli S., 2013, ONCOGENE; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mehta SA, 2007, ONCOGENE, V26, P3329, DOI 10.1038/sj.onc.1210120; Montalbetti N, 2013, MOL ASPECTS MED, V34, P270, DOI 10.1016/j.mam.2013.01.002; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Neilsen PM, 2013, ONCOGENE, V32, P2992, DOI 10.1038/onc.2012.305; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Pietras K, 2003, CANCER CELL, V3, P439, DOI 10.1016/S1535-6108(03)00089-8; Russo A, 2005, J CLIN ONCOL, V23, P7518, DOI 10.1200/JCO.2005.00.471; Serra E, 1998, NUCLEIC ACIDS RES, V26, P3800, DOI 10.1093/nar/26.16.3800; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Steller EJA, 2013, NEOPLASIA, V15, P204, DOI 10.1593/neo.121726; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Wolff NC, 2003, BLOOD, V101, P5010, DOI 10.1182/blood-2002-10-3059	45	328	335	0	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					382	394		10.1016/j.cell.2014.01.066	http://dx.doi.org/10.1016/j.cell.2014.01.066			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725405	Green Accepted, Bronze			2022-12-28	WOS:000334304500012
J	Kevat, D; Wilson, D; Sinha, A				Kevat, Dev; Wilson, Dyanne; Sinha, Ashim			A 5-year-old girl with type 2 diabetes	LANCET			English	Editorial Material									[Kevat, Dev; Wilson, Dyanne; Sinha, Ashim] Cairns Hosp, Cairns, Qld, Australia; [Kevat, Dev; Wilson, Dyanne; Sinha, Ashim] Ctr Diabet, Cairns, Qld, Australia; [Kevat, Dev] Monash Univ, Sch Publ Hlth, Melbourne, Vic 3004, Australia	Monash University	Kevat, D (corresponding author), Cairns Diabet Ctr, 381 Sheridan St, Cairns, Qld 4870, Australia.	dev.kevat@monash.edu		Kevat, Dev/0000-0003-3990-9919				Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Pinhas-Hamiel O, 2005, J PEDIATR-US, V146, P693, DOI 10.1016/j.jpeds.2004.12.042; TODAY Study Group, 2012, NEW ENGL J MED, V366, P2247; Vos T, 2009, INT J EPIDEMIOL, V38, P470, DOI 10.1093/ije/dyn240	5	6	6	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 5	2014	383	9924					1268	1268		10.1016/S0140-6736(14)60487-6	http://dx.doi.org/10.1016/S0140-6736(14)60487-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE6LO	24703566				2022-12-28	WOS:000334104600031
J	Sleigh, J; Warnaby, CE				Sleigh, Jamie; Warnaby, Catherine E.			Functional brain imaging: gatecrashing the clinical party?	LANCET			English	Editorial Material							CONSCIOUSNESS		[Sleigh, Jamie] Univ Auckland, Waikato Hosp, Dept Anaesthesia, Hamilton 3240, New Zealand; [Warnaby, Catherine E.] Univ Oxford, John Radcliff Hosp, Oxford Ctr Funct MRI Brain, Oxford, England	University of Auckland; Waikato Hospital; University of Oxford	Sleigh, J (corresponding author), Univ Auckland, Waikato Hosp, Dept Anaesthesia, Hamilton 3240, New Zealand.	jamie.sleigh@waikatodhb.health.nz	Warnaby, Katie/AAA-3598-2020	Warnaby, Katie/0000-0002-6268-487X				Casali AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006294; Demertzi A, 2014, CORTEX, V52, P35, DOI 10.1016/j.cortex.2013.11.005; Owen AM, 2008, NAT REV NEUROSCI, V9, P235, DOI 10.1038/nrn2330; Owen AM, 2013, ANNU REV PSYCHOL, V64, P109, DOI 10.1146/annurev-psych-113011-143729; Shulman RG, 2009, P NATL ACAD SCI USA, V106, P11096, DOI 10.1073/pnas.0903941106; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Stender J, 2014, LANCET; Thibaut A, 2012, J REHABIL MED, V44, P487, DOI 10.2340/16501977-0940; Vermeij JD, 2013, J NEUROTRAUM, V30, P2073, DOI 10.1089/neu.2013.3060	9	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2014	384	9942					476	477		10.1016/S0140-6736(14)60223-3	http://dx.doi.org/10.1016/S0140-6736(14)60223-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM9JR	24746175				2022-12-28	WOS:000340198300007
J	Binagwaho, A; Farmer, PE; Nsanzimana, S; Karema, C; Gasana, M; Ngirabega, JD; Ngabo, F; Wagner, CM; Nutt, CT; Nyatanyi, T; Gatera, M; Kayiteshonga, Y; Mugeni, C; Mugwaneza, P; Shema, J; Uwaliraye, P; Gaju, E; Muhimpundu, MA; Dushime, T; Senyana, F; Mazarati, JB; Gaju, CM; Tuyisenge, L; Mutabazi, V; Kyamanywa, P; Rusanganwa, V; Nyemazi, JP; Umutoni, A; Kankindi, I; Ntizimira, C; Ruton, H; Mugume, N; Nkunda, D; Ndenga, E; Mubiligi, JM; Kakoma, JB; Karita, E; Sekabaraga, C; Rusingiza, E; Rich, ML; Mukherjee, JS; Rhatigan, J; Cancedda, C; Bertrand-Farmer, D; Bukhman, G; Stulac, SN; Tapela, NM; Holstein, CV; Shulman, LN; Habinshuti, A; Bonds, MH; Wilkes, MS; Lu, CL; Smith-Fawzi, MC; Swain, JD; Murphy, MP; Ricks, A; Kerry, VB; Bush, BP; Siegler, RW; Stern, CS; Sliney, A; Nuthulaganti, T; Karangwa, I; Pegurri, E; Dahl, O; Drobac, PC				Binagwaho, Agnes; Farmer, Paul E.; Nsanzimana, Sabin; Karema, Corine; Gasana, Michel; Ngirabega, Jean de Dieu; Ngabo, Fidele; Wagner, Claire M.; Nutt, Cameron T.; Nyatanyi, Thierry; Gatera, Maurice; Kayiteshonga, Yvonne; Mugeni, Cathy; Mugwaneza, Placidie; Shema, Joseph; Uwaliraye, Parfait; Gaju, Erick; Muhimpundu, Marie Aimee; Dushime, Theophile; Senyana, Florent; Mazarati, Jean Baptiste; Gaju, Celsa Muzayire; Tuyisenge, Lisine; Mutabazi, Vincent; Kyamanywa, Patrick; Rusanganwa, Vincent; Nyemazi, Jean Pierre; Umutoni, Agathe; Kankindi, Ida; Ntizimira, Christian; Ruton, Hinda; Mugume, Nathan; Nkunda, Denis; Ndenga, Esperance; Mubiligi, Joel M.; Kakoma, Jean Baptiste; Karita, Etienne; Sekabaraga, Claude; Rusingiza, Emmanuel; Rich, Michael L.; Mukherjee, Joia S.; Rhatigan, Joseph; Cancedda, Corrado; Bertrand-Farmer, Didi; Bukhman, Gene; Stulac, Sara N.; Tapela, Neo M.; Holstein, Cassia van der Hoof; Shulman, Lawrence N.; Habinshuti, Antoinette; Bonds, Matthew H.; Wilkes, Michael S.; Lu, Chunling; Smith-Fawzi, Mary C.; Swain, JaBaris D.; Murphy, Michael P.; Ricks, Alan; Kerry, Vanessa B.; Bush, Barbara P.; Siegler, Richard W.; Stern, Cori S.; Sliney, Anne; Nuthulaganti, Tej; Karangwa, Injonge; Pegurri, Elisabetta; Dahl, Ophelia; Drobac, Peter C.			Rwanda 20 years on: investing in life	LANCET			English	Article							GLOBAL HEALTH; TREATMENT PROGRAM; CARE; WORLD; INNOVATIONS; DELIVERY; LOOKING; EQUITY; SYSTEM; AGENDA	Two decades ago, the genocide against the Tutsis in Rwanda led to the deaths of 1 million people, and the displacement of millions more. Injury and trauma were followed by the effects of a devastated health system and economy. In the years that followed, a new course set by a new government set into motion equity-oriented national policies focusing on social cohesion and people-centred development. Premature mortality rates have fallen precipitously in recent years, and life expectancy has doubled since the mid-1990s. Here we reflect on the lessons learned in rebuilding Rwanda's health sector during the past two decades, as the country now prepares itself to take on new challenges in health-care delivery.	[Binagwaho, Agnes; Ngirabega, Jean de Dieu; Ngabo, Fidele; Mugeni, Cathy; Shema, Joseph; Uwaliraye, Parfait; Gaju, Erick; Muhimpundu, Marie Aimee; Dushime, Theophile; Senyana, Florent; Gaju, Celsa Muzayire; Rusanganwa, Vincent; Umutoni, Agathe; Kankindi, Ida; Ntizimira, Christian; Ruton, Hinda; Mugume, Nathan; Nkunda, Denis; Ndenga, Esperance; Mubiligi, Joel M.] Minist Hlth, Govt Rwanda, Kigali, Rwanda; [Farmer, Paul E.; Mukherjee, Joia S.; Bukhman, Gene; Holstein, Cassia van der Hoof; Bonds, Matthew H.; Wilkes, Michael S.; Lu, Chunling; Smith-Fawzi, Mary C.] Harvard Univ, Sch Med, Boston, MA USA; [Nsanzimana, Sabin; Karema, Corine; Gasana, Michel; Nyatanyi, Thierry; Gatera, Maurice; Kayiteshonga, Yvonne; Mugwaneza, Placidie; Mazarati, Jean Baptiste; Mutabazi, Vincent; Nyemazi, Jean Pierre] Rwanda Biomed Ctr, Kigali, Rwanda; [Wagner, Claire M.] Global Hlth Delivery Partnership, Boston, MA USA; [Nutt, Cameron T.] Dartmouth Ctr Hlth Care Delivery Sci, Hanover, NH USA; [Tuyisenge, Lisine] Kigali Univ Teaching Hosp, Kigali, Rwanda; [Kyamanywa, Patrick; Rusingiza, Emmanuel] Univ Rwanda, Sch Med, Butare, Rwanda; [Kakoma, Jean Baptiste] Univ Rwanda, Sch Publ Hlth, Kigali, Rwanda; [Karita, Etienne] Project San Francisco, Kigali, Rwanda; [Sekabaraga, Claude] Qual & Equity HealthCare Social Hlth Enterprise, Kigali, Rwanda; [Rich, Michael L.; Bertrand-Farmer, Didi; Habinshuti, Antoinette; Dahl, Ophelia; Drobac, Peter C.] Partners Hlth, Boston, MA USA; [Rhatigan, Joseph; Cancedda, Corrado; Stulac, Sara N.; Tapela, Neo M.; Swain, JaBaris D.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Shulman, Lawrence N.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Murphy, Michael P.; Ricks, Alan] MASS Design Grp, Boston, MA USA; [Kerry, Vanessa B.] Seed Global Hlth, Boston, MA USA; [Bush, Barbara P.] Global Hlth Corps, New York, NY USA; [Siegler, Richard W.] Bridge2Rwanda Scholars, Kigali, Rwanda; [Stern, Cori S.] Strongheart Grp, Austin, TX USA; [Sliney, Anne; Nuthulaganti, Tej; Karangwa, Injonge] Clinton Hlth Access Initiat, Boston, MA USA; [Pegurri, Elisabetta] UNAIDS, Geneva, Switzerland	Harvard University; Harvard Medical School; Rwanda Biomedical Center; Dartmouth College; University of Rwanda; University of Rwanda; Partners Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; UNAIDS	Binagwaho, A (corresponding author), Minist Hlth, Govt Rwanda, Kigali, Rwanda.	agnes_binagwaho@hms.harvard.edu		NYATANYI, Thierry/0000-0003-2300-0479	FIC NIH HHS [K01 TW008773] Funding Source: Medline; NICHD NIH HHS [K01 HD071929] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K01HD071929] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [K01TW008773] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Alleyne G, 2013, LANCET, V381, P566, DOI 10.1016/S0140-6736(12)61806-6; Binagwaho A, 2014, LANCET GLOB HEALTH, V2, pE9, DOI 10.1016/S2214-109X(13)70144-X; Binagwaho A, 2014, LANCET, V383, P3, DOI 10.1016/S0140-6736(13)62423-X; Binagwaho A, 2013, NEW ENGL J MED, V369, P2054, DOI 10.1056/NEJMsr1302176; Binagwaho A, 2013, B WORLD HEALTH ORGAN, V91, P697, DOI 10.2471/BLT.12.116087; Binagwaho A, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-37; Cohen MH, 2005, JAMA-J AM MED ASSOC, V294, P613, DOI 10.1001/jama.294.5.613; Crowe S, 1997, LANCET, V349, P1751, DOI 10.1016/S0140-6736(05)62968-6; Drobac P, 2013, CALIF SER PUB ANTHR, V26, P133; Elul B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053586; Farmer P. E., 2013, BMJ-BRIT MED J, V346, P20; Farmer PE, 2013, NEW ENGL J MED, V369, P2424, DOI 10.1056/NEJMsa1310472; Goosby E, 2012, JAIDS-J ACQ IMM DEF, V60, pS158, DOI 10.1097/QAI.0b013e31825d057c; Government of Rwanda, 2003, CONST REP RWAND; Habumuremyi PD, 2012, LANCET, V380, P78, DOI 10.1016/S0140-6736(12)60904-0; Hall P, 1996, LANCET, V347, P1265, DOI 10.1016/S0140-6736(96)90785-0; Institute for Health Metrics and Evaluation, 2010, GLOB BURD DIS 2010 S; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kalk A, 2010, TROP MED INT HEALTH, V15, P94, DOI 10.1111/j.1365-3156.2009.02424.x; Kim J. Y., 2000, DYING GROWTH GLOBAL; King M, 2006, LANCET, V367, P730, DOI 10.1016/S0140-6736(06)68302-5; KING M, 1994, LANCET, V344, P528, DOI 10.1016/S0140-6736(94)91906-2; Logie DE, 2008, LANCET, V372, P256, DOI 10.1016/S0140-6736(08)60962-9; Lu CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039282; Ministry of Finance and Economic Planning, 2000, VIS 2020; Ministry of Health of Rwanda, 2010, RWAND COMM BAS HLTH; Ministry of Health of Rwanda, 2011, NAT STRAT PLAN EL MO; Moon B., 2013, GLOBAL CAMPAIGN HLTH; National Institute of Statistics of Rwanda, 2012, 3 INT HOUS LIV COND; National Institute of Statistics of Rwanda and Macro International Inc, 2012, RWAND DEM HLTH SURV; Ngabo F, 2012, PAN AFR MED J, V13; Nsanzimana S, 2012, JAIDS-J ACQ IMM DEF, V59, pE17, DOI 10.1097/QAI.0b013e31823e2278; Price JE, 2009, AIDS CARE, V21, P608, DOI 10.1080/09540120802310957; Rich ML, 2012, JAIDS-J ACQ IMM DEF, V59, pE35, DOI 10.1097/QAI.0b013e31824476c4; Rwanda Biomedical Center, TRACNET HIV AIDS INF; Shepard DS, 2012, AM J TROP MED HYG, V86, P902, DOI 10.4269/ajtmh.2012.11-0202; SIDDIQUE AK, 1995, LANCET, V345, P359, DOI 10.1016/S0140-6736(95)90344-5; Stefan DC, 2013, LANCET ONCOL, V14, pE189, DOI 10.1016/S1470-2045(13)70100-1; Umubyeyi AN, 2007, INT J TUBERC LUNG D, V11, P189; UN Inter-Agency Group for Child Mortality Estimation, UND 5 MORT RAT EST; UN Office of the Special Envoy for Haiti, 2012, CAN MOR AID STAY HAI; Westoff CF, 2013, POPUL DEV REV, V38, P169, DOI 10.1111/j.1728-4457.2013.00558.x; WHO, GLOB HLTH EXP DAT; WHO and UN Children's Fund, 2013, EHO UNICEF EST NAT I; World Health Organization, GLOB HLTH OBS DAT RE; World Health Organization, 2010, UN ACC SCAL PRIOR HI	46	118	119	0	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2014	384	9940					371	375		10.1016/S0140-6736(14)60574-2	http://dx.doi.org/10.1016/S0140-6736(14)60574-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3AE	24703831	Green Accepted			2022-12-28	WOS:000339722400033
J	Afdhal, N; Zeuzem, S; Kwo, P; Chojkier, M; Gitlin, N; Puoti, M; Romero-Gomez, M; Zarski, JP; Agarwal, K; Buggisch, P; Foster, GR; Brau, N; Buti, M; Jacobson, IM; Subramanian, GM; Ding, X; Mo, HM; Yang, JC; Pang, PS; Symonds, WT; McHutchison, JG; Muir, AJ; Mangia, A; Marcellin, P				Afdhal, Nezam; Zeuzem, Stefan; Kwo, Paul; Chojkier, Mario; Gitlin, Norman; Puoti, Massimo; Romero-Gomez, Manuel; Zarski, Jean-Pierre; Agarwal, Kosh; Buggisch, Peter; Foster, Graham R.; Braeu, Norbert; Buti, Maria; Jacobson, Ira M.; Subramanian, G. Mani; Ding, Xiao; Mo, Hongmei; Yang, Jenny C.; Pang, Phillip S.; Symonds, William T.; McHutchison, John G.; Muir, Andrew J.; Mangia, Alessandra; Marcellin, Patrick		ION-1 Investigators	Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATITIS; COMBINATION; BOCEPREVIR; TELAPREVIR; RIBAVIRIN; THERAPY	BACKGROUND In phase 2 studies, treatment with the all-oral combination of the nucleotide polymerase inhibitor sofosbuvir and the NS5A inhibitor ledipasvir resulted in high rates of sustained virologic response among previously untreated patients with hepatitis C virus (HCV) genotype 1 infection. METHODS We conducted a phase 3, open-label study involving previously untreated patients with chronic HCV genotype 1 infection. Patients were randomly assigned in a 1:1:1:1 ratio to receive ledipasvir and sofosbuvir in a fixed-dose combination tablet once daily for 12 weeks, ledipasvir-sofosbuvir plus ribavirin for 12 weeks, ledipasvir-sofosbuvir for 24 weeks, or ledipasvir-sofosbuvir plus ribavirin for 24 weeks. The primary end point was a sustained virologic response at 12 weeks after the end of therapy. RESULTS Of the 865 patients who underwent randomization and were treated, 16% had cirrhosis, 12% were black, and 67% had HCV genotype 1a infection. The rates of sustained virologic response were 99% (95% confidence interval [CI], 96 to 100) in the group that received 12 weeks of ledipasvir-sofosbuvir; 97% (95% CI, 94 to 99) in the group that received 12 weeks of ledipasvir-sofosbuvir plus ribavirin; 98% (95% CI, 95 to 99) in the group that received 24 weeks of ledipasvir-sofosbuvir; and 99% (95% CI, 97 to 100) in the group that received 24 weeks of ledipasvir-sofosbuvir plus ribavirin. No patient in either 12-week group discontinued ledipasvir-sofosbuvir owing to an adverse event. The most common adverse events were fatigue, headache, insomnia, and nausea. CONCLUSIONS Once-daily ledipasvir-sofosbuvir with or without ribavirin for 12 or 24 weeks was highly effective in previously untreated patients with HCV genotype 1 infection.	[Afdhal, Nezam] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Zeuzem, Stefan] Goethe Univ Frankfurt, Med Ctr, D-60054 Frankfurt, Germany; [Buggisch, Peter] Asklepios Klin St Georg, Inst Interdisziplinare Med Studien, Hamburg, Germany; [Kwo, Paul] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Chojkier, Mario] Univ Calif San Diego, Med Ctr, San Diego, CA 92103 USA; [Subramanian, G. Mani; Ding, Xiao; Mo, Hongmei; Yang, Jenny C.; Pang, Phillip S.; Symonds, William T.; McHutchison, John G.] Gilead Sci, Foster City, CA USA; [Gitlin, Norman] Atlanta Gastroenterol Associates, Atlanta, GA USA; [Puoti, Massimo] Azienda Osped Osped Niguarda Ca Granda, Milan, Italy; [Mangia, Alessandra] Casa Sollievo Sofferenza Hosp, San Giovanni Rotondo, Italy; [Romero-Gomez, Manuel] Hosp Univ Nuestra Senora de Valme, Seville, Spain; [Buti, Maria] Hosp Univ Vall dHebron, Barcelona, Spain; [Buti, Maria] Ciberhed, Inst Carlos 3, Barcelona, Spain; [Zarski, Jean-Pierre] CHU Grenoble, F-38043 Grenoble, France; [Marcellin, Patrick] Hop Beaujon, F-92110 Clichy, France; [Agarwal, Kosh] Kings Coll Hosp London, Inst Liver Studies, London SE5 8RX, England; [Foster, Graham R.] Queen Mary Univ London, London, England; [Braeu, Norbert] James J Peters Vet Affairs Med Ctr, Bronx, NY USA; [Jacobson, Ira M.] Weill Cornell Med Coll, New York, NY USA; [Muir, Andrew J.] Duke Univ, Med Ctr, Durham, NC USA	Harvard University; Beth Israel Deaconess Medical Center; Goethe University Frankfurt; Asklepios Klinik St. Georg; Indiana University System; Indiana University Bloomington; University of California System; University of California San Diego; Gilead Sciences; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; IRCCS Casa Sollievo Della Sofferenza; Hospital Universitari Vall d'Hebron; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of London; Queen Mary University London; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Cornell University; Duke University	Afdhal, N (corresponding author), Beth Israel Deaconess Med Ctr, 110 Francis St,Suite 4, Boston, MA 02215 USA.	nafdhal@bidmc.harvard.edu; patrick.marcellin@bjn.ap-hop-paris.fr	Puoti, Massimo/AAA-6580-2020; Agarwal, Kosh/ABH-8721-2020; IBIS, DIGESTIVAS/O-1913-2015; Hezode, Christophe/U-4659-2018; Andreone, Pietro/K-8050-2016; Mangia, A/AAL-5357-2020; Romero-Gomez, Manuel/L-8030-2014; Zeuzem, Stefan/AAE-7435-2019	Agarwal, Kosh/0000-0002-4754-828X; Andreone, Pietro/0000-0002-4794-9809; Mangia, A/0000-0002-2600-3555; Romero-Gomez, Manuel/0000-0001-8494-8947; Crespo, Javier/0000-0001-8248-0172; Davis, Mitchell/0000-0002-0526-5564; Puoti, Massimo/0000-0003-3278-7138; Buti Ferret, Maria/0000-0002-0732-3078; Foster, Graham/0000-0002-3704-386X; Ustianowski, Andrew/0000-0002-6134-7855; Afdhal, Nezam/0000-0002-7342-6593	Gilead Sciences	Gilead Sciences(Gilead Sciences)	Supported by Gilead Sciences.	Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Afdhal NH, 2014, GASTROENTEROLOGY, V146, P442, DOI 10.1053/j.gastro.2013.10.012; American Association for the Study of Liver Diseases and Infectious Diseases Society of America, REC TEST MAN TREAT H; [Anonymous], 2013, OL SIM CAPS US PRESC; [Anonymous], 2003, REB RIV CAPS US PRES; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Fattovich G, 1996, J HEPATOL, V24, P38, DOI 10.1016/S0168-8278(96)80184-X; Gane EJ, 2014, GASTROENTEROLOGY, V146, P736, DOI 10.1053/j.gastro.2013.11.007; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Hezode C, 2013, J HEPATOL, V59, P434, DOI 10.1016/j.jhep.2013.04.035; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Lawitz EJ, 2012, J HEPATOL, V57, P24, DOI 10.1016/j.jhep.2011.12.029; Mayne Pharma, 2021, NEXTST EST DROSP TAB; McHutchison JG, 2002, GASTROENTEROLOGY, V123, P1061, DOI 10.1053/gast.2002.35950; Osinusi A, 2013, JAMA-J AM MED ASSOC, V310, P804, DOI 10.1001/jama.2013.109309; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Sherman KE, 2013, CLIN GASTROENTEROL H; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	21	1374	1410	4	124	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2014	370	20					1889	1898		10.1056/NEJMoa1402454	http://dx.doi.org/10.1056/NEJMoa1402454			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UH	24725239	Bronze, Green Published			2022-12-28	WOS:000336123600005
J	Babbin, AR; Keil, RG; Devol, AH; Ward, BB				Babbin, Andrew R.; Keil, Richard G.; Devol, Allan H.; Ward, Bess B.			Organic Matter Stoichiometry, Flux, and Oxygen Control Nitrogen Loss in the Ocean	SCIENCE			English	Article							DEFICIENT ZONE; MINIMUM-ZONE; CARBON; DENITRIFICATION; ANAMMOX; DEGRADATION; OXIDATION; WATERS; CYCLE	Biologically available nitrogen limits photosynthesis in much of the world ocean. Organic matter (OM) stoichiometry had been thought to control the balance between the two major nitrogen removal pathways-denitrification and anammox-but the expected proportion of 30% anammox derived from mean oceanic OM is rarely observed in the environment. With incubations designed to directly test the effects of stoichiometry, however, we showed that the ratio of anammox to denitrification depends on the stoichiometry of OM supply, as predicted. Furthermore, observed rates of nitrogen loss increase with the magnitude of OM supply. The variable ratios between denitrification and anammox previously observed in the ocean are thus attributable to localized variations in OM quality and quantity and do not necessitate a revision to the global nitrogen cycle.	[Babbin, Andrew R.; Ward, Bess B.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Keil, Richard G.; Devol, Allan H.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	Princeton University; University of Washington; University of Washington Seattle	Babbin, AR (corresponding author), Princeton Univ, Dept Geosci, Guyot Hall, Princeton, NJ 08544 USA.	babbin@princeton.edu	Keil, Richard/AAN-4140-2021	Babbin, Andrew/0000-0002-5046-0609	NSF; National Defense Science and Engineering Graduate Fellowship; Division Of Ocean Sciences [1153935, 1029316] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); National Defense Science and Engineering Graduate Fellowship; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the captain and crew of the R/V Thomas G. Thompson for assistance in sampling; C. Buchwald and A. Morello for nutrient measurements; and B. X. Chang, D. Bianchi, and D. M. Sigman for useful discussions of this work. F. M. M. Morel provided invaluable advice in honing and improving this paper. The data presented in this paper are available in the supplementary materials. This study was supported by an NSF grant to A. H. D. and B. B. W. and a National Defense Science and Engineering Graduate Fellowship to A. R. B. A. R. B., A. H. D., and B. B. W. designed and conducted the experiments; R. G. K. collected and analyzed sediment trap material; and A. R. B. and B. B. W. wrote the manuscript with input from all authors.	ANDERSON LA, 1995, DEEP-SEA RES PT I, V42, P1675, DOI 10.1016/0967-0637(95)00072-E; BENDER M, 1989, GEOCHIM COSMOCHIM AC, V53, P685, DOI 10.1016/0016-7037(89)90011-2; Berelson W., 2001, OCEANOGRAPHY, V14, P59, DOI DOI 10.5670/0CEAN0G.2001.07; Bianchi D, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004209; Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; Codispoti LA, 2005, RESPIRATION IN AQUATIC ECOSYSTEMS, P225, DOI 10.1093/acprof:oso/9780198527084.003.0012; Dalsgaard T., 2013, ASS SCI LIMN OC AQ S; Dalsgaard T, 2012, LIMNOL OCEANOGR, V57, P1331, DOI 10.4319/lo.2012.57.5.1331; Devol AH, 2001, LIMNOL OCEANOGR, V46, P1684, DOI 10.4319/lo.2001.46.7.1684; Hartnett HE, 2003, GEOCHIM COSMOCHIM AC, V67, P247, DOI 10.1016/S0016-7037(02)01076-1; Jensen MM, 2008, LIMNOL OCEANOGR, V53, P23, DOI 10.4319/lo.2008.53.1.0023; Kalvelage T, 2013, NAT GEOSCI, V6, P228, DOI [10.1038/ngeo1739, 10.1038/NGEO1739]; Kalvelage T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029299; Kartal B, 2007, ENVIRON MICROBIOL, V9, P635, DOI 10.1111/j.1462-2920.2006.01183.x; Koeve W, 2010, BIOGEOSCIENCES, V7, P2327, DOI 10.5194/bg-7-2327-2010; Kortzinger A, 2001, DEEP-SEA RES PT I, V48, P661, DOI 10.1016/S0967-0637(00)00051-0; Lam P, 2009, P NATL ACAD SCI USA, V106, P4752, DOI 10.1073/pnas.0812444106; LIPSCHULTZ F, 1990, DEEP-SEA RES, V37, P1513, DOI 10.1016/0198-0149(90)90060-9; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; Ogawa H, 2001, SCIENCE, V292, P917, DOI 10.1126/science.1057627; Paulmier A, 2009, PROG OCEANOGR, V80, P113, DOI 10.1016/j.pocean.2008.08.001; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Richards F. A., 1965, CHEM OCEANOGR, V1, P611; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Strous M, 1998, APPL MICROBIOL BIOT, V50, P589, DOI 10.1007/s002530051340; Strous M, 1997, APPL ENVIRON MICROB, V63, P2446, DOI 10.1128/AEM.63.6.2446-2448.1997; Van Mooy BAS, 2002, GEOCHIM COSMOCHIM AC, V66, P457, DOI 10.1016/S0016-7037(01)00787-6; Ward BB, 2009, NATURE, V461, P78, DOI 10.1038/nature08276; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	30	164	168	10	255	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					406	408		10.1126/science.1248364	http://dx.doi.org/10.1126/science.1248364			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763588				2022-12-28	WOS:000334867800039
J	MacArthur, DG; Manolio, TA; Dimmock, DP; Rehm, HL; Shendure, J; Abecasis, GR; Adams, DR; Altman, RB; Antonarakis, SE; Ashley, EA; Barrett, JC; Biesecker, LG; Conrad, DF; Cooper, GM; Cox, NJ; Daly, MJ; Gerstein, MB; Goldstein, DB; Hirschhorn, JN; Leal, SM; Pennacchio, LA; Stamatoyannopoulos, JA; Sunyaev, SR; Valle, D; Voight, BF; Winckler, W; Gunter, C				MacArthur, D. G.; Manolio, T. A.; Dimmock, D. P.; Rehm, H. L.; Shendure, J.; Abecasis, G. R.; Adams, D. R.; Altman, R. B.; Antonarakis, S. E.; Ashley, E. A.; Barrett, J. C.; Biesecker, L. G.; Conrad, D. F.; Cooper, G. M.; Cox, N. J.; Daly, M. J.; Gerstein, M. B.; Goldstein, D. B.; Hirschhorn, J. N.; Leal, S. M.; Pennacchio, L. A.; Stamatoyannopoulos, J. A.; Sunyaev, S. R.; Valle, D.; Voight, B. F.; Winckler, W.; Gunter, C.			Guidelines for investigating causality of sequence variants in human disease	NATURE			English	Article							DE-NOVO MUTATIONS; RARE VARIANTS; GENES; PHENOTYPE; INDIVIDUALS; ASSOCIATION; POPULATION; DISSECTION; EVOLUTION; GENCODE	The discovery of rare genetic variants is accelerating, and clear guidelines for distinguishing disease-causing sequence variants from the many potentially functional variants present in any human genome are urgently needed. Without rigorous standards we risk an acceleration of false-positive reports of causality, which would impede the translation of genomic research findings into the clinical diagnostic setting and hinder biological understanding of disease. Here we discuss the key challenges of assessing sequence variants in human disease, integrating both gene-level and variant-level support for causality. We propose guidelines for summarizing confidence in variant pathogenicity and highlight several areas that require further resource development.	[MacArthur, D. G.; Daly, M. J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [MacArthur, D. G.; Daly, M. J.; Hirschhorn, J. N.; Winckler, W.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Manolio, T. A.] NHGRI, Div Genom Med, Bethesda, MD 20892 USA; [Dimmock, D. P.] Med Coll Wisconsin, Dept Pediat, Div Genet, Milwaukee, WI 53226 USA; [Rehm, H. L.] Partners Healthcare Ctr Personalized Genet Med, Mol Med Lab, Cambridge, MA 02139 USA; [Rehm, H. L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Shendure, J.] Univ Washington, Dept Genome Sci, Seattle, WA 98115 USA; [Abecasis, G. R.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Adams, D. R.] NIH, NIH Undiagnosed Dis Program, Off Rare Dis Res, Bethesda, MD 20892 USA; [Adams, D. R.] NHGRI, Bethesda, MD 20892 USA; [Adams, D. R.] NHGRI, Off Clin Director, NIH, Bethesda, MD 20892 USA; [Altman, R. B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Altman, R. B.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Antonarakis, S. E.] Univ Geneva, Sch Med, Dept Med Genet, CH-1211 Geneva, Switzerland; [Antonarakis, S. E.] iGE3 Inst Genet & Genom Geneva, CH-1211 Geneva, Switzerland; [Ashley, E. A.] Stanford Univ, Sch Med, Ctr Inherited Cardiovasc Dis, Stanford, CA 94305 USA; [Barrett, J. C.] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Biesecker, L. G.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Conrad, D. F.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Conrad, D. F.] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; [Conrad, D. F.] Washington Univ, Sch Med, Dept Immunol, St Louis, MO 63110 USA; [Cooper, G. M.; Gunter, C.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Cox, N. J.] Univ Chicago, Dept Med, Med Genet Sect, Chicago, IL 60637 USA; [Gerstein, M. B.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Gerstein, M. B.] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Gerstein, M. B.] Yale Univ, Dept Mol Biophys, New Haven, CT 06520 USA; [Gerstein, M. B.] Yale Univ, Dept Biochem, New Haven, CT 06520 USA; [Goldstein, D. B.] Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27708 USA; [Hirschhorn, J. N.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Hirschhorn, J. N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Leal, S. M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Pennacchio, L. A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Pennacchio, L. A.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Stamatoyannopoulos, J. A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Sunyaev, S. R.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Sunyaev, S. R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Valle, D.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA; [Voight, B. F.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Voight, B. F.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Medical College of Wisconsin; Partners Healthcare System; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Stanford University; Stanford University; University of Geneva; Stanford University; Wellcome Trust Sanger Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); HudsonAlpha Institute for Biotechnology; University of Chicago; Yale University; Yale University; Yale University; Yale University; Duke University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Baylor College of Medicine; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	MacArthur, DG (corresponding author), Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA.	macarthur@atgu.mgh.harvard.edu; drchrisgunter@gmail.com	Dimmock, David/I-7913-2015; Gunter, Chris/AHA-7271-2022; Antonarakis, Stylianos E/N-8866-2014; Daly, Mark J/B-2453-2017; Goldstein, David/AAY-8125-2020; Shendure, Jay/AAU-3684-2021; Cooper, Gregory/D-6914-2011	Dimmock, David/0000-0001-6690-2523; Antonarakis, Stylianos E/0000-0001-8907-5823; Daly, Mark J/0000-0002-0949-8752; Gunter, Chris/0000-0001-9369-7537; Pennacchio, Len/0000-0002-8748-3732; Altman, Russ/0000-0003-3859-2905; Barrett, Jeffrey/0000-0002-1152-370X; MacArthur, Daniel/0000-0002-5771-2290; Cooper, Gregory/0000-0001-5509-9923; Shendure, Jay/0000-0002-1516-1865; Voight, Benjamin/0000-0002-6205-9994; Rehm, Heidi L./0000-0002-6025-0015	NHGRI NIH HHS [U01 HG007301, U54 HG006997, R01 HG007022] Funding Source: Medline; NHLBI NIH HHS [R01 HL117626] Funding Source: Medline; NIDDK NIH HHS [P30 DK020595] Funding Source: Medline; NIMH NIH HHS [R01 MH101810] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117626] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007022, ZIAHG200387, ZIAHG200328, U54HG006997, ZIAHG200359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101810] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Albers CA, 2012, NAT GENET, V44, P435, DOI 10.1038/ng.1083; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 2012, NATURE, V490, P143; [Anonymous], 2013, CREAT GLOB ALL EN RE; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Bick AG, 2012, AM J HUM GENET, V91, P513, DOI 10.1016/j.ajhg.2012.07.017; Boulding H, 2012, HUM MUTAT, V33, P874, DOI 10.1002/humu.22069; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Flannick J, 2013, NAT GENET, V45, P1380, DOI 10.1038/ng.2794; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Gargis AS, 2012, NAT BIOTECHNOL, V30, P1033, DOI 10.1038/nbt.2403; Giallourakis C, 2005, ANNU REV GENOM HUM G, V6, P381, DOI 10.1146/annurev.genom.6.080604.162234; Goldstein DB, 2013, NAT REV GENET, V14, P460, DOI 10.1038/nrg3455; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hunt KA, 2012, NAT GENET, V44, P3, DOI 10.1038/ng.1037; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Johnston JJ, 2012, AM J HUM GENET, V90, P295, DOI 10.1016/j.ajhg.2011.11.031; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Lage K, 2008, P NATL ACAD SCI USA, V105, P20870, DOI 10.1073/pnas.0810772105; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lemaire M, 2013, NAT GENET, V45, P531, DOI 10.1038/ng.2590; Li BA, 2012, BIOINFORMATICS, V28, P2703, DOI 10.1093/bioinformatics/bts499; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Norton N, 2012, CIRC-CARDIOVASC GENE, V5, P167, DOI 10.1161/CIRCGENETICS.111.961805; O'Connor TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065834; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pasaniuc B, 2012, NAT GENET, V44, P631, DOI 10.1038/ng.2283; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Reed DR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-4; Rehm H. L., 2013, GENET MED IN PRESS; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Walport M, 2011, LANCET, V377, P537, DOI 10.1016/S0140-6736(10)62234-9; Webber C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000531; Weng L, 2005, J CLIN INVEST, V115, P1016, DOI 10.1172/JCI24186; Xue W, 2011, NATURE, V473, P544, DOI 10.1038/nature09909; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	60	849	873	1	121	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					469	476		10.1038/nature13127	http://dx.doi.org/10.1038/nature13127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24759409	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000334741600026
J	Wall, M; McDermott, MP; Kieburtz, KD; Corbett, JJ; Feldon, SE; Friedman, DI; Katz, DM; Keltner, JL; Schron, EB; Kupersmith, MJ				Wall, Michael; McDermott, Michael P.; Kieburtz, Karl D.; Corbett, James J.; Feldon, Steven E.; Friedman, Deborah I.; Katz, David M.; Keltner, John L.; Schron, Eleanor B.; Kupersmith, Mark J.		NORDIC Idiopathic Intracranial	Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss The Idiopathic Intracranial Hypertension Treatment Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PSEUDOTUMOR CEREBRI; PRESSURE; VALIDATION; DIAGNOSIS	IMPORTANCE Acetazolamide is commonly used to treat idiopathic intracranial hypertension (IIH), but there is insufficient information to establish an evidence base for its use. OBJECTIVE To determine whether acetazolamide is beneficial in improving vision when added to a low-sodium weight reduction diet in patients with IIH and mild visual loss. DESIGN, SETTING, AND PARTICIPANTS Multicenter, randomized, double-masked, placebo-controlled study of acetazolamide in 165 participants with IIH and mild visual loss who received a low-sodium weight-reduction diet. Participants were enrolled at 38 academic and private practice sites in North America from March 2010 to November 2012 and followed up for 6 months (last visit in June 2013). All participants met the modified Dandy criteria for IIH and had a perimetric mean deviation (PMD) between -2 dB and -7 dB. The mean age was 29 years and all but 4 participants were women. INTERVENTIONS Low-sodium weight-reduction diet plus the maximally tolerated dosage of acetazolamide (up to 4 g/d) or matching placebo for 6 months. MAIN OUTCOMES AND MEASURES The planned primary outcome variable was the change in PMD from baseline to month 6 in the most affected eye, as measured by Humphrey Field Analyzer. Perimetric mean deviation is a measure of global visual field loss (mean deviation from age-corrected normal values), with a range of 2 to -32 dB; larger negative values indicate greater vision loss. Secondary outcome variables included changes in papilledema grade, quality of life (Visual Function Questionnaire 25 [VFQ-25] and 36-Item Short Form Health Survey), headache disability, and weight at month 6. RESULTS The mean improvement in PMD was greater with acetazolamide (1.43 dB, from -3.53 dB at baseline to -2.10dB at month 6; n = 86) than with placebo (0.71 dB, from -3.53 dB to -2.82 dB; n = 79); the difference was 0.71 dB (95% CI, 0to 1.43 dB; P = .050). Mean improvements in papilledema grade (acetazolamide: -1.31, from 2.76 to 1.45; placebo: -0.61, from 2.76 to 2.15; treatment effect, -0.70; 95% CI, -0.99 to -0.41; P < .001) and vision-related quality of life as measured by the National Eye Institute VFQ-25 (acetazolamide: 8.33, from 82.97 to 91.30; placebo: 1.98, from 82.97 to 84.95; treatment effect, 6.35; 95% CI, 2.22 to 10.47; P = .003) and its 10-item neuro-ophthalmic supplement (acetazolamide: 9.82, from 75.45 to 85.27; placebo: 1.59, from 75.45 to 77.04; treatment effect, 8.23; 95% CI, 3.89 to 12.56; P < .001) were also observed with acetazolamide. Participants assigned to acetazolamide also experienced a reduction in weight (acetazolamide: -7.50 kg, from 107.72 kg to 100.22 kg; placebo: -3.45 kg, from 107.72 kg to 104.27 kg; treatment effect, -4.05 kg, 95% CI, -6.27 to -1.83 kg; P < .001). CONCLUSIONS AND RELEVANCE In patients with IIH and mild visual loss, the use of acetazolamide with a low-sodium weight-reduction diet compared with diet alone resulted in modest improvement in visual field function. The clinical importance of this improvement remains to be determined.	[Wall, Michael] Univ Iowa, Iowa City, IA USA; [McDermott, Michael P.; Kieburtz, Karl D.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Corbett, James J.] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Feldon, Steven E.] Univ Rochester, Inst Eye, Rochester, NY USA; [Friedman, Deborah I.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Katz, David M.] Bethesda Neurol LLC, Bethesda, MD USA; [Keltner, John L.] Univ Calif Davis, Med Ctr, Davis, CA USA; [Schron, Eleanor B.] NEI, Bethesda, MD 20892 USA; [Kupersmith, Mark J.] St Lukes Roosevelt Hosp, New York, NY 10025 USA	University of Iowa; University of Rochester; University of Mississippi; University of Mississippi Medical Center; University of Rochester; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Mount Sinai St. Luke's; Mount Sinai West	Wall, M (corresponding author), Univ Iowa Hosp & Clin, Dept Neurol, 200 Hawkins Dr, Iowa City, IA 52242 USA.	michael-wall@uiowa.edu	Friedman, Deborah I/HCG-8707-2022; McDermott, Michael Francis/GZM-5330-2022	Friedman, Deborah I/0000-0002-6652-6158; Kardon, Randy/0000-0002-3173-7123; Bruce, Beau/0000-0003-3003-2962; Wall, Michael/0000-0002-9802-4806; Subramanian, Prem/0000-0001-5824-8322; Feldon, Steven/0000-0003-0603-9312	National Eye Institute (NEI) [1U10EY017281-01A1, 1U10EY017387-01A1, 3U10EY017281-01A1S1, 1U10EY017387-01A1S1]; NATIONAL EYE INSTITUTE [U10EY017281, U10EY017387] Funding Source: NIH RePORTER	National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Eye Institute (NEI) grants 1U10EY017281-01A1, DCBC 1U10EY017387-01A1, ARRA for NORDIC 3U10EY017281-01A1S1, and DCBC 1U10EY017387-01A1S1, and supplements for NORDIC 3U10EY017281-01A1S2.	Banta JT, 2000, OPHTHALMOLOGY, V107, P1907, DOI 10.1016/S0161-6420(00)00340-7; Dandy WE, 1937, ANN SURG, V106, P492, DOI 10.1097/00000658-193710000-00002; De Wecker L, 1872, INT OPHTHALMOL CONG, V4, P11; EPSTEIN DL, 1977, ARCH OPHTHALMOL-CHIC, V95, P1378, DOI 10.1001/archopht.1977.04450080088009; Friedman DI, 2014, J NEURO-OPHTHALMOL, V34, P107, DOI 10.1097/WNO.0000000000000114; FRISEN L, 1982, J NEUROL NEUROSUR PS, V45, P13, DOI 10.1136/jnnp.45.1.13; GUCER G, 1978, J NEUROSURG, V49, P256, DOI 10.3171/jns.1978.49.2.0256; JEFFERSON A, 1976, J NEUROL NEUROSUR PS, V39, P627, DOI 10.1136/jnnp.39.7.627; Johnson LN, 1998, OPHTHALMOLOGY, V105, P2313, DOI 10.1016/S0161-6420(98)91234-9; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Lubow M., 1976, NEURO-OPHTHALMOLOGY, V9, P199; Lueck C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003434.pub2; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P1496, DOI 10.1001/archopht.116.11.1496; Molenberghs G, 2004, BIOSTATISTICS, V5, P445, DOI 10.1093/biostatistics/kxh001; NEWBORG B, 1974, ARCH INTERN MED, V133, P802, DOI 10.1001/archinte.133.5.802; PATERSON R, 1961, MEDICINE, V40, P85, DOI 10.1097/00005792-196102000-00003; Raphael BA, 2006, AM J OPHTHALMOL, V142, P1026, DOI 10.1016/j.ajo.2006.06.060; RUBIN RC, 1966, J NEUROSURG, V25, P430, DOI 10.3171/jns.1966.25.4.0430; Scott CJ, 2010, ARCH OPHTHALMOL-CHIC, V128, P705, DOI 10.1001/archophthalmol.2010.94; SMITH JL, 1985, J CLIN NEURO-OPHTHAL, V5, P55; Suner IJ, 2009, INVEST OPHTH VIS SCI, V50, P3629, DOI 10.1167/iovs.08-3225; VANDERAR.GD, 1971, J AMER MED ASSOC, V217, P1832, DOI 10.1001/jama.217.13.1832; Wall M, 2014, JAMA NEUROL, V71, P693, DOI 10.1001/jamaneurol.2014.133; Ware JE, 2001, SF 36 PHYSICAL AND M; Woodworth GF, 2005, STEREOT FUNCT NEUROS, V83, P12, DOI 10.1159/000084059	25	270	272	1	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2014	311	16					1641	1651		10.1001/jama.2014.3312	http://dx.doi.org/10.1001/jama.2014.3312			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF4OU	24756514	Bronze, Green Accepted			2022-12-28	WOS:000334693900024
J	Guler, U; Boltasseva, A; Shalaev, VM				Guler, Urcan; Boltasseva, Alexandra; Shalaev, Vladimir M.			Refractory Plasmonics	SCIENCE			English	Editorial Material							HIGH-TEMPERATURE STABILITY; PHOTONIC CRYSTALS; THERMAL EMISSION		[Guler, Urcan] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA; Nanometa Technol Inc, W Lafayette, IN 47906 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Guler, U (corresponding author), Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA.	shalaev@purdue.edu	Guler, Urcan/E-2246-2012; Boltasseva, Alexandra/C-1674-2019; Shalaev, Vladimir M./B-9331-2019	Guler, Urcan/0000-0002-8807-6274; Boltasseva, Alexandra/0000-0001-8905-2605; Shalaev, Vladimir M./0000-0001-8976-1102				Arpin KA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3630; Boltasseva A, 2011, SCIENCE, V331, P290, DOI 10.1126/science.1198258; Boyd DA, 2006, NANO LETT, V6, P2592, DOI 10.1021/nl062061m; Brongersma ML, 2010, SCIENCE, V328, P440, DOI 10.1126/science.1186905; Challener WA, 2009, NAT PHOTONICS, V3, P220, DOI 10.1038/NPHOTON.2009.26; Fan SH, 2014, NAT NANOTECHNOL, V9, P92, DOI 10.1038/nnano.2014.9; Guler U, 2013, NANO LETT, V13, P6078, DOI 10.1021/nl4033457; Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100; Kraemer D, 2011, NAT MATER, V10, P532, DOI [10.1038/NMAT3013, 10.1038/nmat3013]; Lenert A, 2014, NAT NANOTECHNOL, V9, P126, DOI [10.1038/nnano.2013.286, 10.1038/NNANO.2013.286]; Lindquist NC, 2013, LASER PHOTONICS REV, V7, P453, DOI 10.1002/lpor.201209044; Naik GV, 2013, ADV MATER, V25, P3264, DOI 10.1002/adma.201205076; Rinnerbauer V, 2013, OPT EXPRESS, V21, P11482, DOI 10.1364/OE.21.011482; Rousseau E, 2009, NAT PHOTONICS, V3, P514, DOI 10.1038/NPHOTON.2009.144; Wu CH, 2012, J OPTICS-UK, V14, DOI 10.1088/2040-8978/14/2/024005	15	287	288	6	198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					263	264		10.1126/science.1252722	http://dx.doi.org/10.1126/science.1252722			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744364				2022-12-28	WOS:000334474500023
J	Bluestein, D; Slepian, MJ				Bluestein, Danny; Slepian, Marvin J.			Sticking with Synthetic Tissue Sealants	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HYDROGELS	A recent report describes a new agent for the sealing and repair of tissues in animal models. This flowable, blood-resistant tissue glue is intended for use in surgical therapeutics. Tissue reanastomosis and wound closure are vital steps in surgery. Similarly, in percutaneous intervention, localized hemostasis is essential. Traditionally, sutures and staples have been used for tissue approximation and closure. Despite their basic efficacy, these tools have limitations that include the added trauma to tissue during placement and the difficulty of deployment in small spaces and tight geometries. Lang et al.(1) describe a new tool for tissue sealing and repair: a fluid, blood-resistant tissue glue for use in surgical and minimally invasive cardiovascular therapeutic procedures. This glue is a hydrophobic light-activated adhesive (HLAA) that consists of a biocompatible, biodegradable hydrophobic ...	[Bluestein, Danny] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Slepian, Marvin J.] Univ Arizona, Sarver Heart Ctr, Tucson, AZ USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Arizona	Bluestein, D (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.		Bluestein, Danny/P-4073-2014; Slepian, Marvin/ABG-8305-2020	Slepian, Marvin/0000-0002-7864-6691				Lang N, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006557; Ramakumar S, 2002, J ENDOUROL, V16, P489, DOI 10.1089/089277902760367458; SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005; Watts D.C., 2013, BIOMATERIALS SCI INT, V3rd, P889	4	3	4	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 17	2014	370	16					1556	1559		10.1056/NEJMcibr1400477	http://dx.doi.org/10.1056/NEJMcibr1400477			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF3HE	24738673				2022-12-28	WOS:000334601600015
J	Simpson, SJ; Raubenheimer, D				Simpson, Stephen J.; Raubenheimer, David			Tricks of the trade	NATURE			English	Editorial Material									[Simpson, Stephen J.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia	University of Sydney	Simpson, SJ (corresponding author), Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.	stephen.simpson@sydney.edu.au; david.raubenheimer@sydney.edu.au		Simpson, Stephen J./0000-0003-0256-7687; Raubenheimer, David/0000-0001-9050-1447				Austin GL, 2011, AM J CLIN NUTR, V93, P836, DOI 10.3945/ajcn.110.000141; Gosby AK, 2014, OBES REV, V15, P183, DOI 10.1111/obr.12131; Simpson S. J., 2012, 0ATURE NUTR UNIFYING; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009	4	30	30	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					S66	S66		10.1038/508S66a	http://dx.doi.org/10.1038/508S66a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF0KP	24740132				2022-12-28	WOS:000334403000009
J	Sullivan, SR; Taylor, HO				Sullivan, Stephen R.; Taylor, Helena O.			Ear Replantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sullivan, Stephen R.; Taylor, Helena O.] Rhode Isl Hosp, Providence, RI 02903 USA	Lifespan Health Rhode Island; Rhode Island Hospital	Sullivan, SR (corresponding author), Rhode Isl Hosp, Providence, RI 02903 USA.	stephen.sullivan@brown.edu							0	4	5	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 17	2014	370	16					1541	1541		10.1056/NEJMicm1310815	http://dx.doi.org/10.1056/NEJMicm1310815			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AF3HE	24738671				2022-12-28	WOS:000334601600011
J	Zhao, LD; Lo, SH; Zhang, YS; Sun, H; Tan, GJ; Uher, C; Wolverton, C; Dravid, VP; Kanatzidis, MG				Zhao, Li-Dong; Lo, Shih-Han; Zhang, Yongsheng; Sun, Hui; Tan, Gangjian; Uher, Ctirad; Wolverton, C.; Dravid, Vinayak P.; Kanatzidis, Mercouri G.			Ultralow thermal conductivity and high thermoelectric figure of merit in SnSe crystals	NATURE			English	Article							PERFORMANCE BULK THERMOELECTRICS; NANOSTRUCTURES; EFFICIENCY; DISTORTION	The thermoelectric effect enables direct and reversible conversion between thermal and electrical energy, and provides a viable route for power generation from waste heat. The efficiency of thermoelectric materials is dictated by the dimensionless figure of merit, ZT (where Z is the figure of merit and T is absolute temperature), which governs the Carnot efficiency for heat conversion. Enhancements above the generally high threshold value of 2.5 have important implications for commercial deployment(1,2), especially for compounds free of Pb and Te. Here we report an unprecedented ZT of 2.6 +/- 0.3 at 923 K, realized in SnSe single crystals measured along the b axis of the room-temperature orthorhombic unit cell. This material also shows a high ZT of 2.3 +/- 0.3 along thec axis but a significantly reduced ZT of 0.8 +/- 0.2 along the a axis. We attribute the remarkably high ZT along the b axis to the intrinsically ultralow lattice thermal conductivity in SnSe. The layered structure of SnSe derives from a distorted rock-salt structure, and features anomalously high Gruneisen parameters, which reflect the anharmonic and anisotropic bonding. We attribute the exceptionally low lattice thermal conductivity (0.2 +/- 0.03 Wm(-1) K-1 at 973 K) in SnSe to the anharmonicity. These findings highlight alternative strategies to nanostructuring for achieving high thermoelectric performance.	[Zhao, Li-Dong; Tan, Gangjian; Kanatzidis, Mercouri G.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Lo, Shih-Han; Zhang, Yongsheng; Wolverton, C.; Dravid, Vinayak P.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Sun, Hui; Uher, Ctirad] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA	Northwestern University; Northwestern University; University of Michigan System; University of Michigan	Kanatzidis, MG (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	m-kanatzidis@northwestern.edu	Tan, Gangjian/AAG-5433-2019; Tan, Gangjian/M-3509-2014; Dravid, Vinayak/B-6688-2009; Wolverton, Chris/AAZ-3899-2020; Sun, Hui/D-3411-2014; Wolverton, Christopher/B-7542-2009; Zhao, Li-Dong/B-1045-2019	Tan, Gangjian/0000-0002-9087-4048; Tan, Gangjian/0000-0002-9087-4048; Sun, Hui/0000-0002-9745-3510; Zhao, Li-Dong/0000-0003-1247-4345	Revolutionary Materials for Solid State Energy Conversion; Energy Frontier Research Center; US Department of Energy, Office of Science [DE-SC0001054]; US Department of Energy, Office of Basic Energy Sciences [DE-SC0001054]; NSF-NSEC; Keck Foundation; State of Illinois; Northwestern University; NSF-MRSEC	Revolutionary Materials for Solid State Energy Conversion; Energy Frontier Research Center; US Department of Energy, Office of Science(United States Department of Energy (DOE)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF-NSEC(National Science Foundation (NSF)); Keck Foundation(W.M. Keck Foundation); State of Illinois; Northwestern University; NSF-MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by Revolutionary Materials for Solid State Energy Conversion, an Energy Frontier Research Center funded by the US Department of Energy, Office of Science, and Office of Basic Energy Sciences under award number DE-SC0001054 (L.-D.Z., S.-H.L., Y.Z., H.S., G.T., C.U., C.W., V.P.D. and M.G.K.). TEM work was performed in the (EPIC, NIFTI, Keck-II) facility of the NUANCE Center at Northwestern University. The NUANCE Center is supported by NSF-NSEC, NSF-MRSEC, the Keck Foundation, the State of Illinois and Northwestern University.	Baumgardner WJ, 2010, J AM CHEM SOC, V132, P9519, DOI 10.1021/ja1013745; Biswas K, 2012, NATURE, V489, P414, DOI 10.1038/nature11439; Biswas K, 2011, NAT CHEM, V3, P160, DOI [10.1038/nchem.955, 10.1038/NCHEM.955]; Brown SR, 2006, CHEM MATER, V18, P1873, DOI 10.1021/cm060261t; CAHILL DG, 1992, PHYS REV B, V46, P6131, DOI 10.1103/PhysRevB.46.6131; CHATTOPADHYAY T, 1986, J PHYS CHEM SOLIDS, V47, P879, DOI 10.1016/0022-3697(86)90059-4; Clarke DR, 2003, SURF COAT TECH, V163, P67, DOI 10.1016/S0257-8972(02)00593-5; Dresselhaus MS, 2007, ADV MATER, V19, P1043, DOI 10.1002/adma.200600527; Fultz B., 2012, TRANSMISSION ELECT M; Heremans JP, 2008, SCIENCE, V321, P554, DOI 10.1126/science.1159725; Heremans JP, 2013, NAT NANOTECHNOL, V8, P471, DOI 10.1038/nnano.2013.129; Heremans JP, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.115334; HICKS LD, 1993, PHYS REV B, V47, P12727, DOI 10.1103/PhysRevB.47.12727; Hsu KF, 2004, SCIENCE, V303, P818, DOI 10.1126/science.1092963; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kurosaki K, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2009828; Liu W, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.166601; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.16.1746; Morelli DT, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.035901; Nielsen MD, 2013, ENERG ENVIRON SCI, V6, P570, DOI 10.1039/c2ee23391f; Pei YZ, 2011, NATURE, V473, P66, DOI 10.1038/nature09996; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; PETERS MJ, 1990, PHYS REV B, V41, P5893, DOI 10.1103/PhysRevB.41.5893; Rhyee JS, 2009, NATURE, V459, P965, DOI 10.1038/nature08088; Slack GA., 1979, SOLID STATE PHYS, V34, P1, DOI [10.1016/s0081-1947(08)60359-8, DOI 10.1016/S0081-1947(08)60359-8]; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; van de Walle A, 2002, CALPHAD, V26, P539, DOI 10.1016/S0364-5916(02)80006-2; WASSCHER JD, 1963, SOLID STATE ELECTRON, V6, P261, DOI 10.1016/0038-1101(63)90083-2; YU JG, 1981, J CRYST GROWTH, V54, P248, DOI 10.1016/0022-0248(81)90469-3; Zhang YS, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.054306; Zhao LD, 2014, ENERG ENVIRON SCI, V7, P251, DOI 10.1039/c3ee43099e; Zhao LD, 2013, J AM CHEM SOC, V135, P7364, DOI 10.1021/ja403134b; Zhao LD, 2012, J AM CHEM SOC, V134, P16327, DOI 10.1021/ja306527n	33	3234	3270	134	2959	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					373	+		10.1038/nature13184	http://dx.doi.org/10.1038/nature13184			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24740068				2022-12-28	WOS:000334403000047
J	Jakes, AD; Bradley, S; Donlevy, L				Jakes, Adam D.; Bradley, Stephen; Donlevy, Lynn			Dermatitis herpetiformis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CELIAC-DISEASE; DIAGNOSIS; PREVALENCE; MALIGNANCY		[Jakes, Adam D.; Bradley, Stephen] Leeds Teaching Hosp NHS Trust, Leeds LS9 7TF, W Yorkshire, England; [Donlevy, Lynn] Silsden Grp Med Practice, Keighley, W Yorkshire, England	University of Leeds	Jakes, AD (corresponding author), Leeds Teaching Hosp NHS Trust, Leeds LS9 7TF, W Yorkshire, England.	adam.jakes@hyms.ac.uk	Bradley, Stephen/AAX-3023-2020					Alonso-Llamazares J, 2007, INT J DERMATOL, V46, P910, DOI 10.1111/j.1365-4632.2007.03214.x; Bolotin D, 2011, J AM ACAD DERMATOL, V64, P1017, DOI 10.1016/j.jaad.2010.09.777; Caproni M, 2009, J EUR ACAD DERMATOL, V23, P633, DOI 10.1111/j.1468-3083.2009.03188.x; Collin P, 1996, GUT, V38, P528, DOI 10.1136/gut.38.4.528; Collin P, 1997, SCAND J GASTROENTERO, V32, P1129, DOI 10.3109/00365529709002992; Fasano A, 2001, GASTROENTEROLOGY, V120, P636, DOI 10.1053/gast.2001.22123; Fry L, 2002, EUR J DERMATOL, V12, P523; GAWKRODGER DJ, 1984, GUT, V25, P151, DOI 10.1136/gut.25.2.151; Grainge MJ, 2012, ALIMENT PHARM THER, V35, P730, DOI 10.1111/j.1365-2036.2012.04998.x; Herron MD, 2002, DERMATOL THER, V15, P347; Hin H, 1999, BMJ-BRIT MED J, V318, P164, DOI 10.1136/bmj.318.7177.164; Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; Salmi TT, 2011, BRIT J DERMATOL, V165, P354, DOI 10.1111/j.1365-2133.2011.10385.x	13	12	13	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2014	348								g2557	10.1136/bmj.g2557	http://dx.doi.org/10.1136/bmj.g2557			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF5GS	24740905				2022-12-28	WOS:000334742600006
J	Glance, LG; Osler, TM; Neuman, MD				Glance, Laurent G.; Osler, Turner M.; Neuman, Mark D.			Redesigning Surgical Decision Making for High-Risk Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CENTERED MEDICAL HOME; PRIMARY-CARE; ADVERSE EVENTS; PHYSICIANS	Shared decision making in surgical care requires a culture shift. For patients at high risk for adverse events after surgery, or in cases with an equivocal risk-benefit balance, evidence-based decision making may require input from a multidisciplinary group of experts. An 80-year-old nursing home resident has a colon mass and has been scheduled for a colectomy. Has he been told that 30% of elderly nursing home patients who undergo colectomy die within 3 months after the surgery and that 40% of the survivors have a significant decline in functional status, or that 12 months after surgery, half the patients have died and half the survivors have a sustained functional decline?(1) One third of elderly Americans undergo surgery during the last 12 months of their lives, most of them within the last month.(2) Yet three quarters of seriously ill patients say ...	[Glance, Laurent G.] Univ Rochester, Dept Anesthesiol, Sch Med, Rochester, NY 14627 USA; [Osler, Turner M.] Univ Vermont, Coll Med, Dept Surg, Burlington, VT 05405 USA; [Neuman, Mark D.] Univ Penn, Dept Anesthesiol & Crit Care Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Rochester; University of Vermont; University of Pennsylvania; Pennsylvania Medicine	Glance, LG (corresponding author), Univ Rochester, Dept Anesthesiol, Sch Med, Rochester, NY 14627 USA.				NIA NIH HHS [K08 AG043548] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K08AG043548] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		de Vries EN, 2008, QUAL SAF HEALTH CARE, V17, P216, DOI 10.1136/qshc.2007.023622; Finlayson E, 2012, J AM GERIATR SOC, V60, P967, DOI 10.1111/j.1532-5415.2012.03915.x; Fisher ES, 2008, NEW ENGL J MED, V359, P1202, DOI 10.1056/NEJMp0806233; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Gawande AA, 1999, SURGERY, V126, P66, DOI 10.1067/msy.1999.98664; Grumbach K, 2013, JAMA INTERN MED, V173, P1913, DOI 10.1001/jamainternmed.2013.7652; Jackson GL, 2013, ANN INTERN MED, V158, P169, DOI 10.7326/0003-4819-158-3-201302050-00579; Kwok AC, 2011, LANCET, V378, P1408, DOI 10.1016/S0140-6736(11)61268-3; O'Malley AS, 2011, ARCH INTERN MED, V171, P56, DOI 10.1001/archinternmed.2010.480; Pham HH, 2009, ANN INTERN MED, V150, P236, DOI 10.7326/0003-4819-150-4-200902170-00004	10	84	85	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 10	2014	370	15					1379	1381		10.1056/NEJMp1315538	http://dx.doi.org/10.1056/NEJMp1315538			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE6IW	24716679	Green Accepted			2022-12-28	WOS:000334095200005
J	Sharma, P; Greenberger, NJ				Sharma, Prateek; Greenberger, Norton J.			Update in Gastroenterology and Hepatology: Evidence Published in 2013	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Sharma, Prateek] Vet Affairs Med Ctr, Kansas City, MO 64128 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; Brigham & Women's Hospital	Sharma, P (corresponding author), Vet Affairs Med Ctr, 4801 East Linwood Blvd, Kansas City, MO 64128 USA.	psharma@kumc.edu							0	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2014	161	3					205	U157		10.7326/M14-0323	http://dx.doi.org/10.7326/M14-0323			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3KH	24722768				2022-12-28	WOS:000340486000006
J	Skoglund, P; Malmstrom, H; Omrak, A; Raghavan, M; Valdiosera, C; Gunther, T; Hall, P; Tambets, K; Parik, J; Sjogren, KG; Apel, J; Willerslev, E; Stora, J; Gotherstrom, A; Jakobsson, M				Skoglund, Pontus; Malmstrom, Helena; Omrak, Ayca; Raghavan, Maanasa; Valdiosera, Cristina; Gunther, Torsten; Hall, Per; Tambets, Kristiina; Parik, Jueri; Sjogren, Karl-Goran; Apel, Jan; Willerslev, Eske; Stora, Jan; Gotherstrom, Anders; Jakobsson, Mattias			Genomic Diversity and Admixture Differs for Stone-Age Scandinavian Foragers and Farmers	SCIENCE			English	Article							HUNTER-GATHERERS; ANCIENT DNA; CLIMATE	Prehistoric population structure associated with the transition to an agricultural lifestyle in Europe remains a contentious idea. Population-genomic data from 11 Scandinavian Stone Age human remains suggest that hunter-gatherers had lower genetic diversity than that of farmers. Despite their close geographical proximity, the genetic differentiation between the two Stone Age groups was greater than that observed among extant European populations. Additionally, the Scandinavian Neolithic farmers exhibited a greater degree of hunter-gatherer-related admixture than that of the Tyrolean Iceman, who also originated from a farming context. In contrast, Scandinavian hunter-gatherers displayed no significant evidence of introgression from farmers. Our findings suggest that Stone Age foraging groups were historically in low numbers, likely owing to oscillating living conditions or restricted carrying capacity, and that they were partially incorporated into expanding farming groups.	[Skoglund, Pontus; Malmstrom, Helena; Gunther, Torsten; Jakobsson, Mattias] Uppsala Univ, Dept Evolutionary Biol, S-75236 Uppsala, Sweden; [Omrak, Ayca; Stora, Jan; Gotherstrom, Anders] Stockholm Univ, Dept Archaeol & Class studies, S-10691 Stockholm, Sweden; [Raghavan, Maanasa; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Valdiosera, Cristina] La Trobe Univ, Dept Archaeol Environm & Community Planning, Melbourne, Vic 3086, Australia; [Hall, Per] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Tambets, Kristiina; Parik, Jueri] Estonian Bioctr, Evolutionary Biol Grp, EE-51010 Tartu, Estonia; [Tambets, Kristiina; Parik, Jueri] Univ Tartu, EE-51010 Tartu, Estonia; [Sjogren, Karl-Goran] Univ Gothenburg, Dept Hist Studies, S-40530 Gothenburg, Sweden; [Apel, Jan] Lund Univ, Dept Archaeol & Ancient Hist, S-22100 Lund, Sweden; [Jakobsson, Mattias] Uppsala Univ, Sci Life Lab, S-75236 Uppsala, Sweden	Uppsala University; Stockholm University; University of Copenhagen; La Trobe University; Karolinska Institutet; Estonian Biocentre; University of Tartu; University of Gothenburg; Lund University; Uppsala University	Gotherstrom, A (corresponding author), Stockholm Univ, Dept Archaeol & Class studies, S-10691 Stockholm, Sweden.	tsarapkin@googlemail.com; mattias.jakobsson@ebc.uu.se	Tambets, Kristiina/M-2568-2019; Willerslev, Eske/AAA-5686-2019; Willerslev, Eske/A-9619-2011; Jakobsson, Mattias/A-6116-2011; Malmström, Helena/C-2476-2017; Günther, Torsten/I-3355-2019	Tambets, Kristiina/0000-0002-8173-6380; Willerslev, Eske/0000-0002-7081-6748; Jakobsson, Mattias/0000-0001-7840-7853; Malmström, Helena/0000-0002-6456-8055; Günther, Torsten/0000-0001-9460-390X; Skoglund, Pontus/0000-0002-3021-5913; Valdiosera, Cristina/0000-0003-4948-2226; Raghavan, Maanasa/0000-0003-1997-0739; Gotherstrom, Anders/0000-0001-8579-1304; Sjogren, Karl-Goran/0000-0003-1791-3175	Nilsson-Ehle Foundation; Helge Ax:son Foundation; Royal Swedish Academy of Science [FOA12H-177]; Danish National Research Foundation; Swedish Research Council; Berit Wallenberg Foundation; Wenner-Gren Foundations; European Research Council	Nilsson-Ehle Foundation; Helge Ax:son Foundation; Royal Swedish Academy of Science; Danish National Research Foundation(Danmarks Grundforskningsfond); Swedish Research Council(Swedish Research CouncilEuropean Commission); Berit Wallenberg Foundation; Wenner-Gren Foundations; European Research Council(European Research Council (ERC)European Commission)	We thank L. Gattepaille, M. Metspalu, T. Naidoo, M. Rasmussen, S. Rasmussen, D. Reich, E. Salmela, and P. Wallin for technical assistance and discussions. The SNP data for the modern-day Swedish individuals is available from P. Hall at the Karolinska Institute under a materials transfer agreement. We thank the late L. Beckman for contributing the Saami samples; K.T. (ktambets@gmail.com) retains governance over the Saami and the Mari samples. This project was supported by grants from the Nilsson-Ehle Foundation (P. S.), Helge Ax:son Foundation (P. S.), Royal Swedish Academy of Science (FOA12H-177 to P. S.), Danish National Research Foundation (E. W. and M. R.), Swedish Research Council (J.A. and J.S.), Berit Wallenberg Foundation (J.A. and J.S.), Wenner-Gren Foundations (T. G.) and European Research Council (M.J.). P. S., H. M., A. G., and M.J. conceived and designed the study. E. W., J.S., A. G., and M.J. supervised the study. H. M., A. O., M. R., and C. V. generated DNA sequence data from ancient human remains. P. S. processed and prepared the data. P. S., H. M., and T. G. analyzed the genetic data, supervised by M.J. with the following contributions: mtDNA and Y-chromosome (H. M. and P. S.); functional SNPs (T. G. and P. S.); and contamination, biological sex, and population genetic analyses (P. S.). K.-G. S., J.S., and J. A. provided archaeological information and interpretation. P. H., K. T., and J. P. contributed samples. P. S., H. M., J. S., A. G., and M. J. wrote the manuscript with input from all authors. Data are available from the European Nucleotide Archive under accession no. PRJEB6090, and data aligned to the human reference genome are available at www.ebc.uu.se/Jakobsson. The authors declare no competing interests.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bailey G, 2008, MESOLITHIC EUROPE, P1; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Brandt G, 2013, SCIENCE, V342, P257, DOI 10.1126/science.1241844; Childe V. G., 1925, THE DAWN OF EUROPEAN; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Karlsson AO, 2006, EUR J HUM GENET, V14, P963, DOI 10.1038/sj.ejhg.5201651; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Klassen L., 2002, THE NEOLITHISATION O, P305; Mallick CB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003912; Malmer M. P., 2002, THE NEOLITHIC OF SOU; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Riede F, 2009, HUM BIOL, V81, P309, DOI 10.3378/027.081.0311; Shennan S, 2007, J ARCHAEOL SCI, V34, P1339, DOI 10.1016/j.jas.2006.10.031; Skoglund P, 2014, P NATL ACAD SCI USA, V111, P2229, DOI 10.1073/pnas.1318934111; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; Weninger B, 2006, QUATERNARY RES, V66, P401, DOI 10.1016/j.yqres.2006.06.009	24	199	201	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					747	750		10.1126/science.1253448	http://dx.doi.org/10.1126/science.1253448			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24762536				2022-12-28	WOS:000335912900041
J	Jayasekera, CR; Barry, M; Roberts, LR; Nguyen, MH				Jayasekera, Channa R.; Barry, Michele; Roberts, Lewis R.; Nguyen, Mindie H.			Treating Hepatitis C in Lower-Income Countries	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jayasekera, Channa R.; Nguyen, Mindie H.] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA; [Jayasekera, Channa R.; Barry, Michele; Nguyen, Mindie H.] Stanford Univ, Med Ctr, Dept Med, Stanford, CA 94305 USA; [Barry, Michele] Stanford Univ, Ctr Innovat Global Hlth, Stanford, CA 94305 USA; [Roberts, Lewis R.] Mayo Clin, Div Gastroenterol & Hepatol, Dept Med, Rochester, MN USA	Stanford University; Stanford University; Stanford University; Mayo Clinic	Jayasekera, CR (corresponding author), Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA.			Roberts, Lewis/0000-0001-7885-8574				Farmer PE, 2013, NEW ENGL J MED, V369, P2424, DOI 10.1056/NEJMsa1310472; Hagan LM, 2013, J VIRAL HEPATITIS, V20, P847, DOI 10.1111/jvh.12111; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hill A, 2014, CLIN INFECT DIS, V58, P928, DOI 10.1093/cid/ciu012; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0	5	59	63	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2014	370	20					1869	1871		10.1056/NEJMp1400160	http://dx.doi.org/10.1056/NEJMp1400160			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH4UH	24720680				2022-12-28	WOS:000336123600001
J	Zhou, LM; Tian, YH; Myneni, RB; Ciais, P; Saatchi, S; Liu, YY; Piao, SL; Chen, HS; Vermote, EF; Song, CH; Hwang, TH				Zhou, Liming; Tian, Yuhong; Myneni, Ranga B.; Ciais, Philippe; Saatchi, Sassan; Liu, Yi Y.; Piao, Shilong; Chen, Haishan; Vermote, Eric F.; Song, Conghe; Hwang, Taehee			Widespread decline of Congo rainforest greenness in the past decade	NATURE			English	Article							MICROWAVE EMISSION; VEGETATION INDEXES; TROPICAL FORESTS; CLIMATE; MODIS; DROUGHT; GRACE; WATER; PRODUCTS; DYNAMICS	Tropical forests are global epicentres of biodiversity and important modulators of climate change(1), and are mainly constrained by rainfall patterns(1-3). The severe short-term droughts that occurred recently in Amazonia have drawn attention to the vulnerability of tropical forests to climatic disturbances(4-9). The central African rainforests, the second-largest on Earth, have experienced a long-term drying trend(10,11) whose impacts on vegetation dynamics remain mostly unknown because in situ observations are very limited. The Congolese forest, with its drier conditions and higher percentage of semi-evergreen trees(12,13), may be more tolerant to short-term rainfall reduction than are wetter tropical forests(11), but for a long-term drought there may be critical thresholds of water availability below which higher-biomass, closed-canopy forests transition to more open, lower-biomass forests(1,2,14). Here we present observational evidence for a widespread decline in forest greenness over the past decade based on analyses of satellite data (optical, thermal, microwave and gravity) from several independent sensors over the Congo basin. This decline in vegetation greenness, particularly in the northern Congolese forest, is generally consistent with decreases in rainfall, terrestrial water storage, water content in aboveground woody and leaf biomass, and the canopy backscatter anomaly caused by changes in structure and moisture in upper forest layers. It is also consistent with increases in photosynthetically active radiation and land surface temperature. These multiple lines of evidence indicate that this large-scale vegetation browning, or loss of photosynthetic capacity, may be partially attributable to the long-term drying trend. Our results suggest that a continued gradual decline of photosynthetic capacity and moisture content driven by the persistent drying trend could alter the composition and structure of the Congolese forest to favour the spread of drought-tolerant species(1,2,14).	[Zhou, Liming] SUNY Albany, Dept Atmospher & Environm Sci, Albany, NY 12222 USA; [Tian, Yuhong] NOAA, IMSG, NESDIS, Ctr Satellite Applicat & Res,STAR, College Pk, MD 20740 USA; [Myneni, Ranga B.] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA; [Ciais, Philippe] UVSQ, CEA, CNRS, LSCE, F-91191 Gif Sur Yvette, France; [Saatchi, Sassan] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Liu, Yi Y.] Univ New S Wales, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW 2052, Australia; [Liu, Yi Y.] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia; [Piao, Shilong] Peking Univ, Dept Ecol, Coll Urban & Environm Sci, Beijing 100871, Peoples R China; [Chen, Haishan] Nanjing Univ Informat Sci & Technol, Minist Educ, Key Lab Meteorol Disaster, Nanjing 210044, Jiangsu, Peoples R China; [Vermote, Eric F.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Song, Conghe] Univ N Carolina, Dept Geog, Chapel Hill, NC 29599 USA; [Song, Conghe] Anhui Agr Univ, Sch Forestry & Landscape Architecture, Hefei 230036, Anhui, Peoples R China; [Hwang, Taehee] Univ N Carolina, Inst Environm, Chapel Hill, NC 29599 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; National Oceanic Atmospheric Admin (NOAA) - USA; Boston University; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); ARC Centre of Excellence for Climate System Science; University of New South Wales Sydney; University of New South Wales Sydney; Peking University; Nanjing University of Information Science & Technology; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of North Carolina; University of North Carolina Chapel Hill; Anhui Agricultural University; University of North Carolina; University of North Carolina Chapel Hill	Zhou, LM (corresponding author), SUNY Albany, Dept Atmospher & Environm Sci, Albany, NY 12222 USA.	lzhou@albany.edu	Ciais, Philippe/A-6840-2011; Liu, Yi/M-7169-2015; Myneni, Ranga B/F-5129-2012; Saatchi, Sassan/AAQ-2649-2021; Chen, Haishan/W-3747-2018; Zhou, Liming/A-2688-2012; Myneni, Ranga B./AAU-6088-2021; Liu, Yi/H-9226-2013; Song, Conghe/E-3087-2016; Keyes, Dennis/AAZ-9285-2021; Vermote, Eric/K-3733-2012	Ciais, Philippe/0000-0001-8560-4943; Liu, Yi/0000-0001-9059-8269; Myneni, Ranga B/0000-0002-0234-6393; Chen, Haishan/0000-0002-2403-3187; Zhou, Liming/0000-0002-7009-2487; Song, Conghe/0000-0002-4099-4906; 	NOAA NESDIS [NA11NES4400010]; University at Albany, State University of New York; NASA's Earth Science Division; National Natural Science Foundation of China [41230422]	NOAA NESDIS(National Oceanic Atmospheric Admin (NOAA) - USA); University at Albany, State University of New York; NASA's Earth Science Division; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the NOAA NESDIS project (NA11NES4400010) and by the startup funds provided by the University at Albany, State University of New York. R. B. M. was funded by NASA's Earth Science Division. The views, opinions, and findings contained in this report are those of the authors and should not be construed as an official NOAA or US Government position, policy, or decision. H. C. is supported by the National Natural Science Foundation of China (grant number 41230422).	Adams J., 1998, DISTRIBUTION VARIETY; Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Andela N, 2013, BIOGEOSCIENCES, V10, P6657, DOI 10.5194/bg-10-6657-2013; [Anonymous], 2011, MODIS VEGETATION CON; Asefi-Najafabady S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0306; Atkinson PM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049118; Brando PM, 2010, P NATL ACAD SCI USA, V107, P14685, DOI 10.1073/pnas.0908741107; Crowley JW, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027070; de Wasseige C, 2003, AGR FOREST METEOROL, V119, P181, DOI 10.1016/S0168-1923(03)00138-2; Enquist BJ, 2011, GLOBAL CHANGE BIOL, V17, P1408, DOI 10.1111/j.1365-2486.2010.02326.x; Fauset S, 2012, ECOL LETT, V15, P1120, DOI 10.1111/j.1461-0248.2012.01834.x; Halldor B., 1997, 971 MCGILL U CTR CLI; Hansen MC, 2008, REMOTE SENS ENVIRON, V112, P2495, DOI 10.1016/j.rse.2007.11.012; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; JACKSON TJ, 1991, REMOTE SENS ENVIRON, V36, P203, DOI 10.1016/0034-4257(91)90057-D; Jones MO, 2011, REMOTE SENS ENVIRON, V115, P1102, DOI 10.1016/j.rse.2010.12.015; KERR YH, 1990, IEEE T GEOSCI REMOTE, V28, P384, DOI 10.1109/36.54364; King MD, 2003, IEEE T GEOSCI REMOTE, V41, P442, DOI 10.1109/TGRS.2002.808226; Kirdyashev K. P., 1979, Radio Engineering and Electronic Physics, V24, P37; Landerer FW, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011453; Lee H, 2011, REMOTE SENS ENVIRON, V115, P3530, DOI 10.1016/j.rse.2011.08.015; Lewis SL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0295; Lewis SL, 2006, PHILOS T R SOC B, V361, P195, DOI 10.1098/rstb.2005.1711; Liu YY, 2012, REMOTE SENS ENVIRON, V123, P280, DOI 10.1016/j.rse.2012.03.014; Liu YY, 2011, HYDROL EARTH SYST SC, V15, P425, DOI 10.5194/hess-15-425-2011; Liu YY, 2013, GLOBAL ECOL BIOGEOGR, V22, P692, DOI 10.1111/geb.12024; Liu YY, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048684; Liu Y, 2008, ACTA METEOROL SIN, V22, P22; Lucht Wolfgang, 2006, Carbon Balance Manag, V1, P6, DOI 10.1186/1750-0680-1-6; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Morton DC, 2014, NATURE, V506, P221, DOI 10.1038/nature13006; MYNENI RB, 1995, IEEE T GEOSCI REMOTE, V33, P481, DOI 10.1109/36.377948; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Platnick S, 2003, IEEE T GEOSCI REMOTE, V41, P459, DOI 10.1109/TGRS.2002.808301; Reager JT, 2013, WATER RESOUR RES, V49, P3314, DOI 10.1002/wrcr.20264; Remer LA, 2005, J ATMOS SCI, V62, P947, DOI 10.1175/JAS3385.1; Saatchi S, 2013, P NATL ACAD SCI USA, V110, P565, DOI 10.1073/pnas.1204651110; Samanta A, 2012, EARTH INTERACT, V16, DOI 10.1175/2012EI440.1; Schneider U, 2014, THEOR APPL CLIMATOL, V115, P15, DOI 10.1007/s00704-013-0860-x; Shi JC, 2008, REMOTE SENS ENVIRON, V112, P4285, DOI 10.1016/j.rse.2008.07.015; Swenson S, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025285; Tyrrell M.L., 2012, MANAGING EST CARB, P377; Valentini R, 2013, BIOGEOSCIENCES DISCU, V10, P8343, DOI DOI 10.5194/bgd-10-8343-2013; van Leeuwen TT, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001488; Wielicki BA, 1996, B AM METEOROL SOC, V77, P853, DOI 10.1175/1520-0477(1996)077<0853:CATERE>2.0.CO;2; Xu LA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046824; Zhou LM, 2013, EARTH INTERACT, V17, DOI 10.1175/2012EI000510.1	51	255	259	14	433	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					86	+		10.1038/nature13265	http://dx.doi.org/10.1038/nature13265			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24759324				2022-12-28	WOS:000335199100044
J	Bierman, PR; Corbett, LB; Graly, JA; Neumann, TA; Lini, A; Crosby, BT; Rood, DH				Bierman, Paul R.; Corbett, Lee B.; Graly, Joseph A.; Neumann, Thomas A.; Lini, Andrea; Crosby, Benjamin T.; Rood, Dylan H.			Preservation of a Preglacial Landscape Under the Center of the Greenland Ice Sheet	SCIENCE			English	Article							GISP2; CORES; EROSION; BOTTOM; BE-10; POOLS	Continental ice sheets typically sculpt landscapes via erosion; under certain conditions, ancient landscapes can be preserved beneath ice and can survive extensive and repeated glaciation. We used concentrations of atmospherically produced cosmogenic beryllium-10, carbon, and nitrogen to show that ancient soil has been preserved in basal ice for millions of years at the center of the ice sheet at Summit, Greenland. This finding suggests ice sheet stability through the Pleistocene (i.e., the past 2.7 million years). The preservation of this soil implies that the ice has been nonerosive and frozen to the bed for much of that time, that there was no substantial exposure of central Greenland once the ice sheet became fully established, and that preglacial landscapes can remain preserved for long periods under continental ice sheets.	[Bierman, Paul R.; Corbett, Lee B.; Graly, Joseph A.; Neumann, Thomas A.; Lini, Andrea] Univ Vermont, Dept Geol, Burlington, VT 05405 USA; [Bierman, Paul R.; Corbett, Lee B.; Graly, Joseph A.; Neumann, Thomas A.; Lini, Andrea] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT 05405 USA; [Crosby, Benjamin T.] Idaho State Univ, Dept Geosci, Pocatello, ID 83209 USA; [Rood, Dylan H.] Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93016 USA; [Rood, Dylan H.] Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94550 USA	University of Vermont; University of Vermont; Idaho; Idaho State University; University of California System; University of California Santa Barbara; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Bierman, PR (corresponding author), Univ Vermont, Dept Geol, Burlington, VT 05405 USA.	pbierman@uvm.edu	Neumann, Thomas/D-5264-2012; Bierman, Paul/AAA-9466-2020; Lini, Andrea/F-9020-2016	Bierman, Paul/0000-0001-9627-4601; Lini, Andrea/0000-0002-2920-570X; Graly, Joseph/0000-0002-7939-6022	NSF [ARC1023191, ARC0713956, ARC0806394, ARC0806399]; Office of Polar Programs (OPP) [1023191] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Supported by NSF grants ARC1023191 (P. R. B.) and ARC0713956 (P. R. B. and T.A.N.). Alaska soil collection and preparation were supported by NSF grants ARC0806394 and ARC0806399. P. R. B. analyzed the data and wrote the first draft of the manuscript; L. B. C. extracted the <SUP>10</SUP>Be and prepared final drafts of the figures; J.A.G. interpreted the <SUP>10</SUP>Be data; T.A.N. provided glaciological expertise; B. T. C. provided the Alaskan samples and context for their interpretation; D. H. R. made the accelerator mass spectrometry measurements; A. L. made and interpreted the OC and TN measurements; and all authors read and edited multiple versions of the manuscript. The data reported in this paper are tabulated in the supplementary materials.	Bender ML, 2010, EARTH PLANET SC LETT, V299, P466, DOI 10.1016/j.epsl.2010.09.033; Callesen I, 2007, BOREAL ENVIRON RES, V12, P681; Carlson A, 2008, GEOLOGY, V36, P359, DOI 10.1130/G24519A.1; Cremer H, 2008, QUATERNARY SCI REV, V27, P312, DOI 10.1016/j.quascirev.2007.09.004; Cuffey KM, 2000, GEOLOGY, V28, P351, DOI 10.1130/0091-7613(2000)028<0351:EACGB>2.3.CO;2; Eldrett JS, 2007, NATURE, V446, P176, DOI 10.1038/nature05591; Finkel RC, 1997, J GEOPHYS RES-OCEANS, V102, P26699, DOI 10.1029/97JC01282; FUNDER S, 1985, GEOLOGY, V13, P542, DOI 10.1130/0091-7613(1985)13<542:FAEFNG>2.0.CO;2; Gow AJ, 1997, J GEOPHYS RES-OCEANS, V102, P26559, DOI 10.1029/97JC00165; Gow AJ, 1996, ANN GLACIOL, V22, P134, DOI 10.3189/1996AoG22-1-134-140; Graly JA, 2010, GEOCHIM COSMOCHIM AC, V74, P6814, DOI 10.1016/j.gca.2010.08.036; Greve R, 2005, ANN GLACIOL-SER, V42, P424, DOI 10.3189/172756405781812510; Hakansson L, 2011, QUATERNARY RES, V76, P452, DOI 10.1016/j.yqres.2011.06.007; Hamilton T. D., 2003, 121 AL DIV GEOL GEOP; Heisinger B, 2002, GEOCHIM COSMOCHIM AC, V66, pA558; Hugelius G, 2010, PERMAFROST PERIGLAC, V21, P16, DOI 10.1002/ppp.677; Huybrechts P., 1995, ANN GLACIOL, V23, P226; LAINE EP, 1980, QUATERNARY RES, V14, P188, DOI 10.1016/0033-5894(80)90047-2; LARSEN HC, 1994, SCIENCE, V264, P952, DOI 10.1126/science.264.5161.952; Lisiecki L.E., 2005, PALEOCEANOGRAPHY, V20, DOI [10.1029/2004PA001071, DOI 10.1029/2004PA001071]; Long AJ, 2008, EARTH PLANET SC LETT, V272, P8, DOI 10.1016/j.epsl.2008.03.042; Nishiizumi K., 1996, EOS, V77, pOS41B; Refsnider KA, 2013, QUATERNARY SCI REV, V67, P176, DOI 10.1016/j.quascirev.2013.01.010; Souchez R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028424; SOUCHEZ R, 1994, GEOPHYS RES LETT, V21, P693, DOI 10.1029/94GL00641; Stuiver M, 2000, QUATERNARY RES, V53, P277, DOI 10.1006/qres.2000.2127; Suwa M, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006032; Weis D, 1997, EARTH PLANET SC LETT, V150, P161, DOI 10.1016/S0012-821X(97)00073-3; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Winkelmann D, 2010, QUATERNARY SCI REV, V29, P1069, DOI 10.1016/j.quascirev.2010.02.002	30	47	47	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					402	405		10.1126/science.1249047	http://dx.doi.org/10.1126/science.1249047			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763587	Green Submitted			2022-12-28	WOS:000334867800038
J	Soares, B; Rajao, R; Macedo, M; Carneiro, A; Costa, W; Coe, M; Rodrigues, H; Alencar, A				Soares-Filho, Britaldo; Rajao, Raoni; Macedo, Marcia; Carneiro, Arnaldo; Costa, William; Coe, Michael; Rodrigues, Hermann; Alencar, Ane			LAND USE Cracking Brazil's Forest Code	SCIENCE			English	Editorial Material							CONSERVATION		[Soares-Filho, Britaldo; Rajao, Raoni; Macedo, Marcia; Costa, William; Rodrigues, Hermann] Univ Fed Minas Gerais, BR-31270901 Belo Horizonte, MG, Brazil; [Macedo, Marcia; Coe, Michael] Woods Hole Res Ctr, Falmouth, MA 02540 USA; [Carneiro, Arnaldo] Secretaria Assuntos Estrateg Presidencia Republ, BR-70052900 Brasilia, DF, Brazil; [Alencar, Ane] Inst Pesquisa Ambiental Amazonia, BR-71503505 Brasilia, DF, Brazil	Universidade Federal de Minas Gerais; Woods Hole Research Center	Soares, B (corresponding author), Univ Fed Minas Gerais, BR-31270901 Belo Horizonte, MG, Brazil.	britaldo@csr.ufmg.br	/AAX-3684-2020; Noojipady, Praveen/B-2511-2010; Rajão, Raoni/GPX-3719-2022; Macedo, Marcia N/N-3044-2017	/0000-0001-5605-7469; Rajão, Raoni/0000-0002-1133-4837; Macedo, Marcia N/0000-0001-8102-5901; Silveira Soares Filho, Britaldo/0000-0002-7703-946X; Coe, Michael/0000-0002-7470-0697				[Anonymous], 2005, EC HUM WELL BEING SY; Cury R., 2011, MANUAL RESTAURO FLOR; Lees AC, 2008, CONSERV BIOL, V22, P439, DOI 10.1111/j.1523-1739.2007.00870.x; Rajao R, 2012, PUBLIC ADMIN DEVELOP, V32, P229, DOI 10.1002/pad.1620; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rodrigues RR, 2011, FOREST ECOL MANAG, V261, P1605, DOI 10.1016/j.foreco.2010.07.005; Stickler CM, 2013, P NATL ACAD SCI USA, V110, P9601, DOI 10.1073/pnas.1215331110	7	636	657	5	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					363	364		10.1126/science.1246663	http://dx.doi.org/10.1126/science.1246663			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF7BG	24763575				2022-12-28	WOS:000334867800023
J	Chung, RT; Baumert, TF				Chung, Raymond T.; Baumert, Thomas F.			Curing Chronic Hepatitis C - The Arc of a Medical Triumph	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							THERAPIES		[Chung, Raymond T.; Baumert, Thomas F.] Massachusetts Gen Hosp, Ctr Liver, Gastrointestinal Div, Boston, MA 02114 USA; [Chung, Raymond T.; Baumert, Thomas F.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Chung, Raymond T.; Baumert, Thomas F.] Harvard Univ, Sch Med, Boston, MA USA; [Baumert, Thomas F.] Univ Strasbourg, Inst Rech Malad Virales & Hepat, INSERM, U1110, Strasbourg, France; [Baumert, Thomas F.] Hop Univ Strasbourg, Inst Hosp Univ, Strasbourg, France	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Chung, RT (corresponding author), Massachusetts Gen Hosp, Ctr Liver, Gastrointestinal Div, Boston, MA 02114 USA.		Baumert, Thomas/ABF-4718-2020	Baumert, Thomas/0000-0002-8864-2168				CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Ozaras R, 2013, NEW ENGL J MED, V369, P679, DOI 10.1056/NEJMc1307589; Schaefer EAK, 2012, GASTROENTEROLOGY, V142, P1340, DOI 10.1053/j.gastro.2012.02.015; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Zeisel MB, 2013, J HEPATOL, V58, P375, DOI 10.1016/j.jhep.2012.09.022	5	186	193	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 24	2014	370	17					1576	1578		10.1056/NEJMp1400986	http://dx.doi.org/10.1056/NEJMp1400986			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH4TG	24720678				2022-12-28	WOS:000336120500003
J	Hasenclever, J; Theissen-Krah, S; Rupke, LH; Morgan, JP; Iyer, K; Petersen, S; Devey, CW				Hasenclever, Joerg; Theissen-Krah, Sonja; Ruepke, Lars H.; Morgan, Jason P.; Iyer, Karthik; Petersen, Sven; Devey, Colin W.			Hybrid shallow on-axis and deep off-axis hydrothermal circulation at fast-spreading ridges	NATURE			English	Article							EAST PACIFIC RISE; VENT FLUIDS; CRUSTAL ACCRETION; PHASE-SEPARATION; MIDOCEAN RIDGES; OMAN OPHIOLITE; OCEANIC-CRUST; TEMPERATURE; MODEL; FLOW	Hydrothermal flow at oceanic spreading centres accounts for about ten per cent of all heat flux in the oceans(1,2) and controls the thermal structure of young oceanic plates. It also influences ocean and crustal chemistry, provides a basis for chemosynthetic ecosystems, and has formed massive sulphide ore deposits throughout Earth's history. Despite this, how and under what conditions heat is extracted, in particular from the lower crust, remains largely unclear. Here we present high-resolution, whole-crust, two-and three-dimensional simulations of hydrothermal flow beneath fast-spreading ridges that predict the existence of two interacting flow components, controlled by different physical mechanisms, that merge above the melt lens to feed ridge-centred vent sites. Shallow on-axis flow structures develop owing to the thermodynamic properties of water, whereas deeper off-axis flow is strongly shaped by crustal permeability, particularly the brittleductile transition. About 60 per cent of the discharging fluid mass is replenished on-axis by warm (up to 300 degrees Celsius) recharge flow surrounding the hot thermal plumes, and the remaining 40 per cent or so occurs as colder and broader recharge up to several kilometres away from the axis that feeds hot (500-700 degrees Celsius) deep-rooted off-axis flow towards the ridge. Despite its lower contribution to the total mass flux, this deep off-axis flow carries about 70 per cent of the thermal energy released at the ridge axis. This combination of two flow components explains the seismically determined thermal structure of the crust and reconciles previously incompatible models favouring either shallower on-axis(3-5) or deeper off-axis hydrothermal circulation(6-8).	[Hasenclever, Joerg; Ruepke, Lars H.; Iyer, Karthik; Petersen, Sven; Devey, Colin W.] Helmholtz Ctr Ocean Res Kiel, GEOMAR, D-24148 Kiel, Germany; [Theissen-Krah, Sonja] Univ Oslo, Dept Geosci, N-0316 Oslo, Norway; [Theissen-Krah, Sonja] Univ Oslo, CEED, N-0316 Oslo, Norway; [Morgan, Jason P.] Univ London, Dept Earth Sci, Egham TW20 0EX, Surrey, England	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Oslo; University of Oslo; University of London; Royal Holloway University London	Hasenclever, J (corresponding author), Helmholtz Ctr Ocean Res Kiel, GEOMAR, Wischhofstr 1-3, D-24148 Kiel, Germany.	jhasenclever@geomar.de	Devey, Colin/I-3898-2016; Iyer, Karthik/N-4763-2016; Ruepke, Lars/B-8597-2015; Ruepke, Lars/AAA-4099-2020; Zhang, Junyuan/P-9292-2018; Petersen, Sven/N-9528-2016	Devey, Colin/0000-0002-0930-7274; Iyer, Karthik/0000-0003-4689-5543; Ruepke, Lars/0000-0001-7025-4362; Ruepke, Lars/0000-0001-7025-4362; Petersen, Sven/0000-0002-5469-105X; Morgan, Jason/0000-0002-3100-0877; Theissen-Krah, Sonja/0000-0002-6163-5515				Baker ET, 1996, EARTH PLANET SC LETT, V142, P137, DOI 10.1016/0012-821X(96)00097-0; Bani-Hassan N, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004041; Bauer O., PROPERTIES WATER STE; Bird R., 2006, WILEY INT EDITION; Bosch D, 2004, J PETROL, V45, P1181, DOI 10.1093/petrology/egh010; Boudier FO, 2005, INT GEOL REV, V47, P101, DOI 10.2747/0020-6814.47.1.101; Carlson RL, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003624; Cathles LM, 2011, MINER DEPOSITA, V46, P639, DOI 10.1007/s00126-010-0292-9; CATHLES LM, 1993, ECON GEOL BULL SOC, V88, P1977, DOI 10.2113/gsecongeo.88.8.1977; Charlou JL, 1996, J GEOPHYS RES-SOL EA, V101, P15899, DOI 10.1029/96JB00880; Cherkaoui ASM, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000215; Coumou D, 2008, SCIENCE, V321, P1825, DOI 10.1126/science.1159582; Coumou D, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006121; Dabrowski M, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001719; Davis TA, 2009, ACM T MATH SOFTWARE, V35, DOI 10.1145/1462173.1462176; DETRICK RS, 1987, NATURE, V326, P35, DOI 10.1038/326035a0; Dunn RA, 2000, J GEOPHYS RES-SOL EA, V105, P23537, DOI 10.1029/2000JB900210; Fontaine FJ, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002407; Fornari DJ, 2012, OCEANOGRAPHY, V25, P18, DOI 10.5670/oceanog.2012.02; Hannington M.D., 2005, EC GEOLOGY 100 ANNIV, P111; Hannington M, 2011, GEOLOGY, V39, P1155, DOI 10.1130/G32468.1; HARDING AJ, 1993, J GEOPHYS RES-SOL EA, V98, P13925, DOI 10.1029/93JB00886; Hasenclever J., 2010, THESIS HAMBURG U; Hirth G, 1998, GEOPH MONOG SERIES, V106, P291; JOHNSON HP, 1993, GEOPHYS RES LETT, V20, P1875, DOI 10.1029/93GL00734; Jupp T, 2000, NATURE, V403, P880, DOI 10.1038/35002552; LISTER CRB, 1974, GEOPHYS J ROY ASTR S, V39, P465, DOI 10.1111/j.1365-246X.1974.tb05468.x; Magyari E., 2005, HDB POROUS MEDIA, V2nd ed., P373; MORGAN JP, 1993, J GEOPHYS RES-SOL EA, V98, P6283, DOI 10.1029/92JB02650; NEHLIG P, 1993, J GEOPHYS RES-SOL EA, V98, P19621, DOI 10.1029/93JB01822; Nicolas A, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002094; QUICK JE, 1993, J GEOPHYS RES-SOL EA, V98, P14015, DOI 10.1029/93JB00698; Shanks WC, 2001, REV MINERAL GEOCHEM, V43, P469, DOI 10.2138/gsrmg.43.1.469; Shewchuk JR, 2002, COMP GEOM-THEOR APPL, V22, P21, DOI 10.1016/S0925-7721(01)00047-5; Singhal B.B.S., 1999, APPL HYDROGEOLOGY FR; STEIN CA, 1994, J GEOPHYS RES-SOL EA, V99, P3081, DOI 10.1029/93JB02222; Theissen-Krah S, 2011, EARTH PLANET SC LETT, V311, P275, DOI 10.1016/j.epsl.2011.09.018; Tolstoy M, 2008, NATURE, V451, P181, DOI 10.1038/nature06424; VANKO DA, 1988, J GEOPHYS RES-SOLID, V93, P4595, DOI 10.1029/JB093iB05p04595; VanTongeren JA, 2008, EARTH PLANET SC LETT, V267, P69, DOI 10.1016/j.epsl.2007.11.034; Von Damm KL, 2003, EARTH PLANET SC LETT, V206, P365, DOI 10.1016/S0012-821X(02)01081-6; Von Damm KL, 2000, J GEOPHYS RES-SOL EA, V105, P11203, DOI 10.1029/1999JB900414; Zienkiewicz O.C., 2000, FINITE ELEMENT METHO; [No title captured]; [No title captured]; [No title captured]	46	69	72	3	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					508	+		10.1038/nature13174	http://dx.doi.org/10.1038/nature13174			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24759413				2022-12-28	WOS:000334741600033
J	Li, X; Rohrer, F; Hofzumahaus, A; Brauers, T; Haseler, R; Bohn, B; Broch, S; Fuchs, H; Gomm, S; Holland, F; Jager, J; Kaiser, J; Keutsch, FN; Lohse, I; Lu, KD; Tillmann, R; Wegener, R; Wolfe, GM; Mentel, TF; Kiendler-Scharr, A; Wahner, A				Li, Xin; Rohrer, Franz; Hofzumahaus, Andreas; Brauers, Theo; Haeseler, Rolf; Bohn, Birger; Broch, Sebastian; Fuchs, Hendrik; Gomm, Sebastian; Holland, Frank; Jaeger, Julia; Kaiser, Jennifer; Keutsch, Frank N.; Lohse, Insa; Lu, Keding; Tillmann, Ralf; Wegener, Robert; Wolfe, Glenn M.; Mentel, Thomas F.; Kiendler-Scharr, Astrid; Wahner, Andreas			Missing Gas-Phase Source of HONO Inferred from Zeppelin Measurements in the Troposphere	SCIENCE			English	Article							NITROUS-ACID HONO; HUMIC-ACID; PHOTOLYSIS; NO2; OH; CONVERSION; GRADIENTS; DIOXIDE	Gaseous nitrous acid (HONO) is an important precursor of tropospheric hydroxyl radicals (OH). OH is responsible for atmospheric self-cleansing and controls the concentrations of greenhouse gases like methane and ozone. Due to lack of measurements, vertical distributions of HONO and its sources in the troposphere remain unclear. Here, we present a set of observations of HONO and its budget made onboard a Zeppelin airship. In a sunlit layer separated from Earth's surface processes by temperature inversion, we found high HONO concentrations providing evidence for a strong gas-phase source of HONO consuming nitrogen oxides and potentially hydrogen oxide radicals. The observed properties of this production process suggest that the generally assumed impact of HONO on the abundance of OH in the troposphere is substantially overestimated.	[Li, Xin; Rohrer, Franz; Hofzumahaus, Andreas; Brauers, Theo; Haeseler, Rolf; Bohn, Birger; Broch, Sebastian; Fuchs, Hendrik; Gomm, Sebastian; Holland, Frank; Jaeger, Julia; Lohse, Insa; Lu, Keding; Tillmann, Ralf; Wegener, Robert; Mentel, Thomas F.; Kiendler-Scharr, Astrid; Wahner, Andreas] Forschungszentrum Julich, Inst Energie & Klimaforsch Troposphare IEK 8, D-52425 Julich, Germany; [Kaiser, Jennifer; Keutsch, Frank N.; Wolfe, Glenn M.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	Helmholtz Association; Research Center Julich; University of Wisconsin System; University of Wisconsin Madison	Li, X (corresponding author), Forschungszentrum Julich, Inst Energie & Klimaforsch Troposphare IEK 8, D-52425 Julich, Germany.	x.li@fz-juelich.de; f.rohrer@fz-juelich.de	Fuchs, Hendrik/I-9157-2012; Hofzumahaus, Andreas/I-9420-2012; 1294, HALO SPP/AAA-7658-2021; Tillmann, Ralf/AAM-5619-2021; Kiendler-Scharr, Astrid/E-8439-2011; Tillmann, Ralf/I-9203-2012; Bohn, Birger/J-4130-2012; Wahner, Andreas/J-4129-2012; Mentel, Thomas F/A-3576-2011; Kaiser, Jennifer/N-7732-2014; Rohrer, Franz/I-2052-2012; Li, Xin/F-9498-2011; Wegener, Robert/I-8925-2012; Lu, Keding/A-7282-2012; Holland, Frank/J-8812-2012; Wolfe, Glenn/D-5289-2011	Fuchs, Hendrik/0000-0003-1263-0061; Hofzumahaus, Andreas/0000-0003-2876-0880; Tillmann, Ralf/0000-0003-0648-6622; Kiendler-Scharr, Astrid/0000-0003-3166-2253; Tillmann, Ralf/0000-0003-0648-6622; Bohn, Birger/0000-0003-4177-3934; Wahner, Andreas/0000-0001-8948-1928; Mentel, Thomas F/0000-0003-0810-3541; Rohrer, Franz/0000-0003-3436-3419; Wegener, Robert/0000-0003-2042-9333; Lu, Keding/0000-0001-9425-9520; Holland, Frank/0000-0002-2278-4761; Broch, Sebastian/0000-0001-6768-9058; Kaiser, Jennifer/0000-0001-5051-9183	European Commission [FP7-ENV-2010-265148]; Deutsche Forschungsgemeinschaft [WE-4384/2-2, BO1580/4-1]; NDF-AGS [1051338]; Forschungszentrum Julich; Directorate For Geosciences [1051338] Funding Source: National Science Foundation	European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NDF-AGS; Forschungszentrum Julich(Helmholtz Association); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work is within the PEGASOS project, which is funded by the European Commission under the Framework Programme 7 (FP7-ENV-2010-265148). We gratefully acknowledge the efforts that the Zeppelin NT pilots and ground crews made to this work. We also acknowledge Zeppelin Luftschifftechnik (ZLT) and Deutsche Zeppelin Reederei (DZR) for their cooperation. J.J., R. W., I. L., and B. B. thank Deutsche Forschungsgemeinschaft for funding from the priority program HALO (WE-4384/2-2 and BO1580/4-1). J.K., G. M. W., and F.N.K. thank M. Cazorla for helping with the calibration of the HCHO measurements and NDF-AGS (1051338) and Forschungszentrum Julich for support. Our colleague Dr. Theo Brauers, sadly, passed away on 21 February 2014. We would like to take this opportunity to express our sincere appreciation for his excellent work.	Acker K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024643; Alicke B, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000579; Aloisio S, 2000, J PHYS CHEM A, V104, P6212, DOI 10.1021/jp000736i; Ammann M, 1998, NATURE, V395, P157, DOI 10.1038/25965; Bejan I, 2006, PHYS CHEM CHEM PHYS, V8, P2028, DOI 10.1039/b516590c; Broske R, 2003, ATMOS CHEM PHYS, V3, P469; Elshorbany YF, 2010, ATMOS ENVIRON, V44, P5383, DOI 10.1016/j.atmosenv.2009.08.036; Haseler R., 2009, ATMOS MEAS TECH DISC, V2, P2027, DOI [DOI 10.5194/AMTD-2-2027-2009, 10.5194/amtd-2-2027-2009]; Hofzumahaus A, 2009, SCIENCE, V324, P1702, DOI 10.1126/science.1164566; Kleffmann J, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022524; Li SP, 2008, SCIENCE, V319, P1657, DOI 10.1126/science.1151443; Li X, 2012, ATMOS CHEM PHYS, V12, P1497, DOI 10.5194/acp-12-1497-2012; Monks PS, 2009, ATMOS ENVIRON, V43, P5268, DOI 10.1016/j.atmosenv.2009.08.021; Ndour M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032006; Neftel A, 1996, ATMOS ENVIRON, V30, P3017, DOI 10.1016/1352-2310(96)00011-8; Oswald R, 2013, SCIENCE, V341, P1233, DOI 10.1126/science.1242266; Pitts Jr J. N., 2000, CHEM UPPER LOWER ATM; PLATT U, 1980, NATURE, V285, P312, DOI 10.1038/285312a0; SANDER SP, 1984, J PHYS CHEM-US, V88, P1566, DOI 10.1021/j150652a025; SIMONAITIS R, 1974, J PHYS CHEM-US, V78, P653, DOI 10.1021/j100600a001; Sorgel M, 2011, ATMOS CHEM PHYS, V11, P10433, DOI 10.5194/acp-11-10433-2011; Stemmler K, 2007, ATMOS CHEM PHYS, V7, P4237, DOI 10.5194/acp-7-4237-2007; Stemmler K, 2006, NATURE, V440, P195, DOI 10.1038/nature04603; Stull R.B., 1988, ATMOSPHERIC OCEANOGR; Su H, 2011, SCIENCE, V333, P1616, DOI 10.1126/science.1207687; Wong KW, 2012, ATMOS CHEM PHYS, V12, P635, DOI 10.5194/acp-12-635-2012; Zhang BQ, 2010, CHEM PHYS LETT, V489, P143, DOI 10.1016/j.cplett.2010.02.059; Zhang N, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038999; Zhou XL, 2011, NAT GEOSCI, V4, P440, DOI [10.1038/ngeo1164, 10.1038/NGEO1164]; Zhou XL, 2001, GEOPHYS RES LETT, V28, P4087, DOI 10.1029/2001GL013531	30	114	118	12	340	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					292	296		10.1126/science.1248999	http://dx.doi.org/10.1126/science.1248999			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744373				2022-12-28	WOS:000334474500034
J	Detchon, R; Van Leeuwen, R				Detchon, Reid; Van Leeuwen, Richenda			Bring sustainable energy to the developing world	NATURE			English	Editorial Material									[Detchon, Reid; Van Leeuwen, Richenda] United Nations Fdn, Washington, DC 20036 USA		Detchon, R (corresponding author), United Nations Fdn, Washington, DC 20036 USA.	rdetchon@unfoundation.org						Adair-Rohani H, 2013, GLOB HEALTH-SCI PRAC, V1, P249, DOI 10.9745/GHSP-D-13-00037; [Anonymous], 2014, BURD DIS JOINT EFF H; International Energy Agency, 2010, WORLD ENERGY OUTLOOK; International Energy Agency, 2013, WORLD EN OUTL 2013	4	25	25	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					309	311		10.1038/508309a	http://dx.doi.org/10.1038/508309a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF0KP	24754042	Bronze			2022-12-28	WOS:000334403000023
J	DeWeerdt, S				DeWeerdt, Sarah			A complicated relationship status	NATURE			English	Editorial Material							GUT MICROBIOTA; OBESITY											Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Fei N, 2013, ISME J, V7, P880, DOI 10.1038/ismej.2012.153; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liou AP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005687; Ridaura V. K., 2013, SCIENCE, V34; Schele E, 2013, ENDOCRINOLOGY, V154, P3643, DOI 10.1210/en.2012-2151; Wichmann A, 2013, CELL HOST MICROBE, V14, P582, DOI 10.1016/j.chom.2013.09.012; Xiao SM, 2014, FEMS MICROBIOL ECOL, V87, P357, DOI 10.1111/1574-6941.12228	13	15	31	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					S61	S63		10.1038/508S61a	http://dx.doi.org/10.1038/508S61a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF0KP	24740130	Bronze			2022-12-28	WOS:000334403000007
J	Motlagh, HN; Wrabl, JO; Li, J; Hilser, VJ				Motlagh, Hesam N.; Wrabl, James O.; Li, Jing; Hilser, Vincent J.			The ensemble nature of allostery	NATURE			English	Review							INTRINSICALLY DISORDERED PROTEINS; CONFORMATIONAL ENTROPY; X-RAY; MOLECULAR RECOGNITION; QUATERNARY STRUCTURE; ENERGY LANDSCAPE; STRUCTURAL BASIS; NMR RELAXATION; MECHANISM; BINDING	Allostery is the process by which biological macromolecules ( mostly proteins) transmit the effect of binding at one site to another, often distal, functional site, allowing for regulation of activity. Recent experimental observations demonstrating that allostery can be facilitated by dynamic and intrinsically disordered proteins have resulted in a new paradigm for understanding allosteric mechanisms, which focuses on the conformational ensemble and the statistical nature of the interactions responsible for the transmission of information. Analysis of allosteric ensembles reveals a rich spectrum of regulatory strategies, as well as a framework to unify the description of allosteric mechanisms from different systems.	[Motlagh, Hesam N.; Wrabl, James O.; Li, Jing; Hilser, Vincent J.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Motlagh, Hesam N.; Wrabl, James O.; Li, Jing; Hilser, Vincent J.] Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Hilser, VJ (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	Hilser@jhu.edu		Motlagh, Hesam/0000-0003-3834-926X	National Science Foundation [MCB1330211]; National Institutes of Health grants [GM63747, T32-GM008403]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063747, T32GM008403] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation grant MCB1330211 and by National Institutes of Health grants GM63747 and T32-GM008403.	ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Bai F, 2010, SCIENCE, V327, P685, DOI 10.1126/science.1182105; Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102; Bray D, 2004, ANNU REV BIOPH BIOM, V33, P53, DOI 10.1146/annurev.biophys.33.110502.132703; Burnley BT, 2012, ELIFE, V1, DOI 10.7554/eLife.00311; Cavalli A, 2007, P NATL ACAD SCI USA, V104, P9615, DOI 10.1073/pnas.0610313104; Cesareni G., 2005, MODULAR PROTEIN DOMA; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; CHANGEUX JP, 1961, COLD SPRING HARB SYM, V26, P313, DOI 10.1101/SQB.1961.026.01.037; Choi JH, 2013, PROTEIN SCI, V22, P475, DOI 10.1002/pro.2234; Clore GM, 2008, MOL BIOSYST, V4, P1058, DOI 10.1039/b810232e; COLOMBO MF, 1992, SCIENCE, V256, P655, DOI 10.1126/science.1585178; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; Daily MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000293; DICKERSON RE, 1972, ANNU REV BIOCHEM, V41, P815, DOI 10.1146/annurev.bi.41.070172.004123; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; Dror RO, 2012, ANNU REV BIOPHYS, V41, P429, DOI 10.1146/annurev-biophys-042910-155245; Eaton WA, 1999, NAT STRUCT BIOL, V6, P351, DOI 10.1038/7586; Eaton WA, 2007, IUBMB LIFE, V59, P586, DOI 10.1080/15216540701272380; Elber R, 2011, CURR OPIN STRUC BIOL, V21, P167, DOI 10.1016/j.sbi.2011.01.012; England JL, 2011, STRUCTURE, V19, P967, DOI 10.1016/j.str.2011.04.009; Erman B, 2013, PROTEINS, V81, P1097, DOI 10.1002/prot.24284; Fenton AW, 2008, TRENDS BIOCHEM SCI, V33, P420, DOI 10.1016/j.tibs.2008.05.009; Ferreon ACM, 2013, NATURE, V498, P390, DOI 10.1038/nature12294; Fisher CK, 2011, CURR OPIN STRUC BIOL, V21, P426, DOI 10.1016/j.sbi.2011.04.001; Forman-Kay JD, 2013, STRUCTURE, V21, P1492, DOI 10.1016/j.str.2013.08.001; Fraser JS, 2011, P NATL ACAD SCI USA, V108, P16247, DOI 10.1073/pnas.1111325108; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Freiburger LA, 2011, NAT STRUCT MOL BIOL, V18, P288, DOI 10.1038/nsmb.1978; Gao JJ, 2012, BIOCOMPUT-PAC SYM, P94; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gekko K, 2004, BIOCHEMISTRY-US, V43, P3844, DOI 10.1021/bi036271e; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Ha JH, 2012, CHEM-EUR J, V18, P7984, DOI 10.1002/chem.201200348; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Hilser VJ, 2012, ANNU REV BIOPHYS, V41, P585, DOI 10.1146/annurev-biophys-050511-102319; Igumenova TI, 2006, CHEM REV, V106, P1672, DOI 10.1021/cr040422h; Igumenova TI, 2005, BIOCHEMISTRY-US, V44, P12627, DOI 10.1021/bi050832f; Jackson SE, 2013, TOP CURR CHEM, V328, P99, DOI 10.1007/128_2012_323; Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p; Jensen MR, 2009, STRUCTURE, V17, P1169, DOI 10.1016/j.str.2009.08.001; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; KOSHLAND DE, 1959, J CELL COMPAR PHYSL, V54, P245, DOI 10.1002/jcp.1030540420; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Laine O, 2008, J MOL BIOL, V381, P89, DOI 10.1016/j.jmb.2008.05.018; Laskowski RA, 2009, FEBS LETT, V583, P1692, DOI 10.1016/j.febslet.2009.03.019; Lee AL, 2000, NAT STRUCT BIOL, V7, P72; Li ZG, 1996, PROTEIN SCI, V5, P2647, DOI 10.1002/pro.5560051228; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lukin JA, 2003, P NATL ACAD SCI USA, V100, P517, DOI 10.1073/pnas.232715799; Luque I, 2002, PROTEINS, V49, P181, DOI 10.1002/prot.10208; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Manley G, 2013, J PHYS CHEM B, V117, P3063, DOI 10.1021/jp312576v; Marcos E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002201; Marlow MS, 2010, NAT CHEM BIOL, V6, P352, DOI 10.1038/nchembio.347; Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Monod Jacques, 1977, CHANCE NECESSITY ESS; Motlagh HN, 2012, P NATL ACAD SCI USA, V109, P4134, DOI 10.1073/pnas.1120519109; Nussinov R, 2013, ANNU REV BIOPHYS, V42, P169, DOI 10.1146/annurev-biophys-083012-130257; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Pan H, 2000, P NATL ACAD SCI USA, V97, P12020, DOI 10.1073/pnas.220240297; Penczek PA, 2011, STRUCTURE, V19, P1582, DOI 10.1016/j.str.2011.10.003; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; Petit CM, 2009, P NATL ACAD SCI USA, V106, P18249, DOI 10.1073/pnas.0904492106; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Qian H, 2010, J PHYS CHEM B, V114, P16105, DOI 10.1021/jp102400u; Reichheld SE, 2009, P NATL ACAD SCI USA, V106, P22263, DOI 10.1073/pnas.0911566106; Rodgers TL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001651; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Schrank TP, 2009, P NATL ACAD SCI USA, V106, P16984, DOI 10.1073/pnas.0906510106; Sekhar A, 2013, P NATL ACAD SCI USA, V110, P12867, DOI 10.1073/pnas.1305688110; Sevcsik E, 2011, J AM CHEM SOC, V133, P7152, DOI 10.1021/ja2009554; SILVA MM, 1992, J BIOL CHEM, V267, P17248; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Tang C, 2008, NATURE, V455, P693, DOI 10.1038/nature07342; Tang S, 2007, J MOL BIOL, V373, P1361, DOI 10.1016/j.jmb.2007.08.059; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Tzeng SR, 2011, CURR OPIN STRUC BIOL, V21, P62, DOI 10.1016/j.sbi.2010.10.007; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; VanWart AT, 2012, J CHEM THEORY COMPUT, V8, P2949, DOI 10.1021/ct300377a; Wand AJ, 2013, CURR OPIN STRUC BIOL, V23, P75, DOI 10.1016/j.sbi.2012.11.005; Ward AB, 2013, SCIENCE, V339, P913, DOI 10.1126/science.1228565; Weinkam P, 2013, J MOL BIOL, V425, P647, DOI 10.1016/j.jmb.2012.11.041; Whitley MJ, 2009, CURR PROTEIN PEPT SC, V10, P116, DOI 10.2174/138920309787847563; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yang DW, 1996, J MOL BIOL, V263, P369, DOI 10.1006/jmbi.1996.0581; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033; Zayner JP, 2013, BIOPHYS J, V105, P1027, DOI 10.1016/j.bpj.2013.07.010	108	748	753	21	459	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					331	339		10.1038/nature13001	http://dx.doi.org/10.1038/nature13001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24740064	Green Accepted			2022-12-28	WOS:000334403000040
J	Owens, B				Owens, Brian			The changing colour of fat	NATURE			English	Editorial Material																		Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Ferrer-Lorente R, 2005, LIFE SCI, V77, P2051, DOI 10.1016/j.lfs.2005.04.008; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Lichtenbelt WV, 2014, TRENDS ENDOCRIN MET, V25, P165, DOI 10.1016/j.tem.2014.01.001; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	7	10	10	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					S52	S53		10.1038/508S52a	http://dx.doi.org/10.1038/508S52a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF0KP	24740126	Bronze			2022-12-28	WOS:000334403000003
J	Willyard, C				Willyard, Cassandra			The family roots of obesity	NATURE			English	Editorial Material							CONGENITAL LEPTIN DEFICIENCY; MUTATIONS; EXPOSURE; DYSFUNCTION; CHILDHOOD; GENETICS; HUMANS; FTO											Farooqi IS, 2000, ARCH DIS CHILD, V83, P31, DOI 10.1136/adc.83.1.31; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Karra E, 2013, J CLIN INVEST, V123, P3539, DOI 10.1172/JCI44403; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Lubrano-Berthelier C, 2003, ANN NY ACAD SCI, V994, P49, DOI 10.1111/j.1749-6632.2003.tb03161.x; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Pearce LR, 2013, CELL, V155, P765, DOI 10.1016/j.cell.2013.09.058; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Skinner MK, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-228; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Soubry A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-29	16	43	45	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					S58	S60		10.1038/508S58a	http://dx.doi.org/10.1038/508S58a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF0KP	24740129	Bronze			2022-12-28	WOS:000334403000006
J	Ma, LM; Wu, YM; Qiu, Q; Scheerer, H; Moran, A; Yu, CR				Ma, Limei; Wu, Yunming; Qiu, Qiang; Scheerer, Hayley; Moran, Andrea; Yu, C. Ron			A Developmental Switch of Axon Targeting in the Continuously Regenerating Mouse Olfactory System	SCIENCE			English	Article							SENSORY MAP; NEURONAL-ACTIVITY; GLOMERULI; BULB; NEUROGENESIS; TOPOGRAPHY; EXPRESSION; PLASTICITY; ABLATION; ABSENCE	The mammalian olfactory system has the natural capacity to regenerate throughout the animal's life span. Despite constant neurogenesis, olfactory sensory neurons project to precise, stereotypical positions in the brain. Here, we identify a critical period of olfactory sensory axon targeting during postnatal development in mouse. Perturbing axon projection beyond postnatal day 7 permanently disrupts targeting specificity of the sensory neurons. In addition, we find that the establishment of the convergence map requires perinatal sensory neurons. Late-born neurons appear to connect with prospective glomeruli based on homotypic interactions among neurons expressing the same odorant receptor. Our results reveal a developmental switch in axon guidance and a mechanism of circuit integration of adult-born neurons.	[Ma, Limei; Wu, Yunming; Qiu, Qiang; Scheerer, Hayley; Moran, Andrea; Yu, C. Ron] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Yu, C. Ron] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Yu, CR (corresponding author), Stowers Inst Med Res, 1000 East 50th St, Kansas City, MO 64110 USA.	cry@stowers.org			Stowers Institute	Stowers Institute	We thank L. Nay, E. S. Gillespie, and the Laboratory Animal Services at the Stowers Institute for technical assistance and S. Lomvardas, R. Axel, N. Ryba, and P. Mombaerts for sharing transgenic mice. We appreciate helpful discussions with H. Taniguchi, H. Sakano, Y. Zou, and members of the Yu lab. This work fulfills, in part, requirements for Y.W.'s Ph.D. thesis with the Open University, United Kingdom. This work is supported by funding from Stowers Institute.	Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Bulfone A, 1998, NEURON, V21, P1273, DOI 10.1016/S0896-6273(00)80647-9; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Costanzo RM, 2005, CHEM SENSES, V30, pI133, DOI 10.1093/chemse/bjh150; COSTANZO RM, 1991, CIBA F SYMP, V160, P233; Costanzo RM, 2000, CHEM SENSES, V25, P199, DOI 10.1093/chemse/25.2.199; Costanzo RM, 1991, CIBA F SYMP, V160, P243; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Fleischmann A, 2008, NEURON, V60, P1068, DOI 10.1016/j.neuron.2008.10.046; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; GRAZIADEI PPC, 1985, ANN NY ACAD SCI, V457, P127, DOI 10.1111/j.1749-6632.1985.tb20802.x; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Imai T, 2011, EUR J NEUROSCI, V34, P1647, DOI 10.1111/j.1460-9568.2011.07817.x; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Lee P, 1998, P NATL ACAD SCI USA, V95, P11371, DOI 10.1073/pnas.95.19.11371; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Ma LM, 2012, P NATL ACAD SCI USA, V109, P5481, DOI 10.1073/pnas.1117491109; MACKAYSIM A, 1991, EUR J NEUROSCI, V3, P209, DOI 10.1111/j.1460-9568.1991.tb00081.x; MACKAYSIM A, 1991, J NEUROSCI, V11, P979; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Nguyen-Ba-Charvet KT, 2008, J NEUROSCI, V28, P4244, DOI 10.1523/JNEUROSCI.5671-07.2008; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Royal SJ, 1999, J NEUROSCI, V19, P9856; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; St John JA, 2003, CHEM SENSES, V28, P773, DOI 10.1093/chemse/bjg068; Takeuchi H, 2010, CELL, V141, P1056, DOI 10.1016/j.cell.2010.04.041; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zou DJ, 2004, SCIENCE, V304, P1976, DOI 10.1126/science.1093468	31	51	52	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					194	197		10.1126/science.1248805	http://dx.doi.org/10.1126/science.1248805			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24723610				2022-12-28	WOS:000334096300034
J	Adams, K				Adams, Kate			Routine referral letters share clinical data without patients' consent	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												kateadams@doctors.org.uk						British Medical Association (BMA), CONF DISCL HLTH INF; General Medical Council, 2009, CONF DISCL INF SER C; General Medical Council, 2009, CONF; National AIDS Trust (NAT.), 2014, HIV PAT INF NHS CONF	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 4	2014	348								g2419	10.1136/bmj.g2419	http://dx.doi.org/10.1136/bmj.g2419			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4UC	24705717				2022-12-28	WOS:000333978700001
J	Raya-Rivera, AM; Esquiliano, D; Fierro-Pastrana, R; Lopez-Bayghen, E; Valencia, P; Ordorica-Flores, R; Soker, S; Yoo, JJ; Atala, A				Raya-Rivera, Atlantida M.; Esquiliano, Diego; Fierro-Pastrana, Reyna; Lopez-Bayghen, Esther; Valencia, Pedro; Ordorica-Flores, Ricardo; Soker, Shay; Yoo, James J.; Atala, Anthony			Tissue-engineered autologous vaginal organs in patients: a pilot cohort study	LANCET			English	Article							KUSTER-HAUSER-SYNDROME; IN-VITRO; VAGINOPLASTY; RECONSTRUCTION; AGENESIS; GRAFT; MANAGEMENT; OUTCOMES; VIVO	Background Several disorders might require vaginal reconstruction, such as congenital abnormalities, injury, or cancer. Reconstructive techniques for which non-vaginal tissue is used can be associated with complications. We assessed the use of engineered vaginal organs in four patients with vaginal aplasia caused by Mayer-Rokitansky-Kuster-Hauser syndrome (MRKHS). Methods We invited to participate four consecutive patients who presented over a 3-year period with congenital vaginal aplasia due to MRKHS. Patients were aged 13-18 years. We obtained a vulvar biopsy of autologous tissue from every patient. We cultured, expanded, and seeded epithelial and muscle cells onto biodegradable scaffolds. The organs were constructed and allowed to mature in an incubator in a facility approved for human-tissue manufacturing. We used a perineal approach to surgically implant these organs. We recorded history, physical examination, vaginoscopy, serial tissue biopsies, MRIs, and self-administered Female Sexual Function Index questionnaire results for all patients, with a follow-up of up to 8 years. Findings We noted no long-term postoperative surgical complications. Yearly serial biopsies showed a tri-layered structure, consisting of an epithelial cell-lined lumen surrounded by matrix and muscle, with expected components of vaginal tissue present. Immunohistochemical analysis confirmed the presence of phenotypically normal smooth muscle and epithelia. The MRIs, which showed the extent of the vaginal aplasia before surgery, showed the engineered organs and the absence of abnormalities after surgery, which was confirmed with yearly vaginoscopy. A validated self-administered Female Sexual Function Index questionnaire showed variables in the normal range in all areas tested, such as desire, arousal, lubrication, orgasm, satisfaction, and painless intercourse. Interpretation Vaginal organs, engineered from the patient's own cells and implanted, showed normal structural and functional variables with a follow-up of up to 8 years. These technologies could be useful in patients requiring vaginal reconstruction.	[Raya-Rivera, Atlantida M.; Esquiliano, Diego; Fierro-Pastrana, Reyna; Lopez-Bayghen, Esther; Valencia, Pedro; Ordorica-Flores, Ricardo] Childrens Hosp Mexico Federico Gomez HIMFG, Tissue Engn Lab, Mexico City, DF, Mexico; [Raya-Rivera, Atlantida M.; Esquiliano, Diego; Fierro-Pastrana, Reyna; Lopez-Bayghen, Esther; Valencia, Pedro; Ordorica-Flores, Ricardo] Metropolitan Autonomous Univ, Mexico City, DF, Mexico; [Raya-Rivera, Atlantida M.; Esquiliano, Diego; Fierro-Pastrana, Reyna; Lopez-Bayghen, Esther; Valencia, Pedro; Ordorica-Flores, Ricardo] IPN, CINVESTAV, Mexico City 07738, DF, Mexico; [Soker, Shay; Yoo, James J.; Atala, Anthony] Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA	Hospital Infantil de Mexico Federico Gomez; Universidad Autonoma Metropolitana - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Wake Forest University; Wake Forest Baptist Medical Center	Atala, A (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	aatala@wakehealth.edu	Lopez-Bayghen, Esther/A-8006-2008; Yoo, James J./L-4850-2017; ORDORICA-FLORES, RICARDO/AAL-1712-2021; ORDORICA-FLORES, Ricardo Manuel/AAL-5935-2021	Lopez-Bayghen, Esther/0000-0002-2849-7587; ORDORICA-FLORES, RICARDO/0000-0001-6329-7356; 				Aittomaki K, 2001, FERTIL STERIL, V76, P624, DOI 10.1016/S0015-0282(01)01963-X; Ansaloni L, 2007, Hernia, V11, P321, DOI 10.1007/s10029-007-0225-4; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5; Burgu Berk, 2007, J Pediatr Urol, V3, P316, DOI 10.1016/j.jpurol.2006.09.008; Chen KL, 2010, P NATL ACAD SCI USA, V107, P3346, DOI 10.1073/pnas.0909367106; Davies MC, 2005, BJU INT, V95, P1293, DOI 10.1111/j.1464-410X.2005.05522.x; de Filippo RE, 2003, TISSUE ENG, V9, P301, DOI 10.1089/107632703764664765; De Filippo RE, 2002, J UROLOGY, V168, P1789, DOI 10.1016/S0022-5347(05)64414-X; De Philippo RE, 2008, TRANSPLANTATION, V86, P208, DOI 10.1097/TP.0b013e31817f1686; Ding JX, 2013, GYNECOL OBSTET INVES, V75, P93, DOI 10.1159/000343233; Dornelas J, 2012, EUR J OBSTET GYN R B, V163, P204, DOI 10.1016/j.ejogrb.2012.04.018; Gartner LP, 2009, COLOR ATLAS HISTOLOG, P372; HENDREN WH, 1994, J UROLOGY, V152, P752, DOI 10.1016/S0022-5347(17)32698-8; Kimberley N, 2012, J PEDIATR ADOL GYNEC, V25, P54, DOI 10.1016/j.jpag.2011.08.003; Lankford JC, 2013, J MIDWIFERY WOM HEAL, V58, P546, DOI 10.1111/jmwh.12020; Lin WC, 2003, HUM REPROD, V18, P604, DOI 10.1093/humrep/deg095; MCCRAW JB, 1976, PLAST RECONSTR SURG, V58, P176, DOI 10.1097/00006534-197608000-00006; McQuillan SK, 2014, INT UROGYNECOL J, V25, P299, DOI 10.1007/s00192-013-2221-9; MORLEY GW, 1976, CANCER, V38, P581, DOI 10.1002/1097-0142(197607)38:1<581::AID-CNCR2820380182>3.0.CO;2-Y; MORTON KE, 1986, BRIT J OBSTET GYNAEC, V93, P50, DOI 10.1111/j.1471-0528.1986.tb07813.x; MORTON KE, 1986, BRIT J OBSTET GYNAEC, V93, P970, DOI 10.1111/j.1471-0528.1986.tb08018.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149, DOI 10.1038/6146; Oppelt P, 2006, HUM REPROD, V21, P792, DOI 10.1093/humrep/dei381; Panici PB, 2007, HUM REPROD, V22, P2025, DOI 10.1093/humrep/dem096; Raya-Rivera A, 2011, LANCET, V377, P1175, DOI 10.1016/S0140-6736(10)62354-9; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; Schober Justine M, 2007, J Pediatr Urol, V3, P167, DOI 10.1016/j.jpurol.2006.07.010; Shi L, 2013, INT J BURNS TRAUMA, V3, P173; Vecchietti G, 1965, Attual Ostet Ginecol, V11, P131; WISER WL, 1984, SURG GYNECOL OBSTET, V159, P108; Zhao MX, 2009, ANN PLAS SURG, V63, P645, DOI 10.1097/SAP.0b013e31819adfab; Zhou JH, 2010, FERTIL STERIL, V94, P2281, DOI 10.1016/j.fertnstert.2010.02.010; Zhu L, 2013, J SEX MED, V10, P1652, DOI 10.1111/jsm.12143	35	129	139	0	38	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2014	384	9940					329	336		10.1016/S0140-6736(14)60542-0	http://dx.doi.org/10.1016/S0140-6736(14)60542-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3AE	24726478				2022-12-28	WOS:000339722400030
J	van Spronsen, FJ; Derks, TGJ				van Spronsen, Francjan J.; Derks, Terry G. J.			Recombinant phenylalanine ammonia lyase in phenylketonuria	LANCET			English	Editorial Material							TETRAHYDROBIOPTERIN		[van Spronsen, Francjan J.; Derks, Terry G. J.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Sect Metab Dis, NL-9700 RB Groningen, Netherlands	University of Groningen	van Spronsen, FJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Sect Metab Dis, NL-9700 RB Groningen, Netherlands.	f.j.van.spronsen@umcg.nl	Derks, Terry G. J./AGT-9822-2022	Derks, Terry G. J./0000-0002-7259-1095				Blau N, 2010, LANCET, V376, P1417, DOI 10.1016/S0140-6736(10)60961-0; Enns GM, 2010, MOL GENET METAB, V101, P99, DOI 10.1016/j.ymgme.2010.05.017; HAGENFELDT L, 1984, J NEUROCHEM, V42, P833, DOI 10.1111/j.1471-4159.1984.tb02756.x; HOSKINS JA, 1980, LANCET, V1, P392; Iahja R, 2014, J PEDIAT, DOI [10.1016/j.jpeds.2013.12.015, DOI 10.1016/J.JPEDS.2013.12.015]; Kure S, 1999, J PEDIATR-US, V135, P375, DOI 10.1016/S0022-3476(99)70138-1; Leuzzi V, 2004, J INHERIT METAB DIS, V27, P115, DOI 10.1023/B:BOLI.0000028781.94251.1f; Longo N, 2014, LANCET; Muntau AC, 2002, NEW ENGL J MED, V347, P2122, DOI 10.1056/NEJMoa021654; Okano Y, 2013, MOL GENET METAB, V110, P424, DOI 10.1016/j.ymgme.2013.09.007; van Spronsen FJ, 2008, J INHERIT METAB DIS, V31, P673, DOI 10.1007/s10545-008-0918-6; Weglage J, 2013, MOL GENET METAB, V110, pS44, DOI 10.1016/j.ymgme.2013.08.013	12	2	2	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2014	384	9937					6	8		10.1016/S0140-6736(13)62075-9	http://dx.doi.org/10.1016/S0140-6736(13)62075-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1XL	24742999				2022-12-28	WOS:000338919600006
J	Juni, P; Zwahlen, M				Jueni, Peter; Zwahlen, Marcel			It Is Time to Initiate Another Breast Cancer Screening Trial	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MORTALITY		[Jueni, Peter; Zwahlen, Marcel] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland	University of Bern	Juni, P (corresponding author), Univ Bern, Inst Social & Prevent Med, Finkenhubelweg 11, CH-3012 Bern, Switzerland.	juni@ispm.unibe.ch	Juni, Peter/Q-8700-2016; Zwahlen, Marcel/AFF-8559-2022	Juni, Peter/0000-0002-5985-0670; Zwahlen, Marcel/0000-0002-6772-6346				Black WC, 2002, JNCI-J NATL CANCER I, V94, P167, DOI 10.1093/jnci/94.3.167; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Miller Anthony B, 2014, BMJ, V348, pg366, DOI 10.1136/bmj.g366; Swiss Medical Board, 2013, SYST MAMM SCREEN	7	11	11	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12					864	U101		10.7326/M14-0569	http://dx.doi.org/10.7326/M14-0569			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24711124				2022-12-28	WOS:000337374900024
J	Thacker, D; Mohibullah, N; Zhu, X; Keeney, S				Thacker, Drew; Mohibullah, Neeman; Zhu, Xuan; Keeney, Scott			Homologue engagement controls meiotic DNA break number and distribution	NATURE			English	Article							DOUBLE-STRAND BREAKS; SYNAPTONEMAL COMPLEX-FORMATION; SACCHAROMYCES-CEREVISIAE; CROSSING-OVER; MUTS HOMOLOG; ZMM PROTEINS; RECOMBINATION; MEIOSIS; PACHYTENE; MUTANTS	Meiotic recombination promotes genetic diversification as well as pairing and segregation of homologous chromosomes, but the double-strand breaks (DSBs) that initiate recombination are dangerous lesions that can cause mutation or meiotic failure. How cells control DSBs to balance between beneficial and deleterious outcomes is not well understood. Here we test the hypothesis that DSB control involves a network of intersecting negative regulatory circuits. Using multiple complementary methods, we show that DSBs form in greater numbers in Saccharomyces cerevisiae cells lacking ZMM proteins, a suite of recombination-promoting factors traditionally regarded as acting strictly downstream of DSB formation. ZMM-dependent DSB control is genetically distinct from a pathway tying break formation to meiotic progression through the Ndt80 transcription factor. These counterintuitive findings suggest that homologous chromosomes that have successfully engaged one another stop making breaks. Genome-wide DSB maps uncover distinct responses by different subchromosomal domains to the ZMM mutation zip3 (also known as cst9), and show that Zip3 is required for the previously unexplained tendency of DSB density to vary with chromosome size. Thus, feedback tied to ZMM function contributes in unexpected ways to spatial patterning of recombination.	[Thacker, Drew; Mohibullah, Neeman; Zhu, Xuan; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10065 USA; [Thacker, Drew; Zhu, Xuan; Keeney, Scott] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10065 USA; [Mohibullah, Neeman; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10065 USA.	s-keeney@ski.mskcc.org	Keeney, Scott/GVR-8515-2022	Keeney, Scott/0000-0002-1283-6417; Zhu, Xuan/0000-0002-8422-2828	National Institutes of Health [R01 GM058673]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058673] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to S. Burgess, N. Hunter, N. Kleckner, K. Ohta, M. Rout and A. Shinohara for strains or epitope tagging constructs; F. Klein for sharing data; S. Shuman for gifts of T4 RNA ligase; A. Viale and the Memorial Sloan Kettering Cancer Center (MSKCC) Genomics Core Laboratory for sequencing; and N. Socci and the MSKCC Bioinformatics Core for assistance mapping Spo11 oligos. This work was supported by National Institutes of Health grant R01 GM058673. S. K. is an Investigator of the Howard Hughes Medical Institute.	Abdullah MFF, 2001, P NATL ACAD SCI USA, V98, P14524, DOI 10.1073/pnas.201529598; Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Bhagat R, 2004, CYTOGENET GENOME RES, V107, P160, DOI 10.1159/000080594; Blitzblau HG, 2007, CURR BIOL, V17, P2003, DOI 10.1016/j.cub.2007.10.066; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Borde V, 2013, CURR OPIN GENET DEV, V23, P147, DOI 10.1016/j.gde.2012.12.002; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Carballo JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003545; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Chua PR, 1998, CELL, V93, P349, DOI 10.1016/S0092-8674(00)81164-2; Cotton VE, 2009, METHODS MOL BIOL, V557, P3, DOI 10.1007/978-1-59745-527-5_1; Diaz RL, 2002, MOL CELL BIOL, V22, P1106, DOI 10.1128/MCB.22.4.1106-1115.2002; Falk JE, 2010, DEV CELL, V19, P599, DOI 10.1016/j.devcel.2010.09.006; Gray S, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130019; Henzel JV, 2011, GENETICS, V187, P685, DOI 10.1534/genetics.110.124958; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Joyce EF, 2011, J CELL BIOL, V195, P359, DOI 10.1083/jcb.201104121; KABACK DB, 1992, SCIENCE, V256, P228, DOI 10.1126/science.1566070; Kauppi L, 2013, GENE DEV, V27, P873, DOI 10.1101/gad.213652.113; Kee K, 2004, EMBO J, V23, P1815, DOI 10.1038/sj.emboj.7600184; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Lange J, 2011, NATURE, V479, P237, DOI 10.1038/nature10508; Lichten Michael, 2008, V3, P165, DOI 10.1007/7050_2008_040; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Murakami H, 2009, METHODS MOL BIOL, V557, P117, DOI 10.1007/978-1-59745-527-5_9; Nakagawa T, 1999, EMBO J, V18, P5714, DOI 10.1093/emboj/18.20.5714; Neale MJ, 2009, METHODS MOL BIOL, V557, P183, DOI 10.1007/978-1-59745-527-5_12; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Panizza S, 2011, CELL, V146, P372, DOI 10.1016/j.cell.2011.07.003; Pineda-Krch M, 2005, GENETICS, V169, P2319, DOI 10.1534/genetics.104.034363; R Development Core Team, 2012, R LANG ENV STAT COMP; Rockmill B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003932; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Rosu S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003674; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Serrentino ME, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003416; Shinohara M, 2008, NAT GENET, V40, P299, DOI 10.1038/ng.83; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Stamper EL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003679; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Thacker D, 2012, THESIS CORNELL U; Tsubouchi T, 2006, DEV CELL, V10, P809, DOI 10.1016/j.devcel.2006.04.003; Tung KS, 2000, P NATL ACAD SCI USA, V97, P12187, DOI 10.1073/pnas.220464597; Vader G, 2011, NATURE, V477, P115, DOI 10.1038/nature10331; Wojtasz L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000702; XU LZ, 1995, MOL CELL BIOL, V15, P6572; Zhang LR, 2011, P NATL ACAD SCI USA, V108, P20036, DOI 10.1073/pnas.1117937108	54	125	125	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					241	+		10.1038/nature13120	http://dx.doi.org/10.1038/nature13120			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24717437	Green Accepted			2022-12-28	WOS:000337032400044
J	Rhee, C; Gohil, S; Klompas, M				Rhee, Chanu; Gohil, Shruti; Klompas, Michael			Regulatory Mandates for Sepsis Care - Reasons for Caution	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Sepsis, the syndrome of dysregulated inflammation that occurs with severe infection, affects millions of people worldwide each year. Multiple studies suggest that the incidence of sepsis is dramatically increasing. According to the Centers for Disease Control and Prevention (CDC), for example, sepsis rates doubled between 2000 and 2008.(1) In 2010, sepsis was the 11th leading cause of death in the United States,(2) and in 2011, it was the single most expensive condition treated in hospitals.(3) This apparent explosion in sepsis is spurring high-profile initiatives to promote earlier recognition and better treatment. Standardized screening protocols, bundled order sets, and algorithms for . . . The attention and resources being dedicated to improving sepsis care are welcome. The policy response to this apparent epidemic, however, ought to be tempered by recognition that we do not yet have reliable tools for measuring sepsis incidence.	[Rhee, Chanu; Klompas, Michael] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02115 USA; [Rhee, Chanu; Klompas, Michael] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Rhee, Chanu; Klompas, Michael] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Gohil, Shruti] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Brigham & Women's Hospital; University of California System; University of California Irvine	Rhee, C (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02115 USA.		Rhee, Chanu/AAO-8368-2020; Klompas, Michael/Z-2415-2019		NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000147] Funding Source: NIH RePORTER; NCATS NIH HHS [KL2 TR000147] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Hall Margaret Jean, 2011, NCHS Data Brief, P1; Lagu T, 2012, CRIT CARE MED, V40, P2932; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Murphy SL, 2012, NATL VITAL STAT REP, V60, P1; Wachter RM, 2008, ANN INTERN MED, V149, P29, DOI 10.7326/0003-4819-149-1-200807010-00007	5	148	157	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2014	370	18					1673	1676		10.1056/NEJMp1400276	http://dx.doi.org/10.1056/NEJMp1400276			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4QM	24738642	Green Accepted, Green Submitted			2022-12-28	WOS:000335405200003
J	Dickson, N				Dickson, Niall			MEDICAL TRAINING Moving the point of doctors' registration	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												ndickson@gmc-uk.org						[Anonymous], SHAPE TRAINING SECUR; General Medical Counal, 2011, SUMM STAT MED ED PRA; General Medical Council, 2013, CHIEF EXCUTIVES REPO; Medical Schools Council Department of Health, IMPROVING SELECTION; NHS Medical Careers, GRADUATE ENTRY PROGR; Patel N., 2010, REV FUTURE REGULATIO; Tooke JE., 2008, ASPIRING EXCELLENCE; 1944, BMJ, V2, P121	8	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2014	348								g2863	10.1136/bmj.g2863	http://dx.doi.org/10.1136/bmj.g2863			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG1DN	24769837				2022-12-28	WOS:000335155400004
J	Li, GW; Burkhardt, D; Gross, C; Weissman, JS				Li, Gene-Wei; Burkhardt, David; Gross, Carol; Weissman, Jonathan S.			Quantifying Absolute Protein Synthesis Rates Reveals Principles Underlying Allocation of Cellular Resources	CELL			English	Article							SINGLE-MOLECULE LEVEL; ESCHERICHIA-COLI; GENE-EXPRESSION; UNEQUAL SYNTHESIS; ALPHA-SPECTRIN; BETA-SPECTRIN; LIVING CELLS; IN-VIVO; TRANSLATION; YEAST	Quantitative views of cellular functions require precise measures of rates of biomolecule production, especially proteins-the direct effectors of biological processes. Here, we present a genome-wide approach, based on ribosome profiling, for measuring absolute protein synthesis rates. The resultant E. coli data set transforms our understanding of the extent to which protein synthesis is precisely controlled to optimize function and efficiency. Members of multiprotein complexes are made in precise proportion to their stoichiometry, whereas components of functional modules are produced differentially according to their hierarchical role. Estimates of absolute protein abundance also reveal principles for optimizing design. These include how the level of different types of transcription factors is optimized for rapid response and how a metabolic pathway (methionine biosynthesis) balances production cost with activity requirements. Our studies reveal how general principles, important both for understanding natural systems and for synthesizing new ones, emerge from quantitative analyses of protein synthesis.	[Li, Gene-Wei; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Li, Gene-Wei; Burkhardt, David; Gross, Carol; Weissman, Jonathan S.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Li, Gene-Wei; Weissman, Jonathan S.] Univ Calif San Francisco, Ctr RNA Syst Biol, San Francisco, CA 94158 USA; [Burkhardt, David; Gross, Carol] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Burkhardt, David; Gross, Carol] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Li, GW (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	gene-wei.li@ucsf.edu; weissman@cmp.ucsf.edu		Li, Gene-Wei/0000-0001-7036-8511; Weissman, Jonathan/0000-0003-2445-670X	Helen Hay Whitney Foundation; NIH [GM105913]; NIH Center for RNA Systems Biology; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM105913, P50GM102706, K99GM105913] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center for RNA Systems Biology; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Qi for providing material for CRISPRi knockdown; R. Milo, K. C. Huang, J. Elf, J. Dunn, G. Brar, O. Brandman, C. Jan, J. Rabinowitz, and members of the J.S.W. and C.G. labs for discussions; and P. Choi and H. Chen for critical reading of the manuscript. We also thank J. Lund and E. Chow for help on sequencing and C. Reiger and M. DeVera for administrative support. This research was supported by the Helen Hay Whitney Foundation (to G.-W.L.), NIH Pathway to Independence Award (GM105913 to G.-W.L.), NIH Center for RNA Systems Biology (to J.S.W.), and Howard Hughes Medical Institute (to J.S.W.).	Ades SE, 1999, GENE DEV, V13, P2449, DOI 10.1101/gad.13.18.2449; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Barkai N, 2007, MOL CELL, V28, P755, DOI 10.1016/j.molcel.2007.11.013; Batchelor E, 2003, P NATL ACAD SCI USA, V100, P691, DOI 10.1073/pnas.0234782100; BAUGHMAN G, 1983, CELL, V34, P979, DOI 10.1016/0092-8674(83)90555-X; BLIKSTAD I, 1983, CELL, V32, P1081, DOI 10.1016/0092-8674(83)90292-1; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; BRUSILOW WSA, 1982, J BACTERIOL, V151, P1363, DOI 10.1128/JB.151.3.1363-1371.1982; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; DENNIS PP, 1974, J MOL BIOL, V88, P25, DOI 10.1016/0022-2836(74)90293-9; DONG HJ, 1995, J BACTERIOL, V177, P1497, DOI 10.1128/jb.177.6.1497-1504.1995; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fell D., 1997, UNDERSTANDING CONTRO; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; GROSSMAN AD, 1987, GENE DEV, V1, P179, DOI 10.1101/gad.1.2.179; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Hart Y, 2011, MOL CELL, V41, P117, DOI 10.1016/j.molcel.2010.12.023; Hu JC, 2014, NUCLEIC ACIDS RES, V42, pD677, DOI 10.1093/nar/gkt1203; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; LARRABEE KL, 1980, J BIOL CHEM, V255, P4125; LEHNERT ME, 1988, J CELL BIOL, V107, P413, DOI 10.1083/jcb.107.2.413; LEMAUX PG, 1978, CELL, V13, P427, DOI 10.1016/0092-8674(78)90317-3; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Li GW, 2009, NAT PHYS, V5, P294, DOI 10.1038/NPHYS1222; MCCARTHY JEG, 1990, TRENDS GENET, V6, P78, DOI 10.1016/0168-9525(90)90098-Q; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; Oromendia AB, 2012, GENE DEV, V26, P2696, DOI 10.1101/gad.207407.112; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; PETERSEN C, 1990, J BACTERIOL, V172, P431, DOI 10.1128/JB.172.1.431-436.1990; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Quax TEF, 2013, CELL REP, V4, P938, DOI 10.1016/j.celrep.2013.07.049; Rigel NW, 2013, P NATL ACAD SCI USA, V110, P5151, DOI 10.1073/pnas.1302662110; RUSSELL JB, 1995, MICROBIOL REV, V59, P48, DOI 10.1128/MMBR.59.1.48-62.1995; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; SAVAGEAU MA, 1977, P NATL ACAD SCI USA, V74, P5647, DOI 10.1073/pnas.74.12.5647; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Schuetz R, 2012, SCIENCE, V336, P601, DOI 10.1126/science.1216882; Schwanhausser B, 2009, PROTEOMICS, V9, P205, DOI 10.1002/pmic.200800275; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; SHAPIRO AL, 1966, NATURE, V211, P243, DOI 10.1038/211243a0; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; Shinar G, 2006, P NATL ACAD SCI USA, V103, P3999, DOI 10.1073/pnas.0506610103; Springer M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.19; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Swain PS, 2004, J MOL BIOL, V344, P965, DOI 10.1016/j.jmb.2004.09.073; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; von Hippel PH, 2007, ANNU REV BIOPH BIOM, V36, P79, DOI 10.1146/annurev.biophys.34.040204.144521; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6961, DOI 10.1021/bi00527a030; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; You CH, 2013, NATURE, V500, P301, DOI 10.1038/nature12446	63	749	760	8	137	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					624	635		10.1016/j.cell.2014.02.033	http://dx.doi.org/10.1016/j.cell.2014.02.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766808	Bronze, Green Accepted			2022-12-28	WOS:000335392100012
J	Chiong, W; Kim, AS; Huang, IA; Farahany, NA; Josephson, SA				Chiong, Winston; Kim, Anthony S.; Huang, Ivy A.; Farahany, Nita A.; Josephson, S. Andrew			Testing the Presumption of Consent to Emergency Treatment for Acute Ischemic Stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Chiong, Winston; Kim, Anthony S.; Huang, Ivy A.; Josephson, S. Andrew] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Farahany, Nita A.] Duke Univ, Sch Law, Durham, NC 27706 USA	University of California System; University of California San Francisco; Duke University	Chiong, W (corresponding author), Univ Calif San Francisco, 675 Nelson Rising Ln,Ste 190, San Francisco, CA 94158 USA.	winston.chiong@ucsf.edu	Farahany, Nita/AGH-5500-2022	Farahany, Nita/0000-0003-4808-6256	NCATS NIH HHS [KL2 TR000143] Funding Source: Medline; NIA NIH HHS [K23 AG043553] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG043553] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		American Academy of Neurology, AM AC NEUR POL CONS; Callegaro M, 2008, PUBLIC OPIN QUART, V72, P1008, DOI 10.1093/poq/nfn065; Gadhia J, 2010, STROKE, V41, P300, DOI 10.1161/STROKEAHA.109.566935; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; McNally Bryan, 2011, Morbidity and Mortality Weekly Report, V60, P1; Rubin EB, 2010, NEUROL CLIN, V28, P459, DOI 10.1016/j.ncl.2009.11.007	6	19	19	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2014	311	16					1689	1691		10.1001/jama.2014.3302	http://dx.doi.org/10.1001/jama.2014.3302			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF4OU	24756520	Green Accepted, Bronze			2022-12-28	WOS:000334693900030
J	Stansby, G; Avital, L; Jones, K; Marsden, G				Stansby, Gerry; Avital, Liz; Jones, Katie; Marsden, Grace		Guideline Dev Grp	Prevention and management of pressure ulcers in primary and secondary care: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SCALE; RISK		[Stansby, Gerry] Freeman Rd Hosp, Dept Vasc Surg, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Avital, Liz; Jones, Katie; Marsden, Grace] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England	Newcastle Freeman Hospital; Newcastle University - UK; Royal College of Physicians	Avital, L (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	liz.avital@rcplondon.ac.uk	Hampson, Grace/M-4470-2014	Hampson, Grace/0000-0002-2019-1268; McGinnis, Elizabeth/0000-0002-2848-9149; Stansby, Gerard/0000-0001-5539-3049				[Anonymous], 1975, INVESTIGATION GERIAT; BERGSTROM N, 1987, NURS RES, V36, P205, DOI 10.1097/00006199-198707000-00002; Curley MAQ, 2003, NURS RES, V52, P22, DOI 10.1097/00006199-200301000-00004; Mooney H, 2013, HLTH SERV J; National Clinical Guideline Centre, 2013, PRESSURE ULCER PREVE, V179; National Institute for Health and Care Excellence, 2005, PRESSURE ULCER PREVE, V29; National Institute for Health and Care Excellence, 2003, PRESSURE ULCER PREVE, V7; National Pressure Ulcer Advisory Panel (NPUAP) and European Pressure Ulcer Advisory Panel (EPUAP), 2009, TREATMENT PRESSURE U; Niederhauser A, 2012, ADV SKIN WOUND CARE, V25, P167, DOI 10.1097/01.ASW.0000413598.97566.d7; Vanderwee K, 2007, J EVAL CLIN PRACT, V13, P227, DOI 10.1111/j.1365-2753.2006.00684.x; Waterlow J, 1987, Nurs Times, V83, P58	11	29	32	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2014	348								g2592	10.1136/bmj.g2592	http://dx.doi.org/10.1136/bmj.g2592			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG1DH	24760157				2022-12-28	WOS:000335154800002
J	Pandolfi, JM; Lovelock, CE				Pandolfi, John M.; Lovelock, Catherine E.			Novelty Trumps Loss in Global Biodiversity	SCIENCE			English	Editorial Material									[Pandolfi, John M.; Lovelock, Catherine E.] Univ Queensland, Sch Biol Sci, ARC Ctr Excellence Coral Reef Studies, St Lucia, Qld, Australia	University of Queensland	Pandolfi, JM (corresponding author), Univ Queensland, Sch Biol Sci, ARC Ctr Excellence Coral Reef Studies, St Lucia, Qld, Australia.	j.pandolfi@uq.edu.au; c.lovelock@uq.edu.au	Pandolfi, John M/A-3121-2009; Lovelock, Catherine E/G-7370-2012; Lovelock, Catherine E./AAF-7294-2020	Pandolfi, John M/0000-0003-3047-6694; Lovelock, Catherine E/0000-0002-2219-6855; Lovelock, Catherine E./0000-0002-2219-6855				Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Cavanaugh KC, 2014, P NATL ACAD SCI USA, V111, P723, DOI 10.1073/pnas.1315800111; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; Ellis EC, 2013, P NATL ACAD SCI USA, V110, P7978, DOI 10.1073/pnas.1217241110; Graham NAJ, 2014, CURR OPIN ENV SUST, V7, P9, DOI 10.1016/j.cosust.2013.11.023; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hoffmann M, 2011, PHILOS T R SOC B, V366, P2598, DOI 10.1098/rstb.2011.0116; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Sommer B, 2014, ECOLOGY, V95, P1000, DOI 10.1890/13-1445.1; Steffen W, 2011, PHILOS T R SOC A, V369, P842, DOI 10.1098/rsta.2010.0327; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538	12	14	15	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					266	267		10.1126/science.1252963	http://dx.doi.org/10.1126/science.1252963			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744366	Green Published			2022-12-28	WOS:000334474500025
J	Bryson, JB; Machado, CB; Crossley, M; Stevenson, D; Bros-Facer, V; Burrone, J; Greensmith, L; Lieberam, I				Bryson, J. Barney; Machado, Carolina Barcellos; Crossley, Martin; Stevenson, Danielle; Bros-Facer, Virginie; Burrone, Juan; Greensmith, Linda; Lieberam, Ivo			Optical Control of Muscle Function by Transplantation of Stem Cell-Derived Motor Neurons in Mice	SCIENCE			English	Article							IN-VITRO; UNITS	Damage to the central nervous system caused by traumatic injury or neurological disorders can lead to permanent loss of voluntary motor function and muscle paralysis. Here, we describe an approach that circumvents central motor circuit pathology to restore specific skeletal muscle function. We generated murine embryonic stem cell-derived motor neurons that express the light-sensitive ion channel channelrhodopsin-2, which we then engrafted into partially denervated branches of the sciatic nerve of adult mice. These engrafted motor neurons not only reinnervated lower hind-limb muscles but also enabled their function to be restored in a controllable manner using optogenetic stimulation. This synthesis of regenerative medicine and optogenetics may be a successful strategy to restore muscle function after traumatic injury or disease.	[Bryson, J. Barney; Bros-Facer, Virginie; Greensmith, Linda] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disord, London, England; [Machado, Carolina Barcellos; Crossley, Martin; Stevenson, Danielle; Burrone, Juan; Lieberam, Ivo] Kings Coll London, MRC, Ctr Dev Neurobiol, London WC2R 2LS, England; [Greensmith, Linda] UCL, Inst Neurol, MRC, Ctr Neuromuscular Dis, London, England	University of London; University College London; University of London; King's College London; University of London; University College London	Greensmith, L (corresponding author), UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disord, London, England.	l.greensmith@ucl.ac.uk; ivo.lieberam@kcl.ac.uk		Burrone, Juan/0000-0003-1233-668X; Bryson, J. Barney/0000-0001-5486-0258; Lieberam, Ivo/0000-0003-3539-3054; Barcellos Machado, Carolina/0000-0003-4420-6097	Thierry Latran Foundation; Medical Research Council [G0900585]; Biotechnology and Biological Sciences Research Council [G1001234]; King's Health Partners; Association Francaise contre les Myopathies; Brain Research Trust; European Community; MRC [MR/K000608/1, G0901899, G0900585] Funding Source: UKRI; Medical Research Council [G0901899, MR/K000608/1, 985557, 1247820] Funding Source: researchfish	Thierry Latran Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); King's Health Partners; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Brain Research Trust; European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank T. Keck, D. Kullman, and G. Schiavo for constructive feedback on the manuscript and the Thierry Latran Foundation for supporting this study. I. L. is funded by the Medical Research Council (G0900585), the Biotechnology and Biological Sciences Research Council (G1001234), King's Health Partners, and the Association Francaise contre les Myopathies. L. G. is the Graham Watts Senior Research Fellow, funded by The Brain Research Trust, and is supported by the European Community's Seventh Framework Programme (FP7/2007-2013). J.B. is a Wellcome Trust Investigator. The data reported in this paper are tabulated in the supplementary materials. We declare no conflicts of interest. I. L., C. B. M., M. C., and D. S. developed and characterized ESCs, prepared EBs, and purified motor neurons; M. C. and J.B. performed in vitro physiology; J.B.B. performed surgery, in vivo physiology, and histology and drafted the manuscript; V.B.-F. and D. S. assisted with surgery and histology; and L. G. and I. L. developed the original concept, designed and oversaw the study, and revised the manuscript.	Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Carrascal L, 2005, BRAIN RES REV, V49, P377, DOI 10.1016/j.brainresrev.2005.02.003; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Gernandt B., 1946, ACTA PHYSIOL SCAND, V12, P255, DOI 10.1111/j.1748-1716.1946.tb00385.x; GLENN WWL, 1985, NEUROSURGERY, V17, P974, DOI 10.1227/00006123-198512000-00021; Harper JM, 2004, P NATL ACAD SCI USA, V101, P7123, DOI 10.1073/pnas.0401103101; HENNEMAN E, 1957, SCIENCE, V126, P1345, DOI 10.1126/science.126.3287.1345; Hockberger PE, 1999, P NATL ACAD SCI USA, V96, P6255, DOI 10.1073/pnas.96.11.6255; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Llewellyn ME, 2010, NAT MED, V16, P1161, DOI 10.1038/nm.2228; Machado CB, 2014, DEVELOPMENT, V141, P784, DOI 10.1242/dev.097188; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Onders RP, 2009, SURG ENDOSC, V23, P1433, DOI 10.1007/s00464-008-0223-3; Peljto M, 2010, CELL STEM CELL, V7, P355, DOI 10.1016/j.stem.2010.07.013; THOMPSON WJ, 1985, CELL MOL NEUROBIOL, V5, P167, DOI 10.1007/BF00711091; Tonnesen J, 2013, BEHAV BRAIN RES, V255, P35, DOI 10.1016/j.bbr.2013.07.007; Towne C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072691; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yohn DC, 2008, J NEUROSCI, V28, P12409, DOI 10.1523/JNEUROSCI.1761-08.2008; Zhang SC, 2003, J HEMATOTH STEM CELL, V12, P625, DOI 10.1089/15258160360732650	20	118	123	1	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					94	97		10.1126/science.1248523	http://dx.doi.org/10.1126/science.1248523			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700859	Green Accepted			2022-12-28	WOS:000333746100060
J	Maksimovic, S; Nakatani, M; Baba, Y; Nelson, AM; Marshall, KL; Wellnitz, SA; Firozi, P; Woo, SH; Ranade, S; Patapoutian, A; Lumpkin, EA				Maksimovic, Srdjan; Nakatani, Masashi; Baba, Yoshichika; Nelson, Aislyn M.; Marshall, Kara L.; Wellnitz, Scott A.; Firozi, Pervez; Woo, Seung-Hyun; Ranade, Sanjeev; Patapoutian, Ardem; Lumpkin, Ellen A.			Epidermal Merkel cells are mechanosensory cells that tune mammalian touch receptors	NATURE			English	Article							SENSORY NEURONS; TRANSDUCTION; DISCRIMINATION; MECHANISMS; COMPONENTS; CHANNELS	Touch submodalities, such as flutter and pressure, are mediated by somatosensory afferents whose terminal specializations extract tactile features and encode them as action potential trains with unique activity patterns(1). Whether non-neuronal cells tune touch receptors through active or passive mechanisms is debated. Terminal specializations are thought to function as passive mechanical filters analogous to the cochlea's basilar membrane, which deconstructs complex sounds into tones that are transduced by mechanosensory hair cells. The model that cutaneous specializations are merely passive has been recently challenged because epidermal cells express sensory ion channels and neurotransmitters(2,3); however, direct evidence that epidermal cells excite tactile afferents is lacking. Epidermal Merkel cells display features of sensory receptor cells(4,5) and make 'synapse-like' contacts(5,6) with slowly adapting type I (SAI) afferents(7-9). These complexes, which encode spatial features such as edges and texture(1), localize to skin regions with high tactile acuity, including whisker follicles, fingertips and touch domes. Here we show that Merkel cells actively participate in touch reception in mice. Merkel cells display fast, touch-evoked mechanotransduction currents. Optogenetic approaches in intact skin show that Merkel cells are both necessary and sufficient for sustained action-potential firing in tactile afferents. Recordings from touch-dome afferents lacking Merkel cells demonstrate that Merkel cells confer high-frequency responses to dynamic stimuli and enable sustained firing. These data are the first, to our knowledge, to directly demonstrate a functional, excitatory connection between epidermal cells and sensory neurons. Together, these findings indicate that Merkel cells actively tune mechanosensory responses to facilitate high spatio-temporal acuity. Moreover, our results indicate a division of labour in the Merkel cell-neurite complex: Merkel cells signal static stimuli, such as pressure, whereas sensory afferents transduce dynamic stimuli, such as moving gratings. Thus, the Merkel cell-neurite complex is an unique sensory structure composed of two different receptor cell types specialized for distinct elements of discriminative touch.	[Maksimovic, Srdjan; Nakatani, Masashi; Baba, Yoshichika; Nelson, Aislyn M.; Marshall, Kara L.; Lumpkin, Ellen A.] Columbia Univ, Dept Dermatol, New York, NY 10032 USA; [Nakatani, Masashi] Keio Univ, Grad Sch Syst Design & Management, Yokohama, Kanagawa 2238526, Japan; [Nelson, Aislyn M.; Wellnitz, Scott A.; Firozi, Pervez] Baylor Coll Med, Dept Neurosci, Houston, TX 77006 USA; [Woo, Seung-Hyun; Ranade, Sanjeev; Patapoutian, Ardem] Scripps Res Inst, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Lumpkin, Ellen A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Lumpkin, Ellen A.] Columbia Univ, Program Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Keio University; Baylor College of Medicine; Howard Hughes Medical Institute; Scripps Research Institute; Columbia University; Columbia University	Lumpkin, EA (corresponding author), Columbia Univ, Dept Dermatol, New York, NY 10032 USA.	eal2166@columbia.edu		Lumpkin, Ellen/0000-0002-1166-3374; Ranade, Sanjeev/0000-0001-8601-3563; Nakatani, Masashi/0000-0002-0749-2883	NIH/NIAMS [R01AR051219, R21AR062307, R01DE022358]; NIH/NINDS [F32NS080544]; JSPS [24-7585]; McNair Foundation;  [5T32HL087745-05]; NATIONAL CANCER INSTITUTE [P30CA125123, P30CA013696] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL087745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR062307, R01AR051219, P30AR044535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS080544] Funding Source: NIH RePORTER	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); McNair Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Thanks to R. Axel, A. MacDermott and the Lumpkin laboratory for helpful discussions and to D. Florez and R. Piskorowski for advice on whole-cell recordings. Funding was provided by NIH/NIAMS grants R01AR051219 and R21AR062307 (to E. A. L.), R01DE022358 (to A. P.) and fellowships to S. M. (5T32HL087745-05 and NIH/NINDS F32NS080544), M.N. (JSPS Research Fellowships for Young Scientists 24-7585), and A. M.N. (McNair Foundation). Microscopy and flow cytometry was performed with core support from the Columbia SDRC (P30AR044535) and Cancer Center (P30CA013696). Initial studies were performed at Baylor College of Medicine with assistance from Flow Cytometry and Genetically Engineered Mouse Shared Resources (P30CA125123).	Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Drew LJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-12-j0001.2002; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Haeberle H, 2004, P NATL ACAD SCI USA, V101, P14503, DOI 10.1073/pnas.0406308101; Haeberle H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001750; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; HARTSCHUH W, 1980, J INVEST DERMATOL, V75, P159, DOI 10.1111/1523-1747.ep12522555; Holt JR, 1997, J NEUROSCI, V17, P8739; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; IGGO A, 1969, J PHYSIOL-LONDON, V200, P763, DOI 10.1113/jphysiol.1969.sp008721; JOHNSON KO, 1981, J PHYSIOL-LONDON, V310, P117, DOI 10.1113/jphysiol.1981.sp013540; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Lesniak DR, 2014, ELIFE, V3, DOI 10.7554/eLife.01488; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Maksimovic S, 2013, ANN NY ACAD SCI, V1279, P13, DOI 10.1111/nyas.12057; Maricich SM, 2012, J NEUROSCI, V32, P3296, DOI 10.1523/JNEUROSCI.5307-11.2012; Maricich SM, 2009, SCIENCE, V324, P1580, DOI 10.1126/science.1172890; Meyers JR, 2003, J NEUROSCI, V23, P4054; Morrison KM, 2009, DEV BIOL, V336, P76, DOI 10.1016/j.ydbio.2009.09.032; PHILLIPS JR, 1981, J NEUROPHYSIOL, V46, P1192, DOI 10.1152/jn.1981.46.6.1192; Piskorowski R, 2008, PFLUG ARCH EUR J PHY, V457, P197, DOI 10.1007/s00424-008-0496-3; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wellnitz SA, 2010, J NEUROPHYSIOL, V103, P3378, DOI 10.1152/jn.00810.2009; Woo SH, 2012, DEVELOPMENT, V139, P740, DOI 10.1242/dev.070847; Woodbury CJ, 2007, J COMP NEUROL, V505, P547, DOI 10.1002/cne.21517; YAMASHITA Y, 1991, SOMATOSENS MOT RES, V8, P87, DOI 10.3109/08990229109144732; Yang Y, 2004, J NEUROSCI, V24, P7230, DOI 10.1523/JNEUROSCI.2125-04.2004	37	307	315	7	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					617	621		10.1038/nature13250	http://dx.doi.org/10.1038/nature13250			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24717432	Green Accepted			2022-12-28	WOS:000336457100048
J	Nowbar, AN; Mielewczik, M; Karavassilis, M; Dehbi, HM; Shun-Shin, MJ; Jones, S; Howard, JP; Cole, GD; Francis, DP				Nowbar, Alexandra N.; Mielewczik, Michael; Karavassilis, Maria; Dehbi, Hakim-Moulay; Shun-Shin, Matthew J.; Jones, Siana; Howard, James P.; Cole, Graham D.; Francis, Darrel P.		DAMASCENE Writing Grp	Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION; MONONUCLEAR-CELLS; INTRACORONARY; TRANSPLANTATION; THERAPY; SAFETY; CARDIOMYOPATHY; PREDICTORS; MORTALITY	Objective To investigate whether discrepancies in trials of use of bone marrow stem cells in patients with heart disease account for the variation in reported effect size in improvement of left ventricular function. Design Identification and counting of factual discrepancies in trial reports, and sample size weighted regression against therapeutic effect size. Meta-analysis of trials that provided sufficient information. Data sources PubMed and Embase from inception to April 2013. Eligibility for selecting studies Randomised controlled trials evaluating the effect of autologous bone marrow stem cells for heart disease on mean left ventricular ejection fraction. Results There were over 600 discrepancies in 133 reports from 49 trials. There was a significant association between the number of discrepancies and the reported increment in EF with bone marrow stem cell therapy (Spearman's r=0.4, P=0.005). Trials with no discrepancies were a small minority (five trials) and showed a mean EF effect size of -0.4%. The 24 trials with 1-10 discrepancies showed a mean effect size of 2.1%. The 12 with 11-20 discrepancies showed a mean effect of size 3.0%. The three with 21-30 discrepancies showed a mean effect size of 5.7%. The high discrepancy group, comprising five trials with over 30 discrepancies each, showed a mean effect size of 7.7%. Conclusions Avoiding discrepancies is difficult but is important because discrepancy count is related to effect size. The mechanism is unknown but should be explored in the design of future trials because in the five trials without discrepancies the effect of bone marrow stem cell therapy on ejection fraction is zero.	[Nowbar, Alexandra N.; Mielewczik, Michael; Karavassilis, Maria; Dehbi, Hakim-Moulay; Shun-Shin, Matthew J.; Jones, Siana; Howard, James P.; Cole, Graham D.; Francis, Darrel P.; DAMASCENE Writing Grp] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London W2 1LA, England	Imperial College London	Nowbar, AN (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London W2 1LA, England.	alexandra.nowbar09@imperial.ac.uk	Jones, Siana/ADV-3105-2022; Howard, James/ABF-4493-2020; Mielewczik, Michael/H-6491-2015	Mielewczik, Michael/0000-0002-3796-4183; Shun-Shin, Matthew/0000-0002-1179-0867; Cole, Graham/0000-0002-3157-0335; Howard, James/0000-0002-9989-6331	British Heart Foundation senior clinical research fellowship [FS/10/038]; British Heart Foundation [FS/14/27/30752, FS/12/12/29294, FS/10/38/28268, SP/10/002/28189] Funding Source: researchfish; National Institute for Health Research [ACF-2009-21-008, ACF-2011-21-003] Funding Source: researchfish	British Heart Foundation senior clinical research fellowship; British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was not funded by any external organisation. All authors are associated with Imperial College London. For full disclosure, we report that DPF is supported by a British Heart Foundation senior clinical research fellowship FS/10/038 and GDC is a British Heart Foundation clinical research training fellow (FS/12/12/29294). Neither the institution nor any funder had any role in devising, conducting, analysing or reporting this study.	Abbasi M, 2011, INTERACT CARDIOV TH, V12, P229, DOI 10.1510/icvts.2010.252106; [Anonymous], I WAS GOING ST IV; Arnesen H, 2007, LANCET, V369, P2142, DOI 10.1016/S0140-6736(07)60992-1; Bolli R, EFFECT CARDIAC STEM; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bouri S, 2014, JACC-CARDIOVASC IMAG, V7, P104, DOI 10.1016/j.jcmg.2013.11.001; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Charwat S, 2008, EXP HEMATOL, V36, P672, DOI 10.1016/j.exphem.2008.01.005; Clifford DM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006536.pub3; Cole G, 2011, EUR J HEART FAIL, V13, P234, DOI 10.1093/eurjhf/hfq214; Committee EMF-uI, 2012, REP 2012 FOLL UP INV; De Rosa S, 2011, CLIN RES CARDIOL S1, V100; De Rosa S, 2013, CIRC-CARDIOVASC INTE, V6, P44, DOI 10.1161/CIRCINTERVENTIONS.112.971705; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ehrlich JR, STEM CELL THERAPY PR; Feringa HH, 2013, CORONARY ARTERY DIS, V24, P725, DOI 10.1097/MCA.0000000000000052; Finegold JA, 2013, INT J CARDIOL, V168, P934, DOI 10.1016/j.ijcard.2012.10.046; Fraccarollo D, 2012, CARDIOVASC RES, V94, P293, DOI 10.1093/cvr/cvs109; Francis DP, 2013, INT J CARDIOL, V168, P3381, DOI 10.1016/j.ijcard.2013.04.152; Francis DP, 2013, INT J CARDIOL, V167, P102, DOI 10.1016/j.ijcard.2011.12.018; Gyongyosi M, 2013, J AM COLL CARDIOL, V61, pE1633, DOI 10.1016/S0735-1097(13)61633-2; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Huang Rong-chong, 2006, Zhonghua Yi Xue Za Zhi, V86, P1107; Huang Rong-chong, 2006, Zhonghua Xinxueguanbing Zazhi, V34, P111; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Lehman R, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8158; Leistner DM, 2011, EUR HEART J, V32, P485, DOI 10.1093/eurheartj/ehq430; Lipinski MJ, 2007, J AM COLL CARDIOL, V50, P1761, DOI 10.1016/j.jacc.2007.07.041; Lu Min-jie, 2008, Zhonghua Xinxueguanbing Zazhi, V36, P969; Marciniak TA., CARDIOVASCULAR EVENT; MOSTELLER F, 1967, DEMOGRAPHY, V4, P850, DOI 10.2307/2060324; Nature Blogs, EV MISC FOUND CARD; Nijjer SS, 2012, JACC-CARDIOVASC IMAG, V5, P1046, DOI 10.1016/j.jcmg.2012.07.010; R Development Core Team, 2009, R LANG ENV STAT COMP; Sawada T, 2009, EUR HEART J, V30, P2461, DOI 10.1093/eurheartj/ehp363; Shun-Shin M, 2012, PROG CARDIOVASC DIS, V55, P14, DOI 10.1016/j.pcad.2012.05.006; Strauer BE, 2013, EUR J HEART FAIL, V15, P360, DOI 10.1093/eurjhf/hft015; van Vark LC, 2012, EUR HEART J, V33, P2088, DOI 10.1093/eurheartj/ehs075; Vedula SS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001378; Wang Jian-an, 2006, Zhonghua Xinxueguanbing Zazhi, V34, P107; Wickham H, 2009, GPPLOT2 ELEGANT GRAP; Yao Kong, 2006, Zhonghua Xinxueguanbing Zazhi, V34, P577; Yui Y, 2012, LANCET, V379, pE48, DOI 10.1016/S0140-6736(12)60599-6; Zhang CY, 2010, CLIN CARDIOL, V33, P353, DOI 10.1002/clc.20745; Zimmet H, 2012, EUR J HEART FAIL, V14, P91, DOI 10.1093/eurjhf/hfr148	45	160	163	0	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2014	348								g2688	10.1136/bmj.g2688	http://dx.doi.org/10.1136/bmj.g2688			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5RF	24778175	hybrid, Green Published			2022-12-28	WOS:000335475500006
J	Garcia, D				Garcia, David			After a first proximal DVT, compression stockings did not prevent the postthrombotic syndrome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							THROMBOSIS; TRIAL		Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Garcia, D (corresponding author), Univ Washington, Seattle, WA 98195 USA.							Brandjes DPM, 1997, LANCET, V349, P759, DOI 10.1016/S0140-6736(96)12215-7; Prandoni P, 2004, ANN INTERN MED, V141, P249, DOI 10.7326/0003-4819-141-4-200408170-00004; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001	3	0	1	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2014	160	8							JC7	10.7326/0003-4819-160-8-201404150-02007	http://dx.doi.org/10.7326/0003-4819-160-8-201404150-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW3QU	24733224				2022-12-28	WOS:000364907600006
J	Kesser, BW				Kesser, Bradley W.			Parental Perspectives on Adolescent Hearing Loss	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREVALENCE; RISK		Univ Virginia, Sch Med, Dept Otolaryngol Head & Neck Surg, Charlottesville, VA 22908 USA	University of Virginia	Kesser, BW (corresponding author), Univ Virginia, Sch Med, Dept Otolaryngol Head & Neck Surg, Box 800713, Charlottesville, VA 22908 USA.	bwk2n@virginia.edu	Kesser, Brad/AGK-1260-2022					Bess FH, 1998, EAR HEARING, V19, P339, DOI 10.1097/00003446-199810000-00001; Borawski EA, 2003, J ADOLESCENT HEALTH, V33, P60, DOI 10.1016/S1054-139X(03)00100-9; Centers for Disease Control and Prevention (CDC), ADOLESCENT AND SCHOO; Quintanilla-Dieck MD, 2009, J PEDIATR-US, V155, P550, DOI 10.1016/j.jpeds.2009.04.053; Sekhar DL, 2014, JAMA OTOLARYNGOL, V140, P22, DOI 10.1001/jamaoto.2013.5760; Shargorodsky J, 2010, JAMA-J AM MED ASSOC, V304, P772, DOI 10.1001/jama.2010.1124; STEINBERG L, 1994, PEDIATRICS, V93, P1060	7	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2014	311	15					1556	1557		10.1001/jama.2014.1843	http://dx.doi.org/10.1001/jama.2014.1843			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9DX	24737368				2022-12-28	WOS:000334306000023
J	Steinberg, BA; Piccini, JP				Steinberg, Benjamin A.; Piccini, Jonathan P.			Anticoagulation in atrial fibrillation	BMJ-BRITISH MEDICAL JOURNAL			English	Review							NORMALIZED RATIO CONTROL; CLINICAL CLASSIFICATION SCHEMES; RISK STRATIFICATION SCHEMES; VITAMIN-K ANTAGONISM; ORAL DIRECT THROMBIN; STROKE PREVENTION; ANTITHROMBOTIC THERAPY; PREDICTING STROKE; ISCHEMIC-STROKE; INTRACRANIAL HEMORRHAGE	Atrial fibrillation increases the risk of stroke, which is a leading cause of death and disability worldwide. The use of oral anticoagulation in patients with atrial fibrillation at moderate or high risk of stroke, estimated by established criteria, improves outcomes. However, to ensure that the benefits exceed the risks of bleeding, appropriate patient selection is essential. Vitamin K antagonism has been the mainstay of treatment; however, newer drugs with novel mechanisms are also available. These novel oral anticoagulants (direct thrombin inhibitors and factor Xa inhibitors) obviate many of warfarin's shortcomings, and they have demonstrated safety and efficacy in large randomized trials of patients with non-valvular atrial fibrillation. However, the management of patients taking warfarin or novel agents remains a clinical challenge. There are several important considerations when selecting anticoagulant therapy for patients with atrial fibrillation. This review will discuss the rationale for anticoagulation in patients with atrial fibrillation; risk stratification for treatment; available agents; the appropriate implementation of these agents; and additional, specific clinical considerations for treatment.	[Steinberg, Benjamin A.; Piccini, Jonathan P.] Duke Univ, Electrophysiol Sect, Duke Clin Res Inst, Med Ctr, Durham, NC 27715 USA; [Steinberg, Benjamin A.; Piccini, Jonathan P.] Duke Clin Res Inst, Durham, NC USA	Duke University; Duke University	Steinberg, BA (corresponding author), Duke Univ, Electrophysiol Sect, Duke Clin Res Inst, Med Ctr, Durham, NC 27715 USA.	benjamin.steinberg@duke.edu		Steinberg, Benjamin/0000-0002-4729-7820	Janssen Scientific; GE Healthcare; ARCA pharmaceuticals; ResMed; NIH [5 T32 HL 7101-38]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007101] Funding Source: NIH RePORTER	Janssen Scientific; GE Healthcare(General ElectricGE Healthcare); ARCA pharmaceuticals; ResMed; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We have read and understood the BMJ Group policy on declaration of interests and declare the following interests: JPP discloses institutional research grant support from Janssen Scientific, GE Healthcare, ARCA pharmaceuticals, and ResMed; and consulting relationships with Johnson & Johnson, Pfizer/BMS, Medtronic, and Spectranetics. BAS was funded by NIH T-32 training grant #5 T32 HL 7101-38.	Al-Khatib SM, 2013, EUR HEART J, V34, P2464, DOI 10.1093/eurheartj/eht135; Anderson DC, 2002, STROKE, V33, P1963, DOI 10.1161/01.STR.0000023445.20454.A8; [Anonymous], 2011, RIV PRESCR INF SEC R; B-M Squibb, APIXABAN PRESCRIBING; Bartus K, 2013, J AM COLL CARDIOL, V62, P108, DOI 10.1016/j.jacc.2012.06.046; Bartus K, 2011, HEART RHYTHM, V8, P188, DOI 10.1016/j.hrthm.2010.10.040; Bauer KA, 2012, AM J HEMATOL, V87, pS119, DOI 10.1002/ajh.23165; Beasley BN, 2011, NEW ENGL J MED, V364, P1788, DOI 10.1056/NEJMp1103050; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Boehringer-Ingelheim, 2013, DAB PRESCR INF STROK; Boehringer-Ingelheim, DAB PRESCR INF SEC D; BRAND FN, 1985, JAMA-J AM MED ASSOC, V254, P3449, DOI 10.1001/jama.254.24.3449; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Chan Kwan-Leung, 1998, Annals of Internal Medicine, V128, P639; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Conen D, 2011, JAMA-J AM MED ASSOC, V305, P2080, DOI 10.1001/jama.2011.659; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Connolly SJ, 2008, CIRCULATION, V118, P2029, DOI 10.1161/CIRCULATIONAHA.107.750000; Connolly SJ, 2013, CIRCULATION, V128, P237, DOI 10.1161/CIRCULATIONAHA.112.001139; Connolly SJ, 2013, EUR HEART J, V34, P1498, DOI 10.1093/eurheartj/eht039; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dewland TA, 2013, CIRCULATION, V128, P2470, DOI 10.1161/CIRCULATIONAHA.113.002449; Dogliotti A, 2013, HEART; Douketis JD, 2012, CHEST, V141, pE326S, DOI 10.1378/chest.11-2298; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Eikelboom JW, 2013, NEW ENGL J MED, V369, P1206, DOI 10.1056/NEJMoa1300615; Eriksson BI, 2009, CLIN PHARMACOKINET, V48, P1, DOI 10.2165/0003088-200948010-00001; EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002; Ezekowitz MD, 1999, JAMA-J AM MED ASSOC, V281, P1830, DOI 10.1001/jama.281.19.1830; Fang MC, 2012, STROKE, V43, P1795, DOI 10.1161/STROKEAHA.111.630731; Fang MC, 2011, J AM COLL CARDIOL, V58, P395, DOI 10.1016/j.jacc.2011.03.031; Food and Drug Administration, 2011, FDA BRIEF D IN PRESS; Fox KAA, 2011, EUR HEART J, V32, P2387, DOI 10.1093/eurheartj/ehr342; Friberg L, 2012, EUR HEART J, V33, P1500, DOI 10.1093/eurheartj/ehr488; Friberg L, 2012, CIRCULATION, V125, P2298, DOI 10.1161/CIRCULATIONAHA.111.055079; Fuster V, 2011, CIRCULATION, V123, pE269, DOI 10.1161/CIR.0b013e318214876d; Gage BF, 2006, AM HEART J, V151, P713, DOI 10.1016/j.ahj.2005.04.017; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Garcia DA, 2008, ARCH INTERN MED, V168, P63, DOI 10.1001/archinternmed.2007.23; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Go AS, 2003, JAMA-J AM MED ASSOC, V290, P2685, DOI 10.1001/jama.290.20.2685; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hart RG, 2012, STROKE, V43, P1511, DOI 10.1161/STROKEAHA.112.650614; Hashimoto T, 2013, XENOBIOTICA, V43, P534, DOI 10.3109/00498254.2012.738045; Healey JS, 2012, CIRCULATION, V126, P343, DOI 10.1161/CIRCULATIONAHA.111.090464; Heidbuchel H, 2013, EUROPACE, V15, P625, DOI 10.1093/europace/eut083; Hori M, 2012, CIRC J, V76, P2104, DOI 10.1253/circj.CJ-12-0454; Johansson S, 2011, INT J CLIN PHARM TH, V49, P258, DOI 10.5414/CP201465; Keogh C, 2011, THROMB HAEMOSTASIS, V106, P528, DOI 10.1160/TH11-02-0061; Landmesser U, 2012, EUR HEART J, V33, P698, DOI 10.1093/eurheartj/ehr393; Larsen TB, 2013, J AM COLL CARDIOL, V61, P2264, DOI 10.1016/j.jacc.2013.03.020; Limone BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062183; Lin HJ, 1996, STROKE, V27, P1760, DOI 10.1161/01.STR.27.10.1760; Lip GYH, 2012, J AM COLL CARDIOL, V60, P738, DOI 10.1016/j.jacc.2012.03.019; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Lopes RD, 2013, EUR HEART J S1, V34, DOI 10.1093/eurheartj/eht307.P535; Lopes RD, 2012, LANCET, V380, P1749, DOI 10.1016/S0140-6736(12)60986-6; Lu GM, 2013, NAT MED, V19, P446, DOI 10.1038/nm.3102; Mahaffey KW, 2013, CIRC-CARDIOVASC QUAL, V6, P470, DOI 10.1161/CIRCOUTCOMES.113.000132; Majeed A, 2013, CIRCULATION, V128, P2325, DOI 10.1161/CIRCULATIONAHA.113.002332; Marlu R, 2012, THROMB HAEMOSTASIS, V108, P217, DOI 10.1160/TH12-03-0179; MCBRIDE R, 1994, LANCET, V343, P687; MCBRIDE R, 1990, STROKE, V21, P538; McGrath ER, 2013, NEUROLOGY, V81, P825, DOI 10.1212/WNL.0b013e3182a2cc15; Mitusch R, 1996, THROMB HAEMOSTASIS, V75, P219; Morgan CL, 2009, THROMB RES, V124, P37, DOI 10.1016/j.thromres.2008.09.016; Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124; Patel MR, 2013, J AM COLL CARDIOL, V61, P651, DOI 10.1016/j.jacc.2012.09.057; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Patel MR, 2010, AM HEART J, V159, P340, DOI 10.1016/j.ahj.2009.11.025; Perzborn E, 2011, NAT REV DRUG DISCOV, V10, P61, DOI 10.1038/nrd3185; PETERSEN P, 1989, LANCET, V1, P175; Piccini JP, 2013, CIRCULATION, V127, P224, DOI 10.1161/CIRCULATIONAHA.112.107128; Piccini JP, 2012, CIRC-CARDIOVASC QUAL, V5, P85, DOI 10.1161/CIRCOUTCOMES.111.962688; Pinto DJP, 2007, J MED CHEM, V50, P5339, DOI 10.1021/jm070245n; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Reddy VY, 2013, CIRCULATION, V127, P720, DOI 10.1161/CIRCULATIONAHA.112.114389; Reddy VY, 2011, CIRCULATION, V123, P417, DOI 10.1161/CIRCULATIONAHA.110.976449; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Ruff CT, 2013, LANCET; Sherwood MW, 2014, CIRCULATION; Singer DE, 2008, CHEST, V133, p546S, DOI 10.1378/chest.08-0678; Sorensen R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002758; Southworth MR, 2013, NEW ENGL J MED, V368, P1272, DOI 10.1056/NEJMp1302834; Stewart S, 2001, HEART, V86, P516, DOI 10.1136/heart.86.5.516; Tu HTH, 2010, CEREBROVASC DIS, V30, P389, DOI 10.1159/000316886; Uchino K, 2012, ARCH INTERN MED, V172, P397, DOI 10.1001/archinternmed.2011.1666; UNO M, 1988, JPN CIRC J, V52, P9; Wallentin L, 2013, CIRCULATION, V127, P2166, DOI 10.1161/CIRCULATIONAHA.112.142158; Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; WOLF PA, 1978, NEUROLOGY, V28, P973, DOI 10.1212/WNL.28.10.973; Wysokinski WE, 2008, MAYO CLIN PROC, V83, P639, DOI 10.4065/83.6.639	100	46	46	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2014	348								g2116	10.1136/bmj.g2116	http://dx.doi.org/10.1136/bmj.g2116			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF5GH	24733535	Green Published			2022-12-28	WOS:000334741500016
J	Gornall, J				Gornall, Jonathan			New way to call time on high strength, cheap alcohol	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jonathangornall@mac.com			European Community [266813]	European Community(European Commission)	This feature is funded by the European Community's Seventh Framework Programme (FP7/2007-2013), under grant agreement No 266813-Addictions and Lifestyle in Contemporary Europe - Reframing Addictions Project (ALICE RAP). Participant organisations in ALICE RAP can be seen at www.alicerap.eu/about-alice-rap/partners.html. Provenance and peer review: Commissioned; not externally peer reviewed.	Baker N, 2014, HANSARD         0213; Davenport R., 2014, LICENCE NEWS    0307; Gornall J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7571; Griffiths A, 2014, COMMUNICATION; Sheron N, 2014, ALASTAIR CAMPBE 0117	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2014	348								g2572	10.1136/bmj.g2572	http://dx.doi.org/10.1136/bmj.g2572			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SI	24727179				2022-12-28	WOS:000334349200010
J	Widera, A				Widera, Artur			The Advantages of Extra Entanglement	SCIENCE			English	Editorial Material							MULTIPARTICLE ENTANGLEMENT; IONS		[Widera, Artur] Univ Kaiserslautern, Dept Phys, D-67663 Kaiserslautern, Germany; [Widera, Artur] Univ Kaiserslautern, Res Ctr OPTIMAS, D-67663 Kaiserslautern, Germany	University of Kaiserslautern; University of Kaiserslautern	Widera, A (corresponding author), Univ Kaiserslautern, Dept Phys, Erwin Schrodinger Str, D-67663 Kaiserslautern, Germany.	widera@physik.uni-kl.de	Widera, Artur/D-1032-2017	Widera, Artur/0000-0002-0338-9969				Blatt R, 2008, NATURE, V453, P1008, DOI 10.1038/nature07125; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Esteve J, 2008, NATURE, V455, P1216, DOI 10.1038/nature07332; Haas F, 2014, SCIENCE, V344, P180, DOI 10.1126/science.1248905; Haffner H, 2005, NATURE, V438, P643, DOI 10.1038/nature04279; Mandel O, 2003, NATURE, V425, P937, DOI 10.1038/nature02008; Monz T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.130506; Riedel MF, 2010, NATURE, V464, P1170, DOI 10.1038/nature08988	8	0	0	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					160	161		10.1126/science.1251472	http://dx.doi.org/10.1126/science.1251472			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24723603				2022-12-28	WOS:000334096300025
J	Horwich, AL				Horwich, Arthur L.			Molecular Chaperones in Cellular Protein Folding: The Birth of a Field	CELL			English	Editorial Material							HEAT-SHOCK PROTEIN; RIBULOSE BISPHOSPHATE CARBOXYLASE; ESCHERICHIA-COLI; MESSENGER-RNA; UNCOATING ATPASE; STRESS PROTEINS; HSP70; HSP60; POLYPEPTIDES; MITOCHONDRIA		[Horwich, Arthur L.] Yale Univ, Sch Med, Boyer Ctr, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Horwich, Arthur L.] Yale Univ, Sch Med, Boyer Ctr, Dept Genet, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University	Horwich, AL (corresponding author), Yale Univ, Sch Med, Boyer Ctr, Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06510 USA.	arthur.horwich@yale.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BARDWELL JCA, 1984, P NATL ACAD SCI-BIOL, V81, P848, DOI 10.1073/pnas.81.3.848; BARRACLOUGH R, 1980, BIOCHIM BIOPHYS ACTA, V608, P19, DOI 10.1016/0005-2787(80)90129-X; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; Clare DK, 2012, CELL, V149, P113, DOI 10.1016/j.cell.2012.02.047; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; GEORGOPOULOS CP, 1972, NATURE-NEW BIOL, V239, P38, DOI 10.1038/newbio239038a0; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; HAASEPETTINGELL CA, 1988, J BIOL CHEM, V263, P4977; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; Horwich A.L., 2011, MOL MACHINES BIOL, P191; KELLEY PM, 1978, CELL, V15, P1277, DOI 10.1016/0092-8674(78)90053-3; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; LEMAUX PG, 1978, CELL, V13, P427, DOI 10.1016/0092-8674(78)90317-3; LEWIS MJ, 1985, EMBO J, V4, P3137, DOI 10.1002/j.1460-2075.1985.tb04056.x; LINDQUIST S, 1975, P NATL ACAD SCI USA, V72, P1117, DOI 10.1073/pnas.72.3.1117; MARSTON FAO, 1986, BIOCHEM J, V240, P1, DOI 10.1042/bj2400001; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; PELHAM HRB, 1984, EMBO J, V3, P3095, DOI 10.1002/j.1460-2075.1984.tb02264.x; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; READING DS, 1989, NATURE, V337, P655, DOI 10.1038/337655a0; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; SCHEDL P, 1978, CELL, V14, P921, DOI 10.1016/0092-8674(78)90346-X; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; SPRADLING A, 1975, CELL, V4, P395, DOI 10.1016/0092-8674(75)90160-9; TAKANO T, 1972, NATURE-NEW BIOL, V239, P34, DOI 10.1038/newbio239034a0; UNGEWICKELL E, 1985, EMBO J, V4, P3385, DOI 10.1002/j.1460-2075.1985.tb04094.x; WILLIAMS DC, 1982, SCIENCE, V215, P687, DOI 10.1126/science.7036343; Xing Y, 2010, EMBO J, V29, P655, DOI 10.1038/emboj.2009.383; YAMAMORI T, 1978, J BACTERIOL, V134, P1133, DOI 10.1128/JB.134.3.1133-1140.1978; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002	40	31	34	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					285	288		10.1016/j.cell.2014.03.029	http://dx.doi.org/10.1016/j.cell.2014.03.029			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725397	Bronze			2022-12-28	WOS:000334304500002
J	Linster, M; Boheemen, S; de Graaf, M; Schrauwen, EJA; Lexmond, P; Manz, B; Bestebroer, TM; Baumann, J; van Riel, D; Rimmelzwaan, GF; Osterhaus, ADME; Matrosovich, M; Fouchier, RAM; Herfst, S				Linster, Martin; van Boheemen, Sander; de Graaf, Miranda; Schrauwen, Eefje J. A.; Lexmond, Pascal; Manz, Benjamin; Bestebroer, Theo M.; Baumann, Jan; van Riel, Debby; Rimmelzwaan, Guus F.; Osterhaus, Albert D. M. E.; Matrosovich, Mikhail; Fouchier, Ron A. M.; Herfst, Sander			Identification, Characterization, and Natural Selection of Mutations Driving Airborne Transmission of A/H5N1 Virus	CELL			English	Article							AVIAN INFLUENZA-VIRUS; RECEPTOR-BINDING PROPERTIES; UPPER RESPIRATORY-TRACT; A VIRUS; HEMAGGLUTININ PROTEIN; H5 HA; FERRETS; SPECIFICITY; DROPLET; HOST	Recently, A/H5N1 influenza viruses were shown to acquire airborne transmissibility between ferrets upon targeted mutagenesis and virus passage. The critical genetic changes in airborne A/Indonesia/5/05 were not yet identified. Here, five substitutions proved to be sufficient to determine this airborne transmission phenotype. Substitutions in PB1 and PB2 collectively caused enhanced transcription and virus replication. One substitution increased HA thermostability and lowered the pH of membrane fusion. Two substitutions independently changed HA binding preference from a2,3-linked to a2,6-linked sialic acid receptors. The loss of a glycosylation site in HA enhanced overall binding to receptors. The acquired substitutions emerged early during ferret passage as minor variants and became dominant rapidly. Identification of substitutions that are essential for airborne transmission of avian influenza viruses between ferrets and their associated phenotypes advances our fundamental understanding of virus transmission and will increase the value of future surveillance programs and public health risk assessments.	[Linster, Martin; van Boheemen, Sander; de Graaf, Miranda; Schrauwen, Eefje J. A.; Lexmond, Pascal; Manz, Benjamin; Bestebroer, Theo M.; van Riel, Debby; Rimmelzwaan, Guus F.; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.; Herfst, Sander] Erasmus MC, Postgrad Sch Mol Med, Dept Virosci, NL-3015 GE Rotterdam, Netherlands; [Baumann, Jan; Matrosovich, Mikhail] Univ Marburg, Inst Virol, D-35043 Marburg, Germany	Erasmus University Rotterdam; Erasmus MC; Philipps University Marburg	Fouchier, RAM (corresponding author), Erasmus MC, Postgrad Sch Mol Med, Dept Virosci, NL-3015 GE Rotterdam, Netherlands.	r.fouchier@erasmusmc.nl	de Graaf, Miranda/AFM-6878-2022; Linster, Martin/AAY-9088-2020; Fouchier, Ron A/A-1911-2014; de Graaf, Miranda/K-1262-2018	de Graaf, Miranda/0000-0002-7831-0098; Fouchier, Ron A/0000-0001-8095-2869; de Graaf, Miranda/0000-0002-7831-0098; van Riel, Debby/0000-0001-9753-3564; Herfst, Sander/0000-0001-9866-8903; Matrosovich, Mikhail/0000-0003-1618-2083; Linster, Martin/0000-0003-2636-2512	NIH/NIAID [HHSN266200700010C]; EU [223498, 278976, 258084, 278433]; Marie Curie fellowship [PIEF-GA-2009-237505]; NIH/NIAID	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EU(European Commission); Marie Curie fellowship(European Commission); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dennis de Meulder for excellent technical assistance, Nicolai Bovin (Institute of Bio-organic Chemistry, Moscow, Russia) for providing sialylglycopolymers, and Malik Peiris (University of Hong Kong) for providing A/Indonesia/5/2005 with permission from I. Kandun of the Indonesian government. This work was supported by NIH/NIAID contract HHSN266200700010C, EU FP7 grants EMPERIE (223498), ANTIGONE (278976), FLUPIG (258084), and PREDEMICS (278433). MdG was funded in part by a Marie Curie fellowship (PIEF-GA-2009-237505). All experiments involving A/H5N1 virus were performed before January 2012 in agreement with a moratorium on A/H5N1 gain-of-function research and restarted after February 2013 but without NIH/NIAID funding. Special arrangements are in place with the NIH and the contractor at Icahn School of Medicine at Mount Sinai, New York, for sharing the viruses (and plasmids) in the present paper. A.D.M.E.O. and G. F. R. are CSO and part-time employees of ViroClinics Bio-sciences B. V. A.D.M.E.O. has advisory affiliations on behalf of ViroClinics Biosciences B. V. with GlaxoSmithKline, Novartis, and Roche. A.D.M.E.O. and R. A. M. F. are holders of certificates of shares in ViroClinics Biosciences B. V. To avoid any possible conflict of interests, Erasmus MC policy dictates that the shares as such are held by the Stichting Administratiekantoor Erasmus Personeelsparticipaties. The board of this foundation is appointed by the Board of Governors of the Erasmus MC and exercises all voting rights with regard to these shares.	Aggarwal S, 2011, J BIOL CHEM, V286, P34504, DOI 10.1074/jbc.M111.262048; Belser JA, 2013, FUTURE MICROBIOL, V8, P961, DOI [10.2217/FMB.13.64, 10.2217/fmb.13.64]; Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; de Vries RP, 2014, J VIROL, V88, P768, DOI 10.1128/JVI.02690-13; de Wit E, 2010, J VIROL, V84, P1597, DOI 10.1128/JVI.01783-09; Galloway SE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003151; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Krenn BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018577; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; Lu XS, 2013, PROTEIN CELL, V4, P502, DOI 10.1007/s13238-013-3906-z; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich Mikhail N, 2012, Methods Mol Biol, V865, P71, DOI 10.1007/978-1-61779-621-0_5; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Neumann G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002932; Nishiura H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055358; Pappas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011158; Richard M, 2013, NATURE, V501, P560, DOI 10.1038/nature12476; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Russell WMS., 1959, MED J AUSTRALIA; Shaw ML., 2013, FIELDS VIROLOGY, V6th, P1151; Shelton H, 2013, J GEN VIROL, V94, P1220, DOI 10.1099/vir.0.050526-0; Shi Y, 2013, SCIENCE, V342, P243, DOI 10.1126/science.1242917; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sorrell EM, 2011, CURR OPIN VIROL, V1, P635, DOI 10.1016/j.coviro.2011.07.003; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Tharakaraman K, 2013, CELL, V153, P1475, DOI 10.1016/j.cell.2013.05.035; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; van Riel D, 2013, AM J PATHOL, V183, P1137, DOI 10.1016/j.ajpath.2013.06.011; Wang WJ, 2010, J VIROL, V84, P6570, DOI 10.1128/JVI.00221-10; Xiong XL, 2013, NATURE, V497, P392, DOI 10.1038/nature12144; Zaraket H, 2013, J VIROL, V87, P9911, DOI 10.1128/JVI.01175-13; Zhang W, 2013, SCIENCE, V340, P1463, DOI 10.1126/science.1236787; Zhang Y, 2013, SCIENCE, V340, P1459, DOI 10.1126/science.1229455; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	44	178	187	1	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2								10.1016/j.cell.2014.02.040	http://dx.doi.org/10.1016/j.cell.2014.02.040			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725402	Bronze, Green Accepted			2022-12-28	WOS:000334304500008
J	Schmick, M; Vartak, N; Papke, B; Kovacevic, M; Truxius, DC; Rossmannek, L; Bastiaens, PIH				Schmick, Malte; Vartak, Nachiket; Papke, Bjoern; Kovacevic, Marija; Truxius, Dina C.; Rossmannek, Lisaweta; Bastiaens, Philippe I. H.			KRas Localizes to the Plasma Membrane by Spatial Cycles of Solubilization, Trapping and Vesicular Transport	CELL			English	Article							SMALL-MOLECULE INHIBITION; LIPID-BILAYERS; PROTEINS; RAS; MECHANISMS; DIFFUSION; ACTIVATION; VESICLES; K-RAS4B; SURFACE	KRas is a major proto-oncogene product whose signaling activity depends on its level of enrichment on the plasma membrane (PM). This PM localization relies on posttranslational prenylation for membrane affinity, while PM specificity has been attributed to electrostatic interactions between negatively charged phospholipids in the PM and basic aminoacids in the C terminus of KRas. By measuring kinetic parameters of KRas dynamics in living cells with a cellular-automata-based data-fitting approach in realistic cell-geometries, we show that charge-based specificity is not sufficient to generate PM enrichment in light of the total surface area of endomembranes. Instead, mislocalized KRas is continuously sequestered from endomembranes by cytosolic PDE delta to be unloaded in an Arl2-dependent manner to perinuclear membranes. Electrostatic interactions then trap KRas at the recycling endosome (RE), from where vesicular transport restores enrichment on the PM. This energy driven reaction-diffusion cycle explains how small molecule targeting of PDEd affects the spatial organization of KRas.	[Schmick, Malte; Vartak, Nachiket; Papke, Bjoern; Kovacevic, Marija; Truxius, Dina C.; Rossmannek, Lisaweta; Bastiaens, Philippe I. H.] Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44227 Dortmund, Germany; [Bastiaens, Philippe I. H.] Tech Univ Dortmund, Fak Chem, D-44221 Dortmund, Germany	Max Planck Society; Dortmund University of Technology	Bastiaens, PIH (corresponding author), Max Planck Inst Mol Physiol, Dept Syst Cell Biol, Otto Hahn Str 11, D-44227 Dortmund, Germany.	philippe.bastiaens@mpi-dortmund.mpg.de		Vartak, Nachiket/0000-0001-8813-4799; Papke, Bjoern/0000-0001-8156-7508	DFG [SFB642]	DFG(German Research Foundation (DFG))	The project was partly funded by the DFG (SFB642). We kindly thank Prof. Dr. Herbert Waldmann for providing deltarasin.	Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Chandra A, 2012, NAT CELL BIOL, V14, P148, DOI 10.1038/ncb2394; Chen BH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001235; Cho KJ, 2012, J BIOL CHEM, V287, P43573, DOI 10.1074/jbc.M112.424457; Colarusso P, 2002, BIOPHYS J, V82, P752, DOI 10.1016/S0006-3495(02)75437-4; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Fivaz M, 2005, J CELL BIOL, V170, P429, DOI 10.1083/jcb.200409157; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Knight JD, 2010, BIOPHYS J, V99, P2879, DOI 10.1016/j.bpj.2010.08.046; Leventis R, 1998, BIOCHEMISTRY-US, V37, P7640, DOI 10.1021/bi973077h; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Markus M, 1999, MATH BIOSCI, V156, P191, DOI 10.1016/S0025-5564(98)10066-4; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; NIR S, 1983, PROG SURF SCI, V13, P1, DOI 10.1016/0079-6816(83)90010-2; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Peden AA, 2004, MOL BIOL CELL, V15, P3530, DOI 10.1091/mbc.E03-12-0918; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; Ravoo BJ, 1999, BIOPHYS J, V76, P374, DOI 10.1016/S0006-3495(99)77204-8; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Silvius JR, 2006, MOL BIOL CELL, V17, P192, DOI 10.1091/mbc.e05-05-0408; SILVIUS JR, 1994, BIOCHEMISTRY-US, V33, P3014, DOI 10.1021/bi00176a034; Toffoli T, 1987, CELLULAR AUTOMATA MA; von Neumann J, 1966, THEORY SELF PRODUCIN; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zamir E., 2013, VESICLE TRAFFICKING, P57; Ziemba BP, 2013, CHEM PHYS LIPIDS, V172, P67, DOI 10.1016/j.chemphyslip.2013.04.005; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	33	151	155	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					459	471		10.1016/j.cell.2014.02.051	http://dx.doi.org/10.1016/j.cell.2014.02.051			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725411	Bronze			2022-12-28	WOS:000334304500018
J	Malani, PN				Malani, Preeti N.			National Burden of Invasive Methicillin-Resistant Staphylococcus aureus Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; ICU	IMPORTANCE: Estimating the US burden of methicillin-resistant Staphylococcus aureus (MRSA) infections is important for planning and tracking success of prevention strategies. OBJECTIVE: To describe updated national estimates and characteristics of health care- and community-associated invasive methicillin-resistant Staphylococcus aureus (MRSA) infections in 2011. DESIGN, SETTING, AND PARTICIPANTS: Active laboratory-based case finding identified MRSA cultures in 9 US metropolitan areas from 2005 through 2011. Invasive infections (MRSA cultured from normally sterile body sites) were classified as health care-associated community-onset (HACO) infections (cultured = 3 days after admission and/or prior year dialysis, hospitalization, surgery, long-term care residence, or central vascular catheter presence = 2 days before culture); hospital-onset infections (cultured >3 days after admission); or community-associated infections if no other criteria were met. National estimates were adjusted using US census and US Renal Data System data. MAIN OUTCOMES AND MEASURES: National estimates of invasive HACO, hospital-onset, and community-associated MRSA infections using US census and US Renal Data System data as the denominator. RESULTS: An estimated 80,461 (95% CI, 69,515-93,914) invasive MRSA infections occurred nationally in 2011. Of these, 48,353 (95% CI, 40,195-58,642) were HACO infections; 14,156 (95% CI, 10,096-20,440) were hospital-onset infections; and 16,560 (95% CI, 12,806-21,811) were community-associated infections. Since 2005, adjusted national estimated incidence rates decreased among HACO infections by 27.7% and hospital-onset infections decreased by 54.2%; community-associated infections decreased by only 5.0%. Among recently hospitalized community-onset (nondialysis) infections, 64% occurred 3 months or less after discharge, and 32% of these were admitted from long-term care facilities. CONCLUSIONS AND RELEVANCE: An estimated 30,800 fewer invasive MRSA infections occurred in the United States in 2011 compared with 2005; in 2011 fewer infections occurred among patients during hospitalization than among persons in the community without recent health care exposures. Effective strategies for preventing infections outside acute care settings will have the greatest impact on further reducing invasive MRSA infections nationally.	[Malani, Preeti N.] Univ Michigan Hlth Syst, Div Infect Dis, Dept Internal Med, Ann Arbor, MI USA; [Malani, Preeti N.] Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Malani, PN (corresponding author), 3119 Taubman Ctr, Ann Arbor, MI 48109 USA.	pmalani@umich.edu						Bagdasarian N, 2012, INFECT DIS CLIN N AM, V26, P127, DOI 10.1016/j.idc.2011.09.005; Collins AJ, 2013, AM J KIDNEY DIS, V61, pE1, DOI 10.1053/j.ajkd.2012.11.031; Crnich CJ, 2013, CURR GERIATR REP, V2, P125, DOI 10.1007/s13670-013-0047-4; Dantes R, 2013, JAMA INTERN MED, V173, P1970, DOI 10.1001/jamainternmed.2013.10423; Harris AD, 2013, JAMA-J AM MED ASSOC, V310, P1571, DOI 10.1001/jama.2013.277815; Hota B, 2011, CLIN INFECT DIS, V53, P757, DOI 10.1093/cid/cir472; Huang SS, 2013, NEW ENGL J MED, V368, P2255, DOI 10.1056/NEJMoa1207290; Sievert DM, 2008, CLIN INFECT DIS, V46, P668, DOI 10.1086/527392; Stryjewski ME, 2008, CLIN INFECT DIS, V46, pS368, DOI 10.1086/533593	9	26	28	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2014	311	14					1438	1439		10.1001/jama.2014.1666	http://dx.doi.org/10.1001/jama.2014.1666			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4EP	24715075				2022-12-28	WOS:000333935000020
J	van Schaik, KD				van Schaik, Katherine D.			Pimping Socrates	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ART		[van Schaik, Katherine D.] Harvard Univ, Sch Med, Boston, MA 02163 USA; [van Schaik, Katherine D.] Harvard Dept Class, Boston, MA USA	Harvard University; Harvard Medical School	van Schaik, KD (corresponding author), Harvard Univ, Sch Med, Boston, MA 02163 USA.	katherine_vanschaik@hms.harvard.edu						BRANCATI FL, 1989, JAMA-J AM MED ASSOC, V262, P89, DOI 10.1001/jama.262.1.89; Cooke M, 2006, NEW ENGL J MED, V355, P1339, DOI 10.1056/NEJMra055445; Detsky AS, 2009, JAMA-J AM MED ASSOC, V301, P1379, DOI 10.1001/jama.2009.247; Galchen R, 2013, NEW YORKER, P54; Galchen R, 2013, NEW YORKER, P57; Hartocollis Anemona, 2010, NY TIMES; Scott G, 2002, DEGRADABLE POLYMERS: PRINCIPLES AND APPLICATIONS, SECOND EDITION, P1; Scott GA, 2000, PLATOS SOCRATES ED, P46; Vlastos Gregory., 1983, OXFORD STUDIES ANCIE, V1, P27	9	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2014	311	14					1401	1402		10.1001/jama.2014.2155	http://dx.doi.org/10.1001/jama.2014.2155			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4EP	24715073				2022-12-28	WOS:000333935000014
J	Jha, S				Jha, Saurabh			Stop hunting for zebras in Texas: end the diagnostic culture of "rule-out"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Jha, S (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.	saurabh.jha@uphs.upenn.edu							0	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2014	348								g2625	10.1136/bmj.g2625	http://dx.doi.org/10.1136/bmj.g2625			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SB	24709509				2022-12-28	WOS:000334348300012
J	Bauer, S; Hoye, BJ				Bauer, S.; Hoye, B. J.			Migratory Animals Couple Biodiversity and Ecosystem Functioning Worldwide	SCIENCE			English	Review							POPULATION REGULATION; ANNUAL-CYCLE; DISPERSAL; SALMON; DYNAMICS; NETWORK; INFECTION; NUTRIENTS; COMMUNITIES; WATERBIRDS	Animal migrations span the globe, involving immense numbers of individuals from a wide range of taxa. Migrants transport nutrients, energy, and other organisms as they forage and are preyed upon throughout their journeys. These highly predictable, pulsed movements across large spatial scales render migration a potentially powerful yet underappreciated dimension of biodiversity that is intimately embedded within resident communities. We review examples from across the animal kingdom to distill fundamental processes by which migratory animals influence communities and ecosystems, demonstrating that they can uniquely alter energy flow, food-web topology and stability, trophic cascades, and the structure of metacommunities. Given the potential for migration to alter ecological networks worldwide, we suggest an integrative framework through which community dynamics and ecosystem functioning may explicitly consider animal migrations.	[Bauer, S.] Swiss Ornithol Inst, Dept Bird Migrat, CH-6204 Sempach, Switzerland; [Bauer, S.] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, NL-6700 AB Wageningen, Netherlands; [Hoye, B. J.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Hoye, B. J.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Geelong, Vic 3220, Australia	Swiss Ornithological Institute; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of Colorado System; University of Colorado Boulder; Deakin University	Bauer, S (corresponding author), Swiss Ornithol Inst, Dept Bird Migrat, CH-6204 Sempach, Switzerland.	silke.s.bauer@gmail.com	Hoye, Bethany J/A-4486-2010; Bauer, Silke/M-9811-2019; Bauer, Silke/C-3524-2008; KNAW, NIOO-KNAW/A-4320-2012	Hoye, Bethany J/0000-0001-9502-5582; Bauer, Silke/0000-0002-0844-164X; Bauer, Silke/0000-0002-0844-164X; KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Organization for Scientific Research [825.11.036]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	We are grateful to V. Grimm, C. van Leeuwen, G. Hays, and K. Medley for valuable comments and J. Armstrong, D. White Jr., J. Waldenstrom, J. Brodersen, J. Bety, and Bat Conservation International for kindly providing images. B.J.H. was supported by the Netherlands Organization for Scientific Research (825.11.036). This is publication 5591 of the NIOO-KNAW.	Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; [Anonymous], 2020, ECONOMIST 0326; Bartz KK, 2005, ECOSYSTEMS, V8, P529, DOI 10.1007/s10021-005-0064-z; Blonder B, 2012, METHODS ECOL EVOL, V3, P958, DOI 10.1111/j.2041-210X.2012.00236.x; Bowlin MS, 2010, INTEGR COMP BIOL, V50, P261, DOI 10.1093/icb/icq013; Bradley CA, 2005, ECOL LETT, V8, P290, DOI 10.1111/j.1461-0248.2005.00722.x; Brimble SK, 2009, ENVIRON TOXICOL CHEM, V28, P2426, DOI 10.1897/09-235.1; Bronmark C, 2014, CAN J ZOOL, V92, P467, DOI 10.1139/cjz-2012-0277; Buehler DM, 2008, AM NAT, V172, P783, DOI 10.1086/592865; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Caut S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039125; Chapman JW, 2011, ANNU REV ENTOMOL, V56, P337, DOI 10.1146/annurev-ento-120709-144820; Chen GJ, 2011, OIKOS, V120, P1317, DOI 10.1111/j.1600-0706.2011.19042.x; Chen GJ, 2011, FRESHWATER BIOL, V56, P292, DOI 10.1111/j.1365-2427.2010.02496.x; Clausen P, 2002, ACTA OECOL, V23, P191, DOI 10.1016/S1146-609X(02)01150-5; COX GW, 1985, AM NAT, V126, P451, DOI 10.1086/284432; Dobson A, 2009, PHILOS T R SOC B, V364, P1665, DOI 10.1098/rstb.2008.0287; FRYXELL JM, 1988, AM NAT, V131, P781, DOI 10.1086/284822; Galsworthy SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026118; Giroux MA, 2012, J ANIM ECOL, V81, P533, DOI 10.1111/j.1365-2656.2011.01944.x; Guerrero AM, 2013, CONSERV BIOL, V27, P35, DOI 10.1111/j.1523-1739.2012.01964.x; Gylfe A, 2000, NATURE, V403, P724, DOI 10.1038/35001663; Hahn S, 2008, FRESHWATER BIOL, V53, P181, DOI 10.1111/j.1365-2427.2007.01881.x; Hahn S, 2009, OIKOS, V118, P624, DOI 10.1111/j.1600-0706.2009.17309.x; Hamrick JL, 2002, COLUMNAR CACTI THEIR, P122; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; Hastings A, 2012, BIOL LETTERS, V8, P1067, DOI 10.1098/rsbl.2012.0669; Helbing D, 2013, NATURE, V497, P51, DOI 10.1038/nature12047; Holdo RM, 2007, J ECOL, V95, P115, DOI 10.1111/j.1365-2745.2006.01192.x; Holdo RM, 2011, ANIMAL MIGRATION: A SYNTHESIS, P131; Holt RD, 2008, ECOLOGY, V89, P671, DOI 10.1890/07-0348.1; Holtgrieve GW, 2011, ECOLOGY, V92, P373, DOI 10.1890/09-1694.1; Hoye B. J., 2011, THESIS UTRECHT U; Hoye BJ, 2011, OIKOS, V120, P748, DOI 10.1111/j.1600-0706.2010.18961.x; Kirby JS, 2008, BIRD CONSERV INT, V18, pS49, DOI 10.1017/S0959270908000439; Krauss S, 2010, P ROY SOC B-BIOL SCI, V277, P3373, DOI 10.1098/rspb.2010.1090; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; MacKenzie D. R., 1985, MANAGEMENT DISPERSAL, P533; Matias MG, 2013, OIKOS, V122, P395, DOI 10.1111/j.1600-0706.2012.20479.x; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McCann KS, 2005, ECOL LETT, V8, P513, DOI 10.1111/j.1461-0248.2005.00742.x; Michelutti N, 2009, P ROY SOC B-BIOL SCI, V276, P591, DOI 10.1098/rspb.2008.1103; Moore JW, 2010, P ROY SOC B-BIOL SCI, V277, P1695, DOI 10.1098/rspb.2009.2342; Moore JW, 2004, CAN J FISH AQUAT SCI, V61, P1582, DOI [10.1139/f04-103, 10.1139/F04-103]; Nabhan G.P., 2004, CONSERVING MIGRATORY; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Packer C, 2003, ECOL LETT, V6, P797, DOI 10.1046/j.1461-0248.2003.00500.x; Pocock MJO, 2012, SCIENCE, V335, P973, DOI 10.1126/science.1214915; Rooney N, 2008, ECOL LETT, V11, P867, DOI 10.1111/j.1461-0248.2008.01193.x; Rooney N, 2012, TRENDS ECOL EVOL, V27, P40, DOI 10.1016/j.tree.2011.09.001; Sanchez-Zapata JA, 2007, J APPL ECOL, V44, P323, DOI 10.1111/j.1365-2664.2007.01279.x; SINCLAIR ARE, 1985, OECOLOGIA, V65, P266, DOI 10.1007/BF00379227; Sinclair ARE, 2003, PHILOS T R SOC B, V358, P1729, DOI 10.1098/rstb.2003.1359; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330; Valiente-Banuet A, 2013, FRONT ECOL ENVIRON, V11, P408, DOI 10.1890/130002; Van Bael SA, 2008, ECOLOGY, V89, P928, DOI 10.1890/06-1976.1; van Leeuwen CHA, 2012, J BIOGEOGR, V39, P2031, DOI 10.1111/jbi.12004; van Leeuwen CHA, 2012, OECOLOGIA, V170, P101, DOI 10.1007/s00442-012-2293-0; Varpe O, 2005, OECOLOGIA, V146, P443, DOI 10.1007/s00442-005-0219-9; Viana DS, 2013, ECOGRAPHY, V36, P430, DOI 10.1111/j.1600-0587.2012.07588.x; Waldenstrom J, 2002, MOL ECOL, V11, P1545, DOI 10.1046/j.1365-294X.2002.01523.x; White D, 1998, CAN J ZOOL, V76, P221, DOI 10.1139/cjz-76-2-221; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Yang LH, 2010, ECOL LETT, V13, P1, DOI 10.1111/j.1461-0248.2009.01402.x; Zacheis A, 2001, J ECOL, V89, P57, DOI 10.1046/j.1365-2745.2001.00515.x	71	440	454	20	427	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					54	+	1242552	10.1126/science.1242552	http://dx.doi.org/10.1126/science.1242552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700862				2022-12-28	WOS:000333746100049
J	Jackson, GL; Powers, BJ; Chatterjee, R; Bettger, JP; Kemper, AR; Hasselblad, V; Dolor, RJ; Irvine, J; Heidenfelder, BL; Kendrick, AS; Gray, R; Williams, JW				Jackson, George L.; Powers, Benjamin J.; Chatterjee, Ranee; Bettger, Janet Prvu; Kemper, Alex R.; Hasselblad, Vic; Dolor, Rowena J.; Irvine, Julian; Heidenfelder, Brooke L.; Kendrick, Amy S.; Gray, Rebecca; Williams, John W., Jr.			Patient-Centered Medical Home A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							OUTPATIENT GERIATRIC EVALUATION; HEALTH-CARE NEEDS; QUALITY-OF-CARE; GUIDED CARE; YOUNG-CHILDREN; OLDER PERSONS; MANAGEMENT; MODEL; COST; OUTCOMES	Background: The patient-centered medical home (PCMH) describes mechanisms for organizing primary care to provide high-quality care across the full range of individuals' health care needs. It is being widely implemented by provider organizations and third-party payers. Purpose: To describe approaches for PCMH implementation and summarize evidence for effects on patient and staff experiences, process of care, and clinical and economic outcomes. Data Sources: PubMed (through 6 December 2011), Cumulative Index to Nursing & Allied Health Literature, and the Cochrane Database of Systematic Reviews (through 29 June 2012). Study Selection: English-language trials and longitudinal observational studies that met criteria for the PCMH, as defined by the Agency for Healthcare Research and Quality, and included populations with multiple conditions. Data Extraction: Information on study design, populations, interventions, comparators, financial models, implementation methods, outcomes, and risk of bias were abstracted by 1 investigator and verified by another. Data Synthesis: In 19 comparative studies, PCMH interventions had a small positive effect on patient experiences and small to moderate positive effects on the delivery of preventive care services (moderate strength of evidence). Staff experiences were also improved by a small to moderate degree (low strength of evidence). Evidence suggested a reduction in emergency department visits (risk ratio [RR], 0.81 [95% CI, 0.67 to 0.98]) but not in hospital admissions (RR, 0.96 [CI, 0.84 to 1.10]) in older adults (low strength of evidence). There was no evidence for overall cost savings. Limitation: Systematic review is challenging because of a lack of consistent definitions and nomenclature for PCMH. Conclusion: The PCMH holds promise for improving the experiences of patients and staff and potentially for improving care processes, but current evidence is insufficient to determine effects on clinical and most economic outcomes. Ann Intern Med. 2013;158:169-178.	Durham Vet Affairs Med Ctr, Durham, NC USA; Duke Univ, Sch Med, Durham, NC 27710 USA; Duke Univ, Sch Nursing, Durham, NC 27710 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University	Jackson, GL (corresponding author), Duke Univ, Sch Med, Div Gen Internal Med, 307 Trent Dr,DUMC 3322, Durham, NC 27710 USA.	george.l.jackson@duke.edu	Williams, John/AAM-4572-2020	Williams, John/0000-0002-5267-5558; Kendrick, Amy/0000-0001-8769-1702; Dolor, Rowena/0000-0001-7317-9468; Kemper, Alex/0000-0001-5491-3997	AHRQ, U.S. Department of Health and Human Services [290-200710066-I]	AHRQ, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project was funded under contract 290-200710066-I from AHRQ, U.S. Department of Health and Human Services, as part of the series "Closing the Quality Gap: Revisiting the State of the Science."	Agency for Healthcare Research and Quality, METH GUID EFF COMP E; [Anonymous], 2011, CLOS QUAL GAP REV ST; Berwick DM, 2011, NEW ENGL J MED, V365, P1753, DOI 10.1056/NEJMp1111671; Bitton A, 2010, J GEN INTERN MED, V25, P584, DOI 10.1007/s11606-010-1262-8; Bodenheimer T, 2006, NEW ENGL J MED, V355, P861, DOI 10.1056/NEJMp068155; Boult C, 2008, J GERONTOL A-BIOL, V63, P321, DOI 10.1093/gerona/63.3.321; Boult C, 2011, ARCH INTERN MED, V171, P460, DOI 10.1001/archinternmed.2010.540; Boyd CM, 2007, GERONTOLOGIST, V47, P697, DOI 10.1093/geront/47.5.697; Boyd CM, 2008, J GEN INTERN MED, V23, P536, DOI 10.1007/s11606-008-0529-9; Boyd CM, 2010, J GEN INTERN MED, V25, P235, DOI 10.1007/s11606-009-1192-5; Carrier E, 2009, MED CARE, V47, P714, DOI 10.1097/MLR.0b013e3181a469b0; Chandler C, 1997, AM J HEALTH-SYST PH, V54, P1280, DOI 10.1093/ajhp/54.11.1280; Chapman AL, 2010, HEALTH INFO LIBR J, V27, P22, DOI [10.1111/J.1471-1842.2009.00865.x, 10.1111/j.1471-1842.2009.00865.x]; Coleman K, 2010, ANN FAM MED, V8, P493, DOI 10.1370/afm.1190; Crabtree Benjamin F, 2010, Ann Fam Med, V8 Suppl 1, pS80, DOI 10.1370/afm.1107; DePalma JA, 2007, HOME HLTH CARE MAN P, V19, P473, DOI 10.1177/1084822307304916; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Domino ME, 2009, MED CARE, V47, P1113, DOI 10.1097/MLR.0b013e3181adcc65; Dorr David A, 2006, Dis Manag, V9, P1, DOI 10.1089/dis.2006.9.1; Dorr DA, 2008, J AM GERIATR SOC, V56, P2195, DOI 10.1111/j.1532-5415.2008.02005.x; Durlak JA, 2009, J PEDIATR PSYCHOL, V34, P917, DOI 10.1093/jpepsy/jsp004; Farmer JE, 2011, MATERN CHILD HLTH J, V15, P1110, DOI 10.1007/s10995-010-0658-8; Farmer JE, 2005, PEDIATRICS, V116, P649, DOI 10.1542/peds.2004-0647; Farris KB, 2004, CAN FAM PHYSICIAN, V50, P998; Fishman PA, 2012, GERONTOLOGIST; Gilfillan RJ, 2010, AM J MANAG CARE, V16, P607; Ginsburg PB, 2008, MAKING MED HOMES WOR; Grant RW, 2005, DIABETES CARE, V28, P337, DOI 10.2337/diacare.28.2.337; GRUMBACH K, 2009, OUTCOMES IMPLEMENTIN; Hebert R, 2003, CAN FAM PHYSICIAN, V49, P992; Homer CJ, 2008, PEDIATRICS, V122, pE922, DOI 10.1542/peds.2007-3762; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM NEW; Jackson GL, 2010, J GEN INTERN MED, V25, P38, DOI 10.1007/s11606-009-1155-x; Jaen Carlos Roberto, 2010, Ann Fam Med, V8 Suppl 1, pS57, DOI 10.1370/afm.1121; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Katerndabl DA, 2010, ANN FAM MED, V8, P341, DOI [10.1370/afm.1108, 10.1370/afm.1157]; Kilo CM, 2010, HEALTH AFFAIR, V29, P773, DOI 10.1377/hlthaff.2010.0012; Lee James G, 2011, Healthc Financ Manage, V65, P70; Lee JG, 2011, HEALTHC FINANC MANAG, V65, P78; Lee JG, 2011, HEALTHC FINANC MANAG, V65, P80; Leff B, 2009, AM J MANAG CARE, V15, P555; Maeng DD, 2012, AM J MANAG CARE, V18, P149; Marsteller JA, 2010, ANN FAM MED, V8, P308, DOI 10.1370/afm.1134; Martin AB, 2007, J HEALTH CARE POOR U, V18, P916; Martin A, 2011, HEALTH AFFAIR, V30, P11, DOI 10.1377/hlthaff.2010.1032; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Miller William L, 2010, Ann Fam Med, V8 Suppl 1, pS68, DOI 10.1370/afm.1089; Miller WL, 2010, ANN FAM MED S1, V8, pS92; Minkovitz CS, 2003, JAMA-J AM MED ASSOC, V290, P3081, DOI 10.1001/jama.290.23.3081; Minkovitz CS, 2007, PEDIATRICS, V120, pE658, DOI 10.1542/peds.2006-1205; Moreno L, 2010, AHRQ PUBLICATION, V10-0080-EF; Nolte E, 2008, HLTH AFF MILLWOOD, V27, P58; Nutting Paul A, 2010, Ann Fam Med, V8 Suppl 1, pS33, DOI 10.1370/afm.1119; Nutting Paul A, 2010, Ann Fam Med, V8 Suppl 1, pS45, DOI 10.1370/afm.1075; Nutting PA, 2009, ANN FAM MED, V7, P254, DOI 10.1370/afm.1002; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Palfrey JS, 2004, PEDIATRICS, V113, P1507; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Peleg R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-36; Rankin KM, 2009, AM J MED QUAL, V24, P302, DOI 10.1177/1062860609335759; Reid RJ, 2010, HEALTH AFFAIR, V29, P835, DOI 10.1377/hlthaff.2010.0158; Reid RJ, 2009, AM J MANAG CARE, V15, pE71; Rosenthal TC, 2008, J AM BOARD FAM MED, V21, P427, DOI 10.3122/jabfm.2008.05.070287; RUBIN CD, 1992, J AM GERIATR SOC, V40, P989, DOI 10.1111/j.1532-5415.1992.tb04474.x; Rula EY, 2011, POPULATION HLTH MANA, V14, pS; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Samuels RC, 2008, MATERN CHILD HLTH J, V12, P357, DOI 10.1007/s10995-007-0241-0; Schifalacqua M, 2000, Nurs Adm Q, V24, P12; Scholle SH, 2010, AHRQ PUBLICATION, V10-0083-EF; Schraeder C, 2005, J AMBUL CARE MANAG, V28, P201, DOI 10.1097/00004479-200507000-00003; Sia C, 2004, PEDIATRICS, V113, P1473; Solberg LI, 2011, ANN FAM MED, V9, P515, DOI 10.1370/afm.1296; Sommers BD, 2012, JAMA-J AM MED ASSOC, V307, P1697, DOI 10.1001/jama.2012.523; Sommers LS, 2000, ARCH INTERN MED, V160, P1825, DOI 10.1001/archinte.160.12.1825; Stange KC, 2010, J GEN INTERN MED, V25, P601, DOI 10.1007/s11606-010-1291-3; Steele GD, 2010, HEALTH AFFAIR, V29, P2047, DOI 10.1377/hlthaff.2010.0840; Stewart EE, 2010, ANN FAM MED, V8, pS92; Stewart Elizabeth E, 2010, Ann Fam Med, V8 Suppl 1, pS21, DOI 10.1370/afm.1111; Sylvia ML, 2008, DIS MANAGE, V11, P29, DOI 10.1089/dis.2008.111723; Taplin S, 1998, J Am Board Fam Pract, V11, P116; The Robert Graham Center, 2007, PAT CTR MED HOM HIST; Toseland RW, 1997, GERONTOLOGIST, V37, P324, DOI 10.1093/geront/37.3.324; Toseland RW, 1996, MED CARE, V34, P624, DOI 10.1097/00005650-199606000-00011; Treadwell J, 2009, PROF CASE MANAG, V14, P192, DOI 10.1097/NCM.0b013e3181b10a57; Vedel I, 2009, AGING CLIN EXP RES, V21, P414, DOI 10.1007/BF03327446; Vest JR, 2010, MED CARE RES REV, V67, P393, DOI 10.1177/1077558710367794; Wagner E H, 2001, Jt Comm J Qual Improv, V27, P63; Waxmonsky JA, 2011, J AMBUL CARE MANAG, V34, P183, DOI 10.1097/JAC.0b013e31820f64be; Williams JW, 2012, 208 AG HEALTHC RES Q; Wise Christopher G, 2006, Dis Manag, V9, P45, DOI 10.1089/dis.2006.9.45; Wolff JL, 2010, GERONTOLOGIST, V50, P459, DOI 10.1093/geront/gnp124; Wolff JL, 2009, J GERONTOL A-BIOL, V64, P785, DOI 10.1093/gerona/glp030; Zuckerman B, 2004, PEDIATRICS, V114, P820, DOI 10.1542/peds.2003-0999-L	93	472	474	4	113	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2013	158	3					169	+		10.7326/0003-4819-158-3-201302050-00579	http://dx.doi.org/10.7326/0003-4819-158-3-201302050-00579			28	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	087JP	24779044				2022-12-28	WOS:000314757900004
J	Nijs, J; Ickmans, K				Nijs, Jo; Ickmans, Kelly			Chronic whiplash-associated disorders: to exercise or not?	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; PAIN; EDUCATION; PEOPLE		[Nijs, Jo; Ickmans, Kelly] Vrije Univ Brussel, Fac Phys Educ & Physiotherapy, Dept Human Physiol, Pain Mot Res Grp, BE-1090 Brussels, Belgium; [Nijs, Jo; Ickmans, Kelly] Vrije Univ Brussel, Fac Phys Educ & Physiotherapy, Dept Physiotherapy, BE-1090 Brussels, Belgium; [Nijs, Jo] Univ Hosp Brussels, Dept Phys Med & Physiotherapy, Pain Mot Res Grp, Brussels, Belgium	Pain in Motion; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Pain in Motion; University Hospital Brussels	Nijs, J (corresponding author), Vrije Univ Brussel, Fac Phys Educ & Physiotherapy, Dept Human Physiol, Pain Mot Res Grp, BE-1090 Brussels, Belgium.	Jo.Nijs@vub.ac.be	Nijs, Jo/B-3336-2011	Nijs, Jo/0000-0002-4976-6563; Ickmans, Kelly/0000-0003-0751-6504				Brunner E, 2013, DISABIL REHABIL, V35, P1, DOI 10.3109/09638288.2012.683848; Daenen L, 2013, J REHABIL MED, V45, P113, DOI 10.2340/16501977-1091; Dunne RL, 2012, CLIN J PAIN, V28, P755, DOI 10.1097/AJP.0b013e318243e16b; Gaab J, 2005, PAIN, V119, P219, DOI 10.1016/j.pain.2005.10.001; Hodges PW, 2011, PAIN S3, V152, P18; Huijnen IPJ, 2011, EUR J PAIN, V15, P748, DOI 10.1016/j.ejpain.2010.11.015; Lamb SE, 2013, LANCET, V381, P546, DOI 10.1016/S0140-6736(12)61304-X; Meeus M, 2012, PAIN PHYSICIAN, V15, P351; Michaleff ZA, 2014, LANCET; Tucker K, 2012, PAIN, V153, P636, DOI 10.1016/j.pain.2011.11.024; Van Oosterwijck J, 2013, EUR J PAIN, V17, P299, DOI 10.1002/j.1532-2149.2012.00193.x; Van Oosterwijck J, 2012, J PAIN, V13, P242, DOI 10.1016/j.jpain.2011.11.006; Van Oosterwijck J, 2011, J REHABIL RES DEV, V48, P43, DOI 10.1682/JRRD.2009.12.0206	13	12	12	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					109	111		10.1016/S0140-6736(14)60130-6	http://dx.doi.org/10.1016/S0140-6736(14)60130-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL1YC	24703833				2022-12-28	WOS:000338921500010
J	Noubade, R; Wong, K; Ota, N; Rutz, S; Eidenschenk, C; Valdez, PA; Ding, JB; Peng, I; Sebrell, A; Caplazi, P; DeVoss, J; Soriano, RH; Sai, T; Lu, RZ; Modrusan, Z; Hackney, J; Ouyang, WJ				Noubade, Rajkumar; Wong, Kit; Ota, Naruhisa; Rutz, Sascha; Eidenschenk, Celine; Valdez, Patricia A.; Ding, Jiabing; Peng, Ivan; Sebrell, Andrew; Caplazi, Patrick; DeVoss, Jason; Soriano, Robert H.; Sai, Tao; Lu, Rongze; Modrusan, Zora; Hackney, Jason; Ouyang, Wenjun			NRROS negatively regulates reactive oxygen species during host defence and autoimmunity	NATURE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; NEUTROPHIL NADPH OXIDASE; PLASMA-MEMBRANE; LYSOSOMAL MEMBRANE; MACROPHAGES; ENCEPHALOMYELITIS; PHOSPHORYLATION; ACTIVATION; EXPRESSION; APOPTOSIS	Reactive oxygen species (ROS) produced by phagocytes are essential for host defence against bacterial and fungal infections. Individuals with defective ROS production machinery develop chronic granulomatous disease(1,2). Conversely, excessive ROS can cause collateral tissue damage during inflammatory processes and therefore needs to be tightly regulated. Here we describe a protein, we termed negative regulator of ROS (NRROS), which limits ROS generation by phagocytes during inflammatory responses. NRROS expression in phagocytes can be repressed by inflammatory signals. NRROS-deficient phagocytes produce increased ROS upon inflammatory challenges, and mice lacking NRROS in their phagocytes show enhanced bactericidal activity against Escherichia coli and Listeria monocytogenes. Conversely, these mice develop severe experimental autoimmune encephalomyelitis owing to oxidative tissue damage in the central nervous system. Mechanistically, NRROS is localized to the endoplasmic reticulum, where it directly interactswith nascent NOX2 (also known as gp91(phox) and encoded by Cybb) monomer, one of the membrane-bound subunits of the NADPH oxidase complex, and facilitates the degradation of NOX2 through the endoplasmic-reticulum-associated degradation pathway. Thus, NRROS provides a hitherto undefined mechanism for regulating ROS prodution-one that enables phagocytes to produce higher amounts of ROS, if required to control invading pathogens, while minimizing unwanted collateral tissue damage.	[Noubade, Rajkumar; Wong, Kit; Ota, Naruhisa; Rutz, Sascha; Eidenschenk, Celine; Valdez, Patricia A.; Ding, Jiabing; Peng, Ivan; DeVoss, Jason; Lu, Rongze; Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Sebrell, Andrew; Sai, Tao] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Caplazi, Patrick] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Soriano, Robert H.; Modrusan, Zora] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Hackney, Jason] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Ouyang, WJ (corresponding author), Genentech Inc, Dept Immunol, 1 DNA Way, San Francisco, CA 94080 USA.	ouyang.wenjun@gene.com	Ouyang, Wenjun/ABA-8763-2020; Lu, Rongze/R-2149-2016	Ouyang, Wenjun/0000-0002-1811-5864; Caplazi, Patrick/0000-0002-3411-1257; Hackney, Jason/0000-0002-5922-563X				Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Barabutis N, 2008, P NATL ACAD SCI USA, V105, P20470, DOI 10.1073/pnas.0811209106; Barry KC, 2013, J IMMUNOL, V190, P6329, DOI 10.4049/jimmunol.1300100; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Casbon AJ, 2009, J IMMUNOL, V182, P2325, DOI 10.4049/jimmunol.0803476; Chen F, 2012, ARTERIOSCL THROM VAS, V32, P2989, DOI 10.1161/ATVBAHA.112.300361; Chen F, 2011, ANTIOXID REDOX SIGN, V14, P2107, DOI 10.1089/ars.2010.3669; CZUPRYNSKI CJ, 1985, IMMUNOLOGY, V55, P511; DeLeo FR, 2000, J BIOL CHEM, V275, P13986, DOI 10.1074/jbc.275.18.13986; Di AK, 2012, NAT IMMUNOL, V13, P29, DOI 10.1038/ni.2171; Dinauer MC, 1997, J IMMUNOL, V158, P5581; El-Benna J, 2008, SEMIN IMMUNOPATHOL, V30, P279, DOI 10.1007/s00281-008-0118-3; GREEN SA, 1987, J CELL BIOL, V105, P1227, DOI 10.1083/jcb.105.3.1227; Honda F, 2012, NAT IMMUNOL, V13, P369, DOI 10.1038/ni.2234; Hu Y, 2010, J IMMUNOL, V184, P4307, DOI 10.4049/jimmunol.0903614; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; LEWIS V, 1985, J CELL BIOL, V100, P1839, DOI 10.1083/jcb.100.6.1839; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; Mantei A, 2008, EUR J IMMUNOL, V38, P2616, DOI 10.1002/eji.200738075; MCPHAIL LC, 1984, J BIOL CHEM, V259, P5768; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; PARKOS CA, 1989, BLOOD, V73, P1416; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Tse HM, 2010, J IMMUNOL, V185, P5247, DOI 10.4049/jimmunol.1001472; Wallberg M, 2007, EUR J IMMUNOL, V37, P1986, DOI 10.1002/eji.200636912; Wang GX, 2012, J IMMUNOL, V188, P5829, DOI 10.4049/jimmunol.1102620; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973	38	148	155	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					235	+		10.1038/nature13152	http://dx.doi.org/10.1038/nature13152			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24739962				2022-12-28	WOS:000335454300041
J	White, NJ				White, Nicholas J.			Malaria: a molecular marker of artemisinin resistance	LANCET			English	Editorial Material							PLASMODIUM-FALCIPARUM MALARIA; CAMBODIA; CLEARANCE		Mahidol Univ, Fac Trop Med, Bangkok 10400, Thailand	Mahidol University	White, NJ (corresponding author), Mahidol Univ, Fac Trop Med, Bangkok 10400, Thailand.	nickw@tropmedres.ac	White, Nick/AAC-6527-2019	White, Nick/0000-0002-1897-1978	Wellcome Trust [093956] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 2014, STAT REP ART RES; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Carrara VI, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001398; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339; Kyaw MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057689; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4	12	17	20	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2014	383	9927					1439	1440		10.1016/S0140-6736(14)60656-5	http://dx.doi.org/10.1016/S0140-6736(14)60656-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG3NI	24766952				2022-12-28	WOS:000335325800004
J	Afdhal, N; Reddy, KR; Nelson, DR; Lawitz, E; Gordon, SC; Schiff, E; Nahass, R; Ghalib, R; Gitlin, N; Herring, R; Lalezari, J; Younes, ZH; Pockros, PJ; Di Bisceglie, AM; Arora, S; Subramanian, GM; Zhu, YN; Dvory-Sobol, H; Yang, JC; Pang, PS; Symonds, WT; McHutchison, JG; Muir, AJ; Sulkowski, M; Kwo, P				Afdhal, Nezam; Reddy, K. Rajender; Nelson, David R.; Lawitz, Eric; Gordon, Stuart C.; Schiff, Eugene; Nahass, Ronald; Ghalib, Reem; Gitlin, Norman; Herring, Robert; Lalezari, Jacob; Younes, Ziad H.; Pockros, Paul J.; Di Bisceglie, Adrian M.; Arora, Sanjeev; Subramanian, G. Mani; Zhu, Yanni; Dvory-Sobol, Hadas; Yang, Jenny C.; Pang, Phillip S.; Symonds, William T.; McHutchison, John G.; Muir, Andrew J.; Sulkowski, Mark; Kwo, Paul		ION-2 Investigators	Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C VIRUS-INFECTION; HEPATITIS-C; TREATMENT-NAIVE; NS5A INHIBITOR; RIBAVIRIN; PLUS	Background: Effective treatment for hepatitis C virus (HCV) genotype 1 infection in patients who have not had a sustained virologic response to prior interferon-based therapy represents an unmet medical need. Methods: We conducted a phase 3, randomized, open-label study involving patients infected with HCV genotype 1 who had not had a sustained virologic response after treatment with peginterferon and ribavirin, with or without a protease inhibitor. Patients were randomly assigned to receive the NS5A inhibitor ledipasvir and the nucleotide polymerase inhibitor sofosbuvir in a once-daily, fixed-dose combination tablet for 12 weeks, ledipasvir-sofosbuvir plus ribavirin for 12 weeks, ledipasvir-sofosbuvir for 24 weeks, or ledipasvir-sofosbuvir plus ribavirin for 24 weeks. The primary end point was a sustained virologic response at 12 weeks after the end of therapy. Results: Among the 440 patients who underwent randomization and were treated, 20% had cirrhosis and 79% had HCV genotype 1a infection. The rates of sustained virologic response were high in all treatment groups: 94% (95% confidence interval [CI], 87 to 97) in the group that received 12 weeks of ledipasvir-sofosbuvir; 96% (95% CI, 91 to 99) in the group that received 12 weeks of ledipasvir-sofosbuvir and ribavirin; 99% (95% CI, 95 to 100) in the group that received 24 weeks of ledipasvir-sofosbuvir; and 99% (95% CI, 95 to 100) in the group that received 24 weeks of ledipasvir-sofosbuvir and ribavirin. No patient discontinued treatment owing to an adverse event. The most common adverse events were fatigue, headache, and nausea. Conclusions: Treatment with a once-daily, single-tablet regimen of ledipasvir and sofosbuvir resulted in high rates of sustained virologic response among patients with HCV genotype 1 infection who had not had a sustained virologic response to prior interferon-based treatment. (Funded by Gilead Sciences; ION-2 ClinicalTrials.gov number, NCT01768286.)	[Afdhal, Nezam] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Reddy, K. Rajender] Univ Penn, Philadelphia, PA 19104 USA; [Nelson, David R.] Univ Florida, Gainesville, FL USA; [Lawitz, Eric] Univ Texas Hlth Sci Ctr San Antonio, Texas Liver Inst, San Antonio, TX 78229 USA; [Ghalib, Reem] North Texas Res Inst, Arlington, TX USA; [Gordon, Stuart C.] Henry Ford Hlth Syst, Detroit, MI USA; [Schiff, Eugene] Univ Miami, Sch Med, Ctr Liver Dis, Miami, FL USA; [Nahass, Ronald] ID Care, Hillsborough, NJ USA; [Gitlin, Norman] Atlanta Gastroenterol Associates, Atlanta, GA USA; [Herring, Robert] Qual Med Res, Nashville, TN USA; [Younes, Ziad H.] Gastro One, Germantown, TN USA; [Lalezari, Jacob] Quest Clin Res, San Francisco, CA USA; [Pockros, Paul J.] Scripps Clin, La Jolla, CA 92037 USA; [Subramanian, G. Mani; Zhu, Yanni; Dvory-Sobol, Hadas; Yang, Jenny C.; Pang, Phillip S.; Symonds, William T.; McHutchison, John G.] Gilead Sci, Foster City, CA USA; [Di Bisceglie, Adrian M.] St Louis Univ, St Louis, MO 63103 USA; [Arora, Sanjeev] Univ New Mexico, Albuquerque, NM 87131 USA; [Muir, Andrew J.] Duke Univ, Med Ctr, Durham, NC USA; [Sulkowski, Mark] Johns Hopkins Med Ctr, Baltimore, MD USA; [Kwo, Paul] Indiana Univ, Sch Med, Indianapolis, IN USA	Harvard University; Beth Israel Deaconess Medical Center; University of Pennsylvania; State University System of Florida; University of Florida; University of Texas System; University of Texas Health San Antonio; Henry Ford Health System; Henry Ford Hospital; University of Miami; Scripps Research Institute; Gilead Sciences; Saint Louis University; University of New Mexico; Duke University; Johns Hopkins University; Johns Hopkins Medicine; Indiana University System; Indiana University-Purdue University Indianapolis	Afdhal, N (corresponding author), Beth Israel Deaconess Med Ctr, 110 Francis St,Suite 4, Boston, MA 02215 USA.	nafdhal@bidmc.harvard.edu	Vargas, Hugo E./K-1562-2019	Vargas, Hugo E./0000-0002-7802-688X; Afdhal, Nezam/0000-0002-7342-6593	Gilead Sciences; Medgenics; Boehringer Ingelheim; Merck; Abbott Laboratories; Vertex Pharmaceuticals; Bristol-Myers Squibb; AbbVie; Janssen Pharmaceuticals; Genentech-Roche; Idenix Pharmaceuticals; Genfit; Ikaria; Hyperion Therapeutics; Clinical Care Options; Projects in Knowledge; Practice Point Communications; Genentech; Kadmon Pharmaceuticals; Achillion Pharmaceuticals; Novartis; BioCryst Pharmaceuticals; Biotica; Enanta Pharmaceuticals; Santaris Pharma; Theravance; GlaxoSmithKline; Intercept Pharmaceuticals; Medtronic; Presidio Therapeutics; Roche; Janssen-Cilag; Amgen; CVS Caremark; Pharmasset; Idera Pharmaceuticals; Salix Pharmaceuticals; Takeda Pharmaceuticals; ViroChem Pharma; Inhibitex; ZymoGenetics; Biolex Therapeutics; Anadys Pharmaceuticals; Beckman Coulter; Profectus BioSciences; Scy-nexis	Gilead Sciences(Gilead Sciences); Medgenics; Boehringer Ingelheim(Boehringer Ingelheim); Merck(Merck & Company); Abbott Laboratories(Abbott Laboratories); Vertex Pharmaceuticals(Vertex Pharmaceuticals); Bristol-Myers Squibb(Bristol-Myers Squibb); AbbVie(AbbVie); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Genentech-Roche(Roche HoldingGenentech); Idenix Pharmaceuticals; Genfit; Ikaria; Hyperion Therapeutics; Clinical Care Options; Projects in Knowledge; Practice Point Communications; Genentech(Roche HoldingGenentech); Kadmon Pharmaceuticals; Achillion Pharmaceuticals; Novartis(Novartis); BioCryst Pharmaceuticals; Biotica; Enanta Pharmaceuticals; Santaris Pharma; Theravance; GlaxoSmithKline(GlaxoSmithKline); Intercept Pharmaceuticals; Medtronic(Medtronic); Presidio Therapeutics; Roche(Roche Holding); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Amgen(Amgen); CVS Caremark; Pharmasset; Idera Pharmaceuticals; Salix Pharmaceuticals; Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); ViroChem Pharma(Dexcel Pharma); Inhibitex; ZymoGenetics; Biolex Therapeutics; Anadys Pharmaceuticals; Beckman Coulter; Profectus BioSciences; Scy-nexis	Supported by Gilead Sciences. Dr. Afdhal reports receiving fees for serving on advisory boards from Gilead Sciences, Medgenics, and Boehringer Ingelheim; fees for serving on a data and safety monitoring board from Gilead Sciences, Idenix Pharmaceuticals, and Novartis; consulting fees from Merck, Janssen Pharmaceuticals, Vertex Pharmaceuticals, Bristol-Myers Squibb, and Spring Bank Pharmaceuticals; and grant support from Gilead Sciences, Merck, Abbott Laboratories, Vertex Pharmaceuticals, and Bristol-Myers Squibb; and holding stock options in Spring Bank Pharmaceuticals and Medgenics. Dr. Reddy reports receiving fees for serving on advisory boards from Gilead Sciences, Bristol-Myers Squibb, AbbVie, Vertex Pharmaceuticals, Janssen Pharmaceuticals, Merck, Genentech-Roche, and Idenix Pharmaceuticals; fees for serving on a data and safety monitoring board from Novartis; fees for the preparation of educational material and participation in continuing medical education (CME) courses from ViralEd; and grant support from Gilead Sciences, Bristol-Myers Squibb, AbbVie, Vertex Pharmaceuticals, Janssen Pharmaceuticals, Merck, Genentech-Roche, Genfit, Ikaria, and Hyperion Therapeutics. Dr. Nelson reports receiving fees for participating in CME activities from Clinical Care Options, Projects in Knowledge, and Practice Point Communications; and grant support from Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, Idenix Pharmaceuticals, Kadmon Pharmaceuticals, Merck, and Vertex Pharmaceuticals. Dr. Lawitz reports receiving consulting fees from AbbVie, Achillion Pharmaceuticals, Idenix Pharmaceuticals, Janssen Pharmaceuticals, Novartis, Merck, Vertex Pharmaceuticals, BioCryst Pharmaceuticals, Biotica, Enanta Pharmaceuticals, Santaris Pharma, and Theravance; lecture fees from Gilead Sciences, Merck, Vertex Pharmaceuticals, and Kadmon Pharmaceuticals; and grant support from Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Intercept Pharmaceuticals, Medtronic, Presidio Therapeutics, Roche, AbbVie, Achillion Pharmaceuticals, Gilead Sciences, Idenix Pharmaceuticals, Janssen Pharmaceuticals, Novartis, Merck, Santaris Pharma, and Vertex Pharmaceuticals. Dr. Gordon reports receiving fees for serving on a data monitoring board from Janssen-Cilag; consulting fees from AbbVie, Bristol-Myers Squibb, Merck, Vertex Pharmaceuticals, Amgen, CVS Caremark, and Novartis; and grant support from AbbVie, Bristol-Myers Squibb, Merck, Vertex Pharmaceuticals, GlaxoSmithKline, Intercept Pharmaceuticals, and Kadmon Pharmaceuticals. Dr. Schiff reports receiving fees for serving on an advisory board from Gilead Sciences. Dr. Nahass reports receiving fees for serving on advisory boards from Merck, Janssen Pharmaceuticals, Bristol-Myers Squibb, and AbbVie; lecture fees from Merck; and grant support from Merck, Boehringer Ingelheim, Bristol-Myers Squibb, and AbbVie. Dr. Ghalib reports receiving grant support from Gilead Sciences, Pharmasset, Bristol-Myers Squibb, Idenix Pharmaceuticals, Idera Pharmaceuticals, Merck, Novartis, Boehringer Ingelheim, Salix Pharmaceuticals, Takeda Pharmaceuticals, Janssen Pharmaceuticals, Vertex Pharmaceuticals, ViroChem Pharma, Achillion Pharmaceuticals, Inhibitex, ZymoGenetics, Biolex Therapeutics, and Anadys Pharmaceuticals. Dr. Gitlin reports receiving lecture fees and grant support from Gilead Sciences. Dr.; Younes reports receiving lecture fees from Vertex Pharmaceuticals and grant support from AbbVie, Bristol-Myers Squibb, Idenix Pharmaceuticals, Gilead Sciences, Janssen Pharmaceuticals, Merck, and Vertex Pharmaceuticals. Dr. Pockros reports receiving consulting, lecture, and advisory-board fees from Gilead Sciences and grant support from Gilead Sciences, Bristol-Myers Squibb, Janssen Pharmaceuticals, Boehringer Ingelheim, AbbVie, and Novartis. Dr. Di Bisceglie reports receiving personal fees from Genentech, Gilead Sciences, Vertex Pharmaceuticals, AbbVie, Bayer, Salix Pharmaceuticals, and Janssen Pharmaceuticals; and grant -support from Genentech, Gilead Sciences, Idenix Pharmaceuticals, Vertex Pharmaceuticals, Bristol-Myers Squibb, AbbVie, GlobeImmune, Transgene, Salix Pharmaceuticals, and Janssen Pharmaceuticals. Dr. Arora reports receiving grant support from Genentech, Gilead Sciences, Beckman Coulter, and AbbVie. Dr. Muir reports receiving fees for serving on advisory boards from AbbVie, Gilead Sciences, Merck, and Vertex Pharmaceuticals; consulting fees from AbbVie, Achillion Pharmaceuticals, -Bristol-Myers Squibb, Gilead Sciences, Profectus BioSciences, and Scy-nexis; and grant support from GlaxoSmithKline, -GlobeImmune, Medtronic, Pfizer, Roche, Salix Pharmaceuticals, AbbVie, Achillion Pharmaceuticals, Bristol-Myers Squibb, Gilead Sciences, and Merck. Dr. Sulkowski reports receiving consulting fees from AbbVie, Boehringer Ingelheim, BristolMyers Squibb, Janssen Pharmaceuticals, Merck, and Idenix Pharmaceuticals; and grant support from AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, Janssen Pharmaceuticals, Merck, and Vertex Pharmaceuticals. Dr. Kwo reports receiving fees for serving on advisory boards from AbbVie, Bristol-Myers Squibb, Merck, Vertex Pharmaceuticals, Janssen Pharmaceuticals, Boehringer Ingelheim, GlaxoSmithKline, and Novartis; lecture fees from Merck and Vertex Pharmaceuticals; and grant support from AbbVie, Bristol-Myers Squibb, Merck, Janssen Pharmaceuticals, Conatus Pharmaceuticals, and Roche. Dr. Subramanian, Dr. Zhu, Dr. Dvory-Sobol, Dr. Yang, Dr. Pang, Dr. Symonds, and Dr. McHutchison report being employees of and holding stock in Gilead Sciences. Dr. McHutchison reports holding a patent related to an IL28B diagnostic test, which is licensed to Merck. No other potential conflict of interest relevant to this article was reported.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; American Association for the Study of Liver Diseases and Infectious Diseases Society of America, REC TEST MAN TREAT H; [Anonymous], 2003, REB RIB CAPS US PRES; [Anonymous], 2013, OL SIM CAPS US PRESC; Au JS, 2014, CLIN PHARMACOL THER, V95, P78, DOI 10.1038/clpt.2013.206; Gane EJ, 2014, GASTROENTEROLOGY, V146, P736, DOI 10.1053/j.gastro.2013.11.007; Jacobson IM, 2013, HEPATOLOGY, V58, p1379A; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Lawitz EJ, 2012, J HEPATOL, V57, P24, DOI 10.1016/j.jhep.2011.12.029; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Mayne Pharma, 2021, NEXTST EST DROSP TAB; Petta S, 2013, LIVER INT, V33, P23, DOI 10.1111/liv.12053; Sharma NK, 2009, CLIN GASTROENT-SER, P33, DOI 10.1007/978-1-59745-565-7_2; Sheridan C, 2014, NAT BIOTECHNOL, V32, P3, DOI 10.1038/nbt0114-3	15	1081	1117	0	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 17	2014	370	16					1483	1493		10.1056/NEJMoa1316366	http://dx.doi.org/10.1056/NEJMoa1316366			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF3HE	24725238	Bronze			2022-12-28	WOS:000334601600005
J	Costa, LM; Marshall, E; Tesfaye, M; Silverstein, KAT; Mori, M; Umetsu, Y; Otterbach, SL; Papareddy, R; Dickinson, HG; Boutiller, K; VandenBosch, KA; Ohki, S; Gutierrez-Marcos, JF				Costa, Liliana M.; Marshall, Eleanor; Tesfaye, Mesfin; Silverstein, Kevin A. T.; Mori, Masashi; Umetsu, Yoshitaka; Otterbach, Sophie L.; Papareddy, Ranjith; Dickinson, Hugh G.; Boutiller, Kim; VandenBosch, Kathryn A.; Ohki, Shinya; Gutierrez-Marcos, Jose F.			Central Cell-Derived Peptides Regulate Early Embryo Patterning in Flowering Plants	SCIENCE			English	Article							APICAL-BASAL AXIS; DOUBLE FERTILIZATION; STOMATAL DENSITY; GENE-EXPRESSION; ARABIDOPSIS; EMBRYOGENESIS; ENDOSPERM; COMMUNICATION; INFECTION; ORIGIN	Plant embryogenesis initiates with the establishment of an apical-basal axis; however, the molecular mechanisms accompanying this early event remain unclear. Here, we show that a small cysteine-rich peptide family is required for formation of the zygotic basal cell lineage and proembryo patterning in Arabidopsis. EMBRYO SURROUNDING FACTOR 1 (ESF1) peptides accumulate before fertilization in central cell gametes and thereafter in embryo-surrounding endosperm cells. Biochemical and structural analyses revealed cleavage of ESF1 propeptides to form biologically active mature peptides. Further, these peptides act in a non-cell-autonomous manner and synergistically with the receptor-like kinase SHORT SUSPENSOR to promote suspensor elongation through the YODA mitogen-activated protein kinase pathway. Our findings demonstrate that the second female gamete and its sexually derived endosperm regulate early embryonic patterning in flowering plants.	[Costa, Liliana M.; Dickinson, Hugh G.] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [Marshall, Eleanor; Otterbach, Sophie L.; Papareddy, Ranjith; Gutierrez-Marcos, Jose F.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Tesfaye, Mesfin; Silverstein, Kevin A. T.; VandenBosch, Kathryn A.] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; [Mori, Masashi] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Lab Plant Gene Technol, Nonoichi, Ishikawa 9218836, Japan; [Umetsu, Yoshitaka; Ohki, Shinya] Japan Adv Inst Sci & Technol JAIST, Ctr Nano Mat & Technol CNMT, Nomi, Ishikawa 9231292, Japan; [Boutiller, Kim] Plant Res Int, NL-6700 AP Wageningen, Netherlands	University of Oxford; University of Warwick; University of Minnesota System; University of Minnesota Twin Cities; Ishikawa Prefecture University; Japan Advanced Institute of Science & Technology (JAIST)	Gutierrez-Marcos, JF (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	j.f.gutierrez-marcos@warwick.ac.uk	Papareddy, Ranjith Kumar/ABB-6920-2021; Otterbach, Sophie/C-8513-2015; Otterbach, Sophie Lisa/CAI-5079-2022; Gutierrez-Marcos, Jose/AAE-2229-2020	Otterbach, Sophie/0000-0001-7636-2698; Gutierrez-Marcos, Jose/0000-0002-5441-9080	Royal Society; ESF/RTD Framework COST action [FA0903]; Biotechnology and Biological Sciences Research Council [BB/F008082, BB/L003023/1, BB/L003023]; NSF [IOB-0516811]; Nanotechnology Platform Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; BBSRC [BB/L003023/1] Funding Source: UKRI	Royal Society(Royal Society of London); ESF/RTD Framework COST action; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NSF(National Science Foundation (NSF)); Nanotechnology Platform Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank H. Prescott, A. Sarmiento, D. Garcia, and E. Caamano for technical assistance. We also thank T. Laux, W. Lukowitz, I. Moore, B. Scheres, A. Schnittger, M. Bayer, and D. Weijers for seed stocks and valuable suggestions. We acknowledge funding from the Royal Society, ESF/RTD Framework COST action (FA0903), and Biotechnology and Biological Sciences Research Council grants (BB/F008082, BB/L003023/1 and BB/L003023). The work at the University of Minnesota was supported by NSF award IOB-0516811. NMR experiments were partly supported by Nanotechnology Platform Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. K. S. and M. T. acknowledge the Minnesota Supercomputing Institute for computational resources and systems support used in microarray analysis. M. T. and K. S. performed microarray experiments and data analysis. E. M validated the array data, generated most transgenic lines, and conducted genetic analyses. L. M. C designed and performed genetic experiments, generated the LhG4 transactivation lines, and performed immunodetection. S.L.O. and R. P. performed the ovule culture experiments. K. B. identified the suspensor-specific At2g30560 gene and generated pGRP-GUS:GFP lines. M. M. expressed ESF1 peptides. M. M., Y.U. and S.O. purified synthetic wild-type and mutant ESF1 peptides and performed solution NMR structural analysis. J.G-M., K. V., S.O., and M. M. conceived and supervised the study. J.G-M. and L. M. C. wrote the paper with input from S.O. All authors have reviewed and approved the paper, and the authors disclose no conflicts of interest.	Aw SJ, 2010, DEVELOPMENT, V137, P2683, DOI 10.1242/dev.052928; Bayer M, 2009, SCIENCE, V323, P1485, DOI 10.1126/science.1167784; Beets I, 2012, SCIENCE, V338, P543, DOI 10.1126/science.1226860; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Breuninger H, 2008, DEV CELL, V14, P867, DOI 10.1016/j.devcel.2008.03.008; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Costa LM, 2012, CURR BIOL, V22, P160, DOI 10.1016/j.cub.2011.11.059; Dodeman VL, 1997, J EXP BOT, V48, P1493, DOI 10.1093/jexbot/48.313.1493; FRIEDMAN WE, 1994, AM J BOT, V81, P1468, DOI 10.2307/2445320; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Garelli A, 2012, SCIENCE, V336, P579, DOI 10.1126/science.1216735; Gutierrez-Marcos JF, 2004, PLANT CELL, V16, P1288, DOI 10.1105/tpc.019778; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Katsir L, 2011, CURR BIOL, V21, pR356, DOI 10.1016/j.cub.2011.03.012; Kawashima T, 2010, TRENDS PLANT SCI, V15, P23, DOI 10.1016/j.tplants.2009.11.002; Kiyohara S, 2012, PLANT CELL PHYSIOL, V53, P1989, DOI 10.1093/pcp/pcs136; Lau S, 2012, ANNU REV PLANT BIOL, V63, P483, DOI 10.1146/annurev-arplant-042811-105507; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; Marshall E, 2011, J EXP BOT, V62, P1677, DOI 10.1093/jxb/err002; Moore I, 2006, PLANT J, V45, P651, DOI 10.1111/j.1365-313X.2006.02660.x; Nodine MD, 2012, NATURE, V482, P94, DOI 10.1038/nature10756; Nowack MK, 2006, NAT GENET, V38, P63, DOI 10.1038/ng1694; Ohki S, 2008, J BIOMOL NMR, V42, P271, DOI 10.1007/s10858-008-9283-x; Ohki S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1520; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Petricka JJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000497; Rademacher EH, 2012, DEV CELL, V22, P211, DOI 10.1016/j.devcel.2011.10.026; Ron M, 2010, GENE DEV, V24, P1010, DOI 10.1101/gad.1882810; Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200; Sprunck S, 2012, SCIENCE, V338, P1093, DOI 10.1126/science.1223944; Sugano SS, 2010, NATURE, V463, P241, DOI 10.1038/nature08682; Tesfaye M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058992; TRIVERS RL, 1974, AM ZOOL, V14, P249; Weijers D, 2003, PLANT PHYSIOL, V133, P1882, DOI 10.1104/pp.103.030692; YEUNG EC, 1993, PLANT CELL, V5, P1371, DOI 10.1105/tpc.5.10.1371; Zhang ZJ, 2011, SEX PLANT REPROD, V24, P161, DOI 10.1007/s00497-010-0160-x	36	115	137	0	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					168	172		10.1126/science.1243005	http://dx.doi.org/10.1126/science.1243005			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24723605				2022-12-28	WOS:000334096300027
J	Huang, XY; Rosenthal, MB				Huang, Xiaoyan; Rosenthal, Meredith B.			Transforming Specialty Practice - The Patient-Centered Medical Neighborhood	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PRIMARY-CARE; HOME; PHYSICIANS; MARRIAGE	Many patient-centered medical home (PCMH) initiatives wrestle with building effective partnerships with specialty practices that aren't designed to support collaboration. One solution is the specialty analogue to the PCMH: the patient-centered specialty practice. The patient-centered medical home (PCMH) is a well accepted primary care delivery vehicle in the United States.(1) The National Committee for Quality Assurance (NCQA) has recognized nearly 27,000 clinicians at more than 5000 sites throughout the country in its PCMH program. State and private payers have their own certification criteria. As PCMH efforts have spread and met with mixed success, some observers have noted that refurbishing primary care is probably necessary but not sufficient for addressing the fragmentation of care and underlying cost growth. Primary care services themselves account for only 6% of total health care spending. Moreover, attempts to ...	[Huang, Xiaoyan] Providence Heart Clin, Portland, OR 97220 USA; [Rosenthal, Meredith B.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Huang, XY (corresponding author), Providence Heart Clin, Portland, OR 97220 USA.			Rosenthal, Meredith/0000-0003-3410-0184				[Anonymous], 2013, PEDIATRICS, V132, P703; Fisher ES, 2008, NEW ENGL J MED, V359, P1202, DOI 10.1056/NEJMp0806233; Gonzales G, 2014, AM J PUBLIC HEALTH, V104, pE95, DOI 10.2105/AJPH.2013.301577; Grumbach K, 2013, JAMA INTERN MED, V173, P1913, DOI 10.1001/jamainternmed.2013.7652; Hatzenbuehler ML, 2012, AM J PUBLIC HEALTH, V102, P285, DOI 10.2105/AJPH.2011.300382; Hatzenbuehler ML, 2010, AM J PUBLIC HEALTH, V100, P452, DOI 10.2105/AJPH.2009.168815; Jackson GL, 2013, ANN INTERN MED, V158, P169, DOI 10.7326/0003-4819-158-3-201302050-00579; O'Malley AS, 2011, ARCH INTERN MED, V171, P56, DOI 10.1001/archinternmed.2010.480; Pham HH, 2009, ANN INTERN MED, V150, P236, DOI 10.7326/0003-4819-150-4-200902170-00004; Wight RG, 2013, AM J PUBLIC HEALTH, V103, P339, DOI 10.2105/AJPH.2012.301113	10	41	41	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 10	2014	370	15					1376	1379		10.1056/NEJMp1315416	http://dx.doi.org/10.1056/NEJMp1315416			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE6IW	24716678				2022-12-28	WOS:000334095200004
J	Tsang, JS; Schwartzberg, PL; Kotliarov, Y; Biancotto, A; Xie, Z; Germain, RN; Wang, E; Olnes, MJ; Narayanan, M; Golding, H; Moir, S; Dickler, HB; Perl, S; Cheung, F				Tsang, John S.; Schwartzberg, Pamela L.; Kotliarov, Yuri; Biancotto, Angelique; Xie, Zhi; Germain, Ronald N.; Wang, Ena; Olnes, Matthew J.; Narayanan, Manikandan; Golding, Hana; Moir, Susan; Dickler, Howard B.; Perl, Shira; Cheung, Foo		Baylor HIPC Ctr; CHI Consortium	Global Analyses of Human Immune Variation Reveal Baseline Predictors of Postvaccination Responses	CELL			English	Article							PLASMA-CELL DIFFERENTIATION; UNFOLDED PROTEIN RESPONSE; H1N1 INFLUENZA VACCINE; YELLOW-FEVER VACCINE; SYSTEMS BIOLOGY; GENE-EXPRESSION; B-CELLS; SEASONAL INFLUENZA; ANTIBODY; IMMUNIZATION	A major goal of systems biology is the development of models that accurately predict responses to perturbation. Constructing such models requires the collection of dense measurements of system states, yet transformation of data into predictive constructs remains a challenge. To begin to model human immunity, we analyzed immune parameters in depth both at baseline and in response to influenza vaccination. Peripheral blood mononuclear cell transcriptomes, serum titers, cell subpopulation frequencies, and B cell responses were assessed in 63 individuals before and after vaccination and were used to develop a systematic framework to dissect inter- and intra-individual variation and build predictive models of postvaccination antibody responses. Strikingly, independent of age and pre-existing antibody titers, accurate models could be constructed using pre-perturbation cell populations alone, which were validated using independent baseline time points. Most of the parameters contributing to prediction delineated temporally stable baseline differences across individuals, raising the prospect of immune monitoring before intervention.	[Tsang, John S.; Schwartzberg, Pamela L.; Kotliarov, Yuri; Biancotto, Angelique; Xie, Zhi; Germain, Ronald N.; Wang, Ena; Olnes, Matthew J.; Dickler, Howard B.; Perl, Shira; Cheung, Foo] NIH, Trans NIH Ctr Human Immunol Autoimmun & Inflammat, Bethesda, MD 20892 USA; [Tsang, John S.; Narayanan, Manikandan] NIAID, Lab Syst Biol, Syst Genom & Bioinformat Unit, NIH, Bethesda, MD 20892 USA; [Schwartzberg, Pamela L.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Wang, Ena] NIH, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; [Olnes, Matthew J.] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; [Golding, Hana] US FDA, Lab Retrovirus Res, Bethesda, MD 20892 USA; [Moir, Susan] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Tsang, JS (corresponding author), NIH, Trans NIH Ctr Human Immunol Autoimmun & Inflammat, Bethesda, MD 20892 USA.	john.tsang@nih.gov; pams@nhgri.nih.gov	Trinchieri, Giorgio/F-9369-2015; Pós, Zoltán/C-3623-2014; Moir, Susan/AAC-3676-2020; Kotliarov, Yuri/B-6938-2017; Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020; biancotto, angelique/C-4632-2011	Trinchieri, Giorgio/0000-0001-5892-7464; Pós, Zoltán/0000-0002-2574-7616; biancotto, angelique/0000-0003-2271-009X; Narayanan, Manikandan/0000-0002-8490-4087; Xie, Zhi/0000-0002-5589-4836; Kotliarov, Yuri/0000-0002-6558-8883	NIAID; NCI; NHLBI; NIAMS; NICHD; NIDDK; NINDS; NIEHS; NEI; NHGRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123, ZIAHG200391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000974, U19AI089987, ZIAAI000825] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Connors, K. Subbarao, R. Seder, M. Roederer, D. Douek, J. Bennink, I. Fraser, J. Mandl, members of the Systems Genomics and Bioinformatics Unit (NIAID), and M. Eichelberger (FDA) for helpful advice and feedback; the staff of the NIH Clinical Center for outstanding clinical support; and NIAID's high-performance computing team for outstanding support. This work is funded by the Intramural Programs of NIAID, NCI, NHLBI, NIAMS, NICHD, NIDDK, NINDS, NIEHS, NEI, and NHGRI.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biancotto A, 2011, J IMMUNOL METHODS, V363, P245, DOI 10.1016/j.jim.2010.06.010; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; Clutterbuck EA, 2006, IMMUNOLOGY, V119, P328, DOI 10.1111/j.1365-2567.2006.02436.x; COX RJ, 1994, VACCINE, V12, P993, DOI 10.1016/0264-410X(94)90334-4; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Fiore Anthony E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Fonteneau JF, 2003, BLOOD, V101, P3520, DOI 10.1182/blood-2002-10-3063; Frasca D, 2012, INT IMMUNOL, V24, P175, DOI 10.1093/intimm/dxr123; Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15; Gass JN, 2004, TRENDS IMMUNOL, V25, P17, DOI 10.1016/j.it.2003.11.004; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Germain RN, 2011, NAT IMMUNOL, V12, P369, DOI 10.1038/ni0511-369; Gerriets VA, 2012, TRENDS IMMUNOL, V33, P168, DOI 10.1016/j.it.2012.01.010; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Henn AD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02327; Ho J, 2011, AIDS, V25, P295, DOI 10.1097/QAD.0b013e328342328b; Iwakoshi NN, 2003, IMMUNOL REV, V194, P29, DOI 10.1034/j.1600-065X.2003.00057.x; Kaminski DA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00302; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nauta J., 2011, STAT CLIN VACCINE TR; Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Shi YH, 2003, CLIN IMMUNOL, V108, P128, DOI 10.1016/S1521-6616(03)00092-5; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; TULP A, 1986, EMBO J, V5, P1783, DOI 10.1002/j.1460-2075.1986.tb04427.x; van Duin D, 2007, J INFECT DIS, V195, P1590, DOI 10.1086/516788; Withers DR, 2007, BLOOD, V109, P4856, DOI 10.1182/blood-2006-08-043414	41	278	279	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					499	513		10.1016/j.cell.2014.03.031	http://dx.doi.org/10.1016/j.cell.2014.03.031			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725414	Green Accepted, Bronze			2022-12-28	WOS:000334304500021
